PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	ARVANITIDIS, A; HEINISCH, JJ				ARVANITIDIS, A; HEINISCH, JJ			STUDIES ON THE FUNCTION OF YEAST PHOSPOFRUCTOKINASE SUBUNITS BY IN-VITRO MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI PHOSPHOFRUCTOKINASE; SACCHAROMYCES-CEREVISIAE; ACTIVE-SITE; SOLUBLE PHOSPHOFRUCTOKINASE; FRUCTOSE 2,6-BISPHOSPHATE; SHUTTLE VECTORS; MUTANTS; GLYCOLYSIS; EXPRESSION; MUTATIONS	Genetic and biochemical analysis of phosphofructokinase in the yeast Saccharomyces cerevisiae led to contradictory hypotheses about the function of the subunits of this heterooctameric enzyme. To gain further insight, we exchanged four evolutionary conserved amino acid residues in each of the two yeast subunits affecting presumed catalytic and regulatory functions. In conjunction with a complementary wild-type subunit, each of the mutant subunits led to a loss of a maximum of 50% of phosphofructokinase activity as compared to wild-type cells. K-m values for fructose 6-phosphate were increased in most of these mutants. None of the mutant subunits lacking catalytical functions was able to complement the glucose-negative phenotype of a yeast pfk1 pfk2 double mutant when expressed from a single-copy vector. For the beta-subunits, the other mutants did complement, whereas for the alpha-subunits they did not. Concentrations of fructose 1,6-bisphosphate did not drastically change in metabolite determinations in strains carrying one mutant allele, suggesting that the effect of the mutations introduced can be largely compensated by in vivo regulatory mechanisms, as long as one functional subunit is present. The data implicate that each of the yeast phosphofructokinase subunits can serve catalytically as well as regulatory functions.	UNIV DUSSELDORF,INST MIKROBIOL,D-40225 DUSSELDORF,GERMANY	Heinrich Heine University Dusseldorf			Heinisch, Juergen J./G-3801-2017					AVIGAD G, 1981, BIOCHEM BIOPH RES CO, V102, P985, DOI 10.1016/0006-291X(81)91635-1; BANUELOS M, 1977, J BIOL CHEM, V252, P6394; BERGER SA, 1992, BIOCHEMISTRY-US, V31, P9237, DOI 10.1021/bi00153a017; BERGMEYER HU, 1970, VERLAG CHEM WEINHEIM, P100; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; BREITENBACHSCHMITT I, 1984, MOL GEN GENET, V195, P530, DOI 10.1007/BF00341458; CIRIACY M, 1979, J BACTERIOL, V139, P152, DOI 10.1128/JB.139.1.152-160.1979; CLIFTON D, 1982, BIOCHEMISTRY-US, V21, P1935, DOI 10.1021/bi00537a037; CLIFTON D, 1978, GENETICS, V88, P1; DAVIES SEC, 1992, BIOCHEMISTRY-US, V31, P4729, DOI 10.1021/bi00134a028; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; EVANS PR, 1979, NATURE, V279, P500, DOI 10.1038/279500a0; GAYATRI AG, 1991, EUR J BIOCHEM, V200, P149, DOI 10.1111/j.1432-1033.1991.tb21061.x; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HEINISCH J, 1993, MOL MICROBIOL, V8, P559, DOI 10.1111/j.1365-2958.1993.tb01600.x; HEINISCH J, 1991, FEBS LETT, V289, P77, DOI 10.1016/0014-5793(91)80912-M; HEINISCH J, 1989, GENE, V78, P309; HEINISCH J, 1986, MOL GEN GENET, V202, P75, DOI 10.1007/BF00330520; HEINISCH J, 1986, CURR GENET, V11, P227, DOI 10.1007/BF00420611; HEINISCH JJ, 1993, YEAST, V9, P1103, DOI 10.1002/yea.320091010; HEINISCH JJ, 1993, FEBS LETT, V328, P35, DOI 10.1016/0014-5793(93)80960-3; HELLINGA HW, 1987, NATURE, V327, P437, DOI 10.1038/327437a0; HELLINGA HW, 1985, EUR J BIOCHEM, V149, P363, DOI 10.1111/j.1432-1033.1985.tb08934.x; HERS HG, 1982, BIOCHEM J, V206, P1; HESS B, 1971, ANNU REV BIOCHEM, V40, P237, DOI 10.1146/annurev.bi.40.070171.001321; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; KLEBE RJ, 1983, GENE, V25, P333, DOI 10.1016/0378-1119(83)90238-X; KOPPERSCHLAGER G, 1977, EUR J BIOCHEM, V81, P317, DOI 10.1111/j.1432-1033.1977.tb11954.x; KOPPERSCHLAGER G, 1982, ANAL BIOCHEM, V124, P117, DOI 10.1016/0003-2697(82)90228-7; LAINE R, 1992, EUR J BIOCHEM, V207, P1109, DOI 10.1111/j.1432-1033.1992.tb17148.x; LOBO Z, 1983, J BIOL CHEM, V258, P1444; NADKARNI M, 1984, FEBS LETT, V175, P294, DOI 10.1016/0014-5793(84)80754-1; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIRMER T, 1990, NATURE, V343, P140, DOI 10.1038/343140a0; SHIRAKIHARA Y, 1988, J MOL BIOL, V204, P973, DOI 10.1016/0022-2836(88)90056-3; STANSSENS P, 1989, NUCLEIC ACIDS RES, V17, P4441, DOI 10.1093/nar/17.12.4441; TIJANE MN, 1980, J BIOL CHEM, V255, P188; Uyeda K, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P193; ZACHARIAE W, 1993, NUCLEIC ACIDS RES, V21, P69, DOI 10.1093/nar/21.1.69; Zamenhoff S., 1957, METHOD ENZYMOL, V3, P702; ZIMMERMANN FK, 1977, MOL GEN GENET, V154, P75, DOI 10.1007/BF00265579	46	81	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8911	8918						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132627				2022-12-27	WOS:A1994NB41100045
J	MIQUEROL, L; LOPEZ, S; CARTIER, N; TULLIEZ, M; RAYMONDJEAN, M; KAHN, A				MIQUEROL, L; LOPEZ, S; CARTIER, N; TULLIEZ, M; RAYMONDJEAN, M; KAHN, A			EXPRESSION OF THE L-TYPE PYRUVATE-KINASE GENE AND THE HEPATOCYTE NUCLEAR FACTOR-4 TRANSCRIPTION FACTOR IN EXOCRINE AND ENDOCRINE PANCREAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE RECEPTOR SUPERFAMILY; POLYMERASE CHAIN-REACTION; TRANSGENIC MICE; FACTOR-IV; LIVER; RAT; CELLS; PROMOTER; INSULIN; BINDING	The L-pyruvate kinase (L-PK) gene is slightly active in normal and tumoral endocrine pancreatic tissues while, in vivo, this gene is not transcribed in the exocrine pancreas. Nevertheless, the L-PK gene is re-expressed at a very low level in cultured 266.6 cells derived from an exocrine pancreas carcinoma. The L-PK gene is early activated in endodermal tissues, e.g. yolk sac and primitive intestine; it remains transcribed in fetal pancreas. In adult, L-PK gene expression is restricted to some endocrine cells. Hepatocyte nuclear factor (HNF) 1 and HNF4 are the main tissue restricted transcription factors involved in tissue specific expression of the L-PK gene. HNF1 concentration is similar in liver and all pan creatic cells. HNF4 concentration is high in liver, much lower in islets of Langerhans, endocrine pancreatic tumors, and cultured insulinoma cells, and is scarcely detectable in adult exocrine pancreas. This distribution of HNF4 parallels the expression of the L-PK gene. In vivo footprinting experiments show that the HNF1 binding site is similarly occupied in both adult liver and adult pancreas, in which this gene is practically inactive. In this latter tissue, however, the HNF4 binding site is differently occupied with respect to the liver. Since the chromatin structure remains open around the L-PK promoter in pancreas, the L-PK gene can probably be reexpressed under certain circumstances, for instance in cancerous pancreatic cells.	HOP ST VINCENT DE PAUL, INSERM, U342, F-75014 PARIS, FRANCE; HOP COCHIN, ANAT PATHOL LAB, F-75014 PARIS, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	MIQUEROL, L (corresponding author), CHU COCHIN, INST COCHIN GENET MOLEC, INSERM, U129, UNITE RECH GENET & PATHOL MOLEC, F-75014 PARIS, FRANCE.		cartier, nathalie/C-3103-2012	cartier, nathalie/0000-0003-2298-5261				AKLI S, 1991, GENOMICS, V11, P124, DOI 10.1016/0888-7543(91)90109-R; ALPERT S, 1988, CELL, V53, P295, DOI 10.1016/0092-8674(88)90391-1; BERGOT MO, 1992, NUCLEIC ACIDS RES, V20, P1871, DOI 10.1093/nar/20.8.1871; BLUMENFELD M, 1991, DEVELOPMENT, V113, P589; CARTIER N, 1992, ONCOGENE, V7, P1413; CEREGHINI S, 1988, GENE DEV, V2, P957, DOI 10.1101/gad.2.8.957; CHELLY J, 1990, EUR J BIOCHEM, V187, P691, DOI 10.1111/j.1432-1033.1990.tb15355.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COGNET M, 1987, J MOL BIOL, V196, P11, DOI 10.1016/0022-2836(87)90507-9; COGNET M, 1991, J BIOL CHEM, V266, P7368; COSTA RH, 1990, P NATL ACAD SCI USA, V87, P6589, DOI 10.1073/pnas.87.17.6589; CUIF MH, 1993, J BIOL CHEM, V268, P13769; CUIF MH, 1992, MOL CELL BIOL, V12, P4852, DOI 10.1128/MCB.12.11.4852; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOMINGO M, 1992, J HISTOCHEM CYTOCHEM, V40, P665, DOI 10.1177/40.5.1374093; EMENS LA, 1992, P NATL ACAD SCI USA, V89, P7300, DOI 10.1073/pnas.89.16.7300; GAZDAR AF, 1980, P NATL ACAD SCI-BIOL, V77, P3519, DOI 10.1073/pnas.77.6.3519; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; GUERRA MJMD, 1993, MOL CELL BIOL, V13, P7725, DOI 10.1128/MCB.13.12.7725; HATA S, 1992, BIOCHIM BIOPHYS ACTA, V1131, P211, DOI 10.1016/0167-4781(92)90080-J; IMMURA K, 1982, METHOD ENZYMOL, V90, P150; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KAHN A, 1982, METHOD ENZYMOL, V90, P131; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; LEDOUARIN NM, 1988, CELL, V53, P169, DOI 10.1016/0092-8674(88)90375-3; LIU ZR, 1993, J BIOL CHEM, V268, P12787; MEDLOCK ES, 1983, ANAT REC, V207, P31, DOI 10.1002/ar.1092070105; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; MIYAJIMA N, 1988, NUCLEIC ACIDS RES, V16, P11057, DOI 10.1093/nar/16.23.11057; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; NOGUCHI T, 1987, J BIOL CHEM, V262, P14366; NOGUCHI T, 1991, BIOCHEM BIOPH RES CO, V181, P259, DOI 10.1016/S0006-291X(05)81411-1; ORNITZ DM, 1987, SCIENCE, V238, P188, DOI 10.1126/science.2821617; PEARSE AGE, 1966, NATURE, V211, P598, DOI 10.1038/211598a0; PICTET RL, 1972, DEV BIOL, V29, P436, DOI 10.1016/0012-1606(72)90083-8; RAMJI DP, 1991, NUCLEIC ACIDS RES, V19, P1139, DOI 10.1093/nar/19.5.1139; RAYMONDJEAN M, 1988, P NATL ACAD SCI USA, V85, P757, DOI 10.1073/pnas.85.3.757; SCHOWALTER DB, 1989, ANAL BIOCHEM, V177, P90, DOI 10.1016/0003-2697(89)90019-5; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; THOMPSON KS, 1991, J BIOL CHEM, V266, P8679; TIAN JM, 1991, GENE DEV, V5, P2225, DOI 10.1101/gad.5.12a.2225; TREMP GL, 1989, J BIOL CHEM, V264, P19904; VAULONT S, 1989, J MOL BIOL, V209, P205, DOI 10.1016/0022-2836(89)90273-8; VAULONT S, 1986, J BIOL CHEM, V261, P7621; VAULONT S, 1989, MOL CELL BIOL, V9, P4409, DOI 10.1128/MCB.9.10.4409; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0	48	118	123	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8944	8951						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132632				2022-12-27	WOS:A1994NB41100050
J	DELGADO, A; RAMOS, JL				DELGADO, A; RAMOS, JL			GENETIC-EVIDENCE FOR ACTIVATION OF THE POSITIVE TRANSCRIPTIONAL REGULATOR XYLR, A MEMBER OF THE NTRC FAMILY OF REGULATORS, BY EFFECTOR-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS TOL PLASMID; INTEGRATION HOST FACTOR; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; INITIATION SITE; UPPER PATHWAY; PROTEIN; OPERON	The XylR protein positively controls expression from the Pseudomonas putida TOL plasmid sigma(54)-dependent Pu and Ps promoters, in response to the presence of aromatic effecters such as m-xylene, m-methylbenzyl alcohol, and p-chlorobenzaldehyde in the culture medium. XylR also autoregulates its own synthesis. A mutant XylR regulator called XylR7 was isolated after nitrosoguanidine mutagenesis of the wild-type gene and phenotypic selection for mutants that had acquired the ability to recognize m-nitrotoluene, a nitroarene that is not an effector for the wild-type regulator. The mutant regulator exhibited a single point mutation that resulted in a change in codon 172 (GAA --> AAA), which should result in a Glu --> Lys change in the polypeptide chain, The effector profile of the mutant regulator was determined by measuring beta-galactosidase from a fusion of the Pu promoter to a promoterless lacZ gene. The results showed that the mutant regulator had acquired the ability to recognize m-nitrotoluene, and retained the wild type regulator's ability to recognize most of the wild type effecters. Full transcriptional activation of the Pu promoter by XylR7, as with the wild-type XylR protein, requires its full modular structure, namely the sigma 54 recognition site, the integration host factor binding site, and the upstream activation sequences. The XylR7 regulator did not stimulate transcription from the Ps promoter in response to the presence of its effecters, and autoregulated its own synthesis at low levels.	CONSEJO SUPER INVEST CIENT,ESTAC EXPTL ZAIDIN,DEPT PLANT BIOCHEM,E-18008 GRANADA,SPAIN	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)			Delgado, Asunción/HGU-5527-2022	Ramos, Juan L./0000-0002-8731-7435				ABRIL MA, 1993, MOL GEN GENET, V239, P281, DOI 10.1007/BF00281629; ABRIL MA, 1991, J BIOL CHEM, V266, P15832; ABRIL MA, 1989, J BACTERIOL, V171, P6782, DOI 10.1128/jb.171.12.6782-6790.1989; BUCK M, 1987, MOL MICROBIOL, V1, P243, DOI 10.1111/j.1365-2958.1987.tb00518.x; DAYHOFF MO, 1978, ATLAS PROTEIN SEQUEN, V5, P1; DELORENZO V, 1991, EMBO J, V10, P1159, DOI 10.1002/j.1460-2075.1991.tb08056.x; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIXON R, 1986, MOL GEN GENET, V203, P129, DOI 10.1007/BF00330393; DRUMMOND M, 1986, EMBO J, V5, P441, DOI 10.1002/j.1460-2075.1986.tb04230.x; EGAN SM, 1990, J BACTERIOL, V172, P5020, DOI 10.1128/jb.172.9.5020-5029.1990; FRANKLIN FCH, 1983, J BACTERIOL, V154, P676, DOI 10.1128/JB.154.2.676-685.1983; FROST S, 1989, P NATL ACAD SCI USA, V86, P6052; GROSS R, 1989, MOL MICROBIOL, V3, P1661, DOI 10.1111/j.1365-2958.1989.tb00152.x; HARAYAMA S, 1989, GENETICS BACTERIAL D, P154; HOLTEL A, 1992, NUCLEIC ACIDS RES, V20, P1755, DOI 10.1093/nar/20.7.1755; INOUYE S, 1985, J BACTERIOL, V163, P863, DOI 10.1128/JB.163.3.863-869.1985; INOUYE S, 1981, J BACTERIOL, V148, P413, DOI 10.1128/JB.148.2.413-418.1981; INOUYE S, 1990, J MOL BIOL, V216, P251, DOI 10.1016/S0022-2836(05)80317-1; INOUYE S, 1987, P NATL ACAD SCI USA, V84, P5182, DOI 10.1073/pnas.84.15.5182; INOUYE S, 1983, J BACTERIOL, V155, P1192, DOI 10.1128/JB.155.3.1192-1199.1983; INOUYE S, 1988, GENE, V66, P301; INOUYE S, 1984, P NATL ACAD SCI-BIOL, V81, P1688, DOI 10.1073/pnas.81.6.1688; ISHIMOTO KS, 1992, J BACTERIOL, V174, P3514, DOI 10.1128/JB.174.11.3514-3521.1992; JOERGER RD, 1989, J BACTERIOL, V171, P3258, DOI 10.1128/jb.171.6.3258-3267.1989; KEENER J, 1988, P NATL ACAD SCI USA, V85, P4976, DOI 10.1073/pnas.85.14.4976; KUSTU S, 1989, MICROBIOL REV, V53, P367, DOI 10.1128/MMBR.53.3.367-376.1989; MARQUES S, 1994, IN PRESS BIOCH BIOPH; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NINFA AJ, 1986, P NATL ACAD SCI USA, V83, P5909, DOI 10.1073/pnas.83.16.5909; NORTH AK, 1993, J BACTERIOL, V175, P4267, DOI 10.1128/JB.175.14.4267-4273.1993; PITTARD AJ, 1991, MOL MICROBIOL, V5, P1585, DOI 10.1111/j.1365-2958.1991.tb01904.x; RAMAKRISHNAN G, 1990, P NATL ACAD SCI USA, V87, P2369, DOI 10.1073/pnas.87.6.2369; RAMOS JL, 1986, P NATL ACAD SCI USA, V83, P8467, DOI 10.1073/pnas.83.22.8467; RAMOS JL, 1987, MOL MICROBIOL, V1, P293, DOI 10.1111/j.1365-2958.1987.tb01935.x; RONSON CW, 1987, NUCLEIC ACIDS RES, V15, P7921, DOI 10.1093/nar/15.19.7921; SHINGLER V, 1993, J BACTERIOL, V175, P1596, DOI 10.1128/JB.175.6.1596-1604.1993; WEISS V, 1988, P NATL ACAD SCI USA, V85, P8919, DOI 10.1073/pnas.85.23.8919; WORSEY MJ, 1975, J BACTERIOL, V124, P7, DOI 10.1128/JB.124.1.7-13.1975; WOZNIAK DJ, 1991, J BACTERIOL, V173, P1406, DOI 10.1128/jb.173.4.1406-1413.1991; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	40	64	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8059	8062						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132529				2022-12-27	WOS:A1994NB40900037
J	EPSTEIN, J; CAI, JX; GLASER, T; JEPEAL, L; MAAS, R				EPSTEIN, J; CAI, JX; GLASER, T; JEPEAL, L; MAAS, R			IDENTIFICATION OF A PAX PAIRED DOMAIN RECOGNITION SEQUENCE AND EVIDENCE FOR DNA-DEPENDENT CONFORMATIONAL-CHANGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; SEGMENTATION GENE; BINDING DOMAIN; PROTEIN; DROSOPHILA; BOX; MUTATION; HOMEODOMAIN; ENCODES; DIMER	Pax genes encode a family of developmentally regulated transcription factors that have been implicated in a number of human and murine congenital disorders, as well as in tumorigenesis (Gruss, P., and Walther, C. (1992) Cell 69, 719-722; Hill, R., and van Heyningen, V. (1992) Trends Genet. 8, 119-120; Chalepakis, G., Tremblay, P., and Gruss, P. (1992) J. Cell Sci. Suppl. 16, 61-67; Maulbecker, C. C., and Gruss, P. (1993) EMBO J. 12, 2361-2367; Walther, C., Guenet, J. L., Simon, D., Deutsch, U., Jostes, B., Goulding, M. D., Plachov, D., Balling, Il., and Gruss, P. (1991) Genomics 11, 424-434; Barr, R. G., Galili, N., Holick, J., Biegel, J. A., Rovera, G., and Emanuel, B. S. (1993) Nature Genet. 3, 113-117). These genes are defined by the presence of an evolutionarily conserved DNA binding domain, termed the paired domain. The structure and the DNA binding characteristics of the paired domain remain largely unknown. We have utilized repetitive rounds of a polymerase chain reaction-based selection method to identify the optimal DNA binding sequences for the Pax-2 and Pax-6 paired domains. The results suggest that the paired domain family of peptides bind similar DNA sequences. Identification of this binding site has revealed an important structural clue regarding the mechanism of paired domain binding to DNA. CD and NMR structural analyses of the purified Pax-6 paired domain reveal it to be largely structureless in solution. Upon binding the recognition sequence, the complex becomes markedly less soluble and displays CD spectroscopic evidence of significant alpha-helical structure.	HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED,DIV GENET, BOSTON, MA 02115 USA; HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED,DIV CARDIOL, BOSTON, MA 02115 USA; HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, HOWARD HUGHES MED INST, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute					NEI NIH HHS [1RO1EY1012301] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010123] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; AFFOLTER M, 1990, P NATL ACAD SCI USA, V87, P4093, DOI 10.1073/pnas.87.11.4093; AUSBEL FM, 1989, CURRENT PROTOCOLS MO; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BALLING R, 1988, CELL, V55, P531, DOI 10.1016/0092-8674(88)90039-6; BARBERIS A, 1989, GENE DEV, V3, P663, DOI 10.1101/gad.3.5.663; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; CHALEPAKIS G, 1992, J CELL SCI, P61; CORNISHBOWDEN A, 1985, EUR J BIOCHEM, V150, P1; FICKENSCHER HR, 1993, DNA CELL BIOL, V12, P381, DOI 10.1089/dna.1993.12.381; FISHER DE, 1993, CELL, V72, P467, DOI 10.1016/0092-8674(93)90122-7; FRASCH M, 1987, GENE DEV, V1, P981, DOI 10.1101/gad.1.9.981; FRIED MG, 1989, ELECTROPHORESIS, V10, P366, DOI 10.1002/elps.1150100515; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GRAY DM, 1992, METHOD ENZYMOL, V211, P389; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; HILL R, 1992, TRENDS GENET, V8, P119, DOI 10.1016/0168-9525(92)90359-C; HOEY T, 1988, NATURE, V332, P858, DOI 10.1038/332858a0; HOPE IA, 1987, EMBO J, V6, P2781, DOI 10.1002/j.1460-2075.1987.tb02573.x; HOTH CF, 1993, AM J HUM GENET, V52, P455; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; Maxam A M, 1980, Methods Enzymol, V65, P499; MORRISSEY D, 1991, GENE DEV, V5, P1684, DOI 10.1101/gad.5.9.1684; ONEIL KT, 1990, SCIENCE, V249, P774, DOI 10.1126/science.2389143; PATEL L, 1990, NATURE, V347, P572, DOI 10.1038/347572a0; PERBAL B, 1988, PRACTICAL GUIDE MOL, P723; PILZ AJ, 1993, MAMM GENOME, V4, P78, DOI 10.1007/BF00290430; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STAPLETON P, 1993, NAT GENET, V3, P292, DOI 10.1038/ng0493-292; TALANIAN RV, 1990, SCIENCE, V249, P769, DOI 10.1126/science.2389142; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; VOGAN KJ, 1993, GENOMICS, V17, P364, DOI 10.1006/geno.1993.1333; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230	39	314	316	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8355	8361						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132558				2022-12-27	WOS:A1994NB40900079
J	AHN, BY; GERSHON, PD; MOSS, B				AHN, BY; GERSHON, PD; MOSS, B			RNA POLYMERASE-ASSOCIATED PROTEIN RAP94 CONFERS PROMOTER SPECIFICITY FOR INITIATING TRANSCRIPTION OF VACCINIA VIRUS EARLY-STAGE GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPERATURE-SENSITIVE MUTANTS; FACTOR-IIF; 2ND-LARGEST SUBUNIT; INTERMEDIATE GENE; TERNARY COMPLEXES; DNA; EXPRESSION; GENOME; IDENTIFICATION; COMPONENT	The association of a 94,000-Da viral polypeptide, called Rap94, with 30-40% of the multisubunit DNA-dependent RNA polymerase molecules purified from infectious vaccinia virus particles was established by immunoaffinity chromatography. The submolar amount of Rap94, relative to RNA polymerase, was confirmed by quantitative immunoblotting of total virion extracts. Only the RNA polymerase molecules containing Rap94 could functionally interact with VETF, the vaccinia virus early transcription factor, to transcribe a double-stranded DNA template regulated by a viral early stage promoter. Rap94 was required for the synthesis of short oligoribonucleotides and for the formation of stable ter nary transcription complexes. With a nonspecific single stranded DNA template, however, the Rap94-deficient polymerase had greater catalytic activity than the Rap94-containing polymerase. These data support a model in which Rap94 confers specificity to the RNA polymerase for promoters of early stage genes.	NIAID,VIRAL DIS LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)				Moss, Bernard/0000-0002-2154-8564				AHN BY, 1992, P NATL ACAD SCI USA, V89, P3536, DOI 10.1073/pnas.89.8.3536; AHN BY, 1990, MOL CELL BIOL, V10, P5433, DOI 10.1128/MCB.10.10.5433; AMEGADZIE BY, 1991, VIROLOGY, V180, P88, DOI 10.1016/0042-6822(91)90012-Z; AMEGADZIE BY, 1992, J VIROL, V66, P3003, DOI 10.1128/JVI.66.5.3003-3010.1992; BAROUDY BM, 1980, J BIOL CHEM, V255, P4372; BENGAL E, 1991, MOL CELL BIOL, V11, P1195, DOI 10.1128/MCB.11.3.1195; BROYLES SS, 1987, MOL CELL BIOL, V7, P7, DOI 10.1128/MCB.7.1.7; BROYLES SS, 1988, J BIOL CHEM, V263, P10761; BROYLES SS, 1991, J BIOL CHEM, V266, P15539; BROYLES SS, 1990, J VIROL, V64, P1523, DOI 10.1128/JVI.64.4.1523-1529.1990; BROYLES SS, 1986, P NATL ACAD SCI USA, V83, P3141, DOI 10.1073/pnas.83.10.3141; BURGESS RR, 1976, RNA POLYM; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Chamberlin M.J., 1976, RNA POLYMERASE, P159; CONAWAY JW, 1990, SCIENCE, V248, P1550, DOI 10.1126/science.2193400; CONDIT RC, 1983, VIROLOGY, V128, P429, DOI 10.1016/0042-6822(83)90268-4; FLORES O, 1988, J BIOL CHEM, V263, P10812; FLORES O, 1991, P NATL ACAD SCI USA, V88, P9999, DOI 10.1073/pnas.88.22.9999; GERSHON PD, 1990, P NATL ACAD SCI USA, V87, P4401, DOI 10.1073/pnas.87.11.4401; GONG DW, 1992, NUCLEIC ACIDS RES, V20, P6414, DOI 10.1093/nar/20.23.6414; HAGLER J, 1992, J VIROL, V66, P2982, DOI 10.1128/JVI.66.5.2982-2989.1992; HAGLER J, 1992, J BIOL CHEM, V267, P7644; HARRIS N, 1993, P NATL ACAD SCI USA, V90, P2860, DOI 10.1073/pnas.90.7.2860; JONES EV, 1987, J VIROL, V61, P1765, DOI 10.1128/JVI.61.6.1765-1771.1987; KANE EM, 1992, J VIROL, V66, P5752, DOI 10.1128/JVI.66.10.5752-5762.1992; KECK JG, 1990, CELL, V61, P801, DOI 10.1016/0092-8674(90)90190-P; KILLEEN MT, 1992, MOL CELL BIOL, V12, P30, DOI 10.1128/MCB.12.1.30; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; LI J, 1993, J BIOL CHEM, V268, P2773; LUSE DS, 1987, J BIOL CHEM, V262, P14990; MCCRACKEN S, 1991, SCIENCE, V253, P290; MOSS B, 1991, J BIOL CHEM, V266, P1355; MOSS B, 1990, ANNU REV BIOCHEM, V59, P661, DOI 10.1146/annurev.biochem.59.1.661; PATEL DD, 1989, J VIROL, V63, P1076, DOI 10.1128/JVI.63.3.1076-1086.1989; ROSEL JL, 1986, J VIROL, V60, P436, DOI 10.1128/JVI.60.2.436-449.1986; STUNNENBERG HG, 1989, MOL BIOL RNA, P199; THOMPSON CL, 1986, VIROLOGY, V150, P10, DOI 10.1016/0042-6822(86)90261-8; TRAVERS AA, 1969, NATURE, V222, P537, DOI 10.1038/222537a0; VENKATESAN S, 1981, J VIROL, V37, P738, DOI 10.1128/JVI.37.2.738-747.1981; VOS JC, 1991, CELL, V65, P105, DOI 10.1016/0092-8674(91)90412-R; VOS JC, 1991, EMBO J, V10, P2553, DOI 10.1002/j.1460-2075.1991.tb07795.x; WRIGHT CF, 1989, J VIROL, V63, P4224, DOI 10.1128/JVI.63.10.4224-4233.1989; WRIGHT CF, 1991, J VIROL, V65, P3715, DOI 10.1128/JVI.65.7.3715-3720.1991; YUEN L, 1986, J VIROL, V60, P320, DOI 10.1128/JVI.60.1.320-323.1986; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6069, DOI 10.1073/pnas.84.17.6069; ZHANG Y, 1994, IN PRESS J VIROL, V68; ZHANG YF, 1992, J VIROL, V66, P6470, DOI 10.1128/JVI.66.11.6470-6479.1992	48	50	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7552	7557						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125977				2022-12-27	WOS:A1994NA03200082
J	LI, CJ; WANG, CL; PARDEE, AB				LI, CJ; WANG, CL; PARDEE, AB			CAMPTOTHECIN INHIBITS TAT-MEDIATED TRANSACTIVATION OF TYPE-I HUMAN-IMMUNODEFICIENCY-VIRUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							THYMIDINE KINASE PROMOTER; TRANS-ACTIVATOR GENE; KAPPA-B; T-CELLS; REPLICATION; TRANSCRIPTION; BINDING; EXPRESSION; RNA; INDUCTION	Transcription of type I human immunodeficiency virus (HIV-I) is governed by the viral long terminal repeat (LTR). By using HTV-1 LTR-directed reporter gene systems, we found that the DNA topoisomerase I inhibitor camptothecin inhibits Tat-mediated transactivation of HIV-1 LTR. The 293.27.2 cells that carry a stably transfected HIV-1 LTR-directed lacZ gene expression vector (pNAZ) were used. Inhibitions of LTR were observed at camptothecin concentrations (IC50 about 0.03 mu m, which was an order of magnitude lower than for Ro 24-7429), which had minor effects on cell survival, expression of the cellular gene gro, or Rous sarcoma virus-directed chloramphenicol acetyltransferase (CAT) gene expression. Inhibition was also seen with RPMI 8402, which is a human CD4-positive lymphocyte line transiently transfected with a HIV-1 LTR-directed (CAT) gene. Experiments with HIV-1 LTR mutants suggest that transactivation response sequence but not NF-kappa B is responsible for the inhibition by camptothecin. The target for camptothecin may be a cellular factor that is important for the activation of HIV-1 LTR by Tat and thus may offer a potential target for therapy of HIV-1 infection.			LI, CJ (corresponding author), HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DEPT BIOL CHEM & MOLEC PHARMACOL, BOSTON, MA 02115 USA.				NATIONAL CANCER INSTITUTE [R01CA050608] Funding Source: NIH RePORTER; NCI NIH HHS [CA 50608] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANISOWICZ A, 1991, J IMMUNOL, V147, P520; BISWAS DK, 1993, P NATL ACAD SCI USA, V90, P11044, DOI 10.1073/pnas.90.23.11044; BISWAS DK, 1993, J ACQ IMMUN DEF SYND, V6, P778; BRILL SJ, 1987, NATURE, V326, P414, DOI 10.1038/326414a0; CULLEN BR, 1991, FASEB J, V5, P2361, DOI 10.1096/fasebj.5.10.1712325; CULLEN BR, 1989, CELL, V58, P423, DOI 10.1016/0092-8674(89)90420-0; CULLEN BR, 1993, CELL, V73, P417, DOI 10.1016/0092-8674(93)90126-B; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; DOU QP, 1991, P NATL ACAD SCI USA, V88, P1157, DOI 10.1073/pnas.88.4.1157; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; EGYHAZI E, 1987, MOL CELL BIOL, V6, P4221; FAZELY F, 1991, BLOOD, V77, P1653; FISHER AG, 1986, NATURE, V320, P367, DOI 10.1038/320367a0; FRIDOVICHKEIL JL, 1991, CELL GROWTH DIFFER, V2, P67; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; GAUSS GH, 1992, NUCLEIC ACIDS RES, V20, P6739, DOI 10.1093/nar/20.24.6739; HAN XM, 1992, J VIROL, V66, P4065, DOI 10.1128/JVI.66.7.4065-4072.1992; HASELTINE WA, 1991, FASEB J, V5, P2349, DOI 10.1096/fasebj.5.10.1829694; HSIANG YH, 1983, J BIOL CHEM, V260, P14873; HSU MC, 1991, SCIENCE, V254, P1799, DOI 10.1126/science.1763331; HSU MC, 1993, P NATL ACAD SCI USA, V90, P6395, DOI 10.1073/pnas.90.14.6395; KALEBIC T, 1991, P NATL ACAD SCI USA, V88, P986, DOI 10.1073/pnas.88.3.986; KARN J, 1992, TRENDS GENET, V8, P365, DOI 10.1016/0168-9525(92)90284-B; KEYOMARSI K, 1991, CANCER RES, V51, P3602; LI CJ, 1993, J BIOL CHEM, V268, P22463; LI CJ, 1993, P NATL ACAD SCI USA, V90, P1839, DOI 10.1073/pnas.90.5.1839; LI CJ, 1994, IN PRESS TRENDS MICR; LIU JS, 1992, J VIROL, V66, P3883, DOI 10.1128/JVI.66.6.3883-3887.1992; MARCINIAK RA, 1990, P NATL ACAD SCI USA, V87, P3624, DOI 10.1073/pnas.87.9.3624; MERINO A, 1993, NATURE, V365, P227, DOI 10.1038/365227a0; NABEL GJ, 1988, SCIENCE, V239, P1299, DOI 10.1126/science.2830675; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; ROEDERER M, 1990, P NATL ACAD SCI USA, V87, P4884, DOI 10.1073/pnas.87.12.4884; SLICHENMYER WJ, 1993, JNCI-J NATL CANCER I, V85, P271, DOI 10.1093/jnci/85.4.271; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; STEWART AF, 1987, CELL, V50, P1109, DOI 10.1016/0092-8674(87)90177-2	36	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7051	7054						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125909				2022-12-27	WOS:A1994NA03200002
J	MUI, BLS; CULLIS, PR; PRITCHARD, H; MADDEN, TD				MUI, BLS; CULLIS, PR; PRITCHARD, H; MADDEN, TD			INFLUENCE OF PLASMA ON THE OSMOTIC SENSITIVITY OF LARGE UNILAMELLAR VESICLES PREPARED BY EXTRUSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY LIPOPROTEINS; SERUM-INDUCED LEAKAGE; CHOLESTEROL CONTENT; BILAYER-MEMBRANES; RAT PLASMA; LIPOSOMES; RELEASE; SIZE; DISINTEGRATION; INVITRO	In the presence of plasma, the osmotic differential required to trigger lysis of large unilamellar vesicles is significantly decreased with the membrane tension at rupture being reduced from about 36 to about 12 dynes/cm for vesicles composed of palmitoyloleoylphosphatidylcholine: cholesterol (55:45). Despite increasing vesicle sensitivity, however, plasma does not alter the characteristics of osmotically induced lysis. As in the absence of plasma, lysis is not an all or nothing event but instead results in only partial loss of intravesicular solute, so that following membrane resealing the vesicle interior remains hyperosmotic with respect to the external medium. To identify the component responsible for the observed increase in vesicle osmotic sensitivity, plasma was fractionated by density centrifugation. Albumin and other soluble plasma proteins, including those associated with the complement system, were found to exert only a modest influence on vesicle osmotic behavior. In contrast all of the lipoprotein fractions lowered vesicle tolerance to osmotic pressure, with high density lipoprotein exerting an effect comparable to whole plasma.	UNIV BRITISH COLUMBIA,DEPT BIOCHEM,VANCOUVER V6T 1Z3,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT PATHOL,VANCOUVER V6T 1Z3,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT PHARMACOL & THERAPEUT,VANCOUVER V6T 1Z3,BC,CANADA	University of British Columbia; University of British Columbia; University of British Columbia								ALLEN TM, 1992, CANCER RES, V52, P2431; ALLEN TM, 1985, BIOCHIM BIOPHYS ACTA, V818, P205, DOI 10.1016/0005-2736(85)90571-1; ALLEN TM, 1980, BIOCHIM BIOPHYS ACTA, V597, P418, DOI 10.1016/0005-2736(80)90118-2; ALLEN TM, 1983, J PHARMACOL EXP THER, V226, P539; COMISKEY SJ, 1990, BIOCHEMISTRY-US, V29, P3626, DOI 10.1021/bi00467a006; COOPER RA, 1975, J CLIN INVEST, V55, P115, DOI 10.1172/JCI107901; DAMEN J, 1981, BIOCHIM BIOPHYS ACTA, V665, P538, DOI 10.1016/0005-2760(81)90268-X; EPAND RM, 1989, J BIOL CHEM, V264, P4628; EVANS E, 1987, J PHYS CHEM-US, V91, P4219, DOI 10.1021/j100300a003; Fiske CH, 1925, J BIOL CHEM, V66, P375; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; KANELLIS P, 1980, J BIOL CHEM, V255, P1464; KIRBY C, 1980, BIOCHEM J, V186, P591, DOI 10.1042/bj1860591; KLAUSNER RD, 1985, J BIOL CHEM, V260, P3719; LELKES PI, 1982, BIOCHIM BIOPHYS ACTA, V716, P410, DOI 10.1016/0304-4165(82)90034-4; MADDEN TD, 1990, CHEM PHYS LIPIDS, V53, P37, DOI 10.1016/0009-3084(90)90131-A; MAYER LD, 1985, BIOCHIM BIOPHYS ACTA, V817, P193, DOI 10.1016/0005-2736(85)90084-7; MUI BLS, 1993, BIOPHYS J, V64, P443, DOI 10.1016/S0006-3495(93)81385-7; NAKA K, 1992, J AM CHEM SOC, V114, P4011, DOI 10.1021/ja00036a080; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; OSTRO MJ, 1989, AM J HOSP PHARM, V46, P1576, DOI 10.1093/ajhp/46.8.1576; POWNALL HJ, 1979, BIOCHEMISTRY-US, V18, P574, DOI 10.1021/bi00571a004; RAHMAN A, 1980, CANCER RES, V40, P1532; SCHERPHOF G, 1984, BIOCHEM J, V221, P423, DOI 10.1042/bj2210423; SCHERPHOF G, 1978, BIOCHIM BIOPHYS ACTA, V542, P296, DOI 10.1016/0304-4165(78)90025-9; SCHERPHOF GL, 1984, LIPOSOME TECHNOLOGY, V3, P205; WEINSTEIN JN, 1981, BIOCHIM BIOPHYS ACTA, V647, P270, DOI 10.1016/0005-2736(81)90255-8; Weinstein JN, 1984, LIPOSOME TECHNOLOGY, VIII, P183; Whaley K, 1985, METHODS COMPLEMENT C, P77; WILLS GL, 1984, GUIDEBOOK LIPOPROTEI, V14, P18	30	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7364	7370						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125954				2022-12-27	WOS:A1994NA03200053
J	PETER, D; JIMENEZ, J; LIU, YJ; KIM, J; EDWARDS, RH				PETER, D; JIMENEZ, J; LIU, YJ; KIM, J; EDWARDS, RH			THE CHROMAFFIN GRANULE AND SYNAPTIC VESICLE AMINE TRANSPORTERS DIFFER IN SUBSTRATE RECOGNITION AND SENSITIVITY TO INHIBITORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR MONOAMINE TRANSPORTER; FREELY MOVING RATS; RESERPINE BINDING; DIHYDROTETRABENAZINE BINDING; DOPAMINE CONCENTRATIONS; SEROTONIN TRANSPORTERS; STORAGE-VESICLES; MECHANISM; N-METHYL-4-PHENYLPYRIDINIUM; NEUROTRANSMITTERS	Classical studies using bovine chromaffin granules have defined the physiologic and pharmacologic properties of the vesicular amine transporter that packages monoamine transmitters into intracellular vesicles for subsequent regulated release. The recent isolation of two distinct but closely related cDNA clones encoding vesicular amine transport suggests that the activity expressed in the brain (synaptic vesicle amine transporter or SVAT) may differ significantly from the previously described adrenal gland activity (chromaffin granule amine transporter or CGAT). A direct comparison of the two transporters now shows that SVAT has a higher affinity than CGAT for monoamine substrates, in particular for histamine. In addition, SVAT shows approximately 10-fold greater sensitivity to tetrabenazine than CGAT. [H-3]Dihydrotetrabenazine shows no detectable binding to CGAT but does bind to SVAT, accounting for the differential sensitivity. Furthermore, methamphetamine preferentially inhibits transport by SVAT relative to CGAT, apparently by competing at the site of amine recognition rather than by disrupting the vesicular pH gradient. These previously unsuspected differences in the storage of monoamine transmitter in the central nervous system and the adrenal gland may help to account for several classic pharmacological observations.	UNIV CALIF LOS ANGELES, SCH MED, DEPT NEUROL, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT BIOL CHEM, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	PETER, D (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DEPT MICROBIOL & IMMUNOL, LOS ANGELES, CA 90024 USA.		Liu, Yongjian/J-7852-2018					AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; CARBONI E, 1989, NEUROSCIENCE, V28, P653, DOI 10.1016/0306-4522(89)90012-2; Carlsson A, 1965, HDB EXP PHARMAKOL, V19, P529; DARCHEN F, 1989, BIOCHEMISTRY-US, V28, P1692, DOI 10.1021/bi00430a040; DARCHEN F, 1988, MOL PHARMACOL, V33, P672; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; DESNOS C, 1990, DEV BRAIN RES, V52, P161, DOI 10.1016/0165-3806(90)90231-M; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Edwards R H, 1992, Curr Opin Neurobiol, V2, P586, DOI 10.1016/0959-4388(92)90023-E; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; Frize E.D., 1954, NEW ENGL J MED, V251, P1006; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; INNES IR, 1975, PHARMACOL BASIS, P477; JEVITCH J, 1985, P NATL ACAD SCI USA, V82, P2173; JOHNSON RG, 1988, PHYSIOL REV, V68, P232, DOI 10.1152/physrev.1988.68.1.232; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KELLY R B, 1991, Current Opinion in Cell Biology, V3, P654, DOI 10.1016/0955-0674(91)90037-Y; KRUEGER MJ, 1990, BIOCHEM BIOPH RES CO, V169, P123, DOI 10.1016/0006-291X(90)91442-U; LIU Y, 1992, P NATL ACAD SCI USA, V89, P9074, DOI 10.1073/pnas.89.19.9074; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; PLETSCHER A, 1977, BRIT J PHARMACOL, V59, P419, DOI 10.1111/j.1476-5381.1977.tb08395.x; RAMSAY RR, 1986, J BIOL CHEM, V261, P7585; RUDNICK G, 1992, BIOCHEMISTRY-US, V31, P6710, DOI 10.1021/bi00144a010; RUDNICK G, 1990, BIOCHEMISTRY-US, V29, P603, DOI 10.1021/bi00455a002; RUDNICK G, 1993, MOL PHARMACOL, V43, P271; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; SCHERMAN D, 1988, NEUROSCIENCE, V27, P1029, DOI 10.1016/0306-4522(88)90207-2; SCHERMAN D, 1986, J NEUROCHEM, V47, P331; SCHERMAN D, 1984, MOL PHARMACOL, V25, P113; SCHULDINER S, 1993, J BIOL CHEM, V268, P29; SNYDER SH, 1986, MPTP NEUROTOXIN PROD, P191; STERNBACH Y, 1990, J BIOL CHEM, V265, P3961; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; SULZER D, 1990, NEURON, V5, P797, DOI 10.1016/0896-6273(90)90339-H; TRIMBLE WS, 1991, ANNU REV NEUROSCI, V14, P93, DOI 10.1146/annurev.ne.14.030191.000521	37	178	184	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7231	7237						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125935				2022-12-27	WOS:A1994NA03200032
J	FINDLAY, WA; SONNICHSEN, FD; SYKES, BD				FINDLAY, WA; SONNICHSEN, FD; SYKES, BD			SOLUTION STRUCTURE OF THE TR(1)C FRAGMENT OF SKELETAL-MUSCLE TROPONIN-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; CALCIUM-BINDING PROTEINS; DISTANCE CONSTRAINTS; BACKBONE DYNAMICS; REFINED STRUCTURE; NMR-SPECTROSCOPY; CALBINDIN-D9K; RESOLUTION; H-1-NMR; DOMAIN	Residues 12-87 (TR(1)C fragment) of turkey skeletal muscle troponin-C comprises two helix-loop-helix calcium-binding motifs which are the regulatory calcium binding sites in the N-terminal domain of the protein. We have used the combined distance geometry-simu lated annealing protocol DGII (Havel, T F. (1991) Prog. Biophys, Mel. Biol. 56, 43-78) to determine the structure of this 76-residue polypeptide in solution from 475 H-1 NMR-derived distance restraints. The nuclear Overhauser enhancement-derived distance constraints used in the DGII protocol were supplemented by introducing generic hydrogen bond distance restraints for slowly exchanging amide hydrogens in regular secondary structure elements, by restricting the available phi angle space to -180 degrees to 0 degrees for all residues except glycines, and by tailoring the distance boundaries used for quantitating the nuclear Overhauser enhancement intensities to correspond to characteristic distances found in helices. This improved the geometry of the four helices in the resulting structures. The relative positions of helices A and B which flank calcium-binding loop 1, helix D which follows calcium-binding loop 2, and the beta-sheet between the two calcium binding loops were well defined and had an overall root-mean-square deviation for 20 converged structures of 1.4 +/- 0.2 A for backbone atoms. The structure and relative orientations of these regions are very similar to these of the corresponding regions of the protein in the crystal structure of intact turkey skeletal troponin C (Herzberg, O., and James, M, N. G. (1988) Nature 313, 653-659). The structure of helix C was well defined, but its relative position to the other helices was not defined. It occupied a range of positions in the set of 20 DGII structures, the average of which was quite similar to the orientation of helix C in the x-ray structure. The overall structure of the apo regulatory domain of troponin-C is therefore not affected by the loss of the N-helix, or the low pH conditions used for the x-ray structure, but may be more flexible in regions known to be involved in contacts with other skeletal muscle regulatory proteins.	UNIV ALBERTA,DEPT BIOCHEM,EDMONTON T6G 2H7,AB,CANADA; UNIV ALBERTA,MRC,PROT STRUCT & FUNCT,EDMONTON T6G 2H7,AB,CANADA; UNIV ALBERTA,DEPT BIOCHEM,PROT ENGN NETWORK CTR EXCELLANCE,EDMONTON T6G 2S2,AB,CANADA	University of Alberta; University of Alberta; University of Alberta			Sönnichsen, Frank D/D-8408-2011	Sönnichsen, Frank D/0000-0002-4539-3755				AKKE M, 1992, BIOCHEMISTRY-US, V31, P1011, DOI 10.1021/bi00119a009; BROWN SC, 1988, J MAGN RESON, V77, P166, DOI 10.1016/0022-2364(88)90042-X; BRUNGER AT, 1993, SCIENCE, V261, P328, DOI 10.1126/science.8332897; CLORE GM, 1987, BIOCHEMISTRY-US, V26, P8012, DOI 10.1021/bi00398a069; FINDLAY WA, 1993, BIOCHEMISTRY-US, V32, P3461, DOI 10.1021/bi00064a033; GRABAREK Z, 1981, J BIOL CHEM, V256, P3121; GRABAREK Z, 1981, BIOCHIM BIOPHYS ACTA, V671, P227, DOI 10.1016/0005-2795(81)90138-0; HAVEL TF, 1991, PROG BIOPHYS MOL BIO, V56, P43, DOI 10.1016/0079-6107(91)90007-F; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; HERZBERG O, 1986, J BIOL CHEM, V261, P2638; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; HINCKE MT, 1978, CAN J BIOCHEM CELL B, V56, P384, DOI 10.1139/o78-061; HYBERTS SG, 1992, PROTEIN SCI, V1, P736, DOI 10.1002/pro.5560010606; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; KAY LE, 1991, BIOCHEMISTRY-US, V30, P4323, DOI 10.1021/bi00231a031; KOBAYASHI T, 1991, J BIOL CHEM, V266, P13746; KORDEL J, 1992, BIOCHEMISTRY-US, V31, P4856; LINSE S, 1990, BIOCHEMISTRY-US, V29, P5925, DOI 10.1021/bi00477a007; POTTER JD, 1975, J BIOL CHEM, V250, P4628; SATYSHUR KA, 1988, J BIOL CHEM, V263, P1628; SHAW GS, 1992, BIOCHEMISTRY-US, V31, P9572, DOI 10.1021/bi00155a009; SKELTON NJ, 1990, J MOL BIOL, V213, P593, DOI 10.1016/S0022-2836(05)80244-X; SKELTON NJ, 1990, BIOCHEMISTRY-US, V29, P5752, DOI 10.1021/bi00476a016; SMITH LJ, 1992, J MOL BIOL, V224, P899, DOI 10.1016/0022-2836(92)90457-U; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; SUNDARALINGAM M, 1985, SCIENCE, V227, P945, DOI 10.1126/science.3969570; SZEBENYI DME, 1986, J BIOL CHEM, V261, P8761; TSALKOVA TN, 1985, J MOL BIOL, V181, P533, DOI 10.1016/0022-2836(85)90425-5; WANG CK, 1989, PROTEINS, V6, P424, DOI 10.1002/prot.340060409; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	31	22	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6773	6778						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120037				2022-12-27	WOS:A1994MZ50300081
J	MORO, O; SHOCKLEY, MS; LAMEH, J; SADEE, W				MORO, O; SHOCKLEY, MS; LAMEH, J; SADEE, W			OVERLAPPING MULTISITE DOMAINS OF THE MUSCARINIC CHOLINERGIC HM1 RECEPTOR INVOLVED IN SIGNAL-TRANSDUCTION AND SEQUESTRATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; 3RD CYTOPLASMIC LOOP; BETA-2-ADRENERGIC RECEPTOR; ACETYLCHOLINE-RECEPTORS; DOWN-REGULATION; G-PROTEIN; INTERNALIZATION; BINDING; CELLS	Alanine mutagenesis scanning of the intracellular portion of the human muscarinic cholinergic Hm1 receptor was performed to identify domains mediating agonist induced receptor sequestration. Using these multiple alanine point mutants of Hm1, we had previously identified several receptor domains in the intracellular loops i1-3 that play a role in coupling to phosphatidyl inositol turnover, most notably, a lipophilic residue, Leu-131, in the conserved i2 loop domain DRYXXVXXPL (Moro, O., Lameh, J., Hogger, P, and Sadee, W. (1993) J. Biol. Chem. 268, 6862-6865). We now demonstrate that; alanine substitutions in three of these domains, i.e. middle of the i2 loop and both junctions of the i3 loop, also result in defective sequestration (loss of surface receptor sites accessible to a polar tracer) in transfected human kidney U293 cells. The i2 loop was studied further by single point mutations. The strongest impairment of sequestration occurred with mutant L131A which was also highly defective in phosphatidyl inositol (PI) coupling. Substitution of Leu-131 with several distinct amino acids indicated that a bulky lipophilic residue is required for sequestration in this position, as shown for coupling to PI turnover. Further, the double point mutation, V127A/L131A, almost completely suppressed both sequestration and coupling of Hm1, In the beta(2) adrenoceptor, alanine substitution of the i2 residue Phe-139, equivalent to Leu-131 in Hm1, also resulted in impaired coupling to adenylyl cyclase and sequestration, indicating a general role for this conserved i2 loop residue in both processes. The combined results show that the multi-site domain involved in signal transduction of Hm1 is similar to and overlaps with that involved in sequestration. However, three Hm1 mutants that were moderately deficient in stimulating PI turnover displayed normal sequestration, suggesting distinct mechanisms. We propose that cellular mediators of receptor sequestration are structurally similar or identical to the heterotrimeric G proteins.	UNIV CALIF SAN FRANCISCO,DEPT PHARM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco					NIGMS NIH HHS [GM 43102] Funding Source: Medline; NIMH NIH HHS [K21 MH 00996] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K21MH000996] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLEN JM, 1989, MOL PHARMACOL, V36, P248; ARDEN JR, 1990, FEBS LETT, V269, P386; BOMSEL M, 1992, MOL BIOL CELL, V3, P1317, DOI 10.1091/mbc.3.12.1317; CAMPBELL PT, 1991, MOL PHARMACOL, V39, P192; CHEUNG AH, 1990, MOL PHARMACOL, V37, P775; CHEUNG AH, 1989, MOL PHARMACOL, V34, P132; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; FRASER CM, 1989, MOL PHARMACOL, V36, P840; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; HERTEL C, 1990, J BIOL CHEM, V265, P17988; KTISTAKIS NT, 1990, J CELL BIOL, V111, P1393, DOI 10.1083/jcb.111.4.1393; LAMEH J, 1992, J BIOL CHEM, V267, P13406; MAEDA S, 1990, FEBS LETT, V269, P386, DOI 10.1016/0014-5793(90)81199-X; MAHAN LC, 1985, P NATL ACAD SCI USA, V82, P129, DOI 10.1073/pnas.82.1.129; MORO O, 1993, J BIOL CHEM, V268, P6862; MORO O, 1993, J BIOL CHEM, V268, P22273; PIMPLIKAR SW, 1993, NATURE, V362, P456, DOI 10.1038/362456a0; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; RAPOSO G, 1987, BIOL CELL, V60, P117, DOI 10.1111/j.1768-322X.1987.tb00551.x; SHPETNER HS, 1992, NATURE, V355, P733, DOI 10.1038/355733a0; STRADER CD, 1987, CELL, V49, P855, DOI 10.1016/0092-8674(87)90623-4; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; TRAUB LM, 1991, J BIOL CHEM, V266, P24642	23	46	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6651	6655						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120019				2022-12-27	WOS:A1994MZ50300062
J	MOULAND, AJ; BEVAN, S; WHITE, JH; HENDY, GN				MOULAND, AJ; BEVAN, S; WHITE, JH; HENDY, GN			HUMAN CHROMOGRANIN-A GENE - MOLECULAR-CLONING, STRUCTURAL-ANALYSIS, AND NEUROENDOCRINE CELL-SPECIFIC EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY PROTEIN-I; ADRENAL CHROMAFFIN CELLS; BOVINE CHROMOGRANIN; MESSENGER-RNA; CONFORMATIONAL CHANGE; CALCIUM-BINDING; PANCREASTATIN; ENDOCRINE; PEPTIDES; CHROMOSTATIN	Chromogranin A (CgA) is an acidic glycoprotein, which is widely expressed in endocrine and neuroendocrine cells. It plays multiple important roles in the process of regulated hormone secretion. The single copy human CgA gene was isolated from a human fetal liver gene library The gene spans 15 kilobases and contains 8 exons. Exon I encodes the 5'-noncoding region and the majority of the signal peptide coding region. Exons II-V collectively encode the highly conserved amino-terminal domain (the beta-granin sequence). Exon VI encodes a variable domain within which is the chromostatin sequence, and exon VII encodes another variable domain, which contains the pancreastatin sequence. Exon VIII encodes the highly conserved carboxyl-terminal domain and the S'-noncoding region. The human gene promoter has a consensus TATA box, cAMP response element, and Sp-I sequence. 2.3 kilobases of the upstream regulatory region of the human CgA gene directed efficient transcription of a reporter chloramphenicol acetyltransferase gene in several neuroendocrine cell lines, including human medullary thyroid C-cell tumor, mouse pituitary corticotroph, rat pituitary tumor, and rat pheochromocytoma. The promoter was virtually inactive in nonneuroendocrine cell lines. Transient transfection studies with deleted promoter constructs showed that sequences lying between -55 and +32 base pairs relative to the transcription initiation site, containing the consensus cyclic AMP response element and TATA box, were sufficient for neuroendocrine cell-specific expression.	ROYAL VICTORIA HOSP,CALCIUM RES LAB,MONTREAL H3A 1A1,PQ,CANADA; MCGILL UNIV,DEPT MED,MONTREAL H3A 1A1,PQ,CANADA; MCGILL UNIV,DEPT PHYSIOL,MONTREAL H3A 1A1,PQ,CANADA	McGill University; Royal Victoria Hospital; McGill University; McGill University			white, john h/N-9782-2013	white, john h/0000-0002-4785-2687				AARDAL S, 1992, REGUL PEPTIDES, V41, P9, DOI 10.1016/0167-0115(92)90509-S; AHN TG, 1987, P NATL ACAD SCI USA, V84, P5043, DOI 10.1073/pnas.84.14.5043; BENEDUM UM, 1986, EMBO J, V5, P1495, DOI 10.1002/j.1460-2075.1986.tb04388.x; BLASCHKO H, 1967, NATURE, V215, P58, DOI 10.1038/215058a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DEFTOS LJ, 1990, BONE MINER, V9, P169, DOI 10.1016/0169-6009(90)90035-E; DEFTOS LJ, 1989, ENDOCRINOLOGY, V125, P563, DOI 10.1210/endo-125-1-563; DEFTOS LJ, 1990, J BONE MINER RES, V5, P989; DREES BM, 1991, ENDOCRINOLOGY, V129, P3381, DOI 10.1210/endo-129-6-3381; EIDEN LE, 1987, NATURE, V325, P301, DOI 10.1038/325301a0; FASCIOTTO BH, 1993, ENDOCRINOLOGY, V133, P461, DOI 10.1210/en.133.2.461; GALINDO E, 1991, P NATL ACAD SCI USA, V88, P1426, DOI 10.1073/pnas.88.4.1426; GALINDO E, 1992, J BIOL CHEM, V267, P407; GALINDO E, 1992, P NATL ACAD SCI USA, V89, P7398, DOI 10.1073/pnas.89.16.7398; GOEBL MG, 1990, CELL, V61, P1165, DOI 10.1016/0092-8674(90)90676-6; GORR SU, 1988, BONE MINER, V4, P17; GORR SU, 1987, BONE MINER, V2, P251; GOUGH NM, 1988, ANAL BIOCHEM, V173, P93, DOI 10.1016/0003-2697(88)90164-9; HELMAN LJ, 1988, J BIOL CHEM, V263, P11559; HENDY GN, 1992, PARATHYROID HORMONE, P25; HUTTNER WB, 1987, NATURE, V325, P305, DOI 10.1038/325305b0; HUTTNER WB, 1991, TRENDS BIOCHEM SCI, V16, P27, DOI 10.1016/0968-0004(91)90012-K; HUTTON JC, 1985, FEBS LETT, V188, P336, DOI 10.1016/0014-5793(85)80398-7; HUTTON JC, 1988, FEBS LETT, V236, P269, DOI 10.1016/0014-5793(88)80036-X; IACANGELO A, 1986, NATURE, V323, P82, DOI 10.1038/323082a0; IACANGELO AL, 1991, MOL ENDOCRINOL, V5, P1651, DOI 10.1210/mend-5-11-1651; IACANGELO AL, 1988, ENDOCRINOLOGY, V122, P2339, DOI 10.1210/endo-122-5-2339; JUNG YK, 1992, MOL ENDOCRINOL, V6, P2027, DOI 10.1210/me.6.12.2027; KONECKI DS, 1987, J BIOL CHEM, V262, P17026; LAWN RM, 1978, CELL, V15, P1157, DOI 10.1016/0092-8674(78)90043-0; LEISER M, 1989, J BIOL CHEM, V264, P2792; LEVENTIS R, 1990, BIOCHIM BIOPHYS ACTA, V1023, P124, DOI 10.1016/0005-2736(90)90017-I; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; MOULAND AJ, 1991, ENDOCRINOLOGY, V128, P441, DOI 10.1210/endo-128-1-441; MOULAND AJ, 1992, MOL ENDOCRINOL, V6, P1718; PARMER RJ, 1993, J CLIN INVEST, V92, P1042, DOI 10.1172/JCI116609; PARMER RJ, 1989, HYPERTENSION, V14, P435, DOI 10.1161/01.HYP.14.4.435; POHL TM, 1990, FEBS LETT, V262, P219, DOI 10.1016/0014-5793(90)80194-N; REIFFEN FU, 1986, FEBS LETT, V195, P327, DOI 10.1016/0014-5793(86)80187-9; RUSSELL J, 1990, MOL ENDOCRINOL, V4, P505, DOI 10.1210/mend-4-3-505; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCAMMELL JG, 1993, TRENDS ENDOCRIN MET, V4, P14, DOI 10.1016/1043-2760(93)90058-M; SCHIMMEL A, 1992, FEBS LETT, V314, P375, DOI 10.1016/0014-5793(92)81509-K; SEIDAH NG, 1987, FEBS LETT, V211, P144, DOI 10.1016/0014-5793(87)81425-4; SIMON JP, 1988, P NATL ACAD SCI USA, V85, P1712, DOI 10.1073/pnas.85.5.1712; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; WILLIAMS JG, 1985, NUCLEIC ACID HYBRIDI, P139; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N; WU HJ, 1991, J BIOL CHEM, V266, P13130; YOO SH, 1990, J BIOL CHEM, V265, P14414; YOO SH, 1991, J BIOL CHEM, V266, P7740	54	82	85	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6918	6926						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120054				2022-12-27	WOS:A1994MZ50300101
J	PREMONT, RT; KOCH, WJ; INGLESE, J; LEFKOWITZ, RJ				PREMONT, RT; KOCH, WJ; INGLESE, J; LEFKOWITZ, RJ			IDENTIFICATION, PURIFICATION, AND CHARACTERIZATION OF GRK5, A MEMBER OF THE FAMILY OF G-PROTEIN-COUPLED RECEPTOR KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-DEPENDENT PHOSPHORYLATION; BETA-GAMMA-SUBUNITS; ROD OUTER SEGMENTS; RHODOPSIN KINASE; BETA-2-ADRENERGIC RECEPTOR; DESENSITIZATION; SITES; ISOPRENYLATION; LOCALIZATION; TRANSDUCTION	A novel member of the family of G protein-coupled receptor kinases (GRKs), named GRK5, has been cloned from bovine taste epithelium. The cDNA sequence predicts a 590-amino acid protein with high overall similarity to rhodopsin kinase. GRK5 mRNA is found most abundantly in lung, heart, retina, and lingual epithelium hum, but is expressed very little in brain, liver, kidney, or testis. GRK5 expressed in Sf9 cells was purified to apparent homogeneity. GRK5 major autophosphorylation sites were mapped to Ser(484) and Thr(485). Purified GRK5 phosphorylates rhodopsin in a light-dependent manner and beta(2)-adrenergic receptor in an agonist-dependent manner and phosphorylates the C-terminal tail regions of both receptor proteins. GRK5 possesses neither a CAAX motif specifying protein prenylation like rhodopsin kinase nor similarity to the G protein beta gamma-subunit binding domain of beta-adrenergic receptor kinases. GRK5 phosphorylation of rhodopsin or beta(2)-adrenergic receptor is not stimulated by G protein beta gamma-subunits. The GRK5 protein does not undergo agonist-dependent translocation from cytosol to membranes as do beta-adrenergic receptor kinase and rhodopsin kinase, but rather appears to associate with membranes constitutively. GRK5 thus appears functionally similar to other characterized GRKs, but has distinct regulatory properties which may be important for its cellular function.	DUKE UNIV, MED CTR, HOWARD HUGHES MED INST, DEPT MED, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT BIOCHEM, DURHAM, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University			Lefkowitz, Robert/AAW-2649-2021	Premont, Richard/0000-0002-8053-5026	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 16037] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ambrose Christine, 1992, Human Molecular Genetics, V1, P697, DOI 10.1093/hmg/1.9.697; ARRIZA JL, 1992, J NEUROSCI, V12, P4045; BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1989, J BIOL CHEM, V264, P6707; BENOVIC JL, 1987, J BIOL CHEM, V262, P9026; BENOVIC JL, 1986, NATURE, V321, P869, DOI 10.1038/321869a0; BENOVIC JL, 1987, J BIOL CHEM, V262, P17251; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1993, J BIOL CHEM, V268, P19521; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; BUCZYLKO J, 1991, P NATL ACAD SCI USA, V88, P2568, DOI 10.1073/pnas.88.6.2568; CASEY PJ, 1989, BIOCHEMISTRY-US, V28, P611, DOI 10.1021/bi00428a029; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; CHEN CY, 1993, J BIOL CHEM, V268, P7825; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOHLMAN HG, 1987, J BIOL CHEM, V262, P14282; DUCLOS B, 1991, METHOD ENZYMOL, V201, P10; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARIBABU B, 1993, P NATL ACAD SCI USA, V90, P9398, DOI 10.1073/pnas.90.20.9398; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; INGLESE J, 1992, J BIOL CHEM, V267, P1422; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; KAMEYAMA K, 1993, J BIOL CHEM, V268, P7753; KELLEHER DJ, 1990, J BIOL CHEM, V265, P2632; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KUNAPULI P, 1993, P NATL ACAD SCI USA, V90, P5588, DOI 10.1073/pnas.90.12.5588; KWATRA MM, 1993, J BIOL CHEM, V268, P9161; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; LOHSE MJ, 1989, P NATL ACAD SCI USA, V86, P3011, DOI 10.1073/pnas.86.9.3011; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; LORENZ W, 1991, P NATL ACAD SCI USA, V88, P8715, DOI 10.1073/pnas.88.19.8715; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; PALCZEWSKI K, 1989, BIOCHEMISTRY-US, V28, P8764, DOI 10.1021/bi00448a013; PALCZEWSKI K, 1988, J BIOL CHEM, V263, P14067; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PALCZEWSKI K, 1992, NEURON, V8, P117, DOI 10.1016/0896-6273(92)90113-R; PALCZEWSKI K, 1992, J BIOL CHEM, V267, P18991; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; RICHARDSON RM, 1993, J BIOL CHEM, V268, P13650; Sambrook J, 1989, MOL CLONING LABORATO; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; SHICHI H, 1978, J BIOL CHEM, V253, P7040; SOHLEMANN P, 1993, FEBS LETT, V324, P59, DOI 10.1016/0014-5793(93)81532-5; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174	48	177	184	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6832	6841						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120045				2022-12-27	WOS:A1994MZ50300090
J	ZHOU, GC; SMITH, JL; ZALKIN, H				ZHOU, GC; SMITH, JL; ZALKIN, H			BINDING OF PURINE NUCLEOTIDES TO 2 REGULATORY SITES RESULTS IN SYNERGISTIC FEEDBACK INHIBITION OF GLUTAMINE 5-PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE; GENE; PURIFICATION; SYNTHETASE; SEQUENCE; CLONING; ENZYME; PURF	Glutamine 5-phosphoribosylpyrophosphate amidotransferase from Escherichia coli is subject to synergistic feedback regulation by adenine and guanine nucleo tides. Inhibition assays and equilibrium binding measurements have established that synergistic inhibition by AMP and GRIP results from synergistic binding to two sites/enzyme subunit in the homotetramer. Although each nucleotide can bind to both sites, analyses of the wild type and mutant enzymes indicate that binding of GRIP to an A (allosteric) site and AMP to a proximal C (catalytic) site are necessary for synergistic inhibition. K326Q and P410W amino acid replacements result in decreased binding affinity for GRIP and AMP and lead to corresponding reductions in feedback inhibition. The K326Q A site mutation results not only in decreased affinity of GRIP for the mutant A site but also has an adverse effect on AMP affinity for the C site. Similarly, the P410W C site mutation has a detrimental effect on binding of AMP to the mutant C site and also on affinity of GRIP to the A site. The fact that a mutation in one site affects binding of nucleotides to both sites provides further evidence for synergistic binding of nucleotides.	PURDUE UNIV,DEPT BIOCHEM,W LAFAYETTE,IN 47907; PURDUE UNIV,DEPT BIOL SCI,W LAFAYETTE,IN 47907	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus					NIDDK NIH HHS [DK42303, R37 DK042303] Funding Source: Medline; NIGMS NIH HHS [GM24658] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042303, R01DK042303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024658, R01GM024658] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		HOULBERG U, 1983, J BACTERIOL, V153, P837, DOI 10.1128/JB.153.2.837-845.1983; HOVEJENSEN B, 1986, J BIOL CHEM, V261, P6765; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Leatherbarrow R.J, 1987, ENZFITTER NONLINEAR; MAKAROFF CA, 1983, J BIOL CHEM, V258, P586; MEI B, 1989, J BIOL CHEM, V264, P16613; MESSENGER LJ, 1979, J BIOL CHEM, V254, P3382; MEYER E, 1979, J BIOL CHEM, V254, P5397; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; ROLFES RJ, 1990, J BACTERIOL, V172, P5637, DOI 10.1128/jb.172.10.5637-5642.1990; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHENDEL FJ, 1988, BIOCHEMISTRY-US, V27, P2614, DOI 10.1021/bi00407a052; SHEN Y, 1990, BIOCHEMISTRY-US, V29, P218, DOI 10.1021/bi00453a030; TSO JY, 1982, J BIOL CHEM, V257, P3525; WONG JY, 1981, BIOCHEMISTRY-US, V20, P5669, DOI 10.1021/bi00523a005; ZALKIN H, 1992, PROG NUCLEIC ACID RE, V42, P259, DOI 10.1016/S0079-6603(08)60578-4; ZHOU GC, 1993, J BIOL CHEM, V268, P10471	18	34	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6784	6789						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120039				2022-12-27	WOS:A1994MZ50300083
J	LIN, BF; SHANE, B				LIN, BF; SHANE, B			EXPRESSION OF ESCHERICHIA-COLI FOLYLPOLYGLUTAMATE SYNTHETASE IN THE CHINESE-HAMSTER OVARY CELL MITOCHONDRION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMATE SYNTHETASE; FOLATE-DEPENDENT ENZYMES; RAT-LIVER MITOCHONDRIA; ORNITHINE TRANSCARBAMYLASE; DIHYDROFOLATE SYNTHETASE; SUBCELLULAR-LOCALIZATION; FOLC GENE; PROTEINS; DNA; PURIFICATION	Chinese hamster ovary (CHO) cell transfectants expressing Escherichia coli folylpoly-gamma-glutamate synthetase (FPGS) activity solely in their cytosol lack mitochondrial folylpolyglutamates and are auxotrophic for glycine. Addition of a mammalian mitochondrial leader sequence targeted E. coli FPGS to the mitochondria of these cells. Mitochondrial expression of FPGS restored mitochondrial folylpolyglutamate pools and overcame the glycine requirement. Pteroyltriglutamates functioned as effectively as the longer glutamate chain length folates found in wild type CHO cells in the metabolic cycle of glycine synthesis provided they were located in the mitochondria. Although folylpolyglutamates cannot enter the mitochondria, mitochondrial folylpolyglutamates can be released without prior hydrolysis and CHO transfectants expressing E. coli FPGS activity solely in the mitochondria possessed normal cytosolic folylpolyglutamate pools. The proportion of cellular folate in the mitochondrion is governed by competition between mitochondrial and cytosolic FPGS activities.	UNIV CALIF BERKELEY, DEPT NUTR SCI, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley				LIN, BI-FONG/0000-0003-2260-6081	NATIONAL CANCER INSTITUTE [R01CA041991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042033] Funding Source: NIH RePORTER; NCI NIH HHS [CA41991] Funding Source: Medline; NIDDK NIH HHS [DK42033] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARLOWE C K, 1988, Biofactors, V1, P171; BOGNAR AL, 1987, J BIOL CHEM, V262, P12337; BOGNAR AL, 1985, J BIOL CHEM, V260, P5625; CHASIN LA, 1974, P NATL ACAD SCI USA, V71, P718, DOI 10.1073/pnas.71.3.718; CICHOWICZ DJ, 1987, BIOCHEMISTRY-US, V26, P504, DOI 10.1021/bi00376a024; CICHOWICZ DJ, 1987, BIOCHEMISTRY-US, V26, P513, DOI 10.1021/bi00376a025; COOK RJ, 1979, BIOCHEM J, V178, P651, DOI 10.1042/bj1780651; FOO SK, 1982, J BIOL CHEM, V257, P13587; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; HAY R, 1984, BIOCHIM BIOPHYS ACTA, V779, P65, DOI 10.1016/0304-4157(84)90004-2; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; HOFFBRAN.AV, 1969, BIOCHIM BIOPHYS ACTA, V192, P479, DOI 10.1016/0304-4165(69)90397-3; HORNE DW, 1992, J NUTR, V122, P2204, DOI 10.1093/jn/122.11.2204; HORWICH AL, 1984, SCIENCE, V224, P1068, DOI 10.1126/science.6372096; HORWICH AL, 1986, CELL, V44, P451, DOI 10.1016/0092-8674(86)90466-6; KIM JS, 1994, J BIOL CHEM, V269, P9714; KIM JS, 1993, J BIOL CHEM, V268, P21680; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN BF, 1993, J BIOL CHEM, V268, P21674; LOWE KE, 1993, J BIOL CHEM, V268, P21665; MCBURNEY MW, 1974, CELL, V2, P173, DOI 10.1016/0092-8674(74)90091-9; OSBORNE CB, 1993, J BIOL CHEM, V268, P21657; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schirch L. V., 1984, FOLATES PTERINS CHEM, V1, P399; SHANE B, 1989, VITAM HORM, V45, P263; SHIN YS, 1976, BIOCHIM BIOPHYS ACTA, V444, P794; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SUGDEN B, 1985, MOL CELL BIOL, V5, P410, DOI 10.1128/MCB.5.2.410; SUSSMAN DJ, 1986, SOMAT CELL MOLEC GEN, V12, P531, DOI 10.1007/BF01671939; TAYLOR RT, 1977, ARCH BIOCHEM BIOPHYS, V181, P331, DOI 10.1016/0003-9861(77)90512-4; TAYLOR RT, 1982, ARCH BIOCHEM BIOPHYS, V217, P609, DOI 10.1016/0003-9861(82)90543-4	35	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9705	9713						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144561				2022-12-27	WOS:A1994NE05300050
J	RAJ, PA; SONI, SD; LEVINE, MJ				RAJ, PA; SONI, SD; LEVINE, MJ			MEMBRANE-INDUCED HELICAL CONFORMATION OF AN ACTIVE CANDIDACIDAL FRAGMENT OF SALIVARY HISTATINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE-RICH POLYPEPTIDES; NUCLEAR MAGNETIC-RESONANCE; HUMAN-PAROTID-SALIVA; CIRCULAR-DICHROISM; BIOLOGICAL-ACTIVITY; PORPHYROMONAS-GINGIVALIS; ANTICANDIDAL ACTIVITY; H-1-NMR SPECTRA; CHAIN-LENGTH; PEPTIDES	The conformational preference of the candidacidal C-terminal 16 residue fragment (9-24; G-Y-K-R-K-F-H-E-K-H-H-S-H-R-G-Y) of salivary histatin 5 was examined in water, methanol, and dimethyl sulfoxide solutions using 500 MHz two-dimensional-NMR. Fourier transform infrared and CD spectroscopy were used to delineate its membrane-bound conformation in lipid vesicles. The peptide backbone and side-chain proton resonance assignments were accomplished by two-dimensional total correlated and nuclear Overhauser effect (NOE) spectra. The coupling constant (J(NH-C)alpha(H)) values determined from the double quantum-filtered correlated spectra, temperature coefficients of NH chemical shifts (ddelta/dT),H-1/H-2 exchange rates on amide resonances, and the set of NOE connectivities were used to delineate backbone conformational features. The high J(NH-C)alpha(H) values (greater-than-or-equal-to 7.4 Hz), absence of any characteristic NH-NH (i, i+1) or C(alpha)H-C(beta)H (i, i+3) NOE connectivities, high ddelta/dT values (greater-than-or-equal-to 0.004), and the fast H-1/H-2 amide exchange suggest that the histatin peptide favors unfolded random conformations in aqueous solution at pH 3.8. In contrast, the J(NH-C)alpha(H) values (less-than-or-equal-to 6.5 Hz), slow H-1/H-2 exchange, low ddelta/dT values (less-than-or-equal-to 0.003) observed for amide resonances of residues 5-16, and the characteristic NH-NH (i, i+1), C(alpha)H-C(beta)H (i, i+3) NOE connectivities, provide evidence for the presence of largely alpha-helical conformations in dimethyl sulfoxide, which mimics the polar aprotic membrane environment. In methanolic solutions, 3(10)-helical conformations could exist as a minor population together with the major alpha-helical conformations. Fourier transform infrared spectroscopy and CD data indicate that lipid environments such as dimyristoylphosphatidylcholine vesicles could induce the peptide to fold into predominantly alpha-helical conformation. The results suggest that in dimethyl sulfoxide and dimyristoylphosphatidylcholine vesicles the candidacidal domain of salivary histatin 5 prefers a largely helical conformation, which could facilitate its interaction with the membrane of Candida albicans. The mechanism of antimicrobial action of this class of polypeptides appears to involve primarily electrostatic and hydrogen-bonding interaction of cationic and polar residues with the head groups of the plasma membranes of target cells.	SUNY BUFFALO, DENT RES INST, BUFFALO, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	RAJ, PA (corresponding author), SUNY BUFFALO, DEPT ORAL BIOL, BUFFALO, NY 14214 USA.		RAJ, PROFESSORDES/AAA-1007-2020	RAJ, PROFESSORDES/0000-0002-4050-4778	NIDCR NIH HHS [DE08240, DE07585] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE008240, P01DE007585] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BEVINS CL, 1990, ANNU REV BIOCHEM, V59, P395, DOI 10.1146/annurev.bi.59.070190.002143; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BRAUNSCHWEILER L, 1984, J MAGN RESON, V47, P328; Bystrov V. F., 1976, PROGR NMR SPECTROSCO, V10, P41; CLORE GM, 1986, EMBO J, V5, P2729, DOI 10.1002/j.1460-2075.1986.tb04557.x; DALBEY RE, 1990, TRENDS BIOCHEM SCI, V15, P253, DOI 10.1016/0968-0004(90)90047-F; DAVIS DG, 1985, J AM CHEM SOC, V107, P2820, DOI 10.1021/ja00295a052; DYSON HJ, 1988, ANNU REV BIOPHYS BIO, V17, P305; DYSON HJ, 1991, ANNU REV BIOPHYS BIO, V20, P519; Edgerton M., 1993, Journal of Dental Research, V72, P322; EICH G, 1982, J AM CHEM SOC, V104, P3731, DOI 10.1021/ja00377a036; EPAND RM, 1987, J BIOL CHEM, V262, P9389; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GYSIN B, 1983, FEBS LETT, V158, P12, DOI 10.1016/0014-5793(83)80666-8; HAY DI, 1975, ARCH ORAL BIOL, V20, P553, DOI 10.1016/0003-9969(75)90073-4; HOLBROOK IB, 1975, BIOCHEM J, V149, P489, DOI 10.1042/bj1490489; IQBAL M, 1981, BIOCHEMISTRY-US, V20, P7278, DOI 10.1021/bi00528a035; JELICKS LA, 1989, BIOCHEMISTRY-US, V28, P4233, DOI 10.1021/bi00436a017; JUNG G, 1975, EUR J BIOCHEM, V54, P395, DOI 10.1111/j.1432-1033.1975.tb04150.x; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; KENNEDY DF, 1991, BIOCHEMISTRY-US, V30, P6541, DOI 10.1021/bi00240a026; KESSLER H, 1982, ANGEW CHEM INT EDIT, V21, P512, DOI 10.1002/anie.198205121; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V64, P2229; LAL K, 1992, ARCH ORAL BIOL, V37, P7, DOI 10.1016/0003-9969(92)90146-Y; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; MACKAY BJ, 1984, INFECT IMMUN, V44, P695, DOI 10.1128/IAI.44.3.695-701.1984; MACKAY BJ, 1984, INFECT IMMUN, V44, P688, DOI 10.1128/IAI.44.3.688-694.1984; MAYR W, 1979, BIOPOLYMERS, V18, P425, DOI 10.1002/bip.1979.360180217; MILLER BE, 1988, APPL SPECTROSC, V42, P401, DOI 10.1366/0003702884427933; MILON A, 1990, BIOCHEMISTRY-US, V29, P65, DOI 10.1021/bi00453a009; MINAGUCHI K, 1989, J DENT RES, V68, P2, DOI 10.1177/00220345890680010201; MIYATA T, 1989, J BIOCHEM, V106, P663, DOI 10.1093/oxfordjournals.jbchem.a122913; MURAKAMI Y, 1992, FEMS MICROBIOL LETT, V98, P201; MURAKAMI Y, 1991, INFECT IMMUN, V59, P3284, DOI 10.1128/IAI.59.9.3284-3286.1991; MURAKAMI Y, 1990, ARCH ORAL BIOL, V35, P775, DOI 10.1016/0003-9969(90)90103-H; OEKONOMOPULOS R, 1980, BIOPOLYMERS, V19, P203, DOI 10.1002/bip.1980.360190114; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; OPPENHEIM FG, 1986, J BIOL CHEM, V261, P1177; OPPENHEIM FG, 1989, HUMAN SALIVA CLIN CH; OPPENHEIM FG, 1985, J DENT RES, V64, P238; PARDI A, 1983, EUR J BIOCHEM, V137, P445, DOI 10.1111/j.1432-1033.1983.tb07848.x; POLLOCK JJ, 1984, INFECT IMMUN, V44, P702, DOI 10.1128/IAI.44.3.702-707.1984; RAJ PA, 1988, BIOPOLYMERS, V27, P683, DOI 10.1002/bip.360270411; RAJ PA, 1990, J BIOL CHEM, V265, P3898; RAJ PA, 1990, BIOPOLYMERS, V30, P73, DOI 10.1002/bip.360300109; RAJ PA, 1992, J BIOL CHEM, V267, P5968; RAJ PA, 1985, BIOPOLYMERS, V24, P1131, DOI 10.1002/bip.360240703; RANCE M, 1986, J MAGN RESON, V66, P372, DOI 10.1016/0022-2364(86)90043-0; RAVI A, 1983, J AM CHEM SOC, V105, P105, DOI 10.1021/ja00339a019; RICHARDSON CF, 1993, ARCH ORAL BIOL, V38, P997, DOI 10.1016/0003-9969(93)90113-Z; ROSE GD, 1985, ADV PROTEIN CHEM, V37, P1, DOI 10.1016/S0065-3233(08)60063-7; SANTARPIA RP, 1990, ORAL MICROBIOL IMMUN, V5, P226, DOI 10.1111/j.1399-302X.1990.tb00651.x; SANTARPIA RP, 1992, ORAL MICROBIOL IMMUN, V7, P38, DOI 10.1111/j.1399-302X.1992.tb00018.x; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; STRAND SW, 1991, AM LAB, V23, P28; SUDHA TS, 1983, INT J PEPT PROT RES, V22, P464; SWEDBERG SA, 1990, ANAL BIOCHEM, V186, P153, DOI 10.1016/0003-2697(90)90589-2; TROXLER RF, 1990, J DENT RES, V69, P2, DOI 10.1177/00220345900690010101; VANDERSPEK JC, 1990, ARCH ORAL BIOL, V35, P137, DOI 10.1016/0003-9969(90)90175-A; VIJAYAKUMAR EKS, 1984, BIOPOLYMERS, V23, P877, DOI 10.1002/bip.360230505; VIJAYAKUMAR EKS, 1983, TETRAHEDRON, V39, P2725, DOI 10.1016/S0040-4020(01)91984-2; WILLARD HH, 1981, INSTRUMENTAL METHODS; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Wuthrich K., 1986, NMR PROTEINS NUCL AC; Wuthrich K, 1976, NMR BIOL RES PEPTIDE; XU T, 1991, INFECT IMMUN, V59, P2549, DOI 10.1128/IAI.59.8.2549-2554.1991; XU T, 1990, J DENT RES, V69, P1717, DOI 10.1177/00220345900690110301; XU T, 1992, Journal of Dental Research, V71, P305; 1968, BIOCHEMISTRY-US, V7, P2703	70	54	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9610	9619						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144548				2022-12-27	WOS:A1994NE05300035
J	WATANABE, T; SHINTANI, A; NAKATA, M; SHING, Y; FOLKMAN, J; IGARASHI, K; SASADA, R				WATANABE, T; SHINTANI, A; NAKATA, M; SHING, Y; FOLKMAN, J; IGARASHI, K; SASADA, R			RECOMBINANT HUMAN BETACELLULIN - MOLECULAR-STRUCTURE, BIOLOGICAL-ACTIVITIES, AND RECEPTOR INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; FACTOR-ALPHA; EGF RECEPTOR; SIGNAL TRANSDUCTION; FACTOR PRECURSOR; MYXOMA VIRUS; CELLS; BINDING; PROTEIN; SEQUENCE	Soluble forms of human betacellulin (BTC) were purified to homogeneity from the conditioned medium of mouse A9 cells transfected with the BTC precursor cDNA. Three types of soluble BTC, designated BTC-1a, BTC-1b and BTC-2, were resolved by cation-exchange and size-exclusion column chromatography. Physico-chemical analysis has revealed that BTC-1a represents the glycosylated, intact molecule composed of 80 amino acid residues (Asp32 to Tyr111 of the precursor molecule). BTC-1b appears to be a truncated molecule lacking 12 amino acid residues from the amino terminus of BTC-1a. BTC-2 was found to be a 50-amino acid molecule (Arg62 to Tyr111) that corresponds to the epidermal growth factor (EGF) structural unit. The biological activities of these BTC molecules were essentially identical as judged by their mitogenicity on Balb/c 3T3 fibroblasts. BTC and EGF were equipotent in stimulating Balb/c 3T3 cell proliferation and rat mesangial cell Ca2+ mobilization as well as in inhibiting the growth of human epidermoid carcinoma A431 cells. BTC and EGF antagonized each other with similar dose dependence for binding to A431 cells, indicating that these factors bind the same receptor molecules with equivalent avidity. The K(d) value of EGF receptor (EGFR) and BTC is 0.5 nM as determined on Balb/c 3T3 cells. In addition, human mammary carcinoma MDA-MB-453 cells, which express multiple members of the EGFR family, were found to possess 2.7 x 10(3) BTC binding sites/cell, and the binding was readily quenched by EGF. These results suggest that the primary receptor for BTC is EGFR.	HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT SURG,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard Medical School	WATANABE, T (corresponding author), TAKEDA CHEM IND LTD,DIV DISCOVERY,DEPT V,DISCOVERY RES LABS 2,OSAKA 532,JAPAN.							ANKLESARIA P, 1990, P NATL ACAD SCI USA, V87, P3289, DOI 10.1073/pnas.87.9.3289; BESNER G, 1990, CELL REGUL, V1, P811, DOI 10.1091/mbc.1.11.811; Besner GE, 1992, GROWTH FACTORS, V7, P289, DOI 10.3109/08977199209046411; BRACHMANN R, 1989, CELL, V56, P691, DOI 10.1016/0092-8674(89)90591-6; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; CARPENTER G, 1990, HDB EXPT PHARM, V95, P69; CHANG W, 1987, MOL CELL BIOL, V7, P535, DOI 10.1128/MCB.7.1.535; COOK PW, 1991, MOL CELL BIOL, V11, P2547, DOI 10.1128/MCB.11.5.2547; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DERYNCK R, 1992, ADV CANCER RES, V58, P27, DOI 10.1016/S0065-230X(08)60289-4; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; JOLLY DJ, 1983, P NATL ACAD SCI-BIOL, V80, P477, DOI 10.1073/pnas.80.2.477; KIMURA H, 1993, P NATL ACAD SCI USA, V90, P2165, DOI 10.1073/pnas.90.6.2165; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN YZ, 1991, BIOCHEMISTRY-US, V30, P3310, DOI 10.1021/bi00227a020; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; LUPU R, 1990, SCIENCE, V249, P1552, DOI 10.1126/science.2218496; MARQUARDT H, 1983, P NATL ACAD SCI-BIOL, V80, P4684; Marshall R D, 1974, Biochem Soc Symp, P17; MASSAGUE J, 1990, J BIOL CHEM, V265, P21393; MASSAGUE J, 1983, J BIOL CHEM, V258, P3614; MONTELIONE GT, 1987, P NATL ACAD SCI USA, V84, P5226, DOI 10.1073/pnas.84.15.5226; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MROCZKOWSKI B, 1989, MOL CELL BIOL, V9, P2771, DOI 10.1128/MCB.9.7.2771; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; ORITA Y, 1985, FEBS LETT, V192, P155, DOI 10.1016/0014-5793(85)80063-6; PANDIELLA A, 1991, P NATL ACAD SCI USA, V88, P1726, DOI 10.1073/pnas.88.5.1726; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; PLOWMAN GD, 1990, P NATL ACAD SCI USA, V87, P4905, DOI 10.1073/pnas.87.13.4905; PRIGENT SA, 1992, ONCOGENE, V7, P1273; RALL LB, 1985, NATURE, V313, P228, DOI 10.1038/313228a0; Sambrook J, 1989, MOL CLONING LABORATO; SASADA R, 1988, MOL CELL BIOL, V8, P588, DOI 10.1128/MCB.8.2.588; SASADA R, 1988, CELL STRUCT FUNCT, V13, P129, DOI 10.1247/csf.13.129; SASADA R, 1987, CELL STRUCT FUNCT, V12, P205, DOI 10.1247/csf.12.205; SASADA R, 1993, BIOCHEM BIOPH RES CO, V190, P1173, DOI 10.1006/bbrc.1993.1173; SHING Y, 1993, SCIENCE, V259, P1604, DOI 10.1126/science.8456283; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; SHOYAB M, 1988, P NATL ACAD SCI USA, V85, P6528, DOI 10.1073/pnas.85.17.6528; STROOBANT P, 1985, CELL, V42, P383, DOI 10.1016/S0092-8674(85)80133-1; TAKAYASUOKISHIO M, 1990, BIOCHEM PHARMACOL, V40, P2713; UPTON C, 1987, J VIROL, V61, P1271, DOI 10.1128/JVI.61.4.1271-1275.1987; VENKATESAN S, 1982, J VIROL, V44, P637, DOI 10.1128/JVI.44.2.637-646.1982; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; WONG ST, 1989, CELL, V56, P495, DOI 10.1016/0092-8674(89)90252-3; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0	57	96	101	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9966	9973						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144591				2022-12-27	WOS:A1994NE05300087
J	QUINTANA, J; HIPKIN, RW; ASCOLI, M; SANCHEZYAGUE, J				QUINTANA, J; HIPKIN, RW; ASCOLI, M; SANCHEZYAGUE, J			FOLLITROPIN (FSH) AND A PHORBOL ESTER STIMULATE THE PHOSPHORYLATION OF THE FSH RECEPTOR IN INTACT-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEYDIG TUMOR-CELLS; MUSCARINIC CHOLINERGIC RECEPTORS; HUMAN CHORIO-GONADOTROPIN; PROTEIN KINASE-C; ADENYLYL CYCLASE; CYCLIC-AMP; ADENOSINE-MONOPHOSPHATE; CAMP-PHOSPHODIESTERASE; SIGNALING PATHWAYS; CA2+ MOBILIZATION	Using a cell line stably transfected with the rat follitropin (FSH) receptor cDNA we demonstrate that the FSH receptor becomes phosphorylated when cells are exposed to FSH. Since binding of FSH to its receptor results in an increase in cAMP and inositol phosphate accumulation, we examined the potential involvement of protein kinase A and C in mediating receptor phosphorylation. Stimulation of protein kinase A does not appear to be necessary because hFSH-induced receptor phosphorylation was minimally impaired in a cell line that overexpresses cAMP phosphodiesterase. Moreover, stimulation of the protein kinase A pathway with other agonists result in minimal phosphorylation of the FSH receptor. Stimulation of the protein kinase C with a phorbol ester did result in an increase in receptor phosphorylation, and down-regulation of the protein kinase C decreased, but did not abolish, the FSH-induced receptor phosphorylation. The possible impact of phosphorylation on the functions of the receptor was examined by testing if conditions that lead to phosphorylation decrease the ability of FSH to stimulate cAMP synthesis. Our data show that as with the addition of FSH, addition of a phorbol ester also results in a decrease in the ability of FSH to stimulate cAMP synthesis.	UNIV IOWA,COLL MED,DEPT PHARMACOL,IOWA CITY,IA 52242	University of Iowa			Yague, Jesus Sanchez/B-7792-2008; Quintana, José/K-5709-2014	Quintana, José/0000-0001-8225-4538; Sanchez-Yague, Jesus/0000-0003-0409-3198	FIC NIH HHS [TW-04655] Funding Source: Medline; NICHD NIH HHS [HD28962] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028962] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [F05TW004655] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		ASCOLI M, 1982, J BIOL CHEM, V257, P13306; ASCOLI M, 1989, J BIOL CHEM, V264, P6674; ASHKENAZI A, 1987, SCIENCE, V238, P672, DOI 10.1126/science.2823384; BALLISTER R, 1987, J BIOL CHEM, V260, P15194; BOUVIER M, 1987, J BIOL CHEM, V262, P3106; Bradford M. M., 1976, ANAL BIOCHEM, V53, P304; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; CHABRE O, 1992, MOL ENDOCRINOL, V6, P551, DOI 10.1210/me.6.4.551; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COTECCHIA S, 1990, J BIOL CHEM, V265, P63; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; EKSTROM RC, 1989, ENDOCRINOLOGY, V125, P2470, DOI 10.1210/endo-125-5-2470; GUDERMANN T, 1992, MOL ENDOCRINOL, V6, P272, DOI 10.1210/me.6.2.272; GUDERMANN T, 1992, J BIOL CHEM, V267, P4479; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HIPKIN RW, 1993, MOL ENDOCRINOL, V7, P823, DOI 10.1210/me.7.7.823; HIPKIN RW, 1992, MOL ENDOCRINOL, V6, P2210, DOI 10.1210/me.6.12.2210; HOELSCHER SR, 1993, ENDOCRINOLOGY, V132, P2229, DOI 10.1210/en.132.5.2229; KAMEYAMA K, 1993, J BIOL CHEM, V268, P7753; KOSUGI S, 1992, J BIOL CHEM, V267, P24153; KWATRA MM, 1993, J BIOL CHEM, V268, P9161; LEFKOWITZ RJ, 1990, TRENDS PHARMACOL SCI, V11, P190, DOI 10.1016/0165-6147(90)90113-M; MAJERUS PW, 1988, J BIOL CHEM, V263, P3051; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; NAGAYAMA Y, 1992, MOL ENDOCRINOL, V6, P145, DOI 10.1210/me.6.2.145; PALCZEWSKI K, 1991, TRENDS BIOCHEM SCI, V16, P387, DOI 10.1016/0968-0004(91)90157-Q; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; QUINTANA J, 1993, ENDOCRINOLOGY, V133, P2098, DOI 10.1210/en.133.5.2098; REBOIS RV, 1986, ENDOCRINOLOGY, V118, P2340, DOI 10.1210/endo-118-6-2340; REBOIS RV, 1985, J BIOL CHEM, V260, P8026; RICHARDSON RM, 1993, J BIOL CHEM, V268, P13650; RICHARDSON RM, 1992, J BIOL CHEM, V267, P10127; RICHARDSON RM, 1992, J BIOL CHEM, V267, P22249; SANCHEZYAGUE J, 1992, J BIOL CHEM, V267, P7217; SANCHEZYAGUE J, 1993, ENDOCRINOLOGY, V132, P1007, DOI 10.1210/en.132.3.1007; SEGALOFF DL, 1993, ENDOCR REV, V14, P324, DOI 10.1210/er.14.3.324; SHIBATA EF, 1992, ENDOCRINOLOGY, V131, P979, DOI 10.1210/en.131.2.979; SOLANKI V, 1981, P NATL ACAD SCI-BIOL, V78, P1722, DOI 10.1073/pnas.78.3.1722; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; SWINNEN JV, 1991, J BIOL CHEM, V266, P14383; SWINNEN JV, 1989, P NATL ACAD SCI USA, V86, P8197, DOI 10.1073/pnas.86.21.8197; VANSANDE J, 1990, MOL CELL ENDOCRINOL, V74, pR1, DOI 10.1016/0303-7207(90)90209-Q; WANG Z, 1993, MOL ENDOCRINOL, V7, P85, DOI 10.1210/me.7.1.85; ZHOU XM, 1991, J BIOL CHEM, V266, P7462	44	93	95	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8772	8779						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132609				2022-12-27	WOS:A1994NB41100026
J	TING, SM; DIGNAM, JD				TING, SM; DIGNAM, JD			POSTTRANSCRIPTIONAL REGULATION OF GLUTAMYL-PROLYL-TRANSFER-RNA SYNTHETASE IN RAT SALIVARY-GLAND	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; PROTEIN MULTIGENE FAMILIES; ALANYL-TRANSFER RNA; MESSENGER-RNA; ESCHERICHIA-COLI; BOMBYX-MORI; UNTRANSLATED REGION; GLYCYL-TRANSFER; HEAT-SHOCK; AMINOACYL	Treatment of rats with isoproterenol resulted in elevated levels of prolyl- and glutamyl-tRNA synthetase activities in the parotid and submandibular glands. This increase in enzyme activity was accompanied by an increase in the bi-functional glutamyl-prolyl-tRNA synthetase and of a low molecular weight form of prolyl-tRNA synthetase. Isoproterenol also induced the synthesis of proline-rich glycoproteins in the parotid and submandibular glands. Withdrawal from the drug was accompanied by a decline in prolyl- and glutamyl-tRNA synthetase activities and by a decline in the levels of proline-rich glycoproteins in the salivary gland. During the time course of isoproterenol treatment, little change in the levels of mRNA encoding the bi-functional glutamyl-prolyl-tRNA synthetase was detected by Northern blot analysis. These results indicate that the synthesis of glutamyl-prolyl-tRNA synthetase is regulated at a posttranscriptional step and that the synthesis of this bifunctional protein may be linked to the utilization of proline and glutamic acid in protein synthesis.	MED COLL OHIO, DEPT BIOCHEM & MOLEC BIOL, TOLEDO, OH 43699 USA						NIDCR NIH HHS [DE09669] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE009669] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ANN DK, 1987, J BIOL CHEM, V262, P899; AZIZ N, 1987, P NATL ACAD SCI USA, V84, P8478, DOI 10.1073/pnas.84.23.8478; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNGRANT K, 1961, NATURE, V191, P1076, DOI 10.1038/1911076a0; CARLSON DM, 1991, PROG NUCLEIC ACID RE, V41, P1; CASEY JL, 1989, EMBO J, V8, P3693, DOI 10.1002/j.1460-2075.1989.tb08544.x; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; CHAPEVILLE F, 1962, P NATL ACAD SCI USA, V48, P1086, DOI 10.1073/pnas.48.6.1086; CHAVANCY G, 1979, BIOCHIMIE, V61, P71, DOI 10.1016/S0300-9084(79)80314-4; CHEUNG AY, 1985, J BACTERIOL, V161, P212, DOI 10.1128/JB.161.1.212-218.1985; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; DELMONTE U, 1975, FEBS LETT, V49, P380; DIGNAM SS, 1984, J BIOL CHEM, V259, P4043; ENOCH T, 1986, MOL CELL BIOL, V6, P801, DOI 10.1128/MCB.6.3.801; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; FETT R, 1991, J BIOL CHEM, V266, P1448; FREIST W, 1989, BIOCHEMISTRY-US, V28, P6787, DOI 10.1021/bi00443a001; GARRET M, 1991, BIOCHEMISTRY-US, V30, P7809, DOI 10.1021/bi00245a021; GILLAM IC, 1981, SELECTED METHODS ENZ, P43; HATFIELD D, 1982, J BIOL CHEM, V257, P3183; HENTZEN D, 1981, NATURE, V290, P267, DOI 10.1038/290267a0; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HOAGLAND MB, 1956, J BIOL CHEM, V218, P345; JOHNSON RC, 1977, J BIOL CHEM, V252, P878; KAISER E, 1992, J MOL EVOL, V34, P45, DOI 10.1007/BF00163851; KELLERMANN O, 1982, J BIOL CHEM, V257, P1041; KERJAN P, 1992, BIOCHIMIE, V74, P195, DOI 10.1016/0300-9084(92)90046-H; KLEMENZ R, 1985, EMBO J, V4, P2053, DOI 10.1002/j.1460-2075.1985.tb03891.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANKER S, 1992, CELL, V70, P647, DOI 10.1016/0092-8674(92)90433-D; LAZARD L, 1992, FEBS LETT, V216, P27; LAZARD M, 1987, J BIOL CHEM, V262, P3982; MAJIMA R, 1975, J BIOCHEM-TOKYO, V78, P391, DOI 10.1093/oxfordjournals.jbchem.a130919; MEHANSHO H, 1985, J BIOL CHEM, V260, P4418; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MIRANDE M, 1991, PROG NUCLEIC ACID RE, V40, P95; MISETA A, 1991, J BIOL CHEM, V266, P19158; MUELLER PP, 1987, P NATL ACAD SCI USA, V84, P2863, DOI 10.1073/pnas.84.9.2863; NADA S, 1993, J BIOL CHEM, V268, P7660; RABEN N, 1992, NUCLEIC ACIDS RES, V20, P1075, DOI 10.1093/nar/20.5.1075; REEH S, 1977, J BACTERIOL, V129, P702, DOI 10.1128/JB.129.2.702-706.1977; Sambrook J, 1989, MOL CLONING LABORATO; SANFACON H, 1983, GENE, V22, P175, DOI 10.1016/0378-1119(83)90101-4; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; SCHRAY B, 1991, NUCLEIC ACIDS RES, V19, P5307, DOI 10.1093/nar/19.19.5307; SELYE H, 1961, GROWTH, V25, P243; SMITH DE, 1984, J CELL BIOL, V99, P20, DOI 10.1083/jcb.99.1.20; SPRINGER M, 1989, EMBO J, V8, P2417, DOI 10.1002/j.1460-2075.1989.tb08372.x; TING SM, 1992, J BIOL CHEM, V267, P17701; VISWANATHAN S, 1988, DEV BIOL, V129, P350, DOI 10.1016/0012-1606(88)90382-X	51	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8993	8998						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132637				2022-12-27	WOS:A1994NB41100057
J	BOHMAN, C; BALZARINI, J; WIGERINCK, P; VANAERSCHOT, A; HERDEWIJN, P; DECLERCQ, E				BOHMAN, C; BALZARINI, J; WIGERINCK, P; VANAERSCHOT, A; HERDEWIJN, P; DECLERCQ, E			MECHANISM OF CYTOSTATIC ACTION OF NOVEL 5-(THIEN-2-YL)-SUBSTITUTED AND 5-(FURAN-2-YL)-SUBSTITUTED PYRIMIDINE NUCLEOSIDE ANALOGS AGAINST TUMOR-CELLS TRANSFECTED BY THE THYMIDINE KINASE GENE OF HERPES-SIMPLEX VIRUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELA TK-CELLS; THYMIDYLATE SYNTHETASE; FM3A CELLS; (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE BVDU; ANTIVIRAL ACTIVITY; TARGET ENZYME; BRAIN-TUMORS; TYPE-1; 2'-DEOXYURIDINES; ESTABLISHMENT	Several novel 5-substituted 2'-deoxyuridine (dUrd) analogues were evaluated as substrates for highly purified herpes simplex virus type 1 (HSV-1)-encoded thymidine kinase (TK) derived from HSV-1 TK gene-transfected murine mammary carcinoma FM3A cells, and human platelet thymidine (dThd) phosphorylase. The K-i of 5-(furan-2-yl)-dUrd, 5-(thien-2-yl)-dUrd and 5-(thien-2-yl)-dCyd for HSV-1 TK was 0.94, 0.71, and 1.32 mu M, respectively. Inhibition was competitive with respect to the natural substrate dThd. With dCyd as substrate, the K-i of 5-(thien-2 yl)-dCyd for HSV-1 TK was 4.5 mu M (K-i/K-m = 0.17). In striking contrast with (E)-5-(2-bromovinyl)-dUrd, the 5-(thien-2-yl)- and 5-(furan-2-yl)-dUrd derivatives were not substrates for human dThd phosphorylase. 5-(Thien-2-yl)-dUrd, 5-(furan-2-yl) dUrd and 5-(thien-2-yl)-dCyd were at least 100-fold more cytostatic to the HSV TK gene-transfected FM3A tumor cells than wild-type FM3A/0 cells. The viral TK expressed in the HSV-1 TK gene-transfected tumor cells merely acts as an activating enzyme, whereas thymidylate synthase serves as the target enzyme for the cytostatic action of the compounds. The novel 5-substituted dUrd analogues should be further pursued as candidate drugs in the treatment of HSV TK gene-transfected tumors.			BOHMAN, C (corresponding author), KATHOLIEKE UNIV LEUVEN,REGA INST MED RES,MINDERBROEDERSSTRAAT 10,B-3000 LOUVAIN,BELGIUM.			De Clercq, Erik/0000-0002-2985-8890; Van Aerschot, Arthur/0000-0003-3528-8588; Herdewijn, Piet/0000-0003-3589-8503				AYUSAWA D, 1981, CANCER RES, V41, P1497; AYUSAWA D, 1980, SOMAT CELL GENET, V6, P261, DOI 10.1007/BF01538800; AYUSAWA D, 1985, JPN J CANCER RES, V76, P984; BALZARINI J, 1989, METHOD FIND EXP CLIN, V11, P379; BALZARINI J, 1987, MOL PHARMACOL, V32, P410; BALZARINI J, 1984, BIOCHIM BIOPHYS ACTA, V785, P36, DOI 10.1016/0167-4838(84)90231-0; BALZARINI J, 1985, FEBS LETT, V185, P95, DOI 10.1016/0014-5793(85)80747-X; BALZARINI J, 1985, METHOD FIND EXP CLIN, V7, P19; BALZARINI J, 1993, J BIOL CHEM, V268, P6332; BALZARINI J, 1985, MOL PHARMACOL, V28, P581; CHENG YC, 1976, J BIOL CHEM, V251, P2605; CHENG YC, 1976, BIOCHIM BIOPHYS ACTA, V452, P370, DOI 10.1016/0005-2744(76)90186-8; COLBEREGARAPIN F, 1979, P NATL ACAD SCI USA, V76, P3755, DOI 10.1073/pnas.76.8.3755; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; DECLERCQ E, 1993, ADV VIRUS RES, V42, P1, DOI 10.1016/S0065-3527(08)60082-2; DECLERCQ E, 1983, PURE APPL CHEM, V55, P623, DOI 10.1351/pac198855040623; DECLERCQ E, 1981, MOL PHARMACOL, V19, P321; DECLERCQ E, 1985, APPROACHES ANTIVIRAL, P57; DESGRANGES C, 1983, BIOCHEM PHARMACOL, V32, P3583, DOI 10.1016/0006-2952(83)90307-6; Ives D H, 1978, Methods Enzymol, V51, P337; KOWAL EP, 1976, PREP BIOCHEM, V6, P369, DOI 10.1080/00327487608061625; KOWAL EP, 1975, FED PROC, V34, P700; MANCINI WR, 1983, J BIOL CHEM, V258, P792; NAKANO N, 1966, TOHOKU J EXP MED, V88, P69, DOI 10.1620/tjem.88.69; SHIMIZU K, 1986, CELL STRUCT FUNCT, V11, P295, DOI 10.1247/csf.11.295; TAKAMIYA Y, 1992, J NEUROSCI RES, V33, P493, DOI 10.1002/jnr.490330316; WIGERINCK P, 1991, J MED CHEM, V34, P1767, DOI 10.1021/jm00110a003; WIGERINCK P, 1991, J MED CHEM, V34, P2383, DOI 10.1021/jm00112a011	28	29	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8036	8043						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132526				2022-12-27	WOS:A1994NB40900034
J	CHEN, Y; YU, L				CHEN, Y; YU, L			DIFFERENTIAL REGULATION BY CAMP-DEPENDENT PROTEIN-KINASE AND PROTEIN-KINASE-C OF THE MU-OPIOID RECEPTOR COUPLING TO A G-PROTEIN-ACTIVATED K+ CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							INDUCED POTASSIUM CURRENT; GUINEA-PIG; RAT; NEURONS; FAMILY; CELLS; CONDUCTANCE; ANALGESIA; CALCIUM; NODE	A mu opioid receptor and a G protein-activated K+ channel were coexpressed in Xenopus oocytes. Stimulation of the mu opioid receptor induced an inwardly rectifying current that was blocked by opioid receptor antagonist naloxone, indicating that the mu opioid receptor is functionally coupled to the K+ channel. The coupling is mediated by G proteins, since pertussis toxin treatment reduced the K+ current and injection of GTP gamma S (guanosine 5'-O-(thiotriphosphate)) enhanced it. Repeated stimulation of the mu receptor leads to desensitization, as the K+ current from the second stimulation was reduced to 70% of that from the first one. Both cAMP-dependent protein kinase (PKA) and protein kinase C (PKC) regulate this process, but in opposite direction. Activation of PKC by treatment of the oocyte with phorbol ester potentiated the desensitization of the mu receptor-induced current. However, incubation of the cell with a membrane-permeable cAMP analog, 8-chlorophenylthio-cAMP, completely abolished the desensitization. The cAMP effect appears to be mediated by PKA, since injection of a PKA catalytic subunit showed the same effect as cAMP incubation. These results suggest that PKA and PKC differentially regulate the mu opioid receptor coupling to the G protein-activated K+ channel.	INDIANA UNIV,SCH MED,DEPT MED & MOLEC GENET,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis					NINDS NIH HHS [NS01557, NS28190] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K04NS001557, R29NS028190] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; ATTALI B, 1989, J BIOL CHEM, V264, P347; BEAR CE, 1991, J BIOL CHEM, V266, P19142; BOURINET E, 1992, FEBS LETT, V299, P5, DOI 10.1016/0014-5793(92)80087-W; CARIELLO NF, 1991, NUCLEIC ACIDS RES, V19, P4193, DOI 10.1093/nar/19.15.4193; CARTER BD, 1993, P NATL ACAD SCI USA, V90, P4062, DOI 10.1073/pnas.90.9.4062; CAUDLE RM, 1990, J PHARMACOL EXP THER, V252, P1361; CHAILLET P, 1984, EUR J PHARMACOL, V101, P83, DOI 10.1016/0014-2999(84)90033-5; CHEN Y, 1993, MOL PHARMACOL, V44, P8; CHEN Y, 1994, FEBS LETT, V336, P191; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P6596, DOI 10.1073/pnas.90.14.6596; EINHORN LC, 1991, J NEUROSCI, V11, P3727; GOLDSTEIN A, 1987, TRENDS PHARMACOL SCI, V8, P456, DOI 10.1016/0165-6147(87)90038-1; KREBS EG, 1989, JAMA-J AM MED ASSOC, V262, P1815, DOI 10.1001/jama.262.13.1815; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KURTZ A, 1989, P NATL ACAD SCI USA, V86, P3423, DOI 10.1073/pnas.86.9.3423; LEFKOWITZ RJ, 1988, J BIOL CHEM, V263, P4993; MIHARA S, 1987, J PHYSIOL-LONDON, V390, P335, DOI 10.1113/jphysiol.1987.sp016704; MIYAKE M, 1989, P NATL ACAD SCI USA, V86, P3419, DOI 10.1073/pnas.86.9.3419; NOMA A, 1979, PFLUG ARCH EUR J PHY, V381, P255, DOI 10.1007/BF00583257; NOMA A, 1978, PFLUG ARCH EUR J PHY, V377, P193, DOI 10.1007/BF00584272; NORTH RA, 1987, P NATL ACAD SCI USA, V84, P5487, DOI 10.1073/pnas.84.15.5487; OFFERMANNS S, 1991, J BIOL CHEM, V266, P3365; PASTERNAK GW, 1980, SCIENCE, V208, P514, DOI 10.1126/science.6245448; PASTERNAK GW, 1988, OPIATE RECEPTORS; SHEARMAN MS, 1989, PHARMACOL REV, V41, P211; SHEN KZ, 1992, J PHYSIOL-LONDON, V445, P581, DOI 10.1113/jphysiol.1992.sp018941; SIBLEY DR, 1985, NATURE, V317, P124, DOI 10.1038/317124a0; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; UEDA H, 1988, P NATL ACAD SCI USA, V85, P7013, DOI 10.1073/pnas.85.18.7013; WILLIAMS JT, 1988, J NEUROSCI, V8, P4299; WIMPEY TL, 1991, NEURON, V6, P281, DOI 10.1016/0896-6273(91)90363-5; YU L, 1991, MOL BRAIN RES, V11, P143, DOI 10.1016/0169-328X(91)90116-F	33	172	180	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7839	7842						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132498				2022-12-27	WOS:A1994NB40900002
J	LOU, H; HAMMOND, L; SHARMA, V; SPARKES, RS; LUSIS, AJ; STOLZ, A				LOU, H; HAMMOND, L; SHARMA, V; SPARKES, RS; LUSIS, AJ; STOLZ, A			GENOMIC ORGANIZATION AND CHROMOSOMAL LOCALIZATION OF A NOVEL HUMAN HEPATIC DIHYDRODIOL DEHYDROGENASE WITH HIGH-AFFINITY BILE-ACID BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; CYCLICAL OXIDATION REDUCTION; MOUSE VAS-DEFERENS; RAT-LIVER; CHLORDECONE REDUCTASE; S-TRANSFERASES; C-3 POSITION; GENE; INDOMETHACIN; PROTEIN	We previously characterized and cloned a unique human hepatic dihydrodiol dehydrogenase (DDH) that exhibits high affinity binding for bile acids (Stolz, A., Hammond, L., Leu, H., Takikawa, H., Ronk, M., and Shivery, J. E. (1993) J. Biol. Chen. 268, 10448-10457). This hepatic dihydrodiol dehydrogenase demonstrates significant sequence homology with the cytosolic rat bile acid binder 3 alpha-hydroxysteroid dehydrogenase and other members of the monomeric oxidoreductase gene family. We now report the genomic organization and chromosomal localization of the human hepatic DDH in order to further define its physiological role and provide additional insight into the development of this gene family. The 15-kilobase human hepatic DDH gene was contained in an overlapping cosmid and lambda genomic clones and is composed of nine exons. A major transcriptional start site was determined to be 30 base pairs upstream from the ATG initiation methionine by both primer extension and S1 nuclease mapping studies. The human hepatic DDH gene was mapped by chromosomal in situ hybridization and analysis of human-mouse somatic cell hybrids to the tip of the short arm of chromosome 10 at p14. Strict conservation of the intron-exon junctions in the human hepatic DDH and two other members of the monomeric oxidoreductase gene family, aldose reductase and mouse major vas deferens protein suggests evolution from a common ancestral gene. Human hepatic DDH mRNA was identified in both human hepatoma Hep G2 and human lung carcinoma cell line NCI-H322 by RN'ase protection; thus, these cell lines will be useful in examining the regulation of the gene.	UNIV SO CALIF, DIV GASTROINTESTINAL & LIVER DIS, LOS ANGELES, CA 90033 USA; UNIV CALIF LOS ANGELES, DEPT MICROBIOL, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, INST MOLEC BIOL, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT MED, DIV CARDIOL, LOS ANGELES, CA 90024 USA	University of Southern California; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1 RR-43] Funding Source: Medline; NHLBI NIH HHS [HL 30568] Funding Source: Medline; PHS HHS [41014] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABBERGER H, 1983, BILE ACIDS CHOLESTER, P77; BAKER ME, 1990, FASEB J, V4, P222, DOI 10.1096/fasebj.4.2.2153594; BINSTOCK JM, 1992, BIOCHEM BIOPH RES CO, V187, P760, DOI 10.1016/0006-291X(92)91260-W; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COHEN JC, 1992, GENOMICS, V14, P153, DOI 10.1016/S0888-7543(05)80298-8; DEYASHIKI Y, 1992, BIOCHEM J, V282, P741, DOI 10.1042/bj2820741; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; FALZON M, 1986, BIOCHEM PHARMACOL, V35, P563, DOI 10.1016/0006-2952(86)90348-5; GHOSH D, 1993, NUCLEIC ACIDS RES, V21, P3117, DOI 10.1093/nar/21.13.3117; GLATT HR, 1982, SCIENCE, V215, P1507, DOI 10.1126/science.7038877; GRAHAM A, 1991, J BIOL CHEM, V266, P6872; GRANGE T, 1991, NUCLEIC ACIDS RES, V19, P131, DOI 10.1093/nar/19.1.131; GREENE JM, 1992, MOL BIOL; HARA A, 1990, J BIOCHEM-TOKYO, V108, P250, DOI 10.1093/oxfordjournals.jbchem.a123189; JAISWAL AK, 1991, BIOCHEMISTRY-US, V30, P10647, DOI 10.1021/bi00108a007; KLEIN J, 1991, CHEM-BIOL INTERACT, V79, P287, DOI 10.1016/0009-2797(91)90110-S; KLEIN J, 1990, CHEM-BIOL INTERACT, V76, P211, DOI 10.1016/0009-2797(90)90089-6; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOLOWA DT, 1986, J BIOL CHEM, V261, P2624; NAKAGAWA M, 1989, J BIOCHEM-TOKYO, V106, P633, DOI 10.1093/oxfordjournals.jbchem.a122908; NUSSINOV R, 1990, CRIT REV BIOCHEM MOL, V25, P185, DOI 10.3109/10409239009090609; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PAILHOUX E, 1992, J STEROID BIOCHEM, V42, P561, DOI 10.1016/0960-0760(92)90445-O; PAILHOUX EA, 1990, J BIOL CHEM, V265, P19932; PENNING TM, 1987, BIOCHEM BIOPH RES CO, V148, P646, DOI 10.1016/0006-291X(87)90925-9; PENNING TM, 1986, STEROIDS, V47, P221; PENNING TM, 1986, BIOCHEM PHARMACOL, V35, P4203, DOI 10.1016/0006-2952(86)90696-9; STOLZ A, 1984, FEBS LETT, V177, P31, DOI 10.1016/0014-5793(84)80975-8; STOLZ A, 1991, J BIOL CHEM, V266, P15253; STOLZ A, 1993, J BIOL CHEM, V268, P10448; STOLZ A, 1989, ANNU REV PHYSIOL, V51, P161, DOI 10.1146/annurev.ph.51.030189.001113; SUGIYAMA Y, 1983, J BIOL CHEM, V258, P3602; TAKIKAWA H, 1987, J CLIN INVEST, V80, P852, DOI 10.1172/JCI113143; TAKIKAWA H, 1988, J LIPID RES, V29, P279; TAKIKAWA H, 1990, BIOCHIM BIOPHYS ACTA, V1043, P153, DOI 10.1016/0005-2760(90)90289-A; TAKIKAWA H, 1986, J LIPID RES, V27, P652; TAKIKAWA H, 1987, J CLIN INVEST, V80, P861, DOI 10.1172/JCI113144; TAKIKAWA H, 1990, J BIOL CHEM, V265, P2132; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; WANG K, 1993, J BIOL CHEM, V268, P16052; WATANABE K, 1989, ADV PROSTAG THROMB L, V19, P462; WIDDICOMBE JG, 1982, EUR J RESPIR DIS, V63, P202; WINTERS CJ, 1990, BIOCHEMISTRY-US, V29, P1080, DOI 10.1021/bi00456a034; WISTOW G, 1987, SCIENCE, V236, P1554, DOI 10.1126/science.3589669; WORNER W, 1984, FEBS LETT, V170, P263, DOI 10.1016/0014-5793(84)81325-3	47	26	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8416	8422						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132567				2022-12-27	WOS:A1994NB40900088
J	LYNCH, JW; LEMOS, VS; BUCHER, B; STOCLET, JC; TAKEDA, K				LYNCH, JW; LEMOS, VS; BUCHER, B; STOCLET, JC; TAKEDA, K			PERTUSSIS TOXIN-INSENSITIVE CALCIUM INFLUX MEDIATED BY NEUROPEPTIDE Y-2 RECEPTORS IN A HUMAN NEUROBLASTOMA CELL-LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ERYTHROLEUKEMIA-CELLS; ROOT GANGLION NEURONS; RAT SENSORY NEURONS; Y PEPTIDE-YY; N-MC CELLS; ADENYLATE-CYCLASE; G-PROTEIN; INTRACELLULAR CALCIUM; CA2+ INFLUX; CA-2+	Stimulation of neuropeptide Y (NPY) Y-2 receptors induced an intracellular free Ca2+ ([Ca2+](i)) increase in a human neuroblastoma cell line, CHP-234. When NPY in a Ca2+-free solution was applied, this increase was abolished. Depolarization with high KC1 evoked no response, suggesting that the responses were not mediated by voltage-gated Ca2+ channels. There was no evidence that the NPY response consisted of a capacitative Ca2+ entry sensitive to internal Ca2+ store levels. The [Ca2+](i) elevation was diminished by Ni2+, a blocker of Ca2+ entry. Mn2+ induced a quench of the fura-2 fluorescence, which ceased promptly upon the removal of NPY, indicating that Ca2+ entry was linked tightly to receptor activation. Although thapsigargin- and ryanodine-sensitive Ca2+ stores were present, NPY induced responses were not impaired by pretreatment with either drug. Further-more, NPY had no effect on the thapsigargin sensitive store. Pertussis toxin did not affect the NPY-stimulated [Ca2+](i) increase, although it abolished the NPY-dependent inhibition of cAMP production. It is concluded that the Y-2 receptors couple directly to receptor-operated Ca2+ channels without the involvement of intracellular Ca2+ stores. The results also indicate that Y-2 receptors can activate both pertussis toxin-sensitive and -insensitive mechanisms in the same cell.	UNIV LOUIS PASTEUR STRASBOURG,PHARMACOL CELLAIRE & MOLEC LAB,CNRS,URA 600,F-67401 ILLKIRCH GRAFFENS,FRANCE	Centre National de la Recherche Scientifique (CNRS)			Lemos, Virginia/B-7305-2018; Lynch, Joseph/C-8636-2009	Lemos, Virginia/0000-0003-1234-9325; 				AAKERLUND L, 1990, FEBS LETT, V260, P73, DOI 10.1016/0014-5793(90)80069-U; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLACKMORE PF, 1993, CELL CALCIUM, V14, P53, DOI 10.1016/0143-4160(93)90018-2; BLEAKMAN D, 1991, BRIT J PHARMACOL, V103, P1781, DOI 10.1111/j.1476-5381.1991.tb09863.x; Cochran W.G, 1957, STAT METHODS, V6th ed; COLMERS WF, 1989, BRAIN RES, V498, P99, DOI 10.1016/0006-8993(89)90403-4; DANGER JM, 1990, FUNDAM CLIN PHARM, V21, P5; DANIELS AJ, 1989, BIOCHEM BIOPH RES CO, V165, P1138, DOI 10.1016/0006-291X(89)92721-6; DANIELS AJ, 1992, MOL PHARMACOL, V41, P767; EDVINSSON L, 1987, TRENDS PHARMACOL SCI, V8, P231, DOI 10.1016/0165-6147(87)90069-1; EWALD DA, 1989, NEURON, V2, P1185, DOI 10.1016/0896-6273(89)90185-2; FETH F, 1992, BRIT J PHARMACOL, V105, P71, DOI 10.1111/j.1476-5381.1992.tb14212.x; FETH F, 1991, N-S ARCH PHARMACOL, V344, P1; FOUCART S, 1989, N-S ARCH PHARMACOL, V340, P658, DOI 10.1007/BF00717741; FREDHOLM BB, 1985, ACTA PHYSIOL SCAND, V124, P467, DOI 10.1111/j.1748-1716.1985.tb07683.x; FUHLENDORFF J, 1990, P NATL ACAD SCI USA, V87, P182, DOI 10.1073/pnas.87.1.182; GIMPL G, 1993, J NEUROSCI RES, V34, P198, DOI 10.1002/jnr.490340207; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEILIG M, 1990, ACTA PSYCHIAT SCAND, V82, P95, DOI 10.1111/j.1600-0447.1990.tb01366.x; HERZOG H, 1992, P NATL ACAD SCI USA, V89, P5794, DOI 10.1073/pnas.89.13.5794; KOCH B, 1991, MOL CELL ENDOCRINOL, V77, P57, DOI 10.1016/0303-7207(91)90058-Z; LARHAMMAR D, 1992, J BIOL CHEM, V267, P10935; LEHMANN J, 1990, DRUG DEVELOP RES, V19, P329, DOI 10.1002/ddr.430190402; LLOPIS J, 1992, BIOCHEM J, V284, P243, DOI 10.1042/bj2840243; LO TM, 1993, AM J PHYSIOL, V264, pC641, DOI 10.1152/ajpcell.1993.264.3.C641; MELDOLESI J, 1991, TRENDS PHARMACOL SCI, V12, P289, DOI 10.1016/0165-6147(91)90577-F; MICHEL MC, 1992, N-S ARCH PHARMACOL, V345, P370; MIHARA S, 1989, FEBS LETT, V259, P79, DOI 10.1016/0014-5793(89)81499-1; MISSIAEN L, 1992, J BIOL CHEM, V267, P22961; MOTULSKY HJ, 1988, AM J PHYSIOL, V255, pE880, DOI 10.1152/ajpendo.1988.255.6.E880; NEHER E, 1992, NATURE, V355, P298, DOI 10.1038/355298a0; NORENBERG W, 1991, PFLUG ARCH EUR J PHY, V418, P346, DOI 10.1007/BF00550872; PERNEY TM, 1989, J BIOL CHEM, V264, P7317; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; SAGE SO, 1989, BIOCHEM J, V258, P923, DOI 10.1042/bj2580923; SHEIKH SP, 1989, J BIOL CHEM, V264, P6648; SPEDDING M, 1992, PHARMACOL REV, V44, P363; TATEMOTO K, 1982, NATURE, V296, P659, DOI 10.1038/296659a0; TAYLOR CW, 1990, TRENDS PHARMACOL SCI, V11, P269, DOI 10.1016/0165-6147(90)90003-Q; WAHLESTEDT C, 1992, LIFE SCI, V50, pPL7, DOI 10.1016/0024-3205(92)90342-M; WAHLESTEDT C, 1986, REGUL PEPTIDES, V13, P307, DOI 10.1016/0167-0115(86)90048-0; WAHLESTEDT C, 1993, ANN REV PHARM TOXICO, V32, P309; WALKER MW, 1988, J NEUROSCI, V8, P2438; WALKER P, 1991, TRENDS PHARMACOL SCI, V12, P111, DOI 10.1016/0165-6147(91)90518-W	44	42	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8226	8233						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132547				2022-12-27	WOS:A1994NB40900061
J	TENEBERG, S; ANGSTROM, J; JOVALL, PA; KARLSSON, KA				TENEBERG, S; ANGSTROM, J; JOVALL, PA; KARLSSON, KA			CHARACTERIZATION OF BINDING OF GAL-BETA-4GLCNAC-SPECIFIC LECTINS FROM ERYTHRINA-CRISTAGALLI AND ERYTHRINA-CORALLODENDRON TO GLYCOSPHINGOLIPIDS - DETECTION, ISOLATION, AND CHARACTERIZATION OF A NOVEL GLYCOSPHINGOLIPID OF BOVINE BUTTERMILK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; GALACTOSAMINE-SPECIFIC LECTIN; HUMAN MECONIUM; GLYCOLIPID RECEPTORS; H-1-NMR SPECTROSCOPY; EPITHELIAL-CELLS; ESCHERICHIA-COLI; SMALL-INTESTINE; HUMAN-MILK; CARBOHYDRATE	The lectins from seeds of Erythrina cristagalli and Erythrina corallodendron were characterized for binding to glycolipids, using a chromatogram binding assay, a microtiter well assay, and glycolipids coated on erythrocytes. Both lectins bound to glycolipids having a terminal Gal beta 4GlcNAc sequence and also, with similar affinity, to glycolipids with terminal Fuc alpha 2Gal beta 4GlcNAc (blood group H determinant on a type 2 chain). All other substitutions of Gal beta 4GlcNAc tested abolished the binding. A binding epitope for the Erythrina lectins was considered by comparison of minimum energy conformations of binding and nonbinding glycolipids. A non-acid glycolipid, with lectin binding activity, was found in bovine buttermilk. By mass spectrometry and proton NMR spectroscopy it was shown to be a branched hexaglycosylceramide with the structure Gal beta 4Glc-NAc beta 6(Gal beta 4GlcNAc beta 3)Gal beta 4Glc beta Cer. This glycosphingolipid has not been reported before.			TENEBERG, S (corresponding author), UNIV GOTEBURG,DEPT MED BIOCHEM,MED AREGATAN 9,S-41390 GOTHENBURG,SWEDEN.							AGGARWAL BB, 1985, NATURE, V318, P665, DOI 10.1038/318665a0; ANDO S, 1973, J BIOCHEM-TOKYO, V73, P387; BOCK K, 1985, J BIOL CHEM, V260, P8545; BREG J, 1989, EUR J BIOCHEM, V178, P727, DOI 10.1111/j.1432-1033.1989.tb14504.x; BREIMER ME, 1980, ADV MASS SPECTROM, V8, P1097; CALANDER N, 1988, BIOCHIMIE, V70, P1673, DOI 10.1016/0300-9084(88)90302-1; DEBOECK H, 1984, ARCH BIOCHEM BIOPHYS, V234, P297, DOI 10.1016/0003-9861(84)90352-7; DEBRAY H, 1986, CARBOHYD RES, V151, P359, DOI 10.1016/S0008-6215(00)90355-0; EHRLICHROGOZINSKI S, 1987, GLYCOCONJUGATE J, V4, P379, DOI 10.1007/BF01048371; ETO T, 1968, J BIOCHEM, V64, P205, DOI 10.1093/oxfordjournals.jbchem.a128881; FALK P, 1986, BIOCHIM BIOPHYS ACTA, V878, P296, DOI 10.1016/0005-2760(86)90161-X; FOLCH J, 1951, J BIOL CHEM, V191, P819; HAKOMORI S, 1983, HDB LIPID RES, V3, P1; HANDA S, 1963, JPN J EXP MED, V33, P347; HANSSON GC, 1985, ANAL BIOCHEM, V146, P158, DOI 10.1016/0003-2697(85)90410-5; HANSSON GC, 1983, BIOCHIM BIOPHYS ACTA, V750, P214, DOI 10.1016/0005-2760(83)90224-2; HANSSON GC, 1982, FEBS LETT, V139, P291, DOI 10.1016/0014-5793(82)80873-9; HAVERKAMP J, 1982, EUR J BIOCHEM, V122, P305, DOI 10.1111/j.1432-1033.1982.tb05881.x; IGLESIAS JL, 1982, EUR J BIOCHEM, V123, P247, DOI 10.1111/j.1432-1033.1982.tb19760.x; IWAMORI M, 1981, BIOCHIM BIOPHYS ACTA, V665, P205, DOI 10.1016/0005-2760(81)90004-7; KALADAS PM, 1982, ARCH BIOCHEM BIOPHYS, V217, P624, DOI 10.1016/0003-9861(82)90544-6; Karlsson K A, 1978, Prog Chem Fats Other Lipids, V16, P207, DOI 10.1016/0079-6832(78)90045-9; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P220; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; KARLSSON KA, 1979, J BIOL CHEM, V254, P9311; KARLSSON KA, 1981, J BIOL CHEM, V256, P3512; KARLSSON KA, 1974, BIOCHEMISTRY-US, V13, P3643, DOI 10.1021/bi00715a003; KARLSSON KA, 1976, GLYCOLIPID METHODOLO, P97; KOBATA A, 1972, ARCH BIOCHEM BIOPHYS, V150, P273, DOI 10.1016/0003-9861(72)90036-7; LARSON G, 1987, CARBOHYD RES, V161, P281, DOI 10.1016/S0008-6215(00)90085-5; LEFFLER H, 1980, FEMS MICROBIOL LETT, V8, P127, DOI 10.1111/j.1574-6968.1980.tb05064.x; LIS H, 1985, PHYTOCHEMISTRY, V24, P2803, DOI 10.1016/0031-9422(85)80004-2; Lis H., 1977, ANTIGENS, V4, P429; MAYO SL, 1990, J PHYS CHEM-US, V94, P8879; MCKIBBIN JM, 1982, J BIOL CHEM, V257, P755; MILLER KE, 1992, BIOCHEMISTRY-US, V31, P6703, DOI 10.1021/bi00144a009; MONTREUIL J, 1984, BIOL CELL, V51, P115, DOI 10.1111/j.1768-322X.1984.tb00291.x; NAIKI M, 1975, BIOCHEMISTRY-US, V14, P4831, DOI 10.1021/bi00693a009; NILSSON O, 1981, FEBS LETT, V133, P197, DOI 10.1016/0014-5793(81)80504-2; Nyholm P G, 1989, J Mol Recognit, V2, P103, DOI 10.1002/jmr.300020302; PASCHER I, 1977, CHEM PHYS LIPIDS, V20, P263; RAPPE AK, 1991, J PHYS CHEM-US, V95, P3358, DOI 10.1021/j100161a070; SHAANAN B, 1991, SCIENCE, V254, P862, DOI 10.1126/science.1948067; Sharon N., 1989, LECTINS, P37; SIDDIQUI B, 1973, BIOCHIM BIOPHYS ACTA, V330, P147, DOI 10.1016/0005-2736(73)90219-8; SUDAKEVITZ D, 1991, ZBL BAKT-INT J MED M, V275, P343, DOI 10.1016/S0934-8840(11)80298-7; TAKAMIZAWA K, 1986, J BIOL CHEM, V261, P5625; TAKI T, 1992, J BIOL CHEM, V267, P11811; TARRAGO MT, 1988, ARCH BIOCHEM BIOPHYS, V267, P353, DOI 10.1016/0003-9861(88)90041-0; THURIN J, 1989, BIOCHIM BIOPHYS ACTA, V1002, P267, DOI 10.1016/0005-2760(89)90339-1; Waldi D., 1962, DUNNSCHICHT CHROMATO, P496; [No title captured]	52	61	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8554	8563						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132581				2022-12-27	WOS:A1994NB40900109
J	BREYTON, C; DEVITRY, C; POPOT, JL				BREYTON, C; DEVITRY, C; POPOT, JL			MEMBRANE ASSOCIATION OF CYTOCHROME B(6)F SUBUNITS - THE RIESKE IRON-SULFUR PROTEIN FROM CHLAMYDOMONAS-REINHARDTII IS AN EXTRINSIC PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM DODECYL-SULFATE; C REDUCTASE COMPLEX; THYLAKOID MEMBRANE; ELECTROPHORETIC TRANSFER; POLYACRYLAMIDE GELS; UBIQUINOL; MUTANTS; NITROCELLULOSE	The mode of membrane attachment of five subunits from Chlamydomonas reinhardtii cytochrome b(6) f complex has been studied using biochemical approaches. Antisera specific for cytochrome f, cytochrome b(6), the Rieske iron-sulfur protein, subunit IV, and a 4-kDa subunit (product of the petG gene) were used to quantify the degree of extraction of each of these polypeptides following various treatments. In contrast to the other four subunits, the Rieske protein was extracted to extents varying between 50 and 100% following two cycles of freezing and thawing in the presence of chaotropic agents (KSCN, urea, or NaI). The Rieske protein was not extracted by 2 M NaC1 and was rather resistant to alkaline treatments, being extracted by 20 mM 3-(cyclohexylamino)propanesulfonic acid buffer only at pH > 11.5. The hydrodynamic behavior of the isolated Rieske protein was examined in the absence and presence of detergent by ultracentrifugation and by molecular sieving. The extracted protein bound neither to laurylmaltoside nor to C(12)E(8) micelles. Its sedimentation coefficient (D-20,w = 9.6 x 10(-11) m(2.) s(-1), diffusion coefficient (s(20),(w) = 2 S), and deduced molecular mass (20.0 +/- 1.7 kDa) are those expected for the monomeric protein. We conclude that the Rieske protein is extrinsic and therefore does not cross the membrane, although its association with the rest of the complex involves primarily hydrophobic interactions, and that the other four subunits analyzed are intrinsic.	COLL FRANCE,CTR NATL RECH SCI,URA 1187,F-75005 PARIS,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France	BREYTON, C (corresponding author), INST BIOL PHYSICOCHIM,13 RUE PIERRE & MARIE CURIE,F-75005 PARIS,FRANCE.							ATTEIA A, 1992, J BIOL CHEM, V267, P226; BORMANN BJ, 1989, J BIOL CHEM, V264, P4033; BRUCE BD, 1991, PLANT CELL, V3, P203, DOI 10.1105/tpc.3.2.203; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHUA NH, 1975, P NATL ACAD SCI USA, V72, P2175, DOI 10.1073/pnas.72.6.2175; COCCO T, 1991, EUR J BIOCHEM, V195, P731, DOI 10.1111/j.1432-1033.1991.tb15760.x; CRIVELLONE MD, 1988, J BIOL CHEM, V263, P14323; DANDLIKER WB, 1971, CHEM BIOSURFACES, P1; DAVIDSON E, 1992, BIOCHEMISTRY-US, V31, P3351, DOI 10.1021/bi00128a007; DEVITRY C, 1994, J BIOL CHEM, V269, P7603; DEVITRY C, 1991, J BIOL CHEM, V266, P16614; DEVITRY C, 1989, J CELL BIOL, V109, P991, DOI 10.1083/jcb.109.3.991; DRAPIER D, 1992, PLANT CELL, V4, P283, DOI 10.2307/3869540; GAVEL Y, 1991, FEBS LETT, V282, P41, DOI 10.1016/0014-5793(91)80440-E; GONZALEZHALPHEN D, 1991, J BIOL CHEM, V266, P3870; GONZALEZHALPHEN D, 1988, BIOCHEMISTRY-US, V27, P7021, DOI 10.1021/bi00418a053; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; GUTWENIGER H, 1981, J BIOL CHEM, V256, P1132; HALEY J, 1989, P NATL ACAD SCI USA, V86, P1534, DOI 10.1073/pnas.86.5.1534; HARTL FU, 1986, CELL, V47, P939, DOI 10.1016/0092-8674(86)90809-3; HOPE AB, 1993, BIOCHIM BIOPHYS ACTA, V1143, P1, DOI 10.1016/0005-2728(93)90210-7; KNAFF DB, 1993, PHOTOSYNTH RES, V35, P117, DOI 10.1007/BF00014743; Kuntz I D Jr, 1974, Adv Protein Chem, V28, P239, DOI 10.1016/S0065-3233(08)60232-6; LEMAIRE C, 1986, BIOCHIM BIOPHYS ACTA, V851, P229, DOI 10.1016/0005-2728(86)90130-1; LI Y, 1981, FEBS LETT, V135, P277, DOI 10.1016/0014-5793(81)80800-9; LINK TA, 1992, EUR J BIOCHEM, V208, P685, DOI 10.1111/j.1432-1033.1992.tb17235.x; MALKIN R, 1992, PHOTOSYNTH RES, V33, P121, DOI 10.1007/BF00039175; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; PARADIES HH, 1983, COLLOID SURFACE, V6, P405, DOI 10.1016/0166-6622(83)80031-6; PIERRE Y, 1993, CR ACAD SCI III-VIE, P1404; POPOT, 1993, CURR OPIN STRUCT BIO, V3, P532; POPOT JL, 1990, ANNU REV BIOPHYS BIO, V19, P369; RIESKE JS, 1964, BIOCHEM BIOPH RES CO, V15, P338, DOI 10.1016/0006-291X(64)90171-8; ROBINSON NC, 1975, BIOCHEMISTRY-US, V14, P369, DOI 10.1021/bi00673a025; ROSEVEAR P, 1980, BIOCHEMISTRY-US, V19, P4108, DOI 10.1021/bi00558a032; SZCZEPANIAK A, 1991, EMBO J, V10, P2757, DOI 10.1002/j.1460-2075.1991.tb07824.x; Tanford C., 1961, PHYS CHEM MACROMOLEC, P710; TANNER MJA, 1979, CURR TOP MEMBR TRANS, V12, P1; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDOREN SR, 1993, BIOCHEMISTRY-US, V32, P628, DOI 10.1021/bi00053a031	40	67	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7597	7602						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125983				2022-12-27	WOS:A1994NA03200089
J	CONRAD, ME; UMBREIT, JN; MOORE, EG; UZEL, C; BERRY, MR				CONRAD, ME; UMBREIT, JN; MOORE, EG; UZEL, C; BERRY, MR			ALTERNATE IRON TRANSPORT PATHWAY - MOBILFERRIN AND INTEGRIN IN K562 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERRIN-BOUND IRON; RECEPTOR-MEDIATED ENDOCYTOSIS; RAT-LIVER; BINDING PROTEIN; DUODENAL MUCOSA; MEMBRANE; CALRETICULIN; CLEARANCE; SYSTEM	A transferrin-independent iron transport system in cells containing transferrin receptors was described previously by several investigators. Prior studies did not identify the proteins involved in this alternate iron transport pathway. Using a human-derived erythroleukemia tissue culture line, iron-binding proteins were isolated from cytosol and cell membranes. The cytosol protein was soluble in 60% ammonium sulfate, had a molecular mass similar to mobilferrin (56 kDa), and reacted with anti-mobilferrin antibodies. The water-in soluble radiolabeled protein was solubilized with Nonidet P-40 and immunoprecipitated with monoclonal antibody against beta 3 human integrin. Pulse-chase studies suggested sequential passage of iron to integrin, mobilferrin, and ferritin, respectively. Thus, the alternate iron transport pathway contained proteins similar to those observed in intestinal cells which did not possess transferrin receptors on their absorptive surface. The alternate iron transport pathway is only partially shared with zinc and cadmium. Mobilferrin bound zinc and iron competitively, but the two metals were not transported competitively into K562 cells. Immunoprecipitates of integrin containing radiozinc were obtained with a monoclonal antibody against beta 1 human integrin. This suggested iron and zinc may utilize different integrins to passage the cell membrane.	UNIV SO ALABAMA,DEPT PATHOL,MOBILE,AL 36688; UNIV SO ALABAMA,DEPT BIOCHEM,MOBILE,AL 36688	University of South Alabama; University of South Alabama	CONRAD, ME (corresponding author), UNIV SO ALABAMA,USA CANC CTR,DEPT MED,MOBILE,AL 36688, USA.				NIDDK NIH HHS [2R01 DK36112] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036112] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BANERJEE D, 1986, GASTROENTEROLOGY, V91, P861, DOI 10.1016/0016-5085(86)90687-6; BRISSOT P, 1985, J CLIN INVEST, V76, P1463, DOI 10.1172/JCI112125; CONRAD ME, 1993, GASTROENTEROLOGY, V104, P1700, DOI 10.1016/0016-5085(93)90648-V; CONRAD ME, 1993, J AM COLL NUTR, V12, P720; CONRAD ME, 1991, GASTROENTEROLOGY, V100, P129, DOI 10.1016/0016-5085(91)90592-9; CONRAD ME, 1992, BLOOD, V79, P244, DOI 10.1182/blood.V79.1.244.bloodjournal791244; CONRAD ME, 1990, J BIOL CHEM, V265, P5273; CONRAD ME, 1993, AM J HEMATOL, V42, P67, DOI 10.1002/ajh.2830420114; CONRAD ME, 1993, AM J HEMATOL, V43, P234, DOI 10.1002/ajh.2830430315; CONRAD ME, 1993, BLOOD, V81, P517; CONRAD ME, 1987, PHYSL GASTROINTESTIN, P1437; CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457; EGYED A, 1988, BRIT J HAEMATOL, V68, P483, DOI 10.1111/j.1365-2141.1988.tb04241.x; GUAN SH, 1991, BIOCHEMISTRY-US, V30, P9892, DOI 10.1021/bi00105a012; INMAN RS, 1993, J BIOL CHEM, V268, P8521; KAPLAN J, 1991, J BIOL CHEM, V266, P2997; KARIN M, 1981, J BIOL CHEM, V256, P3245; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; LAUFFER RB, 1992, IRON HUMAN DISEASE; MORGAN EH, 1988, BIOCHIM BIOPHYS ACTA, V943, P428, DOI 10.1016/0005-2736(88)90374-4; MUIR WA, 1984, J BIOL CHEM, V259, P4896; NUNEZ MT, 1992, J BIOL CHEM, V267, P11490; OCTAVE JN, 1981, EUR J BIOCHEM, V115, P611; PARMLEY RT, 1985, BRIT J HAEMATOL, V60, P81, DOI 10.1111/j.1365-2141.1985.tb07388.x; POLLACK S, 1965, J CLIN INVEST, V44, P1470, DOI 10.1172/JCI105253; ROJIANI MV, 1991, BIOCHEMISTRY-US, V30, P9859, DOI 10.1021/bi00105a008; SELIGMAN PA, 1991, BLOOD, V78, P1526; STURROCK A, 1990, J BIOL CHEM, V265, P3139; VANBOCKXMEER FM, 1977, BIOCHIM BIOPHYS ACTA, V468, P437, DOI 10.1016/0005-2736(77)90293-0; WRIGHT TL, 1986, J BIOL CHEM, V261, P909; WRIGHT TL, 1988, J BIOL CHEM, V263, P1842	31	63	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7169	7173						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125927				2022-12-27	WOS:A1994NA03200023
J	KELMAN, DJ; DEGRAY, JA; MASON, RP				KELMAN, DJ; DEGRAY, JA; MASON, RP			REACTION OF MYOGLOBIN WITH HYDROGEN-PEROXIDE FORMS A PEROXYL RADICAL WHICH OXIDIZES SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM WHALE MYOGLOBIN; METMYOGLOBIN; RESONANCE; FERRYLMYOGLOBIN; TYR-151; SYSTEMS	Evidence is presented that the radical observed upon reaction of myoglobin with hydrogen peroxide is a peroxyl radical. Simulation of this spectrum gives principal values for the g tenser of g(x) = 2.0357, g(y) = 2.0082, and g(z) = 2.0016, which are consistent with those of a peroxyl radical. Use of molecular oxygen isotopically labeled with O-17 confirmed that the radical observed was a peroxyl radical. Removal of oxygen from the incubation by use of glucose and glucose oxidase revealed two radicals, one at g(iso) = 2.0028 and the other at g(iso) = 2.0073. Addition of various amounts of the spin trap 5,5-dimethyl-1-pyrroline N-oxide revealed that the spin trap and oxygen compete for the same radical site. Four model substrates, glutathione, styrene, arachidonic acid and linoleic acid, were individually added to both the aerobic and anoxic systems. Glutathione reacted with the peroxyl radical, reducing its intensity by 98%, and entirely eliminated the g(iso) = 2.0028 line from the spectrum of the anoxic incubation. Styrene, arachidonic acid and linoleic acid reacted with the peroxyl radical, reducing its amplitude by 84, 57, and 35%, respectively, but did not decrease the amplitude of either radical species in the anoxic incubation. The g(iso) = 2.0028 species detected in the anoxic incubation appears to be the original radical site to which molecular oxygen binds to form the peroxyl radical. This myoglobin-derived peroxyl radical species is responsible for the advent of lipid peroxidation as proposed in ischemia/repurfusion injury, as well as other reactions, as exemplified by the O-2-dependent epoxidation of styrene.	UNIV N CAROLINA, CURRICULUM TOXICOL, CHAPEL HILL, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	KELMAN, DJ (corresponding author), NIEHS, MOLEC BIOPHYS LAB, RES TRIANGLE PK, NC 27709 USA.		Mason, Ronald P/G-5967-2019	Mason, Ronald P/0000-0002-1859-9109				AMBROSIO G, 1992, AM J PHYSIOL, V262, pH23, DOI 10.1152/ajpheart.1992.262.1.H23; ARDUINI A, 1992, FREE RADICAL BIO MED, V13, P449, DOI 10.1016/0891-5849(92)90185-J; CATALANO CE, 1989, J BIOL CHEM, V264, P10534; DAVIES MJ, 1990, FREE RADICAL RES COM, V10, P361, DOI 10.3109/10715769009149905; DAVIES MJ, 1991, BIOCHIM BIOPHYS ACTA, V1077, P86, DOI 10.1016/0167-4838(91)90529-9; DEGRAY JA, 1992, J BIOL CHEM, V267, P23583; DEGRAY JA, 1987, THESIS BROWN U PROVI; DEMONTELLANO PRO, 1985, J BIOL CHEM, V260, P9265; DIMMEY LJ, 1980, P NATL ACAD SCI-BIOL, V77, P343, DOI 10.1073/pnas.77.1.343; GALARIS D, 1990, ARCH BIOCHEM BIOPHYS, V281, P163, DOI 10.1016/0003-9861(90)90427-Z; GIBSON JF, 1958, NATURE, V181, P1398, DOI 10.1038/1811398a0; GRISHAM M B, 1985, Journal of Free Radicals in Biology and Medicine, V1, P227, DOI 10.1016/0748-5514(85)90122-9; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; HARADA K, 1987, J BIOCHEM, V101, P283, DOI 10.1093/oxfordjournals.jbchem.a121903; HONG S-J, 1989, Korean Biochemical Journal, V22, P196; INGOLD KU, 1969, ACCOUNTS CHEM RES, V2, P1, DOI 10.1021/ar50013a001; KELMAN DJ, 1992, FREE RADICAL RES COM, V16, P27, DOI 10.3109/10715769209049156; KING NK, 1967, BIOCHIM BIOPHYS ACTA, V133, P65; KING NK, 1963, J BIOL CHEM, V238, P1520; LOW W, 1957, PHYS REV, V105, P801, DOI 10.1103/PhysRev.105.801; MIKI H, 1989, ARCH BIOCHEM BIOPHYS, V275, P354, DOI 10.1016/0003-9861(89)90382-2; RAO SI, 1993, J BIOL CHEM, V268, P803; RIEGER PH, 1982, J MAGN RESON, V50, P485, DOI 10.1016/0022-2364(82)90013-0; ROBERTS JE, 1981, J BIOL CHEM, V256, P2118; ROMERO FJ, 1992, J BIOL CHEM, V267, P1680; SEVILLA MD, 1990, INT J RADIAT BIOL, V57, P65, DOI 10.1080/09553009014550351; SINCLAIR AJ, 1990, BRIT J HOSP MED, V43, P334; TEW D, 1988, J BIOL CHEM, V263, P17880; VANDERKOOI JM, 1987, J BIOL CHEM, V262, P5476; WILKS A, 1992, J BIOL CHEM, V267, P8827; XU Y, 1990, J AGR FOOD CHEM, V38, P1494, DOI 10.1021/jf00097a014	31	137	138	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7458	7463						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125965				2022-12-27	WOS:A1994NA03200068
J	RAO, GN; GRIENDLING, KK; FREDERICKSON, RM; SONENBERG, N; ALEXANDER, RW				RAO, GN; GRIENDLING, KK; FREDERICKSON, RM; SONENBERG, N; ALEXANDER, RW			ANGIOTENSIN-II INDUCES PHOSPHORYLATION OF EUKARYOTIC PROTEIN-SYNTHESIS INITIATION-FACTOR 4E IN VASCULAR SMOOTH-MUSCLE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-BINDING-PROTEIN; RNA 5' CAP; MESSENGER-RNA; GROWTH-FACTOR; KINASE-C; RIBOSOMAL PROTEIN-S6; HYPERTENSIVE RAT; PHORBOL ESTERS; FACTORS EIF-4F; TRANSLATION	Angiotensin II has been shown to induce hypertrophy of cultured vascular smooth muscle cells (VSMC). To understand the mechanisms of induction of the hypertrophy, we studied its effect on the phosphorylation state of eIF-4E, a rate limiting eukaryotic protein synthesis initiation factor whose activity has been shown to be regulated by phosphorylation. Angiotensin II induced a 2-3-fold increase in the phosphorylation of eIF-4E in VSMC. The stimulation of phosphorylation was apparent at 20 min and persisted for at least 12 h. Phosphoamino acid analysis revealed that serine is the major residue of eIF-4E phosphorylated by angiotensin II. Staurosporine and calphostin C, two potent inhibitors of the serine/threonine protein kinase, protein kinase C, significantly attenuated the angiotensin II-induced eIF-4E phosphorylation. Staurosporine and calphostin C also blunted the angiotensin II-stimulated protein synthesis. Together, these observations indicate that angiotensin II induces phosphorylation of eIF-4E in a protein kinase C-dependent manner and suggest that this pathway may play an important role in the mechanism by which angiotensin II causes hypertrophy of VSMC.	MCGILL UNIV, DEPT BIOCHEM, MONTREAL H3G 1Y6, PQ, CANADA	McGill University	RAO, GN (corresponding author), EMORY UNIV, SCH MED, DIV CARDIOL, PO DRAWER LL, ATLANTA, GA 30322 USA.			Griendling, Kathy/0000-0002-9456-8582	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038206, R29HL038206, R37HL038206] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 38206] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMICK GD, 1992, BIOCHEM BIOPH RES CO, V183, P431, DOI 10.1016/0006-291X(92)90499-B; BERK BC, 1993, J CELL PHYSIOL, V154, P368, DOI 10.1002/jcp.1041540221; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; DEBENEDETTI A, 1990, P NATL ACAD SCI USA, V87, P8212, DOI 10.1073/pnas.87.21.8212; DEBENEDETTI A, 1991, MOL CELL BIOL, V11, P5435, DOI 10.1128/MCB.11.11.5435; DONALDSON RW, 1991, J BIOL CHEM, V266, P3162; DUFF JL, 1992, BIOCHEM BIOPH RES CO, V188, P257, DOI 10.1016/0006-291X(92)92378-B; DUNCAN R, 1987, J BIOL CHEM, V262, P380; DZAU VJ, 1988, AM J CARDIOL, V62, pG30; ERIKSON RL, 1991, J BIOL CHEM, V266, P6007; FREDERICKSON RM, 1991, MOL CELL BIOL, V11, P2896, DOI 10.1128/MCB.11.5.2896; FREDERICKSON RM, 1992, MOL CELL BIOL, V12, P1239, DOI 10.1128/MCB.12.3.1239; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; GRIENDLING KK, 1989, J CARDIOVASC PHARM, V14, pS27, DOI 10.1097/00005344-198906146-00008; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; HILDEBRANDT E, 1989, ANAL BIOCHEM, V177, P407, DOI 10.1016/0003-2697(89)90075-4; HIREMATH LS, 1985, J BIOL CHEM, V260, P7843; HUANG J, 1991, CELL, V65, P271, DOI 10.1016/0092-8674(91)90161-Q; JARAMILLO M, 1991, MOL CELL BIOL, V11, P5992, DOI 10.1128/MCB.11.12.5992; JOSHIBARVE S, 1990, J BIOL CHEM, V265, P2979; KASPAR RL, 1990, J BIOL CHEM, V265, P3619; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWSON TG, 1986, J BIOL CHEM, V261, P13979; LAZARISKARATZAS A, 1992, MOL CELL BIOL, V12, P1234, DOI 10.1128/MCB.12.3.1234; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; MANZELLA JM, 1990, J BIOL CHEM, V265, P11817; MORLEY SJ, 1991, J BIOL CHEM, V266, P4669; MORLEY SJ, 1989, J BIOL CHEM, V264, P2401; MORLEY SJ, 1990, J BIOL CHEM, V265, P10611; NAFTILAN AJ, 1989, J CLIN INVEST, V83, P1419, DOI 10.1172/JCI114032; OSTERRIEDER W, 1991, HYPERTENSION, V18, P60; OWENS GK, 1983, CIRC RES, V53, P491, DOI 10.1161/01.RES.53.4.491; OWENS GK, 1982, CIRC RES, V51, P280, DOI 10.1161/01.RES.51.3.280; POWELL JS, 1989, SCIENCE, V245, P186, DOI 10.1126/science.2526370; RAY BK, 1985, J BIOL CHEM, V260, P7651; RHOADS RE, 1988, TRENDS BIOCHEM SCI, V13, P52, DOI 10.1016/0968-0004(88)90028-X; RINKERSCHAEFFER CW, 1992, J BIOL CHEM, V267, P10659; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; RYCHLIK W, 1987, J BIOL CHEM, V262, P10434; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; SCOTTBURDEN T, 1988, BIOCHEM BIOPH RES CO, V151, P583, DOI 10.1016/0006-291X(88)90634-1; SHIMAMOTO Y, 1993, AM J PHYSIOL, V264, pH1300, DOI 10.1152/ajpheart.1993.264.4.H1300; SMITH M R, 1990, New Biologist, V2, P648; SONENBERG N, 1988, PROG NUCLEIC ACID RE, V35, P173, DOI 10.1016/S0079-6603(08)60614-5; SONENBERG N, 1987, ADV VIRUS RES, V33, P175, DOI 10.1016/S0065-3527(08)60318-8; TAUBMAN MB, 1989, J BIOL CHEM, V264, P526; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAVO P, 1980, BLOOD VESSELS, V17, P110; TSUDA T, 1992, CIRC RES, V71, P620, DOI 10.1161/01.RES.71.3.620; TUAZON PT, 1990, J BIOL CHEM, V265, P10617; WEBB NR, 1984, BIOCHEMISTRY-US, V23, P177, DOI 10.1021/bi00297a001	54	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7180	7184						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125929				2022-12-27	WOS:A1994NA03200025
J	VANDERHEEREN, G; HANSSENS, I				VANDERHEEREN, G; HANSSENS, I			THERMAL UNFOLDING OF BOVINE ALPHA-LACTALBUMIN - COMPARISON OF CIRCULAR-DICHROISM WITH HYDROPHOBICITY MEASUREMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING; LYSOZYME; STATE; INTERMEDIATE; FLUORESCENCE; EQUILIBRIUM; MECHANISM	The thermal unfolding of apo- and Ca2+-loaded bovine alpha-lactalbumin (BLA) determined by circular dichroism measurements at 220 and 270 nm is related to the exposure of its hydrophobic surface measured by the interaction with 1,1'-bi(4-anilino)naphthalene-5,5'-disulfonate. The results indicate that several (about 5) probe molecules are able to bind with low affinity to the compact surface of the native protein. By thermal destabilization to the molten globule state, access is given to two domains with strong hydrophobic character. On further heating the hydrophobic domains degenerate; however, the temperature of destabilization is different for the two domains. A comparable evolution of the hydrophobic behavior is observed for apo- and Ca2+-BLA, but the destabilization steps of Ca2+-BLA occur at higher temperatures than those of apo-BLA. Also, it has not been reported earlier that, at a moderate Ca2+ concentration (2 mM), Ca2+ remains associated with BLA after the thermally induced destabilization of its native tertiary structure. At 70 degrees C, a partially unfolded state of Ca2+-loaded BLA is obtained.	KATHOLIEKE UNIV LEUVEN,INTERDISCIPLINARY RES CTR,B-8500 KORTRIJK,BELGIUM	KU Leuven								ACHARYA KR, 1989, J MOL BIOL, V208, P99, DOI 10.1016/0022-2836(89)90091-0; DESMET J, 1987, BIOCHIM BIOPHYS ACTA, V912, P211, DOI 10.1016/0167-4838(87)90091-4; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; FELDMAN HA, 1972, ANAL BIOCHEM, V48, P317, DOI 10.1016/0003-2697(72)90084-X; HIRAOKA Y, 1980, BIOCHEM BIOPH RES CO, V95, P1098, DOI 10.1016/0006-291X(80)91585-5; IKEGUCHI M, 1986, BIOCHEMISTRY-US, V25, P6965, DOI 10.1021/bi00370a034; KRONMAN MJ, 1964, BIOCHEMISTRY-US, V3, P1145, DOI 10.1021/bi00896a024; KUROKI R, 1992, P NATL ACAD SCI USA, V89, P6803, DOI 10.1073/pnas.89.15.6803; KUWAJIMA K, 1985, BIOCHEMISTRY-US, V24, P874, DOI 10.1021/bi00325a010; LALA AK, 1992, J BIOL CHEM, V267, P19914; MANNING MC, 1989, BIOCHEMISTRY-US, V28, P8609, DOI 10.1021/bi00447a051; MULQUEEN PM, 1982, ARCH BIOCHEM BIOPHYS, V215, P28, DOI 10.1016/0003-9861(82)90275-2; MUSCI G, 1985, BIOCHEMISTRY-US, V24, P3852, DOI 10.1021/bi00336a006; SAITO N, 1988, PROTEINS, V3, P199, DOI 10.1002/prot.340030308; SCATCHARD G, 1954, CHEMICAL SPECIFICITY, P193; SEGAWA T, 1983, J BIOCHEM-TOKYO, V93, P1321, DOI 10.1093/oxfordjournals.jbchem.a134266; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; STUART DI, 1986, NATURE, V324, P84, DOI 10.1038/324084a0; VANDAEL H, 1992, BIOPHYS CHEM, V42, P235, DOI 10.1016/0301-4622(92)80015-W; YOSHIMURA T, 1991, BIOPHYS CHEM, V40, P277, DOI 10.1016/0301-4622(91)80026-N	20	49	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7090	7094						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125916				2022-12-27	WOS:A1994NA03200010
J	FERRI, SR; MEIGHEN, EA				FERRI, SR; MEIGHEN, EA			AN ESSENTIAL HISTIDINE RESIDUE REQUIRED FOR FATTY ACYLATION AND ACYL TRANSFER BY MYRISTOYLTRANSFERASE FROM LUMINESCENT BACTERIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT MAMMARY-GLAND; ACID SYNTHETASE; VIBRIO-HARVEYI; PHOTOBACTERIUM-PHOSPHOREUM; NUCLEOTIDE-SEQUENCE; THIOESTER HYDROLASE; GENE ORGANIZATION; TRIAD FORMS; LUX GENES; EXPRESSION	The lux-specific acyltransferases are serine esterases responsible for preferential diversion of myristic acid from fatty acid biosynthesis to the luminescent system. In contrast to other acyltransferases, an acylated enzyme intermediate can readily be detected making it ideal for the study of the mechanism of acyl transfer. Although the transferase readily cleaves acyl carrier protein and acyl-CoA, an alternate more rapid and convenient assay involving the cleavage of p-nitrophenyl acyl esters was developed and applied in these studies. The cleavage of the oxyesters by the transferase was shown to have a similar dependence on fatty acid chain length and organic solvents as the cleavage of thioesters. Using this assay, it could be demonstrated that the Photobacterium phosphoreun transferase was inactivated at pH 6 with diethyl pyrocarbonate at a rate (73 m(-l) s(-l), 10 degrees C) even faster than that reported for other enzymes with reactive histidyl residues at their active site. Spectral changes during chemical modification as well as restoration of activity by neutral hydroxylamine showed that the loss of activity was associated with modification of a single histidine residue, Replacement of the four histidine residues, conserved in all lux-specific: acyltransferases, by asparagine demonstrated that cleavage of both thioesters and oxyesters by the P. phosphoreum acyltransferase as well as acylation of the enzyme was blocked on mutation of His-244 but not the other three conserved histidines (His-12, -52, and -75). These results suggest that the histidine residue near the carboxyl terminus (His-244) may be part of a catalytic triad essential for cleavage of acyl esters and transfer of the acyl group to the enzyme.	MCGILL UNIV,DEPT BIOCHEM,MONTREAL H3G 1Y6,PQ,CANADA	McGill University			Ferri, Stefano/G-1166-2013					BALDWIN TO, 1989, J BIOLUM CHEMILUM, V4, P326, DOI 10.1002/bio.1170040145; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADY L, 1990, NATURE, V343, P767, DOI 10.1038/343767a0; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; BYERS D, 1985, J BIOL CHEM, V260, P6938; BYERS DM, 1985, P NATL ACAD SCI USA, V82, P6085, DOI 10.1073/pnas.82.18.6085; CAREY LM, 1984, J BIOL CHEM, V259, P216; DERENOBALES M, 1980, ARCH BIOCHEM BIOPHYS, V205, P464, DOI 10.1016/0003-9861(80)90129-0; DERENOBALES M, 1984, ARCH BIOCHEM BIOPHYS, V228, P407, DOI 10.1016/0003-9861(84)90004-3; DWERENDA Z, 1993, TRENDS BIOCHEM SCI, V18, P20; FERRI SR, 1991, J BIOL CHEM, V266, P12852; KNUDSEN J, 1976, BIOCHEM J, V160, P683, DOI 10.1042/bj1600683; KNUDSEN J, 1982, BIOCHEM J, V202, P139, DOI 10.1042/bj2020139; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CY, 1991, EUR J BIOCHEM, V201, P161, DOI 10.1111/j.1432-1033.1991.tb16269.x; LIBERTINI L, 1976, FED PROC, V35, P1671; LIN CY, 1978, J BIOL CHEM, V253, P1954; MANCINI JA, 1988, J BIOL CHEM, V263, P14308; MEIGHEN EA, 1993, ADV MICROB PHYSIOL, V34, P1, DOI 10.1016/S0065-2911(08)60027-2; MEIGHEN EA, 1992, J BACTERIOL, V174, P5371, DOI 10.1128/JB.174.16.5371-5381.1992; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Miles E W, 1977, Methods Enzymol, V47, P431; MIYAMOTO CM, 1990, J BACTERIOL, V172, P2046, DOI 10.1128/jb.172.4.2046-2054.1990; MIYAMOTO CM, 1988, J BIOL CHEM, V263, P13393; MUHLRAD A., 1967, ACTA BIOCHIM BIOPHYS ACAD SCI HUNG, V2, P19; NAGGERT J, 1988, J BIOL CHEM, V263, P1146; POLLARD MR, 1991, ARCH BIOCHEM BIOPHYS, V284, P306, DOI 10.1016/0003-9861(91)90300-8; POULOSE AJ, 1985, J BIOL CHEM, V260, P5953; PRADEL LA, 1968, BIOCHIM BIOPHYS ACTA, V167, P317, DOI 10.1016/0005-2744(68)90211-8; RANDHAWA ZI, 1987, EUR J BIOCHEM, V162, P577, DOI 10.1111/j.1432-1033.1987.tb10678.x; RODRIGUEZ A, 1983, J BIOL CHEM, V258, P5233; RYAN RO, 1982, ARCH BIOCHEM BIOPHYS, V213, P26, DOI 10.1016/0003-9861(82)90435-0; SCHRAG JD, 1991, NATURE, V351, P761, DOI 10.1038/351761a0; SWENSON L, 1992, J MOL BIOL, V227, P572, DOI 10.1016/0022-2836(92)90909-4; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TAI MH, 1993, P NATL ACAD SCI USA, V90, P1852, DOI 10.1073/pnas.90.5.1852; WALL L, 1986, J BIOL CHEM, V261, P5981; WALL L, 1986, BIOCHEMISTRY-US, V25, P4315, DOI 10.1021/bi00363a021; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; WITKOWSKI A, 1991, J BIOL CHEM, V266, P18514	41	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6683	6688						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120025				2022-12-27	WOS:A1994MZ50300068
J	HENRY, R; KAPAZOGLOU, A; MCCAFFERY, M; CLINE, K				HENRY, R; KAPAZOGLOU, A; MCCAFFERY, M; CLINE, K			DIFFERENCES BETWEEN LUMEN TARGETING DOMAINS OF CHLOROPLAST TRANSIT PEPTIDES DETERMINE PATHWAY SPECIFICITY FOR THYLAKOID TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN; MEMBRANES; IMPORT; INSERTION; ATP	Nuclear encoded thylakoid lumen proteins are imported into the chloroplast stroma and further directed across thylakoid membranes by lumen targeting domains. Recently, we showed that there are two protein-specific pathways for transport into the lumen. This was unexpected in that lumen targeting domains have similar properties, all containing bacterial signal peptide motifs. Nevertheless, sequence homology analysis suggests that pathway specificity is determined by elements in the lumen targeting domain. To test this, we constructed and analyzed chimeric proteins in which transit peptides from proteins transported by one pathway were fused to the mature domains of proteins directed by the other. We also investigated the transport characteristics of a previously unexamined protein whose pathway was predicted by sequence similarity analysis. Our results confirm that lumen targeting domains contain pathway sorting elements and further indicate that distinct energy and stroma requirements for transport are pathway characteristics, unrelated to the passenger protein. These findings suggest the operation of two mechanistically different translocators.	UNIV FLORIDA,DEPT HORT SCI,PLANT MOLEC & CELLULAR BIOL PROGRAM,GAINESVILLE,FL 32611; UNIV GEORGIA,DEPT BIOCHEM,ATHENS,GA 30602	State University System of Florida; University of Florida; University System of Georgia; University of Georgia			Cline, Kenneth/J-6238-2013; Kapazoglou, Aliki/AAV-6723-2021	Kapazoglou, Aliki/0000-0002-7584-5994	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046951] Funding Source: NIH RePORTER; NIGMS NIH HHS [1 R01 GM46951] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BASSHAMDC, 1991, J BIOL CHEM, V266, P23606; CLAUSMEYER S, 1993, J BIOL CHEM, V268, P13869; CLINE K, 1988, PLANT PHYSIOL, V86, P1120, DOI 10.1104/pp.86.4.1120; CLINE K, 1992, J BIOL CHEM, V267, P2688; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; CLINE K, 1989, J BIOL CHEM, V264, P14225; CLINE K, 1986, J BIOL CHEM, V261, P4804; CROWE JS, 1991, NUCLEIC ACIDS RES, V19, P184, DOI 10.1093/nar/19.1.184; DEBOER AD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P221, DOI 10.1016/0304-4157(91)90015-O; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DRIESSEN AJM, 1992, TRENDS BIOCHEM SCI, V17, P219, DOI 10.1016/0968-0004(92)90381-I; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; IKEUCHI M, 1992, BOT MAG TOKYO, V105, P327, DOI 10.1007/BF02489425; KNOETZEL J, 1993, PLANT MOL BIOL, V22, P337, DOI 10.1007/BF00014940; NEUPERT W, 1990, CELL, V63, P447, DOI 10.1016/0092-8674(90)90437-J; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; REED JE, 1990, EUR J BIOCHEM, V194, P33, DOI 10.1111/j.1432-1033.1990.tb19423.x; ROBINSON C, 1993, FEBS LETT, V325, P67, DOI 10.1016/0014-5793(93)81415-V; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SIMPSON DJ, 1989, CARLSBERG RES COMMUN, V54, P55, DOI 10.1007/BF02907585	21	76	77	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 8	1994	269	14					10189	10192						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NF017	8144595				2022-12-27	WOS:A1994NF01700002
J	COWLING, RT; BIRNBOIM, HC				COWLING, RT; BIRNBOIM, HC			INCORPORATION OF [P-32] ORTHOPHOSPHATE INTO INORGANIC POLYPHOSPHATES BY HUMAN GRANULOCYTES AND OTHER HUMAN CELL-TYPES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANES; PROTEINS; KINASE	When human peripheral blood granulocytes were metabolically labeled at 37-degrees-C with [P-32] orthophosphate, inorganic polyphosphates became preferentially radiolabeled. Incorporation of radiolabel into the polymer appeared to be ATP-independent. [P-32]Polyphosphate was identified by its (i) characteristic lability to acid hydrolysis, (ii) insolubility in barium acetate (pH 4.5), (iii) conversion to [P-32]trimetaphosphate, (iv) hydrolysis to [P-32]orthophosphate by an exopolyphosphatase (Saccharomyces cerevisiae scPPX1), and (v) conversion to a ''phosphate ladder''which co-migrated on a polyacrylamide gel with a synthetic phosphate ladder. Also, indirect evidence suggested that the [P-32]polyphosphate was strongly, noncovalently associated with another unknown molecule. Particulate fractions (13,000 x g) from lysates of human granulocytes, skin fibroblasts, HL-60 and SK-N-SH cells, all demonstrated radiolabeling of polyphosphate when incubated at 37-degrees-C with [P-32] orthophosphate.	OTTAWA REG CANC CTR,OTTAWA K1H 8L6,ON,CANADA; UNIV OTTAWA,OTTAWA K1H 8L6,ON,CANADA	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa				Birnboim, Hyman C./0000-0001-5830-4769				AHN KH, 1990, J BIOL CHEM, V265, P11734; AKIYAMA M, 1993, J BIOL CHEM, V268, P633; BIRNBOIM HC, 1990, METHOD ENZYMOL, V186, P550; CHEN JH, 1993, DNA CELL BIOL, V12, P177, DOI 10.1089/dna.1993.12.177; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; FITTSCHEN C, 1991, J LEUKOCYTE BIOL, V50, P517, DOI 10.1002/jlb.50.5.517; FURLONG NB, 1965, ANAL BIOCHEM, V12, P349, DOI 10.1016/0003-2697(65)90102-8; GABEL NW, 1971, J NEUROCHEM, V18, P1229, DOI 10.1111/j.1471-4159.1971.tb00222.x; GRIFFIN JB, 1965, J BIOL CHEM, V240, P4427; GURLAND J, 1971, AM STAT, V25, P30, DOI 10.2307/2682923; Hallet M. B., 1989, NEUTROPHIL CELLULAR, P1; HAROLD FM, 1966, BACTERIOL REV, V30, P772, DOI 10.1128/MMBR.30.4.772-794.1966; HAROLD FM, 1962, BIOCHIM BIOPHYS ACTA, V57, P48; HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7; HIRSCH JG, 1965, INFLAMMATORY PROCESS, P245; Kulaev I.S., 1958, P ACAD SCI USSR, V120, P128; KULAEV IS, 1983, ADV MICROB PHYSIOL, V24, P83, DOI 10.1016/S0065-2911(08)60385-9; KULAEV IS, 1975, REV PHYSIOL BIOCH P, V73, P131, DOI 10.1007/BFb0034661; LELOIR LF, 1957, METHOD ENZYMOL, V3, P840, DOI 10.1016/S0076-6879(57)03459-X; MCCORMICK JJ, 1981, DNA REPAIR LABORATOR, P501; Murphy P, 1976, NEUTROPHIL; OFFENBACHER S, 1984, ARCH BIOCHEM BIOPHYS, V231, P114, DOI 10.1016/0003-9861(84)90368-0; PARKER RP, 1970, CURRENT STATUS LIQUI, P00110; PENNIALL R, 1984, BIOSCIENCE REP, V4, P957, DOI 10.1007/BF01116894; PICK U, 1990, FEBS LETT, V274, P15, DOI 10.1016/0014-5793(90)81318-I; PISONI RL, 1992, J BIOL CHEM, V267, P3626; REUSCH RN, 1989, P SOC EXP BIOL MED, V191, P377; REUSCH RN, 1988, P NATL ACAD SCI USA, V85, P4176, DOI 10.1073/pnas.85.12.4176; ROBINSON NA, 1984, BIOCHEM INT, V8, P757; SKORKO R, 1989, BIOCHIMIE, V71, P1089, DOI 10.1016/0300-9084(89)90115-6; TAMAOKI T, 1967, BIOCHEMISTRY-US, V6, P3583, DOI 10.1021/bi00863a033; TINSLEY CR, 1993, INFECT IMMUN, V61, P3703, DOI 10.1128/IAI.61.9.3703-3710.1993; VOLLOCH VZ, 1979, NUCLEIC ACIDS RES, V6, P1521, DOI 10.1093/nar/6.4.1521; WOOD HG, 1985, CURR TOP CELL REGUL, V26, P355; WURST H, 1994, IN PRESS J BIOL CHEM, V269	35	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9480	9485						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144532				2022-12-27	WOS:A1994NE05300016
J	LAWRENCE, R; HARTMANN, DJ; SONENSHEIN, GE				LAWRENCE, R; HARTMANN, DJ; SONENSHEIN, GE			TRANSFORMING GROWTH-FACTOR-BETA-1 STIMULATES TYPE-V COLLAGEN EXPRESSION IN BOVINE VASCULAR SMOOTH-MUSCLE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN MESSENGER-RNAS; FACTOR TYPE-BETA; RAT-KIDNEY; EXTRACELLULAR-MATRIX; CONNECTIVE-TISSUE; III COLLAGEN; XI COLLAGEN; I COLLAGEN; CHAIN; PROLIFERATION	Vascular smooth muscle cells (SMCs) produce the bulk of the connective tissue of major arteries, including collagen types I, III, and V. Recently, we have shown, they also have the capacity to synthesize the alpha1 chain of type XI, a collagen related to type V (Brown, K., Lawrence, R., and Sonenshein, G. (1991) J. Biol. Chem. 266, 23268-23273). Furthermore, expression of types V and XI collagen were coordinately regulated with respect to serum deprivation and cell density in a fashion distinct from that for types I and III. To begin to determine the factors that influence vascular SMC production of types V/XI collagen, we have examined the effects of transforming growth factor (TGF)-beta1, a major modulator of connective tissue expression. In serum-deprived confluent cultures of bovine pulmonary artery SMCs, TGF-beta1 treatment increased the steady-state levels of the mRNAs of collagen types V and XI, as well as of types I and III, elastin and fibronectin. The largest increase was seen for alpha2(V) procollagen. The increase in alpha2(V) mRNA was detectable by 12 h after addition of 2 ng/ml TGF-beta1, and concentrations as little as 0.5 ng/ml were effective. A similar increase in alpha2(V) mRNA levels was observed with SMCs derived from the aortic arch and carotid artery. Type V collagen protein was found to be elevated by TGF-beta1 treatment in both the conditioned media and the cell layer associated fraction of pulse-labeled cultures. A slight decrease in SMC proliferation as judged by DNA content, [H-3]thymidine incorporation, and steady-state levels of histone H3.2 mRNA resulted from TGF-beta1 treatment. These results suggest that the elevated levels of TGF-beta1 in the vessel wall during atherosclerosis may be, in part, responsible for the increase in type V collagen that typifies advanced fibrotic lesions.	BOSTON UNIV,SCH MED,DEPT BIOCHEM,BOSTON,MA 02118; INST PASTEUR,CNRS,URA 1459,CTR RADIOANAL,F-69365 LYON,FRANCE	Boston University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris					NHLBI NIH HHS [HL13262] Funding Source: Medline; NIA NIH HHS [AG00115] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL013262] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADACHI E, 1986, CONNECT TISSUE RES, V14, P257, DOI 10.3109/03008208609017469; ALTERMAN RBM, 1984, MOL CELL BIOL, V4, P123, DOI 10.1128/MCB.4.1.123; ASSOIAN RK, 1986, J CELL BIOL, V102, P1217, DOI 10.1083/jcb.102.4.1217; BARSKY SH, 1982, AM J PATHOL, V108, P276; BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; BELDEKAS JC, 1981, BIOCHEMISTRY-US, V20, P2162, DOI 10.1021/bi00511a014; BERNARD M, 1988, J BIOL CHEM, V263, P17159; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; BIRK DE, 1990, J CELL SCI, V95, P649; BROWN KE, 1991, J BIOL CHEM, V266, P23268; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; CHEN JK, 1987, P NATL ACAD SCI USA, V84, P5287, DOI 10.1073/pnas.84.15.5287; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5284; CHOE I, 1987, J BIOL CHEM, V262, P5408; CHUNG E, 1976, BIOCHEM BIOPH RES CO, V71, P1167, DOI 10.1016/0006-291X(76)90776-2; DEAN M, 1983, NATURE, V305, P443, DOI 10.1038/305443a0; Eyre D, 1987, STRUCTURE FUNCTION C, P261; FAVA RA, 1987, J CELL PHYSIOL, V131, P184, DOI 10.1002/jcp.1041310207; FESSLER JH, 1987, STRUCTURE FUNCTION C, P81; FINE A, 1987, J BIOL CHEM, V262, P3897; GRAHAM MF, 1988, GASTROENTEROLOGY, V94, P257, DOI 10.1016/0016-5085(88)90411-8; GRAHAM MF, 1987, GASTROENTEROLOGY, V92, P400, DOI 10.1016/0016-5085(87)90134-X; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443; KINDY MS, 1986, J BIOL CHEM, V261, P2865; KLEMAN JP, 1992, EUR J BIOCHEM, V210, P329, DOI 10.1111/j.1432-1033.1992.tb17425.x; LAIHO M, 1991, J BIOL CHEM, V266, P9108; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453; LIAU G, 1989, J BIOL CHEM, V264, P10315; LIU JM, 1988, BIOCHEM BIOPH RES CO, V154, P895, DOI 10.1016/0006-291X(88)90224-0; LYONS RM, 1990, EUR J BIOCHEM, V187, P467, DOI 10.1111/j.1432-1033.1990.tb15327.x; MADRI JA, 1979, AM J PATHOL, V94, P323; MAJACK RA, 1987, J CELL BIOL, V105, P465, DOI 10.1083/jcb.105.1.465; MARTINEZHERNANDEZ A, 1982, J CELL BIOL, V92, P343, DOI 10.1083/jcb.92.2.343; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MORRIS NP, 1990, J BIOL CHEM, V265, P10081; MORTON LF, 1982, ATHEROSCLEROSIS, V42, P41, DOI 10.1016/0021-9150(82)90124-1; MOSS NS, 1970, LAB INVEST, V23, P231; MURATA K, 1986, ATHEROSCLEROSIS, V60, P251, DOI 10.1016/0021-9150(86)90172-3; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; NARAYANAN AS, 1983, J BIOL CHEM, V258, P1694; NARAYANAN AS, 1983, COLLAGEN REL RES, V3, P323; NIYIBIZI C, 1989, FEBS LETT, V242, P314, DOI 10.1016/0014-5793(89)80492-2; NUGENT MA, 1989, CANCER RES, V49, P3884; NUGENT MA, 1989, J BIOL CHEM, V264, P18060; OAKES BW, 1982, EUR J CELL BIOL, V27, P34; OCONNORMCCOURT MD, 1987, J BIOL CHEM, V262, P14090; OOSHIMA A, 1981, SCIENCE, V213, P666, DOI 10.1126/science.7256267; OWENS GK, 1988, J CELL BIOL, V107, P771, DOI 10.1083/jcb.107.2.771; PENTTINEN RP, 1988, P NATL ACAD SCI USA, V85, P1105, DOI 10.1073/pnas.85.4.1105; RICH CB, 1989, ARCH BIOCHEM BIOPHYS, V268, P551, DOI 10.1016/0003-9861(89)90322-6; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; ROSS R, 1990, SCIENCE, V248, P1009, DOI 10.1126/science.2343305; SAGE H, 1979, BIOCHEMISTRY-US, V18, P3815, DOI 10.1021/bi00584a027; SCHWARZBAUER JE, 1983, CELL, V35, P421, DOI 10.1016/0092-8674(83)90175-7; SILVER MH, 1984, DIFFERENTIATION, V27, P205, DOI 10.1111/j.1432-0436.1984.tb01430.x; STEPP MA, 1985, ANN NY ACAD SCI, V460, P510, DOI 10.1111/j.1749-6632.1985.tb51225.x; TAKAHARA K, 1991, J BIOL CHEM, V266, P13124; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; WEIL D, 1987, NUCLEIC ACIDS RES, V15, P181, DOI 10.1093/nar/15.1.181; YOSHIOKA H, 1990, J BIOL CHEM, V265, P6423	63	73	74	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9603	9609						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144547				2022-12-27	WOS:A1994NE05300034
J	COOK, WJ; MOSLEY, SP; AUDINO, DC; MULLANEY, DL; ROVELLI, A; STEWART, G; DENIS, CL				COOK, WJ; MOSLEY, SP; AUDINO, DC; MULLANEY, DL; ROVELLI, A; STEWART, G; DENIS, CL			MUTATIONS IN THE ZINC-FINGER REGION OF THE YEAST REGULATORY PROTEIN ADR1 AFFECT BOTH DNA-BINDING AND TRANSCRIPTIONAL ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ALCOHOL-DEHYDROGENASE; ADH2 EXPRESSION; FACTOR-IIIA; GENE; SEQUENCE; MUTAGENESIS; KINASE; SPECIFICITY; KRUPPEL	The expression of the yeast ADH2 gene is controlled by the transcriptional activator ADR1, a zinc-finger pro- tein that binds to an upstream activating sequence (UAS1) in the ADH2 promoter. We report here the isolation of seven mutations in the ADR1-5(c) allele, defining five different amino acid changes, that suppress the enhanced ADH2 expression caused by the ADR1-5(c) allele. Each of the mutations was shown to reduce the activation of ADH2 by a wild-type ADR1 gene, suggesting the mutations disrupt a domain important to the function of both the ADR1 and ADR1-5(c) proteins. All five amino acid changes occurred within the DNA-binding domain of ADR1 and were shown to severely inhibit the ability of ADR1 to bind UAS1 in vitro. These mutations were found, however, to also affect the ability of ADR1 to activate transcription independent of its ability to bind DNA. These results indicate that the DNA-binding region of ADR1 is involved in both transactivation and DNA binding.	UNIV NEW HAMPSHIRE, DEPT BIOCHEM & MOLEC BIOL, DURHAM, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	COOK, WJ (corresponding author), HARVARD UNIV, SCH MED, DEPT BIOL CHEM & MOLEC PHARMACOL, BOSTON, MA 02115 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041215] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41215] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEMIS LT, 1988, MOL CELL BIOL, V8, P2125, DOI 10.1128/MCB.8.5.2125; BEMIS LT, 1989, YEAST, V5, P291, DOI 10.1002/yea.320050409; BLUMBERG H, 1987, NATURE, V328, P443, DOI 10.1038/328443a0; BRAM RJ, 1985, P NATL ACAD SCI USA, V82, P43, DOI 10.1073/pnas.82.1.43; BRENT R, 1985, CELL, V43, P729, DOI 10.1016/0092-8674(85)90246-6; CAMIER S, 1992, MOL CELL BIOL, V12, P5758, DOI 10.1128/MCB.12.12.5758; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CHERRY JR, 1989, CELL, V56, P409, DOI 10.1016/0092-8674(89)90244-4; CIRIACY M, 1975, MOL GEN GENET, V138, P157, DOI 10.1007/BF02428119; COOK WJ, 1993, CURR GENET, V23, P192, DOI 10.1007/BF00351495; COOK WJ, 1994, MOL CELL BIOL, V14, P629, DOI 10.1128/MCB.14.1.629; DELRIO S, 1993, P NATL ACAD SCI USA, V90, P168, DOI 10.1073/pnas.90.1.168; DENIS CL, 1983, MOL CELL BIOL, V3, P360, DOI 10.1128/MCB.3.3.360; DENIS CL, 1986, MOL CELL BIOL, V6, P4026, DOI 10.1128/MCB.6.11.4026; DENIS CL, 1991, MOL GEN GENET, V229, P395, DOI 10.1007/BF00267461; DENIS CL, 1992, MOL CELL BIOL, V12, P1507, DOI 10.1128/MCB.12.4.1507; DENIS CL, 1987, MOL GEN GENET, V208, P101, DOI 10.1007/BF00330429; EISEN A, 1988, MOL CELL BIOL, V8, P4552, DOI 10.1128/MCB.8.10.4552; GOLEMIS EA, 1992, MOL CELL BIOL, V12, P3006, DOI 10.1128/MCB.12.7.3006; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; KIM KS, 1989, NATURE, V342, P200, DOI 10.1038/342200a0; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KURET J, 1988, J BIOL CHEM, V263, P9149; LAWRENCE CW, 1991, METHOD ENZYMOL, V194, P273; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Miller J. H, 1972, EXPT MOL GENETICS; MILNE CA, 1993, J BIOL CHEM, V268, P11364; PARRAGA G, 1988, SCIENCE, V241, P1489, DOI 10.1126/science.3047872; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; ROSENBERG UB, 1986, NATURE, V319, P336, DOI 10.1038/319336a0; RUDEN DM, 1991, NATURE, V350, P250, DOI 10.1038/350250a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHENA M, 1989, GENE DEV, V3, P1590, DOI 10.1101/gad.3.10.1590; SCHUH R, 1986, CELL, V47, P1025, DOI 10.1016/0092-8674(86)90817-2; SUZUKI M, 1989, J MOL BIOL, V207, P61, DOI 10.1016/0022-2836(89)90441-5; TAYLOR WE, 1990, P NATL ACAD SCI USA, V87, P4098, DOI 10.1073/pnas.87.11.4098; THUKRAL SK, 1991, P NATL ACAD SCI USA, V88, P9188, DOI 10.1073/pnas.88.20.9188; THUKRAL SK, 1992, MOL CELL BIOL, V12, P2784, DOI 10.1128/MCB.12.6.2784; THUKRAL SK, 1991, MOL CELL BIOL, V11, P1566, DOI 10.1128/MCB.11.3.1566; THUKRAL SK, 1989, MOL CELL BIOL, V9, P2360, DOI 10.1128/MCB.9.6.2360; THUKRAL SK, 1993, P NATL ACAD SCI USA, V90, P7908; VALLARI RC, 1992, MOL CELL BIOL, V12, P1663, DOI 10.1128/MCB.12.4.1663; WEST RW, 1984, MOL CELL BIOL, V4, P2467, DOI 10.1128/MCB.4.11.2467; YU J, 1989, MOL CELL BIOL, V9, P34, DOI 10.1128/MCB.9.1.34	46	26	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9374	9379						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132676				2022-12-27	WOS:A1994NB41100109
J	GULLIVER, GA; BEDZYK, WD; SMITH, RG; BODE, SL; TETIN, SY; VOSS, EW				GULLIVER, GA; BEDZYK, WD; SMITH, RG; BODE, SL; TETIN, SY; VOSS, EW			CONVERSION OF AN ANTI-SINGLE-STRANDED DNA ACTIVE-SITE TO AN ANTIFLUORESCEIN ACTIVE-SITE THROUGH HEAVY-CHAIN COMPLEMENTARITY-DETERMINING REGION TRANSPLANTATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; FAB COMPLEX; BINDING; AUTOANTIBODY; CLONING	Complementarity determining region (CDR) transplant studies were conducted between two monoclonal antibodies of distinctly different specificities (anti-fluorescein monoclonal antibody (mAb) 4-4-20 and anti-single-stranded DNA (ssDNA) mAb 04-01) which possessed nearly identical light chains but dissimilar heavy chains. The variations in binding specificities between the two immunoglobulins suggested that the active-site features of anti fluorescein antibodies were dictated by characteristics intrinsic to the heavy chain (H-chain). To identify specific regions of the H-chain which influence the structure and function of an anti-fluorescein active site, CDR transplantation was systematically employed to convert the anti-ssDNA 04-01 antibody active site to an active site with anti-fluorescein activity. Each mAb 4-4-20 H-chain CDR (HCDR) was transplanted into the H-chain of a single-chain derivative of the 04-01 molecule. A fluorescence polarization ligand binding assay was utilized to determine the equilibrium dissociation constant, K-d, Of hybrid transplant single-chain antibody HCDR1-HCDR2-HCDR3(4.4.20) for fluorescein (3.8 x 10(-7) M), indicating successful conversion of an anti-ssDNA active site to an anti-fluorescein binding site. A similar K-d (6.3 x 10(-7) M) was determined using a fluorescein fluorescence quenching assay. The transplantation results are discussed in terms of the relative contribution of each HCDR to a successful conversion in antibody specificity.	UNIV ILLINOIS, DEPT MICROBIOL, URBANA, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign								BALLARD DW, 1984, J BIOL CHEM, V259, P3492; BATES RM, 1985, MOL IMMUNOL, V22, P871, DOI 10.1016/0161-5890(85)90072-0; BEAUCAGE SL, 1981, TETRAHEDRON LETT, V22, P1859, DOI 10.1016/S0040-4039(01)90461-7; BEDZYK WD, 1986, MOL IMMUNOL, V23, P1319, DOI 10.1016/0161-5890(86)90017-9; BEDZYK WD, 1990, J BIOL CHEM, V265, P133; BEDZYK WD, 1990, J BIOL CHEM, V265, P18615; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; CHAMBERS SP, 1988, GENE, V68, P139, DOI 10.1016/0378-1119(88)90606-3; DENZIN LK, 1993, MOL IMMUNOL, V30, P1331, DOI 10.1016/0161-5890(93)90094-R; DENZIN LK, 1991, J BIOL CHEM, V266, P14095; GALFRE G, 1977, NATURE, V266, P550, DOI 10.1038/266550a0; GUSSOW D, 1991, METHOD ENZYMOL, V203, P99; HERRON JN, 1991, PROTEINS, V11, P159, DOI 10.1002/prot.340110302; HERRON JN, 1989, PROTEINS, V5, P271, DOI 10.1002/prot.340050404; HERRON JN, 1984, FLUORESCEIN HAPTEN I, P49; KRANZ DM, 1981, P NATL ACAD SCI-BIOL, V78, P5807, DOI 10.1073/pnas.78.9.5807; KRANZ DM, 1982, J BIOL CHEM, V257, P6987; KRANZ DM, 1981, MOL IMMUNOL, V18, P889, DOI 10.1016/0161-5890(81)90012-2; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; REINITZ DM, 1985, J IMMUNOL, V135, P3365; RUMBLEY CA, 1993, J BIOL CHEM, V268, P13667; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SCANDELLA D, 1985, J CELL BIOCH B, V9, P203; SMITH R G, 1989, Journal of the Indian Institute of Science, V69, P25; SMITH RG, 1990, MOL IMMUNOL, V27, P463, DOI 10.1016/0161-5890(90)90171-U; SWINDLEHURST CA, 1991, BIOPHYS J, V59, P619, DOI 10.1016/S0006-3495(91)82277-9	27	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7934	7940						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132513				2022-12-27	WOS:A1994NB40900019
J	SIKKEMA, J; DEBONT, JAM; POOLMAN, B				SIKKEMA, J; DEBONT, JAM; POOLMAN, B			INTERACTIONS OF CYCLIC HYDROCARBONS WITH BIOLOGICAL-MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PROTON-MOTIVE FORCE; NATIVE MEMBRANES; PARTITION-COEFFICIENTS; CYTOPLASMIC MEMBRANES; ANESTHETICS; FLUIDITY; PHOSPHOLIPIDS; LIPOSOMES; VESICLES	Many cyclic hydrocarbons, e.g. aromatics, cycloalkanes, and terpenes, are toxic to microorganisms. The primary site of the toxic action is probably the cytoplasmic membrane, but the mechanism of the toxicity is still poorly understood. The effects of cyclic hydrocarbons were studied in liposomes prepared from Escherichia coli phospholipids. The membrane-buffer partition coefficients of the cyclic hydrocarbons revealed that these lipophilic compounds preferentially reside in the membrane. The partition coefficients closely correlated with the partition coefficients of these compounds in a standard octanol-water system. The accumulation of hydro carbon molecules resulted in swelling of the membrane bilayer, as assessed by the release of fluorescence self-quenching of fluorescent fatty acid and phospholipid analogs. Parallel to the expansion of the membrane, an increase in membrane fluidity was observed. These effects on the integrity of the membrane caused an increased passive flux of protons and carboxyfluorescein. In cytochrome c oxidase containing proteoliposomes, both components of the proton motive force, the pH gradient and the electrical potential, were dissipated with increasing concentrations of cyclic hydrocarbons. The dissipating effect was primarily the result of an increased permeability of the membrane for protons (ions). At higher concentrations, cytochrome c oxidase was also inactivated. The effective concentrations of the different cyclic hydrocarbons correlated with their partition coefficients between the membrane and aqueous phase. The impairment of microbial activity by the cyclic hydrocarbons most likely results from hydrophobic interaction with the membrane, which affects the functioning of the membrane and membrane-embedded proteins.	WAGENINGEN UNIV AGR, DEPT FOOD SCI, DIV IND MICROBIOL, 6700 EV WAGENINGEN, NETHERLANDS; UNIV GRONINGEN, DEPT MICROBIOL, 9750 AA HAREN, NETHERLANDS	Wageningen University & Research; University of Groningen			Poolman, Bert/D-1882-2012					ANTUNESMADEIRA MC, 1986, BIOCHIM BIOPHYS ACTA, V861, P159, DOI 10.1016/0005-2736(86)90414-1; ANTUNESMADEIRA MC, 1989, BIOCHIM BIOPHYS ACTA, V982, P161, DOI 10.1016/0005-2736(89)90187-9; ANTUNESMADEIRA MC, 1985, BIOCHIM BIOPHYS ACTA, V820, P165, DOI 10.1016/0005-2736(85)90109-9; ANTUNESMADEIRA MC, 1987, BIOCHIM BIOPHYS ACTA, V901, P61, DOI 10.1016/0005-2736(87)90256-2; ANTUNESMADEIRA MC, 1984, BIOCHIM BIOPHYS ACTA, V778, P49, DOI 10.1016/0005-2736(84)90446-2; CARTWRIGHT CP, 1986, J GEN MICROBIOL, V132, P369; Chapman D., 1984, LIPOSOME TECHNOLOGY, V1, P1; CLEMENT NR, 1981, BIOCHEMISTRY-US, V20, P1534, DOI 10.1021/bi00509a019; DESMET MJ, 1978, BIOCHIM BIOPHYS ACTA, V506, P64, DOI 10.1016/0005-2736(78)90435-2; DEVRIJ W, 1988, J BACTERIOL, V170, P2359, DOI 10.1128/jb.170.5.2359-2366.1988; DEYOUNG LR, 1988, BIOCHEMISTRY-US, V27, P5281, DOI 10.1021/bi00414a050; Eastcott L., 1988, OIL CHEM POLLUT, V4, P191, DOI DOI 10.1016/S0269-8579(88)80020-0; ELFERINK MGL, 1992, J BIOL CHEM, V267, P1375; FRANKS NP, 1987, TRENDS PHARMACOL SCI, V8, P169, DOI 10.1016/0165-6147(87)90160-X; HINKLE PC, 1972, J BIOL CHEM, V247, P1338; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; KAGAWA Y, 1971, J BIOL CHEM, V235, P769; KATZ Y, 1974, J MEMBRANE BIOL, V17, P69, DOI 10.1007/BF01870173; LABELLA FS, 1981, CAN J PHYSIOL PHARM, V59, P432, DOI 10.1139/y81-067; LEAO C, 1984, BIOCHIM BIOPHYS ACTA, V774, P43, DOI 10.1016/0005-2736(84)90272-4; LENTZ BR, 1989, CHEM PHYS LIPIDS, V50, P171, DOI 10.1016/0009-3084(89)90049-2; LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001; LIDE K, 1992, HDB CHEM PHYSICS; LIEB WR, 1986, TRANSPORT DIFFUSION, P69; LOLKEMA JS, 1982, BIOCHIM BIOPHYS ACTA, V681, P85, DOI 10.1016/0005-2728(82)90281-X; MACHLEIDT H, 1972, BIOCHIM BIOPHYS ACTA, V255, P178, DOI 10.1016/0005-2736(72)90020-X; Overton E., 1897, Z PHYS CHEM, V22, P189; REKKER RF, 1979, EUR J MED CHEM, V14, P479; Rekker RF., 1977, HYDROPHOBIC FRAGMENT; Riddick J. A., 1986, ORGANIC SOLVENTS, VII; ROTTENBERG H, 1990, BIOCHIM BIOPHYS ACTA, V1018, P1, DOI 10.1016/0005-2728(90)90103-B; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; SEEMAN P, 1971, BIOCHIM BIOPHYS ACTA, V225, P171, DOI 10.1016/0005-2736(71)90210-0; SEEMAN P, 1972, PHARMACOL REV, V24, P583; SHINITZKY M, 1978, BIOCHIM BIOPHYS ACTA, V515, P367, DOI 10.1016/0304-4157(78)90010-2; Sikkema J., 1991, Biodegradation, V2, P15, DOI 10.1007/BF00122421; SIKKEMA J, 1992, J BACTERIOL, V174, P2986, DOI 10.1128/JB.174.9.2986-2992.1992; SMITH MR, 1993, BIOCH MICROBIAL DEGR, P347; Tomlinson E, 1986, PARTITION COEFFICIEN, P101; URIBE S, 1990, APPL ENVIRON MICROB, V56, P2114, DOI 10.1128/AEM.56.7.2114-2119.1990; URIBE S, 1985, J BACTERIOL, V161, P1195, DOI 10.1128/JB.161.3.1195-1200.1985; VELD GI, 1991, BIOCHIM BIOPHYS ACTA, V1065, P203, DOI 10.1016/0005-2736(91)90231-V; VELD GI, 1992, BIOCHIM BIOPHYS ACTA, V1104, P250; Verschueren K., 1983, HDB ENV DATA ORGANIC; YEAGLE PL, 1989, FASEB J, V3, P1833, DOI 10.1096/fasebj.3.7.2469614	45	825	883	1	115	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8022	8028						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132524				2022-12-27	WOS:A1994NB40900032
J	AMIN, AA; MURAKAMI, Y; HURWITZ, J				AMIN, AA; MURAKAMI, Y; HURWITZ, J			INITIATION OF DNA-REPLICATION BY SIMIAN-VIRUS-40 T-ANTIGEN IS INHIBITED BY THE P107 PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE TUMOR-ANTIGEN; RETINOBLASTOMA GENE-PRODUCT; SV40 LARGE-T; E2F TRANSCRIPTION FACTOR; CELL-CYCLE; SUSCEPTIBILITY GENE; INVITRO REPLICATION; POLYMERASE-ALPHA; PURIFIED PROTEINS; BINDING ACTIVITY	The p107 protein is related to the Rb protein by a 60-kDa region of homology called the pocket domain that binds cellular proteins such as E2F and cyclins A and E as well as the viral oncoproteins E1A, E7, and SV40 T antigen. The p107 and Rb proteins have both been implicated as negative regulators of cell growth. We have examined the effect of the unphosphorylated pocket domain of p107 on specific stages of the T antigen-mediated replication of SV40 DNA in vitro. The pocket domain inhibited replication by preventing the assembly of T antigen at the SV40 core origin DNA containing binding site II. However, both proteins formed a ternary complex with DNA containing T antigen-binding site I. The pocket domain of p107 did not inhibit the oligomerization of T antigen in the absence of DNA, and the p107 derivative is bound to the intermediates of this reaction. In the unwinding assay, once T antigen was preassembled as hexamers at the core origin, the pocket domain bound to and stabilized the complex, resulting in an increase in the yield of unwound product. Preformed T antigen hexamers complexed with the pocket domain bind to a synthetic replication fork, and this complex supported unwinding. Consistent with this, the p107 pocket domain had no effect on the helicase activity of T antigen in an assay using a partial duplex substrate. However, a complex containing p107 and T antigen assembled at the core origin did not support SV40 DNA replication in HeLa cell crude extracts or in the monopolymerase reaction. This inhibition is due to the inability of the complex to bind to DNA polymerase alpha, which is required for the initiation of DNA synthesis. The data suggest pathways by which the pocket domain of p107 can negatively regulate T antigen-mediated replication in vitro. The binding of T antigen to p107 is discussed with respect to its role in mitigating negative cell growth control, resulting in viral mediated transformation.	MEM SLOAN KETTERING CANC CTR,PROGRAM MOLEC BIOL,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center								AMIN AA, 1992, J BIOL CHEM, V267, P18612; AUWERX J, 1991, CELL, V64, P983, DOI 10.1016/0092-8674(91)90322-P; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAGCHI S, 1990, CELL, V62, P659, DOI 10.1016/0092-8674(90)90112-R; BANDARA LR, 1991, NATURE, V352, P249, DOI 10.1038/352249a0; BANDARA LR, 1991, NATURE, V351, P494, DOI 10.1038/351494a0; BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BOROWIEC JA, 1988, EMBO J, V7, P3149, DOI 10.1002/j.1460-2075.1988.tb03182.x; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BOROWIEC JA, 1988, P NATL ACAD SCI USA, V85, P64, DOI 10.1073/pnas.85.1.64; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CAO L, 1992, NATURE, V355, P176, DOI 10.1038/355176a0; CEGIELSKA A, 1993, MOL CELL BIOL, V13, P1202, DOI 10.1128/MCB.13.2.1202; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P8981, DOI 10.1073/pnas.84.24.8981; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; DEAN FB, 1992, J BIOL CHEM, V267, P14129; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DECAPRIO JA, 1992, P NATL ACAD SCI USA, V89, P1795, DOI 10.1073/pnas.89.5.1795; DIFFLEY JFX, 1992, NATURE, V357, P169, DOI 10.1038/357169a0; DODSON M, 1987, SCIENCE, V238, P964, DOI 10.1126/science.2823389; DORNREITER I, 1990, EMBO J, V9, P3329, DOI 10.1002/j.1460-2075.1990.tb07533.x; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; DYSON N, 1989, CELL, V58, P249, DOI 10.1016/0092-8674(89)90839-8; EKI T, 1992, J BIOL CHEM, V267, P7284; EWEN ME, 1992, SCIENCE, V255, P85, DOI 10.1126/science.1532457; EWEN ME, 1991, CELL, V66, P1155, DOI 10.1016/0092-8674(91)90038-Z; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; EWEN ME, 1989, CELL, V58, P257, DOI 10.1016/0092-8674(89)90840-4; FANNING E, 1992, J VIROL, V66, P1289, DOI 10.1128/JVI.66.3.1289-1293.1992; FRIEDMAN PN, 1990, P NATL ACAD SCI USA, V87, P9275, DOI 10.1073/pnas.87.23.9275; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GOETZ GS, 1988, J BIOL CHEM, V263, P383; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; HU QJ, 1990, EMBO J, V9, P1147, DOI 10.1002/j.1460-2075.1990.tb08221.x; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; IISHIMI Y, 1988, J BIOL CHEM, V263, P19723; KATO J, 1993, GENE DEV, V7, P331; KENNY M K, 1990, Journal of Biological Chemistry, V265, P7693; LEE SH, 1989, P NATL ACAD SCI USA, V86, P7361, DOI 10.1073/pnas.86.19.7361; LEE SH, 1991, J BIOL CHEM, V266, P594; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; LOEBER G, 1991, J VIROL, V65, P3167, DOI 10.1128/JVI.65.6.3167-3174.1991; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; LUDLOW JW, 1990, CELL, V60, P387, DOI 10.1016/0092-8674(90)90590-B; MASTRANGELO IA, 1989, NATURE, V338, P658, DOI 10.1038/338658a0; MCVEY D, 1993, J VIROL, V67, P5206, DOI 10.1128/JVI.67.9.5206-5215.1993; MCVEY D, 1989, NATURE, V341, P503, DOI 10.1038/341503a0; MUDRYJ M, 1990, EMBO J, V9, P2179, DOI 10.1002/j.1460-2075.1990.tb07387.x; MURAKAMI Y, 1993, J BIOL CHEM, V268, P11018; MURAKAMI Y, 1992, P NATL ACAD SCI USA, V89, P952, DOI 10.1073/pnas.89.3.952; MURAKAMI Y, 1993, J BIOL CHEM, V268, P1108; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; OREN M, 1985, BIOCHIM BIOPHYS ACTA, V823, P67, DOI 10.1016/0304-419X(85)90015-0; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PARSONS RE, 1991, J VIROL, V65, P2798, DOI 10.1128/JVI.65.6.2798-2806.1991; PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; RAYCHAUDHURI P, 1991, GENE DEV, V5, P1200, DOI 10.1101/gad.5.7.1200; ROTTER V, 1985, ADV CANCER RES, V43, P113, DOI 10.1016/S0065-230X(08)60944-6; SCHEIDTMANN KH, 1991, J VIROL, V65, P2098, DOI 10.1128/JVI.65.4.2098-2101.1991; SCHWARZ JK, 1993, EMBO J, V12, P1013, DOI 10.1002/j.1460-2075.1993.tb05742.x; SENGUPTA DJ, 1992, SCIENCE, V256, P1656, DOI 10.1126/science.256.5064.1656; SHIRODKAR S, 1992, CELL, V68, P157, DOI 10.1016/0092-8674(92)90214-W; STAHL MH, 1988, EMBO J, V7, P3149; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; TACK LC, 1987, J BIOL CHEM, V262, P6339; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; VIRSHUP DM, 1992, MOL CELL BIOL, V12, P4883, DOI 10.1128/MCB.12.11.4883; WANG EH, 1989, CELL, V57, P379, DOI 10.1016/0092-8674(89)90913-6; WEINBERG DH, 1990, P NATL ACAD SCI USA, V87, P8692, DOI 10.1073/pnas.87.22.8692; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; WIEKOWSKI M, 1988, J BIOL CHEM, V263, P436; WOBBE CR, 1987, PHILOS T ROY SOC B, V317, P439, DOI 10.1098/rstb.1987.0071; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; WOBBE CR, 1985, P NATL ACAD SCI USA, V82, P5710, DOI 10.1073/pnas.82.17.5710; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111	84	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7735	7743						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8126000				2022-12-27	WOS:A1994NA03200108
J	BOLIN, DJ; JONAS, A				BOLIN, DJ; JONAS, A			BINDING OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE TO RECONSTITUTED HIGH-DENSITY-LIPOPROTEINS IS AFFECTED BY THEIR LIPID BUT NOT APOLIPOPROTEIN COMPOSITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-I; DISCOIDAL COMPLEXES; MICELLAR COMPLEXES; MODEL MEMBRANES; HUMAN-PLASMA; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINE; VESICLES; LIPASE; ACID	The reaction of lecithin:cholesterol acyltransferase (LCAT) with high density lipoproteins (HDL) is of critical importance in reverse cholesterol transport. We studied the relationship between LCAT binding and HDL composition using two assays to determine LCAT binding affinity for discoidal reconstituted HDL (rHDL). We prepared rHDL with egg phosphatidylcholine (egg-PC), cholesterol, and either apolipoprotein (apo) A-I or apoA-II. The rHDL, identical in lipid content, had sizes of 96 and 100 Angstrom, respectively. Binding constants (K-d)determined by the activity-inhibition method were 2.2 +/- 0.3 x 10(-7) and 1.1 +/- 0.3 x 10(-6) M, whereas those determined by a solid-phase method were 3.3 +/- 0.9 x 10(-7) and 3.7 +/- 0.9 x 10(-7) M for apoA-I and apoA-II rHDL, respectively. The stoichiometry was 1 LCAT bound/rHDL. The appV(max)/appK(m) for apoA-I was 80 fold higher than for apoA-II rHDL. The large difference between LCAT-binding constants and enzymatic activity measurements for the two particles suggests that LCAT binding and activation by apolipoproteins are independent events. To determine the effects of phospholipid headgroup on LCAT binding affinity, we tested rHDL containing up to 16 mol % of egg phosphatidylethanolamine (egg-PE), egg phosphatidic acid (egg-PA), or bovine phosphatidylserine (PS). K-d was unchanged for PS rHDL, but increased 6-fold with increasing PE content. AppV(max) increased with PE content, but decreased with PS or PA relative to egg-PC controls. AppK(m) increased in PE rHDL, but remained unchanged in rHDL with PA or PS. Fluorescence characterization of the lipid domains of rHDL shows small differences in the polarity of the headgroup region of PE rHDL. Thus, LCAT binding is influenced by the lipid, but not the protein composition of rHDL. AppV(max) values reflect active site preferences, while appK(m) values reflect interfacial binding affinity.	UNIV ILLINOIS,COLL MED,DEPT BIOCHEM,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign					NHLBI NIH HHS [HL 16059, HL 29939] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016059, R01HL029939] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BANERJEE D, 1983, J CELL BIOL, V96, P651, DOI 10.1083/jcb.96.3.651; BONELLI FS, 1989, J BIOL CHEM, V264, P14723; BONOMO EA, 1990, BIOCHEMISTRY-US, V29, P5094, DOI 10.1021/bi00473a014; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; CHRISTNER JE, 1990, ANAL BIOCHEM, V184, P388, DOI 10.1016/0003-2697(90)90698-9; CULLIS PR, 1986, CHEM PHYS LIPIDS, V40, P127, DOI 10.1016/0009-3084(86)90067-8; DOBIASOVA M, 1983, ADV LIPID RES, V20, P107; EDELSTEIN C, 1972, J BIOL CHEM, V247, P5841; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; FIELDING PE, 1986, J BIOL CHEM, V261, P5233; GLOMSET JA, 1972, BLOOD LIPIDS LIPOPRO, P745; GWYNNE J, 1974, J BIOL CHEM, V249, P2411; HOWELL KE, 1982, J CELL BIOL, V92, P833, DOI 10.1083/jcb.92.3.833; JAIN MK, 1986, BIOCHIM BIOPHYS ACTA, V860, P435, DOI 10.1016/0005-2736(86)90541-9; JONAS A, 1983, J BIOL CHEM, V258, P335; JONAS A, 1987, J BIOL CHEM, V262, P3969; JONAS A, 1984, J BIOL CHEM, V259, P6369; JONAS A, 1982, BIOCHEMISTRY-US, V21, P6867, DOI 10.1021/bi00269a037; JONAS A, 1986, J LIPID RES, V27, P689; JONAS A, 1987, PLASMA LIPOPROTEINS, P299; JONAS A, 1992, HIGH DENSITY LIPOPRO, V3, P67; LEROY A, 1993, J BIOL CHEM, V268, P4798; LITMAN BJ, 1973, BIOCHEMISTRY-US, V12, P2545, DOI 10.1021/bi00737a028; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASSEY JB, 1985, BIOCHEMISTRY-US, V24, P6973, DOI 10.1021/bi00345a033; MATZ CE, 1982, J BIOL CHEM, V257, P4541; MATZ CE, 1982, J BIOL CHEM, V257, P4535; MILLER AL, 1973, J BIOL CHEM, V248, P3359; NICHOLS AV, 1971, BIOCHIM BIOPHYS ACTA, V231, P75; POWNALL HJ, 1985, J BIOL CHEM, V260, P2146; POWNALL HJ, 1986, METHOD ENZYMOL, V128, P515; Quinn D., 1982, Progress in Lipid Research, V22, P35, DOI 10.1016/0163-7827(83)90003-6; SLATER SJ, 1993, BIOCHEMISTRY-US, V32, P3714, DOI 10.1021/bi00065a025; STOKKE KT, 1971, SCAND J CLIN LAB INV, V27, P21, DOI 10.3109/00365517109080184; VANTILBEURGH H, 1992, NATURE, V359, P159, DOI 10.1038/359159a0; VERGER R, 1973, J BIOL CHEM, V248, P4023; WALD JH, 1990, J BIOL CHEM, V265, P20044; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; YANG CY, 1987, J BIOL CHEM, V262, P3086; ZORICH NL, 1987, BIOCHIM BIOPHYS ACTA, V919, P181, DOI 10.1016/0005-2760(87)90206-2	40	54	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7429	7434						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125962				2022-12-27	WOS:A1994NA03200063
J	BROMBERG, Y; SHANI, E; JOSEPH, G; GORZALCZANY, Y; SPERLING, O; PICK, E				BROMBERG, Y; SHANI, E; JOSEPH, G; GORZALCZANY, Y; SPERLING, O; PICK, E			THE GDP-BOUND FORM OF THE SMALL G-PROTEIN RAC1 P21 IS A POTENT ACTIVATOR OF THE SUPEROXIDE-FORMING NADPH OXIDASE OF MACROPHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CELL-FREE SYSTEM; GTP-BINDING PROTEIN; SODIUM DODECYL-SULFATE; CHRONIC GRANULOMATOUS-DISEASE; HUMAN-NEUTROPHILS; GUANINE-NUCLEOTIDES; REGULATORY PROTEIN; EXCHANGE PROTEINS; ARACHIDONIC-ACID; CYTOSOLIC FACTOR	Phagocytes produce superoxide by the assembly of a multicomponent complex that utilizes NADPH for the reduction of molecular oxygen (NADPH oxidase). The components participating in the assembly are a membrane-bound flavocytochrome and three cytosolic proteins, one of which was shown to be a dimer of the small GTP-binding protein (G protein) Rac1 p21 or Rac2 p21 with GDP dissociation inhibitor for Rho (Rho GDI). We determined the identity and quantity of the nucleotide bound to Rac1 p21 by high performance anion exchange chromatography of extracts prepared from highly purified Rac1 p21-Rho GDI, isolated from guinea pig macrophage cytosol. Rac1 p21 contained only GDP at a ratio of close to 1 mol of GDP per mol of G protein. The GDP-bound form of Rac1 p21 complexed to Rho GDI functioned as a potent activator of NADPB oxidase in a cell-free system that contained no free GTP or ATP. We propose that the GDP-bound form of Rac1 p21 might be the physiological activator of NADPH oxidase in macrophages, following its dissociation from Rho GDI, and that nucleotide exchange or conversion to GTP is not necessarily involved.	TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN MICROBIOL,IMMUNOPHARMACOL LAB,IL-69978 TEL AVIV,ISRAEL; TEL AVIV UNIV,SACKLER SCH MED,DEPT CHEM PATHOL,IL-69978 TEL AVIV,ISRAEL	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine			Pick, Edgar/B-1795-2008	Pick, Edgar/0000-0003-4625-3233				ABO A, 1991, J BIOL CHEM, V266, P23577; ABO A, 1992, J BIOL CHEM, V267, P16767; ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; AHARONI I, 1990, J LEUKOCYTE BIOL, V48, P107, DOI 10.1002/jlb.48.2.107; ANDO S, 1992, J BIOL CHEM, V267, P25709; BOLSCHER BGJM, 1989, J CLIN INVEST, V83, P757, DOI 10.1172/JCI113954; BOLSCHER BGJM, 1990, J BIOL CHEM, V265, P15782; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROMBERG Y, 1984, CELL IMMUNOL, V88, P213, DOI 10.1016/0008-8749(84)90066-2; BROMBERG Y, 1985, J BIOL CHEM, V260, P3539; CHANG TH, 1993, J BIOL CHEM, V268, P775; CURNUTTE JT, 1985, J CLIN INVEST, V75, P1740, DOI 10.1172/JCI111885; DAVYDOVA EK, 1993, EUR J BIOCHEM, V215, P291, DOI 10.1111/j.1432-1033.1993.tb18034.x; DOUSSIERE J, 1988, BIOCHEM BIOPH RES CO, V152, P993, DOI 10.1016/S0006-291X(88)80382-6; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; FUJITA I, 1987, BIOCHIM BIOPHYS ACTA, V931, P41, DOI 10.1016/0167-4889(87)90048-6; GABIG TG, 1987, J BIOL CHEM, V262, P1685; GABIG TG, 1990, J IMMUNOL, V145, P945; HANCOCK JF, 1993, EMBO J, V12, P1915, DOI 10.1002/j.1460-2075.1993.tb05840.x; HARTWICK RA, 1975, J CHROMATOGR, V112, P651, DOI 10.1016/S0021-9673(00)99994-1; HEYNEMAN RA, 1984, J LEUKOCYTE BIOL, V36, P751, DOI 10.1002/jlb.36.6.751; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P261, DOI 10.1091/mbc.4.3.261; ISOMURA M, 1991, ONCOGENE, V6, P119; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; KNOLLER S, 1991, J BIOL CHEM, V266, P2795; KOSHKIN V, 1993, FEBS LETT, V327, P57, DOI 10.1016/0014-5793(93)81039-3; KWONG CH, 1993, BIOCHEMISTRY-US, V32, P5711, DOI 10.1021/bi00072a029; LIGETI E, 1988, BIOCHEMISTRY-US, V27, P193, DOI 10.1021/bi00401a029; MCPHAIL LC, 1985, J CLIN INVEST, V75, P1735, DOI 10.1172/JCI111884; MIZUNO T, 1992, J BIOL CHEM, V267, P10215; NUNOI H, 1988, SCIENCE, V242, P1298, DOI 10.1126/science.2848319; PERRETT D, 1987, HPLC SMALL MOL PRACT, P221; PEVERI P, 1992, P NATL ACAD SCI USA, V89, P2494, DOI 10.1073/pnas.89.6.2494; Pfeffer S R, 1992, Trends Cell Biol, V2, P41, DOI 10.1016/0962-8924(92)90161-F; PICK E, 1993, EUR J BIOCHEM, V217, P441, DOI 10.1111/j.1432-1033.1993.tb18264.x; PICK E, 1989, J IMMUNOL, V143, P4180; ROTROSEN D, 1993, J BIOL CHEM, V268, P14256; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; ROTROSEN D, 1992, INFLAMMATION BASIC P, P589; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SEIFERT R, 1986, FEBS LETT, V205, P161, DOI 10.1016/0014-5793(86)80886-9; STOUTEN PFW, 1993, FEBS LETT, V320, P1, DOI 10.1016/0014-5793(93)81644-F; UEDA T, 1990, J BIOL CHEM, V265, P9373; UHLINGER DJ, 1991, J BIOL CHEM, V266, P20990; VOLPP BD, 1988, SCIENCE, V242, P1295, DOI 10.1126/science.2848318; WEISS O, 1989, J BIOL CHEM, V264, P21066	47	54	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7055	7058						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125910				2022-12-27	WOS:A1994NA03200003
J	NEBL, G; MERMOD, N; CATO, ACB				NEBL, G; MERMOD, N; CATO, ACB			POSTTRANSCRIPTIONAL DOWN-REGULATION OF EXPRESSION OF TRANSCRIPTION FACTOR NF1 BY HA-RAS ONCOGENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR VIRUS; NUCLEAR FACTOR-I; DNA-BINDING PROTEIN; LONG TERMINAL REPEAT; GROWTH FACTOR-BETA; MESSENGER-RNA; ADENOVIRUS DNA; DEPENDENT TRANSCRIPTION; GLUCOCORTICOID RECEPTOR; GENE-EXPRESSION	NF1 is a family of polypeptides that binds to discrete DNA motifs and plays varying roles in the regulation of gene expression. These polypeptides are also thought to mediate the expression of differentiation-specific markers such as adipocyte and mammary cell type-specific genes. The expression of a number of cellular differentiation-specific markers is down-regulated during neoplastic transformation. We therefore investigated whether oncogenic transformation interferes with the action of NF1. Stable transfection of activated Ha-ras into a number of murine cells correlated with a down-regulation of the expression of the NF1 genes NF1/CTF and NF1/X The down-regulation was not at the transcriptional level but at the level of stability of the NF1 mRNAs. The level of the DNA binding activity of the NF1 proteins was also reduced in Ha-v-ras-transformed cells, and the expression of a gene that depends on this family of transcription factors was specifically repressed. These results demonstrate that an activated Ha-ras-induced pathway destabilizes the half-life of mRNAs encoding specific members in the NF1 family of transcription factors, which leads to a decrease in NF1-dependent gene expression.	KERNFORSCHUNGSZENTRUM KARLSRUHE GMBH,INST GENET,D-76021 KARLSRUHE,GERMANY; UNIV LAUSANNE,INST BIOL ANIM,CH-1015 LAUSANNE,SWITZERLAND	Helmholtz Association; Karlsruhe Institute of Technology; University of Lausanne			Cato, Andrew C. B./H-2071-2013	Cato, Andrew C. B./0000-0001-8508-3834				ANDRES AC, 1988, GENE DEV, V2, P1486, DOI 10.1101/gad.2.11.1486; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; AVVEDIMENTO VE, 1988, P NATL ACAD SCI USA, V85, P1744, DOI 10.1073/pnas.85.6.1744; BARBERIS A, 1987, CELL, V50, P347, DOI 10.1016/0092-8674(87)90489-2; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; BORGMEYER U, 1984, NUCLEIC ACIDS RES, V12, P4295, DOI 10.1093/nar/12.10.4295; BRUGGEMEIER U, 1990, EMBO J, V9, P2233, DOI 10.1002/j.1460-2075.1990.tb07393.x; CATO ACB, 1988, EMBO J, V7, P1403, DOI 10.1002/j.1460-2075.1988.tb02957.x; CATO ACB, 1990, ONCOGENE, V5, P103; CEREGHINI S, 1987, CELL, V50, P627, DOI 10.1016/0092-8674(87)90036-5; COLANTUONI V, 1987, EMBO J, V6, P631, DOI 10.1002/j.1460-2075.1987.tb04801.x; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GIL G, 1988, P NATL ACAD SCI USA, V85, P8963, DOI 10.1073/pnas.85.23.8963; GOYAL N, 1990, MOL CELL BIOL, V10, P1041, DOI 10.1128/MCB.10.3.1041; GRAVES RA, 1991, GENE DEV, V5, P428, DOI 10.1101/gad.5.3.428; HARTIG E, 1993, J VIROL, V67, P813; HARTIG E, 1993, MOL BIOL, V12, P37; HAY RT, 1985, EMBO J, V4, P421, DOI 10.1002/j.1460-2075.1985.tb03645.x; HYNES NE, 1987, CELLULAR MOL BIOL MA, P321; INOUE T, 1990, J BIOL CHEM, V265, P19065; JACKSON DA, 1993, MOL CELL BIOL, V13, P2401, DOI 10.1128/MCB.13.4.2401; JAGGI R, 1986, EMBO J, V5, P2609, DOI 10.1002/j.1460-2075.1986.tb04541.x; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; KARIN M, 1987, MOL CELL BIOL, V7, P606, DOI 10.1128/MCB.7.2.606; KONIG H, 1989, EMBO J, V8, P2559, DOI 10.1002/j.1460-2075.1989.tb08394.x; KUMAR CC, 1992, CANCER RES, V52, P6877; KUMAR CC, 1992, CELL GROWTH DIFFER, V3, P1; LEEGWATER PAJ, 1985, EMBO J, V4, P1515, DOI 10.1002/j.1460-2075.1985.tb03811.x; LERNER RA, 1981, P NATL ACAD SCI-BIOL, V78, P3403, DOI 10.1073/pnas.78.6.3403; LUBON H, 1988, BIOCHEM J, V256, P391, DOI 10.1042/bj2560391; LUCIBELLO FC, 1990, EMBO J, V9, P2827, DOI 10.1002/j.1460-2075.1990.tb07471.x; MEISTERERNST M, 1989, BIOCHEMISTRY-US, V28, P8191, DOI 10.1021/bi00446a034; MIKSICEK R, 1987, EMBO J, V6, P1355, DOI 10.1002/j.1460-2075.1987.tb02375.x; MINK S, 1990, NUCLEIC ACIDS RES, V18, P2017, DOI 10.1093/nar/18.8.2017; MINK S, 1992, MOL CELL BIOL, V12, P4906, DOI 10.1128/MCB.12.11.4906; MIURA M, 1989, GENE, V75, P31; NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P6177, DOI 10.1073/pnas.80.20.6177; OLSON EN, 1987, MOL CELL BIOL, V7, P2104, DOI 10.1128/MCB.7.6.2104; OWEN RD, 1987, MOL CELL BIOL, V7, P2512, DOI 10.1128/MCB.7.7.2512; PAONESSA G, 1988, EMBO J, V7, P3115, DOI 10.1002/j.1460-2075.1988.tb03178.x; ROSSI P, 1988, CELL, V52, P405, DOI 10.1016/S0092-8674(88)80033-3; RUTHER U, 1985, EMBO J, V4, P1775, DOI 10.1002/j.1460-2075.1985.tb03850.x; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SCHEIDEREIT C, 1983, NATURE, V304, P749, DOI 10.1038/304749a0; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHEMSHEDINI L, 1991, EMBO J, V10, P3839, DOI 10.1002/j.1460-2075.1991.tb04953.x; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; TAMURA T, 1988, NUCLEIC ACIDS RES, V16, P11441, DOI 10.1093/nar/16.24.11441; VACCA A, 1989, MOL ENDOCRINOL, V3, P1659, DOI 10.1210/mend-3-10-1659; WATSON CJ, 1991, NUCLEIC ACIDS RES, V19, P6603, DOI 10.1093/nar/19.23.6603; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; YANG BS, 1993, MOL CELL BIOL, V13, P3093, DOI 10.1128/MCB.13.5.3093	55	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7371	7378						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125955				2022-12-27	WOS:A1994NA03200054
J	PETERS, JM; FRANKE, WW; KLEINSCHMIDT, JA				PETERS, JM; FRANKE, WW; KLEINSCHMIDT, JA			DISTINCT 19-S AND 20-S SUBCOMPLEXES OF THE 26-S PROTEASOME AND THEIR DISTRIBUTION IN THE NUCLEUS AND THE CYTOPLASM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH MOLECULAR-WEIGHT; IMMUNOELECTRON MICROSCOPIC LOCALIZATION; MULTICATALYTIC PROTEINASE PROTEASOME; UBIQUITIN-ACTIVATING ENZYME; RABBIT RETICULOCYTE LYSATE; ATP-DEPENDENT PROTEASES; 22-S CYLINDER PARTICLES; XENOPUS-LAEVIS; CULTURED-CELLS; IMMUNOCYTOCHEMICAL LOCALIZATION	The 26 S proteolytic complex (''26 S proteasome'') is a macromolecular assembly thought to be involved in ATP- and ubiquitin-dependent protein degradation in the cytoplasm of higher eukaryotic cells. This complex is composed of one 20 S cylinder particle (multicatalytic proteinase, 20 S proteasome) and two cap-shaped 19 S particles comprising a set of polypeptides in the M(r) range of 35,000-110,000. Here we show that cell supernatant fractions contain both these two subunit complexes as distinct particles as well as assembled to 26 S proteasomes. We have separated and purified all three forms from Xenopus laevis oocytes and have determined their peptidase and protease activities. Using various antibodies specific for either a constitutive p52 polypeptide of the 19 S cap complex or for proteins of the 20 S cylinder der particle, we have immunolocalized these complexes in both the cytoplasm and the nucleus of diverse species and cell types. The occurrence of all three forms, the 26 S proteasome, the 20 S cylinder particle, and the 19 S cap complex in the nucleoplasm has also been demonstrated in analyses of isolated giant nuclei from Xenopus oocytes. In addition, we show that the 19 S and 20 S subcomplexes can be released from 26 S proteasomes by ATP depletion and that readdition of ATP to 19 S and 20 S particles in cell extracts leads to the reformation of 26 S proteasomes. We discuss that all three particles (19 S, 20 S, and 26 S) exist in a dynamic equilibrium in both cell compartments and serve cytoplasmic as well as nucleus-specific functions.	GERMAN CANC RES CTR,DIV CELL BIOL,D-69120 HEIDELBERG,GERMANY; GERMAN CANC RES CTR,DIV APPL TUMOR VIROL,D-69120 HEIDELBERG,GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)				Franke, Werner W./0000-0002-4873-8448				AKHAYAT O, 1987, P NATL ACAD SCI USA, V84, P1595, DOI 10.1073/pnas.84.6.1595; AMSTERDAM A, 1993, P NATL ACAD SCI USA, V90, P99, DOI 10.1073/pnas.90.1.99; ANKENBAUER T, 1989, NATURE, V342, P822, DOI 10.1038/342822a0; ARRIGO AP, 1988, NATURE, V331, P192, DOI 10.1038/331192a0; BARRETT AJ, 1980, BIOCHEM J, V187, P909, DOI 10.1042/bj1870909; BEYETTE JR, 1992, MUSCLE NERVE, V15, P1023, DOI 10.1002/mus.880150907; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRIANE D, 1992, EUR J CELL BIOL, V57, P30; CARLSON N, 1987, J CELL BIOL, V104, P537, DOI 10.1083/jcb.104.3.537; CHI XS, 1992, BIOCHEMISTRY-US, V31, P11963; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; COOK JC, 1991, BIOCHEM BIOPH RES CO, V174, P564, DOI 10.1016/0006-291X(91)91454-K; DABAUVALLE MC, 1982, P NATL ACAD SCI-BIOL, V79, P5302, DOI 10.1073/pnas.79.17.5302; DAHLMANN B, 1989, FEBS LETT, V251, P125, DOI 10.1016/0014-5793(89)81441-3; DEROBERTIS EM, 1983, CELL, V32, P1021, DOI 10.1016/0092-8674(83)90285-4; DESA MFG, 1988, J CELL BIOL, V107, P1517, DOI 10.1083/jcb.107.4.1517; DESA MFG, 1988, J CELL SCI, V89, P151; DRISCOLL J, 1992, P NATL ACAD SCI USA, V89, P4986, DOI 10.1073/pnas.89.11.4986; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; DUBIEL W, 1993, FEBS LETT, V323, P276, DOI 10.1016/0014-5793(93)81356-5; DUBIEL W, 1992, J BIOL CHEM, V267, P22699; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; FRANKE WW, 1979, EXP CELL RES, V123, P25, DOI 10.1016/0014-4827(79)90418-X; GANOTH D, 1988, J BIOL CHEM, V263, P12412; GAUTIER J, 1988, J CELL SCI, V90, P543; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; GRZIWA A, 1992, J STRUCT BIOL, V109, P168, DOI 10.1016/1047-8477(92)90048-F; HAASS C, 1989, EMBO J, V8, P2373, DOI 10.1002/j.1460-2075.1989.tb08366.x; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; HEINEMEYER W, 1993, J BIOL CHEM, V268, P5115; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HILT W, 1993, J BIOL CHEM, V268, P3479; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; HOUGH R, 1986, J BIOL CHEM, V261, P2400; HOUGH R, 1987, J BIOL CHEM, V262, P8303; HUGLE B, 1983, EUR J CELL BIOL, V32, P157; IKAI A, 1991, FEBS LETT, V292, P21, DOI 10.1016/0014-5793(91)80824-M; INABA K, 1993, J CELL SCI, V104, P907; ISHIDA N, 1993, FEBS LETT, V324, P345, DOI 10.1016/0014-5793(93)80148-N; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; KANAYAMA HO, 1992, EUR J BIOCHEM, V206, P567, DOI 10.1111/j.1432-1033.1992.tb16961.x; KAWAHARA H, 1992, DEV BIOL, V151, P27, DOI 10.1016/0012-1606(92)90210-8; KLEIN U, 1990, J CELL BIOL, V111, P2275, DOI 10.1083/jcb.111.6.2275; KLEINSCHMIDT JA, 1982, CELL, V29, P799, DOI 10.1016/0092-8674(82)90442-1; KLEINSCHMIDT JA, 1983, EUR J CELL BIOL, V32, P143; KLOETZEL PM, 1987, EXP CELL RES, V170, P204, DOI 10.1016/0014-4827(87)90130-3; KNAPP AC, 1989, CELL, V59, P67, DOI 10.1016/0092-8674(89)90870-2; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KROHNE G, 1989, J CELL BIOL, V109, P2003, DOI 10.1083/jcb.109.5.2003; KROHNE G, 1980, EXP CELL RES, V129, P167, DOI 10.1016/0014-4827(80)90341-9; KUEHN L, 1992, ARCH BIOCHEM BIOPHYS, V295, P55, DOI 10.1016/0003-9861(92)90487-H; KUMATORI A, 1990, P NATL ACAD SCI USA, V87, P7071, DOI 10.1073/pnas.87.18.7071; MICHALEK MT, 1993, NATURE, V363, P552, DOI 10.1038/363552a0; MURAKAMI K, 1986, P NATL ACAD SCI USA, V83, P7588, DOI 10.1073/pnas.83.20.7588; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; OLINKCOUX M, 1992, EUR J CELL BIOL, V59, P148; ORINO E, 1991, FEBS LETT, V284, P206, DOI 10.1016/0014-5793(91)80686-W; PAINE PL, 1984, J CELL BIOL, V99, pS188, DOI 10.1083/jcb.99.1.188s; PAL JK, 1988, J CELL SCI, V90, P555; PETERS JM, 1991, EUR J CELL BIOL, V56, P422; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; PETERS JM, 1993, J MOL BIOL, V234, P932, DOI 10.1006/jmbi.1993.1646; PETERS JM, 1992, J MOL BIOL, V223, P557, DOI 10.1016/0022-2836(92)90670-F; RECHSTEINER M, 1991, CELL, V66, P615, DOI 10.1016/0092-8674(91)90104-7; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; RICHTERRUOFF B, 1992, FEBS LETT, V302, P192, DOI 10.1016/0014-5793(92)80438-M; RIVETT AJ, 1993, CURR BIOL, V3, P127, DOI 10.1016/0960-9822(93)90173-L; RIVETT AJ, 1993, BIOCHEM J, V291, P1; RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280; SCALENGHE F, 1978, CHROMOSOMA, V66, P299, DOI 10.1007/BF00328531; SCHMIDTZACHMANN MS, 1984, EXP CELL RES, V153, P327, DOI 10.1016/0014-4827(84)90604-9; SCHWARTZ AL, 1992, P NATL ACAD SCI USA, V89, P5542, DOI 10.1073/pnas.89.12.5542; SCHWARTZ AL, 1988, EMBO J, V7, P2961, DOI 10.1002/j.1460-2075.1988.tb03158.x; SEELIG A, 1991, BIOCHEM J, V280, P225, DOI 10.1042/bj2800225; SEUFERT W, 1992, EMBO J, V11, P3077, DOI 10.1002/j.1460-2075.1992.tb05379.x; SHIMBARA N, 1992, J BIOL CHEM, V267, P18100; TANAKA K, 1990, FEBS LETT, V271, P41, DOI 10.1016/0014-5793(90)80367-R; TANAKA K, 1992, NEW BIOL, V4, P173; TANAKA K, 1989, J CELL PHYSIOL, V139, P34, DOI 10.1002/jcp.1041390107; THOMAS JO, 1975, P NATL ACAD SCI USA, V72, P2626, DOI 10.1073/pnas.72.7.2626; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UDVARDY A, 1993, J BIOL CHEM, V268, P9055; UGAI S, 1993, J BIOCHEM, V113, P754, DOI 10.1093/oxfordjournals.jbchem.a124116; van Holde KE., 1989, SPRINGER SERIES MOL; WAXMAN L, 1987, J BIOL CHEM, V262, P2451; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; ZWICKL P, 1992, BIOCHEMISTRY-US, V31, P964, DOI 10.1021/bi00119a004	93	335	344	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7709	7718						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125997				2022-12-27	WOS:A1994NA03200105
J	REILLY, BD; MAKRIDES, SC; FORD, PJ; MARSH, HC; MOLD, C				REILLY, BD; MAKRIDES, SC; FORD, PJ; MARSH, HC; MOLD, C			QUANTITATIVE-ANALYSIS OF C4B DIMER BINDING TO DISTINCT SITES ON THE C3B/C4B RECEPTOR (CR-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-COMPLEMENT; REPEATING DOMAINS; IMMUNE-COMPLEXES; LIGAND-BINDING; C5 CONVERTASE; CR-1; C3B; INHIBITOR; MEMBRANE; PATHWAY	The complement receptor CR1 (CD35) is a transmembrame protein composed in its extracellular portion of short consensus repeats (SCR 1-30) organized into four long homologous repeats (LHR-A, LHR-B, LHR-C, and LHR-D). Each LHR, except LHR-D, contains a binding site for C3b and/or C4b within its first four SCR. The binding reaction between CR1 and soluble dimers of C4b (C4b(2)) was analyzed using the native receptor on human erythrocytes and full-length recombinant CR1 expressed in stably transfected Chinese hamster ovary (CHO) cells. CR1 mutants expressed similarly were used to determine the SCR of LHR-A required for C4b(2) binding and the potential of C3b binding sites in CR1 to bind C4b(2). Erythrocyte CR1, CHO cells expressing full-length recombinant CR1 (ABCD), constructs ACD, and SCR(1-4)D each bound C4b(2) with similar affinities (K-d, similar to 4 x 10(-7) M). Construct SCR(1-2)D bound C4b(2) with lower affinity (K-d, 1.4 x 10(-6) M) indicating that SCR(1-4) are required for a fully functional C4b(2) binding site. Construct SCR(15-18)D, which contains a C3b site, also bound C4b(2) with lower affinity (K-d 1.2 x 10(-6) M) than its binding to C3b dimers. Constructs SCR(15-16)D and D did not bind C4b(2). Each CR1 construct that bound C4b(2) functioned as a cofactor for factor I-mediated cleavage to C4d.	UNIV NEW MEXICO,SCH MED,DEPT MICROBIOL,ALBUQUERQUE,NM 87131; T CELL SCI INC,CAMBRIDGE,MA 02139	University of New Mexico				Marsh, Henry/0000-0001-5637-6013	NIAID NIH HHS [AI 08152, AI 24720] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024720, F32AI008152] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS EM, 1991, J IMMUNOL, V147, P3005; CLEMENZA L, 1993, J IMMUNOL, V150, pA14; FEARON DT, 1979, P NATL ACAD SCI USA, V76, P5867, DOI 10.1073/pnas.76.11.5867; HAMMER CH, 1981, J BIOL CHEM, V256, P3995; IIDA K, 1981, J EXP MED, V153, P1138, DOI 10.1084/jem.153.5.1138; ISENMAN DE, 1982, BIOCHEMISTRY-US, V21, P1109, DOI 10.1021/bi00535a001; KALLI KR, 1991, J EXP MED, V174, P1451, DOI 10.1084/jem.174.6.1451; KINOSHITA T, 1988, J IMMUNOL, V141, P3895; KLICKSTEIN LB, 1988, J EXP MED, V168, P1699, DOI 10.1084/jem.168.5.1699; KLICKSTEIN LB, 1987, J EXP MED, V165, P1095, DOI 10.1084/jem.165.4.1095; KRYCH M, 1991, P NATL ACAD SCI USA, V88, P4353, DOI 10.1073/pnas.88.10.4353; MAKRIDES SC, 1992, J BIOL CHEM, V267, P24754; MEDOF ME, 1984, J EXP MED, V159, P1669, DOI 10.1084/jem.159.6.1669; MEDOF ME, 1982, J EXP MED, V156, P1739, DOI 10.1084/jem.156.6.1739; MEDOF ME, 1983, J IMMUNOL, V130, P1336; MEDOF ME, 1982, J LAB CLIN IMMUNOL, V7, P1; ROSS GD, 1985, ADV IMMUNOL, V37, P217, DOI 10.1016/S0065-2776(08)60341-7; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHREIBER RD, 1984, SPRINGER SEMIN IMMUN, V7, P221, DOI 10.1007/BF01893021; SPINELLA D G, 1984, Complement, V1, P187; TAKATA Y, 1987, J EXP MED, V165, P1494, DOI 10.1084/jem.165.6.1494; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; YOON SH, 1985, J IMMUNOL, V134, P3332	23	29	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7696	7701						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125996				2022-12-27	WOS:A1994NA03200103
J	SEKIMOTO, T; FUKUI, T; TANIZAWA, K				SEKIMOTO, T; FUKUI, T; TANIZAWA, K			INVOLVEMENT OF CONSERVED LYSINE-68 OF BACILLUS-STEAROTHERMOPHILUS LEUCINE DEHYDROGENASE IN SUBSTRATE-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; DEPENDENT GLUTAMATE-DEHYDROGENASE; COMPLETE NUCLEOTIDE-SEQUENCE; NAD(P)+-DEPENDENT DEHYDROGENASES; PHENYLALANINE DEHYDROGENASE; BOVINE ENZYME; GENE; CLONING; PHOSPHATE; LIVER	Lysine 68 of Bacillus stearothermophilus leucine dehydrogenase is highly conserved in the corresponding regions of NAD(P)(+) dependent amino acid dehydrogenase sequences. To elucidate its functional role, the lysyl residue of the recombinant enzyme has been replaced with alanine or arginine by site directed mutagenesis. Either mutation resulted in nearly complete loss of activity in the oxidative deamination, whereas only the mutation to alanine led to a marked increase in Michaelis constants for both amino and keto acid substrates. On the other hand, an ionizable group in the wild-type enzyme with a pK(a) value of 10.1-10.7, which must be protonated for binding of substrate and competitive inhibitor with an alpha-carboxyl group, was unobservable in both mutant enzymes. These results altogether led to the conclusion that Lys 68 is located at the active site of the enzyme and involved in binding of the alpha-carboxyl group of substrate through an ionic interaction. In addition, the alanine mutant enzyme that is almost inactive in the deamination but significantly active in the amination was greatly stimulated by exogenously added ammonia, suggesting that proper binding of the substrate alpha-carboxyl group at Lys-68 is essential for catalysis.	OSAKA UNIV,INST SCI & IND RES,IBARAKI,OSAKA 567,JAPAN	Osaka University								BAKER PJ, 1992, PROTEINS, V12, P75, DOI 10.1002/prot.340120109; BIRKTOFT JJ, 1984, PEPT PROTEIN REV, V4, P1; BLUMENTHAL KM, 1975, J BIOL CHEM, V250, P3644; Cleland W W, 1979, Methods Enzymol, V63, P103; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; HABERLAND ME, 1980, J BIOL CHEM, V255, P7984; HANUKOGLU I, 1989, EUR J BIOCHEM, V180, P479, DOI 10.1111/j.1432-1033.1989.tb14671.x; JULLIARD JH, 1979, J BIOL CHEM, V254, P3427; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KURODA SI, 1990, BIOCHEMISTRY-US, V29, P1009, DOI 10.1021/bi00456a025; LILLEY KS, 1991, BIOCHIM BIOPHYS ACTA, V1080, P191, DOI 10.1016/0167-4838(91)90001-G; MATSUYAMA T, 1992, J BIOCHEM-TOKYO, V112, P258, DOI 10.1093/oxfordjournals.jbchem.a123887; MCPHERSON MJ, 1983, NUCLEIC ACIDS RES, V11, P5257, DOI 10.1093/nar/11.15.5257; MOON K, 1973, J BIOL CHEM, V248, P3082; MOON K, 1972, P NATL ACAD SCI USA, V69, P1380, DOI 10.1073/pnas.69.6.1380; MOYE WS, 1985, J BIOL CHEM, V260, P8502; NAGATA S, 1988, BIOCHEMISTRY-US, V27, P9056, DOI 10.1021/bi00425a026; OKAZAKI N, 1988, GENE, V63, P337, DOI 10.1016/0378-1119(88)90537-9; RIFE JE, 1980, BIOCHEMISTRY-US, V19, P2328, DOI 10.1021/bi00552a008; Rossman M.G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; SEKIMOTO T, 1993, J BIOL CHEM, V268, P27039; SINGH N, 1993, J BIOL CHEM, V268, P21; TAKADA H, 1991, J BIOCHEM-TOKYO, V109, P371, DOI 10.1093/oxfordjournals.jbchem.a123388; VALLE F, 1984, GENE, V27, P193, DOI 10.1016/0378-1119(84)90140-9; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; WOOTTON JC, 1974, P NATL ACAD SCI USA, V71, P4361, DOI 10.1073/pnas.71.11.4361	26	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7262	7266						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125938				2022-12-27	WOS:A1994NA03200037
J	TAWFIC, S; AHMED, K				TAWFIC, S; AHMED, K			ASSOCIATION OF CASEIN KINASE-2 WITH NUCLEAR MATRIX - POSSIBLE ROLE IN NUCLEAR MATRIX PROTEIN-PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA TOPOISOMERASE-II; HORMONE ACTION; CELL-CYCLE; IDENTIFICATION; ORGANIZATION; STIMULATION; ANTIBODIES; INTERPHASE; INVITRO; LAMINA	The nuclear matrix is thought to play a fundamental role in the nuclear structure and functions relating to cell proliferation and regulation of gene activity. Phosphorylation of nuclear matrix proteins has been observed, and multiple protein kinases may be involved in this process. Casein kinase 2 is a ubiquitous messenger-independent serine/threonine protein kinase that has been implicated in cellular growth and proliferation. The presence of immunoreactive casein kinase 2 in purified nuclear matrix preparations was demonstrated in rat liver and prostate tissues by employing specific antibodies. The enzyme was active toward the specific decapeptide substrate Arg-Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu and exhibited other properties characteristic of casein kinase 2. Phosphorylation of nuclear matrix proteins catalyzed by intrinsic protein kinase activity in intact nuclei was also observed, and the results suggested that this reaction was at least in part catalyzed by casein kinase 2. The profile of nuclear matrix proteins labeled with (32)p(i) in situ in intact liver cells was similar to that observed in nuclear matrix proteins isolated from nuclei labeled with [gamma-P-32]ATP in vitro. Association of casein kinase 2 with the nuclear matrix may be of significance in the post-translational modification of certain proteins in this fraction.	DEPT VET AFFAIRS MED CTR, CELLULAR & MOLEC BIOCHEM RES LAB 151, MINNEAPOLIS, MN 55417 USA; UNIV MINNESOTA, DEPT LAB MED & PATHOL, CELLULAR & MOLEC BIOCHEM RES LAB 151, MINNEAPOLIS, MN 55417 USA	University of Minnesota System; University of Minnesota Twin Cities					NCI NIH HHS [CA-15062] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA015062, U01CA015062, R37CA015062] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACKERMAN P, 1985, P NATL ACAD SCI USA, V82, P3164, DOI 10.1073/pnas.82.10.3164; AGOSTINIS P, 1989, FEBS LETT, V259, P75, DOI 10.1016/0014-5793(89)81498-X; AHMED K, 1993, P NATL ACAD SCI USA, V90, P4426, DOI 10.1073/pnas.90.10.4426; AHMED K, 1986, ADV ENZYME REGUL, V25, P401, DOI 10.1016/0065-2571(86)90026-9; AHMED K, 1982, 2ND P WIST S NUCL EN, P31; AHMED K, 1992, RECENT ADV CELLULAR, V4, P7; ALLEN SL, 1977, BIOCHEM BIOPH RES CO, V75, P111, DOI 10.1016/0006-291X(77)91296-7; BEREZNEY R, 1991, J CELL BIOCHEM, V47, P109, DOI 10.1002/jcb.240470204; BEREZNEY R, 1974, BIOCHEM BIOPH RES CO, V60, P1410, DOI 10.1016/0006-291X(74)90355-6; BEREZNEY R, 1984, CHROMOSOMAL NONHISTO, V4, P119; CARDENAS ME, 1993, J CELL SCI, V104, P219; CHRISTMANN JL, 1981, J BIOL CHEM, V256, P3326; COHEN P, 1988, PROC R SOC SER B-BIO, V234, P115, DOI 10.1098/rspb.1988.0040; DESSEV G, 1988, P NATL ACAD SCI USA, V85, P2994, DOI 10.1073/pnas.85.9.2994; DUMBAR TS, 1989, THESIS U MISSISSIPPI; EBERHARTER A, 1993, EUR J BIOCHEM, V212, P573, DOI 10.1111/j.1432-1033.1993.tb17695.x; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FEY E G, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P127; FEY EG, 1988, P NATL ACAD SCI USA, V85, P121, DOI 10.1073/pnas.85.1.121; GETZENBERG RH, 1991, J CELL BIOCHEM, V47, P289, DOI 10.1002/jcb.240470402; GETZENBERG RH, 1990, ENDOCR REV, V11, P399, DOI 10.1210/edrv-11-3-399; GOUELI SA, 1990, BIOCHEM INT, V21, P685; GOUELI SA, 1984, ARCH BIOCHEM BIOPHYS, V234, P646, DOI 10.1016/0003-9861(84)90315-1; GOUELI SA, 1985, BIOCHEM J, V230, P293, DOI 10.1042/bj2300293; GOUELI SA, 1991, MOL CELL BIOCHEM, V101, P145; GOUELI SA, 1986, INT J BIOCHEM, V18, P861, DOI 10.1016/0020-711X(86)90067-4; GRASSER FA, 1988, VIROLOGY, V165, P13, DOI 10.1016/0042-6822(88)90653-8; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HENRY SM, 1983, EUR J BIOCHEM, V133, P23, DOI 10.1111/j.1432-1033.1983.tb07425.x; KUENZEL EA, 1985, P NATL ACAD SCI USA, V82, P737, DOI 10.1073/pnas.82.3.737; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; LI HM, 1992, P NATL ACAD SCI USA, V89, P8434, DOI 10.1073/pnas.89.18.8434; LORENZ P, 1993, J BIOL CHEM, V268, P2733; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUSCHER B, 1991, EMBO J, V10, P865, DOI 10.1002/j.1460-2075.1991.tb08019.x; MEEK DW, 1992, BIOCHEM J, V287, P1; MEGGIO F, 1989, BIOCHIM BIOPHYS ACTA, V1010, P128, DOI 10.1016/0167-4889(89)90193-6; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; MOY BC, 1986, CANCER RES, V46, P4672; NAKAYASU H, 1991, P NATL ACAD SCI USA, V88, P10312, DOI 10.1073/pnas.88.22.10312; NEGRI C, 1992, EXP CELL RES, V200, P452, DOI 10.1016/0014-4827(92)90195-E; NICKERSON JA, 1990, EUKARYOTIC NUCLEUS M, V2, P763; OLSON MOJ, 1990, EUKARYOTIC NUCLEUS M, V2, P520; OTTAVIANO Y, 1985, J BIOL CHEM, V260, P624; PALEN E, 1991, BIOCHEMISTRY-US, V30, P5586, DOI 10.1021/bi00236a035; PAYRASTRE B, 1992, J BIOL CHEM, V267, P5078; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; SEVALJEVIC L, 1982, MOL BIOL REP, V8, P225, DOI 10.1007/BF00776584; STEER RC, 1979, EXP CELL RES, V119, P403, DOI 10.1016/0014-4827(79)90372-0; STUURMAN N, 1990, J BIOL CHEM, V265, P5460; TAWFIC S, 1993, CELL MOL BIOL RES, V39, P43; TOMMASINO M, 1992, GENE, V111, P93, DOI 10.1016/0378-1119(92)90607-Q; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P123; XING YG, 1991, J CELL BIOL, V112, P1055, DOI 10.1083/jcb.112.6.1055	54	51	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7489	7493						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125967				2022-12-27	WOS:A1994NA03200072
J	PEDRAZAALVA, G; ZINGG, JM; JOST, JP				PEDRAZAALVA, G; ZINGG, JM; JOST, JP			AP-1 BINDS TO A PUTATIVE CAMP RESPONSE ELEMENT OF THE MYOD1 PROMOTER AND NEGATIVELY MODULATES MYOD1 EXPRESSION IN DIVIDING MYOBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-SPECIFIC EXPRESSION; TRANSFORMING GROWTH-FACTOR; DNA-BINDING; C-JUN; MYOGENIC DIFFERENTIATION; GLUCOCORTICOID RECEPTOR; FUNCTIONAL ANTAGONISM; INDUCIBLE ENHANCER; ESTROGEN-RECEPTOR; GENE-EXPRESSION	We have studied the transcriptional activity of the mouse MyoD1 gene promoter in vivo and in vitro using mouse G8 myoblasts and muscle cell nuclear extracts. 5' deletion analysis of the promoter and transcription-competition analysis using oligonucleotides corresponding to several cis-acting elements revealed that the basal activity of the MyoD1 promoter is conferred by two SP1 boxes, an AP-2 box, and a CAAT box. We have identified a negative regulatory sequence located between nucleotide position -342 to -322 with respect to the cap site. The negative regulatory element shows sequence homology with cAMP-responsive element (CRE) and AP-1 binding site (5'-GAGCACTGAGGTCAGTACAG-3'). As determined by gel mobility shift competition analysis, oligonucleotides containing AP-1 binding sites inhibit protein interactions with the MyoD1 CRE-like element. We also show that binding to this element is down-regulated during myogenic differentiation and can be reinduced by the addition of serum. Furthermore, mutation of the CRE-like element induces MyoD promoter activity in diving myoblasts. By using anti-c-Fos antibodies we show that AP-1 is binding to the MyoD1 CRE-like element. Our results indicate that AP-1 negatively modulates MyoD1 expression in growing myoblasts and strongly suggest that c-Fos and c-Jun inhibit myogenesis and MyoD1 expression by direct binding to a negative cis-acting element in the MyoD1 promoter.	FRIEDRICH MIESCHER INST,CH-4002 BASEL,SWITZERLAND	Friedrich Miescher Institute for Biomedical Research			Zingg, Jean-Marc/H-6960-2019					ANDRISANI OM, 1987, NUCLEIC ACIDS RES, V15, P5717; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BALDWIN TJ, 1989, NATURE, V314, P716; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; CAOUDY M, 1988, CELL, V55, P1061; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DAVIS RL, 1987, CELL, V51, P485; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; DOUCAS V, 1991, EMBO J, V10, P2237, DOI 10.1002/j.1460-2075.1991.tb07760.x; EDMONDSON DG, 1991, J BIOL CHEM, V266, P21343; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; FRANCK A, 1980, CELL, V21, P285, DOI 10.1016/0092-8674(80)90136-1; GAUB MP, 1990, CELL, V63, P1267, DOI 10.1016/0092-8674(90)90422-B; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GYNHEUNG AN, 1982, MOL CELL BIOL, V2, P1628; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HIRAI SI, 1990, ONCOGENE, V5, P39; ISRAEL A, 1989, EMBO J, V8, P3793, DOI 10.1002/j.1460-2075.1989.tb08556.x; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; KIM SJ, 1992, J BIOL CHEM, V267, P15140; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LASSAR AB, 1989, CELL, V58, P659, DOI 10.1016/0092-8674(89)90101-3; LEE SJ, 1993, NUCLEIC ACIDS RES, V21, P3365; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEY TJ, 1982, P NATL ACAD SCI-BIOL, V79, P4775, DOI 10.1073/pnas.79.15.4775; LIN H, 1991, MOL CELL BIOL, V11, P267, DOI 10.1128/MCB.11.1.267; LUCIBELLO F C, 1989, Methods in Molecular and Cellular Biology, V1, P9; MCBRIDE K, 1993, MOL CELL BIOL, V13, P600, DOI 10.1128/MCB.13.1.600; MINER JH, 1991, MOL CELL BIOL, V11, P2842, DOI 10.1128/MCB.11.5.2842; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NEY PA, 1990, GENE DEV, V4, P993, DOI 10.1101/gad.4.6.993; OLSON EN, 1986, J CELL BIOL, V103, P1799, DOI 10.1083/jcb.103.5.1799; OLSON EN, 1987, MOL CELL BIOL, V7, P2104, DOI 10.1128/MCB.7.6.2104; PARK K, 1992, J BIOL CHEM, V267, P10810; PETERSON CA, 1990, CELL, V62, P492; PIETTE J, 1990, NATURE, V345, P353, DOI 10.1038/345353a0; PINNEY DF, 1988, CELL, V53, P781, DOI 10.1016/0092-8674(88)90095-5; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; SARTORELLI V, 1990, GENE DEV, V4, P1811, DOI 10.1101/gad.4.10.1811; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SCHONTAL A, 1980, CELL, V54, P325; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; SCHULE R, 1990, CELL, V61, P497, DOI 10.1016/0092-8674(90)90531-I; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; VACCARO M, 1990, P NATL ACAD SCI USA, V87, P3047, DOI 10.1073/pnas.87.8.3047; VAIDYA TB, 1989, MOL CELL BIOL, V9, P3576, DOI 10.1128/MCB.9.8.3576; VAIDYA TB, 1992, GENE, V116, P223, DOI 10.1016/0378-1119(92)90519-U; WENTWORTH BM, 1991, P NATL ACAD SCI USA, V88, P1242, DOI 10.1073/pnas.88.4.1242; WICE B, 1987, J BIOL CHEM, V262, P1810; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; ZAHRADKA P, 1989, EXP CELL RES, V185, P8, DOI 10.1016/0014-4827(89)90032-3; ZINGG JM, 1991, NUCLEIC ACIDS RES, V19, P6433, DOI 10.1093/nar/19.23.6433	60	50	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6978	6985						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120060				2022-12-27	WOS:A1994MZ50300109
J	CARMEN, AA; HOLLAND, MJ				CARMEN, AA; HOLLAND, MJ			THE UPSTREAM REPRESSION SEQUENCE FROM THE YEAST ENOLASE GENE ENO1 IS A COMPLEX REGULATORY ELEMENT THAT BINDS MULTIPLE TRANS-ACTING FACTORS INCLUDING REB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ACTIVATING SEQUENCES; MODULATE REPRESSION; PROTEIN-BINDING; IDENTIFICATION; TRANSCRIPTION; EXPRESSION; DNA; SITE; ENHANCER	Cis-acting sequences that modulate ENO1 URS (upstream repression site) element activity were identified by base pair substitution mutagenesis. Base substitution mutations within three distinct regions of the 125-base pair URS element caused partial loss of URS activity in vivo. A URS element containing all three mutations was inactive. A binding site for the yeast REB1 protein was identified near the 5' terminus of the ENO1 URS element. Base substitution mutations that disrupted REB1 binding in vitro caused a 30% loss of URS activity in vivo. A second DNA binding activity was identified which also bound near the 5' terminus of the URS element. This latter binding activity was not antigenically related to REB1 nor was binding of this activity affected by base substitution mutations that abolished REB1 binding. Base substitution mutations within a second region of the ENO1 URS element caused a 38% loss of URS activity in vivo. The nucleotide sequence of this latter region is very similar to essential sequences within the URS elements from the yeast CAR1 and SSA1 genes, respectively. Base substitution mutations within a third region near the 3' terminus of the ENO1 URS element caused a 70% loss of URS activity in vivo. These latter sequences bound a partially purified factor that was distinct from REB1. These results showed that ENO1 URS element activity was modulated by multiple cis-acting sequences that bound distinct trans-acting factors.	UNIV CALIF DAVIS,SCH MED,DEPT BIOL CHEM,DAVIS,CA 95616	University of California System; University of California Davis					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM130307, R01GM030307] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30307] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRAND AH, 1987, CELL, V51, P709, DOI 10.1016/0092-8674(87)90094-8; BRINDLE PK, 1990, MOL CELL BIOL, V10, P4872, DOI 10.1128/MCB.10.9.4872; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; CHASMAN DI, 1990, GENE DEV, V4, P503, DOI 10.1101/gad.4.4.503; CHEN W, 1989, EMBO J, V8, P261, DOI 10.1002/j.1460-2075.1989.tb03372.x; COHEN R, 1987, MOL CELL BIOL, V7, P2753, DOI 10.1128/MCB.7.8.2753; COHEN R, 1986, MOL CELL BIOL, V6, P2287, DOI 10.1128/MCB.6.7.2287; FEDOR MJ, 1988, J MOL BIOL, V204, P109, DOI 10.1016/0022-2836(88)90603-1; HOLLAND JP, 1990, MOL CELL BIOL, V10, P4863, DOI 10.1128/MCB.10.9.4863; HUET J, 1987, P NATL ACAD SCI USA, V84, P3648, DOI 10.1073/pnas.84.11.3648; INNIS MA, 1986, METHOD ENZYMOL, V119, P397; JARVIS EE, 1989, GENE DEV, V3, P936, DOI 10.1101/gad.3.7.936; KELEHER CA, 1989, MOL CELL BIOL, V9, P5228, DOI 10.1128/MCB.9.11.5228; LANG WH, 1993, MOL CELL BIOL, V13, P649, DOI 10.1128/MCB.13.1.649; LAYNE E, 1957, METHOD ENZYMOL, V3, P447, DOI 10.1016/S0076-6879(57)03413-8; LUCHE RM, 1990, MOL CELL BIOL, V10, P3884, DOI 10.1128/MCB.10.8.3884; Maxam A M, 1980, Methods Enzymol, V65, P499; MCALISTER L, 1982, J BIOL CHEM, V257, P7181; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MESTEL R, 1989, MOL CELL BIOL, V9, P1243, DOI 10.1128/MCB.9.3.1243; MORROW BE, 1989, J BIOL CHEM, V264, P9061; MORROW BE, 1990, J BIOL CHEM, V265, P20778; NISHIZAWA M, 1989, MOL CELL BIOL, V9, P442, DOI 10.1128/MCB.9.2.442; PARK HO, 1989, MOL CELL BIOL, V9, P2025, DOI 10.1128/MCB.9.5.2025; PASSMORE S, 1989, GENE DEV, V3, P921, DOI 10.1101/gad.3.7.921; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT EW, 1990, NUCLEIC ACIDS RES, V18, P7099, DOI 10.1093/nar/18.23.7099; SUMRADA RA, 1987, P NATL ACAD SCI USA, V84, P3997, DOI 10.1073/pnas.84.12.3997; SWANSON ME, 1983, J BIOL CHEM, V258, P3242	29	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9790	9797						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144571				2022-12-27	WOS:A1994NE05300062
J	NIEDERWEIS, M; LEDERER, T; HILLEN, W				NIEDERWEIS, M; LEDERER, T; HILLEN, W			MATRIX EFFECTS SUGGEST AN IMPORTANT INFLUENCE OF DNA-POLYACRYLAMIDE INTERACTIONS ON THE ELECTROPHORETIC MOBILITY OF DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GEL-ELECTROPHORESIS; HELICAL REPEAT; CURVED DNA; BENT DNA; B-DNA; FRAGMENTS; REPTATION; MOLECULES; AGAROSE; ANGLES	The electrophoretic mobilities of 34 DNA fragments with a varied phasing of two A-tract bends have been determined in different polyacrylamide gels. They are perfectly described by a cosine function. A systematic variation of the polyacrylamide gel matrix revealed that not only the absolute electrophoretic mobilities of these distance variants, but also their amplitudes and the positions of their extrema, depend on the polyacrylamide content. The displacement of the extrema with increasing polyacrylamide content is attributed to gel-induced unwinding of the DNA. None of these matrix effects can be explained by the change of the pore sizes, which is generally regarded as the central parameter determining electrophoretic mobility of DNA in gels. Instead, we hypothesize an interaction between the electrophoresed DNA and the polyacrylamide matrix and discuss a new qualitative model for electrophoresis of DNA in polyacrylamide gels which accounts for these observations.	UNIV ERLANGEN NURNBERG, INST MIKROBIOL & BIOCHEM, LEHRSTUHL MIKROBIOL, STAUDTSTR 5, D-91058 ERLANGEN, GERMANY	University of Erlangen Nuremberg								BOLSHOY A, 1991, P NATL ACAD SCI USA, V88, P2312, DOI 10.1073/pnas.88.6.2312; CALLADINE CR, 1991, J MOL BIOL, V221, P981, DOI 10.1016/0022-2836(91)80187-Y; CALLADINE CR, 1988, J MOL BIOL, V201, P127, DOI 10.1016/0022-2836(88)90444-5; CHRAMBACH A, 1971, SCIENCE, V172, P440, DOI 10.1126/science.172.3982.440; CHRAMBACH A, 1985, PRACTICE QUANTITATIV, P63; CROTHERS DM, 1990, J BIOL CHEM, V265, P7093; DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789; DIEKMANN S, 1987, NUCLEIC ACIDS RES, V15, P247, DOI 10.1093/nar/15.1.247; DOI M, 1978, J CHEM SOC FARAD T 2, V74, P1789, DOI 10.1039/f29787401789; DRAK J, 1991, P NATL ACAD SCI USA, V88, P3074, DOI 10.1073/pnas.88.8.3074; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; HERVET H, 1987, BIOPOLYMERS, V26, P727, DOI 10.1002/bip.360260512; KABSCH W, 1982, NUCLEIC ACIDS RES, V10, P1097, DOI 10.1093/nar/10.3.1097; KERPPOLA TK, 1991, SCIENCE, V254, P1210, DOI 10.1126/science.1957173; KOUDELKA GB, 1991, NUCLEIC ACIDS RES, V19, P4115, DOI 10.1093/nar/19.15.4115; LANE D, 1992, MICROBIOL REV, V56, P509, DOI 10.1128/MMBR.56.4.509-528.1992; LERMAN LS, 1982, BIOPOLYMERS, V21, P995, DOI 10.1002/bip.360210511; LEVENE SD, 1989, SCIENCE, V245, P396, DOI 10.1126/science.2756426; LUMPKIN OJ, 1982, BIOPOLYMERS, V21, P2315, DOI 10.1002/bip.360211116; MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664; NIEDERWEIS M, 1993, ELECTROPHORESIS, V14, P693, DOI 10.1002/elps.11501401110; NIEDERWEIS M, 1992, J MOL BIOL, V228, P322, DOI 10.1016/0022-2836(92)90820-A; OGSTON AG, 1958, T FARADAY SOC, V54, P1754, DOI 10.1039/tf9585401754; OLIVERA BM, 1964, BIOPOLYMERS, V2, P245, DOI 10.1002/bip.1964.360020306; RIGHETTI PG, 1983, ISOELECTRIC FOCUSING, P154; RODBARD D, 1970, P NATL ACAD SCI USA, V65, P970, DOI 10.1073/pnas.65.4.970; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; STELLWAGEN A, 1990, BIOPOLYMERS, V30, P309, DOI 10.1002/bip.360300309; STELLWAGEN NC, 1987, ADV ELECTROPHORESIS, V1, P179; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; TRAVERS AA, 1992, CURR OPIN STRUC BIOL, V2, P71; WHEELER D, 1993, BIOCHEM BIOPH RES CO, V193, P413, DOI 10.1006/bbrc.1993.1639; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; ZIMM BH, 1992, Q REV BIOPHYS, V25, P171, DOI 10.1017/S0033583500004662; ZIMM BH, 1993, CURR OPIN STRUC BIOL, V3, P373, DOI 10.1016/S0959-440X(05)80108-3; ZINKEL SS, 1987, NATURE, V328, P178, DOI 10.1038/328178a0	36	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10156	10162						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144517				2022-12-27	WOS:A1994NE05300113
J	NOVOTNY, WF; CHASSANDE, O; BAKER, M; LAZDUNSKI, M; BARBRY, P				NOVOTNY, WF; CHASSANDE, O; BAKER, M; LAZDUNSKI, M; BARBRY, P			DIAMINE OXIDASE IS THE AMILORIDE-BINDING PROTEIN AND IS INHIBITED BY AMILORIDE ANALOGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; AMINE OXIDASE; CULTURED-CELLS; SEQUENCE; BLASTOCYST; CHANNEL; SITE	Diamine oxidase (histaminase), an enzyme that oxidatively deaminates putrescine and histamine, was purified from human placenta and from pig kidney. Both NH2-terminal sequences are highly homologous to the human kidney amiloride-binding protein, previously thought to be a component of the amiloride-sensitive Na+ channel. Monoclonal antibodies raised against the pig kidney amiloride-binding protein immunoprecipitate a polypeptide with the same M(r) (105,000) as that of pig kidney diamine oxidase. That polypeptide has both diamine oxidase activity and the capacity to bind [H-3]phenamil, a tritiated amiloride derivative. Cells stably transfected with human kidney amiloride-binding protein cDNA express a high diamine oxidase activity. In transfected cells as well as with the purified enzyme, this activity was inhibited by amiloride and by some of its derivatives, such as phenamil and ethylpropylamiloride. Amiloride inhibition seems to be due to drug binding at the active site of the enzyme. These data indicate that human placental diamine oxidase is identical to the human kidney amiloride-binding protein and that amiloride analogues may have wider physiological effects besides those on epithelial ion transport.	INST PHARMACOL MOLEC & CELLULAIRE, F-06560 VALBONNE, FRANCE		NOVOTNY, WF (corresponding author), UNIV CALIF SAN DIEGO, MED CTR, DEPT MED, DIV HEMATOL ONCOL, SAN DIEGO, CA 92103 USA.		Barbry, Pascal/O-5021-2016	Barbry, Pascal/0000-0001-9632-6483				BACHRACH U, 1987, TISSUE CELL, V19, P39, DOI 10.1016/0040-8166(87)90055-3; BACHRACH U, 1987, J CELL PHYSIOL, V131, P92, DOI 10.1002/jcp.1041310114; BARBRY P, 1990, BIOCHEMISTRY-US, V29, P1039, DOI 10.1021/bi00456a028; BARBRY P, 1990, P NATL ACAD SCI USA, V87, P7347, DOI 10.1073/pnas.87.19.7347; BAYLIN SB, 1977, P NATL ACAD SCI USA, V74, P883, DOI 10.1073/pnas.74.3.883; BENOS DJ, 1987, J BIOL CHEM, V262, P10613; BRUINENBERG PG, 1989, BIOCHIM BIOPHYS ACTA, V1008, P157, DOI 10.1016/0167-4781(80)90003-2; BUFFONI F, 1966, PHARMACOL REV, V18, P1163; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; COUNILLON L, 1993, P NATL ACAD SCI USA, V90, P4508, DOI 10.1073/pnas.90.10.4508; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; DOWLING RH, 1990, DIGESTION, V46, P331, DOI 10.1159/000200406; FRELIN C, 1987, KIDNEY INT, V32, P785, DOI 10.1038/ki.1987.277; GOLDSTEIN O, 1993, J BIOL CHEM, V268, P7856; HANSSON R, 1966, ACTA MED SCAND, V180, P533; HARLOW E, 1988, ANTIBODIES LABORATOR; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; JANES SM, 1990, SCIENCE, V248, P981, DOI 10.1126/science.2111581; JANES SM, 1992, BIOCHEMISTRY-US, V31, P12147, DOI 10.1021/bi00163a025; LINGUEGLIA E, 1993, EUR J BIOCHEM, V216, P679, DOI 10.1111/j.1432-1033.1993.tb18188.x; LINGUEGLIA E, 1993, FEBS LETT, V318, P95, DOI 10.1016/0014-5793(93)81336-X; NOVOTNY WF, 1991, BLOOD, V78, P387; OKUYAMA T, 1961, ARCH BIOCHEM BIOPHYS, V95, P242, DOI 10.1016/0003-9861(61)90141-2; PARCHMENT RE, 1989, CANCER RES, V49, P6680; PIERCE GB, 1991, DIFFERENTIATION, V46, P181, DOI 10.1111/j.1432-0436.1991.tb00880.x; PIERCE GB, 1989, P NATL ACAD SCI USA, V86, P3654, DOI 10.1073/pnas.86.10.3654; ROBINSONWHITE A, 1985, J CLIN INVEST, V76, P93, DOI 10.1172/JCI111983; ROSSI A, 1992, FEBS LETT, V301, P253, DOI 10.1016/0014-5793(92)80251-B; SATTLER J, 1990, J NEUR TR S, P291; SOLOMON EI, 1993, SCIENCE, V259, P1575, DOI 10.1126/science.8384374; THESTRUP PK, 1987, DAN MED B, V34, P3	32	87	90	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9921	9925						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144586				2022-12-27	WOS:A1994NE05300080
J	HIGGINS, JB; CASEY, PJ				HIGGINS, JB; CASEY, PJ			IN-VITRO PROCESSING OF RECOMBINANT G-PROTEIN GAMMA-SUBUNITS - REQUIREMENTS FOR ASSEMBLY OF AN ACTIVE BETA-GAMMA COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING REGULATORY PROTEINS; ALPHA-SUBUNITS; PERTUSSIS TOXIN; BOVINE BRAIN; PRENYLATION; EXPRESSION; DIMERS; CELLS; MYRISTOYLATION; ASSOCIATION	The gamma subunits of the heterotrimeric G proteins (G(gamma)) are subject to carboxyl-terminal processing. This processing involves prenylation of a cysteine residue initially 4 amino acids from the carboxyl terminus, endoproteolytic truncation of the 3 terminal amino acids, and methylation of the now carboxyl-terminal prenylcysteine residue. The significance of each of these modifications in the ultimate properties of G proteins is not yet clear. We have developed in vitro systems for the production of the three processing intermediates (unmodified, prenylated, and truncated-prenylated) for two G(gamma) subunits, one which is subject to farnesylation (G(gamma 1)) and one which is geranylgeranylated (G(gamma 2)). Assessment of the functional consequences of the processing of G(gamma) was found to require reconstitution of the polypeptides with a G protein beta subunit (G(beta)) The ability of recombinant G(beta), produced in Sf9 cells, to assemble into stable beta gamma complexes (G(beta gamma)) with each of the G(gamma) processing intermediates was assessed. Both prenylated and unprenylated G gamma subunits formed stable complexes with G(beta), but surprisingly, neither of the truncated-prenylated G(gamma) subunits were competent for this assembly. The G(beta gamma) complexes which were formed were examined for their ability to interact with a G protein alpha subunit (G(alpha)). Only those G(beta gamma) complexes containing a prenylated G(gamma) subunit were functional in this assay. These data indicate that: 1) prenylation of G(gamma) is not required for G(beta gamma) assembly; 2) assembly of the G(beta gamma) complex occurs prior to the proteolytic processing of G(gamma); and 3) G(beta gamma) complexes require prenylated G(gamma) for interaction with G(alpha).	DUKE UNIV,MED CTR,DEPT MOLEC CANC BIOL,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710	Duke University; Duke University				Casey, Patrick/0000-0002-7366-9309				BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; BUSS JE, 1987, P NATL ACAD SCI USA, V84, P7493, DOI 10.1073/pnas.84.21.7493; CASEY PJ, 1989, BIOCHEMISTRY-US, V28, P611, DOI 10.1021/bi00428a029; CASEY PJ, 1992, J LIPID RES, V33, P1731; CASEY PJ, 1991, P NATL ACAD SCI USA, V88, P8631, DOI 10.1073/pnas.88.19.8631; CHEN WJ, 1993, J BIOL CHEM, V268, P9675; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; GRABER SG, 1992, J BIOL CHEM, V267, P13123; GRAZIANO MP, 1987, J BIOL CHEM, V262, P11375; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; KATADA T, 1986, J BIOL CHEM, V261, P8182; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI RK, 1990, P NATL ACAD SCI USA, V87, P7673, DOI 10.1073/pnas.87.19.7673; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; LINDER ME, 1991, J BIOL CHEM, V266, P4654; MARSHALL CJ, 1993, SCIENCE, V259, P1865, DOI 10.1126/science.8456312; MOOMAW JF, 1992, J BIOL CHEM, V267, P17438; MOORES SL, 1991, J BIOL CHEM, V266, P14603; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P5873, DOI 10.1073/pnas.87.15.5873; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; MUNTZ KH, 1992, MOL BIOL CELL, V3, P49, DOI 10.1091/mbc.3.1.49; O'Reilly D. R., 1992, BACULOVIRUS EXPRESSI, P1; OHGURO H, 1991, EMBO J, V10, P3669, DOI 10.1002/j.1460-2075.1991.tb04934.x; PARENTI M, 1993, BIOCHEM J, V291, P349, DOI 10.1042/bj2910349; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; ROBISHAW JD, 1992, BIOCHEM J, V286, P677, DOI 10.1042/bj2860677; SCHMIDT CJ, 1991, J BIOL CHEM, V266, P4538; SIMONDS WF, 1991, J BIOL CHEM, V266, P5363; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; SUMMERS MD, 1987, MANUAL METHODS BACUL, P1; THISSEN JA, 1993, J BIOL CHEM, V268, P13780; WILDMAN DE, 1993, P NATL ACAD SCI USA, V90, P794, DOI 10.1073/pnas.90.3.794; WINSLOW JW, 1986, J BIOL CHEM, V261, P7571; YAMANE HK, 1990, P NATL ACAD SCI USA, V87, P5868, DOI 10.1073/pnas.87.15.5868	36	90	92	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9067	9073						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132644				2022-12-27	WOS:A1994NB41100068
J	OSTANIN, K; SAEED, A; VANETTEN, RL				OSTANIN, K; SAEED, A; VANETTEN, RL			HETEROLOGOUS EXPRESSION OF HUMAN PROSTATIC ACID-PHOSPHATASE AND SITE-DIRECTED MUTAGENESIS OF THE ENZYME ACTIVE-SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREPRO-ALPHA-FACTOR; PHOSPHOTYROSYL PROTEIN PHOSPHATASE; 6-PHOSPHOFRUCTO-2-KINASE FRUCTOSE-2,6-BISPHOSPHATASE; SACCHAROMYCES-CEREVISIAE; STRUCTURAL GENE; BOVINE HEART; YEAST; INTERMEDIATE; PHOSPHORYLATION; DEPENDENCE	Earlier covalent modification experiments indicated that histidine, arginine, and carboxylic acid residues were involved in the catalytic mechanism of the acid phosphatase enzyme from human prostate. The present study utilizes site-directed mutagenesis to evaluate the catalytic importance of 7 residues of human prostatic phosphatase, namely His(12), His(257), Asp(258), Arg(11), Arg(15), Arg(54), and Arg(79), which are highly conserved in the sequences of high molecular weight acid phosphatases. Both wild type and mutant enzymes were expressed in the yeast Saccharomyces cerevisiae as fusions to a leader peptide of prepro-alpha-factor, which resulted in the secretion of processed proteins into the culture media. The kinetic parameters of the recombinant wild type enzyme were shown to be effectively identical with those of the native protein. The circular dichroism spectra of wild type and mutant proteins were effectively superimposable. Replacement of His(12), which was previously shown to be transiently phosphorylated during catalysis, as well as the adjacent Arg(11), both resulted in >10(4) reductions of enzyme activity. Consistent with a postu lated involvement of arginine residues in substrate binding, large reductions in V-max caused by the R15A and R79A mutations were accompanied by marked increases in K-m. However, the mutation R54A had only small effects on kinetic parameters. Essential roles for both His(257) and Asp(258) were also established. The D258A mutation not only caused larger decreases of V-max toward p-nitrophenyl phosphate compared to the effect of the H257A mutation, but it also caused the reaction to become more sensitive to the nature of the leaving group. It is concluded that His(12) and Asp(258) are involved in the formation of the phosphoenzyme intermediate as an acceptor of the phospho group and a proton donor for the substrate leaving group, respectively, while His(257) may participate in substrate binding or may facilitate the breakdown of the phosphoenzyme by maintaining the protonated state of the phosphorylated His(12) residue.	PURDUE UNIV,DEPT CHEM,W LAFAYETTE,IN 47907	Purdue University System; Purdue University; Purdue University West Lafayette Campus					NIAID NIH HHS [AI 27713] Funding Source: Medline; NIGMS NIH HHS [GM 27003] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027003] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACHSTETTER T, 1985, EMBO J, V4, P173, DOI 10.1002/j.1460-2075.1985.tb02333.x; BAJWA W, 1984, NUCLEIC ACIDS RES, V12, P7721, DOI 10.1093/nar/12.20.7721; BAZAN JF, 1989, P NATL ACAD SCI USA, V86, P9642, DOI 10.1073/pnas.86.24.9642; BEGGS JD, 1981, A BENZON S, V16, P383; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAKE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P4642, DOI 10.1073/pnas.81.15.4642; BRAKE AJ, 1989, YEAST GENETIC ENG, P269; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHO HJ, 1992, J AM CHEM SOC, V114, P7296, DOI 10.1021/ja00044a052; DAVIDSON RE, 1990, THESIS PURDUE U W LA; DUNCAN PH, 1984, CLIN CHEM, V30, P1327; GUAN KL, 1991, J BIOL CHEM, V266, P17026; Huggins C, 1941, CANCER RES, V1, P293; HULTQUIS.DE, 1968, BIOCHIM BIOPHYS ACTA, V153, P329, DOI 10.1016/0005-2728(68)90078-9; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JULIUS D, 1983, CELL, V32, P839, DOI 10.1016/0092-8674(83)90070-3; JULIUS D, 1984, CELL, V36, P309, DOI 10.1016/0092-8674(84)90224-1; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KURJAN J, 1982, CELL, V30, P933, DOI 10.1016/0092-8674(82)90298-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN K, 1992, J BIOL CHEM, V267, P19163; LINDQVIST Y, 1993, J BIOL CHEM, V268, P20744; MCTIGUE JJ, 1978, BIOCHIM BIOPHYS ACTA, V523, P422, DOI 10.1016/0005-2744(78)90044-X; MCTIGUE JJ, 1978, BIOCHIM BIOPHYS ACTA, V523, P407, DOI 10.1016/0005-2744(78)90043-8; MYASNIKOV AN, 1991, CHEM ABSTR P43519M, V115; OSTANIN K, 1993, J BIOL CHEM, V268, P20778; OSTANIN K, 1992, J BIOL CHEM, V267, P22830; OSTANIN K, 1989, Patent No. 4698215; OSTROWSKI W, 1978, BIOCHIM BIOPHYS ACTA, V526, P147, DOI 10.1016/0005-2744(78)90299-1; OSTROWSKI W, 1980, MALE ACCESSORY SEX G, P197; PILKIS SJ, 1987, J BIOL CHEM, V262, P12672; RISLEY J M, 1990, Journal of Protein Chemistry, V9, P366; Rose Z B, 1980, Adv Enzymol Relat Areas Mol Biol, V51, P211; ROTHMAN JH, 1986, P NATL ACAD SCI USA, V83, P3248, DOI 10.1073/pnas.83.10.3248; SAINI MS, 1979, BIOCHIM BIOPHYS ACTA, V568, P370, DOI 10.1016/0005-2744(79)90305-X; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER G, 1993, EMBO J, V12, P2609, DOI 10.1002/j.1460-2075.1993.tb05921.x; SCHWARTZ JH, 1961, P NATL ACAD SCI USA, V47, P1996, DOI 10.1073/pnas.47.12.1996; SHERMAN F, 1978, COLD SPRING HARBOR L; TAULER A, 1990, J BIOL CHEM, V265, P15617; VANETTEN RL, 1977, BIOCHIM BIOPHYS ACTA, V484, P386, DOI 10.1016/0005-2744(77)90094-8; VANETTEN RL, 1991, J BIOL CHEM, V266, P2313; VANETTEN RL, 1982, ANN NY ACAD SCI, V390, P27; VINCENT JB, 1992, TRENDS BIOCHEM SCI, V17, P105, DOI 10.1016/0968-0004(92)90246-6; WO YYP, 1992, BIOCHEMISTRY-US, V31, P1712, DOI 10.1021/bi00121a019; ZHANG ZY, 1991, BIOCHEMISTRY-US, V30, P8954, DOI 10.1021/bi00101a006; ZSEBO KM, 1986, J BIOL CHEM, V261, P5858	50	57	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8971	8978						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132635				2022-12-27	WOS:A1994NB41100054
J	SZWEDA, LI				SZWEDA, LI			AGE-RELATED INCREASE IN LIVER RETINYL PALMITATE - RELATIONSHIP TO LIPOFUSCIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-A; LIPID-PEROXIDATION; AGING RATS; FLUORESCENT; PRODUCTS; TISSUES; INVOLVEMENT; SUBSTANCES; STORAGE	Lipofuscin is a general term assigned to fluorescent material that accumulates in cells as they age. It is apparent from this study that the fluorescent intensity of detergent-solubilized liver from Fisher-344 rats increased as a function of age. The fluorophore responsible for this increase was extracted with methanol and could be resolved from other cellular components when the methanol extracts were chromatographed over a re verse phase column. This compound was identified as retinyl palmitate and was found to increase throughout the entire life of the Fisher-344 rat (2-24 months), from a value of 0.26-1.77 mg/g of liver. In addition, the results presented here demonstrate that concentration, time between extraction and analysis, exposure to light, and degree of purity affect the observed fluorescent properties of retinyl palmitate. These factors affect many fluorophores and are likely to be, at least in part, responsible for the multiplicity of reported properties of lipofuscin. As has been reported for lipofuscin, retinyl palmitate accumulates in intracellular granules and exhibits fluorescence between 450 and 600 nm. Due to these similarities, the relationship between retinyl palmitate and lipofuscin warrants further investigation.			SZWEDA, LI (corresponding author), NHLBI,BIOCHEM LAB,BLDG 3,RM 221,BETHESDA,MD 20892, USA.							BANKSON DD, 1989, EXP GERONTOL, V24, P127, DOI 10.1016/0531-5565(89)90023-5; BHAT PV, 1983, J CHROMATOGR, V272, P269, DOI 10.1016/S0378-4347(00)86129-0; CHIO KS, 1969, SCIENCE, V166, P1535, DOI 10.1126/science.166.3912.1535; CHIO KS, 1969, BIOCHEMISTRY-US, V8, P2821, DOI 10.1021/bi00835a019; CSALLANY AS, 1976, LIPIDS, V11, P412, DOI 10.1007/BF02532849; ELDRED GE, 1989, FREE RADICAL BIO MED, V7, P157, DOI 10.1016/0891-5849(89)90007-5; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FERLAND G, 1992, J GERONTOL, V47, pB3, DOI 10.1093/geronj/47.1.B3; FLETCHER BL, 1973, ANAL BIOCHEM, V52, P1, DOI 10.1016/0003-2697(73)90327-8; GANGULY J, 1989, BIOCH VITAMIN A; GUERRANT N. B., 1949, JOUR NUTRITION, V37, P37; HARMAN D, 1990, LIPOFUSCIN CEROID PI, P3; IVY GO, 1991, MECH AGEING DEV, V57, P213, DOI 10.1016/0047-6374(91)90048-5; KAHAN J, 1967, ACTA CHEM SCAND, V21, P2515, DOI 10.3891/acta.chem.scand.21-2515; KATZ ML, 1987, MECH AGEING DEV, V39, P81, DOI 10.1016/0047-6374(87)90088-1; KIKUGAWA K, 1987, CHEM PHYS LIPIDS, V44, P277, DOI 10.1016/0009-3084(87)90054-5; KIRK JE, 1962, VITAM HORM, V20, P67, DOI 10.1016/S0083-6729(08)60716-5; MOBARHAN S, 1991, J NUTR, V121, P510, DOI 10.1093/jn/121.4.510; Olson JA., 1991, HDB VITAMINS, P1; PLANTA CV, 1962, HELV CHIM ACTA, V45, P548, DOI 10.1002/hlca.19620450218; PORTA EA, 1991, ARCH GERONTOL GERIAT, V12, P303, DOI 10.1016/0167-4943(91)90036-P; Sobotka H, 1943, J AM CHEM SOC, V65, P1959, DOI 10.1021/ja01250a042; SUNDBOOM J, 1984, EXP GERONTOL, V19, P257, DOI 10.1016/0531-5565(84)90021-4; TOTARO EA, 1985, ADV AGE PIGMENTS RES, V64; TSUCHIDA M, 1987, CHEM PHYS LIPIDS, V44, P297, DOI 10.1016/0009-3084(87)90055-7; WOLFE LS, 1977, SCIENCE, V195, P1360, DOI 10.1126/science.841336; ZSNAGY I, 1988, INT C SERIES, V782	27	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8712	8715						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132600				2022-12-27	WOS:A1994NB41100017
J	SUCHARD, SJ; NAKAMURA, T; ABE, A; SHAYMAN, JA; BOXER, LA				SUCHARD, SJ; NAKAMURA, T; ABE, A; SHAYMAN, JA; BOXER, LA			PHOSPHOLIPASE D-MEDIATED DIRADYLGLYCEROL FORMATION COINCIDES WITH H2O2 AND LACTOFERRIN RELEASE IN ADHERENT HUMAN NEUTROPHILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; PROTEIN-KINASE-C; RESPIRATORY BURST; NADPH OXIDASE; PHOSPHATIDIC-ACID; SUBCELLULAR-LOCALIZATION; PHOSPHATIDYLCHOLINE HYDROLYSIS; SUPEROXIDE GENERATION; RECEPTOR EXPRESSION; B-CYTOCHROME	Polymorphonuclear leukocytes (PMNs) adherent to fibrinogen exhibit a delay in the onset of the respiratory burst in response to N-formyl-methionyl-leucyl-phenylalanine (fMLP). Previously, we demonstrated that H2O2 release in adherent PMNs coincides with the exocytosis of lactoferrin containing specific granules. Since diradylglycerol (DRG) has been implicated in PMN secretion and oxidant release, we measured DRG formation during PMN adhesion to fibrinogen. PMNs were added to fibrinogen-coated plastic in the presence of fMLP, and H2O2 release, lactoferrin release, and DRG formation measured over a time course of 120 min. H2O2 and lactoferrin release were not apparent until 45-60 min, reaching maximal levels by 120 min. In contrast, DRG concentration increased by 15-30 min, from 275 +/- 27 pmol/mg of protein in resting cells to 600 +/- 173 pmol/mg protein in cells exposed to fMLP. DRG levels returned to base line by 30-45 min (383 +/- 32 pmol/mg of protein) before increasing again between 60 and 120 min (944 +/- 230 pmol/mg of protein and 1632 +/- 351 pmol/mg of protein, respectively). Propranolol, an inhibitor of phosphatidate phosphohydrolase, caused a dose-dependent inhibition of both H2O2 and lactoferrin release, with maximal inhibition at 50-100 mu M. Propranolol also inhibited the second, but not the first phase of DRG formation. Similarly, ethanol treatment completely blocked H2O2 and lactoferrin release, and the second phase of DRG formation. In the presence of ethanol, phospholipase D (PLD)-mediated formation of [H-3] phosphatidylethanol from H-3-O-alkyl phosphatidylcholine corresponded to the second, but not the first, phase of DRG formation (23,169 +/- 2,017 cpm/mg protein, ethanol versus 2,696 +/- 261 cpm/mg protein, control). These data indicate that DRG, generated through the activation of PLD, plays an important role in degranulation and oxidant release in adherent PMNs.	UNIV MICHIGAN,DEPT INTERNAL MED,DIV NEPHROL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan	SUCHARD, SJ (corresponding author), UNIV MICHIGAN,DEPT PEDIAT,DIV HEMATOL ONCOL,RM 7510B,MSRB-1,BOX 0684,ANN ARBOR,MI 48109, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020065, R29AI026863] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL31963] Funding Source: Medline; NIAID NIH HHS [AI26863, AI20065] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGWU DE, 1991, J CLIN INVEST, V88, P531, DOI 10.1172/JCI115336; BABIOR BM, 1981, METHODS HEMATOLOGY L, P1; BELLAVITE P, 1988, J BIOL CHEM, V263, P8210; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; BIRGENS HS, 1985, SCAND J HAEMATOL, V34, P326; BJERRUM OW, 1989, EUR J HAEMATOL, V43, P67; BONSER RW, 1989, BIOCHEM J, V264, P617, DOI 10.1042/bj2640617; BORREGAARD N, 1984, J BIOL CHEM, V259, P47; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; BOXER LA, 1988, HEMATOL ONCOL CLIN N, V2, P101; BURNHAM DN, 1990, J BIOL CHEM, V265, P17550; CLARK RA, 1987, J BIOL CHEM, V262, P4065; COX CC, 1986, J IMMUNOL, V136, P4611; CURNUTTE JT, 1979, J CLIN INVEST, V63, P637, DOI 10.1172/JCI109346; DELLABIANCA V, 1990, J IMMUNOL, V144, P1411; DELLABIANCA V, 1993, J LEUKOCYTE BIOL, V53, P427; DELLABIANCA V, 1991, BIOCHEM BIOPH RES CO, V177, P948, DOI 10.1016/0006-291X(91)90630-P; DOUGHERTY RW, 1989, J BIOL CHEM, V264, P11263; ENGLISH D, 1991, BLOOD, V77, P2746; FU T, 1992, BIOCHEM J, V283, P347, DOI 10.1042/bj2830347; HAINES KA, 1991, J CELL BIOL, V114, P433, DOI 10.1083/jcb.114.3.433; HUGHES BJ, 1992, J CLIN INVEST, V90, P1687, DOI 10.1172/JCI116041; JACONI MEE, 1991, J CELL BIOL, V112, P1249, DOI 10.1083/jcb.112.6.1249; KESSELS GCR, 1991, J BIOL CHEM, V266, P15870; KORCHAK HM, 1988, J BIOL CHEM, V263, P11098; MAHER RJ, 1993, J CELL PHYSIOL, V156, P226, DOI 10.1002/jcp.1041560203; MARTIN TW, 1988, BIOCHIM BIOPHYS ACTA, V962, P282, DOI 10.1016/0005-2760(88)90258-5; NATHAN C, 1990, J CELL BIOL, V111, P2171, DOI 10.1083/jcb.111.5.2171; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; O'SHEA JJ, 1985, J IMMUNOL, V134, P2580; PERRY DK, 1992, J IMMUNOL, V149, P2749; PREISS J, 1986, J BIOL CHEM, V261, P8597; RANA RS, 1990, PHYSIOL REV, V70, P115, DOI 10.1152/physrev.1990.70.1.115; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; SCHLEIFFENBAUM B, 1989, J IMMUNOL, V142, P3537; SHAYMAN JA, 1991, J BIOL CHEM, V266, P22968; SHUKLA SD, 1991, LIFE SCI, V48, P851, DOI 10.1016/0024-3205(91)90031-6; SINGER II, 1989, J CELL BIOL, V109, P3169, DOI 10.1083/jcb.109.6.3169; SOZZANI S, 1992, J BIOL CHEM, V267, P20481; SUCHARD SJ, 1991, J IMMUNOL, V146, P3945; SUCHARD SJ, 1994, J IMMUNOL, V152, P290; SUCHARD SJ, 1992, BIOCHEM J, V284, P513, DOI 10.1042/bj2840513; THOMPSON NT, 1990, BIOCHEM J, V271, P209, DOI 10.1042/bj2710209; TYAGI SR, 1988, J BIOL CHEM, V263, P13191; TYAGI SR, 1989, J BIOL CHEM, V264, P12977; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; YANG SF, 1967, J BIOL CHEM, V242, P477; YOON PS, 1987, J IMMUNOL, V138, P259	49	59	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8063	8068						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132530				2022-12-27	WOS:A1994NB40900038
J	VANDERZEE, CA; JORDAN, EM; BREEN, GAM				VANDERZEE, CA; JORDAN, EM; BREEN, GAM			ATPF1 BINDING-SITE, A POSITIVE CIS-ACTING REGULATORY ELEMENT OF THE MAMMALIAN ATP SYNTHASE ALPHA-SUBUNIT GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE ADP/ATP TRANSLOCATOR; TRANSCRIPTION FACTOR BINDS; MAJOR LATE PROMOTER; LOOP-HELIX PROTEIN; RNA POLYMERASE-II; DNA-BINDING; SACCHAROMYCES-CEREVISIAE; NUCLEAR GENES; BETA-SUBUNIT; ETS DOMAIN	An analysis of the promoter of a bovine and human nuclear-encoded mitochondrial ATP synthase alpha-subunit gene (ATPA) revealed the presence of a positive control element. DNase I footprinting and electrophoretic mobility shift assays demonstrated that this cis-acting regulatory element contains a binding site for a protein present in human HeLa nuclei, termed ATP factor 1 (ATPF1). The ATPF1 binding site contains the sequence, CANNTG, a sequence identical to the recognition site for a family of transcription factors containing a basic region adjacent to a helix-loop-helix domain. Site-directed point mutations of the basic helix-loop-helix binding site demonstrated the critical role of this element for both binding of ATPF1 and also for transcriptional activation of the ATPA gene.	UNIV TEXAS, DEPT MOLEC & CELL BIOL, RICHARDSON, TX 75083 USA	University of Texas System; University of Texas Dallas					NIGMS NIH HHS [GM41738] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041738] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Ausubel FM, 1991, CURRENT PROTOCOLS MO; BAKER RE, 1990, MOL CELL BIOL, V10, P2458, DOI 10.1128/MCB.10.6.2458; BASU A, 1993, J BIOL CHEM, V268, P4188; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; BUNGERT J, 1992, J MOL BIOL, V223, P885, DOI 10.1016/0022-2836(92)90250-N; CARR CS, 1990, MOL CELL BIOL, V10, P4384, DOI 10.1128/MCB.10.8.4384; CARTER RS, 1992, J BIOL CHEM, V267, P23418; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; CARTHEW RW, 1987, GENE DEV, V1, P973, DOI 10.1101/gad.1.9.973; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CHODOSH LA, 1987, SCIENCE, V238, P684, DOI 10.1126/science.3672119; CHUNG AB, 1992, J BIOL CHEM, V267, P21154; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DEWINDE JH, 1992, MOL CELL BIOL, V12, P2872, DOI 10.1128/MCB.12.6.2872; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DORSMAN JC, 1988, NUCLEIC ACIDS RES, V16, P7287, DOI 10.1093/nar/16.15.7287; DUDEK H, 1992, P NATL ACAD SCI USA, V89, P1291, DOI 10.1073/pnas.89.4.1291; EVANS MJ, 1989, J BIOL CHEM, V264, P14361; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; GEGONNE A, 1993, EMBO J, V12, P1169, DOI 10.1002/j.1460-2075.1993.tb05758.x; GHOSH D, 1990, NUCLEIC ACIDS RES, V18, P1749, DOI 10.1093/nar/18.7.1749; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; GUARENTE L, 1987, ANNU REV GENET, V21, P425, DOI 10.1146/annurev.genet.21.1.425; JORDAN EM, 1993, BIOCHIM BIOPHYS ACTA, V1173, P115, DOI 10.1016/0167-4781(93)90256-D; LI K, 1990, J BIOL CHEM, V265, P20585; Maxam A M, 1980, Methods Enzymol, V65, P499; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; PERITZ LN, 1988, J BIOL CHEM, V263, P5005; PIERCE DJ, 1992, BIOCHIM BIOPHYS ACTA, V1132, P265, DOI 10.1016/0167-4781(92)90160-2; POYTON RO, 1988, ANN NY ACAD SCI, V550, P289, DOI 10.1111/j.1749-6632.1988.tb35344.x; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SCOTTO KW, 1989, GENE DEV, V3, P651, DOI 10.1101/gad.3.5.651; SILVE S, 1992, MOL CELL BIOL, V12, P4197, DOI 10.1128/MCB.12.9.4197; SUZUKI H, 1990, J BIOL CHEM, V265, P8159; TOMURA H, 1990, J BIOL CHEM, V265, P6525; TRAWICK JD, 1992, MOL CELL BIOL, V12, P2302, DOI 10.1128/MCB.12.5.2302; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8; VIRBASIUS JV, 1991, MOL CELL BIOL, V11, P5631, DOI 10.1128/MCB.11.11.5631; VIRBASIUS JV, 1993, GENE DEV, V7, P380, DOI 10.1101/gad.7.3.380; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7	50	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6972	6977						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120059				2022-12-27	WOS:A1994MZ50300108
J	WERNER, A; KEMPSON, SA; BIBER, J; MURER, H				WERNER, A; KEMPSON, SA; BIBER, J; MURER, H			INCREASE OF NA/P-I-COTRANSPORT ENCODING MESSENGER-RNA IN RESPONSE TO LOW P-I DIET IN RAT-KIDNEY CORTEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; BRUSH-BORDER MEMBRANE; EXPRESSION; TRANSPORT; PHOSPHATE; FLUIDITY; SYSTEM	Renal proximal Na/P-i-cotransport is increased in response to low dietary P-i intake. Recently, a cDNA (NaPi-2) related to the rat renal brush membrane Na/P-i-cotransporter has been cloned. In the present study, we used rats fed for 6 days with either a low P-i diet (LPD) or a high P-i diet (HPD), respectively. In parallel to an increased renal brush-border membrane Na/P-i-cotransport in LPD rats, there was also an increased content of NaPi-2 mRNA in renal cortex. After injection into Xenopus laevis oocytes, mRNA isolated from LPD rats induced a greater increase in Na/P-i-cotransport compared to mRNA from HPD rats. Hybrid depletion experiments suggested that mRNA induced Na/P-i-cotransport is related to NaPi-2. We conclude that chronic P-i deprivation leads to an increased brush border membrane Na/P-i-cotransport via an increase in the level of (NaPi-2) mRNA.	INDIANA UNIV,MED CTR,DEPT PHYSIOL & BIOPHYS,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis	WERNER, A (corresponding author), UNIV ZURICH,DEPT PHYSIOL,WINTERTHURERSTR 190,CH-8057 ZURICH,SWITZERLAND.				NIDDK NIH HHS [DK 32148] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032148] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; Berndt T. J., 1992, KIDNEY PHYSL PATHOPH, P2511; BIBER J, 1981, BIOCHIM BIOPHYS ACTA, V647, P169, DOI 10.1016/0005-2736(81)90243-1; DENNIS VW, 1992, RENAL PHYSL, P1785; LEVI M, 1989, AM J PHYSIOL, V256, pF85, DOI 10.1152/ajprenal.1989.256.1.F85; LEVINE BS, 1991, AM J PHYSIOL, V260, pF613, DOI 10.1152/ajprenal.1991.260.5.F613; MAGAGNIN S, 1993, P NATL ACAD SCI USA, V90, P5979, DOI 10.1073/pnas.90.13.5979; MARKOVICH D, 1993, P NATL ACAD SCI USA, V90, P8073, DOI 10.1073/pnas.90.17.8073; MEYERHOF W, 1990, FEBS LETT, V266, P192, DOI 10.1016/0014-5793(90)81537-X; MURER H, 1992, HDB PHYSL 8, V2, P2165; MURER H, 1992, KIDNEY PHYSL PATHOPH, P2481; SHATZ SV, 1979, J CLIN INVEST, V64, P955; WERNER A, 1990, J BIOL CHEM, V265, P12331; WERNER A, 1991, P NATL ACAD SCI USA, V88, P9608, DOI 10.1073/pnas.88.21.9608; YUSUFI ANK, 1989, AM J PHYSIOL, V256, pF852, DOI 10.1152/ajprenal.1989.256.5.F852	15	76	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6637	6639						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120016				2022-12-27	WOS:A1994MZ50300059
J	KUNAPULI, P; GUREVICH, VV; BENOVIC, JL				KUNAPULI, P; GUREVICH, VV; BENOVIC, JL			PHOSPHOLIPID-STIMULATED AUTOPHOSPHORYLATION ACTIVATES THE G-PROTEIN-COUPLED RECEPTOR KINASE GRK5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BETA-ADRENERGIC-RECEPTOR; RHODOPSIN KINASE; PHOSPHORYLATION; FAMILY; IDENTIFICATION; ISOPRENYLATION; MUSCLE; LIGHT	G protein-coupled receptor kinases (GRKs) play an important role in mediating agonist-specific desensitization of numerous G protein-coupled receptors. GRK5, a recently identified member of the GRK family, undergoes a rapid phospholipid-stimulated autophosphorylation to a stoichiometry of similar to 2 mol of phosphate/mol of GRK5. The ability of phospholipids to stimulate autophosphorylation is largely blocked by a glutathione S-transferase fusion protein containing the last 102 amino acids of GRK5 (amino acids 489-590), suggesting that this is a primary region involved in GRK5/phospholipid interaction. Phosphoamino acid determination and mutagenesis studies demonstrate that autophosphorylation of GRK5 occurs primarily at residues Ser-484 and Thr-485. Expression and characterization of a mutant GRK5 that does not autophosphorylate (S484A and T485A) reveals that the mutant has a similar to 15-20-fold reduced ability to phosphorylate the beta(2)-adrenerse receptor and rhodopsin compared to wild type GRK5. These results suggest that phospholipid-stimulated autophosphorylation may represent a novel mechanism for membrane association and regulation of GRK5 activity,	THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,DEPT PHARMACOL,PHILADELPHIA,PA 19107	Jefferson University			Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	NIGMS NIH HHS [GM44944] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044944] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambrose Christine, 1992, Human Molecular Genetics, V1, P697, DOI 10.1093/hmg/1.9.697; BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1993, J BIOL CHEM, V268, P19521; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; BOEKHOFF I, 1994, J BIOL CHEM, V269, P37; BOWNDS D, 1972, NATURE-NEW BIOL, V237, P125, DOI 10.1038/newbio237125a0; BUCZYLKO J, 1991, P NATL ACAD SCI USA, V88, P2568, DOI 10.1073/pnas.88.6.2568; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; CERIONE RA, 1983, NATURE, V306, P562, DOI 10.1038/306562a0; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; FLINT AJ, 1990, SCIENCE, V249, P408, DOI 10.1126/science.2377895; GOMEZ J, 1992, MOL BIOL RECEPTORS T, P1; HAGA T, 1992, J BIOL CHEM, V26, P2222; HARGRAVE PA, 1992, MOL BIOL RECEPTORS T, P49; INGLESE J, 1992, J BIOL CHEM, V267, P1422; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; KIM CM, 1993, J BIOL CHEM, V268, P15412; KIM CM, 1993, RECEPTOR, V3, P39; KUHN H, 1972, FEBS LETT, V20, P1, DOI 10.1016/0014-5793(72)80002-4; KUNAPULI P, 1993, P NATL ACAD SCI USA, V90, P5588, DOI 10.1073/pnas.90.12.5588; KUNAPULI P, 1994, J BIOL CHEM, V269, P1099; KURET J, 1985, J BIOL CHEM, V260, P6427; KWATRA MM, 1989, BIOCHEMISTRY-US, V28, P4543, DOI 10.1021/bi00437a005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; LORENZ W, 1991, P NATL ACAD SCI USA, V88, P8715, DOI 10.1073/pnas.88.19.8715; MOCHLYROSEN D, 1987, J BIOL CHEM, V262, P2291; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; PALCZEWSKI K, 1991, TRENDS BIOCHEM SCI, V16, P387, DOI 10.1016/0968-0004(91)90157-Q; PALCZEWSKI K, 1992, J BIOL CHEM, V267, P18991; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; RANGELALDAO R, 1976, J BIOL CHEM, V251, P3375; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; WANG JH, 1976, J BIOL CHEM, V251, P4521	35	90	92	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 8	1994	269	14					10209	10212						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NF017	8144599				2022-12-27	WOS:A1994NF01700007
J	BABA, T; NIIDA, Y; MICHIKAWA, Y; KASHIWABARA, S; KODAIRA, K; TAKENAKA, M; KOHNO, N; GERTON, GL; ARAI, Y				BABA, T; NIIDA, Y; MICHIKAWA, Y; KASHIWABARA, S; KODAIRA, K; TAKENAKA, M; KOHNO, N; GERTON, GL; ARAI, Y			AN ACROSOMAL PROTEIN, SP32, IN MAMMALIAN SPERM IS A BINDING-PROTEIN SPECIFIC FOR 2 PROACROSINS AND AN ACROSIN INTERMEDIATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUINEA-PIG SPERMATOGENESIS; MOLECULAR-WEIGHT FORM; BOAR PROACROSIN; ZYMOGEN GRANULES; GOLGI-APPARATUS; ACTIVATION; PURIFICATION; SPERMATOZOA; AGGREGATION; BIOGENESIS	An acrosomal protein, sp32, was completely purified from acid extracts of ejaculated porcine sperm. Purified sp32 gave a single 32-kDa protein band on SDS-polyacrylamide gel electrophoresis and was characterized as a binding protein specific for 55-, 53-, and 49-kDa forms of (pro)acrosin. This protein was not capable of binding a 43-kDa acrosin intermediate and 35-kDa mature acrosin. sp32 significantly accelerated autoactivation of proacrosin at a basic pH in vitro and affected the maturation pathway of proacrosin. In the presence of sp32, the 49-kDa acrosin intermediate from the 55- and 53-kDa proacrosins was accumulated, instead of the 43-kDa acrosin intermediate. These results suggest that sp32 interacts with both the amino- and carboxyl-terminal sequences of the 53-kDa proacrosin. The cDNA clones coding for porcine and guinea pig sp32 have been identified from testis cDNA libraries in lambdagt11. The deduced amino acid sequence indicates that sp32 is initially synthesized as a 61-kDa precursor protein with a putative signal peptide at the amino terminus. The carboxyl-terminal half of the precursor molecule corresponds to the mature sp32. Thus, sp32 is produced by post-translational modification of the precursor. The binding of sp32 to proacrosin may be involved in packaging the acrosin zymogen into the acrosomal matrix.	UNIV PENN,SCH MED,DEPT OBSTET & GYNECOL,PHILADELPHIA,PA 19104	University of Pennsylvania	BABA, T (corresponding author), UNIV TSUKUBA,INST APPL BIOCHEM,TSUKUBA SCI CITY,TSUKUBA,IBARAKI 305,JAPAN.		Gerton, George L/A-1039-2007	Gerton, George L/0000-0001-9894-5640	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD006274, R01HD022899] Funding Source: NIH RePORTER; NICHD NIH HHS [P01-HD-06274, R01-HD-22899] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANAKWE OO, 1990, BIOL REPROD, V42, P317, DOI 10.1095/biolreprod42.2.317; ANDERSON RA, 1981, BIOCHEM J, V199, P307, DOI 10.1042/bj1990307; ARBOLEDA CE, 1988, DEV BIOL, V125, P217, DOI 10.1016/0012-1606(88)90075-9; BABA T, 1989, J BIOL CHEM, V264, P11920; BABA T, 1993, MOL REPROD DEV, V34, P233, DOI 10.1002/mrd.1080340302; BABA T, 1989, FEBS LETT, V244, P132, DOI 10.1016/0014-5793(89)81178-0; BABA T, 1989, FEBS LETT, V244, P296, DOI 10.1016/0014-5793(89)80549-6; BABA T, 1989, BIOCHEM BIOPH RES CO, V160, P1026, DOI 10.1016/S0006-291X(89)80105-6; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; BURGOS MH, 1986, ANAT REC, V216, P139, DOI 10.1002/ar.1092160205; ESCALIER D, 1991, DEVELOPMENT, V113, P779; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FULLER SA, 1991, CURRENT PROTCOLS MOL; GERDES HH, 1989, J BIOL CHEM, V264, P12009; GREEN DPL, 1978, J CELL SCI, V32, P153; HARDY DM, 1991, BIOCHEM J, V275, P759, DOI 10.1042/bj2750759; HARRISON RAP, 1982, J REPROD IMMUNOL, V4, P231, DOI 10.1016/0165-0378(82)90029-8; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Hayashi R, 1977, Methods Enzymol, V47, P84; HEDRICK JL, 1989, BIOCATALYSIS AGR BIO, P215; HERMO L, 1980, AM J ANAT, V157, P357, DOI 10.1002/aja.1001570405; HSU SM, 1982, J HISTOCHEM CYTOCHEM, V30, P1079, DOI 10.1177/30.10.6182185; JONES R, 1987, EXP CELL RES, V171, P503, DOI 10.1016/0014-4827(87)90182-0; KASHIWABARA S, 1990, BIOCHEM BIOPH RES CO, V173, P240, DOI 10.1016/S0006-291X(05)81047-2; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; KLEMM U, 1991, HUM GENET, V87, P635; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MOOS J, 1993, BIOL REPROD, V49, P408, DOI 10.1095/biolreprod49.2.408; MULLERESTERL W, 1980, H-S Z PHYSIOL CHEM, V361, P1811, DOI 10.1515/bchm2.1980.361.2.1811; MULLERESTERL W, 1981, METHOD ENZYMOL, V80, P621; PARRISH RF, 1978, ANAL BIOCHEM, V87, P108, DOI 10.1016/0003-2697(78)90574-2; PARRISH RF, 1978, J BIOL CHEM, V253, P8428; POLAKOSKI KL, 1977, J BIOL CHEM, V252, P1888; REGGIO H, 1978, J CELL BIOL, V78, P951, DOI 10.1083/jcb.78.3.951; REGGIO HA, 1978, J CELL BIOL, V77, P288, DOI 10.1083/jcb.77.2.288; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SUSI FR, 1971, AM J ANAT, V130, P251, DOI 10.1002/aja.1001300302; TARTAKOFF A, 1974, J BIOL CHEM, V249, P7420; URCH UA, 1991, DEVELOPMENT, V111, P1165; URCH UA, 1991, BIOL CHEM MAMMALIAN, P233; WICKNER WT, 1985, SCIENCE, V230, P400, DOI 10.1126/science.4048938; YI LSH, 1992, BIOCHEM BIOPH RES CO, V184, P760, DOI 10.1016/0006-291X(92)90655-5; YI LSH, 1992, J REPROD IMMUNOL, V21, P309, DOI 10.1016/0165-0378(92)90033-Z; YI LSH, 1992, ANDROLOGIA, V24, P41	47	124	136	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10133	10140						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144514				2022-12-27	WOS:A1994NE05300110
J	MEISTER, A				MEISTER, A			GLUTATHIONE ASCORBIC-ACID ANTIOXIDANT SYSTEM IN ANIMALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MICROSOMAL LIPID-PEROXIDATION; LOW-DENSITY-LIPOPROTEIN; VITAMIN-E; BUTHIONINE SULFOXIMINE; MITOCHONDRIAL DAMAGE; DEPENDENT PROTECTION; OXIDATIVE STRESS; ONE-ELECTRON; GUINEA-PIGS; METABOLISM				MEISTER, A (corresponding author), CORNELL UNIV, MED CTR, COLL MED, DEPT BIOCHEM, NEW YORK, NY 10021 USA.				NIDDK NIH HHS [2 R37 DK 12034] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK012034] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALCAIN FJ, 1991, BIOCHIM BIOPHYS ACTA, V1073, P380, DOI 10.1016/0304-4165(91)90146-8; ANDERSON ME, 1989, ANAL BIOCHEM, V183, P16, DOI 10.1016/0003-2697(89)90164-4; BENDICH A, 1986, ADV FREE RADICAL BIO, V2, P419, DOI 10.1016/S8755-9668(86)80021-7; BIGLEY R, 1981, BIOCHIM BIOPHYS ACTA, V659, P15, DOI 10.1016/0005-2744(81)90266-7; Borsook H, 1937, J BIOL CHEM, V117, P237; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; BURNS JJ, 1954, J BIOL CHEM, V207, P679; BURTON GW, 1990, LIPIDS, V25, P199, DOI 10.1007/BF02535748; CALVIN HI, 1986, SCIENCE, V233, P553, DOI 10.1126/science.3726547; CHAN AC, 1991, J BIOL CHEM, V266, P17290; CHRISTINE L, 1956, CLIN CHIM ACTA, V1, P557, DOI 10.1016/0009-8981(56)90043-2; COASSIN M, 1991, ARCH BIOCHEM BIOPHYS, V290, P458, DOI 10.1016/0003-9861(91)90566-2; D Dolphin, 1989, COENZYME COFACTORS S, VIII; DALTON DA, 1986, P NATL ACAD SCI USA, V83, P3811, DOI 10.1073/pnas.83.11.3811; DILIBERTO EJ, 1982, J NEUROCHEM, V39, P563, DOI 10.1111/j.1471-4159.1982.tb03982.x; ENGLARD S, 1986, ANNU REV NUTR, V6, P365, DOI 10.1146/annurev.nu.06.070186.002053; FAHEY RC, 1991, ADV ENZYMOL RAMB, V64, P1; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; GOTOH N, 1993, BIOCHEM J, V296, P151, DOI 10.1042/bj2960151; GRIFFITH OW, 1991, FASEB J, V5, pA4708; GUZMANBARRON ES, 1951, ADV ENZYMOL, V11, P201; HAENEN GRMM, 1987, ARCH BIOCHEM BIOPHYS, V259, P449, DOI 10.1016/0003-9861(87)90511-X; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; HILL KE, 1984, BIOCHEM PHARMACOL, V33, P1065, DOI 10.1016/0006-2952(84)90514-8; HOLLOWAY DE, 1984, DRUGS PHARM SCI, V21, P225; Hopkins FG, 1936, BIOCHEM J, V30, P1446, DOI 10.1042/bj0301446; HUANG CS, 1993, J BIOL CHEM, V268, P20578; HUGHES RE, 1964, NATURE, V203, P1068, DOI 10.1038/2031068a0; IYANAGI T, 1985, BIOCHIM BIOPHYS ACTA, V806, P255, DOI 10.1016/0005-2728(85)90103-3; JAIN A, 1991, P NATL ACAD SCI USA, V88, P1913, DOI 10.1073/pnas.88.5.1913; JAIN A, 1992, P NATL ACAD SCI USA, V89, P5093, DOI 10.1073/pnas.89.11.5093; KOIVU J, 1987, J BIOL CHEM, V262, P6447; KUZUYA M, 1989, BIOCHEM BIOPH RES CO, V163, P1466, DOI 10.1016/0006-291X(89)91144-3; Larsson A., 1983, FUNCTIONS GLUTATHION; LEVINE M, 1986, NEW ENGL J MED, V314, P892, DOI 10.1056/NEJM198604033141407; LEVY EJ, 1993, P NATL ACAD SCI USA, V90, P9171, DOI 10.1073/pnas.90.19.9171; MANN GV, 1975, ANN NY ACAD SCI, V258, P243, DOI 10.1111/j.1749-6632.1975.tb29285.x; MARTENSSON J, 1989, P NATL ACAD SCI USA, V86, P8727, DOI 10.1073/pnas.86.22.8727; MARTENSSON J, 1989, P NATL ACAD SCI USA, V86, P471, DOI 10.1073/pnas.86.2.471; MARTENSSON J, 1991, P NATL ACAD SCI USA, V88, P9360, DOI 10.1073/pnas.88.20.9360; MARTENSSON J, 1992, P NATL ACAD SCI USA, V89, P11566, DOI 10.1073/pnas.89.23.11566; MARTENSSON J, 1989, P NATL ACAD SCI USA, V86, P5296, DOI 10.1073/pnas.86.14.5296; MARTENSSON J, 1993, P NATL ACAD SCI USA, V90, P317, DOI 10.1073/pnas.90.1.317; MARTENSSON J, 1990, P NATL ACAD SCI USA, V87, P1715, DOI 10.1073/pnas.87.5.1715; MCCAY PB, 1989, ANN NY ACAD SCI, V570, P32; MCCAY PB, 1986, FASEB J, V45, P451; MCCAY PB, 1989, GLUTATHIONE CHEM B B, P111; MEHLHORN RJ, 1991, J BIOL CHEM, V266, P2724; MEISTER A, 1988, J BIOL CHEM, V263, P17205; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MEISTER A, 1992, BIOCHEM PHARMACOL, V44, P1905, DOI 10.1016/0006-2952(92)90091-V; MEISTER A, 1991, PHARMACOL THERAPEUT, V51, P155, DOI 10.1016/0163-7258(91)90076-X; MEISTER A, 1989, GLUTATHIONE CHEM BIO, V4, P367; MISRA HP, 1974, J BIOL CHEM, V249, P2151; MOORE WR, 1989, P NATL ACAD SCI USA, V86, P1461, DOI 10.1073/pnas.86.5.1461; MRTENSSON J, 1991, P NATL ACAD SCI USA, V88, P4656, DOI 10.1073/pnas.88.11.4656; MYLLYLA R, 1978, BIOCHEM BIOPH RES CO, V83, P441, DOI 10.1016/0006-291X(78)91010-0; NISHIKIMI M, 1992, J BIOL CHEM, V267, P21967; PARTHASARATHY S, 1990, P NATL ACAD SCI USA, V87, P3894, DOI 10.1073/pnas.87.10.3894; REDDY CC, 1982, LIFE SCI, V31, P571, DOI 10.1016/0024-3205(82)90486-6; ROSE RC, 1989, AM J PHYSIOL, V256, pF52, DOI 10.1152/ajprenal.1989.256.1.F52; SCHULZE HU, 1972, H-S Z PHYSIOL CHEM, V353, P1931, DOI 10.1515/bchm2.1972.353.2.1931; SERGEEV IN, 1990, J NUTR, V120, P1185, DOI 10.1093/jn/120.10.1185; STURMAN JA, 1970, SCIENCE, V169, P74, DOI 10.1126/science.169.3940.74; Szent-Gyorgyi A, 1928, BIOCHEM J, V22, P1387, DOI 10.1042/bj0221387; Taniguchi N., 1989, GLUTATHIONE CENTENNI; VERA JC, 1993, NATURE, V364, P79, DOI 10.1038/364079a0; WASHKO PW, 1993, J BIOL CHEM, V268, P15531; WELLS WW, 1990, J BIOL CHEM, V265, P15361; WINKLER BS, 1992, BIOCHIM BIOPHYS ACTA, V1117, P287, DOI 10.1016/0304-4165(92)90026-Q; WINTERBOURN CC, 1993, FREE RADICAL BIO MED, V14, P85, DOI 10.1016/0891-5849(93)90512-S; YAN N, 1990, J BIOL CHEM, V265, P1588; ZANNONI VG, 1987, ANN NY ACAD SCI, V498, P364, DOI 10.1111/j.1749-6632.1987.tb23775.x	73	645	661	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9397	9400						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144521				2022-12-27	WOS:A1994NE05300001
J	WEISEL, JW; NAGASWAMI, C; WOODHEAD, JL; DELACADENA, RA; PAGE, JD; COLMAN, RW				WEISEL, JW; NAGASWAMI, C; WOODHEAD, JL; DELACADENA, RA; PAGE, JD; COLMAN, RW			THE SHAPE OF HIGH-MOLECULAR-WEIGHT KININOGEN - ORGANIZATION INTO STRUCTURAL DOMAINS, CHANGES WITH ACTIVATION, AND INTERACTIONS WITH PREKALLIKREIN, AS DETERMINED BY ELECTRON-MICROSCOPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLASMA PREKALLIKREIN; DISTINCT FUNCTIONAL DOMAINS; AMINO-ACID-SEQUENCE; HAGEMAN-FACTOR; LIGHT CHAIN; HMW-KININOGEN; HEAVY-CHAIN; FACTOR-XII; KALLIKREIN; FIBRINOGEN	Knowledge of the organization of the kininogen gene and protein structure and function correlations has allowed the development of a model of high molecular weight kininogen. Domains 1-3 on the heavy chain are evolutionarily related to cystatin and the latter two are inhibitors of cysteine proteases. Proteolytic cleavage in domain 4 to release bradykinin causes a conformational change, exposing a surface-binding region (domain 5) on the disulfide-linked light chain. The carboxyl-terminal domain 6 contains a zymogen binding sequence for factor XI and prekallikrein which, with domain 5, accounts for its cofactor activity. To explore further the domain structure, we have determined the shapes of high molecular weight kininogen and prekallikrein by electron microscopy of rotary shadowed preparations and computer image processing. High molecular weight kininogen appears to be a linear array of three linked globular regions about 16 nm long, with the two ends also connected by another thin strand. Both prekallikrein and kallikrein have a compact globular shape, with a subdivision that is sometimes visible. Different functional domains of high molecular weight kininogen were identified by monoclonal antibodies against these regions, as well as ligand binding of prekallikrein. These studies indicate that one end globular region is the prekallikrein-binding domain, the other comprises the cysteine protease inhibitor domains and the smaller central nodule is the surface-binding domain. Cleavage of high molecular weight kininogen with plasma kallikrein to yield two-chain high molecular weight kininogen results in a striking change in conformation: the central surface-binding domain swings out so that it is still adjacent to the prekallikrein-binding domain but no longer in the middle. These structural studies provide insight into the interactions of these proteins and aspects of the mechanisms of their actions.	TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT PATHOL,PHILADELPHIA,PA 19140; TEMPLE UNIV,HLTH SCI CTR,SCH MED,SOL SHERRY THROMBOSIS RES CTR,PHILADELPHIA,PA 19140; TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT MED,PHILADELPHIA,PA 19140	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	WEISEL, JW (corresponding author), UNIV PENN,SCH MED,DEPT CELL & DEV BIOL,PHILADELPHIA,PA 19104, USA.				NHLBI NIH HHS [HL45486, HL30954, HL02681] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL045486, K08HL002681, R01HL030954] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASAKURA S, 1992, J CELL BIOL, V116, P465, DOI 10.1083/jcb.116.2.465; BAGDASARIAN A, 1974, J CLIN INVEST, V54, P1444, DOI 10.1172/JCI107892; BRADFORD HN, 1993, J BIOL CHEM, V268, P26546; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; DELACADENA RA, 1988, BLOOD, V72, P1748; DELACADENA RA, 1987, J LAB CLIN MED, V109, P601; DELACADENA RA, 1992, PROTEIN SCI, V1, P151; DELACADENA RA, 1991, THROMB HAEMOSTASIS, V65, P699; FOWLER WE, 1979, J MOL BIOL, V134, P241, DOI 10.1016/0022-2836(79)90034-2; FOWLER WE, 1983, J ULTRA MOL STRUCT R, V83, P319, DOI 10.1016/S0022-5320(83)90139-9; FUJIKAWA K, 1980, BIOCHEMISTRY-US, V19, P1322, DOI 10.1021/bi00548a010; Goding J., 1986, MONOCLONAL ANTIBODIE, P108; GUSTAFSON EJ, 1989, J CLIN INVEST, V84, P28, DOI 10.1172/JCI114151; KELLERMANN J, 1986, EUR J BIOCHEM, V154, P471, DOI 10.1111/j.1432-1033.1986.tb09421.x; KERBIRIOU DM, 1979, J BIOL CHEM, V254, P2020; KUNAPULI SP, 1992, THROMB HAEMOSTASIS, V67, P428; KUNAPULI SP, 1993, J BIOL CHEM, V268, P2486; MANDLE R, 1977, J BIOL CHEM, V252, P6097; MANDLE RJ, 1976, P NATL ACAD SCI USA, V73, P4179, DOI 10.1073/pnas.73.11.4179; MORI K, 1981, J BIOCHEM-TOKYO, V89, P1465, DOI 10.1093/oxfordjournals.jbchem.a133339; PAGE JD, 1991, J BIOL CHEM, V266, P8143; PROCTOR RR, 1961, AM J CLIN PATHOL, V36, P212; SCHMAIER AH, 1987, J BIOL CHEM, V262, P1405; SCOTT CF, 1979, EUR J BIOCHEM, V100, P77, DOI 10.1111/j.1432-1033.1979.tb02035.x; SCOTT CF, 1985, J BIOL CHEM, V260, P856; SCOTT CF, 1980, J CLIN INVEST, V65, P413, DOI 10.1172/JCI109684; SCOTT CF, 1984, J CLIN INVEST, V73, P954, DOI 10.1172/JCI111319; SILVERBERG M, 1980, THROMB RES, V20, P173, DOI 10.1016/0049-3848(80)90383-7; THOMPSON RE, 1977, J CLIN INVEST, V60, P1376, DOI 10.1172/JCI108898; VILLANUEVA GB, 1989, BIOCHEM BIOPH RES CO, V158, P72, DOI 10.1016/S0006-291X(89)80178-0; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; WEISEL JW, 1985, SCIENCE, V230, P1388, DOI 10.1126/science.4071058	32	75	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10100	10106						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144509				2022-12-27	WOS:A1994NE05300105
J	YAMADA, H; WATANABE, K; SHIMONAKA, M; YAMAGUCHI, Y				YAMADA, H; WATANABE, K; SHIMONAKA, M; YAMAGUCHI, Y			MOLECULAR-CLONING OF BREVICAN, A NOVEL BRAIN PROTEOGLYCAN OF THE AGGRECAN VERSICAN FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; LARGE AGGREGATING PROTEOGLYCAN; CARTILAGE PROTEOGLYCAN; CORE PROTEIN; LECTIN-LIKE; SEQUENCES; CDNA; ACID; GLYCOPROTEINS; PRECURSOR	To clone novel brain proteoglycans, we employed a strategy based on polyclonal antisera that recognize multiple proteoglycan core proteins. By using an anti-serum raised against a fraction enriched for proteoglycans, we isolated three groups of cDNAs from a bovine brain lambdagt11 library. One of the cDNA groups has been fully sequenced and shown to encode a novel proteoglycan core protein of the aggrecan/versican family. This proteoglycan, named brevican, carries chondroitin sulfate chains, and, like other members of the family, contains a hyaluronic acid-binding domain in its N-terminal region, an epidermal growth factor-like repeat, a lectin-like and a complement regulatory protein-like domains in its C-terminal region. In contrast, the central region of brevican is much shorter than that of aggrecan, versican, or neurocan, and shows little homology with these proteoglycans. Brevican core protein exsists as a 145 kDa full-length form and a 80 kDa N terminally truncated form. A significant amount of brevican devoid of any glycosaminoglycan chains is present in the brain, indicating that brevican is a ''part-time'' proteoglycan. Northern blot analysis reveals that a single 3.3-kilobase brevican transcript is present predominantly in the brain, and that it is expressed in primary cerebellar astrocytes but not in neurons.	LA JOLLA CANC RES FDN,CANC RES CTR,10901 N TORREY PINES RD,LA JOLLA,CA 92037	Sanford Burnham Prebys Medical Discovery Institute			Watanabe, Ken/I-3960-2013	Watanabe, Ken/0000-0003-0664-3915				AQUINO DA, 1984, J CELL BIOL, V99, P1117, DOI 10.1083/jcb.99.3.1117; ARGRAVES WS, 1986, J BIOL CHEM, V261, P2922; BIGNAMI A, 1993, J NEUROSCI RES, V34, P97, DOI 10.1002/jnr.490340110; BOURDON MA, 1987, P NATL ACAD SCI USA, V84, P3194, DOI 10.1073/pnas.84.10.3194; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; DOEGE K, 1987, J BIOL CHEM, V262, P17757; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; FRYER HJL, 1992, J BIOL CHEM, V267, P9874; HALBERG DF, 1988, J BIOL CHEM, V263, P9486; HARLOW E, 1988, ANTIBODIES LABORATOR; HERNDON ME, 1990, NEURON, V4, P949, DOI 10.1016/0896-6273(90)90148-9; HOCKFIELD S, 1990, COLD SPRING HARB SYM, V55, P505; IWATA M, 1993, J NEUROSCI, V13, P195; JOHNSTON IG, 1990, NEURON, V2, P165; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KIANG WL, 1981, J BIOL CHEM, V256, P529; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KRUEGER RC, 1990, J BIOL CHEM, V265, P1207; KRUSIUS T, 1987, J BIOL CHEM, V262, P13120; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; MARGOLIS RK, 1989, NEUROBIOLOGY GLYCOCO, P85; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; NISHIYAMA A, 1991, J CELL BIOL, V114, P359, DOI 10.1083/jcb.114.2.359; OAKLEY RA, 1991, DEV BIOL, V147, P187, DOI 10.1016/S0012-1606(05)80017-X; OLDBERG A, 1988, J BIOL CHEM, V263, P19430; OLDBERG A, 1987, BIOCHEM J, V243, P255, DOI 10.1042/bj2430255; PERIDES G, 1989, J BIOL CHEM, V264, P5981; RAUCH U, 1992, J BIOL CHEM, V267, P19536; RAUCH U, 1991, J BIOL CHEM, V266, P14785; SALEQUE S, 1993, GLYCOBIOLOGY, V3, P185, DOI 10.1093/glycob/3.2.185; Sambrook J, 1989, MOL CLONING LABORATO; SHIOI J, 1992, J BIOL CHEM, V267, P13819; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; STALLCUP WB, 1983, COLD SPRING HARB SYM, V48, P761, DOI 10.1101/SQB.1983.048.01.078; STALLCUP WB, 1985, P NATL ACAD SCI USA, V82, P1276, DOI 10.1073/pnas.82.4.1276; STREIT A, 1993, J CELL BIOL, V120, P799, DOI 10.1083/jcb.120.3.799; SUZUKI S, 1986, P NATL ACAD SCI USA, V83, P8614, DOI 10.1073/pnas.83.22.8614; ZAREMBA S, 1989, NEURON, V2, P1207, DOI 10.1016/0896-6273(89)90305-X; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	41	223	232	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10119	10126						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144512				2022-12-27	WOS:A1994NE05300108
J	CHAKRABARTI, R; BUXTON, J; JOLY, M; CORVERA, S				CHAKRABARTI, R; BUXTON, J; JOLY, M; CORVERA, S			INSULIN-SENSITIVE ASSOCIATION OF GLUT-4 WITH ENDOCYTIC CLATHRIN-COATED VESICLES REVEALED WITH THE USE OF BREFELDIN-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATABLE GLUCOSE TRANSPORTER; TRANS-GOLGI NETWORK; ORGANELLE STRUCTURE; PLASMA-MEMBRANE; RAT ADIPOCYTES; TRANSLOCATION; PROTEINS; ENDOSOMES; LOCALIZATION; MECHANISM	The interaction of the adipocyte/skeletal muscle glucose transporter (GLUT-4) with clathrin lattices may be important in maintaining its intracellular distribution. To better understand the role of clathrin lattices in the sorting of GLUT-4, we have attempted to determine the cellular origin of clathrin-coated vesicles (CCVs) that contain this transporter. The fungal toxin brefeldin A (BFA) causes the selective disassembly of clathrin lattices at the trans-Golgi network (TGN), but not at the plasma membrane (PM), thus providing a way of estimating the proportion of GLUT-4 in PM- versus TGN-derived clathrin lattices. Exposure of 3T3-L1 adipocytes to BFA resulted in a rapid disassembly of clathrin lattices at the TGN, observed by optical sectioning microscopy, and to a pronounced decrease in the yield of CCVs purified from these cells. Thus, CCVs isolated from BFA-treated cells are likely to be derived from the PM. Immunoblotting experiments revealed the presence of GLUT-4 in such CCVs, suggesting that under basal conditions the transporter is continually retrieved from the PM through the CCV pathway. Exposure of both BFA-treated or non-treated cells to insulin resulted in a 4-6-fold increase in the concentration of GLUT-4 at the PM. In parallel, the concentration of GLUT-4 in PM-derived CCVs decreased by 60%. These results suggest (a) that the effect of insulin to increase the cell surface concentration of GLUT-4 is not inhibited by BFA, and (b) that a decreased association of GLUT-4 with endocytic CCVs may be important in facilitating its increased cell surface concentration in response to the hormone.	UNIV MASSACHUSETTS, SCH MED, DEPT CELL BIOL, WORCESTER, MA 01655 USA; UNIV MASSACHUSETTS, SCH MED, PROGRAM MOLEC MED, WORCESTER, MA 01655 USA; UNIV MASSACHUSETTS, SCH MED, DEPT BIOCHEM & MOLEC BIOL, WORCESTER, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester								BROWN WJ, 1986, J CELL BIOL, V103, P1235, DOI 10.1083/jcb.103.4.1235; BROWN WJ, 1989, P NATL ACAD SCI USA, V81, P5135; CAMPBELL C, 1984, BIOCHEMISTRY-US, V23, P4420, DOI 10.1021/bi00314a028; CARRINGTON WA, 1990, NONINVASIVE TECHNIQU, P53; CORVERA S, 1990, J BIOL CHEM, V265, P15963; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; CZECH MP, 1993, J BIOL CHEM, V268, P9187; DAMKE H, 1991, J BIOL CHEM, V266, P29829; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; JHUN BH, 1992, J BIOL CHEM, V267, P17710; KEDERSHA NL, 1986, ANAL BIOCHEM, V156, P161, DOI 10.1016/0003-2697(86)90168-5; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; RUBINSTEIN JR, 1981, J CELL BIOL, V89, P357; SEEGER M, 1992, EMBO J, V11, P2811, DOI 10.1002/j.1460-2075.1992.tb05348.x; SEEGER M, 1992, J CELL BIOL, V118, P531, DOI 10.1083/jcb.118.3.531; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WONG DH, 1992, J CELL BIOL, V117, P1171, DOI 10.1083/jcb.117.6.1171; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; YANG J, 1993, J BIOL CHEM, V268, P4600	26	60	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7926	7933						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132512				2022-12-27	WOS:A1994NB40900018
J	JIANG, HP; WU, DQ; SIMON, MI				JIANG, HP; WU, DQ; SIMON, MI			ACTIVATION OF PHOSPHOLIPASE-C BETA-4 BY HETEROTRIMERIC GTP-BINDING PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNITS; GQ; ISOZYMES; FAMILY; GENE; EXPRESSION; DIVERSITY; CELLS	Transient transfection assays were used to determine how the activity of phospholipase C beta 4, which is preferentially expressed in retina, was regulated. An expression vector carrying the full-length cDNA corresponding to phospholipase C beta 4 was constructed and co-trans- fected into COS -7 cells together with cDNA encoding the alpha subunits of the Gq class and various beta and gamma subunits corresponding to the heterotrimeric GTP-binding proteins. We found that all the alpha subunits of the Gq class, including G alpha q, G alpha 11, G alpha 14, G alpha 15, and G alpha 16 could activate PLC beta 4 and that none of the G beta gamma subunits that we tested including G beta 1 gamma 1, G beta 1 gamma 2, G beta 1 gamma 3, or G beta 2 gamma 2 activated phospholipase C beta 4. In control experiments, cotransfection with cDNA encoding the alpha subunit of transducin or Gi2 gave no activation of PLC beta 4. These results indicate that phospholipase C beta 4 is activated by G alpha subunits that are members of the Gq class, and, like the phospholipase C beta 1 isoform, it is refractory to activation in the transfection assay by many of the combinations of beta and gamma subunits found in the heterotrimeric G-proteins.	CALTECH, DIV BIOL, PASADENA, CA 91125 USA	California Institute of Technology					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034236, R37GM034236] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34236] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CAROZZI A, 1993, FEBS LETT, V315, P340, DOI 10.1016/0014-5793(93)81190-B; FERREIRA PA, 1993, P NATL ACAD SCI USA, V90, P6042, DOI 10.1073/pnas.90.13.6042; FOECKING MK, 1986, GENE, V45, P101, DOI 10.1016/0378-1119(86)90137-X; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; JHON DY, 1993, J BIOL CHEM, V268, P6654; KATAN M, 1988, CELL, V54, P171, DOI 10.1016/0092-8674(88)90549-1; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRIZ R, 1990, CIBA F SYMP, V150, P112; LEE CH, 1992, J BIOL CHEM, V267, P16044; LEE CW, 1993, J BIOL CHEM, V268, P21318; MIN DS, 1993, J BIOL CHEM, V268, P12207; PARK D, 1992, J BIOL CHEM, V267, P16048; PARK DG, 1993, J BIOL CHEM, V268, P4573; RHEE SG, 1992, J BIOL CHEM, V267, P12393; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; SUH PG, 1988, CELL, V54, P161, DOI 10.1016/0092-8674(88)90548-X; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; WALDO GL, 1991, J BIOL CHEM, V266, P14217; WILKIE TM, 1991, P NATL ACAD SCI USA, V88, P10049, DOI 10.1073/pnas.88.22.10049; WILKIE TM, 1992, NAT GENET, V1, P85, DOI 10.1038/ng0592-85; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; WU DQ, 1993, J BIOL CHEM, V268, P3704; WU DQ, 1992, J BIOL CHEM, V267, P25798; WU DQ, 1992, J BIOL CHEM, V267, P1811	34	102	102	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7593	7596						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125982				2022-12-27	WOS:A1994NA03200088
J	PICKART, CM; KASPEREK, EM; BEAL, R; KIM, A				PICKART, CM; KASPEREK, EM; BEAL, R; KIM, A			SUBSTRATE PROPERTIES OF SITE-SPECIFIC MUTANT UBIQUITIN PROTEIN (G76A) REVEAL UNEXPECTED MECHANISTIC FEATURES OF UBIQUITIN-ACTIVATING ENZYME (E1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE Y-CHROMOSOME; AFFINITY PURIFICATION; MOLECULAR-CLONING; CARRIER PROTEINS; GENE; EXPRESSION; SYSTEM; DEGRADATION	Ubiquitin-mediated proteolysis proceeds via the formation and degradation of ubiquitin-protein conjugates. Ubiquitin (Ub)-activating enzyme (E1) catalyzes the first, MgATP-dependent step in the conjugative reaction sequence. With wild type ubiquitin, the product of the E1 reaction is a ternary complex (E1-Ub.AMP-Ub) containing one thiol-linked ubiquitin (via the Uh COOH terminus, Gly-76) and one tightly bound ubiquitin adenylate. The thiol-linked ubiquitin is subsequently transferred to the thiol of a ubiquitin-conjugating enzyme (E2 protein); the latter adduct is the proximal donor of ubiquitin to the target protein. A mutant ubiquitin, bearing a Gly to Ala substitution at the COOH terminus (G76A-ubiquitin), was characterized as a substrate for E1. G76A-ubiquitin 1) supported PP1-ATP exchange poorly (500-fold decrease in k(cat)/K-m); 2) did not produce detectable AMP-Ub with native E1; 3) produced stoichiometric AMP-Ub with thiol-blocked E1; 4) gave a stoichiometric burst of ATP consumption (1 mol/mol E1) with either native or thiol-blocked E1; 5) supported E1-ubiquitin thiol ester formation with native E1; 6) supported several downstream reactions of the proteolytic pathway at similar to 20% of the rate of wild type ubiquitin. These results indicate that G76A-ubiquitin gives a binary E1 thiol ester complex with native E1, due to the failure of the E1-ubiquitin thiol ester to undergo another round of adenylate synthesis; thus AMP-Ub is detected only if adenylate to thiol transfer is prevented by alkylating E1. The inability of G76A-ubiquitin to support ternary complex formation has implications for E1 active site structure. In other experiments, occupancy of the nucleotide/adenylate site of E1, by either MgATP or AMP-Ub, was found to stimulate ubiquitin transthiolation between E1 and E2 proteins. The intermediacy of ubiquitin adenylate thus provides a previously unrecognized catalytic advantage in the E1 mechanism.			PICKART, CM (corresponding author), SUNY BUFFALO, DEPT BIOCHEM, 140 FARBER HALL, BUFFALO, NY 14214 USA.				NIDDK NIH HHS [DK43769] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043769] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERLETH ES, 1992, J BIOL CHEM, V267, P16403; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; CIECHANOVER A, 1981, P NATL ACAD SCI-BIOL, V78, P761, DOI 10.1073/pnas.78.2.761; COOK JC, 1992, J BIOL CHEM, V267, P24315; COX MJ, 1986, ANAL BIOCHEM, V154, P345, DOI 10.1016/0003-2697(86)90535-X; ECKER DJ, 1987, J BIOL CHEM, V262, P14213; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1985, PREP BIOCHEM, V15, P49; HAAS AL, 1988, J BIOL CHEM, V263, P13268; HAAS AL, 1988, J BIOL CHEM, V263, P13258; HANDLEY PM, 1991, P NATL ACAD SCI USA, V88, P258, DOI 10.1073/pnas.88.1.258; HATFIELD PM, 1992, J BIOL CHEM, V267, P14799; HELLER H, 1990, J BIOL CHEM, V265, P6532; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HODGINS RRW, 1992, J BIOL CHEM, V267, P8807; JENTSCH S, 1991, BIOCHIM BIOPHYS ACTA, V1089, P127, DOI 10.1016/0167-4781(91)90001-3; JONNALAGADDA S, 1988, J BIOL CHEM, V263, P5016; KAY GF, 1991, NATURE, V354, P486, DOI 10.1038/354486a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; MITCHELL MJ, 1991, NATURE, V354, P483, DOI 10.1038/354483a0; PICKART CM, 1985, J BIOL CHEM, V260, P1573; PICKART CM, 1992, J BIOL CHEM, V267, P14418; PICKART CM, 1988, J BIOL CHEM, V263, P12028; ROSE IA, 1987, P NATL ACAD SCI USA, V84, P1477, DOI 10.1073/pnas.84.6.1477; ROSE IA, 1983, BIOCHEMISTRY-US, V22, P4234, DOI 10.1021/bi00287a012; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; TADARI T, 1992, J BIOL CHEM, V267, P719; ZACKSENHAUS E, 1990, EMBO J, V9, P2923, DOI 10.1002/j.1460-2075.1990.tb07483.x	33	74	77	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7115	7123						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125920				2022-12-27	WOS:A1994NA03200015
J	ALBERTS, GF; PEIFLEY, KA; JOHNS, A; KLEHA, JF; WINKLES, JA				ALBERTS, GF; PEIFLEY, KA; JOHNS, A; KLEHA, JF; WINKLES, JA			CONSTITUTIVE ENDOTHELIN-1 OVEREXPRESSION PROMOTES SMOOTH-MUSCLE CELL-PROLIFERATION VIA AN EXTERNAL AUTOCRINE LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-SYNTHESIS; GROWTH-FACTOR; MESSENGER-RNA; VASOCONSTRICTOR PEPTIDE; SEQUENCE-ANALYSIS; EXPRESSION; RECEPTOR; CLONING; CDNA; SECRETION	Endothelin-1 (ET-1) is a potent vasoconstrictor peptide originally purified from endothelial cell-conditioned medium. It has multiple biological activities and has been implicated in a number of human diseases, including hypertension and atherosclerosis. Contradictory reports have been published regarding whether ET-1 is a mitogen for vascular smooth muscle cells (SMC); thus, this issue is presently unresolved. In this study, we demonstrate that rat aortic SMC express functional endothelin cell surface receptors but do not proliferate when ET-1 is added to serum-free culture medium on every other day for a period of 1 week. To determine whether ET-1 could function in an autocrine manner to promote SMC growth, we transfected this same cell line with an ET-1 expression plasmid. Several independent lines expressing variable levels of ET-1 mRNA and biologically active ET-1 were obtained. Cell proliferation assays indicated that the transfected SMC line secreting the highest level of ET-1 had an enhanced growth rate when compared with untransfected or vector-alone transfected cells. The growth rate of this SMC line, but not of untransfected cells, was significantly reduced when the ET(A) receptor subtype-selective antagonist BQ-123 was included in the culture medium. These results indicate that constitutive ET-1 overexpression can promote SMC proliferation. Therefore, it is possible that under certain conditions ET-1 could be an important factor controlling SMC replication in vivo.	AMER RED CROSS,HOLLAND LAB,DEPT MOLEC BIOL,15601 CRABBS BRANCH WAY,ROCKVILLE,MD 20855; BERLEX BIOSCI,DEPT CARDIOVASC RES,RICHMOND,CA 94804	American Red Cross								ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; BAGBY SP, 1992, AM J PHYSIOL, V262, pC578, DOI 10.1152/ajpcell.1992.262.3.C578; BATTISTINI B, 1993, PEPTIDES, V14, P385, DOI 10.1016/0196-9781(93)90057-N; CADE C, 1991, J CARDIOVASC PHARM, V17, pS71, DOI 10.1097/00005344-199100177-00020; CHUA BHL, 1992, AM J PHYSIOL, V262, pE412, DOI 10.1152/ajpendo.1992.262.4.E412; DICKSON RB, 1987, METHOD ENZYMOL, V146, P329; Dubin D, 1989, J VASC MED BIOL, V1, P150; EGUCHI S, 1992, FEBS LETT, V302, P243, DOI 10.1016/0014-5793(92)80451-L; ELSHOURBAGY NA, 1993, J BIOL CHEM, V268, P3873; FOROUGH R, 1993, J BIOL CHEM, V268, P2960; GAY CG, 1991, J CELL PHYSIOL, V147, P121, DOI 10.1002/jcp.1041470116; HAHN AWA, 1990, CELL REGUL, V1, P649, DOI 10.1091/mbc.1.9.649; HECHLER U, 1993, BIOCHEM BIOPH RES CO, V194, P1305, DOI 10.1006/bbrc.1993.1966; HIRATA Y, 1989, ATHEROSCLEROSIS, V78, P225, DOI 10.1016/0021-9150(89)90227-X; HOSODA K, 1991, FEBS LETT, V287, P23, DOI 10.1016/0014-5793(91)80007-P; HSU DKW, 1993, BIOCHEM BIOPH RES CO, V197, P1483, DOI 10.1006/bbrc.1993.2644; IHARA M, 1992, LIFE SCI, V50, P247, DOI 10.1016/0024-3205(92)90331-I; ITOH Y, 1988, FEBS LETT, V231, P440, DOI 10.1016/0014-5793(88)80867-6; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; KOIDE M, 1992, ATHEROSCLEROSIS, V92, P1, DOI 10.1016/0021-9150(92)90003-Y; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; LEPPALUOTO J, 1992, ANN MED, V24, P153, DOI 10.3109/07853899209147813; LERMAN A, 1991, NEW ENGL J MED, V325, P9957; LIN HY, 1991, P NATL ACAD SCI USA, V88, P3185, DOI 10.1073/pnas.88.8.3185; MARTIN ER, 1990, J BIOL CHEM, V265, P14044; MASAKI T, 1992, MED RES REV, V12, P391, DOI 10.1002/med.2610120405; MAURER HR, 1981, CELL TISSUE KINET, V14, P111, DOI 10.1111/j.1365-2184.1981.tb00516.x; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NAMBI P, 1992, J BIOL CHEM, V267, P19555; OGAWA Y, 1991, BIOCHEM BIOPH RES CO, V178, P248, DOI 10.1016/0006-291X(91)91806-N; OHLSTEIN EH, 1992, EUR J PHARM-MOLEC PH, V225, P347, DOI 10.1016/0922-4106(92)90109-9; RESINK TJ, 1990, BIOCHEM BIOPH RES CO, V168, P1303, DOI 10.1016/0006-291X(90)91171-N; ROUBERT P, 1993, J VASC RES, V30, P139; ROUBERT P, 1991, J CARDIOVASC PHARM, V17, pS104, DOI 10.1097/00005344-199100177-00027; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SAKURAI T, 1991, BIOCHEM BIOPH RES CO, V175, P44, DOI 10.1016/S0006-291X(05)81197-0; SCOTTBURDEN T, 1991, J CARDIOVASC PHARM, V17, pS96, DOI 10.1097/00005344-199100177-00025; SHICHIRI M, 1991, J CLIN INVEST, V87, P1867, DOI 10.1172/JCI115210; SOKOLOVSKY M, 1992, J NEUROCHEM, V59, P809, DOI 10.1111/j.1471-4159.1992.tb08318.x; TAKAGI Y, 1990, BIOCHEM BIOPH RES CO, V168, P537, DOI 10.1016/0006-291X(90)92354-3; WEISSBERG PL, 1990, ATHEROSCLEROSIS, V85, P257, DOI 10.1016/0021-9150(90)90118-3; WINKLES JA, 1993, BIOCHEM BIOPH RES CO, V191, P1081, DOI 10.1006/bbrc.1993.1327; WINKLES JA, 1991, CELL GROWTH DIFFER, V2, P531; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	44	123	125	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10112	10118						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144511				2022-12-27	WOS:A1994NE05300107
J	ELBERG, G; LI, JP; SHECHTER, Y				ELBERG, G; LI, JP; SHECHTER, Y			VANADIUM ACTIVATES OR INHIBITS RECEPTOR AND NONRECEPTOR PROTEIN-TYROSINE KINASES IN CELL-FREE EXPERIMENTS, DEPENDING ON ITS OXIDATION-STATE - POSSIBLE ROLE OF ENDOGENOUS VANADIUM IN CONTROLLING CELLULAR PROTEIN-TYROSINE KINASE-ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR; RAT ADIPOCYTES; BLOOD-GLUCOSE; DIABETIC RATS; FA/FA RATS; HL60 CELLS; VANADATE; PHOSPHORYLATION; PHOSPHATASE; MECHANISM	We have shown that vanadium mimics several insulin effects in rat adipocytes, via a staurosporine sensitive cytosolic protein tyrosine kinase (CytPTK; Shisheva, A., and Shechter, Y. (1993) J. Biol. Chem. 268, 6463). Here we demonstrate that vanadium effects on protein tyrosine kinases are preserved after cell disintegration. Vanadium inhibits or activates protein tyrosine kinases depending on its oxidation state and the tyrosine kinase studied. Vanadyl (4+) but not vanadate (5+) inhibits receptor tyrosine kinases such as the insulin receptor (IC50 value = 23 +/- 4 muM) and the insulin-like growth factor-I receptor (IC50 = 19 +/- 3 muM). Inhibition is non-competitive with respect to ATP, Mn2+, or substrate concentrations. Preincubation of adipocytes with vanadyl (0.4 mm), and staurosporine (which arrests the cytosolic enzyme) substantially inhibited insulin-stimulated lipogenesis. Vanadyl is readily oxidized to vanadate by hydrogen peroxide. In contrast, CytPTKs were poorly inhibited by vanadyl, and vanadate stimulated several CytPTKs 2-6-fold. CytPTK derived from rat adipocytes, liver and brain were activated, and CytPTK from Nb2 lymphoma cells was not affected. CytPTK extracted from insulin-responsive tissues are more sensitive to vanadate activation (ED50 = 3 +/- 0.7 muM), whereas the brain enzyme is less sensitive (ED50 = 27 +/- 3 muM). Tungstate, molybdate, and phenylarsine oxide also stimulate CytPTK, suggesting that the vanadate effect is secondary to inhibiting protein phosphotyrosine phosphatases. This study supports a working hypothesis implicating the intracellular vanadyl pool in modulating CytPTK activity. Any physiological conditions converting vanadyl to vanadate (i.e. H2O2 Production) will activate CytPTK and consequently CytPTK-dependent bioeffects.			ELBERG, G (corresponding author), WEIZMANN INST SCI, DEPT HORMONE RES, IL-76100 REHOVOT, ISRAEL.							BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRICHARD SM, 1989, ENDOCRINOLOGY, V125, P2510, DOI 10.1210/endo-125-5-2510; BRICHARD SM, 1992, ENDOCRINOLOGY, V131, P311, DOI 10.1210/en.131.1.311; BRUNATI AM, 1985, BIOCHEM BIOPH RES CO, V133, P929, DOI 10.1016/0006-291X(85)91225-2; DEGANI H, 1981, BIOCHEMISTRY-US, V20, P5795, DOI 10.1021/bi00523a023; FANTUS IG, 1989, BIOCHEMISTRY-US, V28, P8864, DOI 10.1021/bi00448a027; GARCIAMORALES P, 1990, P NATL ACAD SCI USA, V87, P9255, DOI 10.1073/pnas.87.23.9255; GIL J, 1988, J BIOL CHEM, V263, P1868; GOLDFINE ID, 1987, ENDOCR REV, V8, P235, DOI 10.1210/edrv-8-3-235; GOLDMAN R, 1992, FEBS LETT, V309, P190, DOI 10.1016/0014-5793(92)81092-Z; GRINSTEIN S, 1990, J BIOL CHEM, V265, P318; HEYLIGER CE, 1985, SCIENCE, V227, P1474, DOI 10.1126/science.3156405; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMMERS R, 1990, J BIOL CHEM, V265, P16886; LAU KHW, 1989, BIOCHEM J, V257, P23, DOI 10.1042/bj2570023; LINDQUIST RN, 1973, J AM CHEM SOC, V95, P8762, DOI 10.1021/ja00807a043; LIOCHEV S, 1987, ARCH BIOCHEM BIOPHYS, V255, P274, DOI 10.1016/0003-9861(87)90394-8; LOPEZ V, 1976, ANN REV PHARM TOXICO, V24, P501; MACARA IG, 1980, TRENDS BIOCHEM SCI, V5, P92, DOI 10.1016/0968-0004(80)90256-X; MCCLAIN DA, 1989, MOL CELLULAR BIOL DI, V2, P53; MEYEROVITCH J, 1987, J BIOL CHEM, V262, P6658; MEYEROVITCH J, 1990, BIOCHEMISTRY-US, V29, P3654, DOI 10.1021/bi00467a010; MEYEROVITCH J, 1991, J CLIN INVEST, V87, P1286, DOI 10.1172/JCI115131; MEYEROVITCH J, 1992, BIOCHEMISTRY, V31; MOONEY RA, 1989, ENDOCRINOLOGY, V124, P422, DOI 10.1210/endo-124-1-422; NECHAY BR, 1984, ANNU REV PHARMACOL, V24, P501; RODBELL M, 1964, J BIOL CHEM, V239, P375; ROSEN OM, 1983, P NATL ACAD SCI-BIOL, V80, P3237, DOI 10.1073/pnas.80.11.3237; SCHECHTER Y, 1989, EMBO J, V8, P1671, DOI 10.1002/j.1460-2075.1989.tb03558.x; SHECHTER Y, 1990, DIABETES, V39, P1, DOI 10.2337/diabetes.39.1.1; SHISHEVA A, 1991, J BIOCHEM BIOPH METH, V23, P307, DOI 10.1016/0165-022X(91)90006-I; SHISHEVA A, 1992, FEBS LETT, V300, P93, DOI 10.1016/0014-5793(92)80171-C; SHISHEVA A, 1993, J BIOL CHEM, V268, P6463; SHISHEVA A, 1992, BIOCHEMISTRY-US, V31, P8059, DOI 10.1021/bi00149a041; SHOELSON SE, 1989, MOL CELLULAR BIOL DI, V2, P23; SIMONS TJB, 1979, NATURE, V281, P337, DOI 10.1038/281337a0; SRIVASTAVA AK, 1990, INT J BIOCHEM, V22, P1229, DOI 10.1016/0020-711X(90)90303-K; STANKIEWICZ PJ, 1988, BIOCHEMISTRY-US, V27, P206, DOI 10.1021/bi00401a031; STROUT HV, 1989, ENDOCRINOLOGY, V124, P1918, DOI 10.1210/endo-124-4-1918; SWARUP G, 1982, J BIOL CHEM, V257, P7298; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRUDEL S, 1991, BIOCHEM J, V276, P611, DOI 10.1042/bj2760611; TRUDEL S, 1990, BIOCHEM J, V269, P127, DOI 10.1042/bj2690127; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VENKATESAN N, 1991, DIABETES, V40, P492, DOI 10.2337/diabetes.40.4.492; WHITE MF, 1987, J BIOL CHEM, V262, P9769	46	92	93	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9521	9527						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144537				2022-12-27	WOS:A1994NE05300022
J	GHOSH, SJ; XIE, WQ; QUEST, AFG; MABROUK, GM; STRUM, JC; BELL, RM				GHOSH, SJ; XIE, WQ; QUEST, AFG; MABROUK, GM; STRUM, JC; BELL, RM			THE CYSTEINE-RICH REGION OF RAF-1 KINASE CONTAINS ZINC, TRANSLOCATES TO LIPOSOMES, AND IS ADJACENT TO A SEGMENT THAT BINDS GTP-RAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER BINDING; PROTEIN-KINASE; ACTIVATION; PURIFICATION; PATHWAY; CELLS	Different domains of the serine/threonine kinase, raf-1, were expressed as fusion proteins with glutathione S-transferase (GST) in Escherichia coli and purified to near homogeneity by affinity chromatography. A cysteine-rich domain of raf-1 was found to contain 2 mol of zinc (molar basis), similar to analogous cysteine-rich domains of protein kinase C. GST-fusion proteins, containing the cysteine-rich domain of raf-1, bound to liposomes in a phosphatidylserine-dependent manner. In contrast to protein kinase C, the translocation of raf-1 was not dependent upon diacylglycerol, phorbol ester, or calcium, nor did raf-1 bind phorbol esters. A GST-fusion protein encoding residues 1-147 of raf-1 bound to normal GTP-ras with high affinity, but not to mutant GTP-Ala35 ras; no binding was detected to GDP-ras. The binding of a smaller fusion protein (residues 1-130 of raf-1) was about 10-fold weaker, inferring that a 17-amino acid sequence represents a critical binding determinant in intact raf-1. These residues are adjacent to the amino-terminal end of, and partially extend into, the cysteine-rich domain (amino acids 139-184). A synthetic peptide corresponding to this 17-amino acid sequence blocked the interaction of raf-1 with ras. The function of the cysteine-rich region of raf-1 homologous to protein kinase C is to promote translocation of raf-1 kinase to membranes and to form part of the high affinity binding site for GTP-ras.	DUKE UNIV,MED CTR,DEPT MOLEC CANC BIOL,DURHAM,NC 27710	Duke University			GHOSH, SUJOY/I-3729-2017	GHOSH, SUJOY/0000-0002-7601-165X	NIGMS NIH HHS [GM 38737] Funding Source: Medline; NCBDD CDC HHS [DD 20205] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038737] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCBDD CDC HHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BONI LT, 1985, J BIOL CHEM, V260, P819; BURNS DJ, 1991, J BIOL CHEM, V266, P18330; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DICKSON B, 1992, NATURE, V360, P600, DOI 10.1038/360600a0; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Habig W H, 1981, Methods Enzymol, V77, P398; HALL C, 1990, J MOL BIOL, V211, P11, DOI 10.1016/0022-2836(90)90006-8; HAN M, 1993, NATURE, V363, P133, DOI 10.1038/363133a0; HANNUN YA, 1986, J BIOL CHEM, V261, P9341; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; IZUMI T, 1991, J BIOL CHEM, V266, P7933; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mannervik B, 1981, Methods Enzymol, V77, P231; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MOTOJIMA K, 1993, FEBS LETT, V319, P75, DOI 10.1016/0014-5793(93)80040-2; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; POLAKIS P, 1993, J BIOL CHEM, V268, P9157; QUEST AFG, 1994, J BIOL CHEM, V269, P2953; QUEST AFG, 1994, J BIOL CHEM, V269, P2961; QUEST AFG, 1993, METH NEUROSCI, V18, P138; RIZO J, 1992, ANNU REV BIOCHEM, V61, P387, DOI 10.1146/annurev.bi.61.070192.002131; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCAFER GL, 1993, MOL CHEM NEUROPATH, V18, P267; SCHAAP D, 1990, FEBS LETT, V275, P151, DOI 10.1016/0014-5793(90)81461-V; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SIMONS PC, 1977, ANAL BIOCHEM, V82, P334, DOI 10.1016/0003-2697(77)90169-5; SKIPPER J, 1993, J EXP MED, V177, P1493, DOI 10.1084/jem.177.5.1493; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; SOSSIN WS, 1992, J NEUROSCI, V12, P1160; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURNER BC, 1993, P NATL ACAD SCI USA, V90, P5544, DOI 10.1073/pnas.90.12.5544; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; White D.A., 1973, FORM FUNCTION PHOSPH; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	47	162	164	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10000	10007						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144497				2022-12-27	WOS:A1994NE05300091
J	JANIAK, F; LEBER, B; ANDREWS, DW				JANIAK, F; LEBER, B; ANDREWS, DW			ASSEMBLY OF BCL-2 INTO MICROSOMAL AND OUTER MITOCHONDRIAL-MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; HUMAN FOLLICULAR LYMPHOMA; ENDOPLASMIC-RETICULUM; PHOTOACTIVATABLE PHOSPHOLIPIDS; EMBEDDED SEGMENT; CROSS-LINKING; RAT-LIVER; PROTEIN-A; CYTOCHROME-B5; CELL	Bcl-2 is thought to associate spontaneously with membranes via a carboxyl-terminal hydrophobic domain by a mechanism analogous to that of cytochrome b5. We have examined the association of Bcl-2 with a variety of highly purified intracellular membranes in vitro. Fusion proteins were used to assess directly the role of the carboxyl-terminal hydrophobic domain of Bcl-2 in membrane association. Although this domain of Bcl-2 was sufficient to promote the association of a normally cytosolic polypeptide with either microsomal or mitochondrial membranes additional nonhydrophobic amino-terminal residues were required for membrane integration. Furthermore, direct comparison of membrane binding of Bcl-2 and cytochrome b5 revealed that similar to cytochrome b5, membrane targeting of Bcl-2 was not dependent on protease-sensitive components of the recipient membranes. In competition experiments, cytochrome b5 demonstrated the expected preference for integration into endoplasmic reticulum membranes. In contrast, the data presented here suggest that Bcl-2 is targeted to the cytoplasmic surface of multiple intracellular membranes, both in vitro and in human leukemic cells.	MCMASTER UNIV, DEPT BIOCHEM, HAMILTON L8N 3Z5, ONTARIO, CANADA; MCMASTER UNIV, DEPT MED, HAMILTON L8N 3Z5, ONTARIO, CANADA	McMaster University; McMaster University				Andrews, David/0000-0002-9266-7157; Leber, Brian/0000-0001-5502-1480				ALNEMRI ES, 1992, P NATL ACAD SCI USA, V89, P7295, DOI 10.1073/pnas.89.16.7295; ANDERSON DJ, 1983, P NATL ACAD SCI-BIOL, V80, P7249, DOI 10.1073/pnas.80.23.7249; ANDREWS DW, 1992, J BIOL CHEM, V267, P7761; ANDREWS DW, 1993, MOL CELL BIOL, V13, P4703, DOI 10.1128/MCB.13.8.4703; ANDREWS DW, 1989, J CELL BIOL, V108, P797, DOI 10.1083/jcb.108.3.797; AQUILA H, 1985, EMBO J, V4, P2369, DOI 10.1002/j.1460-2075.1985.tb03941.x; ARGAN C, 1983, J BIOL CHEM, V258, P6667; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; CHENLEVY Z, 1989, MOL CELL BIOL, V9, P701, DOI 10.1128/MCB.9.2.701; COLLINS MKL, 1993, TRENDS BIOCHEM SCI, V18, P307, DOI 10.1016/0968-0004(93)90042-L; ENOCH HG, 1979, J BIOL CHEM, V254, P6483; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FUJIKI Y, 1982, J CELL BIOL, V93, P103, DOI 10.1083/jcb.93.1.103; GRAHAM JM, 1990, ANAL BIOCHEM, V187, P318, DOI 10.1016/0003-2697(90)90463-J; GUREVICH VV, 1991, ANAL BIOCHEM, V195, P207, DOI 10.1016/0003-2697(91)90318-N; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; JANIAK F, 1994, IN PRESS BIOCH J; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; LEDERER F, 1983, EUR J BIOCHEM, V132, P95, DOI 10.1111/j.1432-1033.1983.tb07330.x; LIU YJ, 1991, EUR J IMMUNOL, V21, P1905, DOI 10.1002/eji.1830210819; Martin Seamus J., 1993, Trends in Cell Biology, V3, P141, DOI 10.1016/0962-8924(93)90128-N; MITOMA JY, 1992, EMBO J, V11, P4197, DOI 10.1002/j.1460-2075.1992.tb05513.x; MONAGHAN P, 1992, J HISTOCHEM CYTOCHEM, V40, P1819, DOI 10.1177/40.12.1453000; NILSSON B, 1985, EMBO J, V4, P1075, DOI 10.1002/j.1460-2075.1985.tb03741.x; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; OZOLS J, 1989, BIOCHIM BIOPHYS ACTA, V997, P121, DOI 10.1016/0167-4838(89)90143-X; SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1; SHORE GC, 1983, METHOD ENZYMOL, V97, P396; Sottocasa G. L., 1967, METHOD ENZYMOL, V10, P448; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; STRITTMATTER P, 1960, J BIOL CHEM, V235, P2492; TAKAGAKI Y, 1983, J BIOL CHEM, V258, P9128; TAKAGAKI Y, 1983, J BIOL CHEM, V258, P9136; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; TSUJIMOTO Y, 1987, ONCOGENE, V2, P3; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; UHLEN M, 1984, J BIOL CHEM, V259, P1695; WALTER P, 1983, METHOD ENZYMOL, V96, P84; ZEHAVA CL, 1990, J BIOL CHEM, V265, P4929	41	110	113	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9842	9849						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144576				2022-12-27	WOS:A1994NE05300070
J	KAUR, P; ROSEN, BP				KAUR, P; ROSEN, BP			IN-VITRO ASSEMBLY OF AN ANION-STIMULATED ATPASE FROM PEPTIDE-FRAGMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTALLINE ADENYLATE KINASE; NUCLEOTIDE-BINDING SITE; 2 OVERLAPPING FRAGMENTS; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; TRANSLOCATING ATPASE; CATALYTIC SUBUNIT; ARSA PROTEIN; PUMP; RESISTANCE	The oxyanion-translocating ATPase encoded by the ars operon of plasmid R 773 confers resistance to anti-monials and arsenicals in Escherichia coli by extrusion of the oxyanions from the cells. The catalytic subunit, the ArsA protein, is an oxyanion-stimulated ATPase with two nucleotide binding consensus sequences, one in the N-terminal half and one in the C-terminal half of the protein. In this report subclones of the arsA gene were constructed to produce polypeptide fragments of the ArsA protein. By themselves none of the fragments exhibited anion-stimulated ATPase activity. Denaturation and renaturation of mixtures of N- and C-terminal polypeptides that between them comprised an entire ArsA protein resulted in active ATPase complexes.	WAYNE STATE UNIV, SCH MED, DEPT BIOCHEM, DETROIT, MI 48201 USA	Wayne State University				Rosen, Barry P./0000-0002-5230-4271	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019793] Funding Source: NIH RePORTER; NIAID NIH HHS [AI19793] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHEN CM, 1986, J BIOL CHEM, V261, P5030; DHARMAVARAM RM, 1987, J BACTERIOL, V169, P3921, DOI 10.1128/jb.169.9.3921-3925.1987; FRANCISCO MJDS, 1989, MOL MICROBIOL, V3, P15, DOI 10.1111/j.1365-2958.1989.tb00098.x; FRY DC, 1986, P NATL ACAD SCI USA, V83, P907, DOI 10.1073/pnas.83.4.907; FRY DC, 1985, BIOCHEMISTRY-US, V24, P4680, DOI 10.1021/bi00338a030; HSU CM, 1989, J BIOL CHEM, V264, P17349; KARKARIA CE, 1990, J BIOL CHEM, V265, P7832; KARKARIA CE, 1991, ARCH BIOCHEM BIOPHYS, V288, P107, DOI 10.1016/0003-9861(91)90170-N; KATO I, 1969, J BIOL CHEM, V244, P1004; KAUR P, 1993, J BACTERIOL, V175, P351, DOI 10.1128/JB.175.2.351-357.1993; KAUR P, 1992, J BIOL CHEM, V267, P19272; KAUR P, 1992, PLASMID, V27, P29, DOI 10.1016/0147-619X(92)90004-T; KIERDASZUK B, 1988, BIOCHEMISTRY-US, V27, P4952, DOI 10.1021/bi00413a054; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUYAMA S, 1990, J BIOL CHEM, V265, P8760; MEI-HSU C, 1991, Journal of Biological Chemistry, V266, P2327; MOBLEY HLT, 1982, P NATL ACAD SCI-BIOL, V79, P6119, DOI 10.1073/pnas.79.20.6119; PAI EF, 1977, J MOL BIOL, V114, P37, DOI 10.1016/0022-2836(77)90281-9; ROSEN BP, 1992, ANN NY ACAD SCI, V671, P257, DOI 10.1111/j.1749-6632.1992.tb43801.x; ROSEN BP, 1984, BIOCHEM BIOPH RES CO, V124, P760, DOI 10.1016/0006-291X(84)91023-4; ROSEN BP, 1988, J BIOL CHEM, V263, P3067; Rossman M.G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; SACHSENHEIMER W, 1977, J MOL BIOL, V114, P23, DOI 10.1016/0022-2836(77)90280-7; SAMBROOK J, 1989, MOL CLONING CLONING; SILVER S, 1982, P NATL ACAD SCI-BIOL, V79, P6114, DOI 10.1073/pnas.79.20.6114; TANIUCHI H, 1971, J BIOL CHEM, V246, P2291; TISA LS, 1990, J BIOL CHEM, V265, P190; VOGEL G, 1976, BIOCHEMISTRY-US, V15, P208, DOI 10.1021/bi00646a032; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WIERENGA RK, 1985, BIOCHEMISTRY-US, V24, P1346, DOI 10.1021/bi00327a012; WU J, 1991, MOL MICROBIOL, V5, P1331, DOI 10.1111/j.1365-2958.1991.tb00779.x; WU JH, 1992, J BIOL CHEM, V267, P12570; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YUE VT, 1977, BIOCHEMISTRY-US, V16, P4678, DOI 10.1021/bi00640a023	35	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9698	9704						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144560				2022-12-27	WOS:A1994NE05300049
J	SINGH, H; BECKMAN, K; POULOS, A				SINGH, H; BECKMAN, K; POULOS, A			PEROXISOMAL BETA-OXIDATION OF BRANCHED-CHAIN FATTY-ACIDS IN RAT-LIVER - EVIDENCE THAT CARNITINE PALMITOYLTRANSFERASE-I PREVENTS TRANSPORT OF BRANCHED-CHAIN FATTY-ACIDS INTO MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-SKIN FIBROBLASTS; PRISTANOYL-COA OXIDASE; PHYTANIC ACID; ACYL-COA; REFSUMS DISEASE; LONG-CHAIN; TRIHYDROXYCOPROSTANOYL-COA; ZELLWEGERS SYNDROME; ALPHA-OXIDATION; LIGNOCERIC ACID	Fatty acid beta-oxidation was investigated in highly purified mitochondrial and peroxisomal preparations from rat liver. Under isotonic conditions, pristanic and homophytanic acid beta-oxidation in purified peroxisomes was severalfold greater compared to the oxidation in purified mitochondria. Branched chain fatty acid beta-oxidation in purified mitochondria was very low, and the oxidation was not stimulated by exogenous L-carnitine or L-malate. In contrast, stearic acid beta-oxidation by purified mitochondria depended upon exogenous L-Carnitine, and the oxidation was stimulated by L-malate. Both mitochondrial and peroxisomal beta-oxidation of branched chain fatty acids was strongly inhibited by fatty acid-free bovine serum albumin, whereas stearic acid oxidation was either unaffected or slightly inhibited by bovine serum albumin. The results presented clearly indicate that branched chain fatty acids are mainly degraded in peroxisomes in rat liver. Branched chain fatty acids were efficiently converted to coenzyme A thioesters by purified mitochondria, peroxisomes, and microsomes. Although pristanic and phytanic acids were rapidly converted to pristanoyl-CoA and phytanoyl-CoA, respectively, they were not converted to carnitine esters by mitochondrial outer membranes. The results indicate that acyl-CoA synthetase and carnitine acyltransferase located at the mitochondrial outer membranes regulate entry of branched chain fatty acids into mitochondria. Mitochondrial carnitine acyltransferase I appears to be highly specific for straight chain fatty acids and restricts entry of branched chain fatty acids into mitochondria. Thus, branched chain fatty acids which cannot be transported across the mitochondrial membranes via the carnitine acyltransferase system are directed to peroxisomes for beta-oxidation. The results reported indicate that phytanic acid, the fatty acid which can be initially degraded by alpha-oxidation due to the presence of a beta-methyl group in the molecule, cannot be transported across the mitochondrial membranes. The data presented strongly suggest that phytanic acid alpha-oxidation occurs in organelles other than mitochondria and possibly in peroxisomes.			SINGH, H (corresponding author), WOMENS & CHILDRENS HOSP,DEPT CHEM PATHOL,ADELAIDE,SA 5006,AUSTRALIA.							Bergmeyer HU, 1974, METHODS ENZYMATIC AN; BHUIYAN AKMJ, 1992, LIPIDS, V27, P392; BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420; BUECHLER KF, 1990, ARCH BIOCHEM BIOPHYS, V281, P233, DOI 10.1016/0003-9861(90)90437-4; CASTEELS M, 1990, J LIPID RES, V31, P1865; DERRICK JP, 1989, BIOCHEM J, V262, P801, DOI 10.1042/bj2620801; FARRELL SO, 1984, J BIOL CHEM, V259, P3089; GARLAND PB, 1970, BIOCHEM J, V119, P553, DOI 10.1042/bj1190553; GUILBAULT GG, 1968, ANAL CHEM, V40, P190, DOI 10.1021/ac60257a002; HERNDON JH, 1969, J CLIN INVEST, V48, P1017, DOI 10.1172/JCI106058; HUANG S, 1992, ARCH BIOCHEM BIOPHYS, V296, P214, DOI 10.1016/0003-9861(92)90565-E; JOHNSON DW, 1989, BIOMED ENVIRON MASS, V18, P603, DOI 10.1002/bms.1200180816; KASHFI K, 1992, BIOCHEM J, V282, P909, DOI 10.1042/bj2820909; KOLODNY EH, 1976, CLIN CHIM ACTA, V70, P247, DOI 10.1016/0009-8981(76)90426-5; KORNBERG A, 1953, J BIOL CHEM, V204, P329; KRISANS SK, 1980, J BIOL CHEM, V255, P9599; LAZAROW PB, 1978, J BIOL CHEM, V253, P1522; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; MANNAERTS GP, 1979, J BIOL CHEM, V254, P4585; MIYAZAWA S, 1983, J BIOCHEM, V94, P529, DOI 10.1093/oxfordjournals.jbchem.a134384; MORRE DJ, 1971, METHOD ENZYMOL, V22, P130; MURALIDHARAN VB, 1984, J BIOL CHEM, V259, P3021; MURTHY MSR, 1987, P NATL ACAD SCI USA, V84, P378, DOI 10.1073/pnas.84.2.378; NORUM KR, 1966, BIOCHEM BIOPH RES CO, V24, P797, DOI 10.1016/0006-291X(66)90397-4; POULOS A, 1980, LIPIDS, V15, P19, DOI 10.1007/BF02534112; POULOS A, 1989, PROG LIPID RES, V28, P35, DOI 10.1016/0163-7827(89)90006-4; POULOS A, 1993, BIOCHEM J, V292, P457, DOI 10.1042/bj2920457; POULOS A, 1985, HUM GENET, V70, P172, DOI 10.1007/BF00273077; POULOS A, 1981, CLIN GENET, V20, P247; POULOS A, 1984, CLIN GENET, V26, P579; POULOS A, 1986, CLIN GENET, V29, P397; POULOS A, 1988, EUR J PEDIATR, V147, P143, DOI 10.1007/BF00442211; RAMSAY RR, 1988, BIOCHEM J, V249, P239, DOI 10.1042/bj2490239; SCHEPERS L, 1990, J BIOL CHEM, V265, P5242; SHINDO Y, 1978, J BIOCH, V84, P1171; SINGH H, 1988, ARCH BIOCHEM BIOPHYS, V266, P486, DOI 10.1016/0003-9861(88)90281-0; SINGH H, 1992, J LIPID RES, V33, P1597; SINGH H, 1989, ARCH BIOCHEM BIOPHYS, V268, P676, DOI 10.1016/0003-9861(89)90336-6; SINGH H, 1990, J LIPID RES, V31, P217; SINGH H, 1987, ARCH BIOCHEM BIOPHYS, V259, P382, DOI 10.1016/0003-9861(87)90504-2; SINGH H, 1986, ARCH BIOCHEM BIOPHYS, V250, P171, DOI 10.1016/0003-9861(86)90714-9; SINGH H, 1987, ARCH BIOCHEM BIOPHYS, V254, P526, DOI 10.1016/0003-9861(87)90133-0; SINGH H, 1993, J LIPID RES, V34, P467; SINGH I, 1984, P NATL ACAD SCI-BIOL, V81, P4203, DOI 10.1073/pnas.81.13.4203; SKJELDAL OH, 1987, BIOCHIM BIOPHYS ACTA, V921, P38, DOI 10.1016/0005-2760(87)90167-6; TENBRINK HJ, 1992, J LIPID RES, V33, P41; TSAI SC, 1969, J BIOL CHEM, V244, P2682; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; VANHOVE G, 1991, J BIOL CHEM, V266, P24670; VANVELDHOVEN PP, 1991, J BIOL CHEM, V266, P24676; VANVELDHOVEN PP, 1992, J BIOL CHEM, V267, P20065; WANDERS RJA, 1991, J INHERIT METAB DIS, V14, P349, DOI 10.1007/BF01811700; WANDERS RJA, 1992, BIOCHIM BIOPHYS ACTA, V1124, P199, DOI 10.1016/0005-2760(92)90099-H; WATKINS PA, 1990, BIOCHEM BIOPH RES CO, V167, P580, DOI 10.1016/0006-291X(90)92064-7; WATMOUGH NJ, 1989, BIOCHEM J, V262, P261, DOI 10.1042/bj2620261	56	43	43	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9514	9520						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144536				2022-12-27	WOS:A1994NE05300021
J	SOROKIN, A; LEMMON, MA; ULLRICH, A; SCHLESSINGER, J				SOROKIN, A; LEMMON, MA; ULLRICH, A; SCHLESSINGER, J			STABILIZATION OF AN ACTIVE DIMERIC FORM OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR BY INTRODUCTION OF AN INTER-RECEPTOR DISULFIDE BOND	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; CROSS-LINKING; SIGNAL TRANSDUCTION; SENSORY RECEPTOR; ESCHERICHIA-COLI; AUTOPHOSPHORYLATION; PHOSPHORYLATION; BINDING; INSULIN; DIMERIZATION	Populations of the epidermal growth factor receptor (EGFR) with both high and low affinity for EGF are found on the surface of cells. It has been hypothesized that the high-affinity state of the EGFR represents the receptor dimer and that this is also the kinase-active form. We describe here studies aimed at addressing this question directly. To stabilize homodimers of EGFR, we have generated a mutated form of the receptor by inserting a cysteine residue in the extracellular juxtamembranous region, in order to cross-link the extracellular domains of two receptors via disulfide bond formation. The mutation resulted in ligand-induced appearance of covalently linked EGF receptor dimers and, in parallel, increased the number of high-affinity receptors present on the surface of cells expressing the mutated EGFR. Comparison of the tyrosine kinase activity of the covalently linked dimeric and the monomeric forms of the EGF receptor, separated by sucrose density gradient centrifugation, showed that the dimer was significantly more active than monomer in the phosphorylation of exogenous substrate. We conclude that the dimeric form of the EGF-receptor represents the active form, and that dimer formation is associated with the appearance of high-affinity binding EGF receptors on the cell surface.	NYU MED CTR,DEPT PHARMACOL,550 1ST AVE,NEW YORK,NY 10016; MAX PLANCK INST BIOCHEM,DEPT MOLEC BIOL,W-8033 MARTINSRIED,GERMANY	New York University; Max Planck Society				Sorokin, Andrey/0000-0002-5660-0190; Lemmon, Mark/0000-0002-3379-5319				AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BELLOT F, 1990, J CELL BIOL, V110, P491, DOI 10.1083/jcb.110.2.491; BONISCHNETZLER M, 1987, J BIOL CHEM, V262, P8395; BONISCHNETZLER M, 1987, P NATL ACAD SCI USA, V84, P7832, DOI 10.1073/pnas.84.22.7832; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; CAO HN, 1992, J BIOL CHEM, V267, P20489; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; HENEGOUWEN PMP, 1989, J CELL BIOCHEM, V39, P455; HONEGGER A, 1988, EMBO J, V7, P3053, DOI 10.1002/j.1460-2075.1988.tb03170.x; HONEGGER AM, 1990, MOL CELL BIOL, V10, P4035, DOI 10.1128/MCB.10.8.4035; JACOBS S, 1983, ANNU REV PHARMACOL, V23, P461, DOI 10.1146/annurev.pa.23.040183.002333; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; LONARDO F, 1990, New Biologist, V2, P992; LYNCH BA, 1991, P NATL ACAD SCI USA, V88, P10402, DOI 10.1073/pnas.88.23.10402; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; MOHAMMADI M, 1993, BIOCHEMISTRY-US, V32, P8742, DOI 10.1021/bi00085a004; NORTHWOOD IC, 1989, J BIOL CHEM, V264, P5746; PAKULA AA, 1992, P NATL ACAD SCI USA, V89, P4144, DOI 10.1073/pnas.89.9.4144; PESSIN JE, 1985, MOL BASIS INSULIN AC, P3; RIEDEL H, 1986, NATURE, V324, P68, DOI 10.1038/324068a0; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; SCHREIBER AB, 1981, J BIOL CHEM, V256, P716; SORKIN A, 1991, J BIOL CHEM, V266, P23453; SPAARGAREN M, 1991, J BIOL CHEM, V266, P1733; UENO H, 1991, SCIENCE, V252, P844, DOI 10.1126/science.1851331; WALKER F, 1991, J BIOL CHEM, V266, P2746; WATOWICH SS, 1992, P NATL ACAD SCI USA, V89, P2140, DOI 10.1073/pnas.89.6.2140; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; WILEY HS, 1989, J BIOL CHEM, V264, P18912; WINSTON JT, 1991, J CELL BIOCHEM, V47, P79, DOI 10.1002/jcb.240470110; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; ZHOU M, 1993, BIOCHEMISTRY-US, V32, P8193, DOI 10.1021/bi00083a020	40	102	103	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9752	9759						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144568				2022-12-27	WOS:A1994NE05300057
J	STACK, MS; JOHNSON, DA				STACK, MS; JOHNSON, DA			HUMAN MAST-CELL TRYPTASE ACTIVATES SINGLE-CHAIN URINARY-TYPE PLASMINOGEN-ACTIVATOR (PROUROKINASE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PURIFICATION; PROENZYME; SEQUENCE; THROMBIN; FORM; INACTIVATION; PROTEINS; INVITRO; PLASMA; TUMOR	Human lung mast cell tryptase is a trypsin-like serine proteinase that is stored in mast cell granules and released by activated mast cells. Here we report that mast cell tryptase is a potent activator of single-chain urinary-type plasminogen activator (scu-PA, or pro-urokinase), the zymogen form of urinary-type plasminogen activator (u-PA). Activation was complete within 75 min using an enzyme:substrate molar ratio of 1:50 and was accompanied by cleavage of scu-PA at Lys158-Ile159, generating active two-chain u-PA. The reaction was dependent on enzyme concentration and obeyed Michaelis-Menten kinetics. Kinetic constants calculated for scu-PA activation by mast cell tryptase are K(m) = 34 muM, V(max) = 3.6 pmol of u-PA/min, and k(cat) = 0.08 s-1. These data suggest that tryptase from tumor-associated mast cells may participate in the activation of scu-PA.	E TENNESSEE STATE UNIV,COLL MED,DEPT BIOCHEM,JOHNSON CITY,TN 37614	East Tennessee State University	STACK, MS (corresponding author), DUKE UNIV,MED CTR,DEPT PATHOL,BOX 3712,DURHAM,NC 27710, USA.				NATIONAL CANCER INSTITUTE [R01CA058900, R55CA058900, P30CA014236] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL042623] Funding Source: NIH RePORTER; NCI NIH HHS [CA-14236, CA-58900] Funding Source: Medline; NHLBI NIH HHS [HL-42623] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTER SC, 1987, BIOCHEM J, V248, P821, DOI 10.1042/bj2480821; BRUNNER G, 1990, FEBS LETT, V260, P141, DOI 10.1016/0014-5793(90)80087-Y; CROWLE PK, 1989, MAST CELL BASOPHIL D, P307; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; ELLIS V, 1989, J BIOL CHEM, V264, P2185; ETO I, 1992, BIOCHEM J, V283, P209, DOI 10.1042/bj2830209; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FRIEDMAN MM, 1987, AM REV RESPIR DIS, V135, P1157; GLENNER GG, 1960, NATURE, V185, P846, DOI 10.1038/185846a0; GONZALEZGRONOW M, 1984, BIOCHEMISTRY-US, V23, P190, DOI 10.1021/bi00297a003; GUREWICH V, 1987, BLOOD, V69, P769; GUREWICH V, 1984, J CLIN INVEST, V73, P1731, DOI 10.1172/JCI111381; HOLMES WE, 1985, BIO-TECHNOL, V3, P923, DOI 10.1038/nbt1085-923; ICHINOSE A, 1986, J BIOL CHEM, V261, P3486; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; JOHNSON DA, 1992, PROTEIN SCI, V1, P370; KOBAYASHI H, 1991, J BIOL CHEM, V266, P5147; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIJNEN HR, 1990, J BIOL CHEM, V265, P5232; LIJNEN HR, 1987, SEMIN THROMB HEMOST, V13, P152, DOI 10.1055/s-2007-1003486; LIJNEN HR, 1987, EUR J BIOCHEM, V169, P359, DOI 10.1111/j.1432-1033.1987.tb13620.x; LITTLE SS, 1993, THESIS E TENNESSEE S; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MATSUO O, 1981, NATURE, V291, P590, DOI 10.1038/291590a0; NOLAN C, 1977, BIOCHIM BIOPHYS ACTA, V496, P384, DOI 10.1016/0304-4165(77)90321-X; RIFKIN DB, 1989, AM REV RESPIR DIS, V140, P1112, DOI 10.1164/ajrccm/140.4.1112; RIJKEN DC, 1982, J BIOL CHEM, V257, P2920; SCHARTZ LB, 1981, J BIOL CHEM, V256, P11939; SCHWARTZ LB, 1981, J IMMUNOL, V126, P1290; SCHWARTZ LB, 1986, J BIOL CHEM, V261, P7372; SKRIVER L, 1982, EUR J BIOCHEM, V124, P409; SMITH TJ, 1984, J BIOL CHEM, V259, P1046; SMITH TJ, 1984, FED PROC, V43, P1760; TAPIOVAARA H, 1993, INT J CANCER, V53, P499, DOI 10.1002/ijc.2910530324; WASSERMAN SI, 1990, J ALLERGY CLIN IMMUN, V86, P590, DOI 10.1016/S0091-6749(05)80221-0; WUN TC, 1982, J BIOL CHEM, V257, P7262	38	203	213	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9416	9419						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144524				2022-12-27	WOS:A1994NE05300006
J	TAOKA, M; ISOBE, T; OKUYAMA, T; WATANABE, M; KONDO, H; YAMAKAWA, Y; OZAWA, F; HISHINUMA, F; KUBOTA, M; MINEGISHI, A; SONG, SY; YAMAKUNI, T				TAOKA, M; ISOBE, T; OKUYAMA, T; WATANABE, M; KONDO, H; YAMAKAWA, Y; OZAWA, F; HISHINUMA, F; KUBOTA, M; MINEGISHI, A; SONG, SY; YAMAKUNI, T			MURINE CEREBELLAR NEURONS EXPRESS A NOVEL GENE ENCODING A PROTEIN RELATED TO CELL-CYCLE CONTROL AND CELL FATE DETERMINATION PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; STAGGERER MUTANT MICE; POSTNATAL-DEVELOPMENT; BINDING-PROTEIN; PURKINJE-CELLS; RAT CEREBELLUM; MESSENGER-RNA; NOTCH GENE; DNA; DROSOPHILA	We cloned cDNAs of a novel protein (designated V-1) that has been identified from among the developmentally regulated proteins in the rat cerebellum. Protein sequencing analysis (Taoka, M., Yamakuni, T., Song, S.-Y., Yamakawa, Y., Seta, K., Okuyama, T., and Isobe, T. (1992) Eur. J. Biochem. 207, 615-620) and cDNA sequence analysis revealed that the V-1 protein consists of 117 amino acids and contains 2.5 contiguous repeats of the cdc10/SWI6 motif, which was originally found in the products of the cell cycle control genes of yeasts and the cell fate determination genes in Drosophila and Caenorhabditis elegans. In situ hybridization histochemistry revealed that the expression of the V-1 gene is transiently increased in postmigratory granule cells during postnatal rat cerebellar development and thereafter is markedly suppressed, whereas Purkinje cells constitutively express V-1 mRNA. In contrast, cerebellar granule cells of the staggerer mutant mouse continue to express the V-1 gene even when the granule cells of the normal mouse have ceased to express the V-1 gene, suggesting that the expression of the V-1 gene in granule cells is regulated through the interaction with Purkinje cells. On the basis of these results, we postulate that the V-1 protein has a potential role in the differentiation of granule cells.	MITSUBISHI KASEI INST LIFE SCI,DEPT NEUROSCI,MACHIDA,TOKYO 194,JAPAN; TOKYO METROPOLITAN UNIV,FAC SCI,HACHIOJI,TOKYO 19203,JAPAN; NATL INST HLTH,DEPT BIOCHEM & CELL BIOL,SHINJYUKU KU,TOKYO 162,JAPAN; TOHOKU UNIV,SCH MED,DEPT ANAT,SENDAI,MIYAGI 980,JAPAN	Tokyo Metropolitan University; Tohoku University			WATANABE, Masahiko/A-4055-2012; Isobe, Toshiaki/Q-9279-2017; Yamakuni, Tohru/AAE-3541-2019; Watanabe, Masahiko/S-3614-2019	WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138; Taoka, Masato/0000-0001-5554-4951; Yamakuni, Tohru/0000-0003-3968-7949				ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; ANDREWS BJ, 1985, NATURE, V4, P457; AVES SJ, 1985, EMBO J, V4, P457, DOI 10.1002/j.1460-2075.1985.tb03651.x; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BLANK V, 1992, TRENDS BIOCHEM SCI, V17, P135, DOI 10.1016/0968-0004(92)90321-Y; BOURS V, 1990, NATURE, V348, P76, DOI 10.1038/348076a0; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; CAMPOSORTEGA JA, 1988, TRENDS NEUROSCI, V11, P400, DOI 10.1016/0166-2236(88)90077-X; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; EDELMAN GM, 1982, P NATL ACAD SCI-BIOL, V79, P7036, DOI 10.1073/pnas.79.22.7036; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HEKMAT A, 1990, J COMP NEUROL, V291, P457, DOI 10.1002/cne.902910311; HERRUP K, 1987, J NEUROSCI, V7, P829; HIRANO A, 1975, J NEUROPATH EXP NEUR, V34, P1, DOI 10.1097/00005072-197501000-00001; INOUE JI, 1992, P NATL ACAD SCI USA, V89, P4333, DOI 10.1073/pnas.89.10.4333; ISOBE T, 1991, J CHROMATOGR, V588, P115, DOI 10.1016/0021-9673(91)85013-6; ISOBE T, 1991, HPLC PEPTIDES PROTEI, P835; JOHANSEN KM, 1989, J CELL BIOL, V109, P2427, DOI 10.1083/jcb.109.5.2427; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; LANDIS DMD, 1978, J COMP NEUROL, V179, P831, DOI 10.1002/cne.901790408; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; MARIANI J, 1981, J NEUROSCI, V1, P696, DOI 10.1523/JNEUROSCI.01-07-00696.1981; Palay S. L., 1974, CEREBELLAR CORTEX CY; SANDER F, 1977, P NATL ACAD SCI USA, V74, P5463; SHIMONO T, 1976, BRAIN RES, V108, P279, DOI 10.1016/0006-8993(76)90186-4; SIDMAN RL, 1962, SCIENCE, V137, P610, DOI 10.1126/science.137.3530.610; SIMPSON P, 1990, TRENDS GENET, V6, P343, DOI 10.1016/0168-9525(90)90260-D; SOTELO C, 1974, BRAIN RES, V67, P519, DOI 10.1016/0006-8993(74)90499-5; TAOKA M, 1992, EUR J BIOCHEM, V207, P615, DOI 10.1111/j.1432-1033.1992.tb17088.x; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; WALLACE RB, 1981, NUCLEIC ACIDS RES, V9, P879, DOI 10.1093/nar/9.4.879; WATANABE M, 1990, DEV BRAIN RES, V53, P89, DOI 10.1016/0165-3806(90)90127-K; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; YOCHEM J, 1989, CELL, V58, P553, DOI 10.1016/0092-8674(89)90436-4; YOCHEM J, 1988, NATURE, V335, P547, DOI 10.1038/335547a0	41	40	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9946	9951						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144589				2022-12-27	WOS:A1994NE05300084
J	GOMEZMUNOZ, A; MARTIN, A; OBRIEN, L; BRINDLEY, DN				GOMEZMUNOZ, A; MARTIN, A; OBRIEN, L; BRINDLEY, DN			CELL-PERMEABLE CERAMIDES INHIBIT THE STIMULATION OF DNA-SYNTHESIS AND PHOSPHOLIPASE-D ACTIVITY BY PHOSPHATIDATE AND LYSOPHOSPHATIDATE IN RAT FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; PROTEIN KINASE-C; HL-60 CELLS; PHOSPHATIDYLCHOLINE BREAKDOWN; SPHINGOMYELIN METABOLISM; SIGNAL TRANSDUCTION; HUMAN NEUTROPHILS; ACID; DIFFERENTIATION; SPHINGOSINE	The interactions of ceramides with phosphatidate and lysophosphatidate in the regulation of signal transduction in rat fibroblasts were examined. C-2- and C-6-ceramides (N-acetylsphingosine and N-hexanoylsphingosine, respectively) at 10 mu M inhibited the stimulation of DNA synthesis that was produced by 50-100 mu M phosphatidate, or lysophosphatidate, or by exogenous phospholipase D. Sphingosine (10 mu M) had the opposite effect to the ceramides on DNA synthesis. C-2- or C-6-ceramides failed to inhibit the stimulation of DNA synthesis by insulin or serum. The ceramides did not modify the actions of phosphatidate, or lysophosphatidate, in decreasing the forskolin-induced increase in cAMP. C-2- and C-6-ceramides inhibited the stimulation of phospholipase D activity by: (a) phosphatidate, lysophosphatidate, phorbol ester, thrombin, or serum in intact fibroblasts and (b) phorbol ester or guanosine 5'-3-O-(thio)triphosphate in permeabilized fibroblasts. The ceramides can therefore modify cell signaling via phospholipase D, but this effect alone could not explain the decreased DNA synthesis. Incubation of fibroblasts with C-2- or Cs-ceramides or sphingomyelinase inhibited the interaction of exogenous phosphatidate or lysophosphatidate with the fibroblasts by 42 and 53%, respectively. Furthermore, a greater proportion of the phosphatidate, or lysophosphatidate, that was associated with the fibroblasts was metabolized further when the cells were pretreated with ceramides or sphingomyelinase. This effect was accompanied by an increased activity of N-ethylmaleimide-insensitive phosphatidate phosphohydrolase. Ceramides may therefore produce part of their growth inhibitory effects by blocking some of the signal transducing effects of phosphatidate and lysophosphatidate.	UNIV ALBERTA,DEPT BIOCHEM,EDMONTON T6G 2S2,AB,CANADA; UNIV ALBERTA,LIPID & LIPOPROT RES GRP,EDMONTON T6G 2S2,AB,CANADA	University of Alberta; University of Alberta				GOMEZ MUNOZ, ANTONIO/0000-0002-2539-016X				ABE A, 1992, EUR J BIOCHEM, V210, P765, DOI 10.1111/j.1432-1033.1992.tb17479.x; BALLOU LR, 1992, J BIOL CHEM, V267, P20044; BAULDRY SA, 1991, J BIOL CHEM, V266, P4173; BIELAWSKA A, 1992, FEBS LETT, V307, P211, DOI 10.1016/0014-5793(92)80769-D; BOCCKINO SB, 1991, P NATL ACAD SCI USA, V88, P6210, DOI 10.1073/pnas.88.14.6210; CHATTERJEE S, 1993, J BIOL CHEM, V268, P3401; CHEN H, 1992, BIOCHEM J, V286, P771, DOI 10.1042/bj2860771; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; EXTON JH, 1990, J BIOL CHEM, V265, P1; FISHBEIN JD, 1993, J BIOL CHEM, V268, P9255; FLORINCHRISTENSEN J, 1992, J BIOL CHEM, V267, P14783; FRANSON RC, 1992, BIOCHIM BIOPHYS ACTA, V1136, P169, DOI 10.1016/0167-4889(92)90253-8; GODLKORN T, 1991, J BIOL CHEM, V266, P16092; GOMEZMUNOZ A, 1992, BIOCHIM BIOPHYS ACTA, V1127, P49, DOI 10.1016/0005-2760(92)90200-F; GUPTA AK, 1991, J LIPID RES, V32, P125; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; HUANG CF, 1990, J BIOL CHEM, V265, P17468; JALINK K, 1993, P NATL ACAD SCI USA, V90, P1857, DOI 10.1073/pnas.90.5.1857; JALINK K, 1990, J BIOL CHEM, V265, P12232; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; KALEN A, 1992, BIOCHIM BIOPHYS ACTA, V1125, P90, DOI 10.1016/0005-2760(92)90160-W; KIM MY, 1991, J BIOL CHEM, V266, P484; KOLESNICK RN, 1989, J BIOL CHEM, V264, P7617; LISCOVITCH M, 1991, BIOCHEM J, V279, P319, DOI 10.1042/bj2790319; MARTIN A, 1987, BIOCHEM J, V245, P347, DOI 10.1042/bj2450347; MARTIN A, 1993, J BIOL CHEM, V268; MATHIAS S, 1993, SCIENCE, V259, P519, DOI 10.1126/science.8424175; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; MERRILL AH, 1992, NUTR REV, V50, P78; MERRILL AH, 1989, BIOCHIM BIOPHYS ACTA, V1010, P131, DOI 10.1016/0167-4889(89)90152-3; MORITZ A, 1992, J BIOL CHEM, V267, P7207; MURAYAMA T, 1987, J BIOL CHEM, V262, P5522; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OKAZAKI T, 1990, J BIOL CHEM, V265, P15823; ROSSI F, 1990, BIOCHEM BIOPH RES CO, V168, P320, DOI 10.1016/0006-291X(90)91711-Z; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; TOPP WC, 1981, VIROLOGY, V113, P408, DOI 10.1016/0042-6822(81)90168-9; TSAI MH, 1989, SCIENCE, V243, P522, DOI 10.1126/science.2536192; TSAI MH, 1990, SCIENCE, V250, P982, DOI 10.1126/science.2237442; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; VANCORVEN EJ, 1992, BIOCHEM J, V281, P163, DOI 10.1042/bj2810163; VANDERBEND RL, 1992, BIOCHEM J, V285, P235, DOI 10.1042/bj2850235; VANDERBEND RL, 1992, BIOCHIM BIOPHYS ACTA, V1125, P110, DOI 10.1016/0005-2760(92)90163-P; VANVELDHOVEN PP, 1992, BIOCHEM BIOPH RES CO, V187, P209, DOI 10.1016/S0006-291X(05)81480-9; YOUNES A, 1992, J BIOL CHEM, V267, P842; ZHANG H, 1990, J BIOL CHEM, V265, P76	49	186	187	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8937	8943						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132631				2022-12-27	WOS:A1994NB41100049
J	GUREVICH, VV; CHEN, CY; KIM, CM; BENOVIC, JL				GUREVICH, VV; CHEN, CY; KIM, CM; BENOVIC, JL			VISUAL ARRESTIN BINDING TO RHODOPSIN - INTRAMOLECULAR INTERACTION BETWEEN THE BASIC N-TERMINUS AND ACIDIC C-TERMINUS OF ARRESTIN MAY REGULATE BINDING SELECTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							48-KDA PROTEIN; PHOTOEXCITED RHODOPSIN; ACTIVATION; PHOSPHORYLATION; EXPRESSION; KINASE; SITES	Visual arrestin plays an important role in quenching phototransduction via its ability to preferentially bind to phosphorylated light-activated rhodopsin (P-Rh*). Recently we proposed a mechanism for the binding of visual arrestin to P-Rh* that helps to explain the nature of the conformational changes in arrestin observed upon binding. This mechanism involves a multisite interaction between arrestin and P-Rh* and implies an interaction between the C-terminal and N-terminal domains of arrestin. To obtain further insight into the mechanism of arrestin-rhodopsin interaction we have characterized the ability of polyanions to inhibit the interaction of wild type and mutant arrestins to different functional forms of rhodopsin. These studies reveal that: 1) heparin is most potent at inhibiting arrestin binding to dark phosphorylated rhodopsin > light-activated rhodopsin > P-Rh*; 2) C-terminal deletions in arrestin increase arrestin sensitivity to heparin inhibition while an N-terminal deletion (residues 2-16) decreases heparin inhibition; 3) the sensitivity of chimeric arrestins to heparin inhibition is determined by the origin of the N terminus of the chimera; and 4) heparin also inhibits arrestin binding to truncated (329)G-Rh*, suggesting it does not mimic the phosphorylated C terminus of rhodopsin. Taken together, these data suggest that heparin mimics the regulatory acidic C terminus of arrestin. Since the basic N terminal region of arrestin appears to serve as a site of heparin binding it is a likely candidate to be involved in the intramolecular interaction with the C-terminal region. The interaction of the N- and C-terminal domains of arrestin may control the conformational rearrangements in arrestin that occur upon binding to P-Rh*.	THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,DEPT PHARMACOL,PHILADELPHIA,PA 19107	Jefferson University			Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	NHLBI NIH HHS [HL45964] Funding Source: Medline; NIGMS NIH HHS [GM44944] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044944] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNETT N, 1988, BIOCHEMISTRY-US, V27, P1710, DOI 10.1021/bi00405a049; CHEN CY, 1993, J BIOL CHEM, V268, P7825; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; GUREVICH VV, 1993, J BIOL CHEM, V268, P16879; HARGRAVE PA, 1992, MOL BIOL RECEPTORS T, P49; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; KIM CM, 1993, RECEPTOR, V3, P39; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Kuhn H, 1984, PROGR RETINAL RES, V3, P123; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P18649; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; SHINOHARA T, 1987, P NATL ACAD SCI USA, V84, P6975, DOI 10.1073/pnas.84.20.6975; THOMPSON P, 1984, BIOCHEM J, V220, P773, DOI 10.1042/bj2200773; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; ZOZULYA SA, 1990, PROTEIN ENG, V3, P453, DOI 10.1093/protein/3.5.453	21	72	72	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8721	8727						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132602				2022-12-27	WOS:A1994NB41100019
J	SHIGERI, Y; FUJIMOTO, M				SHIGERI, Y; FUJIMOTO, M			Y2 RECEPTORS FOR NEUROPEPTIDE-Y ARE COUPLED TO 3 INTRACELLULAR SIGNAL-TRANSDUCTION PATHWAYS IN A HUMAN NEUROBLASTOMA CELL-LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; ROOT GANGLION NEURONS; RAT SENSORY NEURONS; NEUROTRANSMITTER RELEASE; ADENYLATE-CYCLASE; CALCIUM CHANNELS; PEPTIDE-YY; PRESYNAPTIC INHIBITION; CA-2+ CHANNELS; BRAIN PEPTIDE	Neuropeptide Y (NPY) attenuated angiotensin II (AII)- or bradykinin (BK)-induced Ca2+ release from intracellular stores and inhibited forskolin-stimulated cAMP accumulation and omega conotoxin-sensitive high K+-induced Ca2+ influx in the human neuroblastoma cell line SMS- KAN. All three NPY actions were mediated via Y2 receptors. Pretreatment with pertussis toxin completely abolished all of the NPY actions. Activation or downregulation of protein kinase C had no effect on any NPY-mediated effect; herbimycin A, a tyrosine kinase inhibitor, only abolished the inhibitory effect of NPY on AII- or BK-induced Ca2+ mobilization. Herbimycin A also blocked platelet derived growth factor-induced Ca2+ mobilization, which involves tyrosine kinase activation, and there was a good correlation in the concentration dependency between the two effects of herbimycin A, strongly suggesting that its ability to cancel the NPY effect is due to inhibition of tyrosine kinase activity. NPY attenuated AII or BK-induced inositol 1,4,5-trisphosphate production, and herbimycin A reversed this NPY effect. These results provide the first evidence that Y2 receptors negatively couple to AII- or BK-induced phosphoinositide turnover leading to Ca2+ mobilization through pertussis toxin sensitive GTP-binding protein(s). Inhibition of phospholipase C-beta activity by NPY seems to be mediated by activation of protein-tyro sine kinase or phosphotyrosine-containing protein(s).			SHIGERI, Y (corresponding author), SHIONOGI & CO LTD, SHIONOGI RES LABS, FUKUSHIMA KU, OSAKA 553, JAPAN.							AAKERLUND L, 1990, FEBS LETT, V260, P73, DOI 10.1016/0014-5793(90)80069-U; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BIZZARRI C, 1990, P NATL ACAD SCI USA, V87, P4889, DOI 10.1073/pnas.87.12.4889; BLEAKMAN D, 1992, BRIT J PHARMACOL, V107, P334, DOI 10.1111/j.1476-5381.1992.tb12747.x; BLEAKMAN D, 1991, BRIT J PHARMACOL, V103, P1781, DOI 10.1111/j.1476-5381.1991.tb09863.x; COLMERS WF, 1989, BRAIN RES, V498, P99, DOI 10.1016/0006-8993(89)90403-4; DELAHUNTY TM, 1988, BIOCHEM J, V255, P69, DOI 10.1042/bj2550069; DUMONT Y, 1992, PROG NEUROBIOL, V38, P125, DOI 10.1016/0301-0082(92)90038-G; ENJALBERT A, 1990, J BIOL CHEM, V265, P18816; EWALD DA, 1988, P NATL ACAD SCI USA, V85, P3633, DOI 10.1073/pnas.85.10.3633; EWALD DA, 1988, J NEUROSCI, V8, P2447; EWALD DA, 1989, NEURON, V2, P1185, DOI 10.1016/0896-6273(89)90185-2; FOUCART S, 1993, J PHARMACOL EXP THER, V265, P903; FOUCART S, 1989, N-S ARCH PHARMACOL, V340, P658, DOI 10.1007/BF00717741; FUHLENDORFF J, 1990, P NATL ACAD SCI USA, V87, P182, DOI 10.1073/pnas.87.1.182; FUJIMOTO M, 1991, NEUROSCI LETT, V122, P9, DOI 10.1016/0304-3940(91)90180-2; HIRNING LD, 1990, BRAIN RES, V532, P120, DOI 10.1016/0006-8993(90)91751-2; INUI A, 1992, ENDOCRINOLOGY, V131, P2090, DOI 10.1210/en.131.5.2090; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; LEE KM, 1993, J BIOL CHEM, V268, P9945; LINDER ME, 1990, J BIOL CHEM, V265, P8243; MICHEL MC, 1991, TRENDS PHARMACOL SCI, V12, P389, DOI 10.1016/0165-6147(91)90610-5; MIHARA S, 1989, FEBS LETT, V259, P79, DOI 10.1016/0014-5793(89)81499-1; MIHARA S, 1990, BIOCHEM INT, V22, P205; MILLER RJ, 1990, FASEB J, V4, P3291, DOI 10.1096/fasebj.4.15.1979294; MOTULSKY HJ, 1988, AM J PHYSIOL, V255, pE880, DOI 10.1152/ajpendo.1988.255.6.E880; PERNEY TM, 1989, J BIOL CHEM, V264, P7317; PLUMMER MR, 1991, J NEUROSCI, V11, P2339; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; ROSS RA, 1981, CELL MOL NEUROBIOL, V1, P301, DOI 10.1007/BF00710685; SHEIKH SP, 1989, J BIOL CHEM, V264, P6648; SHIGERI Y, 1992, BIOCHEM BIOPH RES CO, V187, P1565, DOI 10.1016/0006-291X(92)90481-Y; TADDEI S, 1991, HYPERTENSION, V18, P266, DOI 10.1161/01.HYP.18.3.266; TATEMOTO K, 1982, NATURE, V296, P659, DOI 10.1038/296659a0; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P5485, DOI 10.1073/pnas.79.18.5485; UEHARA Y, 1991, METHOD ENZYMOL, V201, P370; WAHLESTEDT C, 1990, ANN NY ACAD SCI, V611, P7; WAHLESTEDT C, 1992, LIFE SCI, V50, pPL7, DOI 10.1016/0024-3205(92)90342-M; WAHLESTEDT C, 1986, REGUL PEPTIDES, V13, P307, DOI 10.1016/0167-0115(86)90048-0; WAHLESTEDT C, 1993, ANNU REV PHARMACOL, V33, P309, DOI 10.1146/annurev.pa.33.040193.001521; WALKER MW, 1988, J NEUROSCI, V8, P2438; WEISS C, 1991, BRAIN RES, V543, P102, DOI 10.1016/0006-8993(91)91053-4; WEISS RH, 1992, J BIOL CHEM, V267, P5608; WILEY JW, 1990, J NEUROPHYSIOL, V63, P1499, DOI 10.1152/jn.1990.63.6.1499	45	46	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8842	8848						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132619				2022-12-27	WOS:A1994NB41100036
J	CHAIKIN, E; HAKEEM, I; RAZIN, E				CHAIKIN, E; HAKEEM, I; RAZIN, E			ENHANCEMENT OF INTERLEUKIN-3-DEPENDENT MAST-CELL PROLIFERATION BY SUPPRESSION OF C-JUN EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GROWTH-FACTOR; GENE-EXPRESSION; FOS; PHOSPHORYLATION; ACTIVATION; CLONING; ELEMENT; DIFFERENTIATION; IDENTIFICATION	We have previously shown that protein kinase C (PKC) depletion is associated with an increase in the proliferation of interleukin 3 (IL-3)-induced mast cells. Here we show that the AP-1 components c-Jun and c-Fos are induced by IL-3. While c-Jun's induction by IL-3 is totally dependent on PKC, c-Fos induction by IL-3 is only attenuated by PKC depletion. AP-1 binding activity was also induced by IL-3 but this induction was PKC independent. These results indicated a possible involvement of c-Jun in the inhibition of IL-3-induced growth regulation. A support for this assumption came from experiments in which an increase in thymidine incorporation into mast cells was noted when c-jun antisense oligomers were administered to IL-3-treated cells. Since the only known effect of direct inhibition of c-Jun on proliferation rates in several cellular systems was a reduction of proliferation, we verified that our c-jun antisense oligomer could also inhibit proliferation rates in fibroblasts where such a repression was previously reported. Thus c-Jun has an inhibitory effect on IL-3 induction of mast cells proliferation that is distinct from its role in several other cellular environments. These observations reveal the involvement of AP-1 and its components in IL-3-induced signal transduction and the importance of the mast cell environment in determining their specific cellular function.	HEBREW UNIV JERUSALEM,HADASSAH MED SCH,INST BIOCHEM,IL-91120 JERUSALEM,ISRAEL	Hebrew University of Jerusalem								ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; AUWERX J, 1991, CELL, V64, P983, DOI 10.1016/0092-8674(91)90322-P; BERGMEYER HU, 1974, METHOD ENZYMAT AN, P574; BLANAR MA, 1992, SCIENCE, V256, P1014, DOI 10.1126/science.1589769; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; CARSTEN J, 1990, CELL, V62, P1189; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; CHAIKIN E, 1990, J BIOL CHEM, V265, P22109; COUGHLIN SR, 1985, CELL, V43, P243, DOI 10.1016/0092-8674(85)90029-7; DUDOV KP, 1984, CELL, V37, P457, DOI 10.1016/0092-8674(84)90376-3; FARRAR WL, 1985, NATURE, V315, P235, DOI 10.1038/315235a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOLDWASER E, 1983, UCLA S MOL CELL BIOL, V1, P301; GRAHAM R, 1991, SCIENCE, V251, P189, DOI 10.1126/science.1898992; HOLGATE ST, 1993, ALLERGY; HORIE M, 1993, J BIOL CHEM, V268, P968; HUANG CL, 1987, NATURE, V329, P849, DOI 10.1038/329849a0; IHLE JN, 1983, J IMMUNOL, V131, P282; IMBRA RJ, 1986, NATURE, V323, P555, DOI 10.1038/323555a0; IMBRA RJ, 1987, MOL CELL BIOL, V7, P1358, DOI 10.1128/MCB.7.4.1358; KOIKE K, 1986, BLOOD, V67, P859; KOVARY K, 1991, MOL CELL BIOL, V11, P2451, DOI 10.1128/MCB.11.5.2451; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; LEWIN I, 1993, BLOOD, V82, P3745; MACGREGOR PF, 1990, ONCOGENE, V5, P451; MECHTA F, 1989, New Biologist, V1, P297; MILLS GB, 1988, CELL, V55, P91, DOI 10.1016/0092-8674(88)90012-8; MOORE MAS, 1988, LYMPHOKINES, V15, P219; NABEL G, 1981, NATURE, V291, P332, DOI 10.1038/291332a0; NEL AE, 1986, BIOCHEM J, V233, P145, DOI 10.1042/bj2330145; NICOLAIDES NC, 1992, J BIOL CHEM, V267, P19665; NISHIZUKA Y, 1992, SCIENCE, V258, P604; OKAZAKI T, 1988, EXP HEMATOL, V16, P42; PAPAVASSILIOU AG, 1992, SCIENCE, V258, P1941, DOI 10.1126/science.1470918; RAZIN E, 1984, J IMMUNOL, V132, P1479; SAGHER F, 1967, MASTOCYTOSIS MAST CE; Sambrook J, 1989, MOL CLONING LABORATO; SHAW PE, 1989, EMBO J, V8, P2567, DOI 10.1002/j.1460-2075.1989.tb08395.x; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; SMEAL T, 1989, GENE DEV, V3, P2091, DOI 10.1101/gad.3.12b.2091; SMITH MJ, 1992, BLOOD, V79, P2107; SOPRANO KJ, 1993, ANN NY ACAD SCI, V666, P231; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0	45	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8498	8503						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132577				2022-12-27	WOS:A1994NB40900100
J	CHALMERS, RM; KLECKNER, N				CHALMERS, RM; KLECKNER, N			TN10/IS10 TRANSPOSASE PURIFICATION, ACTIVATION, AND IN-VITRO REACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TN10 TRANSPOSITION; STRAND TRANSFER; DNA-SEQUENCE; PROTEIN; INVITRO; INTEGRATION; MECHANISM; CLEAVAGE; BINDING; SITE	We describe a method for the purification of Tn10/IS10 transposase that relies on the aggregation of the protein after overexpression in Escherichia coli. Aggregated transposase was solubilized before the final purification step, a gel-filtration column, using a combination of salt and detergent. This procedure is the first reported for the preparation of concentrated and active transposase from any IS element. The yield is 11 mg of purified protein at a concentration of 1 mg/ml from 2.5 g of cells. The procedure can be scaled up with ease. We also describe a treatment that activates transposase in either a crude or purified state. This involves dilution into a solution of salt plus organic solvent. In transposition reactions using supercoiled substrate plasmid, the activity was directly proportional to the amount of transposase added over a wide range of transposase/DNA ratios (0.2-2.0 molecules/DNA substrate molecule). In this range 8 transposase molecules were added per transposition event. Maximum conversion of substrate to product (40%) was with 18 transposase molecules/transposition event. At higher levels of transposase with a constant amount of substrate, activity was reduced but could be restored by addition of nonspecific DNA. Both the specific activity of transposase and the type of products generated can be altered by changing in vitro assay conditions. The effects of salts, solvents, and pH value on the reaction are described.			CHALMERS, RM (corresponding author), HARVARD UNIV,DEPT BIOCHEM & MOLEC BIOL,CAMBRIDGE,MA 02138, USA.			chalmers, ronald/0000-0002-1395-7173	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025326, R37GM025326] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25326] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACKMAN K, 1976, P NATL ACAD SCI USA, V73, P4174, DOI 10.1073/pnas.73.11.4174; BENDER J, 1986, CELL, V45, P801, DOI 10.1016/0092-8674(86)90555-6; BENJAMIN HW, 1989, CELL, V59, P373, DOI 10.1016/0092-8674(89)90298-5; BENJAMIN HW, 1992, P NATL ACAD SCI USA, V89, P4648, DOI 10.1073/pnas.89.10.4648; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; CHACONAS G, 1985, J BIOL CHEM, V260, P2662; CHALMERS RM, 1989, BIOCHEM J, V263, P913, DOI 10.1042/bj2630913; DELACRUZ NB, 1993, J BACTERIOL, V175, P6932, DOI 10.1128/jb.175.21.6932-6938.1993; DERBYSHIRE KM, 1992, EMBO J, V11, P3449, DOI 10.1002/j.1460-2075.1992.tb05424.x; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Fersht A. R., 1985, ENZYME STRUCTURE MEC, P155; HALLING SM, 1982, P NATL ACAD SCI-BIOL, V79, P2608, DOI 10.1073/pnas.79.8.2608; HANIFORD DB, 1991, CELL, V64, P171; HANIFORD DB, 1989, CELL, V59, P385, DOI 10.1016/0092-8674(89)90299-7; ICHIKAWA H, 1987, P NATL ACAD SCI USA, V84, P8220, DOI 10.1073/pnas.84.23.8220; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LEIRMO S, 1987, BIOCHEMISTRY-US, V26, P2095, DOI 10.1021/bi00382a006; MIZUUCHI M, 1989, CELL, V58, P399, DOI 10.1016/0092-8674(89)90854-4; MORISATO D, 1987, CELL, V51, P101, DOI 10.1016/0092-8674(87)90014-6; REED RR, 1981, CELL, V25, P713, DOI 10.1016/0092-8674(81)90178-1; ROBERTS DE, 1991, GENETICS, V128, P37; Sambrook J, 1989, MOL CLONING LABORATO; SCHUKKINK RF, 1990, NUCLEIC ACIDS RES, V18, P859; SEN J, 1988, NUCLEIC ACIDS RES, V16, P4730, DOI 10.1093/nar/16.10.4730; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; [No title captured]	27	71	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8029	8035						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132525				2022-12-27	WOS:A1994NB40900033
J	CHAUDHURI, A; ZBRZEZNA, V; POLYAKOVA, J; POGO, AO; HESSELGESSER, J; HORUK, R				CHAUDHURI, A; ZBRZEZNA, V; POLYAKOVA, J; POGO, AO; HESSELGESSER, J; HORUK, R			EXPRESSION OF THE DUFFY ANTIGEN IN K562 CELLS - EVIDENCE THAT IT IS THE HUMAN ERYTHROCYTE CHEMOKINE RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HUMAN INTERLEUKIN-8 RECEPTOR; CYTOKINE FAMILY; BIOLOGY	The human malarial parasite Plasmodium vivax invades erythrocytes by binding to a cell surface protein identified as the Duffy blood group antigen. The molecular properties of the Duffy antigen, which was recently cloned, are very similar to those of a chemokine binding protein known as the human erythrocyte chemokine receptor. This has led to the suggestion that these two molecules are the same protein. To further investigate the suspected double identity of the Duffy antigen we have transfected it into a human erythroleukemic cell line, K562. Cells stably expressing the Duffy antigen were isolated and used to characterize the protein. K562 cells transfected with the Duffy antigen displayed specific I-125-melanoma growth-stimulating activity (MGSA) binding while mock transfected cells did not. Comparison of I-125-MGSA binding to the Duffy antigen and the human erythrocyte chemokine receptor showed that the specific I-125-MGSA binding to both proteins was displaced by excess unlabeled MGSA, interleukin-8, RANTES, monocyte chemotactic peptide-1, and platelet factor 4, but not by macrophage inflammatory protein-1 alpha or -1 beta. Scatchard analysis of competition binding studies with these unlabeled chemokines revealed high affinity binding to the Duffy antigen with K-D binding values of 24 +/- 4.9, 20 +/- 4.7, 41.9 +/- 12.8, and 33.9 +/- 7 nM for MGSA, interleukin-8, RANTES, and monocyte chemotactic peptide l, respectively. A monoclonal antibody, Fy6, to the Duffy antigen inhibited I-125-MGSA binding to K562 cells expressing the Duffy antigen. Cell membranes from K562 cells permanently expressing the Duffy antigen were chemically cross-linked with I-125-MGSA. SDS-polyacrylamide gel electrophoresis analysis of the cross-linked products showed covalent incorporation of radiolabeled MGSA into a protein of molecular mass 47 kDa, and cross linking was inhibited in the presence of unlabeled MGSA. These studies provide evidence that the Duffy blood group antigen is the same protein as the human erythrocyte chemokine receptor.	GENENTECH INC,S SAN FRANCISCO,CA 94080	Roche Holding; Genentech	CHAUDHURI, A (corresponding author), NEW YORK BLOOD CTR,NEW YORK,NY 10021, USA.							CHAUDHURI A, 1993, P NATL ACAD SCI USA, V90, P10793, DOI 10.1073/pnas.90.22.10793; CHAUDHURI A, 1994, BLOOD CELL BIOCH; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; HEBERT CA, 1990, J IMMUNOL, V145, P3033; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; HORUK R, 1993, BIOCHEMISTRY-US, V32, P5733, DOI 10.1021/bi00073a002; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; HORUK R, 1993, J BIOL CHEM, V268, P541; MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; NEOTE K, 1993, J BIOL CHEM, V268, P12247; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; NICHOLS ME, 1987, J EXP MED, V166, P776, DOI 10.1084/jem.166.3.776; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; TANNER MJA, 1972, BIOCHEM J, V129, P333, DOI 10.1042/bj1290333; WASNIOWSKA K, 1993, BIOCHEM BIOPH RES CO, V192, P366, DOI 10.1006/bbrc.1993.1424	19	142	150	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7835	7838						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132497				2022-12-27	WOS:A1994NB40900001
J	DEVASKAR, SU; GIDDINGS, SJ; RAJAKUMAR, PA; CARNAGHI, LR; MENON, RK; ZAHM, DS				DEVASKAR, SU; GIDDINGS, SJ; RAJAKUMAR, PA; CARNAGHI, LR; MENON, RK; ZAHM, DS			INSULIN GENE-EXPRESSION AND INSULIN SYNTHESIS IN MAMMALIAN NEURONAL CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRAIN GLUCOSE TRANSPORTER; RAT-BRAIN; DEVELOPMENTAL REGULATION; GLUCOKINASE GENE; MESSENGER-RNA; BINDING; INVIVO; IDENTIFICATION; MICROVESSELS; LOCALIZATION	To demonstrate the presence of de novo synthesis in central mammalian neurons, we cloned and sequenced a rabbit insulin cDNA from pancreas and used it to define sequences encoding insulin mRNA from postnatal rabbit brain. We observed transcription/elongation of nascent insulin transcripts, characterized the size of these transcripts, and localized them to specific neurons in certain catecholaminergic-rich areas of the central nervous system. RNase protection assays using a rabbit probe spanning a region from 14 bases 5' to the translation start site through all but 18 bases of the sequence encoding the A-chain of insulin showed two bands in rabbit brain RNA and only one band in pancreas. The larger band in brain was the same size as that in pancreatic RNA; the other was approximately 10 bases shorter. Because the sequence of a reverse transcription-polymerase chain reaction product from brain RNA was identical to pancreatic RNA sequence in the region corresponding to the 3' region of the probe, the smaller band in brain is most consistent with a sequence mismatch in some brain mRNA in the region corresponding to the 5'-end of the probe, In situ hybridization localized insulin mRNA to anatomical regions involved with olfaction and higher association of the limbic system. High performance liquid chromatography, radioimmunoassay, and [S-35]cysteine metabolic labeling of cultured neuronal and glial cells indicated extracellular secretion of immunoprecipitable insulin by neurons only. Presence of insulin transcripts within specific neurons with extracellular secretion of the peptide suggests a specialized biological role.	ST LOUIS UNIV, SCH MED,CARDINAL GLENNON CHILDRENS HOSP, PEDIAT RES INST,DEPT PEDIAT, ST LOUIS, MO 63110 USA; ST LOUIS UNIV, SCH MED,CARDINAL GLENNON CHILDRENS HOSP, PEDIAT RES INST,DEPT ANAT, ST LOUIS, MO 63110 USA; ST LOUIS UNIV, SCH MED,CARDINAL GLENNON CHILDRENS HOSP, PEDIAT RES INST,DEPT NEUROBIOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, DEPT VET AFFAIRS MED CTR, MED SERV 111JC, ST LOUIS, MO 63106 USA; UNIV PITTSBURGH, CHILDRENS HOSP PITTSBURGH, DEPT PEDIAT, DIV ENDOCRINOL, PITTSBURGH, PA 15213 USA	Saint Louis University; Saint Louis University; Saint Louis University; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	DEVASKAR, SU (corresponding author), ST LOUIS UNIV, SCH MED,CARDINAL GLENNON CHILDRENS HOSP, PEDIAT RES INST,DEPT PEDIAT, DIV NEONATOL, ST LOUIS, MO 63110 USA.			Zahm, Daniel/0000-0002-2943-7906	NICHD NIH HHS [HD25024] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025024, R29HD025024] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALPERT S, 1988, CELL, V53, P295, DOI 10.1016/0092-8674(88)90391-1; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BELL GI, 1980, NATURE, V284, P26, DOI 10.1038/284026a0; BOYD FT, 1985, J BIOL CHEM, V260, P5880; COHEN RM, 1986, METABOLISM, V35, P1137, DOI 10.1016/0026-0495(86)90027-2; COKER GT, 1990, MOL BRAIN RES, V8, P93, DOI 10.1016/0169-328X(90)90052-F; COLWELL N, 1992, BIOCHIM BIOPHYS ACTA, V1172, P175; CORDELL B, 1979, CELL, V18, P533, DOI 10.1016/0092-8674(79)90070-9; DEHAEN C, 1976, J MOL BIOL, V106, P639, DOI 10.1016/0022-2836(76)90256-4; DELTOUR L, 1993, P NATL ACAD SCI USA, V90, P527, DOI 10.1073/pnas.90.2.527; DEVASKAR S, 1989, MOLECULAR AND CELLULAR BIOLOGY OF INSULIN-LIKE GROWTH FACTORS AND THEIR RECEPTORS, P231; DEVASKAR S, 1991, ENDOCRINOLOGY, V129, P1530, DOI 10.1210/endo-129-3-1530; DEVASKAR S, 1992, DEV BRAIN RES, V67, P95, DOI 10.1016/0165-3806(92)90029-V; DEVASKAR SU, 1993, REGUL PEPTIDES, V48, P55, DOI 10.1016/0167-0115(93)90335-6; DEVASKAR SU, 1985, BIOCHEM BIOPH RES CO, V133, P670, DOI 10.1016/0006-291X(85)90957-X; DEVASKAR SU, 1993, BRAIN RES, V605, P101, DOI 10.1016/0006-8993(93)91361-U; DICKINSON CJ, 1993, AM J PHYSIOL, V264, pG553, DOI 10.1152/ajpgi.1993.264.3.G553; DUFFY KR, 1987, BRAIN RES, V420, P32, DOI 10.1016/0006-8993(87)90236-8; FRANK HJL, 1985, DIABETES, V34, P728, DOI 10.2337/diabetes.34.8.728; FRANK HJL, 1986, DIABETES, V35, P654, DOI 10.2337/diabetes.35.6.654; GIDDINGS SJ, 1988, J BIOL CHEM, V263, P3845; GIDDINGS SJ, 1989, J BIOL CHEM, V264, P9462; GIDDINGS SJ, 1985, DIABETOLOGIA, V28, P343; HAVRANKOVA J, 1978, P NATL ACAD SCI USA, V75, P5737, DOI 10.1073/pnas.75.11.5737; JANSEN E, 1991, MOL CELL ENDOCRINOL, V78, P115, DOI 10.1016/0303-7207(91)90192-U; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; LOMEDICO P, 1979, CELL, V18, P545, DOI 10.1016/0092-8674(79)90071-0; MAGNUSON MA, 1989, J BIOL CHEM, V264, P15936; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; MARKS JL, 1990, ENDOCRINOLOGY, V127, P3234, DOI 10.1210/endo-127-6-3234; MITCHELL RL, 1986, CELL, V45, P497, DOI 10.1016/0092-8674(86)90281-3; MUKAI T, 1991, EUR J BIOCHEM, V195, P781, DOI 10.1111/j.1432-1033.1991.tb15766.x; SADIQ F, 1990, ENDOCRINOLOGY, V126, P2417, DOI 10.1210/endo-126-5-2417; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHECHTER R, 1990, J HISTOCHEM CYTOCHEM, V38, P829, DOI 10.1177/38.6.2186089; SCHECHTER R, 1988, ENDOCRINOLOGY, V123, P505, DOI 10.1210/endo-123-1-505; SCHECHTER R, 1992, BRAIN RES, V582, P27, DOI 10.1016/0006-8993(92)90313-X; SCHWARTZ MW, 1991, J CLIN INVEST, V88, P1272, DOI 10.1172/JCI115431; SCHWARTZ MW, 1992, ENDOCR REV, V13, P387, DOI 10.1210/er.13.3.387; THOMPSON RJ, 1973, J NEUROCHEM, V21, P19, DOI 10.1111/j.1471-4159.1973.tb04222.x; VANHOUTEN M, 1979, ENDOCRINOLOGY, V105, P666; YALOW R, 1986, PEPTIDES S20, V7, P17	42	261	270	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8445	8454						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132571				2022-12-27	WOS:A1994NB40900092
J	MUH, U; WILLIAMS, CH; MASSEY, V				MUH, U; WILLIAMS, CH; MASSEY, V			LACTATE MONOOXYGENASE .2. SITE-DIRECTED MUTAGENESIS OF THE POSTULATED ACTIVE-SITE BASE HISTIDINE-290	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINACH GLYCOLATE OXIDASE; BAKERS-YEAST; MECHANISM; FLAVOCYTOCHROME-B2; SEQUENCE; INACTIVATION; RESOLUTION; PROTEINS; BINDING	Lactate monooxygenase catalyzes the oxidation of L-lactate with molecular oxygen to acetate, CO2, and water. Histidine 290 has been proposed to be the active site base in lactate monooxygenase (Giegel, D. A., Williams, C. H., Jr, and Massey, V. (1990) J. Biol. Chem. 265, 6626-6632) and was mutated to a glutamine (H290Q). The mutant enzyme shows properties that support strongly the postulated function of the histidine. The ability of L-lactate to reduce the enzyme flavin is essentially abolished, whereas reoxidation of reduced enzyme with oxygen proceeds at 1.4 x 10(4) M(-1) S-1, a rate essentially like that found in the wild type enzyme. The substrate, L-lactate, is bound with a K-d equal to 2.0 x 10(-2) M, and D-lactate, a competitive inhibitor with a K-d of 3.1 X 10(-3) M. Both values are similar to binding measured in the wild type enzyme. Unlike the situation with wild type enzyme, where the transition state analog oxalate is bound tightly in a two-step reaction involving proton uptake from solution (Ghisla, S., and Massey, V. (1977) J. Biol. Chem. 252, 6729-6735), the mutant enzyme binds oxalate weakly, in a single step reaction, with a K-d in the order of 0.1 M. No effect was observed upon varying the pH, indicating that binding does not include a protonation step. Replacing the histidine also has a significant effect on the ability of the enzyme to stabilize the flavin N(5)-sulfite adduct. Sulfite is bound at least 1000-fold weaker than it is in the wild type enzyme.	UNIV MICHIGAN,SCH MED,DEPT BIOL CHEM,ANN ARBOR,MI 48109; DEPT VET AFFAIRS MED CTR,ANN ARBOR,MI 48105	University of Michigan System; University of Michigan					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM011106, R37GM011106] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 21444, GM-11106] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bevington P. R., 1969, DATA REDUCTION ERROR, P235; CEDERLUND E, 1988, EUR J BIOCHEM, V173, P523, DOI 10.1111/j.1432-1033.1988.tb14029.x; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P6030, DOI 10.1021/bi00393a013; GHISLA S, 1976, BIOCHEMISTRY-US, V15, P1791, DOI 10.1021/bi00654a002; GHISLA S, 1975, J BIOL CHEM, V250, P577; GHISLA S, 1977, J BIOL CHEM, V252, P6729; Ghisla S., 1991, CHEM BIOCH FLAVOENZY, P243; GIEGEL DA, 1990, J BIOL CHEM, V265, P6626; HAYAISHI O, 1957, J AM CHEM SOC, V79, P4809, DOI 10.1021/ja01574a060; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDERER F, 1985, EUR J BIOCHEM, V152, P419, DOI 10.1111/j.1432-1033.1985.tb09213.x; LINDQVIST Y, 1989, J BIOL CHEM, V264, P3624; LOCKRIDGE O, 1972, J BIOL CHEM, V247, P8097; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; MASSEY V, 1977, J BIOL CHEM, V252, P5562; MUH U, 1994, J BIOL CHEM, V269, P7982; MUH U, 1994, J BIOL CHEM, V269, P7994; SCHONBRUNN A, 1976, BIOCHEMISTRY-US, V15, P1798, DOI 10.1021/bi00654a003; VOLOKITA M, 1987, J BIOL CHEM, V262, P15825; WALSH C, 1973, J BIOL CHEM, V248, P7049; WALSH CT, 1972, J BIOL CHEM, V247, P6004; XIA ZX, 1990, J MOL BIOL, V212, P837, DOI 10.1016/0022-2836(90)90240-M; XIA ZX, 1987, P NATL ACAD SCI USA, V84, P2629, DOI 10.1073/pnas.84.9.2629	24	41	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7989	7993						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132519				2022-12-27	WOS:A1994NB40900027
J	REDDY, PMS; STAMATOYANNOPOULOS, G; PAPAYANNOPOULOU, T; SHEN, CKJ				REDDY, PMS; STAMATOYANNOPOULOS, G; PAPAYANNOPOULOU, T; SHEN, CKJ			GENOMIC FOOTPRINTING AND SEQUENCING OF HUMAN BETA-GLOBIN LOCUS - TISSUE-SPECIFICITY AND CELL-LINE ARTIFACT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GAMMA-GLOBIN; DOMINANT CONTROL REGION; PROTEIN DNA INTERACTIONS; LIGATION-MEDIATED PCR; I HYPERSENSITIVE SITE; HUMAN ERYTHROID-CELLS; TRANSGENIC MICE; GENE-EXPRESSION; DEVELOPMENTAL REGULATION; NUCLEAR PROTEINS	In order to gain further insights of the regulatory mechanisms of human beta-like globin gene switch during erythroid development, we have studied protein-DNA interaction in vivo at the human adult beta and fetal gamma globin promoters and their upstream enhancer, 5'HS-2, in purified human adult erythroblasts, in which the beta, but not gamma or epsilon, globin gene is actively transcribing. This genomic footprinting analysis of adult erythroblasts was carried out in conjunction with those of different non-erythroid human tissues, an embryonic/fetal erythroid cell line K562, and several non-erythroid human cell lines. Protein-DNA binding in the beta globin promoter, in particular at the two CACC promoter boxes and the CCAAT box, is detectable only in the adult erythroblasts. As expected, the gamma globin promoters were bound with specific nuclear factors in the expressing K562 cells, but not in non-erythroid tissues or cell lines. Relatively weak protein binding could also be detected in the vicinities of the two CCAAT boxes of the inactive gamma globin promoters in the adult erythroblasts. Although the patterns of nuclear factor-DNA interaction in vivo at the NF-E2/AP1, GATA-1, and GT-I motifs of 5'HS-2 enhancer in adult erythroblasts are similar to those in K562 cells, we have identified a previously undetected factor-binding motif of 5'HS-2 that is protected only in the adult erythroblasts. This motif is identical in sequence to the 3'-CACC box of the human beta globin promoter, and it is well conserved at the same location among all mammalian 5'HS-2 enhancers, suggesting an important regulatory role of this element in human beta globin gene transcription in adult erythroblasts. All of the above four motifs of 5'HS-2 are free of nuclear factor tor binding in non-erythroid tissues, but two of them, NF-ES/AP1 and GT-I, are bound with factors in some non-erythroid cell lines but not in others. The functional implications of these genomic footprinting data and the tissue-specific CpG methylation patterns of the beta-like globin promoters we obtained by genomic sequencing are discussed in terms of positive and negative regulation of the human beta-like globin switch during erythroid development.	UNIV CALIF DAVIS,DIV BIOL SCI,MOLEC & CELL BIOL SECT,DAVIS,CA 95616; UNIV WASHINGTON,SCH MED,DIV MED GENET,SEATTLE,WA 98195	University of California System; University of California Davis; University of Washington; University of Washington Seattle					NHLBI NIH HHS [HL 20899] Funding Source: Medline; NIDDK NIH HHS [DK 45365, DK29800] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL020899, R37HL020899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK045365, R37DK045365, R01DK045365, R01DK029800] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBITAR M, 1991, MOL CELL BIOL, V11, P3786, DOI 10.1128/MCB.11.7.3786; ANTONIOU M, 1990, GENE DEV, V4, P1007, DOI 10.1101/gad.4.6.1007; ARAPINIS C, 1986, EUR J BIOCHEM, V156, P123, DOI 10.1111/j.1432-1033.1986.tb09556.x; BARBERIS A, 1987, CELL, V50, P347, DOI 10.1016/0092-8674(87)90489-2; BEHRINGER RR, 1990, GENE DEV, V4, P380, DOI 10.1101/gad.4.3.380; BERRY M, 1992, NATURE, V358, P499, DOI 10.1038/358499a0; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; CAO SX, 1989, P NATL ACAD SCI USA, V86, P5306, DOI 10.1073/pnas.86.14.5306; CATALA F, 1989, NUCLEIC ACIDS RES, V17, P3811, DOI 10.1093/nar/17.10.3811; CATERINA JJ, 1991, P NATL ACAD SCI USA, V88, P1626, DOI 10.1073/pnas.88.5.1626; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; CHU C, 1993, DNA METHYLATION MOL, P385; COLLINS FS, 1984, PROG NUCLEIC ACID RE, V31, P315, DOI 10.1016/S0079-6603(08)60382-7; CURTIN PT, 1989, P NATL ACAD SCI USA, V86, P7082, DOI 10.1073/pnas.86.18.7082; DASGUPTA A, 1985, BLOOD, V66, P522; DEBOER E, 1988, EMBO J, V7, P4203, DOI 10.1002/j.1460-2075.1988.tb03317.x; DIERKS P, 1983, CELL, V32, P695, DOI 10.1016/0092-8674(83)90055-7; DILLON N, 1991, NATURE, V319, P685; ELLIS J, 1993, EMBO J, V12, P127, DOI 10.1002/j.1460-2075.1993.tb05638.x; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; EVANS T, 1990, ANNU REV CELL BIOL, V6, P95, DOI 10.1146/annurev.cellbio.6.1.95; FORRESTER WC, 1987, NUCLEIC ACIDS RES, V15, P10159, DOI 10.1093/nar/15.24.10159; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; GARRITY PA, 1992, P NATL ACAD SCI USA, V89, P1021, DOI 10.1073/pnas.89.3.1021; GONG QH, 1991, MOL CELL BIOL, V11, P2558, DOI 10.1128/MCB.11.5.2558; GONG QH, 1993, MOL CELL BIOL, V13, P911, DOI 10.1128/MCB.13.2.911; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; GUMUCIO DL, 1988, MOL CELL BIOL, V8, P5310, DOI 10.1128/MCB.8.12.5310; GUTMAN PD, 1992, GENE, V110, P197, DOI 10.1016/0378-1119(92)90648-9; HARDISON R, 1993, NUCLEIC ACIDS RES, V21, P1265, DOI 10.1093/nar/21.5.1265; HARTZOG GA, 1993, MOL CELL BIOL, V13, P44, DOI 10.1128/MCB.13.1.44; IKUTA T, 1991, P NATL ACAD SCI USA, V88, P10188, DOI 10.1073/pnas.88.22.10188; JANE SM, 1992, EMBO J, V11, P2961, DOI 10.1002/j.1460-2075.1992.tb05366.x; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KARLSSON S, 1985, ANNU REV BIOCHEM, V54, P1071; LI QL, 1990, P NATL ACAD SCI USA, V87, P8207, DOI 10.1073/pnas.87.21.8207; LLOYD JA, 1992, MOL CELL BIOL, V12, P1561, DOI 10.1128/MCB.12.4.1561; LLOYD JA, 1989, NUCLEIC ACIDS RES, V17, P4339, DOI 10.1093/nar/17.11.4339; MACDONAGH KT, 1991, J BIOL CHEM, V266, P11965; MANTOVANI R, 1988, NUCLEIC ACIDS RES, V16, P4299, DOI 10.1093/nar/16.10.4299; MARTIN DIK, 1989, NATURE, V338, P435, DOI 10.1038/338435a0; MASTRANGELO IA, 1991, P NATL ACAD SCI USA, V88, P5670, DOI 10.1073/pnas.88.13.5670; MAVILIO F, 1983, P NATL ACAD SCI-BIOL, V80, P6907, DOI 10.1073/pnas.80.22.6907; Maxam A M, 1980, Methods Enzymol, V65, P499; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; MOI P, 1990, P NATL ACAD SCI USA, V87, P9000, DOI 10.1073/pnas.87.22.9000; MOON AM, 1990, P NATL ACAD SCI USA, V87, P7693, DOI 10.1073/pnas.87.19.7693; MOTAMED K, 1993, GENE, V123, P235, DOI 10.1016/0378-1119(93)90129-Q; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; MURRAY EJ, 1987, EMBO J, V6, P2329, DOI 10.1002/j.1460-2075.1987.tb02508.x; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; NEY PA, 1990, GENE DEV, V4, P993, DOI 10.1101/gad.4.6.993; NICOLIS S, 1989, NUCLEIC ACIDS RES, V17, P559; OPPENHEIM A, 1985, BLOOD, V66, P1202; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; PERRINE SP, 1988, FEBS LETT, V228, P139, DOI 10.1016/0014-5793(88)80603-3; PFEIFER GP, 1989, SCIENCE, V246, P810, DOI 10.1126/science.2814502; PHILIPSEN S, 1990, EMBO J, V9, P2159, DOI 10.1002/j.1460-2075.1990.tb07385.x; RAICH N, 1992, BLOOD, V79, P861; REDDY PMS, 1993, MOL CELL BIOL, V13, P1093, DOI 10.1128/MCB.13.2.1093; REDDY PMS, 1991, P NATL ACAD SCI USA, V88, P8676, DOI 10.1073/pnas.88.19.8676; RYAN TM, 1989, GENE DEV, V3, P314, DOI 10.1101/gad.3.3.314; SALUZ HP, 1990, LABORATORY GUIDE IN, P52; SHIH DM, 1990, NUCLEIC ACIDS RES, V18, P5465, DOI 10.1093/nar/18.18.5465; SORRENTINO B, 1990, NUCLEIC ACIDS RES, V18, P2721, DOI 10.1093/nar/18.9.2721; STAMATOYANNOPOULOS G, 1991, SCIENCE, V252, P383, DOI 10.1126/science.2017679; STRAUSS EC, 1992, MOL CELL BIOL, V12, P2135, DOI 10.1128/MCB.12.5.2135; STRAUSS EC, 1992, P NATL ACAD SCI USA, V89, P5809, DOI 10.1073/pnas.89.13.5809; TALBOT D, 1990, EMBO J, V9, P2169, DOI 10.1002/j.1460-2075.1990.tb07386.x; TALBOT D, 1991, EMBO J, V10, P1391, DOI 10.1002/j.1460-2075.1991.tb07659.x; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; TUAN DYH, 1989, P NATL ACAD SCI USA, V86, P2554, DOI 10.1073/pnas.86.8.2554; VANDERPLOEG LHT, 1980, CELL, V19, P947, DOI 10.1016/0092-8674(80)90086-0; VYAS P, 1992, BLOOD, V80, P1832; WARD C, 1990, J BIOL CHEM, V265, P3030; WATT P, 1993, GENE EXP, V3, P65; XIAO JH, 1987, GENE DEV, V1, P794, DOI 10.1101/gad.1.8.794; YISRAELI J, 1988, P NATL ACAD SCI USA, V85, P4638, DOI 10.1073/pnas.85.13.4638; YU CY, 1991, J BIOL CHEM, V266, P8907; ZHANG QY, 1993, MOL CELL BIOL, V13, P2298, DOI 10.1128/MCB.13.4.2298	82	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8287	8295						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132552				2022-12-27	WOS:A1994NB40900069
J	LE, AQ; STEINER, JL; FERRELL, GA; SHAKER, JC; SIFERS, RN				LE, AQ; STEINER, JL; FERRELL, GA; SHAKER, JC; SIFERS, RN			ASSOCIATION BETWEEN CALNEXIN AND A SECRETION-INCOMPETENT VARIANT OF HUMAN ALPHA(1)-ANTITRYPSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; ALPHA-1-PROTEINASE INHIBITOR; HUMAN ALPHA-1-ANTITRYPSIN; TRANSGENIC MICE; PROTEIN; TISSUE; ACCUMULATION; DEGRADATION; TRANSPORT; EMPHYSEMA	The naturally occurring null(Hong Kong) variant of human alpha 1-antitrypsin is truncated at its carboxyl terminus, and is retained and degraded in a pre-Gels compartment of stably transfected murine hepatoma cells (Le, A., Graham, K. S., and Sifers, R. N. (1990) J. Biol. Chen. 265, 14001-14007). Long-term metabolic radiolabeling with [S-35]methionine or [P-32]orthophosphate in combination with low stringency immunoprecipitation of the null(Hong Kong) variant has resulted in the co-precipitation of a radiolabeled 90-kDa protein designated p90. Several criteria, including mobility in SDS-polyacrylamide gel electrophoresis, absence of asparagine-linked oligosaccharides, and immunoreactivity with peptide-specific antiserum, have indicated that co-precipitating p90 is identical to calnexin, a calcium-binding phosphoprotein of the endoplasmic reticulum membrane (Wada, I. W., Rindress, P. H., Ou, W. J., Doherty, J. J., Louvard, D., Bell, A. W., Dignard, D., Thomas, D. Y., and Bergeron, J. J. M. (1991) J. Biol. Chem. 266, 19599-19610). Finally, results from co-immunoprecipitation analyses and velocity sedimentation experiments have verified that approximately 30% of the retained null(Hong Kong) variant polypeptides are associated with calnexin in a 1:1 molar ratio and can be dissociated with either deoxycholate or chelation of calcium ions at 37 degrees C. Overall, these findings may extend our current understanding of the molecular pathogenesis of serum alpha 1-antitrypsin deficiency.	BAYLOR COLL MED, DEPT PATHOL, MOLEC PATHOBIOL SECT, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT CELL BIOL, HOUSTON, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine			Sifers, Richard Norman/AGQ-7262-2022		NIDDK NIH HHS [DK42806] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK042806] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHLUWALIA N, 1992, J BIOL CHEM, V267, P10914; BRANTLY M, 1988, AM J MED, V84, P13; BRODBECK RM, 1992, J BIOL CHEM, V267, P294; CALA SE, 1993, J BIOL CHEM, V268, P2969; CARLSON JA, 1988, J CLIN INVEST, V82, P26, DOI 10.1172/JCI113580; Carrell R.W, 1986, PROTEINASE INHIBITOR, P403; DEGEN E, 1992, J EXP MED, V175, P1653, DOI 10.1084/jem.175.6.1653; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; FABBRETTI G, 1992, LIVER, V12, P296; GADEK JE, 1981, J CLIN INVEST, V68, P889, DOI 10.1172/JCI110344; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GRAHAM KS, 1990, J BIOL CHEM, V265, P20463; HANCE AJ, 1975, AM REV RESPIR DIS, V112, P657; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; JANOFF A, 1977, AM REV RESPIR DIS, V115, P461; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; LE A, 1990, J BIOL CHEM, V265, P14001; LE AQ, 1992, J BIOL CHEM, V267, P1072; LODISH HF, 1987, J CELL BIOL, V104, P221, DOI 10.1083/jcb.104.2.221; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LOMAS DA, 1993, J BIOL CHEM, V268, P15333; LONG GL, 1984, BIOCHEMISTRY-US, V23, P4828, DOI 10.1021/bi00316a003; MAZZARELLA RA, 1987, J BIOL CHEM, V262, P8875; OU WJ, 1992, J BIOL CHEM, V267, P23789; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; ROTHMAN JE, 1987, CELL, V50, P521, DOI 10.1016/0092-8674(87)90024-9; SENIOR RM, 1977, AM REV RESPIR DIS, V116, P469, DOI 10.1164/arrd.1977.116.3.469; SIFERS RN, 1992, NATURE, V357, P541, DOI 10.1038/357541a0; SIFERS RN, 1987, NUCLEIC ACIDS RES, V15, P1459, DOI 10.1093/nar/15.4.1459; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; SIFERS RN, 1989, AM J RESP CELL MOL, V1, P341, DOI 10.1165/ajrcmb/1.5.341; WADA I, 1991, J BIOL CHEM, V266, P19599; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8	35	105	106	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7514	7519						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125971				2022-12-27	WOS:A1994NA03200076
J	MATSUSHITA, T; KOJIMA, T; EMI, N; TAKAHASHI, I; SAITO, H				MATSUSHITA, T; KOJIMA, T; EMI, N; TAKAHASHI, I; SAITO, H			IMPAIRED HUMAN TISSUE FACTOR-MEDIATED ACTIVITY IN BLOOD-CLOTTING FACTOR-VII(NAGOYA) (ARG(304)-]TRP) - EVIDENCE THAT A REGION IN THE CATALYTIC DOMAIN OF FACTOR-VII IS IMPORTANT FOR THE ASSOCIATION WITH TISSUE FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION FACTOR-VII; BOVINE FACTOR-VII; FACTOR-IX; FACTOR-X; ENZYMATIC AMPLIFICATION; HAGEMAN-FACTOR; FACTOR PATHWAY; ACTIVATION; DEFICIENCY; PROTEIN	A 37-year-old man was found to have an inherited abnormal factor VII (FVII) (designated FVIINagoya) that has a lower FVII procoagulant activity when tested in a one-stage assay using rabbit, simian, or human tissue factor (TF), but surprisingly has a nearly normal activity using bovine TF. DNA sequence analysis of the propositus' FVII gene revealed a C to T mutation that results in a novel amino acid substitution of Arg(304) to Trp. Restriction enzyme analysis of the amplified fragment obtained from each family member demonstrated that the patient is homozygous for the point mutation, and the mother and sister of the patient are heterozygous for this mutation. To elucidate the abnormality in FVIINagoya, we compared the recombinant mutant FVII with normal FVII. In the presence of human TF, kinetic analyses demonstrated that the apparent K-m values of FVIINagoya for factor Xa-mediated FVII activation and for FVIIa-mediated factor X (FX) activation were 3.6- and 4.5-fold higher than those of normal FVII, respectively. The ligand binding assay to human TF also showed that FVIINagoya had a 5.2-fold larger apparent K-d than normal. In the presence of bovine TF, however, these values showed no difference between normal and mutant FVII. These findings indicate that the major abnormality in FVIINagoya is not a catalytic dysfunction but an impaired complex-formation of human TF.FVII.FX, suggesting the importance of Arg(304) in the interaction with human TF.	NAGOYA UNIV, SCH MED, DEPT INTERNAL MED 1, SHOWA KU, NAGOYA, AICHI 466, JAPAN; JAPANESE RED CROSS, AICHI BLOOD CTR, SETO, AICHI 489, JAPAN; AICHI JURID FDN BLOOD DIS RES, NAGOYA, AICHI 463, JAPAN	Nagoya University; Japanese Red Cross Medical Center			Matsushita, Tadadshi/I-7349-2014; Kojima, Tetsuhito/I-6271-2014	Kojima, Tetsuhito/0000-0002-1905-1065				AMEMIYA Y, 1988, NATURE, V336, P89, DOI 10.1038/336089a0; ARDREWS BS, 1991, TRENDS BIOCHEM SCI, V16, P31; BAJAJ SP, 1981, J BIOL CHEM, V256, P253; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; BROZE GJ, 1980, J BIOL CHEM, V255, P1242; CARSON SD, 1980, THROMB HAEMOSTASIS, V44, P12; CHAING SH, 1990, BLOOD, V76, pA417; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Davie E W, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P277; EMI N, 1991, J VIROL, V65, P1202, DOI 10.1128/JVI.65.3.1202-1207.1991; FREER ST, 1970, BIOCHEMISTRY-US, V9, P1997, DOI 10.1021/bi00811a022; GIROLAMI A, 1977, BLOOD, V50, P603; GIROLAMI A, 1978, J LAB CLIN MED, V91, P387; GIROLAMI A, 1979, BLOOD, V54, P46; HAGEN FS, 1986, P NATL ACAD SCI USA, V83, P2412, DOI 10.1073/pnas.83.8.2412; JAMES HL, 1991, BLOOD, V77, P317; JAMES HL, 1991, THROMB HAEMOSTASIS, V65, P937; JANSON TL, 1984, HAEMOSTASIS, V14, P440; KAMIYA T, 1986, BLOOD, V67, P406; KISIEL W, 1977, BIOCHEMISTRY-US, V16, P4189, DOI 10.1021/bi00638a009; KISIEL W, 1981, THROMB RES, V22, P375, DOI 10.1016/0049-3848(81)90130-4; KOMIYAMA Y, 1990, BIOCHEMISTRY-US, V29, P9418, DOI 10.1021/bi00492a016; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUSHITA T, 1990, J LAB CLIN MED, V116, P492; MATSUSHITA T, 1991, BLOOD S, V78, pA181; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; NAKAGAKI T, 1991, BIOCHEMISTRY-US, V30, P10819, DOI 10.1021/bi00109a001; NAKAGAKI T, 1992, THROMB RES, V65, P105, DOI 10.1016/0049-3848(92)90230-8; NEMERSON Y, 1985, THROMB RES, V40, P351, DOI 10.1016/0049-3848(85)90270-1; NEMERSON Y, 1988, BLOOD, V71, P1; NEWMAN PJ, 1988, J CLIN INVEST, V82, P739, DOI 10.1172/JCI113656; OBRIEN DP, 1991, BLOOD, V78, P132; OHARA PJ, 1987, P NATL ACAD SCI USA, V84, P5158, DOI 10.1073/pnas.84.15.5158; OSTERUD B, 1977, P NATL ACAD SCI USA, V74, P5260, DOI 10.1073/pnas.74.12.5260; PEDERSEN AH, 1989, BIOCHEMISTRY-US, V28, P9331, DOI 10.1021/bi00450a013; RADCLIFFE R, 1977, BLOOD, V50, P611; RADCLIFFE R, 1976, J BIOL CHEM, V251, P4797; RADCLIFFE R, 1975, J BIOL CHEM, V250, P388; RAO LVM, 1988, P NATL ACAD SCI USA, V85, P6687, DOI 10.1073/pnas.85.18.6687; RAO LVM, 1985, BLOOD, V65, P218; RAPAPORT SI, 1991, ANN NY ACAD SCI, V614, P51, DOI 10.1111/j.1749-6632.1991.tb43691.x; RUF W, 1991, J BIOL CHEM, V266, P15719; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAKAI T, 1990, J BIOL CHEM, V265, P1890; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SUGIURA M, 1982, JPN J CLIN CHEM, V11, P83; TAKAHASHI I, 1991, J LAB CLIN MED, V118, P317; TAKAMIYA O, 1988, CLIN LAB HAEMATOL, V10, P159; TAKAYENOKI Y, 1991, BIOCHEM BIOPH RES CO, V181, P1145, DOI 10.1016/0006-291X(91)92058-R; TOOMEY JR, 1991, J BIOL CHEM, V266, P19198; TRIPLETT DA, 1985, BLOOD, V66, P1284; WILDGOOSE P, 1989, BLOOD, V73, P1888; YAMAMOTO K, 1992, J CLIN INVEST, V90, P2439, DOI 10.1172/JCI116135; YAMAMOTO M, 1992, J BIOL CHEM, V267, P19089	54	64	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7355	7363						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125953				2022-12-27	WOS:A1994NA03200052
J	TAKEI, H; GAT, Y; ROTHMAN, Z; LEWIS, A; SHEVES, M				TAKEI, H; GAT, Y; ROTHMAN, Z; LEWIS, A; SHEVES, M			ACTIVE-SITE LYSINE BACKBONE UNDERGOES CONFORMATIONAL-CHANGES IN THE BACTERIORHODOPSIN PHOTOCYCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; N INTERMEDIATE; BINDING-SITE; PROTEIN; RHODOPSIN; MEMBRANE; SPECTRA; MODEL	Results are presented demonstrating that the backbone of the active site lysine of bacteriorhodopsin undergoes light-induced structural alterations during bacteriorhodopsin-mediated light-induced proton pumping. This conclusion is based on difference Fourier transform infrared spectroscopy of isotopically labeled bacteriorhodopsin. The data demonstrate that the backbone carbonyl of lysine achieves an extremely low vibrational frequency during M(412) intermediate formation. This is preceded by a structural transition in the lysine backbone that leads to an active site lysine carbonyl with the observed low vibrational frequency, probably due to a high degree of solvation.	CORNELL UNIV,DEPT APPL PHYS,ITHACA,NY 14853; WEIZMANN INST SCI,DEPT ORGAN CHEM,IL-76100 REHOVOT,ISRAEL; HEBREW UNIV HOSP,HADASSAH LASER CTR,DEPT OPHTHALMOL,EIN KEREM,ISRAEL	Cornell University; Weizmann Institute of Science								ARGADE PV, 1981, P NATL ACAD SCI-BIOL, V78, P1643, DOI 10.1073/pnas.78.3.1643; BALASHOV SP, 1981, BIOPHYSICS-USSR, V26, P566; BIRGE RR, 1990, BIOCHIM BIOPHYS ACTA, V1016, P293, DOI 10.1016/0005-2728(90)90163-X; BRAIMAN MS, 1988, ANNU REV BIOPHYS BIO, V17, P541; DICAPUA FM, 1991, J AM CHEM SOC, V113, P6145, DOI 10.1021/ja00016a034; FODOR SPA, 1988, BIOCHEMISTRY-US, V27, P7097, DOI 10.1021/bi00418a064; GAT Y, 1992, P NATL ACAD SCI USA, V89, P2434, DOI 10.1073/pnas.89.6.2434; GERWERT K, 1990, FEBS LETT, V261, P449, DOI 10.1016/0014-5793(90)80613-N; KATRE NV, 1981, P NATL ACAD SCI-BIOL, V78, P4068, DOI 10.1073/pnas.78.7.4068; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; LEMKE HD, 1981, FEBS LETT, V128, P255, DOI 10.1016/0014-5793(81)80093-2; LEWIS A, 1974, P NATL ACAD SCI USA, V71, P4462, DOI 10.1073/pnas.71.11.4462; LEWIS A, 1973, J CHEM PHYS, V58, P3661, DOI 10.1063/1.1679716; LEWIS A, 1971, MACROMOLECULES, V4, P539, DOI 10.1021/ma60023a003; MAEDA A, 1991, PHOTOCHEM PHOTOBIOL, V54, P911, DOI 10.1111/j.1751-1097.1991.tb02111.x; MATHIES R, 1990, BIOL APPLICATIONS RA, V2, P59; MCMASTER E, 1988, BIOCHEM BIOPH RES CO, V156, P86, DOI 10.1016/S0006-291X(88)80808-8; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OTTOLENGHI M, 1989, J MEMBRANE BIOL, V112, P193, DOI 10.1007/BF01870951; PAPADOPOULOS G, 1990, J MOL BIOL, V214, P15, DOI 10.1016/0022-2836(90)90140-H; PFEFFERLE JM, 1991, BIOCHEMISTRY-US, V30, P6548, DOI 10.1021/bi00240a027; ROTHSCHILD KJ, 1992, J BIOENERG BIOMEMBR, V24, P147, DOI 10.1007/BF00762674; SUBRAMANIAM S, 1993, EMBO J, V12, P1; SUNDARALINGAM M, 1989, SCIENCE, V244, P1333, DOI 10.1126/science.2734612; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; TAKEI H, 1992, BIOPHYS J, V63, P1643, DOI 10.1016/S0006-3495(92)81757-5; UNWIN P, 1975, NATURE, V257, P28	28	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7387	7389						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125956				2022-12-27	WOS:A1994NA03200056
J	TILL, JH; ANNAN, RS; CARR, SA; MILLER, WT				TILL, JH; ANNAN, RS; CARR, SA; MILLER, WT			USE OF SYNTHETIC PEPTIDE LIBRARIES AND PHOSPHOPEPTIDE-SELECTIVE MASS-SPECTROMETRY TO PROBE PROTEIN-KINASE SUBSTRATE-SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; BASIC RESIDUES; PP60V-SRC; MIXTURES; SEQUENCE; LIGANDS; MOTIFS; SITES; VIRUS	To search for peptides which serve as substrates for protein kinases, an approach based on peptide libraries has been developed. These peptide libraries are chemically synthesized by a modified ''divide-couple-recombine'' strategy. After reaction with the kinase of interest, the most highly phosphorylated substrate (selected from the library) is identified using on-line liquid chromatography-electrospray mass spectrometry (LC-ESMS). Negative ion LC-ESMS with stepped collision energy is used to identify phosphorylated peptides in the enzyme reactions. As predicted, the cAMP-dependent protein kinase is shown to preferentially phosphorylate Kemptide (Leu-Arg-Arg-Ala-Ser-Leu-Gly) in a library consisting of 19 variants of Kemptide substituted at position 2. Additional experiments have been carried out on the nonreceptor tyrosine kinase v-Abl using a peptide library based on the v-Src autophosphorylation site (Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly). These results indicate that Ile is the optimal residue at the position N-terminal to tyrosine. Individual peptides containing the Glu-Asp-Ala-Ile-Tyr motif have V-max/K-m values 6-fold higher than the peptide based on the autophosphorylation site itself, confirming the results of the library experiments. This motif has been identified in several tyrosine kinases at a position in the sequence not previously reported to serve as a phosphorylation or autophosphorylation site.	SUNY STONY BROOK, SCH MED, DEPT PHYSIOL & BIOPHYS, STONY BROOK, NY 11794 USA; SMITHKLINE BEECHAM PHARMACEUT INC, DEPT PHYS & STRUCT CHEM, KING OF PRUSSIA, PA USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; GlaxoSmithKline			Carr, Steven A./AAH-8366-2019					Barany G, 1979, PEPTIDES           A, V2, P1; BERMAN J, 1992, J BIOL CHEM, V267, P1434; BIRKETT AJ, 1991, ANAL BIOCHEM, V196, P137, DOI 10.1016/0003-2697(91)90129-H; CARR SA, 1993, PROTEIN SCI, V2, P183; CASNELLIE JE, 1984, ADV ENZYME REGUL, V22, P501, DOI 10.1016/0065-2571(84)90028-1; CASNELLIE JE, 1991, METHOD ENZYMOL, V200, P115; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; Fersht AR., 1977, ENZYME STRUCTURE MEC; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; GARCIA P, 1993, J BIOL CHEM, V268, P25146; GEAHLEN RL, 1990, PEPT PROT PHOSPH, P239; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0; HUDDLESTON MJ, 1993, J AM SOC MASS SPECTR, V4, P710, DOI 10.1016/1044-0305(93)80049-5; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; KEMP BE, 1975, P NATL ACAD SCI USA, V72, P3448, DOI 10.1073/pnas.72.9.3448; KEMP BE, 1977, J BIOL CHEM, V252, P4888; PATSCHINSKY T, 1982, P NATL ACAD SCI-BIOL, V79, P973, DOI 10.1073/pnas.79.4.973; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PETITHORY JR, 1991, P NATL ACAD SCI USA, V88, P11510, DOI 10.1073/pnas.88.24.11510; PIKE LJ, 1982, P NATL ACAD SCI-BIOL, V79, P1443, DOI 10.1073/pnas.79.5.1443; RADZIEJEWSKI C, 1989, BIOCHEMISTRY-US, V28, P9047, DOI 10.1021/bi00449a013; SCHELLENBERGER V, 1993, BIOCHEMISTRY-US, V32, P4349, DOI 10.1021/bi00067a026; SCHELLENBERGER V, 1993, BIOCHEMISTRY-US, V32, P4344, DOI 10.1021/bi00067a025; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; Stewart JM, 1984, SOLID PHASE PEPTIDE; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TINKER DA, 1988, J BIOL CHEM, V263, P5024; TJOENG FS, 1990, INT J PEPT PROT RES, V35, P141; YONEMOTO WM, 1991, METHOD ENZYMOL, V200, P581; ZETTERQVIST O, 1976, BIOCHEM BIOPH RES CO, V70, P696, DOI 10.1016/0006-291X(76)90648-3; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZUCKERMANN RN, 1992, P NATL ACAD SCI USA, V89, P4505, DOI 10.1073/pnas.89.10.4505	34	86	90	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7423	7428						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125961				2022-12-27	WOS:A1994NA03200062
J	HUBER, HE; GOODHART, PJ; HUANG, PS				HUBER, HE; GOODHART, PJ; HUANG, PS			RETINOBLASTOMA PROTEIN REVERSES DNA BENDING BY TRANSCRIPTION FACTOR E2F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MYC PROMOTER; GENE-PRODUCT; BINDING PROTEIN; C-MYC; OPPOSITE ORIENTATIONS; TRANS-ACTIVATION; ESCHERICHIA-COLI; COMPLEX; SITE; RB	E2F is a mammalian transcription factor involved in cell cycle regulation. The retinoblastoma gene product, pRB, binds to E2F in a cell cycle-dependent manner and appears to turn E2F from a transcriptional activator into a repressor. We show here that in vitro binding of pRB has three major effects on the DNA binding properties of E2F affinity-purified from HeLa cells; pRB binding increases the half-life of E2F.DNA complexes 10-15-fold, it reduces E2F specific DNA binding in the presence of nonspecific DNA by sequestering E2F, and it partially reverses the DNA bending induced by E2F, Upon specific DNA binding, E2F induces a DNA bend with a flexure angle of 125 degrees. Both full-length pRB105 and the N-terminally truncated pRB60 bind to the E2F DNA complex with a K-d,K-app of 150 pM and reduce the apparent DNA bending to less than 80 degrees. DNA footprinting analysis indicates that the nonspecific DNA binding activity of pRB is not involved in this effect. Our biochemical data suggest that transcriptional activation by E2F may involve DNA bending and that the reversal of bending upon binding of pRB may turn E2F into a repressor.			HUBER, HE (corresponding author), MERCK SHARP & DOHME LTD,RES LABS,DEPT CANC RES,BLDG WP16-3,W POINT,PA 19486, USA.							ARROYO M, 1992, NUCLEIC ACIDS RES, V20, P5947, DOI 10.1093/nar/20.22.5947; BAGCHI S, 1991, CELL, V65, P1063, DOI 10.1016/0092-8674(91)90558-G; BANDARA LR, 1991, NATURE, V352, P249, DOI 10.1038/352249a0; BLAKE MC, 1989, MOL CELL BIOL, V9, P4994, DOI 10.1128/MCB.9.11.4994; BRACCO L, 1989, EMBO J, V8, P4289, DOI 10.1002/j.1460-2075.1989.tb08615.x; BRENOWITZ M, 1988, CURRENT PROTOCOLS MO, V2; CAO L, 1992, NATURE, V355, P176, DOI 10.1038/355176a0; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHITTENDEN T, 1991, CELL, V65, P1073, DOI 10.1016/0092-8674(91)90559-H; CHITTENDEN T, 1993, MOL CELL BIOL, V13, P3975, DOI 10.1128/MCB.13.7.3975; CROTHERS DM, 1991, METHOD ENZYMOL, V208, P118; DALTON S, 1992, EMBO J, V11, P1797, DOI 10.1002/j.1460-2075.1992.tb05231.x; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; EDWARDS GM, 1992, J BIOL CHEM, V267, P7971; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; FLEMINGTON EK, 1993, P NATL ACAD SCI USA, V90, P6914, DOI 10.1073/pnas.90.15.6914; GARTENBERG MR, 1991, J MOL BIOL, V219, P217, DOI 10.1016/0022-2836(91)90563-L; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GIRLING R, 1993, NATURE, V362, P83, DOI 10.1038/362083a0; HAMEL PA, 1992, MOL CELL BIOL, V12, P3431, DOI 10.1128/MCB.12.8.3431; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; HIEBERT SW, 1989, P NATL ACAD SCI USA, V86, P3594, DOI 10.1073/pnas.86.10.3594; HUANG PS, 1993, MOL CELL BIOL, V13, P953, DOI 10.1128/MCB.13.2.953; HUBER HE, 1993, P NATL ACAD SCI USA, V90, P3525, DOI 10.1073/pnas.90.8.3525; IVEYHOYLE M, 1993, MOL CELL BIOL, V13, P7802, DOI 10.1128/MCB.13.12.7802; JONES N, 1990, CELL, V61, P9, DOI 10.1016/0092-8674(90)90207-U; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KATO J, 1993, GENE DEV, V7, P331; KERPPOLA TK, 1991, SCIENCE, V254, P1210, DOI 10.1126/science.1957173; KERPPOLA TK, 1991, CELL, V66, P317, DOI 10.1016/0092-8674(91)90621-5; KING IN, 1993, J BIOL CHEM, V268, P495; KONIG H, 1992, EMBO J, V11, P2241, DOI 10.1002/j.1460-2075.1992.tb05283.x; LEE WH, 1987, NATURE, V329, P642, DOI 10.1038/329642a0; NEVINS JR, 1992, SCIENCE, V258, P424; NEVINS JR, 1994, IN PRESS CELL; OUELLETTE MM, 1992, ONCOGENE, V7, P1075; PEARSON BE, 1991, MOL CELL BIOL, V11, P2081, DOI 10.1128/MCB.11.4.2081; PEREZMARTIN J, 1993, SCIENCE, V260, P805, DOI 10.1126/science.8387228; QIAN YY, 1992, MOL CELL BIOL, V12, P5363, DOI 10.1128/MCB.12.12.5363; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; RAY SK, 1992, MOL CELL BIOL, V12, P4327, DOI 10.1128/MCB.12.10.4327; RUSTGI AK, 1991, NATURE, V352, P541, DOI 10.1038/352541a0; SCHRECK R, 1990, NUCLEIC ACIDS RES, V18, P6497, DOI 10.1093/nar/18.22.6497; SHAN B, 1992, MOL CELL BIOL, V12, P5620, DOI 10.1128/MCB.12.12.5620; SHIRODKAR S, 1992, CELL, V68, P157, DOI 10.1016/0092-8674(92)90214-W; STAMMERS DK, 1991, FEBS LETT, V283, P298, DOI 10.1016/0014-5793(91)80613-8; STIRDIVANT SM, 1992, MOL CELL BIOL, V12, P1905, DOI 10.1128/MCB.12.5.1905; STIRDIVANT SM, 1992, J BIOL CHEM, V267, P14846; THALMEIER K, 1989, GENE DEV, V3, P527, DOI 10.1101/gad.3.4.527; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; VANDERVLIET PC, 1993, BIOESSAYS, V15, P25, DOI 10.1002/bies.950150105; WANG NP, 1990, CELL GROWTH DIFFER, V1, P233; WECHSLER DS, 1992, P NATL ACAD SCI USA, V89, P7635, DOI 10.1073/pnas.89.16.7635; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; YEE AS, 1987, EMBO J, V6, P2061, DOI 10.1002/j.1460-2075.1987.tb02471.x; ZAMANIAN M, 1992, EMBO J, V11, P2603, DOI 10.1002/j.1460-2075.1992.tb05325.x	61	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6999	7005						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120063				2022-12-27	WOS:A1994MZ50300112
J	LI, Z; MEIGHEN, EA				LI, Z; MEIGHEN, EA			THE TURNOVER OF BACTERIAL LUCIFERASE IS LIMITED BY A SLOW DECOMPOSITION OF THE TERNARY ENZYME-PRODUCT COMPLEX OF LUCIFERASE, FMN, AND FATTY-ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE; VIBRIO-HARVEYI; SUBUNIT; GENE	Bacterial luciferase catalyzes the conversion of reduced flavin mononucleotide, O-2, and fatty aldehyde to FMN, H2O, and fatty acid with light being emitted at a very low rate characterized by the decay of luminescence in single turnover flash assays, The present studies have now revealed that the decomposition of the ternary complex of luciferase with FMN and myristic acid occurs at a rate 10-15 times slower than the decay of luminescence and that functional luciferase is only regenerated after the release of flavin. In contrast, the rate of FMN dissociation and recovery of activity observed with a binary luciferase-FMN complex was more rapid indicating that release of fatty acid played the critical role in determining the rate of FMN dissociation from the ternary complex. Decomposition of the ternary complex was shown to occur by an ordered process involving the slow release of fatty acid followed by the more rapid release of flavin. The present results suggest that the rate-limiting step for the turnover of luciferase occurs subsequent to emission of light and would be the controlling step under conditions (e.g. in cells) with continuous light emission.	MCGILL UNIV,DEPT BIOCHEM,MONTREAL H3G 1Y6,PQ,CANADA	McGill University								ABOUKHAIR NK, 1985, BIOCHEMISTRY-US, V24, P3942, DOI 10.1021/bi00336a021; BALDWIN TO, 1975, J BIOL CHEM, V250, P2763; BALDWIN TO, 1992, CHEM BIOCH FLAVOENZY, V3; COHN DH, 1985, J BIOL CHEM, V260, P6139; GUNSALUSMIGUEL A, 1972, J BIOL CHEM, V247, P398; HASTINGS JW, 1963, J OPT SOC AM, V53, P1410, DOI 10.1364/JOSA.53.001410; HASTINGS JW, 1963, J BIOL CHEM, V238, P2537; HASTINGS JW, 1973, P NATL ACAD SCI USA, V70, P3468, DOI 10.1073/pnas.70.12.3468; HASTINGS JW, 1966, IBOLUMINESCENCE PROG, P151; JOHNSTON TC, 1986, J BIOL CHEM, V261, P4805; LEE J, 1988, BIOCHEMISTRY-US, V27, P4862, DOI 10.1021/bi00413a042; LI Z, 1992, BIOCHEM BIOPH RES CO, V188, P498; MEIGHEN EA, 1971, J BIOL CHEM, V246, P7666; MEIGHEN EA, 1993, ADV MICROB PHYSIOL, V34, P1, DOI 10.1016/S0065-2911(08)60027-2; MITCHELL GW, 1971, ANAL BIOCHEM, V39, P243, DOI 10.1016/0003-2697(71)90481-7; SZITTNER R, 1990, J BIOL CHEM, V265, P16581; ULITZUR S, 1978, P NATL ACAD SCI USA, V75, P266, DOI 10.1073/pnas.75.1.266; ZIEGLERNICOLI M, 1974, J BIOL CHEM, V249, P2385	18	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6640	6644						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120017				2022-12-27	WOS:A1994MZ50300060
J	DAVINO, R; CARUSO, C; TAMBURRINI, M; ROMANO, M; RUTIGLIANO, B; DELAURETO, PP; CAMARDELLA, L; CARRATORE, V; DIPRISCO, G				DAVINO, R; CARUSO, C; TAMBURRINI, M; ROMANO, M; RUTIGLIANO, B; DELAURETO, PP; CAMARDELLA, L; CARRATORE, V; DIPRISCO, G			MOLECULAR CHARACTERIZATION OF THE FUNCTIONALLY DISTINCT HEMOGLOBINS OF THE ANTARCTIC FISH TREMATOMUS-NEWNESI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; NOTOTHENIA-CORIICEPS-NEGLECTA; SINGLE HEMOGLOBIN; CYPRINUS-CARPIO; LIGAND-BINDING; ALPHA-CHAIN; PURIFICATION; KINETICS	Antarctic fish of the family Nototheniidae usually have a single major hemoglobin (Hb 1), often a second, minor component (Hb 2, about 5% of the total), and traces of another component (Hb C, less than 1%). These are functionally similar Bohr and Root effect hemoglobins. All species of other highly endemic fish families so far investigated also have one single major hemoglobin. The hematological features of the nototheniid Trematomus newnesi are remarkably different. It is the only Antarctic species in which Hb 1 and Hb 2 display only a very weak Bohr effect and no Root effect. Perhaps consequentially, Hb C (the only component showing regulation of oxygen binding by protons and other effectors) is not present in traces but accounts for 20-25% of the total. The primary structure of the three hemoglobins of T. newnesi and of Root effect HbC present in trace amounts in another nototheniid (Pagothenia bernacchii) is discussed in relationship with oxygen binding and in terms of molecular and stereochemical models. The hemoglobin multiplicity, the oxygen binding features of Hb 1 and Hb 2, and the presence of functionally distinct components, thus reveal that the oxygen transport of T. newnesi has unique characteristics.	CNR,INST PROT BIOCHEM & ENZYMOL,VIA MARCONI 10,I-80125 NAPLES,ITALY; CNR,INST PROT BIOCHEM & ENZYMOL,I-80125 NAPLES,ITALY	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)				Caruso, Carla/0000-0002-2482-8254; TAMBURRINI, MAURIZIO/0000-0001-5987-0957				ARNONE A, 1972, NATURE, V237, P146, DOI 10.1038/237146a0; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Brunori M, 1975, Curr Top Cell Regul, V9, P1; CAMARDELLA L, 1992, J MOL BIOL, V224, P449, DOI 10.1016/0022-2836(92)91007-C; CAMARDELLA L, 1990, 5TH NAT M PROT 90 UR; CARUSO C, 1992, COMP BIOCHEM PHYS B, V102, P941, DOI 10.1016/0305-0491(92)90106-2; CARUSO C, 1991, BIOCHIM BIOPHYS ACTA, V1078, P273, DOI 10.1016/0167-4838(91)90569-L; d'Avino R., 1991, P15; DAVINO R, 1990, COMP BIOCHEM PHYS B, V97, P803, DOI 10.1016/0305-0491(90)90125-D; DAVINO R, 1989, EUR J BIOCHEM, V179, P707, DOI 10.1111/j.1432-1033.1989.tb14604.x; DAVINO R, 1989, EUR J BIOCHEM, V179, P699, DOI 10.1111/j.1432-1033.1989.tb14603.x; DAVINO R, 1988, COMP BIOCHEM PHYS B, V90, P579, DOI 10.1016/0305-0491(88)90298-2; DAVINO R, 1992, POLAR BIOL, V2, P135; DIPRISCO G, 1991, TRENDS BIOCHEM SCI, V16, P471, DOI 10.1016/0968-0004(91)90182-U; DIPRISCO G, 1988, COMP BIOCHEM PHYS B, V90, P631, DOI 10.1016/0305-0491(88)90304-5; DIPRISCO G, 1988, COMP BIOCHEM PHYS B, V90, P585, DOI 10.1016/0305-0491(88)90299-4; EASTMAN JT, 1988, J MORPHOL, V196, P283, DOI 10.1002/jmor.1051960303; Everson I., 1968, Bulletin British Antarctic Survey, VNo. 15, P59; GILLEN RG, 1972, J BIOL CHEM, V247, P6039; GROSS E, 1961, J AM CHEM SOC, V83, P1510, DOI 10.1021/ja01467a052; HUREAU JC, 1977, LANDJMTIONS ANTARCTI, P459; Landon, 1977, Methods Enzymol, V47, P145; MATHEWS AJ, 1989, J BIOL CHEM, V264, P16573; NAGAI K, 1987, NATURE, V329, P858, DOI 10.1038/329858a0; PERUTZ MF, 1982, NATURE, V299, P421, DOI 10.1038/299421a0; POWERS DA, 1972, SCIENCE, V177, P360, DOI 10.1126/science.177.4046.360; POWERS DA, 1972, J BIOL CHEM, V247, P6686; Riggs A., 1970, FISH PHYSIOL, V4, P209; RIGGS AF, 1988, ANNU REV PHYSIOL, V50, P181, DOI 10.1146/annurev.ph.50.030188.001145; TAMBURRINI M, 1992, ARCH BIOCHEM BIOPHYS, V292, P295, DOI 10.1016/0003-9861(92)90082-8; TAN AL, 1972, J BIOL CHEM, V247, P2493; WELLS RMG, 1980, J FISH BIOL, V17, P517, DOI 10.1111/j.1095-8649.1980.tb02783.x	32	67	74	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9675	9681						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144556				2022-12-27	WOS:A1994NE05300045
J	LU, WP; JABLONSKI, PE; RASCHE, M; FERRY, JG; RAGSDALE, SW				LU, WP; JABLONSKI, PE; RASCHE, M; FERRY, JG; RAGSDALE, SW			CHARACTERIZATION OF THE METAL CENTERS OF THE NI/FE-S COMPONENT OF THE CARBON-MONOXIDE DEHYDROGENASE ENZYME COMPLEX FROM METHANOSARCINA-THERMOPHILA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RES; ACETYL-COENZYME-A; CLOSTRIDIUM-THERMOACETICUM; CO DEHYDROGENASE; METHANOTHRIX-SOEHNGENII; RHODOSPIRILLUM-RUBRUM; PURIFICATION; NICKEL; BACTERIA; PROTEINS	Methanosarcina thermophila contains a multienzyme complex called the carbon-monoxide dehydrogenase complex, which has been resolved into a nickel/iron-sulfur and a corrinoid/iron-sulfur component. This complex plays a central role in acetoclastic methanogenesis. The Ni/Fe-S component catalyzes CO oxidation and has been proposed to be involved in cleavage of acetyl-CoA into its methyl, carbonyl, and CoA moieties. In the work reported here, three metal centers in the Ni/Fe-S component were characterized by electron paramagnetic resonance (EPR) spectroscopy and spectroelectrochemistry and pre-steady state kinetics. Center A contains nickel and iron and forms an EPR active adduct with CO, which is called the NiFeC species. The EPR spectrum of the NiFeC species has g values of 2.059, 2.051, and 2.029 and is observable at temperatures as high as 150 K. This signal had previously been observed only in the carbon-monoxide dehydrogenase complex of M. thermophila and the acetyl-CoA synthase from acetate-producing bacteria. Incubation of the CO-reduced Ni/Fe-S component with acetyl-CoA resulted in an increase in intensity of the NiFeC signal, which supports a role for the component in the cleavage of acetyl-CoA. Generation of the NiFeC EPR signal occurs with a rate constant of 0.4 s-1, a result that demonstrates the kinetic competence of this species in the acetyl-CoA cleavage reaction but rules it out as the site of oxidation of CO to CO2. Center B is likely to be a [4Fe-4S]2+1/1+ center with g values of 2.04, 1.93, and 1.89 (g(av) = 1.95) and a standard reduction potential (E'0) of -444 mV. At potentials less than -500 mV, another EPR signal develops that appears to originate from another state of Center B. Center C is a fast relaxing center with g values of 2.02, 1.88, and 1.71 (g(av) = 1.87) and an E'0, of -154 mV.	VIRGINIA POLYTECH INST & STATE UNIV,DEPT BIOCHEM & ANAEROB MICROBIOL,BLACKSBURG,VA 24061; UNIV NEBRASKA,DEPT BIOCHEM,LINCOLN,NE 68583	Virginia Polytechnic Institute & State University; University of Nebraska System; University of Nebraska Lincoln								ABBANAT DR, 1990, J BACTERIOL, V172, P7145, DOI 10.1128/jb.172.12.7145-7150.1990; ABBANAT DR, 1991, P NATL ACAD SCI USA, V88, P3272, DOI 10.1073/pnas.88.8.3272; ALTMAN TE, 1981, THESIS U ILLINOIS UR; Ballou D P, 1978, Methods Enzymol, V54, P85; BELFORD RL, 1979, 21ST EPR S ROCK MT C; BONAM D, 1987, J BIOL CHEM, V262, P2980; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CIURLI S, 1992, J AM CHEM SOC, V114, P5415, DOI 10.1021/ja00039a063; CONOVER RC, 1990, J AM CHEM SOC, V112, P4562, DOI 10.1021/ja00167a074; DEMOLL E, 1987, J BACTERIOL, V169, P3916, DOI 10.1128/jb.169.9.3916-3920.1987; DULIBA EP, 1983, THESIS U ILLINOIS UR; EGGEN RIL, 1991, J BIOL CHEM, V266, P6883; EMPTAGE MH, 1983, J BIOL CHEM, V258, P1106; FAN CL, 1991, BIOCHEMISTRY-US, V30, P431, DOI 10.1021/bi00216a018; GORST CM, 1991, J BIOL CHEM, V266, P20687; GRAHAME DA, 1987, J BIOL CHEM, V262, P3706; HARDER SR, 1989, ANAL BIOCHEM, V181, P283, DOI 10.1016/0003-2697(89)90244-3; JETTEN MSM, 1989, EUR J BIOCHEM, V181, P437, DOI 10.1111/j.1432-1033.1989.tb14744.x; JETTEN MSM, 1991, EUR J BIOCHEM, V202, P1291, DOI 10.1111/j.1432-1033.1991.tb16502.x; JETTEN MSM, 1991, EUR J BIOCHEM, V195, P385, DOI 10.1111/j.1432-1033.1991.tb15717.x; KRAUT M, 1989, ARCH MICROBIOL, V152, P335, DOI 10.1007/BF00425170; KRZYCKI JA, 1989, J BIOL CHEM, V264, P7217; KRZYCKI JA, 1984, J BACTERIOL, V158, P231, DOI 10.1128/JB.158.1.231-237.1984; KUMAR M, 1992, J AM CHEM SOC, V114, P8713, DOI 10.1021/ja00048a062; KUMAR M, 1993, EUR J BIOCHEM, V115, P11646; LADAPO J, 1990, P NATL ACAD SCI USA, V87, P5598, DOI 10.1073/pnas.87.15.5598; LINDAHL PA, 1990, J BIOL CHEM, V265, P3880; LINDAHL PA, 1990, J BIOL CHEM, V265, P3873; LINDAHL PA, 1985, J BIOL CHEM, V260, P1160; MAURICE AM, 1982, THESIS U ILLINOIS UR; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; MORTON TA, 1991, J BIOL CHEM, V266, P23824; MUHOBERAC BB, 1980, BIOCHIM BIOPHYS ACTA, V626, P337, DOI 10.1016/0005-2795(80)90128-2; Nilges M. J., 1979, THESIS U ILLINOIS UR; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; RAGSDALE SW, 1983, J BACTERIOL, V155, P1224, DOI 10.1128/JB.155.3.1224-1237.1983; RAGSDALE SW, 1991, CRIT REV BIOCHEM MOL, V26, P261, DOI 10.3109/10409239109114070; RAGSDALE SW, 1982, BIOCHEM BIOPH RES CO, V108, P658, DOI 10.1016/0006-291X(82)90880-4; RAGSDALE SW, 1985, J BIOL CHEM, V260, P3970; RAGSDALE SW, 1985, P NATL ACAD SCI USA, V82, P6811, DOI 10.1073/pnas.82.20.6811; RAYBUCK SA, 1991, J BACTERIOL, V173, P929, DOI 10.1128/jb.173.2.929-932.1991; RUPP H, 1978, BIOCHIM BIOPHYS ACTA, V537, P255, DOI 10.1016/0005-2795(78)90509-3; SALMON RT, 1980, J ELECTROANAL CHEM, V112, P253, DOI 10.1016/S0022-0728(80)80407-4; SOWERS KR, 1984, CURR MICROBIOL, V11, P227, DOI 10.1007/BF01567165; STEPHENS PJ, 1989, J BIOL CHEM, V264, P16347; TERLESKY KC, 1987, J BIOL CHEM, V262, P15392; TERLESKY KC, 1986, J BACTERIOL, V168, P1053, DOI 10.1128/jb.168.3.1053-1058.1986; THAUER RK, 1989, ANNU REV MICROBIOL, V43, P43, DOI 10.1146/annurev.mi.43.100189.000355; ZINDER SH, 1985, INT J SYST BACTERIOL, V35, P522, DOI 10.1099/00207713-35-4-522	49	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9736	9742						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144565				2022-12-27	WOS:A1994NE05300054
J	GOSS, GG; WOODSIDE, M; WAKABAYASHI, S; POUYSSEGUR, J; WADDELL, T; DOWNEY, GP; GRINSTEIN, S				GOSS, GG; WOODSIDE, M; WAKABAYASHI, S; POUYSSEGUR, J; WADDELL, T; DOWNEY, GP; GRINSTEIN, S			ATP DEPENDENCE OF NHE-1, THE UBIQUITOUS ISOFORM OF THE NA+/H+ ANTIPORTER - ANALYSIS OF PHOSPHORYLATION AND SUBCELLULAR-LOCALIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM DODECYL-SULFATE; GROWTH-FACTOR; MOLECULAR-CLONING; VOLUME REGULATION; INTRACELLULAR PH; OKADAIC ACID; ACTIVATION; CELLS; DEPLETION; PROTEINS	ATP is not hydrolyzed during the transport cycle of the Na+/H+ exchanger (NHE), yet depletion of the nucleotide drastically reduces the rate of cation exchange. The mechanism underlying this inhibition was investigated in fibroblasts transfected with NHE-1, the growth factor-sensitive isoform of the antiport. NHE-1 was found to be phosphorylated in serum-starved, unstimulated cells. Acute ATP depletion induced a profound inhibition of transport without detectable changes in NHE-1 phosphorylation. Analysis of cells transfected with truncated mutants of NHE-1 indicated that the carboxyl-terminal cytosolic domain of the antiport is required for expression of its ATP dependence. To define whether inhibition of Na+/H+ exchange resulted from internalization of NHE-1, extracellularly exposed proteins were labeled with impermeant biotin derivatives. The proportion of NHE-1 exposed to the surface was comparable before and after ATP depletion. Immunofluorescence determinations revealed focal accumulations of NHE-1 on the membrane of untreated cells. NHE-1 redistributed following ATP depletion, showing a more homogeneous localization. F-actin, which co-localizes with the antiport in untreated cells, also redistributed when cells were ATP depleted. These findings suggest an interaction of NHE-1 with the cytoskeleton. Accordingly, disassembly of actin filaments with cytochalasin D induced redistribution of the antiport. However, Na+/H+ exchange activity was unaltered by cytochalasin D. We propose that ancillary proteins confer ATP sensitivity to the antiporter and may also mediate its association with the cytoskeleton. Depletion of the nucleotide would alter the interaction between NHE-1 and the putative regulator, inhibiting Na+/H+ exchange and inducing subcellular redistribution. However, disruption of the cytoskeleton at distal sites, such as induced by cytochalasins, is insufficient to inactivate the antiport.	HOSP SICK CHILDREN,DIV CELL BIOL,TORONTO M5G 1X8,ON,CANADA; UNIV NICE,CTR NATL RECH SCI,CTR BIOCHIM,F-06034 NICE,FRANCE; UNIV TORONTO,DEPT MED,TORONTO M5S 1A8,ON,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Toronto			; Goss, Greg/D-2723-2015	Downey, Gregory P/0000-0003-3253-5862; Goss, Greg/0000-0003-0786-8868				BIANCHINI L, 1991, J BIOL CHEM, V266, P15406; CASSEL D, 1986, J BIOL CHEM, V261, P5460; CHEN LK, 1991, KIDNEY INT, V40, pS11; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DAVIS BA, 1992, AM J PHYSIOL, V262, pC533, DOI 10.1152/ajpcell.1992.262.2.C533; GABAI VL, 1992, TISSUE CELL, V24, P171, DOI 10.1016/0040-8166(92)90090-T; GLASCOTT PA, 1987, CELL MOTIL CYTOSKEL, V8, P118, DOI 10.1002/cm.970080204; GREEN J, 1993, AM J PHYSIOL, V265, pF440, DOI 10.1152/ajprenal.1993.265.3.F440; GRINSTEIN S, 1993, EMBO J, V12, P5209, DOI 10.1002/j.1460-2075.1993.tb06216.x; GRINSTEIN S, 1992, J BIOL CHEM, V267, P23823; GRINSTEIN S, 1985, J CELL BIOL, V101, P269, DOI 10.1083/jcb.101.1.269; HILGEMANN DW, 1992, J PHYSIOL-LONDON, V454, P59, DOI 10.1113/jphysiol.1992.sp019254; JOHNSON BD, 1993, NEURON, V10, P797, DOI 10.1016/0896-6273(93)90196-X; LISCHWE MA, 1982, ANAL BIOCHEM, V127, P453, DOI 10.1016/0003-2697(82)90203-2; LITTLE PJ, 1988, J BIOL CHEM, V263, P16780; MACHEN TE, 1987, ANNU REV PHYSIOL, V49, P19, DOI 10.1146/annurev.ph.49.030187.000315; MIMURA CS, 1991, P NATL ACAD SCI USA, V88, P84, DOI 10.1073/pnas.88.1.84; NG LL, 1992, KIDNEY INT, V41, P872, DOI 10.1038/ki.1992.133; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; SARDET C, 1990, SCIENCE, V247, P723, DOI 10.1126/science.2154036; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; SARDET C, 1991, J BIOL CHEM, V266, P19166; TSE CM, 1993, J BIOL CHEM, V268, P11917; WAKABAYASHI S, 1992, REV PHYSIOL BIOCH P, V119, P157; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; WANG YL, 1986, EXP CELL RES, V167, P16, DOI 10.1016/0014-4827(86)90200-4; WANG Z, 1993, J BIOL CHEM, V268, P11925	28	103	105	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8741	8748						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132605				2022-12-27	WOS:A1994NB41100022
J	SVAREN, J; KLEBANOW, E; SEALY, L; CHALKLEY, R				SVAREN, J; KLEBANOW, E; SEALY, L; CHALKLEY, R			ANALYSIS OF THE COMPETITION BETWEEN NUCLEOSOME FORMATION AND TRANSCRIPTION FACTOR-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEWLY SYNTHESIZED HISTONES; VIRUS INTERNAL ENHANCER; NUCLEAR FACTOR-I; 5-S RNA GENE; ASSEMBLY INVITRO; DNA-REPLICATION; FACTOR-IIIA; CHROMATIN; CORE; PURIFICATION	We have studied the competitive binding of histones and the Rous sarcoma virus internal enhancer binding factor (IBF) factor (which recent studies indicate is almost certainly cEBP beta). We find that histones and IBF are incapable of forming a ternary complex with a 159- base pair (bp) fragment of DNA containing a single IBF binding site and that histones and factor are mutually exclusive in binding. We have analyzed the various physical parameters of binding, in an attempt to understand how the factor might establish an exclusive binding in the cell. The stability of the nucleosome and the factor-DNA complex have been determined, and in addition a minimum value for the affinity of the histone octamer has been computed. We find that in simple competition the IBF can successfully compete, only if the substrate DNA is shorter than 140 bp. The relevance of these results is discussed in terms of a kinetic model for successful factor competition during the replication of the factor binding site in the cell.	VANDERBILT UNIV, SCH MED, DEPT MOLEC PHYSIOL & BIOPHYS, NASHVILLE, TN 37232 USA	Vanderbilt University			Svaren, John/A-1605-2010	Svaren, John/0000-0003-2963-7921				ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; BAKER RE, 1986, J BIOL CHEM, V261, P5275; BARTLEY JA, 1972, J BIOL CHEM, V247, P3647; BINASTEIN M, 1977, CELL, V11, P609, DOI 10.1016/0092-8674(77)90078-2; BUSTIN M, 1990, BIOCHIM BIOPHYS ACTA, V1049, P231, DOI 10.1016/0167-4781(90)90092-G; CALZONE FJ, 1988, GENE DEV, V2, P1074, DOI 10.1101/gad.2.9.1074; CHATTORAJ DK, 1972, ARCH BIOCHEM BIOPHYS, V152, P778, DOI 10.1016/0003-9861(72)90273-1; CHODOSH LA, 1986, MOL CELL BIOL, V6, P4723, DOI 10.1128/MCB.6.12.4723; COTTEN M, 1987, EMBO J, V6, P3945, DOI 10.1002/j.1460-2075.1987.tb02736.x; COTTEN M, 1985, NUCLEIC ACIDS RES, V13, P401, DOI 10.1093/nar/13.2.401; DREW HR, 1991, J MOL BIOL, V219, P391, DOI 10.1016/0022-2836(91)90179-A; DREW HR, 1985, J MOL BIOL, V186, P773, DOI 10.1016/0022-2836(85)90396-1; EMERSON BM, 1985, CELL, V41, P21, DOI 10.1016/0092-8674(85)90057-1; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; FELTS SJ, 1990, MOL CELL BIOL, V10, P2390, DOI 10.1128/MCB.10.5.2390; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; HAYES JJ, 1991, BIOCHEMISTRY-US, V30, P8434, DOI 10.1021/bi00098a022; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; JACKSON V, 1988, BIOCHEMISTRY-US, V27, P2109, DOI 10.1021/bi00406a044; JACKSON V, 1987, BIOCHEMISTRY-US, V26, P2315, DOI 10.1021/bi00382a037; JACKSON V, 1990, BIOCHEMISTRY-US, V29, P719, DOI 10.1021/bi00455a019; KARNITZ L, 1987, NUCLEIC ACIDS RES, V15, P9841, DOI 10.1093/nar/15.23.9841; KARNITZ L, 1989, MOL CELL BIOL, V9, P1929, DOI 10.1128/MCB.9.5.1929; KARNITZ L, 1988, CIS TRANSACTING ELEM; KLEINSCHMIDT JA, 1990, EMBO J, V9, P1309, DOI 10.1002/j.1460-2075.1990.tb08240.x; KLEVAN L, 1978, BIOCHEMISTRY-US, V17, P4533, DOI 10.1021/bi00614a027; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; LETOVSKY J, 1989, NUCLEIC ACIDS RES, V17, P2639, DOI 10.1093/nar/17.7.2639; LINXWEILER W, 1984, NUCLEIC ACIDS RES, V12, P9395, DOI 10.1093/nar/12.24.9395; LORCH Y, 1992, GENE DEV, V6, P2282, DOI 10.1101/gad.6.12a.2282; MEISTERERNST M, 1990, P NATL ACAD SCI USA, V87, P9153, DOI 10.1073/pnas.87.23.9153; MEISTERERNST M, 1988, NUCLEIC ACIDS RES, V16, P4419, DOI 10.1093/nar/16.10.4419; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; PETERSON CL, 1988, MOL CELL BIOL, V8, P4972, DOI 10.1128/MCB.8.11.4972; PFAFFLE P, 1990, J BIOL CHEM, V265, P16821; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; READ CM, 1985, BIOCHEMISTRY-US, V24, P4435, DOI 10.1021/bi00337a027; REIK A, 1991, EMBO J, V10, P2569, DOI 10.1002/j.1460-2075.1991.tb07797.x; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; ROMANIUK PJ, 1990, J BIOL CHEM, V265, P17593; ROSENFELD PJ, 1986, J BIOL CHEM, V261, P1398; RUIZCARRILLO A, 1979, P NATL ACAD SCI USA, V76, P3284, DOI 10.1073/pnas.76.7.3284; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; SOLLNERWEBB B, 1976, CELL, V9, P179, DOI 10.1016/0092-8674(76)90063-5; STOCKLEY PG, 1979, FEBS LETT, V99, P129, DOI 10.1016/0014-5793(79)80264-1; STRAKA C, 1991, EMBO J, V10, P361, DOI 10.1002/j.1460-2075.1991.tb07957.x; SVAREN J, 1990, TRENDS GENET, V6, P52, DOI 10.1016/0168-9525(90)90074-G; TAN S, 1988, EMBO J, V7, P4255, DOI 10.1002/j.1460-2075.1988.tb03323.x; TATCHELL K, 1979, BIOCHEMISTRY-US, V18, P2870, DOI 10.1021/bi00580a031; TAYLOR ICA, 1991, GENE DEV, V5, P1285, DOI 10.1101/gad.5.7.1285; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; TREMETHICK D, 1990, J BIOL CHEM, V265, P5014; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WOLFFE AP, 1986, CELL, V47, P217, DOI 10.1016/0092-8674(86)90444-7; WOLFFE AP, 1991, J CELL SCI, V99, P201; WORCEL A, 1978, CELL, V15, P969, DOI 10.1016/0092-8674(78)90280-5; WORKMAN JL, 1988, CELL, V55, P211, DOI 10.1016/0092-8674(88)90044-X; WORKMAN JL, 1991, CELL, V64, P533, DOI 10.1016/0092-8674(91)90237-S; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; ZABEL U, 1991, J BIOL CHEM, V266, P252; ZUCKER K, 1990, J BIOL CHEM, V265, P14487	62	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9335	9344						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132673				2022-12-27	WOS:A1994NB41100104
J	KIM, YS; KANG, SW				KIM, YS; KANG, SW			NOVEL MALONAMIDASES IN BRADYRHIZOBIUM-JAPONICUM - PURIFICATION, CHARACTERIZATION, AND IMMUNOLOGICAL COMPARISON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHIZOBIUM-JAPONICUM; NITROSOMONAS-EUROPAEA; SOYBEAN NODULES; OMEGA-AMIDASE; ORGANIC-ACID; AMMONIA; BACTEROIDS; NITROGEN; PROTEINS	Three novel malonamidases (E1a, E1b, and E2) occurring constitutively in Bradyrhizobium japonicum were purified to electrophoretic homogeneity. They were found to catalyze one or more of the following three types of reactions: malonyl transfer to hydroxylamine (reaction 1), hydroxaminolysis of malonamate (reaction 2), and hydrolysis of malonamate (reaction 3). The molecular sizes of E1a, E1b, and E2 were 126, 107, and 103 kDa, respectively, and they were each composed of two identical subunits. The pIs of E1a and E1b, 5.5 and 5.0 respectively, were similar, but that of E2 was 7.2. Optimum pH values varied with the type of reactions catalyzed, but among the enzymes they were found to be similar. The affinity of E2 for malonamate was about 30- and 7O-fold higher than that of E1a and E1b, respectively. Acetate and propionate inhibited E1a activity competitively, whereas malonate inhibited E2 activity noncompetitively. The amino acid composition and N-terminal amino acid sequence of the three enzymes were found to be different. These enzymes were also immunologically different. E1a was found to form a malonyl-enzyme intermediate during the catalysis through the isolation of [C-14]malonyl-enzyme with gel filtration and through isotope exchange experiments with [O-18]malonate. These malonamidases may play a role for the self-protection against malonate toxicity in nodule bacteroids and may also be involved in the transport of fixed nitrogen to the plant cell.			KIM, YS (corresponding author), YONSEI UNIV,COLL SCI,DEPT BIOCHEM,SEOUL 120749,SOUTH KOREA.							BENTLEY LE, 1952, NATURE, V170, P847, DOI 10.1038/170847b0; BERGERSE.FJ, 1967, BIOCHIM BIOPHYS ACTA, V141, P507, DOI 10.1016/0304-4165(67)90179-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN CM, 1975, J GEN MICROBIOL, V86, P39, DOI 10.1099/00221287-86-1-39; CALDERON J, 1985, J BACTERIOL, V161, P807; FERNALD NJ, 1972, ARCH BIOCHEM BIOPHYS, V153, P95, DOI 10.1016/0003-9861(72)90425-0; HERSH LB, 1971, BIOCHEMISTRY-US, V10, P2884, DOI 10.1021/bi00791a014; HERSH LB, 1972, BIOCHEMISTRY-US, V11, P2251, DOI 10.1021/bi00762a007; HOLLOCHER TC, 1981, J BIOL CHEM, V256, P834; JOHNSTONE A, 1987, IMMUNOCYTOCHEMISTRY, P50; KIM YS, 1991, BIOCHEM J, V273, P511, DOI 10.1042/bj2730511; KIM YS, 1988, ANAL BIOCHEM, V170, P45, DOI 10.1016/0003-2697(88)90087-5; KIM YS, 1990, BIOCHEM BIOPH RES CO, V169, P692, DOI 10.1016/0006-291X(90)90386-2; KIM YS, 1991, KOREAN J MICROBIOL, V29, P40; KOUCHI H, 1985, SOIL SCI PLANT NUTR, V31, P323, DOI 10.1080/00380768.1985.10557440; KRALLMANNWENZEL U, 1985, AM REV RESPIR DIS, V131, P432; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsudaira P. T., 1989, PRACTICAL GUIDE PROT, P53; MEISTER A, 1953, J BIOL CHEM, V200, P571; MEISTER A, 1955, J BIOL CHEM, V216, P441; OGARA F, 1976, BIOCHIM BIOPHYS ACTA, V437, P313, DOI 10.1016/0304-4165(76)90001-5; Ouchterlony O, 1986, HDB EXPT IMMUNOLOGY; REIBACH PH, 1984, J BACTERIOL, V159, P47, DOI 10.1128/JB.159.1.47-52.1984; RIGO B, 1989, TETRAHEDRON LETT, V30, P3073, DOI 10.1016/S0040-4039(00)99406-1; Sambrook J, 1989, MOL CLONING LABORATO; SCHRAMM RW, 1992, SYMBIOSIS, V14, P103; SIMPSON RJ, 1976, J BIOL CHEM, V251, P1936; SOBERON M, 1987, J GEN MICROBIOL, V161, P807; STREETER JG, 1987, PLANT PHYSIOL, V85, P768, DOI 10.1104/pp.85.3.768; STUMPF DK, 1981, PLANT PHYSIOL, V68, P989, DOI 10.1104/pp.68.5.989; SU S, 1969, J BIOL CHEM, V244, P2956; SUZUKI I, 1981, CAN J BIOCHEM CELL B, V59, P484, DOI 10.1139/o81-067; UDVARDI MK, 1990, PLANT PHYSIOL, V94, P71, DOI 10.1104/pp.94.1.71; WERNER D, 1982, Z NATURFORSCH C, V37, P921; YANG LJO, 1990, PLANTA, V182, P437, DOI 10.1007/BF02411397	35	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8014	8021						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132523				2022-12-27	WOS:A1994NB40900031
J	KITA, K; ISHIZUKA, T; ISHIJIMA, S; SONODA, T; TATIBANA, M				KITA, K; ISHIZUKA, T; ISHIJIMA, S; SONODA, T; TATIBANA, M			NOVEL 39-KDA PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE-ASSOCIATED PROTEIN OF RAT-LIVER - CLONING, HIGH SEQUENCE SIMILARITY TO THE CATALYTIC SUBUNITS, AND A NEGATIVE REGULATORY ROLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYROPHOSPHATE SYNTHETASE; ESCHERICHIA-COLI; 5-PHOSPHORIBOSYL 1-PYROPHOSPHATE; NUCLEOTIDE-SEQUENCE; BACILLUS-SUBTILIS; PURIFIED ENZYME; BINDING-SITE; PRS GENE; CDNA; PURIFICATION	The rat liver phosphoribosylpyrophosphate (PRPP) synthetase exists as complex aggregates composed of the 34-kDa catalytic subunits (PRS I and II) and other 39- and 41-kDa proteins (Kita, K., Otsuki, T., Ishizuka, T., and Tatibana, M. (1989) J. Biochem. (Tokyo) 105, 736-741), which are termed here PRPP synthetase-associated proteins (PAPs). We have cloned the cDNA for the major one of 39 kDa (PAP39) from a rat liver cDNA library. Nucleotide sequencing showed that the clone encoded 356 amino acids containing sequences of all five peptides derived from PAP39. Surprisingly, the deduced amino acid sequence is markedly similar to those of the 34-kDa catalytic subunits. Excluding two regions (about 45 residues in total), PAP39 has a 48% identity with PRS I. Northern analysis detected a major 1.9-kilobase transcript in all 16 rat tissues examined, and the relative amounts of PAP39 mRNA to PRS I mRNA varied with tissues. Covalent cross-linking experiments gave definitive evidence for molecular interaction of PAP39 with the catalytic subunits. Immunoprecipitation experiments revealed that all the catalytic subunits existed as complexes containing PAP39. When PAPs were eliminated from the rat liver enzyme complex by gel filtration in the presence of 1 M MgCl2, a lyotrope, or by mild tryptic treatment, the enzyme activity of the remaining catalytic subunits increased. Based on these results, we propose that PAP39, the major component of PAPs, plays a negative regulatory role in PRPP synthesis and hence is an important factor controlling nucleotide syntheses in general.			KITA, K (corresponding author), CHIBA UNIV,SCH MED,DEPT BIOCHEM,CHUO KU,INOHANA,CHIBA 260,JAPAN.							ARNVIG K, 1990, EUR J BIOCHEM, V192, P195, DOI 10.1111/j.1432-1033.1990.tb19214.x; BAGNARA AS, 1974, EUR J BIOCHEM, V41, P421, DOI 10.1111/j.1432-1033.1974.tb03283.x; BOER SG, 1988, J BACTERIOL, V170, P3243; BOWER SG, 1989, J BIOL CHEM, V264, P10287; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIKENJI T, 1988, METABOLISM, V37, P1114, DOI 10.1016/0026-0495(88)90186-2; CHIKENJI T, 1984, BIOCHIM BIOPHYS ACTA, V802, P274, DOI 10.1016/0304-4165(84)90171-5; FLAKS JG, 1957, J BIOL CHEM, V228, P201; FOX IH, 1971, J BIOL CHEM, V246, P5739; FOX IH, 1971, ANN INTERN MED, V74, P424, DOI 10.7326/0003-4819-74-3-424; FRY DC, 1986, P NATL ACAD SCI USA, V83, P907, DOI 10.1073/pnas.83.4.907; GARVEY JS, 1977, METHOD IMMUNOL, P223; GERHARD W, 1980, MONOCLONAL ANTIBODIE, P370; HENDRICKSON N, 1993, MOL BIOCHEM PARASIT, V59, P15, DOI 10.1016/0166-6851(93)90003-G; HIRANO H, 1992, J BIOCHEM-TOKYO, V111, P754, DOI 10.1093/oxfordjournals.jbchem.a123831; HOLMES EW, 1978, HDB EXPT PHARM, V51, P21; HOVEJENSEN B, 1986, J BIOL CHEM, V261, P6765; IIZASA T, 1989, FEBS LETT, V244, P47, DOI 10.1016/0014-5793(89)81159-7; ISHIJIMA S, 1991, J BIOL CHEM, V266, P15693; ISHIJIMA S, 1988, J BIOCHEM-TOKYO, V104, P570, DOI 10.1093/oxfordjournals.jbchem.a122512; KAWASAKI H, 1990, ANAL BIOCHEM, V191, P1; KEPPLER D, 1982, METABOLIC COMPARTMEN, P147; KITA K, 1989, J BIOCHEM, V105, P736, DOI 10.1093/oxfordjournals.jbchem.a122737; KORNBERG A, 1955, J BIOL CHEM, V215, P417; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALANNE M, 1975, CAN J BIOCHEM CELL B, V53, P394, DOI 10.1139/o75-055; LEE CC, 1988, SCIENCE, V239, P1288, DOI 10.1126/science.3344434; LERNER RA, 1981, P NATL ACAD SCI-BIOL, V78, P3403, DOI 10.1073/pnas.78.6.3403; LUDUENA RF, 1977, J BIOL CHEM, V252, P7006; Maniatis T, 1989, DECONTAMINATION DILU; MORI M, 1979, P NATL ACAD SCI USA, V76, P5071, DOI 10.1073/pnas.76.10.5071; NILSSON D, 1987, GENE, V53, P247, DOI 10.1016/0378-1119(87)90013-8; NOSAL JM, 1993, J BIOL CHEM, V268, P10168; ROBERTS MF, 1978, ARCH BIOCHEM BIOPHYS, V185, P391, DOI 10.1016/0003-9861(78)90181-9; ROESSLER BJ, 1990, NUCLEIC ACIDS RES, V18, P193, DOI 10.1093/nar/18.1.193; ROTH DG, 1974, J BIOL CHEM, V249, P291; SCHUBERT KR, 1975, J BIOL CHEM, V250, P7492; SONODA T, 1991, J BIOCHEM-TOKYO, V109, P361; Switzer R L, 1978, Methods Enzymol, V51, P3; TAIRA M, 1990, J BIOL CHEM, V265, P16491; TAIRA M, 1989, BIOCHIM BIOPHYS ACTA, V1007, P203, DOI 10.1016/0167-4781(89)90040-7; TAIRA M, 1987, J BIOL CHEM, V262, P14867; TATIBANA M, 1972, J BIOCHEM, V72, P549, DOI 10.1093/oxfordjournals.jbchem.a129934; TATIBANA M, 1978, HDB EXPT PHARM, V51, P125	45	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8334	8340						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132556				2022-12-27	WOS:A1994NB40900076
J	SHEN, BH; JOLLIE, DR; STOUT, CD; DILLER, TC; ARMSTRONG, FA; GORST, CM; LAMAR, GN; STEPHENS, PJ; BURGESS, BK				SHEN, BH; JOLLIE, DR; STOUT, CD; DILLER, TC; ARMSTRONG, FA; GORST, CM; LAMAR, GN; STEPHENS, PJ; BURGESS, BK			AZOTOBACTER-VINELANDII FERREDOXIN-I - ALTERATION OF INDIVIDUAL SURFACE-CHARGES AND THE [4FE-4S](2+/+) CLUSTER REDUCTION POTENTIAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTIDA 7-IRON FERREDOXINS; AMINO-ACID-SEQUENCE; 7FE FERREDOXIN; FERRICYANIDE OXIDATION; REFINEMENT; PROTEINS; RESOLUTION; RESONANCES	The structures of Azotobacter vinelandii ferredoxin I (AvFdI) and Peptococcus aerogenes ferredoxin (PaFd), near their analogous [4Fe-4S](2+/+) clusters, are highly conserved (Backes, G., Mine, Y., Loehr, T M., Meyer, T E., Cusanovich, M. A., Sweeney, W V., Adman, E. T., and Sanders-Loehr, J. (1991) J. Am. Chem. Sec. 11, 2055-2064). Despite these similarities, the reduction potential (E(0')) of the AvFdI [4Fe-4S](2+/+) cluster is more than 200 mV more negative than that of PaFd. We have tested the contribution that individual amino acid residues make to the control of E(0') by converting residues in AvFdI into the corresponding residue in PaFd. Four mutations involved substitutions of negatively charged surface residues with neutral residues and two involved substitution of buried hydrophobic residues. All AvFdI variants were characterized by x-ray crystallography, absorption, CD, EPR, and H-1 NMR spectroscopies and by electrochemical methods. For the F25I mutation, significant structural changes occurred that affected the EPR and H-1 NMR spectroscopic properties of AvFdI and had a minor influence on E(0'). For all other mutations there were no changes in reduction potential. Thus we conclude, that variations in charged surface residues do not account for the observed differences in E(0') between the analogous [4Fe-4S](2+/+) cluster of PaFd and AvFdI. These differences are therefore most likely to be due to differences in solvent accessibility.	UNIV CALIF IRVINE, DEPT MOLEC BIOL & BIOCHEM, IRVINE, CA 92717 USA; Scripps Res Inst, RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA; UNIV SO CALIF, DEPT CHEM, LOS ANGELES, CA 90089 USA; UNIV CALIF DAVIS, DEPT CHEM, DAVIS, CA 95616 USA; UNIV CALIF IRVINE, DEPT CHEM, IRVINE, CA 92717 USA	University of California System; University of California Irvine; Scripps Research Institute; University of Southern California; University of California System; University of California Davis; University of California System; University of California Irvine				Shen, Binghui/0000-0002-4408-407X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036325, R01GM045209] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-45209, GM-36325] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADMAN ET, 1976, J BIOL CHEM, V251, P3801; ADMAN ET, 1973, J BIOL CHEM, V248, P3986; ARMSTRONG FA, 1988, FEBS LETT, V234, P107, DOI 10.1016/0014-5793(88)81313-9; BACKES G, 1991, J AM CHEM SOC, V113, P2055, DOI 10.1021/ja00006a027; Berg J.M., 1982, IRON SULFUR PROTEINS, P1; BRUNGER AT, 1989, ACTA CRYSTALLOGR A, V45, P50, DOI 10.1107/S0108767388009195; BRUSCHI M, 1988, FEMS MICROBIOL LETT, V54, P155, DOI 10.1111/j.1574-6968.1988.tb02741.x; BUSSE SC, 1992, BIOCHEMISTRY-US, V31, P11952, DOI 10.1021/bi00162a038; CHENG H, 1990, J BIOL CHEM, V265, P12388; CHENG H, 1992, J BIOL CHEM, V267, P8073; DUPORT C, 1990, NUCLEIC ACIDS RES, V18, P4618, DOI 10.1093/nar/18.15.4618; ERIKSSON AE, 1993, J MOL BIOL, V229, P747, DOI 10.1006/jmbi.1993.1077; HASE T, 1978, FEBS LETT, V91, P315, DOI 10.1016/0014-5793(78)81200-9; HOWARD AJ, 1985, METHOD ENZYMOL, V114, P452; HOWARD JB, 1983, J BIOL CHEM, V258, P508; IISMAA SE, 1991, J BIOL CHEM, V266, P21563; LANGEN R, 1992, J BIOL CHEM, V267, P25625; LESLIE AGW, 1986, CCP4 NEWSLETTER, V18, P33; MACEDO AL, 1993, INORG CHEM, V32, P1101, DOI 10.1021/ic00059a013; MARTIN AE, 1989, J BACTERIOL, V171, P3162, DOI 10.1128/jb.171.6.3162-3167.1989; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MORGAN TV, 1985, FEBS LETT, V183, P206, DOI 10.1016/0014-5793(85)80777-8; MORGAN TV, 1984, P NATL ACAD SCI-BIOL, V81, P1931, DOI 10.1073/pnas.81.7.1931; MORGAN TV, 1988, J BIOL CHEM, V263, P1370; REES DC, 1985, P NATL ACAD SCI USA, V82, P3082, DOI 10.1073/pnas.82.10.3082; SACKI K, 1988, J BIOCH, V104, P242; SHEN BH, 1993, J BIOL CHEM, V268, P25928; SOMAN J, 1991, J BIOL CHEM, V266, P21558; STEPHENS PJ, 1991, BIOCHEMISTRY-US, V30, P3200, DOI 10.1021/bi00227a007; STOMBAUGH NA, 1976, BIOCHEMISTRY-US, V15, P2633, DOI 10.1021/bi00657a024; STOUT CD, 1989, J MOL BIOL, V205, P545, DOI 10.1016/0022-2836(89)90225-8; STOUT CD, 1979, J BIOL CHEM, V254, P3598; STURA E A, 1990, Methods (Orlando), V1, P38, DOI 10.1016/S1046-2023(05)80145-8; SWEENEY WV, 1981, J BIOL CHEM, V256, P2222; TANAKA M, 1975, BIOCHEMISTRY-US, V14, P1938, DOI 10.1021/bi00680a021; TANAKA M, 1964, BIOCHEM BIOPH RES CO, V16, P422, DOI 10.1016/0006-291X(64)90369-9; THOMSON AJ, 1991, FEBS LETT, V285, P230, DOI 10.1016/0014-5793(91)80807-F; VAZQUEZ A, 1994, IN PRESS PROTEIN PUR	38	57	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8564	8575						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132582				2022-12-27	WOS:A1994NB40900110
J	SUNG, P; WATKINS, JF; PRAKASH, L; PRAKASH, S				SUNG, P; WATKINS, JF; PRAKASH, L; PRAKASH, S			NEGATIVE SUPERHELICITY PROMOTES ATP-DEPENDENT BINDING OF YEAST RAD3 PROTEIN TO ULTRAVIOLET-DAMAGED DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOBUTANE PYRIMIDINE DIMERS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; DHFR GENE; REPAIR; CELLS; HELICASE; PHOTOPRODUCTS; REPLICATION; REMOVAL	The RAD3 gene of Saccharomyces cereuisiae is required for excision repair of UV-damaged DNA and is essential for cell viability. Remarkable homology exists between RAD3 and the human excision repair gene XPD, whose mutational inactivation underlies the cancer-prone disorder in xeroderma pigmentosum group D patients. Our previous work demonstrated that RAD3-encoded protein contains a DNA helicase activity. Here, we show that RAD3 binds preferentially to UV-damaged DNA over nondamaged DNA. Removal of pyrimidine dimers from damaged DNA by enzymatic photoreactivation does not affect binding, suggesting an affinity of RAD3 for pyrimidine (6-4) pyrimidone photoproducts. Damage-specific binding by RADS is strongly dependent on ATP and on the degree of negative superhelicity in DNA. The requirement of superhelicity in damage binding may target RAD3 to regions of DNA undergoing transcription, resulting in the preferential repair of these regions. The rad3 Arg-48 mutant protein, which lacks the DNA helicase activity, also binds UV-damaged DNA preferentially, indicating that DNA helicase and damage binding are two distinct and separable functional entities in RAD3.	UNIV TEXAS,SEALY CTR MOLEC SCI,MED BRANCH,GALVESTON,TX 77555; UNIV ROCHESTER,DEPT BIOL,ROCHESTER,NY 14642; UNIV ROCHESTER,DEPT BIOPHYS,ROCHESTER,NY 14642	University of Texas System; University of Texas Medical Branch Galveston; University of Rochester; University of Rochester			Prakash, Louise/C-7891-2012; Prakash, Satya/C-6420-2013	Prakash, Louise/0000-0001-9143-6261; Prakash, Satya/0000-0001-7228-1444	NCI NIH HHS [CA35035] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA035035, R01CA035035] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; BROWN WC, 1989, J BIOL CHEM, V264, P6748; DOETSCH PW, 1985, NUCLEIC ACIDS RES, V13, P3285, DOI 10.1093/nar/13.9.3285; FULLER RS, 1983, P NATL ACAD SCI-BIOL, V80, P5817, DOI 10.1073/pnas.80.19.5817; FUNNELL BE, 1986, J BIOL CHEM, V261, P5616; GUZDER SN, 1993, P NATL ACAD SCI USA, V90, P5433, DOI 10.1073/pnas.90.12.5433; KELLER W, 1975, P NATL ACAD SCI USA, V72, P4876, DOI 10.1073/pnas.72.12.4876; LIM HM, 1992, J BIOL CHEM, V267, P11176; LJUNGMAN M, 1992, P NATL ACAD SCI USA, V89, P6055, DOI 10.1073/pnas.89.13.6055; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MITCHELL DL, 1985, MUTAT RES, V143, P109, DOI 10.1016/S0165-7992(85)80018-X; MIZUTANI M, 1991, P NATL ACAD SCI USA, V88, P718, DOI 10.1073/pnas.88.3.718; NAEGELI H, 1992, J BIOL CHEM, V267, P392; NORANELLI F, 1980, P NATL ACAD SCI USA, V77, P3201; ODAY CL, 1992, NUCLEIC ACIDS RES, V20, P5403, DOI 10.1093/nar/20.20.5403; PARK E, 1992, P NATL ACAD SCI USA, V89, P11416, DOI 10.1073/pnas.89.23.11416; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; SEEBERG E, 1982, P NATL ACAD SCI-BIOL, V79, P988, DOI 10.1073/pnas.79.4.988; SELBY CP, 1990, J BIOL CHEM, V265, P21330; SUNG P, 1987, P NATL ACAD SCI USA, V84, P6045, DOI 10.1073/pnas.84.17.6045; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; WOOD RD, 1989, BIOCHEMISTRY-US, V28, P8287, DOI 10.1021/bi00447a005; ZDZIENICKA MZ, 1992, MUTAT RES, V273, P73, DOI 10.1016/0921-8777(92)90051-4	25	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8303	8308						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132553				2022-12-27	WOS:A1994NB40900071
J	TODA, K; SHIZUTA, Y				TODA, K; SHIZUTA, Y			IDENTIFICATION AND CHARACTERIZATION OF CIS-ACTING REGULATORY ELEMENTS FOR THE EXPRESSION OF THE HUMAN AROMATASE CYTOCHROME-P-450 GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENCODING HUMAN AROMATASE; HUMAN PLACENTAL AROMATASE; ADIPOSE STROMAL CELLS; ESTROGEN BIOSYNTHESIS; ENHANCER ELEMENTS; MAMMALIAN-CELLS; PHORBOL ESTERS; DNA; AROMATIZATION; BINDING	CYP19, the human aromatase cytochrome P-450 (P450arom) gene, encodes an enzyme which converts androgens to estrogens by three successive hydroxylation reactions by coupling with NADPH-cytochrome P-450 reductase. In the present study, we have characterized two cis-acting transcriptional regulatory elements of CYP19, termed as hATRE-1 (human aromatase cytochrome P-450 gene transcriptional regulatory element-1) (5'-CTTTCTGGCCTAAGGGTTGGAGAGC-3') and hATRE-2 (5'-CTTTTATGTTGCCCAATACCTGCTCTGCCTCGAGGGTCACTGTC-3'). These sequences are located between -2238 and -2214, and between -2141 and -2098 relative to the major cap site of the gene, respectively. Transient expression analysis in human BeWo choriocarcinoma cells, in which CYP19 is expressed, shows that hATRE-1 represses the expression of the bacterial chloramphenicol acetyltransferase reporter gene driven by the promoter of CYP19, whereas hATRE-2 enhances the reporter gene expression in response to 12-O-tetradecanoylphorbol 13-acetate. Electrophoretic mobility shift analysis indicates that nuclear binding factors specific to hATRE-1 are present in BeWo cells, but not in HeLa cells nor in TYK-nu cells that lack the expression of CYP19. In contrast, nuclear binding factors to hATRE-2 are present not only in BeWo cells but also in the latter two types of cells. Nevertheless, hATRE-2 does not affect the reporter gene expression in HeLa cells and TYK-nu cells. These results indicate that hATRE-1 and hATRE-2 are cis-acting transcriptional regulatory elements involving in the regulation of the cell type-specific expression of CYP19.	KOCHI MED SCH, DEPT MED CHEM, NANKO KU, KOCHI 783, JAPAN	Kochi University								AKHTAR M, 1982, BIOCHEM J, V201, P569, DOI 10.1042/bj2010569; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BERKOVITZ GD, 1992, J CLIN ENDOCR METAB, V74, P629, DOI 10.1210/jc.74.3.629; CORBIN CJ, 1988, P NATL ACAD SCI USA, V85, P8948, DOI 10.1073/pnas.85.23.8948; EVANS CT, 1987, J BIOL CHEM, V262, P6914; FISHMAN J, 1981, J BIOL CHEM, V256, P4466; FOSTER R, 1988, J BIOL CHEM, V263, P11528; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAHAMLORENCE S, 1991, J BIOL CHEM, V266, P11939; HAGERMAN DD, 1987, J BIOL CHEM, V262, P2398; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; HARADA N, 1988, BIOCHEM BIOPH RES CO, V156, P725, DOI 10.1016/S0006-291X(88)80903-3; HARADA N, 1990, BIOCHEM BIOPH RES CO, V166, P365, DOI 10.1016/0006-291X(90)91954-Q; HERBST RS, 1990, MOL CELL BIOL, V10, P3896, DOI 10.1128/MCB.10.8.3896; JUNGMANN RA, 1966, STEROIDS, V8, P977, DOI 10.1016/0039-128X(66)91022-1; KELLIS JT, 1987, J BIOL CHEM, V262, P4413; LAIMINS LA, 1984, J VIROL, V49, P183, DOI 10.1128/JVI.49.1.183-189.1984; LANOUX MJ, 1985, ENDOCRINOLOGY, V117, P361, DOI 10.1210/endo-117-1-361; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LOBO JO, 1989, J CLIN ENDOCR METAB, V69, P868, DOI 10.1210/jcem-69-4-868; LONGCOPE C, 1978, J CLIN ENDOCR METAB, V46, P146, DOI 10.1210/jcem-46-1-146; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHENDROO MS, 1991, J BIOL CHEM, V266, P11276; Maxam A M, 1980, Methods Enzymol, V65, P499; MEANS GD, 1989, J BIOL CHEM, V264, P19385; MENDELSON CR, 1986, ENDOCRINOLOGY, V118, P968, DOI 10.1210/endo-118-3-968; MOROHASHI K, 1992, J BIOL CHEM, V267, P17913; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; POMPON D, 1989, MOL ENDOCRINOL, V3, P1477, DOI 10.1210/mend-3-9-1477; PRICE T, 1992, J CLIN ENDOCR METAB, V74, P879, DOI 10.1210/jc.74.4.879; RICE DA, 1991, MOL ENDOCRINOL, V5, P1552, DOI 10.1210/mend-5-10-1552; RITVOS O, 1992, ENDOCRINOLOGY, V130, P61, DOI 10.1210/en.130.1.61; RYAN KJ, 1966, J CLIN ENDOCR METAB, V26, P46, DOI 10.1210/jcem-26-1-46; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMPSON ER, 1981, P NATL ACAD SCI-BIOL, V78, P5690, DOI 10.1073/pnas.78.9.5690; SMUK M, 1977, J CLIN ENDOCR METAB, V45, P1009, DOI 10.1210/jcem-45-5-1009; STAUDT LM, 1986, NATURE, V323, P640, DOI 10.1038/323640a0; THOMPSON EA, 1974, J BIOL CHEM, V249, P5373; TODA K, 1989, FEBS LETT, V247, P371, DOI 10.1016/0014-5793(89)81373-0; TODA K, 1992, EUR J BIOCHEM, V205, P303, DOI 10.1111/j.1432-1033.1992.tb16781.x; TODA K, 1993, EUR J BIOCHEM, V213, P383, DOI 10.1111/j.1432-1033.1993.tb17772.x; TODA K, 1990, EUR J BIOCHEM, V193, P559, DOI 10.1111/j.1432-1033.1990.tb19372.x; YOSHIDA N, 1991, BIOCHEMISTRY-US, V30, P3003, DOI 10.1021/bi00226a004	45	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8099	8107						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132535				2022-12-27	WOS:A1994NB40900043
J	KAYA, SJ; TSUDA, T; HAGIWARA, K; FUKUI, T; TANIGUCHI, K				KAYA, SJ; TSUDA, T; HAGIWARA, K; FUKUI, T; TANIGUCHI, K			PYRIDOXAL 5'-PHOSPHATE PROBES AT LYS-480 CAN SENSE THE BINDING OF ATP AND THE FORMATION OF PHOSPHOENZYMES IN NA+,K+-ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORT ADENOSINE-TRIPHOSPHATASE; AMINO-ACID-SEQUENCE; CONFORMATIONAL CHANGE; CA-2+-TRANSPORTING ATPASE; SARCOPLASMIC-RETICULUM; INORGANIC-PHOSPHATE; ESSENTIAL RESIDUE; ACTIVE-SITE; NA+; K+	The Lys-480 in the alpha-subunits of Na+,K+-ATPase from pig kidneys was specifically modified with pyridoxal 5'-phosphate (PLP) or pyridoxal 5'-diphospho-5'-adenosine (AP(2)PL) probes in the presence of NaCl. The site was shown to be the same as the ATP-protectable binding of these probes (Hint, H. R., and Kirley, T. L. (1990) J. Biol. Chem. 265, 10260-10265). Modifications strongly reduced both Na+,K+-ATPase activity and the amount of Na+-dependent phosphoenzyme from [P-32]ATP but not from [P-32]acetyl-phosphate (AcP). Addition of AcP to the enzyme induced a slight decrease in the fluorescence of the PLP probe in the presence of 2 M NaCl and 4 mM MgCl2 but a single exponential increase in the presence of 16 mM NaCl and 4 mM MgCl2. The addition of ATP induced single exponential fluorescence increases at both Na+ concentrations. The data show that these probes can sense molecular events related to the formation of phosphoenzymes induced by AcP and presumably to the formation of Mg-Na-ATP-enzyme complex. The data also suggest that PLP or AP(2)PL probes at Lys-480 in the presence of Na+ and Mg2+ do not affect the transphosphorylation from AcP to Asp-369 to form phosphoenzymes but that they inhibit the transphosphorylation from the gamma-phosphoryl group of ATP and also ATP binding in the absence of Mg2+.	OSAKA UNIV,INST SCI & IND RES,IBARAKI,OSAKA 567,JAPAN	Osaka University	KAYA, SJ (corresponding author), HOKKAIDO UNIV,FAC SCI,DEPT CHEM,SAPPORO,HOKKAIDO 060,JAPAN.							ABBOTT AJ, 1991, BIOCHEMISTRY-US, V30, P1692, DOI 10.1021/bi00220a035; ALBERS RW, 1976, ENZYMES BIOLOGICAL M, V3, P283; BERBERIAN G, 1991, BIOCHIM BIOPHYS ACTA, V1063, P217, DOI 10.1016/0005-2736(91)90374-H; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DAVID P, 1991, J BIOL CHEM, V266, P14896; ELISDAVIES GCR, 1993, J BIOL CHEM, V268, P11622; FARLEY RA, 1984, J BIOL CHEM, V259, P9532; Fiske CH, 1925, J BIOL CHEM, V66, P375; Glynn I. M., 1985, ENZYMES BIOL MEMBR, P35; HEGYVARY C, 1981, J BIOL CHEM, V256, P6296; HINZ HR, 1990, J BIOL CHEM, V265, P10260; KARLISH SJD, 1980, J BIOENERG BIOMEMBR, V12, P111, DOI 10.1007/BF00744678; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V527, P115, DOI 10.1016/0005-2744(78)90261-9; KIRLEY TL, 1984, BIOCHEM BIOPH RES CO, V125, P767, DOI 10.1016/0006-291X(84)90605-3; MAEDA M, 1988, J BIOL CHEM, V263, P3652; NAGAI M, 1986, J BIOL CHEM, V261, P3197; PEDEMONTE CH, 1990, AM J PHYSIOL, V258, pC1, DOI 10.1152/ajpcell.1990.258.1.C1; POST RL, 1969, J GEN PHYSIOL, V54, pS306, DOI 10.1085/jgp.54.1.306; REPKE KRH, 1992, BIOL REV, V67, P31; ROBINSON JD, 1993, BIOCHIM BIOPHYS ACTA, V1154, P83, DOI 10.1016/0304-4157(93)90018-J; SCHULL GE, 1985, NATURE, V316, P691; SKOU JC, 1982, BIOCHIM BIOPHYS ACTA, V688, P369, DOI 10.1016/0005-2736(82)90348-0; STEINBERG M, 1989, J BIOL CHEM, V264, P2726; SUZUKI K, 1987, J BIOL CHEM, V262, P11752; TAGAYA M, 1986, BIOCHEMISTRY-US, V25, P2958, DOI 10.1021/bi00358a034; TANIGUCHI K, 1975, J BIOL CHEM, V250, P3010; TANIGUCHI K, 1991, J BIOCHEM-TOKYO, V109, P299; TANIGUCHI K, 1986, J BIOL CHEM, V261, P3272; TANIGUCHI K, 1993, J BIOL CHEM, V268, P15588; TANIGUCHI K, 1984, J BIOL CHEM, V259, P5228; TANIGUCHI K, 1982, J BIOL CHEM, V257, P659; TANIGUCHI K, 1988, J BIOL CHEM, V263, P12943; Taniguchi K, 1988, Prog Clin Biol Res, V268A, P369; TANIGUCHI K, 1980, J BIOCHEM-TOKYO, V88, P609, DOI 10.1093/oxfordjournals.jbchem.a133010; WANG K, 1992, J BIOL CHEM, V267, P3577; XU KY, 1989, BIOCHEMISTRY-US, V28, P5764, DOI 10.1021/bi00440a010; YAMAMOTO H, 1988, J BIOCHEM-TOKYO, V103, P452, DOI 10.1093/oxfordjournals.jbchem.a122291; YAMAMOTO H, 1989, J BIOCHEM-TOKYO, V106, P1121, DOI 10.1093/oxfordjournals.jbchem.a122976	38	19	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7419	7422						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125960				2022-12-27	WOS:A1994NA03200061
J	RAO, SI; WILKS, A; HAMBERG, M; DEMONTELLANO, PRO				RAO, SI; WILKS, A; HAMBERG, M; DEMONTELLANO, PRO			THE LIPOXYGENASE ACTIVITY OF MYOGLOBIN - OXIDATION OF LINOLEIC-ACID BY THE FERRYL OXYGEN RATHER THAN PROTEIN RADICAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN-H SYNTHASE; SPERM WHALE MYOGLOBIN; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; FATTY-ACIDS; METMYOGLOBIN; IDENTIFICATION; HYDROPEROXIDE; SPECTROSCOPY; BIOSYNTHESIS	Linoleic (9(Z),12(Z)-octadecadienoic) acid is oxidized by sperm whale myoglobin and H2O2 to an 84:16 (9S):(9R) enantiomer mixture of 9-hydroperoxy-10(E),12(Z)-octadecadienoic acid. Neither the 9,10- nor 12,13-epoxide of linoleic acid, nor 9-hydroxy-10(E),12(Z)-octadecadienoic nor 13-hydroperoxy-9(Z),11(E)-octadeca-dienoic acids, is detectably formed. Incubations with [(11R)-H-2]- and [(11S)-H-2]linoleic acids indicate that the pro-R hydrogen is abstracted 76% of the time. An H64V mutant in which access to the heme crevice is increased oxidizes linoleic acid exclusively by abstraction of the pro-R hydrogen to give the (9S)-hydroperoxide. Spectroscopic studies show that the K-d value for binding of linoleic acid to myoglobin is similar to the K-m value for its oxidation and indicate that linoleic acid reduces the ferryl species to the ferric state. The stereochemical results, supported by O-18-labeling studies, definitively rule out a significant role for singlet oxygen in the myoglobin-catalyzed, H2O2-dependent oxidation of linoleic acid. The myoglobin protein radical formed with H2O2 also plays no part in the reaction because the K-m and V-max values for the oxidation of linoleic acid are similar for native myoglobin and two mutants (K102Q/ Y103F/Y146F/Y151F and H64V/K102Q/Y103F/Y146F/ Y151F) with no tyrosine residues. Furthermore, the rate of formation of the 9-hydroperoxide is not changed if the protein radical is allowed to decay before linoleic acid is added. The results establish that linoleic acid is oxidized within the heme crevice by reaction with the ferryl oxygen rather than a protein radical. They indicate, furthermore, that hydrogen abstraction and oxygen addition occur in an antarafacial manner and suggest a specific model for binding of linoleic acid within the myoglobin active site.	UNIV CALIF SAN FRANCISCO, SCH PHARM, DEPT PHARMACEUT CHEM, SAN FRANCISCO, CA 94143 USA; KAROLINSKA INST, DEPT PHYSIOL CHEM, S-10401 STOCKHOLM, SWEDEN	University of California System; University of California San Francisco; Karolinska Institutet					NCRR NIH HHS [RR01614] Funding Source: Medline; NIDDK NIH HHS [DK30297, P-50 DK26743] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK030297] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALVAREZ JC, 1992, BIOCHEMISTRY-US, V31, P8315, DOI 10.1021/bi00150a027; CATALANO CE, 1989, J BIOL CHEM, V264, P10534; CATALANO CE, 1987, BIOCHEMISTRY-US, V26, P8373, DOI 10.1021/bi00399a052; CHANCE M, 1986, BIOCHEMISTRY-US, V25, P1259, DOI 10.1021/bi00354a010; DAVIES MJ, 1990, FREE RADICAL RES COM, V10, P361, DOI 10.3109/10715769009149905; DAVIES MJ, 1991, BIOCHIM BIOPHYS ACTA, V1077, P86, DOI 10.1016/0167-4838(91)90529-9; DEMONTELLANO PRO, 1985, J BIOL CHEM, V260, P9265; DIETZ R, 1988, EUR J BIOCHEM, V171, P321, DOI 10.1111/j.1432-1033.1988.tb13793.x; DIX TA, 1985, J BIOL CHEM, V260, P5351; EGGER KW, 1973, HELV CHIM ACTA, V56, P1516, DOI 10.1002/hlca.19730560509; FANTONE J, 1989, J BIOL CHEM, V264, P9408; FUNK MO, 1976, LIPIDS, V11, P113, DOI 10.1007/BF02532660; GALARIS D, 1990, ARCH BIOCHEM BIOPHYS, V281, P163, DOI 10.1016/0003-9861(90)90427-Z; GALARIS D, 1989, ARCH BIOCHEM BIOPHYS, V273, P497, DOI 10.1016/0003-9861(89)90509-2; GALARIS D, 1988, ARCH BIOCHEM BIOPHYS, V262, P221, DOI 10.1016/0003-9861(88)90184-1; GRISHAM M B, 1985, Journal of Free Radicals in Biology and Medicine, V1, P227, DOI 10.1016/0748-5514(85)90122-9; HSUANYU YC, 1992, J BIOL CHEM, V267, P17649; HUBBARD WC, 1980, PROSTAGLANDINS, V20, P431; KANNER J, 1985, ARCH BIOCHEM BIOPHYS, V237, P314, DOI 10.1016/0003-9861(85)90282-6; KELMAN DJ, 1992, FREE RADICAL RES COM, V16, P27, DOI 10.3109/10715769209049156; KING NK, 1967, BIOCHIM BIOPHYS ACTA, V133, P65; KING NK, 1963, J BIOL CHEM, V238, P1520; KUHN H, 1987, ANAL BIOCHEM, V160, P24, DOI 10.1016/0003-2697(87)90609-9; KUHN H, 1981, EUR J BIOCHEM, V120, P161, DOI 10.1111/j.1432-1033.1981.tb05684.x; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1169, P80, DOI 10.1016/0005-2760(93)90085-N; LAMAR GN, 1983, J AM CHEM SOC, V105, P782, DOI 10.1021/ja00342a022; MIEYAL JJ, 1985, REV BIOCHEM TOXICOL, V7, P1; MIKI H, 1989, ARCH BIOCHEM BIOPHYS, V275, P354, DOI 10.1016/0003-9861(89)90382-2; MITSOS SE, 1988, LAB INVEST, V59, P824; NEWMAN ESR, 1991, BIOCHEM BIOPH RES CO, V179, P1414, DOI 10.1016/0006-291X(91)91730-Z; OLIW EH, 1993, ARCH BIOCHEM BIOPHYS, V300, P434, DOI 10.1006/abbi.1993.1059; OZAWA T, 1986, BIOCHEM BIOPH RES CO, V134, P1071, DOI 10.1016/0006-291X(86)90360-8; RAO SI, 1993, J BIOL CHEM, V268, P803; RINGE D, 1984, BIOCHEMISTRY-US, V23, P2, DOI 10.1021/bi00296a001; SHINAR E, 1990, SEMIN HEMATOL, V27, P70; SITTER AJ, 1985, BIOCHIM BIOPHYS ACTA, V828, P229, DOI 10.1016/0167-4838(85)90301-2; SMITH WL, 1992, BIOCHEMISTRY-US, V31, P3, DOI 10.1021/bi00116a001; SMITH WL, 1991, PHARMACOL THERAPEUT, V49, P153, DOI 10.1016/0163-7258(91)90054-P; STARKE DW, 1989, BIOCHEM PHARMACOL, V38, P201, DOI 10.1016/0006-2952(89)90169-X; TEW D, 1988, J BIOL CHEM, V263, P17880; WILKS A, 1992, J BIOL CHEM, V267, P8827; YONETANI T, 1967, J BIOL CHEM, V242, P1974	42	104	104	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7210	7216						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125933				2022-12-27	WOS:A1994NA03200029
J	YANG, LJ; RHEE, SG; WILLIAMSON, JR				YANG, LJ; RHEE, SG; WILLIAMSON, JR			EPIDERMAL GROWTH FACTOR-INDUCED ACTIVATION AND TRANSLOCATION OF PHOSPHOLIPASE C-GAMMA-1 TO THE CYTOSKELETON IN RAT HEPATOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING PROTEIN; FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; PERTUSSIS TOXIN; C-GAMMA; SIGNAL TRANSDUCTION; CALCIUM RELEASE; DNA-SYNTHESIS; EGF RECEPTOR; SH3 DOMAINS	In this study, we have examined the relationship between epidermal growth factor (EGF)-induced tyrosine phosphorylation of phospholipase C-gamma 1 (PLC-gamma 1) and its translocation from the cytosol to the Triton X-100-insoluble cytoskeleton fraction in rat hepatocytes. The translocation of PLC-gamma 1 was specific for EGF stimulation, because a similar effect was not observed with insulin or vasopressin. EGF caused a transient increase of PLC activity in the cytoskeleton fraction which could be abolished by immunoprecipitating PLC-gamma 1. Tyrosine phosphorylated PLC-gamma 1 was seen only in the cytoskeleton fraction, suggesting that tyrosine phosphorylation is required for PLC-gamma 1 translocation to the cytoskeleton. This process may involve binding of PLC-gamma 1 to actin filaments, since actin was immunoprecipitated together with PLC-gamma 1 in the cytoskeleton after EGF treatment. EGF-induced translocation of PLC-gamma 1 to the cytoskeleton was not inhibited by pertussis toxin, but Gi alpha was translocated in an EGF dependent manner, suggesting that the interaction of PLC-gamma 1 with its activated Gi-protein is downstream from both PLC-gamma 1 tyrosine phosphorylation and its translocation to the cytoskeleton. Taken together, the present studies indicate that EGF-induced tyrosine phosphorylation of PLC-gamma 1, its association with the cytoskeleton, and its interaction with activated Gi alpha protein are all obligatory for PLC-gamma 1 activation in hepatocytes.	NHLBI, BIOCHEM LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	YANG, LJ (corresponding author), UNIV PENN, DEPT BIOCHEM & BIOPHYS, 37TH & HAMILTON WALK, PHILADELPHIA, PA 19104 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015120, P30DK019525] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-19525, DK-07314, DK-15120] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAFFY G, 1992, J CELL PHYSIOL, V153, P332, DOI 10.1002/jcp.1041530213; BARSAGI D, 1993, CELL, V74, P83, DOI 10.1016/0092-8674(93)90296-3; BELL RM, 1991, J BIOL CHEM, V266, P4661; BELLOT F, 1990, J CELL BIOL, V110, P491, DOI 10.1083/jcb.110.2.491; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1987, BIOCHIM BIOPHYS ACTA, V907, P33, DOI 10.1016/0304-419X(87)90017-5; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHANG CP, 1991, J BIOL CHEM, V266, P23467; COCKCROFT S, 1992, BIOCHEM J, V288, P1; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; ENHENEGOUWEN PMP, 1989, J CELL BIOCHEM, V39, P455; ENHENEGOUWEN PMPV, 1992, EXP CELL RES, V199, P90, DOI 10.1016/0014-4827(92)90465-K; FERRIS CD, 1992, NATURE, V356, P350, DOI 10.1038/356350a0; GOLDSCHMIDTCLERMONT PJ, 1990, SCIENCE, V247, P1575, DOI 10.1126/science.2157283; GOLDSCHMIDTCLERMONT PJ, 1991, SCIENCE, V251, P1231, DOI 10.1126/science.1848725; HANSEN CA, 1991, J BIOL CHEM, V266, P18573; HEPLER JR, 1990, BIOCHEM J, V270, P337, DOI 10.1042/bj2700337; HERNANDEZSOTOMAYOR SMT, 1993, BIOCHEM J, V293, P507, DOI 10.1042/bj2930507; HORVATH AR, 1992, EMBO J, V11, P855, DOI 10.1002/j.1460-2075.1992.tb05123.x; HUANG CL, 1989, J BIOL CHEM, V264, P4391; JONES GA, 1993, J BIOL CHEM, V268, P20845; KHAN AA, 1992, SCIENCE, V257, P815, DOI 10.1126/science.1323146; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KIM JW, 1990, J BIOL CHEM, V265, P3940; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LANDRETH GE, 1985, J CELL BIOL, V101, P1341, DOI 10.1083/jcb.101.4.1341; LI W, 1991, CELL REGUL, V2, P641, DOI 10.1091/mbc.2.8.641; LIANG M, 1992, MOL PHARMACOL, V42, P743; LIANG M, 1991, J BIOL CHEM, V266, P13342; LLOPIS J, 1992, BIOCHEM J, V284, P243, DOI 10.1042/bj2840243; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MCBRIDE K, 1991, P NATL ACAD SCI USA, V88, P7111, DOI 10.1073/pnas.88.16.7111; MOZHAYEVA GN, 1990, FEBS LETT, V277, P233, DOI 10.1016/0014-5793(90)80853-B; MUALLEM S, 1989, J BIOL CHEM, V264, P205; NISHIBE S, 1989, J BIOL CHEM, V264, P10335; NISHIBE S, 1990, P NATL ACAD SCI USA, V87, P424, DOI 10.1073/pnas.87.1.424; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PAYRASTRE B, 1991, J CELL BIOL, V115, P121, DOI 10.1083/jcb.115.1.121; PIKE LJ, 1987, J BIOL CHEM, V262, P1644; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RHEE SG, 1991, TRENDS BIOCHEM SCI, V16, P297, DOI 10.1016/0968-0004(91)90122-C; RODAWAY ARF, 1989, NATURE, V342, P624, DOI 10.1038/342624a0; SHI YE, 1989, CANCER RES, V49, P3574; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SUH PG, 1988, J BIOL CHEM, V263, P14497; TAYLOR CW, 1988, BIOCHEM J, V249, P917, DOI 10.1042/bj2490917; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VEGA QC, 1992, MOL CELL BIOL, V12, P128, DOI 10.1128/MCB.12.1.128; VOLPE P, 1988, P NATL ACAD SCI USA, V85, P1091, DOI 10.1073/pnas.85.4.1091; WAHL MI, 1990, J BIOL CHEM, V265, P3944; WAHL MI, 1992, J BIOL CHEM, V267, P10447; WHITMAN M, 1989, BIOCHIM BIOPHYS ACTA, V948, P327, DOI 10.1016/0304-419X(89)90005-X; WILLIAMSON JR, 1989, ANNU REV PHYSIOL, V51, P107, DOI 10.1146/annurev.ph.51.030189.000543; YANG LJ, 1991, J BIOL CHEM, V266, P22451; YANG LJ, 1993, J BIOL CHEM, V268, P3739; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	59	109	109	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7156	7162						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125925				2022-12-27	WOS:A1994NA03200021
J	HAUSER, JML; BUEHRER, BM; BELL, RM				HAUSER, JML; BUEHRER, BM; BELL, RM			ROLE OF CERAMIDE IN MITOGENESIS INDUCED BY EXOGENOUS SPHINGOID BASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; CELLULAR PROLIFERATION; SIGNAL TRANSDUCTION; MONOCYTIC DIFFERENTIATION; HL-60 CELLS; SPHINGOMYELIN TURNOVER; ENDOGENOUS GANGLIOSIDE; PHOSPHATIDIC-ACID; A431 CELLS	Dihydrosphingosine, an intermediate in the de novo synthesis of ceramide, induced proliferation of Swiss 3T3 cells. The proliferative effects of this lipid were much more potent than those of sphingosine, a breakdown product of ceramide. The maximal proliferative response to dihydrosphingosine occurred at relatively low concentrations (1 mu M), while sphingosine produced its maximal effect at much higher concentrations (15 mu M), The cell-permeable ceramide, N-hexanoylsphingosine (C-6-ceramide), which was also a mitogen in these cells (at 1 mu M), caused a striking morphological change when added to the cells at concentrations of 5-10 mu M. This shape change was reversible with the removal of ceramide. Exogenous dihydrosphingosines and sphingosines have at least two metabolic fates in Swiss 3T3 cells, conversion to ceramide or to sphingosine 1-phosphate, Surprisingly, both the synthetic threo- isomer and the naturally occurring erythro- isomer of dihydrosphingosine and sphingosine (D-erythro-sphingosine, L-threo-sphingosine, DL-threo-dihydrosphingosine, and DL-erythro-dihydrosphingosine) were readily phosphorylated in in tact Swiss 3T3 cells. This substrate specificity may be an indication of a sphingosine kinase activity which is distinct from that of platelets or rat brain. Although sphingosine 1-phosphate and ceramide were both produced upon the addition of sphingosine and dihydrosphingosine, no sphingosine 1-phosphate was produced when Swiss 3T3 cells were treated with mitogenic concentrations of C-6-ceramide. These data are consistent with the formation of ceramide and not sphingosine 1-phosphate being required for the mitogenesis produced by exogenous sphingoid bases.	DUKE UNIV,MED CTR,CELL GROWTH REGULAT & ONCOGENESIS SECT,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710	Duke University; Duke University				Buehrer, Benjamin/0000-0001-6654-4367	NIDDK NIH HHS [DK 20205] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK020205, R01DK020205] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMES BN, 1960, J BIOL CHEM, V235, P769; BALLOU LR, 1992, J BIOL CHEM, V267, P20044; BARBOUR S, 1992, J CELL PHYSIOL, V150, P610, DOI 10.1002/jcp.1041500322; BELL RM, 1988, COLD SPRING HARB SYM, V53, P103, DOI 10.1101/SQB.1988.053.01.016; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRESTSCHER A, 1991, ANN REV CELL BIOL, V7, P337; BUEHRER BM, 1992, J BIOL CHEM, V267, P3154; DESAI NN, 1991, BIOCHEM BIOPH RES CO, V181, P361, DOI 10.1016/S0006-291X(05)81427-5; DESAI NN, 1992, J BIOL CHEM, V267, P26121; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; FELDINGHABERMANN B, 1990, BIOCHEMISTRY-US, V29, P6314, DOI 10.1021/bi00478a028; GHIDONI R, 1986, BIOCHEM J, V237, P147, DOI 10.1042/bj2370147; GHIDONI R, 1983, BIOCHEM J, V213, P321, DOI 10.1042/bj2130321; GOLDKORN T, 1991, J BIOL CHEM, V266, P16092; HAKOMORI S, 1983, SPHINGOLIPID BIOCH, P327; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; HANNUN YA, 1989, CLIN CHIM ACTA, V185, P333, DOI 10.1016/0009-8981(89)90224-6; HARTWIG JH, 1989, J CELL BIOL, V109, P1571, DOI 10.1083/jcb.109.4.1571; HARTWIG JH, 1989, J CELL BIOL, V108, P467, DOI 10.1083/jcb.108.2.467; IGARASHI Y, 1990, J BIOL CHEM, V265, P5385; JANMEY PA, 1989, J BIOL CHEM, V264, P4825; KIM MY, 1991, J BIOL CHEM, V266, P484; KOLESNICK RN, 1991, PROG LIPID RES, V30, P1, DOI 10.1016/0163-7827(91)90005-P; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; MATHIAS S, 1991, P NATL ACAD SCI USA, V88, P10009, DOI 10.1073/pnas.88.22.10009; MEDLOCK KA, 1988, BIOCHEM BIOPH RES CO, V157, P232, DOI 10.1016/S0006-291X(88)80037-8; MERRILL AH, 1991, J BIOENERG BIOMEMBR, V23, P83; MERRILL AH, 1989, BIOCHIM BIOPHYS ACTA, V1010, P131, DOI 10.1016/0167-4889(89)90152-3; MOOLENAAR WH, 1986, NATURE, V323, P171, DOI 10.1038/323171a0; NOJIRI H, 1986, P NATL ACAD SCI USA, V83, P782, DOI 10.1073/pnas.83.3.782; OKADA Y, 1988, FEBS LETT, V235, P25, DOI 10.1016/0014-5793(88)81227-4; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OKAZAKI T, 1990, J BIOL CHEM, V265, P15823; OLIVERA A, 1992, J BIOL CHEM, V267, P26121; PREISS J, 1986, J BIOL CHEM, V261, P8597; RADIN NS, 1991, TRENDS GLYCOSCI GLYC, V3, P200; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SAITO M, 1985, BIOCHEM BIOPH RES CO, V132, P223, DOI 10.1016/0006-291X(85)91011-3; SHARIFF A, 1992, SCIENCE, V256, P245, DOI 10.1126/science.1373523; SHAYMAN JA, 1991, J BIOL CHEM, V266, P22968; SHUKLA GS, 1991, BIOCHIM BIOPHYS ACTA, V1083, P101, DOI 10.1016/0005-2760(91)90130-A; SPIEGEL S, 1989, J BIOL CHEM, V264, P16512; SPIEGEL S, 1987, P NATL ACAD SCI USA, V84, P141, DOI 10.1073/pnas.84.1.141; SPIEGEL S, 1988, EXP CELL RES, V177, P414, DOI 10.1016/0014-4827(88)90474-0; STEVENS VL, 1989, CANCER RES, V49, P3229; STOSSEL TP, 1989, J BIOL CHEM, V264, P18261; TRINCHERA M, 1988, BIOCHEM J, V252, P375, DOI 10.1042/bj2520375; TRINCHERA M, 1990, BIOCHEM J, V270, P815, DOI 10.1042/bj2700815; TSAI MH, 1989, MOL CELL BIOL, V9, P5260, DOI 10.1128/MCB.9.11.5260; TSAI MH, 1989, SCIENCE, V243, P522, DOI 10.1126/science.2536192; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; VANVELDHOVEN PP, 1989, J LIPID RES, V30, P611; VANVELDHOVEN PP, 1989, ANAL BIOCHEM, V183, P177, DOI 10.1016/0003-2697(89)90186-3; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; WANG E, 1991, J BIOL CHEM, V266, P14486; WIEGMANN K, 1992, J BIOL CHEM, V267, P17997; ZHANG H, 1990, J BIOL CHEM, V265, P76; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; ZHANG H, 1990, J BIOL CHEM, V265, P21309	60	58	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6803	6809						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120042				2022-12-27	WOS:A1994MZ50300086
J	KNORR, BA; LIPKOWITZ, MS; POTTER, BJ; MASUR, SK; ABRAMSON, RG				KNORR, BA; LIPKOWITZ, MS; POTTER, BJ; MASUR, SK; ABRAMSON, RG			ISOLATION AND IMMUNOLOCALIZATION OF A RAT RENAL CORTICAL MEMBRANE URATE TRANSPORTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-SPECIFIC EXPRESSION; URICASE; ANTIBODIES; VESICLES; OXIDASE	Two modalities of urate transport have been reported in rat kidney, a urate/anion exchanger and a potential sensitive, uricase-like uniporter. As an initial attempt to isolate and characterize the responsible transport protein(s), rat renal cortical membranes were harvested, solubilized, and subjected to affinity chromatography with urate or xanthine as the affinity ligand. Pig liver peroxisomal uricase was purified with the same system, and the enzymatically active protein was used to generate polyclonal antibodies in rabbit, Silver stain of SDS-polyacrylamide gel electrophoresis gels of the eluted fraction containing the affinity-purified renal membrane protein(s) demonstrated bands at 25, 32, 36, and 41 kDa. On Western blot, two of these bands (32 and 36 kDa) were immunoreactive to the polyclonal antibody to pig liver uricase. In 6 of 10 studies, the affinity-purified renal membrane protein(s) also oxidized urate. Anti-pig liver uricase produced a selective and dose-dependent inhibition of the uricase like urate uniporter in renal membrane vesicles, but did not affect the urate/anion exchanger or the sodium-dependent glucose transporter. Immunocytochemical studies of rat renal cortex with the same antibody indicated that the immunoreactivity was localized to proximal tubules. These studies demonstrate that the renal cortical plasma membranes contain urate-binding proteins, which have some func tional and immunological homology to the hepatic per oxisomal core protein, uricase. Within the renal cortex, these proteins are localized to proximal tubules, the site of urate transport. Since the antibody that reacts with the affinity-purified urate-binding proteins on Western blot selectively inhibits urate transport in intact membrane vesicles, it is concluded that at least one of the affinity-purified urate-binding proteins is a uricase like urate transporter.	MT SINAI SCH MED,DEPT OPTHALMOL,NEW YORK,NY 10029; MT SINAI SCH MED,DEPT OPHTHALMOL,NEW YORK,NY 10029; LOUISIANA STATE UNIV,MED CTR,DEPT PHYSIOL,NEW ORLEANS,LA 70112	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Louisiana State University System					NATIONAL EYE INSTITUTE [R03EY009244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK008419, R01DK037315] Funding Source: NIH RePORTER; NEI NIH HHS [EY09244] Funding Source: Medline; NIDDK NIH HHS [DK08419, DK37315] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAMSON RG, 1982, AM J PHYSIOL, V242, pF158, DOI 10.1152/ajprenal.1982.242.2.F158; ABRAMSON RG, 1974, J APPL PHYSIOL, V36, P500, DOI 10.1152/jappl.1974.36.4.500; ABRAMSON RG, 1990, EVOLUTION URIC ACID, P115; ABRAMSON RG, 1985, AM J PHYSIOL, V17, pF574; AHMED K, 1964, BIOCHIM BIOPHYS ACTA, V93, P603, DOI 10.1016/0304-4165(64)90343-5; BATISTAVIERA F, 1977, PREP BIOCHEM, V7, P103, DOI 10.1080/00327487708061629; BAUDHUIN P, 1965, BIOCHEM BIOPH RES CO, V20, P53, DOI 10.1016/0006-291X(65)90949-6; BEARD ME, 1968, J EXP ZOOL, V168, P477, DOI 10.1002/jez.1401680408; BURRIDGE K, 1976, P NATL ACAD SCI USA, V73, P4457, DOI 10.1073/pnas.73.12.4457; DEDUVE C, 1966, PHYSIOL REV, V46, P323, DOI 10.1152/physrev.1966.46.2.323; FRIDOVIC.I, 1965, J BIOL CHEM, V240, P2491; GREGER R, 1974, PFLUG ARCH EUR J PHY, V352, P115, DOI 10.1007/BF00587510; HEIDRICH HG, 1980, J CELL BIOL, V54, P232; Hruban Z, 1969, MICROBODIES RELATED; HTAY HH, 1989, COMP BIOCHEM PHYS B, V92, P583, DOI 10.1016/0305-0491(89)90135-1; KAHN AM, 1983, AM J PHYSIOL, V245, pF151, DOI 10.1152/ajprenal.1983.245.2.F151; KAHN AM, 1985, AM J PHYSIOL, V249, pF684; KINNE R, 1982, AM J PHYSIOL, V242, pF158; KRAMP RA, 1975, AM J PHYSIOL, V288, P875; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHLER HR, 1956, SCIENCE, V124, P705, DOI 10.1126/science.124.3225.705; MOTOJIMA K, 1990, BIOCHIM BIOPHYS ACTA, V1087, P316, DOI 10.1016/0167-4781(90)90005-M; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; PORDY WT, 1987, AM J PHYSIOL, V253, pF702, DOI 10.1152/ajprenal.1987.253.4.F702; REDDY PG, 1988, P NATL ACAD SCI USA, V85, P9081, DOI 10.1073/pnas.85.23.9081; USADA N, 1988, LAB INVEST, V58, P100; VOLKL A, 1988, J HISTOCHEM CYTOCHEM, V36, P329, DOI 10.1177/36.4.3346536; WADE JB, 1986, AM J PHYSIOL, V251, pC380, DOI 10.1152/ajpcell.1986.251.3.C380; WATANABE T, 1978, ANAL BIOCHEM, V86, P357, DOI 10.1016/0003-2697(78)90758-3	30	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6759	6764						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120036				2022-12-27	WOS:A1994MZ50300079
J	RAMOS, C; WINTHER, JR; KIELLANDBRANDT, MC				RAMOS, C; WINTHER, JR; KIELLANDBRANDT, MC			REQUIREMENT OF THE PROPEPTIDE FOR IN-VIVO FORMATION OF ACTIVE YEAST CARBOXYPEPTIDASE-Y	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN CONFORMATION; SECRETORY PATHWAY; ESCHERICHIA-COLI; PRO-SEQUENCE; TRANSPORT; VACUOLE; GENE; SUBTILISIN; PRECURSOR	Deletions have been constructed in the region encoding the 91-amino acid propeptide of the vacuolar enzyme carboxypeptidase Y of Saccharomyces cerevisiae, and in vivo effects of these mutations on the intracellular transport of the mutant proenzymes have been examined. Deletions did not include the vacuolar targeting signal, and none of the mutated forms of procarboxypeptidase Y was found to be secreted. All deletions, however, re suited in a decreased rate of transport of the truncated proenzymes from the endoplasmic reticulum to the Golgi apparatus. Up to 29 residues close to the N terminus can be removed without completely eliminating transport of the mutated proenzymes to the vacuole. However, the C-terminal part of the propeptide contains elements which are essential, since two small deletions, of 9 and 15 residues, respectively, within this area re suited in loss of carboxypeptidase Y activity. This region is, however, not sufficient for efficient formation of active carboxypeptidase Y, since truncated precursors in which the vacuolar targeting signal was fused to the C-terminal part of the proregion did not give rise to active enzyme. Based on the results, we propose that the carboxypeptidase Y propeptide plays an essential role in guiding the proper folding of the protein in vivo and that many parts of the propeptide contribute, in an additive way, to this function.	CARLSBERG LAB, DEPT YEAST GENET, DK-2500 COPENHAGEN, DENMARK				Winther, Jakob R./K-4451-2014; Kielland-Brandt, Morten C./D-2563-2015; RAMOS, CAYO/G-3818-2011	Winther, Jakob R./0000-0001-6995-9154; RAMOS, CAYO/0000-0002-2362-5041; Kielland-Brandt, Morten/0000-0002-1272-3877				AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; BIELEFELD M, 1989, MOL GEN GENET, V215, P401, DOI 10.1007/BF00427036; BLACHLYDYSON E, 1987, J CELL BIOL, V104, P1183, DOI 10.1083/jcb.104.5.1183; CAPLAN S, 1991, J BACTERIOL, V173, P627, DOI 10.1128/jb.173.2.627-635.1991; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; FABRE E, 1991, J BIOL CHEM, V266, P3782; FEDER J, 1970, BIOCHEMISTRY-US, V9, P2784, DOI 10.1021/bi00816a005; FUJISHIGE A, 1992, J CELL BIOL, V118, P33, DOI 10.1083/jcb.118.1.33; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HASILIK A, 1978, EUR J BIOCHEM, V85, P599, DOI 10.1111/j.1432-1033.1978.tb12275.x; HEMMINGS BA, 1981, P NATL ACAD SCI-BIOL, V78, P435, DOI 10.1073/pnas.78.1.435; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; IKEMURA H, 1987, J BIOL CHEM, V262, P7859; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSON LM, 1987, CELL, V48, P875, DOI 10.1016/0092-8674(87)90084-5; JONES EW, 1991, METHOD ENZYMOL, V194, P428; KIZER JS, 1991, BIOCHEM BIOPH RES CO, V174, P586, DOI 10.1016/0006-291X(91)91457-N; KLIONSKY DJ, 1988, MOL CELL BIOL, V8, P2105, DOI 10.1128/MCB.8.5.2105; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; KOBAYASHI T, 1992, J MOL BIOL, V226, P931, DOI 10.1016/0022-2836(92)91042-N; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS MK, 1990, NUCLEIC ACIDS RES, V18, P3439, DOI 10.1093/nar/18.12.3439; MUKHTAR M, 1992, GENE, V121, P173, DOI 10.1016/0378-1119(92)90178-R; NEBES VL, 1991, J BIOL CHEM, V266, P22851; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; NIELSEN TL, 1990, APPL MICROBIOL BIOT, V33, P307, DOI 10.1007/BF00164527; OLESEN K, 1993, PROTEIN ENG, V6, P409, DOI 10.1093/protein/6.4.409; PAYNE GS, 1988, J CELL BIOL, V106, P1453, DOI 10.1083/jcb.106.5.1453; RAYMOND CK, 1992, INT REV CYTOL, V139, P59, DOI 10.1016/S0074-7696(08)61410-2; Sambrook J, 1989, MOL CLONING LABORATO; SHA X, 1991, J CELL BIOL, V114, P827, DOI 10.1083/jcb.114.4.827; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SORENSEN SO, 1994, IN PRESS EUR J BIOCH; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; STEVENS TH, 1986, J CELL BIOL, V102, P1551, DOI 10.1083/jcb.102.5.1551; TRIMBLE RB, 1983, J BIOL CHEM, V258, P2562; VALLS LA, 1990, J CELL BIOL, V111, P361, DOI 10.1083/jcb.111.2.361; VALLS LA, 1987, CELL, V48, P887, DOI 10.1016/0092-8674(87)90085-7; VATER CA, 1992, J CELL BIOL, V119, P773, DOI 10.1083/jcb.119.4.773; VIDA TA, 1990, J CELL BIOL, V111, P2871, DOI 10.1083/jcb.111.6.2871; WEISSMAN JS, 1992, CELL, V71, P841, DOI 10.1016/0092-8674(92)90559-U; WINTHER JR, 1991, EUR J BIOCHEM, V197, P681, DOI 10.1111/j.1432-1033.1991.tb15959.x; WINTHER JR, 1991, P NATL ACAD SCI USA, V88, P9330, DOI 10.1073/pnas.88.20.9330; ZHU XL, 1989, NATURE, V339, P483, DOI 10.1038/339483a0	45	52	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					7006	7012						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120064				2022-12-27	WOS:A1994MZ50300113
J	BERNSTEIN, LR; FERRIS, DK; COLBURN, NH; SOBEL, ME				BERNSTEIN, LR; FERRIS, DK; COLBURN, NH; SOBEL, ME			A FAMILY OF MITOGEN-ACTIVATED PROTEIN KINASE-RELATED PROTEINS INTERACTS IN-VIVO WITH ACTIVATOR PROTEIN-1 TRANSCRIPTION FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							C-JUN; TYROSINE KINASE; DNA-BINDING; MAP KINASES; FACTOR AP-1; JB6 CELLS; PHOSPHORYLATION; FOS; RESISTANT; THREONINE	The activator protein-1 (AP-1) transcription factor modulates expression of genes involved in growth regulation, differentiation, and neoplastic transformation. Several mitogen-activated protein kinases (MAP kinases) as well as other kinases phosphorylate c-Jun and c-Fos in vitro and are postulated to control AP-1 activity. However, since many protein kinases phosphorylate substrates in vitro with which they have no association in vivo, we sought evidence for interaction in vivo between AP-1 and MAP kinase proteins. We now report detection of an association in vivo of MAP kinase-related proteins with c-Jun and AP-1 dimers by peptide mapping and two-dimensional electrophoretic analyses of proteins co-immunoprecipitated with AP-1 antigens. Extracellular signal-regulated kinase-2 and several apparently novel MAP kinase-related proteins are among the species that bind to AP-1. The large number of MAP kinase-related proteins associated with AP-1 implicates them on an important gene regulation pathway. Combinatorial association between MAP kinase-related proteins and AP-1 dimers could potentially create numerous distinct complexes that could regulate diverse genes.	NCI,FREDERICK CANC RES & DEV CTR,PROGRAM RESOURCES DYNCORP,BIOL CARCINOGENESIS & DEV PROGRAM,FREDERICK,MD 21702; NCI,FREDERICK CANC RES & DEV CTR,VIRAL CARCINOGENESIS,FREDERICK,MD 21702	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	BERNSTEIN, LR (corresponding author), NCI,PATHOL LAB,BLDG 10,RM 2A33,9000 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.							ADLER V, 1992, P NATL ACAD SCI USA, V89, P5341, DOI 10.1073/pnas.89.12.5341; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BAIROCH A, 1992, PC GENE SEQUENCE ANA; BARABAN JM, 1993, J NEUROCHEM, V60, P330, DOI 10.1111/j.1471-4159.1993.tb05855.x; BASKER SJ, 1992, MOL CELL BIOL, P4694; BERNSTEIN LR, 1989, SCIENCE, V244, P566, DOI 10.1126/science.2541502; BERNSTEIN LR, 1992, MOL CARCINOGEN, V6, P221, DOI 10.1002/mc.2940060308; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; CHENG HC, 1991, J BIOL CHEM, V266, P17919; CHOU S, 1991, MOL CELL BIOL, V3, P1117; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; CURRAN T, 1984, CELL, V36, P259; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; FARRAR WL, 1989, J BIOL CHEM, V264, P12562; FRAME MC, 1991, ONCOGENE, V6, P205; FRANKLIN CC, 1992, P NATL ACAD SCI USA, V89, P7247, DOI 10.1073/pnas.89.15.7247; HU Q, 1992, MOL CELL BIOL, V12, P971, DOI 10.1128/MCB.12.3.971; KYRIAKIS JM, 1991, J BIOL CHEM, V266, P10043; LEE H, 1993, J BIOL CHEM, V268, P8181; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEE W, 1987, CELL, V49, P35; LEVINE RA, 1990, CELL REGUL, V1, P215, DOI 10.1091/mbc.1.2.215; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; PULVERER BJ, 1993, ONCOGENE, V8, P407; RICE NR, 1992, CELL, V71, P243, DOI 10.1016/0092-8674(92)90353-E; ROSSOMANDO A, 1992, P NATL ACAD SCI USA, V89, P5221, DOI 10.1073/pnas.89.12.5221; SANGHERA JS, 1992, MOL BIOL CELL, V3, P775, DOI 10.1091/mbc.3.7.775; 1993, ECL DETECTION W BLOT, P10	34	72	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9401	9404						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144522				2022-12-27	WOS:A1994NE05300002
J	KWON, KS; KIM, JH; SHIN, HS; YU, MH				KWON, KS; KIM, JH; SHIN, HS; YU, MH			SINGLE AMINO-ACID SUBSTITUTIONS OF ALPHA(1)-ANTITRYPSIN THAT CONFER ENHANCEMENT IN THERMAL-STABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-1-PROTEINASE INHIBITOR; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; REACTIVE CENTER; SITE LOOP; ALPHA-1-ANTITRYPSIN; SERPINS; VARIANTS; INTACT; RECOMBINANT	A recombinant alpha1-antitrypsin variant which increased thermal stability was obtained from random mutagenesis followed by screening. The clone was identified as having a single mutation of Phe51 --> Cys. Heat deactivation of purified recombinant alpha1-antitrypsin produced in Escherichia coli revealed that the mutation slowed down the deactivation rate 10-fold at 57-degrees-C, increasing thermal stability of recombinant protein to almost that of natural glycosylated plasma form. The mutant protein also exhibited increased stability against denaturant. The urea-induced unfolding monitored by the changes in fluorescence intensity at 360 nm showed that the mutation shifted midpoint of the transition from 1.9 m to 2.8 m. The mutation site is particularly interesting in that some genetic variants mapped at adjacent positions were shown previously to cause aggregation of the polypeptides, while the Phe51 --> Cys mutation decreased aggregation rate significantly during heat deactivation. The association rate constant with porcine pancreatic elastase revealed that the mutation did not affect inhibitory activity significantly. The site identified may be critical for regulating stability of alpha1-antitrypsin. Characterization of various single amino acid substitutions at position 51 suggests that volume and flexibility of hydrophobic side chain at the site are critical factors for enhancing the stability of alpha1-antitrypsin.	KOREA INST SCI & TECHNOL,GENET ENGN RES INST,PROT ENGN GRP,TAEJON 305333,SOUTH KOREA	Korea Institute of Science & Technology (KIST)								BEATTY K, 1980, J BIOL CHEM, V255, P3931; BRUCH M, 1988, J BIOL CHEM, V263, P16626; CARRELL RW, 1991, NATURE, V353, P576, DOI 10.1038/353576a0; COPLEN LJ, 1990, PROTEINS, V7, P16, DOI 10.1002/prot.340070103; CURIEL DT, 1989, J BIOL CHEM, V264, P13938; ECKERT KA, 1991, PCR PRACTICAL APPROA, P255; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; ENGH RA, 1990, PROTEIN ENG, V3, P469, DOI 10.1093/protein/3.6.469; HERVE M, 1990, EUR J BIOCHEM, V191, P653, DOI 10.1111/j.1432-1033.1990.tb19171.x; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; KATAGIRI K, 1988, EUR J BIOCHEM, V176, P81, DOI 10.1111/j.1432-1033.1988.tb14253.x; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEE KN, 1993, MOL CELLS, V3, P71; LIFSON S, 1979, NATURE, V282, P109, DOI 10.1038/282109a0; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LOMAS DA, 1993, BIOCHEMISTRY-US, V32, P500, DOI 10.1021/bi00053a014; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LOMAS DA, 1993, J BIOL CHEM, V268, P15333; MAST AE, 1992, BIOCHEMISTRY-US, V31, P2720, DOI 10.1021/bi00125a012; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; PACE CN, 1986, METHOD ENZYMOL, V115, P359; PERKINS SJ, 1992, J MOL BIOL, V228, P1235, DOI 10.1016/0022-2836(92)90329-I; POWELL LM, 1992, J MOL BIOL, V224, P241, DOI 10.1016/0022-2836(92)90587-A; SCHULZE AJ, 1991, EUR J BIOCHEM, V202, P1147, DOI 10.1111/j.1432-1033.1991.tb16483.x; SCHULZE AJ, 1990, EUR J BIOCHEM, V194, P51, DOI 10.1111/j.1432-1033.1990.tb19425.x; SCHULZE AJ, 1992, BIOCHEMISTRY-US, V31, P7560, DOI 10.1021/bi00148a017; SEYAMA K, 1991, J BIOL CHEM, V266, P12627; STEIN P, 1991, J MOL BIOL, V221, P615, DOI 10.1016/0022-2836(91)80076-7; STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TRAVIS J, 1985, J BIOL CHEM, V260, P4384; TRAVIS J, 1981, METHOD ENZYMOL, V80, P754	32	85	93	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9627	9631						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144550				2022-12-27	WOS:A1994NE05300037
J	TAYLOR, KA; VARGA, S				TAYLOR, KA; VARGA, S			SIMILARITY OF 3-DIMENSIONAL MICROCRYSTALS OF DETERGENT-SOLUBILIZED (NA+,K+)-ATPASE FROM PIG-KIDNEY AND CA2+-ATPASE FROM SKELETAL-MUSCLE SARCOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; TWO-DIMENSIONAL CRYSTALS; ELECTRON-MICROSCOPY; COMPLEMENTARY-DNA; MEMBRANE CRYSTALS; (NA+ +K+)-ATPASE; MAMMALIAN KIDNEY; PUMP PROTEIN; CA-2+-ATPASE; CRYSTALLIZATION	Image analysis has been used to compare the projection structure of three-dimensional crystals of (Na+,K)-ATPase from pig kidney and the Ca2+-ATPase from rabbit muscle sarcoplasmic reticulum. These crystals, formed from detergent-solubilized protein in the presence of 20% glycerol and at a low detergent to protein ratio, crystallize in nearly identical unit cells in the space group C2. Average cell dimensions for the Ca2+-ATPase were a = 166.8 +/- 4.5 angstrom, b = 57.7 +/- 4.4 angstrom gamma 90-degrees while those for the (Na+,K+)-ATPase were a = 166.2 +/- 3.8angstrom, b = 54.25 +/- 3.5angstrom, gamma = 90-degrees. Their projected structures at the resolution of 25-angstrom resolution are indistinguishable. Thus, the (Na+,K+)-ATPase crystals appear to contain only the alpha chain of the alphabeta heterodimer found in native membranes. We conclude from this that the three-dimensional structure of the a chain of the (Na+,K+)-ATPase is very similar to that of the Ca2+-ATPase despite their relatively weak overall sequence homology.	DEBRECEN UNIV MED, SCH MED, FRITZ VERZAR INT LAB EXPTL GERONTOL, HUNGARIAN SECT, H-4012 DEBRECEN, HUNGARY	University of Debrecen	TAYLOR, KA (corresponding author), DUKE UNIV, MED CTR, DEPT CELL BIOL, DURHAM, NC 27710 USA.							BARNETT RE, 1970, BIOCHEMISTRY-US, V9, P4644, DOI 10.1021/bi00826a004; BEALL HC, 1989, J MICROSC-OXFORD, V154, P71, DOI 10.1111/j.1365-2818.1989.tb00569.x; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; CAMPBELL AM, 1991, J BIOL CHEM, V266, P16050; CANTLEY LC, 1976, BIOCHEMISTRY-US, V15, P5280, DOI 10.1021/bi00669a013; CARAFOLI E, 1982, BIOCHIM BIOPHYS ACTA, V683, P279, DOI 10.1016/0304-4173(82)90004-0; CASTELLANI L, 1985, J MOL BIOL, V185, P579, DOI 10.1016/0022-2836(85)90073-7; CASTELLANI L, 1983, J CELL BIOL, V97, P557, DOI 10.1083/jcb.97.2.557; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; DUX L, 1985, J BIOL CHEM, V260, P1730; DUX L, 1987, J BIOL CHEM, V262, P6439; Erickson H P, 1978, Methods Enzymol, V49, P39; Fukami A, 1965, J Electron Microsc (Tokyo), V14, P112; Glynn I. M., 1985, ENZYMES BIOL MEMBR, P35; GREEN NM, 1992, ACTA PHYSIOL SCAND, V146, P59; GREEN NM, 1988, ION PUMPS STRUCTURE, P15; GREEN NM, 1992, ION PUMPS, V146, P59; HEBERT H, 1990, FEBS LETT, V268, P83, DOI 10.1016/0014-5793(90)80978-R; HEBERT H, 1985, J ULTRA MOL STRUCT R, V92, P28, DOI 10.1016/0889-1605(85)90124-7; HEBERT H, 1988, J ULTRA MOL STRUCT R, V100, P86, DOI 10.1016/0889-1605(88)90061-4; HEBERT H, 1982, BIOCHIM BIOPHYS ACTA, V689, P571, DOI 10.1016/0005-2736(82)90316-9; HEBERT H, 1985, FEBS LETT, V187, P182; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; HERBETTE L, 1985, BIOCHIM BIOPHYS ACTA, V817, P103, DOI 10.1016/0005-2736(85)90073-2; Holser W.T., 1958, Z KRIST-CRYST MATER, V110, P266, DOI [10.1524/zkri.1958.110.1-6.266, DOI 10.1524/ZKRI.1958.110.1-6.266]; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; JORGENSEN PL, 1982, BIOCHIM BIOPHYS ACTA, V694, P27, DOI 10.1016/0304-4157(82)90013-2; JORGENSEN PL, 1988, NA PLUS K PLUS PUM A, P19; KAWAKAMI K, 1985, NATURE, V316, P733, DOI 10.1038/316733a0; KERESZTES T, 1990, ACTA BIOCHIM BIOPHYS, V25, P125; LINGREL JB, 1990, PROG NUCLEIC ACID RE, V38, P37; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MISRA M, 1990, J STRUCT BIOL, V105, P67, DOI 10.1016/1047-8477(90)90100-Q; MISRA M, 1991, BIOCHIM BIOPHYS ACTA, V1077, P107, DOI 10.1016/0167-4838(91)90532-5; MOHRAZ M, 1984, J CELL BIOL, V98, P1836, DOI 10.1083/jcb.98.5.1836; MOHRAZ M, 1987, J CELL BIOL, V105, P1, DOI 10.1083/jcb.105.1.1; MOHRAZ M, 1984, ANN NY ACAD SCI, V435, P561, DOI 10.1111/j.1749-6632.1984.tb13883.x; NAKAMURA H, 1976, J BIOL CHEM, V251, P5414; OVCHINNIKOV YA, 1985, FEBS LETT, V190, P73, DOI 10.1016/0014-5793(85)80430-0; PIKULA S, 1988, J BIOL CHEM, V263, P5277; SCHMID MF, 1993, ULTRAMICROSCOPY, V48, P251, DOI 10.1016/0304-3991(93)90099-J; SHULL GE, 1986, NATURE, V321, P429, DOI 10.1038/321429a0; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; SKOU JC, 1990, FEBS LETT, V268, P314, DOI 10.1016/0014-5793(90)81278-V; SKRIVER E, 1992, J STRUCT BIOL, V108, P176, DOI 10.1016/1047-8477(92)90017-5; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; TAYLOR K, 1984, J MOL BIOL, V174, P193, DOI 10.1016/0022-2836(84)90372-3; TAYLOR KA, 1986, J MOL BIOL, V187, P417, DOI 10.1016/0022-2836(86)90442-0; TAYLOR KA, 1986, ANN NY ACAD SCI, V483, P31, DOI 10.1111/j.1749-6632.1986.tb34493.x; TAYLOR KA, 1988, J BIOL CHEM, V263, P5287; TAYLOR KA, 1993, J MOL BIOL, V230, P196, DOI 10.1006/jmbi.1993.1136; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; TOYOSHIMA C, 1989, ULTRAMICROSCOPY, V30, P439, DOI 10.1016/0304-3991(89)90076-4; VARGA S, 1991, BIOCHIM BIOPHYS ACTA, V1070, P374, DOI 10.1016/0005-2736(91)90078-M; VARGA S, 1993, ACTA PHYSL HUNG, V81, P417; WEBER K, 1969, J BIOL CHEM, V244, P4406; ZAMPIGHI G, 1984, J CELL BIOL, V98, P1851, DOI 10.1083/jcb.98.5.1851	59	10	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10107	10111						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144510				2022-12-27	WOS:A1994NE05300106
J	KRAMER, RH; LENFERINK, AEG; VANBUERENKOORNNEEF, IL; VANDERMEER, A; VANDEPOLL, MLM; VANZOELEN, EJJ				KRAMER, RH; LENFERINK, AEG; VANBUERENKOORNNEEF, IL; VANDERMEER, A; VANDEPOLL, MLM; VANZOELEN, EJJ			IDENTIFICATION OF THE HIGH-AFFINITY BINDING-SITE OF TRANSFORMING GROWTH-FACTOR-ALPHA (TGF-ALPHA) FOR THE CHICKEN EPIDERMAL GROWTH-FACTOR (EGF) RECEPTOR USING EGF/TGF-ALPHA CHIMERAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LIGAND; PROTEOLYSIS; ANTIBODIES; MOLECULES; PROTEINS	Human epidermal growth factor (hEGF) and human transforming growth factor-alpha (hTGF-alpha) are structurally related growth factors that share relatively little sequence homology. They both exert their biological action by binding to the cell-surface EGF receptor. hEGF and hTGF-alpha bind with similar affinity to the hEGF re receptor, but hEGF binds with an similar to 100-fold lower affinity to the chicken EGF receptor compared with hTGF-alpha. To map the region in hTGF-alpha that confers its ability to bind with high affinity to the chicken EGF receptor, 10 hybrids of hEGF and hTGF-alpha were constructed by exchanging domains bordered by the third, fourth, and sixth conserved cysteine residues. The activity of the expressed chimeric proteins was determined by their ability to compete with I-125-labeled mouse EGF for bind binding to NIH-3T3 cells transfected with the hEGF receptor. Subsequent binding competition studies of NIH-3T3 cells transfected with the chicken EGF receptor showed that chimeras carrying TGF-alpha sequences COOH-terminal of the sixth cysteine have a high affinity for this receptor, similar to hTGF-alpha. In contrast, chimeras with EGF sequences in this COOH-terminal domain have only low binding affinity, similar to hEGF. We conclude that the COOH-terminal linear region of hTGF-alpha is important for its high affinity interaction with the chicken EGF receptor.	UNIV NIJMEGEN, DEPT CELL BIOL, 6525 ED NIJMEGEN, NETHERLANDS	Radboud University Nijmegen			van der Meer, Arnold/M-1693-2016	van der Meer, Arnold/0000-0001-8274-414X				AVIVI A, 1991, ONCOGENE, V6, P673; BURGESS AW, 1988, BIOCHEMISTRY-US, V27, P4977, DOI 10.1021/bi00414a005; BUTTERWITH SC, 1992, J ENDOCRINOL, V134, P163, DOI 10.1677/joe.0.1340163; Campbell I D, 1989, Prog Growth Factor Res, V1, P13, DOI 10.1016/0955-2235(89)90038-0; CAMPION SR, 1992, J CELL BIOCHEM, V50, P35; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; CARPENTER G, 1991, PEPTIDE GROWTH FACTO, V1, P69; DERYNCK R, 1988, CELL, V54, P593, DOI 10.1016/S0092-8674(88)80001-1; ENGEL H, 1992, PROTEIN EXPRES PURIF, V3, P108, DOI 10.1016/S1046-5928(05)80026-9; FIELD JA, 1992, BIOCHEM J, V283, P91; HOEPRICH PD, 1989, J BIOL CHEM, V264, P19086; KATSUURA M, 1989, J BIOCHEM-TOKYO, V106, P87, DOI 10.1093/oxfordjournals.jbchem.a122826; KAUSHANSKY K, 1992, PROTEINS, V12, P1, DOI 10.1002/prot.340120102; KIENHUIS CBM, 1991, CLIN CHEM, V37, P1749; KING IC, 1990, ANAL BIOCHEM, V188, P97, DOI 10.1016/0003-2697(90)90533-F; KOHDA D, 1992, BIOCHEMISTRY-US, V31, P11928, DOI 10.1021/bi00162a036; LAROCHELLE WJ, 1992, J BIOL CHEM, V267, P17074; LAX I, 1989, EMBO J, V8, P421, DOI 10.1002/j.1460-2075.1989.tb03393.x; MCKENZIE ANJ, 1991, EMBO J, V10, P1193, DOI 10.1002/j.1460-2075.1991.tb08060.x; NAGAI K, 1987, METHOD ENZYMOL, V153, P461; NILSSON B, 1990, METHOD ENZYMOL, V185, P144; PRIGENT S A, 1992, Progress in Growth Factor Research, V4, P1, DOI 10.1016/0955-2235(92)90002-Y; PURCHIO AF, 1987, GENE, V60, P175, DOI 10.1016/0378-1119(87)90225-3; SCHULTZ G, 1991, METHOD ENZYMOL, V198, P200; SORVILLO JM, 1990, ONCOGENE, V5, P377; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; van Zoelen E J, 1990, Prog Growth Factor Res, V2, P131, DOI 10.1016/0955-2235(90)90001-Z; VANZOELEN EJJ, 1993, BIOCHEMISTRY-US, V32, P6275, DOI 10.1021/bi00075a022; VIOLAND BN, 1991, INT J PEPT PROT RES, V37, P463; WALKER F, 1990, BIOCHEMISTRY-US, V29, P10635, DOI 10.1021/bi00499a009	30	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8708	8711						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132599				2022-12-27	WOS:A1994NB41100016
J	BAFFY, G; YANG, LJ; RAJ, S; MANNING, DR; WILLIAMSON, JR				BAFFY, G; YANG, LJ; RAJ, S; MANNING, DR; WILLIAMSON, JR			G-PROTEIN COUPLING TO THE THROMBIN RECEPTOR IN CHINESE-HAMSTER LUNG FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERTUSSIS TOXIN; PHOSPHOLIPASE-C; PROTEOLYTIC MECHANISM; RAT HEPATOCYTES; HUMAN-PLATELETS; GROWTH-FACTORS; ALPHA-SUBUNIT; ACTIVATION; PHOSPHORYLATION; CELLS	The specific involvement of G proteins in thrombin receptor-mediated Ca2+ mobilization and DNA synthesis has been studied in single Chinese hamster lung fibroblasts (CCL39 cells) activated by the hexapeptide SFLLRN. Immunoblots performed with antibodies directed against the COOH terminus of G protein cu subunits revealed that alpha(q), alpha(i), and alpha(o), were each present in CCL39 cells. The Ca2+ response to SFLLRN was measured after microinjection of anti-alpha(q) or anti-alpha(o) antibodies, which produced a total blockade in 71 and 46% of cells, respectively. A partial inhibition of the SFLLRN-induced Ca2+ response was observed in the remaining cells. The lag time between exposure of the cells to SFLLRN and the onset of Ca2+ mobilization was significantly longer (20-24 s) in cells microinjected with anti-alpha(q)- or anti-alpha(o)-antibodies than in control cells microinjected with preimmune serum (9 +/- 1 s). Moreover, the peak height of the Ca2+ response to SFLLRN was de creased by 36 and 73%, respectively in cells microinjected with anti-alpha(q) or anti-alpha(o) antibodies. SFLLRN-induced DNA synthesis in growth arrested CCL39 cells was also inhibited (44-78%) by prior microinjection of anti-alpha(q) or anti-alpha(o) antibodies. Anti-alpha(i) antibodies had no effect on the SFLLRN-induced Ca2+ response or on DNA synthesis. These results provide direct evidence that the thrombin receptor in CCL39 cells is coupled to two different types of G proteins, G(q) and G(o), both causing Ca2+ mobilization and mitogenesis.	UNIV PENN,DEPT BIOCHEM & BIOPHYS,PHILADELPHIA,PA 19104; UNIV PENN,DEPT PHARMACOL,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania			Baffy, Gyorgy/P-7986-2018	Baffy, Gyorgy/0000-0002-8334-0400	NIDDK NIH HHS [DK-15120, DK-19525] Funding Source: Medline; NIMH NIH HHS [MH-48125] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015120, P30DK019525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH048125] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAFFY G, 1993, DIABETES, V42, P1878, DOI 10.2337/diabetes.42.12.1878; BERSTEIN G, 1992, J BIOL CHEM, V267, P8081; BRASS LF, 1991, J BIOL CHEM, V266, P958; BRASS LF, 1992, J BIOL CHEM, V267, P6044; CARLSON KE, 1989, J BIOL CHEM, V264, P13298; CHAMBARD JC, 1987, NATURE, V326, P800, DOI 10.1038/326800a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HANSEN CA, 1991, J BIOL CHEM, V266, P18573; HUNG DT, 1992, J CELL BIOL, V116, P827, DOI 10.1083/jcb.116.3.827; JHON DY, 1993, J BIOL CHEM, V268, P6654; KAHAN C, 1992, J BIOL CHEM, V267, P13369; KROLL SD, 1991, P NATL ACAD SCI USA, V88, P5182, DOI 10.1073/pnas.88.12.5182; KROLL SD, 1992, J BIOL CHEM, V267, P23183; LALLEMAIN G, 1991, CELL REGUL, V2, P675, DOI 10.1091/mbc.2.8.675; LAMORTE VJ, 1993, J CELL BIOL, V121, P91, DOI 10.1083/jcb.121.1.91; LAMORTE VJ, 1992, J BIOL CHEM, V267, P691; LAW SF, 1991, J BIOL CHEM, V266, P17885; LEE CH, 1992, J BIOL CHEM, V267, P16044; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MELOCHE S, 1992, MOL ENDOCRINOL, V6, P845, DOI 10.1210/me.6.5.845; NEER EJ, 1990, SOC GEN PHY, V45, P143; NEYLON CB, 1992, J BIOL CHEM, V267, P7295; OFFERMANNS S, 1993, BIOCHEM J, V290, P27, DOI 10.1042/bj2900027; PANDRELL E, 1991, J BIOL CHEM, V266, P9771; PEREZRODRIGUEZ R, 1981, CELL BIOL INT REP, V5, P347, DOI 10.1016/0309-1651(81)90004-7; REILLY CF, 1993, BIOCHEM BIOPH RES CO, V190, P1001, DOI 10.1006/bbrc.1993.1148; SHEARS SB, 1989, J BIOL CHEM, V264, P19879; SHENKER A, 1991, J BIOL CHEM, V266, P9309; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SPIEGEL A M, 1992, Current Opinion in Cell Biology, V4, P203, DOI 10.1016/0955-0674(92)90034-A; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; VASSALLO RR, 1992, J BIOL CHEM, V267, P6081; VOURETCRAVIARI V, 1993, BIOCHEM J, V289, P209, DOI 10.1042/bj2890209; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; YANG LJ, 1991, J BIOL CHEM, V266, P22451; YANG LJ, 1993, J BIOL CHEM, V268, P3739	37	67	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8483	8487						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132575				2022-12-27	WOS:A1994NB40900097
J	KNOTT, TG; ROBINSON, C				KNOTT, TG; ROBINSON, C			THE SECA INHIBITOR, AZIDE, REVERSIBLY BLOCKS THE TRANSLOCATION OF A SUBSET OF PROTEINS ACROSS THE CHLOROPLAST THYLAKOID MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							OXYGEN-EVOLVING COMPLEX; COLI PLASMA-MEMBRANE; ESCHERICHIA-COLI; PRECURSOR PROTEIN; PROTON GRADIENT; TRANSIT PEPTIDE; FULL PRECURSOR; TRANSPORT; IMPORT; GENE	The presence of secA and secY gene homologues in the plastid genomes of red algae and cyanophytes has raised the possibility that the products of these genes are involved in protein translocation across the thylakoid membrane. Bacterial SecA proteins are effectively inhibited by azide, and we have tested the effects of this compound on the transport of lumenal proteins across the thylakoid membrane in pea chloroplasts. Recent studies have shown that lumenal proteins are transported by two different mechanisms, one dependent on the thylakoidal Delta pH and the other requiring the presence of a stromal protein factor and ATP. In this report we show that azide inhibits the transport across the thylakoid membrane of the latter group of proteins, which includes plastocyanin and the lumenal 33-kDa protein of photosystem II; translocation of proteins by the Delta pH-dependent pathway is unaffected. Following import into isolated chloroplasts in the presence of azide, a substantial proportion of plastocyanin and the 33-kDa protein is found as the stromal intermediate form; the proportion increases with lower ATP concentrations, suggesting that azide and ATP may compete for a single site. The presence of azide completely inhibits the import of the 33-kDa protein by isolated thylakoids, but import is restored if the azide is removed from the stromal extract or thylakoids, prior to the import incubation. The data thus indicate that azide reversibly inhibits the transport of a subset of proteins across the thylakoid membrane, consistent with the involvement of a SecA homolog. The results also indicate that azide is potentially a valuable tool for the future assignment of novel lumenal proteins to one of the thylakoidal protein transport mechanisms.	UNIV WARWICK, DEPT BIOL SCI, COVENTRY CV4 7AL, W MIDLANDS, ENGLAND	University of Warwick								BRIGGS LM, 1990, PLANT MOL BIOL, V15, P633, DOI 10.1007/BF00017837; CAI D, 1993, PLANT J, V3, P383, DOI 10.1046/j.1365-313X.1993.t01-21-00999.x; CHITNIS PR, 1987, PLANT MOL BIOL, V10, P3, DOI 10.1007/BF00014181; CLINE K, 1992, J BIOL CHEM, V267, P2688; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; DOUGLAS SE, 1992, FEBS LETT, V298, P93, DOI 10.1016/0014-5793(92)80029-G; FLACHMANN R, 1993, J BIOL CHEM, V268, P7514; HAGEMAN J, 1986, NATURE, V324, P567, DOI 10.1038/324567a0; HALPIN C, 1989, EMBO J, V8, P3917, DOI 10.1002/j.1460-2075.1989.tb08572.x; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; HULFORD A, 1994, J BIOL CHEM, V269, P3251; JAMES HE, 1989, J BIOL CHEM, V264, P19573; KLOSGEN RB, 1992, PLANT MOL BIOL, V18, P1031, DOI 10.1007/BF00019226; KO K, 1989, EMBO J, V8, P3187, DOI 10.1002/j.1460-2075.1989.tb08477.x; MEADOWS JW, 1991, PLANT MOL BIOL, V17, P1241, DOI 10.1007/BF00028739; MOULD RM, 1991, J BIOL CHEM, V266, P17286; MOULD RM, 1991, J BIOL CHEM, V266, P12189; NIELSEN VS, 1994, J BIOL CHEM, V269, P3762; OLIVER DB, 1990, J BIOENERG BIOMEMBR, V22, P311, DOI 10.1007/BF00763170; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; PFANNER N, 1987, EUR J BIOCHEM, V169, P289, DOI 10.1111/j.1432-1033.1987.tb13610.x; ROBINSON C, 1994, EMBO J, V13, P279, DOI 10.1002/j.1460-2075.1994.tb06260.x; SCARAMUZZI CD, 1992, CURR GENET, V22, P421, DOI 10.1007/BF00352444; SEIDLER A, 1990, EMBO J, V9, P1743, DOI 10.1002/j.1460-2075.1990.tb08298.x; SMEEKENS S, 1986, CELL, V46, P365, DOI 10.1016/0092-8674(86)90657-4; VALENTIN K, 1993, MOL GEN GENET, V236, P245, DOI 10.1007/BF00277119; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P1165	28	69	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7843	7846						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132499				2022-12-27	WOS:A1994NB40900003
J	PLATT, FM; NEISES, GR; DWEK, RA; BUTTERS, TD				PLATT, FM; NEISES, GR; DWEK, RA; BUTTERS, TD			N-BUTYLDEOXYNOJIRIMYCIN IS A NOVEL INHIBITOR OF GLYCOLIPID BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCEREBROSIDE SYNTHETASE; GLUCOSYLCERAMIDE SYNTHASE; CERAMIDE; GLUCOSYLTRANSFERASE; 1-DEOXYNOJIRIMYCIN; GLYCOSPHINGOLIPIDS; DERIVATIVES; DISEASE; BRAIN	The imino sugar deoxynojirimycin and its alkylated derivatives are inhibitors of the N-linked oligosaccharide processing enzymes alpha-glucosidase I and II. These compounds are glucose analogues and have the potential to inhibit both glucosidases and glucosyltransferases. However, to date there has been no report of deoxynojirimycin or similar analogues inhibiting a mammalian glucosyltransferase. We have investigated the effects of deoxynojirimycin and its alkylated derivatives on the biosynthesis of glycolipids in HL-60 cells. We have found that the N-butyl and N-hexyl derivatives of deoxynojirimycin, but not deoxynojirimycin itself, are novel inhibitors of the glucosyltransferase-catalyzed biosynthesis of glucosylceramide. This results in the inhibition of biosynthesis of all glucosylceramide-based glycosphingolipids. We have investigated the ability of one of these compounds, N-butyldeoxynojirimycin, to offset glucosylceramide accumulation in an in vitro Gaucher's disease model. This compound prevents lysosomal glycolipid storage and offers a novel therapeutic approach for the management of this and other glycolipid storage disorders.	MONSANTO CO,ST LOUIS,MO 63198	Monsanto	PLATT, FM (corresponding author), UNIV COLL OXFORD,INST GLYCOBIOL,DEPT BIOCHEM,S PARKS RD,OXFORD OX1 3QU,ENGLAND.		Platt, Frances/G-1004-2010	Platt, Frances/0000-0001-7614-0403				ABE A, 1992, J BIOCHEM-TOKYO, V111, P191, DOI 10.1093/oxfordjournals.jbchem.a123736; Barranger J. A., 1989, METABOLIC BASIS INHE, P1677; BASU S, 1973, J BIOL CHEM, V248, P1388; BEUTLER E, 1992, SCIENCE, V256, P794, DOI 10.1126/science.1589760; BUTTERS TD, 1981, IN VITRO CELL DEV B, V17, P831, DOI 10.1007/BF02618451; COSTE H, 1985, BIOCHIM BIOPHYS ACTA, V814, P1, DOI 10.1016/0005-2736(85)90412-2; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; FELDINGHABERMANN B, 1990, BIOCHEMISTRY-US, V29, P6314, DOI 10.1021/bi00478a028; FLEET GWJ, 1988, FEBS LETT, V237, P128, DOI 10.1016/0014-5793(88)80185-6; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; INOKUCHI J, 1987, CANCER LETT, V38, P23, DOI 10.1016/0304-3835(87)90196-0; INOKUCHI J, 1990, CANCER RES, V50, P6731; INOKUCHI JI, 1987, J LIPID RES, V28, P565; JACOB GS, 1992, NATURAL PRODUCTS AS ANTIVIRAL AGENTS, P137; KARLSSON GB, 1993, J BIOL CHEM, V268, P570; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309, DOI 10.1146/annurev.bi.58.070189.001521; KARPAS A, 1988, P NATL ACAD SCI USA, V85, P9229, DOI 10.1073/pnas.85.23.9229; MANNORI G, 1990, INT J CANCER, V45, P984, DOI 10.1002/ijc.2910450535; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; NEWBRUN E, 1987, ARCH ORAL BIOL, V28, P531; NEWBURG DS, 1988, EXP MOL PATHOL, V48, P317, DOI 10.1016/0014-4800(88)90068-8; Parkin J L, 1982, Prog Clin Biol Res, V95, P151; PLATT FM, 1992, EUR J BIOCHEM, V208, P187, DOI 10.1111/j.1432-1033.1992.tb17173.x; SAUNIER B, 1982, J BIOL CHEM, V257, P4155; TAN A, 1991, J BIOL CHEM, V266, P14504; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; VANHEYNI.WE, 1974, NATURE, V249, P415, DOI 10.1038/249415a0; VUNNAM RR, 1980, CHEM PHYS LIPIDS, V26, P265; WANG YF, 1993, TETRAHEDRON LETT, V34, P403	30	362	391	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8362	8365						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132559				2022-12-27	WOS:A1994NB40900080
J	FRAGA, D; HERMOLIN, J; OLDENBURG, M; MILLER, MJ; FILLINGAME, RH				FRAGA, D; HERMOLIN, J; OLDENBURG, M; MILLER, MJ; FILLINGAME, RH			ARGININE-41 OF SUBUNIT-C OF ESCHERICHIA-COLI H+-ATP SYNTHASE IS ESSENTIAL IN BINDING AND COUPLING OF F1 TO F-0	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLAR LOOP REGION; OXIDATIVE-PHOSPHORYLATION; UNCE PROTEIN; F0 SECTOR; MUTATIONS; F1; TRANSLOCATION; MEMBRANE; COMPLEX; ALTER	Two substitutions were made for Arg(41) in the polar loop of subunit c of the Escherichia coli F1F0 H+-transporting ATP synthase. The R41K and R41H mutants were initially studied by use of a plasmid carrying the complete c R41K or c R41H unc (F1F0) operon in a chromosomal strain deleted for the unc operon. The extent of F-0 incorporation into membranes of these cells was quite variable, and the system was concluded to be unsuitable for biochemical characterization. Ultimately, the mutant genes were recombined into the chromosome using a novel method for the unc system. The biochemical phenotype of the chromosomally expressed mutants proved to be reproducible. The c R41H mutation causes a specific defect in assembly of F-0, i.e. subunit alpha was not incorporated into the membrane despite near normal incorporation of subunits b and c. On the other hand, c R41K mutant F-0 assembled normally in one of two background strains studied. (In the second genetic background, subunit alpha was inefficiently incorporated into the c R41K membrane.) In membranes prepared from a c R41K strain assembling a complete F-0, R41K F-0 was found to bind F-1 with near normal affinity and to transport H+ at near normal rates. Although R41K F-0 binds F-1, F-1-ATPase activity and H+ transport remained uncoupled. The uncoupling was indicated by a lack of ATP-driven H+ translocation and by the high proton permeability of membranes with F-1 bound to F-0. The uncoupled phenotype of the R41K mutant closely resembles that previously reported for the c Q42E mutant.	UNIV WISCONSIN,SCH MED,DEPT BIOMOLEC CHEM,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison				Fraga, Dean/0000-0002-9933-665X	NIGMS NIH HHS [GM23105] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023105, R01GM023105] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; DECKERSHEBESTREIT G, 1986, EUR J BIOCHEM, V161, P225, DOI 10.1111/j.1432-1033.1986.tb10146.x; FELTON J, 1980, J BACTERIOL, V142, P221, DOI 10.1128/JB.142.1.221-228.1980; FILLINGAME RH, 1986, J BACTERIOL, V165, P244, DOI 10.1128/jb.165.1.244-251.1986; FILLINGAME RH, 1984, J BACTERIOL, V158, P1078, DOI 10.1128/JB.158.3.1078-1083.1984; FILLINGAME RH, 1983, J BIOL CHEM, V258, P604; FILLINGAME RH, 1975, J BACTERIOL, V124, P870, DOI 10.1128/JB.124.2.870-883.1975; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; FOSTER DL, 1982, J BIOL CHEM, V257, P2009; FRAGA D, 1991, J BACTERIOL, V173, P2639, DOI 10.1128/jb.173.8.2639-2643.1991; FRAGA D, 1989, J BIOL CHEM, V264, P6797; FRAGA D, 1994, J BIOL CHEM, V269, P2562; FUTAI M, 1974, P NATL ACAD SCI USA, V71, P2725, DOI 10.1073/pnas.71.7.2725; GIBSON F, 1977, BIOCHEM J, V162, P665, DOI 10.1042/bj1620665; GIRVIN ME, 1989, BIOCHEMISTRY-US, V28, P4340, DOI 10.1021/bi00436a032; GUNSALUS RP, 1982, P NATL ACAD SCI-BIOL, V79, P320, DOI 10.1073/pnas.79.2.320; Haddock B A, 1974, Biochem J, V142, P703; HATCH L, 1993, BIOCHIM BIOPHYS ACTA, V1141, P183, DOI 10.1016/0005-2728(93)90041-D; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; KRAMER W, 1984, NUCLEIC ACIDS RES, V12, P9441, DOI 10.1093/nar/12.24.9441; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUCKEN U, 1990, BIOCHEMISTRY-US, V29, P5339; Maniatis T., 1982, MOL CLONING; Miller J.H., 1972, EXPT MOL GENETICS; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MILLER MJ, 1989, J BIOL CHEM, V264, P305; MITRA B, 1990, BIOCHEMISTRY-US, V29, P9879, DOI 10.1021/bi00494a018; MOSHER ME, 1985, J BIOL CHEM, V260, P4807; MOSHER ME, 1983, J BACTERIOL, V156, P1078, DOI 10.1128/JB.156.3.1078-1092.1983; PAULE CR, 1989, ARCH BIOCHEM BIOPHYS, V274, P270, DOI 10.1016/0003-9861(89)90439-6; PERLIN DS, 1985, ARCH BIOCHEM BIOPHYS, V236, P603, DOI 10.1016/0003-9861(85)90664-2; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALKER JE, 1984, BIOCHIM BIOPHYS ACTA, V768, P164, DOI 10.1016/0304-4173(84)90003-X; ZHANG Y, 1994, J BIOL CHEM, V269, P5473	35	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7532	7537						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125974				2022-12-27	WOS:A1994NA03200079
J	BECKWITT, R; ARCIDIACONO, S				BECKWITT, R; ARCIDIACONO, S			SEQUENCE CONSERVATION IN THE C-TERMINAL REGION OF SPIDER SILK PROTEINS (SPIDROIN) FROM NEPHILA-CLAVIPES (TETRAGNATHIDAE) AND ARANEUS-BICENTENARIUS (ARANEIDAE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY-STRUCTURE; DRAGLINE SILK	The polymerase chain reaction (PCR) has been used to amplify the portion of the Spidroin 1 gene that codes for the C-terminal part of the silk protein of the spider Nephila clavipes, Along with some substitution mutations of minor consequence, the PCR derived sequence reveals an additional base missing from the previously published Nephila Spidroin 1 sequence. Comparison of the PCR-derived sequence with the equivalent region of Spidroin 2 indicates that the insertion of this single base results in greatly increased similarity in the resulting amino acid sequences of Spidroin 1 and Spidroin 2 (75% over 97 amino acids). The same PCR primers also amplified a fragment of the same length from Araneus bicentenarius. This sequence is also very similar to Spidroin 1 of Nephila (71% over 238 bases excluding the PCR primers, which translates into 76% over 79 amino acids).	USA,NATICK RES DEV & ENGN CTR,DIV BIOTECHNOL,NATICK,MA 01760; FRAMINGHAM STATE COLL,DEPT BIOL,FRAMINGHAM,MA 01701	Massachusetts System of Public Higher Education; Framingham State College			Beckwitt, Richard/A-8507-2009	Beckwitt, Richard/0000-0003-4315-2808				Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; KAPLAN DL, 1992, MRS BULL, V17, P41, DOI 10.1557/S0883769400046479; KERKAM K, 1991, NATURE, V349, P596, DOI 10.1038/349596a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAMBROOOK J, 1989, MOL CLONING LABORATO; Strauss WM, 1987, CURRENT PROTOCOLS MO, P631; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; ZUROVEC M, 1992, INSECT BIOCHEM MOLEC, V22, P55, DOI 10.1016/0965-1748(92)90100-S	10	86	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6661	6663						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120021				2022-12-27	WOS:A1994MZ50300064
J	SCHMIDT, AM; MORA, R; CAO, R; YAN, SD; BRETT, J; RAMAKRISHNAN, R; TSANG, TC; SIMIONESCU, M; STERN, D				SCHMIDT, AM; MORA, R; CAO, R; YAN, SD; BRETT, J; RAMAKRISHNAN, R; TSANG, TC; SIMIONESCU, M; STERN, D			THE ENDOTHELIAL-CELL BINDING-SITE FOR ADVANCED GLYCATION END-PRODUCTS CONSISTS OF A COMPLEX - AN INTEGRAL MEMBRANE-PROTEIN AND A LACTOFERRIN-LIKE POLYPEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR; GLUCOSE; SURFACE; BOVINE; COMPLICATIONS; TRANSFERRIN	Advanced glycation end products (AGEs), formed as the result of the extended interaction of proteins with ketoses, modulate central properties of endothelial cells and mononuclear phagocytes by interacting with a cell surface binding site comprised of a novel integral membrane protein (receptor for AGE = RAGE) and a lactoferrin-like polypeptide (LF-L), the latter having sequence identity to lactoferrin (LF). To further understand this cellular binding site, the interaction of RAGE with LF-L and LF was characterized. By ligand blotting and a solid state competitive binding assay, I-125-LF-L and I-125-LF bound to RAGE immobilized on nitrocellulose membranes or polypropylene tubes in a time-dependent and reversible manner, demonstrating a high affinity component with K(d) almost-equal-to 100 pm. The interaction of I-125-LF-L and I-125-LF with RAGE was independent of iron in LF and was competed by addition of an excess of unlabeled carboxyl-terminal portion of LF. Cross-linking studies with purified I-125-LF-L and RAGE, in the presence of disuccinimidyl suberate, showed a new, slowly migrating band, corresponding to a complex of RAGE and LF-L, and cross-linking on mouse aortic endothelial cells showed two new slowly migrating bands on immunoblotting visualized with both anti-RAGE IgG and anti-LF-L IgG. These data lead us to propose that the endothelial cell surface binding site for AGEs consists of LF-L bound noncovalently to RAGE anchored in the cell membrane.	COLUMBIA UNIV COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032; HOFFMANN LA ROCHE INC,ROCHE RES CTR,DEPT MOLEC GENET,NUTLEY,NJ 07110; INST CELL BIOL & PATHOL,BUCHAREST,ROMANIA	Columbia University; Roche Holding; Romanian Academy of Sciences; Nicolae Simionescu Institute of Cellular Biology & Pathology	SCHMIDT, AM (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT PHYSIOL,P&S 11-518,NEW YORK,NY 10032, USA.		Simionescu, Maya/C-4794-2011		NHLBI NIH HHS [HL21006, HL42833] Funding Source: Medline; NIA NIH HHS [AG00602] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL021006, R01HL042833] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON BF, 1989, J MOL BIOL, V209, P711, DOI 10.1016/0022-2836(89)90602-5; BATES GW, 1973, J BIOL CHEM, V248, P3228; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; DANIEL TO, 1983, J BIOL CHEM, V258, P4606; ESPOSITO C, 1989, J EXP MED, V170, P1387, DOI 10.1084/jem.170.4.1387; FRENS G, 1973, NATURE-PHYS SCI, V241, P120; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINEBACKZINS J, 1980, J BIOL CHEM, V255, P708; MEAD PE, 1990, NUCLEIC ACIDS RES, V18, P7167, DOI 10.1093/nar/18.23.7167; MONTESANO L, 1982, BIOCHEM BIOPH RES CO, V109, P7, DOI 10.1016/0006-291X(82)91558-3; NEEPER M, 1992, J BIOL CHEM, V267, P14998; OBESO J, 1990, LAB INVEST, V63, P259; REHMAN J, 1989, COMP BIOCH PHYSL B, V93, P929; RUDERMAN NB, 1992, FASEB J, V6, P2905, DOI 10.1096/fasebj.6.11.1644256; SCATCHARD G, 1957, J AM CHEM SOC, V79, P12, DOI 10.1021/ja01558a003; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; SCHMIDT AM, 1993, J CLIN INVEST, V92, P2155; SHIMAZAKI K, 1991, COMP BIOCHEM PHYS B, V98, P417, DOI 10.1016/0305-0491(91)90199-N; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSANG T, 1991, FASEB J, V6, pA233; YAN SD, 1994, J BIOL CHEM, V269, P9889; YANG Z, 1991, J EXP MED, V174, P515, DOI 10.1084/jem.174.3.515	24	111	121	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9882	9888						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144581				2022-12-27	WOS:A1994NE05300075
J	THNG, JPH; GUO, XW; SWANK, RA; CRISSMAN, HA; BRADBURY, EM				THNG, JPH; GUO, XW; SWANK, RA; CRISSMAN, HA; BRADBURY, EM			INHIBITION OF HISTONE PHOSPHORYLATION BY STAUROSPORINE LEADS TO CHROMOSOME DECONDENSATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; LYSINE-RICH HISTONE; CELL-CYCLE; POTENT INHIBITOR; G2 PHASE; PHYSARUM-POLYCEPHALUM; H3 PHOSPHORYLATION; MAMMALIAN-CELLS; CDC2 KINASE; CONDENSATION	In mammalian cells, hyperphosphorylation of histone H1 and phosphorylation of histone H3 correlate well with the G2 phase to metaphase condensation of chromosomes, and these phosphorylations most probably have a role in initiating and controlling the entry into mitosis. The protein kinase inhibitor staurosporine has been used to examine the role of H1 and H3 phosphorylations in controlling chromosome condensation in the mouse FM3A cell line. We present evidence that (i) staurosporine inhibits the protein kinases that phosphorylate histone H1 during mitosis, (ii) staurosporine also inhibits the histone H3-specific kinase, (iii) the inhibition of these kinase activities prevent cells from entering mitosis, and (iv) addition of staurosporine to cells already arrested at metaphase by nocodazole causes a rapid dephosphorylation of histones H1 and H3 and the decondensation of the metaphase chromosomes. The results show that the hyperphosphorylation of histone H1 and phosphorylation of histone H3 are required to maintain metaphase chromosomes in their condensed state.	LOS ALAMOS NATL LAB,DIV LIFE SCI,LOS ALAMOS,NM 87545	United States Department of Energy (DOE); Los Alamos National Laboratory	THNG, JPH (corresponding author), UNIV CALIF DAVIS,SCH MED,DEPT BIOL CHEM,DAVIS,CA 95616, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045890] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45890-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE K, 1991, EXP CELL RES, V192, P122, DOI 10.1016/0014-4827(91)90166-R; AJIRO K, 1983, J BIOL CHEM, V258, P4534; BRADBURY EM, 1973, EUR J BIOCHEM, V33, P131, DOI 10.1111/j.1432-1033.1973.tb02664.x; BRADBURY EM, 1974, NATURE, V249, P553, DOI 10.1038/249553a0; BRADBURY EM, 1974, NATURE, V247, P257, DOI 10.1038/247257a0; BRADBURY EM, 1992, BIOESSAYS, V14, P9; CHAMBERS TC, 1990, J BIOL CHEM, V265, P16940; CRISSMAN HA, 1991, P NATL ACAD SCI USA, V88, P7580, DOI 10.1073/pnas.88.17.7580; ELLEDGE SJ, 1992, P NATL ACAD SCI USA, V89, P2907, DOI 10.1073/pnas.89.7.2907; ENOCH T, 1991, J CELL BIOL, V112, P797, DOI 10.1083/jcb.112.5.797; FALLON RJ, 1990, BIOCHEM BIOPH RES CO, V170, P1191, DOI 10.1016/0006-291X(90)90519-S; FANG F, 1991, CELL, V66, P731, DOI 10.1016/0092-8674(91)90117-H; FINE RL, 1988, P AM ASSOC CANC RES, V29, P301; GADBOIS DM, 1992, BIOCHEM BIOPH RES CO, V184, P80, DOI 10.1016/0006-291X(92)91160-R; GROSS JL, 1990, BIOCHEM PHARMACOL, V40, P343, DOI 10.1016/0006-2952(90)90697-J; GURLEY LR, 1975, J BIOL CHEM, V250, P3936; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; HAMAGUCHI JR, 1992, J CELL BIOL, V117, P1041, DOI 10.1083/jcb.117.5.1041; HANKS SK, 1983, EXP CELL RES, V148, P293, DOI 10.1016/0014-4827(83)90153-2; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V171, P189, DOI 10.1016/0006-291X(90)91375-3; LANGAN TA, 1989, MOL CELL BIOL, V9, P3860, DOI 10.1128/MCB.9.9.3860; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; MITCHELSON K, 1978, FEBS LETT, V92, P339, DOI 10.1016/0014-5793(78)80782-0; NAKANO H, 1987, J ANTIBIOT, V40, P706, DOI 10.7164/antibiotics.40.706; NIGGLI V, 1991, J BIOL CHEM, V266, P7927; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PAGANO M, 1993, J CELL BIOL, V121, P101, DOI 10.1083/jcb.121.1.101; PAGANO M, 1992, EMBO J, V11, P761; PANYIM S, 1969, BIOCHEM BIOPH RES CO, V37, P1042, DOI 10.1016/0006-291X(69)90237-X; PETER M, 1991, EMBO J, V10, P1535, DOI 10.1002/j.1460-2075.1991.tb07673.x; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; RIABOWOL K, 1989, CELL, V57, P393, DOI 10.1016/0092-8674(89)90914-8; ROBERGE M, 1990, J CELL BIOL, V111, P1753, DOI 10.1083/jcb.111.5.1753; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; SHOEMAKER CB, 1980, J BIOL CHEM, V255, P1048; SHOEMAKER CB, 1978, J BIOL CHEM, V253, P5802; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; THNG JPH, 1990, CELL, V63, P313, DOI 10.1016/0092-8674(90)90164-A; Tobey R A, 1973, Methods Cell Biol, V6, P67, DOI 10.1016/S0091-679X(08)60048-5; TSAI LH, 1991, NATURE, V353, P174, DOI 10.1038/353174a0; UCHIDA S, 1990, MOL CELL BIOL, V10, P577, DOI 10.1128/MCB.10.2.577; VEGESNA RVK, 1988, MOL PHARMACOL, V33, P537	43	78	80	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9568	9573						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144543				2022-12-27	WOS:A1994NE05300029
J	CHARNESS, ME; SAFRAN, RM; PERIDES, G				CHARNESS, ME; SAFRAN, RM; PERIDES, G			ETHANOL INHIBITS NEURAL CELL-CELL ADHESION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FETAL ALCOHOL SYNDROME; OSTEOGENIC PROTEIN-1; HOMOPHILIC BINDING; PRENATAL EXPOSURE; NERVOUS-SYSTEM; MESSENGER-RNA; MOLECULE; INVITRO; MIGRATION; SURFACE	Gestational exposure to ethanol causes defects in neuronal migration, fasciculation, and synaptogenesis, developmental events that depend on the patterned expression and function of cell adhesion molecules (CAMs). Recombinant human osteogenic protein-1 (hOP-1) increases cell-cell adhesion and promotes cell clustering in proliferating neuroblastoma x glioma hybrid NG108-15 cells by strongly inducing N-CAM and L1. Here we show that concentrations of ethanol achieved during social drinking inhibit hOP-1-induced cell clustering without affecting cell proliferation, the induction and cell surface expression of N-CAM and L1, or the alternative splicing and sialylation of N-CAM. This inhibition was reproduced by other alcohols in proportion to their chain length, but not by teratogenic anticonvulsants or phenylalanine. Ethanol inhibition of hOP-1 morphogenesis was inversely proportional to the concentration of hOP-1 and, hence, to the levels of N-CAM and L1. Low concentrations of ethanol (IC50 5-10 mM) inhibited cell-cell adhesion in hOP-1-treated cells, and this action too was reproduced more potently by propa- nol and butanol. Ethanol may perturb brain and skeletal development by inhibiting CAM-mediated cell-cell interactions.	HARVARD UNIV,SCH MED,DEPT NEUROSCI,BOSTON,MA; BRIGHAM & WOMENS HOSP,DIV NEUROL,BOSTON,MA 02115; W ROXBURY VET ADM MED CTR,NEUROL SECT 127,BOSTON,MA 02132; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA; W ROXBURY VET ADM MED CTR,SPINAL CORD INJURY RES LAB,BOSTON,MA 02132	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	CHARNESS, ME (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROL 127,1400 VFW PKWY,BOSTON,MA 02132, USA.			Charness, Michael/0000-0002-3301-8966	NIAAA NIH HHS [AA06662] Funding Source: Medline; NINDS NIH HHS [NS13034] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA006662] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ABEL EL, 1987, DRUG ALCOHOL DEPEN, V19, P51, DOI 10.1016/0376-8716(87)90087-1; BHAT S, 1988, BRAIN RES, V452, P373, DOI 10.1016/0006-8993(88)90042-X; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; CHARNESS ME, 1989, NEW ENGL J MED, V321, P442, DOI 10.1056/NEJM198908173210706; CHARNESS ME, 1992, DIAGNOSIS TREATMENT, P155; CLARREN SK, 1978, J PEDIATR-US, V92, P64, DOI 10.1016/S0022-3476(78)80072-9; CLODE AM, 1987, TERATOLOGY, V35, P395, DOI 10.1002/tera.1420350313; COLE GJ, 1986, NATURE, V320, P445, DOI 10.1038/320445a0; DEITRICH RA, 1989, PHARMACOL REV, V41, P489; DOHERTY P, 1992, J NEUROCHEM, V58, P2338, DOI 10.1111/j.1471-4159.1992.tb10984.x; DOHERTY P, 1991, CELL, V67, P21, DOI 10.1016/0092-8674(91)90569-K; EDELMAN GM, 1982, P NATL ACAD SCI-BIOL, V79, P7036, DOI 10.1073/pnas.79.22.7036; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; GRESSENS P, 1992, ALCOHOL ALCOHOLISM, V27, P219; HORSTKORTE R, 1993, J CELL BIOL, V121, P1409, DOI 10.1083/jcb.121.6.1409; HU G, 1993, J BIOL CHEM, V268, P23441; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; JONES KL, 1973, LANCET, V2, P999; KOCH R, 1991, J NIH RES, V3, P61; KOERKER RL, 1976, TOXICOL APPL PHARM, V37, P281, DOI 10.1016/0041-008X(76)90091-0; LEE YS, 1992, J BONE MINER RES, V7, P1435; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; LINNEMANN D, 1989, DEV NEUROSCI-BASEL, V11, P149, DOI 10.1159/000111896; MACGREGOR RR, 1974, NEW ENGL J MED, V291, P642, DOI 10.1056/NEJM197409262911302; MAGUIRE C, 1991, INT J DEV NEUROSCI, V9, P581, DOI 10.1016/0736-5748(91)90019-I; MILES MF, 1992, BIOCHIM BIOPHYS ACTA, V1138, P268, DOI 10.1016/0925-4439(92)90003-6; MILLER MW, 1993, J COMP NEUROL, V337, P253, DOI 10.1002/cne.903370206; MILLER MW, 1986, SCIENCE, V233, P1308, DOI 10.1126/science.3749878; MIURA M, 1992, J BIOL CHEM, V267, P10752; MOCHLYROSEN D, 1988, NATURE, V333, P848, DOI 10.1038/333848a0; MODELL JG, 1990, NEW ENGL J MED, V323, P455, DOI 10.1056/NEJM199008163230706; MORLAND B, 1985, ALCOHOL, V2, P425, DOI 10.1016/0741-8329(85)90108-9; PENTNEY RJ, 1992, DEV CENTRAL NERVOUS, P71; PERIDES G, 1993, J BIOL CHEM, V268, P25197; PERIDES G, 1992, P NATL ACAD SCI USA, V89, P10326, DOI 10.1073/pnas.89.21.10326; PERIDES G, 1994, J BIOL CHEM, V269, P765; RAO Y, 1992, J CELL BIOL, V118, P937, DOI 10.1083/jcb.118.4.937; RATHJEN FG, 1984, EMBO J, V3, P1; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; RUTISHAUSER U, 1991, TRENDS NEUROSCI, V14, P528, DOI 10.1016/0166-2236(91)90006-G; RUTISHAUSER U, 1984, NATURE, V310, P549, DOI 10.1038/310549a0; SAMPATH TK, 1992, J BIOL CHEM, V267, P20352; SCHENKER S, 1990, ALCOHOL CLIN EXP RES, V14, P635, DOI 10.1111/j.1530-0277.1990.tb01220.x; SHETTY AK, 1992, J COMP NEUROL, V321, P19, DOI 10.1002/cne.903210103; STREISSGUTH AP, 1980, SCIENCE, V209, P353, DOI 10.1126/science.6992275; SULIK KK, 1981, SCIENCE, V214, P936, DOI 10.1126/science.6795717; WEST JR, 1981, SCIENCE, V211, P957; WOOD PM, 1990, J NEUROSCI, V10, P3635	50	121	122	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9304	9309						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132668				2022-12-27	WOS:A1994NB41100099
J	FRAIZER, GC; WU, YJ; HEWITT, SM; MAITY, T; TON, CCT; HUFF, V; SAUNDERS, GF				FRAIZER, GC; WU, YJ; HEWITT, SM; MAITY, T; TON, CCT; HUFF, V; SAUNDERS, GF			TRANSCRIPTIONAL REGULATION OF THE HUMAN WILMS-TUMOR GENE (WT1) - CELL-TYPE-SPECIFIC ENHANCER AND PROMISCUOUS PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-A-CHAIN; RETINOBLASTOMA GENE; MAMMALIAN-CELLS; SUPPRESSOR WT1; EXPRESSION; DNA; DELETION; BINDING; PROTEIN; MUTATIONS	The Wilms' tumor gene, WT1, is expressed in few tissues, mainly the developing kidney, genitourinary system, and mesothelium, and in immature hematopoietic cells. To develop an understanding of the role of WT1 in development and tumorigenesis, we have identified transcriptional regulatory elements that function in transient reporter gene constructs transfected into kid ney and hematopoietic cell lines. We found three transcription start sites of the WT1 gene and have identified an essential promoter region by deletion analysis. The WT1 promoter is a member of the GC-rich, TATA-less, and CCAAT-less class of polymerase II promoters. Whereas the WT1 promoter is similar to other tumor suppressor gene promoters, the WT1 expression pattern (unlike Rb and p53) is tissue-restricted. The WT1 GC-rich promoter is promiscuous, functioning in all cell lines tested, independent of WT1 expression. This finding suggests that the promoter is not tissue-specific, but that tissue-specific expression of WT1 is modulated by additional regulatory elements. Indeed, we have identified a transcriptional enhancer located 3' of the WT1 gene >50 kilobases downstream from the promoter. This orientation-independent enhancer increases the basal transcription rate of the WT1 promoter in the human erythroleukemia cell line K562, but not in any of the other cell lines tested.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT BIOCHEM & MOLEC BIOL,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center				Hewitt, Stephen/0000-0001-8283-1788	NATIONAL CANCER INSTITUTE [P30CA016672, R01CA046720, P01CA034936] Funding Source: NIH RePORTER; NCI NIH HHS [CA 46720, CA 16672, CA 34936] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BECKWITH J B, 1990, Pediatric Pathology, V10, P1; Bennington JI, 1975, TUMORS KIDNEY RENAL; BICKMORE WA, 1992, SCIENCE, V257, P235, DOI 10.1126/science.1321494; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; BOOKSTEIN R, 1990, P NATL ACAD SCI USA, V87, P7762, DOI 10.1073/pnas.87.19.7762; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; COMPTON DA, 1990, GENOMICS, V6, P309, DOI 10.1016/0888-7543(90)90571-B; DANG CV, 1992, P NATL ACAD SCI USA, V89, P599, DOI 10.1073/pnas.89.2.599; DRESSLER GR, 1992, P NATL ACAD SCI USA, V89, P1179, DOI 10.1073/pnas.89.4.1179; DRUMMOND IA, 1992, SCIENCE, V257, P674, DOI 10.1126/science.1323141; ECCLES MR, 1992, CELL GROWTH DIFFER, V3, P279; EVANS GA, 1987, METHOD ENZYMOL, V152, P604; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; GARVIN AJ, 1993, AM J PATHOL, V142, P375; GASHLER AL, 1992, P NATL ACAD SCI USA, V89, P10984, DOI 10.1073/pnas.89.22.10984; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GESSLER M, 1992, GENOMICS, V12, P807, DOI 10.1016/0888-7543(92)90313-H; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; HOFMANN W, 1993, ONCOGENE, V8, P3123; HUANG A, 1990, SCIENCE, V250, P991, DOI 10.1126/science.2173145; HUFF V, 1991, AM J HUM GENET, V48, P997; HUFF V, 1993, BIOCHIM BIOPHYS ACTA, V1155, P295, DOI 10.1016/0304-419X(93)90011-Z; ISHII S, 1985, SCIENCE, V230, P1378, DOI 10.1126/science.2999983; JAKOBOVITS EB, 1988, MOL CELL BIOL, V8, P5549, DOI 10.1128/MCB.8.12.5549; KANEKO Y, 1981, CANCER RES, V42, P4577; KIDD JM, 1984, TUMOR, P265; KINGSTON RE, 1990, CURRENT PROTOCOLS MO; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; LITTLE MH, 1992, P NATL ACAD SCI USA, V89, P4791, DOI 10.1073/pnas.89.11.4791; MADDEN SL, 1991, SCIENCE, V253, P1550, DOI 10.1126/science.1654597; MANIATIS T, 1982, MOL CLONING LABORATO, P309; MIWA H, 1992, LEUKEMIA, V6, P405; OKA T, 1991, ONCOGENE, V6, P2077; PASTAN I, 1985, P NATL ACAD SCI USA, V82, P4920; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PELLETIER J, 1991, GENE DEV, V5, P1345, DOI 10.1101/gad.5.8.1345; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; RICCARDI VM, 1978, PEDIATRICS, V61, P604; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEHGAL A, 1988, MOL CELL BIOL, V8, P3160, DOI 10.1128/MCB.8.8.3160; TADAKORO K, 1992, JPN J CANCER RES, V83, P1198; WANG ZY, 1992, J BIOL CHEM, V267, P21999; WERNER H, 1993, P NATL ACAD SCI USA, V90, P5828, DOI 10.1073/pnas.90.12.5828; YOUNG JL, 1975, J PEDIATR-US, V86, P254, DOI 10.1016/S0022-3476(75)80484-7; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230; 1991, PROGRAM MANUAL GCG P	57	80	83	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8892	8900						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132626				2022-12-27	WOS:A1994NB41100043
J	HIGH, KP; JOINER, KA; HANDSCHUMACHER, RE				HIGH, KP; JOINER, KA; HANDSCHUMACHER, RE			ISOLATION, CDNA SEQUENCES, AND BIOCHEMICAL-CHARACTERIZATION OF THE MAJOR CYCLOSPORINE-BINDING PROTEINS OF TOXOPLASMA-GONDII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS-ISOMERASE; STEROID-RECEPTOR COMPLEXES; TOXOPLASMA-GONDII; SACCHAROMYCES-CEREVISIAE; NEUROSPORA-CRASSA; ESCHERICHIA-COLI; FK506-BINDING PROTEIN; GENE ENCODES; CYCLOPHILIN; CALCINEURIN	The activities of the immunosuppressive, antifungal compounds cyclosporin A (CsA), FK-506, and rapamycin are dependent upon high affinity binding proteins collectively termed immunophilins. We report the isolation, biochemical characterization, and amino acid sequences of two major CsA-binding proteins, cyclophilins, from the pathogenic protozoan, Toxoplasma gondii. The 18.5- and 20-kDa molecular mass proteins exhibit peptidylproline cis-trans-isomerase activity, which is inhibitable by 10(-8) M CsA. The amino acid sequences of these two proteins, deduced from cDNA clones, reveal up to 70% amino acid identity to previously isolated cyclophilins. The 18.5-kDa protein appears to be synthesized as a precursor with a 15 amino acid signal peptide. The amino-terminal region of the mature 2O-kDa protein has significant homology to the B subunit of the calmodulin-dependent phosphatase, calcineurin. The two T. gondii cyclophilins are products of different genes and appear to have different subcellular distributions.	YALE UNIV,SCH MED,DEPT MED,INFECT DIS SECT,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510	Yale University; Yale University			Joiner, Keith/AAH-1059-2021	Joiner, Keith/0000-0003-3062-823X	NIDDK NIH HHS [DK 07476] Funding Source: Medline; NIGMS NIH HHS [GM 49858, GM 40660] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049858, P01GM040660] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARGAET VP, 1992, J PARASITOL, V78, P660, DOI 10.2307/3283541; BLISKA JB, 1993, CELL, V73, P903, DOI 10.1016/0092-8674(93)90270-Z; BRIZUELA L, 1991, MOL CELL BIOL, V11, P4616, DOI 10.1128/MCB.11.9.4616; CIANCIOTTO NP, 1990, J INFECT DIS, V162, P121, DOI 10.1093/infdis/162.1.121; CIANCIOTTO NP, 1989, INFECT IMMUN, V57, P1255, DOI 10.1128/IAI.57.4.1255-1262.1989; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; DREYFUSS M, 1976, EUR J APPL MICROBIOL, V3, P125, DOI 10.1007/BF00928431; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FISCHER G, 1992, MOL MICROBIOL, V6, P1375, DOI 10.1111/j.1365-2958.1992.tb00858.x; FOOR F, 1992, NATURE, V360, P682; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; HAENDLER B, 1989, GENE, V83, P39, DOI 10.1016/0378-1119(89)90401-0; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HAYANO T, 1991, BIOCHEMISTRY-US, V30, P3041, DOI 10.1021/bi00226a009; HERRLER M, 1992, FEBS LETT, V309, P231, DOI 10.1016/0014-5793(92)80779-G; HIGH KP, 1992, INFECT AGENT DIS, V1, P121; JOINER KA, 1990, SCIENCE, V249, P641, DOI 10.1126/science.2200126; KIEFFER LJ, 1992, J BIOL CHEM, V267, P5503; KIEFFER LJ, 1993, J BIOL CHEM, V268, P12303; KIM JH, 1989, REV INFECT DIS, V11, P677; KINO T, 1987, J ANTIBIOT, V40, P1249, DOI 10.7164/antibiotics.40.1249; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; KOLETSKY AJ, 1986, J IMMUNOL, V137, P1054; KOLTIN Y, 1991, MOL CELL BIOL, V11, P1718, DOI 10.1128/MCB.11.3.1718; KOSER PL, 1990, GENE, V96, P189, DOI 10.1016/0378-1119(90)90252-M; LEBEAU MC, 1992, J BIOL CHEM, V267, P4281; LERICHE MA, 1991, MOL BIOCHEM PARASIT, V45, P249, DOI 10.1016/0166-6851(91)90092-K; LI W, 1993, J BIOL CHEM, V268, P14040; LIGHTOWLERS MW, 1989, MOL BIOCHEM PARASIT, V36, P287, DOI 10.1016/0166-6851(89)90177-1; LIU J, 1990, P NATL ACAD SCI USA, V87, P4028, DOI 10.1073/pnas.87.11.4028; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LIU J, 1991, BIOCHEMISTRY-US, V30, P2306, DOI 10.1021/bi00223a003; LIU J, 1992, BIOCHEMISTRY-US, V31, P3896, DOI 10.1021/bi00131a002; LUNDEMOSE AG, 1993, MOL MICROBIOL, V7, P777, DOI 10.1111/j.1365-2958.1993.tb01168.x; LUNDEMOSE AG, 1991, MOL MICROBIOL, V5, P109, DOI 10.1111/j.1365-2958.1991.tb01831.x; MACK DG, 1984, ANTIMICROB AGENTS CH, V26, P26, DOI 10.1128/AAC.26.1.26; MARKS WH, 1991, TRANSPLANTATION, V52, P340, DOI 10.1097/00007890-199108000-00030; MCCABE RE, 1986, TRANSPLANTATION, V41, P611, DOI 10.1097/00007890-198605000-00012; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; PORTER SB, 1992, NEW ENGL J MED, V327, P1643, DOI 10.1056/NEJM199212033272306; PRATT WB, 1993, J STEROID BIOCHEM, V46, P269, DOI 10.1016/0960-0760(93)90216-J; PRATT WB, 1993, J BIOL CHEM, V268, P21455; RATAJCZAK T, 1993, J BIOL CHEM, V268, P13187; RYFFEL B, 1993, BIOCHEM BIOPH RES CO, V194, P1074, DOI 10.1006/bbrc.1993.1931; Sambrook J, 1989, MOL CLONING LABORATO; SAMPSON BA, 1992, P NATL ACAD SCI USA, V89, P1164, DOI 10.1073/pnas.89.4.1164; SANCHEZ ER, 1990, BIOCHEMISTRY-US, V29, P5145, DOI 10.1021/bi00473a021; SANCHEZ ER, 1990, J BIOL CHEM, V265, P22067; SARRIS AH, 1992, TRANSPLANTATION, V54, P904, DOI 10.1097/00007890-199211000-00026; SCHNEUWLY S, 1989, P NATL ACAD SCI USA, V86, P5390, DOI 10.1073/pnas.86.14.5390; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; SCHREIBER SL, 1992, CELL, V70, P365, DOI 10.1016/0092-8674(92)90158-9; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; STARZL TE, 1989, LANCET, V2, P1000; STONE KL, 1989, TECHNIQUES PROTEIN C, P377; TAI PKK, 1986, BIOCHEMISTRY-US, V25, P5269, DOI 10.1021/bi00366a043; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; TRAN PV, 1990, J BACTERIOL, V172, P347; TROPSCHUG M, 1989, NATURE, V342, P953, DOI 10.1038/342953a0; TROPSCHUG M, 1990, NATURE, V346, P674, DOI 10.1038/346674a0; TROPSCHUG M, 1988, J BIOL CHEM, V263, P14433; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; WIEDERRECHT G, 1991, P NATL ACAD SCI USA, V88, P1029, DOI 10.1073/pnas.88.3.1029; 1983, NEW ENGL J MED, V309, P809; 1986, NEW ENGL J MED, V314, P1219	69	51	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9105	9112						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132648				2022-12-27	WOS:A1994NB41100074
J	JAIN, R; GOMER, RH				JAIN, R; GOMER, RH			A DEVELOPMENTALLY-REGULATED CELL-SURFACE RECEPTOR FOR A DENSITY-SENSING FACTOR IN DICTYOSTELIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA PROTEIN SUBUNITS; SIGNAL TRANSDUCTION; GROWTH-FACTOR; DISCOIDEUM; BINDING; GENES	Conditioned medium factor (CMF) is an 80-kDa glycoprotein which is the signal in a cell density sensing system used by developing Dictyostelium cells. CMF is slowly secreted by cells when they starve, and the extracellular level of CMF then becomes an indicator of the density of starving cells. To examine how CMF is sensed, we have made bacterially synthesized recombinant CMF and found that it has as much activity as native CMF, indicating that glycosylation is not part of the active site of CMF. Expression of recombinant fragments of CMF indicates that the active site lies within an 88-amino acid region near the N terminus. To determine whether CMF is sensed by cell surface receptors, we examined binding of iodinated recombinant CMF to live cells. We found saturable binding to 6-h starved cells at 3.9 x 10(4) molecules/cell with a K-D of 2.1 nM. The binding saturates in 30 min, and a Scatchard plot indicates that there is only one class of receptor, The binding is competed off by the addition of either the native or recombinant CMF, or the 88-amino acid active fragment region; no binding competition is seen from the nonactive regions or other proteins. Very little binding to vegetative cells is seen, with maximal binding seen in cells starved for 6-8 h. The amount of cell surface CMF binding then decreases during later development. Normal levels of CMF binding are seen to CMF(-) cells, indicating that CMF is not required for the accumulation of its own receptor.	RICE UNIV, DEPT BIOCHEM & CELL BIOL, HOUSTON, TX 77251 USA; RICE UNIV, HOWARD HUGHES MED INST, HOUSTON, TX 77251 USA	Rice University; Howard Hughes Medical Institute; Rice University				Gomer, Richard/0000-0003-2361-4307	NIGMS NIH HHS [GM42604] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042604] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKERA T, 1977, BIOCHIM BIOPHYS ACTA, V470, P412, DOI 10.1016/0005-2736(77)90132-8; BYLUND DB, 1980, RECEPTOR BINDING TEC, P70; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; CATERINA MJ, 1991, FASEB J, V5, P3078, DOI 10.1096/fasebj.5.15.1743439; CLARKE M, 1992, DEV BIOL, V152, P403, DOI 10.1016/0012-1606(92)90147-9; DEVREOTES PN, 1982, DEV DICTYOSTELIUM DI, P117; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; FIRTEL RA, 1991, TRENDS GENET, V7, P381, DOI 10.1016/0168-9525(91)90260-W; GOMER RH, 1983, J CELL BIOL, V96, P321, DOI 10.1083/jcb.96.2.321; GOMER RH, 1987, METHOD CELL BIOL, V28, P471; GOMER RH, 1987, SCIENCE, V237, P758, DOI 10.1126/science.3039657; GOMER RH, 1986, J CELL BIOL, V103, P1999, DOI 10.1083/jcb.103.5.1999; GOMER RH, 1991, DEV BIOL, V64, P203; GRABEL L, 1978, DEV BIOL, V64, P203, DOI 10.1016/0012-1606(78)90072-6; GREEN AA, 1975, CELL, V6, P129, DOI 10.1016/0092-8674(75)90003-3; GREINER RA, 1992, J BIOL CHEM, V267, P5096; HARLOW E, 1988, ANTIBODIES LABORATOR; HELDIN CH, 1981, P NATL ACAD SCI-BIOL, V78, P3664, DOI 10.1073/pnas.78.6.3664; INSALL R, 1990, EMBO J, V9, P3323, DOI 10.1002/j.1460-2075.1990.tb07532.x; JAIN R, 1992, GENE DEV, V6, P390, DOI 10.1101/gad.6.3.390; JANSSENS PMW, 1987, MICROBIOL REV, V51, P396, DOI 10.1128/MMBR.51.4.396-418.1987; KLEIN C, 1976, P NATL ACAD SCI USA, V73, P1250, DOI 10.1073/pnas.73.4.1250; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; KNECHT DA, 1986, MOL CELL BIOL, V6, P3973, DOI 10.1128/MCB.6.11.3973; KNECHT DA, 1990, DEV GENET, V11, P403, DOI 10.1002/dvg.1020110513; KUMAGAI A, 1989, CELL, V57, P265, DOI 10.1016/0092-8674(89)90964-1; KUMAGAI A, 1991, J BIOL CHEM, V266, P1220; Loomis WF., 1975, DICTYOSTELIUM DISCOI; MALCHOW D, 1974, P NATL ACAD SCI USA, V71, P2423, DOI 10.1073/pnas.71.6.2423; MASSAGUE J, 1985, J BIOL CHEM, V260, P2636; MEHDY MC, 1985, MOL CELL BIOL, V5, P705, DOI 10.1128/MCB.5.4.705; MEHDY MC, 1983, CELL, V32, P763, DOI 10.1016/0092-8674(83)90062-4; NANDINIKISHORE SG, 1981, P NATL ACAD SCI-BIOL, V78, P7299, DOI 10.1073/pnas.78.12.7299; NEWELL PC, 1977, RECEPTORS RECOGNIT B, V3, P3; Sambrook J, 1989, MOL CLONING LABORATO; SAXE CL, 1991, DEV GENET, V12, P6, DOI 10.1002/dvg.1020120104; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; VANHAASTERT PJM, 1991, EUR J BIOCHEM, V195, P289; WURSTER B, 1980, EUR J BIOCHEM, V109, P613, DOI 10.1111/j.1432-1033.1980.tb04834.x; WURSTER B, 1983, FEMS MICROBIOL LETT, V18, P139; YUEN IS, 1991, DEVELOPMENT, V113, P1375; YUEN IS, 1994, IN PRESS J THEOR BIO	42	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9128	9136						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132650				2022-12-27	WOS:A1994NB41100077
J	IMBALZANO, AN; ZARET, KS; KINGSTON, RE				IMBALZANO, AN; ZARET, KS; KINGSTON, RE			TRANSCRIPTION FACTOR (TF) IIB AND TFIIA CAN INDEPENDENTLY INCREASE THE AFFINITY OF THE TATA-BINDING PROTEIN FOR PNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; PREINITIATION COMPLEX; ACTIVATION DOMAIN; BASIC REPEAT; BOX FACTOR; INITIATION; DNA; MECHANISM; IDENTIFICATION; SEQUENCES	The general transcription factors (TF) IIB and TFIIA are the first factors to associate with the TATA-binding protein (TBP) during formation of a transcription initiation complex on RNA polymerase II promoters. DNase I footprint titration was used to measure the effects of TFIIB and TFIIA on binding of TBP to a consensus TATA box. Under reaction conditions optimized for TBP.DNA complex formation, the presence of TFIIB increased affinity of TBP for the TATA box by 2.5-fold, while TFIIA had no effect. When TBP binding conditions were suboptimal, both TFIIB and TFIIA independently increased TBP affinity by approximately 10-fold. Therefore both TFIIB and TFIIA have the intrinsic ability to directly increase the affinity of TBP for the TATA box. We suggest that this property of TFIIA and TFIIB may increase the range of conditions under which high affinity TBP.DNA interactions can occur and may therefore favor the formation of the preinitiation complex.	MASSACHUSETTS GEN HOSP,DEPT MOLEC BIOL,BOSTON,MA 02114; BROWN UNIV,BIOCHEM SECT,PROVIDENCE,RI 02912	Harvard University; Massachusetts General Hospital; Brown University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048405] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48405] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BRENOWITZ M, 1986, P NATL ACAD SCI USA, V83, P8462, DOI 10.1073/pnas.83.22.8462; BRENOWITZ M, 1986, METHOD ENZYMOL, V130, P132; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; CAREY M, 1992, J VIROL, V66, P4803, DOI 10.1128/JVI.66.8.4803-4813.1992; CONAWAY JW, 1989, J BIOL CHEM, V264, P2357; CONAWAY RC, 1991, P NATL ACAD SCI USA, V88, P6205, DOI 10.1073/pnas.88.14.6205; CORTES P, 1992, MOL CELL BIOL, V12, P413, DOI 10.1128/MCB.12.1.413; DAVISON BL, 1983, NATURE, V301, P680, DOI 10.1038/301680a0; FIRE A, 1984, J BIOL CHEM, V259, P2509; FLORES O, 1991, P NATL ACAD SCI USA, V88, P9999, DOI 10.1073/pnas.88.22.9999; GREENBLATT J, 1991, CELL, V66, P1067, DOI 10.1016/0092-8674(91)90027-V; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; HAGEMEIER C, 1992, J VIROL, V66, P4452, DOI 10.1128/JVI.66.7.4452-4456.1992; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; HAHN S, 1989, EMBO J, V8, P3379, DOI 10.1002/j.1460-2075.1989.tb08501.x; HOEY T, 1990, CELL, V61, P1179, DOI 10.1016/0092-8674(90)90682-5; HOOPES BC, 1992, J BIOL CHEM, V267, P11539; HORIKOSHI N, 1991, P NATL ACAD SCI USA, V88, P5124, DOI 10.1073/pnas.88.12.5124; JOHNSON AD, 1979, P NATL ACAD SCI USA, V76, P5061, DOI 10.1073/pnas.76.10.5061; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; LEE DK, 1992, MOL CELL BIOL, V12, P5189, DOI 10.1128/MCB.12.11.5189; LEE WS, 1991, CELL, V67, P365, DOI 10.1016/0092-8674(91)90188-5; LEIBERMAN PM, 1991, MOL CELL BIOL, V11, P63; LIEBERMAN PM, 1991, GENE DEV, V5, P2441, DOI 10.1101/gad.5.12b.2441; LIN YS, 1991, CELL, V64, P971, DOI 10.1016/0092-8674(91)90321-O; MALDONADO E, 1990, MOL CELL BIOL, V10, P6335, DOI 10.1128/MCB.10.12.6335; MEISTERERNST M, 1991, CELL, V66, P981, DOI 10.1016/0092-8674(91)90443-3; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; PUGH BF, 1992, J BIOL CHEM, V267, P679; RANISH JA, 1992, SCIENCE, V255, P1127, DOI 10.1126/science.1546313; RANISH JA, 1991, J BIOL CHEM, V266, P19320; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SAYRE MH, 1992, J BIOL CHEM, V267, P23376; SCHMIDT MC, 1989, MOL CELL BIOL, V9, P3299, DOI 10.1128/MCB.9.8.3299; SMITH CA, 1993, J VIROL, V67, P4676, DOI 10.1128/JVI.67.8.4676-4687.1993; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; SUNDSETH R, 1992, J BIOL CHEM, V267, P7845; WAMPLER SL, 1990, J BIOL CHEM, V265, P21223; ZAWEL L, 1993, PROG NUCLEIC ACID RE, V44, P67, DOI 10.1016/S0079-6603(08)60217-2	42	100	103	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8280	8286						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132551				2022-12-27	WOS:A1994NB40900068
J	KUAN, CT; WANG, QC; PASTAN, I				KUAN, CT; WANG, QC; PASTAN, I			PSEUDOMONAS EXOTOXIN-A MUTANTS - REPLACEMENT OF SURFACE-EXPOSED RESIDUES IN DOMAIN-II WITH CYSTEINE RESIDUES THAT CAN BE MODIFIED WITH POLYETHYLENE-GLYCOL IN A SITE-SPECIFIC MANNER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT INTERLEUKIN-2; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; AERUGINOSA; PROTEIN; TOXIN; GENE; CONJUGATION; MUTAGENESIS; EXPRESSION	Pseudomonas exotoxin A (PE) is a three-domain protein in which domain Ia is involved in recognition of receptors on eukaryotic target cells, domain II promotes translocation of PE into the cytosol, and domain III en- zymatically ADP-ribosylates elongation factor 2. Modification of proteins with polyethylene glycol (PEG) has been shown to prolong circulating plasma lifetime and may reduce or eliminate immunogenicity. However, in the case of toxins, PEG may interfere with or block toxin activity. To investigate the effect of polyethylene glycolation on specific residues located on the surface of PE domain II, we substituted cysteine, for each of the five most exposed surface amino acids (H276, E282, N306, R313, and E327) in domain II. These cysteines can serve as unique sites for PEG modification. The PE-Cys proteins retained most of their cytotoxicity even when the free sulfhydryl group was blocked by 5,5'-dithiobis(nitrobenzoic acid) or glutathione. When the PE-Cys proteins were conjugated with ovalbumin using a cleavable disulfide linkage, cytotoxicity was retained, but it was lost with a non-cleavable thioether linkage. In contrast, cytotoxicity was maintained when PE-Cys mutants were coupled to 5- or 20-kDa mPEG, using either a disulfide or a thioether linkage. Unexpectedly in some cases, the thioether conjugate was more active than the disulfide linkage. Pharmacokinetic studies on one of the polyethylene glycolated molecules (R313C) showed that the mean residence time (t(1/2) was prolonged to 72 min, compared to 20 min for unpolyethylene glycolated PECys(R313C). These studies show it is possible to derivatize PE at specific residues in domain II, maintain significant cytotoxic activity, and alter pharmacokinetics. These studies also suggest that large mPEG molecules can be translocated to the cytosol while still attached to domain II of PE.	NCI,DIV CANC BIOL DIAG & CTR,MOLEC BIOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270				ALLURED VS, 1986, P NATL ACAD SCI USA, V83, P1320, DOI 10.1073/pnas.83.5.1320; BATRA JK, 1989, P NATL ACAD SCI USA, V86, P8545, DOI 10.1073/pnas.86.21.8545; BRINKMANN U, 1992, P NATL ACAD SCI USA, V89, P3065, DOI 10.1073/pnas.89.7.3065; BUCHNER J, 1991, CURR OPIN BIOTECH, V2, P532, DOI 10.1016/0958-1669(91)90077-I; CARLSSON J, 1978, BIOCHEM J, V173, P723, DOI 10.1042/bj1730723; CHAUDHARY VK, 1987, P NATL ACAD SCI USA, V84, P4538, DOI 10.1073/pnas.84.13.4538; CHILDS CE, 1975, MICROCHEM J, V20, P190, DOI 10.1016/0026-265X(75)90038-7; ELLISON JW, 1982, NUCLEIC ACIDS RES, V10, P4071, DOI 10.1093/nar/10.13.4071; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FitzGerald D J, 1987, Methods Enzymol, V151, P139, DOI 10.1016/S0076-6879(87)51015-1; GOODSON RJ, 1990, BIO-TECHNOL, V8, P343, DOI 10.1038/nbt0490-343; GRAY GL, 1984, P NATL ACAD SCI-BIOL, V81, P2645, DOI 10.1073/pnas.81.9.2645; Habeeb A F, 1972, Methods Enzymol, V25, P457, DOI 10.1016/S0076-6879(72)25041-8; HWANG J, 1987, CELL, V48, P129, DOI 10.1016/0092-8674(87)90363-1; IGLEWSKI BH, 1975, P NATL ACAD SCI USA, V72, P2284, DOI 10.1073/pnas.72.6.2284; JINNO Y, 1989, J BIOL CHEM, V264, P15953; JINNO Y, 1988, J BIOL CHEM, V263, P13203; KASTURI S, 1992, J BIOL CHEM, V267, P23427; KATRE NV, 1987, P NATL ACAD SCI USA, V84, P1487, DOI 10.1073/pnas.84.6.1487; KATRE NV, 1990, J IMMUNOL, V144, P209; KNAUF MJ, 1988, J BIOL CHEM, V263, P15064; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LISI PL, 1982, J APPL BIOCHEM, V4, P1933; MAACK T, 1979, KIDNEY INT, V16, P251, DOI 10.1038/ki.1979.128; OGATA M, 1992, J BIOL CHEM, V267, P25396; OLSON JC, 1990, MOL IMMUNOL, V27, P981, DOI 10.1016/0161-5890(90)90121-F; PASTAN I, 1991, SCIENCE, V254, P1173, DOI 10.1126/science.1683495; PASTAN I, 1992, ANNU REV BIOCHEM, V61, P331, DOI 10.1146/annurev.bi.61.070192.001555; PRIOR TI, 1991, CELL, V64, P1017, DOI 10.1016/0092-8674(91)90325-S; SIMS GEC, 1980, ANAL BIOCHEM, V107, P60, DOI 10.1016/0003-2697(80)90492-3; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; THEUER CP, 1992, CANCER RES, V53, P1; WANG QC, 1993, CANCER RES, V53, P4588; WAWRZYNCZAK EJ, 1992, ANTI-CANCER DRUG DES, V7, P427; YOSHITAKE S, 1982, J BIOCHEM-TOKYO, V92, P1413, DOI 10.1093/oxfordjournals.jbchem.a134065	36	64	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7610	7616						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125985				2022-12-27	WOS:A1994NA03200091
J	LIEBERHERR, M; GROSSE, B				LIEBERHERR, M; GROSSE, B			ANDROGENS INCREASE INTRACELLULAR CALCIUM-CONCENTRATION AND INOSITOL 1,4,5-TRISPHOSPHATE AND DIACYLGLYCEROL FORMATION VIA A PERTUSSIS-TOXIN-SENSITIVE G-PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE CA-2+ CONCENTRATIONS; CYTOPLASMIC FREE CA-2+; HORMONE-INDUCED SPIKE; C-DEPENDENT PROCESSES; SIGNAL TRANSDUCTION; TUMOR PROMOTER; CELLS; PHOSPHATES; BONE; PROGESTERONE	Bone is a target tissue of androgens, but the mechanisms by which they act on bone are still unclear. This study examines the early (5-60 s) effects of 1 pM to 1 mu M testosterone on cytosolic free Ca2+ concentration ([Ca2+](i)) and inositol 1,4,5-trisphosphate (InsP(3)) and diacylglycerol (DAG) formation in confluent male rat osteoblasts. 10 pM to 10 nM testosterone increased [Ca2+](i) within 5 s via Ca2+ influx as shown by the effects of EGTA and the Ca2+ channel blockers nifedipine and verapamil and via Ca2+ mobilization from the endoplasmic reticulum as shown by the effects of thapsigargin and neomycin. 10 pM to 10 nM testosterone increased InsP(3) and DAG formation within 10 s. Testosterone immobilized on bovine serum albumin (testosterone (O-carboxymethyl)oxime/bovine serum albumin) and its derivative, (O-carboxymethyl)oxime, rapidly increased [Ca2+](i) and InsP(3) and DAG formation and were full agonists, although they were less potent than the free steroid. Cyproterone acetate, a nuclear antagonist, did not block the increase in [Ca2+](i) and InsP(3) and DAG formation induced by testosterone. Finally, neomycin and pertussis toxin totally abolished the effects of testosterone on InsP(3) and DAG. These results suggest that male rat osteoblasts bear nongenomic unconventional cell-surface receptors for testosterone that belong to the class of the membrane receptors coupled to a phospholipase C via a pertussis toxin-sensitive G-protein.	UNIV PARIS 05, CNRS, URA 583, F-75015 PARIS, FRANCE; GRP HOSP NECKER ENFANTS MALADES, F-75015 PARIS, FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite								ALBERT PR, 1984, J BIOL CHEM, V259, P5350; ALBERT PR, 1984, J BIOL CHEM, V259, P5827; BARAN DT, 1978, CALC TISS RES, V26, P103, DOI 10.1007/BF02013243; BATRA S, 1987, BRIT J PHARMACOL, V92, P389, DOI 10.1111/j.1476-5381.1987.tb11335.x; BAULIEU EE, 1978, NATURE, V275, P593, DOI 10.1038/275593a0; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BLACKMORE PF, 1991, J BIOL CHEM, V266, P18655; BLEASDALE JE, 1989, ADV PROSTAG THROMB L, V19, P590; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHESNOYMARCHAIS D, 1988, J PHYSIOL-LONDON, V398, P291, DOI 10.1113/jphysiol.1988.sp017043; COLVARD DS, 1989, P NATL ACAD SCI USA, V86, P854, DOI 10.1073/pnas.86.3.854; CRILLY RG, 1981, CLIN ENDOCRINOL META, V10, P115, DOI 10.1016/S0300-595X(81)80041-2; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; JOSEPH SK, 1989, ARCH BIOCHEM BIOPHYS, V273, P1, DOI 10.1016/0003-9861(89)90156-2; KERRIGAN JR, 1992, ENDOCR REV, V13, P281, DOI 10.1210/er.13.2.281; KORTE K, 1982, J CHROMATOGR, V232, P47, DOI 10.1016/S0378-4347(00)86006-5; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LIEBERHERR M, 1989, J BIOL CHEM, V264, P20403; LIEBERHERR M, 1993, J BONE MINER RES, V8, P1365; LIEBERHERR M, 1987, J BIOL CHEM, V262, P13168; MOOLENAAR WH, 1984, J BIOL CHEM, V259, P8066; MORLEY P, 1992, ENDOCRINOLOGY, V131, P1305, DOI 10.1210/en.131.3.1305; PRENTKI M, 1986, FEBS LETT, V197, P285, DOI 10.1016/0014-5793(86)80343-X; SADLER SE, 1982, P NATL ACAD SCI USA, V77, P1534; SANCHEZBUENO A, 1991, BIOCHEM J, V280, P273, DOI 10.1042/bj2800273; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; STEINSAPIR J, 1991, BIOCHEM BIOPH RES CO, V179, P90, DOI 10.1016/0006-291X(91)91338-D; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; VITIELLO F, 1978, J CHROMATOGR, V166, P637, DOI 10.1016/S0021-9673(00)95654-1; WALI RK, 1990, J CLIN INVEST, V85, P1296, DOI 10.1172/JCI114567; WONG G, 1974, NATURE, V252, P713, DOI 10.1038/252713a0	34	236	247	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7217	7223						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125934				2022-12-27	WOS:A1994NA03200030
J	MISHRA, VK; PALGUNACHARI, MN; SEGREST, JP; ANANTHARAMAIAH, GM				MISHRA, VK; PALGUNACHARI, MN; SEGREST, JP; ANANTHARAMAIAH, GM			INTERACTIONS OF SYNTHETIC PEPTIDE ANALOGS OF THE CLASS A AMPHIPATHIC HELIX WITH LIPIDS - EVIDENCE FOR THE SNORKEL HYPOTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; CHOLESTEROL ACYLTRANSFERASE; SECONDARY STRUCTURE; PROTEIN INTERACTIONS; PLASMA LIPOPROTEINS; PHOSPHATIDYLCHOLINE; FLUORESCENCE; ACTIVATION; COMPLEXES; LECITHIN	Class A amphipathic helixes present in exchangeable plasma apolipoproteins are characterized by the location of positively charged amino acid residues at the non-polar-polar interface and negatively charged amino acid residues at the center of the polar face. The objectives of the present study were: (i) to investigate the role of hydrocarbon side chain length of the interfacial positively charged amino acid residues in the lipid affinity of class A amphipathic helixes, and (ii) to investigate the importance of the nature of interfacial charge in the lipid affinity of class A amphipathic helixes. Toward this end, lipid interactions of the following two analogs of the class A amphipathic helix, Ac-18A-NH2 (acetyl-Asp-Trp-Leu-Lys-Ala-Phe-Tyr-Asp-Lys-Val-Ala-Glu-Lys-Leu-Lys-Glu-Ala-Phe-NH2), and Ac-18A(Lys>Haa)-NH2 (acetyl-Asp-Trp-Leu-Haa-Ala-Phe-Tyr-Asp-Haa-Val-Ala- Glu-Haa-Leu-Haa-Glu-Ala-Phe-NH2) (Haa = homoaminoalanine), were studied. The side chain of Has has two CH2 groups less than that of lysine. The lipid affinities of these two peptide analogs were compared with that of Ac-18R-NH2, an analog of Ac-18A-NH2 with positions of the charged amino acid residues reversed. The techniques used in these studies were circular dichroism, fluorescence spectroscopy, right-angle light scattering measurements, and differential scanning calorimetry. The results of these studies indicated the following rank order of lipid affinity: Ac-18A-NH2 > Ac-18A(Lys>Haa)NH2 > Ac-18R-NH2. These results are in agreement with the ''snorkel' model proposed earlier to explain the higher lipid affinity of class A amphipathic helixes (Segrest, J. P., Loof, H. D., Dohlman, J. G., Brouillette, C. G., and Anantharamaiah, G. M. (1990) Proteins Struct. Funct. Genetics 8, 103-117). In addition, it was observed from the differential scanning calorimetry studies that Ac-18A-NH2 and Ac-18A(Lys>Haa)-NH2 interact more strongly than Ac-18R-NH2 with negatively charged dimyristoyl phosphatidylglycerol. The weaker interaction of Ac-18R-NH2 with dimyristoyl phosphatidylglycerol is suggested to be due to electrostatic repulsion between the negatively charged lipid and the interfacial negative charges of the peptide.	UNIV ALABAMA,MED CTR,DEPT MED,BIRMINGHAM,AL 35294; UNIV ALABAMA,MED CTR,DEPT BIOCHEM,BIRMINGHAM,AL 35294; UNIV ALABAMA,MED CTR,ATHEROSCLEROSIS RES UNIT,BIRMINGHAM,AL 35294	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham				Mishra, Vinod/0000-0002-4527-1512	NHLBI NIH HHS [HL34343] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034343] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANANTHARAMAIAH GM, 1985, J BIOL CHEM, V260, P248; ANANTHARAMAIAH GM, 1993, AMPHIPATHIC HELIX, P109; ANANTHARAMAIAH GM, 1986, METHOD ENZYMOL, V128, P626; BLACKBURN WD, 1991, J LIPID RES, V32, P1911; CALHOUN DB, 1983, BIOCHEMISTRY-US, V22, P1533, DOI 10.1021/bi00276a003; CHUNG BH, 1985, J BIOL CHEM, V260, P256; EFTINK MR, 1993, BIOCHEMISTRY-US, V32, P9189, DOI 10.1021/bi00086a026; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; EPAND RM, 1990, J BIOL CHEM, V265, P20829; EPAND RM, 1987, J BIOL CHEM, V262, P9389; EPAND RM, 1989, J BIOL CHEM, V264, P4628; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; KAISER ET, 1984, SCIENCE, V223, P249, DOI 10.1126/science.6322295; KANELIS P, 1980, J BIOL CHEM, V260, P10248; KROON AIP, 1990, BIOCHEMISTRY-US, V29, P8229; KURZBAN GP, 1989, BIOCHEMISTRY-US, V28, P8537, DOI 10.1021/bi00447a040; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LEDGER R, 1965, AUST J CHEM, V18, P933, DOI 10.1071/CH9650933; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; LIE D, 1990, BIOCHEMISTRY-US, V29, P3637; MAO SJT, 1977, BIOCHEMISTRY-US, V16, P4150, DOI 10.1021/bi00638a003; Marsh D., 2013, HDB LIPID BILAYERS; MCLEAN LR, 1991, BIOCHEMISTRY-US, V30, P31, DOI 10.1021/bi00215a005; MEL SF, 1993, BIOCHEMISTRY-US, V32, P2082, DOI 10.1021/bi00059a028; MORRISET.JD, 1973, BIOCHEMISTRY-US, V12, P1290, DOI 10.1021/bi00731a008; MORRISETT JD, 1977, BIOCHIM BIOPHYS ACTA, V472, P93, DOI 10.1016/0304-4157(77)90015-6; OWENS RJ, 1990, J CLIN INVEST, V86, P1142, DOI 10.1172/JCI114819; PONSIN G, 1984, BIOCHEMISTRY-US, V23, P5337, DOI 10.1021/bi00317a036; PONSIN G, 1986, J BIOL CHEM, V261, P9202; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; SEGREST JP, 1992, J LIPID RES, V33, P141; SEGREST JP, 1991, MOL CONFORMATION BIO, P597; SISSEL LK, 1990, J BIOL CHEM, V265, P12217; SMALL DM, 1992, PLASMA LIPOPROTEINS, P57; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; SPARROW JT, 1981, PEPTIDES, P253; SUREWICZ WK, 1986, J BIOL CHEM, V261, P6191; TYTLER EM, 1993, J BIOL CHEM, V268, P22112; VENKATACHALAPAT.YV, 1991, MOL CONFORMATION BIO, P585; VENKATACHALAPATHI YV, 1993, PROTEINS, V15, P349, DOI 10.1002/prot.340150403; Woody RW, 1985, PEPTIDES ANAL SYNTHE, P15; YANG JT, 1986, METHOD ENZYMOL, V130, P208; YOKOYAMA S, 1980, J BIOL CHEM, V255, P7333; ZHANG YP, 1993, BIOCHEMISTRY-US, V32, P3942, DOI 10.1021/bi00066a014	45	164	171	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7185	7191						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125930				2022-12-27	WOS:A1994NA03200026
J	NIKOLOFF, DM; HENRY, SA				NIKOLOFF, DM; HENRY, SA			FUNCTIONAL-CHARACTERIZATION OF THE INO2 GENE OF SACCHAROMYCES-CEREVISIAE - A POSITIVE REGULATOR OF PHOSPHOLIPID BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEIN; POLYMERASE CHAIN-REACTION; DNA-BINDING; SUBSTRATE-SPECIFICITY; SYNTHETIC PEPTIDES; ESCHERICHIA-COLI; YEAST; TRANSFORMATION; MUTAGENESIS; EXPRESSION	The INO2 locus encodes a novel product showing structural similarity to the basic helix-loop-helix (b-HLH) family of regulatory proteins (Nikoloff, D. M., McGraw, P., and Henry, S. A. (1992) Nucleic Acids Res. 20, 3253). The ino2 mutants exhibit pleiotropic defects in phospholipid metabolism including inability to derepress the biosynthetic enzyme inositol-1-phosphate synthase. Localization of mutations in ino2 strains has demonstrated that the b-HLH domain is required for biological activity and is sensitive to perturbation, thereby establishing a correlation between the structure and function of Ino2p. Defects in the b-HLH domain of Ino2p resulted in reduced DNA binding activity. In addition, the absence of a specific DNA-protein complex correlated with a reduction or loss of INO1 transcription. Studies using Ino2p-specific antibody revealed that Ino2p participates in the formation of specific DNA-protein complexes. Ino2p-dependent binding activity overlapped with a region of the INO1 promoter that contains two potential HLH consensus binding sites. Furthermore, Ino2p showed single base pair discrimination in a putative binding site, establishing a relationship between Ino2p and its target binding site.	CARNEGIE MELLON UNIV,DEPT BIOL SCI,PITTSBURGH,PA 15213	Carnegie Mellon University			Henry, Susan/K-5464-2014		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019629, R01GM019629] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-19629] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILIS AM, 1987, MOL CELL BIOL, V7, P167, DOI 10.1128/MCB.7.1.167; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN TJ, 1991, P NATL ACAD SCI USA, V88, P5675, DOI 10.1073/pnas.88.13.5675; CAI MJ, 1989, MOL CELL BIOL, V9, P2544, DOI 10.1128/MCB.9.6.2544; CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; COMPANY M, 1988, MOL CELL BIOL, V8, P2545, DOI 10.1128/MCB.8.6.2545; CULBERTSON MR, 1975, GENETICS, V80, P23; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; DONAHUE TF, 1981, GENETICS, V98, P491; FISHER DE, 1993, CELL, V72, P467, DOI 10.1016/0092-8674(93)90122-7; FISHER F, 1992, EMBO J, V11, P4103, DOI 10.1002/j.1460-2075.1992.tb05503.x; GREENBERG ML, 1982, GENETICS, V100, P19; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HAYASHI N, 1991, MOL CELL BIOL, V11, P785, DOI 10.1128/MCB.11.2.785; HEGEMANN JH, 1988, MOL CELL BIOL, V8, P2523, DOI 10.1128/MCB.8.6.2523; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HOPE IA, 1985, CELL, V43, P177, DOI 10.1016/0092-8674(85)90022-4; HOROWICZ, 1981, NUCLEIC ACIDS RES, V9, P2989; HOSHIZAKI DK, 1990, J BIOL CHEM, V265, P4736; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KLEID DG, 1981, SCIENCE, V214, P1125, DOI 10.1126/science.6272395; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; LOEWY BS, 1984, MOL CELL BIOL, V4, P2479, DOI 10.1128/MCB.4.11.2479; LOPES JM, 1991, NUCLEIC ACIDS RES, V19, P1687, DOI 10.1093/nar/19.7.1687; LOPES JM, 1991, NUCLEIC ACIDS RES, V19, P3987, DOI 10.1093/nar/19.14.3987; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; MCGRAW P, 1989, GENETICS, V122, P317; MELLOR J, 1991, NUCLEIC ACIDS RES, V19, P2961, DOI 10.1093/nar/19.11.2961; Miller J.H., 1972, EXPT MOL GENETICS; NIKOLOFF DM, 1992, NUCLEIC ACIDS RES, V20, P3253, DOI 10.1093/nar/20.12.3253; NIKOLOFF DM, 1991, ANNU REV GENET, V25, P559; OGAWA N, 1990, MOL CELL BIOL, V10, P2224, DOI 10.1128/MCB.10.5.2224; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sherman F., 1978, METHODS YEAST GENETI; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VOGEL K, 1989, MOL CELL BIOL, V9, P2050, DOI 10.1128/MCB.9.5.2050; VORONOVA A, 1990, P NATL ACAD SCI USA, V87, P4722, DOI 10.1073/pnas.87.12.4722; WINTER B, 1992, EMBO J, V11, P1843, DOI 10.1002/j.1460-2075.1992.tb05236.x; WOODGETT JR, 1986, EUR J BIOCHEM, V161, P177, DOI 10.1111/j.1432-1033.1986.tb10139.x	48	59	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7402	7411						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125958				2022-12-27	WOS:A1994NA03200059
J	CHRISTNER, RB; MORTENSEN, RF				CHRISTNER, RB; MORTENSEN, RF			SPECIFICITY OF THE BINDING INTERACTION BETWEEN HUMAN SERUM AMYLOID P-COMPONENT AND IMMOBILIZED HUMAN C-REACTIVE PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; DNA-SEQUENCE; CALCIUM; FIBRONECTIN; COMPLEMENT; CHROMATIN; HISTONES; PEPTIDES; REGION; LOCALIZATION	C-reactive protein (CRP) and serum amyloid P-component (SAP) are two members of a group of plasma proteins termed pentraxins, which are composed of five identical noncovalently linked subunits that display Ca2+-dependent binding to a wide variety of substrates. Purified human SAP binds to CRP, only when the latter is immobilized, in a Ca2+-dependent manner under physiological conditions. Externally labeled SAP rapidly binds to two distinct forms of immobilized CRP (direct and phosphorylcholine captured) with a relatively high affinity (K(D) = 5 nM) at a molar ratio of specifically bound SAP/CRP = 0.3. Studies of binding inhibition using monoclonal antibodies to CRP or synthetic peptides of CRP revealed that residues 134-148 and the COOH-terminal region (residues 191-206) were recognized by SAP. A fragment of CRP consisting of the COOH-terminal 60 residues within each subunit was also selectively bound by SAP. The ability of immobilized CRP to bind SAP was distinguished from CRPs lectin-like binding reactivity since deglycosylated SAP retained its binding reactivity for CRP and sugars that inhibit CRP's lectin-like binding activity failed to inhibit binding. A peptide from trypsin digested SAP composed of residues 144-199 retained CRP binding activity, implicating the COOH-terminal region of SAP as the CRP recognition site.	OHIO STATE UNIV,DEPT MICROBIOL,484 W 12TH AVE,COLUMBUS,OH 43210	Ohio State University					NATIONAL CANCER INSTITUTE [P30CA016058, R01CA030015] Funding Source: NIH RePORTER; NCI NIH HHS [2 P30 CA 16058, CA 30015] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALLOU SP, 1992, ADV INTERNAL MED, V37, P313; BALTZ ML, 1982, BIOCHIM BIOPHYS ACTA, V701, P229, DOI 10.1016/0167-4838(82)90118-2; BALTZ ML, 1980, IMMUNOLOGY, V41, P59; BUTLER PJG, 1990, J EXP MED, V172, P13, DOI 10.1084/jem.172.1.13; CATHCART ES, 1965, NEW ENGL J MED, V273, P143, DOI 10.1056/NEJM196507152730306; DEBEER FC, 1981, J EXP MED, V154, P1134, DOI 10.1084/jem.154.4.1134; DUCLOS TW, 1988, J IMMUNOL, V141, P4266; DUCLOS TW, 1989, J IMMUNOL, V143, P2553; FERNANDEZ MC, 1992, J CELL BIOCHEM, V50, P83, DOI 10.1002/jcb.240500113; HAMAZAKI H, 1990, BIOCHIM BIOPHYS ACTA, V1037, P435, DOI 10.1016/0167-4838(90)90047-J; HAMAZAKI H, 1987, J BIOL CHEM, V262, P1456; HICKS PS, 1992, J IMMUNOL, V149, P3689; INOUE S, 1991, CELL TISSUE RES, V263, P431, DOI 10.1007/BF00327277; JIANG HX, 1991, J IMMUNOL, V146, P2324; KILPATRICK JM, 1982, MOL IMMUNOL, V19, P1159, DOI 10.1016/0161-5890(82)90326-1; KILPATRICK JM, 1991, IMMUNOL RES, V10, P43, DOI 10.1007/BF02918166; KINOSHITA CM, 1989, BIOCHEMISTRY-US, V28, P9840, DOI 10.1021/bi00451a044; KOTTGEN E, 1992, J IMMUNOL, V149, P445; KUBAK BM, 1988, MOL IMMUNOL, V25, P851, DOI 10.1016/0161-5890(88)90121-6; KUSHNER I, 1963, J CLIN INVEST, V42, P286, DOI 10.1172/JCI104715; LEI KJ, 1985, J BIOL CHEM, V260, P3377; LIU T, 1985, J PROTEIN CHEM, V6, P263; LOVELESS RW, 1992, EMBO J, V11, P813, DOI 10.1002/j.1460-2075.1992.tb05118.x; MANTZOURANIS EC, 1985, J BIOL CHEM, V260, P7752; MOYLE WR, 1975, J BIOL CHEM, V250, P9163; OSMAND A, 1977, P NATL ACAD SCI USA, V54, P739; PEPYS MB, 1977, LANCET, V1, P1029; PEPYS MB, 1979, CLIN EXP IMMUNOL, V38, P284; PEPYS MB, 1978, CLIN EXP IMMUNOL, V32, P119; PEPYS MB, 1987, BIOCHEM BIOPH RES CO, V148, P308, DOI 10.1016/0006-291X(87)91111-9; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; POTEMPA L, 1985, J BIOL CHEM, V260, P1242; REES RF, 1988, CLIN IMMUNOL IMMUNOP, V48, P95, DOI 10.1016/0090-1229(88)90160-2; ROBEY FA, 1987, J BIOL CHEM, V262, P7053; ROBEY FA, 1984, J BIOL CHEM, V259, P7311; SALONEN EM, 1984, J BIOL CHEM, V259, P1496; SHEPHARD EG, 1990, J IMMUNOL, V145, P1469; SHIELDS MJ, 1993, IMMUNOL RES, V12, P37, DOI 10.1007/BF02918367; SOELTER J, 1986, IMMUNOLOGY, V58, P139; SWANSON SJ, 1990, MOL IMMUNOL, V27, P679, DOI 10.1016/0161-5890(90)90011-N; SWANSON SJ, 1992, BIOCHIM BIOPHYS ACTA, V1160, P309, DOI 10.1016/0167-4838(92)90093-S; SWANSON SJ, 1991, J IMMUNOL, V147, P2248; TEBO JM, 1991, BIOCHIM BIOPHYS ACTA, V1095, P210, DOI 10.1016/0167-4889(91)90101-3; TEBO JM, 1990, J IMMUNOL, V144, P231; TSENG J, 1988, MOL IMMUNOL, V25, P679, DOI 10.1016/0161-5890(88)90103-4; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612; VOLANAKIS JE, 1981, J IMMUNOL, V126, P1820; WOO P, 1985, J BIOL CHEM, V260, P3384; YING SC, 1992, MOL IMMUNOL, V29, P677, DOI 10.1016/0161-5890(92)90205-C; YING SC, 1993, J IMMUNOL, V150, P169; YING SC, 1989, J IMMUNOL, V143, P221; YOUNG NM, 1978, J IMMUNOL, V121, P1893	52	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9760	9766						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144569				2022-12-27	WOS:A1994NE05300058
J	ETTER, EF; KUHN, MA; FAY, FS				ETTER, EF; KUHN, MA; FAY, FS			DETECTION OF CHANGES IN NEAR-MEMBRANE CA2+ CONCENTRATION USING A NOVEL MEMBRANE-ASSOCIATED CA2+ INDICATOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; CALCIUM-CONCENTRATION; TRANSMITTER RELEASE; SARCOPLASMIC-RETICULUM; CHROMAFFIN CELLS; LIPID DOMAINS; ACINAR-CELLS; CHANNELS; HETEROGENEITY; FACILITATION	A Ca2+ indicator has been synthesized and characterized which can be used to monitor rapid changes in the free Ca2+ concentration ([Ca2+]) immediately adjacent to cell membranes. This indicator, referred to as C18-Fura-2, consists of a Fura-2 molecule conjugated to a lipophilic alkyl chain which will insert into cell membranes. When associated with cell membranes in low concentrations, C18-Fura-2 exhibits an excitation spectrum with a large Stokes shift and a single isobestic point, thus [Ca2+] can be calculated ratiometrically. The apparent Ca2+ dissociation constant of cell-associated C18-Fura-2 is around 150 nm. C18-Fura-2 orients in the cell membrane so that the fluorophore is facing the side to which it was applied. C18-Fura-2 was used to record rapid changes in intracellular [Ca2+] which occurred in response to membrane depolarization in isolated smooth muscle cells. The initial rise of the [Ca2+] transient reported by C18-Fura-2 was four to six times faster than the rise of the [Ca2+] transient reported by cytosolic Fura-2. This result suggests that C18-Fura-2 was located at the plasma membrane near sites of Ca2+ influx and indicates that membrane-associated Ca2+ indicators can be used to detect rapid, localized changes in [Ca2+] which are obscured in signals recorded using water-soluble, bulk cytosolic fluorescent Ca2+ indicators.	UNIV MASSACHUSETTS, SCH MED,PROGRAM MOLEC MED,BIOTECH 2,SUITE 114, 373 PLANTAT ST, WORCESTER, MA 01605 USA; UNIV MASSACHUSETTS, SCH MED, DEPT PHYSIOL, WORCESTER, MA 01605 USA; MOLEC PROBES INC, EUGENE, OR 97402 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL014523, R37HL014523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM014157] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL14523] Funding Source: Medline; NIGMS NIH HHS [F32 GM14157-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHCROFT FM, 1981, SCIENCE, V213, P224, DOI 10.1126/science.213.4504.224; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BECKER PL, 1989, SCIENCE, V244, P211, DOI 10.1126/science.2704996; CARRINGTON WA, 1990, P SOC PHOTO-OPT INS, V1205, P72, DOI 10.1117/12.17785; CARRINGTON WA, 1990, MODERN CELL BIOL, V9, P53; ECKERT R, 1981, FED PROC, V40, P2226; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; FAY FS, 1982, METHOD ENZYMOL, V85, P284; FOGELSON AL, 1985, BIOPHYS J, V48, P1003, DOI 10.1016/S0006-3495(85)83863-7; GABELLA G, 1973, PHILOS T R SOC B, V265, P7, DOI 10.1098/rstb.1973.0004; GABELLA G, 1978, CELL TISSUE RES, V190, P255; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALLAM TJ, 1985, FEBS LETT, V186, P175, DOI 10.1016/0014-5793(85)80703-1; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; Katz B., 1969, RELEASE NEURAL TRANS; KLAUSNER RD, 1980, BIOCHEMISTRY-US, V19, P6199, DOI 10.1021/bi00567a039; KLAUSNER RD, 1980, J BIOL CHEM, V255, P1286; KWAN CY, 1990, J BIOL CHEM, V265, P678; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; LOEW LM, 1993, BIOPHYS J, V65, P2396, DOI 10.1016/S0006-3495(93)81318-3; MEECH RW, 1978, ANNU REV BIOPHYS BIO, V7, P1, DOI 10.1146/annurev.bb.07.060178.000245; MERRITT JE, 1987, J BIOL CHEM, V262, P4958; MOORE EDW, 1993, NATURE, V365, P657, DOI 10.1038/365657a0; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; OSULLIVAN AJ, 1989, EMBO J, V8, P401, DOI 10.1002/j.1460-2075.1989.tb03391.x; RASMUSSEN H, 1984, PHYSIOL REV, V64, P938, DOI 10.1152/physrev.1984.64.3.938; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; SHIBUYA I, 1992, ENDOCRINOLOGY, V131, P1936, DOI 10.1210/en.131.4.1936; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SIMS PJ, 1974, BIOCHEMISTRY-US, V13, P3315, DOI 10.1021/bi00713a022; SMITH SJ, 1980, J PHYSIOL-LONDON, V300, P167, DOI 10.1113/jphysiol.1980.sp013157; SOMLYO AP, 1971, J CELL BIOL, V51, P722, DOI 10.1083/jcb.51.3.722; TSIEN RY, 1983, ANNU REV BIOPHYS BIO, V12, P91, DOI 10.1146/annurev.bb.12.060183.000515; WOLF DE, 1988, SPECTROSCOPIC MEMBRA, V1, P193; YAGI S, 1988, P NATL ACAD SCI USA, V85, P4109, DOI 10.1073/pnas.85.11.4109	40	94	97	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10141	10149						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144515				2022-12-27	WOS:A1994NE05300111
J	FAUST, JR; RODMAN, JS; DANIEL, PF; DICE, JF; BRONSON, RT				FAUST, JR; RODMAN, JS; DANIEL, PF; DICE, JF; BRONSON, RT			2 RELATED PROTEOLIPIDS AND DOLICHOL-LINKED OLIGOSACCHARIDES ACCUMULATE IN MOTOR-NEURON DEGENERATION MICE (MND MND), A MODEL FOR NEURONAL CEROID-LIPOFUSCINOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ATP SYNTHASE; VACUOLAR H+-ATPASES; SUBUNIT-C; BATTEN DISEASE; MOLECULAR-CLONING; MAJOR COMPONENT; PROTEIN; STORAGE; LIVER; EVOLUTION	In this study, we show that two biochemical markers of neuronal ceroid lipofuscinoses (NCLs) are present in a mutant mouse (mnd/mnd) that exhibits symptoms of the disease. Subunit c of the mitochondrial F1F0-ATP synthase, a proteolipid that accumulates in storage bodies of most forms of NCL and several animal models, is dramatically increased in mnd/mnd mouse brain, kidney, liver, heart, and pancreas. Interestingly, another related proteolipid, subunit c of the vacuolar H+-ATPase, also accumulates in several mnd/mnd tissues. The molar ratio of the vacuolar subunit c to the F1F0 subunit c is approximately one to two in enriched storage bodies from brain. The relative accumulation of the vacuolar subunit c correlates with its abundance in normal tissues. It appears in decreasing amounts in brain, kidney, and liver and is not detected in heart or pancreas. Aged mice and two mutant mouse lines, juvenile bare (jb) and mucopolysaccharidosis, type VII (gus(mps)), did not accumulate either of these proteolipids. Dolichol-linked oligosaccharides also accumulate in NCLs and are increased 17-fold in mnd/mnd mouse brain. Thus, mnd/mnd mnd mice seem to be an excellent model for NCLs since they not only share clinical signs and histopathology, but also two biochemical markers. The accumulation of the vacuolar subunit c in this model may prove to be a marker for distinguishing different forms of NCLs.	TUFTS UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02111; TUFTS UNIV,SCH VET MED,BOSTON,MA 02111; JACKSON LAB,BAR HARBOR,ME 04609; EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC,DEPT BIOMED,WALTHAM,MA 02254	Tufts University; Tufts University; Jackson Laboratory	FAUST, JR (corresponding author), TUFTS UNIV,SCH MED,DEPT PHYSIOL,BOSTON,MA 02111, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030160, R01NS030148, R01NS030153] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 30148, NS 30160, NS 30153] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERMANN F, 1977, SCIENCE, V195, P1360; BIRKENMEIER EH, 1989, J CLIN INVEST, V83, P1258, DOI 10.1172/JCI114010; BRONSON RT, 1993, ANN NEUROL, V33, P381, DOI 10.1002/ana.410330408; DANIEL PF, 1992, AM J MED GENET, V42, P586, DOI 10.1002/ajmg.1320420432; DANIEL PF, 1987, METHOD ENZYMOL, V138, P94; DERMIETZEL R, 1989, FEBS LETT, V253, P1, DOI 10.1016/0014-5793(89)80917-2; DICE JF, 1987, FASEB J, V1, P349, DOI 10.1096/fasebj.1.5.2824267; DZELZKALNS VA, 1988, EMBO J, V7, P333, DOI 10.1002/j.1460-2075.1988.tb02817.x; FARRELL LB, 1987, BIOCHEM BIOPH RES CO, V144, P1257, DOI 10.1016/0006-291X(87)91446-X; FEARNLEY IM, 1990, BIOCHEM J, V268, P751, DOI 10.1042/bj2680751; FOLCH J, 1951, J BIOL CHEM, V191, P807; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; GAY NJ, 1985, EMBO J, V4, P3519, DOI 10.1002/j.1460-2075.1985.tb04111.x; Hall N A, 1988, Am J Med Genet Suppl, V5, P221; HALL NA, 1989, BIOCHEM SOC T, V17, P1032, DOI 10.1042/bst0171032; HALL NA, 1991, BIOCHEM J, V275, P269, DOI 10.1042/bj2750269; HALL NA, 1990, LIPOFUSCIN CEROID PI, P225; HANADA H, 1991, BIOCHEM BIOPH RES CO, V176, P1062, DOI 10.1016/0006-291X(91)90391-J; HARE JF, 1990, BIOCHIM BIOPHYS ACTA, V1031, P71, DOI 10.1016/0304-4157(90)90003-U; KOMINAMI E, 1992, J BIOCHEM, V111, P278, DOI 10.1093/oxfordjournals.jbchem.a123749; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; MARTINUS RD, 1991, VET RES COMMUN, V15, P85, DOI 10.1007/BF00405140; MEDD SM, 1993, BIOCHEM J, V293, P65, DOI 10.1042/bj2930065; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NEZU J, 1992, J BIOCHEM, V112, P212, DOI 10.1093/oxfordjournals.jbchem.a123879; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; PALMER DN, 1986, J BIOL CHEM, V261, P1773; PEDERSON PL, 1983, ANN REV BIOCH, V52, P8011; RIDER JA, 1992, AM J MED GENET, V42, P519, DOI 10.1002/ajmg.1320420419; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SPENCE MW, 1989, METABOLIC BASIS INHE, P1655; SUN SZ, 1987, J BIOL CHEM, V262, P14790; TYYNELA J, 1993, FEBS LETT, V330, P8, DOI 10.1016/0014-5793(93)80908-D; WARREN CD, 1988, J BIOL CHEM, V263, P15041	35	62	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10150	10155						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144516				2022-12-27	WOS:A1994NE05300112
J	SOLIOZ, M; DAVIES, K				SOLIOZ, M; DAVIES, K			OPERON OF VACUOLAR-TYPE NA+-ATPASE OF ENTEROCOCCUS-HIRAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-FAECALIS; H+-ATPASE; ESCHERICHIA-COLI; PROTEOLIPID SUBUNIT; PROTON PUMPS; ALKALINE PH; GENE; ANTIPORTER; SEQUENCE; CLONING	The Gram-positive bacteria Enterococcus hirae expel sodium by two systems: a Na+/H+-antiporter and a vacuolar-type Na+-ATPase. We isolated a mutant, NalkA, defective in the Na+-ATPase. NalkA grew normally at neutral pH but was unable to grow in the presence of >100 mM sodium at pH 9.5. By functional complementation at high pH, we cloned pES1, a plasmid from an E. hirae gene bank containing a 5.2-kilobase pair region of genomic DNA. The genomic DNA in pES1 contains five complete open reading frames, ntpM, -N, -O, -P, and -Q, encoding proteins of 75, 16, 23, 38, and 11 kDa. A sixth incomplete open reading frame, ntp'L, precedes ntpM. The 3'-end of the cloned DNA overlaps with a previously published sequence encoding the ntpA and ntpB subunits of the E. hirae Na+-ATPase (Takase, K., Yamato, I., and Kakinuma, Y. 1993) J. Biol. Chem. 268,11610-11616). The insert of pES1 therefore represents the upstream region of the ntp operon that encodes the E. hirae Na+-ATPase. Complementation analysis with various deletions derived from pES1 suggest that the original mutation is in the ntpM gene. Of the new genes described here, three exhibited significant sequence similarity to known proteins; ntpM shares 24% identical amino acid residues with the ''116-kDa'' subunits of eukaryotic vacuolar ATPases, ntpN exhibits 28% sequence identity with the 16-kDa proteolipid of human vacuolar ATPase, and ntpO has sequence homology to the 31-kDa subunit of the bovine kidney vacuolar ATPase. No known proteins with sequence similarity to ntp'L, -P, or -Q could be identified. Disruption of either ntpM, -N, or -O in wild-type cells by cassette mutagenesis resulted in mutants unable to effect ATP-driven sodium extrusion. NtpM, -N, and -O therefore represent three new gene products involved in sodium extrusion by the vacuolar-type Na+-ATPase of E. hirae, and three more gene products, NtpL, -P, and -Q, may also be constituents of this enzyme. The ntp operon thus contains at least eight genes.			SOLIOZ, M (corresponding author), UNIV BERN,DEPT CLIN PHARMACOL,MURTENSTR 35,CH-3010 BERN,SWITZERLAND.		Solioz, Marc/I-3162-2013	Solioz, Marc/0000-0002-7989-6721; Davies, Kelvin/0000-0002-0201-9210				ANDERSON DG, 1983, APPL ENVIRON MICROB, V46, P549, DOI 10.1128/AEM.46.3.549-552.1983; AVETISYAN AV, 1993, FEBS LETT, V317, P267, DOI 10.1016/0014-5793(93)81290-G; BROWN D, 1988, NATURE, V331, P622, DOI 10.1038/331622a0; DENDA K, 1989, J BIOL CHEM, V264, P7119; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; HAROLD FM, 1970, J BACTERIOL, V101, P152, DOI 10.1128/JB.101.1.152-159.1970; HASEBE M, 1992, BIOCHEM BIOPH RES CO, V183, P856, DOI 10.1016/0006-291X(92)90562-Y; HIRSCH S, 1988, P NATL ACAD SCI USA, V85, P3004, DOI 10.1073/pnas.85.9.3004; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; KAKINUMA Y, 1987, J BACTERIOL, V169, P4403, DOI 10.1128/jb.169.9.4403-4405.1987; KAKINUMA Y, 1990, FEBS LETT, V261, P135, DOI 10.1016/0014-5793(90)80654-2; KAKINUMA Y, 1990, J BACTERIOL, V172, P1732, DOI 10.1128/jb.172.4.1732-1735.1990; KAKINUMA Y, 1987, J BACTERIOL, V169, P3886, DOI 10.1128/jb.169.9.3886-3890.1987; KAKINUMA Y, 1988, J BIOL CHEM, V263, P14166; KAKINUMA Y, 1990, FEBS LETT, V271, P987; KARPEL R, 1988, J BIOL CHEM, V263, P10408; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MACRINA FL, 1982, GENE, V19, P345, DOI 10.1016/0378-1119(82)90025-7; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; Maniatis T., 1982, MOL CLONING; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; MEAGHER L, 1990, NUCLEIC ACIDS RES, V18, P6712, DOI 10.1093/nar/18.22.6712; NELSON H, 1989, FEBS LETT, V247, P147, DOI 10.1016/0014-5793(89)81259-1; PERIN MS, 1991, J BIOL CHEM, V266, P3877; PINNER E, 1992, J BIOL CHEM, V267, P11064; SOLIOZ M, 1984, TRENDS BIOCHEM SCI, V9, P309, DOI 10.1016/0968-0004(84)90298-6; SOLIOZ M, 1990, BIOCHIMIE, V72, P279, DOI 10.1016/0300-9084(90)90084-T; STAUSAK D, 1993, J BIOL CHEM, V268, P26334; STONE DK, 1989, J BIOENERG BIOMEMBR, V21, P605, DOI 10.1007/BF00808116; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; TAKASE K, 1993, J BIOL CHEM, V268, P11610; WACHTER E, 1980, FEBS LETT, V113, P265, DOI 10.1016/0014-5793(80)80606-5; WASER M, 1992, J BIOL CHEM, V267, P5396	34	25	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9453	9459						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144530				2022-12-27	WOS:A1994NE05300012
J	XU, YR; BARBANCONFINCK, V; BARBIERI, JT				XU, YR; BARBANCONFINCK, V; BARBIERI, JT			ROLE OF HISTIDINE 35 OF THE S1-SUBUNIT OF PERTUSSIS TOXIN IN THE ADP-RIBOSYLATION OF TRANSDUCIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET-ACTIVATING PROTEIN; ESCHERICHIA-COLI; DIPHTHERIA-TOXIN; S-1 SUBUNIT; RIBOSYLTRANSFERASE ACTIVITY; NAD GLYCOHYDROLASE; BINDING-SITE; EXPRESSION; IDENTIFICATION; MUTATIONS	Molecular modeling of the S1 subunit (S1) of pertussis toxin with other ADP-ribosylating bacterial exotoxins predicted that histidine 35 (His-35) would reside within the active site of S1. Recombinant derivatives of S1 (rS1 and the C180 peptide) which contained either a H35Q or H35P mutation were analyzed to determine the role of His-35 in ADP-ribosylation. C180 peptide is a recombinant peptide composed of the amino-terminal 180 amino acids of S1. Under linear velocity conditions, C180H35Q possessed 2% of wild type C 180 peptide activity and C180H35P possessed no detectable activity in the ADP-ribosylation of transducin. The H35Q mutation did not change the affinity of recombinant peptides for NAD or two targets for ADP-ribosylation, transducin, or alpha(i3)C20, but did lower the k(cat) in the NAD glycohydrolase and ADP-ribosyltransferase reactions. Neither the H35Q nor H35P mutation reduced the ability of recombinant proteins to be photocross-linked with NAD which was consistent with the His-35 mutations not reducing the affinity for NAD. These data indicate that His-35 does not reduce the affinity of S1 for NAD or transducin, but functions as a catalytic residue in the ADP-ribosylation reaction possibly in a hydrogen bonding capacity.	MED COLL WISCONSIN,DEPT MICROBIOL,8701 WATERTOWN PLANK RD,MILWAUKEE,WI 53226	Medical College of Wisconsin					NIAID NIH HHS [AI-30162, AI-01087] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030162] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANTOINE R, 1990, INFECT IMMUN, V58, P1518, DOI 10.1128/IAI.58.6.1518-1526.1990; BAEHR W, 1982, J BIOL CHEM, V257, P6452; BARBIERI JT, 1988, INFECT IMMUN, V56, P1934, DOI 10.1128/IAI.56.8.1934-1941.1988; BARBIERI JT, 1989, J BACTERIOL, V171, P4362, DOI 10.1128/JB.171.8.4362-4369.1989; BARBIERI JT, 1992, INFECT IMMUN, V60, P5071, DOI 10.1128/IAI.60.12.5071-5077.1992; BARBIERI JT, 1989, INFECT IMMUN, V57, P3549, DOI 10.1128/IAI.57.11.3549-3554.1989; BARBIERI JT, 1987, INFECT IMMUN, V55, P1321, DOI 10.1128/IAI.55.5.1321-1323.1987; BURNETTE WN, 1988, BIO-TECHNOL, V6, P699, DOI 10.1038/nbt0688-699; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; CIEPLAK W, 1990, BIOCHEM J, V268, P547, DOI 10.1042/bj2680547; CIEPLAK W, 1988, P NATL ACAD SCI USA, V85, P4667, DOI 10.1073/pnas.85.13.4667; COCKLE SA, 1989, FEBS LETT, V249, P329, DOI 10.1016/0014-5793(89)80652-0; CORTINA G, 1989, J BIOL CHEM, V264, P17322; CORTINA G, 1991, J BIOL CHEM, V266, P23810; Dayhoff M.O., 1978, ATLAS PROTEIN SEQ ST; DEONARAIN MP, 1989, BIOCHEMISTRY-US, V28, P9602, DOI 10.1021/bi00451a008; DOMENIGHINI M, 1991, MOL MICROBIOL, V5, P23, DOI 10.1111/j.1365-2958.1991.tb01822.x; Gill D., 1978, BACTERIAL TOXINS CEL, P291; GRAF R, 1992, MOL PHARMACOL, V42, P70; HSIA JA, 1984, J BIOL CHEM, V259, P1086; KASLOW HR, 1989, J BIOL CHEM, V264, P6386; KATADA T, 1983, ARCH BIOCHEM BIOPHYS, V224, P290, DOI 10.1016/0003-9861(83)90212-6; KOMIVES EA, 1991, BIOCHEMISTRY-US, V30, P3011, DOI 10.1021/bi00226a005; LOCHT C, 1989, P NATL ACAD SCI USA, V86, P3075, DOI 10.1073/pnas.86.9.3075; LOCHT C, 1987, INFECT IMMUN, V55, P2546, DOI 10.1128/IAI.55.11.2546-2553.1987; LOCHT C, 1986, SCIENCE, V232, P1258, DOI 10.1126/science.3704651; LOOSMORE SM, 1990, INFECT IMMUN, V58, P3653, DOI 10.1128/IAI.58.11.3653-3662.1990; MOSS J, 1983, J BIOL CHEM, V258, P1879; NICOSIA A, 1987, INFECT IMMUN, V55, P963, DOI 10.1128/IAI.55.4.963-967.1987; NICOSIA A, 1986, P NATL ACAD SCI USA, V83, P4631, DOI 10.1073/pnas.83.13.4631; PAPINI E, 1989, J BIOL CHEM, V264, P12385; PIZZA M, 1989, SCIENCE, V246, P497, DOI 10.1126/science.2683073; PIZZA M, 1988, P NATL ACAD SCI USA, V85, P7521, DOI 10.1073/pnas.85.20.7521; Segel I.H., 1975, ENZYME KINETICS; TAMURA M, 1982, BIOCHEMISTRY-US, V21, P5516, DOI 10.1021/bi00265a021; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; WILSON BA, 1990, BIOCHEMISTRY-US, V29, P8643, DOI 10.1021/bi00489a021	37	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9993	9999						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144593				2022-12-27	WOS:A1994NE05300090
J	CLARK, CD; PALZKILL, T; BOTSTEIN, D				CLARK, CD; PALZKILL, T; BOTSTEIN, D			SYSTEMATIC MUTAGENESIS OF THE YEAST MATING PHEROMONE RECEPTOR 3RD INTRACELLULAR LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-FACTOR RECEPTOR; STE2 GENE-PRODUCT; SACCHAROMYCES-CEREVISIAE; CELL-TYPE; A-FACTOR; PROTEIN; TRANSFORMATION; SEQUENCE; BINDING; SUBSTITUTIONS	Signal transduction in the mating pathway of the yeast Saccharomyces cerevisiae is initiated by binding of a peptide pheromone to a G protein-coupled receptor (Ste2). We systematically have mutated the third intracellular loop of the Ste2 receptor to investigate its functional significance. We substituted each of the 13 amino acids in the loop with alanine individually or together with one other residue. In addition, we used a site-directed random replacement mutagenesis technique to replace a region encoding three amino acids in the loop with random sequence. Over 80 such Ste2 mutants have been analyzed by several functional and biochemical criteria in a yeast strain that carries a genomic deletion of the STE2 gene. The mutant phenotypes range from fully functional to severely compromised in signaling. The observation that amino acid substitutions in the third intracellular loop of the Ste2 receptor can affect activation of the yeast mating response implicates the loop in this signal transduction pathway. The types of mutations that compromise the function of the receptor may provide clues to the physical interaction between the receptor and the G protein.	STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA 94305; BAYLOR COLL MED,DEPT MICROBIOL & IMMUNOL,HOUSTON,TX 77030	Stanford University; Baylor College of Medicine					NIGMS NIH HHS [GM46406, GM46888] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046406, R01GM046888, R01GM046406] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARNES DA, 1985, THESIS U CALIFORNIA; BENDER A, 1986, CELL, V47, P929, DOI 10.1016/0092-8674(86)90808-1; BLUMER KJ, 1990, P NATL ACAD SCI USA, V87, P4363, DOI 10.1073/pnas.87.11.4363; BLUMER KJ, 1991, ANNU REV PHYSIOL, V53, P37; BLUMER KJ, 1988, COLD SPRING HARB SYM, V53, P591, DOI 10.1101/SQB.1988.053.01.068; BLUMER KJ, 1988, J BIOL CHEM, V263, P10836; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BOONE C, 1993, P NATL ACAD SCI USA, V90, P9921, DOI 10.1073/pnas.90.21.9921; BURKHOLDER AC, 1985, NUCLEIC ACIDS RES, V13, P8463, DOI 10.1093/nar/13.23.8463; CARTWRIGHT CP, 1991, MOL CELL BIOL, V11, P2620, DOI 10.1128/MCB.11.5.2620; CHAN RK, 1982, MOL CELL BIOL, V2, P11, DOI 10.1128/MCB.2.1.11; CIEJEK E, 1979, CELL, V18, P623, DOI 10.1016/0092-8674(79)90117-X; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DIETZEL C, 1987, MOL CELL BIOL, V7, P4169, DOI 10.1128/MCB.7.12.4169; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; HAGEN DC, 1986, P NATL ACAD SCI USA, V83, P1418, DOI 10.1073/pnas.83.5.1418; HICKS JB, 1976, NATURE, V260, P246, DOI 10.1038/260246a0; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JENNESS DD, 1986, MOL CELL BIOL, V6, P318, DOI 10.1128/MCB.6.1.318; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; KONOPKA JB, 1991, CELL REGUL, V2, P439, DOI 10.1091/mbc.2.6.439; KONOPKA JB, 1988, CELL, V54, P609, DOI 10.1016/S0092-8674(88)80005-9; KURJAN J, 1992, ANNU REV BIOCHEM, V61, P1097; KURJAN J, 1991, GENE DEV, V5, P11; LEFKOWITZ RJ, 1993, ADV SEC MESS PHOSPH, V28, P1; LEFKOWITZ RJ, 1992, COLD SPRING HARB SYM, V57, P127, DOI 10.1101/SQB.1992.057.01.016; MACKAY VL, 1988, P NATL ACAD SCI USA, V85, P55, DOI 10.1073/pnas.85.1.55; MARSH L, 1991, ANNU REV CELL BIOL, V7, P699, DOI 10.1146/annurev.cellbio.7.1.699; MARSH L, 1992, MOL CELL BIOL, V12, P3959, DOI 10.1128/MCB.12.9.3959; MIYAJIMA I, 1989, MOL CELL BIOL, V9, P2289, DOI 10.1128/MCB.9.6.2289; NAKAYAMA N, 1985, EMBO J, V4, P2643, DOI 10.1002/j.1460-2075.1985.tb03982.x; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; PALZKILL T, 1992, PROTEINS, V14, P29, DOI 10.1002/prot.340140106; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; RHODES N, 1990, GENE DEV, V4, P1862, DOI 10.1101/gad.4.11.1862; Rose M. D., 1990, METHODS YEAST GENETI, P155; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SAVARESE TM, 1992, BIOCHEM J, V283, P1; Sherman F., 1974, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; SPRAGUE GF, 1981, J MOL BIOL, V153, P305, DOI 10.1016/0022-2836(81)90280-1; TRUEHEART J, 1987, MOL CELL BIOL, V7, P2316, DOI 10.1128/MCB.7.7.2316; WEINER JL, 1993, J BIOL CHEM, V268, P8070	45	51	54	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8831	8841						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132618				2022-12-27	WOS:A1994NB41100035
J	GUTIERREZCIRLOS, EB; ANTARAMIAN, A; VAZQUEZACEVEDO, M; CORIA, R; GONZALEZHALPHEN, D				GUTIERREZCIRLOS, EB; ANTARAMIAN, A; VAZQUEZACEVEDO, M; CORIA, R; GONZALEZHALPHEN, D			A HIGHLY-ACTIVE UBIQUINOL-CYTOCHROME-C REDUCTASE (BC(1) COMPLEX) FROM THE COLORLESS ALGA POLYTOMELLA SPP, A CLOSE RELATIVE OF CHLAMYDOMONAS - CHARACTERIZATION OF THE HEME-BINDING SITE OF CYTOCHROME-C(1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; BC1 COMPLEX; EUGLENA-GRACILIS; MITOCHONDRIAL PROTEINS; BEEF-HEART; PURIFICATION; MEMBRANE; SEQUENCE; POTATO; AGILIS	The alga Polytomella spp. offers extraordinary advantages in the preparation of mitochondria since it lacks chloroplasts and a cell wall. In this work the mitochondrial bc(1) complex from Polytomella spp. was solubilized and purified by ion exchange chromatography. The complex was found to be composed of 10 polypeptides and exhibited high rates of ubiquinol-cytochrome c oxido-reductase activity (>300 s(-1)) sensitive to antimycin and myxothiazol. The molecular mass of the bc(1) complex from Polytomella spp. was assayed by gel filtration and estimated to be of 256,300 Da. Therefore, this complex exhibits the unique property of behaving as a monomer. Amino-terminal sequencing of cytochrome c(1) identified 7 residues, from which a deoxyoligonucleotide was designed. A second deoxyoligonucleotide was constructed based on a highly conserved region of the c(1) type cytochromes. With these probes, a fragment of the cytochrome c(1) gene was amplified by polymerase chain reaction and sequenced. The deduced sequence of the apoprotein exhibited a consensus binding site CXXCH. The data suggest that the cytochrome c(1) from Polytomella spp. differs from other protoctists like Crithidia and Euglena, i.e. it exhibits a heme binding domain structurally related to the bovine, yeast, and Neurospora c(1) type cytochromes.	UNIV NACL AUTONOMA MEXICO,INST FISIOL CELULAR,DEPT BIOENERGET,MEXICO CITY 04510,DF,MEXICO; UNIV NACL AUTONOMA MEXICO,INST FISIOL CELULAR,DEPT MICROBIOL,MEXICO CITY 04510,DF,MEXICO	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico			Gutierrez Cirlos, Emma Berta/D-4463-2011; Gutiérrez, Emma/AAG-5191-2021	Gonzalez-Halphen, Diego/0000-0003-0654-655X; Gutierrez Cirlos, Emma Berta/0000-0002-6672-1711				ANDREWS KM, 1990, BIOCHEMISTRY-US, V29, P2645, DOI 10.1021/bi00463a004; ARAGAO H, 1910, MEM I O CRUZ, V2, P42; ATTEIA A, 1992, J BIOL CHEM, V267, P226; BALL MB, 1977, FEBS LETT, V83, P99, DOI 10.1016/0014-5793(77)80650-9; BAUM H, 1967, J BIOL CHEM, V242, P4876; BERRY EA, 1991, J BIOL CHEM, V266, P9064; BRAUN HP, 1992, EUR J BIOCHEM, V208, P761, DOI 10.1111/j.1432-1033.1992.tb17245.x; BRAUN HP, 1992, EMBO J, V11, P3219, DOI 10.1002/j.1460-2075.1992.tb05399.x; BROWN DL, 1976, J CELL BIOL, V69, P106, DOI 10.1083/jcb.69.1.106; BURTON MD, 1974, J ULTRA MOL STRUCT R, V48, P414, DOI 10.1016/S0022-5320(74)80011-0; CAPALDI RA, 1972, FEBS LETT, V26, P261, DOI 10.1016/0014-5793(72)80587-8; CONNER TW, 1989, GENE, V84, P345, DOI 10.1016/0378-1119(89)90509-X; DEVRIES S, 1986, J BIOENERG BIOMEMBR, V18, P195, DOI 10.1007/BF00743464; ENGEL WD, 1983, EUR J BIOCHEM, V132, P395, DOI 10.1111/j.1432-1033.1983.tb07376.x; EVANS DA, 1966, J PROTOZOOL, V13, P119; GENCIC S, 1991, EUR J BIOCHEM, V199, P123, DOI 10.1111/j.1432-1033.1991.tb16099.x; GONZALEZHALPHEN D, 1991, J BIOL CHEM, V266, P3870; GONZALEZHALPHEN D, 1988, BIOCHEMISTRY-US, V27, P7021, DOI 10.1021/bi00418a053; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HAUSKA G, 1983, BIOCHIM BIOPHYS ACTA, V726, P97, DOI 10.1016/0304-4173(83)90002-2; HAUSKA G, 1988, J BIOENERG BIOMEMBR, V20, P211, DOI 10.1007/BF00768395; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS E, 1974, J PROTOZOOL, V21, P647, DOI 10.1111/j.1550-7408.1974.tb03720.x; LI Y, 1981, FEBS LETT, V135, P277, DOI 10.1016/0014-5793(81)80800-9; LJUNGDAHL PO, 1989, J BIOL CHEM, V264, P3723; LLOYD D, 1968, BIOCHEM J, V107, P829, DOI 10.1042/bj1070829; LLOYD D, 1968, BIOCHEM J, V109, P897, DOI 10.1042/bj1090897; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Mattox K. R., 1984, SYSTEMATICS GREEN AL, V27, P29; Melkonian M., 1990, P608; MORDEN CW, 1992, BIOSYSTEMS, V28, P75, DOI 10.1016/0303-2647(92)90010-V; MUKAI K, 1989, EUR J BIOCHEM, V178, P649, DOI 10.1111/j.1432-1033.1989.tb14494.x; MUKAI K, 1989, J BIOCHEM-TOKYO, V106, P479, DOI 10.1093/oxfordjournals.jbchem.a122877; PETTIGREW GW, 1975, BIOCHEM J, V147, P291, DOI 10.1042/bj1470291; PETTIGREW GW, 1979, BIOCH PHYSL PROTOZOA, V1, P59; PIEZ KA, 1968, ANAL BIOCHEM, V26, P305, DOI 10.1016/0003-2697(68)90342-4; PRIEST JW, 1992, J BIOL CHEM, V267, P20188; PRINGSHEIM EG, 1955, J PROTOZOOL, V2, P137, DOI 10.1111/j.1550-7408.1955.tb02413.x; ROUND FE, 1980, BIOSYSTEMS, V12, P61, DOI 10.1016/0303-2647(80)90038-6; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1986, METHOD ENZYMOL, V126, P224; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHMITT ME, 1991, J BIOL CHEM, V266, P14958; SCHULTE U, 1989, NATURE, V339, P147, DOI 10.1038/339147a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; VAZQUEZACEVEDO M, 1993, J BIOENERG BIOMEMBR, V25, P401, DOI 10.1007/BF00762466; VONJAGOW G, 1977, BIOCHIM BIOPHYS ACTA, V462, P549, DOI 10.1016/0005-2728(77)90100-1; WEISS H, 1979, EUR J BIOCHEM, V99, P139, DOI 10.1111/j.1432-1033.1979.tb13240.x; WISE DL, 1959, J PROTOZOOL, V6, P19, DOI 10.1111/j.1550-7408.1959.tb03921.x	53	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9147	9154						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132652				2022-12-27	WOS:A1994NB41100079
J	LIM, F; SPINGOLA, M; PEABODY, DS				LIM, F; SPINGOLA, M; PEABODY, DS			ALTERING THE RNA-BINDING SPECIFICITY OF A TRANSLATIONAL REPRESSOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAT PROTEIN; SITE; SEQUENCE; PLASMID; DNA; GA	The coat proteins of RNA phages MS2 and GA are specific RNA-binding proteins which function to encapsidate viral RNA and to translationally repress synthesis of the viral replicase. The two proteins have highly ho mologous amino acid sequences, yet they show different RNA binding specificities, recognizing RNA stem-loop structures which differ primarily in the nucleotide sequences of their loops. We sought to convert MS2 coat protein to the RNA binding specificity of GA through the introduction of GA-like amino acid substitutions into the MS2 coat protein RNA-binding site. The effects of the mutations were determined by measuring the affinity of the coat protein variants for RNA in vitro and by measuring translational repression in vivo. We found five substitutions that affect RNA binding. One dramatically reduces binding of MS2 coat protein to both operators. Three others compensate for this defect by nonspecifically strengthening the interaction. Another substitution accounts for the ability to recognize the differences in the RNA loop sequence.	UNIV NEW MEXICO, SCH MED, CTR CANC RES & TREATMENT, DEPT CELL BIOL, ALBUQUERQUE, NM 87131 USA	University of New Mexico								BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; CAREY J, 1983, BIOCHEMISTRY-US, V22, P2601, DOI 10.1021/bi00280a002; DRAPER DE, 1988, METHOD ENZYMOL, V164, P221; GOTT JM, 1991, NUCLEIC ACIDS RES, V19, P6499, DOI 10.1093/nar/19.23.6499; INOKUCHI Y, 1986, J BIOCHEM-TOKYO, V99, P1169, DOI 10.1093/oxfordjournals.jbchem.a135580; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; PEABODY DS, 1990, J BIOL CHEM, V265, P5684; PEABODY DS, 1993, EMBO J, V12, P595, DOI 10.1002/j.1460-2075.1993.tb05691.x; ROMANIUK PJ, 1987, BIOCHEMISTRY-US, V26, P1563, DOI 10.1021/bi00380a011; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; VALEGARD K, 1990, NATURE, V345, P36, DOI 10.1038/345036a0; WEBER H, 1983, NUCLEIC ACIDS RES, V11, P5661, DOI 10.1093/nar/11.16.5661	13	49	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9006	9010						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132638				2022-12-27	WOS:A1994NB41100059
J	VERGHESE, GM; JOHNSON, JD; VASULKA, C; HAUPT, DM; STUMPO, DJ; BLACKSHEAR, PJ				VERGHESE, GM; JOHNSON, JD; VASULKA, C; HAUPT, DM; STUMPO, DJ; BLACKSHEAR, PJ			PROTEIN-KINASE C-MEDIATED PHOSPHORYLATION AND CALMODULIN-BINDING OF RECOMBINANT MYRISTOYLATED ALANINE-RICH C-KINASE SUBSTRATE (MARCKS) AND MARCKS-RELATED PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMINENT CELLULAR SUBSTRATE; DEPENDENT BINDING; SITE DOMAIN; PEPTIDES; IDENTIFICATION; MYOCYTES; ABSENCE; DESIGN	The myristoylated alanine-rich C kinase substrate (MARCKS) and the MARCKS-related protein (MRP) are members of a distinct family of protein kinase C (PKC) substrates that also bind calmodulin in a manner regulated by phosphorylation by PKC. The kinetics of PKC-mediated phosphorylation and the calmodulin binding properties of intact, recombinant MARCKS and MRP were investigated and compared with previous studies of synthetic peptides spanning the PKC phosphorylation site/calmodulin binding domains (PSCBD) of these proteins. Both MARCKS and MRP were high affinity substrates for the catalytic fragment of PKC, and their phosphorylation occurred with positive cooperativity (MARCKS: S-0.5 = 100 nM, K-H = 1.43; MRP: S-0.5 = 238 nM, K-H = 1.72). These affinities are similar to the values determined from studies of their respective PSCBD peptides. Two-dimensional mapping of MRP and its synthetic PSCBD peptide yielded identical patterns of tryptic phosphopeptides, indicating that, as in the case of MARCKS, all of the PKC phosphorylation sites in MRP lie within the 24-amino acid PSCBD. Sequence analysis of tryptic phosphopeptides revealed that the first and third, but not the second, serines in the MRP PSCBD were phosphorylated by PKC. Both MARCKS and MRP bound dansyl-calmodulin with high affinity, with a K-app of 4.6 and 9.5 nM, respectively. Phosphorylation of MARCKS and MRP by PKC disrupted the protein-calmodulin complexes, with half-lives of 4.0 and 3.5 min, respectively. These studies suggest that intact, recombinant MARCKS and MRP are accurately modeled by their synthetic PSCBD peptides with respect to PKC phosphorylation kinetics and their phosphorylation-dependent calmodulin binding properties.	DUKE UNIV, MED CTR, HOWARD HUGHES MED INST LABS, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR,DEPT MED,DIV ENDOCRINOL METAB & NUTR, DIABET & METAB SECT, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT BIOCHEM, DURHAM, NC 27710 USA; OHIO STATE UNIV, DEPT MED BIOCHEM, COLUMBUS, OH 43210 USA	Duke University; Duke University; Duke University; University System of Ohio; Ohio State University			Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529				ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; ADEREM AA, 1988, NATURE, V332, P362, DOI 10.1038/332362a0; AMESS B, 1992, FEBS LETT, V297, P285; BLACKSHEAR PJ, 1992, J BIOL CHEM, V267, P13540; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BUSS JE, 1986, J VIROL, V58, P468, DOI 10.1128/JVI.58.2.468-474.1986; CLARKE PR, 1993, FEBS LETT, V336, P37, DOI 10.1016/0014-5793(93)81604-X; COBURN C, 1993, BIOPHYS J, V64, pA60; DEGRADO WF, 1988, ADV PROTEIN CHEM, V39, P51; GEORGE DJ, 1992, J BIOL CHEM, V267, P24879; GRAFF JM, 1989, SCIENCE, V246, P503, DOI 10.1126/science.2814478; GRAFF JM, 1991, J BIOL CHEM, V266, P14390; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; GRAFF JM, 1989, J BIOL CHEM, V264, P11912; HARLAN DM, 1991, J BIOL CHEM, V266, P14399; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HEEMSKERK FMJ, 1993, BIOCHEM BIOPH RES CO, V190, P236, DOI 10.1006/bbrc.1993.1036; JAMES G, 1989, J BIOL CHEM, V264, P20928; JOHNSON JD, 1983, BIOCHEM J, V211, P473, DOI 10.1042/bj2110473; KEMP BE, 1991, METHOD ENZYMOL, V200, P121; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALENCIK DA, 1982, BIOCHEMISTRY-US, V21, P3480, DOI 10.1021/bi00257a035; MCILROY BK, 1991, J BIOL CHEM, V266, P4959; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; ROACH PJ, 1991, METHOD ENZYMOL, V201, P200; Segel IH, 1975, ENZYME KINETICS, P346; SPACH DH, 1986, J BIOL CHEM, V261, P2750; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SULLIVAN S, 1991, ANAL BIOCHEM, V197, P65, DOI 10.1016/0003-2697(91)90356-X; UMEKAGE T, 1991, FEBS LETT, V286, P147, DOI 10.1016/0014-5793(91)80961-2	31	88	89	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9361	9367						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132675				2022-12-27	WOS:A1994NB41100107
J	LEMAIRE, S; DERAPPE, C; MICHALSKI, JC; AUBERY, M; NEEL, D				LEMAIRE, S; DERAPPE, C; MICHALSKI, JC; AUBERY, M; NEEL, D			EXPRESSION OF BETA-1-6-BRANCHED N-LINKED OLIGOSACCHARIDES IS ASSOCIATED WITH ACTIVATION IN HUMAN T4 AND T8 CELL-POPULATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAS-LIQUID-CHROMATOGRAPHY; METASTATIC TUMOR-CELLS; MEMBRANE-GLYCOPROTEINS; METHYL GLYCOSIDES; GLYCOSYLATION; LINES; DIFFERENTIATION; PROTEINS; BINDING; IDENTIFICATION	Activation of human T lymphocytes by phorbol 12-myristate 13-acetate and leukoagglutinin from Phaseolus vulgaris (L PHA) results in important changes in N-glycosylation. The most important event is the increase, in both T4 and T8 cells (especially the latter), of L-PHA(+) structures characterized by beta 1-6-branching of complex-type oligosaccharides. Moreover, the existence of a CD4-mediated increase of these beta 1-6-branched structures on positively selected T4 cells, as compared with the negatively selected ones, suggests that the presence of these structures, not detectable on T8 resting cells, could be related to stimulation events triggered by both selection methods. This beta 1-6-branching on N-glycans, strongly associated with a metastatic phenotype in human and rodent tumors, is exhibited by numerous glycoproteins on stimulated cells, as shown by blot analysis.	UNIV PARIS 05,INSERM,U180,F-75006 PARIS,FRANCE; UNIV SCI & TECHNOL LILLE 1,CNRS,UMR 111,CHIM BIOL LAB,F-59655 VILLENEUVE DASCQ,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille								BISSON JR, 1983, BIOCHEMISTRY-US, V22, P3680; BOLSCHER JGM, 1988, EMBO J, V7, P3361, DOI 10.1002/j.1460-2075.1988.tb03208.x; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; CHEN JW, 1985, J CELL BIOL, V101, P85, DOI 10.1083/jcb.101.1.85; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; CONZELMANN A, 1980, EUR J IMMUNOL, V10, P860, DOI 10.1002/eji.1830101111; CONZELMANN A, 1984, J BIOL CHEM, V259, P2528; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1235; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; FOURNET B, 1981, ANAL BIOCHEM, V116, P489, DOI 10.1016/0003-2697(81)90393-6; GOULUTCHASSAING C, 1992, BIOCHIMIE, V74, P101, DOI 10.1016/0300-9084(92)90189-L; HAMANN A, 1989, IMMUNOL REV, V108, P19, DOI 10.1111/j.1600-065X.1989.tb00011.x; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HOVDENES J, 1989, SCAND J IMMUNOL, V29, P641, DOI 10.1111/j.1365-3083.1989.tb01168.x; KHAN SH, 1993, J BIOL CHEM, V268, P2468; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAFERTE S, 1989, BIOCHEM J, V259, P569, DOI 10.1042/bj2590569; LAFERTE S, 1992, BIOCHEM J, V283, P193, DOI 10.1042/bj2830193; LAFERTE S, 1988, CANCER RES, V48, P4743; LEFRANCOIS L, 1985, J EXP MED, V162, P1275, DOI 10.1084/jem.162.4.1275; LEIVESTAD T, 1987, TRANSPLANT P, V19, P265; LESLEY J, 1990, EXP CELL RES, V187, P224, DOI 10.1016/0014-4827(90)90085-O; MERLU B, 1989, EUR J BIOCHEM, V181, P755, DOI 10.1111/j.1432-1033.1989.tb14788.x; MONTREUIL J, 1984, BIOL CELL, V51, P115, DOI 10.1111/j.1768-322X.1984.tb00291.x; NEEL D, 1987, BIOCHEM J, V244, P433, DOI 10.1042/bj2440433; OGIERDENIS E, 1988, J BIOL CHEM, V263, P6031; PALCIC MM, 1990, J BIOL CHEM, V265, P6759; PIERCE M, 1986, J BIOL CHEM, V261, P772; PILLER F, 1988, J BIOL CHEM, V263, P15146; SHIMIZU Y, 1991, FASEB J, V5, P2292, DOI 10.1096/fasebj.5.9.1860621; SUTTON P, 1992, IMMUNOLOGY, V76, P472; TAKASAKI S, 1982, METHOD ENZYMOL, V83, P263; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WEISS A, 1986, ANNU REV IMMUNOL, V44, P313; YAGEL S, 1989, INT J CANCER, V44, P685, DOI 10.1002/ijc.2910440422; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772; ZANETTA JP, 1972, J CHROMATOGR, V69, P291, DOI 10.1016/S0021-9673(00)92897-8	38	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8069	8074						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132531				2022-12-27	WOS:A1994NB40900039
J	LUO, GX; HOROWITZ, PM				LUO, GX; HOROWITZ, PM			THE SULFURTRANSFERASE ACTIVITY AND STRUCTURE OF RHODANESE ARE AFFECTED BY SITE-DIRECTED REPLACEMENT OF ARG-186 OR LYS-249	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE LIVER RHODANESE; MUTAGENESIS; CATALYSIS; SULFUR	Two mutants of the enzyme rhodanese that replace Arg-186 with Leu (R186L) or Lys-249 with Ala (K249A) were prepared to test suggestions that these residues are involved in catalysis and structure. The predominant effect with R186L was functional, and K-m for the sulfur donor, thiosulfate, increased from 3.7 mM to 73 mM with a modest decrease in V-max (672 IU/mg to 576 IU/mg). However, K249A was virtually inactive using thiosulfate, but it was active with thiosulfonates such as p-toluene-, 2-aminoethane-, or ethanethiosulfonate, and these compounds could be demonstrated to form persulfide-substituted rhodanese. Compared with wild type enzyme, K249A had (a) reduced stability, (b) comparable secondary structure, (c) more easily exposed hydrophobic surfaces, and (d) a core structure that denatured similarly to the wild type enzyme. Thus, Arg-186 and Lys-249 are important in rhodanese catalysis, and Lys-249 is particularly critical for substrate selectivity and protein stability. Finally, the results suggest that there can be active rhodanese species in vivo that will be undetected using thiosulfate as a sulfur donor.	UNIV TEXAS,HLTH SCI CTR,DEPT BIOCHEM,SAN ANTONIO,TX 78284	University of Texas System; University of Texas Health San Antonio					NIEHS NIH HHS [ES05729] Funding Source: Medline; NIGMS NIH HHS [GM25177] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025177] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atkinson T., 1984, OLIGONUCLEOTIDE SYNT, P35; BANKIER AT, 1983, TECHNIQUES NUCLEIC B, V5, P1; CANNELLA C, 1983, FEBS LETT, V162, P180, DOI 10.1016/0014-5793(83)81074-6; CHOW SF, 1986, J BIOL CHEM, V261, P7264; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HOROWITZ P, 1983, J BIOL CHEM, V258, P7894; HOROWITZ PM, 1988, J BIOL CHEM, V263, P10278; HOROWITZ PM, 1993, J BIOL CHEM, V268, P2500; HOROWITZ PM, 1990, J BIOL CHEM, V265, P2576; HOROWITZ PM, 1992, ACS SYM SER, V526, P156; ISLAM Z, 1994, J BIOL CHEM, V269, P7908; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Kurzban G P, 1991, Protein Expr Purif, V2, P379, DOI 10.1016/1046-5928(91)90097-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIJK LJ, 1984, EUR J BIOCHEM, V142, P399, DOI 10.1111/j.1432-1033.1984.tb08301.x; MILLER DM, 1992, BIOCHIM BIOPHYS ACTA, V1121, P286, DOI 10.1016/0167-4838(92)90158-A; MILLER DM, 1991, J BIOL CHEM, V266, P4686; MILLERMARTINI DM, 1994, J BIOL CHEM, V269, P3423; MINTEL R, 1966, J BIOL CHEM, V241, P3381; NISBET IT, 1985, GENE ANAL TECH, V2, P23, DOI 10.1016/0735-0651(85)90001-9; Pace C N, 1986, Methods Enzymol, V131, P266; PLOEGMAN JH, 1978, J MOL BIOL, V123, P557, DOI 10.1016/0022-2836(78)90207-3; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; TANDON S, 1989, J BIOL CHEM, V264, P9859; VOLINI M, 1973, J BIOL CHEM, V248, P7386; WANG SF, 1968, J BIOL CHEM, V243, P5465; WENG L, 1978, J BIOL CHEM, V253, P8109; WESTLEY J, 1971, J BIOL CHEM, V246, P1468; WESTLEY J, 1973, ADV ENZYMOL RAMB, V39, P327	30	42	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8220	8225						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132546				2022-12-27	WOS:A1994NB40900060
J	MANENTI, S; SOROKINE, O; VANDORSSELAER, A; TANIGUCHI, H				MANENTI, S; SOROKINE, O; VANDORSSELAER, A; TANIGUCHI, H			DEMYRISTOYLATION OF THE MAJOR SUBSTRATE OF PROTEIN-KINASE-C (MARCKS) BY THE CYTOPLASMIC FRACTION OF BRAIN SYNAPTOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; CELLULAR SUBSTRATE; RAT-BRAIN; PHOSPHORYLATION; 80-KDA; MYRISTOYLATION; CALMODULIN; BINDING; EXPRESSION; MEMBRANE	Myristoylated alanine-rich C kinase substrate (MARCKS) is a major substrate of protein kinase C, whose interaction with the plasma membrane is dependent on its phosphorylation by protein kinase C and on its N-terminal myristoylation. We describe a hitherto undescribed demyristoylation activity of the protein in cytoplasmic fraction of synaptosomes from bovine brain. The activity is dependent on ATP but independent from calcium. The formation of the demyristoylated form, characterized by an increased mobility on SDS gel (70 kDa instead of 85 kDa), was confirmed by mass spectrometry and amino acid sequencing. The molecular mass of the demyristoylated protein as well as the incorporation of radioactive phosphate from [gamma-P-32]ATP indicated that one phosphoryl group was incorporated during the demyristoylation process. Calmodulin, which binds to the protein kinase C phosphorylation domain of MARCKS, inhibited the reaction in a calcium-dependent manner. These data suggest that the demyristoylation is regulated by the signal transduction pathways and that the two conserved domains of the protein, namely the N-terminal myristoylated region and the phosphorylation site domain, are functionally interdependent. The localization of MARCKS in the cells may be regulated not only by its phosphorylation with protein kinase C but also by a reversible myristoylation of the protein in situ.	CHIM ORGAN SUBST NAT LAB,CNRS,URA 31,F-67084 STRASBOURG,FRANCE; FUJITA HLTH UNIV,INST COMPREHENS MED SCI,DIV BIOPOLYMER SCI,TOYOAKE,AICHI 47011,JAPAN	Centre National de la Recherche Scientifique (CNRS); Fujita Health University	MANENTI, S (corresponding author), UNIV BASEL,BIOCTR,DEPT BIOPHYS CHEM,KLINGELBERGSTR 70,CH-4056 BASEL,SWITZERLAND.		manenti, stephane/P-1518-2014	manenti, stephane/0000-0002-4793-3196				ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; ADEREM AA, 1988, NATURE, V332, P362, DOI 10.1038/332362a0; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DASILVA AM, 1990, J CELL BIOL, V111, P401, DOI 10.1083/jcb.111.2.401; DODD PR, 1981, BRAIN RES, V226, P107, DOI 10.1016/0006-8993(81)91086-6; ERUSALIMSKY JD, 1991, J BIOL CHEM, V266, P7073; GORDON JI, 1991, J BIOL CHEM, V266, P8647; GRAFF JM, 1989, SCIENCE, V246, P503, DOI 10.1126/science.2814478; GRAFF JM, 1989, MOL ENDOCRINOL, V3, P1903, DOI 10.1210/mend-3-11-1903; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; HARLAN DM, 1991, J BIOL CHEM, V266, P14399; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HINRICHSEN RD, 1993, P NATL ACAD SCI USA, V90, P1585, DOI 10.1073/pnas.90.4.1585; JAMES G, 1989, J BIOL CHEM, V264, P20928; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANENTI S, 1993, J BIOL CHEM, V268, P6878; MANENTI S, 1992, J BIOL CHEM, V267, P22310; MCILHINNEY RAJ, 1990, BIOCHEM J, V271, P681, DOI 10.1042/bj2710681; MCILROY BK, 1991, J BIOL CHEM, V266, P4959; SEYKORA JT, 1991, P NATL ACAD SCI USA, V88, P2505, DOI 10.1073/pnas.88.6.2505; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; TANIGUCHI H, 1993, J BIOL CHEM, V268, P9960; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; WANG JKT, 1989, P NATL ACAD SCI USA, V86, P2253, DOI 10.1073/pnas.86.7.2253; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	27	57	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8309	8313						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132554				2022-12-27	WOS:A1994NB40900072
J	SIEGFRIED, JM; HAN, YH; DEMICHELE, MAA; HUNT, JD; GAITHER, AL; CUTTITTA, F				SIEGFRIED, JM; HAN, YH; DEMICHELE, MAA; HUNT, JD; GAITHER, AL; CUTTITTA, F			PRODUCTION OF GASTRIN-RELEASING PEPTIDE BY A NONSMALL CELL LUNG-CARCINOMA CELL-LINE ADAPTED TO SERUM-FREE AND GROWTH FACTOR-FREE CONDITIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRONCHIAL EPITHELIAL-CELLS; BOMBESIN-LIKE PEPTIDES; TUMOR PROGRESSION; ENDOCRINE TUMORS; FACTOR RECEPTOR; FETAL LUNG; CANCER; EXPRESSION; CULTURE; ORIGIN	Gastrin-releasing peptide is an important growth-modulating factor in developing lung epithelium. It is known to be produced by small cell carcinomas of the lung, and an autocrine loop involving gastrin-releasing peptide and its receptor has been demonstrated in many small cell lung tumors. We investigated whether such an autocrine loop could also be demonstrated in non-small cell lung carcinoma, since gastrin-releasing peptide is known to stimulate human bronchial epithelial cells, from which non-small cell tumors should emerge. We report here that gastrin-releasing peptide is produced by a bronchiolo-alveolar carcinoma cell line (A549) adapted to serum-free and growth factor-free conditions. A549 cells adapted to these conditions, termed A549-R(0) cells, display extensive membrane interdigitations, Gels apparatus, and secretory-like granules, and grow as a mixture of attached colonies and floating cells. Gastrin-releasing peptide is present in the conditioned medium produced by A549-R(0) cells. Colony formation of cells derived from a squamous cell carcinoma of the lung, 239T, was stimulated 9-fold by A549-R(0) conditioned medium or by authentic gastrin-releasing peptide, measured in serum-free conditions. The growth stimulatory activity was inhibited by a monoclonal antibody to gastrin-releasing peptide. Transcripts for receptors for the bombesin family of peptides were also demonstrated in A549-R(0) cells and 239T cells. These results demonstrate that non-small cell lung carcinomas can secrete gastrin-releasing peptide and can also respond to the peptide.	UNIV PITTSBURGH,PITTSBURGH CANC INST,PITTSBURGH,PA 15261; NCI,BIOMARKERS & PREVENT BRANCH,ROCKVILLE,MD 20850	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	SIEGFRIED, JM (corresponding author), UNIV PITTSBURGH,DEPT PHARMACOL,E1347 BIOMED SCI TOWER,PITTSBURGH,PA 15261, USA.			Hunt, Jay/0000-0002-8838-201X	NCI NIH HHS [CA-09033, CA-50694] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA009033, R01CA050694] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADRIAENSEN D, 1993, ANAT RECORD, V236, P70, DOI 10.1002/ar.1092360111; AGUAYO SM, 1989, J CLIN INVEST, V84, P1105, DOI 10.1172/JCI114273; BAYLIN SB, 1985, PEPTIDE HORMONES MED, P1; BERGER CL, 1981, J CLIN ENDOCR METAB, V53, P422, DOI 10.1210/jcem-53-2-422; CARNEY DN, 1985, CANCER RES, V45, P2913; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COHEN MH, 1978, SEMIN ONCOL, V5, P234; CORJAY MH, 1991, J BIOL CHEM, V266, P18771; COY DH, 1989, J BIOL CHEM, V264, P14691; CUTTITTA F, 1988, J CLIN ENDOCR METAB, V67, P576, DOI 10.1210/jcem-67-3-576; CUTTITTA F, 1985, NATURE, V316, P823, DOI 10.1038/316823a0; DAMSTRUP L, 1992, CANCER RES, V52, P3089; DENHARDT DT, 1966, BIOCHEM BIOPH RES CO, V23, P641, DOI 10.1016/0006-291X(66)90447-5; FALCO JP, 1990, J CLIN INVEST, V85, P1740, DOI 10.1172/JCI114630; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GAZDAR AF, 1988, CANCER RES, V48, P4078; GOSNEY JR, 1989, J PATHOL, V157, P127, DOI 10.1002/path.1711570207; HAEDER M, 1988, CANCER RES, V48, P1132; HIRSCH FR, 1989, CHEST, V96, pS34; HIRSCH FR, 1993, LUNG CANCER, V9, P89; HOYT RF, 1990, ANAT REC, V227, P340, DOI 10.1002/ar.1092270309; HOYT RF, 1993, ANAT REC, V236, P15, DOI 10.1002/ar.1092360106; JOHNSON DE, 1982, PEDIATR RES, V16, P446, DOI 10.1203/00006450-198206000-00009; KANE M, 1988, P AM ASSOC CANC RES, V29, P47; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; MABRY M, 1988, P NATL ACAD SCI USA, V85, P6523, DOI 10.1073/pnas.85.17.6523; MABRY M, 1991, CANCER CELL-MON REV, V3, P53; MCDOWELL EM, 1993, ANAT REC, V236, P11; MCDOWELL EM, 1981, ARCH PATHOL LAB MED, V105, P20; PEARSE AGE, 1974, MED BIOL, V52, P3; PEARSE AGE, 1969, J HISTOCHEM CYTOCHEM, V17, P303, DOI 10.1177/17.5.303; PEARSE AGE, 1977, MED BIOL, V55, P115; SIEGFRIED JM, 1993, ANAT RECORD, V236, P241, DOI 10.1002/ar.1092360129; SIEGFRIED JM, 1988, CANCER RES, V48, P4976; SIEGFRIED JM, 1987, CANCER RES, V47, P2903; SIEGFRIED JM, 1984, CARCINOGENESIS, V5, P1317, DOI 10.1093/carcin/5.10.1317; SODERDAHL G, 1988, INT J CANCER, V41, P636, DOI 10.1002/ijc.2910410426; SUNDAY ME, 1990, AM J RESP CELL MOL, V3, P199, DOI 10.1165/ajrcmb/3.3.199; VEALE D, 1987, BRIT J CANCER, V55, P513, DOI 10.1038/bjc.1987.104; WILLEY JC, 1984, EXP CELL RES, V153, P245, DOI 10.1016/0014-4827(84)90466-X	40	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8596	8603						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132585				2022-12-27	WOS:A1994NB40900114
J	DALLAS, SL; PARKSNYDER, S; MIYAZONO, K; TWARDZIK, D; MUNDY, GR; BONEWALD, LF				DALLAS, SL; PARKSNYDER, S; MIYAZONO, K; TWARDZIK, D; MUNDY, GR; BONEWALD, LF			CHARACTERIZATION AND AUTOREGULATION OF LATENT TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) COMPLEXES IN OSTEOBLAST-LIKE CELL-LINES - PRODUCTION OF A LATENT COMPLEX LACKING THE LATENT TGF-BETA-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT COMPLEX; MARFAN-SYNDROME; HUMAN-PLATELETS; BONE-FORMATION; MESSENGER-RNA; FACTOR-BETA-1; EXPRESSION; PRECURSOR; SEQUENCES; INVIVO	We have previously shown that bone organ cultures produce large amounts of latent transforming growth factor beta (TGF beta), which lacks latent TGF beta-binding protein (LTBP). In this study we used the known osteoblastlike cell lines UMR-106, ROS 17/2.8, and MG63 as models to further examine latent TGF beta expression in bone. We found that the osteosarcoma cell line UMR-106 secreted latent TGF beta almost exclusively as a 100-kDa complex lacking LTBP. ROS 17/2.8 cells produced both the 100-kDa complex and also a 290-kDa complex containing the fibroblastic (190 kDa) form of LTBP. MG63 cells (like human foreskin fibroblasts) expressed almost exclusively the 290-kDa complex. To investigate the regulation of latent TGF beta complexes in bone cells we assessed the effects of TGF beta 1 treatment on expression of active and latent TGF beta. TGF beta 1 induced secretion of latent but not active TGF beta in all cell types examined. In human foreskin fibroblast cells, TGF beta 1 and LTBP mRNA were expressed concomitantly. In contrast, in osteosarcoma cell lines autoinduction of TGF beta 1 mRNA was associated with either a delayed increase or no change in LTBP mRNA In UMR-106 cells LTBP message was virtually undetectable. We postulate that the expression of different latent TGF beta forms by osteoblast-like cells may reflect their maturation states and that different latent TGF beta complexes may have different functions, for example as secretory forms or as matrix storage forms.	LUDWIG INST CANC RES,UPPSALA,SWEDEN; BRISTOL MYERS SQUIBB,SEATTLE,WA 98121; UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,SAN ANTONIO,TX 78284; AUDIE L MURPHY MEM VET ADM MED CTR,SAN ANTONIO,TX 78284	Ludwig Institute for Cancer Research; Bristol-Myers Squibb; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	DALLAS, SL (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT MED,DIV ENDOCRINOL & METAB,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284, USA.		Bonewald, Lynda/Q-3638-2019		NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE008569] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE-08569] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; BASCOM CC, 1989, MOL CELL BIOL, V9, P5508, DOI 10.1128/MCB.9.12.5508; BONEWALD LF, 1991, MOL ENDOCRINOL, V5, P741, DOI 10.1210/mend-5-6-741; BOYAN BD, 1989, J BIOL CHEM, V264, P11879; COLOSETTI P, 1993, FEBS LETT, V320, P140, DOI 10.1016/0014-5793(93)80079-A; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; FLAUMENHAFT R, 1993, J CELL BIOL, V120, P995, DOI 10.1083/jcb.120.4.995; GENTRY LE, 1987, MOL CELL BIOL, V7, P3418, DOI 10.1128/MCB.7.10.3418; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; KIM SJ, 1989, J BIOL CHEM, V264, P7041; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; MACKIE EJ, 1990, BONE, V11, P295, DOI 10.1016/8756-3282(90)90083-B; MARCELLI C, 1990, J BONE MINER RES, V5, P1087; MASLEN CL, 1991, NATURE, V352, P334, DOI 10.1038/352334a0; MILLER DM, 1992, MOL ENDOCRINOL, V6, P694, DOI 10.1210/me.6.5.694; MIYAZONO K, 1992, J BIOL CHEM, V267, P5668; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; NODA M, 1989, ENDOCRINOLOGY, V124, P2991, DOI 10.1210/endo-124-6-2991; OLOFSSON A, 1992, J BIOL CHEM, V267, P19482; PFEILSCHIFTER J, 1987, P NATL ACAD SCI USA, V84, P2024, DOI 10.1073/pnas.84.7.2024; SEYEDIN SM, 1986, J BIOL CHEM, V261, P5693; SEYEDIN SM, 1985, P NATL ACAD SCI USA, V82, P2267, DOI 10.1073/pnas.82.8.2267; SEYEDIN SM, 1987, J BIOL CHEM, V262, P1946; TSUJI T, 1990, P NATL ACAD SCI USA, V87, P8835, DOI 10.1073/pnas.87.22.8835; TWARDZIK DR, 1990, ANN NY ACAD SCI, V593, P276, DOI 10.1111/j.1749-6632.1990.tb16119.x; VANOBBERGHENSCHILLING E, 1988, J BIOL CHEM, V263, P7741; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646	29	155	162	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6815	6822						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120044				2022-12-27	WOS:A1994MZ50300088
J	PEPPERKOK, R; LORENZ, P; ANSORGE, W; PYERIN, W				PEPPERKOK, R; LORENZ, P; ANSORGE, W; PYERIN, W			CASEIN KINASE-II IS REQUIRED FOR TRANSITION OF G(0)/G(1), EARLY G(1), AND G(1)/S PHASES OF THE CELL-CYCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; DNA-BINDING ACTIVITY; C-FOS GENE; BETA-SUBUNIT; CAPILLARY MICROINJECTION; PROTEIN-KINASES; GROWTH-FACTOR; PHOSPHORYLATION; TRANSCRIPTION; STIMULATION	Casein kinase II (CKII) is a ubiquitous serine/ threonine protein kinase with many cellular functions, including participation in mitogenic signaling by cytoplasmic nuclear translocation (Lorenz, P., Pepperkok, R., Ansorge, W., and Pyerin, W. (1993) J. Biol. Chem. 268, 2733-2739). To examine whether cell compartment-specific availability is a requirement for CKII function during cell cycle progression, antibodies against CKII beta, the regulatory subunit of CKII, were microinjected into the cytoplasm or the nucleus of G(0)-synchronized human primary fibroblasts (IMR-90) at the time of mitogenic stimulation or at various intervals thereafter. Significant inhibition of the stimulation was obtained with both cytoplasmic and nuclear injections. The inhibition was reversible, was not observed with control antibodies, and was abolished by co-injection of purified CKII holoenzyme. The inhibition differed, however, in extent, duration, and cell cycle phase between cytoplasmic and nuclear injections. After cytoplasmic injection, inhibition reached 45-50% and was effective at two intervals within the first 2 h and at 12-16 h post-stimulation, i.e. at G(0)/G(1) phase transition and at the G(1)/S phase boundary of the cell cycle. After injection into the nucleus, the inhibition was considerably stronger, reaching 80-85%, and was effective for the first 6 h post-stimulation, i.e. for the transition of G(0)/G(1) phase and the adjoining first part of G(1) phase. Cytoplasmic or nuclear injections within S phase affected neither DNA synthesis nor cell division. The data suggest that cell cycle transition from G(0) to S phase requires the presence of a certain functional level of CKII at defined times and at defined cellular locations as follows: for transition of G(0)/G(1) at both the nucleus and the cytoplasm, for transition of early G(1) at the nucleus, and for transition of G(1)/S at the cytoplasm.	GERMAN CANC RES CTR, W-6900 HEIDELBERG, GERMANY; EUROPEAN MOLEC BIOL LAB, D-69120 HEIDELBERG, GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL)			Ansorge, Wilhelm/AAN-8780-2020	Lorenz, Peter A./0000-0001-7925-1002; Pepperkok, Rainer/0000-0002-9762-3583				ACKERMAN P, 1990, P NATL ACAD SCI USA, V87, P821, DOI 10.1073/pnas.87.2.821; ANSORGE W, 1988, J BIOCHEM BIOPH METH, V16, P283, DOI 10.1016/0165-022X(88)90062-0; BELENGUER P, 1989, NUCLEIC ACIDS RES, V17, P6625; BERBERICH SJ, 1992, GENE DEV, V6, P166, DOI 10.1101/gad.6.2.166; BODENBACH L, 1994, IN PRESS EUR J BIOCH; CARROLL D, 1989, J BIOL CHEM, V264, P7345; COCHET C, 1983, J BIOL CHEM, V258, P1403; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FILHOL O, 1991, BIOCHEMISTRY-US, V30, P11133, DOI 10.1021/bi00110a016; FILHOL O, 1992, J BIOL CHEM, V267, P20577; FILHOL O, 1990, BIOCHEMISTRY-US, V29, P9928, DOI 10.1021/bi00494a025; GAUTHIERROUVIERE C, 1991, EMBO J, V10, P2921, DOI 10.1002/j.1460-2075.1991.tb07842.x; GRANKOWSKI N, 1991, EUR J BIOCHEM, V198, P25, DOI 10.1111/j.1432-1033.1991.tb15982.x; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HELLERHARRISON RA, 1991, J BIOL CHEM, V266, P14435; HUNTER T, 1988, COLD SPRING HARB SYM, V53, P131, DOI 10.1101/SQB.1988.053.01.019; KREBS EG, 1988, COLD SPRING HARB SYM, V53, P77, DOI 10.1101/SQB.1988.053.01.012; KREK W, 1992, J CELL BIOL, V116, P43, DOI 10.1083/jcb.116.1.43; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; LITCHFIELD DW, 1992, J BIOL CHEM, V267, P13943; LITCHFIELD DW, 1991, J BIOL CHEM, V266, P20380; LORENZ P, 1993, J BIOL CHEM, V268, P2733; MANAK JR, 1993, ONCOGENE, V8, P703; MANAK JR, 1990, GENE DEV, V4, P955, DOI 10.1101/gad.4.6.955; MARAIS RM, 1992, EMBO J, V11, P97, DOI 10.1002/j.1460-2075.1992.tb05032.x; Meisner H, 1991, CURR OPIN CELL BIOL, V3, P474, DOI 10.1016/0955-0674(91)90076-B; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; PADMANABHA R, 1990, MOL CELL BIOL, V10, P4089, DOI 10.1128/MCB.10.8.4089; PEPPERKOK R, 1991, EXP CELL RES, V197, P245, DOI 10.1016/0014-4827(91)90429-X; PEPPERKOK R, 1993, EXP CELL RES, V204, P278, DOI 10.1006/excr.1993.1034; PEPPERKOK R, 1988, EXP CELL RES, V178, P369, DOI 10.1016/0014-4827(88)90406-5; PFAFF M, 1988, BIOCHIM BIOPHYS ACTA, V969, P100, DOI 10.1016/0167-4889(88)90093-6; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; PYERIN W, 1987, BIOL CHEM H-S, V368, P215, DOI 10.1515/bchm3.1987.368.1.215; PYERIN W, 1992, ANN NY ACAD SCI, V660, P295, DOI 10.1111/j.1749-6632.1992.tb21091.x; PYERIN W, 1992, RECENT ADV CELL MOL, V4, P87; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; ROBITZKI A, 1993, J BIOL CHEM, V268, P5694; RUSSO GL, 1992, J BIOL CHEM, V267, P20317; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P123; VOIT R, 1992, EMBO J, V11, P2211, DOI 10.1002/j.1460-2075.1992.tb05280.x; VOSS H, 1991, J BIOL CHEM, V266, P13706; YU IJ, 1991, J CELL BIOL, V114, P1217, DOI 10.1083/jcb.114.6.1217	45	171	172	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6986	6991						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120061				2022-12-27	WOS:A1994MZ50300110
J	BETTER, M; BERNHARD, SL; FISHWILD, DM; NOLAN, PA; BAUER, RJ; KUNG, AHC; CARROLL, SF				BETTER, M; BERNHARD, SL; FISHWILD, DM; NOLAN, PA; BAUER, RJ; KUNG, AHC; CARROLL, SF			GELONIN ANALOGS WITH ENGINEERED CYSTEINE RESIDUES FORM ANTIBODY IMMUNOCONJUGATES WITH UNIQUE PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-INACTIVATING PROTEINS; RICIN-A-CHAIN; MONOCLONAL-ANTIBODY; DISULFIDE BOND; IMMUNOTOXINS; INVITRO; PHARMACOKINETICS; TOXICITY; INVIVO; CELLS	We engineered the ribosome inactivating-protein gelonin (Gel) to generate a family of Gel analogs, each with a single unpaired cysteine residue. The cysteine sites coincide with surface-accessible loops in the probable three-dimensional structure of Gel, or with the positions of endogenous cysteine residues. In most cases, enzymatic activity in vitro was unaltered by this modification. The rGel analogs were conjugated via their unpaired cysteine residue to the anti-CD5 antibody H65, or to H65 Fab and F(ab')2. Several rGel analogs formed immunoconjugates that were up to 6-fold more cytotoxic to antigen-bearing cells than those made with linker-modified rGel, whereas others were less potent. In the rat, the in vivo clearance rates of whole antibody conjugates correlated with their relative in vitro disulfide bond stability, and deconjugation to intact antibody and rGel was the predominant clearance mechanism. Fab conjugates to rGel analogs which differed in their in vitro disulfide bond stability had similar serum clearance rates, suggesting that clearance occurs mainly by removal of intact immunoconjugate from the serum, and is less dependent on deconjugation. Our results demonstrate that rGel analogs with a single cysteine at various positions on the solvent exposed surface are produced efficiently in Escherichia coli (>1 g/liter), and that the position of the cysteine greatly influences the potency and stability of the resulting immunoconjugates.	XOMA CORP,BERKELEY,CA 94710		BETTER, M (corresponding author), XOMA CORP,1545 17TH ST,SANTA MONICA,CA 90404, USA.							BARNETT BB, 1991, ANTIVIR RES, V15, P125, DOI 10.1016/0166-3542(91)90030-U; BATTELLI MG, 1990, APMIS, V98, P585, DOI 10.1111/j.1699-0463.1990.tb04975.x; BERNHARD S, 1994, IN PRESS BIOCONJUGAT; BETTER M, 1992, J BIOL CHEM, V267, P16712; BETTER M, 1993, P NATL ACAD SCI USA, V90, P457, DOI 10.1073/pnas.90.2.457; BOLOGNESI A, 1992, CLIN EXP IMMUNOL, V89, P341; BYERS VS, 1990, BLOOD, V75, P1426; COLOMBATTI M, 1983, J IMMUNOL, V131, P3091; COVELL DG, 1986, CANCER RES, V46, P3969; Ebert RF, 1990, BIOCONJUGATE CHEM, V1, P331, DOI 10.1021/bc00005a006; ENDO Y, 1987, J BIOL CHEM, V262, P5908; ENDO Y, 1988, BIOCHIM BIOPHYS ACTA, V954, P224, DOI 10.1016/0167-4838(88)90075-1; FISHWILD DM, 1991, CLIN EXP IMMUNOL, V86, P506; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GIABLDI N, 1982, PHARMACOKINETICS; Goff DA, 1990, BIOCONJUGATE CHEM, V1, P381, DOI 10.1021/bc00006a003; HARRIS P, 1991, CELL IMMUNOL, V134, P85, DOI 10.1016/0008-8749(91)90333-7; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; ISAACS JD, 1992, J IMMUNOL, V148, P3062; JOCELYN PC, 1987, METHOD ENZYMOL, V143, P44; KATZIN BJ, 1991, PROTEINS, V10, P251, DOI 10.1002/prot.340100309; KERNAN NA, 1984, J IMMUNOL, V133, P137; LUPU R, 1990, SCIENCE, V249, P1552, DOI 10.1126/science.2218496; MILLER RG, 1986, SIMULTANEOUS STATIST; NOLAN PA, 1993, GENE, V134, P223, DOI 10.1016/0378-1119(93)90097-M; PRESS OW, 1986, IMMUNOL LETT, V14, P37, DOI 10.1016/0165-2478(86)90017-9; REIMANN KA, 1988, J CLIN INVEST, V82, P129, DOI 10.1172/JCI113560; Robinson R R, 1991, Hum Antibodies Hybridomas, V2, P84; ROSENBLUM M G, 1991, Molecular Biotherapy, V3, P6; ROSENBLUM MG, 1992, MOL BIOTHER, V4, P122; SCOTT CF, 1987, JNCI-J NATL CANCER I, V79, P1163; SCOTT CF, 1987, INT J IMMUNOPHARMACO, V9, P211, DOI 10.1016/0192-0561(87)90096-8; SINGH V, 1989, J BIOL CHEM, V264, P3089; SINGH V, 1991, BIOCHEM INT, V25, P531; STIRPE F, 1988, NUCLEIC ACIDS RES, V16, P1349, DOI 10.1093/nar/16.4.1349; STIRPE F, 1992, BIO-TECHNOL, V10, P405, DOI 10.1038/nbt0492-405; STRAND V, 1993, ARTHRITIS RHEUM-US, V36, P620, DOI 10.1002/art.1780360508; STUDNICKA GM, 1993, IN PRESS PROTEIN ENG; THORPE PE, 1988, CANCER RES, V48, P6396; THORPE PE, 1981, EUR J BIOCHEM, V116, P447, DOI 10.1111/j.1432-1033.1981.tb05356.x; THORPE PE, 1987, CANCER RES, V47, P5924; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; WAWRZYNCZAK EJ, 1990, CANCER RES, V50, P7519	44	26	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9644	9650						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144553				2022-12-27	WOS:A1994NE05300040
J	KATZ, RW; KOENIG, RJ				KATZ, RW; KOENIG, RJ			NUCLEOTIDE SUBSTITUTIONS DIFFERENTIALLY AFFECT DIRECT REPEAT AND PALINDROMIC THYROID-HORMONE RESPONSE ELEMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; NUCLEAR RECEPTORS; AUXILIARY PROTEIN; ACID RECEPTORS; BINDING-SITE; T3 RECEPTOR; DNA-BINDING; RXR-BETA; PROMOTER; TRANSACTIVATION	Thyroid hormone receptors are transcription factors that bind to specific DNA sequences and regulate gene expression in a ligand-dependent manner. Thyroid hormone response elements can be composed of direct repeat or palindromic arrangements of half-sites. The traditional half-site has been considered to be the sequence 5'-AGGTCA, although we recently demonstrated that the optimal monomer-binding site is 2 base pairs larger, 5'-TAAGGTCA. It has generally been presumed that alterations in half-site sequence have commensurate effects on gene expression from direct repeat and palindromic response elements. However, in the present studies we demonstrate that palindromic elements are highly dependent on the presence of the two 5'-nucleotides (TA) for function, whereas this portion of the response element has minimal influence on hormone induction from direct repeat elements. Hormone induction correlates poorly with binding affinity for thyroid hormone receptor monomers, homodimers, or heterodimers with retinoid X receptors, either in the absence or presence of ligands. We speculate that the magnitude of hormone induction may reflect protein conformation differences induced by a combination of the presence of the appropriate 5'-nucleotides plus half-site orientation.	UNIV MICHIGAN,MED CTR,5560 MSRB II,1150 W MED CTR DR,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan					NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K11DE000301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044155] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE00301] Funding Source: Medline; NIDDK NIH HHS [DK44155] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; BERKENSTAM A, 1992, CELL, V69, P401, DOI 10.1016/0092-8674(92)90443-G; BRENT GA, 1992, MOL ENDOCRINOL, V6, P502, DOI 10.1210/me.6.4.502; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FARSETTI A, 1992, J BIOL CHEM, V267, P15784; FLINK IL, 1990, J BIOL CHEM, V265, P11233; FONDELL JD, 1993, GENE DEV, V7, P1400, DOI 10.1101/gad.7.7b.1400; FORMAN BM, 1992, MOL ENDOCRINOL, V6, P429, DOI 10.1210/me.6.3.429; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; KATZ RW, 1993, J BIOL CHEM, V268, P19392; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KOENIG RJ, 1988, P NATL ACAD SCI USA, V85, P5031, DOI 10.1073/pnas.85.14.5031; KOENIG RJ, 1987, P NATL ACAD SCI USA, V84, P5670, DOI 10.1073/pnas.84.16.5670; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; MARKS MS, 1992, EMBO J, V11, P1419, DOI 10.1002/j.1460-2075.1992.tb05187.x; MITSUHASHI T, 1990, J BIOL CHEM, V265, P7395; MIYAMOTO T, 1993, MOL ENDOCRINOL, V7, P224, DOI 10.1210/me.7.2.224; MOORE DD, 1986, GENE AMST, V45, P107; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; PROST E, 1988, NUCLEIC ACIDS RES, V16, P6248, DOI 10.1093/nar/16.13.6248; RIBEIRO RC, 1992, MOL ENDOCRINOL, V6, P1142, DOI 10.1210/me.6.7.1142; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WILLIAMS GR, 1991, J BIOL CHEM, V266, P19636; WILLIAMS GR, 1992, MOL ENDOCRINOL, V6, P1527, DOI 10.1210/me.6.10.1527; YEN PM, 1992, J BIOL CHEM, V267, P3565; YEN PM, 1992, J BIOL CHEM, V267, P23248; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	31	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9500	9505						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144535				2022-12-27	WOS:A1994NE05300019
J	IWASAKI, M; DARDEN, TA; PARKER, CE; TOMER, KB; PEDERSEN, LG; NEGISHI, M				IWASAKI, M; DARDEN, TA; PARKER, CE; TOMER, KB; PEDERSEN, LG; NEGISHI, M			INHERENT VERSATILITY OF P-450 OXYGENASE - CONFERRING DEHYDROEPIANDROSTERONE HYDROXYLASE-ACTIVITY TO P-450 2A-4 BY A SINGLE AMINO-ACID MUTATION AT POSITION-117	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE; PROTEINS	Mouse steroid 15 alpha hydroxylase P-450 2a-4 is restricted in its substrate specificity to the Delta(4), 3-ketone steroids such as androstenedione. As a result, the P-450 exhibits little hydroxylase activity toward Delta(5), 3 hydroxysteroids including dehydroepiandrosterone (DHEA). A single amino acid mutation of Ala at position 117 to Val, however, is enough to confer a high DHEA hydroxylase activity to P-450 2a-4 with 7 alpha-OH DHEA as one of the two major hydroxylated metabolites. Mouse coumarin 7-hydroxylase P-450 2a-5 contains Val at position 117, but it exhibits very low DHEA hydroxylase activity. P-450 2a-5 acquires high DHEA hydroxylase activity, however, by a mutation of Phe-209 to Asn. Moreover, the mutant P-450 2a-5 loses its activity when Val is replaced by Ala at position 117. The residue at position 117, therefore, plays the principal role in the determination of the DHEA hydroxylase activity of the P-450s. Conversely, mutations at residue 117 have little effect on the androstenedione hydroxylase activities of the P-450s. Further modeling of the DHEA binding orientation in the substrate-heme pocket of bacterial P-450cam (Iwasaki, M., Darden, T., Pedersen, L., Davis, D. G., Juvonen, R. O., Sueyoshi, T., and Negishi, M. (1993) J. Biol. Chem. 268, 759-762) provides support for the hypothesis that the type of residue at position 117 determines the steroid-substrate speci ficity of the P-450 depending on the substituent at the C3 position of steroid molecule.	NIEHS, REPROD & DEV TOXICOL LAB, PHARMACOGENET SECT, RES TRIANGLE PK, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)			Pedersen, Lee G/E-3405-2013; Negishi, Masahiko/F-7805-2019; Tomer, Kenneth B/E-8018-2013	Pedersen, Lee G/0000-0003-1262-9861; Negishi, Masahiko/0000-0002-2076-8928; 				AKWA Y, 1992, BIOCHEM J, V288, P959, DOI 10.1042/bj2880959; BUSETTA B, 1972, CRYST STRUCT COMMUN, V1, P129; Duax W. L., 1975, ATLAS STEROID STRUCT; DUAX WL, 1975, CRYST STRUCT COMMUN, V4, P249; GOTOH O, 1992, J BIOL CHEM, V267, P83; HALPERT JR, 1993, J BIOL CHEM, V268, P4453; HARADA N, 1988, BIOCHEM PHARMACOL, V37, P4778; HARADA N, 1984, J BIOL CHEM, V259, P2285; IWASAKI M, 1993, J BIOL CHEM, V268, P759; IWASAKI M, 1991, J BIOL CHEM, V266, P3380; IWASAKI M, 1993, BIOCHEM J, V291, P569, DOI 10.1042/bj2910569; JOHNSON EF, 1992, TRENDS PHARMACOL SCI, V13, P122, DOI 10.1016/0165-6147(92)90042-5; KEDZIE KM, 1991, J BIOL CHEM, V266, P22515; LINDBERG RLP, 1989, NATURE, V339, P632, DOI 10.1038/339632a0; LOIDA PJ, 1993, PROTEIN ENG, V6, P207, DOI 10.1093/protein/6.2.207; NEGISHI M, 1992, J STEROID BIOCHEM, V43, P1031, DOI 10.1016/0960-0760(92)90330-L; POULOS TL, 1991, METHOD ENZYMOL, V206, P11; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; WATERMAN MR, 1992, CURR OPIN STRUC BIOL, V2, P384; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051	21	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9079	9083						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132645				2022-12-27	WOS:A1994NB41100070
J	KAWANO, T; KOZUTSUMI, Y; KAWASAKI, T; SUZUKI, A				KAWANO, T; KOZUTSUMI, Y; KAWASAKI, T; SUZUKI, A			BIOSYNTHESIS OF N-GLYCOLYLNEURAMINIC ACID-CONTAINING GLYCOCONJUGATES - PURIFICATION AND CHARACTERIZATION OF THE KEY ENZYME OF THE CYTIDINE MONOPHOSPHO-N-ACETYLNEURAMINIC ACID HYDROXYLATION SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HANGANUTZIU-DEICHER ANTIGEN; MOUSE-LIVER CYTOSOL; NADH-CYTOCHROME-B5 REDUCTASE; EXPRESSION CLONING; MOLECULAR-CLONING; SMALL-INTESTINE; SIALIC ACIDS; RAT-KIDNEY; CELL-LINE; GANGLIOSIDE	We have proposed that cytidine monophospho-N-acetylneuraminic acid (CMP-NeuAc) hydroxylation is carried out by a multienzyme system involving CMP-NeuAc hydroxylase (the terminal enzyme of the system), cytochrome b(5), and an NADH dependent cytochrome b(5)-reducing factor (Kozutsumi, Y., Kawano, T, Yamakawa, T, and Suzuki, A. (1990) J. Biochem. 108, 704-706). The CMP-NeuAc hydroxylase was purified to homogeneity from the cytosolic fraction of mouse liver, using ion exchange columns, a Red-Sepharose column, and a soluble cytochrome b(5)-immobilized Sepharose column. The purified enzyme exhibited a single band (64 kDa) on sodium dodecyl sulfate-polyacrylamide gel electrophoresis and a single peak (58 kDa) on gel permeation chromatography, indicating that it is composed of a single polypeptide chain. The absorption spectrum did not indicate the presence of a heme prosthetic group in the enzyme. Atomic absorption spectrometry and an inhibition test using an iron chelator indicate that the enzyme contains non-heme iron as an electron acceptor. A reconstitution experiment with the purified CMP-NeuAc hydroxylase, soluble cytochrome b(5), and recombinant NADH-cytochrome b(5) reductase revealed that these three factors are essential for the reaction. The hydroxylase exhibited high affinity to CMP-NeuAc (K-m = 5 mu M) and was greatly stabilized by CMP-NeuAc. The molecular activity of the enzyme (similar to 500/min) is much lower than that reported for NADH-cytochrome b(5) reductase, suggesting that the activity or amount of hydroxylase is rate-limiting in CMP-N-glycolylneuraminic acid (NeuGc) biosynthesis. These results, together with the previous observation that the level of CMP-NeuAc hydroxylase activity was associated with the expression of NeuGc in various tissues, support the notion that the enzyme is the key for regulation of the overall velocity of CMP-NeuAc hydroxylation and consequently for the expression of NeuGc-containing glycoconjugates.	TOKYO METROPOLITAN INST MED SCI, DEPT MEMBRANE BIOCHEM, BUNKYO KU, TOKYO 113, JAPAN; KYOTO UNIV, FAC PHARMACEUT SCI, DEPT BIOL CHEM, SAKYO KU, KYOTO 606, JAPAN	Tokyo Metropolitan Institute of Medical Science; Kyoto University			Kawano, Takehiro/A-3080-2016					BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; BOUHOURS JF, 1989, J BIOL CHEM, V264, P16992; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; FUKUI Y, 1989, BIOCHEM BIOPH RES CO, V160, P1149, DOI 10.1016/S0006-291X(89)80123-8; GILLESPIE W, 1992, J BIOL CHEM, V267, P21004; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; HIGASHI H, 1984, J BIOCHEM, V95, P785, DOI 10.1093/oxfordjournals.jbchem.a134670; HIGASHI H, 1985, CANCER RES, V45, P3796; HIGASHI H, 1977, BIOCHEM BIOPH RES CO, V79, P388, DOI 10.1016/0006-291X(77)90169-3; HIRABAYASHI Y, 1987, JPN J CANCER RES, V78, P614; HIRABAYASHI Y, 1987, JPN J CANCER RES, V78, P251; HOKKE CH, 1990, FEBS LETT, V275, P9, DOI 10.1016/0014-5793(90)81427-P; IWAMORI M, 1978, BIOCHIM BIOPHYS ACTA, V528, P257; KAWANO T, 1993, GLYCOCONJUGATE J, V10, P109, DOI 10.1007/BF00731194; KOHN J, 1982, BIOCHEM BIOPH RES CO, V107, P878, DOI 10.1016/0006-291X(82)90604-0; KOZUTSUMI Y, 1991, J BIOCHEM, V110, P429, DOI 10.1093/oxfordjournals.jbchem.a123598; KOZUTSUMI Y, 1990, J BIOCHEM, V108, P704, DOI 10.1093/oxfordjournals.jbchem.a123268; KUKOWSKALATALLO JF, 1990, GENE DEV, V4, P1288, DOI 10.1101/gad.4.8.1288; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEPERS A, 1990, EUR J BIOCHEM, V193, P715, DOI 10.1111/j.1432-1033.1990.tb19391.x; MIYAKE M, 1990, CANCER, V65, P499, DOI 10.1002/1097-0142(19900201)65:3<499::AID-CNCR2820650321>3.0.CO;2-P; NAGATA Y, 1992, J BIOL CHEM, V267, P12082; NAKAMURA K, 1988, J BIOCHEM-TOKYO, V103, P201, DOI 10.1093/oxfordjournals.jbchem.a122232; NELSON DR, 1989, BIOCHEMISTRY-US, V28, P656, DOI 10.1021/bi00428a036; NISHIKAWA A, 1992, J BIOL CHEM, V267, P18199; OHASHI Y, 1983, AM J OPHTHALMOL, V96, P321, DOI 10.1016/S0002-9394(14)77822-5; OSHINO N, 1966, BIOCHIM BIOPHYS ACTA, V128, P13, DOI 10.1016/0926-6593(66)90137-8; PALTAUF F, 1973, J BIOL CHEM, V248, P1609; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; SCHAUER R, 1991, CARBOHYD RES, V213, P353, DOI 10.1016/S0008-6215(00)90623-2; Schauer R., 1982, SIALIC ACIDS CHEM ME; SHAW L, 1992, EUR J BIOCHEM, V206, P269, DOI 10.1111/j.1432-1033.1992.tb16925.x; SHAW L, 1988, BIOL CHEM H-S, V369, P477, DOI 10.1515/bchm3.1988.369.1.477; SHAW L, 1989, BIOCHEM J, V263, P355, DOI 10.1042/bj2630355; SHIRABE K, 1989, BIOCHIM BIOPHYS ACTA, V1008, P189, DOI 10.1016/0167-4781(80)90007-X; SHOREIBAH MG, 1992, J BIOL CHEM, V267, P2920; TAKEMATSU H, 1994, IN PRESS J BIOCH, V115; VARKI A, 1992, GLYCOBIOLOGY, V2, P25, DOI 10.1093/glycob/2.1.25; WANG YC, 1992, J BIOL CHEM, V267, P2728; WEN DX, 1992, J BIOL CHEM, V267, P21011; YAMAMOTO F, 1990, J BIOL CHEM, V265, P1146; YUBISUI T, 1982, J BIOCHEM, V91, P1467, DOI 10.1093/oxfordjournals.jbchem.a133838; YUBISUI T, 1987, P NATL ACAD SCI USA, V84, P3609, DOI 10.1073/pnas.84.11.3609	43	52	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9024	9029						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132639				2022-12-27	WOS:A1994NB41100062
J	COOPER, LF; UOSHIMA, K				COOPER, LF; UOSHIMA, K			DIFFERENTIAL ESTROGENIC REGULATION OF SMALL M(R), HEAT-SHOCK PROTEIN EXPRESSION IN OSTEOBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNAS; MOLECULAR-CLONING; CELLS; BONE; OSTEOPOROSIS; ESTRADIOL; SEQUENCE; GENES; RATS; DNA	Polymerase chain reaction amplification and sequencing of heat shock protein (HSP) 27-related transcripts present in cDNAs generated from heat-shocked osteoblast RNA revealed the expression of three related open reading frames that encode proteins of 208, 197, or 175 amino acids. Their expression as recombinant proteins in Escherichia coli demonstrated that they encode 27,000, 25,000, or 22,000 M(r) proteins. Northern blot analysis of heat shock protein 27-related transcript expression revealed that, while HSP 27 expression (850-nucleotide transcript) was induced by heat shock alone, the expression of a smaller transcript was facilitated by estrogen treatment prior to heat shock. This corresponded with the co-induction of 18,000 and 22,000 M(r) proteins by estrogen-pretreated, heat-shocked osteoblasts as revealed by fluorography. The identification of these multiple small M(r) heat shock-induced proteins demonstrated that the stress response of mammalian cells is composed of multiple, related proteins whose expression is differentially regulated. The importance of estrogen regulation of the small M(r) heat shock protein component of the stress response may be of particular significance to osteoblast physiology.	NIDR, CLIN INVEST & PATIENT CARE BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)				Cooper, Lyndon/0000-0002-6577-781X				AMIN J, 1991, MOL CELL BIOL, V11, P5937, DOI 10.1128/MCB.11.12.5937; ARRIGO AP, 1987, J BIOL CHEM, V262, P15359; BLAKE MJ, 1990, J BIOL CHEM, V265, P15275; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRAIG EA, 1985, CRC CR REV BIOCH MOL, V18, P239, DOI 10.3109/10409238509085135; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ERNST M, 1988, P NATL ACAD SCI USA, V85, P2307, DOI 10.1073/pnas.85.7.2307; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FROHLI E, 1993, GENE, V128, P279; FROST HM, 1991, BONE, V12, P429, DOI 10.1016/8756-3282(91)90032-E; FUQUA SAW, 1989, CANCER RES, V49, P4126; GAESTEL M, 1993, GENE, V128, P279, DOI 10.1016/0378-1119(93)90575-N; GAESTEL M, 1989, EUR J BIOCHEM, V179, P209, DOI 10.1111/j.1432-1033.1989.tb14542.x; HICKEY E, 1986, NUCLEIC ACIDS RES, V14, P4127, DOI 10.1093/nar/14.10.4127; JAKOB U, 1993, J BIOL CHEM, V268, P1517; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; KOMM BS, 1988, SCIENCE, V241, P81, DOI 10.1126/science.3164526; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVOIE J, 1990, NUCLEIC ACIDS RES, V18, P1637, DOI 10.1093/nar/18.6.1637; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; LINDSAY R, 1976, LANCET, V1, P1038; LOWE DG, 1986, J BIOL CHEM, V261, P2102; MCGARRY TJ, 1985, CELL, V42, P903, DOI 10.1016/0092-8674(85)90286-7; MIRON T, 1991, J CELL BIOL, V14, P225; MORETTIROJAS I, 1988, BREAST CANCER RES TR, V11, P155, DOI 10.1007/BF01805839; MORIMOTO R I, 1990, P1; RAVE N, 1979, NUCLEIC ACIDS RES, V6, P3559, DOI 10.1093/nar/6.11.3559; RODAN GA, 1991, J BONE MINER RES, V6, P527; Sambrook J, 1989, MOL CLONING LABORATO; SATO M, 1989, CELL SHAPE DETERMINA, P329; SHAKOORI AR, 1992, J CELL BIOCHEM, V48, P277, DOI 10.1002/jcb.240480308; SUDO H, 1983, J CELL BIOL, V96, P192; TAKANOYAMAMOTO T, 1990, P NATL ACAD SCI USA, V87, P2172, DOI 10.1073/pnas.87.6.2172; TAKECHI H, 1994, MOL CELL BIOL, V14, P567, DOI 10.1128/MCB.14.1.567; ZIMMERMAN JL, 1983, CELL, V32, P1161; [No title captured]	37	65	67	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7869	7873						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132504				2022-12-27	WOS:A1994NB40900009
J	KIM, ST; MALHOTRA, K; SMITH, CA; TAYLOR, JS; SANCAR, A				KIM, ST; MALHOTRA, K; SMITH, CA; TAYLOR, JS; SANCAR, A			CHARACTERIZATION OF (6-4)-PHOTOPRODUCT DNA PHOTOLYASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOBUTANE PYRIMIDINE DIMERS; COLI DNA; LIGHT; CELLS	Pyrimidine (6-4) pyrimidone photoproduct is the second most abundant UV photoproduct in DNA. Recently, it was reported that Drosophila melanogaster cell-free extracts restored the biological activity of (6-4) photoproduct-containing DNA in a light-dependent reaction (Todo, T., Takemori, H., Rye, H., Ihara, M., Matsunaga, T., Nikaido, O., Sate, K., and Nomura, T. (1993) Nature 361, 372-374) concomitant with the loss of (6-4) photoproduct antigenic sites and (6-4) photoproduct-caused alkali-labile sites. In the present study we show that the (6-4) photoproduct but not its Dewar isomer is the substrate for the enzyme, that the enzyme has an action spectrum peak at 400 nm, and that the efficiency of repair per incident photon is very low compared with cyclobutane pyrimidine dimer photolyases. Furthermore, we provide evidence that the (6-4) photoproduct photolyase converts the photoproduct to unmodified bases probably through an oxetane intermediate.	UNIV N CAROLINA,SCH MED,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599; WASHINGTON UNIV,DEPT CHEM,ST LOUIS,MO 63130	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Washington University (WUSTL)			Taylor, John-Stephen/AAA-3218-2020	Taylor, John-Stephen/0000-0002-8615-7257; Smith, Colin/0000-0001-5652-0855	NATIONAL CANCER INSTITUTE [R01CA040463, R37CA040463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES005557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031082, R01GM031082] Funding Source: NIH RePORTER; NCI NIH HHS [CA40463] Funding Source: Medline; NIEHS NIH HHS [ES5557] Funding Source: Medline; NIGMS NIH HHS [GM31082] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRASH DE, 1985, J BIOL CHEM, V260, P1438; CLIVIO P, 1991, J AM CHEM SOC, V113, P5481, DOI 10.1021/ja00014a065; FRANKLIN WA, 1982, J BIOL CHEM, V257, P13535; HIRSCHFELD S, 1990, MOL CELL BIOL, V10, P2041, DOI 10.1128/MCB.10.5.2041; IKENAGA M, 1970, PHOTOCHEM PHOTOBIOL, V11, P487, DOI 10.1111/j.1751-1097.1970.tb06019.x; IKENAGA M, 1971, PHOTOCHEM PHOTOBIOL, V14, P175, DOI 10.1111/j.1751-1097.1971.tb06161.x; JAGGER J, 1970, PHOTOCHEM PHOTOBIOL, V12, P185, DOI 10.1111/j.1751-1097.1970.tb06050.x; KATCHER HL, 1983, BIOCHEMISTRY-US, V22, P4071, DOI 10.1021/bi00286a013; KIM ST, 1993, PHOTOCHEM PHOTOBIOL, V57, P895, DOI 10.1111/j.1751-1097.1993.tb09232.x; MITCHELL DL, 1985, MUTAT RES, V143, P109, DOI 10.1016/S0165-7992(85)80018-X; MITCHELL DL, 1989, PHOTOCHEM PHOTOBIOL, V49, P805, DOI 10.1111/j.1751-1097.1989.tb05578.x; NISHIO T, 1981, J CHEM SOC PERK T 1, P943, DOI 10.1039/p19810000943; PATRICK MH, 1970, PHOTOCHEM PHOTOBIOL, V11, P477, DOI 10.1111/j.1751-1097.1970.tb06018.x; PAYNE G, 1990, BIOCHEMISTRY-US, V29, P7715, DOI 10.1021/bi00485a021; RAHN RO, 1969, PHOTOCHEM PHOTOBIOL, V10, P131, DOI 10.1111/j.1751-1097.1969.tb07230.x; REARDON JT, 1993, J BIOL CHEM, V268, P21301; RUPERT CS, 1962, J GEN PHYSIOL, V45, P725, DOI 10.1085/jgp.45.4.725; SANCAR A, 1983, CELL, V33, P249, DOI 10.1016/0092-8674(83)90354-9; SANCAR A, 1993, SCIENCE, V259, P1415, DOI 10.1126/science.8451638; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; SANCAR A, 1992, ADV ELECTRON TRANSFE, V2, P215; SMITH CA, 1993, J BIOL CHEM, V268, P11143; SVOBODA DL, 1993, J BIOL CHEM, V268, P10694; TAYLOR JS, 1988, BIOCHEMISTRY-US, V27, P7206, DOI 10.1021/bi00419a007; TAYLOR JS, 1987, J AM CHEM SOC, V109, P2834, DOI 10.1021/ja00243a052; TODO T, 1993, NATURE, V361, P371, DOI 10.1038/361371a0; TODO T, 1992, MUTAT RES, V273, P85, DOI 10.1016/0921-8777(92)90052-5; WALLACE SS, 1988, ENVIRON MOL MUTAGEN, V12, P471; Wang S.Y., 1976, PHOTOCHEM PHOTOBIOL, P295	29	143	146	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8535	8540						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132580				2022-12-27	WOS:A1994NB40900106
J	ZANETTI, M; STORICI, P; TOSSI, A; SCOCCHI, M; GENNARO, R				ZANETTI, M; STORICI, P; TOSSI, A; SCOCCHI, M; GENNARO, R			MOLECULAR-CLONING AND CHEMICAL SYNTHESIS OF A NOVEL ANTIBACTERIAL PEPTIDE DERIVED FROM PIG MYELOID CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BOVINE NEUTROPHILS; MEMBRANE PERMEABILIZATION; ANTIBIOTIC DODECAPEPTIDE; ANTIMICROBIAL PEPTIDES; BACTERICIDAL ACTIVITY; CDNA SEQUENCE; BACTENECINS; POLYPEPTIDES; INDOLICIDIN; PRECURSOR	A group of myeloid precursors of defense peptides has recently been shown to have highly homologous N-terminal regions. Using a strategy based on this homology, a novel cDNA was cloned from pig bone marrow RNA and found to encode a 153-residue polypeptide. This comprises a highly conserved region encompassing a 29-residue signal peptide and a 101-residue prosequence, followed by a unique, 23-residue, cationic, C-terminal sequence. A peptide corresponding to this C-terminal sequence was chemically synthesized and shown to exert antimicrobial activity against both Gram positive and negative bacteria at concentrations of 2-16 mu M. The activity of this potent and structurally novel antibacterial peptide appears to be mediated by its ability to damage bacterial membranes, as shown by the rapid permeabilization of the inner membrane of Escherichia coli.	UNIV UDINE,DIPARTIMENTO SCI & TECNOL BIOMED,I-33100 UDINE,ITALY; UNIV TRIESTE,DIPARTIMENTO BIOCHIM BIOFIS & CHIM MACROMOLEC,I-34127 TRIESTE,ITALY	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine; University of Trieste	ZANETTI, M (corresponding author), LAB NAZL CONSORZIO INTERUNIV BIOTECNOL,AREA SCI PK,PADRICIANO 99,I-34012 TRIESTE,ITALY.		Tossi, Alessandro/ABC-9061-2020; Gennaro, Renato/AAJ-2511-2021	storici, paola/0000-0002-2590-3332; Tossi, Alessandro/0000-0001-9087-5764; Gennaro, Renato/0000-0003-1331-3885				BOMAN HG, 1991, CELL, V65, P205, DOI 10.1016/0092-8674(91)90154-Q; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COHEN SA, 1988, ANAL BIOCHEM, V174, P1, DOI 10.1016/0003-2697(88)90512-X; DAHER KA, 1988, P NATL ACAD SCI USA, V85, P7327, DOI 10.1073/pnas.85.19.7327; DELSAL G, 1992, BIOCHEM BIOPH RES CO, V187, P467, DOI 10.1016/S0006-291X(05)81517-7; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; ELSBACH P, 1993, CURR OPIN IMMUNOL, V5, P103, DOI 10.1016/0952-7915(93)90088-A; FRANK RW, 1990, J BIOL CHEM, V265, P18871; GABAY JE, 1993, CURR OPIN IMMUNOL, V5, P97, DOI 10.1016/0952-7915(93)90087-9; GENNARO R, 1989, INFECT IMMUN, V57, P3142, DOI 10.1128/IAI.57.10.3142-3146.1989; GENNARO R, 1991, BLOOD CELL BIOCH, V3, P335; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; HOLAK TA, 1988, BIOCHEMISTRY-US, V27, P7620, DOI 10.1021/bi00420a008; JOINER KA, 1989, J CELL BIOL, V109, P2771, DOI 10.1083/jcb.109.6.2771; JONES DE, 1992, J BIOL CHEM, V267, P23216; Klebanoff SJ., 1988, INFLAMMATION BASIC P, P391; KOKRYAKOV VN, 1993, FEBS LETT, V327, P231, DOI 10.1016/0014-5793(93)80175-T; LARRICK JW, 1991, BIOCHEM BIOPH RES CO, V179, P170, DOI 10.1016/0006-291X(91)91350-L; LEHER RI, 1993, ANNU REV IMMUNOL, V11, P105; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; LEVY O, 1993, J BIOL CHEM, V268, P6058; MARION D, 1988, FEBS LETT, V227, P21, DOI 10.1016/0014-5793(88)81405-4; RITONJA A, 1989, FEBS LETT, V255, P211, DOI 10.1016/0014-5793(89)81093-2; ROMEO D, 1988, J BIOL CHEM, V263, P9573; SCOCCHI M, 1992, EUR J BIOCHEM, V209, P589, DOI 10.1111/j.1432-1033.1992.tb17324.x; SELSTED ME, 1993, J BIOL CHEM, V268, P6641; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; SKERLAVAJ B, 1990, INFECT IMMUN, V58, P3724, DOI 10.1128/IAI.58.11.3724-3730.1990; STORICI P, 1993, BIOCHEM BIOPH RES CO, V196, P1363, DOI 10.1006/bbrc.1993.2403; STORICI P, 1992, FEBS LETT, V314, P187, DOI 10.1016/0014-5793(92)80971-I; STORICI P, 1993, BIOCHEM BIOPH RES CO, V196, P1058, DOI 10.1006/bbrc.1993.2358; ZANETTI M, 1991, J IMMUNOL, V146, P4295; ZANETTI M, 1990, J CELL BIOL, V111, P1363, DOI 10.1083/jcb.111.4.1363; ZANETTI M, 1993, J BIOL CHEM, V268, P522; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; ZASLOFF M, 1992, CURR OPIN IMMUNOL, V4, P3, DOI 10.1016/0952-7915(92)90115-U	36	90	99	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7855	7858						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132502				2022-12-27	WOS:A1994NB40900006
J	BRIGELIUS-FLOHE, R; AUMANN, KD; BLOCKER, H; GROSS, G; KIESS, M; KLOPPEL, KD; MAIORINO, M; ROVERI, A; SCHUCKELT, R; URSINI, F; WINGENDER, E; FLOHE, L				BRIGELIUS-FLOHE, R; AUMANN, KD; BLOCKER, H; GROSS, G; KIESS, M; KLOPPEL, KD; MAIORINO, M; ROVERI, A; SCHUCKELT, R; URSINI, F; WINGENDER, E; FLOHE, L			PHOSPHOLIPID-HYDROPEROXIDE GLUTATHIONE-PEROXIDASE - GENOMIC DNA, CDNA, AND DEDUCED AMINO-ACID-SEQUENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE; RESPONSIVE ELEMENT; NUCLEAR-PROTEIN; BINDING-PROTEIN; GENE; SELENOCYSTEINE; HOMOLOGY; IDENTIFICATION; EXPRESSION; RECEPTOR	The complete amino acid sequence of the selenoprotein phospholipid hydroperoxide glutathione peroxidase (PHGPX) from pig heart has been deduced from the corresponding genomic DNA, the cDNA covering the coding region, and by sequencing the N terminus of the protein. The maximum length of the peptide chain derived from the cDNA amounts to 170 amino acid residues. By protein sequencing the N-terminal residues methionine and cysteine of the deduced sequence were found to be cleaved. The molecular mass of 19,671 Da obtained by laser desorption mass spectroscopy, however, significantly exceeds the mean molecular mass of 19,257.09 calculated for the sequence 3-170 of PHGPX, thus indicating posttranscriptional modification. In contrast to glutathione peroxidase (GPX) the coding area of the PHGPX gene is composed of seven exons. Only the amino acid sequences encoded by the third and fifth exon are highly homologous to GPX sequences. The amino acid residues selenocysteine, tryptophan, and glutamine forming the catalytic site in bovine GPX are conserved in homologous positions of PHGPX, whereas the arginine residues presumed to bind GSH in GPX are not. Gaps in the PHGPX sequence correspond to subunit interaction sites of the tetrameric GPX. The data suggest an identical catalytic mechanism of the selenoperoxidases, a less stringent substrate specificity of PHGPX, and explain the monomeric nature of PHGPX. As in other selenoproteins, the selenocysteine residue of PHGPX is encoded by UGA, The 3'-untranslated region (UTR) of the PHGPX shows a limited consensus with that of GPX and 5'-deiodinase, where it was shown to be responsible for the decoding of UGA as selenocysteine. The 3'-UTR of PHGPX can form a stem/loop as in other mammalian selenoprotein genes. The 5'-UTR and the first intron of the PHGPX gene contain a variety of putative regulatory elements indicating hormonal control.	GESELL BIOTECHNOL FORSCH MBH, D-38124 BRAUNSCHWEIG, GERMANY; UNIV PADUA, DEPT BIOL CHEM, I-35121 PADUA, ITALY; GRUNENTHAL GMBH, CTR RES, D-52078 AACHEN, GERMANY; UNIV UDINE, DEPT CHEM, I-33100 UDINE, ITALY	Gesellschaft fur Biotechnologische Forschung mbH; University of Padua; Grunenthal Group; University of Udine			Roveri, Antonella/AAF-3669-2019	Roveri, Antonella/0000-0002-3252-0559				AKASAKA M, 1989, NUCLEIC ACIDS RES, V17, P2136, DOI 10.1093/nar/17.5.2136; BEATO M, 1987, BIOCHIM BIOPHYS ACTA, V910, P95, DOI 10.1016/0167-4781(87)90060-1; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BEHNE D, 1988, BIOCHIM BIOPHYS ACTA, V966, P12, DOI 10.1016/0304-4165(88)90123-7; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; BORGMEYER U, 1984, NUCLEIC ACIDS RES, V12, P4295, DOI 10.1093/nar/12.10.4295; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; CHU FF, 1993, J BIOL CHEM, V268, P2571; COOKSON E, 1992, P NATL ACAD SCI USA, V89, P5837, DOI 10.1073/pnas.89.13.5837; CRIQUI MC, 1992, PLANT MOL BIOL, V18, P623, DOI 10.1007/BF00040684; DEAR TN, 1991, BIOCHEMISTRY-US, V30, P10376, DOI 10.1021/bi00107a003; EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x; FLOHE L, 1993, ACTIVE OXYGENS, LIPID PEROXIDES, AND ANTIOXIDANTS, P299; FLOHE L, 1973, FEBS LETT, V32, P132, DOI 10.1016/0014-5793(73)80755-0; FLOHE L, 1971, H-S Z PHYSIOL CHEM, V352, P159, DOI 10.1515/bchm2.1971.352.1.159; FLOHE L, 1989, HDB FREE RADICALS AN, V3, P281; Flohe L., 1989, GLUTATHIONE CHEM BIO, P643; FRIEDRICH MJ, 1986, J BACTERIOL, V167, P928, DOI 10.1128/jb.167.3.928-934.1986; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FROHMAN MA, 1990, AMPLIFICATIONS, V5, P11; GHYSELINCK NB, 1990, NUCLEIC ACIDS RES, V18, P7144, DOI 10.1093/nar/18.23.7144; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GUNZLER WA, 1984, H-S Z PHYSIOL CHEM, V365, P195, DOI 10.1515/bchm2.1984.365.1.195; HEIDER J, 1992, EMBO J, V11, P3759, DOI 10.1002/j.1460-2075.1992.tb05461.x; HO YS, 1988, NUCLEIC ACIDS RES, V16, P5207, DOI 10.1093/nar/16.11.5207; ISHIDA K, 1987, NUCLEIC ACIDS RES, V15, P10051, DOI 10.1093/nar/15.23.10051; KLEINHITPASS L, 1988, NUCLEIC ACIDS RES, V16, P647, DOI 10.1093/nar/16.2.647; LEEGWATER PAJ, 1986, EMBO J, V5, P381, DOI 10.1002/j.1460-2075.1986.tb04223.x; LINCOLN D, 1989, GENMON VERSION 41 MA; MAIORINO M, 1994, BIOL OXIDANTS ANTIOX; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MULLENBACH GT, 1988, PROTEIN ENG, V2, P239, DOI 10.1093/protein/2.3.239; ROVERI A, 1994, METHOD ENZYMOL, V233, P202; ROVERI A, 1992, J BIOL CHEM, V267, P6142; RYDEN TA, 1989, MOL CELL BIOL, V9, P1155, DOI 10.1128/MCB.9.3.1155; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUCKELT R, 1991, FREE RADICAL RES COM, V14, P343, DOI 10.3109/10715769109093424; SCHULE R, 1988, NATURE, V332, P87, DOI 10.1038/332087a0; TAKAHASHI K, 1990, J BIOCHEM-TOKYO, V108, P145, DOI 10.1093/oxfordjournals.jbchem.a123172; THOMAS JP, 1990, J BIOL CHEM, V265, P454; URSINI F, 1982, BIOCHIM BIOPHYS ACTA, V710, P197, DOI 10.1016/0005-2760(82)90150-3; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; WEITZEL F, 1990, BIOCHIM BIOPHYS ACTA, V1036, P88, DOI 10.1016/0304-4165(90)90018-R; WILLIAMS DL, 1992, MOL BIOCHEM PARASIT, V52, P127, DOI 10.1016/0166-6851(92)90042-I; YOSHIMURA S, 1991, J BIOCHEM-TOKYO, V109, P918, DOI 10.1093/oxfordjournals.jbchem.a123480; ZHANG LP, 1989, BIOCHIM BIOPHYS ACTA, V1006, P140, DOI 10.1016/0005-2760(89)90336-6; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	48	179	184	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7342	7348						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125951				2022-12-27	WOS:A1994NA03200050
J	HUANG, SL; CARLSON, GM; CHEUNG, WY				HUANG, SL; CARLSON, GM; CHEUNG, WY			CALMODULIN-DEPENDENT ENZYMES UNDERGO A PROTON-INDUCED CONFORMATIONAL CHANGE THAT IS ASSOCIATED WITH THEIR INTERACTIONS WITH CALMODULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; PHOSPHORYLASE-KINASE; INTRACELLULAR PH; BOVINE BRAIN; DOMAIN ORGANIZATION; PROTEIN PHOSPHATASE; LIMITED PROTEOLYSIS; CALCIUM-BINDING; PEPTIDE COMPLEX	The anionic hydrophobic (amphipathic) fluorescent probe 2-(p-toluidinyl)-naphthalene-6-sulfonate was used to investigate the surface hydrophobic properties of calmodulin (caM)-dependent enzymes as follows: calcineurin, myosin light chain kinase, cyclic nucleotide phosphodiesterase, CaM-dependent protein kinase II, and the gamma-subunit of phosphorylase kinase. We found that certain domains of these enzymes that interacted with 2-(p-toluidinyl)-naphthalene-6 sulfonate were exposed by a transient proton (H+) increase within the neutral pH range. This H+-induced exposure, which could be caused either by direct addition of H+ or by the release of H+ from metal chelators upon their binding of Ca2+, seemed to be more closely linked with a change in pH value (i.e. transient H+ increase) than with the actual equilibrium pH value of the system. Unlike the case with CaM-dependent enzymes, the H+-induced conformational change was uncommon in caM-independent enzymes. When CaM-binding domains were removed from calcineurin and smooth muscle myosin light chain kinase, the resultant enzymes no longer exposed new do mains in response to H+ increase. Using dansylated CaM to monitor the formation of CaM-enzyme complexes, we found that complex formation occurred with an uptake of H+ from solution. When caM-dependent enzymes were evaluated at suboptimal concentrations of Ca2+, addition of H+ enhanced both the formation of CaM-enzyme complexes and the caM-dependent catalytic activities, but this synergistic H+ effect occurred within only a narrow range of Ca2+ concentrations. These findings suggest that the H+-exposed domains in CaM-dependent enzymes are involved in the binding of CaM and that both conformational changes in caM and its enzyme targets are necessary for complex formation. Further, the findings are consistent with the notion that CaM-binding domains are masked in the nonactivated (uncomplexed) conformations of CaM-dependent enzymes. The interplay between H+ and Ca2+ is discussed in relation to other systems that display interdependent effects of these two ions.	ST JUDE CHILDRENS RES HOSP, DEPT BIOCHEM, MEMPHIS, TN 38105 USA; UNIV TENNESSEE, DEPT BIOCHEM, MEMPHIS, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center					NCI NIH HHS [CA 210765] Funding Source: Medline; NIDDK NIH HHS [DK 32953] Funding Source: Medline; NIGMS NIH HHS [GM 36734] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036734] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartfai T, 1979, Adv Cyclic Nucleotide Res, V10, P219; BAUER PJ, 1981, ANAL BIOCHEM, V110, P61, DOI 10.1016/0003-2697(81)90112-3; BESSEY OA, 1952, J BIOL CHEM, V196, P175; BLUMENTHAL DK, 1985, P NATL ACAD SCI USA, V82, P3187, DOI 10.1073/pnas.82.10.3187; BLUMENTHAL DK, 1982, BIOCHEMISTRY-US, V21, P2386, DOI 10.1021/bi00539a017; BUDUNOVA I, 1991, FEBS LETT, V279, P52, DOI 10.1016/0014-5793(91)80248-2; BULLEIT RF, 1988, NEURON, V1, P63, DOI 10.1016/0896-6273(88)90210-3; BUSA WB, 1984, AM J PHYSIOL, V246, pR409, DOI 10.1152/ajpregu.1984.246.4.R409; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CHARBONNEAU H, 1991, BIOCHEMISTRY-US, V30, P7931, DOI 10.1021/bi00246a009; CHEUNG WY, 1980, SCIENCE, V207, P19, DOI 10.1126/science.6243188; DASGUPTA M, 1989, J BIOL CHEM, V264, P17156; GILLETTE R, 1990, BIOCHIM BIOPHYS ACTA, V1036, P207, DOI 10.1016/0304-4165(90)90036-V; GUERRIERO V, 1986, BIOCHEMISTRY-US, V25, P8372, DOI 10.1021/bi00374a007; HUANG S, 1990, FASEB J, V4, pA1960; HUBBARD MJ, 1989, BIOCHEMISTRY-US, V28, P1868, DOI 10.1021/bi00430a066; IKEBE M, 1987, J BIOL CHEM, V262, P13828; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; ITO A, 1989, BIOCHEM BIOPH RES CO, V163, P1492, DOI 10.1016/0006-291X(89)91148-0; JARRETT HW, 1991, J BIOL CHEM, V266, P362; KEE SM, 1987, J BIOL CHEM, V262, P9448; KILHOFFER MC, 1992, BIOCHEMISTRY-US, V31, P8098, DOI 10.1021/bi00149a046; KINCAID RL, 1982, J BIOL CHEM, V257, P638; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; KRAUSE KH, 1991, J BIOL CHEM, V266, P9453; LADOUX A, 1989, BIOCHIM BIOPHYS ACTA, V1013, P55, DOI 10.1016/0167-4889(89)90127-4; LAPORTE DC, 1980, BIOCHEMISTRY-US, V19, P3814, DOI 10.1021/bi00557a025; MALENCIK DA, 1982, CALCIUM CELL FUNCTIO, V3, P161; MANALAN AS, 1983, P NATL ACAD SCI-BIOL, V80, P4291, DOI 10.1073/pnas.80.14.4291; MARGOLIS LB, 1988, FEBS LETT, V234, P449, DOI 10.1016/0014-5793(88)80135-2; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MERAT DL, 1985, J BIOL CHEM, V260, P1053; MILOS M, 1986, BIOCHEMISTRY-US, V25, P6279, DOI 10.1021/bi00368a067; MILOS M, 1988, J BIOL CHEM, V263, P9218; Nuccitelli R., 1982, INTRACELLULAR PH ITS, P567; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PALLEN CJ, 1983, J BIOL CHEM, V258, P8550; PAUDEL HK, 1987, J BIOL CHEM, V262, P11912; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; ROTH SM, 1991, BIOCHEMISTRY-US, V30, P10078, DOI 10.1021/bi00106a003; SCHWERT GW, 1955, BIOCHIM BIOPHYS ACTA, V16, P570, DOI 10.1016/0006-3002(55)90280-8; SELLERS P, 1991, BIOPHYS CHEM, V39, P199, DOI 10.1016/0301-4622(91)85022-I; SHOEMAKER MO, 1990, J CELL BIOL, V111, P1107, DOI 10.1083/jcb.111.3.1107; SLOTKI IN, 1989, AM J PHYSIOL, V257, pF210, DOI 10.1152/ajprenal.1989.257.2.F210; TALLANT EA, 1984, BIOCHEMISTRY-US, V23, P973, DOI 10.1021/bi00300a027; TANAKA T, 1980, J BIOL CHEM, V255, P1078; TKACHUK V A, 1981, Biokhimiya, V46, P963; WALLACE RW, 1980, CALCIUM CELL FUNCTIO, V1, P33; [No title captured]	49	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7631	7638						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125988				2022-12-27	WOS:A1994NA03200094
J	MAKITA, N; BENNETT, PB; GEORGE, AL				MAKITA, N; BENNETT, PB; GEORGE, AL			VOLTAGE-GATED NA+ CHANNEL BETA(1) SUBUNIT MESSENGER-RNA EXPRESSED IN ADULT HUMAN SKELETAL-MUSCLE, HEART, AND BRAIN IS ENCODED BY A SINGLE-GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT SODIUM-CHANNEL; RAT-BRAIN; CALCIUM-CHANNEL; FUNCTIONAL EXPRESSION; XENOPUS-OOCYTES; MESSENGER-RNA; MOLECULAR-CLONING; ALPHA-SUBUNIT; CLONED CDNA; MALIGNANT HYPERTHERMIA	Voltage-gated Na+ channels are heteromeric proteins consisting of alpha and beta subunits. Although alpha subunits alone are sufficient to encode functional channels, beta(1) subunits appear to modulate the kinetics of inactivation. We have used a cross-species reverse transcriptase polymerase chain reaction approach to isolate cDNAs encoding a Na+ channel beta(1) subunit from human heart and skeletal muscle. The deduced amino acid sequence of the human beta(1) subunit exhibits 96% identity with the rat brain beta(1) subunit. Human beta(1) mRNA transcripts are abundantly expressed in skeletal muscle, heart, and brain. Genomic Southern blot hybridization experiments suggest that a single gene located on chromosome 19 encodes the human beta(1) subunit that is expressed in all three of these tissues. Co-expression of the human beta(1) subunit with the recombinant human skeletal muscle alpha subunit (hSkM1) in Xenopus oocytes results in Na+ currents that inactivate rapidly. In contrast, the human beta(1) subunit has no effect on the function of the tetrodotoxin-insensitive human heart Na+ channel (hH1). These findings indicate that the human beta(1) subunit is widely expressed but does not functionally modify all Na+ channel isoforms.	VANDERBILT UNIV,SCH MED,DEPT MED,NASHVILLE,TN 37232; VANDERBILT UNIV,SCH MED,DEPT PHARMACOL,NASHVILLE,TN 37232	Vanderbilt University; Vanderbilt University					NHLBI NIH HHS [HL40608] Funding Source: Medline; NIAMS NIH HHS [AR01862] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL040608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR001862] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BARCHI RL, 1988, ANNU REV NEUROSCI, V11, P455, DOI 10.1146/annurev.ne.11.030188.002323; BENNETT PB, 1993, FEBS LETT, V326, P21, DOI 10.1016/0014-5793(93)81752-L; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CHAHINE M, 1993, BIOPHYS J, V64, pA4; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GAUTRON S, 1992, P NATL ACAD SCI USA, V89, P7272, DOI 10.1073/pnas.89.15.7272; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; GEORGE AL, 1992, P NATL ACAD SCI USA, V89, P4893, DOI 10.1073/pnas.89.11.4893; GEORGE AL, 1992, ANN NEUROL, V31, P131, DOI 10.1002/ana.410310203; GOLDIN AL, 1986, P NATL ACAD SCI USA, V83, P7503, DOI 10.1073/pnas.83.19.7503; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; KAYANO T, 1988, FEBS LETT, V228, P187, DOI 10.1016/0014-5793(88)80614-8; KIM HL, 1992, P NATL ACAD SCI USA, V89, P3251, DOI 10.1073/pnas.89.8.3251; KRAFTE DS, 1988, J NEUROSCI, V8, P2859; KRAFTE DS, 1990, J GEN PHYSIOL, V96, P689, DOI 10.1085/jgp.96.4.689; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; MCCLATCHEY AI, 1993, HUM MOL GENET, V2, P745, DOI 10.1093/hmg/2.6.745; MESSNER DJ, 1986, J BIOL CHEM, V261, P4882; MESSNER DJ, 1985, J BIOL CHEM, V260, P597; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PEREZREYES E, 1990, J BIOL CHEM, V265, P20430; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; PO S, 1993, CIRC RES, V72, P1326, DOI 10.1161/01.RES.72.6.1326; PRAGNELL M, 1991, FEBS LETT, V291, P253, DOI 10.1016/0014-5793(91)81296-K; ROBERTS RH, 1987, J BIOL CHEM, V262, P2298; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; SATIN J, 1992, J MEMBRANE BIOL, V130, P11; SCHOWALTER DB, 1989, ANAL BIOCHEM, V177, P90, DOI 10.1016/0003-2697(89)90019-5; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; SUTKOWSKI EM, 1990, J BIOL CHEM, V265, P12393; SUZUKI H, 1988, FEBS LETT, V228, P195, DOI 10.1016/0014-5793(88)80615-X; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; WHITE MM, 1991, MOL PHARMACOL, V39, P604; YANG JS, 1993, NEURON, V11, P915, DOI 10.1016/0896-6273(93)90121-7; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	47	142	151	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7571	7578						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125980				2022-12-27	WOS:A1994NA03200085
J	WERTHEIMER, E; BARBETTI, F; MUGGEO, M; ROTH, J; TAYLOR, SI				WERTHEIMER, E; BARBETTI, F; MUGGEO, M; ROTH, J; TAYLOR, SI			2 MUTATIONS IN A CONSERVED STRUCTURAL MOTIF IN THE INSULIN-RECEPTOR INHIBIT NORMAL FOLDING AND INTRACELLULAR-TRANSPORT OF THE RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; GROWTH-FACTOR; CELL-SURFACE; EXTRACELLULAR DOMAIN; CATALYTIC SUBUNIT; IMPAIRS TRANSPORT; PROLINE MUTATION; MUTANT ALLELES; ALPHA-SUBUNIT; RESISTANCE	Insulin initiates its biological response by binding to the extracellular domain of the insulin receptor. The N-terminal half of the alpha-subunit contains several repeats of a loosely conserved motif consisting of a central glycine plus several hydrophobic amino acid residues upstream from the glycine, Hy phi Xaa-Xaa-Hy phi-Xaa-Hy phi Hy phi-Xaa-Gly (where Hy phi represents a hydrophobic amino acid residue). This structural motif has been proposed to be important in determining the three-dimensional structure of the insulin binding domain. We have identified two naturally occurring mutant alleles of the insulin receptor gene in an insulin-resistant patient, substitution of Ala for Val(28) and Arg for Gly(366). The mu- tations alter conserved amino acid residues in two distinct repeats of the structural motif described above, When mutant cDNAs were expressed in NIH-3T3 cells, both mutations severely impaired proteolytic processing of the proreceptor to mature alpha and beta-subunits. Transport of mutant receptors to the plasma membrane was also impaired. However, the minority (<1O%) of receptors that were eventually transported to the plasma membrane retained the ability to bind insulin with nor- mal affinity and to undergo insulin-stimulated phosphorylation. In conclusion, the effects of these naturally occurring mutations provide experimental support for the importance of the conserved glycine-containing structural motifs described above. By interrupting these structural motifs, the Ala(28) and Arg(366) mutations prevent normal folding of the insulin receptor alpha-subunit, thereby inhibiting post-translational processing and intracellular transport of the mutant receptors.	NIDDKD,DIABET BRANCH,BETHESDA,MD 20892; OSPED POLICLIN UNIV VERONA,DEPT METAB DIS,I-37134 VERONA,ITALY	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)			Barbetti, Fabrizio/I-7351-2018; Barbetti, Fabrizio/AAK-9106-2021	Barbetti, Fabrizio/0000-0003-4687-980X; Barbetti, Fabrizio/0000-0003-4687-980X				ACCILI D, 1992, J BIOL CHEM, V267, P586; ACCILI D, 1991, J BIOL CHEM, V266, P434; ACCILI D, 1989, EMBO J, V8, P2509, DOI 10.1002/j.1460-2075.1989.tb08388.x; ANDERSEN AS, 1990, BIOCHEMISTRY-US, V29, P7363, DOI 10.1021/bi00484a002; BAJAJ M, 1987, BIOCHIM BIOPHYS ACTA, V916, P220, DOI 10.1016/0167-4838(87)90112-9; BARBETTI F, 1992, DIABETES, V41, P408, DOI 10.2337/diabetes.41.4.408; BARBETTI F, 1993, 75TH ANN M END SOC, V452; BONISCHNETZLER M, 1986, J BIOL CHEM, V261, P5281; BONISCHNETZLER M, 1988, J BIOL CHEM, V263, P6822; CAMA A, 1993, J BIOL CHEM, V268, P8060; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; KADOWAKI T, 1990, J CLIN INVEST, V86, P254, DOI 10.1172/JCI114693; KADOWAKI T, 1988, SCIENCE, V240, P787, DOI 10.1126/science.2834824; KADOWAKI T, 1991, J BIOL CHEM, V266, P21224; KADOWAKI T, 1990, J BIOL CHEM, V265, P19143; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; KLINKHAMER MP, 1989, EMBO J, V8, P2503, DOI 10.1002/j.1460-2075.1989.tb08387.x; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; LEVITOLEDANO R, 1993, ENDOCRINOLOGY, V133, P1803; LONGO N, 1993, P NATL ACAD SCI USA, V90, P60, DOI 10.1073/pnas.90.1.60; MAASSEN JA, 1991, BIOCHEMISTRY-US, V30, P10778, DOI 10.1021/bi00108a024; MOLLER DE, 1990, J BIOL CHEM, V265, P14979; ODAWARA M, 1989, SCIENCE, V245, P66, DOI 10.1126/science.2544998; OLSON TS, 1988, J BIOL CHEM, V263, P7342; SCHUMACHER R, 1991, J BIOL CHEM, V266, P19288; SWEET LJ, 1987, J BIOL CHEM, V262, P16730; TAYLOR SI, 1992, ENDOCR REV, V13, P566, DOI 10.1210/er.13.3.566; TAYLOR SI, 1992, DIABETES, V41, P1473, DOI 10.2337/diabetes.41.11.1473; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; VANDERVORM ER, 1992, J BIOL CHEM, V267, P66	31	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7587	7592						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125981				2022-12-27	WOS:A1994NA03200087
J	DEWAARD, M; WITCHER, DR; CAMPBELL, KP				DEWAARD, M; WITCHER, DR; CAMPBELL, KP			FUNCTIONAL-PROPERTIES OF THE PURIFIED N-TYPE CA2+ CHANNEL FROM RABBIT BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE CALCIUM-CHANNEL; DEPENDENT PROTEIN-KINASE; EATON MYASTHENIC SYNDROME; CONOTOXIN GVIA RECEPTOR; CHICK SENSORY NEURONS; SKELETAL-MUSCLE; BETA-SUBUNIT; DIHYDROPYRIDINE RECEPTOR; CA-2+ CHANNELS; SMOOTH-MUSCLE	N-type Ca2+ channels control a variety of key neuronal functions including transmitter release at synaptic terminals. The purified omega-conotoxin receptor from rabbit brain is a multisubunit complex composed of alpha(1B), alpha 2 delta, beta 3, and 95-kDa subunits. Immunoadsorption experiments confirm that the purified preparation does not contain cn, subunits other than the omega-conotoxin-sensitive class B isoform. The functional properties of the purified channel have been analyzed further in lipid bilayers, and similarities to or differences from the native N-type Ca2+ channel have been outlined. Conserved properties include ion selectivity, open-time duration, and pharmacology (insensitivity to drugs affecting skeletal muscle L-type Ca2+ channels). Observed properties of the reconstituted channel which differ from the native channel include (a) sustained channel activity without Ca2+- or voltage-induced inactivation; (b) examples of extremely high open-state probability; (c) the absence of ''run-down''; and (d) voltage independence of the Ca2+ channel gating. In addition, the conductance of the purified receptor is comprised between 7 and 27 picosiemens. Our results suggest that cellular components may play critical roles in the regulation of several biophysical properties and neuronal function of the native N-type Ca2+ channel,	UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242	Howard Hughes Medical Institute; University of Iowa			De Waard, Michel/G-7406-2014	De Waard, Michel/0000-0002-2782-9615; Campbell, Kevin/0000-0003-2066-5889				AFFOLTER H, 1985, BIOPHYS J, V48, P341, DOI 10.1016/S0006-3495(85)83789-9; AHLIJANIAN MK, 1991, J BIOL CHEM, V266, P20192; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BOHEIM G, 1985, MOL BASIS NERVE ACTI, P131; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; CORONADO R, 1986, ION CHANNEL RECONSTI, P483; DELCOUR AH, 1993, SCIENCE, V259, P980, DOI 10.1126/science.8094902; DEWAARD M, 1991, EUR J NEUROSCI, V3, P771; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; FLOCKERZI V, 1986, NATURE, V323, P66, DOI 10.1038/323066a0; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; GROSS RA, 1989, J NEUROPHYSIOL, V61, P97, DOI 10.1152/jn.1989.61.1.97; HAMILTON SL, 1991, J BIOL CHEM, V266, P19528; HANKE W, 1984, BIOELECTROCH BIOENER, V12, P329, DOI 10.1016/0302-4598(84)87013-0; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HULIN R, 1992, EMBO J, V11, P885; HYMEL L, 1988, P NATL ACAD SCI USA, V85, P4290, DOI 10.1073/pnas.85.12.4290; ITAGAKI K, 1992, FEBS LETT, V297, P221, DOI 10.1016/0014-5793(92)80542-O; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; LEVEQUE C, 1992, P NATL ACAD SCI USA, V89, P3625, DOI 10.1073/pnas.89.8.3625; LOPEZ HS, 1991, NEURON, V7, P1061, DOI 10.1016/0896-6273(91)90350-9; MCCARRON JG, 1992, NATURE, V357, P74, DOI 10.1038/357074a0; MCENERY MW, 1991, P NATL ACAD SCI USA, V88, P11095, DOI 10.1073/pnas.88.24.11095; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; PELZER D, 1988, CALCIUM CHANNEL STRU, P217; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; ROSENBERG RL, 1988, J GEN PHYSIOL, V92, P27, DOI 10.1085/jgp.92.1.27; SAKAMOTO J, 1991, J BIOL CHEM, V266, P18914; SCHINDLER H, 1984, P NATL ACAD SCI-BIOL, V81, P6222, DOI 10.1073/pnas.81.19.6222; SHER E, 1989, LANCET, V2, P640; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; SWARTZ KJ, 1993, NATURE, V361, P165, DOI 10.1038/361165a0; TAUSSIG R, 1992, NEURON, V8, P799, DOI 10.1016/0896-6273(92)90100-R; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; VALDIVIA HH, 1990, J GEN PHYSIOL, V95, P1, DOI 10.1085/jgp.95.1.1; WEI XY, 1991, J BIOL CHEM, V266, P21943; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; WILLIAMS ME, 1992, SCIENCE, V257, P889; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754; YATANI A, 1987, SCIENCE, V238, P1288, DOI 10.1126/science.2446390; YATANI A, 1988, J BIOL CHEM, V263, P9887	50	15	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6716	6724						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120030				2022-12-27	WOS:A1994MZ50300073
J	OKAZAKI, S; TANASE, S; CHOUDHURY, BK; SETOYAMA, K; MIURA, R; OGAWA, M; SETOYAMA, C				OKAZAKI, S; TANASE, S; CHOUDHURY, BK; SETOYAMA, K; MIURA, R; OGAWA, M; SETOYAMA, C			A NOVEL NUCLEAR-PROTEIN WITH ZINC FINGERS DOWN-REGULATED DURING EARLY MAMMALIAN-CELL DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERATOCARCINOMA STEM-CELLS; DNA-BINDING; RETINOIC ACID; TRANSCRIPTIONAL ACTIVATION; EXPRESSION; GENE; MOUSE; SEQUENCE; PARIETAL; ENDODERM	We introduced a promoter trap vector carrying a neo gene as a selectable marker into F9 cells and established several cell lines in which the expression of neo gene is under the control of an endogenous host gene that is active only in the undifferentiated F9 cells. Using one of these cell lines, G19, we isolated the integrated neo construct and its flanking host sequences by the plasmid rescue method, identified the host gene which contributes to the expression of neo gene, and named it the ZfP-57 gene. Two different Zfp-57 transcripts (1.8 and 3.2 kilobases) were identified in the undifferentiated F9 cells, and the levels of these transcripts were decreased significantly within a short time after induction of differentiation. We examined mouse organs for the pres ence of the ZfP-57 RNAs and found that the 1.8-kilobase RNA was detected only in the testis. The Zfp-57 cDNAs corresponding to the two different RNAs were isolated, and a comparison of the nucleotide sequences revealed that their coding regions were completely identical, but they differed both in length and in sequence of the 3'-untranslated region. The Zfp-57 cDNA encoded a protein consisting of 421 amino acids with an extremely high content of basic amino acid residues and multiple zinc finger moths. Immunocytochemical analysis revealed that this protein is localized in the nucleus. These findings suggest that the Zfp-57 protein is a DNA-binding protein.	KUMAMOTO UNIV,SCH MED,DEPT BIOCHEM,KUMAMOTO 860,JAPAN; KUMAMOTO UNIV,SCH MED,DEPT SURG 2,KUMAMOTO 860,JAPAN	Kumamoto University; Kumamoto University								CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOWDHURY K, 1988, NUCLEIC ACIDS RES, V16, P9995, DOI 10.1093/nar/16.21.9995; CHOWDHURY K, 1987, CELL, V48, P771, DOI 10.1016/0092-8674(87)90074-2; CUNLIFFE V, 1990, EMBO J, V9, P197, DOI 10.1002/j.1460-2075.1990.tb08096.x; ERNOULTLANGE M, 1990, MOL CELL BIOL, V10, P418, DOI 10.1128/MCB.10.1.418; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GIBSON TJ, 1988, PROTEIN ENG, V2, P209, DOI 10.1093/protein/2.3.209; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; HOGAN BLM, 1981, NATURE, V291, P235, DOI 10.1038/291235a0; HOSLER BA, 1989, MOL CELL BIOL, V9, P5623, DOI 10.1128/MCB.9.12.5623; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; KOOPMAN P, 1989, NATURE, V342, P940, DOI 10.1038/342940a0; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LEVINE RA, 1984, MOL CELL BIOL, V4, P2142, DOI 10.1128/MCB.4.10.2142; MARTIN GR, 1980, SCIENCE, V209, P768, DOI 10.1126/science.6250214; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; NAGAMINE CM, 1990, GENE DEV, V4, P63, DOI 10.1101/gad.4.1.63; NIETFELD W, 1989, J MOL BIOL, V208, P639, DOI 10.1016/0022-2836(89)90155-1; NOCE T, 1992, DEV BIOL, V155, P409; ROGERS MB, 1991, DEVELOPMENT, V113, P815; SAHA S, 1993, NATURE, V363, P648, DOI 10.1038/363648a0; SANGER F, 1981, SCIENCE, V214, P1205, DOI 10.1126/science.7302589; SETOYAMA C, 1986, P NATL ACAD SCI USA, V83, P3213, DOI 10.1073/pnas.83.10.3213; SETOYAMA C, 1990, J BIOL CHEM, V26, P1293; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; TAKAHASHI M, 1988, MOL CELL BIOL, V8, P1853, DOI 10.1128/MCB.8.4.1853; WIGLER M, 1979, CELL, V16, P777, DOI 10.1016/0092-8674(79)90093-X	32	19	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6900	6907						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120052				2022-12-27	WOS:A1994MZ50300099
J	TOMIYAMA, T; ASANO, S; FURIYA, Y; SHIRASAWA, T; ENDO, N; MORI, H				TOMIYAMA, T; ASANO, S; FURIYA, Y; SHIRASAWA, T; ENDO, N; MORI, H			RACEMIZATION OF ASP(23) RESIDUE AFFECTS THE AGGREGATION PROPERTIES OF ALZHEIMER AMYLOID-BETA PROTEIN ANALOGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ASPARTYL RESIDUES; FIBRIL FORMATION; DISEASE; PEPTIDES; PRECURSOR; METHYLTRANSFERASE; ASPARAGINYL; DEGRADATION; MODEL	The beta proteins in amyloid deposits of Alzheimer's disease have been found to be racemized and/or isomerized at their Asp residues (Roher, A. E., Lowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I. M., Zurcher-Neely, H. A., Heinrikson, R. L., Ball, M. J., and Greenberg, B. D. (1993) J. Biol. Chem. 268, 3072-3083). To elucidate the effect of racemization on the aggregation properties of beta proteins, we synthesized four beta protein analogues in which D-Asp was substituted for L-Asp residues, i.e. normal beta 1-35, [D-Asp(7)]beta 1-35, [D-Asp(23)]beta 135, and [D-Asp(7),D-Asp(23)]beta 1-35. The aggregation and fibril formation of the peptides were examined by means of spectrophotometry, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and electron microscopy. Of the four peptides, [D-Asp(23)]beta 1-35 showed the earliest increase in turbidity and appearance of a smear in SDS-PAGE. This was followed by [D-Asp(7),D-Asp(23)]beta 1-35 and normal beta 1-35. [D-Asp(7)]beta 1-35 was considerably delayed in showing these signs of aggregation. Corresponding with the increase in turbidity and the appearance of a smear in SDS-PAGE, fibril formation was observed in electron microscopy. These results reveal that the aggregation properties of beta 1-35 peptides are affected by racemization of their Asp residues depending on their position. Racemization at amino acid position 23 accelerated the peptide aggregation and fibril formation, while that at position 7 slowed down this reaction. This suggests that the site specific racemization of p protein may be involved in the amyloid fibril formation in Alzheimer's disease.	TEIJIN INST BIOMED RES,HINO,TOKYO 191,JAPAN; TOKYO METROPOLITAN GERIATR HOSP & INST GERENTOL,ITABASHI KU,TOKYO 173,TOKYO,JAPAN		TOMIYAMA, T (corresponding author), TOKYO INST PSYCHIAT,DEPT MOLEC BIOL,SETAGAYA KU,2-1-8 KAMIKITAZAWA,TOKYO 156,JAPAN.							BADA JL, 1984, METHOD ENZYMOL, V106, P98; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; BURDICK D, 1992, J BIOL CHEM, V267, P546; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CONNOR JR, 1992, J NEUROSCI RES, V31, P75, DOI 10.1002/jnr.490310111; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DYRKS T, 1992, J BIOL CHEM, V267, P18210; DYRKS T, 1993, FEBS LETT, V324, P231, DOI 10.1016/0014-5793(93)81399-K; EMRE M, 1992, NEUROBIOL AGING, V13, P553, DOI 10.1016/0197-4580(92)90055-3; FISHER GH, 1992, BRAIN RES BULL, V28, P127, DOI 10.1016/0361-9230(92)90239-T; FRASER PE, 1992, BIOCHEMISTRY-US, V31, P10716, DOI 10.1021/bi00159a011; GEIGER T, 1987, J BIOL CHEM, V262, P785; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; LOWENSON JD, 1992, J BIOL CHEM, V267, P5985; MARSHALL T, 1988, BIOCHEM SOC T, V16, P640, DOI 10.1042/bst0160640; MASTERS PM, 1983, J AM GERIATR SOC, V31, P426, DOI 10.1111/j.1532-5415.1983.tb03719.x; MORI H, 1992, J BIOL CHEM, V267, P17082; PIKE CJ, 1993, J NEUROSCI, V13, P1676; ROHER AE, 1993, J BIOL CHEM, V268, P3072; RUSH DK, 1992, NEUROBIOL AGING, V13, P591, DOI 10.1016/0197-4580(92)90061-2; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHAPIRA R, 1988, J NEUROCHEM, V50, P69, DOI 10.1111/j.1471-4159.1988.tb13231.x; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531	32	146	152	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 8	1994	269	14					10205	10208						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NF017	8144598				2022-12-27	WOS:A1994NF01700006
J	KOBAYASHI, T; HONKE, K; MIYAZAKI, T; MATSUMOTO, K; NAKAMURA, T; ISHIZUKA, I; MAKITA, A				KOBAYASHI, T; HONKE, K; MIYAZAKI, T; MATSUMOTO, K; NAKAMURA, T; ISHIZUKA, I; MAKITA, A			HEPATOCYTE GROWTH-FACTOR SPECIFICALLY BINDS TO SULFOGLYCOLIPIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY RECEPTOR; RENAL-CELL CARCINOMA; SULFATED GLYCOLIPIDS; VONWILLEBRAND-FACTOR; SEQUENCE HOMOLOGY; RAT HEPATOCYTES; IDENTIFICATION; LAMININ; THROMBOSPONDIN; EXPRESSION	Hepatocyte growth factor (HGF) is a heparin-binding pleiotropic factor that acts on a variety of epithelial cells. The interaction of human HGF with glycolipids was studied by overlaying them with I-125-HGF on thin layer chromatograms and by a solid-phase assay using lipids adsorbed on microtiter plates. Among various glycolipids tested, HGF was found to bind to sulfoglycolipids, including galactosylceramide sulfate (SM4), lactosylceramide sulfate (SM3), and gangliotriaosylceramide bis-sulfate. In contrast, HGF failed to bind to gangliosides or neutral glycolipids. HGF binding to SM4 was strongly inhibited by dextran sulfate, heparin, and fucoidan, whereas neither keratan sulfate nor hyaluronic acid had any inhibitory activity. When glycolipids from a renal cancer cell line, SMKT-R3, which overexpresses sulfoglycolipids, were developed on a thin layer chromatogram, SM4 and SM3 were the only glycolipids that bound HGF. We further examined the effect of the incorporation of glycolipids into SMKT-R3 cells on HGF binding to the cells. The incorporation of SM4 into the cells enhanced HGF binding to SMKT-R3 cells, while that of galactosylceramide, a precursor of SM4, had no effect. These observations indicated that SM4 exogenously incorporated into the cell membranes could react with HGF and suggested that endogenous sulfoglycolipids on SMKT-R3 cells might function as reservoirs for HGF.	HOKKAIDO UNIV, SCH MED, INST CANC, BIOCHEM LAB, KITA KU, N15W7, SAPPORO, HOKKAIDO 060, JAPAN; HOKKAIDO UNIV, SCH MED, DEPT INTERNAL MED 3, SAPPORO, HOKKAIDO 060, JAPAN; OSAKA UNIV, SCH MED, BIOMED RES CTR, DEPT BIOCHEM, SUITA, OSAKA 565, JAPAN; TEIKYO UNIV, SCH MED, DEPT BIOCHEM, TOKYO 173, JAPAN	Hokkaido University; Hokkaido University; Osaka University; Teikyo University								ARAKAKI N, 1992, J BIOL CHEM, V267, P7101; BRANKAMP RG, 1991, BIOCHEM BIOPH RES CO, V181, P245; CHRISTOPHE O, 1991, BLOOD, V78, P2310; FAROOQUI AA, 1985, MOL CELL BIOCHEM, V66, P87; FREDMAN P, 1988, BIOCHEM J, V251, P17, DOI 10.1042/bj2510017; HIGUCHI O, 1991, BIOCHEM BIOPH RES CO, V176, P599, DOI 10.1016/S0006-291X(05)80226-8; HIGUCHI O, 1992, FEBS LETT, V301, P282, DOI 10.1016/0014-5793(92)80257-H; HOLT GD, 1989, J BIOL CHEM, V264, P12138; HOLT GD, 1990, J BIOL CHEM, V265, P2852; KOBAYASHI T, 1993, BRIT J CANCER, V67, P76, DOI 10.1038/bjc.1993.12; KOMADA M, 1992, EUR J BIOCHEM, V204, P857, DOI 10.1111/j.1432-1033.1992.tb16705.x; LAINE RA, 1973, BIOCHEM BIOPH RES CO, V54, P1039, DOI 10.1016/0006-291X(73)90798-5; MAKITA A, 1985, NEW COMPREHENSIVE BI, V10, P1; MATSUMOTO K, 1991, BIOCHEM BIOPH RES CO, V181, P691, DOI 10.1016/0006-291X(91)91246-9; MATSUMOTO K, 1992, Critical Reviews in Oncogenesis, V3, P27; MIYAO N, 1989, UROL RES, V17, P317; MOHAN PS, 1992, BIOCHEM BIOPH RES CO, V182, P689, DOI 10.1016/0006-291X(92)91787-Q; MOHAN PS, 1990, J NEUROCHEM, V54, P2024, DOI 10.1111/j.1471-4159.1990.tb04907.x; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1986, P NATL ACAD SCI USA, V83, P6489, DOI 10.1073/pnas.83.17.6489; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; OHKUBO I, 1991, BIOCHEM BIOPH RES CO, V174, P1133, DOI 10.1016/0006-291X(91)91538-N; ROBERTS DD, 1988, CANCER RES, V48, P6785; ROBERTS DD, 1985, J BIOL CHEM, V260, P9405; ROBERTS DD, 1987, METHOD ENZYMOL, V138, P473; ROBERTS DD, 1985, P NATL ACAD SCI USA, V82, P1306, DOI 10.1073/pnas.82.5.1306; ROBERTS DD, 1986, J BIOL CHEM, V261, P6872; ROBERTS DD, 1986, J BIOL CHEM, V261, P3306; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; SAKAKIBARA N, 1989, CANCER RES, V49, P335; SVENNERHOLM L, 1956, J NEUROCHEM, V1, P42, DOI 10.1111/j.1471-4159.1956.tb12053.x; TAJIMA H, 1992, EXP CELL RES, V202, P423, DOI 10.1016/0014-4827(92)90095-P; TARABOLETTI G, 1990, J BIOL CHEM, V265, P12253; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; ZARNEGAR R, 1990, BIOCHEM BIOPH RES CO, V173, P1179, DOI 10.1016/S0006-291X(05)80910-6	36	54	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9817	9821						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144574				2022-12-27	WOS:A1994NE05300066
J	IMAGAWA, S; IZUMI, T; MIURA, Y				IMAGAWA, S; IZUMI, T; MIURA, Y			POSITIVE AND NEGATIVE REGULATION OF THE ERYTHROPOIETIN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE HELIX FORMATION; EXPRESSION; TRANSCRIPTION; DNA; ENHANCER; PROTEIN; OLIGONUCLEOTIDES; ANTISENSE; ELEMENTS; CONTAINS	In order to investigate positive and negative regulatory elements of the erythropoietin (Epo) gene, synthetic oligonucleotides were designed to control Epo transcription by means of an antigene strategy. We devised a new method for detecting regulatory elements of genes that have a weak promoter. Synthetic oligonucleotides were incubated with Hep3B cells in the presence or absence of CoCl2 or hypoxia. To exclude the effect of translational regulation, Epo mRNA concentration was determined by competitive polymerase chain reaction. The addition of antisense oligonucleotide for CACCC elements decreased the production of Epo mRNA in a dose-dependent fashion when cells were stimulated by CoCl2 or hypoxia. In contrast, the addition of antisense oligonucleotide for the GATA element caused a dose dependent stimulation of Epo mRNA production either in the presence or absence of CoCl2 or hypoxia. Triple helix formation was revealed by electrophoresis. CACCC elements were demonstrated to be positive regulatory elements of the Epo gene, whereas the GATA element was a negative regulatory element. Furthermore, by gel mobility shift assays, we demonstrated evidence for the presence of factors in Hep3B cell nuclear extract that spe cifically bind to CACCC or GATA elements. Based on these observations, we presented the possibility that triple helix formation could serve as a novel means for transcriptional regulation of the gene.			IMAGAWA, S (corresponding author), JICHI MED SCH, DEPT MED, DIV HEMATOL, MINAMI KAWACHI, TOCHIGI 32904, JAPAN.							BERU N, 1990, J BIOL CHEM, V265, P14100; BLANCHARD KL, 1992, MOL CELL BIOL, V12, P5373, DOI 10.1128/MCB.12.12.5373; COONEY M, 1988, SCIENCE, V241, P456, DOI 10.1126/science.3293213; COSTAGIOMI P, 1990, J BIOL CHEM, V265, P10185; EVANS T, 1990, ANNU REV CELL BIOL, V6, P95, DOI 10.1146/annurev.cellbio.6.1.95; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; GILMAN M, 1988, CURRENT PROTOCOLS MO, V1; GOLDBERG MA, 1987, P NATL ACAD SCI USA, V84, P7972, DOI 10.1073/pnas.84.22.7972; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; GOLDWASSER E, 1958, BLOOD, V13, P55, DOI 10.1182/blood.V13.1.55.55; GRABER SE, 1989, HEMATOL ONCOL CLIN N, V3, P369; HELENE C, 1991, ANTI-CANCER DRUG DES, V6, P569; HELENE C, 1990, BIOCHIM BIOPHYS ACTA, V1049, P99, DOI 10.1016/0167-4781(90)90031-V; HELENE C, 1991, EUR J CANCER, V27, P1466, DOI 10.1016/0277-5379(91)90033-A; HERBST RS, 1990, MOL CELL BIOL, V10, P3896, DOI 10.1128/MCB.10.8.3896; HOOGSTEEN K, 1959, ACTA CRYSTALLOGR, V12, P822, DOI 10.1107/S0365110X59002389; IMAGAWA S, 1991, BLOOD, V77, P278; LEDOAN T, 1987, NUCLEIC ACIDS RES, V15, P8643, DOI 10.1093/nar/15.21.8643; MAHER LJ, 1989, SCIENCE, V245, P725, DOI 10.1126/science.2549631; MERGNY JL, 1992, SCIENCE, V256, P1681, DOI 10.1126/science.256.5064.1681; MOSER HE, 1987, SCIENCE, V238, P645, DOI 10.1126/science.3118463; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; RAJAGOPAL P, 1989, BIOCHEMISTRY-US, V28, P7859, DOI 10.1021/bi00445a048; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SHOEMAKER CB, 1986, MOL CELL BIOL, V6, P849, DOI 10.1128/MCB.6.3.849; TSUCHIYA M, 1987, EUR J BIOCHEM, V165, P7, DOI 10.1111/j.1432-1033.1987.tb11187.x; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650	27	35	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9038	9044						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132641				2022-12-27	WOS:A1994NB41100064
J	MCNEIL, JB; MCINTOSH, EM; TAYLOR, BV; ZHANG, FR; TANG, S; BOGNAR, AL				MCNEIL, JB; MCINTOSH, EM; TAYLOR, BV; ZHANG, FR; TANG, S; BOGNAR, AL			CLONING AND MOLECULAR CHARACTERIZATION OF 3 GENES, INCLUDING 2 GENES ENCODING SERINE HYDROXYMETHYLTRANSFERASES, WHOSE INACTIVATION IS REQUIRED TO RENDER YEAST AUXOTROPHIC FOR GLYCINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLATE-DEPENDENT ENZYMES; CHINESE-HAMSTER CELLS; SACCHAROMYCES-CEREVISIAE; THYMIDYLATE SYNTHASE; NUCLEOTIDE-SEQUENCE; MESSENGER-RNAS; GLYA GENE; EXPRESSION; DNA; IDENTIFICATION	The genes encoding both the cytosolic and mitochondrial serine hydroxymethyltransferases (SHM2 and SHM1, respectively) and a third unidentified gene of the yeast Saccharomyces cerevisiae have been isolated and their nucleotide sequences determined. Analysis of the predicted amino acid sequence of the amino-terminal regions, sequence comparison with other genes encoding SHMT enzymes, and subcellular fractionation studies all suggested that the SHM1 gene encodes the mitochondrial SHMT, while the SHM2 gene encodes the cytosolic enzyme. The SHM2 gene but not the SHM1 gene has putative GCN4 sites upstream of the putative TATA box, suggesting regulation of its transcription by the general amino acid control system. Yeast mutants with disruptions at each SHM gene and in both genes were constructed and all mutants had the same growth requirements as the parental strains. Mutagenesis of the double-disrupted, shm1 shm2 yeast yielded strains of a single complementation group that are auxotrophic for glycine. Complementation of the glycine auxotrophy using a yeast genomic library retrieved the SHM1 and SHM2 genes and a third gene designated GLY1. Gene disruption studies demonstrated that inactivation of SHM1, SHM2, and GLY1 is required to yield yeast that are completely auxotrophic for glycine.	UNIV TORONTO,DEPT MICROBIOL,TORONTO M5S 1A8,ON,CANADA; YORK UNIV,DEPT BIOL,N YORK M3J 1P3,ON,CANADA	University of Toronto; York University - Canada								BARLOWE C K, 1988, Biofactors, V1, P171; BRAUS GH, 1991, MICROBIOL REV, V55, P349, DOI 10.1128/MMBR.55.3.349-370.1991; BROACH JR, 1979, GENE, V8, P121, DOI 10.1016/0378-1119(79)90012-X; BYRNE PC, 1992, BIOCHEM J, V286, P117, DOI 10.1042/bj2860117; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CHAN VL, 1991, GENE, V101, P51, DOI 10.1016/0378-1119(91)90223-X; CHASIN LA, 1974, P NATL ACAD SCI USA, V71, P718, DOI 10.1073/pnas.71.3.718; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; DENTE L, 1983, NUCLEIC ACIDS RES, V11, P1645, DOI 10.1093/nar/11.6.1645; DOIGNON F, 1993, YEAST, V9, P189, DOI 10.1002/yea.320090210; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARROW TA, 1992, P NATL ACAD SCI USA, V89, P9151, DOI 10.1073/pnas.89.19.9151; GARROW TA, 1993, J BIOL CHEM, V268, P11910; GELLER AM, 1989, ANAL BIOCHEM, V180, P120, DOI 10.1016/0003-2697(89)90098-5; HAMILTON R, 1987, NUCLEIC ACIDS RES, V15, P3581, DOI 10.1093/nar/15.8.3581; HSIAO KC, 1991, NUCLEIC ACIDS RES, V19, P2787, DOI 10.1093/nar/19.10.2787; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGOSKY PA, 1987, NUCLEIC ACIDS RES, V15, P10355, DOI 10.1093/nar/15.24.10355; MARTINI F, 1987, J BIOL CHEM, V262, P5499; MARTINI F, 1989, J BIOL CHEM, V264, P8509; MCBURNEY MW, 1974, CELL, V2, P173, DOI 10.1016/0092-8674(74)90091-9; MCCLUNG CR, 1992, MOL CELL BIOL, V12, P1412, DOI 10.1128/MCB.12.4.1412; MCGUIRE JJ, 1980, J BIOL CHEM, V255, P5776; MCINTOSH EM, 1988, MOL CELL BIOL, V8, P4616, DOI 10.1128/MCB.8.11.4616; MCINTOSH EM, 1993, CURR GENET, V24, P185, DOI 10.1007/BF00351790; MCINTOSH EM, 1991, MOL CELL BIOL, V11, P329, DOI 10.1128/MCB.11.1.329; MCINTOSH EM, 1986, MOL GEN GENET, V204, P363, DOI 10.1007/BF00331011; MCNEIL JB, 1988, MOL CELL BIOL, V8, P1045, DOI 10.1128/MCB.8.3.1045; MEHTA PK, 1989, EUR J BIOCHEM, V186, P249, DOI 10.1111/j.1432-1033.1989.tb15202.x; MEHTA PK, 1993, EUR J BIOCHEM, V211, P373, DOI 10.1111/j.1432-1033.1993.tb19907.x; MILLER JH, 1972, EXPT MOL GENETICS, P203; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; PLAMANN MD, 1983, NUCLEIC ACIDS RES, V11, P2065, DOI 10.1093/nar/11.7.2065; ROSSBACH S, 1991, MOL MICROBIOL, V5, P39, DOI 10.1111/j.1365-2958.1991.tb01824.x; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J, 1989, MOL CLONING LABORATO; SANCAR A, 1979, BIOCHEM BIOPH RES CO, V90, P123, DOI 10.1016/0006-291X(79)91598-5; SANCAR A, 1981, J MOL BIOL, V148, P45, DOI 10.1016/0022-2836(81)90234-5; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIRCH L, 1982, ADV ENZYMOL RAMB, V53, P83; SCHMIDT B, 1984, EUR J BIOCHEM, V144, P581, DOI 10.1111/j.1432-1033.1984.tb08505.x; SHERMAN F, 1977, METHODS YEAST GENETI; STAUFFER GV, 1981, GENE, V14, P63, DOI 10.1016/0378-1119(81)90148-7; STORMS RK, 1984, MOL CELL BIOL, V4, P2858, DOI 10.1128/MCB.4.12.2858; TAYLOR RT, 1977, ARCH BIOCHEM BIOPHYS, V181, P331, DOI 10.1016/0003-9861(77)90512-4; TAYLOR RT, 1982, ARCH BIOCHEM BIOPHYS, V217, P609, DOI 10.1016/0003-9861(82)90543-4; TURNER SR, 1992, J BIOL CHEM, V267, P13528; URBANOWSKI ML, 1984, GENE, V27, P47, DOI 10.1016/0378-1119(84)90237-3; WEST MG, 1993, J BIOL CHEM, V268, P153	49	80	85	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9155	9165						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132653				2022-12-27	WOS:A1994NB41100080
J	MENDOZA, I; RUBIO, F; RODRIGUEZNAVARRO, A; PARDO, JM				MENDOZA, I; RUBIO, F; RODRIGUEZNAVARRO, A; PARDO, JM			THE PROTEIN PHOSPHATASE CALCINEURIN IS ESSENTIAL FOR NACL TOLERANCE OF SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM-TRANSPORT; LACZ FUSIONS; YEAST; GENE; ACTIVATION; HOMOLOGS; KINASE	NaCl-sensitive yeast mutants were isolated to identify genes essential for NaCl tolerance. Complementation of a mutant highly sensitive to Na+ and Li+ led to the isolation of the CNB1 gene. This gene encodes the regulatory subunit (CNB) of the Ca2+/calmodulin-dependent protein phosphatase calcineurin. Cells deficient in CNB accumulated Li+ due to reduced expression of ENA1, a gene encoding a P-type ATPase involved in Na+ and Li+ efflux. In addition, the K+ transport system of cnb1 Delta cells was not converted to the high affinity state that facilitates better discrimination of K+ over Na+. Thus the cnb1 Delta strain resembled a trk1 mutant. These results indicate that adaptation to NaCl stress in Saccharomyces cerevisiae requires a signal transduction pathway involving Ca2+ and protein phosphorylation-dephosphorylation. In this pathway, calcineurin would coordinate gene expression and activity of ion transporters to facilitate ion homeostasis.	CSIC, INST RECURSOS NAT & AGROBIOL, E-41080 SEVILLE, SPAIN; ESCUELA TECN SUPER INGN AGRON, DEPT MICROBIOL, E-28040 MADRID, SPAIN	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS)			Rodriguez-Navarro, Alonso/AAB-4574-2019; Pardo, Jose M./B-4652-2009; Rubio, Francisco/K-2854-2014; Rubio, Francisco/ABF-8662-2020; Mendoza, Imelda/I-2864-2015	Rodriguez-Navarro, Alonso/0000-0003-0462-223X; Pardo, Jose M./0000-0003-4510-8624; Rubio, Francisco/0000-0001-7640-9548; Rubio, Francisco/0000-0001-7640-9548; Mendoza, Imelda/0000-0002-2673-3961				ARMSTRONG DL, 1989, TRENDS NEUROSCI, V12, P117, DOI 10.1016/0166-2236(89)90168-9; BECKER DM, 1991, METHOD ENZYMOL, V194, P182; BORSTPAUWELS GWFH, 1981, BIOCHIM BIOPHYS ACTA, V650, P88, DOI 10.1016/0304-4157(81)90002-2; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CYERT MS, 1992, MOL CELL BIOL, V12, P3460, DOI 10.1128/MCB.12.8.3460; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; DELCASSOTREMOUSAYGUE D, 1988, EUR J BIOCHEM, V172, P767, DOI 10.1111/j.1432-1033.1988.tb13956.x; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; GABER RF, 1988, MOL CELL BIOL, V8, P2848, DOI 10.1128/MCB.8.7.2848; GARCIADEBLAS B, 1993, MOL GEN GENET, V236, P363, DOI 10.1007/BF00277134; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; HARO R, 1991, FEBS LETT, V291, P189, DOI 10.1016/0014-5793(91)81280-L; HARO R, 1993, PHYSIOL PLANTARUM, V89, P868, DOI 10.1111/j.1399-3054.1993.tb05298.x; HSIAO KC, 1991, NUCLEIC ACIDS RES, V19, P2787, DOI 10.1093/nar/19.10.2787; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; LAWRENCE CW, 1991, METHOD ENZYMOL, V194, P273; LUAN S, 1993, P NATL ACAD SCI USA, V90, P2202, DOI 10.1073/pnas.90.6.2202; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; RAMOS J, 1985, ARCH MICROBIOL, V143, P88, DOI 10.1007/BF00414774; RAMOS J, 1990, BIOCHIM BIOPHYS ACTA, V1029, P211, DOI 10.1016/0005-2736(90)90156-I; RAMOS J, 1986, EUR J BIOCHEM, V154, P307, DOI 10.1111/j.1432-1033.1986.tb09398.x; ROBINSON LC, 1992, P NATL ACAD SCI USA, V89, P28, DOI 10.1073/pnas.89.1.28; RODRIGUEZNAVARRO A, 1984, J BACTERIOL, V159, P940; RODRIGUEZNAVARRO A, 1982, FEBS LETT, V138, P205, DOI 10.1016/0014-5793(82)80442-0; Sambrook J, 1989, MOL CLONING LABORATO; SHERMAN F, 1991, METHOD ENZYMOL, V194, P21; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SKALA J, 1991, YEAST, V7, P651, DOI 10.1002/yea.320070614; UEKI K, 1993, J BIOL CHEM, V268, P6554	32	288	296	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8792	8796						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132612				2022-12-27	WOS:A1994NB41100029
J	MICHIKAWA, T; HAMANAKA, H; OTSU, H; YAMAMOTO, A; MIYAWAKI, A; FURUICHI, T; TASHIRO, Y; MIKOSHIBA, K				MICHIKAWA, T; HAMANAKA, H; OTSU, H; YAMAMOTO, A; MIYAWAKI, A; FURUICHI, T; TASHIRO, Y; MIKOSHIBA, K			TRANSMEMBRANE TOPOLOGY AND SITES OF N-GLYCOSYLATION OF INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE CEREBELLUM; RYANODINE RECEPTOR; MOLECULAR-CLONING; INSP3 RECEPTOR; P-400 PROTEIN; PURKINJE-CELL; TRISPHOSPHATE RECEPTOR; MONOCLONAL-ANTIBODIES; SODIUM-CHANNELS; P400 PROTEIN	To define the transmembrane topology of the inositol 1,4,5-trisphosphate receptor (InsP(3)R), we determined the subcellular location of the hydrophilic segment (residues 2463-2529 of mouse type 1 InsP(3)R) believed to be located at the luminal side of the endoplasmic reticulum (ER) in the six-transmembrane model but at the cytoplasmic side in the eight-transmembrane model. This hydrophilic segment includes two consensus sites for N-glycosylation (Asn-2475 and Asn-2503). We prepared an anti-peptide antibody against residues 2504-2523. Electron microscope immunocytochemical studies of mouse cerebellar Purkinje cells showed that binding of this antibody frequently occurs in the intracisternal space of the ER. We constructed three mutant receptors by site-directed mutagenesis of Asn to Gin (N2475Q, N2503Q, and N2475and/N2503Q), By concanavalin A column chromatography of these receptors, we found that both Asn-2475 and Asn-2503 are glycosylated. These results indicate that residues 2504-2523, Asn-2475, and Asn-2503 are exposed to the ER lumen. We therefore propose that InsP(3)R has six membrane spanning segments. Based on the transmembrane topology and subunit organization, we suggest that InsP(3)R is a member of the superfamily that includes the voltage- and second messenger-gated ion channels on the plasma membrane.	UNIV TOKYO,INST MED SCI,DEPT MOLEC NEUROBIOL,MINATO KU,TOKYO,TOKYO 108,JAPAN; KANSAI MED UNIV,DEPT MED 3,MORIGUCHI,OSAKA 570,JAPAN; KANSAI MED UNIV,DEPT PHYSIOL,MORIGUCHI,OSAKA 570,JAPAN; RIKEN,TSUKUBA LIFE SCI CTR,TSUKUBA,IBARAKI 305,JAPAN	University of Tokyo; Kansai Medical University; Kansai Medical University; RIKEN			Mikoshiba, Katsuhiko/N-7943-2015; Miyawaki, Atsushi/K-3569-2014	Miyawaki, Atsushi/0000-0002-2329-3235; Furuichi, Teiichi/0000-0002-9676-1888				BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CHADWICK CC, 1990, P NATL ACAD SCI USA, V87, P2132, DOI 10.1073/pnas.87.6.2132; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FURUICHI T, 1989, NUCLEIC ACIDS RES, V17, P5385, DOI 10.1093/nar/17.13.5385; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GILLY WF, 1990, NEURON, V5, P633; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; JAN LY, 1992, CELL, V69, P715, DOI 10.1016/0092-8674(92)90280-P; KHAN AA, 1992, P NATL ACAD SCI USA, V89, P2849, DOI 10.1073/pnas.89.7.2849; KUME S, 1993, CELL, V73, P555, DOI 10.1016/0092-8674(93)90142-D; KUWAJIMA G, 1992, NEURON, V9, P1133, DOI 10.1016/0896-6273(92)90071-K; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; MAEDA N, 1991, J BIOL CHEM, V266, P1109; MAEDA N, 1988, J NEUROCHEM, V51, P1724, DOI 10.1111/j.1471-4159.1988.tb01151.x; MAEDA N, 1989, DEV BIOL, V133, P67, DOI 10.1016/0012-1606(89)90297-2; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; MIKOSHIBA K, 1979, DEV NEUROSCI-BASEL, V2, P254, DOI 10.1159/000112489; Miller Christopher, 1992, Current Biology, V2, P573, DOI 10.1016/0960-9822(92)90146-2; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; MIYAWAKI A, 1991, P NATL ACAD SCI USA, V88, P4911, DOI 10.1073/pnas.88.11.4911; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; NAKADE S, 1991, BIOCHEM J, V277, P125, DOI 10.1042/bj2770125; OTSU H, 1990, CELL STRUCT FUNCT, V15, P163, DOI 10.1247/csf.15.163; RECIOPINTO E, 1990, NEURON, V5, P675, DOI 10.1016/0896-6273(90)90221-Z; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; RYO Y, 1993, J NEUROSCI RES, V36, P19, DOI 10.1002/jnr.490360104; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; WAECHTER CJ, 1983, J BIOL CHEM, V258, P5117; WATRAS J, 1991, J NEUROSCI, V11, P3239; YAMAMOTOHINO M, 1994, IN PRESS RECEPORS CH; YOSHIKAWA S, 1992, J BIOL CHEM, V267, P16613; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	44	121	124	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9184	9189						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132655				2022-12-27	WOS:A1994NB41100083
J	SHANI, N; ROSENBERG, N; KASARDA, DD; GALILI, G				SHANI, N; ROSENBERG, N; KASARDA, DD; GALILI, G			MECHANISMS OF ASSEMBLY OF WHEAT HIGH-MOLECULAR-WEIGHT GLUTENINS INFERRED FROM EXPRESSION OF WILD-TYPE AND MUTANT SUBUNITS IN TRANSGENIC TOBACCO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRITICUM-AESTIVUM L; GEL-ELECTROPHORESIS; NUCLEOTIDE-SEQUENCE; DISULFIDE BONDS; PROTEIN BODIES; GENERAL-METHOD; BREAD WHEAT; ENDOSPERM; REVEALS; VECTORS	Following sequestration into the endoplasmic reticulum, wheat high molecular weight glutenin subunits (HMW-GS) assemble into polymers through intermolecular disulfide bond formation. These polymers, which also include low molecular weight glutenin subunits (HMW-GS), have a broad distribution of molecular mass reaching up to several million daltons. To study the mechanism of assembly of the HMW-GS, we have expressed x- and y-type HMW-GS in transgenic tobacco plants. Both types, when expressed individually or in combination, were incorporated into polymers. Partial reduction of polymers formed by different subunits re suited in different patterns of release of homodimers, heterodimers, and monomers. This suggested different arrangements of intermolecular disulfide bonds or different peptide conformations in the vicinity of the disulfide bonds linking x-x, y-y, and x-y type HMW-GS. A mutant of the x type subunit, lacking a conserved cysteine in the C-terminal domain, assembled into oligomers linked by intermolecular disulfide bonds, but not into large polymers. This mutant was deposited, however, in dense protein bodies, similar to those formed by the native HMW-GS, suggesting that polymer formation and packaging into protein bodies may be the result of different types of interactions. Pulse-chase labeling of proteins in wheat endosperm showed that the assembly of the HMW-GS into insoluble polymers occurs by a slow process which apparently continues after the initiation of protein body formation.	WEIZMANN INST SCI,DEPT PLANT GENET,IL-76100 REHOVOT,ISRAEL; USDA ARS,WESTERN REG RES CTR,ALBANY,CA 94710	Weizmann Institute of Science; United States Department of Agriculture (USDA)								AN GH, 1986, PLANT PHYSIOL, V81, P86, DOI 10.1104/pp.81.1.86; ANDERSON OD, 1989, THEOR APPL GENET, V77, P689, DOI 10.1007/BF00261246; COLMAN A, 1984, BIOCHEM SOC T, V12, P932, DOI 10.1042/bst0120932; EWART JAD, 1979, J SCI FOOD AGR, V30, P482, DOI 10.1002/jsfa.2740300507; EWART JAD, 1968, J SCI FOOD AGR, V19, P617, DOI 10.1002/jsfa.2740191101; EWART JAD, 1987, J SCI FOOD AGR, V38, P277, DOI 10.1002/jsfa.2740380312; EWART JAD, 1988, CEREAL CHEM, V65, P95; FORDE J, 1985, NUCLEIC ACIDS RES, V13, P6817, DOI 10.1093/nar/13.19.6817; GALILI G, 1983, THEOR APPL GENET, V66, P77, DOI 10.1007/BF00281853; GALLIE DR, 1989, PLANT CELL, V1, P301, DOI 10.1105/tpc.1.3.301; GAO L, 1992, CEREAL CHEM, V69, P452; GRAVELAND A, 1985, J CEREAL SCI, V3, P1, DOI 10.1016/S0733-5210(85)80029-1; HALFORD NG, 1987, THEOR APPL GENET, V75, P117, DOI 10.1007/BF00249151; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Kasarda D.D., 1989, WHEAT UNIQUE, V277, P302; KHAN K, 1979, CEREAL CHEM, V56, P63; KOHLER P, 1991, Z LEBENSM UNTERS FOR, V192, P234, DOI 10.1007/BF01202885; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE GJ, 1988, J CEREAL SCI, V7, P109, DOI [10.1016/S0733-5210(88)80012-2, 10.1006/jcrs.1997.0158]; LAWRENCE GJ, 1983, J EXP BOT, V34, P254, DOI 10.1093/jxb/34.3.254; MATSUSHIMA N, 1992, BIOCHEM BIOPH RES CO, V186, P1057, DOI 10.1016/0006-291X(92)90854-E; Miflin B. J., 1983, Seed proteins, P255; MILLET E, 1991, PHYSIOL PLANTARUM, V83, P591, DOI 10.1111/j.1399-3054.1991.tb02473.x; PAYNE PI, 1981, THEOR APPL GENET, V60, P229, DOI 10.1007/BF02342544; PAYNE PI, 1984, PHILOS T R SOC B, V304, P359, DOI 10.1098/rstb.1984.0031; ROBERT LS, 1989, PLANT CELL, V1, P569, DOI 10.1105/tpc.1.6.569; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; RUBIN R, 1992, PLANT PHYSIOL, V99, P718, DOI 10.1104/pp.99.2.718; SHANI N, 1992, PLANT PHYSIOL, V98, P433, DOI 10.1104/pp.98.2.433; SHEWRY PR, 1989, OXFORD SURV PLANT MO, V6, P163; SHOTWELL MA, 1988, BIOCH PLANTS, P297; SUGIYAMA T, 1985, NUCLEIC ACIDS RES, V13, P8729, DOI 10.1093/nar/13.24.8729; TAO HP, 1992, BIOCHIM BIOPHYS ACTA, V1159, P13; TATHAM AS, 1984, FEBS LETT, V177, P205, DOI 10.1016/0014-5793(84)81284-3; THOMPSON RD, 1985, NUCLEIC ACIDS RES, V13, P6833, DOI 10.1093/nar/13.19.6833; WALLACE JC, 1988, SCIENCE, V240, P662, DOI 10.1126/science.2834822; WERNER WE, 1992, CEREAL CHEM, V69, P535	38	36	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8924	8930						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132629				2022-12-27	WOS:A1994NB41100047
J	WHITE, AL; HIXSON, JE; RAINWATER, DL; LANFORD, RE				WHITE, AL; HIXSON, JE; RAINWATER, DL; LANFORD, RE			MOLECULAR-BASIS FOR NULL LIPOPROTEIN(A) PHENOTYPES AND THE INFLUENCE OF APOLIPOPROTEIN(A) SIZE ON PLASMA LIPOPROTEIN(A) LEVEL IN THE BABOON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APO(A) MESSENGER-RNA; PROTEIN; CELL; OLIGOSACCHARIDES; HETEROGENEITY; POLYMORPHISM; HEPATOCYTES; INHERITANCE; SEQUENCE; ISOFORMS	High plasma levels of lipoprotein(a) (Lp(a)) and its unique apolipoprotein, apo(a), are an independent risk factor for cardiovascular disease. Plasma Lp(a) levels vary over a 1000-fold range and are determined by the apo(a) locus, which has at least 34 alleles expressing apo(a) isoforms with molecular weights from <300,000 to >800,000. In addition, ''null'' apo(a) alleles produce no detectable plasma apo(a). We used primary cultures of baboon hepatocytes to investigate the molecular basis for null apo(a) phenotypes. Immunoprecipitation of apo(a) after radiolabeling of hepatocytes revealed that some null alleles gave rise to intracellular protein products that were not secreted. Pulse chase analysis and endoglycosidase digests demonstrated that these proteins were retained in the endoplasmic reticulum. We also examined the molecular basis for the documented inverse correlation between apo(a) size and plasma Lp(a) concentration. Steady-state labeling and pulse-chase analysis of hepatocytes from animals expressing two isoforms of apo(a) revealed that the endoplasmic reticulum residence time of secreted apo(a) isoforms was determined by their size. This accounted for the inverse relationship between isoform size and level of secretion. We conclude that the efficiency of post-translational processing of apo(a) is a major determinant of plasma Lp(a) concentration.	SW FDN BIOMED RES,DEPT VIROL & IMMUNOL,SAN ANTONIO,TX 78228; SW FDN BIOMED RES,DEPT GENET,SAN ANTONIO,TX 78228	Texas Biomedical Research Institute; Texas Biomedical Research Institute				Hixson, James/0000-0002-0849-9315	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL040637, P01HL028972] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL40637, HL28972] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERS JJ, 1977, J LIPID RES, V18, P331; Amara J F, 1992, Trends Cell Biol, V2, P145, DOI 10.1016/0962-8924(92)90101-R; AZROLAN N, 1991, J BIOL CHEM, V266, P13866; BERG K, 1963, ACTA PATHOL MIC SC, V59, P369; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; COHEN JC, 1993, J CLIN INVEST, V91, P1630, DOI 10.1172/JCI116370; FLESS GM, 1986, J BIOL CHEM, V261, P8712; Gaubatz J W, 1986, Methods Enzymol, V129, P167; GAUBATZ JW, 1990, J LIPID RES, V31, P603; GAVISH D, 1989, J CLIN INVEST, V84, P2021, DOI 10.1172/JCI114395; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HERBERT PN, 1983, METABOLIC BASIS INHE, P589; HIXSON JE, 1989, J BIOL CHEM, V264, P6013; HUGHES RC, 1964, BIOCHEMISTRY-US, V3, P1535, DOI 10.1021/bi00898a025; KAMBOH MI, 1991, AM J HUM GENET, V49, P1063; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KRAFT HG, 1989, J CLIN INVEST, V83, P137, DOI 10.1172/JCI113849; KREMPLER F, 1980, J CLIN INVEST, V65, P1483, DOI 10.1172/JCI109813; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; LACKNER C, 1991, J CLIN INVEST, V87, P2153, DOI 10.1172/JCI115248; LANFORD RE, 1989, IN VITRO CELL DEV B, V25, P174; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; MARCOVINA SM, 1993, BIOCHEM BIOPH RES CO, V191, P1192, DOI 10.1006/bbrc.1993.1343; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; RAINWATER DL, 1989, BIOCHIM BIOPHYS ACTA, V1003, P30, DOI 10.1016/0005-2760(89)90094-5; RAINWATER DL, 1986, BIOCHIM BIOPHYS ACTA, V877, P75, DOI 10.1016/0005-2760(86)90120-7; RAINWATER DL, 1989, J LIPID RES, V30, P549; RAINWATER DL, 1988, ATHEROSCLEROSIS, V73, P23, DOI 10.1016/0021-9150(88)90159-1; SANDHOLZER C, 1991, HUM GENET, V86, P607; SCANU AM, 1990, J CLIN INVEST, V85, P1709, DOI 10.1172/JCI114625; TANABE S, 1989, IN VITRO CELL DEV B, V25, P1129; TARENTINO AL, 1974, J BIOL CHEM, V249, P818; TOMLINSON JE, 1989, J BIOL CHEM, V264, P5957; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; UTERMANN G, 1987, J CLIN INVEST, V80, P458, DOI 10.1172/JCI113093; WETTESTEN M, 1985, EUR J BIOCHEM, V149, P461, DOI 10.1111/j.1432-1033.1985.tb08947.x; WHITE AL, 1993, J LIPID RES, V34, P509; WHITE AL, 1992, J BIOL CHEM, V267, P15657; WHITE AL, 1994, IN PRESS CHEM PHYS L	40	89	91	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9060	9066						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132643				2022-12-27	WOS:A1994NB41100067
J	CAZAUX, C; LARMINAT, F; VILLANI, G; JOHNSON, NP; SCHNARR, M; DEFAIS, M				CAZAUX, C; LARMINAT, F; VILLANI, G; JOHNSON, NP; SCHNARR, M; DEFAIS, M			PURIFICATION AND BIOCHEMICAL-CHARACTERIZATION OF ESCHERICHIA-COLI RECA PROTEINS MUTATED IN THE PUTATIVE DNA-BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; LARGE-SCALE PURIFICATION; MUTAGENESIS PROTEIN; LAMBDA-REPRESSOR; DEPENDENT ATPASE; LEXA REPRESSOR; SSB PROTEIN; EXCHANGE; RECOMBINATION; CLEAVAGE	Escherichia coli RecA protein plays a central role both in DNA repair and in recombination. We report biochemical properties of three new RecA proteins mutated at positions 199 (RecA694), 207 (RecA659), and 211 (RecA611) in the putative DNA binding site. RecA694 had a wild-type phenotype, whereas RecA611 and RecA659 were deficient in promoting both the self-cleavage of LexA repressor and the DNA-strand exchange reaction. In order to determine the origin of this inhibition, we examined the capacity of wild-type and mutant proteins to bind to single-stranded DNA (with and without single- stranded binding protein, SSB), double-stranded DNA, and ATP. DNA strand exchange defects were correlated with the inability of mutant proteins to displace SSB from DNA. For the recA659 mutation this inhibition was reversed by equimolar wild-type protein. In contrast, mixtures of either wild-type/RecA659 or wild-type/ RecA611 proteins remained deficient in LexA cleavage, suggesting that the dominant negative phenotype of the mutant proteins may be a consequence of the formation heterologous RecA complexes. Various mutations in the putative DNA binding site of RecA protein altered ATP binding, ATPase activity, displacement of SSB from single-stranded DNA, and protein-protein interactions. These results are consistent with the hypothesis that DNA binding to this site of RecA relays allosteric effects to several functional domains throughout the protein.	LAB PHARMACOL & TOXICOL FONDAMENTALES,CNRS,UPR 8221,F-31077 TOULOUSE,FRANCE	Centre National de la Recherche Scientifique (CNRS)								BEDALE WA, 1991, J BIOL CHEM, V266, P6499; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; BLANCO M, 1975, MOL MECHANISMS REPAI, P379; BRYANT FR, 1985, J BIOL CHEM, V260, P1196; BURCKHARDT SE, 1988, P NATL ACAD SCI USA, V85, P1811, DOI 10.1073/pnas.85.6.1811; CALSOU P, 1987, J BACTERIOL, V169, P4816, DOI 10.1128/jb.169.10.4816-4821.1987; CALSOU P, 1985, MOL GEN GENET, V201, P1162; CAZAUX C, 1991, BIOCHIMIE, V73, P281, DOI 10.1016/0300-9084(91)90214-L; CAZAUX C, 1992, J MOL BIOL, V223, P823, DOI 10.1016/0022-2836(92)90243-D; COX MM, 1983, J BIOL CHEM, V258, P2577; COX MM, 1981, J BIOL CHEM, V256, P4676; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; COX MM, 1987, ANNU REV BIOCHEM, V56, P229, DOI 10.1146/annurev.bi.56.070187.001305; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; DICAPUA E, 1992, J MOL BIOL, V226, P707, DOI 10.1016/0022-2836(92)90627-V; DONNELLY CE, 1989, J BACTERIOL, V171, P6117, DOI 10.1128/jb.171.11.6117-6125.1989; DUTREIX M, 1989, J BACTERIOL, V171, P2415, DOI 10.1128/jb.171.5.2415-2423.1989; GUDAS LJ, 1977, P NATL ACAD SCI USA, V74, P5280, DOI 10.1073/pnas.74.12.5280; HONIGBERG SM, 1985, J BIOL CHEM, V260, P1845; HOWARDFLANDERS P, 1987, DNA REPLICATION RECO, P609; IWABUCHI MA, 1983, J BIOL CHEM, V258, P2394; JWANG BR, 1992, P NATL ACAD SCI USA, V89, P7596, DOI 10.1073/pnas.89.16.7596; KNIGHT KL, 1985, J BIOL CHEM, V260, P177; KNIGHT KL, 1985, J BIOL CHEM, V260, P185; KOWALCZYKOWSKI SC, 1987, TRENDS BIOCHEM SCI, V12, P141, DOI 10.1016/0968-0004(87)90070-3; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; KRUEGER JH, 1984, P NATL ACAD SCI-BIOL, V81, P1499, DOI 10.1073/pnas.81.5.1499; LARMINAT F, 1989, MOL GEN GENET, V216, P106, DOI 10.1007/BF00332237; LARMINAT F, 1992, J BACTERIOL, V174, P6264, DOI 10.1128/JB.174.19.6264-6269.1992; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; LU C, 1987, J MOL BIOL, V196, P497, DOI 10.1016/0022-2836(87)90027-1; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; MENETSKI JP, 1990, J MOL BIOL, V211, P845, DOI 10.1016/0022-2836(90)90078-Z; MENETSKI JP, 1988, BIOCHEMISTRY-US, V27, P1205, DOI 10.1021/bi00404a021; MOREAU PL, 1984, MOL GEN GENET, V198, P25, DOI 10.1007/BF00328696; MORRICAL SW, 1990, BIOCHEMISTRY-US, V29, P837, DOI 10.1021/bi00455a034; NOHMI T, 1988, P NATL ACAD SCI USA, V85, P1816, DOI 10.1073/pnas.85.6.1816; Ogawa H, 1986, Adv Biophys, V21, P135, DOI 10.1016/0065-227X(86)90019-5; OGAWA T, 1979, COLD SPRING HARB SYM, V43, P909, DOI 10.1101/SQB.1979.043.01.099; PANUSKA JR, 1980, J BIOL CHEM, V255, P5208; Radding C.M., 1988, GENETIC RECOMBINATIO, P193; REBOLLO JE, 1984, MOL GEN GENET, V195, P83, DOI 10.1007/BF00332728; RIDDLES PW, 1985, J BIOL CHEM, V260, P170; ROBERTS JW, 1983, LAMBDA, V2, P123; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; ROSSELLI W, 1990, J MOL BIOL, V216, P335, DOI 10.1016/S0022-2836(05)80325-0; ROSSELLI W, 1991, EMBO J, V10, P4391, DOI 10.1002/j.1460-2075.1991.tb05017.x; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; RYDBERG B, 1990, J BIOL CHEM, V265, P9563; SCHNARR M, 1985, BIOCHEMISTRY-US, V24, P2812, DOI 10.1021/bi00332a032; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8764; WANG TV, 1986, MUTAT RES, V165, P39, DOI 10.1016/0167-8817(86)90007-6; WANG WB, 1986, J BACTERIOL, V168, P901, DOI 10.1128/jb.168.2.901-910.1986; WEST SC, 1981, NATURE, V294, P659, DOI 10.1038/294659a0; WOODGATE R, 1989, P NATL ACAD SCI USA, V86, P7301, DOI 10.1073/pnas.86.19.7301; YANCEY SD, 1984, MOL GEN GENET, V193, P53, DOI 10.1007/BF00327413	61	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8246	8254						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132549				2022-12-27	WOS:A1994NB40900064
J	GAUDU, P; TOUATI, D; NIVIERE, V; FONTECAVE, M				GAUDU, P; TOUATI, D; NIVIERE, V; FONTECAVE, M			THE NAD(P)H-FLAVIN OXIDOREDUCTASE FROM ESCHERICHIA-COLI AS A SOURCE OF SUPEROXIDE RADICALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISMUTASE; REDUCTASE; GENERATION; EXPRESSION; REGULON; OXYGEN; ENZYME; FUR; ARC	The NAD(P)H:flavin oxidoreductase (encoded by the fre gene) of Escherichia coli is a soluble enzyme which, under aerobic conditions and together with NAD(P)H and flavins, generates superoxide radicals selectively. This was demonstrated from spin trapping experiments and from the ability of the flavin reductase to achieve a superoxide dismutase (SOD)-sensitive reduction of cyto chrome c. The participation of the flavin reductase to O-2(radical-anion). generation in E. coli cells has been studied. Superoxide production in dialyzed cytosolic fraction of SOD-deficient E. coli was stimulated by the addition of flavins. There was no stimulation in soluble extracts of flavin reductase-deficient strains. Moreover, using fusions of sodA promoter to lacZ, we showed that sodA transcription was diminished in flavin reductase-deficient E. coli and that the induction of MnSOD by flavin reductase was SoxRS-independent. These results suggest that the flavin reductase might: (i) in vivo, be an important cytosolic site of O-2(radical-anion). generation; (ii) in vitro, serve as a simple, efficient, and selective O-2(radical-anion). generator.	UNIV JOSEPH FOURIER, ETUD DYNAM & STRUCT SELECT LAB, CTR NATL RECH SCI, UNITE ASSOCIEE 332, F-38041 GRENOBLE 9, FRANCE; UNIV PARIS 07, INST JACQUES MONOD, CTR NATL RECH SCI, F-75251 PARIS 05, FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite			GAUDU, Philippe/AFE-8376-2022	Niviere, Vincent/0000-0002-5132-457X				BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; COMPAN I, 1993, J BACTERIOL, V175, P1687, DOI 10.1128/JB.175.6.1687-1696.1993; COVES J, 1993, J BIOL CHEM, V268, P18604; COVES J, 1993, EUR J BIOCHEM, V211, P635, DOI 10.1111/j.1432-1033.1993.tb17591.x; DAVIES MJ, 1987, BIOCHEM J, V246, P725, DOI 10.1042/bj2460725; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; FARR SB, 1986, P NATL ACAD SCI USA, V83, P8268, DOI 10.1073/pnas.83.21.8268; FEE JA, 1991, MOL MICROBIOL, V5, P2599, DOI 10.1111/j.1365-2958.1991.tb01968.x; FINKELSTEIN E, 1979, MOL PHARMACOL, V16, P676; FONTECAVE M, 1987, J BIOL CHEM, V262, P12325; FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6; Fridovich I., 1985, CRC HDB METHODS OXYG; GARDNER PR, 1993, J BIOL CHEM, V268, P12958; GREENBERG JT, 1990, P NATL ACAD SCI USA, V87, P6181, DOI 10.1073/pnas.87.16.6181; GROVER TA, 1981, ARCH BIOCHEM BIOPHYS, V212, P105, DOI 10.1016/0003-9861(81)90348-9; HASSAN HM, 1992, P NATL ACAD SCI USA, V89, P3217, DOI 10.1073/pnas.89.8.3217; HASSAN HM, 1979, ARCH BIOCHEM BIOPHYS, V196, P385, DOI 10.1016/0003-9861(79)90289-3; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; LLOYD RV, 1990, J BIOL CHEM, V265, P16733; Miller J.H., 1972, EXPT MOL GENETICS; MISRA HP, 1972, J BIOL CHEM, V247, P188; ROSEN GM, 1982, ARCH BIOCHEM BIOPHYS, V215, P367, DOI 10.1016/0003-9861(82)90097-2; ROWLEY DL, 1991, J BACTERIOL, V173, P968, DOI 10.1128/jb.173.3.968-977.1991; SPYROU G, 1991, J BACTERIOL, V173, P3673, DOI 10.1128/JB.173.12.3673-3679.1991; TARDAT B, 1991, MOL MICROBIOL, V5, P455, DOI 10.1111/j.1365-2958.1991.tb02129.x; TSANEVA IR, 1990, J BACTERIOL, V172, P4197, DOI 10.1128/jb.172.8.4197-4205.1990	27	60	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8182	8188						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132544				2022-12-27	WOS:A1994NB40900056
J	JACOBSEN, JS; SPRUYT, MA; BROWN, AM; SAHASRABUDHE, SR; BLUME, AJ; VITEK, MP; MUENKEL, HA; SONNENBERGREINES, J				JACOBSEN, JS; SPRUYT, MA; BROWN, AM; SAHASRABUDHE, SR; BLUME, AJ; VITEK, MP; MUENKEL, HA; SONNENBERGREINES, J			THE RELEASE OF ALZHEIMERS-DISEASE BETA-AMYLOID PEPTIDE IS REDUCED BY PHORBOL TREATMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PRECURSOR PROTEIN; INDEPENDENT MECHANISMS; MANNOSE 6-PHOSPHATE; PHOSPHORYLATION; RECEPTOR; CLEAVAGE; DERIVATIVES; SECRETION; MEMBRANE	Amyloid precursor protein (APP) is cleaved predominantly within the beta amyloid peptide (BAP) domain to release a non-amyloidogenic amino-terminal PN2 fragment. Treatment of cells with phorbol dibutyrate, an agent which activates protein kinase C, has been shown to increase the release of an amino-terminal fragment. A panel of mutant APP reporter constructs was expressed in which each of the potential phosphorylation sites located within the cytoplasmic domain of APP was replaced with alanine residues. Phorbol response patterns were unchanged for each of these mutants, suggesting that induced cleavage occurs independently of APP substrate phosphorylation. We find that phorbol (a) increases the release of a PN2 fragment that is consistent with the normal secretase activity, (b) decreases the release of a shorter amino terminal APP fragment that is cleaved near the amino terminus of BAP, and (c) decreases the release of BAP which was identified based on electrophoretic mobility, epitope mapping, and radiosequencing. These data demonstrate that pharmacological treatment can reduce the formation of BAP and suggests that protein kinase C activators could be developed as therapeutic agents to block BAP formation.	AMER CYANAMID CO, LEDERLE LABS, DIV MED RES, DEPT MOLEC PHARMACOL, PEARL RIVER, NY 10965 USA		JACOBSEN, JS (corresponding author), AMER CYANAMID CO, LEDERLE LABS, DIV MED RES, DEPT CENT NERVOUS SYST BIOL RES, BLDG 200, PEARL RIVER, NY 10965 USA.		brown, abraham/R-8823-2019	Vitek, Michael/0000-0001-8140-8048				ANDERSON JP, 1992, J NEUROCHEM, V59, P2328; BEGUINOT L, 1985, P NATL ACAD SCI USA, V82, P2774, DOI 10.1073/pnas.82.9.2774; BRAULKE T, 1990, EUR J BIOCHEM, V189, P609, DOI 10.1111/j.1432-1033.1990.tb15529.x; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; CHAPLINE C, 1993, J BIOL CHEM, V268, P6858; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; DAMKE H, 1992, BIOCHEM J, V281, P225, DOI 10.1042/bj2810225; DESTROOPER B, 1992, FEBS LETT, V308, P50, DOI 10.1016/0014-5793(92)81048-Q; DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295; DOWNING JR, 1989, MOL CELL BIOL, V9, P2890, DOI 10.1128/MCB.9.7.2890; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P10065, DOI 10.1021/bi00106a001; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; FLOOD JF, 1991, P NATL ACAD SCI USA, V88, P3363, DOI 10.1073/pnas.88.8.3363; GANDY S, 1988, P NATL ACAD SCI USA, V85, P6218, DOI 10.1073/pnas.85.16.6218; GILLESPIE SL, 1992, BIOCHEM BIOPH RES CO, V187, P1285, DOI 10.1016/0006-291X(92)90442-N; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HARDY J, 1992, SCIENCE, V359, P268; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; ISHIURA S, 1991, J NEUROCHEM, V56, P363, DOI 10.1111/j.1471-4159.1991.tb08160.x; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LANTZ M, 1990, J CLIN INVEST, V86, P1396, DOI 10.1172/JCI114853; LIN CR, 1986, CELL, V44, P839, DOI 10.1016/0092-8674(86)90006-1; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; PALMERT MR, 1989, BIOCHEM BIOPH RES CO, V165, P182, DOI 10.1016/0006-291X(89)91052-8; PANDIELLA A, 1991, P NATL ACAD SCI USA, V88, P1726, DOI 10.1073/pnas.88.5.1726; SAHASRABUDHE SR, 1992, J BIOL CHEM, V267, P25602; SAMBAMURTI K, 1992, J NEUROSCI RES, V33, P319, DOI 10.1002/jnr.490330216; SELKOE DJ, 1989, CELL, V58, P611, DOI 10.1016/0092-8674(89)90093-7; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1992, ANN NY ACAD SCI, V674, P53, DOI 10.1111/j.1749-6632.1992.tb27476.x; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SUZUKI T, 1992, NEUROSCIENCE, V48, P755, DOI 10.1016/0306-4522(92)90264-3; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531	55	88	95	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8376	8382						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132561				2022-12-27	WOS:A1994NB40900082
J	MIURA, S; ICHIKAWA, Y				MIURA, S; ICHIKAWA, Y			INTERACTION OF NADPH-ADRENOFERREDOXIN REDUCTASE WITH NADP(+) AND ADRENOFERREDOXIN - EQUILIBRIUM AND DYNAMIC PROPERTIES INVESTIGATED BY PROTON NUCLEAR-MAGNETIC-RESONANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROIDOGENIC ELECTRON-TRANSPORT; BOVINE ADRENOCORTICAL MITOCHONDRIA; ADRENODOXIN REDUCTASE; ADRENAL-CORTEX; GLUTATHIONE-REDUCTASE; CONFORMATIONAL CHANGE; SEQUENCE-ANALYSIS; FERREDOXIN; PROTEINS; COMPLEX	NADPH-adrenoferredoxin reductase, a flavoprotein from bovine adrenocortical mitochondria, has been investigated to elucidate the equilibrium and dynamic properties of the interaction with NADP(+) and adrenoferredoxin (adrenodoxin) using proton NMR spectroscopy. The line width of the signals from NADP(+) depends on the presence of the reductase. The off rate constant of NADP(+) from the reductase is estimated to be about 15 similar to 20 s(-1) on the basis of line width measurements. No appreciable difference in off rate is detected between adenine and nicotinamide moieties of NADP(+). Transferred nuclear Overhauser effect experiments for NADP(+) indicate the time-dependent magnetization transfer profiles with a long lag phase. The proton NMR spectra during the titration of the reductase with adrenodoxin reveal that the reductase possesses distinct binding sites for both NADP(+) and adrenodoxin. The sharp resonances in the aromatic region due to His-10 and His-62 of adrenodoxin were utilized as a probe to explore the interaction with the reductase. In the mixture of adrenodoxin and the reductase at the mol ratio of 6:1, T-1 values of the histidine residue in adrenodoxin were measured by the inversion recovery method. At low ionic strength, T-1 values of the resonances are not affected in the presence or absence of the reductase, In the presence of the reductase, T-1 values of resonances resulting from the histidine residues become shorter as the concentration of KCl increases because of rapid exchange between bound and free states. At low ionic strength (10 mM phosphate buffer), the off rate from the reductase is estimated to be less than about 4 s(-1). The off rate of adrenodoxin from the reductase could be the rate-limiting step in cytochrome c reductase activity at low ionic strength.			MIURA, S (corresponding author), KAGAWA MED SCH,DEPT BIOCHEM,MIKI,KAGAWA 76107,JAPAN.							BANERJEE A, 1987, BIOCHEMISTRY-US, V26, P8443, DOI 10.1021/bi00399a062; CHU JW, 1973, J BIOL CHEM, V248, P5183; CLORE GM, 1983, J MAGN RESON, V53, P423, DOI 10.1016/0022-2364(83)90215-9; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; COGHLAN VM, 1991, J BIOL CHEM, V266, P18606; COGHLAN VM, 1992, J BIOL CHEM, V267, P8932; FERRIN LJ, 1985, BIOCHEMISTRY-US, V24, P6904, DOI 10.1021/bi00345a024; GEREN LM, 1984, J BIOL CHEM, V261, P15491; HIWATASHI A, 1976, BIOCHEMISTRY-US, V15, P3082, DOI 10.1021/bi00659a023; HIWATASHI A, 1986, FEBS LETT, V209, P311, DOI 10.1016/0014-5793(86)81133-4; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; KAMIN H, 1982, FLAVINS FLAVOPROTEIN, P655; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; KARPLUS PA, 1987, J MOL BIOL, V195, P701, DOI 10.1016/0022-2836(87)90191-4; KOUDA D, 1987, BIOCHEMISTRY-US, V26, P6531; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBETH JD, 1980, J BIOL CHEM, V255, P4667; LAMBETH JD, 1979, J BIOL CHEM, V254, P7255; LAMBETH JD, 1981, J BIOL CHEM, V256, P3674; LAMBETH JD, 1982, MOL CELL BIOCHEM, V45, P13, DOI 10.1007/BF01283159; LIGHT DR, 1980, J BIOL CHEM, V255, P4264; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MIURA S, 1991, EUR J BIOCHEM, V197, P747, DOI 10.1111/j.1432-1033.1991.tb15967.x; MIURA S, 1991, J BIOL CHEM, V266, P19212; MIURA S, 1991, J BIOL CHEM, V266, P6252; NONAKA Y, 1987, BIOCHEM BIOPH RES CO, V145, P1239, DOI 10.1016/0006-291X(87)91570-1; NONAKA Y, 1985, J BIOCHEM-TOKYO, V97, P1263, DOI 10.1093/oxfordjournals.jbchem.a135177; OMURA T, 1966, ARCH BIOCHEM BIOPHYS, V117, P660, DOI 10.1016/0003-9861(66)90108-1; PAI EF, 1988, BIOCHEMISTRY-US, V27, P4465, DOI 10.1021/bi00412a038; PUEYO JJ, 1989, EUR J BIOCHEM, V183, P539, DOI 10.1111/j.1432-1033.1989.tb21082.x; ROSEVEAR PR, 1987, BIOCHEMISTRY-US, V26, P5338, DOI 10.1021/bi00391a018; SAGARA Y, 1987, J BIOCHEM-TOKYO, V102, P1333, DOI 10.1093/oxfordjournals.jbchem.a122178; SANDSTROM J, 1982, DYNAMIC NMR SPECTROS, P6; SHIN M, 1968, FLAVINS FLAVOPROTEIN, P1; SUHARA K, 1972, FEBS LETT, V28, P45, DOI 10.1016/0014-5793(72)80673-2; WEBER DJ, 1991, BIOCHEMISTRY-US, V30, P7425, DOI 10.1021/bi00244a009; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P93; ZUIDERWEG ERP, 1986, J MAGN RESON, V70, P336, DOI 10.1016/0022-2364(86)90020-X	39	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8001	8006						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132521				2022-12-27	WOS:A1994NB40900029
J	ALBERTY, RA				ALBERTY, RA			THERMODYNAMICS OF THE NITROGENASE REACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIFIED PH; PMG	The thermodynamics of the nitrogenase reactions are discussed in terms of chemical equations and biochemical equations. Chemical equations balance all elements and electric charge. Biochemical equations represent changes at specified pH and specified free concentrations of metal ions that are bound by reactants, but they do not balance hydrogen or metal ions that have specified free concentrations. At a specified pH, it takes three separate biochemical equations to represent the changes catalyzed by nitrogenase. N-2(g) + 8 Fd(red) = 2 ammonia + 8 Fd(ox) + H-2(g) 2 Fd(red) = 2 Fd(ox) + H-2(g) ATP + H2O = ADP + P-i. The first two equations are required because the nitrogenase and hydrogenase activities of the enzyme have not been separated. The hydrolysis of ATP is necessary, but it is not coupled stoichiometrically to the first two equations. The function of the hydrolysis of ATP by nitrogenase may be to provide the 10 H+ required per mol of N-2 consumed. However, reactions cannot generally be coupled stoichiometrically through H+ because H+ is potentially available by dissociation of protein, buffer, and H2O. The standard Gibbs energies of formation of the reactant species are calculated for 25 degrees C, 1 bar, and ionic strengths of 0 and 0.25 M. The standard transformed Gibbs energies of formation of the reactants are calculated at 25 degrees C, 1 bar, pH 7, and ionic strengths of 0 and 0.25 M.			ALBERTY, RA (corresponding author), MIT,DEPT CHEM,CAMBRIDGE,MA 02139, USA.							ALBERTY RA, 1992, BIOPHYS CHEM, V42, P117, DOI 10.1016/0301-4622(92)85002-L; ALBERTY RA, 1992, BIOCHEMISTRY-US, V31, P10610, DOI 10.1021/bi00158a025; ALBERTY RA, 1992, BIOPHYS CHEM, V43, P239, DOI 10.1016/0301-4622(92)85024-X; BURRIS RH, 1991, J BIOL CHEM, V266, P9339; CLARKE HB, 1954, BIOCHEM J, V58, P146, DOI 10.1042/bj0580146; GOLDBERG RN, 1989, J PHYS CHEM REF DATA, V18, P809, DOI 10.1063/1.555831; HADFIELD KL, 1969, BIOCHEMISTRY-US, V8, P5103, DOI 10.1021/bi00840a064; HAGEMAN RV, 1980, BIOCHIM BIOPHYS ACTA, V591, P63, DOI 10.1016/0005-2728(80)90220-0; JENG DY, 1970, J BIOL CHEM, V245, P2809; LIANG JH, 1988, BIOCHEMISTRY-US, V27, P6726, DOI 10.1021/bi00418a013; SEIDEL A, 1919, SOLUBILITIES; SIMPSON FB, 1984, SCIENCE, V224, P1095, DOI 10.1126/science.6585956; STOMBAUGH NA, 1976, BIOCHEMISTRY-US, V15, P2633, DOI 10.1021/bi00657a024; TAGAWA K, 1968, BIOCHIM BIOPHYS ACTA, V153, P602, DOI 10.1016/0005-2728(68)90188-6; Wagman D. D., 1982, J PHYS CHEM REF D S2, V11; Webb E. C., 1992, ENZYME NOMENCLATURE; WINTER HC, 1968, J BIOL CHEM, V243, P940	17	40	40	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7099	7102						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125917				2022-12-27	WOS:A1994NA03200012
J	ASTURIAS, JA; ELTIS, LD; PRUCHA, M; TIMMIS, KN				ASTURIAS, JA; ELTIS, LD; PRUCHA, M; TIMMIS, KN			ANALYSIS OF 3,2,3-DIHYDROXYBIPHENYL 1,2-DIOXYGENASES FOUND IN RHODOCOCCUS-GLOBERULUS P6 - IDENTIFICATION OF A NEW FAMILY OF EXTRADIOL DIOXYGENASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCHLORINATED BIPHENYL DEGRADATION; CATECHOL 2,3-OXYGENASE GENES; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; PSEUDOMONAS-PSEUDOALCALIGENES; ENCODING BIPHENYL; TOL PLASMID; EXPRESSION; CLONING; DNA	The polychlorobiphenyl-degrading bacterium Rhodococcus globerulus P6 contains three bphC genes encoding 2,3-dihydroxybiphenyl 1,2-dioxygenases. One of them, bphC1, is clustered with the bphB gene which encodes 2,3-dihydroxy-4-phenylhexa-4,6-diene dehydrogenase and constitutes part of the bph operon specifying the degradation of biphenyl. The nucleotide sequence of bphB and the three bphC genes has been determined. The protein products of the bphBC1 gene cluster were found to exhibit significant homology with the corresponding proteins of analogous degradative pathways in Gram-negative bacteria; the highest homology was in those of the toluene degradation pathway of Pseudomonas putida strain F1. No homology was found between bphC2 and bphC3 and any other sequence in the database. At least two of the three meta cleavage enzymes are inducible by biphenyl. 2,3-Dihydroxybiphenyl 1,2-dioxygenase II, encoded by the bphC2 gene, was purified to apparent homogeneity from a recombinant Escherichia coli strain. The enzyme differed from other extradiol dioxygenases in having a subunit molecular mass of 21 kDa and a hexameric structure. The enzyme contains one tightly bound iron per subunit. These characteristics demonstrate that the 2,3-dihydroxybiphenyl 1,2-dioxygenases encoded by bphC2 and bphC3 belong to a new class of extradiol dioxygenases.	GESELL BIOTECHNOL FORSCH MBH,NATL RES CTR BIOTECHNOL,DEPT MICROBIOL,D-38124 BRAUNSCHWEIG,GERMANY	Gesellschaft fur Biotechnologische Forschung mbH			Eltis, Lindsay D/J-8272-2015	Eltis, Lindsay D/0000-0002-6774-8158; Asturias, Juan/0000-0001-9570-522X				ABRAMOWICZ DA, 1990, CRIT REV BIOTECHNOL, V10, P241, DOI 10.3109/07388559009038210; ADAMS RH, 1992, APPL ENVIRON MICROB, V58, P647, DOI 10.1128/AEM.58.2.647-654.1992; AHMAD D, 1990, GENE, V86, P53, DOI 10.1016/0378-1119(90)90113-6; AHMED M, 1973, CAN J MICROBIOL, V19, P47, DOI 10.1139/m73-007; ASTURIAS JA, 1993, J BACTERIOL, V175, P4631, DOI 10.1128/JB.175.15.4631-4640.1993; BLOCK DW, 1992, BIOL CHEM H-S, V373, P343, DOI 10.1515/bchm3.1992.373.1.343; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHATFIELD LK, 1986, J BACTERIOL, V168, P878, DOI 10.1128/jb.168.2.878-885.1986; CHEN CM, 1991, APPL ENVIRON MICROB, V57, P2217, DOI 10.1128/AEM.57.8.2217-2222.1991; CRESPI M, 1992, EMBO J, V11, P795, DOI 10.1002/j.1460-2075.1992.tb05116.x; DESOMER J, 1992, MOL MICROBIOL, V6, P2377, DOI 10.1111/j.1365-2958.1992.tb01412.x; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; ELTIS LD, 1993, J BIOL CHEM, V268, P2727; ERICKSON BD, 1992, J BACTERIOL, V174, P2903, DOI 10.1128/JB.174.9.2903-2912.1992; FINNERTY WR, 1992, ANNU REV MICROBIOL, V46, P193, DOI 10.1146/annurev.mi.46.100192.001205; FURUKAWA K, 1987, J BACTERIOL, V169, P427, DOI 10.1128/jb.169.1.427-429.1987; FURUKAWA K, 1986, J BACTERIOL, V166, P392, DOI 10.1128/jb.166.2.392-398.1986; FURUKAWA K, 1987, J BACTERIOL, V169, P924, DOI 10.1128/jb.169.2.924-927.1987; GHOSAL D, 1987, GENE, V55, P19, DOI 10.1016/0378-1119(87)90244-7; HAPPE B, 1993, J BACTERIOL, V175, P7313, DOI 10.1128/JB.175.22.7313-7320.1993; HARAYAMA S, 1993, MOL GEN GENET, V239, P81, DOI 10.1007/BF00281605; HARAYAMA S, 1992, ANNU REV MICROBIOL, V46, P565, DOI 10.1146/annurev.mi.46.100192.003025; HARAYAMA S, 1989, J BIOL CHEM, V264, P15328; HART S, 1960, J GEN MICROBIOL, V136, P1357; HAYASE N, 1990, J BACTERIOL, V172, P1160, DOI 10.1128/jb.172.2.1160-1164.1990; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HOFER B, 1993, GENE, V130, P47, DOI 10.1016/0378-1119(93)90345-4; IKEHATA O, 1989, EUR J BIOCHEM, V181, P563, DOI 10.1111/j.1432-1033.1989.tb14761.x; KABISCH M, 1990, NUCLEIC ACIDS RES, V18, P5543, DOI 10.1093/nar/18.18.5543; KEIL H, 1985, J BACTERIOL, V163, P248, DOI 10.1128/JB.163.1.248-255.1985; KHAN A, 1989, APPL ENVIRON MICROB, V55, P798, DOI 10.1128/AEM.55.4.798-805.1989; KIMBARA K, 1989, J BACTERIOL, V171, P2740, DOI 10.1128/jb.171.5.2740-2747.1989; Kuhm A E, 1991, Biodegradation, V2, P115, DOI 10.1007/BF00114601; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Miller J.H., 1972, EXPT MOL GENETICS; MONDELLO FJ, 1989, J BACTERIOL, V171, P1725, DOI 10.1128/jb.171.3.1725-1732.1989; NAKAI C, 1983, J BIOL CHEM, V258, P2923; NEIDLE EL, 1991, EUR J BIOCHEM, V204, P113; NOZAKI M, 1963, BIOCHEM Z, V338, P582; OLSON PE, 1992, APPL ENVIRON MICROB, V58, P2820, DOI 10.1128/AEM.58.9.2820-2826.1992; PELOQUIN L, 1993, GENE, V125, P35, DOI 10.1016/0378-1119(93)90742-L; RAMOS JL, 1987, SCIENCE, V235, P593, DOI 10.1126/science.3468623; RUSSEL M, 1984, J BACTERIOL, V159, P1034, DOI 10.1128/JB.159.3.1034-1039.1984; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; SHINGLER V, 1992, J BACTERIOL, V174, P711, DOI 10.1128/jb.174.3.711-724.1992; STROHL WR, 1992, NUCLEIC ACIDS RES, V20, P961, DOI 10.1093/nar/20.5.961; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TAIRA K, 1992, J BIOL CHEM, V267, P4844; TAIRA K, 1988, BIOCHEMISTRY-US, V27, P3990, DOI 10.1021/bi00411a015; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WIERENGA RK, 1986, J MOL BIOL, V187, P105; ZYLSTRA GJ, 1989, J BIOL CHEM, V264, P14940	54	90	94	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7807	7815						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8126007				2022-12-27	WOS:A1994NA03200118
J	BEELER, T; GABLE, K; ZHAO, C; DUNN, T				BEELER, T; GABLE, K; ZHAO, C; DUNN, T			A NOVEL PROTEIN, CSG2P, IS REQUIRED FOR CA2+ REGULATION IN SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR MEMBRANE; CELL-CYCLE; SUBUNIT-II; YEAST; CALCIUM; GENE; CALMODULIN; MUTANTS; CA-2+; DNA	Nineteen mutants that lost the ability to grow in 100 mM Ca2+ (but remained insensitive to 50 mM Sr2+) were identified in a screen of approximately 60,000 mutagenized yeast colonies. Cells carrying mutations in the CSG2 gene grow normally in low Ca2+ medium but have decreased growth rates when the Ca2+ concentration is above 10 mM. The csg2 mutant cells accumulate much higher levels of Ca2+ in a compartment that is exchangeable with extracellular Ca2+ but the nonexchangeable Ca2+ pool which predominates in wild-type cells is not influenced. Sr2+ influx is not increased in the csg2 mutant cells. Mg2+ decreases the amount of Ca2+ in the nonexchangeable pool without influencing the csg2-induced exchangeable Ca2+ pool. The data indicate that the csg2 mutation causes a selective increase in Ca2+ accumulation into a pool which is distinct from the vacuolar pool. The CSG2 protein consists of 410 amino acids, contains nine putative transmembrane segments, four potential sites for N-linked glycosylation, and a sequence with homology to the EF-hand Ca2+-binding site.	UNIFORMED SERV UNIV HLTH SCI,DEPT BIOCHEM,BETHESDA,MD 20814	Uniformed Services University of the Health Sciences - USA					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046495] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46495] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERTL A, 1990, P NATL ACAD SCI USA, V87, P7824, DOI 10.1073/pnas.87.20.7824; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; DASILVA ACR, 1991, TRENDS BIOCHEM SCI, V16, P53, DOI 10.1016/0968-0004(91)90024-P; DAVIS TN, 1986, CELL, V47, P423, DOI 10.1016/0092-8674(86)90599-4; DAVIS TN, 1986, YEAST CELL BIOL, P477; DUNN T, 1994, J BIOL CHEM, V269, P7273; EILAM Y, 1982, MICROBIOS, V35, P99; FRANCOIS J, 1988, EUR J BIOCHEM, V174, P561, DOI 10.1111/j.1432-1033.1988.tb14135.x; HOLM C, 1986, GENE, V42, P169, DOI 10.1016/0378-1119(86)90293-3; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; IIDA H, 1990, J BIOL CHEM, V265, P21216; IIDA H, 1990, J BIOL CHEM, V265, P13391; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEVIN DE, 1990, CELL, V62, P213, DOI 10.1016/0092-8674(90)90360-Q; LINDEGRE.G, 1965, CAN J GENET CYTOL, V7, P491, DOI 10.1139/g65-064; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; MIYAMOTO S, 1987, GENE, V54, P125, DOI 10.1016/0378-1119(87)90354-4; MIZUNO K, 1989, BIOCHEM BIOPH RES CO, V159, P305, DOI 10.1016/0006-291X(89)92438-8; NEVES MJ, 1992, BIOCHEM J, V288, P859, DOI 10.1042/bj2880859; OHSUMI Y, 1983, J BIOL CHEM, V258, P5614; OHYA Y, 1991, J BIOL CHEM, V266, P12784; OHYA Y, 1984, MOL GEN GENET, V193, P389, DOI 10.1007/BF00382073; OHYA Y, 1986, J GEN MICROBIOL, V132, P979; OHYA Y, 1986, J BACTERIOL, V165, P28, DOI 10.1128/jb.165.1.28-33.1986; OHYA Y, 1991, J BIOL CHEM, V266, P13971; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; SCHMITT HD, 1988, CELL, V53, P635, DOI 10.1016/0092-8674(88)90579-X; SCHULZE M, 1988, MOL GEN GENET, V211, P492, DOI 10.1007/BF00425706; SCHULZE M, 1989, MOL GEN GENET, V216, P37, DOI 10.1007/BF00332228; Sherman F., 1974, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; YOKOO T, 1993, P NATL ACAD SCI USA, V90, P1804, DOI 10.1073/pnas.90.5.1804; [No title captured]	40	92	95	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7279	7284						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125941				2022-12-27	WOS:A1994NA03200040
J	FROELICHAMMON, SJ; GALE, KC; OSHEROFF, N				FROELICHAMMON, SJ; GALE, KC; OSHEROFF, N			SITE-SPECIFIC CLEAVAGE OF A DNA HAIRPIN BY TOPOISOMERASE-II - DNA SECONDARY STRUCTURE AS A DETERMINANT OF ENZYME RECOGNITION/CLEAVAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER CHROMATID EXCHANGES; CHINESE-HAMSTER CELLS; EUKARYOTIC TOPOISOMERASE; ILLEGITIMATE RECOMBINATION; STRANDED-DNA; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; NUCLEOTIDE-SEQUENCE; MITOCHONDRIAL-DNA; INVITRO	To further define the nucleic acid determinants that govern the recognition of DNA by topoisomerase II, the ability of the enzyme to cleave a 51-base oligonucleotide that contained a centrally located 19-base hairpin was characterized. Topoisomerase II cleaved the 51-mer in a site-specific fashion, within the hairpin, one nucleotide from the 3'-base of the stem. Protein denaturants were not required to trap cleavage products. Although the sequence of the oligonucleotide influenced levels of enzyme-mediated DNA scission, it did not affect the spatial location of cleavage. DNA scission required a doublestranded/single-stranded junction at the 3'-base of the hairpin and a tail (either single- or double-stranded) at least 8 bases in length on the 5'-side. Cleavage was not observed when base-pairing within the oligonucleotide was eliminated or when the hairpin was extended to produce a completely double stranded substrate. Finally, the enzyme displayed a size constraint for both the stem and loop structures of the hairpin. These results indicate that topoisomerase II is capable of recognizing secondary structure within nucleic acids and identifies the first secondary structure-specific DNA recognition/cleavage site for the type II enzyme.	VANDERBILT UNIV,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232	Vanderbilt University					NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033944] Funding Source: NIH RePORTER; NCI NIH HHS [5 T32 CA09582] Funding Source: Medline; NIGMS NIH HHS [GM33944] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI Y, 1991, CELL, V64, P137, DOI 10.1016/0092-8674(91)90215-K; AKINS RA, 1990, CURR GENET, V18, P365, DOI 10.1007/BF00318218; ALMASAN A, 1991, P NATL ACAD SCI USA, V88, P7684, DOI 10.1073/pnas.88.17.7684; ANDERSEN AH, 1991, J BIOL CHEM, V266, P9203; ANDERSEN AH, 1989, BIOCHEMISTRY-US, V28, P6237, DOI 10.1021/bi00441a015; ANDERSSON HC, 1989, CARCINOGENESIS, V10, P123, DOI 10.1093/carcin/10.1.123; BAE YS, 1988, P NATL ACAD SCI USA, V85, P2076, DOI 10.1073/pnas.85.7.2076; BAE YS, 1991, GENE, V101, P285; BERRIOS M, 1985, P NATL ACAD SCI USA, V82, P4142, DOI 10.1073/pnas.82.12.4142; BULLOCK P, 1985, SCIENCE, V230, P954, DOI 10.1126/science.2997924; CHARRON M, 1991, CHROMOSOMA, V100, P97, DOI 10.1007/BF00418242; CHARTRAND P, 1991, DNA TOPOISOMERASES C, P240; CHATTERJEE S, 1990, CANCER RES, V50, P2713; CHRISTMAN MF, 1988, CELL, V55, P413, DOI 10.1016/0092-8674(88)90027-X; CORBETT AH, 1992, J BIOL CHEM, V267, P683; Cox M. M., 1989, MOBILE DNA, P661; COX MM, 1987, ANNU REV BIOCHEM, V56, P229, DOI 10.1146/annurev.bi.56.070187.001305; CRAIG NL, 1988, ANNU REV GENET, V22, P77; DALE EC, 1990, GENE, V91, P79, DOI 10.1016/0378-1119(90)90165-N; DEGRASSI F, 1989, MUTAT RES, V211, P125, DOI 10.1016/0027-5107(89)90112-7; DEVORE R, 1989, ANN INTERN MED, V110, P704, DOI 10.7326/0003-4819-110-9-740; DILLEHAY LE, 1989, MUTAT RES, V215, P15, DOI 10.1016/0027-5107(89)90213-3; DINARDO S, 1984, P NATL ACAD SCI-BIOL, V81, P2616, DOI 10.1073/pnas.81.9.2616; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; EARNSHAW WC, 1985, J CELL BIOL, V100, P1716, DOI 10.1083/jcb.100.5.1716; ECHOLS H, 1990, J BIOL CHEM, V265, P14697; FRANZ B, 1990, J MOL BIOL, V215, P523, DOI 10.1016/S0022-2836(05)80165-2; FREUDENREICH CH, 1993, EMBO J, V12, P2085, DOI 10.1002/j.1460-2075.1993.tb05857.x; GALE KC, 1990, BIOCHEMISTRY-US, V29, P9538, DOI 10.1021/bi00493a007; GALE KC, 1992, J BIOL CHEM, V267, P12090; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; GASSER SM, 1986, EMBO J, V5, P511, DOI 10.1002/j.1460-2075.1986.tb04240.x; GELLERT M, 1992, TRENDS GENET, V8, P408, DOI 10.1016/0168-9525(92)90322-U; GODSON GN, 1978, SINGLE STRANDED DNA, P51; HANYH, 1993, J MOL BIOL, V229, P52; HIRANO T, 1991, J CELL BIOL, V115, P1479, DOI 10.1083/jcb.115.6.1479; HIRANO T, 1993, J CELL BIOL, V120, P601, DOI 10.1083/jcb.120.3.601; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; HUANG WM, 1990, DNA TOPOLOGY ITS BIO, P409; IKEDA H, 1986, P NATL ACAD SCI USA, V83, P922, DOI 10.1073/pnas.83.4.922; KREUZER KN, 1984, J BIOL CHEM, V259, P5347; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; LEE MP, 1989, J BIOL CHEM, V264, P21779; LIM M, 1986, CELL BIOL TOXICOL, V2, P485, DOI 10.1007/BF00117850; LINDSLEY JE, 1991, P NATL ACAD SCI USA, V88, P10485, DOI 10.1073/pnas.88.23.10485; LIU LF, 1983, J BIOL CHEM, V258, P5365; LONN U, 1989, CANCER RES, V49, P6202; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; MULLER MT, 1988, BIOCHEMISTRY-US, V27, P8369, DOI 10.1021/bi00422a012; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; NEWPORT J, 1987, CELL, V48, P219, DOI 10.1016/0092-8674(87)90425-9; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; OSHEROFF N, 1991, BIOESSAYS, V13, P269, DOI 10.1002/bies.950130603; OSHEROFF N, 1987, BIOCHEMISTRY-US, V26, P4303, DOI 10.1021/bi00388a018; OSHEROFF N, 1989, PHARMACOL THERAPEUT, V41, P223, DOI 10.1016/0163-7258(89)90108-3; OSHEROFF N, 1986, J BIOL CHEM, V261, P9944; PEDERSENBJERGAARD J, 1992, LEUKEMIA RES, V16, P733, DOI 10.1016/0145-2126(92)90150-6; POMMIER Y, 1991, NUCLEIC ACIDS RES, V19, P5973, DOI 10.1093/nar/19.21.5973; POMMIER Y, 1985, CANCER RES, V45, P3143; RENAULT G, 1987, TOXICOL APPL PHARM, V89, P281, DOI 10.1016/0041-008X(87)90049-4; ROBINSON MJ, 1991, BIOCHEMISTRY-US, V30, P1807, DOI 10.1021/bi00221a012; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; ROSE D, 1990, CELL, V60, P1009, DOI 10.1016/0092-8674(90)90349-J; ROWE TC, 1984, J BIOL CHEM, V259, P9177; SANDER M, 1985, NUCLEIC ACIDS RES, V13, P1057, DOI 10.1093/nar/13.4.1057; SANDER M, 1983, J BIOL CHEM, V258, P8421; SANGER F, 1978, J MOL BIOL, V125, P225, DOI 10.1016/0022-2836(78)90346-7; SHAMU CE, 1992, J CELL BIOL, V117, P921, DOI 10.1083/jcb.117.5.921; SHELTON ER, 1983, J BIOL CHEM, V258, P9530; SPERRY AO, 1989, P NATL ACAD SCI USA, V86, P5497, DOI 10.1073/pnas.86.14.5497; THOMSEN B, 1990, J MOL BIOL, V215, P237, DOI 10.1016/S0022-2836(05)80342-0; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; UEMURA T, 1986, EMBO J, V5, P1003, DOI 10.1002/j.1460-2075.1986.tb04315.x; UEMURA T, 1984, EMBO J, V3, P1737, DOI 10.1002/j.1460-2075.1984.tb02040.x; WANG JC, 1990, CELL, V62, P403, DOI 10.1016/0092-8674(90)90002-V; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WELLS RD, 1988, J BIOL CHEM, V263, P1095; WINICK NJ, 1993, J CLIN ONCOL, V11, P209, DOI 10.1200/JCO.1993.11.2.209; WOOD ER, 1990, J CELL BIOL, V111, P2839, DOI 10.1083/jcb.111.6.2839; WORLAND ST, 1989, J BIOL CHEM, V264, P4412; WYCKOFF E, 1989, J MOL BIOL, V205, P1, DOI 10.1016/0022-2836(89)90361-6; ZECHIEDRICH EL, 1989, BIOCHEMISTRY-US, V28, P6229, DOI 10.1021/bi00441a014; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x	83	81	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7719	7725						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125998				2022-12-27	WOS:A1994NA03200106
J	GU, H; WALL, SC; RUDNICK, G				GU, H; WALL, SC; RUDNICK, G			STABLE EXPRESSION OF BIOGENIC-AMINE TRANSPORTERS REVEALS DIFFERENCES IN INHIBITOR SENSITIVITY, KINETICS, AND ION DEPENDENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET SEROTONIN TRANSPORT; PLASMA-MEMBRANE VESICLES; DOPAMINE TRANSPORTER; NORADRENALINE TRANSPORT; CHLORIDE DEPENDENCE; ACTIVE-TRANSPORT; NEURONAL UPTAKE; RAT-BRAIN; GBR 12783; CLONING	We have constructed stable cell lines expressing transporters for dopamine (DA), norepinephrine (NE), and serotonin (5-HT) by transfection with cloned cDNAs. The parental LLC-PK1 cell does not express any of these neurotransmitter transporters. Therefore, monoamine transport activities in each of these cell lines are due to the transfected DNA only, allowing comparison in the same background. Drug inhibition profiles for each cell line are distinct and as expected for each transporter. LLC-NET and LLC-DAT cells transported both NE and DA and both cell types exhibited a lower K-M for DA transport than for NE transport. Analysis of V-max data for LLC-NET cells suggests that substrate is bound to the NE transporter during the rate-limiting step(s) in transport, The cocaine analog 2-beta carbomethoxy-3 beta-(4-[I-125]iodophenyl)tropane binds to each cell type, and is displaced by transport substrate in each case. Binding and transport measurements on parallel cell cultures allowed estimation of turnover numbers for norepinephrine, dopamine, and serotonin transporters. All three transporters require external Na+ and Cl-. The Na+ concentration dependence suggests that a single Na+ ion is involved in transport catalyzed by norepinephrine and serotonin transporters while more than one Na+ ion participate in transport mediated by the dopamine transporter.			GU, H (corresponding author), YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510, USA.				NIDA NIH HHS [DA 7259, DA 8213] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008213, R01DA007259] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; AMEJDKICHAB N, 1992, J NEUROCHEM, V59, P1795, DOI 10.1111/j.1471-4159.1992.tb11012.x; AMEJDKICHAB N, 1992, J NEUROCHEM, V58, P793, DOI 10.1111/j.1471-4159.1992.tb09327.x; BALKOVETZ DF, 1989, J BIOL CHEM, V264, P2195; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BOJA JW, 1992, SYNAPSE, V12, P27, DOI 10.1002/syn.890120104; CHO AK, 1990, SCIENCE, V249, P631, DOI 10.1126/science.249.4969.631; COOL DR, 1990, BIOCHEMISTRY-US, V29, P1818, DOI 10.1021/bi00459a022; COOL DR, 1990, AM J PHYSIOL, V259, pC196, DOI 10.1152/ajpcell.1990.259.2.C196; ENNA SJ, 1981, ANTIDEPRESSANTS NEUR; FRIEDRICH U, 1986, N-S ARCH PHARMACOL, V333, P246, DOI 10.1007/BF00512937; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; GIROS B, 1992, MOL PHARMACOL, V42, P383; HARDER R, 1985, J NEUROCHEM, V45, P1154, DOI 10.1111/j.1471-4159.1985.tb05536.x; HARDER R, 1984, BIOCHIM BIOPHYS ACTA, V775, P95, DOI 10.1016/0005-2736(84)90239-6; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; HORN AS, 1970, MOL PHARMACOL, V7, P66; IVERSEN LL, 1965, ADV DRUG RES, V2, P5; IZENWASSER S, 1992, LIFE SCI, V50, P541, DOI 10.1016/0024-3205(92)90365-V; JOHNSON AM, 1992, INT CLIN PSYCHOPHARM, V6, P15, DOI 10.1097/00004850-199206004-00005; KEYES SR, 1982, J BIOL CHEM, V257, P1172; KILTY JE, 1991, SCIENCE, V254, P578, DOI 10.1126/science.1948035; KUHAR MJ, 1978, J NEUROCHEM, V31, P251, DOI 10.1111/j.1471-4159.1978.tb12456.x; LINGJAERDE O, 1969, FEBS LETT, V3, P103, DOI 10.1016/0014-5793(69)80108-0; LOPEZIBOR JJ, 1992, INT CLIN PSYCHOPHARM, V7, P5, DOI 10.1097/00004850-199210002-00003; MCELVAIN JS, 1992, BIOCHEM PHARMACOL, V43, P2189, DOI 10.1016/0006-2952(92)90178-L; NELSON PJ, 1979, J BIOL CHEM, V254, P84; NELSON PJ, 1982, J BIOL CHEM, V257, P6151; NEUMEYER JL, 1991, J MED CHEM, V34, P3144, DOI 10.1021/jm00114a027; OHRBERG S, 1992, ACTA PSYCHIAT SCAND, V86, P437, DOI 10.1111/j.1600-0447.1992.tb03294.x; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; RAMAMOORTHY S, 1992, AM J PHYSIOL, V262, pC1189, DOI 10.1152/ajpcell.1992.262.5.C1189; RAMAMOORTHY S, 1993, BIOCHEMISTRY-US, V32, P1346, DOI 10.1021/bi00056a021; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; RUDNICK G, 1977, J BIOL CHEM, V252, P2170; RUDNICK G, 1986, SEROTONIN TRANSPORT, P119; Sambrook J, 1989, MOL CLONING LABORATO; SEIDEN LS, 1993, ANNU REV PHARMACOL, V33, P639, DOI 10.1146/annurev.pa.33.040193.003231; SHIMADA S, 1991, SCIENCE, V254, P576, DOI 10.1126/science.1948034; SNEDDON JM, 1969, BRIT J PHARMACOL, V37, P680, DOI 10.1111/j.1476-5381.1969.tb08506.x; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; UHL GR, 1992, TRENDS PHARMACOL SCI, V13, P421, DOI 10.1016/0165-6147(92)90133-Q; USDIN TB, 1991, P NATL ACAD SCI USA, V88, P11168, DOI 10.1073/pnas.88.24.11168; WALL SC, 1993, MOL PHARMACOL, V43, P264	47	291	313	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7124	7130						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125921				2022-12-27	WOS:A1994NA03200016
J	CYR, DM; DOUGLAS, MG				CYR, DM; DOUGLAS, MG			DIFFERENTIAL REGULATION OF HSP70 SUBFAMILIES BY THE EUKARYOTIC DNAJ HOMOLOG YDJ1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PEPTIDE-BINDING; PROTEIN IMPORT; YEAST HOMOLOG; TRANSLOCATION; GENES; GROWTH; BIP; TEMPERATURES; CHAPERONES	In Saccharomyces cerevisiae Ydj1p, a DnaJ homolog, is localized to the cytosol with the Ssa and Ssb Hsp70 proteins. Ydj1p helps facilitate polypeptide translocation across mitochondrial and endoplasmic reticulum membranes (Caplan, A. J., Cyr, D. M., and Douglas, M. G. (1992) Cell 71, 1143-1155) and can directly interact with Ssa1p to regulate chaperone activity (Cyr, D. M., Lu, X., and Douglas, M. G. (1992) J. Biol. Chem. 267, 20927-20931). In this study, the role of Ydj1p in modulating ATP-dependent reactions catalyzed by Ssa and Ssb Hsp70 proteins has been examined using purified components and compared with that of other Hsp70 homologs BiP and DnaK. Ssa1p, Ssa2p, and Ssb1/2p all formed stable complexes with the mitochondrial presequence peptide, F1beta(1-51). ATP alone had only modest effects on polypeptide complex formation with Ssa1p and Ssa2p, but prevented the majority of polypeptide binding to BiP and DnaK. ATP by itself also reduced polypeptide binding to Ssb1/2p to a level that was intermediate between that observed for the Ssa Hsp70 proteins tested and BiP and DnaK. ATP hydrolysis by Ssa1p, Ssa2p, and Ssb1/2p occurred at similar rates. Ydj1p was a potent modulator of the both the ATPase and polypeptide binding activities of Ssa1p and Ssa2p. In contrast, Ydj1p had little effect on the ATPase and polypeptide binding activity of Ssb1/2p. Therefore the chaperone-related activities of Ssa and Ssb Hsp70 proteins exhibit significant differences in sensitivity to ATP and YDJ1p. These data indicate that regulation of Hsp70 activity by DnaJ homologs can be specific. The specificity of interactions between Ydj1p and the Ssa and Ssb Hsp70 proteins observed could contribute in determining the functional specificity of these chaperones in the cytosol. In related experiments, F1beta(1-51) was found to reduce the extent to which Ydj1p stimulated Ssa1p ATPase activity. This effect correlated with the formation of F1beta(1-51)-Ssa1p complexes. We propose that intramolecular communication between the polypeptide binding, ATPase and DnaJ regulatory domains on Ssa1p plays a role in the regulation of chaperone activity.	UNIV N CAROLINA,SCH MED,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine				Cyr, Douglas/0000-0002-4928-3414				ATENCIO DP, 1992, MOL CELL BIOL, V12, P283, DOI 10.1128/MCB.12.1.283; BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; CAPLAN AJ, 1991, J CELL BIOL, V114, P609, DOI 10.1083/jcb.114.4.609; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; CHIRICO WJ, 1992, BIOCHEM BIOPH RES CO, V189, P1150, DOI 10.1016/0006-291X(92)92324-Q; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; CRAIG EA, 1984, CELL, V38, P841, DOI 10.1016/0092-8674(84)90279-4; CRAIG EA, 1985, MOL CELL BIOL, V5, P3517, DOI 10.1128/MCB.5.12.3517; CRIAG EA, 1993, MICROBIOL REV, V7, P402; CRY DRM, 1991, J BIOL CHEM, V266, P21700; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; GAO BC, 1991, J BIOL CHEM, V266, P19565; GEORGOPOULOS C, 1990, STRESS PROTEINS BIOL, P191; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HENDRICK JP, 1993, ANN REV BIOCH, V62, P348; HOYT DW, 1991, J BIOL CHEM, V266, P21693; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LUKE MM, 1991, J CELL BIOL, V114, P623, DOI 10.1083/jcb.114.4.623; MANNINGKRIEG UC, 1991, EMBO J, V10, P3273, DOI 10.1002/j.1460-2075.1991.tb04891.x; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; NGUYEN TH, 1991, P NATL ACAD SCI USA, V88, P1565, DOI 10.1073/pnas.88.4.1565; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; PELHAM HRB, 1990, STRESS PROTEINS BIOL, P287; SANDERS SL, 1992, CELL, V69, P353, DOI 10.1016/0092-8674(92)90415-9; SEDIS S, 1992, BIOCHEMISTRY-US, V31, P9406; SHIRAYAMA M, 1993, MOL GEN GENET, V240, P323, DOI 10.1007/BF00280382; SILVER PA, 1993, CELL, V74, P5, DOI 10.1016/0092-8674(93)90287-Z; SLATER MR, 1989, NUCLEIC ACIDS RES, V17, P805, DOI 10.1093/nar/17.2.805; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; WICKNER S, 1991, NATURE, V350, P165, DOI 10.1038/350165a0; ZHONG T, 1993, CELL, V73, P1175, DOI 10.1016/0092-8674(93)90646-8	36	94	96	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9798	9804						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144572				2022-12-27	WOS:A1994NE05300063
J	KMIEC, EB; HOLLOMAN, WK				KMIEC, EB; HOLLOMAN, WK			DNA STRAND EXCHANGE IN THE ABSENCE OF HOMOLOGOUS PAIRING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER PROTEIN-ALPHA; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; RECA PROTEIN; BRANCH MIGRATION; PARTIAL-PURIFICATION; ELECTRON-MICROSCOPY; POLYMER-SOLUTIONS; HUMAN-CELLS; GENE	The strand exchange reaction that is widely used for in vitro studies on recombination of DNA molecules is generally presumed to result from a preceding homologous pairing step. With the use of a single-stranded circular DNA and a short homologous linear duplex fragment as substrates in a model strand exchange reaction, it was found that modest concentrations of polyethylene glycol or salt promote formation of heteroduplex molecules and strand exchange. When the duplex fragment was partially resected with an exonuclease exposing a short single-stranded stretch on the ends, the reaction was promoted by the addition of commercial bovine serum albumin. The transcription factor TFIIIA promoted strand exchange when the DNA substrates contained the cognate DNA binding sequence recognized by the protein. These observations suggest that detection of strand exchange in vitro does not necessarily imply a preceding homologous pairing step.	CORNELL UNIV,MED CTR,COLL MED,DEPT MICROBIOL,BOX 62,1300 YORK AVE,NEW YORK,NY 10021; THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,PHILADELPHIA,PA 19107	Cornell University; Jefferson University								ALBERTY RA, 1949, J PHYS COLLOID CHEM, V53, P114, DOI 10.1021/j150466a009; BAKER RT, 1992, CELL, V70, P877, DOI 10.1016/0092-8674(92)90238-8; BAZETTJONES DP, 1989, MOL CELL BIOL, V9, P336, DOI 10.1128/MCB.9.1.336; BOGENHAGEN DF, 1980, CELL, V19, P27, DOI 10.1016/0092-8674(80)90385-2; BORTNER C, 1993, J MOL BIOL, V231, P241, DOI 10.1006/jmbi.1993.1279; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHRISTIANSEN C, 1977, J MOL BIOL, V115, P441, DOI 10.1016/0022-2836(77)90164-4; CLARK AB, 1991, MOL CELL BIOL, V11, P2576, DOI 10.1128/MCB.11.5.2576; COX MM, 1981, NUCLEIC ACIDS RES, V9, P389, DOI 10.1093/nar/9.2.389; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P6018, DOI 10.1073/pnas.78.10.6018; CRAIG ME, 1971, J MOL BIOL, V62, P383, DOI 10.1016/0022-2836(71)90434-7; DONELSON JE, 1972, J BIOL CHEM, V247, P4661; DYKSTRA CC, 1991, MOL CELL BIOL, V11, P2583, DOI 10.1128/MCB.11.5.2583; EISEN A, 1988, P NATL ACAD SCI USA, V85, P7481, DOI 10.1073/pnas.85.20.7481; EVDOKIMOV YM, 1972, FEBS LETT, V23, P180, DOI 10.1016/0014-5793(72)80335-1; FISERLITTELL RM, 1988, J BIOL CHEM, V263, P17136; FISHEL RA, 1988, P NATL ACAD SCI USA, V85, P36, DOI 10.1073/pnas.85.1.36; GRALLA J, 1973, J MOL BIOL, V78, P301, DOI 10.1016/0022-2836(73)90118-6; HALBROOK J, 1989, J BIOL CHEM, V264, P21403; HAYES JJ, 1992, J MOL BIOL, V227, P407, DOI 10.1016/0022-2836(92)90897-S; HEYER WD, 1993, PROG NUCLEIC ACID RE, V46, P221, DOI 10.1016/S0079-6603(08)61023-5; HSIEH P, 1989, J BIOL CHEM, V264, P5089; HSIEH P, 1986, CELL, V44, P885, DOI 10.1016/0092-8674(86)90011-5; JENSEN DE, 1976, J BIOL CHEM, V251, P7198; JOHNSON AW, 1991, J BIOL CHEM, V266, P14046; JORDAN CF, 1972, NATURE-NEW BIOL, V236, P67, DOI 10.1038/newbio236067a0; KIM JM, 1990, GENETICS, V126, P799; KIPLING D, 1991, NUCLEIC ACIDS RES, V19, P1385, DOI 10.1093/nar/19.7.1385; KIPLING D, 1991, NATURE, V353, P509, DOI 10.1038/353509a0; KMIEC E, 1982, CELL, V29, P367, DOI 10.1016/0092-8674(82)90153-2; KMIEC EB, 1983, CELL, V33, P857, DOI 10.1016/0092-8674(83)90028-4; KMIEC EB, 1983, CELL, V34, P919, DOI 10.1016/0092-8674(83)90549-4; KOLODNER R, 1987, P NATL ACAD SCI USA, V84, P5560, DOI 10.1073/pnas.84.16.5560; KOLODNER RD, 1992, MECHANISMS EUKARYOTI, P127; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; LAEMMLI UK, 1975, P NATL ACAD SCI USA, V72, P4288, DOI 10.1073/pnas.72.11.4288; LARIMER FW, 1990, GENE, V95, P85, DOI 10.1016/0378-1119(90)90417-P; LEE CS, 1970, J MOL BIOL, V48, P1, DOI 10.1016/0022-2836(70)90215-9; LERMAN LS, 1971, P NATL ACAD SCI USA, V68, P1886, DOI 10.1073/pnas.68.8.1886; MCCARTHY JG, 1988, P NATL ACAD SCI USA, V85, P5854, DOI 10.1073/pnas.85.16.5854; MCGHEE JD, 1977, BIOCHEMISTRY-US, V16, P3276, DOI 10.1021/bi00634a002; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; MINTON AP, 1981, BIOPOLYMERS, V20, P2093, DOI 10.1002/bip.1981.360201006; MOORE SP, 1990, J BIOL CHEM, V265, P11108; POINTIUS BW, 1991, P NATL ACAD SCI USA, V88, P8237; PONTIUS BW, 1990, P NATL ACAD SCI USA, V87, P8403, DOI 10.1073/pnas.87.21.8403; PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5; QUARTIN RS, 1989, BIOCHEMISTRY-US, V28, P8676, DOI 10.1021/bi00448a002; RADDING CM, 1977, J MOL BIOL, V116, P825, DOI 10.1016/0022-2836(77)90273-X; RADDING CM, 1989, BIOCHIM BIOPHYS ACTA, V1008, P131, DOI 10.1016/0167-4781(80)90001-9; RAVZI E, 1983, GENE AMST, V23, P175; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; ROSS PD, 1962, J AM CHEM SOC, V84, P4503, DOI 10.1021/ja00882a026; SANDER M, 1991, NUCLEIC ACIDS RES, V19, P4523, DOI 10.1093/nar/19.16.4523; SCHROTH GP, 1989, NATURE, V340, P487, DOI 10.1038/340487a0; SIKORAV JL, 1991, J MOL BIOL, V222, P1085, DOI 10.1016/0022-2836(91)90595-W; SMITH DR, 1984, CELL, V37, P645, DOI 10.1016/0092-8674(84)90396-9; STEVENS A, 1980, J BIOL CHEM, V255, P3080; SUGINO A, 1988, P NATL ACAD SCI USA, V85, P3683, DOI 10.1073/pnas.85.11.3683; TISHKOFF DX, 1991, MOL CELL BIOL, V11, P2593, DOI 10.1128/MCB.11.5.2593; WEST SC, 1992, ANNU REV BIOCHEM, V61, P603, DOI 10.1146/annurev.bi.61.070192.003131; WETMUR JG, 1968, J MOL BIOL, V31, P349, DOI 10.1016/0022-2836(68)90414-2; WETMUR JG, 1975, BIOPOLYMERS, V14, P2517, DOI 10.1002/bip.1975.360141208; WETMUR JG, 1991, CRIT REV BIOCHEM MOL, V26, P227, DOI 10.3109/10409239109114069; ZHANG WD, 1993, J VIROL, V67, P204, DOI 10.1128/JVI.67.1.204-212.1993	65	14	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10163	10168						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144518				2022-12-27	WOS:A1994NE05300114
J	MIKAMI, K; SAKAMOTO, A; IWABUCHI, M				MIKAMI, K; SAKAMOTO, A; IWABUCHI, M			THE HBP-1 FAMILY OF WHEAT BASIC LEUCINE-ZIPPER PROTEINS INTERACTS WITH OVERLAPPING CIS-ACTING HEXAMER MOTIFS OF PLANT HISTONE GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; INVITRO TRANSCRIPTION SYSTEM; CHALCONE SYNTHASE PROMOTER; G-BOX; NUCLEOTIDE-SEQUENCE; GENOMIC ORGANIZATION; ARABIDOPSIS-THALIANA; NUCLEAR-PROTEIN; REGULATED GENE; H-3 GENE	The type I element (CCACGTCANCGATCCGCG) is a cis-acting element that is essential for the transcriptional regulation of the wheat histone H3 (TH012) gene. The sequence CCACGTCA in the type I element resembles various plant regulatory elements that share an ACGT core sequence, which can be recognized by different basic/leucine zipper (bZIP) proteins. Here we describe the isolation and characterization of wheat cDNA clones encoding three novel bZIP proteins, designated HBP(histone promoter-binding protein)-1a(1), HBP-1a(c14), and HBP-1b(c1). These proteins specifically bind to the ACGT core sequence and, together with previously identified HBP-1a(17) and HBP-1b(c38), constitute a protein family, named the HBP-1 family. Based on their structural characteristies and DNA binding specificities, members of the HBP-1 family can be grouped into HBP-1a and HBP-1b subfamilies. The HBP-1a isoforms are characterized by their N-terminal proline-rich domain and a C-terminal bZIP domain, which binds to the CCACGT motif. In contrast, the HBP-1b isoforms have a bZIP domain at the N terminus, which binds to the ACGTCA motif, and a glutamine-rich domain at the C terminus. All members of both subfamilies interact with the CCACGTCA sequence, but their DNA binding specificities and affinities differ. Since HBP-1a isoforms form heterodimers in all pairwise combinations, heterodimer formation among these bZIP proteins may generate an expanded repertoire of regulatory potential for gene expression in plants.	KYOTO UNIV,FAC SCI,DEPT BOT,KYOTO 60601,JAPAN; NATL INST BASIC BIOL,DIV DEV BIOL,OKAZAKI,AICHI 444,JAPAN	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)			Mikami, Koji/A-9825-2012	Mikami, Koji/0000-0003-3811-0072				ALLIOTTE T, 1989, PLANT PHYSIOL, V89, P743, DOI 10.1104/pp.89.3.743; BOUCHEZ D, 1989, EMBO J, V8, P4197, DOI 10.1002/j.1460-2075.1989.tb08605.x; BUSCH SJ, 1990, TRENDS GENET, V6, P36, DOI 10.1016/0168-9525(90)90071-D; CHOI HK, 1989, PLANT MOL BIOL, V13, P731, DOI 10.1007/BF00016030; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; DONALD RGK, 1990, EMBO J, V9, P1717, DOI 10.1002/j.1460-2075.1990.tb08295.x; EHRLICH KC, 1992, GENE, V117, P169, DOI 10.1016/0378-1119(92)90726-6; FRANCK A, 1980, CELL, V21, P285, DOI 10.1016/0092-8674(80)90136-1; GIGOT C, 1987, PLANT PHYSIOL BIOCH, V25, P234; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; GUILTINAN MJ, 1990, SCIENCE, V250, P267, DOI 10.1126/science.2145628; HARTINGS H, 1989, EMBO J, V8, P2795, DOI 10.1002/j.1460-2075.1989.tb08425.x; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KATAGIRI F, 1990, GENE DEV, V4, P1899, DOI 10.1101/gad.4.11.1899; KATAGIRI F, 1989, NATURE, V340, P727, DOI 10.1038/340727a0; KAWATA T, 1990, DEV GENET, V11, P205, DOI 10.1002/dvg.1020110306; KAWATA T, 1992, NUCLEIC ACIDS RES, V20, P1141, DOI 10.1093/nar/20.5.1141; KODRZYCKI R, 1989, PLANT CELL, V1, P105, DOI 10.1105/tpc.1.1.105; KUHLEMEIER C, 1992, PLANT MOL BIOL, V19, P1, DOI 10.1007/BF00015603; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; LICHT JD, 1990, NATURE, V346, P76, DOI 10.1038/346076a0; LOAKE GJ, 1992, P NATL ACAD SCI USA, V89, P9230, DOI 10.1073/pnas.89.19.9230; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MIKAMI K, 1989, NUCLEIC ACIDS RES, V17, P9707, DOI 10.1093/nar/17.23.9707; Mikami K., 1993, Control of plant gene expression., P51; MIKAMI K, 1989, FEBS LETT, V256, P67, DOI 10.1016/0014-5793(89)81719-3; MIKAMI K, 1987, FEBS LETT, V223, P273, DOI 10.1016/0014-5793(87)80303-4; MINAMI M, 1993, PLANT MOL BIOL, V23, P429, DOI 10.1007/BF00029019; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MUNDY J, 1990, P NATL ACAD SCI USA, V87, P1406, DOI 10.1073/pnas.87.4.1406; NAKAYAMA T, 1992, FEBS LETT, V300, P167, DOI 10.1016/0014-5793(92)80188-M; NAKAYAMA T, 1993, CRIT REV PLANT SCI, V12, P97, DOI 10.1080/07352689309382357; NASUDA S, 1993, PLANT MOL BIOL, V22, P603, DOI 10.1007/BF00047401; OEDA K, 1991, EMBO J, V10, P1793, DOI 10.1002/j.1460-2075.1991.tb07704.x; PHILIPPS G, 1986, GENE, V42, P225, DOI 10.1016/0378-1119(86)90301-X; PYSH LD, 1993, PLANT CELL, V5, P227, DOI 10.1105/tpc.5.2.227; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHINDLER U, 1992, EMBO J, V11, P1275, DOI 10.1002/j.1460-2075.1992.tb05171.x; SCHINDLER U, 1992, PLANT CELL, V4, P1309, DOI 10.1105/tpc.4.10.1309; SCHINDLER U, 1992, EMBO J, V11, P1261, DOI 10.1002/j.1460-2075.1992.tb05170.x; SCHMIDT RJ, 1990, P NATL ACAD SCI USA, V87, P46, DOI 10.1073/pnas.87.1.46; SCHULE R, 1991, TRENDS GENET, V7, P377, DOI 10.1016/0168-9525(91)90259-S; SCHULZE-LEFERT P, 1989, EMBO J, V8, P651, DOI 10.1002/j.1460-2075.1989.tb03422.x; SINGH K, 1990, PLANT CELL, V2, P891, DOI 10.1105/tpc.2.9.891; STAIGER D, 1989, P NATL ACAD SCI USA, V86, P6930, DOI 10.1073/pnas.86.18.6930; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TABATA T, 1984, MOL GEN GENET, V196, P397, DOI 10.1007/BF00436185; TABATA T, 1989, SCIENCE, V245, P965, DOI 10.1126/science.2772648; TABATA T, 1991, EMBO J, V10, P1459, DOI 10.1002/j.1460-2075.1991.tb07666.x; TABATA T, 1983, NUCLEIC ACIDS RES, V11, P5865, DOI 10.1093/nar/11.17.5865; TAKASE H, 1991, BIOCHEM BIOPH RES CO, V176, P1593, DOI 10.1016/0006-291X(91)90470-R; TAKASE H, 1993, J PLANT RES SPECIAL, V3, P37; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801; WEISSHAAR B, 1991, EMBO J, V10, P1777, DOI 10.1002/j.1460-2075.1991.tb07702.x; WU SC, 1988, PLANT MOL BIOL, V11, P641, DOI 10.1007/BF00017464; YAMAZAKI K, 1990, P NATL ACAD SCI USA, V87, P7035, DOI 10.1073/pnas.87.18.7035	57	35	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9974	9985						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144592				2022-12-27	WOS:A1994NE05300088
J	FAIRCHILD, CD; GLAZER, AN				FAIRCHILD, CD; GLAZER, AN			OLIGOMERIC STRUCTURE, ENZYME-KINETICS, AND SUBSTRATE-SPECIFICITY OF THE PHYCOCYANIN ALPHA-SUBUNIT PHYCOCYANOBILIN LYASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIVERDIN-IX-ALPHA; INVITRO ATTACHMENT; BILIN ATTACHMENT; C-PHYCOCYANIN; APOPHYCOCYANIN; PURIFICATION; ADDUCT; PHYCOERYTHROBILIN; PHYCOBILIPROTEINS; IDENTIFICATION	Phycobiliproteins carry linear tetrapyrrole chromophores (bilins) thioether linked to specific cysteine residues. The process of bilin attachment to apoprotein in vivo has been characterized for only one bilin attachment site on one phycobiliprotein, that on the alpha subunit of phycocyanin (alpha(PC)). In the cyanobacterium Synechococcus sp. PCC 7002, the addition of phycocyanobilin to apo-alpha(PC) is catalyzed by the protein products of the cpcE and cpcF genes. We have purified and further characterized the recombinant CpcE and CpcF proteins. CpcE and CpcF form an enzymatically active 1:1 complex (Cp -cEF), stable to size exclusion chromatography CpcEF causes a reduction in alpha(PC) fluorescence and strongly affects its absorption spectrum but has no effect on the beta subunit. The CpcEF bilin addition activity exhibits simple Michaelis-Menten kinetics with respect to the apo-alpha(PC) and to bilin. CpcEF also catalyzes the addition of phycoerythrobilin to apo-alpha(PC); phycoerythrobilin is thought to be on the biosynthetic pathway of phycocyanobilin. CpcEF shows a preference for phycocyanobilin relative to phycoerythrobilin, both in binding affinity and in the rate of catalysis, sufficient to account for selective attachment of phycocyanobilin to apo-alpha(PC).	UNIV CALIF BERKELEY, DEPT MOLEC & CELLULAR BIOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028994] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 28994] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], [No title captured]; ARCIERO DM, 1988, J BIOL CHEM, V263, P18343; ARCIERO DM, 1988, J BIOL CHEM, V263, P18358; ARCIERO DM, 1988, J BIOL CHEM, V263, P18350; BEALE SI, 1991, J BIOL CHEM, V266, P22333; BEALE SI, 1991, J BIOL CHEM, V266, P22341; BRASLAVSKY SE, 1991, J AM CHEM SOC, V113, P7322, DOI 10.1021/ja00019a033; CHAPMAN DJ, 1967, J AM CHEM SOC, V89, P5976, DOI 10.1021/ja00999a058; Cohen-Bazire G., 1982, BIOL CYANOBACTERIA, P143; COLE WJ, 1967, J AM CHEM SOC, V89, P3643, DOI 10.1021/ja00990a055; DICERA E, 1992, METHOD ENZYMOL, V210, P68; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; FU E, 1979, BIOCHEM J, V179, P1; GARDNER EE, 1980, BIOCHIM BIOPHYS ACTA, V624, P187; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GLAZER AN, 1973, J BIOL CHEM, V248, P659; HOLZWARTH AR, 1978, LIEBIGS ANN CHEM, P2002; KLOTZ AV, 1985, J BIOL CHEM, V260, P4856; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUCHINS J, 1978, SCIENCE, V199, P425, DOI 10.1126/science.619462; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; MARSTON FAO, 1986, BIOCHEM J, V240, P1, DOI 10.1042/bj2400001; SCHIRMER T, 1987, J MOL BIOL, V196, P677, DOI 10.1016/0022-2836(87)90040-4; SWANSON RV, 1992, J BIOL CHEM, V267, P16146; SWANSON RV, 1990, ANAL BIOCHEM, V188, P295, DOI 10.1016/0003-2697(90)90609-D; WILBANKS SM, 1993, J BIOL CHEM, V268, P1226; ZHOU JH, 1992, J BIOL CHEM, V267, P16138	27	95	102	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8686	8694						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132596				2022-12-27	WOS:A1994NB41100013
J	BERLINER, E; MAHTANI, HK; KARKI, S; CHU, LF; CRONAN, JE; GELLES, J				BERLINER, E; MAHTANI, HK; KARKI, S; CHU, LF; CRONAN, JE; GELLES, J			MICROTUBULE MOVEMENT BY A BIOTINATED KINESIN BOUND TO A STREPTAVIDIN-COATED SURFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUID GIANT-AXON; DROSOPHILA KINESIN; EXPRESSION SYSTEM; LIGHT-MICROSCOPY; HEAVY-CHAIN; PROTEIN; MOLECULES; MOTILITY; ATPASE; IDENTIFICATION	Kinesin, an ATP-dependent microtubule motor, can be studied in vitro in motility assays where the kinesin is nonspecifically adsorbed to a surface. However, adsorption can inactivate kinesin and may alter its reaction kinetics. We therefore prepared a biotinated kinesin derivative, K612-BIO, and characterized its activity in solution and when bound to streptavidin-coated surfaces. K612-BIO consists of the N-terminal 612 amino acids of the Drosophila kinesin alpha subunit linked to the 87-amino acid C-terminal domain of the biotin carboxyl carrier protein subunit of Escherichia coli acetyl-CoA carboxylase. The C-terminal domain directs the efficient posttranslational biotination of the protein. We expressed K612-BIO at high levels using the baculovirus expression vector system and purified it to near-homogeneity. The expressed protein is completely soluble, and >90% is bound by streptavidin. K612-BIO steady-state ATPase kinetics (K-M,K-ATP = 24 mu M, K-0.5,K-microtubule = 0.61 mg ml(-1),V-max = similar to 25 s(-1) head(-1), 25 degrees C) are similar to those reported for intact kinesin. ATPase kinetics are not affected by the addition of streptavidin. Enzyme bound to a surface coated with streptavidin drove microtubule gliding in the presence of 2 mM ATP at 750 +/- 130 nm s(-1) (26 degrees C). Activity was abolished by pretreatment of the surface with biotin, indicating that the microtubule movements are due to specifically bound enzyme. Motility assays based on specific attachment of biotinated enzyme to streptavidin coated surfaces will be useful for quantitative analysis of kinesin motility and may provide a way to detect activity in kinesin derivatives or kinesin-like proteins that have not yet been shown to move microtubules.	BRANDEIS UNIV, GRAD DEPT BIOCHEM, WALTHAM, MA 02254 USA; BRANDEIS UNIV, BIOPHYS PROGRAM, WALTHAM, MA 02254 USA; BRANDEIS UNIV, CTR COMPLEX SYST, WALTHAM, MA 02254 USA; UNIV ILLINOIS, DEPT MICROBIOL, URBANA, IL 61801 USA; UNIV ILLINOIS, DEPT BIOCHEM, URBANA, IL 61801 USA	Brandeis University; Brandeis University; Brandeis University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign			Cronan, John/V-6626-2019; Chu, Larry/B-5324-2008	Chu, Larry/0000-0003-0814-6402				ACKERMAN SH, 1992, J BIOL CHEM, V267, P7386; ALLEN RD, 1982, SCIENCE, V218, P1127, DOI 10.1126/science.6183744; AMARATUNGA A, 1993, J BIOL CHEM, V268, P17427; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DECUEVAS M, 1992, J CELL BIOL, V116, P957, DOI 10.1083/jcb.116.4.957; FALL RR, 1973, J BIOL CHEM, V248, P2078; FASMAN GD, 1976, HDB BIOCH MOL BIOL; FRANKEL S, 1991, P NATL ACAD SCI USA, V88, P1192, DOI 10.1073/pnas.88.4.1192; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; GILBERT S P, 1990, Journal of Cell Biology, V111, p416A; GILBERT SP, 1993, BIOCHEMISTRY-US, V32, P4677, DOI 10.1021/bi00068a028; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; GREEN NM, 1965, BIOCHEM J, V94, pC23, DOI 10.1042/bj0940023C; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; HACKNEY DD, 1991, BIOCHEM BIOPH RES CO, V174, P810, DOI 10.1016/0006-291X(91)91490-4; HALL K, 1993, NATURE, V364, P457, DOI 10.1038/364457a0; HINK WF, 1970, NATURE, V226, P466, DOI 10.1038/226466b0; HIROKAWA N, 1991, J CELL BIOL, V114, P295, DOI 10.1083/jcb.114.2.295; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; HUNT A, 1993, BIOPHYS J, V64, pA263; KACHAR B, 1987, J BIOL CHEM, V262, P16180; KUO SC, 1993, SCIENCE, V260, P232, DOI 10.1126/science.8469975; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI SJ, 1992, J BIOL CHEM, V267, P855; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; NA GC, 1980, BIOCHEMISTRY-US, V19, P1347, DOI 10.1021/bi00548a013; NERVI AM, 1971, ARCH BIOCHEM BIOPHYS, V143, P401, DOI 10.1016/0003-9861(71)90227-X; ROMBERG L, 1993, NATURE, V361, P168, DOI 10.1038/361168a0; Sambrook J, 1989, MOL CLONING LABORATO; SARVARI M, 1990, BIOCHEM BIOPH RES CO, V167, P1154, DOI 10.1016/0006-291X(90)90644-3; SAXTON WM, 1988, P NATL ACAD SCI USA, V85, P1109, DOI 10.1073/pnas.85.4.1109; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; SCHNAPP B J, 1991, Biophysical Journal, V59, p567A; SCHNAPP BJ, 1986, METHOD ENZYMOL, V134, P561; SCHOLEY JM, 1989, NATURE, V338, P355, DOI 10.1038/338355a0; STEWART RJ, 1993, P NATL ACAD SCI USA, V90, P5209, DOI 10.1073/pnas.90.11.5209; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; Summers MD, 1987, MANUAL METHODS BACUL; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; VALE RD, 1985, CELL, V40, P559, DOI 10.1016/0092-8674(85)90204-1; WAGNER MC, 1989, CELL MOTIL CYTOSKEL, V12, P195, DOI 10.1002/cm.970120403; WEISENBERG RC, 1968, BIOCHEMISTRY-US, V7, P4466, DOI 10.1021/bi00852a043; WILCHEK M, 1988, ANAL BIOCHEM, V171, P1, DOI 10.1016/0003-2697(88)90120-0; YANG JT, 1988, P NATL ACAD SCI USA, V85, P1864, DOI 10.1073/pnas.85.6.1864; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2; YANG JT, 1990, SCIENCE, V249, P42, DOI 10.1126/science.2142332	52	64	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8610	8615						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132586				2022-12-27	WOS:A1994NB40900116
J	DUHE, RJ; NIELSEN, MD; DITTMAN, AH; VILLACRES, EC; CHOI, EJ; STORM, DR				DUHE, RJ; NIELSEN, MD; DITTMAN, AH; VILLACRES, EC; CHOI, EJ; STORM, DR			OXIDATION OF CRITICAL CYSTEINE RESIDUES OF TYPE-I ADENYLYL-CYCLASE BY O-IODOSOBENZOATE OR NITRIC-OXIDE REVERSIBLY INHIBITS STIMULATION BY CALCIUM AND CALMODULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; ACID; EXPRESSION; PROTEINS; CLONING; IDENTIFICATION; FAMILY	The calmodulin binding domain of the type I adenylyl cyclase has recently been identified as an amino acid sequence (residues 495-522) that contains 2 cysteine residues. Therefore, we examined the effect of several sulfhydryl reagents on the calmodulin sensitivity of the enzyme. Treatment of membranes containing the type I adenylyl cyclase with N-ethylmaleimide rapidly inhibited basal, calcium/calmodulin-stimulated, and forskolin-stimulated adenylyl cyclase activity. When the enzyme was treated with limiting amounts of o-iodosobenzoate, which oxidizes vicinal sulfhydryls to disulfides, stimulation by Ca2+ and calmodulin was eliminated at concentrations which did not affect basal adenylyl cyclase activity. Calmodulin stimulation of the enzyme was restored by treatment with dithiothreitol or glutathione which reduce disulfides to free thiols. NO and sodium nitroprusside also reversible inhibited calmodulin stimulation of the enzyme. We propose that the loss in calmodulin sensitivity caused by these reagents may be due to the oxidation one or more sets of vicinal thiols present in the enzyme.	UNIV WASHINGTON,DEPT PHARMACOL,SEATTLE,WA 98195	University of Washington; University of Washington Seattle					NIDDK NIH HHS [DK07441-09] Funding Source: Medline; NINDS NIH HHS [NS08816-02, NS 20498] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS008816, R01NS020498] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ausubel FM., 2006, ENZYMATIC MANIPULATI; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; BRUNE B, 1989, J BIOL CHEM, V264, P8455; CHOI EJ, 1992, BIOCHEMISTRY-US, V31, P6492, DOI 10.1021/bi00143a019; CHOI EJ, 1992, J BIOL CHEM, V267, P12440; Choi EJ, 1993, CURR OPIN CELL BIOL, V5, P269, DOI 10.1016/0955-0674(93)90115-7; ERICKSONVIITANEN S, 1987, METHOD ENZYMOL, V139, P455; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; FONTANA A, 1981, BIOCHEMISTRY-US, V20, P6997, DOI 10.1021/bi00527a034; GAO BN, 1991, P NATL ACAD SCI USA, V88, P10178, DOI 10.1073/pnas.88.22.10178; GARTHWAITE J, 1987, J NEUROCHEM, V48, P29, DOI 10.1111/j.1471-4159.1987.tb13123.x; GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2; HILL HD, 1988, ANAL BIOCHEM, V170, P203, DOI 10.1016/0003-2697(88)90109-1; ISHIKAWA Y, 1992, J BIOL CHEM, V267, P13553; KIM DS, 1987, J BIOL CHEM, V262, P14250; KRUPINSKI J, 1992, J BIOL CHEM, V267, P24858; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; KRUPINSKI J, 1991, MOL CELL BIOCHEM, V104, P73; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; MAHONEY WC, 1981, BIOCHEMISTRY-US, V20, P443, DOI 10.1021/bi00505a033; MANZONI O, 1992, NEURON, V8, P653, DOI 10.1016/0896-6273(92)90087-T; MASURE HR, 1984, BIOCHEM J, V218, P691, DOI 10.1042/bj2180691; PARK JW, 1985, NEW ENGL J MED, V313, P1547; PEN J, 1989, NUCLEIC ACIDS RES, V17, P451, DOI 10.1093/nar/17.1.451; PIASCIK MT, 1980, J BIOL CHEM, V255, P4176; PROMONT RT, 1992, P NATL ACAD SCI USA, V89, P9809; RADI R, 1991, J BIOL CHEM, V266, P4244; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SHIBUKI K, 1990, NEUROSCI RES, V9, P69, DOI 10.1016/0168-0102(90)90048-J; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; SUMMERS MD, 1987, TEXAS AGR EXPT STATI, V1555, P1; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; TANG WJ, 1991, J BIOL CHEM, V266, P8595; TAO YP, 1992, FEBS LETT, V314, P49, DOI 10.1016/0014-5793(92)81459-Y; Torchinsky Y, 1981, SULFUR PROTEINS; VALLEJOS RH, 1977, BIOCHIM BIOPHYS ACTA, V459, P20, DOI 10.1016/0005-2728(77)90004-4; VORHERR T, 1993, BIOCHEMISTRY-US, V32, P6081, DOI 10.1021/bi00074a020; WU ZL, 1993, J BIOL CHEM, V268, P23766; XIA ZG, 1993, J NEUROCHEM, V60, P305, DOI 10.1111/j.1471-4159.1993.tb05852.x; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T	41	85	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7290	7296						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125943				2022-12-27	WOS:A1994NA03200042
J	LI, BY; ADAMS, CC; WORKMAN, JL				LI, BY; ADAMS, CC; WORKMAN, JL			NUCLEOSOME BINDING BY THE CONSTITUTIVE TRANSCRIPTION FACTOR SP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; SIMIAN VIRUS-40 ENHANCER; POSITIONED NUCLEOSOMES; HYPERSENSITIVE SITES; CHROMATIN TEMPLATES; ACTIVATION DOMAINS; PROMOTER ELEMENTS; DNA-REPLICATION; MMTV PROMOTER; INVITRO	The constitutive transcription factor Sp1 plays a role in the transcription of numerous viral and cellular genes including constitutive ''housekeeping'' genes and inducible genes. Sp1 has also been implicated in the formation of a nucleosome free region in Simian virus 40 (SV40) minichromosomes. To investigate the potential functions of Sp1 in remodeling chromatin structures, Sp1 was analyzed for the ability to bind its recognition sites (GC boxes) in DNA fragments reconstituted into nucleosome cores. Sp1 was found to bind to the GC boxes of the SV40 early promoter when this element was reconstituted into nucleosome cores. The affinity of Sp1 for the nucleosomal SV40 early promoter DNA was reduced approximately 10-20-fold relative to naked DNA. A peptide containing only the zinc fingers of Sp1 was also capable of binding nucleosomal DNA, indicating that the glutamine rich and serine/threonine-rich domains of Sp1 are not required for nucleosome binding. The binding of Sp1 to nucleosome cores resulted in the formation of a ternary Sp1-nucleosome complex.	PENN STATE UNIV,ALTHOUSE LAB 301,DEPT BIOCHEM & MOLEC BIOL,UNIV PK,PA 16802; PENN STATE UNIV,CTR GENE REGULAT,UNIV PK,PA 16802	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM015861, R01GM047867, R37GM047867] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM15861, GM47867] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS CC, 1993, CELL, V72, P305, DOI 10.1016/0092-8674(93)90109-4; AMBROSE C, 1990, J MOL BIOL, V214, P875, DOI 10.1016/0022-2836(90)90342-J; AMBROSE C, 1989, J MOL BIOL, V210, P255, DOI 10.1016/0022-2836(89)90328-8; ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; BATSON SC, 1993, NUCLEIC ACIDS RES, V21, P3459; BATSON SC, 1992, MOL CELL BIOL, V12, P1639, DOI 10.1128/MCB.12.4.1639; BRESNICK EH, 1992, NUCLEIC ACIDS RES, V20, P273, DOI 10.1093/nar/20.2.273; BUCHANAN RL, 1987, MOL CELL BIOL, V7, P1554, DOI 10.1128/MCB.7.4.1554; CARR KD, 1990, P NATL ACAD SCI USA, V87, P9300, DOI 10.1073/pnas.87.23.9300; CHEN H, 1994, IN PRESS EMBO J; CLARKE MF, 1985, J BIOL CHEM, V260, P2394; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; CROSTON GE, 1992, GENE DEV, V6, P2270, DOI 10.1101/gad.6.12a.2270; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; Elgin SCR, 1990, CURR OPIN CELL BIOL, V2, P437, DOI 10.1016/0955-0674(90)90125-X; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; JACKSON SP, 1989, P NATL ACAD SCI USA, V86, P1781, DOI 10.1073/pnas.86.6.1781; JONGSTRA J, 1984, NATURE, V307, P708, DOI 10.1038/307708a0; JUAN L, 1994, IN PRESS COLD SPRING, V58; KERPPOLA TK, 1991, CELL, V66, P317, DOI 10.1016/0092-8674(91)90621-5; KORNBERG RD, 1991, CELL, V67, P833, DOI 10.1016/0092-8674(91)90354-2; KORNBERG RD, 1992, ANNU REV CELL BIOL, V8, P563, DOI 10.1146/annurev.cellbio.8.1.563; KRIWACKI RW, 1992, P NATL ACAD SCI USA, V89, P9759, DOI 10.1073/pnas.89.20.9759; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; LI Q, 1993, GENE DEV, V7, P2471, DOI 10.1101/gad.7.12a.2471; LORCH Y, 1992, GENE DEV, V6, P2282, DOI 10.1101/gad.6.12a.2282; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; PERLMANN T, 1992, P NATL ACAD SCI USA, V89, P3884, DOI 10.1073/pnas.89.9.3884; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; RHODES D, 1985, EMBO J, V4, P3473, DOI 10.1002/j.1460-2075.1985.tb04106.x; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; SCHMID A, 1992, CELL, V71, P853, DOI 10.1016/0092-8674(92)90560-Y; SOLOMON MJ, 1987, MOL CELL BIOL, V7, P3822, DOI 10.1128/MCB.7.10.3822; STEIN A, 1987, J BIOL CHEM, V262, P3872; SVAREN J, 1993, CURR OPIN GENET DEV, V3, P219, DOI 10.1016/0959-437X(93)90026-L; SVAREN J, 1990, TRENDS GENET, V6, P52, DOI 10.1016/0168-9525(90)90074-G; TAYLOR ICA, 1991, GENE DEV, V5, P1285, DOI 10.1101/gad.5.7.1285; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; WOLFFE AP, 1991, J CELL SCI, V99, P201; WORKMAN JL, 1993, TRENDS BIOCHEM SCI, V18, P90, DOI 10.1016/0968-0004(93)90160-O; WORKMAN JL, 1991, CELL, V64, P533, DOI 10.1016/0092-8674(91)90237-S; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613	47	84	85	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7756	7763						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8126002				2022-12-27	WOS:A1994NA03200111
J	LOMBARDO, A; COSTA, E; CHAO, WR; TOLL, L; HOBBS, PD; JONG, L; LEE, MO; PFAHL, M; ELY, KR; DAWSON, MI				LOMBARDO, A; COSTA, E; CHAO, WR; TOLL, L; HOBBS, PD; JONG, L; LEE, MO; PFAHL, M; ELY, KR; DAWSON, MI			RECOMBINANT HUMAN RETINOIC ACID RECEPTOR-BETA - BINDING OF SYNTHETIC RETINOIDS AND TRANSCRIPTIONAL ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHARMACOLOGICAL ACTIVITY; NUCLEAR RECEPTORS; ESCHERICHIA-COLI; IDENTIFICATION; GAMMA; MOUSE; ALPHA; PROTEINS; PURIFICATION; ISOFORMS	All-trans-retinoic acid mediates cell growth and differentiation by binding to and then activating nuclear retinoid receptor proteins that regulate gene transcription. Recombinant human retinoic acid receptor beta was cloned and expressed in Escherichia coli as a fusion protein rMBP-RAR beta with maltose-binding protein to facilitate purification. After isolation from bacterial lysates, rMBP-RAR beta was used for binding with selected retinoids. Scatchard analysis with [11,12-H-3(2)]all-trans-retinoic acid gave a K-d of 0.34 nM. Competitive binding studies with a series of conformationally restricted aromatic retinoids indicated that the K-i values for binding to rMBP-RAR beta correlated with the logs of the EC(50) values for gene transcriptional activation (p less than or equal to 0.05) and with those for the relative activation compared to that of all-trans-retinoic acid (p less than or equal to 0.01). Inspection of binding-activation correlation diagrams indicates candidate structures for improved retinoid agonists or antagonists.	SRI INT,BIOORGAN CHEM LAB,MENLO PK,CA 94025; LA JOLLA CANC RES FDN,CANC RES CTR,LA JOLLA,CA 92037; SRI INT,DEPT NEUROSCI,MENLO PK,CA 94025	SRI International; Sanford Burnham Prebys Medical Discovery Institute; SRI International					NATIONAL CANCER INSTITUTE [P01CA051993] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA51993] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; APFEL C, 1991, RETINOIDS : 10 YEARS ON, P110; APFEL C, 1992, P NATL ACAD SCI USA, V89, P7129, DOI 10.1073/pnas.89.15.7129; APFEL C, 1992, RETINOIDS NORMAL DEV, P65; BEATO M, 1972, J BIOL CHEM, V247, P7890; BENBROOK D, 1988, NATURE, V333, P669, DOI 10.1038/333669a0; BERNARD BA, 1992, BIOCHEM BIOPH RES CO, V186, P977, DOI 10.1016/0006-291X(92)90842-9; BOURGUET W, 1992, BIOCHEM BIOPH RES CO, V187, P711, DOI 10.1016/0006-291X(92)91253-M; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CRETTAZ M, 1990, BIOCHEM J, V272, P391, DOI 10.1042/bj2720391; DAWSON MI, 1984, J MED CHEM, V27, P1516, DOI 10.1021/jm00377a022; DAWSON MI, 1983, J MED CHEM, V26, P1653, DOI 10.1021/jm00365a021; DAWSON MI, 1981, J MED CHEM, V24, P583, DOI 10.1021/jm00137a019; DAWSON MI, 1989, J MED CHEM, V32, P1504, DOI 10.1021/jm00127a018; DAWSON MI, 1993, RETINOIDS PROGR RES, P205; DAWSON MI, 1993, RETINOIDS BIOL CHEM, P5; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DOLLE P, 1989, NATURE, V342, P702, DOI 10.1038/342702a0; DOLLE P, 1990, DEVELOPMENT, V110, P1133; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FUKASAWA H, 1993, BIOL PHARM BULL, V16, P343; GIGUERE V, 1990, MOL CELL BIOL, V10, P2335, DOI 10.1128/MCB.10.5.2335; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; HERMANN T, 1991, CELL REGUL, V2, P565, DOI 10.1091/mbc.2.7.565; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; HUSMANN M, 1991, MOL CELL BIOL, V11, P4094; JOHNSTON TC, 1986, J BIOL CHEM, V261, P4805; KASTNER P, 1990, P NATL ACAD SCI USA, V87, P2700, DOI 10.1073/pnas.87.7.2700; KEIDEL S, 1992, EUR J BIOCHEM, V204, P1141, DOI 10.1111/j.1432-1033.1992.tb16739.x; KRUST A, 1989, P NATL ACAD SCI USA, V86, P5310, DOI 10.1073/pnas.86.14.5310; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHMANN JM, 1991, CANCER RES, V51, P4804; LEHMANN JM, 1991, NUCLEIC ACIDS RES, V19, P573, DOI 10.1093/nar/19.3.573; LEROY P, 1991, EMBO J, V10, P59, DOI 10.1002/j.1460-2075.1991.tb07921.x; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; LOELIGER P, 1980, EUR J MED CHEM, V15, P9; LOTAN R, 1980, BIOCHIM BIOPHYS ACTA, V605, P33, DOI 10.1016/0304-419X(80)90021-9; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; REDDY AP, 1992, BIOCHEM J, V287, P833, DOI 10.1042/bj2870833; Roberts A.B., 1984, RETINOIDS, V2, P210; RUBERTE E, 1990, DEVELOPMENT, V108, P213; SCHIFF LJ, 1990, CHEM BIOL SYNTHETIC, P308; THALLER C, 1990, NATURE, V345, P815, DOI 10.1038/345815a0; ZELENT A, 1991, EMBO J, V10, P71, DOI 10.1002/j.1460-2075.1991.tb07922.x	49	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7297	7303						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125944				2022-12-27	WOS:A1994NA03200043
J	WILDE, A; DEMPSEY, C; BANTING, G				WILDE, A; DEMPSEY, C; BANTING, G			THE TYROSINE-CONTAINING INTERNALIZATION MOTIF IN THE CYTOPLASMIC DOMAIN OF TGN38/41 LIES WITHIN A NASCENT HELIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; LYSOSOMAL ACID-PHOSPHATASE; INTEGRAL MEMBRANE-PROTEIN; FACTOR-II RECEPTOR; SECONDARY STRUCTURE; PEPTIDE-FRAGMENTS; BREFELDIN-A; MEDIATED INTERNALIZATION; COMPLETE SEQUENCE; SIGNAL	TGN38 and TGN41 are isoforms of an integral membrane protein (TGN38/41) which is predominantly located in the trans-Golgi network of mammalian cells, but which constitutively recycles between the TGN and the plasma membrane. The cytoplasmic domain tetrapeptide sequence ''YQRL'' is responsible for the internalization of TGN38/41 from the plasma membrane. This sequence conforms to the tyrosine containing internal ization motif (''YXYhydro,'' where X is any amino acid and hydro is any large bulky hydrophobic amino acid) found in other integral membrane proteins which are internalized from the plasma membrane via clathrin-coated vesicles. Structural predictions have suggested that the YXXhydro motif might adopt a tight turn structure in solution, a prediction supported previously by nuclear magnetic resonance (NMR) studies on short synthetic peptides corresponding to variants of the generic YXXhydro motif. We have synthesized a 21-amino acid peptide which encompasses the TGN38/41 internalization motif and used it as template for two-dimensional NMR analysis. The data from these experiments demonstrate that the internalization motif in the cytoplasmic domain of TGN38/41 lies within a nascent helix, not a tight turn. This is the first study to show that tyrosine containing internalization motifs do not necessarily adopt a beta-turn conformation.	UNIV BRISTOL, SCH MED SCI, DEPT BIOCHEM, BRISTOL BS8 1TD, ENGLAND; UNIV BRISTOL, SCH MED SCI, SCI & ENGN RES COUNCIL MOLEC RECOGNIT CTR, BRISTOL BS8 1TD, ENGLAND	University of Bristol; University of Bristol				Wilde, Andrew/0000-0002-9812-3847; Dempsey, Christopher/0000-0002-1933-7805; Banting, George/0000-0001-8249-1621				AMIGORENA S, 1992, NATURE, V358, P337, DOI 10.1038/358337a0; BACKER JM, 1990, J BIOL CHEM, V265, P16450; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; BOS K, 1993, EMBO J, V12, P2219, DOI 10.1002/j.1460-2075.1993.tb05870.x; BRAUN M, 1989, EMBO J, V8, P3633, DOI 10.1002/j.1460-2075.1989.tb08537.x; BREITFELD PP, 1990, J BIOL CHEM, V265, P13750; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; CHEGE NW, 1990, J CELL BIOL, V111, P893, DOI 10.1083/jcb.111.3.893; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; DAVIS AG, 1983, J AM CHEM SOC, V107, P2821; DYSON HJ, 1992, J MOL BIOL, V226, P819, DOI 10.1016/0022-2836(92)90634-V; DYSON HJ, 1992, J MOL BIOL, V226, P795, DOI 10.1016/0022-2836(92)90633-U; DYSON HJ, 1988, J MOL BIOL, V201, P201, DOI 10.1016/0022-2836(88)90447-0; EBERLE W, 1991, CELL, V67, P1203, DOI 10.1016/0092-8674(91)90296-B; FARQUHAR MG, 1985, ANNU REV CELL BIOL, V1, P447, DOI 10.1146/annurev.cb.01.110185.002311; FUHRER C, 1991, J CELL BIOL, V114, P423, DOI 10.1083/jcb.114.3.423; GRANGER BL, 1990, J BIOL CHEM, V265, P12036; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HONG WJ, 1993, BIOESSAYS, V15, P231, DOI 10.1002/bies.950150403; HUMPHREY JS, 1993, J CELL BIOL, V120, P1123, DOI 10.1083/jcb.120.5.1123; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; KLEVIT RE, 1985, J MAGN RESON, V62, P551, DOI 10.1016/0022-2364(85)90227-6; KTISTAKIS NT, 1990, J CELL BIOL, V111, P1393, DOI 10.1083/jcb.111.4.1393; LADINSKY MS, 1992, EUR J CELL BIOL, V59, P92; LEHMANN LE, 1992, EMBO J, V11, P4391, DOI 10.1002/j.1460-2075.1992.tb05539.x; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LUZIO JP, 1990, BIOCHEM J, V270, P97, DOI 10.1042/bj2700097; MERESSE S, 1993, J CELL BIOL, V120, P67, DOI 10.1083/jcb.120.1.67; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; REAVES B, 1992, J CELL BIOL, V116, P85, DOI 10.1083/jcb.116.1.85; REAVES B, 1993, MOL BIOL CELL, V4, P93, DOI 10.1091/mbc.4.1.93; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; ROTH MG, 1986, J CELL BIOL, V102, P1271, DOI 10.1083/jcb.102.4.1271; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q; VAUX D, 1992, Trends in Cell Biology, V2, P189, DOI 10.1016/0962-8924(92)90232-C; WAGNER G, 1986, J MOL BIOL, V187, P131, DOI 10.1016/0022-2836(86)90413-4; WILEMAN T, 1985, BIOCHEM J, V232, P1; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WONG SH, 1993, J BIOL CHEM, V268, P22853; WUTHRICH K, 1984, J MOL BIOL, V180, P715, DOI 10.1016/0022-2836(84)90034-2; Wuthrich K., 1986, NMR PROTEINS NUCL AC	46	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7131	7136						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125922				2022-12-27	WOS:A1994NA03200017
J	LI, N; MATTOO, AK				LI, N; MATTOO, AK			DELETION OF THE CARBOXYL-TERMINAL REGION OF 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID SYNTHASE, A KEY PROTEIN IN THE BIOSYNTHESIS OF ETHYLENE, RESULTS IN CATALYTICALLY HYPERACTIVE, MONOMERIC ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENCODING 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE; CUCURBITA-MAXIMA DUCH; TOBACCO LEAF-DISKS; ESCHERICHIA-COLI; MESSENGER-RNA; ARABIDOPSIS-THALIANA; MOLECULAR-CLONING; TOMATO; GENE; EXPRESSION	1-Aminocyclopropane-1-carboxylic acid (ACC) synthase is a key enzyme regulating biosynthesis of the plant hormone ethylene, The expression of an enzymatically active, wound-inducible tomato (Lycopersicon esculentum L. cv Pik-Red) ACC synthase (485 amino acids long) in a heterologous Escherichia coli system allowed us to study the importance of hypervariable COOH terminus in enzymatic activity and protein conformation. We constructed several deletion mutants of the gene, expressed these in E. coli, purified the protein products to apparent homogeneity, and analyzed both conformation and enzyme kinetic parameters of the wild-type and truncated ACC syntheses. Deletion of the COOH terminus through Arg(429) results in complete inactivation of the enzyme. Deletion of 46-52 amino acids from the COOH terminus results in an enzyme that has nine times higher affinity for the substrate S-adenosylmethionine than the wild-type enzyme. The highly efficient, truncated ACC synthase was found to be a monomer of 52 +/- 1.8 kDa as determined by gel filtration, whereas the wild-type ACC synthase, analyzed under similar conditions, is a dimer. These results demonstrate that the nonconserved COOH terminus of ACC synthase affects its enzymatic function as well as dimerization.	USDA ARS, BARC W, PLANT MOLEC BIOL LAB, BELTSVILLE, MD 20705 USA	United States Department of Agriculture (USDA)			Mattoo, Autar/U-9751-2019; Mattoo, Autar/G-9863-2011	Mattoo, Autar/0000-0001-9226-7164; 				ANDERSON JD, 1982, BIOCHEM BIOPH RES CO, V107, P588, DOI 10.1016/0006-291X(82)91532-7; BAILEY BA, 1992, PLANT PHYSIOL, V100, P1615, DOI 10.1104/pp.100.3.1615; BLEECKER AB, 1987, CURR TOP PLANT BIOCH, V6, P15; BOTTELA JR, 1992, PLANT MOL BIOL, V18, P793; CALLAHAN FE, 1989, PLANT PHYSIOL, V91, P629, DOI 10.1104/pp.91.2.629; CHALUTZ E, 1984, PLANT PHYSIOL, V74, P99, DOI 10.1104/pp.74.1.99; DONG JG, 1991, PLANTA, V185, P38, DOI 10.1007/BF00194512; EDELMAN L, 1990, PLANTA, V182, P635, DOI 10.1007/BF02341042; ELLIOTT JI, 1978, ARCH BIOCHEM BIOPHYS, V190, P351, DOI 10.1016/0003-9861(78)90285-0; Haldane J. B. S., 1965, ENZYMES; HEROLD M, 1990, BIOCHEMISTRY-US, V29, P1907, DOI 10.1021/bi00459a035; HUANG PL, 1991, P NATL ACAD SCI USA, V88, P7021, DOI 10.1073/pnas.88.16.7021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI N, 1992, PLANT MOL BIOL, V18, P477, DOI 10.1007/BF00040664; LI N, 1992, FEBS LETT, V306, P103, DOI 10.1016/0014-5793(92)80978-P; LIANG XW, 1992, P NATL ACAD SCI USA, V89, P11046, DOI 10.1073/pnas.89.22.11046; MARDER JB, 1986, METHOD ENZYMOL, V118, P384; MATTOO AK, 1993, CURR PLANT SCI BIOT, V16, P223; MATTOO AK, 1984, ETHYLENE BIOCH PHYSL, P139; Mattoo AK, 1991, PLANT HORMONE ETHYLE, P21; MEHTA AM, 1988, P NATL ACAD SCI USA, V85, P8810, DOI 10.1073/pnas.85.23.8810; MEHTA R, 1993, THESIS U MARYLAND BA; NAKAJIMA N, 1988, PLANT CELL PHYSIOL, V29, P989; NAKAJIMA N, 1990, PLANT CELL PHYSIOL, V31, P1021; NAKAJIMA N, 1986, PLANT CELL PHYSIOL, V27, P969; ONEILL SD, 1993, PLANT CELL, V5, P419, DOI 10.1105/tpc.5.4.419; PARK KY, 1992, PLANT MOL BIOL, V18, P377, DOI 10.1007/BF00034964; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; PENACORTES H, 1989, P NATL ACAD SCI USA, V86, P9851, DOI 10.1073/pnas.86.24.9851; ROTTMANN WH, 1991, J MOL BIOL, V222, P937, DOI 10.1016/0022-2836(91)90587-V; SATO T, 1991, J BIOL CHEM, V266, P3752; SATO T, 1989, P NATL ACAD SCI USA, V86, P6621, DOI 10.1073/pnas.86.17.6621; SATOH S, 1993, PLANT CELL PHYSIOL, V34, P753, DOI 10.1093/oxfordjournals.pcp.a078479; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; THEOLOGIS A, 1992, CELL, V70, P181, DOI 10.1016/0092-8674(92)90093-R; VAN DER STRAETEN D, 1990, P NATL ACAD SCI USA, V87, P4859, DOI 10.1073/pnas.87.12.4859; VAN DER STRAETEN D, 1992, P NATL ACAD SCI USA, V89, P9969, DOI 10.1073/pnas.89.20.9969; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; YIP WK, 1990, P NATL ACAD SCI USA, V87, P7930, DOI 10.1073/pnas.87.20.7930	40	54	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6908	6917						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120053				2022-12-27	WOS:A1994MZ50300100
J	PRASAD, K; HEUSER, J; EISENBERG, E; GREENE, L				PRASAD, K; HEUSER, J; EISENBERG, E; GREENE, L			COMPLEX-FORMATION BETWEEN CLATHRIN AND UNCOATING ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COATED VESICLES; HEAT-SHOCK; STRESS PROTEINS; TRANSLOCATION; DISSOCIATION; BINDING; HSP70; CAGES	The bovine brain uncoating ATPase, a constitutive 70-kDa heat shock protein, uncoats clathrin coated vesicles in an ATP dependent reaction. The uncoating ATPase-clathrin complex formed from the uncoating reaction was compared to the complex formed by directly binding free clathrin to uncoating ATPase. The amount of the latter complex shows a simple hyperbolic dependence on either free clathrin or free uncoating ATPase concentration, whichever is in excess, with a binding stoichiometry of one uncoating ATPase per clathrin heavy chain. ATP markedly increases the rates of formation and dissociation of this complex while ADP profoundly inhibits these rates. At low uncoating ATPase concentrations, much more complex is formed by uncoating than by directly binding clathrin to enzyme. However, during column chromatography or dilution for electron microscopy, both types of complex dissociate in ATP but not ADP, and electron microscopy of both types of complex diluted into ADP shows binding only to the vertex of the clathrin triskelion. We conclude that the uncoating ATPase forms only one type of complex with clathrin and has only one site for nucleotide; ADP at this site prevents either formation or dissociation of complex, whereas ATP at this site allows both processes to occur rapidly.	NHLBI,CELL BIOL LAB,BETHESDA,MD 20892; WASHINGTON UNIV,SCH MED,DEPT CELL BIOL & PHYSIOL,ST LOUIS,MO 63110	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Washington University (WUSTL)								BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; CHOCK SP, 1979, J BIOL CHEM, V254, P3229; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; GAO BC, 1991, J BIOL CHEM, V266, P19565; GAO BC, 1993, J BIOL CHEM, V268, P8507; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GREENE LE, 1990, J BIOL CHEM, V265, P6682; HEUSER J, 1989, J CELL BIOL, V109, P1457, DOI 10.1083/jcb.109.4.1457; HEUSER JE, 1983, J MOL BIOL, V169, P155, DOI 10.1016/S0022-2836(83)80179-X; JENTOFT N, 1983, METHOD ENZYMOL, V91, P570; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; NANDI PK, 1982, P NATL ACAD SCI USA, V107, P5885; PELHAM HRB, 1989, EMBO J, V8, P3171, DOI 10.1002/j.1460-2075.1989.tb08475.x; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SCHMID SL, 1985, J BIOL CHEM, V260, P10050; SCHMID SL, 1985, J BIOL CHEM, V260, P57; SCHMID SL, 1985, J BIOL CHEM, V260, P44; SCHMID SL, 1984, NATURE, V311, P228, DOI 10.1038/311228a0	25	44	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6931	6939						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120055				2022-12-27	WOS:A1994MZ50300103
J	SONG, ES; YANG, Y; JACKSON, MR; PETERSON, PA				SONG, ES; YANG, Y; JACKSON, MR; PETERSON, PA			IN-VIVO REGULATION OF THE ASSEMBLY AND INTRACELLULAR-TRANSPORT OF CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER CELLS; ENDOPLASMIC-RETICULUM; PEPTIDE; BINDING; HEAVY; ASSOCIATION; SEQUENCES; ANTIGENS; CALNEXIN; RESIDENT	Using H-2K(b)-transfected Balb/c 3T3 cells which generate ''empty'' H-2K(b) molecules devoid of antigenic pep tides, we show that peptide availability determines the stability of class I molecules and dictates the overall intracellular transport rate of the class I complexes. Our data also indicate that chaperonin-like proteins are involved in class I assembly. Using Drosophila cells transfected with H-2K(b) and murine beta(2)-microglobulin, we show that one possible candidate, calnexin, associates with class I molecules prior to peptide acquisition. These data suggest that both peptide supply and assembly proteins dictate cell surface expression of class I major histocompatibility complex molecules and ultimately influence T cell recognition. The role of beta(2)-microglobulin in class I assembly is also discussed.			SONG, ES (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA.				NCI NIH HHS [CA97489] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALEXANDER J, 1990, IMMUNOGENETICS, V31, P169; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; CAPPS GG, 1993, J BIOL CHEM, V268, P21263; DEGAN E, 1991, J CELL BIOL, V112, P1099; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; ELLIOTT T, 1991, NATURE, V351, P402, DOI 10.1038/351402a0; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; GALVIN K, 1992, P NATL ACAD SCI USA, V89, P8452, DOI 10.1073/pnas.89.18.8452; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; LJUNGGREN HG, 1989, J IMMUNOL, V142, P2911; MATSUMURA M, 1992, J BIOL CHEM, V267, P23589; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; OTTEN GR, 1992, J IMMUNOL, V148, P3723; PAABO S, 1987, CELL, V50, P311, DOI 10.1016/0092-8674(87)90226-1; REYES AA, 1982, P NATL ACAD SCI-BIOL, V79, P3270, DOI 10.1073/pnas.79.10.3270; SCHMACHER TNM, 1990, CELL, V62, P563; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; WADA I, 1991, J BIOL CHEM, V266, P19599	24	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					7024	7029						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120066				2022-12-27	WOS:A1994MZ50300116
J	BLUMENFELD, N; GONEN, H; MAYER, A; SMITH, CE; SIEGEL, NR; SCHWARTZ, AL; CIECHANOVER, A				BLUMENFELD, N; GONEN, H; MAYER, A; SMITH, CE; SIEGEL, NR; SCHWARTZ, AL; CIECHANOVER, A			PURIFICATION AND CHARACTERIZATION OF A NOVEL SPECIES OF UBIQUITIN-CARRIER PROTEIN, E2, THAT IS INVOLVED IN DEGRADATION OF NON-N-END RULE PROTEIN SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPAIR GENE RAD6; CONJUGATING ENZYME; AFFINITY PURIFICATION; BINDING-SITES; POLYVINYLIDENE DIFLUORIDE; DEPENDENT PROTEOLYSIS; SEQUENCE-ANALYSIS; ENCODES; LIGASE; SYSTEM	Ubiquitin-carrier proteins (E2s, ubiquitin-conjugating enzymes, UBCs) participate in proteolysis by catalyzing transfer of activated ubiquitin to the protein substrates, which are bound to specific ubiquitin-protein ligases (E3s). Yeast UBC2 (RAD6) and the mammalian E214kDa bind to the ligase that recognizes and is involved in the degradation of certain free amino-terminal substrates (''N-end rule'' substrates). As such proteins are rather scarce, the role of these E2s in general proteolysis is probably limited. Here, we report the purification and characterization of a novel 18-kDa species of E2 from rabbit reticulocytes. Unlike most members of the E2 family, this enzyme does not adsorb to anion exchange resin in neutral pH, and it is purified from the unadsorbed material (Fraction 1). Thus, it is designated E2-F1. Like all members of the E2 family, it generates a thiol ester with ubiquitin that serves as an intermediate in the conjugation reaction. Sequence analysis revealed a significant homology to many known species of E2s. The enzyme generates multiply ubiquitinated proteins in the presence of an E3 that has not been characterized yet. Most importantly, the ubiquitination via this E2 leads to the degradation of certain non-''N-end rule'' substrates such as glyceraldehyde-3-phosphate dehydrogenase (Val at the NH2 terminus) and to the ubiquitination and degradation of certain N-alpha-acetylated proteins such as histone H2A, actin, and alpha-crystallin. The enzyme is also involved in the conjugation and degradation of the tumor suppressor protein p53.	TECHNION ISRAEL INST TECHNOL,FAC MED,RAPPAPORT INST RES MED SCI,IL-31096 HAIFA,ISRAEL; MONSANTO INC,ST LOUIS,MO 63198; ST LOUIS CHILDRENS HOSP,EDWARD MALLINCKRODT DEPT PEDIAT,ST LOUIS,MO 63178; ST LOUIS CHILDRENS HOSP,EDWARD MALLINCKRODT DEPT PHARMACOL,ST LOUIS,MO 63178	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Monsanto; St. Louis Children's Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL)	BLUMENFELD, N (corresponding author), TECHNION ISRAEL INST TECHNOL,FAC MED,DEPT BIOCHEM,IL-31096 HAIFA,ISRAEL.		Ciechanover, Aaron J/C-9166-2017					BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; BILOFSKY HS, 1988, NUCLEIC ACIDS RES, V16, P1861, DOI 10.1093/nar/16.5.1861; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN JL, 1976, J BIOL CHEM, V251, P1009; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; CIECHANOVER A, 1994, J BIOL CHEM, V269, P9582; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; FERBER S, 1985, J BIOL CHEM, V261, P3128; FERNANDEZ J, 1992, ANAL BIOCHEM, V201, P255, DOI 10.1016/0003-2697(92)90336-6; GIROD PA, 1993, J BIOL CHEM, V268, P955; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; GONEN H, 1991, J BIOL CHEM, V266, P19221; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; HERSHKO A, 1979, P NATL ACAD SCI USA, V76, P3107, DOI 10.1073/pnas.76.7.3107; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HINGAMP PM, 1992, EMBO J, V11, P361, DOI 10.1002/j.1460-2075.1992.tb05058.x; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P399; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; JOHNSTON NL, 1991, BIOCHEMISTRY-US, V30, P7514, DOI 10.1021/bi00244a021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MAYER A, 1989, SCIENCE, V244, P1480, DOI 10.1126/science.2544030; PICKART CM, 1985, J BIOL CHEM, V260, P1573; PUTNEY SD, 1983, NATURE, V302, P718, DOI 10.1038/302718a0; REISS Y, 1989, J BIOL CHEM, V264, P10378; REISS Y, 1988, J BIOL CHEM, V263, P2693; REISS Y, 1990, J BIOL CHEM, V265, P3685; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SEUFERT W, 1990, EMBO J, V9, P4535, DOI 10.1002/j.1460-2075.1990.tb07905.x; SIDMAN KE, 1980, NUCLEIC ACIDS RES, V16, P1869; SULLIVAN ML, 1989, P NATL ACAD SCI USA, V86, P9861, DOI 10.1073/pnas.86.24.9861; SULLIVAN ML, 1991, J BIOL CHEM, V266, P23878; SUNG P, 1991, EMBO J, V10, P2187, DOI 10.1002/j.1460-2075.1991.tb07754.x; TREIER M, 1992, EMBO J, V11, P367, DOI 10.1002/j.1460-2075.1992.tb05059.x; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; WING SS, 1992, J BIOL CHEM, V267, P6495	40	65	72	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9574	9581						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144544				2022-12-27	WOS:A1994NE05300030
J	FUKUDA, R; HORIUCHI, H; OHTA, A; TAKAGI, M				FUKUDA, R; HORIUCHI, H; OHTA, A; TAKAGI, M			THE PROSEQUENCE OF RHIZOPUS-NIVEUS ASPARTIC PROTEINASE-I SUPPORTS CORRECT FOLDING AND SECRETION OF ITS MATURE PART IN SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-SEQUENCE; PROPEPTIDE; GENE; PEPSINOGEN; PROTEASE; TRANSPORT; TRANSIT; CLONING; REGION; SIGNAL	Extracellular Rhizopus niveus aspartic proteinase-I (RNAP-I) was secreted effectively by Saccharomyces cerevisiae when RNAP-I with its preprosequence was synthesized in this organism (Horiuchi, H., Ashikari, T., Amachi, T., Yoshizumi, H., Takagi, M., and Yano, K. (1990) Agric. Biol. Chem. 54, 1771-1779). Certain deletions (DELTApro, DELTA1, DELTA2), and amino acid substitutions (MI) in the prosequence blocked secretion of RNAP-I, although the protease protection assay revealed that even DELTApro could be translocated across the membrane of the endoplasmic reticulum. When Apro or Ml was synthesized simultaneously with the wild-type preprosequence in S. cerevisiae, secretion of RNAP-I was recovered. Therefore, the physical linkage of the prosequence to the mature region is not a prerequisite for secretion of active RNAP-I. Purified RNAP-I with the prosequence once denatured in 6 m guanidine HCl could be renatured and activated to have its enzymatic activity by removing guanidine HCl in vitro, but RNAP-I without the prosequence could not. Furthermore, the wild-type prosequence helped the recovery of the activity of the denatured RNAP-I in trans, but the prosequence of M1 with which secretion of RNAP-I was not observed in vivo, did not. From these results we concluded that the prosequence of RNAP-I supports correct folding of RNA-P-I in the endoplasmic reticulum lumen and its subsequent secretion in S. cerevisiae. The functional role of the prosequence of an aspartic proteinase was elucidated.	UNIV TOKYO, DEPT AGR CHEM, BUNKYO KU, TOKYO 113, JAPAN	University of Tokyo								BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; BAKER D, 1990, P NATL ACAD SCI USA, V87, P355, DOI 10.1073/pnas.87.1.355; CHEN Z, 1991, J BIOL CHEM, V266, P11718; FABRE E, 1992, J BIOL CHEM, V267, P15049; FRANZUSOFF A, 1991, METHOD ENZYMOL, V194, P662; HAYANO T, 1988, J BIOL CHEM, V263, P1382; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; HORIUCHI H, 1988, J BACTERIOL, V170, P272, DOI 10.1128/jb.170.1.272-278.1988; HORIUCHI H, 1990, AGR BIOL CHEM TOKYO, V54, P1771, DOI 10.1080/00021369.1990.10870223; HORIUCHI H, 1988, J BIOCHEM-TOKYO, V103, P408, DOI 10.1093/oxfordjournals.jbchem.a122284; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JAMES MNG, 1986, NATURE, V319, P33, DOI 10.1038/319033a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARRIBA G, 1993, YEAST, V9, P441, DOI 10.1002/yea.320090502; LEE YC, 1992, FEMS MICROBIOL LETT, V92, P73, DOI 10.1016/0378-1097(92)90544-X; Maniatis T., 1982, MOL CLONING; NEURATH H, 1989, TRENDS BIOCHEM SCI, V14, P268, DOI 10.1016/0968-0004(89)90061-3; RAZANAMPARANY V, 1992, CURR GENET, V21, P455, DOI 10.1007/BF00351655; Sakaguchi K, 1992, APPL MOL GENETICS FI, P54; SOGAWA K, 1983, J BIOL CHEM, V258, P5306; STOLLER TJ, 1989, J CELL BIOL, V108, P1647, DOI 10.1083/jcb.108.5.1647; SUTER U, 1991, EMBO J, V10, P2395, DOI 10.1002/j.1460-2075.1991.tb07778.x; TONOUCHI N, 1986, NUCLEIC ACIDS RES, V14, P7557, DOI 10.1093/nar/14.19.7557; VALLS LA, 1990, J CELL BIOL, V111, P361, DOI 10.1083/jcb.111.2.361; VANDENHAZEL HB, 1993, J BIOL CHEM, V268, P18002; WANDERSMAN C, 1992, TRENDS GENET, V8, P317, DOI 10.1016/0168-9525(92)90264-5; WEISSMAN JS, 1992, CELL, V71, P841, DOI 10.1016/0092-8674(92)90559-U; WINTHER JR, 1991, P NATL ACAD SCI USA, V88, P9330, DOI 10.1073/pnas.88.20.9330; WIREN KM, 1988, J BIOL CHEM, V263, P19771; ZHU XL, 1989, NATURE, V339, P483, DOI 10.1038/339483a0	30	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9556	9561						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144542				2022-12-27	WOS:A1994NE05300027
J	LAL, A; SCHUTZBACH, JS; FORSEE, WT; NEAME, PJ; MOREMEN, KW				LAL, A; SCHUTZBACH, JS; FORSEE, WT; NEAME, PJ; MOREMEN, KW			ISOLATION AND EXPRESSION OF MURINE AND RABBIT CDNAS ENCODING AN ALPHA-1,2-MANNOSIDASE INVOLVED IN THE PROCESSING OF ASPARAGINE-LINKED OLIGOSACCHARIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEINS; LIVER GOLGI MEMBRANES; ALPHA-MANNOSIDASE-II; GLYCOPROTEIN-BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; TRIMMING MAN9-MANNOSIDASE; PIG-LIVER; PURIFICATION; ENZYME	We have isolated a full-length cDNA clone encoding a murine alpha1,2-mannosidase involved in the processing of mammalian Asn-linked oligosaccharides. Oligonucleotide primers were designed based on peptide sequences derived from the purified rabbit liver enzyme and were used to generate a 1011-base pair probe using the polymerase chain reaction. This probe was used to isolate clones from rabbit and mouse cDNA libraries. The full-length murine cDNA clone encodes a 655-amino acid type II transmembrane protein with a 43-amino acid cytoplasmic tail, a single transmembrane domain, and a large COOH-terminal catalytic domain containing two potential N-glycosylation sites. Stable transfection of the murine alpha1,2-mannosidase cDNA into mouse L cells resulted in a approximately 22-fold overexpression of alpha1,2-mannosidase activity. Three transcripts were detected in rabbit tissues, whereas two were found in rat and mouse tissues. The sequences of the rabbit and mouse cDNA clones indicate that the multiple transcripts differ in the length of their 3' sequences as a result of the use of multiple polyadenylation signals. Immunolocalization detected cross-reactive material in a juxtanuclear pattern consistent with the Golgi complex. The catalytic portion of the murine alpha1,2-mannosidase was found to bear a strong similarity to the processing alpha1,2-mannosidase from Saccharomyces cerevisiae.	UNIV GEORGIA,DEPT BIOCHEM,B314A LIFE SCI BLDG,ATHENS,GA 30602; UNIV GEORGIA,COMPLEX CARBOHYDRATE RES CTR,ATHENS,GA 30602; UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294; SHRINERS HOSP CRIPPLED CHILDREN,TAMPA,FL 33612	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Alabama System; University of Alabama Birmingham			Moremen, Kelley/AAD-4661-2019		NCRR NIH HHS [RR05351] Funding Source: Medline; NIGMS NIH HHS [GM47462, GM47533] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047533, R01GM047462] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BAUSE E, 1992, EUR J BIOCHEM, V208, P451, DOI 10.1111/j.1432-1033.1992.tb17207.x; BIEBERICH E, 1993, GLYCOCONJUGATE J, V10, P240, DOI 10.1007/BF01209870; BISCHOFF J, 1990, J BIOL CHEM, V265, P17110; BISCHOFF J, 1986, J BIOL CHEM, V261, P4768; CAMIRAND A, 1991, J BIOL CHEM, V266, P15120; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Coulombe PA, 1993, CURR OPIN CELL BIOL, V5, P17, DOI 10.1016/S0955-0674(05)80004-3; FORSEE WT, 1981, J BIOL CHEM, V256, P6577; FORSEE WT, 1989, J BIOL CHEM, V264, P3869; FUHRMANN U, 1985, BIOCHIM BIOPHYS ACTA, V825, P95, DOI 10.1016/0167-4781(85)90095-8; HERSCOVICS A, 1987, ANAL BIOCHEM, V166, P85, DOI 10.1016/0003-2697(87)90550-1; HERSCOVICS A, 1994, J BIOL CHEM, V269, P9864; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; JELINEKKELLY S, 1988, J BIOL CHEM, V263, P14757; JELINEKKELLY S, 1985, J BIOL CHEM, V260, P2253; KAUSHAL GP, 1993, TRENDS GLYCOSCI GLYC, V5, P209; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LEE LG, 1992, NUCLEIC ACIDS RES, V20, P2471, DOI 10.1093/nar/20.10.2471; LOUVARD D, 1982, J CELL BIOL, V92, P92, DOI 10.1083/jcb.92.1.92; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; MOREMEN K, 1988, PROTEIN TRANSFER ORG, P209; MOREMEN KW, 1991, J CELL BIOL, V115, P1521, DOI 10.1083/jcb.115.6.1521; MOREMEN KW, 1991, J BIOL CHEM, V266, P16876; MOREMEN KW, 1989, P NATL ACAD SCI USA, V86, P5276, DOI 10.1073/pnas.86.14.5276; MOREMEN KW, 1985, J BIOL CHEM, V260, P6654; MOREMEN KW, 1994, IN PRESS GLYCOBIOLOG; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; NILSSON T, 1991, EMBO J, V10, P3567, DOI 10.1002/j.1460-2075.1991.tb04923.x; OBERMAIER B, 1992, BIOTECHNIQUES, V13, P46; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; RIZZOLO LJ, 1988, J BIOL CHEM, V263, P9520; ROTH J, 1990, EUR J CELL BIOL, V53, P131; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUTZBACH JS, 1990, J BIOL CHEM, V265, P2546; SCHWEDEN J, 1989, BIOCHEM J, V264, P347, DOI 10.1042/bj2640347; SCHWEDEN J, 1986, EUR J BIOCHEM, V157, P563, DOI 10.1111/j.1432-1033.1986.tb09703.x; SHAPER NL, 1988, J BIOL CHEM, V263, P10420; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; STADEN R, 1987, NUCLEIC ACID PROTEIN, P173; SZEBENYI DME, 1986, J BIOL CHEM, V261, P8761; TEASDALE RD, 1992, J BIOL CHEM, V267, P4084; TULSIANI DRP, 1988, J BIOL CHEM, V263, P5408; TULSIANI DRP, 1982, J BIOL CHEM, V257, P3660; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; WEINSTEIN J, 1987, J BIOL CHEM, V262, P17735; ZIEGLER F D, 1991, Glycobiology, V1, P605, DOI 10.1093/glycob/1.6.605	53	73	83	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9872	9881						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144580				2022-12-27	WOS:A1994NE05300074
J	MASOLIVA, J; ARNOLD, KS; WAGNER, WD; PHILLIPS, DR; PITAS, RE; INNERARITY, TL				MASOLIVA, J; ARNOLD, KS; WAGNER, WD; PHILLIPS, DR; PITAS, RE; INNERARITY, TL			ISOLATION AND CHARACTERIZATION OF A PLATELET-DERIVED MACROPHAGE-BINDING PROTEOGLYCAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; CHONDROITIN 4-SULFATE PROTEOGLYCAN; SMOOTH-MUSCLE CELLS; HERITABLE HYPERLIPIDEMIC RABBIT; ENDOTHELIAL-CELLS; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN FIBROBLASTS; RECEPTOR; ATHEROSCLEROSIS; DEGRADATION	A macromolecule in human platelet secretory products was demonstrated previously to inhibit the binding and uptake of acetoacetylated (AcAc) low density lipoproteins (LDL) by scavenger receptors on mouse peritoneal macrophages. In the current study, this macromolecule was purified to apparent homogeneity by DEAE-Sephacel chromatography, Sephacryl S-300 chromatography, and sucrose gradient centrifugation. SDS-polyacrylamide gel electrophoresis revealed a single band with an apparent molecular mass of approximately 120 kDa. Chemical analysis indicated that the macromolecule (designated platelet-derived macrophage-binding proteoglycan (PDMBP)) was a chondroitin 4-sulfate proteoglycan with an approximately 32-kDa core protein. A polyclonal antibody produced against this proteoglycan identified only PDMBP on Western blots of platelet secretory products and removed all ability of these products to inhibit the binding of AcAc LDL to macrophages. Treatment of purified PDMBP with protease or chondroitinase AC or A.BC abolished the ability of the proteoglycan to inhibit the binding of AcAc LDL to macrophages. Binding studies using radiolabeled PDMBP demonstrated that the proteoglycan bound directly to the macrophage cell surface and was competitively inhibited by AcAc LDL, acetyl-LDL, fucoidin, and unlabeled PDMBP. PDMBP inhibited binding of I-125-labeled AcAc LDL to macrophages but had no effect on binding to endothelial cells. The finding that PDMBP binds to the scavenger receptor on macrophages suggests a mechanism for the inhibition of foam cell formation and suggests that the receptor could be involved in the plasma clearance of chondroitin sulfate proteoglycans.	UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94141; COR THERAPEUT INC,S SAN FRANCISCO,CA 94080; WAKE FOREST UNIV,BOWMAN GRAY SCH MED,WINSTON SALEM,NC 27157	University of California System; University of California San Francisco; Wake Forest University; Wake Forest Baptist Medical Center					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045848, P01HL047660] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 47660, HL 45848] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACTON S, 1993, J BIOL CHEM, V268, P3530; BARBER AJ, 1972, BIOCHIM BIOPHYS ACTA, V286, P312, DOI 10.1016/0304-4165(72)90267-X; BICKEL PE, 1992, J CLIN INVEST, V90, P1450, DOI 10.1172/JCI116012; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BROWN MS, 1974, J BIOL CHEM, V249, P789; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CAREW TE, 1987, P NATL ACAD SCI USA, V84, P7725, DOI 10.1073/pnas.84.21.7725; COHN ZA, 1965, J EXP MED, V121, P153, DOI 10.1084/jem.121.1.153; DODGSON KS, 1961, BIOCHEM J, V78, P312, DOI 10.1042/bj0780312; FITZGERALD LA, 1985, J BIOL CHEM, V260, P893; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; HABERLAND ME, 1987, AM HEART J, V113, P573, DOI 10.1016/0002-8703(87)90635-1; HENRIKSEN T, 1981, P NATL ACAD SCI-BIOL, V78, P6499, DOI 10.1073/pnas.78.10.6499; HUANG SS, 1982, J BIOL CHEM, V257, P1546; Innerarity T L, 1986, Methods Enzymol, V129, P542; KERBY GP, 1959, J LAB CLIN MED, V53, P708; KERBY GP, 1992, J LAB CLIN MED, V90, P1450; KITA T, 1987, P NATL ACAD SCI USA, V84, P5928, DOI 10.1073/pnas.84.16.5928; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; KURIHARA Y, 1991, CURR OPIN LIPIDOL, V2, P295; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MOREL DW, 1984, ARTERIOSCLEROSIS, V4, P357, DOI 10.1161/01.ATV.4.4.357; NADER HB, 1991, J BIOL CHEM, V266, P10518; OKAYAMA M, 1986, BIOCHEM J, V233, P73, DOI 10.1042/bj2330073; PARTHASARATHY S, 1985, P NATL ACAD SCI USA, V82, P3000, DOI 10.1073/pnas.82.9.3000; PERIN JP, 1988, BIOCHEM J, V255, P1007, DOI 10.1042/bj2551007; PHILLIPS DR, 1985, NATURE, V316, P746, DOI 10.1038/316746a0; PITAS RE, 1985, J CELL BIOL, V100, P103, DOI 10.1083/jcb.100.1.103; PITAS RE, 1990, J BIOL CHEM, V265, P12722; RADHAKRISHNAMURTHY B, 1980, J BIOL CHEM, V255, P7575; ROHRER L, 1990, NATURE, V343, P570, DOI 10.1038/343570a0; SELDIN DC, 1984, ANAL BIOCHEM, V141, P291, DOI 10.1016/0003-2697(84)90459-7; SILVESTRI L, 1981, J BIOL CHEM, V256, P7383; STANTON LW, 1992, J BIOL CHEM, V267, P22446; STEIN O, 1980, BIOCHIM BIOPHYS ACTA, V620, P631, DOI 10.1016/0005-2760(80)90155-1; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; WEISGRABER KH, 1978, J BIOL CHEM, V253, P9053	39	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10177	10183						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144520				2022-12-27	WOS:A1994NE05300116
J	NAG, B; ARIMILLI, S; KOUKIS, B; RHODES, E; BAICHWAL, V; SHARMA, SD				NAG, B; ARIMILLI, S; KOUKIS, B; RHODES, E; BAICHWAL, V; SHARMA, SD			INTRAMOLECULAR CHARGE HETEROGENEITY IN PURIFIED MAJOR HISTOCOMPATIBILITY CLASS-II ALPHA-POLYPEPTIDE AND BETA-POLYPEPTIDE CHAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION 2-DIMENSIONAL ELECTROPHORESIS; N-LINKED OLIGOSACCHARIDES; ANTIGENIC PEPTIDE BINDING; T-CELL RECOGNITION; HLA-DR; TUNICAMYCIN INHIBITION; B-CELL; MOLECULES; COMPLEX; SEQUENCE	Major histocompatibility (MHC) class II antigens are heterodimeric cell surface glycoproteins consisting of an alpha and beta chain. Although one-dimensional SDS-polyacrylamide gel electrophoresis analysis of purified MHC class II antigens shows a single diffuse band for each chain, multiple spots of identical molecular size were observed for each chain when analyzed by two-dimensional electrophoresis. The basis of this heterogeneity has not been clearly defined and has been predicted partially to be due to glycosylation and/or phosphorylation of the mature protein. To investigate the role of the three N-linked oligosaccharides of the alpha and beta chains in determining the isoelectric point of each chain, affinity-purified MHC class II antigens from human and rat sources were deglycosylated using asparagine amidase. The complete enzymatic removal of all three N-linked oligosaccharides was confirmed by SDS-polyacrylamide gel electrophoresis as well as by four different lectin-linked Western blot analyses. Two-dimensional gel analysis of the deglycosylated molecules shows no significant difference from the fully glycosylated chains. We have expressed truncated forms of the HLA DR2 chains which lack the transmembrane and cytoplasmically exposed regions in Escherichia coli. Two-dimensional electrophoresis of these single chains also reveal multiple banding patterns. The two-dimensional banding patterns described are unaffected by exposure to acidic or basic conditions, increased gel running time in the first dimension, treatment of the proteins with alkaline phosphatase to remove any potential phosphorylation, or preincubation in the presence of iodoacetamide. Multiple forms of recombinant alpha and beta chains were also observed in Tris-glycine-urea gels which merged into a single band in the presence of SDS. In addition, partially fractionated bands from preparative isoelectric focusing gels, when refocused, showed an identical number of multiple spots spanning the same range of isoelectric points. These results together suggest that each polypeptide chain of MHC class II antigens may exist in multiconformational forms, and the observed charge heterogeneity is independent of glycosylation and phosphorylation of the proteins.			NAG, B (corresponding author), ANERGEN INC,REDWOOD CITY,CA 94063, USA.							ALLEN PM, 1987, IMMUNOL REV, V98, P171, DOI 10.1111/j.1600-065X.1987.tb00524.x; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; BASHEERUDDIN K, 1985, APPL BIOCHEM BIOTECH, V11, P133, DOI 10.1007/BF02798545; BENOIST CO, 1983, P NATL ACAD SCI-BIOL, V80, P534, DOI 10.1073/pnas.80.2.534; BONTROP RE, 1990, J EXP MED, V172, P53, DOI 10.1084/jem.172.1.53; BRACIALE TJ, 1987, IMMUNOL REV, V98, P95, DOI 10.1111/j.1600-065X.1987.tb00521.x; BUSS S, 1986, CELL, V47, P1071; BUSS S, 1987, IMMUNOL REV, V98, P95; CARDEN MJ, 1985, J BIOL CHEM, V260, P9805; CHARRON DJ, 1990, J EXP MED, V152, pS18; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; CHICZ RM, 1993, NATURE, V178, P27; CHOI E, 1983, SCIENCE, V221, P283, DOI 10.1126/science.6407114; COWING C, 1983, P NATL ACAD SCI-BIOL, V80, P6000, DOI 10.1073/pnas.80.19.6000; CULLEN SE, 1976, TRANSPLANT REV-DENMA, V30, P236; CULLEN SE, 1981, J IMMUNOL, V127, P1478; CULLEN SE, 1975, TRANSPL P, V8, P237; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DORNMAIR K, 1989, COLD SPRING HARB SYM, V54, P409; ESTESS P, 1986, P NATL ACAD SCI USA, V83, P3594, DOI 10.1073/pnas.83.11.3594; FROHMAN M, 1985, J IMMUNOL, V134, P2269; FUKS A, 1977, TRANSPL P, V9, P1685; LEHLE L, 1976, FEBS LETT, V71, P167, DOI 10.1016/0014-5793(76)80922-2; MALISSEN M, 1983, SCIENCE, V221, P750, DOI 10.1126/science.6410508; NAG B, 1993, P NATL ACAD SCI USA, V90, P1604, DOI 10.1073/pnas.90.4.1604; NAG B, 1993, J IMMUNOL, V150, P1358; NAG B, 1991, J IMMUNOL METHODS, V142, P105, DOI 10.1016/0022-1759(91)90297-S; NAG B, 1992, J IMMUNOL, V148, P369; NAG B, 1992, J BIOL CHEM, V267, P22624; NEEL D, 1987, BIOCHEM J, V244, P433, DOI 10.1042/bj2440433; NEPOM BS, 1983, P NATL ACAD SCI-BIOL, V80, P6962, DOI 10.1073/pnas.80.22.6962; NEWCOMB JR, 1993, J IMMUNOL, V150, P499; O'Farrell P H, 1977, Methods Cell Biol, V16, P407; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OFARRELL PZ, 1976, CELL, V9, P289, DOI 10.1016/0092-8674(76)90119-7; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; PASSMORE D, 1992, J IMMUNOL METHODS, V155, P193, DOI 10.1016/0022-1759(92)90285-2; POBER JS, 1978, P NATL ACAD SCI USA, V75, P6002, DOI 10.1073/pnas.75.12.6002; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROTHENHAUSLER B, 1990, P NATL ACAD SCI USA, V87, P352, DOI 10.1073/pnas.87.1.352; SCHWARTZ RH, 1985, ANNU REV IMMUNOL, V3, P237, DOI 10.1146/annurev.iy.03.040185.001321; SHACKELFORD DA, 1980, J EXP MED, V151, P144, DOI 10.1084/jem.151.1.144; SHACKELFORD DA, 1983, J IMMUNOL, V130, P274; SWIEDLER SJ, 1985, J BIOL CHEM, V260, P4046; TAMPE R, 1991, SCIENCE, V254, P87, DOI 10.1126/science.1656526; TKACZ JS, 1975, BIOCHEM BIOPH RES CO, V65, P248, DOI 10.1016/S0006-291X(75)80086-6; WATTS TH, 1986, P NATL ACAD SCI USA, V83, P9660, DOI 10.1073/pnas.83.24.9660; YEWDELL JW, 1990, CELL, V62, P203, DOI 10.1016/0092-8674(90)90356-J	50	13	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10061	10070						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144505				2022-12-27	WOS:A1994NE05300100
J	BERGSTEN, P; GRAPENGIESSER, E; GYLFE, E; TENGHOLM, A; HELLMAN, B				BERGSTEN, P; GRAPENGIESSER, E; GYLFE, E; TENGHOLM, A; HELLMAN, B			SYNCHRONOUS OSCILLATIONS OF CYTOPLASMIC CA2+ AND INSULIN RELEASE IN GLUCOSE-STIMULATED PANCREATIC-ISLETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BURSTING ELECTRICAL-ACTIVITY; BETA-CELLS; CYCLIC-AMP; B-CELLS; CA-2+; CALCIUM; ATP; CONDUCTANCE; LANGERHANS; ACTIVATION	The cytoplasmic Ca2+ concentration ([Ca2+](i)) was measured in single pancreatic mouse islets superfused in a system allowing concomitant recordings of insulin release. When glucose was raised from 3 to 11 mM, [Ca2+](i) responded by a transient lowering followed by a rise to an average level of 192 +/- 11 nM. In 77% of the islets the rise was associated with the gradual appearance of oscillations, which were either fast (2-7/min), slow (0.3-0.9/min), or a combination of both types. The characteristics of the fast [Ca2+](i) oscillations were those expected from a relationship with the electrical burst activity in islets. Accordingly, in most cases the fast oscillations were remarkably regular. The slow [Ca2+](i) oscillations had characteristics similar to the large amplitude ones in individual beta-cells. Whereas glucagon and dibutyryl cAMP could transform slow islet oscillations into fast ones, the alpha(2)-adrenergic agonist clonidine had the opposite effect. The rapid islet oscillations were also facilitated by elevated concentrations of extracellular Ca2+. Reinforcing the arguments for [Ca2+](i) oscillations as responsible for a pulsatile insulin secretion it was possible to demonstrate that the release of the hormone from single islets is synchronized with the slow [Ca2+](i) oscillations.	UPPSALA UNIV,BIOMEDICUM,DEPT MED CELL BIOL,S-75123 UPPSALA,SWEDEN	Uppsala University				Gylfe, Erik/0000-0002-8414-2107				AMMALA C, 1991, NATURE, V353, P849, DOI 10.1038/353849a0; ARKHAMMAR P, 1989, BIOCHEM BIOPH RES CO, V159, P223, DOI 10.1016/0006-291X(89)92426-1; BERGSTEN P, 1993, DIABETES, V42, P670, DOI 10.2337/diabetes.42.5.670; CHANCE B, 1975, ANAL BIOCHEM, V66, P498, DOI 10.1016/0003-2697(75)90617-X; COOK DL, 1983, METABOLISM, V32, P681, DOI 10.1016/0026-0495(83)90124-5; COOK DL, 1982, DIABETES, V31, P985, DOI 10.2337/diabetes.31.11.985; GARCIAMORALES P, 1984, BIOSCIENCE REP, V4, P511, DOI 10.1007/BF01122227; GILON P, 1992, J BIOL CHEM, V267, P20713; GRAPENGIESSER E, 1992, CELL CALCIUM, V13, P219, DOI 10.1016/0143-4160(92)90010-P; GRAPENGIESSER E, 1991, J BIOL CHEM, V266, P12207; GRAPENGIESSER E, 1989, ARCH BIOCHEM BIOPHYS, V268, P404, DOI 10.1016/0003-9861(89)90602-4; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GYLFE E, 1991, CELL CALCIUM, V12, P229, DOI 10.1016/0143-4160(91)90023-8; GYLFE E, 1987, BRIT J PHARMACOL, V92, P281, DOI 10.1111/j.1476-5381.1987.tb11322.x; GYLFE E, 1988, J BIOL CHEM, V263, P5044; HAHN HJ, 1974, J BIOL CHEM, V249, P5275; HELLMAN B, 1990, CELL CALCIUM, V11, P413, DOI 10.1016/0143-4160(90)90053-W; HELLMAN B, 1965, ANN NY ACAD SCI, V131, P541, DOI 10.1111/j.1749-6632.1965.tb34819.x; HELLMAN B, 1992, BIOCHIM BIOPHYS ACTA, V1113, P295, DOI 10.1016/0304-4157(92)90003-S; HELLMAN B, 1975, ENDOCRINOLOGY, V97, P392, DOI 10.1210/endo-97-2-392; Hellman B., 1992, NUTR REGULATION INSU, P213; HENQUIN JC, 1982, PFLUG ARCH EUR J PHY, V393, P322, DOI 10.1007/BF00581418; LEFEBVRE PJ, 1987, DIABETOLOGIA, V30, P443, DOI 10.1007/BF00279610; LONGO EA, 1991, J BIOL CHEM, V266, P9314; RORSMAN P, 1991, NATURE, V349, P77, DOI 10.1038/349077a0; SANTOS RM, 1992, BIOCHEM BIOPH RES CO, V187, P872, DOI 10.1016/0006-291X(92)91278-X; SANTOS RM, 1991, PFLUG ARCH EUR J PHY, V418, P417, DOI 10.1007/BF00550880; SMITH PA, 1990, FEBS LETT, V261, P187, DOI 10.1016/0014-5793(90)80667-8; STAGNER JI, 1992, DIABETES, V41, P93, DOI 10.2337/diabetes.41.1.93; SYKES JA, 1959, P SOC EXP BIOL MED, V100, P125, DOI 10.3181/00379727-100-24546; THELER JM, 1992, J BIOL CHEM, V267, P18110; VALDEOLMILLOS M, 1989, FEBS LETT, V259, P19, DOI 10.1016/0014-5793(89)81484-X; WANG JL, 1990, BIOCHEM BIOPH RES CO, V166, P813, DOI 10.1016/0006-291X(90)90882-N; WEBSTER HV, 1990, J IMMUNOL METHODS, V134, P95, DOI 10.1016/0022-1759(90)90116-D	34	230	245	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8749	8753						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132606				2022-12-27	WOS:A1994NB41100023
J	DAVIDSON, WS; SPARKS, DL; LUNDKATZ, S; PHILLIPS, MC				DAVIDSON, WS; SPARKS, DL; LUNDKATZ, S; PHILLIPS, MC			THE MOLECULAR-BASIS FOR THE DIFFERENCE IN CHARGE BETWEEN PRE-BETA AND ALPHA-MIGRATING HIGH-DENSITY-LIPOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; ELECTROPHORETIC MOBILITY; CHOLESTEROL TRANSPORT; SERUM LIPOPROTEINS; PARTICLES; CHROMATOGRAPHY; HETEROGENEITY; MEMBRANES; CELLS	Several subspecies of human high density lipoprotein (HDL) exist, and particle surface charge is one parameter that can be used to distinguish them. For instance, pre-beta HDL has a lower negative surface charge than the bulk of plasma HDL resulting in slower migration when subjected to electrophoresis in an agarose gel at pH 8.6. The molecular basis for the variations in HDL particle surface charge have been established in this work. Quantitative analysis of electrophoretic mobilities in agarose gels indicates that the surface potentials of reconstituted pre-beta HDL and alpha-HDL(3) are -7.6 and -11.4 mV, respectively. The difference of 3.8 mV corresponds to an apparent le more net negative charge on alpha-migrating HDL(3). The contributions of the lipid and protein components to the charge of HDL(3) were defined using reconstituted particles (rHDL) containing various combinations of HDL(3) protein and lipid. The surface potentials of spherical and discoidal rHDL are not affected by the particle apoprotein composition. Thin layer chromatography of the HDL(3) phospholipid fraction from five normolipidemic subjects revealed that it consists of approximately 84% phosphatidylcholine, 12% sphingomyelin, and 4% phosphatidylinositol (PI) by weight. PI significantly affects the charge of discoidal rHDL and is responsible for similar to 0.7 mV of the surface potential difference between pre-beta and alpha-HDL. Reconstitution of spherical complexes containing apolipoprotein AI, palmitoyl-oleoyl phosphatidylcholine, and HDL(3) neutral lipid esters showed that particles containing a neutral lipid core migrate to an ct position in an agarose gel. The change in particle shape accounts for similar to 3 mV of the difference in surface potential between pre-beta and alpha-HDL. Overall, the charge of HDL particles is determined by 1) a direct contribution of negative charge from PI molecules in the surface of the lipoprotein and 2) the conformation of the resident apolipoprotein(s) which is influenced by the presence of neutral lipids and the particle shape. This quantitative understanding of surface charge provides a basis for understanding variations in function of HDL subspecies.	MED COLL PENN,DEPT BIOCHEM,PHILADELPHIA,PA 19129	Drexel University				Davidson, William/0000-0003-2756-2989; Phillips, Michael/0000-0002-7147-8007	NHLBI NIH HHS [HL07443, HL22633] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007443, P01HL022633] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CASTRO GR, 1988, BIOCHEMISTRY-US, V27, P25, DOI 10.1021/bi00401a005; CHEUNG MC, 1984, J BIOL CHEM, V259, P2201; FIEVET C, 1991, DIABETES METAB REV, V7, P155, DOI 10.1002/dmr.5610070304; FORTE TM, 1986, METHOD ENZYMOL, V128, P442; FRANCONE OL, 1990, EUR HEART J, V11, P218, DOI 10.1093/eurheartj/11.suppl_E.218; HAVEL RJ, 1955, J CLIN INVEST, V34, P476; HIRZ R, 1970, BIOCHIM BIOPHYS ACTA, V207, P364, DOI 10.1016/0005-2795(70)90029-2; HUANG YD, 1993, ARTERIOSCLER THROMB, V13, P445, DOI 10.1161/01.ATV.13.3.445; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; KAWANO M, 1993, BIOCHEMISTRY-US, V32, P5025, DOI 10.1021/bi00070a008; KUNITAKE ST, 1985, J LIPID RES, V26, P549; LEFEVRE M, 1988, J LIPID RES, V29, P1139; LUNDKATZ S, 1986, BIOCHEMISTRY-US, V25, P1562, DOI 10.1021/bi00355a016; MARCEL YL, 1984, EUR J BIOCHEM, V143, P467, DOI 10.1111/j.1432-1033.1984.tb08394.x; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MIIDA T, 1992, BIOCHEMISTRY-US, V31, P11112, DOI 10.1021/bi00160a022; NELSON GJ, 1972, BLOOD LIPIDS LIPOPRO, P317; NOWICKA G, 1990, J LIPID RES, V31, P1947; Patsch J. R, 1987, PLASMA LIPOPROTEINS, P221; PITTMAN RC, 1987, J BIOL CHEM, V262, P2435; RADER DJ, 1991, J LIPID RES, V32, P1849; SCANU AM, 1971, ANAL BIOCHEM, V44, P576, DOI 10.1016/0003-2697(71)90247-8; SHEN BW, 1977, P NATL ACAD SCI USA, V74, P837, DOI 10.1073/pnas.74.3.837; SKIPSKI VP, 1972, BLOOD LIPIDS LIPOPRO, P471; SOKOLOFF L, 1974, P SOC EXP BIOL MED, V146, P1166; SPARKS DL, 1992, J LIPID RES, V33, P123; SPARKS DL, 1993, J BIOL CHEM, V268, P23250; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; SWANEY JB, 1986, METHOD ENZYMOL, V128, P613; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1; [No title captured]	33	91	96	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8959	8965						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132633				2022-12-27	WOS:A1994NB41100052
J	FLOCCO, MM; MOWBRAY, SL				FLOCCO, MM; MOWBRAY, SL			THE 1.9 ANGSTROM X-RAY STRUCTURE OF A CLOSED UNLIGANDED FORM OF THE PERIPLASMIC GLUCOSE/GALACTOSE RECEPTOR FROM SALMONELLA-TYPHIMURIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL CHANGE; GALACTOSE CHEMOSENSORY RECEPTOR; MALTODEXTRIN-BINDING-PROTEIN; ESCHERICHIA-COLI; ACTIVE-TRANSPORT; RIBOSE RECEPTOR; SUGAR BINDING; CHEMOTAXIS; RESOLUTION; LIGAND	The three-dimensional structure of a ligand-free closed form of the glucose/galactose binding protein from Salmonella typhimurium has been determined at a resolution of 1,9 Angstrom The crystallographic R-factor for the refined structure is 17.9%. The model contains all the atoms of the 309 residues of the protein sequence, a calcium ion, and 174 water molecules. The root mean square (r.m.s.) deviations for the whole molecule are: 0.010 A for bond lengths and 2.44 degrees for bond angles, indicating a good stereochemistry for the model. This structure shows that the protein is able to close in the absence of ligand, adopting a conformation similar to the liganded form but slightly more open. Water molecules satisfy the hydrogen bonding ability of the hydrophilic side chains of the binding site in a manner which is reminiscent of the sugars' hydrogen-bonding patterns. Since packing forces are weak, the crystallization event is unlikely to trigger a change from an open to a closed conformation. Instead, the latter must be one of the species in equilibrium in solution which is selected by packing in the crystal lattice.	SWEDISH UNIV AGR SCI,UPPSALA BIOMED CTR,DEPT MOLEC BIOL,S-75123 UPPSALA,SWEDEN	Swedish University of Agricultural Sciences			Mowbray, Sherry L/D-2141-2013					ANDERSON BF, 1990, NATURE, V344, P784, DOI 10.1038/344784a0; ANRAKU Y, 1968, J BIOL CHEM, V243, P3116; ANRAKU Y, 1968, J BIOL CHEM, V243, P3123; BINNIE RA, 1992, PROTEIN SCI, V1, P1642, DOI 10.1002/pro.5560011212; BOOS W, 1972, J BIOL CHEM, V247, P917; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JONES TA, 1990, CRYSTALLOGRAPHIC MOD, P189; JONES TA, 1992, O MANUAL VERSION 5 8; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LUCK LA, 1991, BIOCHEMISTRY-US, V30, P4248, DOI 10.1021/bi00231a021; LUCK LA, 1991, BIOCHEMISTRY-US, V30, P6484, DOI 10.1021/bi00240a019; MANSON MD, 1992, ADV MICROB PHYSIOL, V33, P277, DOI 10.1016/S0065-2911(08)60219-2; MCGOWAN EB, 1974, BIOCHEMISTRY-US, V13, P993, DOI 10.1021/bi00702a025; MILLER DM, 1980, J BIOL CHEM, V255, P2465; Mowbray S L, 1990, Receptor, V1, P41; MOWBRAY SL, 1992, J MOL BIOL, V225, P155, DOI 10.1016/0022-2836(92)91033-L; MOWBRAY SL, 1983, J BIOL CHEM, V258, P7991; NEWCOMER ME, 1981, J BIOL CHEM, V256, P3218; OH BH, 1993, J BIOL CHEM, V268, P1138; Quiocho FA, 1991, CURR OPIN STRUC BIOL, V1, P922, DOI 10.1016/0959-440X(91)90087-A; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; SACK JS, 1989, J MOL BIOL, V206, P193, DOI 10.1016/0022-2836(89)90532-9; SATO M, 1992, J APPL CRYSTALLOGR, V25, P348, DOI 10.1107/S0021889891012955; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; STEWART RC, 1987, CHEM REV, V87, P997, DOI 10.1021/cr00081a007; STRANGE PG, 1976, P NATL ACAD SCI USA, V73, P762, DOI 10.1073/pnas.73.3.762; VYAS NK, 1988, SCIENCE, V242, P1290, DOI 10.1126/science.3057628; YAGHMAI R, 1992, EMBO J, V12, P1897; ZOU JY, 1993, IN PRESS J MOL BIOL; ZUKIN RS, 1979, BIOCHEMISTRY-US, V18, P5599, DOI 10.1021/bi00592a012; ZUKIN RS, 1977, P NATL ACAD SCI USA, V74, P1932, DOI 10.1073/pnas.74.5.1932	35	105	107	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8931	8936						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132630				2022-12-27	WOS:A1994NB41100048
J	MOTOJIMA, K; GOTO, S				MOTOJIMA, K; GOTO, S			HISTIDYL PHOSPHORYLATION AND DEPHOSPHORYLATION OF P36 IN RAT-LIVER EXTRACT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LABILE HISTONE PHOSPHATES; GROWTH-FACTOR RECEPTOR; PROTEIN-KINASES; PEROXISOME-PROLIFERATOR; SIGNAL TRANSDUCTION; GENISTEIN; IDENTIFICATION; CLASSIFICATION; CLOFIBRATE; INHIBITOR	Protein histidine kinase (Motojima, K., and Goto, S. (1993) FEBS Lett. 319, 75-79) and phosphatase in rat liver extract were characterized. The histidine kinase was recovered mostly in the membrane and the phosphatase in the soluble fraction. The kinase and its substrate 36-kDa protein (P36) were co-solubilized from the membrane under conditions in which most of the other kinases, and their substrate proteins were not solubilized. The solubilized kinase and P36 were co-eluted after high pressure liquid chromatography gel filtration, showing an apparent molecular mass of 70-75 kDa. They were also co-eluted after ion exchange chromatography. These characteristics, together with its complete resistance to genistein, indicate that the rat liver histidine kinase is not cognate to the yeast enzyme (Huang, J., Nasr, M., Kim, Y., and Matthews, H. R. (1992) J. Biol. Chem. 267, 15511-15515). The phosphatase that dephosphorylates histidyl-phosphorylated P36 was also studied using rat liver subcellular fractions and in vitro phosphorylated P36 as the substrate. The characteristics of the phosphatase, that is, 1) Mg2+ requirement for activity, 2) apparent molecular mass of 45 kDa by high performance liquid chromatography gel filtration, and 3) resistance to 100 mu M okadaic acid, suggest that the primary phosphatase active in vitro is protein phosphatase 2C.			MOTOJIMA, K (corresponding author), TOHO UNIV, SCH PHARMACEUT SCI, DEPT BIOCHEM, MIYAMA 2-2-1, FUNABASHI, CHIBA 274, JAPAN.							AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ASAOKA Y, 1992, TRENDS BIOCHEM SCI, V17, P414, DOI 10.1016/0968-0004(92)90011-W; BOURRET RB, 1991, ANNU REV BIOCHEM, V60, P401, DOI 10.1146/annurev.bi.60.070191.002153; CHEN CC, 1977, BIOCHEMISTRY-US, V16, P4852, DOI 10.1021/bi00641a016; CHEN CC, 1974, BIOCHEMISTRY-US, V13, P3785, DOI 10.1021/bi00715a026; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1991, METHOD ENZYMOL, V201, P389; COHEN P, 1992, TRENDS BIOCHEM SCI, V17, P408, DOI 10.1016/0968-0004(92)90010-7; DEUTSCHER J, 1982, BIOCHEMISTRY-US, V21, P4867, DOI 10.1021/bi00263a006; FERRELL JE, 1991, METHOD ENZYMOL, V200, P430; FUKUNAGA K, 1993, J BIOL CHEM, V268, P133; HENNING WD, 1988, P NATL ACAD SCI USA, V85, P1432, DOI 10.1073/pnas.85.5.1432; HIRAGA A, 1981, EUR J BIOCHEM, V119, P503, DOI 10.1111/j.1432-1033.1981.tb05636.x; HUANG J, 1991, J BIOL CHEM, V257, P14477; HUANG JM, 1992, J BIOL CHEM, V267, P15511; HUBBARD AL, 1983, J CELL BIOL, V96, P217, DOI 10.1083/jcb.96.1.217; HUNTER T, 1991, METHOD ENZYMOL, V200, P3; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P297, DOI 10.1111/j.1432-1033.1983.tb07362.x; JOHNSON LN, 1993, ANNU REV BIOPH BIOM, V22, P199, DOI 10.1146/annurev.bb.22.060193.001215; KALBITZER HR, 1982, BIOCHEMISTRY-US, V21, P2879, DOI 10.1021/bi00541a012; KARIN M, 1992, TRENDS BIOCHEM SCI, V17, P418, DOI 10.1016/0968-0004(92)90012-X; KIM Y, 1993, ANAL BIOCHEM, V211, P28, DOI 10.1006/abio.1993.1227; KREIL G, 1964, BIOCHEM BIOPH RES CO, V16, P551, DOI 10.1016/0006-291X(64)90191-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lipmann F, 1941, ADV ENZYMOL REL S BI, V1, P99, DOI 10.1002/9780470122464.ch4; LISCOVITCH M, 1992, TRENDS BIOCHEM SCI, V17, P393, DOI 10.1016/0968-0004(92)90007-V; MARSHALL MS, 1993, TRENDS BIOCHEM SCI, V18, P250, DOI 10.1016/0968-0004(93)90175-M; MCCUNE BK, 1989, J BIOL CHEM, V264, P15501; MORGAN M, 1976, BIOCHEM J, V157, P687, DOI 10.1042/bj1570687; MOTOJIMA K, 1992, FEBS LETT, V308, P207, DOI 10.1016/0014-5793(92)81275-Q; MOTOJIMA K, 1992, BIOCHEM BIOPH RES CO, V188, P799, DOI 10.1016/0006-291X(92)91127-C; MOTOJIMA K, 1993, FEBS LETT, V319, P75, DOI 10.1016/0014-5793(93)80040-2; NISHIBE S, 1989, J BIOL CHEM, V264, P10335; OGAWARA H, 1986, J ANTIBIOT, V39, P606, DOI 10.7164/antibiotics.39.606; OHKUMA S, 1982, P NATL ACAD SCI-BIOL, V79, P2758, DOI 10.1073/pnas.79.9.2758; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; PAZIN MJ, 1992, TRENDS BIOCHEM SCI, V17, P374, DOI 10.1016/0968-0004(92)90003-R; PETERSON G, 1991, BIOCHEM BIOPH RES CO, V179, P661, DOI 10.1016/0006-291X(91)91423-A; REDPATH NT, 1993, EUR J BIOCHEM, V213, P689, DOI 10.1111/j.1432-1033.1993.tb17809.x; SMITH DL, 1973, NATURE, V246, P103, DOI 10.1038/246103a0; SMITH DL, 1974, BIOCHEMISTRY-US, V13, P3780, DOI 10.1021/bi00715a025; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; THOEN C, 1985, BIOCHEM BIOPH RES CO, V131, P84, DOI 10.1016/0006-291X(85)91773-5; TOMONAGA T, 1992, BIOCHEM BIOPH RES CO, V182, P894, DOI 10.1016/0006-291X(92)91816-9; WIELAND T, 1956, CHEM BER-RECL, V89, P2476, DOI 10.1002/cber.19560891046	45	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9030	9037						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132640				2022-12-27	WOS:A1994NB41100063
J	POSTEL, EH; FERRONE, CA				POSTEL, EH; FERRONE, CA			NUCLEOSIDE DIPHOSPHATE KINASE ENZYME-ACTIVITY OF NM23-H2/PUF IS NOT REQUIRED FOR ITS DNA-BINDING AND IN-VITRO TRANSCRIPTIONAL FUNCTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TUMOR-METASTASIS; NM23 GENE; DROSOPHILA DEVELOPMENT; MAST-CELLS; EXPRESSION; PROTEIN; PRODUCT; DISEASE; RNA	nm23 genes encode proteins that participate in tumor metastasis regulation and in various fundamental cellular processes, although the mechanisms remain undefined. All Nm23 proteins contain nucleoside diphosphate kinase (NDPK) activity whose significance to these regulatory effects is not yet evident. The protein product of the human nm23-H2 gene functions in vitro both as a nucleoside diphosphate kinase enzyme (NDPK-B; Gilles, A.-M., Presecan, E., Vonica, A. and Lascu, I. (1991) J. Biol. Chem. 266, 8784-8789) and as a transcription factor (PuF; Postel, E. H., Berberich, S. J., Flint, S. J. and Ferrone, C. A (1993) Science 261, 478-480). To understand the significance of these two biochemical activities to NM23-H2 function, we have investigated the relationship between the DNA binding and transcriptional activity of NM23-H2 and its NDPK function. Using site-directed mutagenesis of the cDNA encoding NM23-H2, we have created a mutant substituting for the amino acid histidine 118, the presumed site of phosphorylation in the formation of the phosphoenzyme intermediate, the nonphosphorylatable amino acid phenylalanine. The H118F mutant protein is shown to be catalytically inactive as measured both in a radioisotopic assay that detects formation of the phosphorylated enzyme intermediate and in a coupled enzyme assay that indicates nucleoside diphosphate formation. These results confirm that histidine 118 is the critical residue for NDPK-B activity. In addition, the H118F mutant protein lacking enzymatic activity displayed normal DNA binding affinity for the c-myc promoter in electrophoretic mobility shift assays, and retained full transcriptional activity using the c-myc gene in vitro. These results indicate a lack of correlation between nucleoside diphosphate kinase activity of nm23-H2 on the one hand, and its DNA binding and transcriptional activity on the other, suggesting that the nm23-H2 gene encodes a bifunctional protein molecule.			POSTEL, EH (corresponding author), PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08540, USA.				NCI NIH HHS [R01 CA55884] Funding Source: Medline; NIGMS NIH HHS [R01 GM37705] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037705] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal R P, 1978, Methods Enzymol, V51, P376; BACKER JM, 1993, ONCOGENE, V8, P497; BEVILACQUA G, 1989, CANCER RES, V49, P5185; BIGGS J, 1990, CELL, V63, P933, DOI 10.1016/0092-8674(90)90496-2; BOMINAAR AA, 1993, EMBO J, V12, P2275, DOI 10.1002/j.1460-2075.1993.tb05881.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DEAROLF CR, 1988, DEV BIOL, V129, P169, DOI 10.1016/0012-1606(88)90171-6; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DUMAS C, 1992, EMBO J, V11, P3203, DOI 10.1002/j.1460-2075.1992.tb05397.x; ENGEL M, 1993, INT J CANCER, V55, P375, DOI 10.1002/ijc.2910550306; FLORENES VA, 1992, CANCER RES, V52, P6088; GILLES AM, 1991, J BIOL CHEM, V266, P8784; HAILAT N, 1991, J CLIN INVEST, V88, P341, DOI 10.1172/JCI115299; HAUT M, 1991, J NATL CANCER I, V83, P712, DOI 10.1093/jnci/83.10.712; HEMMERICH S, 1992, BIOCHEMISTRY-US, V31, P4574, DOI 10.1021/bi00134a006; HEMMERICH S, 1992, BIOCHEMISTRY-US, V31, P4580, DOI 10.1021/bi00134a007; HIRAYAMA R, 1991, J NATL CANCER I, V83, P1249, DOI 10.1093/jnci/83.17.1249; KANTOR JD, 1993, CANCER RES, V53, P1971; KEIM D, 1992, J CLIN INVEST, V89, P919, DOI 10.1172/JCI115672; LACOMBE ML, 1991, EUR J CANCER, V27, P1302, DOI 10.1016/0277-5379(91)90101-I; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKSO M, 1992, CELL GROWTH DIFFER, V3, P873; LASCU I, 1992, J BIOL CHEM, V267, P12775; LEONE A, 1993, ONCOGENE, V8, P2325; MACDONALD NJ, 1993, J BIOL CHEM, V268, P25780; MUNOZDORADO J, 1993, J BACTERIOL, V175, P1176; MYEROFF LL, 1993, J NATL CANCER I, V85, P148; NAKAYAMA T, 1992, J NATL CANCER I, V84, P1349, DOI 10.1093/jnci/84.17.1349; OKABEKADO J, 1988, J BIOL CHEM, V263, P10994; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; POSTEL EH, 1993, SCIENCE, V261, P478, DOI 10.1126/science.8392752; POSTEL EH, 1989, MOL CELL BIOL, V9, P5123, DOI 10.1128/MCB.9.11.5123; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STAHL JA, 1991, CANCER RES, V51, P445; WALLET V, 1990, J NATL CANCER I, V82, P1199, DOI 10.1093/jnci/82.14.1199	37	120	122	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8627	8630						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132589				2022-12-27	WOS:A1994NB41100002
J	SCHAEFER, A; MAGOCSI, M; STOCKER, U; KOSA, F; MARQUARDT, H				SCHAEFER, A; MAGOCSI, M; STOCKER, U; KOSA, F; MARQUARDT, H			EARLY TRANSIENT SUPPRESSION OF C-MYB MESSENGER-RNA LEVELS AND INDUCTION OF DIFFERENTIATION IN FRIEND-ERYTHROLEUKEMIA CELLS BY THE [CA-2+](I)-INCREASING AGENTS CYCLOPIAZONIC ACID AND THAPSIGARGIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; ERYTHROID-DIFFERENTIATION; MESSENGER-RNA; GLOBIN GENES; CALCIUM; ERYTHROPOIETIN; ONCOGENE; COMMITMENT; RETICULUM; TURNOVER	Cyclopiazonic acid and thapsigargin, inhibitors of the endoplasmic reticulum Ca2+ pump were shown to elevate [Ca2+](i) in Friend erythroleukemia cells, line F4-6, at concentrations of 1-5 mu M and 0.5-2 nM, respectively. At the same concentrations, these agents induced a strong suppression of c-myb mRNA levels within 3 h, whereas c-myc expression remained unaffected. The c-myb expression recovered and approached pretreatment levels at 9-12 h of incubation. The decrease in c-myb mRNA was prevented in Ca2+-free medium. Treatment of F4-6 cells with EGTA led to a transient increase in c-myb mRNA with the same kinetics as the Ca2+ pump inhibitor-induced suppression, indicating that c-myb expression is bidirectionally regulated by changes in [Ca2+](i). Studies on the differentiation status of F4-6 cells following cyclopiazonic acid or thapsigargin exposure demonstrated a marked increase in P-globin mRNA synthesis at 60h and in hemoglobin production at 96 h. These results provide further evidence that a rise in the cytosolic Ca2+ concentration is capable, in Friend erythroleukemia cells, of inducing an early transient suppression of c-myb mRNA levels, which is followed by terminal erythroid differentiation.	FRAUNHOFER INST TOXICOL & MOLEC BIOL,D-21046 HAMBURG,GERMANY; NATL INST HEMATOL BLOOD TRANSFUS & IMMUNOL,H-1113 BUDAPEST,HUNGARY	Fraunhofer Gesellschaft	SCHAEFER, A (corresponding author), UNIV HAMBURG,SCH MED,DEPT TOXICOL,GRINDELALLEE 117,D-20146 HAMBURG,GERMANY.		Kósa, Ferenc/ABC-4078-2020	Kósa, Ferenc/0000-0002-2921-2379				BUSFIELD SJ, 1992, BLOOD, V80, P412; CATT KJ, 1989, ANNU REV MED, V40, P487; CHERN Y, 1990, J BIOL CHEM, V266, P2009; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; CRAIG RW, 1984, CANCER RES, V44, P442; DANISH R, 1992, ONCOGENE, V7, P901; DEMAUREX N, 1992, J BIOL CHEM, V267, P2318; EVANS JL, 1990, MOL CELL BIOL, V10, P5747, DOI 10.1128/MCB.10.11.5747; FALETTO DL, 1985, J BIOL CHEM, V260, P4884; GILLO B, 1993, BLOOD, V81, P783; HENSOLD JO, 1991, BLOOD, V77, P1362; KIRSCH IR, 1986, J CELL BIOCHEM, V32, P11, DOI 10.1002/jcb.240320103; KONKEL DA, 1979, CELL, V18, P865, DOI 10.1016/0092-8674(79)90138-7; KUME TU, 1988, J MOL BIOL, V202, P779, DOI 10.1016/0022-2836(88)90558-X; LACHMAN HM, 1984, NATURE, V310, P249; LUFTIG RB, 1977, J VIROL, V23, P799, DOI 10.1128/JVI.23.3.799-810.1977; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MARKS PA, 1978, ANNU REV BIOCHEM, V47, P419, DOI 10.1146/annurev.bi.47.070178.002223; MARKS PA, 1987, CANCER RES, V47, P659; MCCLINTON D, 1990, MOL CELL BIOL, V10, P705, DOI 10.1128/MCB.10.2.705; OSTERTAG W, 1972, NATURE-NEW BIOL, V239, P231, DOI 10.1038/newbio239231a0; PATEL HR, 1992, J BIOL CHEM, V267, P21300; RAMSAY RG, 1986, P NATL ACAD SCI USA, V83, P6849, DOI 10.1073/pnas.83.18.6849; REITSMA PH, 1983, NATURE, V306, P492, DOI 10.1038/306492a0; SCHAEFER A, 1993, J BIOL CHEM, V268, P10876; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; SHENONG GLC, 1990, BIOCHIM BIOPHYS ACTA, V1032, P39, DOI 10.1016/0304-419X(90)90011-O; SIMONS M, 1993, J BIOL CHEM, V268, P627; SPIVAK JL, 1992, EXP HEMATOL, V20, P283; SPOTTS GD, 1990, MOL CELL BIOL, V10, P3952, DOI 10.1128/MCB.10.8.3952; TIEMEIER DC, 1978, CELL, V14, P237, DOI 10.1016/0092-8674(78)90110-1; TODOKORO K, 1988, P NATL ACAD SCI USA, V85, P8900, DOI 10.1073/pnas.85.23.8900; TSIEN RY, 1982, J CELL BIOL, V94, P325, DOI 10.1083/jcb.94.2.325; WATSON RJ, 1988, MOL CELL BIOL, V8, P3938, DOI 10.1128/MCB.8.9.3938; ZOBEL A, 1992, BIOCHEM BIOPH RES CO, V186, P715, DOI 10.1016/0006-291X(92)90805-U	36	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8786	8791						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132611				2022-12-27	WOS:A1994NB41100028
J	VRTOVSNIK, F; JOURDAIN, M; CHERQUI, G; LEFEBVRE, J; FRIEDLANDER, G				VRTOVSNIK, F; JOURDAIN, M; CHERQUI, G; LEFEBVRE, J; FRIEDLANDER, G			GLUCOCORTICOID INHIBITION OF NA-P-I COTRANSPORT IN RENAL EPITHELIAL-CELLS IS MEDIATED BY PROTEIN-KINASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARATHYROID-HORMONE INHIBITION; PROXIMAL TUBULAR CELLS; OPOSSUM KIDNEY-CELLS; BORDER MEMBRANE-VESICLES; H+ EXCHANGE ACTIVITY; PHOSPHATE-TRANSPORT; RAT-KIDNEY; OK CELLS; COUPLED UPTAKES; DOWN-REGULATION	The effect and mechanism of action of glucocorticoids (GC) on Na-P-i cotransport were evaluated in opossum kidney cells. Dexamethasone (1-1000 nM) inhibited sodium-dependent P-i uptake in a time- and concentration dependent manner. Inhibition was maximal after a 6-h incubation with dexamethasone and was prevented by cycloheximide and actinomycin D. The effect was related to a 37% decrease of the V-max value after incubation with 100 nM dexamethasone. The effect of dexamethasone was mimicked by cortisol and blocked by GC receptor antagonists RU38486 and progesterone. GC affected neither glucose or alanine uptake nor Na/H exchange activity. Inhibition of P-i uptake persisted when Na/H was blocked by amiloride or dimethylamiloride. GC had no effect on basal or parathyroid hormone- and forskolin-stimulated intracellular cAMP content. Dexamethasone and extracellular cAMP, parathyroid hormone, or 3-isobutyl-1-methylxanthine had additive inhibitory effects on P-i uptake. Staurosporine, GF109203X, or calphostin C (three dissimilar inhibitors of protein kinase C (PKC)) and PKC down-regulation blunted the inhibitory effect of glucocorticoids on P-i uptake. GC increased both membrane-bound PKC activity and the membrane/cytosol PKC activity ratio. This is the first report of GC activation of PKC in renal cells, which appears to mediate the steroid inhibitory effect on P-i transport.	UNIV PARIS 07,FAC MED XAVIER BICHAT,INSERM,U251,F-75018 PARIS,FRANCE; UNIV PARIS 06,INSERM,U181,BIOCHIM BIOL CELLULAIRE LAB,F-75571 PARIS,FRANCE; CTR OSCAR LAMBRET,ENDOCRINOL EXPTL LAB,F-59000 LILLE,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UNICANCER; Centre Oscar Lambret	VRTOVSNIK, F (corresponding author), UNIV PARIS 07,FAC MED XAVIER BICHAT,DEPT PHYSIOL,F-75018 PARIS,FRANCE.			Vrtovsnik, Francois/0000-0003-1554-314X; Friedlander, Gerard/0000-0002-6854-4261				BAUM M, 1993, AM J PHYSIOL, V264, pF1027, DOI 10.1152/ajprenal.1993.264.6.F1027; BECK CA, 1993, P NATL ACAD SCI USA, V90, P4441, DOI 10.1073/pnas.90.10.4441; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNSTEIN KL, 1990, J BIOL CHEM, V265, P7284; CAVERZASIO J, 1986, J BIOL CHEM, V261, P3233; CHEN TL, 1978, ENDOCRINOLOGY, V102, P589, DOI 10.1210/endo-102-2-589; COLE JA, 1987, AM J PHYSIOL, V253, pE221, DOI 10.1152/ajpendo.1987.253.2.E221; COLE JA, 1989, AM J PHYSIOL, V256, pF672, DOI 10.1152/ajprenal.1989.256.4.F672; DECOURCELLES DD, 1985, J BIOL CHEM, V260, P5762; DELAGE S, 1993, CANCER RES, V53, P2762; DUDEJA PK, 1987, BIOCHIM BIOPHYS ACTA, V905, P485, DOI 10.1016/0005-2736(87)90478-0; DURASIN I, 1984, RENAL PHYSIOL BIOCH, V7, P115; DUVAL D, 1983, BIOCHIM BIOPHYS ACTA, V737, P409, DOI 10.1016/0304-4157(83)90008-4; ELLIS D, 1988, IN VITRO CELL DEV B, V24, P811, DOI 10.1007/BF02623652; FREIBERG JM, 1982, P NATL ACAD SCI-BIOL, V79, P4932, DOI 10.1073/pnas.79.16.4932; FRICK A, 1981, PFLUG ARCH EUR J PHY, V392, P99, DOI 10.1007/BF00581256; FRIEDLANDER G, 1992, J CLIN INVEST, V90, P848, DOI 10.1172/JCI115960; FRIEDLANDER G, 1989, J BIOL CHEM, V264, P3935; FRIEDLANDER G, 1990, AM J PHYSIOL, V259, pF816, DOI 10.1152/ajprenal.1990.259.5.F816; GLUSMAN J, 1993, ENDOCRINOLOGY, V132, P261, DOI 10.1210/en.132.1.261; JOURDAIN M, 1992, AM J PHYSIOL, V263, pC1141, DOI 10.1152/ajpcell.1992.263.6.C1141; KALIMI MY, 1988, BIOCHEM BIOPH RES CO, V153, P365, DOI 10.1016/S0006-291X(88)81232-4; KAUFMANN M, 1991, ENDOCRINOLOGY, V128, P1819, DOI 10.1210/endo-128-4-1819; KINSELLA J, 1984, P NATL ACAD SCI-BIOL, V81, P630, DOI 10.1073/pnas.81.2.630; LEGOAS F, 1991, AM J PHYSIOL, V261, pF587, DOI 10.1152/ajprenal.1991.261.4.F587; MANGANIELLO V, 1972, J CLIN INVEST, V51, P2763, DOI 10.1172/JCI107096; MCLELLAN AR, 1992, J MOL ENDOCRINOL, V9, P237, DOI 10.1677/jme.0.0090237; MISHINA T, 1981, AM J PHYSIOL, V240, pF38, DOI 10.1152/ajprenal.1981.240.1.F38; NORONHABLOB L, 1986, J BIOL CHEM, V261, P2164; OBEID LM, 1990, J BIOL CHEM, V265, P2370; OKRET S, 1986, P NATL ACAD SCI USA, V83, P5899, DOI 10.1073/pnas.83.16.5899; Philibert D, 1985, ANTIPROGESTIN STEROI, P49; POLLOCK AS, 1986, AM J PHYSIOL, V250, pF217, DOI 10.1152/ajprenal.1986.250.2.F217; POUJEOL P, 1985, AM J PHYSIOL, V249, pF74, DOI 10.1152/ajprenal.1985.249.1.F74; QUAMME G, 1989, BIOCHIM BIOPHYS ACTA, V1013, P159, DOI 10.1016/0167-4889(89)90044-X; QUAMME G, 1989, BIOCHEM BIOPH RES CO, V158, P951, DOI 10.1016/0006-291X(89)92814-3; RIZZOLI R, 1987, J CELL PHYSIOL, V132, P517, DOI 10.1002/jcp.1041320314; ROBERTS KE, 1953, ENDOCRINOLOGY, V52, P324, DOI 10.1210/endo-52-3-324; RODAN SB, 1984, ENDOCRINOLOGY, V115, P951, DOI 10.1210/endo-115-3-951; SNEDECOR GW, 1972, STATISTICAL METHODS; SVEC F, 1981, J BIOL CHEM, V256, P5984; TODDTURLA KM, 1993, AM J PHYSIOL, V264, pF781, DOI 10.1152/ajprenal.1993.264.5.F781; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TURNER ST, 1982, AM J PHYSIOL, V243, pC227, DOI 10.1152/ajpcell.1982.243.5.C227; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WEBSTER SK, 1986, AM J PHYSIOL, V251, pF576, DOI 10.1152/ajprenal.1986.251.4.F576; YONEMURA K, 1990, AM J PHYSIOL, V258, pF333, DOI 10.1152/ajprenal.1990.258.2.F333; YUN CHC, 1993, J BIOL CHEM, V268, P206	48	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8872	8877						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132623				2022-12-27	WOS:A1994NB41100040
J	FALNES, PO; CHOE, S; MADSHUS, IH; WILSON, BA; OLSNES, S				FALNES, PO; CHOE, S; MADSHUS, IH; WILSON, BA; OLSNES, S			INHIBITION OF MEMBRANE TRANSLOCATION OF DIPHTHERIA-TOXIN-A FRAGMENT BY INTERNAL DISULFIDE BRIDGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN; ESCHERICHIA-COLI; LOW PH; A-FRAGMENT; MITOCHONDRIA; CELLS; CYTOSOL; IMPORT; ENTRY; TRANSPORT	Fragment A of diphtheria toxin is translocated to the cytosol when the toxin is presented to receptor-positive cells. The toxin binds to cell surface receptors through its B-fragment, and after endocytotic uptake, the low endosomal pH triggers translocation of the A-fragment across the membrane. Translocation can also be induced at the level of the plasma membrane by exposure to low pH medium. Based on the diphtheria toxin crystal structure, we made five double cysteine mutants of the A-fragment, each expected to form an intramolecular disulfide bond. Four of the double cysteine mutants efficiently formed an intramolecular disulfide bridge, and these same mutants showed a strong reduction in their translocating ability. The inhibition of translocation was observed both when the toxin was endocytosed and when translocation was induced by exposing surface-bound toxin to low pH. The data indicate that extensive unfolding of the A-fragment is required for translocation.	NORWEGIAN RADIUM HOSP,INST CANC RES,DEPT BIOCHEM,N-0310 OSLO 3,NORWAY; UNIV CALIF LOS ANGELES,DEPT CHEM & BIOCHEM,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024; HARVARD UNIV,SCH MED,DEPT MICROBIOL & MOLEC GENET,BOSTON,MA 02115	University of Oslo; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Harvard Medical School			Falnes, Pål Ø./AAA-4581-2020	Falnes, Pal/0000-0001-8114-6025	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022021, R37AI022021] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-22021] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARIANSEN S, 1993, BIOCHEMISTRY-US, V32, P83, DOI 10.1021/bi00052a012; ARKOWITZ RA, 1993, EMBO J, V12, P243, DOI 10.1002/j.1460-2075.1993.tb05650.x; CHEN WJ, 1987, J BIOL CHEM, V262, P15605; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; DRAPER RK, 1980, J CELL BIOL, V87, P849, DOI 10.1083/jcb.87.3.849; DUMONT ME, 1988, J BIOL CHEM, V263, P2087; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; ESBENSEN Y, 1993, BIOCHEM J, V294, P663; GLOVER LA, 1992, BIOCHEM J, V284, P609, DOI 10.1042/bj2840609; GREENFIELD L, 1983, P NATL ACAD SCI-BIOL, V80, P6853, DOI 10.1073/pnas.80.22.6853; JIANG JX, 1970, BIOCHEMISTRY-US, V227, P680; KLAUSER T, 1992, EMBO J, V11, P2327, DOI 10.1002/j.1460-2075.1992.tb05292.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAHER PA, 1986, P NATL ACAD SCI USA, V83, P9001, DOI 10.1073/pnas.83.23.9001; MCGILL S, 1989, EMBO J, V8, P2843, DOI 10.1002/j.1460-2075.1989.tb08431.x; MEKADA E, 1985, J BIOL CHEM, V260, P2148; MOSKAUG JO, 1988, J BIOL CHEM, V263, P2518; NUNNARI J, 1992, Current Opinion in Cell Biology, V4, P573, DOI 10.1016/0955-0674(92)90074-M; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; RAPOPORT TA, 1992, SCIENCE, V258, P931, DOI 10.1126/science.1332192; RASSOW J, 1989, J CELL BIOL, V109, P1421, DOI 10.1083/jcb.109.4.1421; SANDVIG K, 1986, J BIOL CHEM, V261, P1639; SANDVIG K, 1984, J CELL BIOL, V98, P963, DOI 10.1083/jcb.98.3.963; SANDVIG K, 1980, J CELL BIOL, V87, P828, DOI 10.1083/jcb.87.3.828; STENMARK H, 1992, BIOCHEM J, V281, P619, DOI 10.1042/bj2810619; TANI K, 1990, J BIOL CHEM, V265, P17341; UCHIDA T, 1972, SCIENCE, V175, P901, DOI 10.1126/science.175.4024.901; VESTWEBER D, 1988, J CELL BIOL, V107, P2037, DOI 10.1083/jcb.107.6.2037; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P101, DOI 10.1146/annurev.bi.60.070191.000533; WIEDLOCHA A, 1992, EMBO J, V11, P4835, DOI 10.1002/j.1460-2075.1992.tb05589.x	31	57	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8402	8407						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132565				2022-12-27	WOS:A1994NB40900086
J	FAURE, M; VOYNOYASENETSKAYA, TA; BOURNE, HR				FAURE, M; VOYNOYASENETSKAYA, TA; BOURNE, HR			CAMP AND BETA-GAMMA-SUBUNITS OF HETEROTRIMERIC G-PROTEINS STIMULATE THE MITOGEN-ACTIVATED PROTEIN-KINASE PATHWAY IN COS-7 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MAP KINASE; ADENYLYL CYCLASE; PHOSPHOLIPASE-C; ALPHA-SUBUNIT; EXPRESSION	Mitogen-activated protein kinases (MAPKs) are activated by a variety of extracellular stimuli, including agonists for G protein coupled receptors. Using transient transfection of COS-7 cells, we have studied the stimulation of a hemagglutinin-tagged p44(mapk) (p44(HA-mapk)) by receptors coupled to G(s), G(q), and G(i). Agonists that act via all three G proteins stimulated p44(HA-mapk) activity. A constitutively activated alpha(s) mutant, forskolin, and a cAMP analog also increased p(44HA-mapk) activity, indicating that cAMP in COS-7 cells, in contrast to other cell types, activates the MAPK pathway, Similarly, a constitutively activated alpha(q), mutant, overexpression of phospholipase C-beta 2, and a phorbol ester also stimulated p44(HA-mapk), suggesting that G(q)-coupled receptors stimulate the MAPK pathway by increasing phosphatidylinositol turnover and probably stimulating protein kinase C, In COS-7 cells, in contrast to Rat-1 cells, mutationally activated alpha(i) did not stimulate the MAPK pathway. G protein beta and gamma subunits, overexpressed together, did activate p44(HA-mapk); this finding suggests that in COS-7 cells G(i)-coupled receptors may stimulate the MAPK pathway through beta gamma. These unexpected results in COS-7 cells show that G proteins and second messengers regulate the MAPK pathway differently in different cell types.	UNIV CALIF SAN FRANCISCO,DEPT PHARMACOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco					NCI NIH HHS [CA-54427] Funding Source: Medline; NIGMS NIH HHS [GM-27800] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA054427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027800, R37GM027800] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BURGERING BMT, 1993, EMBO J, V12, P4211, DOI 10.1002/j.1460-2075.1993.tb06105.x; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FEIG LA, 1993, SCIENCE, V260, P767, DOI 10.1126/science.8484117; GAO B, 1987, P NATL ACAD SCI USA, V84, P6122, DOI 10.1073/pnas.84.17.6122; GRABER SG, 1992, J BIOL CHEM, V267, P13123; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; GUPTA SK, 1992, J BIOL CHEM, V267, P7987; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LAMY F, 1993, J BIOL CHEM, V268, P8398; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; LUSTIG KD, 1993, J BIOL CHEM, V268, P13900; MASTERS SB, 1989, J BIOL CHEM, V264, P15467; MCCORMICK F, 1993, NATURE, V363, P15, DOI 10.1038/363015a0; MELOCHE S, 1992, MOL BIOL CELL, V3, P63, DOI 10.1091/mbc.3.1.63; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; NEIMAN AM, 1993, TRENDS GENET, V9, P390, DOI 10.1016/0168-9525(93)90139-9; PACE AM, 1991, P NATL ACAD SCI USA, V88, P7031, DOI 10.1073/pnas.88.16.7031; PARK D, 1992, J BIOL CHEM, V267, P16048; PRONIN AN, 1992, P NATL ACAD SCI USA, V89, P6220, DOI 10.1073/pnas.89.13.6220; ROBISHAW JD, 1989, J BIOL CHEM, V264, P15758; SCHMIDT CJ, 1992, J BIOL CHEM, V267, P13807; SEGER R, 1992, J BIOL CHEM, V267, P14373; SEVETSON BR, 1993, P NATL ACAD SCI USA, V90, P10305, DOI 10.1073/pnas.90.21.10305; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WINITZ S, 1993, J BIOL CHEM, V268, P19196; WONG YH, 1991, NATURE, V351, P63, DOI 10.1038/351063a0; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; YATSUNAMI K, 1985, P NATL ACAD SCI USA, V82, P1936, DOI 10.1073/pnas.82.7.1936	43	448	450	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7851	7854						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132501				2022-12-27	WOS:A1994NB40900005
J	HUANG, Q; ALVARES, K; CHU, RY; BRADFIELD, CA; REDDY, JK				HUANG, Q; ALVARES, K; CHU, RY; BRADFIELD, CA; REDDY, JK			ASSOCIATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AND HSP72	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; GLUCOCORTICOID RECEPTOR; BINDING-PROTEIN; FATTY-ACIDS; RAT-LIVER; MEMBER; IDENTIFICATION; FAMILY; SUPERFAMILY; COMPLEX	In an effort to understand the relationship between a 72-kDa heat shock protein (Hsp72) and peroxisome proliferator-activated receptors (PPARs), we have characterized their interaction using clofibric acid-Sepharose chromatography and co-immunoprecipitation with antisera raised against either rat PPAR (rPPAR) or Hsp72. First, we observed that both rPPAR and Hsp72 elute in a clofibrate-dependent manner from the clofibric acid-Sepharose matrix. Second, we found that immunoprecipitation of either protein from solution resulted in the precipitation of the other. This result was obtained from rat liver cytosol, from Spodoptera frugiperda (Sf9) insect cells expressing rPPAR, and from reticulocyte lysate rPPAR expression systems. These results suggest that Hsp72 and rPPAR form a complex in vivo and that Hsp72 may play a role in the folding, subcellular localization, and/or signaling pathway of PPARs.	NORTHWESTERN UNIV,SCH MED,DEPT PATHOL,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,DEPT PHARMACOL,CHICAGO,IL 60611	Northwestern University; Northwestern University				Alvares, Keith/0000-0003-3710-4367	NIGMS NIH HHS [GM23750] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023750, R01GM023750] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALVARES K, 1990, P NATL ACAD SCI USA, V87, P5293, DOI 10.1073/pnas.87.14.5293; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; GEARING KL, 1993, P NATL ACAD SCI USA, V90, P1440, DOI 10.1073/pnas.90.4.1440; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; KOST SL, 1989, MOL CELL BIOL, V9, P3829, DOI 10.1128/MCB.9.9.3829; LALWANI ND, 1987, P NATL ACAD SCI USA, V84, P5242, DOI 10.1073/pnas.84.15.5242; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; NADLER SG, 1992, SCIENCE, V258, P484, DOI 10.1126/science.1411548; NIHEI T, 1993, CANCER RES, V53, P1702; PONGRATZ I, 1992, J BIOL CHEM, V267, P13728; REDDY JK, 1983, CRC CR REV TOXICOL, V12, P1, DOI 10.3109/10408448309029317; REDDY JK, 1986, TRENDS PHARMACOL SCI, V7, P438, DOI 10.1016/0165-6147(86)90416-5; REDDY JK, 1975, SCIENCE, V190, P787, DOI 10.1126/science.1198095; REDDY JK, 1986, P NATL ACAD SCI USA, V83, P1747, DOI 10.1073/pnas.83.6.1747; REDDY JK, 1992, MECHANISM CARCINOGEN, P225; REXIN M, 1991, J BIOL CHEM, V266, P24601; SANCHEZ ER, 1990, J BIOL CHEM, V265, P20123; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; SLINGERLAND JM, 1993, EMBO J, V12, P1029, DOI 10.1002/j.1460-2075.1993.tb05744.x; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TAI PKK, 1992, SCIENCE, V256, P1315, DOI 10.1126/science.1376003; THEVENIAU M, 1992, P NATL ACAD SCI USA, V89, P4314, DOI 10.1073/pnas.89.10.4314; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WATOWICH SS, 1988, MOL CELL BIOL, V8, P393, DOI 10.1128/MCB.8.1.393; YEM AW, 1992, J BIOL CHEM, V267, P2868; ZHANG BW, 1992, P NATL ACAD SCI USA, V89, P7541, DOI 10.1073/pnas.89.16.7541; ZHU YJ, 1993, J BIOL CHEM, V268, P26817	30	54	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8493	8497						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132576				2022-12-27	WOS:A1994NB40900099
J	KERNER, J; ZALUZEC, E; GAGE, D; BIEBER, LL				KERNER, J; ZALUZEC, E; GAGE, D; BIEBER, LL			CHARACTERIZATION OF THE MALONYL-COA-SENSITIVE CARNITINE PALMITOYLTRANSFERASE (CPT(O)) OF A RAT-HEART MITOCHONDRIAL PARTICLE - EVIDENCE THAT THE CATALYTIC UNIT IS CPT(I)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER MEMBRANE; LIVER MITOCHONDRIA; BINDING-PROTEIN; OUTER-MEMBRANE; COENZYME-A; SITE; ACYLTRANSFERASE; PEROXISOMES; INHIBITION; ANTIBODIES	A post 30,000 x g particulate fraction was isolated from rat heart. This mixed membrane fraction is enriched in a carnitine palmitoyltransferase which is sensitive to both malonyl-CoA and etomoxiryl-CoA at concentrations that inhibit the malonyl-CoA-sensitive carnitine palmitoyltransferase (CPTo/CPT-I) of intact mitochondria. Tritiated etomoxiryl-CoA labels two proteins with the same molecular weight as the labeled proteins from rat heart mitochondria. Malonyl-CoA-sensitive carnitine palmitoyltransferase in the particulate fraction is stable to freeze-thawing, and the activity is not latent. These data show that the carnitine palmitoyltransferase associated with this particle is CPTo/CPT-I. Positive Western blots were obtained, with the particle using anti-CPTi/CPT-II at a molecular weight identical with the CPTi/CPT-II purified from rat heart mitochondria. Catalytic activity was purified to near homogeneity in approximately 40% yield. The purified protein has a molecular weight identical with CPTi/CPT-II, it cross-reacts with antibody against CPTiCPT-II, it is not inhibited by malonyl-CoA or etomoxiryl-CoA, and mass spectral analyses of the tryptic peptides give the same molecular masses as CPTi/CPT-II, and, when mixed with equal amounts of CPTi/CPT-II, one uniform spot is found by two-dimensional electrophoresis. These data indicate that the catalytic subunit of CPTo/CPT-I is the same as CPTi/CPT-II. The average inhibition of the CPT of frozen-thawed particles is 71% by 50 nM etomoxiryl-CoA and 62% by 50 nM malonyl-CoA. The inhibitor sensitivity, but not the catalytic activity, is lost by solubilization in 1% Triton X-114; removal of Triton X-114 using Extracti-Gel D restores etomoxiryl-CoA and malonyl-CoA sensitivity (both 50 nM) of CPT to an average of 77 and 48%, respectively. Consistent with previous reports, these results show that CPTo/CPT-I is NOT inactivated by detergents, rather detergents both desensitize it to malonyl-CoA and alter its V-max. These data show the assumption that CPTo/CPT-I is inactivated by detergents is untenable.			KERNER, J (corresponding author), MICHIGAN STATE UNIV, DEPT BIOCHEM, E LANSING, MI 48824 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018427] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 18427] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADRAIL D, 1990, J BIOL CHEM, V265, P18797; BERGSETH S, 1986, BIOCHEM SOC T, V14, P671, DOI 10.1042/bst0140671; BHAIRD NN, 1992, BIOCHEM J, V28, P637; BIEBER L, 1991, CURRENT CONCEPTS CAR, P129; BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; BILLECI TM, 1993, ANAL CHEM, V65, P1709, DOI 10.1021/ac00061a013; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRADY PS, 1987, BIOCHEM J, V241, P751, DOI 10.1042/bj2410751; BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420; CARBAL F, 1979, METHOD ENZYMOL, V56, P602; CATRAVAS GN, 1974, RADIAT RES, V58, P462, DOI 10.2307/3573915; Chung C, 1991, Protein Expr Purif, V2, P426, DOI 10.1016/1046-5928(91)90104-Q; CHUNG CD, 1993, J BIOL CHEM, V268, P4519; CHUNG CH, 1992, BIOCHEMISTRY-US, V31, P9777, DOI 10.1021/bi00155a034; CLARKE PRH, 1981, J BIOL CHEM, V256, P9869; DECHLERCQ PE, 1987, J BIOL CHEM, V262, P9812; DERRICK JP, 1989, BIOCHEM J, V262, P801, DOI 10.1042/bj2620801; ESSER V, 1993, J BIOL CHEM, V268, P5817; ESSER V, 1993, J BIOL CHEM, V268, P5810; FARRELL SO, 1984, J BIOL CHEM, V259, P13088; FIOL CJ, 1987, BIOCHIM BIOPHYS ACTA, V916, P482, DOI 10.1016/0167-4838(87)90195-6; GHADIMINEJAD I, 1990, FEBS LETT, V269, P406, DOI 10.1016/0014-5793(90)81204-2; GHADIMINEJAD I, 1990, BIOCHEM J, V270, P787, DOI 10.1042/bj2700787; GHADIMINEJAD I, 1992, INT J BIOCHEM, V24, P573, DOI 10.1016/0020-711X(92)90329-Y; GHADIMINEJAD I, 1991, BIOCHIM BIOPHYS ACTA, V1083, P166, DOI 10.1016/0005-2760(91)90038-J; HEALY MJ, 1988, BIOCHEM J, V249, P231, DOI 10.1042/bj2490231; HOPPEL CL, 1992, CURRENT CONCEPTS IN CARNITINE RESEARCH, P153; JUHASZ P, 1992, 40TH P ASMS C MASS S, P1913; KERNER J, 1990, BIOCHEMISTRY-US, V29, P4326, DOI 10.1021/bi00470a010; KIORPES TC, 1984, J BIOL CHEM, V259, P9750; KOLODZIEJ MP, 1990, BIOCHEM J, V272, P421, DOI 10.1042/bj2720421; KOLODZIEJ MP, 1992, BIOCHEM J, V282, P415, DOI 10.1042/bj2820415; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LILLY K, 1992, BIOCHEM PHARMACOL, V43, P353, DOI 10.1016/0006-2952(92)90298-W; LILLY K, 1990, ARCH BIOCHEM BIOPHYS, V280, P167, DOI 10.1016/0003-9861(90)90532-4; LUND H, 1986, BIOCHIM BIOPHYS ACTA, V878, P243, DOI 10.1016/0005-2760(86)90152-9; Markwell M A, 1981, Methods Enzymol, V72, P296; MCGARRY JD, 1989, DIABETES METAB REV, V5, P271, DOI 10.1002/dmr.5610050305; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; MCMILLIN JB, 1992, J MOL CELL CARDIOL, V24, P259, DOI 10.1016/0022-2828(92)93163-E; MOCK KK, 1992, RAPID COMMUN MASS SP, V6, P233, DOI 10.1002/rcm.1290060402; MURTHY MSR, 1990, BIOCHEM J, V268, P599, DOI 10.1042/bj2680599; MURTHY MSR, 1987, P NATL ACAD SCI USA, V84, P378, DOI 10.1073/pnas.84.2.378; MURTHY MSR, 1992, CURRENT CONCEPTS CAR, P192; PANDE SV, 1986, BIOCHIM BIOPHYS ACTA, V877, P223, DOI 10.1016/0005-2760(86)90298-5; RAMSAY RR, 1988, BIOCHEM J, V249, P239, DOI 10.1042/bj2490239; SAGGERSON D, 1992, ADV ENZYME REGUL, V32, P285; SCHOLTE HR, 1973, BIOCHIM BIOPHYS ACTA, V305, P413, DOI 10.1016/0005-2728(73)90187-4; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Tanaka T, 1981, Methods Enzymol, V71 Pt C, P334; WILSON JE, 1983, METHOD ENZYMOL, V97, P469; WOELTJE KF, 1987, J BIOL CHEM, V262, P9822; WOELTJE KF, 1990, J BIOL CHEM, V265, P10720; WOLDEGIORGIS G, 1992, ARCH BIOCHEM BIOPHYS, V295, P348, DOI 10.1016/0003-9861(92)90527-4; Yonetani T, 1967, METHODS ENZYMOL, V10, P332	55	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8209	8219						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132545				2022-12-27	WOS:A1994NB40900059
J	PISANI, FM; ROSSI, M				PISANI, FM; ROSSI, M			EVIDENCE THAT AN ARCHAEAL ALPHA-LIKE DNA-POLYMERASE HAS A MODULAR ORGANIZATION OF ITS ASSOCIATED CATALYTIC ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXONUCLEASE ACTIVE-SITE; I KLENOW FRAGMENT; ESCHERICHIA-COLI; 3'-5' EXONUCLEASE; SULFOLOBUS-SOLFATARICUS; AMINO-ACID; FUNCTIONAL DOMAINS; CRYSTAL-STRUCTURE; BINDING; IDENTIFICATION	In this study we report on the evidence that an alpha-like DNA polymerase purified from the thermoacidophilic archaeon Sulfolobus solfataricus has a modular organization of its associated catalytic activities (polymerase and 3'-5' exonuclease). This enzyme, a monomer of about 100 kDa whose complete primary structure is available, has a protease hypersensitive site that is likely to be cleaved by the action of endogenous proteases during the purification procedure. As a consequence of that, two proteolytic fragments of about 50 and 40 kDa, in addition to the intact 100 M)a molecular species, can be detected upon SDS-PAGE of highly purified S. solfataricus DNA polymerase samples. The amino-terminal microsequence analysis by Edman degradation has revealed that the 50- and the 40-kDa polypeptides correspond to the carboxyl- and the amino-terminal portion of the protein molecule, respectively. Using the bidimensional activity gel assay procedure, recently described by Longley and Mosbaugh (Longley, M. J., and Mosbaugh, D. W. (1991) Biochemistry 30, 2655-2664), we have demonstrated that the 50-kDa fragment retains a Mg2+ dependent DNA polymerizing activity, whereas the 40-kDa polypeptide is able to catalyze the excision of mispaired nucleotides at the 3'-OH terminus of a primer/ template DNA substrate in the presence of Mn2+ ions. On the other hand, the 100-kDa protein possess both activities. To date, this is the first report indicating, on the basis of direct functional data, that the polymerization and the 3'-5' exonuclease activity of a family B DNA polymerase can be ascribed to physically distinct modules of the enzyme molecule.			PISANI, FM (corresponding author), CNR,IST BIOCHIM PROT & ENZIMOL,VIA MARCONI 10,I-80125 NAPLES,ITALY.		Pisani, Francesca M./AAX-4025-2020					ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BERNAD A, 1990, P NATL ACAD SCI USA, V87, P4610, DOI 10.1073/pnas.87.12.4610; BLANCO L, 1991, GENE, V100, P27, DOI 10.1016/0378-1119(91)90346-D; BLANCO L, 1992, GENE, V112, P139, DOI 10.1016/0378-1119(92)90316-H; BLASCO MA, 1992, J BIOL CHEM, V267, P19427; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; BRENOWITZ S, 1991, J BIOL CHEM, V266, P7888; CARROLL SS, 1990, CHEM REV, V90, P1291, DOI 10.1021/cr00105a011; CATALANO CE, 1989, BIOCHEMISTRY-US, V28, P4374, DOI 10.1021/bi00436a038; CHEN M, 1989, P NATL ACAD SCI USA, V86, P6116, DOI 10.1073/pnas.86.16.6116; CHENG CH, 1993, BIOCHEMISTRY-US, V32, P8568, DOI 10.1021/bi00084a025; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; DERBYSHIRE V, 1991, EMBO J, V10, P17, DOI 10.1002/j.1460-2075.1991.tb07916.x; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; ESTEBAN JA, 1992, BIOCHEMISTRY-US, V31, P350, DOI 10.1021/bi00117a006; FREEMONT P S, 1986, Proteins Structure Function and Genetics, V1, P66, DOI 10.1002/prot.340010111; FREY MW, 1993, P NATL ACAD SCI USA, V90, P2578; GIBBS JS, 1991, MOL CELL BIOL, V11, P4786, DOI 10.1128/MCB.11.9.4786; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; Joyce CM, 1991, CURR OPIN STRUC BIOL, V1, P123, DOI 10.1016/0959-440X(91)90020-T; JOYCE CM, 1987, TRENDS BIOCHEM SCI, V12, P288, DOI 10.1016/0968-0004(87)90143-5; KARAWYA E, 1983, ANAL BIOCHEM, V135, P318, DOI 10.1016/0003-2697(83)90689-9; KLENOW H, 1970, P NATL ACAD SCI USA, V65, P168, DOI 10.1073/pnas.65.1.168; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; KONG HM, 1993, J BIOL CHEM, V268, P1965; Kornberg A., 1992, DNA REPLICATION; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHMAN IR, 1964, J BIOL CHEM, V239, P233; LONGLEY MJ, 1991, BIOCHEMISTRY-US, V30, P2655, DOI 10.1021/bi00224a014; MORRISON A, 1991, P NATL ACAD SCI USA, V88, P9473, DOI 10.1073/pnas.88.21.9473; MULLEN GP, 1990, J BIOL CHEM, V265, P14327; OLLIS DL, 1985, NATURE, V313, P726; PISANI FM, 1992, NUCLEIC ACIDS RES, V20, P2711, DOI 10.1093/nar/20.11.2711; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; POLESKY AH, 1990, J BIOL CHEM, V265, P14579; REHAKRANTZ LJ, 1992, GENE, V112, P133, DOI 10.1016/0378-1119(92)90315-G; REISFELD RA, 1962, NATURE, V195, P281, DOI 10.1038/195281a0; RELLA R, 1990, ITAL J BIOCHEM, V39, P83; ROSSI M, 1986, SYST APPL MICROBIOL, V7, P337; SOENGAS MS, 1992, EMBO J, V11, P4227, DOI 10.1002/j.1460-2075.1992.tb05517.x; STEITZ TA, 1993, CURR OPIN STRUC BIOL, V3, P31, DOI 10.1016/0959-440X(93)90198-T; WANG TSF, 1989, FASEB J, V3, P14, DOI 10.1096/fasebj.3.1.2642867	45	32	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7887	7892						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132506				2022-12-27	WOS:A1994NB40900012
J	SHEN, LM; WU, LC; SANLIOGLU, S; CHEN, RJ; MENDOZA, AR; DANGEL, AW; CARROLL, MC; ZIPF, WB; YU, CY				SHEN, LM; WU, LC; SANLIOGLU, S; CHEN, RJ; MENDOZA, AR; DANGEL, AW; CARROLL, MC; ZIPF, WB; YU, CY			STRUCTURE AND GENETICS OF THE PARTIALLY DUPLICATED GENE RP LOCATED IMMEDIATELY UPSTREAM OF THE COMPLEMENT C4A AND THE C4B GENES IN THE HLA CLASS-III REGION - MOLECULAR-CLONING, EXON-INTRON STRUCTURE, COMPOSITE RETROPOSON, AND BREAKPOINT OF GENE DUPLICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; STEROID 21-HYDROXYLASE GENES; EXTRACELLULAR-MATRIX PROTEIN; SYSTEMIC LUPUS-ERYTHEMATOSUS; HUMAN ENDOGENOUS RETROVIRUS; NUCLEOTIDE-SEQUENCE; NASOPHARYNGEAL CARCINOMA; IGA DEFICIENCY; 4TH COMPONENT; DNA-SEQUENCES	The correlation of many HLA-associated autoimmune and genetic diseases with the polymorphic complement C4 genes may be attributed to the presence of disease susceptibility genes in the close proximity of C4. We have cloned and characterized a pair of partially duplicated genes, RP1 and RP2, located 611 base pairs upstream of the human C4A and C4B genes, respectively. The putative RP protein, consisting of 364 amino acid residues, is basic and highly hydrophilic. There is a bipartite nuclear localization signal at residues 114-131 and therefore RP may be a nuclear protein. Northern blot analysis suggested that RP is ubiquitously expressed. The 5' region of the RP1 gene is CpG rich, which is a characteristic of housekeeping genes. The RP1 gene contains nine exons. Located in the fourth intron is a cluster of Alu elements, and a newly defined composite retroposon SVA with a SINE, multiple copies of GC-rich VNTRs and an Alu element altogether enclosed by direct terminal repeats. Members of SVA are also present in the complement C2 gene located about 20 kilobases upstream of RP1 in the DLA and in the cytochrome CYP1A1 gene. Determination of the DNA sequences for RP2 from two different HLA haplotypes revealed identical hybrid sequences which resulted from fusion of RP with the tenascin-like Gene X and truncation of the 5' regions of both genes. Cumulative data suggest that the four tandemly arranged genes RP, complement C4, steroid 21-hydroxylase (CYP21), and Gene X altogether form a modular structure, RCCX. The number of RCCX modules varies from one to three or more in the population. Absence of the truncated genes RP2 and Gene XA have been detected in genomes with single RCCX modules. Duplication of the RCCX modules probably occurred before the speciation of great apes and humans as they contain the same breakpoint region of RP and Gene X gene duplication.	OHIO STATE UNIV,WEXNER INST PEDIAT RES,DEPT PEDIAT,COLUMBUS,OH 43210; CHILDRENS HOSP RES FDN,COLUMBUS,OH 43205; OHIO STATE UNIV,OHIO STATE BIOCHEM PROGRAM,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT MED BIOCHEM,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT INTERNAL MED,MOLEC CELLULAR & DEV BIOL PROGRAM,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT MED MICROBIOL & IMMUNOL,COLUMBUS,OH 43210; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Harvard University; Harvard Medical School			Wu, Lai-Chu/E-4328-2011; Sanlioglu, Salih/F-9305-2016; Yu, Chack-Yung/E-4360-2011	Wu, Lai-Chu/0000-0002-1348-269X; Sanlioglu, Salih/0000-0001-8379-5678; Yu, Chack-Yung/0000-0002-5218-7503				ALPER CA, 1991, IMMUNOGENETICS AUTOI, V1, P166; ATKINSON JP, 1986, SPRINGER SEMIN IMMUN, V9, P179, DOI 10.1007/BF02099021; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; AWDEH ZL, 1980, P NATL ACAD SCI-BIOL, V77, P3576, DOI 10.1073/pnas.77.6.3576; BANKIER AT, 1989, NUCLEIC ACID SEQUENC, P37; BELT KT, 1985, IMMUNOGENETICS, V21, P173; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; CARROLL MC, 1985, IMMUNOL REV, V87, P39, DOI 10.1111/j.1600-065X.1985.tb01144.x; CARROLL MC, 1984, NATURE, V307, P237, DOI 10.1038/307237a0; CARROLL MC, 1984, PHILOS T ROY SOC B, V306, P379, DOI 10.1098/rstb.1984.0098; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FIELDER AHL, 1983, BMJ-BRIT MED J, V286, P425, DOI 10.1136/bmj.286.6363.425; GITELMAN SE, 1992, MOL CELL BIOL, V12, P2124, DOI 10.1128/MCB.12.5.2124; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; Hu Xiuyuan, 1992, Human Mutation, V1, P3, DOI 10.1002/humu.1380010103; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; JURKA J, 1988, P NATL ACAD SCI USA, V85, P4775, DOI 10.1073/pnas.85.13.4775; KAWAGUCHI H, 1991, MOL EVOLUTION MAJOR, P357; KAWAJIRI K, 1986, EUR J BIOCHEM, V159, P219, DOI 10.1111/j.1432-1033.1986.tb09857.x; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUNZ HW, 1980, J EXP MED, V152, P1506, DOI 10.1084/jem.152.6.1506; LAITINEN T, 1991, HUM REPROD, V6, P1384, DOI 10.1093/oxfordjournals.humrep.a137273; LEVISTRAUSS M, 1988, SCIENCE, V240, P201, DOI 10.1126/science.3353717; LI WH, 1991, FUNDAMENTALS MOL EVO, P172; LU SJ, 1990, NATURE, V346, P470, DOI 10.1038/346470a0; MATSUMOTO K, 1992, IMMUNOGENETICS, V36, P400; MATSUMOTO K, 1992, GENOMICS, V12, P485, DOI 10.1016/0888-7543(92)90438-X; MELHEM MF, 1993, P NATL ACAD SCI USA, V90, P1967, DOI 10.1073/pnas.90.5.1967; MESSING J, 1989, NUCLEIC ACIDS SEQUEN, P1; MILLER WL, 1989, ANNU REV GENET, V23, P371, DOI 10.1146/annurev.ge.23.120189.002103; MOREL Y, 1989, P NATL ACAD SCI USA, V86, P6582, DOI 10.1073/pnas.86.17.6582; ONO M, 1986, J VIROL, V60, P589, DOI 10.1128/JVI.60.2.589-598.1986; ONO M, 1987, NUCLEIC ACIDS RES, V15, P8725, DOI 10.1093/nar/15.21.8725; PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9; PEROZZI G, 1986, MOL CELL BIOL, V6, P1497, DOI 10.1128/MCB.6.5.1497; Porter R R, 1983, Mol Biol Med, V1, P161; PROUDFOOT N, 1991, CELL, V64, P671, DOI 10.1016/0092-8674(91)90495-K; REID KBM, 1988, MOL IMMUNOL, P215; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; RODRIGUES NR, 1987, EMBO J, V6, P1653, DOI 10.1002/j.1460-2075.1987.tb02414.x; RUKSTALIS DB, 1989, CANCER RES, V49, P5087; RYDER LP, 1981, ANNU REV GENET, V15, P169, DOI 10.1146/annurev.ge.15.120181.001125; Saiki R. K., 1990, PCR PROTOCOLS GUIDE, P13; SARGENT CA, 1989, EMBO J, V8, P2305, DOI 10.1002/j.1460-2075.1989.tb08357.x; SATYANARAYANA K, 1992, IMMUNOGENETICS, V35, P235, DOI 10.1007/BF00166828; SCHAFFER FM, 1989, P NATL ACAD SCI USA, V86, P8015, DOI 10.1073/pnas.86.20.8015; SCHNEIDER PM, 1986, J CLIN INVEST, V78, P650, DOI 10.1172/JCI112623; SCHNEIDER R, 1991, FEBS LETT, V283, P203, DOI 10.1016/0014-5793(91)80588-T; SHIOTA S, 1989, MOL GEN GENET, V217, P332, DOI 10.1007/BF02464901; SHIROISHI T, 1987, P NATL ACAD SCI USA, V84, P2819, DOI 10.1073/pnas.84.9.2819; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPEISER PW, 1989, DNA-J MOLEC CELL BIO, V8, P745, DOI 10.1089/dna.1989.8.745; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; TROWSDALE J, 1991, IMMUNOL TODAY, V12, P443, DOI 10.1016/0167-5699(91)90017-N; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111; WILTON AN, 1985, IMMUNOGENETICS, V21, P333, DOI 10.1007/BF00430799; WU LC, 1987, CELL, V48, P331, DOI 10.1016/0092-8674(87)90436-3; YU CY, 1986, EMBO J, V5, P2873, DOI 10.1002/j.1460-2075.1986.tb04582.x; YU CY, 1991, J IMMUNOL, V146, P1057; YU CY, 1987, IMMUNOGENETICS, V25, P384; ZHANG HY, 1989, INTERVIROLOGY, V30, P52, DOI 10.1159/000150076; ZHU ZB, 1992, J EXP MED, V175, P1783, DOI 10.1084/jem.175.6.1783; 1991, GCG SEQUENCE ANAL SO; [No title captured]	64	158	166	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8466	8476						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132574				2022-12-27	WOS:A1994NB40900095
J	WEN, W; TAYLOR, SS				WEN, W; TAYLOR, SS			HIGH-AFFINITY BINDING OF THE HEAT-STABLE PROTEIN-KINASE INHIBITOR TO THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN-KINASE IS SELECTIVELY ABOLISHED BY MUTATION OF ARG(133)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II REGULATORY SUBUNIT; AMINO-ACID-SEQUENCE; MOLECULAR-CLONING; SKELETAL-MUSCLE; CDNA CLONES; C-GAMMA; SITE; IDENTIFICATION; PEPTIDES; FORM	The two classes of physiological inhibitors of the catalytic subunit of cAMP-dependent protein kinase are the regulatory subunits and the heat-stable protein kinase inhibitors (PKIs), and both share a common mechanism of inhibition. Each has a similar inhibitor site that resembles a peptide substrate, and this occupies the P-3 to P+1 portion of the peptide recognition site. However, in addition to this consensus site, each inhibitor requires a peripheral binding site to achieve high affinity binding. Arg(134) and Arg(133) lie on the surface of the catalytic subunit with Arg(133) coming close to the amphipathic helix of PKI(5-24) (Knighton, D. R., Zheng, J., Ten Eyck, L. F., Xuong, N. h., Taylor, S. S., and Sowadski, J. M. (1991) Science 253, 414-420). Replacement of Arg(134) and Arg(133) with Ala selectively abolishes the high affinity binding of PKI. Replacement of Arg(133) alone is sufficient to give the same phenotype. In the presence of MgATP, the K-d,K-app,K- is increased from <0.2 to 105 nM and, in the absence of ATP, the K-d is too large to be reliably measured. Based on the crystal structure, Arg(133) hydrogen bonds to the P-7 backbone carbonyl of PKI(5-24). However, more importantly, it also contributes to the hydrophobicity of the P-11 binding site in the C.PKI(5-24) complex. We predict that it is the perturbation of this hydrophobic pocket that accounts for the effects of this mutation. In the absence of peptide, Arg(133) may help to stabilize Glu(230), a buried carboxylate that binds to the P-2 Arg in the crystal structure of C.PKI(5-24). Replacement of Arg(133) and Arg(134) With Ala has little effect on catalysis using a heptapeptide substrate and has no effect on the inhibition of the catalytic subunit by the regulatory subunit. The results thus demonstrate that these two inhibitor proteins that both bind to the catalytic subunit with a high affinity utilize different sites on the enzyme to achieve tight binding. The gamma isoform of the catalytic subunit is insensitive to inhibition by PKI and in this isoform Arg(133) is replaced with Gln. We predict that this change accounts for the altered inhibitor properties of C gamma.	UNIV CALIF SAN DIEGO, DEPT CHEM, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego								BEEBE SJ, 1992, J BIOL CHEM, V267, P25505; BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; BEEBE SJ, 1986, ENZYMES, V17, P43; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; BUBIS J, 1988, J BIOL CHEM, V263, P9668; BUECHLER JA, 1990, BIOCHEMISTRY-US, V29, P1937, DOI 10.1021/bi00459a039; BUECHLER JA, 1988, BIOCHEMISTRY-US, V27, P7356, DOI 10.1021/bi00419a027; BUECHLER YJ, 1993, J BIOL CHEM, V268, P16495; BUECHLER YJ, 1991, J BIOL CHEM, V266, P3491; CHENG HC, 1985, BIOCHEM J, V231, P655, DOI 10.1042/bj2310655; CLEGG CH, 1988, P NATL ACAD SCI USA, V85, P3703, DOI 10.1073/pnas.85.11.3703; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; GIBBS CS, 1992, J BIOL CHEM, V267, P4806; GIBBS CS, 1991, BIOCHEMISTRY-US, V30, P5329, DOI 10.1021/bi00236a001; GLASS DB, 1989, J BIOL CHEM, V264, P8802; GLASS DB, 1989, J BIOL CHEM, V264, P14579; GLASS DB, 1992, BIOCHEMISTRY-US, V31, P1728, DOI 10.1021/bi00121a021; GRANOT J, 1980, J BIOL CHEM, V255, P4569; HERBERG FW, 1993, PROTEIN ENG, V6, P771, DOI 10.1093/protein/6.7.771; HERBERG FW, 1993, BIOCHEMISTRY-US, V32, P14015, DOI 10.1021/bi00213a035; HOFMANN F, 1980, J BIOL CHEM, V255, P1559; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1993, ACTA CRYSTALLOGR D, V49, P357, DOI 10.1107/S0907444993000502; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KURET J, 1988, J BIOL CHEM, V263, P9149; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE DC, 1983, P NATL ACAD SCI-BIOL, V80, P3608, DOI 10.1073/pnas.80.12.3608; OLSEN SR, 1991, J BIOL CHEM, V266, P11158; ORELLANA SA, 1992, P NATL ACAD SCI USA, V89, P4726, DOI 10.1073/pnas.89.10.4726; RICHARDSON JM, 1990, J BIOL CHEM, V265, P13635; SCARPETTA MA, 1993, J BIOL CHEM, V268, P10927; SCOTT JD, 1990, J BIOL CHEM, V265, P21561; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; SHOWERS MO, 1986, J BIOL CHEM, V261, P6288; SLICE LW, 1989, J BIOL CHEM, V264, P20940; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4200, DOI 10.1021/bi00313a029; TASKEN K, 1993, J BIOL CHEM, V268, P21276; TAYLOR SS, 1993, TRENDS BIOCHEM SCI, V18, P84, DOI 10.1016/0968-0004(93)80001-R; TITANI K, 1984, BIOCHEMISTRY-US, V23, P4193, DOI 10.1021/bi00313a028; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; UHLER MD, 1986, J BIOL CHEM, V261, P5360; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; VANPATTEN SM, 1986, J BIOL CHEM, V261, P5514; VANPATTEN SM, 1991, P NATL ACAD SCI USA, V88, P5383, DOI 10.1073/pnas.88.12.5383; Walsh D.A., 2018, PEPT PROT PHOSPH, P43; WALSH DA, 1971, J BIOL CHEM, V246, P1977; WEBER W, 1979, BIOCHEM BIOPH RES CO, V90, P1073, DOI 10.1016/0006-291X(79)91935-1; WELDON SL, 1985, J BIOL CHEM, V260, P4203; WHITEHOUSE S, 1983, J BIOL CHEM, V258, P3682; YONEMOTO WM, 1991, METHOD ENZYMOL, V200, P581; Zetterqvist O.Z., 1990, PEPTIDES PROTEIN PHO, P171; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	54	31	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8423	8430						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132568				2022-12-27	WOS:A1994NB40900089
J	ZHANG, ZY; MALACHOWSKI, WP; VANETTEN, RL; DIXON, JE				ZHANG, ZY; MALACHOWSKI, WP; VANETTEN, RL; DIXON, JE			NATURE OF THE RATE-DETERMINING STEPS OF THE REACTION CATALYZED BY THE YERSINIA PROTEIN-TYROSINE-PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATIC-ACID-PHOSPHATASE; ALKALINE-PHOSPHATASE; VIRULENCE DETERMINANT; MECHANISM; INTERMEDIATE; HYDROLYSIS; PURIFICATION; EXPRESSION; DEPENDENCE; KINASES	Product inhibition and O-18 exchange experiments suggest that the Yersinia protein-tyrosine phosphatase-catalyzed phosphate monoester hydrolysis proceeds through at least two different chemical steps, i.e. the formation and breakdown of a covalent phosphoenzyme intermediate. The pH dependence of k(cat) values is bell-shaped, with the apparent pK(a) derived from the acidic limb of the profile at 4.6 for both p-nitrophenyl phosphate and beta-naphthyl phosphate, whereas the apparent pK(a), derived from the basic limb of the profile is substrate dependent, with apparent pK(a) values of 5.2 and 5.8 for p-nitrophenyl phosphate and beta-naphthyl phosphate, respectively. Twelve aryl phosphates with leaving groups having pK(a) values from similar to 7 to 10 are also examined as substrates at two pH values. At pH 4.0, the beta(lg) value is effectively zero, whereas at pH 7.5, a beta(lg) value of 0.16 is observed. Collectively, our results suggest that the rate-determining step under acidic conditions corresponds to the breakdown of the phosphoenzyme intermediate, whereas under more alkaline conditions, substrate effects also contribute to the rate-limiting step. A model is proposed for the mechanism of the Yersinia protein-tyrosine phosphatase-catalyzed reaction.	UNIV MICHIGAN, SCH MED, WALTHER CANC INST, DEPT BIOL CHEM, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT MED CHEM, ANN ARBOR, MI 48109 USA; PURDUE UNIV, DEPT CHEM, W LAFAYETTE, IN 47907 USA	University of Michigan System; University of Michigan; Walther Cancer Institute; University of Michigan System; University of Michigan; Purdue University System; Purdue University; Purdue University West Lafayette Campus				Malachowski, William/0000-0003-1215-3808	NIGMS NIH HHS [GM 27003] Funding Source: Medline; PHS HHS [18849] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027003] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APPLEBUR.ML, 1970, J BIOL CHEM, V245, P4968; BLISKA JB, 1991, P NATL ACAD SCI USA, V88, P1187, DOI 10.1073/pnas.88.4.1187; BOURNE N, 1984, J ORG CHEM, V49, P1200, DOI 10.1021/jo00181a011; CHO HJ, 1992, J AM CHEM SOC, V114, P7296, DOI 10.1021/ja00044a052; CHO HJ, 1992, BIOCHEMISTRY-US, V31, P133, DOI 10.1021/bi00116a019; COHN M, 1978, P NATL ACAD SCI USA, V75, P200, DOI 10.1073/pnas.75.1.200; COLEMAN JE, 1983, ADV ENZYMOL RAMB, V55, P381; DESJOBERT A, 1963, B SOC CHIM FR, P683; EARGLE DH, 1977, ANAL BIOCHEM, V81, P186, DOI 10.1016/0003-2697(77)90612-1; FALLER LD, 1989, BIOCHEMISTRY-US, V28, P6908, DOI 10.1021/bi00443a020; Fersht A. R., 1985, ENZYME STRUCTURE MEC, P155; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; GUAN KL, 1990, SCIENCE, V249, P553, DOI 10.1126/science.2166336; GUAN KL, 1991, J BIOL CHEM, V266, P17026; HICKEY ME, 1976, ARCH BIOCHEM BIOPHYS, V172, P439, DOI 10.1016/0003-9861(76)90096-5; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; KIRBY AJ, 1965, J AM CHEM SOC, V87, P3209, DOI 10.1021/ja01092a036; Leatherbarrow R.J, 1987, ENZFITTER NONLINEAR; LOWE G, 1971, BIOCHEM J, V124, P117, DOI 10.1042/bj1240117; MILSTIEN S, 1967, J AM CHEM SOC, V89, P5820, DOI 10.1021/ja00999a016; POT DA, 1992, BIOCHIM BIOPHYS ACTA, V1136, P35, DOI 10.1016/0167-4889(92)90082-M; RISLEY JM, 1978, J LABELLED COMPD RAD, V15, P533, DOI 10.1002/jlcr.2580150162; Rudolph F B, 1979, Methods Enzymol, V63, P411; SCHWARTZ JH, 1961, P NATL ACAD SCI USA, V47, P1996, DOI 10.1073/pnas.47.12.1996; VANETTEN RL, 1977, ARCH BIOCHEM BIOPHYS, V183, P250, DOI 10.1016/0003-9861(77)90438-6; VANETTEN RL, 1982, ANN NY ACAD SCI, V390, P27; VANETTEN RL, 1978, P NATL ACAD SCI USA, V75, P4784; WALTON KM, 1993, ANNU REV BIOCHEM, V62, P101; WO YYP, 1992, BIOCHEMISTRY-US, V31, P1712, DOI 10.1021/bi00121a019; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; ZERNER B, 1964, J AM CHEM SOC, V86, P3674, DOI 10.1021/ja01072a016; ZHANG ZY, 1992, J BIOL CHEM, V267, P23759; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012; ZHANG ZY, 1993, P NATL ACAD SCI USA, V90, P4446, DOI 10.1073/pnas.90.10.4446; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224; ZHANG ZY, 1991, J BIOL CHEM, V266, P1516; ZHANG ZY, 1994, IN PRESS P NATL ACAD	39	92	94	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8140	8145						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132539				2022-12-27	WOS:A1994NB40900049
J	HAJEK, P; BEDWELL, DM				HAJEK, P; BEDWELL, DM			CHARACTERIZATION OF THE MITOCHONDRIAL BINDING AND IMPORT PROPERTIES OF PURIFIED YEAST F1-ATPASE BETA-SUBUNIT PRECURSOR - IMPORT REQUIRES EXTERNAL ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; OUTER-MEMBRANE; NUCLEOSIDE TRIPHOSPHATES; ESCHERICHIA-COLI; RECEPTOR COMPLEX; INNER MEMBRANE; TRANSLOCATION; IDENTIFICATION; RECOGNITION; PRESEQUENCE	To better understand the early events of the mitochondrial protein import process, we purified the precursor of the F-1-ATPase beta subunit (pre F-1 beta) and examined its import into isolated mitochondria. Import of purified urea-denatured pre-F-1 beta did not require cytosolic factors. However, the period of productive import was prolonged by the addition of reticulocyte lysate, suggesting that cytosolic factors such as molecular chaperones were acting to extend the period of import competence of pre-F-1 beta. Purified pre-F-1 beta bound extensively to both cardiolipin-containing liposomes and to intact mitochondria, indicating that a direct interaction between mitochondrial precursors and the mitochondrial outer membrane surface can occur. The ability to chase this surface-bound pre-F-1 beta into mitochondria suggests that precursors bound to the mitochondrial surface can be maintained in an import competent conformation. Finally, our defined mitochondrial import system was used to characterize the ATP requirements of pre-F-1 beta import in the absence of cytosol. We found a strong requirement for ATP on both sides of the mitochondrial inner membrane, suggesting that one or more previously undetected mitochondrial proteins outside the inner membrane utilize ATP to promote efficient pre-F-1 beta import.	UNIV ALABAMA, DEPT MICROBIOL, BIRMINGHAM, AL 35294 USA	University of Alabama System; University of Alabama Birmingham				Bedwell, David/0000-0002-6605-818X				BAKER KP, 1990, NATURE, V348, P605, DOI 10.1038/348605a0; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; BECKER K, 1992, J BIOL CHEM, V267, P5637; BEDWELL DM, 1989, MOL CELL BIOL, V9, P1014, DOI 10.1128/MCB.9.3.1014; BEDWELL DM, 1987, MOL CELL BIOL, V7, P4038, DOI 10.1128/MCB.7.11.4038; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; CHEN WJ, 1987, CELL, V49, P651, DOI 10.1016/0092-8674(87)90541-1; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; EILERS M, 1987, EMBO J, V6, P1073, DOI 10.1002/j.1460-2075.1987.tb04860.x; EILERS M, 1988, EMBO J, V7, P1139, DOI 10.1002/j.1460-2075.1988.tb02923.x; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; EMTAGE JLT, 1993, J CELL BIOL, V122, P1003, DOI 10.1083/jcb.122.5.1003; FUJIKI M, 1993, J BIOL CHEM, V268, P1914; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; HINES V, 1993, J BIOL CHEM, V268, P449; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; HWANG ST, 1989, P NATL ACAD SCI USA, V86, P8432, DOI 10.1073/pnas.86.21.8432; IWAHASHI J, 1992, J BIOCHEM-TOKYO, V111, P451, DOI 10.1093/oxfordjournals.jbchem.a123778; KASSENBROCK CK, 1993, EMBO J, V12, P3023, DOI 10.1002/j.1460-2075.1993.tb05971.x; KIEBLER M, 1993, CELL, V74, P483, DOI 10.1016/0092-8674(93)80050-O; KIEBLER M, 1990, NATURE, V348, P610, DOI 10.1038/348610a0; LOWRY OH, 1946, J BIOL CHEM, V162, P421; MADUKE M, 1993, SCIENCE, V260, P364, DOI 10.1126/science.8385804; MOCZKO M, 1992, FEBS LETT, V310, P265, DOI 10.1016/0014-5793(92)81345-M; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; MURAKAMI K, 1990, EMBO J, V9, P3201, DOI 10.1002/j.1460-2075.1990.tb07518.x; OHTA S, 1984, EMBO J, V3, P651, DOI 10.1002/j.1460-2075.1984.tb01862.x; OU WJ, 1988, J BIOCHEM-TOKYO, V103, P589, DOI 10.1093/oxfordjournals.jbchem.a122312; PAIN D, 1990, NATURE, V347, P444, DOI 10.1038/347444a0; PFALLER R, 1988, J CELL BIOL, V107, P2483, DOI 10.1083/jcb.107.6.2483; PFANNER N, 1987, CELL, V49, P815, DOI 10.1016/0092-8674(87)90619-2; PFANNER N, 1990, J BIOL CHEM, V265, P16324; PORITZ MA, 1990, SCIENCE, V250, P1111, DOI 10.1126/science.1701272; ROISE D, 1992, P NATL ACAD SCI USA, V89, P608, DOI 10.1073/pnas.89.2.608; ROISE D, 1988, J BIOL CHEM, V263, P4509; SEQUIREAL B, 1993, EMBO J, V12, P2211, DOI 10.1002/j.1460-2075.1993.tb05869.x; SIMBENI R, 1991, J BIOL CHEM, V266, P10047; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WACHTER C, 1992, EMBO J, V11, P4787, DOI 10.1002/j.1460-2075.1992.tb05584.x; ZWIZINSKI C, 1984, J BIOL CHEM, V259, P7850	45	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7192	7200						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125931				2022-12-27	WOS:A1994NA03200027
J	NAGAICH, AK; BHATTACHARYYA, D; BRAHMACHARI, SK; BANSAL, M				NAGAICH, AK; BHATTACHARYYA, D; BRAHMACHARI, SK; BANSAL, M			CA/TG SEQUENCE AT THE 5' END OF OLIGO(A)-TRACTS STRONGLY MODULATES DNA CURVATURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETOPLAST DNA; CURVED DNA; POTASSIUM-PERMANGANATE; DEOXYRIBONUCLEIC-ACID; ADENINE TRACTS; B-DNA; BENT; CONFORMATION; DUPLEXES; FRAGMENT	An analysis of the base pair doublet geometries in available crystal structures indicates that the often reported intrinsic curvature of DNA containing oligo-(d(A).d(T)) tracts may also depend on the nature of the flanking sequences. The presence of CA/TG doublet in particular at the 5' end of these tracts is expected to enhance their intrinsic bending property. To test this proposition, three oligonucleotides, d(GAAAAACCCCCC), d(CCCCCCAAAAAG), d(GAAAAATTTTTC), and their complementary sequences were synthesized to study the effect of various flanking sequences, at the 5' and 3' ends of the A-tracts, on the curvature of DNA in solution. An analysis of the polyacrylamide gel electrophoretic mobilities of these sequences under different conditions of salts and temperatures (below their melting points) clearly showed that the oligomer with CA/TG sequence in the center was always more retarded than the oligomer with AC/GT sequence, as well as the oligomer with AT/AT sequence. Hydroxyl radical probing of the sequences with AC/GT and CA/TG doublet junctions gives a similar cutting pattern in the A-tracts, which is quite different from that in the C-tracts, indicating that the oligo(A)-tracts have similar structures in the two oligomers. KMnO4 probing shows that the oligomer with a CA/TG doublet junction forms a kink that is responsible for its inherent curvature and unusual electrophoretic mobility. UV melting shows a reduced thermal stability of the duplex with CA/TG doublet junction, and circular dichroism (CD) studies indicate that a premelting transition occurs in the oligomer with CA/TG doublet step before global melting but not in the oligomer with AC/GT doublet step, which may correspond to thermally induced unbending of the oligomer. These observations indicate that the CA/TG doublet junction at the 5' end of the oligo(A)-tract has a crucial role in modulating the overall curvature in DNA.	INDIAN INST SCI,MOLEC BIOPHYS UNIT,BANGALORE 560012,KARNATAKA,INDIA; INDIAN INST SCI,CTR GENET ENGN,BANGALORE 560012,KARNATAKA,INDIA	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore								ABAGYAN RA, 1989, NUCLEIC ACIDS RES, V16, P989; BALAGURUMOORTHY P, 1992, NUCLEIC ACIDS RES, V20, P4061, DOI 10.1093/nar/20.15.4061; BANSAL M, 1991, MOL CONFORMATION BIO, P347; BERMAN HM, 1992, BIOPHYS J, V63, P751, DOI 10.1016/S0006-3495(92)81649-1; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BEUTEL BA, 1992, J MOL BIOL, V228, P803, DOI 10.1016/0022-2836(92)90865-H; BHATTACHARYA D, 1988, J BIOMOL STRUCT DYN, V6, P93, DOI 10.1080/07391102.1988.10506484; BHATTACHARYYA D, 1990, J BIOMOL STRUCT DYN, V8, P539, DOI 10.1080/07391102.1990.10507828; BOLSHOY A, 1991, P NATL ACAD SCI USA, V88, P2312, DOI 10.1073/pnas.88.6.2312; BOSSI L, 1984, CELL, V39, P643, DOI 10.1016/0092-8674(84)90471-9; BRACCO L, 1989, EMBO J, V8, P4289, DOI 10.1002/j.1460-2075.1989.tb08615.x; BRAHMS S, 1990, NUCLEIC ACIDS RES, V18, P1559, DOI 10.1093/nar/18.6.1559; BURKHOFF AM, 1987, CELL, V48, P935, DOI 10.1016/0092-8674(87)90702-1; BURKHOFF AM, 1988, NATURE, V331, P455, DOI 10.1038/331455a0; CHAN SS, 1990, BIOCHEMISTRY-US, V29, P6161, DOI 10.1021/bi00478a008; CHEN JH, 1988, NUCLEIC ACIDS RES, V16, P6803, DOI 10.1093/nar/16.14.6803; DESANTIS P, 1990, BIOCHEMISTRY-US, V29, P9269, DOI 10.1021/bi00491a023; DIEKMANN S, 1985, J MOL BIOL, V186, P1, DOI 10.1016/0022-2836(85)90251-7; DIEKMANN S, 1992, J MOL BIOL, V225, P729, DOI 10.1016/0022-2836(92)90397-3; GOODSELL DS, 1993, P NATL ACAD SCI USA, V90, P2930, DOI 10.1073/pnas.90.7.2930; HAGERMAN PJ, 1984, P NATL ACAD SCI-BIOL, V81, P4632, DOI 10.1073/pnas.81.15.4632; HAGERMAN PJ, 1986, NATURE, V321, P449, DOI 10.1038/321449a0; HAYATSU H, 1967, BIOCHEM BIOPH RES CO, V29, P556, DOI 10.1016/0006-291X(67)90521-9; HOWGATE P, 1968, J CHEM SOC C, P275, DOI 10.1039/j39680000275; IIDA S, 1971, BIOCHIM BIOPHYS ACTA, V240, P370, DOI 10.1016/0005-2787(71)90530-2; JERNIGAN RL, 1987, J BIOMOL STRUCT DYN, V4, P561, DOI 10.1080/07391102.1987.10507660; JIANG H, 1991, NUCLEIC ACIDS RES, V19, P6943, DOI 10.1093/nar/19.24.6943; KITCHIN PA, 1986, J BIOL CHEM, V261, P1302; KOO HS, 1986, NATURE, V320, P501, DOI 10.1038/320501a0; KOO HS, 1988, P NATL ACAD SCI USA, V85, P1763, DOI 10.1073/pnas.85.6.1763; LYUBCHENKO YL, 1993, BIOCHEMISTRY-US, V32, P4121, DOI 10.1021/bi00066a038; MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; MCCARTHY JG, 1991, NUCLEIC ACIDS RES, V19, P3421, DOI 10.1093/nar/19.12.3421; MCCARTHY JG, 1990, BIOCHEMISTRY-US, V29, P6071, DOI 10.1021/bi00477a027; MILTON DL, 1990, NUCLEIC ACIDS RES, V18, P817, DOI 10.1093/nar/18.4.817; NUSSINOV R, 1988, J BIOMOL STRUCT DYN, V6, P543, DOI 10.1080/07391102.1988.10506506; OLSON WK, 1993, J MOL BIOL, V232, P530, DOI 10.1006/jmbi.1993.1409; PARK YW, 1991, P NATL ACAD SCI USA, V88, P1551, DOI 10.1073/pnas.88.4.1551; PATEL DJ, 1987, UNUSUAL DNA STRUCTUR, P115; RUBIN CM, 1980, NUCLEIC ACIDS RES, V8, P4613, DOI 10.1093/nar/8.20.4613; SRINIVASAN AR, 1987, J BIOMOL STRUCT DYN, V5, P459, DOI 10.1080/07391102.1987.10506409; STELLWAGEN NC, 1983, BIOCHEMISTRY-US, V22, P6186, DOI 10.1021/bi00295a023; ULANOVSKY LE, 1987, NATURE, V326, P720, DOI 10.1038/326720a0; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; YANAGI K, 1991, J MOL BIOL, V217, P201, DOI 10.1016/0022-2836(91)90620-L; ZAHN K, 1987, SCIENCE, V236, P416, DOI 10.1126/science.2951850; ZHURKIN VB, 1991, P NATL ACAD SCI USA, V88, P7046, DOI 10.1073/pnas.88.16.7046; 1989, J MOL BIOL, V205, P787	49	61	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7824	7833						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8126009				2022-12-27	WOS:A1994NA03200120
J	TAKETANI, S; KOHNO, H; OKUDA, M; FURUKAWA, T; TOKUNAGA, R				TAKETANI, S; KOHNO, H; OKUDA, M; FURUKAWA, T; TOKUNAGA, R			INDUCTION OF PERIPHERAL-TYPE BENZODIAZEPINE RECEPTORS DURING DIFFERENTIATION OF MOUSE ERYTHROLEUKEMIA-CELLS - A POSSIBLE INVOLVEMENT OF THESE RECEPTORS IN HEME-BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; ERYTHROID DIFFERENTIATION; ENDOGENOUS LIGANDS; EXPRESSION; BINDING; PROTEIN; FERROCHELATASE; PURIFICATION; PORPHYRINS	To search for a possible role for peripheral-type benzodiazepine receptors (PBR) during erythroid differentiation, we cloned the PBR isoquinoline carboxamide-binding protein (PBR/IBP), an 18-kDa protein on PBR, from a mouse erythroleukemia (MEL) cell cDNA library. Sequence analysis revealed that PBR/IBP comprises 169 amino acid residues (M(r) 18,828), and has a high homology with PBR/IBP from other sources. The cDNA allows for the expression of active PBR/IBP, exhibiting a high affinity for isoquinoline carboxamide, [H-3]PK11195, with K-d of 0.80 and 1.56 nM. RNA blot analysis revealed that treatment of MEL cells with dimethyl sulfoxide led to an increase in PBR/IBP mRNA (?1.0 kilobases) for up to 72 h, with a concomitant induction of mRNAs for heme biosynthetic enzymes, coproporphyrinogen oxidase and ferrochelatase. The induction of PBR/IBP mRNA was also observed in MEL cells induced with diazepam. The binding activity of [H-3]PK11195 in MEL cells showed a high affinity with K-d of 0.69-2.13 nM, and increased during erythroid differentiation. The order of potency of different ligands to compete against [H-3]PK11195 binding in induced MEL cells was PK11195 > protoporphyrin IX > diazepam > coproporphyrinogen III > coproporphyrin III > estazolam. In contrast to the induction of PBR/IBP in induced MEL cells, the voltage-dependent anion channel (mitochondrial porin) associated with PBR remained unchanged. These results suggest that PBR/IBP on PBR may be involved in porphyrin transport and may even be a critical factor in erythroid-specific induction of heme biosynthesis.			TAKETANI, S (corresponding author), KANSAI MED UNIV,DEPT HYG,MORIGUCHI,OSAKA 570,JAPAN.							ANHALT RRH, 1986, J BIOL CHEM, V261, P576; ANHALT RRH, 1985, J PHARMACOL EXP THER, V233, P517; ANTKIEWICZMICHALUK L, 1988, J BIOL CHEM, V263, P17317; CLARKE GD, 1980, NATURE, V287, P160, DOI 10.1038/287160a0; DELBATLLE AM, 1979, CLIN SCI, V57, P63, DOI 10.1042/cs0570063; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GUIDOTTI A, 1983, P NATL ACAD SCI-BIOL, V80, P3531, DOI 10.1073/pnas.80.11.3531; HA HJ, 1993, J BIOL CHEM, V268, P12143; HIRSCH JD, 1989, MOL PHARMACOL, V35, P164; KOHNO H, 1993, J BIOL CHEM, V268, P21359; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCABE RT, 1989, FEBS LETT, V244, P263, DOI 10.1016/0014-5793(89)80541-1; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; MUKHIN AG, 1989, P NATL ACAD SCI USA, V86, P9813, DOI 10.1073/pnas.86.24.9813; NAKAHASHI Y, 1990, BIOCHIM BIOPHYS ACTA, V1037, P321, DOI 10.1016/0167-4838(90)90032-B; PAPADOPOULOS V, 1990, J BIOL CHEM, V265, P3772; PAROLA AL, 1991, J BIOL CHEM, V266, P14082; PROULX KL, 1993, PROTEIN SCI, V2, P1092, DOI 10.1002/pro.5560020703; RIOND J, 1991, EUR J PHARM-MOLEC PH, V208, P307, DOI 10.1016/0922-4106(91)90076-T; RIOND J, 1991, EUR J BIOCHEM, V195, P305, DOI 10.1111/j.1432-1033.1991.tb15707.x; SAMBROOK T, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; SASSA S, 1976, J EXP MED, V143, P305, DOI 10.1084/jem.143.2.305; SNYDER SH, 1987, FASEB J, V1, P282, DOI 10.1096/fasebj.1.4.2820823; SPRENGEL R, 1989, J BIOL CHEM, V264, P20415; TAKETANI S, 1990, J BIOL CHEM, V265, P19377; TAKETANI S, 1990, J BIOL CHEM, V265, P13981; VERMA A, 1988, MOL PHARMACOL, V34, P800; VERMA A, 1987, P NATL ACAD SCI USA, V84, P2256, DOI 10.1073/pnas.84.8.2256; WANG JKT, 1984, P NATL ACAD SCI-BIOL, V81, P3770, DOI 10.1073/pnas.81.12.3770	33	84	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7527	7531						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125973				2022-12-27	WOS:A1994NA03200078
J	BOURNE, Y; AYOUBA, A; ROUGE, P; CAMBILLAU, C				BOURNE, Y; AYOUBA, A; ROUGE, P; CAMBILLAU, C			INTERACTION OF A LEGUME LECTIN WITH 2 COMPONENTS OF THE BACTERIAL-CELL WALL - A CRYSTALLOGRAPHIC STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURE; LATHYRUS-OCHRUS; ISOLECTIN-I; RESOLUTION; SPECIFICITY; REFINEMENT; COMPLEX; SEEDS	We describe herein the refined high resolution x-ray structures of two components of the bacterial cell wall, muramic acid and muramyl dipeptide complexed to isolectin I from Lathyrus ochrus seeds. In both complexes, only the ring hydroxyl oxygen atoms of the bound sugar establish direct hydrogen bonds with isolectin I, as in the case of all the previously determined monosaccharide-lectin complexes. In addition, the lactyl methyl of both components strongly interacts via hydrophobic contacts with the side chains of residues Tyr100 and Trp128 of isolectin I, which could explain the higher affinity of isolectin I for muramic acid as compared with glucose. These 2 residues, however, are not involved in the stabilization of the oligosaccharide-isolectin I complexes. The dipeptide (D-Ala-D-iGln) of the second component is in stacking interaction with the N-acetyl group of glucose and with loop Gly97-Gly98 of isolectin I. In addition to these van der Waals' contacts, the dipeptide interacts with the lectin via well ordered water molecules also. Superposition of the structures of the muramyl dipeptide complex and of the muramic acid complex shows that the glucose ring in the dipeptide compound is tilted by about 15-degrees in comparison with that of muramic acid. The fact that the lactyl group has the same confrontation in both components reveals that the lectin is stereospecific and recognizes only diastereoisomer S of this group, which better fits the saccharide-binding site.	FAC SCI PHARMACEUT TOULOUSE,DEPT BIOL STRUCT & INGN PROT,CNRS,F-31062 TOULOUSE,FRANCE	Centre National de la Recherche Scientifique (CNRS)	BOURNE, Y (corresponding author), FAC MED SECTEUR N,CRISTALLOG & CRISTALLISAT MACROMOLEC BIOL LAB,CNRS,UNITE RECH 1296,F-13916 MARSEILLE 20,FRANCE.		Rouge, Pierre/T-2059-2019; Ayouba, Ahidjo/G-8775-2017; Bourne, Yves/AAC-4635-2022	Ayouba, Ahidjo/0000-0002-5081-1632; Bourne, Yves/0000-0003-3850-0548				ADAM A, 1981, MOL CELL BIOCHEM, V41, P27; AGRAWAL BBL, 1967, BIOCHIM BIOPHYS ACTA, V147, P262, DOI 10.1016/0005-2795(67)90404-7; AYOUBA A, 1991, FEBS LETT, V289, P102, DOI 10.1016/0014-5793(91)80918-S; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Beveridge T J, 1981, Int Rev Cytol, V72, P229, DOI 10.1016/S0074-7696(08)61198-5; BOURNE Y, 1990, J BIOL CHEM, V265, P18161; BOURNE Y, 1992, J BIOL CHEM, V267, P197; BOURNE Y, 1990, PROTEINS, V8, P365, DOI 10.1002/prot.340080410; BOURNE Y, 1990, J MOL BIOL, V214, P571, DOI 10.1016/0022-2836(90)90199-V; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; DIAZ CL, 1989, NATURE, V338, P579, DOI 10.1038/338579a0; ETZLER ME, 1985, ANNU REV PLANT PHYS, V36, P209, DOI 10.1146/annurev.pp.36.060185.001233; KOIKE K, 1990, AGR BIOL CHEM TOKYO, V54, P2931, DOI 10.1080/00021369.1990.10870398; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lis H., 1981, The biochemistry of plants. A comprehensive treatise. Volume 6. Proteins and nucleic acids., P371; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; PISTOLE TG, 1981, ANNU REV MICROBIOL, V35, P85, DOI 10.1146/annurev.mi.35.100181.000505; ROUGE P, 1984, PLANT SCI LETT, V37, P21, DOI 10.1016/0304-4211(84)90197-4; ROUSSEL A, 1992, SILICON GRAPHICS GEO, P77; VANDRIESSCHE E, 1988, ADV LECTIN RES, V1, P73; 1979, SERC CCP4	21	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9429	9435						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144527				2022-12-27	WOS:A1994NE05300009
J	JOST, JP; JOST, YC				JOST, JP; JOST, YC			TRANSIENT DNA DEMETHYLATION IN DIFFERENTIATING MOUSE MYOBLASTS CORRELATES WITH HIGHER ACTIVITY OF 5-METHYLDEOXYCYTIDINE EXCISION-REPAIR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROLEUKEMIA-CELLS; WIDE LOSS; METHYLATION; HYPOMETHYLATION; EXPRESSION; GENE; ACTIVATION; CYTOSINE; BREAKS; SITES	It has been recently shown that in developing chicken embryonic nuclear extracts there is a 5-methyldeoxycytidine excision repair activity (Jost, J. P. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 4684-4688). We show that in differentiating mouse myoblasts, a similar enzymatic reaction may be responsible for the genome-wide DNA demethylation (up to 50% of all CmCGG) occurring between the 3rd and 5th days of differentiation. Furthermore, in differentiating myoblasts, there is first a 50% transient decrease in DNA methyltransferase activity and a 90% drop in the rate of DNA synthesis, followed by an increase in 5-methyl-CpG endonuclease and 5-methyldeoxycytidine excision repair activities. As tested in vitro, the maximal activity of the 5-methyldeoxycytidine excision repair coincides with the maximal in vivo genome-wide DNA demethylation. We also find that 3-aminobenzamide, a potent inhibitor of ADP-ribosyltransferase, blocks the differentiation of myoblasts, the 5-methyldeoxycytidine excision repair activity, and the genome-wide demethylation.			JOST, JP (corresponding author), FRIEDRICH MIESCHER INST,POB 2543,CH-4002 BASEL,SWITZERLAND.							ADAMS RLP, 1990, BIOCHEM J, V265, P309, DOI 10.1042/bj2650309; ADAMS RLP, 1990, FEBS LETT, V269, P29, DOI 10.1016/0014-5793(90)81111-Z; ALTHAUS FR, 1982, NATURE, V300, P366, DOI 10.1038/300366a0; BESTOR TH, 1984, MOL CELL BIOL, V4, P1800, DOI 10.1128/MCB.4.9.1800; CEDAR H, 1979, NUCLEIC ACIDS RES, V6, P2125, DOI 10.1093/nar/6.6.2125; CEDAR H, 1990, BIOCHIM BIOPHYS ACTA, V1049, P1, DOI 10.1016/0167-4781(90)90076-E; CHRISTMAN JK, 1977, EUR J BIOCHEM, V81, P53, DOI 10.1111/j.1432-1033.1977.tb11926.x; FARZANEH F, 1982, NATURE, V300, P362, DOI 10.1038/300362a0; FRANK D, 1991, NATURE, V351, P239, DOI 10.1038/351239a0; HOLLIDAY R, 1990, BIOL REV, V65, P431, DOI 10.1111/j.1469-185X.1990.tb01233.x; HUGHES BP, 1962, CLIN CHIM ACTA, V7, P597, DOI 10.1016/0009-8981(62)90137-7; JOHNSTONE AP, 1982, NATURE, V300, P368, DOI 10.1038/300368a0; JOST JP, 1993, P NATL ACAD SCI USA, V90, P4684, DOI 10.1073/pnas.90.10.4684; JOST JP, 1993, DNA METHYLATION MOL; LEWIS J, 1991, FEBS LETT, V285, P155, DOI 10.1016/0014-5793(91)80795-5; MANES C, 1981, NATURE, V293, P589, DOI 10.1038/293589a0; PAROUSH Z, 1990, CELL, V63, P1229, DOI 10.1016/0092-8674(90)90418-E; RAZIN A, 1988, P NATL ACAD SCI USA, V85, P9003, DOI 10.1073/pnas.85.23.9003; RAZIN A, 1984, P NATL ACAD SCI-BIOL, V81, P2275, DOI 10.1073/pnas.81.8.2275; RAZIN A, 1986, P NATL ACAD SCI USA, V83, P2827, DOI 10.1073/pnas.83.9.2827; ROCAMORA N, 1989, FEBS LETT, V247, P415, DOI 10.1016/0014-5793(89)81382-1; SALUZ HP, 1986, P NATL ACAD SCI USA, V83, P7167, DOI 10.1073/pnas.83.19.7167; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; SZYF M, 1985, J BIOL CHEM, V260, P8653; SZYF M, 1991, J BIOL CHEM, V266, P10027; YOUNG PR, 1984, MOL CELL BIOL, V4, P898, DOI 10.1128/MCB.4.5.898	26	60	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10040	10043						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144502				2022-12-27	WOS:A1994NE05300097
J	KANG, SM; WELLS, RD				KANG, SM; WELLS, RD			ZINC DESTABILIZES DNA WATSON-CRICK PAIRS AT AGCT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOPURINE-HOMOPYRIMIDINE SEQUENCES; SPECIFICITY; BINDING; TRANSCRIPTION; RECOGNITION	Zinc, a component of a large number of enzymes and an abundant and essential trace metal, alters the structure of AGCT sites in negatively supercoiled DNA. Related sequences show little or no effect. Cobalt and cadmium show reactivities similar to zinc. The conformational change in DNA was fine mapped with haloacetaldehydes using chemical cleavage or primer extension methods. Since a many fold excess of zinc to AGCT sites is required to saturate the reaction, we propose that the zinc-AGCT complex is preferentially accessible to the haloacetaldehyde probes due to a conformational deformation. Hence, zinc is the smallest ligand (by approximately 500-fold) that causes a perturbation of a specific DNA sequence.	TEXAS A&M UNIV,TEXAS MED CTR,INST BIOSCI & TECHNOL,HOUSTON,TX 77030	Baylor College of Medicine; Texas A&M University System					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030822] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30822] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERNUES J, 1989, EMBO J, V8, P2087, DOI 10.1002/j.1460-2075.1989.tb03617.x; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; FURLONG JC, 1989, BIOCHEMISTRY-US, V28, P2009, DOI 10.1021/bi00431a008; GOODISMAN J, 1992, BIOCHEMISTRY-US, V31, P1046, DOI 10.1021/bi00119a013; HANVEY JC, 1988, P NATL ACAD SCI USA, V85, P6592; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; KANG S, 1992, J BIOL CHEM, V267, P19435; KANG S, 1992, J BIOL CHEM, V257, P1259; KANG S, 1992, J BIOL CHEM, V267, P20889; KOHWI Y, 1988, P NATL ACAD SCI USA, V85, P3781, DOI 10.1073/pnas.85.11.3781; KOPKA ML, 1985, P NATL ACAD SCI USA, V82, P1376, DOI 10.1073/pnas.82.5.1376; LEONARD NJ, 1992, CHEMTRACTS BIOCH MOL, V3, P273; LESSER DR, 1990, SCIENCE, V250, P776, DOI 10.1126/science.2237428; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MANIATIS T, 1982, MOL CLONING LABORATO, P90; MARCHAND C, 1992, NUCLEIC ACIDS RES, V20, P5601, DOI 10.1093/nar/20.21.5601; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MCLEAN MJ, 1987, NUCLEIC ACIDS RES, V15, P6917, DOI 10.1093/nar/15.17.6917; NICKOL J, 1992, J MOL BIOL, V228, P1115, DOI 10.1016/0022-2836(92)90319-F; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; RADLOFF R, 1967, P NATL ACAD SCI USA, V57, P1514, DOI 10.1073/pnas.57.5.1514; RAHMOUNI AR, 1992, J MOL BIOL, V223, P131, DOI 10.1016/0022-2836(92)90721-U; RAHMOUNI AR, 1989, SCIENCE, V246, P358, DOI 10.1126/science.2678475; Sinden Richard R., 1992, Current Opinion in Biotechnology, V3, P612, DOI 10.1016/0958-1669(92)90005-4; STEITZ TA, 1990, Q REV BIOPHYS, V23, P205, DOI 10.1017/S0033583500005552; VANHOUTE LPA, 1993, BIOCHEMISTRY-US, V32, P1667, DOI 10.1021/bi00057a034	26	9	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9528	9532						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144538				2022-12-27	WOS:A1994NE05300023
J	REGAN, LM; LAMPHEAR, BJ; HUGGINS, CF; WALKER, FJ; FAY, PJ				REGAN, LM; LAMPHEAR, BJ; HUGGINS, CF; WALKER, FJ; FAY, PJ			FACTOR-IXA PROTECTS FACTOR-VIIIA FROM ACTIVATED PROTEIN-C - FACTOR-IXA INHIBITS ACTIVATED PROTEIN-C-CATALYZED CLEAVAGE OF FACTOR-VIIIA AT ARG(562)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE FACTOR-VIII; COAGULATION FACTOR-V; FACTOR-XA; VONWILLEBRAND-FACTOR; A1/A3-C1-C2 DIMER; BLOOD-COAGULATION; SUBUNIT STRUCTURE; COFACTOR ACTIVITY; A2 SUBUNIT; INACTIVATION	Factor VIIIa is inactivated by both factor IXa and activated protein C. The latter protease rapidly attacked a site at Arg562 (A2 subunit), whereas both proteases slowly cleaved factor VIIIa at Arg336 (A1 subunit). Cofactor inactivation catalyzed by activated protein C was 8-fold faster than that catalyzed by factor IXa. Simultaneous reaction of factor VIIIa with the two enzymes resulted in a rate of inactivation intermediate to that observed for the individual proteases. Under these conditions, the activated protein C-catalyzed cleavage at Arg562 was inhibited such that cofactor inactivation resulted primarily from cleavage at Arg336. Substitution of factor IXa modified in its active site with 6-(dimethylamino)-2-naphthalenesulfonyl-glutamylglycylarginyl chloromethyl ketone (DEGR-IXa) for the native enzyme yielded a similar rate of activated protein C-catalyzed cleavage at the Al site, whereas cleavage at the A2 site was virtually eliminated. However, the inclusion of protein S resulted in a marked increase in cleavage at the A2 site that correlated with an increased rate of cofactor inactivation. Active site-modified activated protein C inhibited the factor IXa-dependent enhancement of factor VIIIa reconstitution from isolated subunits. In addition, the factor VIIIa-dependent fluorescence enhancement of DEGR-activated protein C was inhibited by EGR-IXa. These results indicate that factor IXa can reduce the rate of activated protein C-catalyzed cofactor inactivation by selectively blocking cleavage at the A2 domainal site, an effect reversed by protein S. One mechanism consistent with the reciprocal inhibitory effects of the proteases is that activated protein C and factor IXa occupy overlapping sites on the cofactor. Thus, factor IXa may protect factor VIIIa by preventing activated protein C binding.	UNIV ROCHESTER,MED CTR,SCH MED & DENT,DEPT MED,HEMATOL UNIT,POB 610,601 ELMWOOD AVE,ROCHESTER,NY 14642; UNIV ROCHESTER,SCH MED & DENT,DEPT BIOCHEM,ROCHESTER,NY 14642; UNIV CONNECTICUT,CTR HLTH,DEPT MED,FARMINGTON,CT 06032; UNIV CONNECTICUT,CTR HLTH,DEPT LAB MED,FARMINGTON,CT 06032; UNIV CONNECTICUT,CTR HLTH,AMER RED CROSS,BLOOD SERV,FARMINGTON,CT 06032	University of Rochester; University of Rochester; University of Connecticut; University of Connecticut; American Red Cross; University of Connecticut				Huggins, Christine/0000-0002-5873-1194	NHLBI NIH HHS [HL38199, HL40328] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040328, R01HL038199] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSSON LO, 1986, P NATL ACAD SCI USA, V83, P2979, DOI 10.1073/pnas.83.9.2979; BERTINA RM, 1984, BIOCHEM BIOPH RES CO, V125, P177, DOI 10.1016/S0006-291X(84)80351-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASILLAS G, 1971, COAGULATION, V4, P107; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; FASS DN, 1982, BLOOD, V59, P594; FAY PJ, 1989, J BIOL CHEM, V264, P14005; FAY PJ, 1993, J BIOL CHEM, V268, P17861; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1992, J BIOL CHEM, V267, P13246; FAY PJ, 1991, J BIOL CHEM, V266, P8957; FAY PJ, 1986, BIOCHIM BIOPHYS ACTA, V871, P268, DOI 10.1016/0167-4838(86)90208-6; FAY PJ, 1991, J BIOL CHEM, V266, P2172; GUINTO ER, 1984, J BIOL CHEM, V259, P3986; HEBB MJ, 1993, J BIOL CHEM, V268, P2872; KANE WH, 1988, BLOOD, V71, P539; KOEDAM JA, 1988, J CLIN INVEST, V82, P1236, DOI 10.1172/JCI113721; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPHEAR BJ, 1992, BLOOD, V80, P3120; LAMPHEAR BJ, 1992, J BIOL CHEM, V267, P3725; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1984, ARCH BIOCHEM BIOPHYS, V233, P438, DOI 10.1016/0003-9861(84)90465-X; LOLLAR P, 1984, BLOOD, V63, P1303; LOLLAR P, 1989, BIOCHEMISTRY-US, V28, P666, DOI 10.1021/bi00428a038; LOLLAR P, 1991, J BIOL CHEM, V266, P12481; MERTENS K, 1985, THROMB HAEMOSTASIS, V54, P654; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NESHEIM ME, 1982, J BIOL CHEM, V257, P1443; OBRIEN DP, 1992, BIOCHEMISTRY-US, V31, P2805, DOI 10.1021/bi00125a022; ODEGAARD B, 1987, J BIOL CHEM, V262, P11233; PIETERS J, 1989, BLOOD, V74, P1021; RICK ME, 1990, J LAB CLIN MED, V115, P415; SOLYMOSS S, 1988, J BIOL CHEM, V263, P14884; SUZUKI K, 1983, J BIOL CHEM, V258, P1914; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; WALKER FJ, 1981, J BIOL CHEM, V256, P1128; WALKER FJ, 1987, ARCH BIOCHEM BIOPHYS, V252, P322, DOI 10.1016/0003-9861(87)90037-3; WALKER FJ, 1990, J BIOL CHEM, V265, P1484; WALKER FJ, 1992, FASEB J, V6, P2561, DOI 10.1096/fasebj.6.8.1317308; WALKER FJ, 1980, J BIOL CHEM, V255, P5521; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0	42	68	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9445	9452						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144529				2022-12-27	WOS:A1994NE05300011
J	BLOOMQUIST, BT; DARLINGTON, DN; MAINS, RE; EIPPER, BA				BLOOMQUIST, BT; DARLINGTON, DN; MAINS, RE; EIPPER, BA			RESP18, A NOVEL ENDOCRINE SECRETORY PROTEIN TRANSCRIPT, AND 4 OTHER TRANSCRIPTS ARE REGULATED IN PARALLEL WITH PROOPIOMELANOCORTIN IN MELANOTROPES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROOPIOMELANOCORTIN GENE-EXPRESSION; CHAIN BINDING-PROTEIN; MESSENGER-RNA LEVELS; CHROMOGRANIN-B; SECRETOGRANIN-II; RAT PITUITARY; INSITU HYBRIDIZATION; ANTERIOR-PITUITARY; INTERMEDIATE LOBE; PROHORMONE CONVERTASES	The homogeneous nature of the rat intermediate pituitary makes it a powerful model system in which to study peptide hormone secretion. Adult male rats were treated with bromocriptine, a dopamine agonist, or haloperidol, a dopamine antagonist, for 3 weeks. In cDNA libraries prepared from the neurointermediate pituitaries of these rats, pro-opiomelanocortin (POMC) expression exhibited the expected decrease in response to bromocriptine, and increase in response to haloperidol. We report the identification of six transcripts that are coregulated with POMC in the intermediate pituitary by these dopaminergic agents. In addition to demonstrating parallel dopamine-regulated expression of carboxypeptidase E, chromogranin B, binding protein/glucose-regulated protein, and tenascin, two novel regulated transcripts are described. The expression of one of these novel transcripts, RESP18, is limited to neural and endocrine tissue. The RESP18 transcript is approximately 800 nucleotides in length; its cognate translation product is 20 +/- 1 kDa, contains a putative signal sequence, and has many characteristics of a secreted protein. Cell-free translation experiments in the presence of microsomal membranes demonstrate that the 20 +/- 1-kDa RESP18 protein is cleaved to an 18 +/- 1-kDa protein and sequestered within the lumen of the rough endoplasmic reticulum. Tissue in situ hybridization analysis shows that RESP18 mRNA is highly expressed in both the intermediate and anterior pituitary, as well as in the paraventricular and supraoptic nuclei of the hypothalamus.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; UNIV MARYLAND,DEPT SURG,BALTIMORE,MD 21201	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore			Darlington, Daniel/CAG-1917-2022		NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-00097, DA-00266, DA-00098] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ARNAULD E, 1991, NEUROSCI LETT, V130, P12, DOI 10.1016/0304-3940(91)90216-G; AUTELITANO DJ, 1989, MOL CELL ENDOCRINOL, V67, P101, DOI 10.1016/0303-7207(89)90235-9; BENEDUM UM, 1987, EMBO J, V6, P1203, DOI 10.1002/j.1460-2075.1987.tb02355.x; BENJONATHAN N, 1990, NEUROENDOCRINE PERSP, V8, P1; BENSON D, 1993, NUCLEIC ACIDS RES, V21, P2963, DOI 10.1093/nar/21.13.2963; BHAT RV, 1992, J PHARMACOL EXP THER, V263, P343; BLOOMQUIST BT, 1991, MOL ENDOCRINOL, V5, P2014, DOI 10.1210/mend-5-12-2014; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; CETIN Y, 1991, CELL TISSUE RES, V264, P231, DOI 10.1007/BF00313960; CHRONWALL BM, 1988, ENDOCRINOLOGY, V123, P1992, DOI 10.1210/endo-123-4-1992; CHRONWALL BM, 1987, ENDOCRINOLOGY, V120, P1201, DOI 10.1210/endo-120-3-1201; DAY R, 1992, MOL ENDOCRINOL, V6, P485, DOI 10.1210/me.6.3.485; DILLEN L, 1993, NEUROCHEM INT, V22, P315, DOI 10.1016/0197-0186(93)90016-X; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; ENDO T, 1991, MOL ENDOCRINOL, V5, P905, DOI 10.1210/mend-5-7-905; ERICKSON HP, 1989, ANNU REV CELL BIOL, V5, P71, DOI 10.1146/annurev.cb.05.110189.000443; FISCHERCOLBRIE R, 1988, P NATL ACAD SCI USA, V85, P3240, DOI 10.1073/pnas.85.9.3240; FRICKER LD, 1991, PEPTIDE BIOSYNTHESIS, P199; GATCHALIAN CL, 1989, J CELL BIOL, V108, P1873, DOI 10.1083/jcb.108.5.1873; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GOLDSMITH PC, 1979, J HISTOCHEM CYTOCHEM, V27, P1205, DOI 10.1177/27.8.383827; GUEST PC, 1989, BIOCHEM J, V257, P431, DOI 10.1042/bj2570431; HASSAN MN, 1986, LIFE SCI, V39, P513, DOI 10.1016/0024-3205(86)90507-2; HOLZBAUER M, 1985, MED BIOL, V63, P97; HUTTNER WB, 1987, TRENDS BIOCHEM SCI, V12, P361, DOI 10.1016/0968-0004(87)90166-6; HUTTNER WB, 1991, TRENDS BIOCHEM SCI, V16, P27, DOI 10.1016/0968-0004(91)90012-K; HYDE JF, 1987, ENDOCRINOLOGY, V121, P1531, DOI 10.1210/endo-121-4-1531; JONES FS, 1988, P NATL ACAD SCI USA, V85, P2186, DOI 10.1073/pnas.85.7.2186; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; KIM PS, 1993, J BIOL CHEM, V268, P4873; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KUHL D, 1992, J CELL BIOL, V119, P1069, DOI 10.1083/jcb.119.5.1069; KUNKEL TA, 1987, CURR PROTOCOLS M S13, V13; LLOYD RV, 1992, LAB INVEST, V67, P394; MAINS RE, 1990, FRONT NEUROENDOCRIN, V11, P52; MAINS RE, 1990, TRENDS ENDOCRIN MET, V1, P388, DOI 10.1016/1043-2760(90)90097-M; MCKENNA PJ, 1987, BRIT J PSYCHIAT, V151, P288, DOI 10.1192/bjp.151.3.288; MILLINGTON WR, 1986, ENDOCRINOLOGY, V118, P2024, DOI 10.1210/endo-118-5-2024; MILLINGTON WR, 1989, NEUROENDOCRINE PERSP, V7, P1; MOORE HP, 1983, J CELL BIOL, V97, P810, DOI 10.1083/jcb.97.3.810; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; PARDY K, 1990, ENDOCRINOLOGY, V126, P2960, DOI 10.1210/endo-126-6-2960; PEARSON CA, 1988, EMBO J, V7, P2977, DOI 10.1002/j.1460-2075.1988.tb03160.x; PRITCHETT DB, 1987, P NATL ACAD SCI USA, V84, P5545, DOI 10.1073/pnas.84.16.5545; ROSA P, 1985, J CELL BIOL, V101, P1999, DOI 10.1083/jcb.101.5.1999; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; RUSSEL M, 1986, GENE, V45, P333, DOI 10.1016/0378-1119(86)90032-6; SAGA Y, 1991, GENE, V104, P177, DOI 10.1016/0378-1119(91)90248-A; SCAMMELL JG, 1990, J HISTOCHEM CYTOCHEM, V38, P949, DOI 10.1177/38.7.2192000; SCAMMELL JG, 1986, ENDOCRINOLOGY, V119, P1543, DOI 10.1210/endo-119-4-1543; SEIDAH NG, 1992, TRENDS ENDOCRIN MET, V3, P133, DOI 10.1016/1043-2760(92)90102-7; SHARIFI BG, 1992, J BIOL CHEM, V267, P23910; SITLANDMARKEN PA, 1990, J CLIN PSYCHIAT, V51, P68; SIVE HL, 1988, NUCLEIC ACIDS RES, V16, P10937, DOI 10.1093/nar/16.22.10937; SWANSON LW, 1980, J COMP NEUROL, V194, P555, DOI 10.1002/cne.901940306; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; THIELE EA, 1990, ENDOCRINOLOGY, V126, P809, DOI 10.1210/endo-126-2-809; THIELE EA, 1990, THESIS J HOPKINS U B; TUCKER RP, 1993, J CELL SCI, V104, P69; VINCENT S, 1993, NUCLEIC ACIDS RES, V21, P1498, DOI 10.1093/nar/21.6.1498; VOLLMER G, 1992, CANCER RES, V52, P4642; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; WAND GS, 1991, ENDOCRINOLOGY, V128, P1345, DOI 10.1210/endo-128-3-1345; WATOWICH SS, 1988, MOL CELL BIOL, V8, P393, DOI 10.1128/MCB.8.1.393; WICKENS M, 1984, SCIENCE, V226, P1045, DOI 10.1126/science.6208611; WIEDENMANN B, 1989, VIRCHOWS ARCH B, V58, P95, DOI 10.1007/BF02890062; YUN HY, 1993, ARCH BIOCHEM BIOPHYS, V301, P77, DOI 10.1006/abbi.1993.1117; ZHOU A, 1993, J BIOL CHEM, V268, P1763; ZIMMERMAN EA, 1984, PITUITARY HYPERFUNCT, P1	73	29	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9113	9122						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132649				2022-12-27	WOS:A1994NB41100075
J	GIDROL, X; CHRESTIN, H; TAN, HL; KUSH, A				GIDROL, X; CHRESTIN, H; TAN, HL; KUSH, A			HEVEIN, A LECTIN-LIKE PROTEIN FROM HEVEA-BRASILIENSIS (RUBBER TREE) IS INVOLVED IN THE COAGULATION OF LATEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; CELL-ADHESION; MOLECULES	Hevein, a lectin-like protein is the major protein of vacuolar structures called lutoids in the latex of rubber trees. We have shown both by in planta and ex planta studies that hevein is involved in the coagulation of latex by bringing together rubber particles. This polyvalent bridging between hevein and rubber particles is mediated by N-acetyl-D-glucosamine and involves a receptor glycoprotein of 22 kDa, which is localized on the surface of the rubber particles. The proposed role of hevein helps us to understand the mechanism of coagulation of latex and assigns a physiological intracellular function to one of the smallest lectins.	NATL UNIV SINGAPORE,INST MOLEC & CELL BIOL,SINGAPORE 0511,SINGAPORE	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore				Gidrol, Xavier/0000-0002-4233-3749				ARCHER B. L., 1969, Journal of the Rubber Research Institute, V21, P560; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BOUTRY M, 1985, EMBO J, V4, P2159, DOI 10.1002/j.1460-2075.1985.tb03910.x; BRANDLEY BK, 1990, CELL, V63, P861, DOI 10.1016/0092-8674(90)90487-Y; BROEKAERT W, 1990, P NATL ACAD SCI USA, V87, P7633, DOI 10.1073/pnas.87.19.7633; BROGLIE KE, 1986, P NATL ACAD SCI USA, V83, P6820, DOI 10.1073/pnas.83.18.6820; BUTTERY BR, 1967, J EXP BOT, V17, P283; Chrestin H., 1989, PHYSL RUBBER TREE LA, P431; CHRISPEELS MJ, 1991, PLANT CELL, V3, P1, DOI 10.1105/tpc.3.1.1; CHYE ML, 1991, PLANT MOL BIOL, V16, P567, DOI 10.1007/BF00023422; Coupe M., 1989, PHYSL RUBBER TREE LA, P295; D'Auzac J., 1989, PHYSL RUBBER TREE LA, P257, DOI [10.1590/S0104-14282006000300015, DOI 10.1590/S0104-14282006000300015]; de Fay E, 1989, PHYSL RUBBER TREE LA, P3, DOI DOI 10.1111/J.1432-2277.2005.00166.X.; de Fay E., 1989, PHYSL RUBBER TREE LA, P407; DENNIS MS, 1989, J BIOL CHEM, V264, P18608; HANOWER P, 1976, PHYSIOL VEG, V14, P677; KUSH A, 1990, P NATL ACAD SCI USA, V87, P1787, DOI 10.1073/pnas.87.5.1787; Lis H., 1981, The biochemistry of plants. A comprehensive treatise. Volume 6. Proteins and nucleic acids., P371; MARTIN MN, 1991, PLANT PHYSIOL, V95, P469, DOI 10.1104/pp.95.2.469; MOIR GFJ, 1959, NATURE, V184, P1626, DOI 10.1038/1841626a0; RIBAILLIER D, 1971, PHYSL VEG, V2, P413; Sambrook J, 1989, MOL CLONING LABORATO; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; VANPARIJS J, 1991, PLANTA, V183, P258, DOI 10.1007/BF00197797; WALUJONO K, 1975, P INT RUBBER C KUALA, P518; WRIGHT HT, 1985, J MOL EVOL, V21, P133, DOI 10.1007/BF02100087	28	118	158	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9278	9283						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132664				2022-12-27	WOS:A1994NB41100095
J	GROEBE, DR; DUMM, JM; ABRAMSON, SN				GROEBE, DR; DUMM, JM; ABRAMSON, SN			IRREVERSIBLE INHIBITION OF NICOTINIC ACETYLCHOLINE-RECEPTORS BY THE BIPINNATINS - TOXIN ACTIVATION AND KINETICS OF RECEPTOR INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNIT; AGONIST SITES; LOPHOTOXIN; LABEL; BRAIN	Bipinnatin-A, -B, and -C belong to a family of naturally occurring marine neurotoxins known as the lophotoxins. The lophotoxins are unique in that they irreversibly inhibit nicotinic acetylcholine receptors by forming a covalent bond with a tyrosine residue at position 190 in the alpha-subunit of the receptor. In this study, we show that the inhibitory activity of the bipinnatins against the nicotinic receptor increased with preincubation of the toxins in aqueous buffer prior to incubation with the receptor. The parent species of the bipinnatins displayed little, if any, affinity for the nicotinic receptor. Preincubation of the toxins appeared to produce a single, relatively stable, active toxin species that irreversibly inhibited the two acetylcholine-binding sites on the nicotinic receptor with two distinguishable apparent pseudo first-order rates. The difference in the rates of irreversible inhibition of the two binding sites on the receptor was exploited to selectively inhibit one site for the pharmacological investigation of the other. The bipinnatins preferentially inhibited the binding site near the alpha/delta-subunit interface that displays low affinity for metocurine and high affinity for acetylcholine. The bimolecular reaction constants for the interaction of the bipinnatins with the nicotinic receptor decreased in the order bipinnatin-B > bipinnatin-A > bipinnatin-C for both acetylcholine-binding sites. The ratio of the bimolecular reaction constants for the two binding sites on the receptor was not the same for the three bipinnatins. This indicates that the reaction of the bipinnatins with the nicotinic receptor is sensitive to differences in the structure of the two acetylcholine-binding sites. The bipinnatins may be useful in the design of novel drugs for the nicotinic receptor that exclusively inhibit one of the two binding sites and for the investigation of structural differences between the two acetylcholine binding sites of the receptor.	UNIV PITTSBURGH, SCH MED, DEPT PHARMACOL, PITTSBURGH, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NINDS NIH HHS [NS29951] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS029951, R55NS029951] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMSON SN, 1991, DRUG DEVELOP RES, V24, P297, DOI 10.1002/ddr.430240402; ABRAMSON SN, 1991, J MED CHEM, V34, P1798, DOI 10.1021/jm00110a007; ABRAMSON SN, 1989, J BIOL CHEM, V264, P12666; ABRAMSON SN, 1988, J BIOL CHEM, V263, P18568; ANAND R, 1991, J BIOL CHEM, V266, P11192; ASHANI Y, 1972, BIOCHIM BIOPHYS ACTA, V284, P427, DOI 10.1016/0005-2744(72)90139-8; BALANT LP, 1990, EUR J DRUG METAB PH, V15, P143, DOI 10.1007/BF03190197; BERMAN HA, 1989, J BIOL CHEM, V264, P3942; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; CONROY WG, 1992, NEURON, V9, P679, DOI 10.1016/0896-6273(92)90031-8; CULVER P, 1985, MOL PHARMACOL, V28, P436; CULVER P, 1984, J BIOL CHEM, V259, P3763; FENICAL W, 1981, SCIENCE, V212, P1512, DOI 10.1126/science.6112796; GALZI JL, 1991, ANNU REV PHARMACOL, V31, P37, DOI 10.1146/annurev.pa.31.040191.000345; KITZ R, 1962, J BIOL CHEM, V237, P3245; KRANTZ A, 1991, BIOCHEMISTRY-US, V30, P4678, DOI 10.1021/bi00233a007; LANGDON RB, 1985, BRAIN RES, V359, P233, DOI 10.1016/0006-8993(85)91433-7; LUETJE CW, 1990, J NEUROCHEM, V55, P632, DOI 10.1111/j.1471-4159.1990.tb04180.x; MAIN AR, 1964, SCIENCE, V144, P992, DOI 10.1126/science.144.3621.992; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; RAKITZIS ET, 1974, BIOCHEM J, V141, P601, DOI 10.1042/bj1410601; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; SINE SM, 1980, J BIOL CHEM, V255, P144; SINE SM, 1991, J BIOL CHEM, V266, P10144; Taylor P., 1990, PHARMACOL BASIS THER, P166; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M	26	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8885	8891						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132625				2022-12-27	WOS:A1994NB41100042
J	LECO, KJ; KHOKHA, R; PAVLOFF, N; HAWKES, SP; EDWARDS, DR				LECO, KJ; KHOKHA, R; PAVLOFF, N; HAWKES, SP; EDWARDS, DR			TISSUE INHIBITOR OF METALLOPROTEINASES-3 (TIMP-3) IS AN EXTRACELLULAR MATRIX-ASSOCIATED PROTEIN WITH A DISTINCTIVE PATTERN OF EXPRESSION IN MOUSE CELLS AND TISSUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROID-POTENTIATING ACTIVITY; CHICKEN-EMBRYO FIBROBLASTS; TRANSFORMATION-SENSITIVE PROTEIN; MESSENGER-RNA DEGRADATION; 3' UNTRANSLATED REGION; COLLAGENASE INHIBITOR; IV COLLAGENASE; DEVELOPMENTAL EXPRESSION; HORMONAL-REGULATION; RESPONSIVE ELEMENT	We have isolated cDNA clones corresponding to a novel mouse metalloproteinase inhibitor. Five overlap ping cDNA clones contain most of the information for a prominent 4.5-kilobase transcript that was detected in RNA from mouse fibroblasts and adult tissues. Sequence analysis revealed an open reading frame (ORF) for a protein of 212 amino acids that is 80% identical to chicken inhibitor of metalloproteinases-3 (ChIMP-3). The 3'-untranslated sequence also showed remarkable conservation with the chicken gene. The ORF directed the expression of a 24-kDa protein in COS-1 cells that localized to the extracellular matrix (ECM). On the basis of these similarities we propose to identify the new gene as murine tissue inhibitor of metalloproteinases-3 (TIMP-3). Mouse C3H 10T1/2 fibroblasts produced a 24- kDa metalloproteinase inhibitor that also localized to the ECM and was recognized by a polyclonal antibody to ChIMP-3. Like TIMP-1, TIMP-3 was highly inducible in mouse C3H 10T1/2 fibroblasts by phorbol ester (PMA), epidermal growth factor (EGF), and transforming growth factor-beta 1, but nuclear run-on assays showed that the on/off transcription kinetics were faster for TIMP-3 than TIMP-1. A major difference in vitro was the stimulation of expression of TIMP-3 by dexamethasone which inhibits EGF- and PMA-induced TIMP-1 transcription. Also, TIMP-3 showed a distinctive pattern of expression in adult tissues with abundant transcripts detected in kidney, lung, and brain but only low levels detected in bone, a prominent location of TIMP-1 transcripts. We propose that TIMP-3 functions in a tissue specific fashion as part of an acute response to remodeling stimuli.	LONDON REG CANC CTR,DEPT ONCOL,LONDON N6A 4L6,ON,CANADA; UNIV CALIF SAN FRANCISCO,DEPT PHARM,SAN FRANCISCO,CA 94143	Western University (University of Western Ontario); University of California System; University of California San Francisco	LECO, KJ (corresponding author), UNIV CALGARY,DEPT PHARMACOL & THERAPEUT,3330 HOSP DR NW,CALGARY T2N 4N1,AB,CANADA.		Edwards, Dylan R/B-4734-2009	Edwards, Dylan R/0000-0002-3292-2064	NCI NIH HHS [CA 39919] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039919] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander CM, 1991, CELL BIOL EXTRACELLU, P255; BERTAUX B, 1991, J INVEST DERMATOL, V97, P679, DOI 10.1111/1523-1747.ep12483956; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; BLENIS J, 1983, P NATL ACAD SCI-BIOL, V80, P770, DOI 10.1073/pnas.80.3.770; BLENIS J, 1984, J BIOL CHEM, V259, P1563; BOONE TC, 1990, P NATL ACAD SCI USA, V87, P2800, DOI 10.1073/pnas.87.7.2800; CAMPBELL CE, 1991, J BIOL CHEM, V266, P7199; CARMICHAEL DF, 1986, P NATL ACAD SCI USA, V83, P2407, DOI 10.1073/pnas.83.8.2407; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DENHARDT DT, 1993, PHARMACOL THERAPEUT, V59, P329, DOI 10.1016/0163-7258(93)90074-N; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; EDWARDS DR, 1992, BIOCHIM BIOPHYS ACTA, V1171, P41, DOI 10.1016/0167-4781(92)90138-P; EDWARDS DR, 1992, EMBO J, V11, P2415, DOI 10.1002/j.1460-2075.1992.tb05306.x; EDWARDS DR, 1986, NUCLEIC ACIDS RES, V14, P8863, DOI 10.1093/nar/14.22.8863; FLENNIKEN AM, 1990, GENE DEV, V4, P1094, DOI 10.1101/gad.4.7.1094; FREUDENSTEIN J, 1990, BIOCHEM BIOPH RES CO, V171, P250, DOI 10.1016/0006-291X(90)91384-5; GASSON JC, 1985, NATURE, V315, P768, DOI 10.1038/315768a0; GAUB MP, 1990, CELL, V63, P1267, DOI 10.1016/0092-8674(90)90422-B; GEWERT DR, 1987, EMBO J, V6, P651, DOI 10.1002/j.1460-2075.1987.tb04804.x; GOLDBERG GI, 1989, P NATL ACAD SCI USA, V86, P8207, DOI 10.1073/pnas.86.21.8207; GRAFI G, 1993, MOL CELL BIOL, V13, P3497; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; HOROWITZ S, 1989, J BIOL CHEM, V264, P7092; JOHNSON MD, 1987, MOL CELL BIOL, V7, P2821, DOI 10.1128/MCB.7.8.2821; JONAT G, 1990, CELL, V62, P1189; KERPPOLA TK, 1993, MOL CELL BIOL, V13, P3782, DOI 10.1128/MCB.13.6.3782; KHOKHA R, 1992, J NATL CANCER I, V84, P1017, DOI 10.1093/jnci/84.13.1017; KHOKHA R, 1989, SCIENCE, V243, P947, DOI 10.1126/science.2465572; KLEINER DE, 1992, BIOCHEMISTRY-US, V31, P1665, DOI 10.1021/bi00121a013; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LECO KJ, 1992, GENE, V117, P209, DOI 10.1016/0378-1119(92)90731-4; LOTZ M, 1991, J BIOL CHEM, V266, P2017; MANN JS, 1991, ENDOCRINOLOGY, V128, P1825, DOI 10.1210/endo-128-4-1825; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MURPHY G, 1992, BIOCHEM J, V283, P637, DOI 10.1042/bj2830637; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; MURPHY G, 1985, J BIOL CHEM, V260, P3079; NISKANEN E, 1988, BLOOD, V72, P806; NOMURA S, 1989, DEVELOPMENT, V105, P575; PAVLOFF N, 1992, J BIOL CHEM, V267, P17321; PONTON A, 1992, GENE, V116, P187, DOI 10.1016/0378-1119(92)90515-Q; RATHJEN PD, 1990, CELL, V62, P1105, DOI 10.1016/0092-8674(90)90387-T; ROEB E, 1993, HEPATOLOGY, V18, P1437, DOI 10.1016/0270-9139(93)90236-G; ROUAULT TA, 1988, SCIENCE, V241, P1207, DOI 10.1126/science.3413484; Sambrook J, 1989, MOL CLONING LABORATO; SATO T, 1991, BIOCHEM J, V275, P645, DOI 10.1042/bj2750645; SHAPIRO SD, 1991, J IMMUNOL, V146, P2724; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SMITH RF, 1992, PROTEIN ENG, V5, P35, DOI 10.1093/protein/5.1.35; SMITH RF, 1990, P NATL ACAD SCI USA, V87, P118, DOI 10.1073/pnas.87.1.118; STASKUS PW, 1991, J BIOL CHEM, V266, P449; STETLERSTEVENSON WG, 1992, FEBS LETT, V296, P231, DOI 10.1016/0014-5793(92)80386-U; STETLERSTEVENSON WG, 1990, J BIOL CHEM, V265, P13933; SU ZZ, 1993, ONCOGENE, V8, P1211; TALHOUK RS, 1992, J CELL BIOL, V118, P1271, DOI 10.1083/jcb.118.5.1271; TANAKA T, 1992, MOL CELL ENDOCRINOL, V83, P65, DOI 10.1016/0303-7207(92)90196-D; TUCK AB, 1991, J NATL CANCER I, V83, P485; WATERHOUSE P, 1993, MOL REPROD DEV, V35, P219, DOI 10.1002/mrd.1080350302; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; WILLIAMSON RA, 1990, BIOCHEM J, V268, P267, DOI 10.1042/bj2680267; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; YANG TT, 1992, P NATL ACAD SCI USA, V89, P10676, DOI 10.1073/pnas.89.22.10676; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YOU Y, 1992, MOL CELL BIOL, V12, P2931, DOI 10.1128/MCB.12.7.2931	70	446	455	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9352	9360						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132674				2022-12-27	WOS:A1994NB41100106
J	BODE, AM; FOSTER, JD; NORDLIE, RC				BODE, AM; FOSTER, JD; NORDLIE, RC			GLYCOGENESIS FROM GLUCOSE AND UREAGENESIS IN ISOLATED-PERFUSED RAT LIVERS - INFLUENCE OF AMMONIUM ION, NORVALINE, AND ETHOXYZOLAMIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSOMAL GLUCOSE-6-PHOSPHATASE SYSTEM; STREPTOZOTOCIN-DIABETIC RAT; CARBAMYL-PHOSPHATE; CARBONIC-ANHYDRASE; GLUTAMINASE; BIOSYNTHESIS; GLUCOKINASE; METABOLISM; PROTEIN; UREA	The probable involvement of hepatic carbamyl-P in the reciprocal relationship between hepatic ureagenesis and glycogenesis from glucose was explored. Isolated perfused liver preparations from 48-h fasted rats were employed. Moderate (9.2 mM) and relatively high levels of glucose (34 mM) were perfused. Hepatic glycogenesis, glucose-6-P, carbamyl-P and citrulline levels, hepatic urea formation, and ureagenesis based upon perfusate urea levels were measured. Experimental probes selected to modify hepatic ureagenesis and carbamyl-P production and utilization included: (a) NH4Cl, maintained at 5 mM by continuous infusion (NH4+ is a substrate for carbamyl-P synthase I and glutamate dehydrogenase); (b) norvaline, an inhibitor of ornithine transcarbamylase which catalyzes the first committed step in the urea cycle; and (c) ethoxyzolamide, an inhibitor of carbonic anhydrase which produces HCO3-, an essential substrate for carbamyl-P synthase I. NH4+ increased ureagenesis and decreased glycogenesis. The inclusion of norvaline with NH4+ decreased ureagenesis and increased glycogenesis. Ethoxyzolamide with or without NH4+ inhibited both ureagenesis and glycogenesis, and decreased the hepatic glucose-6-P level. Glycogenesis was greater at 34 mM than 9.2 mM glucose, increased in norvaline-containing preparations correlative with increased availability of carbamyl-P, and decreased when carbamyl-P formation was inhibited by ethoxyzolamide. Kinetic analysis indicated a K-m,K- Glc Of 31 mM for glucose phosphorylation preliminary to glycogenesis. Glycogen formation via the ''indirect pathway'' (i.e. involving extrahepatic glycolysis, transport of lactate to the liver, and glyconeogenesis therefrom) was quantitatively insufficient to account for the observed glycogenesis. Glucokinase is contraindicated by the inverse relationship between hepatic glycogenesis and ATP availability in the ethoxyzolamide-treated preparations. In contrast, carbamyl-P:glucose phosphotransferase activity of the glucose-6-phosphatase system has the characteristics to bridge hepatic ureagenesis and glycogenesis.	UNIV N DAKOTA,SCH MED,DEPT BIOCHEM & MOLEC BIOL,IRELAND RES LAB,GRAND FORKS,ND 58202; UNIV N DAKOTA,SCH MED,DEPT PHYSIOL,GRAND FORKS,ND 58202	University of North Dakota Grand Forks; University of North Dakota Grand Forks					NIDDK NIH HHS [DK07141] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK007141] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALVARES FL, 1977, J BIOL CHEM, V252, P8404; ARION WJ, 1980, J BIOL CHEM, V255, P396; BODE AM, 1993, J BIOL CHEM, V268, P16298; COHEN NS, 1980, J BIOL CHEM, V255, P248; COHEN PP, 1962, ENZYMES, V6, P477; COHEN PP, 1964, MANOMETRIC TECHNIQUE, P149; DETHEUX M, 1991, EUR J BIOCHEM, V200, P553, DOI 10.1111/j.1432-1033.1991.tb16218.x; DIXON WJ, 1957, INTRO STATISTICAL AN, P19; DODGSON SJ, 1986, ARCH BIOCHEM BIOPHYS, V251, P198, DOI 10.1016/0003-9861(86)90066-4; DODGSON SJ, 1990, ARCH BIOCHEM BIOPHYS, V277, P410, DOI 10.1016/0003-9861(90)90597-R; DODGSON SJ, 1991, CARBONIC ANHYDRASES, P297; FOSTER JD, 1991, BIOCHIM BIOPHYS ACTA, V1118, P91, DOI 10.1016/0167-4838(91)90445-6; FOSTER JD, 1993, FASEB J, V7, pA848; Frieden C., 1963, ENZYMES 7, P3; HAUSSINGER D, 1986, BIOCHEM PHARMACOL, V35, P3317, DOI 10.1016/0006-2952(86)90429-6; HERS HG, 1976, ANNU REV BIOCHEM, V45, P167, DOI 10.1146/annurev.bi.45.070176.001123; Hohorst H.-J., 1965, METHOD ENZYMAT AN, P134, DOI DOI 10.1016/B978-0-12-395630-9.50025-6; HUE L, 1967, EUR J BIOCHEM, V2, P5056; JACOBSON GR, 1973, ENZYMES, V9, P225; Keppler D., 1974, METHODS ENZYM ANALYS, V3, P1127; KERSCHER L, 1985, METHOD ENZYMAT AN, V3, P444; Lehninger A. L., 1993, PRINCIPLES BIOCH, P514; LUECK JD, 1972, BIOCHEMISTRY-US, V11, P2792, DOI 10.1021/bi00765a010; LUECK JD, 1970, BIOCHEM BIOPH RES CO, V39, P190, DOI 10.1016/0006-291X(70)90776-X; MEHLER AH, 1992, TXB BIOCH, P478; MEIJER AJ, 1985, EUR J BIOCHEM, V148, P189, DOI 10.1111/j.1432-1033.1985.tb08824.x; MEIJER AJ, 1982, METABOLIC COMPARTMEN, P259; NATALE PJ, 1969, BIOCHEM BIOPH RES CO, V37, P512, DOI 10.1016/0006-291X(69)90945-0; Nordlie R C, 1974, Curr Top Cell Regul, V8, P33; NORDLIE RC, 1980, J BIOL CHEM, V255, P1834; OLSON MS, 1992, TXB BIOCH, P257; ROCHOVANSKY O, 1977, J BIOL CHEM, V252, P5287; ROGNSTAD R, 1985, BIOCHEM BIOPH RES CO, V130, P229, DOI 10.1016/0006-291X(85)90406-1; SCHIMKE RT, 1962, J BIOL CHEM, V237, P1921; SCHMIDT E, 1974, METHOD ENZYMAT AN, V2, P650; Smith E.L., 1975, ENZYMES, P293, DOI DOI 10.1016/S1874-6047(08)60213-9; SMITH EM, 1988, ARCH BIOCHEM BIOPHYS, V260, P740, DOI 10.1016/0003-9861(88)90504-8; SUKALSKI KA, 1986, J BIOL CHEM, V261, P6860; SZWEDA LI, 1990, J BIOL CHEM, V265, P20869; TREMBLAY GC, 1977, ARCH BIOCHEM BIOPHYS, V178, P264, DOI 10.1016/0003-9861(77)90191-6; VANDERCAMMEN A, 1991, EUR J BIOCHEM, V200, P545, DOI 10.1111/j.1432-1033.1991.tb16217.x; VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P179; WATFORD M, 1988, TRENDS BIOCHEM SCI, V13, P329, DOI 10.1016/0968-0004(88)90099-0; WATFORD M, 1984, BIOCHEM J, V224, P207, DOI 10.1042/bj2240207	44	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7879	7886						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132505				2022-12-27	WOS:A1994NB40900011
J	GAO, GJ; FONDA, ML				GAO, GJ; FONDA, ML			IDENTIFICATION OF AN ESSENTIAL CYSTEINE RESIDUE IN PYRIDOXAL PHOSPHATASE FROM HUMAN ERYTHROCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSYL PROTEIN PHOSPHATASE; WEIGHT ACID-PHOSPHATASE; TYROSINE-PHOSPHATASE; RAT-LIVER; INTERMEDIATE; EXPRESSION; CLONING; LOCALIZATION; PURIFICATION; MECHANISM	Pyridoxal-specific phosphatase purified from human erythrocytes was inactivated by a variety of thiol-specific reagents in a time- and concentration-dependent manner. The presence of pyridoxal phosphate, a substrate, or inorganic phosphate, a competitive inhibitor, protected the enzyme from inactivation. Phosphatase inactivated by disulfide reagents was reactivated by the addition of excess dithiothreitol, indicating that the inactivation was due to formation of a mixed disulfide between the reagent and a free cysteinyl residue at or near the active site of the enzyme. Incorporation of either 1 mol of 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB), 0.6 mol of iodo[H-3]acetate, or 0.6 mol of N-[H-3]ethylmaleimide per mol of subunit led to complete inactivation of the enzyme. High concentration of phosphate prevented the incorporation of DTNB and iodo[H-3]acetate. Amino acid analysis of carboxymethylated enzyme and DTNB titration of the denatured phosphatase indicated that there may be only 1 cysteinyl residue per subunit. Modification by iodoacetate did not affect the quaternary structure of the enzyme. The phosphatase modified by iodo[H-3]acetate was subjected to trypsin digestion, and the resulting peptides were separated on a reverse phase C-18 column. Two radioactive peaks were obtained and contained a peptide with the N-terminal sequence of Ala-Gln-Gly-Val-Leu-Phe-Asp-Cys(Cm)-Asp-Gly-Val-Leu-X -Asn-Gly. Most of the radioactivity was released with Cys(Cm). These results indicate that the cysteinyl residue in this sequence is at or near the active site and is essential for activity. Residues 5-12 and 15 of this peptide are identical with a sequence of a yeast alkaline p-nitrophenylphosphatase, and the peptide has little homology with other mammalian phosphatases.	UNIV LOUISVILLE,SCH MED,DEPT BIOCHEM,LOUISVILLE,KY 40292	University of Louisville								ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ATTIAS J, 1973, BIOCHIM BIOPHYS ACTA, V321, P561, DOI 10.1016/0005-2744(73)90199-X; ATTIAS J, 1972, BIOCHIM BIOPHYS ACTA, V268, P422, DOI 10.1016/0005-2744(72)90338-5; BREWER CF, 1967, ANAL BIOCHEM, V18, P248, DOI 10.1016/0003-2697(67)90007-3; CAMICI G, 1989, J BIOL CHEM, V264, P2560; CHIARUGI P, 1992, FEBS LETT, V310, P9, DOI 10.1016/0014-5793(92)81134-8; CIRRI P, 1993, EUR J BIOCHEM, V214, P647, DOI 10.1111/j.1432-1033.1993.tb17965.x; CIRRI P, 1993, BIOCHIM BIOPHYS ACTA, V1161, P216, DOI 10.1016/0167-4838(93)90216-E; Coburn SP, 1988, CLIN PHYSL APPLICATI, P65; COLLIER HB, 1973, ANAL BIOCHEM, V56, P310, DOI 10.1016/0003-2697(73)90196-6; Ebadi M., 1986, VITAMIN B6 PYRIDOXAL, P449; FONDA ML, 1992, J BIOL CHEM, V267, P15978; FONDA ML, 1989, ALCOHOL CLIN EXP RES, V3, P804; FUJIMOTO S, 1984, J BIOCHEM, V96, P1079, DOI 10.1093/oxfordjournals.jbchem.a134925; GUAN KL, 1991, J BIOL CHEM, V266, P17026; KALLEN RG, 1985, TRANSAMINASES, P37; KANEKO Y, 1989, MOL GEN GENET, V220, P133, DOI 10.1007/BF00260867; KYAW A, 1980, BIOCHEM MED METAB B, V24, P27, DOI 10.1016/0006-2944(80)90083-6; LUMENG L, 1975, J BIOL CHEM, V250, P8126; MURAKAMI K, 1986, CHEM PHARM BULL, V34, P3320; OSTANIN K, 1992, J BIOL CHEM, V267, P22830; POT DA, 1992, BIOCHIM BIOPHYS ACTA, V1136, P35, DOI 10.1016/0167-4889(92)90082-M; POT DA, 1992, J BIOL CHEM, V267, P140; POT DA, 1991, J BIOL CHEM, V266, P19688; ROIKO K, 1990, GENE, V89, P223, DOI 10.1016/0378-1119(90)90009-G; SARASWATHI S, 1963, J NEUROCHEM, V10, P127, DOI 10.1111/j.1471-4159.1963.tb11473.x; SMYTH DG, 1964, BIOCHEM J, V91, P589, DOI 10.1042/bj0910589; SPETH M, 1989, ARCH BIOCHEM BIOPHYS, V275, P202, DOI 10.1016/0003-9861(89)90365-2; STONE KL, 1989, PRACTICAL GUIDE PROT, P37; VAKILI B, 1981, BIOCHEM J, V194, P319, DOI 10.1042/bj1940319; VANETTEN RL, 1991, J BIOL CHEM, V266, P2313; WO YYP, 1992, BIOCHEMISTRY-US, V31, P1712, DOI 10.1021/bi00121a019; WO YYP, 1992, J BIOL CHEM, V267, P10856; WORKU Y, 1984, FEBS LETT, V167, P235, DOI 10.1016/0014-5793(84)80133-7; ZHANG ZY, 1992, BIOCHEMISTRY-US, V31, P1701, DOI 10.1021/bi00121a018	35	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8234	8239						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132548				2022-12-27	WOS:A1994NB40900062
J	ITAKURA, M; IWASHINA, M; MIZUNO, T; ITO, T; HAGIWARA, H; HIROSE, S				ITAKURA, M; IWASHINA, M; MIZUNO, T; ITO, T; HAGIWARA, H; HIROSE, S			MUTATIONAL ANALYSIS OF DISULFIDE BRIDGES IN THE TYPE-C ATRIAL-NATRIURETIC-PEPTIDE RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEARANCE RECEPTOR; GUANYLATE-CYCLASE; FUNCTIONAL EXPRESSION; BOVINE KIDNEY; CDNA; PURIFICATION; LUNG; PROLIFERATION; ACTIVATION; EFFICIENT	The type C receptor (ANP-C or NPR-C) for the natriuretic peptides was demonstrated, by site directed mutagenesis, to have an immunoglobulin-like disulfide bonding pattern that is very similar to that of the cytokine receptor superfamily, The mature form of ANP-C has a disulfide-linked homodimeric structure and contains 5 conserved cysteine residues per subunit, all in the extracellular domain. To identify the cysteine residue involved in the dimerization and further to determine the intramolecular disulfide bridges and their functional roles, cysteine to serine mutations of the 5 cysteine residues were constructed. An analysis of the mutant receptors expressed in COS-1 cells by I-125-ANP binding assay and by measuring difference in their electrophoretic mobilities on sodium dodecyl sulfate-polyacrylamide gels indicated that 1) the first 4 cysteine residues are joined sequentially, forming the Cys(104)-Cys(132) and Cys(209)-Cys(257) loops of 29 and 49 residues, respectively; 2) the two disulfide-linked loops are essential for the ligand binding activity; 3) the 5th cysteine residue Cys(469) is used in the formation of covalently linked dimers; and 4) the covalent association of the subunit through the disulfide bond involving Cys(469) has no apparent influence on ligand-receptor interactions. The intramolecular disulfide bond Cys(104)-Cys(132) was also confirmed by direct protein sequencing of tryptic fragments of purified ANP-C receptor. The secondary structural features revealed here will be useful in understanding the structure and function relationships of not only the dimeric ANP-C receptor, which has only a short cytoplasmic tail, but also the ANP-A (GC-A) and ANP-B (GC-B) receptor subtypes, which have a guanylate cyclase domain in their long cytoplasmic tail and have recently been shown to possess an oligomeric structure, since they have similarly spaced cysteine residues in their extracellular domains.	TOKYO INST TECHNOL,DEPT BIOL SCI,MIDORI KU,YOKOHAMA,KANAGAWA,JAPAN	Tokyo Institute of Technology								APPEL RG, 1992, AM J PHYSIOL, V262, pF911, DOI 10.1152/ajprenal.1992.262.6.F911; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; CAHILL PA, 1993, J CELL PHYSIOL, V154, P28, DOI 10.1002/jcp.1041540105; CAHILL PA, 1991, BIOCHEM BIOPH RES CO, V179, P1606, DOI 10.1016/0006-291X(91)91758-5; CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; CHINKERS M, 1991, ANNU REV BIOCHEM, V60, P553, DOI 10.1146/annurev.bi.60.070191.003005; CHINKERS M, 1992, J BIOL CHEM, V267, P18589; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; DEBOLD AJ, 1985, SCIENCE, V230, P767, DOI 10.1126/science.2932797; FULLER F, 1988, J BIOL CHEM, V263, P9395; IWATA T, 1991, J BIOCHEM-TOKYO, V110, P35, DOI 10.1093/oxfordjournals.jbchem.a123539; KACZMARSKI RS, 1991, BLOOD REV, V5, P193, DOI 10.1016/0268-960X(91)90036-C; KAWAGUCHI S, 1989, J HISTOCHEM CYTOCHEM, V37, P1739, DOI 10.1177/37.11.2553804; KOLLER KJ, 1992, CIRCULATION, V86, P1081, DOI 10.1161/01.CIR.86.4.1081; KOLLER KJ, 1991, SCIENCE, V252, P120, DOI 10.1126/science.1672777; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEVIN ER, 1991, AM J PHYSIOL, V261, pR453, DOI 10.1152/ajpregu.1991.261.2.R453; LOWE DG, 1992, BIOCHEMISTRY-US, V31, P10421, DOI 10.1021/bi00158a001; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; LOWE DG, 1990, NUCLEIC ACIDS RES, V18, P3412, DOI 10.1093/nar/18.11.3412; MAACK T, 1987, SCIENCE, V238, P675, DOI 10.1126/science.2823385; MIZUNO T, 1993, J BIOL CHEM, V268, P5162; OHYAMA Y, 1992, BIOCHEM BIOPH RES CO, V183, P743, DOI 10.1016/0006-291X(92)90546-W; PANDEY KN, 1990, J BIOL CHEM, V265, P12342; PORTER JG, 1989, J BIOL CHEM, V264, P14179; PORTER JG, 1990, BIOCHEM BIOPH RES CO, V171, P796, DOI 10.1016/0006-291X(90)91216-F; ROSENZWEIG A, 1991, ANNU REV BIOCHEM, V60, P229, DOI 10.1146/annurev.biochem.60.1.229; SCHENK DB, 1987, P NATL ACAD SCI USA, V84, P1521, DOI 10.1073/pnas.84.6.1521; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; SHIMONAKA M, 1987, J BIOL CHEM, V262, P5510; SHIMONAKA M, 1987, AM J PHYSIOL, V253, pF1058, DOI 10.1152/ajprenal.1987.253.5.F1058; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; UCHIDA K, 1989, BIOCHEM J, V263, P671, DOI 10.1042/bj2630671	33	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8314	8318						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132555				2022-12-27	WOS:A1994NB40900073
J	MARSTON, SB; FRASER, IDC; HUBER, PAJ; PRITCHARD, K; GUSEV, NB; TOROK, K				MARSTON, SB; FRASER, IDC; HUBER, PAJ; PRITCHARD, K; GUSEV, NB; TOROK, K			LOCATION OF 2 CONTACT SITES BETWEEN HUMAN SMOOTH-MUSCLE CALDESMON AND CA2+-CALMODULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; TROPONIN-I; CALMODULIN-BINDING; THIN-FILAMENTS; CA-2+ REGULATION; ACTIN; MYOSIN; MECHANISM; PROTEIN; EXPRESSION	We measured Ca2+-calmodulin binding to expressed human caldesmon fragments by three techniques: tryptophan fluorescence enhancement, change in fluorescence of TA-calmodulin, and cosedimentation with calmodulin- Sepharose. Ca2+-calmodulin bound with similar affinity to peptide M73 (C(714)SMWEKGNVFSSPGF(727), N terminus of domain 4b), to all the fragments of caldesmon containing this peptide, and also to H9 (Thr(726)-Val(793)), which did not contain this peptide (K-d = 0.2-0.8 mu M) We conclude that Ca2+-calmodulin binds at two sites on caldesmon; site A is the sequence (715)MWEKGNVFS(723) previously identified by Zhan et al. (Zhan, Q., Wong, S. S., and Wang, C.-L. A. (1991) J. Biol. Chem. 266, 21810-21814), and site B is located nearer the C terminus of caldesmon. Ca2+-calmodulin binding at site B is coupled to reversal of caldesmon inhibition of actin-tropomyosin activated myosin MgATPase, while calmodulin binding at site A has no detectable function. H9 did not displace M73 from Ca2+-calmodulin, while the other fragments did. High concentrations of M73 (>1000 x K-d) could not displace H9 bound to Ca2+-calmodulin-Sepharose. Thus sites A and B in calmodulin are functionally separate. Analysis of overlapping expressed fragments indicates that site B is located in the sequence Thr(726)-Leu(767), which includes Trp(749). The minimal Ca2+-calmodulin binding sequence could be (744)SRINEWLTK(752).	MOSCOW MV LOMONOSOV STATE UNIV, SCH BIOL, DEPT BIOCHEM, MOSCOW 119899, RUSSIA; NATL INST MED RES, LONDON NW7 1AA, ENGLAND	Lomonosov Moscow State University; MRC National Institute for Medical Research	MARSTON, SB (corresponding author), NATL HEART & LUNG INST, DEPT CARDIAC MED, DOVEHOUSE ST, LONDON SW3 6LY, ENGLAND.		Fraser, Iain DC/L-4735-2017; B.Gusev, Nikolai/D-7533-2012	Fraser, Iain DC/0000-0003-2272-3907; Torok, Katalin/0000-0002-3107-4534; Marston, Steven/0000-0001-6054-6070; Huber, Pia AJ/0000-0001-9823-7863				BARTEGI A, 1990, J BIOL CHEM, V265, P15231; BARTEGI A, 1991, Biophysical Journal, V59, p56A; BRYAN J, 1989, J BIOL CHEM, V264, P13873; CAMPBELL AP, 1991, J MOL BIOL, V222, P405, DOI 10.1016/0022-2836(91)90219-V; CHALOVICH JM, 1990, ANN NY ACAD SCI, V599, P85, DOI 10.1111/j.1749-6632.1990.tb42367.x; DALGARNO DC, 1982, FEBS LETT, V150, P54, DOI 10.1016/0014-5793(82)81303-3; FRASER IDC, 1994, IN PRESS J MUSC RES, V15; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; GRABAREK Z, 1992, J MUSCLE RES CELL M, V13, P383, DOI 10.1007/BF01738034; HAYASHI K, 1992, P NATL ACAD SCI USA, V89, P12122, DOI 10.1073/pnas.89.24.12122; HAYASHI K, 1991, J BIOL CHEM, V266, P355; HUBER PAJ, 1993, J MUSCLE RES CELL M, V14, P385, DOI 10.1007/BF00121289; HUMPHREY MB, 1992, GENE, V112, P197, DOI 10.1016/0378-1119(92)90376-Z; KATSUYAMA H, 1992, J BIOL CHEM, V267, P14555; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MARSTON SB, 1992, J BIOL CHEM, V267, P16796; MARSTON SB, 1983, PROG BIOPHYS MOL BIO, V41, P1, DOI 10.1016/0079-6107(83)90024-X; MARSTON SB, 1985, J MUSCLE RES CELL M, V6, P669, DOI 10.1007/BF00712237; MARSTON SB, 1991, BIOCHEM J, V279, P1; MARSTON SB, 1993, J BIOL CHEM, V268, P12317; MARSTON SB, 1994, IN PRESS J MUSCLE RE, V15; MEZGUELDI M, 1994, IN PRESS J MUSC RES, V15; NGAI SM, 1992, J BIOL CHEM, V267, P15715; PRITCHARD K, 1993, BIOCHEM BIOPH RES CO, V190, P668, DOI 10.1006/bbrc.1993.1100; PRITCHARD K, 1989, BIOCHEM J, V257, P839, DOI 10.1042/bj2570839; PRITCHARD K, 1991, BIOCHEM J, V277, P819, DOI 10.1042/bj2770819; PRITCHARD K, 1988, SARCOMERIC NONSARCOM, P649; REDWOOD CS, 1993, J BIOL CHEM, V268, P10969; REDWOOD CS, 1993, FEBS LETT, V327, P85, DOI 10.1016/0014-5793(93)81045-2; REDWOOD CS, 1993, J MUSCLE RES CELL M, V14, P241; REDWOOD CS, 1993, BIOPHYS J, V64, pA30; SHENG ZL, 1992, J BIOL CHEM, V267, P25407; SHIRINSKY VP, 1988, BIOCHEM J, V255, P203; SMITH CWJ, 1987, J BIOL CHEM, V262, P116; SOBUE K, 1982, BIOMED RES-TOKYO, V3, P188, DOI 10.2220/biomedres.3.188; Straub F.B., 1942, STUDIES I MED CHEM U, P3; SZPACENKO A, 1986, FEBS LETT, V202, P182, DOI 10.1016/0014-5793(86)80683-4; TANAKA T, 1990, EUR J BIOCHEM, V188, P495, DOI 10.1111/j.1432-1033.1990.tb15427.x; VELAZ L, 1990, J BIOL CHEM, V265, P2929; VOROTNIKOV AV, 1994, IN PRESS J MUSC RES, V15; WANG CLA, 1991, J BIOL CHEM, V266, P9166; ZHAN Q, 1991, J BIOL CHEM, V266, P21810	42	59	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8134	8139						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132538				2022-12-27	WOS:A1994NB40900048
J	MATHENY, C; DAY, ML; MILBRANDT, J				MATHENY, C; DAY, ML; MILBRANDT, J			NUCLEAR-LOCALIZATION SIGNAL OF NGFI-A IS LOCATED WITHIN THE ZINC-FINGER DNA-BINDING DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-ANTIGEN; GLUCOCORTICOID RECEPTOR; PROGESTERONE-RECEPTOR; TRANSCRIPTION FACTORS; TARGETING SEQUENCES; FUNCTIONAL REGIONS; MAMMALIAN-CELLS; GROWTH-FACTORS; C-FOS; PROTEIN	NGFI-A is an immediate-early gene that encodes a transcription factor whose DNA binding domain is composed of three C2H2 zinc fingers. To identify its nuclear localization signal (NLS), wild type NGFI-A and various mutants were transfected into COS cells and their cellular location assayed by indirect immunofluorescence. Although wild type NGFI-A was located exclusively within the nucleus, deletions lacking the highly basic zinc finger region were not efficiently translocated to the nucleus. However, DNA binding per se is not required for nuclear localization, as an NGFI-A mutant (A Y339G), which does not bind DNA, is still faithfully directed to the nucleus. To determine the minimal region(s) of NGFI-A sufficient to direct nuclear localization, the cellular location of various NGFI-A/beta-galactosidase fusion proteins was examined. Fusion proteins containing all three zinc fingers were found in the nucleus, but those containing only two zinc fingers were predominantly cytoplasmic. When the zinc finger structure was altered by mutating a zinc-chelating cysteine residue in any one of the three zinc fingers, the resulting domain was no longer capable of directing beta-galactosidase to the nucleus. Furthermore, the mutation of an arginine residue in the third zinc finger of NGFI-A, a position which is occupied by a leucine residue in most C2H2 zinc fingers, abolished nuclear localization, but had no effect on DNA binding. These studies suggest that NGFI-A contains a novel NLS which is dependent on the overall structure of the DNA binding domain and not solely upon its highly basic nature.	WASHINGTON UNIV,SCH MED,DEPT PATHOL,DIV LAB MED,ST LOUIS,MO 63110; WASHINGTON UNIV,DEPT INTERNAL MED,DIV LAB MED,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)				Milbrandt, Jeffrey/0000-0002-5477-7689				BERG JM, 1990, ANNU REV BIOPHYS BIO, V19, P405; BICKMORE WA, 1992, SCIENCE, V257, P235, DOI 10.1126/science.1321494; BLACKMAN MA, 1991, ADV EXP MED BIOL, V292, P159; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; CHAVRIER P, 1989, MOL CELL BIOL, V9, P787, DOI 10.1128/MCB.9.2.787; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; CROSBY SD, 1991, MOL CELL BIOL, V11, P3835, DOI 10.1128/MCB.11.8.3835; DANG CV, 1989, J BIOL CHEM, V264, P18019; DAY ML, 1990, J BIOL CHEM, V265, P15253; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; GARCIABUSTOS J, 1991, BIOCHIM BIOPHYS ACTA, V1071, P83, DOI 10.1016/0304-4157(91)90013-M; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GOLDFARB DS, 1986, NATURE, V322, P641, DOI 10.1038/322641a0; GUIOCHONMANTEL A, 1992, J STEROID BIOCHEM, V41, P209; GUIOCHONMANTEL A, 1991, EMBO J, V10, P3851, DOI 10.1002/j.1460-2075.1991.tb04954.x; HAMY F, 1992, BIOCHEM BIOPH RES CO, V182, P289, DOI 10.1016/S0006-291X(05)80143-3; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; JENSTER G, 1992, J STEROID BIOCHEM, V41, P671, DOI 10.1016/0960-0760(92)90402-5; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; KAPPLER JW, 1992, J EXP MED, V175, P387, DOI 10.1084/jem.175.2.387; LANFORD RE, 1984, CELL, V37, P801, DOI 10.1016/0092-8674(84)90415-X; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; MOORE MS, 1992, CELL, V69, P939, DOI 10.1016/0092-8674(92)90613-H; NIGG EA, 1991, CELL, V66, P15, DOI 10.1016/0092-8674(91)90135-L; PATWARDHAN S, 1991, ONCOGENE, V6, P917; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PICARD D, 1990, CELL REGUL, V1, P291, DOI 10.1091/mbc.1.3.291; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PULLEN AM, 1992, J EXP MED, V175, P41, DOI 10.1084/jem.175.1.41; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; SCHREIBER V, 1992, EMBO J, V11, P3263, DOI 10.1002/j.1460-2075.1992.tb05404.x; SILVER PA, 1991, CELL, V64, P489, DOI 10.1016/0092-8674(91)90233-O; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; VESQUE C, 1992, NUCLEIC ACIDS RES, V20, P2485, DOI 10.1093/nar/20.10.2485; WILSON TE, 1992, J BIOL CHEM, V267, P3718; YLIKOMI T, 1992, EMBO J, V11, P3681, DOI 10.1002/j.1460-2075.1992.tb05453.x; ZACK DJ, 1991, NEURON, V6, P187, DOI 10.1016/0896-6273(91)90355-4; ZHAO LJ, 1991, NEW BIOL, V3, P1074	48	73	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8176	8181						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132543				2022-12-27	WOS:A1994NB40900055
J	MUH, U; MASSEY, V; WILLIAMS, CH				MUH, U; MASSEY, V; WILLIAMS, CH			LACTATE MONOOXYGENASE .1. EXPRESSION OF THE MYCOBACTERIAL GENE IN ESCHERICHIA-COLI AND SITE-DIRECTED MUTAGENESIS OF LYSINE-266	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; LACZ GENE; OXIDASE; MECHANISM; SEQUENCE; FLAVOCYTOCHROME-B2; FLAVOPROTEINS; INACTIVATION; RESOLUTION; OXIDATION	Lactate monooxygenase utilizes oxygen in the conversion of L-lactate to acetate, CO2, and water. The gene for the enzyme from Mycobacterium smegmatis had been cloned into Escherichia coli (Giegel, D. A., Williams, C. H., Jr., and Massey, V. (1990) J. Biol. Chem. 265, 6626-6632) and the derived amino acid sequence compared to glycolate oxidase and flavocytochrome b(2), enzymes of known three-dimensional structure (Lindqvist, Y., and Branden, C. I. (1989) J. Biol. Chem. 264, 3624-3628; Xia, Z. X., and Mathews, S. F. (1990) J. Mol. Biol. 212, 837-863). There is strong homology, especially around residues in the active site. The mechanism proposed for lactate monooxygenase involves an intermediate having a negative charge at the N(1)-position of the FMN. Based on the homology, lysine 266 is the residue suggested to neutralize that charge. Wild type enzyme and several forms of the enzyme altered at active site residues by site-directed mutagenesis have been expressed in E. coli and purification procedures developed. The properties determined for the recombinant wild type enzyme were, in every case, the same as those previously determined for the enzyme isolated from M. smegmatis. Mutation of lysine 266 to a methionine created K266M. The semiquinone showed spectral features different from those found in the wild type enzyme and was no longer thermodynamically stable. This indicates a redox potential for the enzyme-bound semiquinone/reduced flavin couple that is higher than the midpoint potential for the oxidized flavin/semiquinone couple. The two-electron redox potential was determined to be -180 mV at 25 degrees C, pH 7.0. In wild type enzyme, attack of the flavin ring by sulfite creates a negative charge at the FMN N(1)-position. In K266M, the stabilization of the sulfite adduct was 17,000-fold weaker (K-d similar to 10(-3) M) than in the wild type enzyme, with a rate of association that is lowered by 10,000-fold (k(on) = 1.2 M(-1) S-1). The rate of reduction with L-lactate is significantly decreased in K266M. Unexpectedly, binding of substrate and inhibitors is significantly weaker in K266M than in the wild type enzyme. In all properties involving a negative charge at position N(1) of the FMN, K266M is distinctly different from wild type enzyme. This makes it quite likely that lysine 266 serves the postulated role of interacting with this negative charge.	UNIV MICHIGAN, SCH MED, DEPT BIOL CHEM, ANN ARBOR, MI 48109 USA; DEPT VET AFFAIRS MED CTR, ANN ARBOR, MI 48105 USA	University of Michigan System; University of Michigan					NIGMS NIH HHS [GM 11106, GM 21444] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM011106, R01GM011106] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; CHOONG YS, 1975, BIOCHEM J, V145, P37, DOI 10.1042/bj1450037; Clark W. M., 1960, OXIDATION REDUCTION; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; GHISLA S, 1976, BIOCHEMISTRY-US, V15, P1791, DOI 10.1021/bi00654a002; GHISLA S, 1975, J BIOL CHEM, V250, P577; GHISLA S, 1977, J BIOL CHEM, V252, P6729; GHISLA S, 1976, FLAVINS FLAVOPROTEIN, P213; Ghisla S., 1991, CHEM BIOCH FLAVOENZY, P243; GIEGEL DA, 1987, J BIOL CHEM, V262, P5705; GIEGEL DA, 1990, J BIOL CHEM, V265, P6626; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDQVIST Y, 1989, J BIOL CHEM, V264, P3624; LOOMAN AC, 1987, EMBO J, V6, P2489, DOI 10.1002/j.1460-2075.1987.tb02530.x; MANSTEIN DJ, 1988, BIOCHEMISTRY-US, V27, P2300, DOI 10.1021/bi00407a009; MANSTEIN DJ, 1986, BIOCHEMISTRY-US, V25, P6807, DOI 10.1021/bi00370a012; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; MASSEY V, 1977, J BIOL CHEM, V252, P5612; MASSEY V, 1979, J BIOL CHEM, V254, P9640; MASSEY V, 1969, J BIOL CHEM, V244, P3999; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; MUH U, 1994, J BIOL CHEM, V269, P7994; MUH U, 1994, J BIOL CHEM, V269, P7989; MUH U, 1993, THESIS U MICHIGAN; MULLER F, 1969, J BIOL CHEM, V244, P4007; OLINS PO, 1988, GENE, V73, P227, DOI 10.1016/0378-1119(88)90329-0; OLINS PO, 1989, J BIOL CHEM, V264, P16973; Ratledge C, 1982, BIOL MYCOBACTERIA; REID GA, 1988, EUR J BIOCHEM, V178, P329, DOI 10.1111/j.1432-1033.1988.tb14454.x; Sambrook J, 1989, MOL CLONING LABORATO; SCHONBRUNN A, 1976, BIOCHEMISTRY-US, V15, P1798, DOI 10.1021/bi00654a003; STANKOVICH M, 1983, BIOCHEMISTRY-US, V22, P4466, DOI 10.1021/bi00288a018; STUDIER WF, 1990, METHOD ENZYMOL, V185, P60, DOI DOI 10.1016/0076-6879(90)85008-C; SULLIVAN PA, 1977, BIOCHEM J, V165, P375, DOI 10.1042/bj1650375; TARTOF KD, 1987, FOCUS, V9, P12; WALSH C, 1973, J BIOL CHEM, V248, P7049; WALSH CT, 1972, J BIOL CHEM, V247, P6004; XIA ZX, 1990, J MOL BIOL, V212, P837, DOI 10.1016/0022-2836(90)90240-M; XIA ZX, 1987, P NATL ACAD SCI USA, V84, P2629, DOI 10.1073/pnas.84.9.2629	39	33	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7982	7988						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132518				2022-12-27	WOS:A1994NB40900026
J	GALLIE, DR; TRAUGH, JA				GALLIE, DR; TRAUGH, JA			SERUM AND INSULIN REGULATE CAP FUNCTION IN 3T3-L1 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC INITIATION-FACTORS; MESSENGER-RNA; PROTEIN-SYNTHESIS; TRANSLATIONAL CONTROL; RIBOSOMAL PROTEIN-S6; BINDING PROTEIN; PHORBOL ESTERS; FACTORS EIF-4F; POLY(A) TAIL; PHOSPHORYLATION	Serum starvation and readdition of serum, insulin, or mitogens result in changes in phosphorylation of several eukaryotic initiation factors that correlate with a decrease or stimulation in translation, respectively. We have introduced in vitro synthesized reporter mRNAs into exponentially growing and serum-deprived 3T3-L1 cells to examine whether serum deprivation affects capdependent translation. In serum-fed control cells, addition of a cap to poly(A)(-) or poly(A)(+) mRNA increased translational efficiency by 43- and 460-fold, respectively. In serum-deprived cells, the relative rate of translational efficiency of capped mRNA was reduced 2.6-fold relative from that observed in serum-fed cells with little change in the relative functional half-life. The effect of serum deprivation on translation was rapid and occurred within 90 min, and cap function was restored upon addition of serum or insulin to starved cells. Analysis of the dose dependence for reversal of the effects of serum starvation on cap dependent translation indi cated that 10 nm insulin was optimal. Little change in the function of the poly(A) tail was observed during serum starvation or hormone treatment. However, a decrease in the synergism between the cap and a poly(A) tail was observed upon starvation which was reversed by serum, and in part, by insulin.			GALLIE, DR (corresponding author), UNIV CALIF RIVERSIDE, DEPT BIOCHEM, RIVERSIDE, CA 92521 USA.							BONNEAU AM, 1987, J BIOL CHEM, V262, P11134; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DUNCAN R, 1985, J BIOL CHEM, V260, P5486; DUNCAN R, 1985, J BIOL CHEM, V260, P5493; DUNCAN R, 1987, J BIOL CHEM, V262, P380; DUNCAN RF, 1989, J CELL BIOL, V109, P1467, DOI 10.1083/jcb.109.4.1467; EDERY I, 1983, J BIOL CHEM, V258, P1398; FREDERICKSON RM, 1991, MOL CELL BIOL, V11, P2896, DOI 10.1128/MCB.11.5.2896; GALLIE DR, 1991, MOL GEN GENET, V228, P258, DOI 10.1007/BF00282474; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; JACKSON RJ, 1990, CELL, V62, P15, DOI 10.1016/0092-8674(90)90235-7; JARAMILLO M, 1991, MOL CELL BIOL, V11, P5992, DOI 10.1128/MCB.11.12.5992; KAEMPFER R, 1978, P NATL ACAD SCI USA, V75, P650, DOI 10.1073/pnas.75.2.650; KASPAR RL, 1990, J BIOL CHEM, V265, P3619; KEPES A, 1963, BIOCHIM BIOPHYS ACTA, V76, P293; LEVENSON RM, 1989, J BIOL CHEM, V264, P11904; MANZELLA JM, 1991, J BIOL CHEM, V266, P2383; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MORLEY SJ, 1991, J BIOL CHEM, V266, P4669; MORLEY SJ, 1989, J BIOL CHEM, V264, P2401; MORLEY SJ, 1990, J BIOL CHEM, V265, P10611; MORLEY SJ, 1993, IN PRESS BIOCHEMIE; PEDERSEN S, 1978, MOL GEN GENET, V166, P329, DOI 10.1007/BF00267626; PERISIC O, 1983, J BIOL CHEM, V258, P3998; RHOADS RE, 1993, J BIOL CHEM, V268, P3017; SMITH CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2641, DOI 10.1073/pnas.77.5.2641; SONENBERG N, 1978, P NATL ACAD SCI USA, V75, P4843, DOI 10.1073/pnas.75.10.4843; SONENBERG N, 1988, PROG NUCLEIC ACID RE, V35, P173, DOI 10.1016/S0079-6603(08)60614-5; THOMAS G, 1982, CELL, V30, P235, DOI 10.1016/0092-8674(82)90029-0; TOWLE CA, 1984, BIOCHEM BIOPH RES CO, V121, P134, DOI 10.1016/0006-291X(84)90697-1; VANHEUGTEN HAA, 1991, J BIOL CHEM, V266, P7279; WELSH GI, 1992, BIOCHEM J, V284, P19, DOI 10.1042/bj2840019; YISRAELI JK, 1989, METHOD ENZYMOL, V180, P42	34	24	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7174	7179						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125928				2022-12-27	WOS:A1994NA03200024
J	GAO, GJ; FONDA, ML				GAO, GJ; FONDA, ML			KINETIC-ANALYSIS AND CHEMICAL MODIFICATION OF VITAMIN-B-6 PHOSPHATASE FROM HUMAN ERYTHROCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATIC-ACID-PHOSPHATASE; PYRIDOXAL 5'-PHOSPHATE; ALKALINE-PHOSPHATASE; RAT-LIVER; INORGANIC PYROPHOSPHATASE; PROTEIN PHOSPHATASE; COVALENT STRUCTURE; BINDING; SITE; INTERMEDIATE	The specificity and active site properties of vitamin B-6 phosphatase purified from human erythrocytes were studied by kinetic analyses with vitamin B-6 compounds and derivatives and chemical modification with group-specific reagents. The kinetic constants for pyridoxal phosphate (PLP), 4-pyridoxic acid phosphate, pyridoxine phosphate, and pyridoxamine phosphate were determined from pH 5 to 9. The values of V-max/K-m and pK(m) were highest for PLP and 4-pyridoxic acid phosphate and lowest for pryidoxamine phosphate. V-max/K-m and pK(m) for the four substrates were maximum between pH 6 and 8. Ionizable groups with pK alpha values about 6 and 8 affected substrate binding to the enzyme. V-max values for all the substrates gradually decreased with increasing pH. The enzyme also catalyzed the dephosphorylation of 4'-secondary amine derivatives of vitamin B-6-phosphate. The phosphatase had greatest catalytic efficiency with substrates that contained a negatively charged group on the 4'-position of the pyridine ring. It is concluded that there are one or two positively charged groups at the active site of the enzyme that interact with the substrate's phosphate ester and 4'-substituent. The phosphatase was inactivated by phenylglyoxal, and PLP protected the enzyme against this inactivation. Phenylglyoxal did not modify Lys or Cys residues or an ru-amino group since the enzyme's NH2 terminus is blocked, and it did not affect the quaternary structure of the phosphatase. The enzyme was inactivated by the incorporation of 1 mol of phenylglyoxal/ subunit. Diethylpyrocarbonate inactivated the enzyme by reacting with a group with a pK alpha of 6.7, and pyridoxine phosphate protected the enzyme against this inactivation. These data suggest that Arg and His residues are at or near the active site and may play roles in substrate binding and/or catalysis.	UNIV LOUISVILLE,SCH MED,DEPT BIOCHEM,LOUISVILLE,KY 40292	University of Louisville					NIAAA NIH HHS [AA06861] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA006861] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ANDERSON BB, 1980, GUT, V21, P192, DOI 10.1136/gut.21.3.192; Arnone A, 1985, TRANSAMINASES, P138; BOND MW, 1980, BIOCHEMISTRY-US, V19, P94, DOI 10.1021/bi00542a015; BORDERS CL, 1975, BIOCHEMISTRY-US, V14, P4699, DOI 10.1021/bi00692a021; CHEUNG ST, 1979, BIOCHEM BIOPH RES CO, V90, P940, DOI 10.1016/0006-291X(79)91918-1; CHOI JD, 1977, BIOCHEMISTRY-US, V20, P5722; Coburn SP, 1988, CLIN PHYSL APPLICATI, P65; DEPECOL ME, 1980, ANAL BIOCHEM, V101, P435, DOI 10.1016/0003-2697(80)90210-9; Ebadi M., 1986, VITAMIN B6 PYRIDOXAL, P449; FONDA ML, 1982, AM J CLIN NUTR, V35, P1391, DOI 10.1093/ajcn/35.6.1391; FONDA ML, 1991, ARCH BIOCHEM BIOPHYS, V288, P79, DOI 10.1016/0003-9861(91)90167-H; FONDA ML, 1992, J BIOL CHEM, V267, P15978; FONDA ML, 1989, ALCOHOL CLIN EXP RES, V3, P804; FUJIMOTO S, 1984, J BIOCHEM, V96, P1079, DOI 10.1093/oxfordjournals.jbchem.a134925; FUJIMOTO S, 1987, CHEM PHARM BULL, V35, P2011; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; HENDERSON JM, 1986, HEPATOLOGY, V6, P464, DOI 10.1002/hep.1840060324; HIRANO N, 1991, BIOCHEM J, V278, P595, DOI 10.1042/bj2780595; IGARASHI M, 1970, BIOCHIM BIOPHYS ACTA, V220, P85, DOI 10.1016/0005-2744(70)90231-7; JANSONIUS JN, 1985, TRANSAMINASES, P110; KALLEN RG, 1985, TRANSAMINASES, P37; KAZARINOFF MN, 1975, J BIOL CHEM, V250, P3436; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; KYAW A, 1980, BIOCHEM MED METAB B, V24, P27, DOI 10.1016/0006-2944(80)90083-6; LUMENG L, 1975, J BIOL CHEM, V250, P8126; MCCORMICK D, 1961, J BIOL CHEM, V236, P2076; MCCORMICK D, 1961, J BIOL CHEM, V236, P2085; MCKEE JS, 1989, BIOCHEM J, V261, P301, DOI 10.1042/bj2610301; Miles E W, 1977, Methods Enzymol, V47, P431; MURAKAMI K, 1986, CHEM PHARM BULL, V34, P3320; OSTANIN K, 1992, J BIOL CHEM, V267, P22830; RAIBAUD O, 1974, FEBS LETT, V40, P41, DOI 10.1016/0014-5793(74)80889-6; REYNOLDS RD, 1991, AM J CLIN NUTR, V53, P698, DOI 10.1093/ajcn/53.3.698; RIORDAN JF, 1979, MOL CELL BIOCHEM, V26, P71; SARASWATHI S, 1963, J NEUROCHEM, V10, P127, DOI 10.1111/j.1471-4159.1963.tb11473.x; STOCK A, 1966, BIOCHEM Z, V344, P353; STONE KL, 1989, PRACTICAL GUIDE PROT, P37; TAKAHASHI K, 1968, J BIOL CHEM, V243, P6171; VANETTEN RL, 1991, J BIOL CHEM, V266, P2313; VANETTEN RL, 1977, ARCH BIOCHEM BIOPHYS, V183, P250, DOI 10.1016/0003-9861(77)90438-6; VANETTEN RL, 1982, ANN NY ACAD SCI, V390, P27; WADA H, 1961, J BIOL CHEM, V236, P2089; WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324; WOODROOFE M N, 1978, Biochemical Society Transactions, V6, P562; ZHANG Z, 1991, P NATL ACAD SCI USA, V88, P10407, DOI 10.1073/pnas.88.23.10407; ZHANG ZY, 1992, BIOCHEMISTRY-US, V31, P1701, DOI 10.1021/bi00121a018	46	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7163	7168						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125926				2022-12-27	WOS:A1994NA03200022
J	MANCHESTER, M; EVERITT, L; LOEB, DD; HUTCHISON, CA; SWANSTROM, R				MANCHESTER, M; EVERITT, L; LOEB, DD; HUTCHISON, CA; SWANSTROM, R			IDENTIFICATION OF TEMPERATURE-SENSITIVE MUTANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE THROUGH SATURATION MUTAGENESIS - AMINO-ACID SIDE-CHAIN REQUIREMENTS FOR TEMPERATURE SENSITIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHETIC HIV-1 PROTEASE; CRYSTAL-STRUCTURE; BACTERIOPHAGE-T4 LYSOZYME; ASPARTIC PROTEINASES; VIRAL INFECTIVITY; ESCHERICHIA-COLI; RESOLUTION; INHIBITOR; MUTATIONS; HOMOLOGY	Human immunodeficiency virus type 1 encodes a protease whose activity is required for the production of infectious virus. An Escherichia coli expression and processing assay system was used to screen 285 protease mutants for temperature-sensitive activity. Fourteen protease mutants had a temperature-sensitive phenotype, and approximately half resulted from conservative amino acid substitutions. Of the 14 substitutions that conferred a temperature-sensitive phenotype, 11 substitutions occurred at 6 positions that represent 3 pairs of residues in the protease that contact each other in the three-dimensional structure. These mutants assist in pinpointing regions of the protease that are important for enzyme activity and stability.	UNIV N CAROLINA, LINEBERGER COMPREHENS CANC CTR, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, DEPT BIOCHEM & BIOPHYS, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, DEPT MICROBIOL & IMMUNOL, CHAPEL HILL, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill				Manchester, Marianne/0000-0002-7143-5744	NIAID NIH HHS [R01-AI25321] Funding Source: Medline; NIGMS NIH HHS [232-GM07092] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBER T, 1987, BIOCHEMISTRY-US, V26, P3754, DOI 10.1021/bi00387a002; BAUM EZ, 1990, P NATL ACAD SCI USA, V87, P5573, DOI 10.1073/pnas.87.14.5573; DEBOUCK C, 1992, AIDS RES HUM RETROV, V8, P153, DOI 10.1089/aid.1992.8.153; ERICKSON J, 1990, SCIENCE, V249, P527, DOI 10.1126/science.2200122; GOLDENBERG DP, 1988, ANNU REV BIOPHYS BIO, V17, P481; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; GRAY TM, 1987, J BIOL CHEM, V262, P16858; GRUTTER MG, 1979, NATURE, V277, P667, DOI 10.1038/277667a0; GRUTTER MG, 1987, J MOL BIOL, V197, P315, DOI 10.1016/0022-2836(87)90126-4; GUSTCHINA A, 1990, FEBS LETT, V269, P269, DOI 10.1016/0014-5793(90)81171-J; HUTCHISON CA, 1991, METHOD ENZYMOL, V202, P356; JASKOLSKI M, 1990, BIOCHEMISTRY-US, V29, P5889, DOI 10.1021/bi00477a002; JASKOLSKI M, 1991, BIOCHEMISTRY-US, V30, P1600, DOI 10.1021/bi00220a023; JONES TA, 1982, COMPUTATIONAL CRYSTA, P303; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAPATTO R, 1989, NATURE, V342, P299, DOI 10.1038/342299a0; LOEB DD, 1989, J VIROL, V63, P111, DOI 10.1128/JVI.63.1.111-121.1989; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; LOUIS JM, 1989, BIOCHEM BIOPH RES CO, V164, P30, DOI 10.1016/0006-291X(89)91678-1; Maniatis T, 1982, MOL CLONING LABORATO, P68; MATTHEWS BW, 1987, BIOCHEMISTRY-US, V26, P6885, DOI 10.1021/bi00396a001; MILLER M, 1989, SCIENCE, V246, P1149, DOI 10.1126/science.2686029; MILLER M, 1989, NATURE, V337, P576, DOI 10.1038/337576a0; MULICHAK AM, 1993, J BIOL CHEM, V268, P13103; NAVIA MA, 1989, NATURE, V337, P615, DOI 10.1038/337615a0; OHLENDORF DH, 1992, PROTEINS, V14, P382; OROSZLAN S, 1990, CURR TOP MICROBIOL, V157, P153; PENG C, 1989, J VIROL, V63, P2550, DOI 10.1128/JVI.63.6.2550-2556.1989; Pettit Steve C., 1993, Perspectives in Drug Discovery and Design, V1, P69, DOI 10.1007/BF02171656; RAO JKM, 1991, BIOCHEMISTRY-US, V30, P4663, DOI 10.1021/bi00233a005; RATNER L, 1987, AIDS RES HUM RETROV, V3, P57, DOI 10.1089/aid.1987.3.57; ROCKENBACH SK, 1990, AIDS RES HUM RETROV, V6, P543, DOI 10.1089/aid.1990.6.543; TONG L, 1993, P NATL ACAD SCI USA, V90, P8387, DOI 10.1073/pnas.90.18.8387; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WEBER IT, 1990, J BIOL CHEM, V265, P10492; WEBER IT, 1989, GENE, V85, P565, DOI 10.1016/0378-1119(89)90453-8; WLODAWER A, 1993, ANNU REV BIOCHEM, V62, P543, DOI 10.1146/annurev.bi.62.070193.002551; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279	39	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7689	7695						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125995				2022-12-27	WOS:A1994NA03200102
J	SCHWIEBERT, EM; MILLS, JW; STANTON, BA				SCHWIEBERT, EM; MILLS, JW; STANTON, BA			ACTIN-BASED CYTOSKELETON REGULATES A CHLORIDE CHANNEL AND CELL-VOLUME IN A RENAL CORTICAL COLLECTING DUCT CELL-LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY EPITHELIAL-CELLS; CYCLIC-AMP ACCUMULATION; S49 LYMPHOMA-CELLS; ION CHANNELS; F-ACTIN; PROXIMAL TUBULE; CYTOCHALASIN-B; ACTIVATED CHANNELS; CYSTIC-FIBROSIS; MDCK CELLS	The regulatory volume decrease (RVD) of a renal cortical collecting duct cell line (RCCT-28A) exposed to a hypotonic solution was studied using electronic cell sizing to measure cell volume and the patch clamp technique to measure Cl- channel activity. Results demonstrate that RVD was mediated in part by KCl loss through separate K+ and Cl- channels. The Cl- channel had a conductance of 305 pS and was activated by cell swelling, membrane stretch, and disruption of F-actin by dihydrocytochalasins. In contrast, stabilizing F-actin with phalloidin prevented swelling and stretch activation of the Cl- channel and inhibited the RVD. Thus, the state of actin polymerization regulates the probability of the 305 pS Cl- channel being open. Short actin filaments activate whereas long actin filaments inactivate the channel. Taken together, our studies suggest that RVD in this renal collecting duct cell line cell is mediated in part by a 305 pS Cl- channel, which is activated, during cell swelling, by a signaling pathway that includes disruption of F-actin.	DARTMOUTH COLL, SCH MED, DEPT PHYSIOL, HANOVER, NH 03755 USA	Dartmouth College					NIDDK NIH HHS [DK-34533] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034533] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALAWQATI Q, 1989, METHOD ENZYMOL, V172, P49; AREND LJ, 1989, AM J PHYSIOL, V256, pF1067, DOI 10.1152/ajprenal.1989.256.6.F1067; BENNETT V, 1985, ANNU REV BIOCHEM, V54, P273, DOI 10.1146/annurev.biochem.54.1.273; BLOCH RJ, 1989, J CELL BIOL, V108, P481, DOI 10.1083/jcb.108.2.481; CANTIELLO HF, 1991, AM J PHYSIOL, V261, pC882, DOI 10.1152/ajpcell.1991.261.5.C882; CANTIELLO HF, 1993, J BIOL CHEM, V268, P4596; CASSIMERIS L, 1990, J CELL BIOL, V110, P1067, DOI 10.1083/jcb.110.4.1067; CHAMBERLIN ME, 1989, AM J PHYSIOL, V257, pC159, DOI 10.1152/ajpcell.1989.257.2.C159; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CIVAN MM, 1992, EXP EYE RES, V54, P181, DOI 10.1016/S0014-4835(05)80207-6; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; CORNET M, 1987, PFLUG ARCH EUR J PHY, V410, P223, DOI 10.1007/BF00581921; DAVIS JQ, 1990, J BIOL CHEM, V265, P17252; DIETL P, 1992, AM J PHYSIOL, V263, pF243, DOI 10.1152/ajprenal.1992.263.2.F243; DIETL P, 1992, AM J PHYSIOL, V262, pF578, DOI 10.1152/ajprenal.1992.262.4.F578; DRENCKHAHN D, 1985, SCIENCE, V230, P1287, DOI 10.1126/science.2933809; FALKE LC, 1989, P NATL ACAD SCI USA, V86, P3919, DOI 10.1073/pnas.86.10.3919; FILIPOVIC D, 1992, AM J PHYSIOL, V262, pF857, DOI 10.1152/ajprenal.1992.262.5.F857; FOSKETT JK, 1985, AM J PHYSIOL, V248, pC27, DOI 10.1152/ajpcell.1985.248.1.C27; GOGELEIN H, 1988, BIOCHIM BIOPHYS ACTA, V947, P521, DOI 10.1016/0304-4157(88)90006-8; GRINSTEIN S, 1990, ANNU REV PHYSIOL, V52, P399; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; HALLOWS KR, 1991, AM J PHYSIOL, V261, pC1154, DOI 10.1152/ajpcell.1991.261.6.C1154; HOFFMANN EK, 1987, CURR TOP MEMBR TRANS, V30, P125; HOFFMANN EK, 1989, PHYSIOL REV, V69, P315, DOI 10.1152/physrev.1989.69.2.315; HUDSON RL, 1988, P NATL ACAD SCI USA, V85, P279, DOI 10.1073/pnas.85.1.279; HURST AM, 1990, J PHYSIOL-LONDON, V430, P13, DOI 10.1113/jphysiol.1990.sp018278; INSEL PA, 1982, J BIOL CHEM, V257, P9717; KELLY SM, 1991, AM J PHYSIOL, V260, pC652, DOI 10.1152/ajpcell.1991.260.3.C652; KENNEDY MS, 1979, MOL PHARMACOL, V16, P215; Kleinzeller A., 1990, Comparative Physiology, V4, P59; KOOB R, 1990, EUR J CELL BIOL, V53, P93; KORN ED, 1982, PHYSIOL REV, V62, P672, DOI 10.1152/physrev.1982.62.2.672; LEWIS RS, 1990, ANNU REV PHYSIOL, V52, P415; LEWIS SA, 1990, NEWS PHYSIOL SCI, V5, P112; LIGHT DB, 1990, AM J PHYSIOL, V258, pF273, DOI 10.1152/ajprenal.1990.258.2.F273; LINSHAW MA, 1992, AM J PHYSIOL, V262, pF144, DOI 10.1152/ajprenal.1992.262.1.F144; LOPES AG, 1988, P NATL ACAD SCI USA, V85, P2873, DOI 10.1073/pnas.85.8.2873; LOW I, 1975, FEBS LETT, V54, P263, DOI 10.1016/0014-5793(75)80088-3; LOW SH, 1992, J CELL BIOL, V118, P51, DOI 10.1083/jcb.118.1.51; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; MEYERLEHNERT H, 1993, CLIN INVESTIGATOR, V71, P153; MILLS JW, 1987, CURR TOP MEMBR TRANS, V30, P75; MILLS JW, 1986, AM J PHYSIOL, V250, pC319, DOI 10.1152/ajpcell.1986.250.2.C319; MOLDAY LL, 1990, J BIOL CHEM, V265, P18690; MOLITORIS BA, 1991, AM J PHYSIOL, V260, pF769; MONTROSERAFIZADEH C, 1990, ANNU REV PHYSIOL, V52, P761; MORRIS CE, 1990, J MEMBRANE BIOL, V113, P93, DOI 10.1007/BF01872883; MORROW JS, 1989, J CELL BIOL, V108, P455, DOI 10.1083/jcb.108.2.455; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Pollard TD, 1990, CURR OPIN CELL BIOL, V2, P33, DOI 10.1016/S0955-0674(05)80028-6; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; SACHS F, 1991, MOL CELL BIOCHEM, V104, P57; SACKIN H, 1987, AM J PHYSIOL, V253, pF1253; SACKIN H, 1989, P NATL ACAD SCI USA, V86, P1731, DOI 10.1073/pnas.86.5.1731; SARKADI B, 1991, BIOCHIM BIOPHYS ACTA, V1071, P407, DOI 10.1016/0304-4157(91)90005-H; SCHWIEBERT E M, 1991, Journal of the American Society of Nephrology, V2, P750; SCHWIEBERT EM, 1992, P NATL ACAD SCI USA, V89, P10623, DOI 10.1073/pnas.89.22.10623; SCHWIEBERT EM, 1992, J CLIN INVEST, V89, P834, DOI 10.1172/JCI115662; SCHWIEBERT EM, 1991, FASEB J, V5, P739; SHAPIRO M, 1991, J CLIN INVEST, V87, P1903, DOI 10.1172/JCI115215; SMITH PR, 1991, P NATL ACAD SCI USA, V88, P6971, DOI 10.1073/pnas.88.16.6971; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; STANTON B A, 1991, Journal of the American Society of Nephrology, V2, P751; STANTON BA, 1990, J AM SOC NEPHROL, V1, P492; STRANGE K, 1991, AM J PHYSIOL, V260, pF225, DOI 10.1152/ajprenal.1991.260.2.F225; STRANGE K, 1988, AM J PHYSIOL, V255, pC612, DOI 10.1152/ajpcell.1988.255.5.C612; TANIGUCHI J, 1989, AM J PHYSIOL, V257, pF347, DOI 10.1152/ajprenal.1989.257.3.F347; TSENG GN, 1992, AM J PHYSIOL, V262, pC1056, DOI 10.1152/ajpcell.1992.262.4.C1056; VALE RD, 1992, MOL NEUROBIOL, P247; WATSON PA, 1991, FASEB J, V5, P2013, DOI 10.1096/fasebj.5.7.1707019; WELLING PA, 1990, AM J PHYSIOL, V258, pF951, DOI 10.1152/ajprenal.1990.258.4.F951; YANTORNO RE, 1992, AM J PHYSIOL, V262, pC501, DOI 10.1152/ajpcell.1992.262.2.C501; YANTORNO RE, 1989, EXP EYE RES, V49, P423, DOI 10.1016/0014-4835(89)90051-1; ZIYADEH FN, 1992, AM J PHYSIOL, V262, pF468, DOI 10.1152/ajprenal.1992.262.3.F468	75	190	195	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7081	7089						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125915				2022-12-27	WOS:A1994NA03200009
J	TACCIOLI, GE; CHENG, HL; VARGHESE, AJ; WHITMORE, G; ALT, FW				TACCIOLI, GE; CHENG, HL; VARGHESE, AJ; WHITMORE, G; ALT, FW			A DNA-REPAIR DEFECT IN CHINESE-HAMSTER OVARY CELLS AFFECTS V(D)J RECOMBINATION SIMILARLY TO THE MURINE ACID MUTATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-B CELLS; JUNCTIONAL SEQUENCES; RECEPTOR GAMMA; SCID MUTATION; GENES; MICE; MUTANTS; DEFICIENCY; RADIATION; SIGNAL	Lymphocyte antigen receptor variable regions are encoded by gene segments that are assembled by the site-specific variable (diversity) joining (V(D)J) recombination process. We have assayed the V-3 Chinese hamster ovary cell line, which has a double-strand DNA break repair (dsbr) defect, for the ability to carry out V(D)J recombination following transfection of constructs that encode the RAG-1 and RAG-2 proteins necessary to confer V(D)J recombination activity to non-lymphoid cells. The V-3 cells had substantially impaired ability to undergo V(D)J recombination of transiently introduced test substrates. Although these cells can initiate V(D)J recombination by introducing endonucleolytic scissions at the junctions of V(D)J recombination signal sequences and the flanking coding sequences, they have a greatly impaired ability to rejoin the coding sequences. Detailed characterization of attempted coding joins recovered from these cells indicated that the V(D)J recombination defect in V-3 is similar in phenotype to the murine severe combined immunodeficient (scid) defect and quite distinct from that found in other Chinese hamster ovary dsbr mutant cell lines. Somatic cell complementation analyses between homozygous scid mutant fibroblasts and V-3 cells confirmed that these mutations fall into the same genetic complementation group.	HARVARD UNIV, CHILDRENS HOSP, SCH MED, HOWARD HUGHES MED INST, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, CTR BLOOD RES, BOSTON, MA 02115 USA; ONTARIO CANC INST, TORONTO M4X 1K9, ON, CANADA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto					NIAID NIH HHS [AI20047] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047, R37AI020047] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALT FW, 1992, IMMUNOL TODAY, V13, P306, DOI 10.1016/0167-5699(92)90043-7; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; BLACKWELL TK, 1989, EMBO J, V8, P735, DOI 10.1002/j.1460-2075.1989.tb03433.x; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P271, DOI 10.1007/BF01538965; DISNEY JE, 1992, CYTOGENET CELL GENET, V59, P39, DOI 10.1159/000133196; FRIEDBERG EC, 1991, BIOESSAYS, V13, P295, DOI 10.1002/bies.950130607; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; GELLERT M, 1992, ANNU REV GENET, V22, P425; HENDRICKSON EA, 1991, P NATL ACAD SCI USA, V88, P4061, DOI 10.1073/pnas.88.10.4061; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; HOEIJMAKERS JHJ, 1993, TRENDS GENET, V9, P173, DOI 10.1016/0168-9525(93)90164-D; JEGGO PA, 1990, MUTAT RES, V239, P1, DOI 10.1016/0165-1110(90)90028-A; KIENKER LJ, 1991, J EXP MED, V174, P769, DOI 10.1084/jem.174.4.769; LAFAILLE JJ, 1989, CELL, V59, P859, DOI 10.1016/0092-8674(89)90609-0; LEWIS SM, 1991, EMBO J, V10, P3631, DOI 10.1002/j.1460-2075.1991.tb04929.x; LIEBER MR, 1991, FASEB J, V5, P2934, DOI 10.1096/fasebj.5.14.1752360; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; MALYNN BA, 1988, CELL, V54, P453, DOI 10.1016/0092-8674(88)90066-9; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; ROBSON CN, 1988, MUTAT RES, V193, P157, DOI 10.1016/0167-8817(88)90046-6; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHULER W, 1991, EUR J IMMUNOL, V21, P589, DOI 10.1002/eji.1830210309; STAMATO TD, 1983, SOMAT CELL GENET, V9, P165, DOI 10.1007/BF01543175; Taccioli G E, 1992, Curr Top Microbiol Immunol, V182, P107; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; VARGHESE AJ, 1990, J CELL BIOCH SAB, V14; WEEDA G, 1993, BIOESSAYS, V15, P249, DOI 10.1002/bies.950150405; WHITMORE GF, 1989, INT J RADIAT BIOL, V56, P657, DOI 10.1080/09553008914551881	29	83	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7439	7442						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125964				2022-12-27	WOS:A1994NA03200065
J	TAKASUKA, T; SAKURAI, T; GOTO, K; FURUICHI, Y; WATANABE, T				TAKASUKA, T; SAKURAI, T; GOTO, K; FURUICHI, Y; WATANABE, T			HUMAN ENDOTHELIN RECEPTOR ET(B) - AMINO-ACID-SEQUENCE REQUIREMENTS FOR SUPER STABLE COMPLEX-FORMATION WITH ITS LIGAND	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; CDNA; BINDING; ETB; IDENTIFICATION; CELLS; MEMBRANES; SUBTYPES; SITES	ET(B) type endothelin receptor (ET(B)R) forms a stable complex with its ligand endothelin-1 (ET-1). The ligand-receptor complex can survive in the presence of 2% SDS and migrate in SDS-polyacrylamide gel electrophoresis at reduced temperature. This is not the case for the ET(A) type endothelin receptor (ET(A)R). Most of ET(B)R from various animals, except rat, can form such a stable complex. Examination of stability in the ligand-receptor complex which was formed by chimeric receptors constructed from human ET(B)R and rat ET(B)R demonstrated that the region containing 29 amino acids in the N-terminal extracellular domain is responsible for the formation of such a stable complex. Site-directed mutagenesis focused on this particular region revealed that Asp(75) and Pro(93) are involved in the formation of the stable complex. This unique observation contributes to the elucidation of the structure of the stable ET(B)R.ET-1 complex at the molecular level.	NIPPON ROCHE RES CTR,DEPT MOLEC GENET,KAMAKURA,KANAGAWA 247,JAPAN; UNIV TSUKUBA,INST BASIC MED SCI,DEPT PHARMACOL,TSUKUBA,IBARAKI 305,JAPAN	Roche Holding; University of Tsukuba								ADACHI M, 1991, BIOCHEM BIOPH RES CO, V180, P1265, DOI 10.1016/S0006-291X(05)81332-4; ADACHI M, 1992, FEBS LETT, V311, P179, DOI 10.1016/0014-5793(92)81393-Z; AKIYAMA N, 1992, PROTEIN EXPRES PURIF, V3, P427, DOI 10.1016/S1046-5928(05)80046-4; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; CLOZEL M, 1989, J CLIN INVEST, V83, P1758, DOI 10.1172/JCI114078; ELSHOURBAGY NA, 1993, J BIOL CHEM, V268, P3873; ELSHOURBAGY NA, 1992, MOL PHARMACOL, V41, P465; FISCHLI W, 1989, LIFE SCI, V44, P1429, DOI 10.1016/0024-3205(89)90321-4; HORI S, 1992, ENDOCRINOLOGY, V130, P1885, DOI 10.1210/en.130.4.1885; HOSODA K, 1991, FEBS LETT, V287, P23, DOI 10.1016/0014-5793(91)80007-P; LIN HY, 1991, P NATL ACAD SCI USA, V88, P3185, DOI 10.1073/pnas.88.8.3185; MARTIN ER, 1989, BIOCHEM BIOPH RES CO, V162, P130, DOI 10.1016/0006-291X(89)91972-4; NAKAMUTA M, 1991, BIOCHEM BIOPH RES CO, V177, P34, DOI 10.1016/0006-291X(91)91944-8; NELSON CA, 1993, P NATL ACAD SCI USA, V90, P1227, DOI 10.1073/pnas.90.4.1227; OGAWA Y, 1991, BIOCHEM BIOPH RES CO, V178, P248, DOI 10.1016/0006-291X(91)91806-N; RUBANYI GM, 1991, FASEB J, V5, P2713, DOI 10.1096/fasebj.5.12.1916094; SAITO Y, 1991, J BIOL CHEM, V266, P23433; SAKAMOTO A, 1991, BIOCHEM BIOPH RES CO, V178, P656, DOI 10.1016/0006-291X(91)90158-4; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SAKURAI T, 1992, TRENDS PHARMACOL SCI, V13, P103; SOKOLOVSKY M, 1991, TRENDS BIOCHEM SCI, V16, P261, DOI 10.1016/0968-0004(91)90100-A; TAKASUKA T, 1992, J BIOCHEM-TOKYO, V112, P396, DOI 10.1093/oxfordjournals.jbchem.a123911; TAKASUKA T, 1992, J BIOCHEM-TOKYO, V111, P748, DOI 10.1093/oxfordjournals.jbchem.a123830; TAKASUKA T, 1991, BIOCHEM BIOPH RES CO, V176, P392, DOI 10.1016/0006-291X(91)90937-3; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315; YANAGISAWA M, 1989, TRENDS PHARMACOL SCI, V10, P374; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	27	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7509	7513						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125970				2022-12-27	WOS:A1994NA03200075
J	KUROKAWA, H; MIKAMI, B; HIROSE, M				KUROKAWA, H; MIKAMI, B; HIROSE, M			CRUCIAL ROLE OF INTRALOBE PEPTIDE-PEPTIDE INTERACTIONS IN THE UPTAKE AND RELEASE OF IRON BY OVOTRANSFERRIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL HALF; HUMAN LACTOFERRIN; SERUM TRANSFERRIN; X-RAY; BINDING; RESOLUTION; FRAGMENTS; MOLECULE; LACTOTRANSFERRIN; PYROPHOSPHATE	The mechanism for reversible iron binding in the N-terminal lobe of ovotransferrin was investigated by a protein fragmentation approach, The iron-saturated N-terminal half-molecule of ovotransferrin was proteo- lyzed into large 30-kDa (1-279) and small 6-kDa (280-332) fragments by a single cleavage with Achromobacter protease I, producing a stable nicked form. For the separation of the two fragments, denaturing conditions were required. The isolated large fragment contained all four iron-coordinating ligands and the anion-binding ligand, and according to spectroscopic titration analysis, it showed iron binding capacity. The iron-bound large fragment, however, showed a blue-shifted visible absorption spectrum and a much decreased iron stability compared with those of the intact half-molecule. Analyses by ion-exchange chromatography revealed that the large fragment reassociates with the small fragment, In order for reassociation to occur, iron must be bound to the large fragment; upon reassociation, the large fragment regained its stable iron binding capacity as well as a visible absorption spectrum almost indistinguishable from those of the intact half-molecule. These data are consistent with a two step sequential pathway for re- versible iron binding in the N-terminal lobe of ovotransferrin that includes an initial iron binding intermediate having a perturbed metal environment and its transformation into the stable iron-bound holoform by peptide-peptide interactions between the large coordinating and small noncoordinating segments.	KYOTO UNIV,FOOD SCI RES INST,UJI,KYOTO 611,JAPAN	Kyoto University			Kurokawa, Hirofumi/A-7231-2010	Hirose, Masaaki/0000-0003-2672-4384				AISEN P, 1980, ANNU REV BIOCHEM, V49, P357, DOI 10.1146/annurev.bi.49.070180.002041; ANDERSON BF, 1990, NATURE, V344, P784, DOI 10.1038/344784a0; ANDERSON BF, 1987, P NATL ACAD SCI USA, V84, P1769, DOI 10.1073/pnas.84.7.1769; ANDERSON BF, 1989, J MOL BIOL, V209, P711, DOI 10.1016/0022-2836(89)90602-5; AZARI PR, 1958, J BIOL CHEM, V232, P293; BAILEY S, 1988, BIOCHEMISTRY-US, V27, P5804, DOI 10.1021/bi00415a061; BAKER EN, 1987, TRENDS BIOCHEM SCI, V12, P350, DOI 10.1016/0968-0004(87)90163-0; BALI PK, 1989, J AM CHEM SOC, V111, P4457, DOI 10.1021/ja00194a047; COWART RE, 1982, J BIOL CHEM, V257, P7560; COWART RE, 1986, J BIOL CHEM, V261, P4607; DAY CL, 1992, J BIOL CHEM, V267, P13857; DEWAN JC, 1993, BIOCHEMISTRY-US, V32, P11963, DOI 10.1021/bi00096a004; GROSSMANN JG, 1993, J MOL BIOL, V229, P585, DOI 10.1006/jmbi.1993.1063; GROSSMANN JG, 1992, J MOL BIOL, V225, P811, DOI 10.1016/0022-2836(92)90402-6; JAENICKE R, 1991, BIOCHEMISTRY-US, V30, P3147, DOI 10.1021/bi00227a001; JELTSCH JM, 1987, NUCLEIC ACIDS RES, V15, P7643, DOI 10.1093/nar/15.18.7643; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEGRAND D, 1984, BIOCHIM BIOPHYS ACTA, V787, P90, DOI 10.1016/0167-4838(84)90111-0; LEGRAND D, 1990, BIOCHEM J, V266, P575; MAZURIER J, 1980, BIOCHIM BIOPHYS ACTA, V629, P399, DOI 10.1016/0304-4165(80)90112-9; OE H, 1989, J BIOCHEM-TOKYO, V106, P858, DOI 10.1093/oxfordjournals.jbchem.a122942; OE H, 1988, J BIOCHEM-TOKYO, V103, P1066, DOI 10.1093/oxfordjournals.jbchem.a122381; SANCHO J, 1992, J MOL BIOL, V224, P749, DOI 10.1016/0022-2836(92)90559-3; SARRA R, 1990, ACTA CRYSTALLOGR B, V46, P763, DOI 10.1107/S0108768190006450; TASAYCO ML, 1992, SCIENCE, V255, P594, DOI 10.1126/science.1736361; Wetlaufer D B, 1981, Adv Protein Chem, V34, P61, DOI 10.1016/S0065-3233(08)60518-5; WILLIAMS J, 1982, EUR J BIOCHEM, V122, P297, DOI 10.1111/j.1432-1033.1982.tb05880.x; WILLIAMS J, 1988, BIOCHEM J, V251, P849, DOI 10.1042/bj2510849; WOODWORTH RC, 1991, BIOCHEMISTRY-US, V30, P10824, DOI 10.1021/bi00109a002	29	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6671	6676						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120023				2022-12-27	WOS:A1994MZ50300066
J	NAKADE, S; RHEE, SK; HAMANAKA, H; MIKOSHIBA, K				NAKADE, S; RHEE, SK; HAMANAKA, H; MIKOSHIBA, K			CYCLIC-AMP-DEPENDENT PHOSPHORYLATION OF AN IMMUNOAFFINITY-PURIFIED HOMOTETRAMERIC INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR (TYPE-I) INCREASES CA2+ FLUX IN RECONSTITUTED LIPID VESICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM RELEASE; INSP3 RECEPTOR; PROTEIN-KINASE; CA-2+ RELEASE; TRISPHOSPHATE RECEPTOR; ACETYLCHOLINE-RECEPTOR; MONOCLONAL-ANTIBODIES; MOLECULAR-CLONING; MOUSE CEREBELLUM; PURKINJE-CELL	We established a novel method to isolate a single type of inositol 1,4,5-trisphosphate receptor (IP(3)R) among the heterogeneous population of receptors to study the regulatory mechanism of Ca2+ release. We raised in the rabbit a polyclonal antibody against synthetic peptide corresponding to amino acids 2736-2747 (pep 6) of type I IP(3)R (IP(3)R-I) that is most abundant in cerebellum. We purified IP(3)R-I from a 1% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid solubilized mouse cerebellar microsomal fraction by immunoaffinity chromatography on an anti-pep 6 antibody-Sepharose 4B column with specific elution by the pep 6 peptide (GHPPHMNVNPQQ) of the IP(3)R-I C terminus. Immunoaffinity-purified IP(3)R reconstituted into lipid vesicles formed a homotetramer structure. Monoclonal antibody 18A10, which partially blocks the Ca2+ release from cerebellar microsome, almost completely inhibited IP3-induced Ca-45(2+) influx into proteoliposomes, whereas monoclonal antibody that recognizes other regions did not inhibit Ca2+ influx. Both the rate and extent of Ca-45(2+) influx into proteoliposomes increased 20% after incubation with the catalytic subunit of cyclic AMP-dependent protein kinase, accompanied by stoichiometric phosphorylation of IP(3)R protein.	UNIV TOKYO,INST MED SCI,DEPT MOLEC NEUROBIOL,MINATO KU,TOKYO,TOKYO 108,JAPAN; INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,MOLEC NEUROBIOL LAB,TSUKUBA,IBARAKI 305,JAPAN	University of Tokyo; RIKEN	NAKADE, S (corresponding author), ONO PHARMACEUT CO LTD,MINASE RES INST,BASIC RES LAB,3-1-1 SAKURAI,SHIMAMOTO,OSAKA 618,JAPAN.		Mikoshiba, Katsuhiko/N-7943-2015					BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; BOURGUIGNON LYW, 1993, J BIOL CHEM, V268, P7290; BURGESS GM, 1991, J BIOL CHEM, V266, P4772; CHOW SC, 1990, J BIOL CHEM, V265, P902; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; ENOUF J, 1987, BIOCHIM BIOPHYS ACTA, V928, P76, DOI 10.1016/0167-4889(87)90087-5; FERRIS CD, 1992, J BIOL CHEM, V267, P7036; FERRIS CD, 1992, NATURE, V356, P350, DOI 10.1038/356350a0; FERRIS CD, 1990, P NATL ACAD SCI USA, V87, P2147, DOI 10.1073/pnas.87.6.2147; FERRIS CD, 1992, ANNU REV PHYSIOL, V54, P469, DOI 10.1146/annurev.physiol.54.1.469; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GHOSH TK, 1989, NATURE, V340, P236, DOI 10.1038/340236a0; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HARTZELL HC, 1991, NATURE, V351, P573, DOI 10.1038/351573a0; HEUSCHNEIDER G, 1989, P NATL ACAD SCI USA, V86, P2938, DOI 10.1073/pnas.86.8.2938; HUGANIR RL, 1986, NATURE, V321, P774, DOI 10.1038/321774a0; HUGANIR RL, 1982, J BIOL CHEM, V257, P9372; JOSEPH SK, 1989, BIOCHEM J, V258, P261, DOI 10.1042/bj2580261; KAGAWA Y, 1973, J BIOL CHEM, V248, P676; KHODAKHAH K, 1993, P NATL ACAD SCI USA, V90, P4976, DOI 10.1073/pnas.90.11.4976; KIEHM DJ, 1977, J BIOL CHEM, V252, P8524; KUME S, 1993, CELL, V73, P555, DOI 10.1016/0092-8674(93)90142-D; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI M, 1992, NEURON, V8, P1151, DOI 10.1016/0896-6273(92)90135-Z; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; MAEDA N, 1991, J BIOL CHEM, V266, P1109; MAEDA N, 1988, J NEUROCHEM, V51, P1724, DOI 10.1111/j.1471-4159.1988.tb01151.x; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; MIYAZAKI S, 1992, SCIENCE, V257, P251, DOI 10.1126/science.1321497; NAKADE S, 1991, BIOCHEM J, V277, P125, DOI 10.1042/bj2770125; NAKAGAWA T, 1991, P NATL ACAD SCI USA, V88, P6244, DOI 10.1073/pnas.88.14.6244; NAKANISHI S, 1991, J NEUROSCI, V11, P2075; NUNOKI K, 1989, P NATL ACAD SCI USA, V86, P6816, DOI 10.1073/pnas.86.17.6816; OTSU H, 1990, CELL STRUCT FUNCT, V15, P163, DOI 10.1247/csf.15.163; PIETRI F, 1990, J BIOL CHEM, V265, P17478; QUINTON TM, 1992, BIOCHEM BIOPH RES CO, V184, P893, DOI 10.1016/0006-291X(92)90675-B; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; RICHARDSON CD, 1985, J VIROL, V54, P186, DOI 10.1128/JVI.54.1.186-193.1985; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; Shears Stephen B., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P63; SMITH JB, 1985, J BIOL CHEM, V260, P4413; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; VOLPE P, 1990, AM J PHYSIOL, V258, pC1086, DOI 10.1152/ajpcell.1990.258.6.C1086; WATRAS J, 1991, J NEUROSCI, V11, P3239; YAMAMOTO H, 1989, J NEUROCHEM, V53, P917, DOI 10.1111/j.1471-4159.1989.tb11792.x; YAMAMOTOHINO M, 1994, IN PRESS RECEPT CHAN; YOSHIKAWA S, 1992, J BIOL CHEM, V267, P16613	53	148	149	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6735	6742						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120033				2022-12-27	WOS:A1994MZ50300076
J	TROPPMAIR, J; BRUDER, JT; MUNOZ, H; LLOYD, PA; KYRIAKIS, J; BANERJEE, P; AVRUCH, J; RAPP, UR				TROPPMAIR, J; BRUDER, JT; MUNOZ, H; LLOYD, PA; KYRIAKIS, J; BANERJEE, P; AVRUCH, J; RAPP, UR			MITOGEN-ACTIVATED PROTEIN-KINASE EXTRACELLULAR SIGNAL-REGULATED PROTEIN-KINASE ACTIVATION BY ONCOGENES, SERUM, AND 12-O-TETRADECANOYLPHORBOL-13-ACETATE REQUIRES RAF AND IS NECESSARY FOR TRANSFORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIH 3T3 CELLS; MAP KINASE; XENOPUS OOCYTES; A-RAF; V-RAF; GROWTH; PHOSPHORYLATION; RECEPTOR; TRANSDUCTION; ONCOPROTEIN	The protein kinase cascade Raf-MAPKK/MEK-MAPK/ERK connects protein tyrosine kinase receptors in the membrane with control of transcription factor activity in the nucleus. We have examined whether Raf is obligatory for activation of this cascade and whether this signaling pathway is relevant to transformation. By use of transient assays with epitope-tagged ERK-1 cDNA and a dominant inhibitory mutant of Raf-1 we found that serum and 12-O-tetradecanoylphorbol-13-acetate as well as representatives of three classes of oncogenes (protein tyrosine kinases abl/src, Ras, and protein serine/ threonine kinases mos/cot) were all Raf-dependent for stimulation of MAPK. All of the MAPK stimulating oncogenes were also activators of Raf kinase as judged by shift induction. It thus appears that there is little or no redundancy in pathways used by growth regulators for activation of MAPK/ERK. Furthermore, the ability to stimulate MAPK/ERK appears to be critical for transformation by oncogenic Raf-1 as ERK-1 and -2 synergized with v-raf in a focus induction assay on NIH3T3 cells and kinase dead mutants of ERK-2 were inhibitory. Raf/ERK synergism was also observed in transcriptional transactivation of the oncogene-response element in the polyoma enhancer. We conclude that this Raf signaling pathway, which connects to many upstream activators and downstream effecters, is essential for transformation by most oncogenes.	LAB VIRAL CARCINOGENESIS,VIRAL PATHOL SECT,FREDERICK,MD 21702; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,BOSTON,MA 02129	Harvard University; Harvard Medical School; Massachusetts General Hospital				Troppmair, Jakob/0000-0002-0611-3837				AHMED S, 1990, BIOCHEM J, V272, P767, DOI 10.1042/bj2720767; ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; APP H, 1991, MOL CELL BIOL, V11, P913, DOI 10.1128/MCB.11.2.913; BECK TW, 1987, NUCLEIC ACIDS RES, V15, P595, DOI 10.1093/nar/15.2.595; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BRUDER JT, 1992, GENE DEV, V6, P5454; CAI H, 1990, MOL CELL BIOL, V10, P5314, DOI 10.1128/MCB.10.10.5314; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DEVRIESSMITS AMM, 1992, NATURE, V357, P602, DOI 10.1038/357602a0; DORN P, 1990, J VIROL, V64, P1616, DOI 10.1128/JVI.64.4.1616-1624.1990; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; HULEIHEL M, 1986, MOL CELL BIOL, V6, P2655, DOI 10.1128/MCB.6.7.2655; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; JOHNSON PJ, 1985, MOL CELL BIOL, V5, P1073, DOI 10.1128/MCB.5.5.1073; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; KOLCH W, 1993, ONCOGENE, V8, P361; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; KYRIAKIS JM, 1993, J BIOL CHEM, V268, P16009; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; LEVIN DE, 1993, J NIH RES, V5, P49; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; MIYOSHI J, 1991, MOL CELL BIOL, V11, P4088, DOI 10.1128/MCB.11.8.4088; NEBREDA AR, 1993, EMBO J, V12, P1979, DOI 10.1002/j.1460-2075.1993.tb05847.x; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; NODA M, 1983, P NATL ACAD SCI-BIOL, V80, P5602, DOI 10.1073/pnas.80.18.5602; POMERANCE M, 1992, J BIOL CHEM, V267, P16155; POSADA J, 1993, MOL CELL BIOL, V13, P2546, DOI 10.1128/MCB.13.4.2546; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; RADLERPOHL A, 1993, EMBO J, V12, P1005, DOI 10.1002/j.1460-2075.1993.tb05741.x; RAPP UR, 1988, COLD SPRING HARB SYM, V53, P173, DOI 10.1101/SQB.1988.053.01.023; RAPP UR, 1991, ONCOGENE, V6, P495; RAPP UR, 1993, IN PRESS CRITICAL RE; RAPP UR, 1988, HDB ONCOGENES, P213; REED JC, 1991, CELL GROWTH DIFFER, V2, P235; ROBINSON DJ, 1993, J BIOL CHEM, V268, P5097; SHIBUYA EK, 1992, P NATL ACAD SCI USA, V89, P9831, DOI 10.1073/pnas.89.20.9831; SIEGEL JN, 1993, J IMMUNOL, V151, P4116; SMEAL T, 1992, MOL CELL BIOL, V12, P3507, DOI 10.1128/MCB.12.8.3507; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TROPPMAIR J, 1992, ONCOGENE, V7, P1867; TSUDA L, 1993, CELL, V72, P407, DOI 10.1016/0092-8674(93)90117-9; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	54	235	240	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					7030	7035						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120067				2022-12-27	WOS:A1994MZ50300117
J	LEIDICH, SD; DRAPP, DA; ORLEAN, P				LEIDICH, SD; DRAPP, DA; ORLEAN, P			A CONDITIONALLY LETHAL YEAST MUTANT BLOCKED AT THE FIRST STEP IN GLYCOSYL PHOSPHATIDYLINOSITOL ANCHOR SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PHOSPHATE MANNOSE SYNTHASE; CELL-SURFACE MOLECULES; SACCHAROMYCES-CEREVISIAE; BIOSYNTHESIS; MEMBRANE; PROTEIN; LYMPHOMA; GENE; DEFICIENT; THY-1	Glycosyl phosphatidylinositols (GPIs) anchor many proteins to the surface of eukaryotic cells and may also serve as sorting signals on proteins and participate in signal transduction. We have isolated a Saccharomyces cerevisiae GPI anchoring mutant, gpi1, using a colony screen for cells blocked in [H-3]inositol incorporation into protein. The gpi1 mutant is defective in vitro in the synthesis of N-acetylglucosaminyl phosphatidylinositol, the first intermediate in GPI synthesis, and is also temperature-sensitive for growth. Completion of the first step in GPI assembly is therefore required for growth of the unicellular eukaryote S. cerevisiae. GPI synthesis could therefore be exploited as a target for antifungal or antiparasitic agents.	UNIV ILLINOIS,DEPT BIOCHEM,ROGER ADAMS LAB 309,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign					NIGMS NIH HHS [GM46220] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046220] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CONZELMANN A, 1986, EMBO J, V5, P3291, DOI 10.1002/j.1460-2075.1986.tb04642.x; CONZELMANN A, 1990, EMBO J, V9, P653, DOI 10.1002/j.1460-2075.1990.tb08157.x; COSTELLO LC, 1992, J BIOL CHEM, V267, P8599; DEGASPERI R, 1990, SCIENCE, V250, P988, DOI 10.1126/science.1978413; DOERING TL, 1989, J BIOL CHEM, V264, P11168; DOERING TL, 1991, SCIENCE, V252, P1851, DOI 10.1126/science.1829548; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; FATEMI SH, 1986, CELL, V46, P653, DOI 10.1016/0092-8674(86)90340-5; HANSON BA, 1980, J LIPID RES, V21, P309; HIROSE S, 1992, J BIOL CHEM, V267, P5272; HIROSE S, 1992, P NATL ACAD SCI USA, V89, P6025, DOI 10.1073/pnas.89.13.6025; HUFFAKER TC, 1982, J BIOL CHEM, V257, P3203; HYMAN R, 1988, TRENDS GENET, V4, P5, DOI 10.1016/0168-9525(88)90120-5; KAMITANI T, 1993, J BIOL CHEM, V268, P20733; KEPES F, 1988, J BIOL CHEM, V263, P9155; Lee G. Richard, 1993, P1232; LISANTI MP, 1990, TRENDS BIOCHEM SCI, V15, P113, DOI 10.1016/0968-0004(90)90195-H; LOW MG, 1988, SCIENCE, V239, P268, DOI 10.1126/science.3276003; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; MENON AK, 1990, EMBO J, V9, P4249, DOI 10.1002/j.1460-2075.1990.tb07873.x; MIYATA T, 1993, SCIENCE, V259, P1318, DOI 10.1126/science.7680492; NUOFFER C, 1991, MOL CELL BIOL, V11, P27, DOI 10.1128/MCB.11.1.27; ORLEAN P, 1988, J BIOL CHEM, V263, P17499; ORLEAN P, 1990, MOL CELL BIOL, V10, P5796, DOI 10.1128/MCB.10.11.5796; POPOLO L, 1993, J BACTERIOL, V175, P1879, DOI 10.1128/JB.175.7.1879-1885.1993; PUOTI A, 1991, J BIOL CHEM, V266, P21051; PUOTI A, 1991, J CELL BIOL, V113, P515, DOI 10.1083/jcb.113.3.515; Rose MD., 1990, METHODS YEAST GENETI; SMITH SW, 1974, J BIOL CHEM, V249, P3395; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; STEVENS VL, 1991, J BIOL CHEM, V266, P10039; SUGIYAMA E, 1991, J BIOL CHEM, V266, P12119; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; THOMAS JR, 1990, BIOCHEMISTRY-US, V29, P5413, DOI 10.1021/bi00475a001; THOMAS LJ, 1991, J BIOL CHEM, V266, P23175; VAI M, 1991, J BIOL CHEM, V266, P12242; YEH ETH, 1988, CELL, V52, P665, DOI 10.1016/0092-8674(88)90404-7	38	140	143	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 8	1994	269	14					10193	10196						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NF017	8144596				2022-12-27	WOS:A1994NF01700003
J	YANG, XD; MCDONOUGH, J; FYODOROV, D; MORRIS, M; WANG, F; DENERIS, ES				YANG, XD; MCDONOUGH, J; FYODOROV, D; MORRIS, M; WANG, F; DENERIS, ES			CHARACTERIZATION OF AN ACETYLCHOLINE-RECEPTOR ALPHA-3 GENE PROMOTER AND ITS ACTIVATION BY THE POU DOMAIN FACTOR SCIP/TST-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; CHICK CILIARY GANGLIA; RAT CENTRAL NEURONS; TRANSCRIPTION FACTOR; NICOTINIC RECEPTOR; HOMEOBOX GENE; FUNCTIONAL DIVERSITY; CPG ISLANDS; EXPRESSION; PROTEIN	Genes encoding neuronal nicotinic acetylcholine receptors exhibit restricted patterns of expression in the nervous system. We are interested in elucidating the molecular mechanisms responsible for establishing these patterns of expression. This paper presents the characterization of regulatory elements upstream of the neuronal nicotinic acetylcholine receptor alpha 3 gene. We have identified a GC-rich multistart site promoter adjacent to the alpha 3 coding region. Similar alpha 3 start sites were identified in PC12 cells and sympathetic ganglion neurons, suggesting similar control mechanisms in the clonal line and peripheral neurons. The start site region lacks TATA-like sequences but does contain initiator-like sequences. We show in transient transfection assays, that the POU domain transcription factor, SCI/Tst-1, specifically activates alpha 3 in a neural context. Other POU domain factors tested only weakly activated or repressed alpha 3. Unexpectedly, we found that alpha 3 basal activity and SCIP/Tst-1 activation of alpha 3 is not dependent on the SCIP/Tst-1 binding sites found upstream of the gene. In addition, mutations in the SCIP/Tst-1 coding region that prevent the factor from binding to DNA with high affinity do not obliterate alpha 3 activation. These results lead us to propose that alpha 3 activation by SCIP/Tst-1 is achieved via protein-protein interactions between SCIP/Tst-1 and a specific complement of transcription factors that act directly on the promoter.	CASE WESTERN RESERVE UNIV, SCH MED, DEPT NEUROSCI, CLEVELAND, OH 44106 USA	Case Western Reserve University					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029123] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS29123] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BOULTER J, 1986, NATURE, V319, P368, DOI 10.1038/319368a0; BOULTER J, 1990, J BIOL CHEM, V265, P4472; BOYD RT, 1988, NEURON, V1, P495; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARKE PBS, 1990, NICOTINE PSYCHOPHARM, P158; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; CORCORAN LM, 1993, GENE DEV, V7, P570, DOI 10.1101/gad.7.4.570; COUTURIER S, 1990, J BIOL CHEM, V265, P17560; DENERIS ES, 1991, TRENDS PHARMACOL SCI, V12, P34, DOI 10.1016/0165-6147(91)90486-C; DENERIS ES, 1988, NEURON, V1, P45, DOI 10.1016/0896-6273(88)90208-5; DENERIS ES, 1989, J BIOL CHEM, V264, P6268; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DUVOISIN RM, 1993, BRAZ J MED BIOL RES, V26, P137; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; GALZI JL, 1991, ANNU REV PHARMACOL, V31, P37, DOI 10.1146/annurev.pa.31.040191.000345; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HALVORSEN SW, 1990, J NEUROSCI, V10, P1711; HARA Y, 1992, P NATL ACAD SCI USA, V89, P3280, DOI 10.1073/pnas.89.8.3280; HE X, 1991, MOL CELL BIOL, V11, P1739, DOI 10.1128/MCB.11.3.1739; HE X, 1991, NEURON, V7, P183, DOI 10.1016/0896-6273(91)90257-Z; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; JAIN VK, 1991, ANAL BIOCHEM, V199, P119, DOI 10.1016/0003-2697(91)90278-2; JOHNSON WA, 1990, NATURE, V343, P467, DOI 10.1038/343467a0; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KO HS, 1988, CELL, V55, P135, DOI 10.1016/0092-8674(88)90016-5; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; LAI JS, 1992, GENE DEV, V6, P2058, DOI 10.1101/gad.6.11.2058; LEMOINE C, 1992, P NATL ACAD SCI USA, V89, P3285, DOI 10.1073/pnas.89.8.3285; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LU S, 1992, P NATL ACAD SCI USA, V89, P8053, DOI 10.1073/pnas.89.17.8053; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; MATHIS JM, 1992, EMBO J, V11, P2551, DOI 10.1002/j.1460-2075.1992.tb05320.x; Maxam A M, 1980, Methods Enzymol, V65, P499; MCCORMICK DA, 1987, J NEUROSCI, V7, P742; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MEIJER D, 1992, NUCLEIC ACIDS RES, V20, P2241, DOI 10.1093/nar/20.9.2241; MONUKI ES, 1993, MECH DEVELOP, V42, P15, DOI 10.1016/0925-4773(93)90095-F; MONUKI ES, 1990, SCIENCE, V249, P1300, DOI 10.1126/science.1975954; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; MULLE C, 1990, J NEUROSCI, V10, P169; MULLE C, 1991, J NEUROSCI, V11, P2588; MULLE C, 1992, NEURON, V8, P937, DOI 10.1016/0896-6273(92)90208-U; MULLE C, 1992, NEURON, V8, P135, DOI 10.1016/0896-6273(92)90115-T; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; PORTEUS MH, 1991, NEURON, V7, P221, DOI 10.1016/0896-6273(91)90260-7; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; ROGERS SW, 1992, J NEUROSCI, V12, P4611; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SCHOEPFER R, 1989, FEBS LETT, V257, P393, DOI 10.1016/0014-5793(89)81580-7; SCHOLER HR, 1991, TRENDS GENET, V7, P323, DOI 10.1016/0168-9525(91)90422-M; SIMEONE A, 1988, NUCLEIC ACIDS RES, V16, P5379, DOI 10.1093/nar/16.12.5379; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SOGAARDANDERSEN L, 1993, CELL, V75, P557, DOI 10.1016/0092-8674(93)90389-8; STROUD RM, 1990, BIOCHEMISTRY-US, V29, P11009, DOI 10.1021/bi00502a001; STURM RA, 1988, NATURE, V336, P601, DOI 10.1038/336601a0; SUZUKI N, 1990, EMBO J, V9, P3723, DOI 10.1002/j.1460-2075.1990.tb07585.x; TREACY MN, 1992, ANNU REV NEUROSCI, V15, P139, DOI 10.1146/annurev.ne.15.030192.001035; VOSS JW, 1991, GENE DEV, V5, P1309, DOI 10.1101/gad.5.7.1309; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; WEIS L, 1992, FASEB J, V6, P3300, DOI 10.1096/fasebj.6.14.1426767; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	74	52	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	1994	269	14					10252	10264						13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NF017	8144606				2022-12-27	WOS:A1994NF01700016
J	DENG, SJ; MACKENZIE, CR; SADOWSKA, J; MICHNIEWICZ, J; YOUNG, NM; BUNDLE, DR; NARANG, SA				DENG, SJ; MACKENZIE, CR; SADOWSKA, J; MICHNIEWICZ, J; YOUNG, NM; BUNDLE, DR; NARANG, SA			SELECTION OF ANTIBODY SINGLE-CHAIN VARIABLE FRAGMENTS WITH IMPROVED CARBOHYDRATE-BINDING BY PHAGE DISPLAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; B O-ANTIGEN; MONOCLONAL-ANTIBODY; FILAMENTOUS PHAGE; SALMONELLA; PROTEINS; MUTAGENESIS; LIBRARIES; SITE; OLIGOSACCHARIDE	A single-chain variable fragment (Fv) version of a murine monoclonal antibody, Se155-4, specific for Salmonella serogroup B O-polysaccharide, was used as a model system for testing monovalent phage display as a route for enhancing the relatively low affinities that typify anti-carbohydrate antibodies. Random single-chain Fv mutant libraries generated by chemical and error-prone polymerase chain reaction methods were panned against the serogroup B lipopolysaccharide. Panning of a randomly mutated heavy chain variable domain library indicated selection for improved serogroup B binders and yielded six mutants, rive of which showed wild type activity by enzyme immunoassay. Two of these were apparently selected on the basis of better functional single-chain Fv yield in Escherichia coli. A heavy chain mutation (Ile77 --> Thr) in one mutant, 3B1, appeared to have a particularly dramatic effect, resulting in yields of approximately 120 mg/liter of functional periplasmic product. The sixth mutant, 4B2, had complementarity determining region 1 (CDR1) and CDR2 mutations and demonstrated 10-fold improved binding, by enzyme immunoassay, relative to the wild type. Extensive analysis of antigen-antibody interactions indicated that the improved binding properties of 4B2 were attributable to a higher association rate constant and interaction with an epitope that is larger than the trisaccharide recognized by the wild type. None of the mutations involved known trisaccharide contact residues; this was consistent with analysis of wild type and mutant single-chain Fvs by titration microcalorimetry. Examination of the structure indicated that two mutations in the heavy chain CDR2 provided improved surface complementarity between the protein and the extended epitope encompassing 2 additional hexose residues. However, introduction of only the CDR2 mutations into the wild type structure failed to confer the improved binding properties of 4B2, indicating an indirect effect by the more distant mutations. Panning of randomly mutated light chain variable domain and full-length single-chain Fv mutant libraries did not yield mutants with improved assembly or binding properties.	NATL RES COUNCIL CANADA,INST BIOL SCI,OTTAWA K1A 0R6,ONTARIO,CANADA	National Research Council Canada								ANAND NN, 1991, GENE, V100, P39, DOI 10.1016/0378-1119(91)90347-E; ANAND NN, 1991, J BIOL CHEM, V266, P21874; AZIMZADEH A, 1992, Journal of Molecular Recognition, V5, P9, DOI 10.1002/jmr.300050103; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P4457, DOI 10.1073/pnas.89.10.4457; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; BASS S, 1990, PROTEINS, V8, P309, DOI 10.1002/prot.340080405; BRUMMELL DA, 1993, BIOCHEMISTRY-US, V32, P1180, DOI 10.1021/bi00055a024; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; CYGLER M, 1991, SCIENCE, V253, P442, DOI 10.1126/science.1713710; DENG SJ, 1993, NUCLEIC ACIDS RES, V21, P4418, DOI 10.1093/nar/21.18.4418; DIAZ JJ, 1991, BIOTECHNIQUES, V11, P204; DRICKAMER K, 1992, CURR OPIN STRUC BIOL, V2, P653; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; HERRON JN, 1986, BIOCHEMISTRY-US, V25, P4602, DOI 10.1021/bi00364a022; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; LAVOIE TB, 1992, J IMMUNOL, V148, P503; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Leung DW, 1989, TECHNIQUE, V1, P11; MAEDA H, 1977, BIOCHEMISTRY-US, V16, P4086, DOI 10.1021/bi00637a023; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MARKS JD, 1992, J BIOL CHEM, V267, P16007; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; MYERS RM, 1985, SCIENCE, V229, P242, DOI 10.1126/science.2990046; PECHT I, 1982, ANTIGENS, V6, P1; Sambrook J, 1989, MOL CLONING LABORATO; SHARON J, 1990, P NATL ACAD SCI USA, V87, P4814, DOI 10.1073/pnas.87.12.4814; SIGURSKJOLD BW, 1991, EUR J BIOCHEM, V197, P239, DOI 10.1111/j.1432-1033.1991.tb15904.x; SIGURSKJOLD BW, 1992, J BIOL CHEM, V267, P8371; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	30	89	115	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9533	9538						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144539				2022-12-27	WOS:A1994NE05300024
J	KHAN, MT; WANG, KKW; VILLALOBO, A; ROUFOGALIS, BD				KHAN, MT; WANG, KKW; VILLALOBO, A; ROUFOGALIS, BD			CHARACTERIZATION OF A NOVEL HIGH-MOLECULAR-MASS PROTEIN WITH PEPTIDASE ACTIVITY PURIFIED FROM THE HUMAN ERYTHROCYTE-MEMBRANE BY CALMODULIN AFFINITY-CHROMATOGRAPHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTICATALYTIC PROTEINASE; RAT-LIVER; THERMOPLASMA-ACIDOPHILUM; SENSITIVE METHOD; TRITON X-100; PURIFICATION; BINDING; COMPLEX; PROTEASOME; QUANTITIES	A previously undescribed high molecular mass protein (HMP) from human erythrocyte membranes was solubilized by Triton X-100 and purified on a calmodulin-agarose column in the presence of Ca2+. It was shown to have a native molecular mass of 522-560 kDa, comprised of a single subunit of a molecular mass of 28 kDa (p28). The protein is associated with the lipid bilayer rather than with the cytoskeletal component of the membrane. The purified HMP showed peptidase-hydrolyzing activity toward substrates containing hydrophobic amino acids at the P1 position of the P2-P1 cleavage site. The activity was inhibited by serine proteinase inhibitors (leupeptin, phenylmethanesulfonyl fluoride) and chymotrypsin inhibitors in particular (chymostatin, N-tosyl-L-phenylalanine chloromethyl ketone). The enzyme exhibited maximal activity at slightly alkaline pH (7.5-8.5) and at 37-degrees-C and was stimulated over a narrow range of SDS concentrations (maximal at 0.05%). HMP was found to cross-react in Western blots with an antibody raised against the rabbit multicatalytic proteinase. The single subunit of HMP therefore contains both the catalytic activity and a sequence necessary for its association into a multimeric complex. The properties of the human erythrocyte membrane HMP described indicate that it is a novel peptidase related to the ubiquitous multicatalytic proteinase.	UNIV SYDNEY,DEPT PHARM,SYDNEY,NSW 2006,AUSTRALIA; CSIC,INST INVEST BIOMED,E-28029 MADRID,SPAIN; UNIV BRITISH COLUMBIA,FAC PHARMACEUT SCI,VANCOUVER V6T 1Z3,BC,CANADA; PARK DAVIS CO,DIV PHARMACEUT RES,DEPT PHARMACOL,NEUROSCI SECT,ANN ARBOR,MI 48105	University of Sydney; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of British Columbia			Villalobo, Antonio/K-2902-2017; Villalobo, Antonio/O-9621-2019	Villalobo, Antonio/0000-0002-4200-374X; Wang, Kevin/0000-0002-9343-6473; Roufogalis, Basil/0000-0001-9123-5478				ARRIBAS J, 1990, J BIOL CHEM, V265, P13969; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CARDOZO C, 1992, BIOCHEMISTRY-US, V31, P7373, DOI 10.1021/bi00147a023; CLARK SJ, 1988, BIOCHIM BIOPHYS ACTA, V957, P243, DOI 10.1016/0167-4838(88)90279-8; DAHLMANN B, 1992, EUR J BIOCHEM, V208, P789, DOI 10.1111/j.1432-1033.1992.tb17249.x; DJABALLAH H, 1992, EUR J BIOCHEM, V209, P629, DOI 10.1111/j.1432-1033.1992.tb17329.x; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; FERGUSON KA, 1964, METABOLISM, V13, P985, DOI 10.1016/S0026-0495(64)80018-4; GARDNER K, 1986, J BIOL CHEM, V261, P1339; HEARING VJ, 1976, ANAL BIOCHEM, V72, P113, DOI 10.1016/0003-2697(76)90512-1; HOLLOWAY PW, 1973, ANAL BIOCHEM, V53, P304, DOI 10.1016/0003-2697(73)90436-3; KINOSHITA M, 1990, J BIOCHEM-TOKYO, V107, P440, DOI 10.1093/oxfordjournals.jbchem.a123064; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MASON RW, 1990, BIOCHEM J, V265, P479, DOI 10.1042/bj2650479; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCGUIRE MJ, 1989, BIOCHIM BIOPHYS ACTA, V995, P181, DOI 10.1016/0167-4838(89)90078-2; MELLGREN RL, 1990, BIOCHIM BIOPHYS ACTA, V1040, P28, DOI 10.1016/0167-4838(90)90142-3; MYKLES DL, 1991, ARCH BIOCHEM BIOPHYS, V288, P543, DOI 10.1016/0003-9861(91)90233-9; MYKLES DL, 1989, ARCH BIOCHEM BIOPHYS, V274, P216, DOI 10.1016/0003-9861(89)90433-5; ORLOWSKI M, 1990, BIOCHEMISTRY-US, V29, P10289, DOI 10.1021/bi00497a001; RIVETT AJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P1, DOI 10.1016/0003-9861(89)90558-4; RIVETT AJ, 1993, BIOCHEM J, V291, P1; SASAKI T, 1984, J BIOL CHEM, V259, P2489; TANAKA K, 1986, J BIOL CHEM, V261, P5197; TYLER JM, 1979, P NATL ACAD SCI USA, V76, P5192, DOI 10.1073/pnas.76.10.5192; WANG JH, 1985, CURR TOP CELL REGUL, V27, P419; WANG KKW, 1988, ARCH BIOCHEM BIOPHYS, V267, P317, DOI 10.1016/0003-9861(88)90037-9; ZOLFAGHARI R, 1987, ARCH BIOCHEM BIOPHYS, V258, P42, DOI 10.1016/0003-9861(87)90320-1; ZWICKL P, 1991, FEBS LETT, V278, P217, DOI 10.1016/0014-5793(91)80120-R	31	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10016	10021						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144498				2022-12-27	WOS:A1994NE05300093
J	SUN, HQ; WOOTEN, DC; JANMEY, PA; YIN, HL				SUN, HQ; WOOTEN, DC; JANMEY, PA; YIN, HL			THE ACTIN SIDE-BINDING DOMAIN OF GELSOLIN ALSO CAPS ACTIN-FILAMENTS - IMPLICATIONS FOR ACTIN FILAMENT SEVERING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE CAPPING PROTEIN; F-ACTIN; END; IDENTIFICATION; GCAP39; VILLIN; REQUIREMENTS; SEQUENCES; PLASMA; FAMILY	Gelsolin is an actin filament-severing and -capping protein which is inhibited by polyphosphoinositides (PPI). Severing requires gelsolin binding to the side of the filaments through a site in segments 2 and 3 (S2-3) to position another site in segment 1 (S1) to sever filaments. In this paper, we report that S2-3, like S1, caps actin filaments. Since neither S1 and S2-3 caps as well as gelsolin, and neither severs actin filament, S2-3 may actively contribute to severing by capping filaments cooperatively with S1. We used deletional mutagenesis to locate the S2-3 sequence required for actin filament side binding, capping, and PPI binding and found that these sites are located close to the NH 2 terminus of S2 (residues 161-172). S3, a segment which has no known function up to now and does not by itself bind actin, contributes to stable capping and may contain an additional PPI-binding site.	UNIV TEXAS,SW MED CTR,DEPT PHYSIOL,DALLAS,TX 75235; HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DIV EXPTL MED,BOSTON,MA 02115	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital; Harvard Medical School					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR038910, R01AR038910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031430] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR38910] Funding Source: Medline; NIGMS NIH HHS [GM51112] Funding Source: Medline; NINDS NIH HHS [NS31430] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEARER EL, 1991, J CELL BIOL, V115, P1629, DOI 10.1083/jcb.115.6.1629; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYAN J, 1988, J CELL BIOL, V106, P1553, DOI 10.1083/jcb.106.5.1553; CANO ML, 1992, CELL MOTIL CYTOSKEL, V21, P147, DOI 10.1002/cm.970210208; CHAPONNIER C, 1986, J CELL BIOL, V103, P1473, DOI 10.1083/jcb.103.4.1473; DABIRI GA, 1992, J BIOL CHEM, V267, P16545; DEARRUDA MV, 1992, J BIOL CHEM, V267, P13079; EICHINGER L, 1992, BIOCHEMISTRY-US, V31, P4779, DOI 10.1021/bi00135a006; HALTIA M, 1990, AM J PATHOL, V136, P1223; JANMEY PA, 1987, J BIOL CHEM, V262, P12228; JANMEY PA, 1989, J BIOL CHEM, V264, P4825; JANMEY PA, 1992, J BIOL CHEM, V267, P11818; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; KWIATKOWSKI DJ, 1985, J BIOL CHEM, V260, P5232; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; MACIVER SK, 1991, J CELL BIOL, V115, P1611, DOI 10.1083/jcb.115.6.1611; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; POPE B, 1991, FEBS LETT, V280, P70, DOI 10.1016/0014-5793(91)80206-I; RUHNAU K, 1989, J MOL BIOL, V210, P141, DOI 10.1016/0022-2836(89)90296-9; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SELVE N, 1986, EUR J BIOCHEM, V155, P937; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; WAY M, 1992, J CELL BIOL, V116, P1135, DOI 10.1083/jcb.116.5.1135; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835; WEBER A, 1991, BIOCHEMISTRY-US, V30, P9327, DOI 10.1021/bi00102a027; WEEDS AG, 1991, BIOCHEM SOC T, V19, P1016, DOI 10.1042/bst0191016; Weeds A, 1993, CURR OPIN CELL BIOL, V5, P63, DOI 10.1016/S0955-0674(05)80009-2; WEIGT C, 1992, J MOL BIOL, V227, P593, DOI 10.1016/0022-2836(92)90915-7; YIN HL, 1988, J CELL BIOL, V106, P805, DOI 10.1083/jcb.106.3.805; YIN HL, 1987, BIOESSAYS, V7, P176, DOI 10.1002/bies.950070409; YOUNG CL, 1990, BIOCHEMISTRY-US, V29, P2232, DOI 10.1021/bi00461a005; YU FX, 1990, SCIENCE, V250, P1413, DOI 10.1126/science.2255912; YU FX, 1991, J BIOL CHEM, V266, P19269; YU FX, 1992, J BIOL CHEM, V267, P14616	35	56	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9473	9479						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144531				2022-12-27	WOS:A1994NE05300015
J	UDOVICHENKO, IP; CUNNICK, J; GONZALEZ, K; TAKEMOTO, DJ				UDOVICHENKO, IP; CUNNICK, J; GONZALEZ, K; TAKEMOTO, DJ			FUNCTIONAL EFFECT OF PHOSPHORYLATION OF THE PHOTORECEPTOR PHOSPHODIESTERASE INHIBITORY SUBUNIT BY PROTEIN-KINASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENTS; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; LIGHT-MEDIATED BREAKDOWN; AMINO-ACID SEQUENCE; CGMP PHOSPHODIESTERASE; GAMMA-SUBUNIT; INOSITOL TRISPHOSPHATE; GMP PHOSPHODIESTERASE; SYNTHETIC PEPTIDES; VISUAL EXCITATION	In rod outer segments the light activation of cGMP phosphodiesterase (PDEalphabetagamma2) is accomplished by removal of the gamma inhibitory subunit (PDEgamma) from the PDEalphabeta catalytic subunits. A light activation of the inositol signaling pathway also occurs, but there is little information linking these two signal transduction pathways. Here we report that protein kinase C (PKC) purified from bovine rod outer segment phosphorylates the bovine PDEgamma with incorporation of 0.9 +/- 0.1 mol of phosphate/mol of PDEgamma. Phosphorylation of PDEgamma increases its ability to inhibit PDEalphabeta catalytic activity (trypsin-activated PDE, tPDE) with an IC50 for phosphorylated PDEgamma of 26 +/- 4 pM and an IC50 of 60 +/- 5 pM for unphosphorylated PDEgamma. Inhibition of tPDE by PDEgamma is characterized by two values of K(d), K(d1) = 34 pm and K(d2) = 760 pM. Phosphorylation of PDEgamma by PKC eliminates the functional heterogeneity of the PDEgamma population resulting in a single value of K(d) = 23 pM. Free PDEgamma (without PDEalphabeta catalytic subunits) is a better substrate for PKC than PDEgamma in a complex with PDEalphabeta. Phosphorylation of free PDEgamma by PKC is characterized by a value of V(max) = 1,550 +/- 148 units/mg (K(m) = 21.0 +/- 1.9 muM). In contrast, phosphorylation of PDEgamma in PDEalphabetagamma2 complex has two values of V(max), V(max1) = 0.3 +/- 0.1 units/mg of PDEgamma (K(m1) = 0.4 +/- 0.2 muM) and V(max2) = 0.7 +/- 0.2 units/mg of PDEgamma (K(m2) = 4.6 +/- 0.9 muM). ROS PKC phosphorylates Thr35 in PDEgamma. We have previously reported (Morrison, D. F., Rider, M. A., and Takemoto, D. J. (1987) FEBS Lett. 222, 266-270; Lipkin, V. M., Udovichenko, I. P., Bodarenko, V. A., Yurovskaya, A. A., Telnykh, E. V., and Skiba, N. P. (1990) Biomed. Sci. (Lond.) 1, 305-308) that the central fragment of PDEgamma (24-45) is responsible for binding to PDE catalytic subunits. The new data suggests that this region of PDEgamma also includes the site for phosphorylation by PKC and that phosphorylation increases the ability of PDEgamma to inhibit PDE catalytic activity. This altered regulation of visual transduction may play a role in desensitization or light adaptation.	KANSAS STATE UNIV AGR & APPL SCI, DEPT BIOCHEM, WILLARD HALL, MANHATTAN, KS 66506 USA	Kansas State University			Cunnick, Jess/F-1715-2018		NCI NIH HHS [CA-09418] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009418] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BINDER BM, 1989, J BIOL CHEM, V264, P8857; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN JE, 1984, NATURE, V311, P160, DOI 10.1038/311160a0; BROWN RL, 1989, P NATL ACAD SCI USA, V86, P4922, DOI 10.1073/pnas.86.13.4922; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DAS ND, 1987, CELL STRUCT FUNCT, V12, P471, DOI 10.1247/csf.12.471; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; GEHM BD, 1990, BIOCHEMISTRY-US, V29, P5447, DOI 10.1021/bi00475a006; GHALAYINI A, 1984, BIOCHEM BIOPH RES CO, V124, P503, DOI 10.1016/0006-291X(84)91582-1; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GORMAN JJ, 1984, ANAL BIOCHEM, V136, P397, DOI 10.1016/0003-2697(84)90235-5; HANSEN RS, 1988, METHOD ENZYMOL, V159, P543; HAYASHI F, 1991, P NATL ACAD SCI USA, V88, P4333, DOI 10.1073/pnas.88.10.4333; HAYASHI F, 1985, BIOCHEM BIOPH RES CO, V128, P954, DOI 10.1016/0006-291X(85)90139-1; HUANG KP, 1986, J BIOL CHEM, V261, P2134; KAPOOR CL, 1984, BIOCHEM BIOPH RES CO, V122, P1397, DOI 10.1016/0006-291X(84)91246-4; KELLEHER DJ, 1985, J CYCLIC NUCL PROT, V10, P579; KELLEHER DJ, 1986, J BIOL CHEM, V261, P4749; KINCAID RL, 1988, METHOD ENZYMOL, V159, P457; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lipkin V M, 1990, Biomed Sci, V1, P305; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MORRISON DF, 1989, J BIOL CHEM, V264, P11671; MORRISON DF, 1987, FEBS LETT, V222, P266, DOI 10.1016/0014-5793(87)80383-6; NEWTON AC, 1991, J BIOL CHEM, V266, P17725; NEWTON AC, 1993, TRENDS BIOCHEM SCI, V18, P275, DOI 10.1016/0968-0004(93)90032-I; OTTOBRUC A, 1993, BIOCHEMISTRY-US, V32, P8636, DOI 10.1021/bi00084a035; OVCHINNIKOV YA, 1986, FEBS LETT, V201, P237, DOI 10.1016/0014-5793(86)80616-0; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SEGEL MR, 1961, THEORY PROBLEMS STAT; STRYER L, 1991, J BIOL CHEM, V266, P10711; SZUTS EZ, 1986, BIOCHEM J, V240, P929, DOI 10.1042/bj2400929; TUTEJA N, 1990, GENE, V88, P227, DOI 10.1016/0378-1119(90)90035-P; TUTEJA N, 1988, FEBS LETT, V232, P182, DOI 10.1016/0014-5793(88)80413-7; UDOVICHENKO IP, 1993, BIOCHEM J, V295, P49, DOI 10.1042/bj2950049; UDOVICHENKO IP, 1993, INVEST OPHTH VIS SCI, V34, P1325; WEYAND I, 1990, EUR J BIOCHEM, V193, P459, DOI 10.1111/j.1432-1033.1990.tb19360.x; WHALEN MM, 1989, BIOCHEM J, V259, P13, DOI 10.1042/bj2590013; WILDEN U, 1986, FEBS LETT, V207, P292, DOI 10.1016/0014-5793(86)81507-1; Williams LT, 1978, RECEPTOR BINDING STU; WITT JJ, 1975, ANAL BIOCHEM, V66, P253, DOI 10.1016/0003-2697(75)90743-5; WOLBRING G, 1991, EUR J BIOCHEM, V201, P601, DOI 10.1111/j.1432-1033.1991.tb16320.x	47	44	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9850	9856						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144577				2022-12-27	WOS:A1994NE05300071
J	YAMANOUCHI, T; TACHIBANA, Y; SEKINO, N; AKANUMA, H; AKAOKA, I; MIYASHITA, H				YAMANOUCHI, T; TACHIBANA, Y; SEKINO, N; AKANUMA, H; AKAOKA, I; MIYASHITA, H			TRANSPORT AND ACCUMULATION OF 1,5-ANHYDRO-D-GLUCITOL IN THE HUMAN ERYTHROLEUKEMIA CELL-LINE K-562	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETES-MELLITUS; PLASMA 1,5-ANHYDRO-D-GLUCITOL; CEREBROSPINAL-FLUID; MAJOR POLYOL; 1,5-ANHYDROGLUCITOL; RATS; REDUCTION; MEMBRANES; GLUCOSE; BINDING	The transport and intracellular accumulation of 1,5-anhydro-D-glucitol (AG) was studied in the human erythroleukemia cell line K-562 by gas chromatography-mass spectrometry in conjunction with liquid scintillation spectrometry. K-562 cells contained 106 +/- 6 nM/10(6) cells of free AG, primarily in the cytosol. Addition of physiologic amounts of AG to the extracellular medium resulted in rapid intracellular incorporation of AG, with a half-saturation time of 5 s. Intracellular accumulation was linear for 2 h and subsequently reached saturation. AG uptake was temperature and concentration dependent with an apparent K(m) of 127 mm. AG uptake and accumulation was not inhibited by fructose, fucose, galactose, mannose, glucose, or 3-O-methyl-D-glucose and was less affected by cytochalasin B or phloretin than that of 2-deoxyglucose. Phloridzin did not affect AG uptake but did inhibit 2-deoxyglucose uptake. Efflux of AG from K-562 cells depended on external AG concentration alone and was not affected by extracellular glucose concentration. Intracellular AG concentration decreased rapidly and reached zero within 10 min following removal of AG from the external medium. We therefore propose that both transport and countertransport of AG in K-562 cells are mediated by a specific carrier system.	UNIV TOKYO,COLL ARTS & SCI,DEPT CHEM,TOKYO 153,JAPAN	University of Tokyo	YAMANOUCHI, T (corresponding author), TEIKYO UNIV,DEPT INTERNAL MED 2,ITABASHI KU,TOKYO 173,JAPAN.							AKANUMA Y, 1988, DIABETOLOGIA, V31, P831; AKANUMA Y, 1981, DIABETES S1, V30, P124; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; CHODAT R, 1888, ARCH SCI PHYS MATER, V19, P590; CRANE RK, 1960, BIOCHIM BIOPHYS ACTA, V45, P460, DOI 10.1016/0006-3002(60)91482-7; CRANE RK, 1957, J BIOL CHEM, V224, P649; CRANE RK, 1962, FED PROC, V21, P891; KAHLENBERG A, 1972, CAN J BIOCHEM CELL B, V50, P638, DOI 10.1139/o72-088; KAMETANI S, 1987, J BIOCHEM-TOKYO, V102, P1599, DOI 10.1093/oxfordjournals.jbchem.a122210; KHYM JX, 1975, CLIN CHEM, V21, P1245; KLEINZELLER A, 1980, BIOCHIM BIOPHYS ACTA, V600, P513, DOI 10.1016/0005-2736(80)90453-8; KLEMPNER MS, 1980, J CELL BIOL, V86, P21, DOI 10.1083/jcb.86.1.21; NAKAMURA T, 1986, J BIOCHEM-TOKYO, V99, P607, DOI 10.1093/oxfordjournals.jbchem.a135519; NAKANISHI T, 1989, P NATL ACAD SCI USA, V86, P6002, DOI 10.1073/pnas.86.15.6002; NEMATGORGANI M, 1986, ARCH BIOCHEM BIOPHYS, V251, P97, DOI 10.1016/0003-9861(86)90055-X; OKUNO Y, 1992, J BIOCHEM-TOKYO, V111, P99, DOI 10.1093/oxfordjournals.jbchem.a123726; PETERSON JI, 1968, ANAL BIOCHEM, V23, P301, DOI 10.1016/0003-2697(68)90361-8; PITKANEN E, 1972, CLIN CHIM ACTA, V38, P221, DOI 10.1016/0009-8981(72)90230-6; PITKANEN E, 1973, CLIN CHIM ACTA, V48, P159, DOI 10.1016/0009-8981(73)90361-6; PITKANEN E, 1984, EXPERIENTIA, V40, P463, DOI 10.1007/BF01952387; Richtmyer NK, 1943, J AM CHEM SOC, V65, P1477, DOI 10.1021/ja01248a013; SAMARZIJA I, 1982, PFLUG ARCH EUR J PHY, V393, P190, DOI 10.1007/BF00582943; SERVO C, 1975, DIABETOLOGIA, V11, P575, DOI 10.1007/BF01222109; SUZUKI M, 1988, J BIOCHEM-TOKYO, V104, P956, DOI 10.1093/oxfordjournals.jbchem.a122590; ULLRICH KJ, 1974, PFLUG ARCH EUR J PHY, V351, P35, DOI 10.1007/BF00603509; YAMANOUCHI T, 1992, METABOLISM, V41, P862, DOI 10.1016/0026-0495(92)90168-A; YAMANOUCHI T, 1989, DIABETES, V38, P723, DOI 10.2337/diabetes.38.6.723; YAMANOUCHI T, 1986, DIABETES, V35, P204, DOI 10.2337/diabetes.35.2.204; YAMANOUCHI T, 1987, DIABETES, V36, P709, DOI 10.2337/diabetes.36.6.709; YAMANOUCHI T, 1992, AM J PHYSIOL, V263, pE268, DOI 10.1152/ajpendo.1992.263.2.E268; YAMANOUCHI T, 1985, DIABETES, V34, P347, DOI 10.2337/diabetes.34.4.347; YAMANOUCHI T, 1991, DIABETES, V40, P52, DOI 10.2337/diabetes.40.1.52; YAMANOUCHI T, 1990, AM J PHYSIOL, V258, pE423, DOI 10.1152/ajpendo.1990.258.3.E423; YAMANOUCHI T, 1988, DIABETOLOGIA, V31, P41; YOSHIOKA S, 1983, CLIN CHEM, V29, P1396	35	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9664	9668						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144554				2022-12-27	WOS:A1994NE05300043
J	LAND, M; ISLASTREJO, A; FREEDMAN, JH; RUBIN, CS				LAND, M; ISLASTREJO, A; FREEDMAN, JH; RUBIN, CS			STRUCTURE AND EXPRESSION OF A NOVEL, NEURONAL PROTEIN-KINASE-C (PKC1B) FROM CAENORHABDITIS-ELEGANS - PKC1B IS EXPRESSED SELECTIVELY IN NEURONS THAT RECEIVE, TRANSMIT, AND PROCESS ENVIRONMENTAL SIGNALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; DEVELOPMENTAL REGULATION; CATALYTIC SUBUNIT; GENE-EXPRESSION; II-BETA; CLONING; FAMILY; PURIFICATION; SEQUENCE; MUTATIONS	The nematode Caenorhabditis elegans provides an advantageous system for investigating the regulation, expression, and functions of protein kinase C (PKC) isoforms. We cloned and characterized cDNAs encoding a novel C. elegans PKC designated PKC1B. The predicted PKC1B polypeptide contains features characteristic of the nPKC subfamily of PKC isoforms. The levels of PKC1B and its cognate mRNA vary over a 7-fold range during C. elegans postembryonic development. PKC1B protein and mRNA are abundant at the earliest larval stage, but their relative concentrations decrease coordinately in late larvae. Embryos, which are enriched in PKC1B mRNA, contain little PKC1B protein. Thus, PKC1B expression is regulated at a translational or post-translational level during early development. Cells engaged in PKC1B gene transcription were identified in transgenic C. elegans that carry the lacZ gene under the regulation of the PKC1B promoter. Staining for beta galactosidase revealed PKC1B promoter activity exclusively in sensory neurons and interneurons. Immunofluorescence microscopy disclosed that the PKC1B polypeptide is located in the processes (axons and dendrites) and perinuclear regions of similar to 75 neurons that constitute the sensory circuitry of the nematode. The intracellular lo calization of PKC1B and the enzyme's differential solubility in ionic and nonionic detergents suggest that the kinase is associated with membranes and the cytoskeleton.	ALBERT EINSTEIN COLL MED, DEPT MOLEC PHARMACOL, ATRAN LABS, BRONX, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine					NIDDK NIH HHS [DK07513, DK44957] Funding Source: Medline; NIGMS NIH HHS [GM 07260] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044957, T32DK007513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007260] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ASAOKA Y, 1992, TRENDS BIOCHEM SCI, V17, P414, DOI 10.1016/0968-0004(92)90011-W; BAIER G, 1993, J BIOL CHEM, V268, P4997; BARGMANN CI, 1990, COLD SPRING HARB SYM, V55, P529; BLUMENTHAL T, 1988, TRENDS GENET, V4, P305, DOI 10.1016/0168-9525(88)90107-2; BREGMAN DB, 1991, J BIOL CHEM, V266, P7207; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; COULSON A, 1991, BIOESSAYS, V13, P413, DOI 10.1002/bies.950130809; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; FIRE A, 1991, DEVELOPMENT, V113, P503; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; FIRE A, 1986, EMBO J, V5, P2673, DOI 10.1002/j.1460-2075.1986.tb04550.x; FREEDMAN JH, 1993, J BIOL CHEM, V268, P2554; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; GROSS RE, 1990, J BIOL CHEM, V265, P6896; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HIRSCH AH, 1992, J BIOL CHEM, V267, P2131; HODGKIN J, 1988, NEMATODE CAENORHABDI, P493; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HU E, 1991, J BIOL CHEM, V266, P19796; HU ED, 1990, J BIOL CHEM, V265, P5072; HUANG KP, 1991, METHOD ENZYMOL, V200, P241; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Jaken S, 1990, CURR OPIN CELL BIOL, V2, P192, DOI 10.1016/0955-0674(90)90006-Z; KENYON C, 1988, SCIENCE, V240, P1448, DOI 10.1126/science.3287621; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; KNOPF JL, 1986, CELL, V46, P491, DOI 10.1016/0092-8674(86)90874-3; KOIDE H, 1992, P NATL ACAD SCI USA, V89, P1149, DOI 10.1073/pnas.89.4.1149; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; KRUGER KE, 1991, J NEUROSCI, V11, P2303; LU X, 1990, J BIOL CHEM, V265, P3292; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OHNO S, 1988, CELL, V53, P731, DOI 10.1016/0092-8674(88)90091-8; ONO Y, 1988, J BIOL CHEM, V263, P6927; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RUVKUN G, 1989, NATURE, V338, P313, DOI 10.1038/338313a0; Sambrook J, 1989, MOL CLONING LABORATO; SASSA T, 1992, BIOCHEM J, V282, P219, DOI 10.1042/bj2820219; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOSSIN WS, 1993, J BIOL CHEM, V268, P5763; STABEL S, 1991, PHARMACOL THERAPEUT, V51, P71, DOI 10.1016/0163-7258(91)90042-K; SUL HS, 1984, J BIOL CHEM, V259, P1201; SULSTON J, 1988, NEMATODE CAENORHABDI, P123; Sulston J., 1988, NEMATODE CAENORHABDI, P603; TABUSE Y, 1983, CARCINOGENESIS, V4, P783, DOI 10.1093/carcin/4.6.783; TABUSE Y, 1989, SCIENCE, V243, P1713, DOI 10.1126/science.2538925; TAYLOR SS, 1993, TRENDS BIOCHEM SCI, V18, P84, DOI 10.1016/0968-0004(93)80001-R; WETSEL WC, 1992, J CELL BIOL, V117, P121, DOI 10.1083/jcb.117.1.121; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1987, J CELL BIOL, V105, P41, DOI 10.1083/jcb.105.1.41; WOOD WB, 1980, DEV BIOL, V74, P446, DOI 10.1016/0012-1606(80)90445-5; [No title captured]	55	52	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9234	9244						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132661				2022-12-27	WOS:A1994NB41100090
J	MOCZKO, M; EHMANN, B; GARTNER, F; HONLINGER, A; SCHAFER, E; PFANNER, N				MOCZKO, M; EHMANN, B; GARTNER, F; HONLINGER, A; SCHAFER, E; PFANNER, N			DELETION OF THE RECEPTOR MOM19 STRONGLY IMPAIRS IMPORT OF CLEAVABLE PREPROTEINS INTO SACCHAROMYCES-CEREVISIAE MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; YEAST MITOCHONDRIA; PRECURSOR PROTEINS; OUTER-MEMBRANE; INTERMEMBRANE SPACE; INNER MEMBRANE; TRANSLOCATION; COMPLEX; IDENTIFICATION; CYTOCHROME-B2	The mitochondrial outer membrane proteins MOM19 and MOM72 are thought to function as import receptors for nuclear encoded preproteins. Different views exist about the importance of each receptor in the import of cleavable and noncleavable preproteins into mitochondria. Here we cloned and sequenced MOM19 from Saccharomyces cerevisiae and constructed a gene disruption mutant. Yeast cells lacking MOM19 were unable to grow on nonfermentable carbon sources and were slow in growing on a fermentable medium, while the growth of yeast cells lacking MOM72 (Mas70p) was much less impaired. Delta MOM19 cells accumulated considerable amounts of mitochondrial preproteins in vivo. The import of cleavable preproteins into isolated Delta MOM19 mitochondria was strongly inhibited, while import of the noncleavable ADP/ATP carrier and phosphate carrier was only slightly inhibited. The reciprocal situation was found for protein import into Delta MOM72 mitochondria. In particular, import of the cleavable precursor of cytochrome c(1) into Delta MOM72 mitochondria was, in agreement with a previous report (Hines, V., and Schatz, G. (1993) J. Biol. Chem. 268, 449-454), found to be partially inhibited, yet a much stronger inhibition of import was seen into Delta MOM19 mitochondria. The direct comparison of protein import into yeast mutants of either receptor yields a unifying hypothesis on mitochondrial preprotein targeting; both receptors have an overlapping specificity, and MOM19 plays a major role for cleavable preproteins. Interestingly, the primary sequence of MOM19 predicts the presence of a tetratricopeptide motif that was also found in MOM72, in the peroxisomal membrane protein PAS8/PAS10, and in several proteins involved in RNA synthesis or mitosis.	UNIV FREIBURG, INST BIOCHEM, D-79104 FREIBURG, GERMANY; UNIV FREIBURG, INST BIOL 2, D-79104 FREIBURG, GERMANY	University of Freiburg; University of Freiburg			Pfanner, Nikolaus/AAV-7878-2021					Ausubel F.M., 1992, SHORT PROTOCOLS MOL; BAKER KP, 1990, NATURE, V348, P605, DOI 10.1038/348605a0; BAKER KP, 1991, NATURE, V349, P205, DOI 10.1038/349205a0; BECKER K, 1992, J BIOL CHEM, V267, P5637; DAUM G, 1982, J BIOL CHEM, V257, P3028; DIETMEIER K, 1993, J BIOL CHEM, V268, P25958; DOUGLAS MG, 1986, MICROBIOL REV, V50, P166, DOI 10.1128/MMBR.50.2.166-178.1986; GASSER SM, 1982, P NATL ACAD SCI-BIOL, V79, P267, DOI 10.1073/pnas.79.2.267; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; HARTL FU, 1987, CELL, V51, P1027, DOI 10.1016/0092-8674(87)90589-7; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; HINES V, 1993, J BIOL CHEM, V268, P449; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; Horwich A, 1990, CURR OPIN CELL BIOL, V2, P625, DOI 10.1016/0955-0674(90)90103-L; KASSENBROCK CK, 1993, EMBO J, V12, P3023, DOI 10.1002/j.1460-2075.1993.tb05971.x; KIEBLER M, 1993, CELL, V74, P483, DOI 10.1016/0092-8674(93)80050-O; KIEBLER M, 1990, NATURE, V348, P610, DOI 10.1038/348610a0; MARTIN J, 1991, J BIOL CHEM, V266, P18051; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; MOCZKO M, 1993, FEBS LETT, V326, P251, DOI 10.1016/0014-5793(93)81801-6; MOCZKO M, 1992, FEBS LETT, V310, P265, DOI 10.1016/0014-5793(92)81345-M; PFALLER R, 1987, EMBO J, V6, P2635, DOI 10.1002/j.1460-2075.1987.tb02554.x; PFALLER R, 1989, J BIOL CHEM, V264, P34; PFANNER N, 1987, EMBO J, V6, P3449, DOI 10.1002/j.1460-2075.1987.tb02668.x; PFANNER N, 1988, TRENDS BIOCHEM SCI, V13, P165, DOI 10.1016/0968-0004(88)90140-5; RAMAGE L, 1993, EMBO J, V12, P4115, DOI 10.1002/j.1460-2075.1993.tb06095.x; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER H, 1991, SCIENCE, V254, P1659, DOI 10.1126/science.1661031; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1992, NATURE, V355, P84, DOI 10.1038/355084a0; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; SOLLNER T, 1991, METHOD CELL BIOL, V34, P345; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; TEINTZE M, 1982, J BIOL CHEM, V257, P364; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535	38	115	116	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9045	9051						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132642				2022-12-27	WOS:A1994NB41100065
J	LEITINGER, B; BROWN, JL; SPIESS, M				LEITINGER, B; BROWN, JL; SPIESS, M			TAGGING SECRETORY AND MEMBRANE-PROTEINS WITH A TYROSINE SULFATION SITE - TYROSINE SULFATION PRECEDES GALACTOSYLATION AND SIALYLATION IN COS-7 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI-APPARATUS; TYROSYLPROTEIN SULFOTRANSFERASE; ALPHA-1-PROTEINASE INHIBITOR; HELA-CELLS; TRANSPORT; SURFACE; GALACTOSYLTRANSFERASE; GLYCOSYLATION; EXPRESSION; PATHWAYS	Sulfation of proteins on tyrosines is a late Golgi modification that can be used to label proteins with [S-35]sulfate for the analysis of post-Golgi transport. To extend the use of this modification to proteins not naturally sulfated, we fused a tyrosine sulfation site, the carboxyl-terminal nonapeptide of cholecystokinin precursor, to the carboxyl terminus of two normally unsulfated proteins: alpha(1)-proteinase inhibitor, a secretory protein, and subunit H1 of the asialoglycoprotein receptor, a type II membrane protein. The tagged proteins were efficiently sulfated in transfected COS-7 and Madin-Darby canine kidney cells. Specifically in COS-7 cells, the proteins were sulfated before they were galactosylated and sialylated and were converted to the mature forms with a half-time of approximately 2-3 min. This is in contrast to other cell types in which tyrosine sulfation was found to be virtually the last modification of the Golgi apparatus. Our results suggest that tyrosine sulfation occurs before the trans-Golgi in transfected COS-7 cells.	UNIV BASEL,BIOZENTRUM,DEPT BIOCHEM,CH-4056 BASEL,SWITZERLAND; UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM BIOPHYS & GENET,DENVER,CO 80262	University of Basel; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver				Spiess, Martin/0000-0001-7139-0550				ADRIAN TE, 1986, FEBS LETT, V196, P5, DOI 10.1016/0014-5793(86)80203-4; ARATANI Y, 1988, FEBS LETT, V235, P129, DOI 10.1016/0014-5793(88)81247-X; BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; BRANTLY M, 1988, AM J MED, V84, P13; BRODBECK RM, 1992, J BIOL CHEM, V267, P294; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DUNPHY WG, 1983, J CELL BIOL, V97, P270, DOI 10.1083/jcb.97.1.270; DUNPHY WG, 1981, P NATL ACAD SCI-BIOL, V78, P7453, DOI 10.1073/pnas.78.12.7453; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FRIEDERICH E, 1988, J CELL BIOL, V107, P1655, DOI 10.1083/jcb.107.5.1655; GEFFEN I, 1992, INT REV CYTOL, V137B, P181; GOLDBERG DE, 1983, J BIOL CHEM, V258, P3159; GRIMES M, 1992, J CELL BIOL, V117, P539, DOI 10.1083/jcb.117.3.539; HORTIN G, 1986, BIOCHEM BIOPH RES CO, V141, P326, DOI 10.1016/S0006-291X(86)80372-2; HUTTNER WB, 1984, METHOD ENZYMOL, V107, P200; HUTTNER WB, 1988, ANNU REV PHYSIOL, V50, P363, DOI 10.1146/annurev.ph.50.030188.002051; KAWAI S, 1984, MOL CELL BIOL, V4, P1172, DOI 10.1128/MCB.4.6.1172; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; MEGA T, 1980, J BIOL CHEM, V255, P4057; NIEHRS C, 1990, EMBO J, V9, P35, DOI 10.1002/j.1460-2075.1990.tb08077.x; NIEHRS C, 1992, J BIOL CHEM, V267, P15938; NIEHRS C, 1990, J BIOL CHEM, V265, P8525; NIEHRS C, 1990, J BIOL CHEM, V265, P9314; REGNIERVIGOUROUX A, 1991, EMBO J, V10, P3589, DOI 10.1002/j.1460-2075.1991.tb04925.x; ROSA P, 1992, J BIOL CHEM, V267, P1227; ROSENQUIST GL, 1993, PROTEIN SCI, V2, P215; ROTH J, 1982, J CELL BIOL, V93, P223, DOI 10.1083/jcb.93.1.223; ROTH J, 1985, CELL, V43, P287, DOI 10.1016/0092-8674(85)90034-0; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; SLOT JW, 1983, J HISTOCHEM CYTOCHEM, V31, P1049, DOI 10.1177/31.8.6863900; SPIESS M, 1985, J BIOL CHEM, V260, P1979; STROUS GJ, 1983, J CELL BIOL, V97, P723, DOI 10.1083/jcb.97.3.723; TOOZE SA, 1990, CELL, V60, P837, DOI 10.1016/0092-8674(90)90097-X	35	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8115	8121						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132536				2022-12-27	WOS:A1994NB40900045
J	LIPPUNER, V; CHOUS, IT; SCOTT, SV; ETTINGER, WF; THEG, SM; GASSER, CS				LIPPUNER, V; CHOUS, IT; SCOTT, SV; ETTINGER, WF; THEG, SM; GASSER, CS			CLONING AND CHARACTERIZATION OF CHLOROPLAST AND CYTOSOLIC FORMS OF CYCLOPHILIN FROM ARABIDOPSIS-THALIANA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS-ISOMERASE; BINDING PROTEIN CYCLOPHILIN; ESCHERICHIA-COLI; CYCLOSPORINE-A; ENDOPLASMIC-RETICULUM; PEPTIDYLPROLYL-CIS; PROLYL ISOMERASE; GENE; DNA; EXPRESSION	Cyclophilin (CyP), a protein with peptidyl-prolyl cistrans isomerase (rotamase) activity, is the specific cellular target of cyclosporin A, We have isolated cDNA clones of two genes (designated ROC1 and ROC4) encoding CyP homologs from Arabidopsis thaliana (L.). The protein products of these genes are distinct from a previously identified Arabidopsis CyP. ROC1 is expressed in all tested plant organs and encodes a protein which is highly similar to previously described cytosolic CyP isoforms of other plants. In contrast, ROC4 is expressed only in photosynthetic organs and encodes a protein which includes an amino-terminal extension with properties of known chloroplast transit peptides. In vitro import experiments using the putative precursor protein to ROC4 showed that the protein is imported into chloroplasts where it is processed to the predicted mature size. Rotamase assays and immunoblot analysis of subcellular fractions indicate the presence of a CyP isoform in the stroma of chloroplasts but not in the thylakoid membranes or thylakoid lumen. Together, these data show that ROC4 is a novel CyP isoform which is located in the stroma of chloroplasts. In vitro chloroplast import of precursors of other chloroplast proteins was unaffected by concentrations of cyclosporin A which completely inhibit rotamase activity of chloroplast stromal CyP. Thus, this activity is not essential for protein import into chloroplasts.	UNIV CALIF DAVIS,DIV BIOL SCI,MOLEC & CELLULAR BIOL SECT,DAVIS,CA 95616; UNIV CALIF DAVIS,DIV BIOL SCI,PLANT BIOL SECT,DAVIS,CA 95616	University of California System; University of California Davis; University of California System; University of California Davis				Gasser, Charles/0000-0001-5735-8175	NIGMS NIH HHS [GM07377] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; BARTLING D, 1992, PLANT MOL BIOL, V19, P529, DOI 10.1007/BF00023405; BEERS EP, 1992, J BIOL CHEM, V267, P15432; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; BREIMAN A, 1992, J BIOL CHEM, V267, P21293; CLINE K, 1985, J BIOL CHEM, V260, P3691; CROUSE GF, 1983, METHOD ENZYMOL, V101, P78; DAVIS JM, 1989, J BIOL CHEM, V264, P8956; Davis R., 1980, ADV BACTERIAL GENETI; DELLACIOPPA G, 1988, EMBO J, V7, P1299, DOI 10.1002/j.1460-2075.1988.tb02944.x; ETTINGER WF, 1991, J CELL BIOL, V115, P321, DOI 10.1083/jcb.115.2.321; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FISCHER G, 1984, BIOCHIM BIOPHYS ACTA, V791, P87, DOI 10.1016/0167-4838(84)90285-1; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; FOOR F, 1992, NATURE, V360, P682; FRIEDMAN J, 1993, P NATL ACAD SCI USA, V90, P6815, DOI 10.1073/pnas.90.14.6815; FRIEDMAN J, 1991, CELL, V66, P799, DOI 10.1016/0092-8674(91)90123-G; GASSER CS, 1989, PLANT CELL, V1, P15, DOI 10.1105/tpc.1.1.15; GASSER CS, 1990, P NATL ACAD SCI USA, V87, P9519, DOI 10.1073/pnas.87.24.9519; HAENDLER B, 1987, EMBO J, V6, P947, DOI 10.1002/j.1460-2075.1987.tb04843.x; HAENDLER B, 1989, GENE, V83, P39, DOI 10.1016/0378-1119(89)90401-0; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; HARLOW D, 1988, ANTIBODIES LABORATOR, P61; HASEL KW, 1991, MOL CELL BIOL, V11, P3484, DOI 10.1128/MCB.11.7.3484; HAYANO T, 1991, BIOCHEMISTRY-US, V30, P3041, DOI 10.1021/bi00226a009; HERRLER M, 1992, FEBS LETT, V309, P231, DOI 10.1016/0014-5793(92)80779-G; KOLETSKY AJ, 1986, J IMMUNOL, V137, P1054; Kranz A. R., 1987, ARABIDOPSIS INF SERV, V24; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; LIU J, 1990, P NATL ACAD SCI USA, V87, P4028, DOI 10.1073/pnas.87.11.4028; LIU J, 1990, P NATL ACAD SCI USA, V87, P2304, DOI 10.1073/pnas.87.6.2304; LODISH HF, 1991, J BIOL CHEM, V266, P14835; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; MARIVET J, 1992, PLANT SCI, V84, P171, DOI 10.1016/0168-9452(92)90131-5; MEYEROWITZ EM, 1989, CELL, V56, P263, DOI 10.1016/0092-8674(89)90900-8; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMID FX, 1978, P NATL ACAD SCI USA, V75, P4764, DOI 10.1073/pnas.75.10.4764; SCHREIBER SL, 1992, CELL, V70, P365, DOI 10.1016/0092-8674(92)90158-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; THEG SM, 1989, J BIOL CHEM, V264, P6730; Theg Steven M., 1993, Trends in Cell Biology, V3, P186, DOI 10.1016/0962-8924(93)90212-J; TITUS DE, 1991, PROMEGA PROTOCOLS AP, P59; TROPSCHUG M, 1988, J BIOL CHEM, V263, P14433; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; WAEGEMANN K, 1990, FEBS LETT, V261, P89, DOI 10.1016/0014-5793(90)80643-W; WALSH CT, 1992, J BIOL CHEM, V267, P13115	56	127	133	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7863	7868						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132503				2022-12-27	WOS:A1994NB40900008
J	YORK, JD; MAJERUS, PW				YORK, JD; MAJERUS, PW			NUCLEAR PHOSPHATIDYLINOSITOLS DECREASE DURING S-PHASE OF THE CELL-CYCLE IN HELA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SWISS 3T3 CELLS; INOSITOL POLYPHOSPHATE 1-PHOSPHATASE; GROWTH FACTOR-I; PHOSPHOLIPASE-C; PORE COMPLEX; DNA; DIACYLGLYCEROL; INHIBITION; MEMBRANE; KINASE	In the current study we have measured phosphatidylinositols during the cell cycle. HeLa cells were labeled with [H-3]myoinositol to a steady state, synchronized to the G1/S boundary, and the levels of phosphatidylinositol (PtdIns) lipids were measured at various times after release from the block. The levels of total cellular PtdIns, PtdIns(4)P, and PtdIns(4,5)P-2 relative to total cellular phospholipid did not vary throughout the cell cycle. We then isolated nuclei from synchronized cells using a non detergent method and found that the levels of nuclear PtdIns lipids decreased by over 50% at 2 and 4 h after release from the G1/S boundary (S-phase of the cell cycle) and returned to the original levels by 9 h. Separation of individual inositol containing nuclear lipids showed that PtdIns decreased by 50% while levels of PtdIns(4)P and PtdIns(4,B)P-2 decreased by 66%. Levels of the cytoplasmic PtdIns lipids remained constant throughout this period, This experiment indicates that there is specific nuclear PtdIns turnover that is activated during DNA synthesis.			YORK, JD (corresponding author), WASHINGTON UNIV, SCH MED, DIV HEMATOL ONCOL, ST LOUIS, MO 63110 USA.				NHGRI NIH HHS [HG 00304] Funding Source: Medline; NHLBI NIH HHS [HL 14147, HL 16634] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL014147, R37HL016634, R01HL016634] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000304] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AMES BN, 1960, J BIOL CHEM, V235, P769; BUNCE CM, 1988, ANAL BIOCHEM, V175, P67, DOI 10.1016/0003-2697(88)90362-4; COCCO L, 1989, BIOCHEM BIOPH RES CO, V159, P720, DOI 10.1016/0006-291X(89)90054-5; COCCO L, 1988, BIOCHEM BIOPH RES CO, V154, P1266, DOI 10.1016/0006-291X(88)90276-8; COCCO L, 1987, BIOCHEM J, V248, P765, DOI 10.1042/bj2480765; CUNNINGHAM TW, 1990, J BIOL CHEM, V265, P21676; DINGWALL C, 1992, SCIENCE, V258, P942, DOI 10.1126/science.1439805; DIVECHA N, 1993, BIOCHEM J, V289, P617, DOI 10.1042/bj2890617; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; FLEISCHMAN LF, 1988, AM J PHYSIOL, V255, pC531, DOI 10.1152/ajpcell.1988.255.4.C531; FORBES DJ, 1992, ANNU REV CELL BIOL, V8, P495, DOI 10.1146/annurev.cb.08.110192.002431; GURR MI, 1963, BIOCHIM BIOPHYS ACTA, V70, P400; HOY CA, 1989, CYTOMETRY, V10, P718, DOI 10.1002/cyto.990100608; HUNTER T, 1993, CELL, V75, P839, DOI 10.1016/0092-8674(93)90528-X; INHORN RC, 1988, J BIOL CHEM, V263, P14559; INHORN RC, 1987, J BIOL CHEM, V262, P15946; KAUFMANN SH, 1981, EXP CELL RES, V132, P105, DOI 10.1016/0014-4827(81)90088-4; KURIKI H, 1992, J BIOCHEM-TOKYO, V111, P283, DOI 10.1093/oxfordjournals.jbchem.a123750; MAJERUS PW, 1985, TRENDS BIOCHEM SCI, V10, P168, DOI 10.1016/0968-0004(85)90160-4; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; MANZOLI FA, 1989, ADV ENZYME REGUL, V28, P25, DOI 10.1016/0065-2571(89)90061-7; MARTELLI AM, 1992, NATURE, V358, P242, DOI 10.1038/358242a0; MARTELLI AM, 1994, IN PRESS EMBO J; NEUFELD EJ, 1985, J CELL BIOL, V101, P573, DOI 10.1083/jcb.101.2.573; PAYRASTRE B, 1992, J BIOL CHEM, V267, P5078; RHEE SG, 1992, J BIOL CHEM, V267, P12393; SMITH CD, 1983, J BIOL CHEM, V258, P9368; SMITH MR, 1990, SCIENCE, V247, P1074, DOI 10.1126/science.2408147; SMITH MR, 1989, P NATL ACAD SCI USA, V86, P3659, DOI 10.1073/pnas.86.10.3659; SYLVIA V, 1988, CELL, V54, P651, DOI 10.1016/S0092-8674(88)80009-6	30	118	119	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7847	7850						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132500				2022-12-27	WOS:A1994NB40900004
J	ALBARRACIN, CT; PALFREY, HC; DUAN, WR; RAO, MC; GIBORI, G				ALBARRACIN, CT; PALFREY, HC; DUAN, WR; RAO, MC; GIBORI, G			PROLACTIN REGULATION OF THE CALMODULIN-DEPENDENT PROTEIN-KINASE-III ELONGATION FACTOR-II SYSTEM IN THE RAT CORPUS-LUTEUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE-CHAIN ELONGATION; MR 100,000 SUBSTRATE; PC12 CELLS; PHOSPHORYLATION; ESTRADIOL; RECEPTOR; PROGESTERONE; ESTROGEN; PSEUDOPREGNANCY; IDENTIFICATION	AM(r) 100,000 phosphoprotein in the corpus luteum was identified as elongation factor 2 (EF-2). Since prolactin (PRL) is necessary for optimal luteal development and protein synthesis, we determined whether this hormone affects the content and/or phosphorylation of EF-2 in the corpus luteum. PRL treatment enhanced the Ca2+/calmodulin (CaM) dependent phosphorylation of endogenous EF-2 in luteal cytoplasmic extracts. Immunoblot analysis revealed that PRL had no effect on EF-2 levels, but examination of luteal EF-2 by two dimensional isoelectric focusing/SDS-polyacrylamide gel electrophoresis showed that PRL increased the relative amount of the most basic dephosphorylated forms of EF-2. This suggests that PRL induces net dephosphorylation of the protein in vivo. Since EF-2 phosphorylation is regulated by both Ca2+/CaM-dependent kinase III (CaM kinase III) and protein phosphatase 2A, we examined the effect of PRL on both enzymes. Paradoxically, PRL enhanced the in vitro activity of CaM kinase III, possibly reflecting increased kinase levels, but had no effect on phosphatase activity. These results suggest that PRL maintains luteal EF-2 in a relatively dephosphorylated state in vivo by limiting the availability of Ca2+ and/or CaM to CaM kinase III. These data provide strong evidence for a role of the EF-2/CaM kinase III system in PRL action in the corpus luteum.	UNIV ILLINOIS, DEPT PHYSIOL & BIOPHYS, CHICAGO, IL 60612 USA; UNIV CHICAGO, DEPT PHARMACOL & PHYSIOL SCI, CHICAGO, IL 60637 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago					NICHD NIH HHS [HD-11119] Funding Source: Medline; NIGMS NIH HHS [GM-42715] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD011119, R37HD011119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042715] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBARRACIN CT, 1991, ENDOCRINOLOGY, V129, P1821, DOI 10.1210/endo-129-4-1821; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; ARMSTRON.DT, 1970, ENDOCRINOLOGY, V86, P634, DOI 10.1210/endo-86-3-634; ARMSTRON.DT, 1969, ENDOCRINOLOGY, V85, P393, DOI 10.1210/endo-85-3-393; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BOUTIN JM, 1988, CELL, V53, P69, DOI 10.1016/0092-8674(88)90488-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADY MJ, 1990, J NEUROCHEM, V54, P1034, DOI 10.1111/j.1471-4159.1990.tb02354.x; BRANTLEY KM, 1990, J STEROID BIOCHEM, V35, P367, DOI 10.1016/0022-4731(90)90242-K; DOHLER KD, 1974, ENDOCRINOLOGY, V94, P1595; GEHRKE L, 1981, J BIOL CHEM, V256, P2514; GIBORI G, 1988, RECENT PROG HORM RES, V44, P377; GIBORI G, 1977, ENDOCRINOLOGY, V100, P1483, DOI 10.1210/endo-100-6-1483; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; ILAN J, 1984, P NATL ACAD SCI-BIOL, V81, P1366, DOI 10.1073/pnas.81.5.1366; KELLY PA, 1991, ENDOCR REV, V12, P235, DOI 10.1210/edrv-12-3-235; KRASNOW JS, 1990, MOL ENDOCRINOL, V4, P13, DOI 10.1210/mend-4-1-13; MACKIE KP, 1989, J BIOL CHEM, V264, P1748; MCKERNS KW, 1977, BIOCHIM BIOPHYS ACTA, V478, P68, DOI 10.1016/0005-2787(77)90244-1; MITSUI K, 1993, J BIOL CHEM, V268, P13422; NAIRN AC, 1985, P NATL ACAD SCI USA, V82, P7939, DOI 10.1073/pnas.82.23.7939; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; NAIRN AC, 1987, J BIOL CHEM, V262, P14265; NYGARD O, 1991, J BIOL CHEM, V266, P16425; PALFREY HC, 1987, J BIOL CHEM, V262, P9785; PARMER TG, 1993, JJUN ANN M END SOC L; PROUD CG, 1992, CURR TOP CELL REGUL, V32, P243; RAO MC, 1987, ENDOCRINOLOGY, V120, P1010, DOI 10.1210/endo-120-3-1010; REDPATH NT, 1993, EUR J BIOCHEM, V212, P511, DOI 10.1111/j.1432-1033.1993.tb17688.x; REDPATH NT, 1989, BIOCHEM J, V262, P69, DOI 10.1042/bj2620069; RILLEMA JA, 1992, ENDOCRINOLOGY, V131, P973, DOI 10.1210/en.131.2.973; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; SANCHEZCRIADO JE, 1988, J ENDOCRINOL, V117, P455, DOI 10.1677/joe.0.1170455; SMITH MS, 1976, ENDOCRINOLOGY, V98, P1370, DOI 10.1210/endo-98-6-1370; STEINSCHNEIDER A, 1991, ENDOCRINOLOGY, V128, P263, DOI 10.1210/endo-128-1-263; VENKITARAMAN AR, 1992, P NATL ACAD SCI USA, V89, P12083, DOI 10.1073/pnas.89.24.12083; WHELLY SM, 1974, BIOCHEMISTRY-US, V13, P341, DOI 10.1021/bi00699a019; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L	38	19	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7772	7776						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8126003				2022-12-27	WOS:A1994NA03200113
J	NAKAHARA, DH; LINGAPPA, VR; CHUCK, SL				NAKAHARA, DH; LINGAPPA, VR; CHUCK, SL			TRANSLOCATIONAL PAUSING IS A COMMON STEP IN THE BIOGENESIS OF UNCONVENTIONAL INTEGRAL MEMBRANE AND SECRETORY PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; PRION PROTEIN; APOLIPOPROTEIN-B; TRANSMEMBRANE ORIENTATION; TOPOGENIC SEQUENCE; STOP TRANSFER; ER MEMBRANE; PRE-GOLGI; DEGRADATION; TRANSLATION	Signal, stop transfer, and signal-anchor sequences direct a nascent polypeptide to a single topology with respect to the membrane of the endoplasmic reticulum. However, other types of sequences direct nascent proteins, either transiently or permanently, to more than one topologic form. Pause transfer sequences direct nascent apolipoprotein B to pause during its translocation, resulting in nonintegrated, transmembrane intermediates that become fully translocated over time. The stop transfer effector sequence (STE) directs the nascent prion protein either to integrate at the hydrophobic domain which immediately follows (TM1) or to become fully translocated, in a manner dependent on cytosolic factors. Although the action of pause transfer sequences has been dissected into stop and restart steps, the mechanism of STE action is unknown. Using chimeric proteins expressed in vitro, we show that STE, inde- pendent of TM1, acts as a pause transfer sequence. We also demonstrate that translocational pausing at STE is a common step preceding either complete translocation or integration into the membrane of a chimeric protein containing STE and TM1. These findings have implications for the role of pausing in the biogenesis of both secretory and membrane proteins.	UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,BIOMED SCI GRAD PROGRAM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco				Lingappa, Vishwanath R./0000-0003-0962-6571	NIA NIH HHS [AG02132] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG002132] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AMARA JF, 1989, J CELL BIOL, V109, P3315, DOI 10.1083/jcb.109.6.3315; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; CHUCK SL, 1993, J BIOL CHEM, V268, P22794; CHUCK SL, 1992, CELL, V68, P9, DOI 10.1016/0092-8674(92)90202-N; CHUCK SL, 1990, NATURE, V346, P382, DOI 10.1038/346382a0; DAVIS RA, 1990, J BIOL CHEM, V265, P10005; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; GILMORE R, 1985, CELL, V42, P497, DOI 10.1016/0092-8674(85)90107-2; HAY B, 1987, BIOCHEMISTRY-US, V26, P8110, DOI 10.1021/bi00399a014; HAY B, 1987, MOL CELL BIOL, V7, P914, DOI 10.1128/MCB.7.2.914; KANG HS, 1991, J BIOL CHEM, V266, P5643; LINGAPPA VR, 1991, CELL, V65, P527, DOI 10.1016/0092-8674(91)90081-9; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; LOPEZ CD, 1990, SCIENCE, V248, P226, DOI 10.1126/science.1970195; PERARA E, 1986, SCIENCE, V232, P348, DOI 10.1126/science.3961485; PERARA E, 1985, J CELL BIOL, V101, P2292, DOI 10.1083/jcb.101.6.2292; PERARA E, 1988, PROTEIN TRANSFER ORG, P3; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; REDMAN CM, 1966, P NATL ACAD SCI USA, V56, P608, DOI 10.1073/pnas.56.2.608; SATO R, 1990, J BIOL CHEM, V265, P11880; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; SINGER SJ, 1987, P NATL ACAD SCI USA, V84, P1960, DOI 10.1073/pnas.84.7.1960; SIUTAMANGANO P, 1981, J BIOL CHEM, V256, P2094; SKACH WR, 1993, MECH INTRACELLULAR T, P19; THRIFT RN, 1991, J CELL BIOL, V112, P809, DOI 10.1083/jcb.112.5.809; YOST CS, 1990, NATURE, V343, P669, DOI 10.1038/343669a0; YOST CS, 1983, CELL, V34, P759; YOUNG SG, 1990, CIRCULATION, V82, P1574, DOI 10.1161/01.CIR.82.5.1574	29	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7617	7622						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125986				2022-12-27	WOS:A1994NA03200092
J	STILLMAN, B				STILLMAN, B			INITIATION OF CHROMOSOMAL DNA-REPLICATION IN EUKARYOTES - LESSONS FROM LAMBDA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NUCLEOPROTEIN STRUCTURES; BACTERIOPHAGE-LAMBDA; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; SUBCELLULAR-LOCALIZATION; MULTIPROTEIN COMPLEX; ORIGIN; YEAST; PROTEIN; ACTIVATION				STILLMAN, B (corresponding author), COLD SPRING HARBOR LAB,COLD SPRING HARBOR,NY 11724, USA.			Stillman, Bruce/0000-0002-9453-4091				ALFANO C, 1989, J BIOL CHEM, V264, P10709; BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BENBOW RM, 1992, BIOESSAYS, V14, P661, DOI 10.1002/bies.950141004; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; BLOW JJ, 1993, J CELL BIOL, V122, P993, DOI 10.1083/jcb.122.5.993; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; CALLAN HG, 1973, COLD SPRING HARB SYM, V38, P195; Campbell JL, 1991, MOL CELLULAR BIOL YE, P41; CELNIKER SE, 1984, MOL CELL BIOL, V4, P2455, DOI 10.1128/MCB.4.11.2455; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; CHEN YR, 1992, P NATL ACAD SCI USA, V89, P10459, DOI 10.1073/pnas.89.21.10459; COVERLEY D, 1993, J CELL BIOL, V122, P985, DOI 10.1083/jcb.122.5.985; COX LS, 1991, CELL, V66, P271, DOI 10.1016/0092-8674(91)90617-8; Depamphilis Melvin L., 1993, Trends in Cell Biology, V3, P161, DOI 10.1016/0962-8924(93)90137-P; DEPAMPHILIS ML, 1993, J BIOL CHEM, V268, P1; DEPAMPHILIS ML, 1993, ANNU REV BIOCHEM, V62, P29; DERSHOWITZ A, 1993, MOL CELL BIOL, V13, P391, DOI 10.1128/MCB.13.1.391; DESHPANDE AM, 1992, MOL CELL BIOL, V12, P4305, DOI 10.1128/MCB.12.10.4305; DIFFLEY JFX, 1992, NATURE, V357, P169, DOI 10.1038/357169a0; DODSON M, 1989, J BIOL CHEM, V264, P10719; DUBEY DD, 1991, MOL CELL BIOL, V11, P5346, DOI 10.1128/MCB.11.10.5346; ECHOLS H, 1990, J BIOL CHEM, V265, P14697; ESTES HG, 1992, P NATL ACAD SCI USA, V89, P11156, DOI 10.1073/pnas.89.23.11156; FANGMAN WL, 1991, ANNU REV CELL BIOL, V7, P375, DOI 10.1146/annurev.cb.07.110191.002111; FANGMAN WL, 1992, CELL, V71, P363, DOI 10.1016/0092-8674(92)90505-7; FERGUSON BM, 1992, CELL, V68, P333, DOI 10.1016/0092-8674(92)90474-Q; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; FRIEDMAN J M, 1992, Current Biology, V2, P296, DOI 10.1016/0960-9822(92)90870-G; HAMLIN JL, 1992, BIOESSAYS, V14, P651, DOI 10.1002/bies.950141002; HARLAND RM, 1980, CELL, V21, P761, DOI 10.1016/0092-8674(80)90439-0; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; HENNESSY KM, 1990, GENE DEV, V4, P2252, DOI 10.1101/gad.4.12b.2252; HUANG RY, 1993, EMBO J, V12, P4521, DOI 10.1002/j.1460-2075.1993.tb06141.x; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; KITSBERG D, 1993, NATURE, V366, P588, DOI 10.1038/366588a0; Kornberg A., 1991, DNA REPLICATION; KRYSAN PJ, 1991, MOL CELL BIOL, V11, P1464, DOI 10.1128/MCB.11.3.1464; KRYSAN PJ, 1993, MOL CELL BIOL, V13, P2688, DOI 10.1128/MCB.13.5.2688; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; LIBEREK K, 1990, J BIOL CHEM, V265, P3022; MAHBUBANI HM, 1992, NUCLEIC ACIDS RES, V20, P1457, DOI 10.1093/nar/20.7.1457; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; MASUKATA H, 1993, MOL BIOL CELL, V4, P1121, DOI 10.1091/mbc.4.11.1121; MCMACKEN R, 1992, DNA REPLICATION CELL, P35; MENSAWILMOT K, 1989, J BIOL CHEM, V264, P2853; MICKLEM G, 1993, NATURE, V366, P87, DOI 10.1038/366087a0; NATALE DA, 1993, NUCLEIC ACIDS RES, V21, P555, DOI 10.1093/nar/21.3.555; OSIPIUK J, 1993, J BIOL CHEM, V268, P4821; RIVIER DH, 1992, SCIENCE, V256, P659, DOI 10.1126/science.1585179; SCHNOS M, 1970, J MOL BIOL, V51, P61, DOI 10.1016/0022-2836(70)90270-6; SCHNOS M, 1988, CELL, V52, P385, DOI 10.1016/S0092-8674(88)80031-X; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; STILLMAN B, 1993, NATURE, V366, P506, DOI 10.1038/366506a0; WYMAN C, 1993, J BIOL CHEM, V268, P25192; YAN H, 1993, GENE DEV, V7, P2149, DOI 10.1101/gad.7.11.2149	57	67	67	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7047	7050						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125908				2022-12-27	WOS:A1994NA03200001
J	MAHADEO, D; KAPLAN, L; CHAO, MV; HEMPSTEAD, BL				MAHADEO, D; KAPLAN, L; CHAO, MV; HEMPSTEAD, BL			HIGH-AFFINITY NERVE GROWTH-FACTOR BINDING DISPLAYS A FASTER RATE OF ASSOCIATION THAN P140(TRK) BINDING - IMPLICATIONS FOR MULTISUBUNIT POLYPEPTIDE RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PC12 PHEOCHROMOCYTOMA CELLS; TRK PROTOONCOGENE PRODUCT; HUMAN NGF RECEPTOR; NEUROTROPHIC FACTOR; MOLECULAR-CLONING; MESSENGER-RNA; GENE-TRANSFER; FACTOR FAMILY; NEURONAL SURVIVAL; EXPRESSION	Nerve growth factor (NGF) binds to two cell surface receptors, p140(frk) and p75(NGFR), which are both expressed in responsive sensory, sympathetic, and basal forebrain cholinergic neurons. While p140(trk) belongs to the family of receptor tyrosine kinases, p75(NGFR) is a member of the TNF/Fas/CD40/CD30 family of receptors. Current views of neurotrophin receptor function have tended to interpret p140(trK) as the high affinity NGF-binding site. To assess if the binding of NGF to p140(trk) was distinguishable from binding to high affinity sites on neuronal cells, PC12 cell sublines were generated which expressed p140(trk) alone, or coexpressed both p140(trk) and p75(NGFR). Kinetic analysis of I-125-NGF binding indicates that it has an unusually slow rate of association with p140(trk) (k(+1) = 8 x 10(5) M(-1) S-1). When both p140(trk) and p75(NGFR) receptors are coexpressed, the rate of association of NGF is increased 25-fold to produce a higher affinity binding site. An increase in the rate of internalization was also observed. Since high affinity binding and internalization are believed to be prerequisite for the biological activities of NGF, these results suggest that the biological effects by NGF are derived from a novel kinetic binding site that requires the expression of both receptors. The implications of these results with respect to multisubunit polypeptide receptors are discussed.	CORNELL UNIV,COLL MED,DIV HEMATOL ONCOL,NEW YORK,NY 10021; CORNELL UNIV,COLL MED,DEPT CELL BIOL & ANAT,NEW YORK,NY 10021	Cornell University; Cornell University				Chao, Moses/0000-0002-6969-3744				BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BATTLEMAN DS, 1993, J NEUROSCI, V13, P941; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BERND P, 1984, J BIOL CHEM, V259, P5509; BIRREN SJ, 1992, SCIENCE, V257, P395, DOI 10.1126/science.1321502; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; BOTHWELL MA, 1980, CELL, V21, P857, DOI 10.1016/0092-8674(80)90449-3; BUXSER S, 1985, J BIOL CHEM, V260, P1917; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GRANT AJ, 1992, P NATL ACAD SCI USA, V89, P2165, DOI 10.1073/pnas.89.6.2165; HAIGLER HT, 1980, J BIOL CHEM, V255, P1239; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HARTMAN DS, 1992, J BIOL CHEM, V267, P24516; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HOLTZMAN DM, 1992, NEURON, V9, P465, DOI 10.1016/0896-6273(92)90184-F; IBANEZ CF, 1993, EMBO J, V12, P2281, DOI 10.1002/j.1460-2075.1993.tb05882.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JOHNSON EM, 1987, J NEUROSCI, V7, P923; KAHLE P, 1992, J BIOL CHEM, V267, P22707; KAHLE P, 1992, J BIOL CHEM, V267, P13917; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MEAKIN SO, 1991, NEURON, V6, P153, DOI 10.1016/0896-6273(91)90130-R; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MEAKIN SO, 1992, P NATL ACAD SCI USA, V89, P2374, DOI 10.1073/pnas.89.6.2374; NICOLA NA, 1992, CELL, V67, P1; PLEASURE SJ, 1990, P NATL ACAD SCI USA, V87, P8496, DOI 10.1073/pnas.87.21.8496; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SUTTER A, 1979, J BIOL CHEM, V254, P5972; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; VERGE VMK, 1992, J NEUROSCI, V12, P4011; VOSS SD, 1993, P NATL ACAD SCI USA, V90, P2428, DOI 10.1073/pnas.90.6.2428; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A	56	270	274	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6884	6891						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120051				2022-12-27	WOS:A1994MZ50300097
J	OMKUMAR, RV; DARNAY, BG; RODWELL, VW				OMKUMAR, RV; DARNAY, BG; RODWELL, VW			MODULATION OF SYRIAN-HAMSTER 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE-ACTIVITY BY PHOSPHORYLATION - ROLE OF SERINE-871	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; COENZYME-A REDUCTASE; HMG-COA REDUCTASE; RAT-LIVER; ISOCITRATE DEHYDROGENASE; ENZYMIC ACTIVITY; SITE; INACTIVATION; INVITRO; DEPHOSPHORYLATION	Attenuation of Syrian hamster 3-hydroxy-3-methyl-glutaryl coenzyme A reductase (HMG-CoA reductase, EC 1.1.1.34) activity by in vitro phosphorylation was studied using AMP-activated protein kinase and wild type and mutant forms of HMG-CoA reductase. The only residue of the wild-type enzyme phosphorylated was Sers?l. Substrates protected against kinase mediated attenuation of activity, consistent with substrate-induced conformational changes at the C-terminal region. Although close to the catalytic histidine His(865), Ser(871) appears to play no direct role in catalysis or substrate recognition. Mu tent enzymes S871A, S871H, S871N, and S871Q exhibited from 62-106% of wild-type activity and had wild-type K-M values for HMG-CoA and NADPH. Replacement of Ser(871) by aspartate or glutamate, but not by glutamine, asparagine, histidine, or tyrosine, severely attenuated activity, Attenuation of catalytic activity that accompanies phosphorylation thus appears to result primarily from the introduction of negative charge, not merely steric hindrance. Other than the wild-type enzyme, only mutant enzyme S871T was phosphorylated, and phosphorylation was accompanied by attenuation of activity. The AMP-activated kinase thus can also phosphorylate threonyl residues.	PURDUE UNIV, DEPT BIOCHEM, W LAFAYETTE, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus					NHLBI NIH HHS [HL 47113] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047113] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BANERJEE P, 1990, P NATL ACAD SCI USA, V87, P8550, DOI 10.1073/pnas.87.21.8550; BARFORD D, 1991, BIOCHIM BIOPHYS ACTA, V1133, P55, DOI 10.1016/0167-4889(91)90241-O; BEG ZH, 1987, J BIOL CHEM, V262, P13228; BEG ZH, 1985, J BIOL CHEM, V260, P1682; BEG ZH, 1980, J BIOL CHEM, V255, P8541; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLING D, 1989, BIOCHIM BIOPHYS ACTA, V1012, P81, DOI 10.1016/0167-4889(89)90014-1; CLARKE PR, 1990, FEBS LETT, V269, P213, DOI 10.1016/0014-5793(90)81157-J; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; DARNAY BG, 1993, J BIOL CHEM, V268, P8429; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; DEAN AM, 1989, J BIOL CHEM, V264, P20482; FRIMPONG K, 1993, PROTEIN EXPRES PURIF, V4, P337, DOI 10.1006/prep.1993.1044; GILLESPIE JG, 1992, FEBS LETT, V306, P59, DOI 10.1016/0014-5793(92)80837-7; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HARDIE DG, 1989, TRENDS BIOCHEM SCI, V14, P20; HSIAO KC, 1991, NUCLEIC ACIDS RES, V19, P2787, DOI 10.1093/nar/19.10.2787; HUNTER CF, 1980, J LIPID RES, V21, P399; HURLEY JH, 1990, SCIENCE, V249, P1012, DOI 10.1126/science.2204109; JORDANSTARCK TC, 1989, J BIOL CHEM, V264, P17913; KEITH ML, 1983, J PROTEIN CHEM, V2, P209, DOI 10.1007/BF01025355; KEITH ML, 1979, BIOCHEM BIOPH RES CO, V90, P969, DOI 10.1016/0006-291X(79)91922-3; KENNELLY PJ, 1983, BIOCHEMISTRY-US, V22, P2784, DOI 10.1021/bi00281a002; KENNELLY PJ, 1985, J LIPID RES, V26, P903; LAWRENCE CM, 1994, UNPUB SCIENCE; MACKINTOSH RW, 1992, EUR J BIOCHEM, V209, P923, DOI 10.1111/j.1432-1033.1992.tb17364.x; OFIR R, 1990, NATURE, V348, P80, DOI 10.1038/348080a0; Omkumari R. V, 1991, BIOCHIM BIOPHYS ACTA, V1078, P219; PARKER RA, 1989, J BIOL CHEM, V264, P4877; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; ROITELMAN J, 1989, J LIPID RES, V30, P97; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPRANG SR, 1988, NATURE, V336, P215, DOI 10.1038/336215a0; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; THEROUX SJ, 1992, J BIOL CHEM, V267, P7967; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; WANG YL, 1990, J BIOL CHEM, V265, P21634; 1991, PROTOCOLS APPLICATIO, P109; 1983, OLIGONUCLEOTIDE DIRE, P1	41	60	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6810	6814						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120043				2022-12-27	WOS:A1994MZ50300087
J	SATO, MH; KASAHARA, M; ISHII, N; HOMAREDA, H; MATSUI, H; YOSHIDA, M				SATO, MH; KASAHARA, M; ISHII, N; HOMAREDA, H; MATSUI, H; YOSHIDA, M			PURIFIED VACUOLAR INORGANIC PYROPHOSPHATASE CONSISTING OF A 75-KDA POLYPEPTIDE CAN PUMP H+ INTO RECONSTITUTED PROTEOLIPOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C OXIDASE; ARABIDOPSIS-THALIANA; BEEF-HEART; RED BEET; PURIFICATION; MEMBRANE; TRANSPORT; PROTEINS; ANTIPORTER; VESICLES	Inorganic pyrophosphatase was purified to homogeneity from the vacuolar membranes of pumpkin hypocotyl tissue. The purified Inorganic pyrophosphatase consists of a single kind of 75-kDa polypeptide, and the stacked molecules with a repeating unit of 5.8 x 3.8 nm are seen under electron micrography. It exhibits H+-translocating activity across membranes coupled with PPi hydrolysis when it is reconstituted into proteoliposomes. A monovalent cation is required for the H+ translocation with the K+ ion being the most effective, but evidence for active transport of K-42(+) into proteoliposomes was not obtained under the conditions tested. The hydrolysis of PPi by the reconstituted proteoliposomes is stimulated by the addition of a H+ ionophore, carbonyl cyanide p-trifluoromethyoxyphenylhydrazone, but not by a K+ ionophore, valinomycin. Both hydrolysis of PPi and PPi-dependent H+ translocation of the proteoliposomes are inhibited by N,N'-dicyclohexylcarbodiimide.	TOKYO INST TECHNOL,RESOURCES UTILIZAT RES LAB,MIDORI KU,YOKOHAMA,KANAGAWA 227,JAPAN; INST PHYS & CHEM RES,WAKO,SAITAMA 35101,JAPAN; KYORIN UNIV,SCH MED,DEPT BIOCHEM,MITAKA,TOKYO 181,JAPAN	Tokyo Institute of Technology; RIKEN; Kyorin University			Ishii, Noriyuki/E-5661-2011; Sato, Masa/P-6487-2019	Ishii, Noriyuki/0000-0002-4120-6203; Sato, Masa H./0000-0001-5794-4545				BRITTEN CJ, 1989, FEBS LETT, V256, P200, DOI 10.1016/0014-5793(89)81748-X; BRITTEN CJ, 1992, J BIOL CHEM, V267, P21850; DAVIES JM, 1992, P NATL ACAD SCI USA, V89, P11701, DOI 10.1073/pnas.89.24.11701; Fiske CH, 1925, J BIOL CHEM, V66, P375; FULLER SD, 1979, J MOL BIOL, V134, P305, DOI 10.1016/0022-2836(79)90037-8; FULLER SD, 1982, BIOCHEMISTRY-US, V21, P2525, DOI 10.1021/bi00539a036; HOFTE H, 1992, PLANT PHYSIOL, V99, P561, DOI 10.1104/pp.99.2.561; HOLLOWAY PW, 1973, ANAL BIOCHEM, V53, P304, DOI 10.1016/0003-2697(73)90436-3; HOMAREDA H, 1991, J BIOCHEM-TOKYO, V109, P70; HOMAREDA H, 1986, Radioisotopes, V35, P543; JEZEK P, 1990, J BIOL CHEM, V265, P10522; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; KASAHARA M, 1977, J BIOL CHEM, V252, P7384; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI XQ, 1990, J BIOL CHEM, V265, P15316; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAESHIMA M, 1992, PLANT PHYSIOL, V98, P1248, DOI 10.1104/pp.98.4.1248; MAESHIMA M, 1989, J BIOL CHEM, V264, P20068; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MAUREL C, 1993, EMBO J, V12, P2241, DOI 10.1002/j.1460-2075.1993.tb05877.x; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; REA PA, 1985, PLANT PHYSIOL, V77, P46, DOI 10.1104/pp.77.1.46; SARAFIAN V, 1989, PLANT PHYSIOL, V91, P34, DOI 10.1104/pp.91.1.34; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; SATO MH, 1991, FEBS LETT, V290, P177, DOI 10.1016/0014-5793(91)81254-6; TAYLOR KA, 1988, J BIOL CHEM, V263, P5287	26	44	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6725	6728						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120031				2022-12-27	WOS:A1994MZ50300074
J	LEE, YC; KOJIMA, N; WADA, E; KUROSAWA, N; NAKAOKA, T; HAMAMOTO, T; TSUJI, S				LEE, YC; KOJIMA, N; WADA, E; KUROSAWA, N; NAKAOKA, T; HAMAMOTO, T; TSUJI, S			CLONING AND EXPRESSION OF CDNA FOR A NEW-TYPE OF GAL-BETA-1,3GALNAC ALPHA-2,3-SIALYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; GENE FAMILY; RAT-LIVER; SIALYLTRANSFERASE; PURIFICATION; HOMOGENEITY; TRANSFERASE; PROTEIN	Based on the sequences of the highly conserved segments in the previously cloned sialyltransferases, a cDNA encoding a new type of Galbeta1,3GalNAc alpha2,3-sialyltransferase (ST3GalA.2) has been isolated from both mouse and rat brain cDNA libraries. The cDNA sequences included an open reading frame coding for 350 amino acids, and the primary structure of this enzyme suggested a putative domain structure consisting of four regions, like that in other glycosyltransferases. The deduced amino acid sequence of ST3GalA.2 (mouse) showed 76% identity in the active domain with that of the previously cloned mouse Galbeta1,3GalNAc alpha2,3-sialyltransferase (ST3GalA.1 (Lee, Y.-C., Kurosawa, N., Hamamoto, T., Nakaoka, T., and Tsuji, S. (1993) Eur. J. Biochem. 216, 377-385)). Northern blotting indicated that the expression of ST3GalA.2 mRNA is tissue-specific, it being prominent in brain and liver, while that in the other tissues is very low. This enzyme expressed in COS-7 cells exhibited transferase activity only toward the disaccharide moiety of Galbeta1,3GalNAc of glycolipids as well as glycoproteins and oligosaccharides like ST3GalA.1, but showed a difference in acceptor substrate preference, i.e. asialo-G(M1) and G(M1) were much more suitable substrates for ST3GalA.2 than for ST3GalA.1.	INST PHYS & CHEM RES,FRONTIER RES PROGRAM,GLYCO MOLEC BIOL,WAKO,SAITAMA 35101,JAPAN	RIKEN				Kurosawa, Nobuyuki/0000-0002-1548-4541				ARCE A, 1966, ARCH BIOCHEM BIOPHYS, V116, P52, DOI 10.1016/0003-9861(66)90011-7; BAST BJEG, 1992, J CELL BIOL, V116, P423, DOI 10.1083/jcb.116.2.423; Beyer T A, 1981, Adv Enzymol Relat Areas Mol Biol, V52, P23; DEN H, 1971, J BIOL CHEM, V121, P483; DRICKAMER K, 1993, GLYCOBIOLOGY, V3, P2, DOI 10.1093/glycob/3.1.2; DUFFARD RO, 1972, BIOCHEMISTRY-US, V11, P1396, DOI 10.1021/bi00758a011; GILLESPIE W, 1992, J BIOL CHEM, V267, P21004; GRUNDMANN U, 1990, NUCLEIC ACIDS RES, V18, P667, DOI 10.1093/nar/18.3.667; Hamamoto T, 1993, Bioorg Med Chem, V1, P141, DOI 10.1016/S0968-0896(00)82111-2; JUOZIASSE DH, 1985, J BIOL CHEM, V2260, P4941; KAUFMAN B, 1968, J BIOL CHEM, V243, P5804; KITAGAWA H, 1994, J BIOL CHEM, V269, P1394; KITAGAWA H, 1993, BIOCHEM BIOPH RES CO, V194, P375, DOI 10.1006/bbrc.1993.1830; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOSZDIN KL, 1992, BIOCHEM BIOPH RES CO, V187, P152, DOI 10.1016/S0006-291X(05)81472-X; KUROSAWA N, 1994, J BIOL CHEM, V219, P375; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE YC, 1993, EUR J BIOCHEM, V216, P377, DOI 10.1111/j.1432-1033.1993.tb18155.x; LIVINGSTON BD, 1993, J BIOL CHEM, V268, P11504; MACHER B A, 1991, Glycobiology, V1, P577, DOI 10.1093/glycob/1.6.577; MESTRALLET MG, 1974, BIOCHEM BIOPH RES CO, V59, P1, DOI 10.1016/S0006-291X(74)80165-8; POHLENTZ G, 1988, P NATL ACAD SCI USA, V85, P7044, DOI 10.1073/pnas.85.19.7044; PUALSON JC, 1991, GLYCOCONJUGATE J, V8, P145; SADLER JE, 1979, J BIOL CHEM, V254, P4434; Sambrook J, 1989, MOL CLONING LABORATO; SASAKI K, 1993, J BIOL CHEM, V268, P22782; Svennerholm L, 1980, Adv Exp Med Biol, V125, P533; SVENNERHOLM L, 1964, J LIPID RES, V5, P145; VANDENEIJNDEN DH, 1974, BIOCHIM BIOPHYS ACTA, V362, P136, DOI 10.1016/0304-4165(74)90035-X; WEIGANDT H, 1967, J NEUROCHEM, V14, P671; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13835; WEISTEIN J, 1987, J BIOL CHEM, V262, P17735; WEN DX, 1992, J BIOL CHEM, V267, P21011; WESTON BW, 1992, J BIOL CHEM, V267, P24575	34	110	114	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10028	10033						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144500				2022-12-27	WOS:A1994NE05300095
J	LIN, Q; MA, L; BURKHART, W; SPREMULLI, LL				LIN, Q; MA, L; BURKHART, W; SPREMULLI, LL			ISOLATION AND CHARACTERIZATION OF CDNA CLONES FOR CHLOROPLAST TRANSLATIONAL INITIATION FACTOR-III FROM EUGLENA-GRACILIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; FACTOR-III; SECONDARY-STRUCTURE; COMPLEX FORMS; BINDING; GENE; DNA; IDENTIFICATION; PURIFICATION	A complete cDNA clone encoding Euglena gracilis chloroplast translational initiation factor 3 (IF-3chl) has been obtained. Analysis of the sequence indicates that the IF-3chl mRNA contains the spliced leader found at the 5' end of nuclear encoded mRNAs in E. gracilis. The open reading frame for IF-3chl encodes a 537-amino acid protein. IF-3chl appears to be divided into four domains. The first 140 amino acids correspond to a transit peptide required for the import of IF-3chl into the chloroplast. The mature form of IF-3chl encompasses domains 2-4 and is about twice the size of Escherichia coli IF-3. The second domain has no homology to other known proteins. It begins with a stretch of 35 residues, of which about 30% are proline. Downstream from this region is a stretch of about 25 amino acids with a repeating (GX)n motif followed by a very acidic region. The third domain comprises a region of about 175 residues and has between 31 and 37% homology to the IF-3s found in other organisms. The IF-3 homology domain is followed by an acidic region which has no detectable homology to other sequences. Analysis of E. gracilis genomic DNA suggests that there are about four copies of the IF-3chl gene, one of which is probably a pseudogene. The activity of IF-3chl is inducible by light. However, the IF-3chl mRNA is present in approximately equal amounts in both dark- and light-grown cells, suggesting that the light-dependent induction of IF-3chl activity is post-transcriptional.	UNIV N CAROLINA, DEPT CHEM, CHAPEL HILL, NC 27599 USA; GLAXO RES INST, DEPT STRUCT & BIOPHYS CHEM, RES TRIANGLE PK, NC 27709 USA; UNIV N CAROLINA, LINEBERGER COMPREHENS CANC RES CTR, CHAPEL HILL, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; GlaxoSmithKline; University of North Carolina; University of North Carolina Chapel Hill			Ma, Lan/B-9295-2009	Ma, Lan/0000-0001-9034-5472	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024963] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24963] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BERKHOUT B, 1986, BIOCHIM BIOPHYS ACTA, V866, P144, DOI 10.1016/0167-4781(86)90111-9; BURKHART W, 1992, TECHNIQUES PROTEIN C, V4, P399; CANONACO MA, 1989, EUR J BIOCHEM, V182, P501, DOI 10.1111/j.1432-1033.1989.tb14856.x; Carmichael G G, 1980, Methods Enzymol, V65, P380; DEBELLIS D, 1992, BIOCHEMISTRY-US, V31, P11984, DOI 10.1021/bi00163a005; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GIBBS SP, 1981, ANN NY ACAD SCI, V361, P193; GOTTESMAN MM, 1987, METHOD ENZYMOL, V151, P363; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; GUMPEL NJ, 1992, EUR J BIOCHEM, V210, P721, DOI 10.1111/j.1432-1033.1992.tb17473.x; HARTZ D, 1989, GENE DEV, V3, P1899, DOI 10.1101/gad.3.12a.1899; HARTZ D, 1990, GENE DEV, V4, P1790, DOI 10.1101/gad.4.10.1790; HENIKOFF S, 1991, NUCLEIC ACIDS RES, V19, P6565, DOI 10.1093/nar/19.23.6565; HU WS, 1993, GENE, V127, P79, DOI 10.1016/0378-1119(93)90619-E; HUNT AG, 1987, PLANT MOL BIOL, V8, P23, DOI 10.1007/BF00016431; JACOBSON A, 1987, METHOD ENZYMOL, V152, P254; KELLER M, 1992, NUCLEIC ACIDS RES, V20, P1711, DOI 10.1093/nar/20.7.1711; KIMURA M, 1983, FEBS LETT, V160, P78, DOI 10.1016/0014-5793(83)80940-5; KRAUS BL, 1986, J BIOL CHEM, V261, P4781; KRAUS BL, 1988, PLANT PHYSIOL, V88, P993, DOI 10.1104/pp.88.4.993; LEFORTTRAN M, 1981, BER DEUT BOT GES, V94, P463; MA L, 1992, J BIOL CHEM, V267, P18356; MA L, 1990, J BIOL CHEM, V265, P13560; MCCARTHY SA, 1984, PLANT SCI LETT, V35, P61, DOI 10.1016/0304-4211(84)90158-5; MONTANDON PE, 1990, NUCLEIC ACIDS RES, V18, P75, DOI 10.1093/nar/18.1.75; MURAYAMA Y, 1993, PLANT MOL BIOL, V22, P767, DOI 10.1007/BF00027363; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NISHIKAWA K, 1983, BIOCHIM BIOPHYS ACTA, V748, P285, DOI 10.1016/0167-4838(83)90306-0; PON CL, 1974, P NATL ACAD SCI USA, V71, P4950, DOI 10.1073/pnas.71.12.4950; RAWSON JRY, 1979, BIOCHIM BIOPHYS ACTA, V563, P1, DOI 10.1016/0005-2787(79)90002-9; ROTH MJ, 1985, J BIOL CHEM, V260, P9326; SACERDOT C, 1982, EMBO J, V1, P311, DOI 10.1002/j.1460-2075.1982.tb01166.x; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHASHIDHARA LS, 1992, J BIOL CHEM, V267, P12885; STERN AI, 1964, PLANT PHYSIOL, V39, P220, DOI 10.1104/pp.39.2.220; TESSIER LH, 1991, EMBO J, V10, P2621, DOI 10.1002/j.1460-2075.1991.tb07804.x; VANKNIPPENBERG PH, 1990, RIBOSOME, P265; VONHEIJNE G, 1991, FEBS LETT, V278, P1, DOI 10.1016/0014-5793(91)80069-F; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WANG CC, 1991, J BIOL CHEM, V266, P17079; WICKSTROM E, 1980, ARCH BIOCHEM BIOPHYS, V200, P296, DOI 10.1016/0003-9861(80)90357-4; WOODCOCK E, 1980, ARCH MICROBIOL, V124, P33, DOI 10.1007/BF00407025; WU DY, 1991, DNA CELL BIOL, V10, P233, DOI 10.1089/dna.1991.10.233	45	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9436	9444						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144528				2022-12-27	WOS:A1994NE05300010
J	MIGEON, JC; NATHANSON, NM				MIGEON, JC; NATHANSON, NM			DIFFERENTIAL REGULATION OF CAMP-MEDIATED GENE-TRANSCRIPTION BY M1 AND M4 MUSCARINIC ACETYLCHOLINE-RECEPTORS - PREFERENTIAL COUPLING OF M4 RECEPTORS TO G(I)ALPHA-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE ACTIVITY; RAT OLFACTORY-BULB; DEPENDENT PROTEIN-KINASE; CELL-SPECIFIC EXPRESSION; CYCLIC-AMP ACCUMULATION; GTP-BINDING PROTEIN; NEUROBLASTOMA-CELLS; HYDROLYSIS; CLONING; STIMULATION	We have used a luciferase reporter gene under the transcriptional control of a cAMP response element as a sensitive monitor of the regulation by muscarinic acetylcholine receptors (mAChRs) of intracellular cAMP levels and cAMP-regulated gene expression. Treatment with the muscarinic agonist carbachol results in an increase in luciferase activity in JEG-3 cells transiently transfected with mouse ml (8-10-fold) and chick m4 (3-5-fold) mAChRs. Control experiments indicate that these responses are not due to a calcium-mediated pathway and are dependent upon a functional protein kinase A. The m1 and m4 responses are not sensitive to pertussus toxin and the m4 response was potentiated by it. Thus, these responses do not result from direct stimulation of adenylate cyclase by betagamma subunits released from pertussis toxin-sensitive G-proteins. Atropine treatment of cells transfected with high levels of m4 mAChR, but not m1, causes an elevation in basal levels of cAMP response element-mediated luciferase expression in the absence of agonist. This suggests that the m4 receptor is spontaneously active and can cause constitutive inhibition of adenylyl cyclase that is relieved by atropine treatment. Surprisingly, the m4 receptor exhibits little if any agonist-induced inhibition of luciferase expression at either low or high levels of receptor expression. JEG-3 cells express G(i)alpha-1 and G(i)alpha-3 but not G(i)alpha-2. Cotransfection of G(i)alpha subunits with m4 demonstrates that the m4 receptor requires G(i)alpha-2 for optimal agonist-mediated inhibition. Even in the presence of G(i)alpha-2, high levels of receptor increased luciferase expression at high concentrations of agonist. Thus, the m4 mAChR can undergo a switch in functional coupling from inhibition to stimulation of adenylyl cyclase. This switch is dependent on the level of receptor expression, the subtypes of G-proteins coexpressed with the receptor, and the concentration of agonist. Furthermore, we demonstrate that the G(i)alpha-2 G-protein alpha subunit preferentially couples the m4 mAChR to inhibition of adenylyl cyclase in JEG-3 cells.	UNIV WASHINGTON,DEPT PHARMACOL,SJ30,SEATTLE,WA 98195	University of Washington; University of Washington Seattle					NHLBI NIH HHS [HL30639] Funding Source: Medline; NIGMS NIH HHS [GM07108] Funding Source: Medline; NINDS NIH HHS [NS26920] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026920] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASHKENAZI A, 1989, CELL, V56, P487, DOI 10.1016/0092-8674(89)90251-1; BAUMGOLD J, 1992, J NEUROCHEM, V58, P1754, DOI 10.1111/j.1471-4159.1992.tb10050.x; BAUMGOLD J, 1989, BIOCHEM BIOPH RES CO, V154, P1137; BEALS CR, 1987, P NATL ACAD SCI USA, V84, P7886, DOI 10.1073/pnas.84.22.7886; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; DAY RN, 1989, J BIOL CHEM, V264, P431; DELLACQUA ML, 1993, J BIOL CHEM, V268, P5676; EASON MG, 1992, J BIOL CHEM, V267, P15795; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FELDER CC, 1989, FEBS LETT, V245, P75, DOI 10.1016/0014-5793(89)80195-4; FELDER CC, 1989, J BIOL CHEM, V264, P20356; GOLDSMITH P, 1987, J BIOL CHEM, V262, P14683; HANF R, 1993, J PHYSIOL-LONDON, V461, P743, DOI 10.1113/jphysiol.1993.sp019539; HUGHES AR, 1984, P NATL ACAD SCI-BIOL, V81, P5680, DOI 10.1073/pnas.81.18.5680; JANSSON CC, 1991, BIOCHIM BIOPHYS ACTA, V1095, P255, DOI 10.1016/0167-4889(91)90108-A; JONES DT, 1987, J BIOL CHEM, V262, P14241; JONES SVP, 1991, MOL PHARMACOL, V40, P242; KUBO T, 1986, FEBS LETT, V209, P367, DOI 10.1016/0014-5793(86)81144-9; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; LIM K, 1989, BIOTECHNIQUES, V7, P576; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUETJE CW, 1987, BIOCHEMISTRY-US, V26, P4876, DOI 10.1021/bi00389a040; MATESIC DF, 1991, FEBS LETT, V284, P184, DOI 10.1016/0014-5793(91)80680-2; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; MONTMAYEUR JP, 1993, MOL ENDOCRINOL, V7, P161, DOI 10.1210/me.7.2.161; NATHANSON NM, 1992, METHODS NEUROSCI, V9, P116; OLIANAS MC, 1990, J NEUROCHEM, V55, P1083, DOI 10.1111/j.1471-4159.1990.tb04603.x; OLIANAS MC, 1991, J PHARMACOL EXP THER, V259, P680; OLIANAS MC, 1992, J NEUROCHEM, V58, P1723, DOI 10.1111/j.1471-4159.1992.tb10046.x; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; PEI L, 1991, MOL ENDOCRINOL, V5, P521, DOI 10.1210/mend-5-4-521; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; PERALTA EG, 1987, SCIENCE, V236, P600, DOI 10.1126/science.3107123; PERALTA EG, 1987, EMBO J, V6, P3923, DOI 10.1002/j.1460-2075.1987.tb02733.x; SHAPIRO RA, 1988, J BIOL CHEM, V263, P18397; SHUTZ W, 1992, TRENDS PHARMACOL SCI, V13, P376; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; SPIEGEL AM, 1990, G RPTEINS SIGNAL TRA, P186; TIETJE KM, 1990, J BIOL CHEM, V265, P2828; WALSH DA, 1971, J BIOL CHEM, V246, P1977; WOODFORD TA, 1989, J BIOL CHEM, V264, P13321	43	72	74	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9767	9773						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144570				2022-12-27	WOS:A1994NE05300059
J	TAKADA, T; IIDA, K; MOSS, J				TAKADA, T; IIDA, K; MOSS, J			EXPRESSION OF NAD GLYCOHYDROLASE ACTIVITY BY RAT MAMMARY ADENOCARCINOMA CELLS TRANSFORMED WITH RAT T-CELL ALLOANTIGEN-RT6.2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; EXOTOXIN-A; ADP-RIBOSYLTRANSFERASE; NUCLEOTIDE-SEQUENCE; TOXIN; GENE; ENTEROTOXIN; CLONING; RT6	RT6.2 is a 26-kDa alloantigen expressed only on postthymic T cells and attached to the cell membrane through a glycosylphosphatidylinositol (GPI) anchor. It has been reported that expression of RT6.2 in animal models may correlate with lymphopenia and genetically-induced insulin-dependent diabetes mellitus. Its physiological function is unclear. Since RT6.2 has significant amino acid identity with a GPI-anchored rabbit muscle NAD:arginine ADP-ribosyltransferase, RT6.2 was expressed in rat mammary adenocarcinoma cells and the ability of the expressed protein to catalyze ADP-ribose transfer reactions was examined. Cells transformed with the RT6.2 gene expressed NAD glycohydrolase activity that was released from intact cells by phosphatidylinositol-specific phospholipase C, consistent with its presence on the cell surface. A similar activity was not detected with vector-transformed cells. RT6.2 did not ADP-ribosylate simple guanidino compounds. The molecular weight of the phosphatidylinositol-specific phospholipase C-released NAD glycohydrolase, determined by SDS-polyacrylamide gel electrophoresis, was 22,000-24,000, in good agreement with that of native RT6.2. These results strongly suggest that the rat T cell alloantigen RT6.2 is a GPI-anchored NAD glycohydrolase.			TAKADA, T (corresponding author), NHLBI, CELLULAR METAB LAB, RM 5N-307, BLDG 10, BETHESDA, MD 20892 USA.							ALLURED VS, 1986, P NATL ACAD SCI USA, V83, P1320, DOI 10.1073/pnas.83.5.1320; Ausubel F, 1990, CURRENT PROTOCOLS MO, V1; CARROLL SF, 1987, J BIOL CHEM, V262, P8707; FANGMANN J, 1991, EUR J IMMUNOL, V21, P2011, DOI 10.1002/eji.1830210907; GRAY GL, 1984, P NATL ACAD SCI-BIOL, V81, P2645, DOI 10.1073/pnas.81.9.2645; GREINER DL, 1986, J IMMUNOL, V136, P148; HOWARD M, 1993, NATURE, V262, P1056; JUNG M, 1993, J BIOL CHEM, V268, P23215; KIM H, 1993, SCIENCE, V261, P1330, DOI 10.1126/science.8395705; KIM UH, 1993, ARCH BIOCHEM BIOPHYS, V305, P147, DOI 10.1006/abbi.1993.1404; KOCH F, 1990, P NATL ACAD SCI USA, V87, P964, DOI 10.1073/pnas.87.3.964; KOCH F, 1988, IMMUNOLOGY, V65, P259; KONTANI K, 1993, J BIOL CHEM, V268, P16895; LANG F, 1989, EUR J IMMUNOL, V19, P1785, DOI 10.1002/eji.1830191004; MEKALANOS JJ, 1983, NATURE, V306, P551, DOI 10.1038/306551a0; MOSS J, 1976, P NATL ACAD SCI USA, V73, P4424, DOI 10.1073/pnas.73.12.4424; NEMOTO Y, 1991, J BIOL CHEM, V266, P19312; OKAZAKI IJ, 1993, FASEB J, V7, pA1042; SIXMA TK, 1991, NATURE, V351, P371, DOI 10.1038/351371a0; TSUJI T, 1990, J BIOL CHEM, V265, P22520; YAMAMOTO T, 1984, J BIOL CHEM, V259, P5037; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416; ZOLKIEWSKA A, 1993, J BIOL CHEM, V268, P25273; ZOLKIEWSKA A, 1992, P NATL ACAD SCI USA, V89, P11352, DOI 10.1073/pnas.89.23.11352; [No title captured]	25	71	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9420	9423						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144525				2022-12-27	WOS:A1994NE05300007
J	PROKIPCAK, RD; HERRICK, DJ; ROSS, J				PROKIPCAK, RD; HERRICK, DJ; ROSS, J			PURIFICATION AND PROPERTIES OF A PROTEIN THAT BINDS TO THE C-TERMINAL CODING REGION OF HUMAN C-MYC MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; SULFATE-POLYACRYLAMIDE GELS; 3' UNTRANSLATED REGION; SODIUM DODECYL-SULFATE; BETA-TUBULIN; POSTTRANSCRIPTIONAL REGULATION; CELL-DIFFERENTIATION; ONCOGENE EXPRESSION; OXIDATION-REDUCTION; GENE-EXPRESSION	The short half-life of c-myc mRNA is influenced by sequences in the 3'-untranslated region and the C-terminal part of the coding region. In cell-free extracts, a polysomal protein binds to RNA corresponding to the coding region stability determinant. This and other observations suggest that the protein is bound to polysome-associated c-myc mRNA and protects the mRNA from a ribosome-associated endoribonuclease (Bernstein, P. L., Herrick, D. J., Prokipcak, R. D., and Ross, J. (1992) Genes and Dev. 6, 642-654). Here, we describe a four-step purification of the binding protein: solubilization from ribo somes, ammonium sulfate precipitation, RNA affinity chromatography, and reverse-phase high performance liquid chromatography. The 7O-kDa protein can be renatured from solutions containing sodium dodecyl sulfate or organic solvents, greatly facilitating its purification. Protein binding to c-myc coding region RNA is blocked by diamide and N-ethylmaleimide, indicating a requirement for sulfhydryl groups. The protein also binds to N-myc coding region RNA but with approximately 5-fold lower affinity than to the comparable c-myc region. Excess c-myc competitor RNA induces 8-fold destabilization of c-myc mRNA in cell-free mRNA decay extracts. In contrast, N-myc coding region competitor RNA has no effect on c-nye mRNA half-life. Therefore, the protein we have purified probably affects c-myc mRNA metabolism with high specificity.	UNIV WISCONSIN, MCARDLE LAB CANC RES, MADISON, WI 53706 USA; UNIV WISCONSIN, DEPT PATHOL, MADISON, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison					NCI NIH HHS [CA63676, CA07175, CA23076] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA023076, P30CA007175, R01CA063676] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; BISHOP JO, 1974, NATURE, V250, P199, DOI 10.1038/250199a0; BONNIEU A, 1988, ONCOGENE RES, V3, P155; BONNIEU A, 1990, ONCOGENE, V5, P1585; BRADFIELD CA, 1991, MOL PHARMACOL, V39, P13; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAWERMAN G, 1989, CELL, V57, P9, DOI 10.1016/0092-8674(89)90166-9; BREWER G, 1988, MOL CELL BIOL, V8, P1697, DOI 10.1128/MCB.8.4.1697; BREWER G, 1991, MOL CELL BIOL, V11, P2460, DOI 10.1128/MCB.11.5.2460; BREWER G, 1990, METHOD ENZYMOL, V181, P202; BREWER G, 1989, MOL CELL BIOL, V9, P1996, DOI 10.1128/MCB.9.5.1996; BROWN PH, 1989, J BIOL CHEM, V264, P13383; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CHEN CYA, 1992, MOL CELL BIOL, V12, P5748, DOI 10.1128/MCB.12.12.5748; CLEVELAND D W, 1989, New Biologist, V1, P121; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; DANI C, 1985, P NATL ACAD SCI USA, V82, P4896, DOI 10.1073/pnas.82.15.4896; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; EICK D, 1985, EMBO J, V4, P3717, DOI 10.1002/j.1460-2075.1985.tb04140.x; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; FREYTAG SO, 1990, CELL GROWTH DIFFER, V1, P339; GAY DA, 1989, P NATL ACAD SCI USA, V86, P5763, DOI 10.1073/pnas.86.15.5763; GAY DA, 1987, CELL, V50, P671, DOI 10.1016/0092-8674(87)90325-4; GRIEP AE, 1986, P NATL ACAD SCI USA, V83, P5539, DOI 10.1073/pnas.83.15.5539; GUREVICH VV, 1991, ANAL BIOCHEM, V195, P207, DOI 10.1016/0003-2697(91)90318-N; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; HARGROVE JL, 1991, BIOESSAYS, V13, P667, DOI 10.1002/bies.950131209; HARRELL CM, 1991, P NATL ACAD SCI USA, V88, P4166, DOI 10.1073/pnas.88.10.4166; HENTZE MW, 1989, SCIENCE, V244, P357, DOI 10.1126/science.2711187; HERRICK DJ, 1994, IN PRESS MOL CELL BI, V14; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; KABNICK KS, 1988, MOL CELL BIOL, V8, P3244, DOI 10.1128/MCB.8.8.3244; KINDY MS, 1986, J BIOL CHEM, V261, P2865; KOELLER DM, 1991, P NATL ACAD SCI USA, V88, P7778, DOI 10.1073/pnas.88.17.7778; KOHL NE, 1984, SCIENCE, V226, P1335, DOI 10.1126/science.6505694; LACHMAN HM, 1986, P NATL ACAD SCI USA, V83, P6480, DOI 10.1073/pnas.83.17.6480; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAIRDOFFRINGA IA, 1991, NUCLEIC ACIDS RES, V19, P2387, DOI 10.1093/nar/19.9.2387; LEE C, 1987, ANAL BIOCHEM, V166, P308, DOI 10.1016/0003-2697(87)90579-3; LEE WMF, 1985, MOL CELL BIOL, V5, P3345, DOI 10.1128/MCB.5.12.3345; LEE WMF, 1988, MOL CELL BIOL, V8, P5521, DOI 10.1128/MCB.8.12.5521; LUSCHER B, 1990, GENE DEV, V4, P2025, DOI 10.1101/gad.4.12a.2025; MALTER JS, 1991, J BIOL CHEM, V266, P3167; MASTERS PS, 1988, J VIROL, V62, P2658, DOI 10.1128/JVI.62.8.2658-2664.1988; MATTAJ IW, 1989, CELL, V57, P1, DOI 10.1016/0092-8674(89)90164-5; MEIJLINK F, 1985, P NATL ACAD SCI USA, V82, P4987, DOI 10.1073/pnas.82.15.4987; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; NEUPERT B, 1990, NUCLEIC ACIDS RES, V18, P51, DOI 10.1093/nar/18.1.51; OLSEN HS, 1990, SCIENCE, V247, P845, DOI 10.1126/science.2406903; PARIA BC, 1992, P NATL ACAD SCI USA, V89, P10051, DOI 10.1073/pnas.89.21.10051; PELTZ S W, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P99; PIECHACZYK M, 1985, CELL, V42, P589, DOI 10.1016/0092-8674(85)90116-3; POGNONEC P, 1992, J BIOL CHEM, V267, P24563; RABBITTS PH, 1985, EMBO J, V4, P3727, DOI 10.1002/j.1460-2075.1985.tb04141.x; RAHMSDORF HJ, 1987, NUCLEIC ACIDS RES, V15, P1643, DOI 10.1093/nar/15.4.1643; ROSS J, 1986, J MOL BIOL, V188, P579, DOI 10.1016/S0022-2836(86)80008-0; ROSS J, 1987, J BIOL CHEM, V262, P9374; RYFFEL GU, 1975, BIOCHEMISTRY-US, V14, P1379, DOI 10.1021/bi00678a006; SACHS AB, 1985, MOL CELL BIOL, V5, P1993, DOI 10.1128/MCB.5.8.1993; SACHS AB, 1992, CELL, V70, P961, DOI 10.1016/0092-8674(92)90246-9; SAXENA VP, 1970, BIOCHEMISTRY-US, V9, P5015; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; SMITH MJ, 1990, MOL CELL BIOL, V10, P5333, DOI 10.1128/MCB.10.10.5333; SPENCER CA, 1991, ADV CANCER RES, V56, P1; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; WALDEN WE, 1989, J BIOL CHEM, V264, P13765; WISDOM R, 1990, J BIOL CHEM, V265, P19015; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232; YEN TJ, 1988, NATURE, V334, P580, DOI 10.1038/334580a0; YEN TJ, 1988, MOL CELL BIOL, V8, P1224, DOI 10.1128/MCB.8.3.1224; YOU Y, 1992, MOL CELL BIOL, V12, P2931, DOI 10.1128/MCB.12.7.2931	85	105	119	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9261	9269						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132663				2022-12-27	WOS:A1994NB41100093
J	TAGUCHI, T; SEKO, A; KITAJIMA, K; MUTO, Y; INOUE, S; KHOO, KH; MORRIS, HR; DELL, A; INOUE, Y				TAGUCHI, T; SEKO, A; KITAJIMA, K; MUTO, Y; INOUE, S; KHOO, KH; MORRIS, HR; DELL, A; INOUE, Y			STRUCTURAL STUDIES OF A NOVEL TYPE OF PENTAANTENNARY LARGE GLYCAN UNIT IN THE FERTILIZATION-ASSOCIATED CARBOHYDRATE-RICH GLYCOPEPTIDE ISOLATED FROM THE FERTILIZED-EGGS OF ORYZIAS-LATIPES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; LYSOSOMAL MEMBRANE-GLYCOPROTEINS; DE-N-GLYCOSYLATION; UNFERTILIZED EGGS; SIALYL-LEX; FREE SIALOOLIGOSACCHARIDES; HUMAN-GRANULOCYTES; ZONA-PELLUCIDA; STORAGE POOL; MEDAKA FISH	In a previous report (Kitajima, K., Inoue, S., and Inoue, Y. (1989) Dev. Biol. 132, 544-553), we found the presence of a heavily glycosylated polyprotein, ''H-hyosophorin,'' isolated from the unfertilized eggs of Oryzias latipes. We now report our detailed analysis of the structure of the N-glycan chain in L-hyosophorin, the smallest repeating unit of H-hyosophorin, which was isolated from the fertilized eggs of O. latipes and formed from H-hyosophorin upon fertilization. The N-glycan structures were defined by a combination of compositional analysis, methylation analysis, selective chemical degradation (i.e. mild methanolysis, periodate-Smith degradation, and hydrazinolysis nitrous acid deamination), enzymatic (endo-beta-galactosidase, peptide:N-glycanase and Newcastle disease virus sialidase) digestion, and instrumental analyses (one- and two-dimensional proton nuclear magnetic resonance spectroscopy and fast atom bombardment mass spectrometry) which revealed novel and unique features: (a) the presence of highly branched poly-N-acetyllactosamino pentaantennary structures; (b) the presence of a beta-galactosylated Lewis X antigenic epitope, Gal beta 1 --> 4 Gal beta 1 --> 4 (Fuc alpha 1 --> 3)GlcNAc beta 1 -->; (c) the presence of a beta-galactosylated sialyl Lewis X structure, Gal beta 1 --> 4(Neu5Ac alpha 2 --> 3)Gal beta 1 --> 4(Fuc alpha 1 --> 3)GlcNAc beta 1 -->; (d) the presence of Gal beta 1 --> 4Gal beta 1 --> and Gal beta 1 -->; 4Gal beta 1 --> 4Gal beta 1 --> as the major and minor groupings, respectively; and (e) the presence of the branched Gal residues, --> 4GlcNAc beta 1 --> 3(Gal beta 1 --> 4) Gal beta 1 -->. This study represents the first detailed investigation regarding the nature of highly branched complex asparagine-linked pentaantennary glycans in glycoproteins. The unique expression of such bulky multiantennary glycan units on proteins could be essential during early embryogenesis.	UNIV TOKYO, FAC SCI, DEPT BIOPHYS & BIOCHEM, TOKYO 113, JAPAN; SHOWA UNIV, SCH PHARMACEUT SCI, TOKYO 142, JAPAN; IMPERIAL COLL SCI TECHNOL & MED, DEPT BIOCHEM, LONDON SW7 2AZ, ENGLAND	University of Tokyo; Showa University; Imperial College London			Khoo, Kay-Hooi/E-1989-2019	Khoo, Kay-Hooi/0000-0003-2906-406X; Taguchi, Tomohiko/0000-0003-0464-6370	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AMINOFF D, 1961, BIOCHEM J, V81, P384, DOI 10.1042/bj0810384; BROCKHAUSEN I, 1989, J BIOL CHEM, V264, P11211; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; DELL A, 1994, IN PRESS GLYCOBIOLOG; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FUKUDA M, 1981, P NATL ACAD SCI-BIOL, V78, P6299, DOI 10.1073/pnas.78.10.6299; FUKUDA M, 1985, Biochimica et Biophysica Acta, V780, P119; FUKUDA M, 1984, J BIOL CHEM, V259, P8260; FUKUDA M, 1984, J BIOL CHEM, V259, P4782; FUKUDA M, 1984, J BIOL CHEM, V259, P925; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; HAKOMORI S, 1982, TERATOCARCINOMA EMBR, P179; INOUE S, 1989, J BIOL CHEM, V264, P18520; INOUE Y, 1993, POLYSIALIC ACID MICR, P171; ISHII K, 1989, J BIOL CHEM, V264, P1623; IWASAKI M, 1992, J BIOL CHEM, V267, P24287; KAMADA Y, 1987, EUR J BIOCHEM, V163, P497, DOI 10.1111/j.1432-1033.1987.tb10896.x; KITAGAWA H, 1989, BIOCHEMISTRY-US, V28, P8891, DOI 10.1021/bi00448a031; KITAJIMA K, 1989, DEV BIOL, V132, P544, DOI 10.1016/0012-1606(89)90249-2; MAEMURA K, 1992, J BIOL CHEM, V267, P24379; MURAMATSU H, 1983, J BIOCHEM-TOKYO, V94, P799, DOI 10.1093/oxfordjournals.jbchem.a134422; MURAMATSU T, 1978, P NATL ACAD SCI USA, V75, P2315, DOI 10.1073/pnas.75.5.2315; NIMTZ M, 1993, EUR J BIOCHEM, V213, P39, DOI 10.1111/j.1432-1033.1993.tb17732.x; NOGUCHI S, 1992, EUR J BIOCHEM, V209, P883, DOI 10.1111/j.1432-1033.1992.tb17361.x; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; PIERCE M, 1986, J BIOL CHEM, V261, P772; PRIEM B, 1990, GLYCOCONJUGATE J, V7, P121, DOI 10.1007/BF01050375; Segrest J P, 1971, Biochem Biophys Res Commun, V44, P390; SAWADA R, 1993, J BIOL CHEM, V268, P12675; SEKO A, 1991, BIOCHEM BIOPH RES CO, V180, P1165, DOI 10.1016/S0006-291X(05)81318-X; SEKO A, 1989, J BIOL CHEM, V264, P15922; SEKO A, 1991, J BIOL CHEM, V266, P22110; SHIMODA Y, 1993, GLYCOCONJUGATE J, V10, P264, DOI 10.1007/BF01209938; SPOONCER E, 1984, J BIOL CHEM, V259, P4792; SVENNERHOLM L, 1963, METHOD ENZYMOL, V6, P459, DOI 10.1016/0076-6879(63)06206-6; TAGUCHI T, 1993, J BIOL CHEM, V268, P2353; UCHIDA Y, 1977, J BIOCHEM-TOKYO, V82, P1425, DOI 10.1093/oxfordjournals.jbchem.a131830; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1; WALZ G, 1990, SCIENCE, V250, P1132, DOI 10.1126/science.1701275; WOODWARD JR, 1992, GLYCOBIOLOGY, V2, P241, DOI 10.1093/glycob/2.3.241; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772; YUREWICZ EC, 1987, J BIOL CHEM, V262, P564	42	40	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8762	8771						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132608				2022-12-27	WOS:A1994NB41100025
J	AOKI, J; KOIKE, S; ISE, I; SATOYOSHIDA, Y; NOMOTO, A				AOKI, J; KOIKE, S; ISE, I; SATOYOSHIDA, Y; NOMOTO, A			AMINO-ACID-RESIDUES ON HUMAN POLIOVIRUS RECEPTOR INVOLVED IN INTERACTION WITH POLIOVIRUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN SUPERFAMILY; MONOCLONAL-ANTIBODIES; MOLECULAR-CLONING; N-GLYCOSYLATION; BINDING; DOMAINS; MURINE; ICAM-1; SITE; CD4	We have previously demonstrated that the N-terminal immunoglobulin-like domain (domain 1; 115 amino acids) of human poliovirus receptor (hPVR) is essential for poliovirus binding and infection to cells. To identify amino acids involved in the interaction with poliovirus, we constructed a number of cDNAs encoding mutant hPVRs whose domain 1 was partially derived from mouse PVR (mPVR) homolog, which does not serve as a binding site for poliovirus. Poliovirus binding and infection assays were performed on mouse L cells that express these chimera cDNAs. Anti-hPVR monoclonal antibodies were employed to confirm the presence of mutant PVRs on the surface of mouse cells and to know conformational alteration of these PVRs. A significant decrease in efficiency of both poliovirus binding and infection to the cells was observed when one or a few amino acids of hPVR at Gly(73), Ser(74), Gln(82), Leu(99)-Glu(102), or Gln(130)-Ser(132) were substituted by the corresponding amino acids of mPVR. Similar results were obtained when a a amino acid insertion of mPVR, which was missing in hPVR, was introduced at the corresponding site (between Arg(98) and Leu(99)) of hPVR. These amino acids were highly conserved in functional PVRs of primates but not in unfunctional PVRs of rodents. These results indicate that the amino acids identified may have important roles in interaction of PVR with poliovirus that leads to the establishment of the virus infection. In the three-dimensional model of the domain 1 of hPVR, these amino acids are located on one side of the molecule. This suggests that the interaction with poliovirus occurs on this side of the domain 1.	UNIV TOKYO,INST MED SCI,DEPT MICROBIOL,MINATO KU,TOKYO 108,JAPAN	University of Tokyo	AOKI, J (corresponding author), TOKYO METROPOLITAN INST MED SCI,DEPT MICROBIOL,BUNKYO KU,TOKYO 113,JAPAN.			Aoki, Junken/0000-0001-9435-1896				AARNES CM, 1987, EXP CELL RES, V170, P483, DOI 10.1016/0014-4827(87)90322-3; ARTHOS J, 1989, CELL, V57, P469, DOI 10.1016/0092-8674(89)90922-7; CLAYTON LK, 1988, NATURE, V335, P363, DOI 10.1038/335363a0; FILMAN DJ, 1989, EMBO J, V8, P1567, DOI 10.1002/j.1460-2075.1989.tb03541.x; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; IIZUKA N, 1991, J VIROL, V65, P4867, DOI 10.1128/JVI.65.9.4867-4873.1991; KAWAMURA N, 1989, J VIROL, V63, P1302, DOI 10.1128/JVI.63.3.1302-1309.1989; KOCH F, 1985, MOL BIOL POLIOVIRUS, P1; KOIKE S, 1991, P NATL ACAD SCI USA, V88, P4104, DOI 10.1073/pnas.88.10.4104; KOIKE S, 1990, EMBO J, V9, P3217, DOI 10.1002/j.1460-2075.1990.tb07520.x; Koike S., 1992, Seminars in Virology, V3, P109; KOIKE S, 1992, J VIROL, V66, P7059, DOI 10.1128/JVI.66.12.7059-7066.1992; KOIKE S, 1994, IN PRESS TRANSGENIC; KRAMER W, 1987, METHOD ENZYMOL, V154, P350; MASON PW, 1993, VIROLOGY, V192, P568, DOI 10.1006/viro.1993.1073; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; MORRISON ME, 1992, J VIROL, V66, P2807, DOI 10.1128/JVI.66.5.2807-2813.1992; REGISTER RB, 1991, J VIROL, V65, P6589, DOI 10.1128/JVI.65.12.6589-6596.1991; ROSSMANN MG, 1988, VIROLOGY, V164, P373, DOI 10.1016/0042-6822(88)90550-8; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOCKMEL GA, 1992, J EXP MED, V175, P301, DOI 10.1084/jem.175.1.301; SELINKA HC, 1991, P NATL ACAD SCI USA, V88, P3598, DOI 10.1073/pnas.88.9.3598; SPITZ M, 1984, J IMMUNOL METHODS, V70, P39, DOI 10.1016/0022-1759(84)90387-9; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; TAMATANI T, 1990, INT IMMUNOL, V2, P165, DOI 10.1093/intimm/2.2.165; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; ZIBERT A, 1992, J VIROL, V66, P7368, DOI 10.1128/JVI.66.12.7368-7373.1992	27	78	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8431	8438						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132569				2022-12-27	WOS:A1994NB40900090
J	LI, RS; ABRAHAMSEN, MS; JOHNSON, RR; MORRIS, DR				LI, RS; ABRAHAMSEN, MS; JOHNSON, RR; MORRIS, DR			COMPLEX INTERACTIONS AT A GC-RICH DOMAIN REGULATE CELL TYPE-DEPENDENT ACTIVITY OF THE ORNITHINE DECARBOXYLASE PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX-BINDING-PROTEINS; TRANSCRIPTIONAL ACTIVATION; RESPONSE ELEMENT; RETINOIC ACID; MAMMALIAN-CELLS; GENE-EXPRESSION; SP1; MECHANISMS; CLONING; FAMILY	Regulation of ornithine decarboxylase (ODC) is critical to the control of cellular growth, differentiation, and carcinogenesis. A GC-rich region in the ODC promoter contains two overlapping protein binding sites that interact to regulate basal level expression in some cell types. A perfect binding motif for transcription factor Sp1 (CCCCGCCCC) is located at nucleotides -114 to -106 relative to the site of transcriptional initiation, binds strongly to purified Spl protein, and forms several complexes when incubated with nuclear extracts. Only one of these complexes is recognized by Sp1-specific antibody. A new protein-binding motif (GCCCCTCCCCC, located at -110 to -100) partially overlaps with the Spl site and analysis by DNase I protection showed that a new protein (''NF-ODC1'') and the Sp1-like proteins interact with the ODC promoter in a mutually exclusive manner. Mutation of the NF-ODC1 binding motif strongly enhanced ODC promoter strength in some cell types, but had little or no influence in others. The effect of mutating the Sp1 site also varied with cell type. These cell type specificities did not correlate with the levels of Sp1 and NF-ODC1, binding activities in nuclear extracts. These results show that regulation of the ODC promoter by the Sp1 family is cell type specific and modulated by a negative effector that we have termed NF-ODC1.	UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195; MONTANA STATE UNIV,DEPT VET MOLEC BIOL,BOZEMAN,MT 59717	University of Washington; University of Washington Seattle; Montana State University System; Montana State University Bozeman			Morris, David/G-4503-2011; Li, Runsheng/AFR-9519-2022	Li, Runsheng/0000-0003-1563-1844	NCI NIH HHS [CA39053] Funding Source: Medline; NIDCR NIH HHS [DE08229] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE008229] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABRAHAMSEN MS, 1990, MOL CELL BIOL, V10, P5525, DOI 10.1128/MCB.10.10.5525; ABRAHAMSEN MS, 1992, J BIOL CHEM, V267, P18866; ABRAHAMSEN MS, 1991, PERSPECTIVES CELL RE, P107; ACKERMAN SL, 1991, P NATL ACAD SCI USA, V88, P7523, DOI 10.1073/pnas.88.17.7523; AMMOENDOLA R, 1992, J BIOL CHEM, V267, P17944; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; BHAT G, 1987, EMBO J, V6, P2045, DOI 10.1002/j.1460-2075.1987.tb02469.x; BRABANT M, 1988, P NATL ACAD SCI USA, V85, P2200, DOI 10.1073/pnas.85.7.2200; BROU C, 1993, EMBO J, V12, P489, DOI 10.1002/j.1460-2075.1993.tb05681.x; CORNWELL MM, 1993, J BIOL CHEM, V268, P19505; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DARROW AL, 1990, MOL CELL BIOL, V10, P5883, DOI 10.1128/MCB.10.11.5883; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; FITZGERALD MC, 1989, DNA-J MOLEC CELL BIO, V8, P623, DOI 10.1089/dna.1.1989.8.623; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HANNINK M, 1990, ONCOGENE, V5, P1843; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; HENTHORN P, 1988, P NATL ACAD SCI USA, V85, P6342, DOI 10.1073/pnas.85.17.6342; HENTHORN P, 1989, NUCLEIC ACIDS RES, V17, P6545; HOLTTA E, 1988, J BIOL CHEM, V263, P4500; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; JANSON L, 1990, P NATL ACAD SCI USA, V87, P4732, DOI 10.1073/pnas.87.12.4732; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KATZ A, 1987, MOL CELL BIOL, V7, P2641, DOI 10.1128/MCB.7.7.2641; KATZ A, 1988, J BIOL CHEM, V263, P7604; KIM SJ, 1992, MOL CELL BIOL, V12, P2455, DOI 10.1128/MCB.12.6.2455; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; LEHMANN JM, 1992, MOL CELL BIOL, V12, P2976, DOI 10.1128/MCB.12.7.2976; LEONARD J, 1992, P NATL ACAD SCI USA, V89, P6247, DOI 10.1073/pnas.89.14.6247; LUK GD, 1984, NEW ENGL J MED, V311, P80, DOI 10.1056/NEJM198407123110202; MATSUZAWA Y, 1991, ONCOGENE, V6, P1561; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MORRIS DR, 1991, J CELL BIOCHEM, V46, P102, DOI 10.1002/jcb.240460203; MOSHIER JA, 1993, CANCER RES, V53, P2618; MOSHIER JA, 1992, NUCLEIC ACIDS RES, V20, P2581, DOI 10.1093/nar/20.10.2581; PALVIMO JJ, 1991, NUCLEIC ACIDS RES, V19, P3921, DOI 10.1093/nar/19.14.3921; PARVIN JD, 1992, CELL, V68, P1135, DOI 10.1016/0092-8674(92)90084-P; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; QUINN PG, 1993, J BIOL CHEM, V268, P16999; ROBIDOUX S, 1992, MOL CELL BIOL, V12, P3797; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Sambrook J, 1989, MOL CLONING LABORATO; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TAN SH, 1992, NUCLEIC ACIDS RES, V20, P251, DOI 10.1093/nar/20.2.251; VERMA AK, 1988, CANCER RES, V48, P2168; WEINTRAUB SJ, 1992, MOL CELL BIOL, V12, P512, DOI 10.1128/MCB.12.2.512; WEN L, 1989, J BIOL CHEM, V264, P9016; WINOTO A, 1989, EMBO J, V8, P729, DOI 10.1002/j.1460-2075.1989.tb03432.x; WRIGHTON C, 1993, MOL CELL BIOL, V13, P4657, DOI 10.1128/MCB.13.8.4657; YAMAGUCHI M, 1988, NUCLEIC ACIDS RES, V16, P8773, DOI 10.1093/nar/16.18.8773	56	35	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7941	7949						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132514				2022-12-27	WOS:A1994NB40900020
J	ORR, JW; NEWTON, AC				ORR, JW; NEWTON, AC			INTRAPEPTIDE REGULATION OF PROTEIN-KINASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRASTERIC REGULATION; CATALYTIC SUBUNIT; ACTIVATION; PHOSPHOLIPIDS; BINDING; PHOSPHATIDYLSERINE; COOPERATIVITY; SUBSTRATE; CALCIUM; DOMAIN	Protein kinase C is allosterically activated by diacylglycerol and phosphatidylserine. The enzyme is also activated by surprisingly dissimilar compounds such as short chained phosphatidylcholines and protamine sulfate. Here we show that conventional and nonconventional activators of protein kinase C beta II produce the same structural alteration. They expose Arg(19) of the autoinhibitory pseudosubstrate domain to proteolysis. Molecular modeling of protein kinase C beta II's catalytic domain, based on the structure of the cAMP-dependent kinase's catalytic domain, indicates that Arg(19) is shielded by a cluster of acidic, residues when the pseudosubstrate occupies the substrate-binding site. Our biochemical data and structural modeling indicate a common mechanism of intrapeptide regulation of protein kinase C by all activators that involves release of the pseudosubstrate from the active site.	INDIANA UNIV, DEPT CHEM, BLOOMINGTON, IN 47405 USA	Indiana University System; Indiana University Bloomington					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043154, R37GM043154] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 43154] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; CHAKRAVARTHY BR, 1991, ANAL BIOCHEM, V196, P144, DOI 10.1016/0003-2697(91)90130-L; FLINT AJ, 1990, SCIENCE, V249, P408, DOI 10.1126/science.2377895; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HOUSE C, 1990, CELL SIGNAL, V2, P187, DOI 10.1016/0898-6568(90)90022-3; HOUSE C, 1989, FEBS LETT, V249, P243, DOI 10.1016/0014-5793(89)80632-5; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; KEMP BE, 1991, BIOCHIM BIOPHYS ACTA, V1094, P67, DOI 10.1016/0167-4889(91)90027-U; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; LEE MH, 1989, J BIOL CHEM, V264, P14797; LEVENTHAL PS, 1991, BIOCHEMISTRY-US, V30, P1385, DOI 10.1021/bi00219a031; MURAKAMI K, 1985, FEBS LETT, V192, P189, DOI 10.1016/0014-5793(85)80105-8; MURAMATSU M, 1992, FEBS LETT, V311, P75, DOI 10.1016/0014-5793(92)81371-R; NEWTON AC, 1993, ANNU REV BIOPH BIOM, V22, P1, DOI 10.1146/annurev.bb.22.060193.000245; NEWTON AC, 1989, J BIOL CHEM, V264, P14909; NEWTON AC, 1987, J BIOL CHEM, V262, P10185; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; ORELLANA SA, 1993, J BIOL CHEM, V268, P6843; ORR JW, 1992, J BIOL CHEM, V267, P15263; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4661, DOI 10.1021/bi00134a018; PEARS CJ, 1990, EUR J BIOCHEM, V194, P89, DOI 10.1111/j.1432-1033.1990.tb19431.x; SHAH J, 1992, BIOCHIM BIOPHYS ACTA, V1119, P19, DOI 10.1016/0167-4838(92)90228-6; TAKAI Y, 1977, J BIOL CHEM, V252, P7603; TAKAI Y, 1979, J BIOL CHEM, V254, P3692; WALKER JM, 1988, J BIOL CHEM, V263, P4537; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; [No title captured]	31	122	125	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8383	8387						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132562				2022-12-27	WOS:A1994NB40900083
J	STANLEY, BA; SHANTZ, LM; PEGG, AE				STANLEY, BA; SHANTZ, LM; PEGG, AE			EXPRESSION OF MAMMALIAN S-ADENOSYLMETHIONINE DECARBOXYLASE IN ESCHERICHIA-COLI - DETERMINATION OF SITES FOR PUTRESCINE ACTIVATION OF ACTIVITY AND PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-METHIONINE DECARBOXYLASE; PROENZYME FORM; MESSENGER-RNA; RAT-LIVER; POLYAMINES; SPERMIDINE; INHIBITION; PLANT; BIS(GUANYLHYDRAZONE); PURIFICATION	Mammalian S-adenosylmethionine decarboxylase (AdoMetDC) is known to be regulated by putrescine in two ways: (a) acceleration of the rate of conversion of the proenzyme into the mature enzyme in a reaction that forms the pyruvate prosthetic group and (b) activation of the mature enzyme activity. To determine sites of putrescine interaction with AdoMetDC, putrescine stimulation of both proenzyme processing and catalytic activity was tested with mutant AdoMetDCs in which specific amino acid residues, conserved between mammalian and yeast AdoMetDCs, had been altered by site-directed mutagenesis. Mutations E178Q or E256Q (and the previously reported mutation E11Q (Stanley, B. A., and Pegg, A. E. (1991) J. Biol. Chem. 266, 18502-18506)) abolished stimulation by putrescine without an effect on the processing rate in the absence of putrescine. Mutations E11K, as well as Y112A and L259Stop, completely abolished processing regardless of putrescine concentration, whereas mutation E133Q conferred an absolute putrescine requirement for processing to occur. Mutation E132Q, E135Q, E183Q, or D185N had no effect on proenzyme processing. The effects of mutations on enzyme activity were determined using AdoMetDC protein produced in Escherichia coli and purified by affinity chromatography. Mutation E11Q completely inactivated the enzyme, mutation E133Q reduced the catalytic constant by >10(4), and mutation E256Q produced a 20-fold decrease. Putrescine did not stimulate the activity of mutants E178Q and E256Q but did activate mutants E133Q and E183Q. It is concluded that residues Glu-11, Glu-178, and Glu-256 are critical residues in the putrescine stimulation of AdoMetDC proenzyme processing and that Glu-178 and Glu 256 are critical for putrescine stimulation of AdoMetDC catalytic activity.	PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,DEPT PHARMACOL,HERSHEY,PA 17033	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	STANLEY, BA (corresponding author), PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,DEPT CELLULAR & MOLEC PHYSIOL,POB 850,HERSHEY,PA 17033, USA.		Stanley, Bruce/R-9856-2019	Shantz, Lisa/0000-0001-8814-4022; Stanley, Bruce/0000-0003-1338-2928	NATIONAL CANCER INSTITUTE [R01CA018138, R37CA018138] Funding Source: NIH RePORTER; NCI NIH HHS [CA 18138] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUTELLI R, 1991, EUR J BIOCHEM, V196, P551, DOI 10.1111/j.1432-1033.1991.tb15849.x; BAXTER C, 1973, BIOCHEM BIOPH RES CO, V54, P147, DOI 10.1016/0006-291X(73)90901-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COPPOC GL, 1971, INT J BIOCHEM, V2, P673, DOI 10.1016/0020-711X(71)90058-9; CORTI A, 1974, BIOCHEM J, V139, P351, DOI 10.1042/bj1390351; DESCENZO RA, 1993, PLANT MOL BIOL, V22, P113, DOI 10.1007/BF00039000; DEZEURE F, 1989, INT J BIOCHEM, V21, P889, DOI 10.1016/0020-711X(89)90288-7; DUFFAUD GD, 1987, METHOD ENZYMOL, V153, P492; EVANS PT, 1989, ANNU REV PLANT PHYS, V40, P235, DOI 10.1146/annurev.pp.40.060189.001315; FERSHT A, 1985, ENZYME STRUCTURE MEC, P98; GALLAGHER T, 1993, J MOL BIOL, V230, P516, DOI 10.1006/jmbi.1993.1168; HAFNER EW, 1979, J BIOL CHEM, V254, P2419; HILL JR, 1992, J BIOL CHEM, V267, P21886; KAMEJI T, 1987, BIOCHEM J, V243, P285, DOI 10.1042/bj2430285; KAMEJI T, 1987, J BIOL CHEM, V262, P2427; KASHIWAGI K, 1990, J BIOL CHEM, V265, P22321; KOLB M, 1982, J MED CHEM, V25, P550, DOI 10.1021/jm00347a014; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; PAJUNEN A, 1988, J BIOL CHEM, V263, P17040; PEGG AE, 1969, J BIOL CHEM, V244, P682; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; PEGG AE, 1988, BIOCHEM BIOPH RES CO, V150, P788, DOI 10.1016/0006-291X(88)90460-3; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; PEGG AE, 1992, PHARMACOL THERAPEUT, V56, P359, DOI 10.1016/0163-7258(92)90025-U; PEGG AE, 1984, CELL BIOCHEM FUNCT, V2, P11, DOI 10.1002/cbf.290020105; PEGG AE, 1983, BIOCHEM J, V213, P495, DOI 10.1042/bj2130495; PEGG AE, 1983, METHOD ENZYMOL, V94, P239; PEGG AE, 1982, BIOCH S ADENOSYLMETH, P547; PERSSON L, 1989, BIOCHEM J, V257, P929, DOI 10.1042/bj2570929; POSO H, 1982, BIOCHEMISTRY-US, V21, P3116, DOI 10.1021/bi00256a013; PULKKA A, 1993, GENOMICS, V16, P342, DOI 10.1006/geno.1993.1195; SAKAI T, 1979, BIOCHEMISTRY-US, V18, P5541, DOI 10.1021/bi00592a003; Sambrook J, 1989, MOL CLONING LABORATO; SHANTZ LM, 1992, BIOCHEM J, V288, P511, DOI 10.1042/bj2880511; SHANTZ LM, 1992, BIOCHEMISTRY-US, V31, P6848, DOI 10.1021/bi00144a027; STANLEY BA, 1991, J BIOL CHEM, V266, P18502; STANLEY BA, 1989, J BIOL CHEM, V264, P21073; STANLEY BA, 1993, FASEB J, V7, pA1071; SURESH MR, 1977, EUR J BIOCHEM, V79, P511, DOI 10.1111/j.1432-1033.1977.tb11835.x; TABOR CW, 1987, J BIOL CHEM, V262, P16037; TABOR CW, 1984, ADV ENZYMOL RAMB, V56, P251; TAYLOR MA, 1992, PLANT MOL BIOL, V20, P641, DOI 10.1007/BF00046449; TEKWANI BL, 1992, BIOCHIM BIOPHYS ACTA, V1130, P221, DOI 10.1016/0167-4781(92)90533-6; VANPOELJE PD, 1990, ANNU REV BIOCHEM, V59, P29, DOI 10.1146/annurev.bi.59.070190.000333; WHITE MW, 1990, BIOCHEM J, V268, P657, DOI 10.1042/bj2680657; WHITE MW, 1989, PHYSL POLYAMINES, P331; WILLIAMSASHMAN HG, 1972, BIOCHEM BIOPH RES CO, V46, P288, DOI 10.1016/0006-291X(72)90661-4; YAMANOHA B, 1985, PLANT PHYSIOL, V78, P784, DOI 10.1104/pp.78.4.784; YANG YG, 1991, BIOCHEM BIOPH RES CO, V181, P1181, DOI 10.1016/0006-291X(91)92063-P	49	49	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7901	7907						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132508				2022-12-27	WOS:A1994NB40900014
J	CARMEL, G; LEICHUS, B; CHENG, XD; PATTERSON, SD; MIRZA, U; CHAIT, BT; KURET, J				CARMEL, G; LEICHUS, B; CHENG, XD; PATTERSON, SD; MIRZA, U; CHAIT, BT; KURET, J			EXPRESSION, PURIFICATION, CRYSTALLIZATION, AND PRELIMINARY-X-RAY ANALYSIS OF CASEIN KINASE-1 FROM SCHIZOSACCHAROMYCES-POMBE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CATALYTIC SUBUNIT; SACCHAROMYCES-CEREVISIAE; PHOSPHATE; DETERMINANTS; MUTAGENESIS; SEQUENCES; AFFINITY; RESIDUES	The catalytic domain of Schizosaccharomyces pombe casein kinase-1 (the product of the cki1 gene) has been overexpressed in Escherichia coli, purified by chromatographic methods, characterized in vitro, and crystallized in the presence and absence of nucleotide substrate. The best crystals belong to the trigonal space group P3(1)21 or its enantiomorph, have unit cell parameters a = b = 79 Angstrom, c = 121 Angstrom, and diffract x-rays to 2.0-Angstrom resolution. Kinetic characterization of the purified catalytic domain and other C-terminal deletion mutants of Cki1 suggests that it is subject to two forms of regulation. One mechanism involves autophosphorylation, and results in a 4-fold decrease in the affinity for protein substrate. In contrast, truncation of intact Cki1 results in a 3-fold activation in its catalytic rate. This activation may arise from the removal of an inhibitory domain present in the intact enzyme.	COLD SPRING HARBOR LAB, COLD SPRING HARBOR, NY 11724 USA; ROCKEFELLER UNIV, NEW YORK, NY 10021 USA	Cold Spring Harbor Laboratory; Rockefeller University			Patterson, Scott/A-7404-2009		NIGMS NIH HHS [GM 44806, GM 48216] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R13GM048216, R01GM044806] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGUILAR CF, 1993, ACTA CRYSTALLOGR A, V49, P306, DOI 10.1107/S010876739200847X; ALLEN G, 1981, SEQUENCING PROTEINS, P64; BEAVIS RC, 1990, ANAL CHEM, V62, P1836, DOI 10.1021/ac00216a020; BUSS JE, 1983, METHOD ENZYMOL, V99, P7; CARMEL G, 1992, ANAL BIOCHEM, V203, P274, DOI 10.1016/0003-2697(92)90313-V; CHIJIWA T, 1989, J BIOL CHEM, V264, P4924; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; DEMAGGIO AJ, 1992, P NATL ACAD SCI USA, V89, P7008, DOI 10.1073/pnas.89.15.7008; EGHTEDARZADEH MK, 1986, NUCLEIC ACIDS RES, V14, P5115, DOI 10.1093/nar/14.12.5115; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; GRAVES PR, 1993, J BIOL CHEM, V268, P6394; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KUMAR S, 1992, BIOCHEMISTRY-US, V31, P8648, DOI 10.1021/bi00151a035; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KURET J, 1988, J BIOL CHEM, V263, P9149; KURET J, 1991, BIOCHEMISTRY-US, V30, P10595, DOI 10.1021/bi00107a031; MANN M, 1989, ANAL CHEM, V61, P1702, DOI 10.1021/ac00190a023; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MEGGIO F, 1990, EUR J BIOCHEM, V187, P89, DOI 10.1111/j.1432-1033.1990.tb15280.x; MEGGIO F, 1991, FEBS LETT, V283, P303, DOI 10.1016/0014-5793(91)80614-9; PERICH JW, 1992, BIOCHEMISTRY-US, V31, P5893, DOI 10.1021/bi00140a027; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; ROBINSON LC, 1992, P NATL ACAD SCI USA, V89, P28, DOI 10.1073/pnas.89.1.28; ROWLES J, 1991, P NATL ACAD SCI USA, V88, P9548, DOI 10.1073/pnas.88.21.9548; STEIGEMANN W, 1974, THESIS TU MUNCHEN; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P123; UMPHRESS JL, 1992, EUR J BIOCHEM, V203, P239, DOI 10.1111/j.1432-1033.1992.tb19852.x; VANCURA A, 1993, ARCH BIOCHEM BIOPHYS, V305, P47, DOI 10.1006/abbi.1993.1391; WANG PC, 1992, MOL BIOL CELL, V3, P275, DOI 10.1091/mbc.3.3.275; WEISSMAN L, 1982, COMPUTATIONAL CRYSTA, P56; WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324	39	57	57	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7304	7309						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125945				2022-12-27	WOS:A1994NA03200044
J	COGHLAN, VM; LANGEBERG, LK; FERNANDEZ, A; LAMB, NJC; SCOTT, JD				COGHLAN, VM; LANGEBERG, LK; FERNANDEZ, A; LAMB, NJC; SCOTT, JD			CLONING AND CHARACTERIZATION OF AKAP-95, A NUCLEAR-PROTEIN THAT ASSOCIATES WITH THE REGULATORY SUBUNIT OF TYPE-II CAMP-DEPENDENT PROTEIN-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY BINDING; CYCLIC-AMP; CATALYTIC SUBUNITS; SUBCELLULAR-LOCALIZATION; ANCHORING PROTEINS; HEPATOMA-CELLS; GOLGI-COMPLEX; BOVINE BRAIN; RII; EXPRESSION	The subcellular location of the type II cAMP-depend- ent protein kinase is dictated by the interaction of the regulatory subunit (RII) with A-kinase anchor proteins (AKAPs). Using an interaction cloning strategy with RII alpha as a probe, we have isolated cDNAs encoding a novel 761-amino acid protein (named AKAP 95) that con- tains both RII- and DNA-binding domains. Deletion analysis and peptide studies revealed that the RII-binding domain of AKAP 95 is located between residues 642 and 659 and includes a predicted amphipathic helix. Zinc overlay and DNA binding studies suggest that the DNA-binding domain is composed of two CC/HH-type zinc fingers between residues 464 and 486 and residues 553 and 576. The AKAP was detected in a nuclear matrix fraction, and immunofluorescence using purified anti-AKAP 95 antibodies revealed a distinct nuclear staining in a variety of cell types. Direct overlay of fluorescein isothiocyanate-labeled RII alpha onto fixed rat embryo fibroblasts showed that high-affinity binding sites for RII exist in the nucleus and that these sites are blocked by an anchoring inhibitor peptide. Furthermore, AKAP 95 was detected in preparations of RII that were purified from cellular extracts using cAMP-agarose. The results suggest that AKAP 95 could play a role in targeting type II cAMP-dependent protein kinase for cAMP-responsive nuclear events.	CNRS,CTR RECH BIOCHIM MACROMOLEC,F-34033 MONTPELLIER,FRANCE; OREGON HLTH SCI UNIV,VOLLUM INST ADV BIOMED RES,PORTLAND,OR 97201	Centre National de la Recherche Scientifique (CNRS); Oregon Health & Science University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK044239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048231, R37GM048231] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK44239] Funding Source: Medline; NIGMS NIH HHS [GM48231] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; BERG JM, 1990, ANNU REV BIOPHYS BIO, V19, P405; BREGMAN DB, 1989, J BIOL CHEM, V264, P4648; BYUS CV, 1982, J CELL BIOL, V93, P727, DOI 10.1083/jcb.93.3.727; CARR DW, 1992, J BIOL CHEM, V267, P16816; CARR DW, 1992, TRENDS BIOCHEM SCI, V17, P246, DOI 10.1016/0968-0004(92)90402-U; CARR DW, 1992, J BIOL CHEM, V267, P13376; CARR DW, 1991, J BIOL CHEM, V266, P14188; COGHLAN VM, 1993, MOL CELL BIOCHEM, V128, P309, DOI 10.1007/BF01076780; CORBIN JD, 1978, J BIOL CHEM, V253, P3997; CORBIN JD, 1975, J BIOL CHEM, V250, P218; CORBIN JD, 1977, J BIOL CHEM, V252, P3854; CUMMING R, 1981, NEUROSCIENCE, V6, P953, DOI 10.1016/0306-4522(81)90176-7; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; DESJARLAIS JR, 1992, P NATL ACAD SCI USA, V89, P7345, DOI 10.1073/pnas.89.16.7345; FEY EG, 1986, J CELL BIOL, V102, P1654, DOI 10.1083/jcb.102.5.1654; FLETCHER WH, 1986, J BIOL CHEM, V261, P5504; GAUTHIERROUVIERE C, 1991, CELL REGUL, V2, P575, DOI 10.1091/mbc.2.7.575; GLANTZ SB, 1993, J BIOL CHEM, V268, P12796; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HAKES DJ, 1991, P NATL ACAD SCI USA, V88, P6186, DOI 10.1073/pnas.88.14.6186; HAKES DJ, 1991, J BIOL CHEM, V266, P11131; HARPER JF, 1985, VITAM HORM, V42, P197; HIRSCH AH, 1992, J BIOL CHEM, V267, P2131; HOFMANN F, 1975, J BIOL CHEM, V250, P7795; JACOBS GH, 1992, EMBO J, V11, P4507, DOI 10.1002/j.1460-2075.1992.tb05552.x; JOACHIM S, 1990, EUR J CELL BIOL, V51, P76; JOLY JC, 1989, J CELL BIOL, V109, P2289, DOI 10.1083/jcb.109.5.2289; KAPTEIN R, 1991, CURR OPIN STRUC BIOL, V2, P109; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; KUETTEL MR, 1985, J CELL BIOL, V101, P965, DOI 10.1083/jcb.101.3.965; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMB NJC, 1991, EMBO J, V10, P1523, DOI 10.1002/j.1460-2075.1991.tb07672.x; LEISER M, 1986, J BIOL CHEM, V261, P1904; LOHMANN SM, 1984, P NATL ACAD SCI-BIOL, V81, P6723, DOI 10.1073/pnas.81.21.6723; LUO ZJ, 1990, J BIOL CHEM, V265, P21804; MEINKOTH JL, 1990, P NATL ACAD SCI USA, V87, P9595, DOI 10.1073/pnas.87.24.9595; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; NICKERSON JA, 1992, J CELL BIOL, V116, P977, DOI 10.1083/jcb.116.4.977; NIGG EA, 1985, CELL, V41, P1039, DOI 10.1016/S0092-8674(85)80084-2; NIGG EA, 1985, EMBO J, V4, P2801, DOI 10.1002/j.1460-2075.1985.tb04006.x; NILAVER G, 1989, TECHNIQUES IMMUNOCYT, V4, P199; RUBIN CS, 1972, J BIOL CHEM, V247, P6135; RUBIN CS, 1979, J BIOL CHEM, V254, P3797; SALVATORI S, 1990, BIOCHEM J, V267, P679, DOI 10.1042/bj2670679; SAMBROOK J, 1989, MOL CLON LABORATORY; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT JD, 1992, NEWS PHYSIOL SCI, V7, P143; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; SCOTT JD, 1990, J BIOL CHEM, V265, P21561; SIKORSKA M, 1988, J BIOL CHEM, V263, P3005; STAUFENBIEL M, 1984, J CELL BIOL, V98, P1886, DOI 10.1083/jcb.98.5.1886; STOFKOHAHN RE, 1992, FEBS LETT, V302, P274, DOI 10.1016/0014-5793(92)80458-S; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUTHERLAND EW, 1972, SCIENCE, V177, P401, DOI 10.1126/science.177.4047.401; VANDRIEL R, 1991, J CELL BIOCHEM, V47, P311, DOI 10.1002/jcb.240470405; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455	59	114	119	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7658	7665						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125992				2022-12-27	WOS:A1994NA03200098
J	CRAMM, R; SIDDIQUI, RA; FRIEDRICH, B				CRAMM, R; SIDDIQUI, RA; FRIEDRICH, B			PRIMARY SEQUENCE AND EVIDENCE FOR A PHYSIOLOGICAL-FUNCTION OF THE FLAVOHEMOPROTEIN OF ALCALIGENES-EUTROPHUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-BINDING FLAVOHEMOPROTEIN; MEMBRANE-BOUND HYDROGENASE; ESCHERICHIA-COLI; GENE-EXPRESSION; NITRIC-OXIDE; HETEROLOGOUS EXPRESSION; BACTERIAL HEMOGLOBIN; NUCLEOTIDE-SEQUENCES; PSEUDOMONAS-STUTZERI; REDUCTASE	The flavohemoprotein (FHP) encoding gene of the strictly respiratory Gram-negative bacterium Alcaligenes eutrophus was isolated from a megaplasmid library by using FHP-specific antibodies and oligonucleotide probes based on the amino-terminal polypeptide sequence of FHP, determined previously (Zhu, H., and Riggs, A. F. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 5015-5019). The fhp gene codes for a monomeric polypeptide of 403 amino acids (M(r) 44,796) whose structure is highly homologous to the proteins of the two-domain flavohemoglobin family comprising the hemoproteins from Escherichia coli and Saccharomyces cerevisiae. FHP consists of an amino-terminal-located O-2-binding hemoglobin domain and a carboxyl-terminal-located redox active domain with potential binding sites for NAD(P)H and FAD. Two potential binding motifs for NARL and FNR upstream of fhp suggest a role of FHP in the anaerobic metabolism of A. eutrophus. Isogenic Fhp-negative mutants showed no significant delay in aerobic or anaerobic growth. Compared with the wild type, however, the mutant did not accumulate nitrous oxide during denitrification with nitrite as electron acceptor. This property was restored by complementation. The result suggests that FHP interacts directly or indirectly with the gas metabolism during denitrification in A. eutrophus.	FREE UNIV BERLIN,INST PFLANZENPHYSIOL & MIKROBIOL,D-14195 BERLIN,GERMANY	Free University of Berlin								APPLEBY CA, 1988, PLANT CELL ENVIRON, V11, P359, DOI 10.1111/j.1365-3040.1988.tb01360.x; Aragno M., 1981, PROKARYOTES HDB HABI, P865, DOI [10.1007/978-3-662-13187-9_70, DOI 10.1007/978-3-662-13187-9_70]; BOLIVAR F, 1978, GENE, V4, P121, DOI 10.1016/0378-1119(78)90025-2; BONNEFOY V, 1992, MOL MICROBIOL, V6, P3595; BOWIEN B, 1981, ANNU REV MICROBIOL, V35, P405, DOI 10.1146/annurev.mi.35.100181.002201; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; CARR GJ, 1990, BIOCHEM J, V269, P423, DOI 10.1042/bj2690423; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; DIKSHIT KL, 1990, NUCLEIC ACIDS RES, V18, P4149, DOI 10.1093/nar/18.14.4149; EITINGER T, 1991, J BIOL CHEM, V266, P3222; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; HEISS B, 1989, J BACTERIOL, V171, P3288, DOI 10.1128/jb.171.6.3288-3297.1989; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; KHOSLA C, 1989, J BACTERIOL, V171, P5995, DOI 10.1128/jb.171.11.5995-6004.1989; KHOSLA C, 1988, NATURE, V331, P633, DOI 10.1038/331633a0; KNAUF VC, 1982, PLASMID, V8, P45, DOI 10.1016/0147-619X(82)90040-3; KORTLUKE C, 1992, J BACTERIOL, V174, P6290; KORTLUKE C, 1992, J BACTERIOL, V174, P6277; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI J, 1992, J BACTERIOL, V174, P4935, DOI 10.1128/JB.174.15.4935-4942.1992; LI SF, 1988, J BIOL CHEM, V263, P13700; LOWE RH, 1964, BIOCHIM BIOPHYS ACTA, V85, P377, DOI 10.1016/0926-6569(64)90301-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NEIDLE EL, 1991, J BACTERIOL, V173, P5385, DOI 10.1128/jb.173.17.5385-5395.1991; OSHINO R, 1973, EUR J BIOCHEM, V35, P23, DOI 10.1111/j.1432-1033.1973.tb02805.x; OSTROWSKI J, 1989, J BIOL CHEM, V264, P15796; PERUTZ MF, 1965, J MOL BIOL, V13, P669, DOI 10.1016/S0022-2836(65)80134-6; PROBST I, 1979, BIOCHIM BIOPHYS ACTA, V576, P471, DOI 10.1016/0005-2795(79)90422-7; PROBST I, 1976, BIOCHIM BIOPHYS ACTA, V440, P412, DOI 10.1016/0005-2728(76)90075-X; RIGGS AF, 1991, AM ZOOL, V31, P535; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLEGEL HG, 1961, ARCH MIKROBIOL, V38, P209, DOI 10.1007/BF00422356; SIDDIQUI RA, 1993, J BACTERIOL, V175, P5867, DOI 10.1128/JB.175.18.5867-5876.1993; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPIRO S, 1990, FEMS MICROBIOL LETT, V75, P399, DOI 10.1016/0378-1097(90)90690-R; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRANBETCKE A, 1990, J BACTERIOL, V172, P2920, DOI 10.1128/jb.172.6.2920-2929.1990; TYREE B, 1978, J BIOL CHEM, V253, P6988; UNDEN G, 1990, FORUM MIKROBIOLOGIE, V4, P211; VASUDEVAN SG, 1991, MOL GEN GENET, V226, P49, DOI 10.1007/BF00273586; WAKABAYASHI S, 1986, NATURE, V322, P481, DOI 10.1038/322481a0; WEIHS V, 1989, ARCH MICROBIOL, V151, P546, DOI 10.1007/BF00454873; WITTENBERG JB, 1990, ANNU REV BIOPHYS BIO, V19, P217; ZHU H, 1992, P NATL ACAD SCI USA, V89, P5015, DOI 10.1073/pnas.89.11.5015; ZUMFT WG, 1993, ARCH MICROBIOL, V160, P253, DOI 10.1007/BF00292074; ZUMFT WG, 1992, EUR J BIOCHEM, V208, P31, DOI 10.1111/j.1432-1033.1992.tb17156.x	49	106	110	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7349	7354						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125952				2022-12-27	WOS:A1994NA03200051
J	PAPADOPOULOU, B; ROY, G; MOURAD, W; LEBLANC, E; OUELLETTE, M				PAPADOPOULOU, B; ROY, G; MOURAD, W; LEBLANC, E; OUELLETTE, M			CHANGES IN FOLATE AND PTERIN METABOLISM AFTER DISRUPTION OF THE LEISHMANIA-H LOCUS SHORT-CHAIN DEHYDROGENASE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DIHYDROPTERIDINE REDUCTASE; P-GLYCOPROTEIN GENE; TRYPANOSOMA-BRUCEI; DIHYDROFOLATE-REDUCTASE; CRITHIDIA-FASCICULATA; TETRAHYDROBIOPTERIN BIOSYNTHESIS; HOMOLOGOUS RECOMBINATION; REGION AMPLIFICATION; DRUG-RESISTANCE; TUBULIN GENE	The short chain dehydrogenase gene ltdh, which is derived from the H locus of Leishmania, confers high level resistance to the dihydrofolate reductase inhibitor methotrexate via a novel mechanism. Resistance is correlated with LTDH overproduction. High level resistance of ltdh transfectants was observed even in poor media where reduced folates are essential for the synthesis of thymidylate precursors. The ltdh transfectants were also capable of growing for several passages, at slightly reduced rates, in unsupplemented folate-deficient medium (fdDME-L), unlike the wild-type cells that could grow only in fdDME-L if supplemented with various folates or pterins. An homozygous ltdh mutant was obtained by gene targeting. This mutant became hypersensitive to methotrexate, but unlike wild-type cells, methotrexate toxicity could not be circumvented by the addition of thymidine. Although the homozygous mutant was capable of growing in fdDME-L supplemented with folate derivatives, it lost its ability to thrive in fdDME-L supplemented with pterins. Our results support the model in which LTDH is a key enzyme responsible for the conversion of a pterin derivative into an essential cofactor. This essential cofactor can also be converted into reduced folates at sufficient levels for growth when LTDH is overproduced, rendering dihydrofolate reductase dispensable. The novelty and uniqueness of LTDH opens the possibility of developing parasite specific inhibitors.	CHU LAVAL, CTR RECH, SERV INFECTIOL, ST FOY G1V 4G2, PQ, CANADA; UNIV LAVAL, FAC MED, DEPT MICROBIOL, ST FOY G1V 4G2, PQ, CANADA	Laval University; Laval University			Ouellette, Marc/K-8694-2017	Ouellette, Marc/0000-0002-6743-9646; Mourad, Walid/0000-0002-1859-9387				AMYES SGB, 1990, J MED MICROBIOL, V31, P1, DOI 10.1099/00222615-31-1-1; BAKER ME, 1991, STEROIDS, V56, P354, DOI 10.1016/0039-128X(91)90067-6; BECK JT, 1991, MOL BIOCHEM PARASIT, V49, P21, DOI 10.1016/0166-6851(91)90126-Q; BECK JT, 1990, MOL BIOCHEM PARASIT, V43, P221, DOI 10.1016/0166-6851(90)90147-E; BERMAN JD, 1988, REV INFECT DIS, V10, P560; BLAU N, 1993, PTERIDINES, V4, P1; Brown G. M., 1987, ESCHERICHIA COLI SAL, V1, P521; CALLAHAN HL, 1992, J BIOL CHEM, V267, P24165; CHUNG HMM, 1993, MOL CELL BIOL, V13, P3734, DOI 10.1128/MCB.13.6.3734; CODERRE JA, 1983, P NATL ACAD SCI-BIOL, V80, P2132, DOI 10.1073/pnas.80.8.2132; COOPER R, 1993, J CELL BIOL, V122, P149, DOI 10.1083/jcb.122.1.149; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; CRUZ A, 1990, NATURE, V348, P171, DOI 10.1038/348171a0; DAHL HHM, 1987, NUCLEIC ACIDS RES, V15, P1921, DOI 10.1093/nar/15.5.1921; DELAFAILLE MAC, 1992, J BIOL CHEM, V267, P23839; DEWES H, 1986, MOL BIOCHEM PARASIT, V19, P149, DOI 10.1016/0166-6851(86)90120-9; EID J, 1991, P NATL ACAD SCI USA, V88, P2118, DOI 10.1073/pnas.88.6.2118; ELLENBERGER TE, 1987, J BIOL CHEM, V262, P10053; ELLENBERGER TE, 1989, J BIOL CHEM, V264, P15960; ELLENBERGER TE, 1987, J BIOL CHEM, V262, P13501; HAMMALVAREZ SF, 1990, J BIOL CHEM, V265, P9850; HARLOW E, 1988, ANTIBODIES LABORATOR; HIGHTOWER RC, 1988, J BIOL CHEM, V263, P16970; ICHINOSE H, 1991, BIOCHEM BIOPH RES CO, V179, P183, DOI 10.1016/0006-291X(91)91352-D; IOVANNISCI DM, 1983, J PARASITOL, V69, P633, DOI 10.2307/3281131; KAUR K, 1988, J BIOL CHEM, V263, P7020; KIDDER GW, 1972, J PROTOZOOL, V19, P93, DOI 10.1111/j.1550-7408.1972.tb03420.x; KIDDER GW, 1973, BIOCHEM BIOPH RES CO, V53, P929, DOI 10.1016/0006-291X(73)90181-2; LEE MGS, 1990, SCIENCE, V250, P1583, DOI 10.1126/science.2177225; LEE MGS, 1991, GENE, V105, P255, DOI 10.1016/0378-1119(91)90159-9; LOCKYER J, 1987, P NATL ACAD SCI USA, V84, P3329, DOI 10.1073/pnas.84.10.3329; MOERTENSEN RM, 1992, MOL CELL BIOL, V12, P2391; OE H, 1984, AGR BIOL CHEM TOKYO, V48, P505; OUELLETTE M, 1991, RES MICROBIOL, V142, P737, DOI 10.1016/0923-2508(91)90089-S; OUELLETTE M, 1990, EMBO J, V9, P1027, DOI 10.1002/j.1460-2075.1990.tb08206.x; OUELLETTE M, 1993, PARASITOL TODAY, V9, P150, DOI 10.1016/0169-4758(93)90135-3; PAPADOPOULOU B, 1992, EMBO J, V11, P3601, DOI 10.1002/j.1460-2075.1992.tb05444.x; PAPADOPOULOU B, 1993, NUCLEIC ACIDS RES, V21, P4305, DOI 10.1093/nar/21.18.4305; PAPADOPOULOU B, 1993, ADV EXP MED BIOL, V338, P559; PARK YS, 1991, BIOCHEM BIOPH RES CO, V175, P738, DOI 10.1016/0006-291X(91)91628-P; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; PETRILLOPEIXOTO ML, 1988, MOL CELL BIOL, V8, P5188, DOI 10.1128/MCB.8.12.5188; PETRILLOPEIXOTO MP, 1987, ANTIMICROB AGENTS CH, V31, P1575; SCOTT DA, 1987, MOL BIOCHEM PARASIT, V23, P139, DOI 10.1016/0166-6851(87)90149-6; SHABBAZ M, 1987, J BIOL CHEM, V262, P16412; TENASBROEK ALMA, 1990, NATURE, V348, P174, DOI 10.1038/348174a0; TOBIN JF, 1992, J BIOL CHEM, V267, P4752; WHITE TC, 1988, J BIOL CHEM, V263, P16977; WHITELEY JM, 1993, CHEM BIOL PTERIDINES	49	48	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7310	7315						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125946				2022-12-27	WOS:A1994NA03200045
J	DEMARIA, S; SCHWAB, R; GOTTESMAN, SRS; BUSHKIN, Y				DEMARIA, S; SCHWAB, R; GOTTESMAN, SRS; BUSHKIN, Y			SOLUBLE BETA(2)-MICROGLOBULIN-FREE CLASS-I HEAVY-CHAINS ARE RELEASED FROM THE SURFACE OF ACTIVATED AND LEUKEMIA-CELLS BY A METALLOPROTEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTOCOMPATIBILITY COMPLEX-MOLECULES; T-CELL; HUMAN LYMPHOCYTES; ALPHA-3 DOMAIN; MHC; PEPTIDE; ANTIGEN; BETA-2-MICROGLOBULIN; ASSOCIATION; EXPRESSION	Regulation of the expression of major histocompatibility complex (MHC) class I heavy chains not associated with beta(2)-microglobulin (beta(2)m) on freshly isolated and in vitro cultured human B and T leukemia cells was analyzed. These beta(2)m-free class I heavy chains originate from surface beta(2)m-associated MHC class I molecules and are expressed as integral membrane glycoproteins on activated, but not resting, cells. We found that the levels of beta(2)m-free class I heavy chains can be regulated by proteolytic cleavage and release into the medium of soluble molecules containing the extracellular domains. The release is mediated by a Zn2+ dependent, membrane-bound metalloprotease that does not cleave HLA-DR, CD4, and CD71 surface receptors and can be activated by phorbol myristate acetate. Specific cleavage by the metalloprotease occurs at a site close to the papain cleavage site in the alpha 3 domain of class I heavy chains. This site is not accessible to the metalloprotease in beta(2)m-associated MHC class I molecules. The dissociation of beta(2)m-associated MHC class I molecules and subsequent cleavage of beta(2)m-free class I heavy chains may be partially responsible for controlling the levels of MHC class I molecules on the surface of activated cells.	PUBL HLTH RES INST CITY NEW YORK INC,MOLEC IMMUNOL LAB,NEW YORK,NY 10016; CORNELL UNIV,COLL MED,DEPT MED,NEW YORK,NY 10021; NYU MED CTR,DEPT PATHOL,NEW YORK,NY 10016; NYU MED CTR,KAPLAN CANC CTR,NEW YORK,NY 10016	Cornell University; New York University; New York University			Demaria, Sandra/AAA-5816-2020; Demaria, Sandra/A-8959-2008	Demaria, Sandra/0000-0003-4426-0499; 	NIAID NIH HHS [T32 AI 07382] Funding Source: Medline; NIA NIH HHS [AG 08092] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008092] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AOSAI F, 1991, EUR J IMMUNOL, V21, P2767, DOI 10.1002/eji.1830211118; BAAS EJ, 1992, J EXP MED, V176, P147, DOI 10.1084/jem.176.1.147; BAZIL V, 1993, P NATL ACAD SCI USA, V90, P3792, DOI 10.1073/pnas.90.9.3792; BENJAMIN RJ, 1992, IMMUNOGENETICS, V37, P73; BIX M, 1992, J EXP MED, V176, P829, DOI 10.1084/jem.176.3.829; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BUSHKIN Y, 1986, J EXP MED, V164, P458, DOI 10.1084/jem.164.2.458; BUSHKIN Y, 1988, P NATL ACAD SCI USA, V85, P3985, DOI 10.1073/pnas.85.11.3985; CARBONE E, 1993, EUR J IMMUNOL, V23, P1752, DOI 10.1002/eji.1830230803; CHAKRABARTI A, 1992, BIOCHEMISTRY-US, V31, P7182, DOI 10.1021/bi00146a022; CSERMELY P, 1987, BIOCHEM BIOPH RES CO, V144, P863, DOI 10.1016/S0006-291X(87)80044-X; CSERMELY P, 1988, J BIOL CHEM, V263, P6487; DEMARIA S, 1993, INT J CLIN LAB RES, V23, P61, DOI 10.1007/BF02592285; DEMARIA S, 1992, CELL IMMUNOL, V142, P103, DOI 10.1016/0008-8749(92)90272-Q; DOBBE LME, 1988, IMMUNOGENETICS, V27, P203, DOI 10.1007/BF00346587; DUE C, 1986, P NATL ACAD SCI USA, V83, P6007, DOI 10.1073/pnas.83.16.6007; ELLIOTT T, 1991, IMMUNOL TODAY, V12, P386; ELLIOTT T, 1991, NATURE, V351, P402, DOI 10.1038/351402a0; ERDOS EG, 1989, J BIOL CHEM, V264, P14519; FELLOUS M, 1982, P NATL ACAD SCI-BIOL, V79, P3082, DOI 10.1073/pnas.79.10.3082; GEPPERT TD, 1988, J IMMUNOL, V140, P2155; GILLILAND LK, 1989, HUM IMMUNOL, V25, P269, DOI 10.1016/0198-8859(89)90089-X; GLAS R, 1992, P NATL ACAD SCI USA, V89, P1138; GRASSI F, 1991, J EXP MED, V174, P53, DOI 10.1084/jem.174.1.53; HARRISON D, 1991, J IMMUNOL, V147, P3459; HOXIE JA, 1986, J IMMUNOL, V137, P1194; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; KLAR D, 1989, EMBO J, V8, P475, DOI 10.1002/j.1460-2075.1989.tb03400.x; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; LOOK AT, 1989, J CLIN INVEST, V83, P1299, DOI 10.1172/JCI114015; MADRIGAL JA, 1991, J EXP MED, V174, P1085, DOI 10.1084/jem.174.5.1085; MAUDSLEY DJ, 1991, IMMUNOL TODAY, V12, P429, DOI 10.1016/0167-5699(91)90013-J; MAY WS, 1984, P NATL ACAD SCI-BIOL, V81, P2016, DOI 10.1073/pnas.81.7.2016; MCCUNE JM, 1975, P NATL ACAD SCI USA, V72, P3206, DOI 10.1073/pnas.72.8.3206; NEEFJES JJ, 1988, EUR J IMMUNOL, V18, P801, DOI 10.1002/eji.1830180522; ORR HT, 1979, BIOCHEMISTRY-US, V18, P5711, DOI 10.1021/bi00592a030; OTTEN GR, 1992, J IMMUNOL, V148, P3723; PICKL WF, 1993, J IMMUNOL, V151, P2613; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Powers J.C., 1986, PROTEINASE INHIBITOR, P219; QUARANTA V, 1981, IMMUNOGENETICS, V13, P285, DOI 10.1007/BF00364494; ROCK KL, 1991, CELL, V65, P611, DOI 10.1016/0092-8674(91)90093-E; ROMAGNOLI P, 1991, EMBO J, V10, P1303, DOI 10.1002/j.1460-2075.1991.tb07648.x; SAMBHARA SR, 1991, SCIENCE, V252, P1424; SCHNABL E, 1990, J EXP MED, V171, P1431, DOI 10.1084/jem.171.5.1431; SHIPP MA, 1989, P NATL ACAD SCI USA, V86, P297, DOI 10.1073/pnas.86.1.297; SMITH JD, 1992, J EXP MED, V175, P191, DOI 10.1084/jem.175.1.191; SPIER CM, 1986, HUM PATHOL, V17, P1126, DOI 10.1016/S0046-8177(86)80418-X; SPRINGER TA, 1976, P NATL ACAD SCI USA, V73, P2481, DOI 10.1073/pnas.73.7.2481; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; STAM NJ, 1986, J IMMUNOL, V137, P2299; TANABE M, 1992, J IMMUNOL, V148, P3202; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; WU Q, 1991, P NATL ACAD SCI USA, V88, P676, DOI 10.1073/pnas.88.2.676	55	82	85	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6689	6694						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120026				2022-12-27	WOS:A1994MZ50300069
J	FOLEY, M; DEADY, LW; NG, K; COWMAN, AF; TILLEY, L				FOLEY, M; DEADY, LW; NG, K; COWMAN, AF; TILLEY, L			PHOTOAFFINITY-LABELING OF CHLOROQUINE-BINDING PROTEINS IN PLASMODIUM-FALCIPARUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE GENE; HUMAN MALARIA PARASITES; ANTIMALARIAL SCHIZONTOCIDES; MECHANISM; PH; IDENTIFICATION; PROTEASE; INVITRO	A photoreactive analog of chloroquine, N-(4-(4-diethylamino-1 -methylbutylamino) quinolin-6-yl)-4-azido-2-hydroxybenzamide (referred to as ASA-Q), has been synthesized and shown to mimic the action of chloroquine in possessing substantial antimalarial activity against a chloroquine-sensitive strain of Plasmodium falciparum. As for chloroquine, ASA-Q is less effective at killing drug-resistant strains of malaria, and the resistance can be modulated using the reagent verapamil. ASA-Q has been radiolabeled with (NaI)-I-125 and used as a photoaffinity probe for labeling chloroquine-binding proteins in malaria-infected erythrocytes. Two proteins have been identified with apparent molecular masses of 42 and 33 kDa in both chloroquine-sensitive and chloroquine-resistant strains of malaria. Photoaffinity labeling of the two proteins by iodo-ASA-Q and was competitively inhibited by an excess of unlabeled chloroquine. The structurally related antimalarials amodiaquine and quinine also inhibited labeling of the two proteins, while verapamil and doxycyclin had no effect. We suggest that the two labeled proteins are the macromolecular targets of chloroquine action in malaria parasites.	LA TROBE UNIV, DEPT BIOCHEM, BUNDOORA, VIC 3083, AUSTRALIA; LA TROBE UNIV, DEPT CHEM, BUNDOORA, VIC 3083, AUSTRALIA; UNIV MELBOURNE, SCH BOT, PLANT CELL BIOL RES CTR, PARKVILLE, VIC 3052, AUSTRALIA; WALTER & ELIZA HALL INST MED RES, IMMUNOPARASITOL UNIT, MELBOURNE, VIC 3052, AUSTRALIA	La Trobe University; La Trobe University; University of Melbourne; Walter & Eliza Hall Institute			Ng, Ken/L-5370-2015; Cowman, Alan F/C-7642-2013	Ng, Ken/0000-0002-1843-0506; Cowman, Alan F/0000-0001-5145-9004; Foley, Michael/0000-0003-1349-4698	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALEY SB, 1986, PARASITOLOGY, V92, P511, DOI 10.1017/S0031182000065410; BAKER RH, 1946, J AM CHEM SOC, V68, P1267, DOI 10.1021/ja01211a039; BARNES DA, 1992, EMBO J, V11, P3067, DOI 10.1002/j.1460-2075.1992.tb05378.x; Bayley H, 1977, Methods Enzymol, V46, P69; CHARET P, 1980, COMP BIOCHEM PHYS B, V65, P519, DOI 10.1016/0305-0491(80)90305-3; CHOU AC, 1980, BIOCHEMISTRY-US, V19, P1543, DOI 10.1021/bi00549a600; COWMAN AF, 1991, J CELL BIOL, V113, P1033, DOI 10.1083/jcb.113.5.1033; EKONG RM, 1993, PARASITOLOGY, V106, P107, DOI 10.1017/S0031182000074904; FITCH CD, 1972, P HELM SOC WASH, V39, P265; FITCH CD, 1986, PARASITOL TODAY, V2, P330, DOI 10.1016/0169-4758(86)90051-7; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; GEARY TG, 1990, BIOCHEM PHARMACOL, V40, P685, DOI 10.1016/0006-2952(90)90302-2; GINSBURG H, 1987, BIOCHEM PHARMACOL, V36, P1567, DOI 10.1016/0006-2952(87)90038-4; GOLDBERG DE, 1991, J EXP MED, V173, P961, DOI 10.1084/jem.173.4.961; GYANG FN, 1982, MOL BIOCHEM PARASIT, V5, P263, DOI 10.1016/0166-6851(82)90034-2; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; HUSAIN SN, 1983, CARBOHYD RES, V118, P57, DOI 10.1016/0008-6215(83)88035-5; JI I, 1985, ANAL BIOCHEM, V151, P348, DOI 10.1016/0003-2697(85)90186-1; KROGSTAD DJ, 1985, J CELL BIOL, V101, P2302, DOI 10.1083/jcb.101.6.2302; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; PETERS W, 1970, CHEMOTHERAPY DRUG RE, P540; RIEGEL B, 1946, J AM CHEM SOC, V68, P1264, DOI 10.1021/ja01211a038; SHERMAN IW, 1983, MOL BIOCHEM PARASIT, V8, P207, DOI 10.1016/0166-6851(83)90044-0; SLATER AFG, 1992, NATURE, V355, P167, DOI 10.1038/355167a0; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VANDERJAGT DI, 1986, MOL BIOCHEM PARASIT, V18, P389, DOI 10.1016/0166-6851(86)90095-2; VANDERJAGT DL, 1987, BIOCHEM PHARMACOL, V36, P3285, DOI 10.1016/0006-2952(87)90646-0; VANDERJAGT DL, 1992, BIOCHIM BIOPHYS ACTA, V1122, P256, DOI 10.1016/0167-4838(92)90401-X; WARHURST DC, 1986, PARASITOL TODAY, V2, P331, DOI 10.1016/0169-4758(86)90052-9; YA Z, 1986, J PARASITOL, V72, P830, DOI 10.2307/3281830; YAYON A, 1985, P NATL ACAD SCI USA, V82, P2784, DOI 10.1073/pnas.82.9.2784	34	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6955	6961						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120058				2022-12-27	WOS:A1994MZ50300106
J	HERELD, D; VAUGHAN, R; KIM, JY; BORLEIS, J; DEVREOTES, P				HERELD, D; VAUGHAN, R; KIM, JY; BORLEIS, J; DEVREOTES, P			LOCALIZATION OF LIGAND-INDUCED PHOSPHORYLATION SITES TO SERINE CLUSTERS IN THE C-TERMINAL DOMAIN OF THE DICTYOSTELIUM CAMP RECEPTOR, CAR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC 3',5'-AMP RELAY; CELL-CELL INTERACTIONS; RHODOPSIN KINASE; CHEMOTACTIC RECEPTOR; GUANINE-NUCLEOTIDES; SIGNALING RESPONSE; ADENYLATE-CYCLASE; AMP RECEPTOR; DISCOIDEUM; ADAPTATION	When Dictyostelium cells are stimulated with cyclic adenosine 3',5'-monophosphate (cAMP), the major surface cAMP receptor expressed in early development, cAR1, undergoes a rapid phosphorylation and parallel decrease in electrophoretic mobility which may serve to regulate the activity of this G protein-coupled receptor. Biochemical analyses indicate the electrophoretic mobility shift is caused by phosphorylation of serine residues within the C-terminal cytoplasmic domain. The 18 serines of this domain are grouped in four clusters, designated 1 to 4 (in N- to C-terminal order). Two approaches were taken to determine the distribution of phosphorylation sites among the serine clusters. First, a proteolytic analysis of the C-terminal domain was performed. Second, mutants lacking various combinations of the serine clusters were created by site-directed mutagenesis and their abilities to undergo ligand-induced modification were determined. Both approaches yielded corroborative results consistent with the following model: the stimulus induces the addition of approximately two phosphates to cluster 1 and one to cluster 2; basal phosphorylation occurs predominantly in cluster 3 and to a lesser extent in cluster 2; and cluster 4 is not phosphorylated. The phosphorylation-deficient receptor mutants should be useful for establishing the role of ligand-induced phosphorylation of cAR1 in chemotaxis, cell-cell signaling, and gene expression.	JOHNS HOPKINS UNIV, SCH MED, DEPT BIOL CHEM, BALTIMORE, MD 21205 USA	Johns Hopkins University					NIGMS NIH HHS [GM34933] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034933] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1990, BRIT J CLIN PHARMACO, V30, pS3, DOI 10.1111/j.1365-2125.1990.tb05462.x; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; CHEN CY, 1993, J BIOL CHEM, V268, P7825; DEVREOTES P, 1989, SCIENCE, V245, P1054, DOI 10.1126/science.2672337; DEVREOTES P, 1987, METHOD CELL BIOL, V28, P299; DINAUER MC, 1980, J CELL BIOL, V86, P545, DOI 10.1083/jcb.86.2.545; DINAUER MC, 1980, J CELL BIOL, V86, P554, DOI 10.1083/jcb.86.2.554; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DYNES JL, 1989, P NATL ACAD SCI USA, V86, P7966, DOI 10.1073/pnas.86.20.7966; FIRTEL RA, 1991, TRENDS GENET, V7, P381, DOI 10.1016/0168-9525(91)90260-W; JOHNSON RL, 1992, COLD SPRING HARB SYM, V57, P169, DOI 10.1101/SQB.1992.057.01.022; JOHNSON RL, 1991, BIOCHEMISTRY-US, V30, P6982, DOI 10.1021/bi00242a025; JOHNSON RL, 1993, GENE DEV, V7, P273, DOI 10.1101/gad.7.2.273; KLEIN P, 1987, J BIOL CHEM, V262, P352; KLEIN P, 1985, COLD SPRING HARB SYM, V50, P787, DOI 10.1101/SQB.1985.050.01.097; KLEIN P, 1987, J BIOL CHEM, V262, P358; KLEIN P, 1985, J BIOL CHEM, V260, P1757; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LISCHWE MA, 1982, ANAL BIOCHEM, V127, P453, DOI 10.1016/0003-2697(82)90203-2; LORENZ W, 1991, P NATL ACAD SCI USA, V88, P8715, DOI 10.1073/pnas.88.19.8715; MEIER K, 1988, P NATL ACAD SCI USA, V85, P2181, DOI 10.1073/pnas.85.7.2181; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; PUPILLO M, 1992, MOL BIOL CELL, V3, P1229, DOI 10.1091/mbc.3.11.1229; SAXE CL, 1993, GENE DEV, V7, P262, DOI 10.1101/gad.7.2.262; SAXE CL, 1991, DEV GENET, V12, P6, DOI 10.1002/dvg.1020120104; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; SUN TJ, 1991, GENE DEV, V5, P572, DOI 10.1101/gad.5.4.572; TAO YP, 1990, J BIOL CHEM, V265, P15584; THEIBERT A, 1986, J BIOL CHEM, V261, P5121; VANHAASTERT PJM, 1983, J CELL BIOL, V96, P1559, DOI 10.1083/jcb.96.6.1559; VANHAASTERT PJM, 1987, EUR J BIOCHEM, V162, P251; VANHAASTERT PJM, 1992, MOL BIOL CELL, V3, P603, DOI 10.1091/mbc.3.6.603; VAUGHAN RA, 1988, J BIOL CHEM, V263, P14538	40	48	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					7036	7044						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120068				2022-12-27	WOS:A1994MZ50300118
J	KALOUSEK, MB; TRUB, T; SCHUERMANN, M; KLEMENZ, R				KALOUSEK, MB; TRUB, T; SCHUERMANN, M; KLEMENZ, R			T1 IS A C-FOS-RESPONSIVE AND FOSB-RESPONSIVE GENE WHICH IS INDUCED BY GROWTH-FACTORS THROUGH MULTIPLE SIGNAL-TRANSDUCTION PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SWISS 3T3 CELLS; CYCLIC-AMP; HEAT-SHOCK; TRANSCRIPTIONAL ACTIVATION; CARCINOEMBRYONIC ANTIGEN; G0-TO-G1 TRANSITION; MITOGENIC RESPONSE; MOLECULAR-CLONING; MOUSE FIBROBLASTS	Stimulation of quiescent cells with growth factors triggers changes in gene expression through multiple signal transduction pathways. One of these changes in Swiss 3T3 cells is the strong accumulation of T1 mRNA which encodes a secreted glycoprotein of the immunoglobulin superfamily. Proliferating cells continued to express T1 mRNA at a lower level, whereas growth arrest induced either by serum deprivation or by contact inhibition was paralleled by the disappearance of the T1 mRNA. T1 mRNA synthesis in response to serum and platelet-derived growth factor stimulation is mediated through protein kinase C-dependent and protein kinase C-independent pathways. Activation of protein kinase A also led to T1 gene expression. Ongoing protein synthesis is a prerequisite for TI gene induction by growth factors which defines T1 as a delayed early serum re sponsive gene. The ability of the immediate early transcription factors c-Fos and FosB to directly induce the T1 gene was demonstrated in a conditional expression system in the absence of protein synthesis. Furthermore, all known inducers of the T1 gene also lead to c-fos gene activation. Thus we show that the T1 gene is regulated by signals which are transduced through multiple pathways and provide evidence that the Fos proteins play an important role in the integration of these pathways.	UNIV HOSP ZURICH,DEPT PATHOL,DIV CANC RES,CH-8091 ZURICH,SWITZERLAND; IMT,D-35037 MARBURG,GERMANY	University of Zurich; University Zurich Hospital								ABATE C, 1991, ONCOGENE, V6, P2179; AMIN C, 1993, MOL CELL BIOL, V13, P383, DOI 10.1128/MCB.13.1.383; ANDREWS GK, 1987, MOL CELL BIOL, V7, P3452, DOI 10.1128/MCB.7.10.3452; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; AOYAMA A, 1993, CRIT REV ONCOGENESIS, V4, P53; AUWERX J, 1992, ONCOGENE, V7, P2271; AUWERX J, 1991, CELL, V64, P983, DOI 10.1016/0092-8674(91)90322-P; BAKER SJ, 1992, MOL CELL BIOL, V12, P4694, DOI 10.1128/MCB.12.10.4694; BEAUCHEMIN N, 1987, MOL CELL BIOL, V7, P3221, DOI 10.1128/MCB.7.9.3221; BORRELLI E, 1992, Critical Reviews in Oncogenesis, V3, P321; Bravo R, 1990, Semin Cancer Biol, V1, P37; BUTLERGRALLA E, 1981, J CELL PHYSIOL, V107, P59, DOI 10.1002/jcp.1041070108; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CHEN RH, 1991, MOL CELL BIOL, V11, P1861, DOI 10.1128/MCB.11.4.1861; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLOTTA F, 1990, BIOCHEM BIOPH RES CO, V168, P1013, DOI 10.1016/0006-291X(90)91130-K; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; DEGROOT RP, 1992, ONCOGENE, V7, P2281; DOBRZANSKI P, 1991, MOL CELL BIOL, V11, P5470, DOI 10.1128/MCB.11.11.5470; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Foulkes, 1991, HORMONAL CONTROL REG, P257; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2; GILMAN MZ, 1988, GENE DEV, V2, P394, DOI 10.1101/gad.2.4.394; GINZBURG I, 1980, NUCLEIC ACIDS RES, V8, P3553, DOI 10.1093/nar/8.16.3553; GRAHAM R, 1991, SCIENCE, V251, P189, DOI 10.1126/science.1898992; KLEMENZ R, 1989, P NATL ACAD SCI USA, V86, P5708, DOI 10.1073/pnas.86.15.5708; KOVARY K, 1992, MOL CELL BIOL, V12, P5015, DOI 10.1128/MCB.12.11.5015; KOVARY K, 1991, MOL CELL BIOL, V11, P2451, DOI 10.1128/MCB.11.5.2451; KOZAK M, 1986, CELL, V47, P481, DOI 10.1016/0092-8674(86)90609-4; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; LUSCHER B, 1988, MOL CELL BIOL, V8, P2504; MATRISIAN LM, 1985, EMBO J, V4, P1435, DOI 10.1002/j.1460-2075.1985.tb03799.x; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MCDONNELL SE, 1990, MOL CELL BIOL, V10, P4284, DOI 10.1128/MCB.10.8.4284; MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835; MUMBERG D, 1991, GENE DEV, V5, P1212, DOI 10.1101/gad.5.7.1212; NIKAIDO T, 1991, EXP CELL RES, V192, P102, DOI 10.1016/0014-4827(91)90163-O; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; PETES TD, 1978, J BACTERIOL, V134, P295, DOI 10.1128/JB.134.1.295-305.1978; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; ROZENGURT E, 1983, CELL, V34, P265, DOI 10.1016/0092-8674(83)90157-5; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANO M, 1990, J NEUROCHEM, V55, P427, DOI 10.1111/j.1471-4159.1990.tb04154.x; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SCHUERMANN M, 1993, ONCOGENE, V8, P2781; SEILERTUYNS A, 1981, J MOL BIOL, V151, P607, DOI 10.1016/0022-2836(81)90426-5; STUBER D, 1991, IMMUNOL METHODS, P121; SUKHATME VP, 1990, J AM SOC NEPHROL, V1, P859; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; TRUB T, 1994, IN PRESS P NATL ACAD; VOGT PK, 1989, TRENDS BIOCHEM SCI, V14, P172, DOI 10.1016/0968-0004(89)90268-5; WASYLYK C, 1991, EMBO J, V10, P1127, DOI 10.1002/j.1460-2075.1991.tb08053.x; WERENSKIOLD AK, 1989, MOL CELL BIOL, V9, P5207, DOI 10.1128/MCB.9.11.5207; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WOODGETT JR, 1989, BRIT MED BULL, V45, P529, DOI 10.1093/oxfordjournals.bmb.a072340; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	61	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6866	6873						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120048				2022-12-27	WOS:A1994MZ50300094
J	WARTMANN, M; DAVIS, RJ				WARTMANN, M; DAVIS, RJ			THE NATIVE STRUCTURE OF THE ACTIVATED RAF PROTEIN-KINASE IS A MEMBRANE-BOUND MULTISUBUNIT COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN; REGULATED EIF-2-ALPHA KINASE; ROUS-SARCOMA VIRUS; GLUCOCORTICOID RECEPTOR; MAP KINASE; SIGNAL TRANSDUCTION; CELLS; EXPRESSION; SEQUENCE; GROWTH	Raf is a mitogen-stimulated protein kinase that functions as a component of the signaling cascade that leads to the stimulation of mitogen-activated protein kinase. Here we show that the native structure of Raf is a large multi-subunit protein complex with an apparent mass of 300-500 kDa that interacts with Res and the mitogen-activated protein kinase kinase Mek. Analysis of the structure of the Raf complex demonstrates that it contains a single Raf protein kinase together with the molecular chaperones hsp90 and p50. The Raf-hsp90-p50 complex was observed in starved cells and in cells activated with serum or phorbol ester. Thus, changes in complex formation with hsp90 and p50 are not required for activation of the Raf protein kinase, However, Raf activation caused by Res was associated with the translocation of the cytoplasmic Raf-hsp90-p50 complex to the cell membrane. Significantly, it is only the membrane-bound complex that exhibits increased protein kinase activity. Thus, the Has-activated Raf protein kinase functions as a membrane-bound multi-subunit complex,	UNIV MASSACHUSETTS,SCH MED,DEPT BIOCHEM & MOLEC BIOL,PROGRAM MOLEC MED,WORCESTER,MA 01605; UNIV MASSACHUSETTS,SCH MED,HOWARD HUGHES MED INST,WORCESTER,MA 01605	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester					NATIONAL CANCER INSTITUTE [R01CA058396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037845] Funding Source: NIH RePORTER; NCI NIH HHS [CA58396] Funding Source: Medline; NIGMS NIH HHS [GM37845] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; AMBROSIO L, 1989, NATURE, V342, P288, DOI 10.1038/342288a0; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BONNER TI, 1986, NUCLEIC ACIDS RES, V14, P1009, DOI 10.1093/nar/14.2.1009; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; BORNER C, 1989, J BIOL CHEM, V264, P13902; BRESNICK EH, 1990, BIOCHEMISTRY-US, V29, P520, DOI 10.1021/bi00454a028; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; CATELLI MG, 1985, EMBO J, V4, P3131, DOI 10.1002/j.1460-2075.1985.tb04055.x; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DENIS M, 1987, J BIOL CHEM, V262, P11803; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DENT P, 1993, MOL BIOL CELL, V4, P483, DOI 10.1091/mbc.4.5.483; DICKSON B, 1992, NATURE, V360, P600, DOI 10.1038/360600a0; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GONZALEZ FA, 1992, FEBS LETT, V304, P170, DOI 10.1016/0014-5793(92)80612-K; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; HAN M, 1993, NATURE, V363, P133, DOI 10.1038/363133a0; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; ITOH T, 1993, P NATL ACAD SCI USA, V90, P975, DOI 10.1073/pnas.90.3.975; ITOH T, 1993, J BIOL CHEM, V268, P3025; JOAB I, 1984, NATURE, V308, P850, DOI 10.1038/308850a0; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; MATSUDA S, 1993, J BIOL CHEM, V268, P3277; MATTS RL, 1989, J BIOL CHEM, V264, P15542; MENDEL DB, 1988, J BIOL CHEM, V263, P6695; MIYATA Y, 1991, J BIOL CHEM, V266, P8779; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; ROSE DW, 1987, BIOCHEMISTRY-US, V26, P6583, DOI 10.1021/bi00395a003; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; SANCHEZ ER, 1985, J BIOL CHEM, V260, P2398; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; SETH A, 1992, J BIOL CHEM, V267, P24796; SHIBUYA EK, 1992, P NATL ACAD SCI USA, V89, P9831, DOI 10.1073/pnas.89.20.9831; SHIH TY, 1984, CANCER INVEST, V2, P109, DOI 10.3109/07357908409020294; SOZERI O, 1992, ONCOGENE, V7, P3345; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; SZYSZKA R, 1989, BIOCHEMISTRY-US, V28, P1435, DOI 10.1021/bi00430a001; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WHITELAW ML, 1991, J BIOL CHEM, V266, P16436; WILHELMSSON A, 1990, EMBO J, V9, P69, DOI 10.1002/j.1460-2075.1990.tb08081.x; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	60	251	253	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6695	6701						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120027				2022-12-27	WOS:A1994MZ50300070
J	ZGOMBICKNIGHT, M; SATRE, MA; DUESTER, G				ZGOMBICKNIGHT, M; SATRE, MA; DUESTER, G			DIFFERENTIAL ACTIVITY OF THE PROMOTER FOR THE HUMAN ALCOHOL-DEHYDROGENASE (RETINOL DEHYDROGENASE) GENE ADH3 IN NEURAL-TUBE OF TRANSGENIC MOUSE EMBRYOS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID RESPONSE ELEMENT; CHICK LIMB BUD; BINDING-PROTEIN; POLARIZING ACTIVITY; ETHANOL INHIBITION; HENSEN NODE; HUMAN LIVER; VITAMIN-A; IDENTIFICATION; FAMILY	Mammalian alcohol dehydrogenase (ADH) has previously been shown to function in vitro as a retinol dehydrogenase as well as an ethanol dehydrogenase. Thus, ADH participates in the conversion of retinol (vitamin A alcohol) to retinoic acid, a regulatory ligand for the retinoic acid receptor class of transcription factors. Human ADH exists as a family of isozymes encoded by seven genes, which are differentially expressed in adult liver and extrahepatic tissues, being found preferentially in the epithelial cells which are retinoid target tissues. However, human ADH expression patterns have not been analyzed in early embryonic tissues, which are known to synthesize and respond to retinoic acid such as the neural tube and limb buds. To estimate the embryonic expression pattern for one member of the human ADH family, we have constructed transgenic mouse lines carrying the human ADH3 promoter fused to the lacZ gene. ADH3-lacZ transgene expression was first noted at embryonic day 9.5 and was active in the neural tube extending from the midbrain to the spinal cord, as well as the heart and proximal regions of the forelimb buds. In day 12.5 and 13.5 embryos, ADH3 transgene expression remained in the neural tube and heart and was also observed in more distal regions of the forelimb and hindlimb buds as well as the kidney. Expression in the neural tube was highest in the ventral midline including the floor plate and showed a ventral to dorsal gradient of decreasing expression. These findings indicate that at least one human ADH isozyme may exist in the correct tissues to act as an embryonic retinol dehydrogenase catalyzing the synthesis of retinoic acid.	LA JOLLA CANC RES FDN, CANC RES CTR, LA JOLLA, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute					NIAAA NIH HHS [AA07261] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007261] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ALGAR EM, 1983, EUR J BIOCHEM, V137, P139, DOI 10.1111/j.1432-1033.1983.tb07807.x; BALKAN W, 1992, P NATL ACAD SCI USA, V89, P3347, DOI 10.1073/pnas.89.8.3347; BLISS AF, 1951, ARCH BIOCHEM BIOPHYS, V31, P197, DOI 10.1016/0003-9861(51)90206-8; BUHLER R, 1983, PHARMACOL BIOCHEM BE, V18, P55, DOI 10.1016/0091-3057(83)90147-8; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10056, DOI 10.1073/pnas.89.21.10056; CLARREN SK, 1978, NEW ENGL J MED, V298, P1063, DOI 10.1056/NEJM197805112981906; DENCKER L, 1987, DEV PHARMACOL THERAP, V10, P212, DOI 10.1159/000457746; DUESTER G, 1991, MOL CELL BIOL, V11, P1638, DOI 10.1128/MCB.11.3.1638; DUESTER G, 1986, J BIOL CHEM, V261, P2027; DUESTER G, 1991, ALCOHOL CLIN EXP RES, V15, P568, DOI 10.1111/j.1530-0277.1991.tb00562.x; Duester G., 1991, LIVER PATHOLOGY ALCO, P375; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; HALEVY O, 1993, J CELL PHYSIOL, V154, P566, DOI 10.1002/jcp.1041540315; HENEHAN GTM, 1993, BIOCHEMISTRY-US, V32, P736, DOI 10.1021/bi00054a001; HOGAN B, 1986, MANIPULATING MOUSE E; HOGAN BLM, 1992, NATURE, V359, P237, DOI 10.1038/359237a0; HUNTER K, 1991, P NATL ACAD SCI USA, V88, P3666, DOI 10.1073/pnas.88.9.3666; IWAMOTO M, 1993, EXP CELL RES, V205, P213, DOI 10.1006/excr.1993.1079; JONES KL, 1973, LANCET, V2, P999; JULIA P, 1983, BIOCHEM J, V213, P547, DOI 10.1042/bj2130547; KIM CI, 1992, ARCH BIOCHEM BIOPHYS, V294, P388, DOI 10.1016/0003-9861(92)90700-7; KOCHHAR DM, 1967, ACTA PATHOL MIC SC, V70, P398; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; LEE MO, 1991, BIOCHEM PHARMACOL, V42, P1279, DOI 10.1016/0006-2952(91)90266-8; MARSH JL, 1984, GENE, V32, P481, DOI 10.1016/0378-1119(84)90022-2; MENDELSOHN C, 1991, DEVELOPMENT, V113, P723; MEZEY E, 1971, EXP MOL PATHOL, V15, P148, DOI 10.1016/0014-4800(71)90095-5; MURRAY RF, 1971, SCIENCE, V171, P71, DOI 10.1126/science.171.3966.71; NOJI S, 1991, NATURE, V350, P83, DOI 10.1038/350083a0; PARES X, 1992, FEBS LETT, V303, P69, DOI 10.1016/0014-5793(92)80479-Z; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PIETRUSZKO R, 1979, BIOCH PHARMACOLOGY E, V1, P87; POCKER Y, 1993, ADV EXP MED BIOL, V328, P411; POCKER Y, 1987, ADV BIOMEDICAL ALCOH, P181; POSCH KC, 1991, BIOCHEMISTRY-US, V30, P6224, DOI 10.1021/bi00239a021; ROBERTS AB, 1984, RETINOIDS, V2, P209; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; RUGH R, 1990, MOUSE ITS REPRODUCTI; SMITH M, 1971, ANN HUM GENET, V34, P251, DOI 10.1111/j.1469-1809.1971.tb00238.x; STEWART MJ, 1990, GENE, V90, P271, DOI 10.1016/0378-1119(90)90190-3; THALLER C, 1987, NATURE, V327, P625, DOI 10.1038/327625a0; VANOOIJ C, 1992, MOL CELL BIOL, V12, P3023, DOI 10.1128/MCB.12.7.3023; VANTHIEL DH, 1974, SCIENCE, V186, P941, DOI 10.1126/science.186.4167.941; WAGNER M, 1990, NATURE, V345, P819, DOI 10.1038/345819a0; WAGNER M, 1992, DEVELOPMENT, V116, P55; WANEK N, 1991, NATURE, V350, P81, DOI 10.1038/350081a0; WOLF G, 1984, PHYSIOL REV, V64, P873, DOI 10.1152/physrev.1984.64.3.873; Yang Z. N., 1993, Alcoholism Clinical and Experimental Research, V17, P496; YIN SJ, 1993, ALCOHOL CLIN EXP RES, V17, P376, DOI 10.1111/j.1530-0277.1993.tb00779.x; ZACHMAN RD, 1961, J BIOL CHEM, V236, P2309	51	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6790	6795						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120040				2022-12-27	WOS:A1994MZ50300084
J	COLAMONICI, OR; PORTERFIELD, B; DOMANSKI, P; CONSTANTINESCU, S; PFEFFER, LM				COLAMONICI, OR; PORTERFIELD, B; DOMANSKI, P; CONSTANTINESCU, S; PFEFFER, LM			COMPLEMENTATION OF THE INTERFERON-ALPHA RESPONSE IN RESISTANT CELLS BY EXPRESSION OF THE CLONED SUBUNIT OF THE INTERFERON-ALPHA RECEPTOR - A CENTRAL ROLE OF THIS SUBUNIT IN INTERFERON - SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING; CLONING; CDNA; HORMONE; KINASE; LINES	A subunit of the interferon alpha receptor (IFNalphaR) that confers biologic response to and specific ''binding''1 for IFNalpha8 has recently been cloned. We have explored the biological consequences of expressing the cloned IFNalphaR subunit in human cells resistant to IFNalpha and in mouse cell lines nonresponsive to human IFNalpha. The expression of the cloned IFNalphaR subunit in the human IFNalpha-resistant K-562 cell line restored sensitivity to the antiviral effect of not only IFNalpha8 but also IFNalpha2 and IFNalphaCon1. In mouse L-929 cells the expression of the cloned receptor subunit markedly increased antiviral sensitivity to human type I IFNs. In either human K-562 or mouse L-929 cells these effects were observed without a detectable increase in the binding for any of the subtypes of IFNalpha tested. We propose that the cloned IFNalphaR subunit functions as a transducer subunit for the IFNalphaR. This concept is supported by the finding that the cloned receptor protein, when it is expressed in Cos cells, has an M(r) of 75 kDa, which is different from the main IFNalpha-binding proteins, the alpha and beta subunits of the IFNalphaR. This report also suggests that alterations at the receptor level could be involved in IFNalpha resistance in some cell lines.	UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637	University of Chicago	COLAMONICI, OR (corresponding author), UNIV TENNESSEE CTR HLTH SCI,DEPT PATHOL,800 MADISON AVE,MEMPHIS,TN 38163, USA.		Constantinescu, Stefan N/E-5277-2012	Constantinescu, Stefan N./0000-0002-8599-2699; Pfeffer, Lawrence/0000-0003-2809-1234	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036716] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM36716] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGUET M, 1980, NATURE, V284, P459, DOI 10.1038/284459a0; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BAZAN JF, 1990, CELL, V61, P753, DOI 10.1016/0092-8674(90)90182-E; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BAZAN JF, 1989, BIOCHEM BIOPH RES CO, V164, P788, DOI 10.1016/0006-291X(89)91528-3; BENOIT P, 1993, J IMMUNOL, V150, P707; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; COLAMONICI OR, 1986, MOL CELL BIOL, V6, P1847, DOI 10.1128/MCB.6.5.1847; COLAMONICI OR, 1993, J BIOL CHEM, V268, P10895; COLAMONICI OR, 1990, P NATL ACAD SCI USA, V87, P7230, DOI 10.1073/pnas.87.18.7230; COLAMONICI OR, 1992, J IMMUNOL, V148, P2126; COLAMONICI OR, 1991, PHARMACOL THERAPEUT, V52, P227, DOI 10.1016/0163-7258(91)90010-J; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GROGER RK, 1989, GENE, V81, P285, DOI 10.1016/0378-1119(89)90189-3; KESSLER DS, 1988, EMBO J, V7, P3779, DOI 10.1002/j.1460-2075.1988.tb03262.x; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; PFEFFER LM, 1990, CANCER RES, V50, P2654; PFEFFER LM, 1990, P NATL ACAD SCI USA, V87, P6537, DOI 10.1073/pnas.87.17.6537; PFEFFER LM, 1987, J BIOL CHEM, V262, P3665; UZE G, 1992, P NATL ACAD SCI USA, V89, P4774, DOI 10.1073/pnas.89.10.4774; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; VANDENBROECKE C, 1988, J INTERFERON RES, V8, P803; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L	25	48	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9598	9602						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144546				2022-12-27	WOS:A1994NE05300033
J	NORDSTEDT, C; NASLUND, J; THYBERG, J; MESSAMORE, E; GANDY, SE; TERENIUS, L				NORDSTEDT, C; NASLUND, J; THYBERG, J; MESSAMORE, E; GANDY, SE; TERENIUS, L			HUMAN NEUTROPHIL PHAGOCYTIC GRANULES CONTAIN A TRUNCATED SOLUBLE FORM OF THE ALZHEIMER BETA/A4 AMYLOID PRECURSOR PROTEIN (APP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; INHIBITORY PROPERTIES; HUMAN-PLATELETS; SECRETED FORM; KUNITZ DOMAIN; NEXIN-II; DISEASE; CELLS; CDNA; IDENTIFICATION	We have characterized the molecular species and subcellular distribution of Alzheimer beta/A4 amyloid precursor protein (APP) in neutrophilic granulocytes purified from human peripheral blood. APP was readily detectable in these cells. Immunochemical analysis with a panel of antibodies revealed that this APP species lacked the transmembrane and cytoplasmic domains previously demonstrated in cell-associated APP. However, it contained a protease inhibitor domain of the Kunitz type, indicating that neutrophil APP is a potent inhibitor of certain serine proteases. Upon subcellular fractionation, APP was primarily localized to azurophilic granules, which are neutrophil-specific phagocytic organelles assigned to enzymatic digestion of invading microbes and dead or injured tissue. Apparently, in the neutrophil, a nonsecretory organelle stores truncated, soluble APP, a species previously found only in blood plasma and cerebrospinal fluid or in conditioned medium of cultured cells. Soluble APP in neutrophils may therefore have intracellular functions in addition to its previously described extracellular functions. These findings also indicate that there are previously uncharacterized cell-specific differences in processing, trafficking, and storage of the APP molecule. Finally, the precise subcellular localization of APP to neutrophil-specific phagocytic organelles is suggestive of a role for APP in the nonimmunological host defense.	KAROLINSKA INST, MED NOBEL INST, DEPT CELL & MOLEC BIOL, S-17177 STOCKHOLM, SWEDEN; KAROLINSKA INST, HUDDINGE UNIV HOSP, DEPT GERIATR MED, S-14186 HUDDINGE, SWEDEN; CORNELL UNIV, MED CTR, COLL MED, DEPT NEUROL & NEUROSCI, NEW YORK, NY 10021 USA	Karolinska Institutet; Karolinska Institutet; Cornell University	NORDSTEDT, C (corresponding author), KAROLINSKA INST, DEPT CLIN NEUROSCI, DRUG ADDICT RES SECT, S-17176 STOCKHOLM, SWEDEN.				NHLBI NIH HHS [HL49571-01] Funding Source: Medline; NIA NIH HHS [AG 11508] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011508, R55AG011508] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BUSH AI, 1990, J BIOL CHEM, V265, P15977; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; DESAUVAGE F, 1989, SCIENCE, V245, P651, DOI 10.1126/science.2569763; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GABAY JE, 1986, J EXP MED, V164, P1407, DOI 10.1084/jem.164.5.1407; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HALLET MB, 1989, NEUTROPHIL CELLULAR; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; MIYAZAKI K, 1993, NATURE, V362, P839, DOI 10.1038/362839a0; MONNING U, 1990, FEBS LETT, V277, P261, DOI 10.1016/0014-5793(90)80861-C; MONNING U, 1992, J BIOL CHEM, V267, P23950; MUSTARD JF, 1989, METHOD ENZYMOL, V169, P3; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; OLTERSDORF T, 1989, NATURE, V341, P144, DOI 10.1038/341144a0; PERLMUTTER DH, 1990, P NATL ACAD SCI USA, V87, P3753, DOI 10.1073/pnas.87.10.3753; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SEUERT P, 1992, NATURE, V359, P325; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SINHA S, 1990, J BIOL CHEM, V265, P8983; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; SPITZNAGEL JK, 1974, LAB INVEST, V30, P774; STORRIE B, 1990, GUIDE PROTEIN PURIFI; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANNOSTRAND WE, 1990, J BIOL CHEM, V265, P9591; VANNOSTRAND WE, 1989, NATURE, V341, P546; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WUNDERLICH D, 1992, J IMMUNOL METHODS, V147, P1	40	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9805	9810						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144573				2022-12-27	WOS:A1994NE05300064
J	AYOUBI, TAY; CREEMERS, JWM; ROEBROEK, AJM; VANDEVEN, WJM				AYOUBI, TAY; CREEMERS, JWM; ROEBROEK, AJM; VANDEVEN, WJM			EXPRESSION OF THE DIBASIC PROPROTEIN PROCESSING ENZYME FURIN IS DIRECTED BY MULTIPLE PROMOTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBTILISIN-LIKE PROTEASE; GENE-EXPRESSION; BETA-SUBUNIT; YEAST KEX2; TRANSCRIPTION; ENDOPROTEASE; SEQUENCE; CDNA; CLEAVAGE; PROTEINS	The prototype mammalian proprotein processing enzyme furin is shown to be encoded by three distinct FUR mRNA isoforms which differ only in their 5'-untranslated regions. By primer extension analysis, the transcription start sites of the three mRNA isoforms were defined. The genomic regions located immediately up stream of the three alternative transcriptional start sites were shown to possess promoter activity in transfection experiments using the luciferase encoding gene as reporter. In a liver cell line, the P1 promoter appeared to be the strongest; in a lung cell line, the P1A promoter. Human FUR promoter P1 but not P1A or P1B was transactivated by transcription factor C/EBP beta. Other members of this family of bZIP transcription factors, C/EBP alpha and C/EBP delta, were not able to transactivate the P1 promoter. Promoter P1A and P1B have characteristics of promoters of housekeeping genes. They lack TATA or CAAT boxes upstream of the transcription start site but are very GC-rich and contain several SP1 sites. Promoter P1, on the other hand, has a TATA box in the proximal promoter region. In electromobility shift assays and DNase I footprinting analysis, transcription factor SP1 was found to bind to the proximal region of the P1 promoter. Altogether, our results indicate that expression of the human FUR gene is directed by alternative promoters, housekeeping (GC-rich) as well as regulated (TATA-containing) promoters, suggesting that their differential use may be a mechanism to modulate levels of the furin enzyme.			AYOUBI, TAY (corresponding author), UNIV LEUVEN,CTR HUMAN GENET,MOLEC ONCOL LAB,HERESTR 49,B-3000 LOUVAIN,BELGIUM.							BARR PJ, 1991, DNA CELL BIOL, V10, P319, DOI 10.1089/dna.1991.10.319; BAUMANN H, 1992, J BIOL CHEM, V267, P19744; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CARCAMO J, 1990, GENE DEV, V4, P1611, DOI 10.1101/gad.4.9.1611; CARR FE, 1987, J BIOL CHEM, V262, P981; CREEMERS JWM, 1992, FEBS LETT, V300, P82, DOI 10.1016/0014-5793(92)80169-H; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; HATSUZAWA K, 1990, J BIOL CHEM, V265, P22075; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KASAI Y, 1992, MOL CELL BIOL, V12, P2884, DOI 10.1128/MCB.12.6.2884; KIM JG, 1992, MOL CELL BIOL, V12, P5631; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; KLIMPEL KR, 1992, P NATL ACAD SCI US, V89; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; MISUMI Y, 1991, J BIOL CHEM, V266, P16954; MISUMI Y, 1990, NUCLEIC ACIDS RES, V18, P6719, DOI 10.1093/nar/18.22.6719; NAKAYAMA K, 1992, J BIOL CHEM, V267, P5897; RAMJI DP, 1993, NUCLEIC ACIDS RES, V21, P289, DOI 10.1093/nar/21.2.289; ROBIDOUX S, 1992, MOL CELL BIOL, V12, P3796, DOI 10.1128/MCB.12.9.3796; Roebroek A. J. M., 1992, MOL BIOL LIFE SCI AD, V11, P127; ROEBROEK AJM, 1986, EMBO J, V5, P2197, DOI 10.1002/j.1460-2075.1986.tb04484.x; Sambrook J, 1989, MOL CLONING LABORATO; SCHAFER MKH, 1993, J NEUROSCI, V13, P1258; SCHALKEN JA, 1987, J CLIN INVEST, V80, P1545, DOI 10.1172/JCI113240; SCHIBLER U, 1987, ANNU REV GENET, V21, P237, DOI 10.1146/annurev.ge.21.120187.001321; SEIDAH NG, 1992, TRENDS ENDOCRIN MET, V3, P133, DOI 10.1016/1043-2760(92)90102-7; SEIDAH NG, 1992, MOL ENDOCRINOL, V6, P1559, DOI 10.1210/me.6.10.1559; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; STEINER DF, 1992, J BIOL CHEM, V267, P23435; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; UDVADIA AJ, 1993, P NATL ACAD SCI USA, V90, P3265, DOI 10.1073/pnas.90.8.3265; VANDENOUWELAND AMW, 1989, NUCLEIC ACIDS RES, V17, P7101, DOI 10.1093/nar/17.17.7101; VANDENOUWELAND AMW, 1990, NUCLEIC ACIDS RES, V18, P664, DOI 10.1093/nar/18.3.664; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896; VANDEVEN WJM, 1993, CRIT REV ONCOGENESIS, V4, P115; WASLEY LC, 1993, J BIOL CHEM, V268, P8458; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; WISE RJ, 1990, P NATL ACAD SCI USA, V87, P9378, DOI 10.1073/pnas.87.23.9378; WOLF O, 1987, J BIOL CHEM, V262, P16596	45	60	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9298	9303						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132667				2022-12-27	WOS:A1994NB41100098
J	KAMPER, JT; KAMPER, U; ROGERS, LM; KOLATTUKUDY, PE				KAMPER, JT; KAMPER, U; ROGERS, LM; KOLATTUKUDY, PE			IDENTIFICATION OF REGULATORY ELEMENTS IN THE CUTINASE PROMOTER FROM FUSARIUM-SOLANI F SP PISI (NECTRIA-HAEMATOCOCCA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; ASPERGILLUS-NIDULANS; NEUROSPORA-CRASSA; ACTIVATOR PROTEIN; ETHANOL REGULON; GENE; TRANSCRIPTION; REGION; ALCR; PHOSPHORYLATION	The cutinase gene from Fusarium solani f. sp. pisi (Nectria haematococca) is induced upon contact with the plant cuticular polymer, cutin, by the unique hydroxy fatty acid monomers released by cutinase carried by virulent strains of the fungus, and this gene is also catabolite-repressed by glucose. Functional elements of the cutinase promoter were studied in vivo by transforming Et solani pisi with fusions of 5'-flanking regions of the cutinase gene and the gene encoding chloramphenicol acetyltransferase (cat). DNA-binding proteins from F. solani pisi were analyzed in vitro by gel shift experiments, methylation interference analysis, and UV-cross-linking experiments. Thus, we identified four promoter elements involved in cutinase gene regulation: a silencer, positive-acting G-rich element, an element that binds a basal transcription factor, and a palindrome necessary for induction by cutin monomer. A silencer between -287 and -249 keeps basal gene expression low but also influences the inducibility of the gene. To restore high levels of induction, a G-rich positive-acting element with sequence similarities to other fungal elements acts as an antagonist to the silencer. Basal transcription is mediated by the first 141 base pairs of the cutinase promoter. The binding site of transcription factor CTF2 was identified between the TATA box and the transcription initiation sites. Gene induction by cutin monomers is regulated by CTF1, most probably a dimeric DNA-binding protein of 49 kDa with a palindromic recognition site at -170.	OHIO STATE UNIV,OHIO STATE BIOTECHNOL CTR,COLUMBUS,OH 43210	University System of Ohio; Ohio State University			kolattukudy, pappachan e/A-1350-2012					ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; AUSUBEL GM, 1989, CURRENT PROTOCOLS MO; AUWERX J, 1991, CELL, V64, P983, DOI 10.1016/0092-8674(91)90322-P; BAJAR A, 1991, P NATL ACAD SCI USA, V88, P8208, DOI 10.1073/pnas.88.18.8208; BAUM JA, 1987, MOL CELL BIOL, V7, P1256, DOI 10.1128/MCB.7.3.1256; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGER G, 1991, MOL CELL BIOL, V11, P795, DOI 10.1128/MCB.11.2.795; DOWZER CEA, 1991, MOL CELL BIOL, V11, P5701, DOI 10.1128/MCB.11.11.5701; ENGLANDER EW, 1991, NUCLEIC ACIDS RES, V19, P3369, DOI 10.1093/nar/19.12.3369; FELENBOK B, 1988, GENE, V73, P385, DOI 10.1016/0378-1119(88)90503-3; FU YH, 1990, P NATL ACAD SCI USA, V87, P5331, DOI 10.1073/pnas.87.14.5331; GONZALEZCANDELAS L, 1992, J BACTERIOL, V174, P6343; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Gurr SJ, 1987, GENE STRUCTURE EUKAR, P93; HAI T, 1988, GENE DEV, V2, P1216, DOI 10.1101/gad.2.10.1216; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KOLATTUKUDY PE, 1992, MOL SIGNALS PLANT MI, P65; KOLLER W, 1982, PHYSIOL PLANT PATHOL, V20, P47, DOI 10.1016/0048-4059(82)90023-6; KULMBURG P, 1992, J BIOL CHEM, V267, P21146; KULMBURG P, 1992, MOL CELL BIOL, V12, P1932, DOI 10.1128/MCB.12.5.1932; LANE D, 1992, MICROBIOL REV, V56, P509, DOI 10.1128/MMBR.56.4.509-528.1992; LIN TS, 1978, J BACTERIOL, V133, P942, DOI 10.1128/JB.133.2.942-951.1978; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; PODILA GK, 1989, MOL BIOL FILAMENTOUS, P217; PUNT PJ, 1990, GENE, V93, P101, DOI 10.1016/0378-1119(90)90142-E; PUNT PJ, 1991, MOL BIOL FILAMENTOUS, P177; Sambrook J, 1989, MOL CLONING LABORATO; Slater M L, 1978, Methods Cell Biol, V20, P135, DOI 10.1016/S0091-679X(08)62015-4; SOLIDAY CL, 1989, J BACTERIOL, V171, P1942, DOI 10.1128/jb.171.4.1942-1951.1989; STAIGER D, 1991, EUR J BIOCHEM, V199, P519, DOI 10.1111/j.1432-1033.1991.tb16150.x; WOLOSHUK CP, 1986, P NATL ACAD SCI USA, V83, P1704, DOI 10.1073/pnas.83.6.1704; YUAN GF, 1991, MOL CELL BIOL, V11, P5735, DOI 10.1128/MCB.11.11.5735; 1986, FOCUS, V8, P2	35	48	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9195	9204						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132657				2022-12-27	WOS:A1994NB41100085
J	MYERS, KA; RAHISAUND, V; DAVISON, MD; YOUNG, JA; CHEATER, AJ; STERN, PL				MYERS, KA; RAHISAUND, V; DAVISON, MD; YOUNG, JA; CHEATER, AJ; STERN, PL			ISOLATION OF A CDNA-ENCODING 5T4 ONCOFETAL TROPHOBLAST GLYCOPROTEIN - AN ANTIGEN ASSOCIATED WITH METASTASIS CONTAINS LEUCINE-RICH REPEATS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEIN; VONWILLEBRAND-FACTOR; SEQUENCE; DROSOPHILA; MEMBRANE; ACID; TOLL; ALPHA-2-GLYCOPROTEIN; DEGLYCOSYLATION; HOMOLOGY	The monoclonal antibody 5T4 defines a human oncotrophoblast antigen expressed by a variety of carcinomas but with a restricted pattern of expression in normal adult tissues. The 5T4 antigen has been isolated from term placenta as a 72-kDa glycoprotein consisting of a 42-kDa core protein with extensive N-linked glycosylation. A cDNA has been isolated from a human placental library using pools of oligonucleotides based on amino acid sequence obtained from purified 5T4 molecules. The predicted open reading frame encodes a pro- tein of 420 amino acids with a molecular mass of 46 kDa and 8 potential N-glycosylation sites. There are N- and C-terminal hydrophobic segments corresponding to putative signal and membrane anchorage sequences, respectively. Northern analysis has demonstrated a major 2.5-kilobase mRNA present in cell lines serologically reactive with the monoclonal antibody 5T4. Comparison of the 5T4 protein sequence with current sequence data bases has identified the presence of leucine-rich repeats, which are found in a variety of proteins from yeast, insects, and mammals. The 5T4 antigen expression is strongly associated with metastasis in colorectal and gastric cancer, and, hence, the possible functions of the gene product and its relationship to tumor growth and progression are discussed.	CHRISTIE HOSP,PATTERSON INST CANC RES,DEPT IMMUNOL,CANC RES CAMPAIGN,MANCHESTER M20 9BX,LANCS,ENGLAND; ZENECA PHARMACEUT,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND	Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research			Myers, Kevin/GZK-8865-2022					BOYLE JM, 1990, HUM GENET, V84, P455; BOYLE JM, 1992, GENOMICS, V12, P693, DOI 10.1016/0888-7543(92)90296-5; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DAVISON MD, 1992, J GEN VIROL, V73, P2709, DOI 10.1099/0022-1317-73-10-2709; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FISHER LW, 1989, J BIOL CHEM, V264, P4571; GAY NJ, 1991, FEBS LETT, V291, P87, DOI 10.1016/0014-5793(91)81110-T; GEARING AJH, 1993, IMMUNOL TODAY, V14, P506, DOI 10.1016/0167-5699(93)90267-O; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; HERZBERG VL, 1985, BIOCHEM BIOPH RES CO, V129, P789, DOI 10.1016/0006-291X(85)91961-8; HICKEY MJ, 1989, P NATL ACAD SCI USA, V86, P6773, DOI 10.1073/pnas.86.17.6773; HOLE N, 1990, INT J CANCER, V45, P179, DOI 10.1002/ijc.2910450132; HOLE N, 1988, BRIT J CANCER, V57, P239, DOI 10.1038/bjc.1988.53; HOLE N, 1987, EXP CELL BIOL, V56, P39; KEITH FJ, 1990, EMBO J, V9, P4299, DOI 10.1002/j.1460-2075.1990.tb07878.x; LOPEZ JA, 1987, P NATL ACAD SCI USA, V84, P5615, DOI 10.1073/pnas.84.16.5615; MATSUDAIRA P, 1987, J BIOL CHEM, V262; MILLAN JL, 1986, J BIOL CHEM, V261, P3112; NEAME PJ, 1989, J BIOL CHEM, V264, P8653; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; RAHI V, 1990, AMERSHAM INT LIFE SC, V2, P9; REINKE R, 1988, CELL, V52, P291, DOI 10.1016/0092-8674(88)90518-1; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; SADLER JE, 1991, J BIOL CHEM, V266, P22777; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER R, 1988, EMBO J, V7, P4151, DOI 10.1002/j.1460-2075.1988.tb03310.x; SMITH NC, 1974, NATURE, V252, P302, DOI 10.1038/252302b0; SOUTHALL PJ, 1990, BRIT J CANCER, V61, P89, DOI 10.1038/bjc.1990.20; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STARZYNSKA T, 1992, BRIT J CANCER, V66, P867, DOI 10.1038/bjc.1992.375; STARZYNSKA T, 1994, IN PRESS BR J CANCER; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; TAN FL, 1990, J BIOL CHEM, V265, P13; TITANI K, 1987, P NATL ACAD SCI USA, V84, P5610, DOI 10.1073/pnas.84.16.5610; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683	36	63	72	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9319	9324						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132670				2022-12-27	WOS:A1994NB41100101
J	SHELNESS, GS; MORRISROGERS, KC; INGRAM, MF				SHELNESS, GS; MORRISROGERS, KC; INGRAM, MF			APOLIPOPROTEIN B48-MEMBRANE INTERACTIONS - ABSENCE OF TRANSMEMBRANE LOCALIZATION IN NONHEPATIC CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; BETA-N-ACETYLGLUCOSAMINIDASE; LOW-DENSITY LIPOPROTEINS; PROTEIN TRANSLOCATION; MICROSOMAL-MEMBRANES; SEQUENCE; IDENTIFICATION; PURIFICATION; OLIGOSACCHARIDES; RECONSTITUTION	Apolipoprotein B (apoB) is essential for the hepatic assembly and secretion of triglyceride-rich very low density lipoproteins. Recent studies have revealed that in both hepatic and nonhepatic cells a large percentage of newly synthesized apoB polypeptides engage in transmembrane interactions with the endoplasmic reticulum (ER). These apoB-membrane interactions have been implicated in the processes of lipoprotein assembly and regulation. To identify domains of apoB that are responsible for its transmembrane localization, overlapping 300 amino acid segments of human apoB48 (amino-terminal 48% of apoB) and two control proteins, human complement component C3 and mouse CD4, were appended to the amino-terminal 77 amino acids of a soluble secretory precursor protein and expressed in COS-1 cells. While the integral membrane protein CD4 conferred predictable transmembrane orientation on the hybrid protein, as evidenced by its partial protease accessibility in intact microsomes, all of the apoB-containing proteins and the soluble secretory control, C3, were fully protease-resistant, consistent with their complete translocation into the ER. To determine if conformational properties of apoB are responsible for its transmembrane interactions with the ER, proteins containing the entire amino-terminal similar to 50% of apoB (apoB50) were expressed in COS-1 cells. Irrespective of whether targeting and translocation initiation were directed by a heterologous signal peptide or the native apoB signal peptide, apoB50 appeared to undergo complete membrane translocation into a protease inaccessible compartment. These results demonstrate that the amino-terminal 50% of apoB lacks autonomous signals or properties that can fully block ER membrane translocation or promote any other form of stable transmembrane assembly in nonhepatic cells.	WAKE FOREST UNIV,BOWMAN GRAY SCH MED,MOLEC GENET RES & TRAINING PROGRAM,WINSTON SALEM,NC 27157	Wake Forest University; Wake Forest Baptist Medical Center	SHELNESS, GS (corresponding author), WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT COMPARAT MED,WINSTON SALEM,NC 27157, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-O5404] Funding Source: Medline; NHLBI NIH HHS [HL49373] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BLANAR MA, 1992, SCIENCE, V256, P1014, DOI 10.1126/science.1589769; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; BOREN J, 1993, BIOCHEM SOC T, V21, P487, DOI 10.1042/bst0210487; BOREN J, 1993, ARTERIOSCLER THROMB, V18, P1748; BRIZZARD B, 1994, IN PRESS BIOTECHNIQU; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; CHAN L, 1992, J BIOL CHEM, V267, P25621; CHUCK SL, 1993, J BIOL CHEM, V268, P22794; CHUCK SL, 1992, CELL, V68, P9, DOI 10.1016/0092-8674(92)90202-N; CHUCK SL, 1990, NATURE, V346, P382, DOI 10.1038/346382a0; CONNOLLY T, 1986, J CELL BIOL, V103, P2253, DOI 10.1083/jcb.103.6.2253; DAVIS RA, 1990, J BIOL CHEM, V265, P10005; DEBRUIJN MHL, 1985, P NATL ACAD SCI USA, V82, P708; DIXON JL, 1992, J CELL BIOL, V117, P1161, DOI 10.1083/jcb.117.6.1161; DIXON JL, 1993, J LIPID RES, V34, P167; ESSER V, 1988, J BIOL CHEM, V263, P13282; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FURUKAWA S, 1992, J BIOL CHEM, V267, P22630; GILMORE R, 1991, Current Opinion in Cell Biology, V3, P580, DOI 10.1016/0955-0674(91)90026-U; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HAMES BD., 1981, GEL ELECTROPHORESIS, P1; Higuchi R., 1989, PCR TECHNOLOGY, P61; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; HOWELL KE, 1982, J CELL BIOL, V92, P822, DOI 10.1083/jcb.92.3.822; KNOTT TJ, 1986, NUCLEIC ACIDS RES, V14, P7501, DOI 10.1093/nar/14.18.7501; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; PARNES JR, 1987, IMMUNOL REV, V100, P109, DOI 10.1111/j.1600-065X.1987.tb00529.x; PEASE RJ, 1991, NATURE, V353, P448, DOI 10.1038/353448a0; PEASE RJ, 1993, CIRCULATION, V88, P177; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; PRICKETT KS, 1989, BIOTECHNIQUES, V7, P580; RUSINOL AE, 1993, J BIOL CHEM, V268, P25168; Sambrook J, 1989, MOL CLONING LABORATO; SASAVAGE NL, 1982, J BIOL CHEM, V257, P678; SCHEELE G, 1983, METHOD ENZYMOL, V96, P94; SHELNESS GS, 1993, J BIOL CHEM, V268, P5201; TARENTINO AL, 1974, J BIOL CHEM, V249, P811; THRIFT RN, 1992, P NATL ACAD SCI USA, V89, P9161, DOI 10.1073/pnas.89.19.9161; TRIMBLE RB, 1984, ANAL BIOCHEM, V141, P515, DOI 10.1016/0003-2697(84)90080-0; VERKADE HJ, 1993, J BIOL CHEM, V268, P24990; WALTER P, 1979, P NATL ACAD SCI USA, V76, P1795, DOI 10.1073/pnas.76.4.1795; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WALTER P, 1986, ANNU REV CELL BIOL, V2, P499, DOI 10.1146/annurev.cellbio.2.1.499; WILKINSON J, 1993, J LIPID RES, V34, P815; YANG CY, 1990, P NATL ACAD SCI USA, V87, P5523, DOI 10.1073/pnas.87.14.5523; YANG CY, 1989, ARTERIOSCLEROSIS, V9, P96, DOI 10.1161/01.ATV.9.1.96; YAO ZM, 1991, J BIOL CHEM, V266, P3300; YOUNG SG, 1990, CIRCULATION, V82, P1574, DOI 10.1161/01.CIR.82.5.1574	52	51	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9310	9318						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132669				2022-12-27	WOS:A1994NB41100100
J	COELHOSAMPAIO, T; VOSS, EW				COELHOSAMPAIO, T; VOSS, EW			ANTI-METATYPE ANTIBODIES STABILIZE THE FLUORESCEIN SINGLE-CHAIN ANTIBODY-4-4-20 COMPLEX AGAINST DISSOCIATION BY HYDROSTATIC-PRESSURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; FAB COMPLEX; AFFINITY; PROTEINS; IDIOTYPE; DNA	Hydrostatic pressure was used to promote dissociation of fluorescein (Fl) from single-chain antibody 4-4-20 (SCA 4-4-20). Fl fluorescence intensity was quenched by 97% upon binding to SCA 4-4-20. Increasing pressure to 2.4 kbar enhanced Fl fluorescence from the remaining 3% to 14-17%. The capacity of anti-metatype antibodies (anti-Met), which specifically recognize liganded anti-Fl antibodies, to protect against pressure-induced Fl dissociation was tested. Both polyclonal and monoclonal anti-Met antibodies protected against Fl dissociation, reducing the fluorescence intensity at 2.4 kbar from 14-17% to 6-8%. Additive effects of anti-Met antibodies in protection against pressure-induced Fl dissociation were suggested by the fact that a 2-fold molar excess polyclonal anti-Met reagent promoted additional protection relative to an equimolar amount. On the other hand, combination of different monoclonal anti-Met antibodies did not promote additive protection, suggesting recognition of overlapping metatopes by these monoclonals. The complex formed by SCA 4-4-20 and the Fl analog HPF was more sensitive to pressure than the Fl-SCA 4-4-20 complex. Addition of both polyclonal and monoclonal anti Met antibodies reduced the Fl fluorescence recovery at 2.4 kbar from 75% to 40-55%. In order to directly study binding of anti-Met antibodies to mAb 4-4-20, monoclonal anti-Met antibody 3A5-1 was labeled with 2-dimethylaminonaphthalene-5-sulfonyl chloride (2,5-Dns Cl) and Dns fluorescence anisotropy measured. Unliganded mAb 4-4-20 did not bind to 2,5-Dns-3A5-1 as indicated by the absence of measurable changes in Dns fluorescence anisotropy upon increasing mAb concentration. Addition of mAb 4-4-20 bound to Fl produced a sigmoidal increase in Dns anisotropy, compatible with association of the primary im immune complex and 3A5-1. An affinity constant, K-0.5, of 1.5 x 10(-7) M and a cooperativity coefficient (n) of 3.1 were calculated for formation of the Fl-mAb 4-4-20 complex. The HPF mAb 4-4-20 complex was also recognized by 2,5-Dns-3A5-1 but with lower affinity, indicating that the monoclonal anti-Met 3A5-1 distinguished between mAb 4-4-20 liganded to different haptens.	UNIV ILLINOIS,DEPT MICROBIOL,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign								BEDZYK WD, 1992, BIOCHIM BIOPHYS ACTA, V1119, P27, DOI 10.1016/0167-4838(92)90229-7; BEDZYK WD, 1990, J BIOL CHEM, V265, P18615; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; COELHOSAMPAIO T, 1993, BIOCHEMISTRY-US, V32, P10929, DOI 10.1021/bi00092a001; DENZIN LK, 1991, J BIOL CHEM, V266, P14095; HERRON JN, 1991, PROTEINS, V11, P159, DOI 10.1002/prot.340110302; HERRON JN, 1989, PROTEINS, V5, P271, DOI 10.1002/prot.340050404; HERRON JN, 1981, J BIOCHEM BIOPH METH, V5, P1, DOI 10.1016/0165-022X(81)90029-4; HERRON JN, 1984, FLUORESCEIN HAPTEN I, P49; Karush F, 1978, IMMUNOGLOBULINS, P85; KRANZ DM, 1983, MOL IMMUNOL, V20, P1313, DOI 10.1016/0161-5890(83)90162-1; KRANZ DM, 1981, MOL IMMUNOL, V18, P889, DOI 10.1016/0161-5890(81)90012-2; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034; REINITZ DM, 1984, MOL IMMUNOL, V21, P775, DOI 10.1016/0161-5890(84)90164-0; RUMBLEY CA, 1993, J BIOL CHEM, V268, P13667; SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.pc.44.100193.000513; SMITH RG, 1990, MOL IMMUNOL, V27, P463, DOI 10.1016/0161-5890(90)90171-U; VOSS EW, 1988, MOL IMMUNOL, V25, P751, DOI 10.1016/0161-5890(88)90111-3; VOSS EW, 1989, MOL IMMUNOL, V26, P971, DOI 10.1016/0161-5890(89)90115-6; VOSS EW, 1992, MOL IMMUNOL, V29, P241, DOI 10.1016/0161-5890(92)90105-7; VOSS EW, 1993, MOL IMMUNOL, V30, P949, DOI 10.1016/0161-5890(93)90020-C; WEBER G, 1983, Q REV BIOPHYS, V16, P89, DOI 10.1017/S0033583500004935; Weber G., 1992, PROTEIN INTERACTIONS; WEBER G, 1987, NATO ASI SER C, V197, P401; WEIDNER KM, 1992, J BIOL CHEM, V267, P10281; WEIDNER KM, 1993, MOL IMMUNOL, V30, P1003, DOI 10.1016/0161-5890(93)90125-U; WEIDNER KM, 1991, J BIOL CHEM, V266, P2513	28	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8146	8152						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132540				2022-12-27	WOS:A1994NB40900050
J	KOKEN, SEC; GREIJER, AE; VERHOEF, K; VANWAMEL, J; BUKRINSKAYA, AG; BERKHOUT, B				KOKEN, SEC; GREIJER, AE; VERHOEF, K; VANWAMEL, J; BUKRINSKAYA, AG; BERKHOUT, B			INTRACELLULAR ANALYSIS OF IN-VITRO MODIFIED HIV TAT PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DNA-BINDING ACTIVITY; TRANS-ACTIVATION; MUTATIONAL ANALYSIS; FUNCTIONAL DOMAINS; N-ACETYLCYSTEINE; RNA STRUCTURE; TYPE-1; INVITRO; CELLS	Human immunodeficiency viruses HIV-1 and HIV-2 encode a Tat protein that specifically activates transcription from the viral long terminal repeat. To characterize the properties of the Tat proteins, we have expressed them in Escherichia coli. The purified Tat protein was biochemically analyzed and tested for activity upon electroporation into human cell lines. This protein electroporation was used for the intracellular analysis of in vitro modified Tat protein. Our results indicate that the transcriptionally active form of the Tat protein is a monomer. Furthermore, we found that Tat activity is dramatically inhibited by preincubation of the protein with strongly reducing agents. In contrast, no inhibitory effect was measured upon incubation with metal-chelating reagents. These results suggest that the cysteine residues of Tat are involved in the formation of intramolecular disulfide bonds.	UNIV AMSTERDAM, DEPT VIROL, 1105 AZ AMSTERDAM, NETHERLANDS	University of Amsterdam								ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BALHORN R, 1992, ARCH BIOCHEM BIOPHYS, V296, P384, DOI 10.1016/0003-9861(92)90588-N; BALHORN R, 1991, BIOCHEMISTRY-US, V30, P175, DOI 10.1021/bi00215a026; BERKHOUT B, 1990, NUCLEIC ACIDS RES, V18, P1839, DOI 10.1093/nar/18.7.1839; BERKHOUT B, 1989, J VIROL, V63, P5501, DOI 10.1128/JVI.63.12.5501-5504.1989; BOGERD HP, 1993, J VIROL, V67, P5030, DOI 10.1128/JVI.67.8.5030-5034.1993; BRAKE DA, 1990, J VIROL, V64, P962, DOI 10.1128/JVI.64.2.962-965.1990; CHANDRA A, 1988, FEBS LETT, V236, P282, DOI 10.1016/0014-5793(88)80038-3; DINGWALL C, 1990, EMBO J, V9, P4145, DOI 10.1002/j.1460-2075.1990.tb07637.x; EMERMAN M, 1987, EMBO J, V6, P3755, DOI 10.1002/j.1460-2075.1987.tb02710.x; FELBER BK, 1988, SCIENCE, V239, P184, DOI 10.1126/science.3422113; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; GARCIA JA, 1988, EMBO J, V7, P3143, DOI 10.1002/j.1460-2075.1988.tb03181.x; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; HAUBER J, 1987, P NATL ACAD SCI USA, V84, P6364, DOI 10.1073/pnas.84.18.6364; HAUBER J, 1989, J VIROL, V63, P1181, DOI 10.1128/JVI.63.3.1181-1187.1989; HAYASHI T, 1993, J BIOL CHEM, V268, P1138; KALEBIC T, 1991, P NATL ACAD SCI USA, V88, P986, DOI 10.1073/pnas.88.3.986; KAMINE J, 1991, VIROLOGY, V182, P570, DOI 10.1016/0042-6822(91)90598-6; KASHANCHI F, 1992, NUCLEIC ACIDS RES, V20, P4673, DOI 10.1093/nar/20.17.4673; KIM YS, 1993, J VIROL, V67, P3739, DOI 10.1128/JVI.67.7.3739-3747.1993; KOBAYASHI Y, 1991, BIOPOLYMERS, V31, P1213, DOI 10.1002/bip.360311009; KUBOTA S, 1990, AIDS RES HUM RETROV, V6, P919, DOI 10.1089/aid.1990.6.919; KUPPUSWAMY M, 1989, NUCLEIC ACIDS RES, V17, P3551, DOI 10.1093/nar/17.9.3551; Maniatis T., 1982, MOL CLONING; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; MYERS G, 1990, HUMAN RETROVIRUSES A; PETERLIN BM, 1986, P NATL ACAD SCI USA, V83, P9734, DOI 10.1073/pnas.83.24.9734; PHILPOTT CC, 1993, J BIOL CHEM, V268, P17655; RAPPAPORT J, 1989, New Biologist, V1, P101; RHIM H, 1993, J VIROL, V67, P1110, DOI 10.1128/JVI.67.2.1110-1121.1993; RICE AP, 1990, J VIROL, V64, P1864, DOI 10.1128/JVI.64.4.1864-1868.1990; RICE AP, 1990, J VIROL, V64, P6018, DOI 10.1128/JVI.64.12.6018-6026.1990; RICE AP, 1991, VIROLOGY, V185, P451, DOI 10.1016/0042-6822(91)90797-F; ROEDERER M, 1991, AIDS RES HUM RETROV, V7, P563, DOI 10.1089/aid.1991.7.563; ROTH EJ, 1993, J BIOL CHEM, V267, P16390; ROY S, 1990, GENE DEV, V4, P1365, DOI 10.1101/gad.4.8.1365; RUBEN S, 1989, J VIROL, V63, P1; SADAIE MR, 1988, P NATL ACAD SCI USA, V85, P9224, DOI 10.1073/pnas.85.23.9224; SANGER F, 1953, NATURE, V171, P1025, DOI 10.1038/1711025a0; SCHIAVO G, 1990, INFECT IMMUN, V58, P4136, DOI 10.1128/IAI.58.12.4136-4141.1990; SCHRECK R, 1992, J VIROL, V66, P6288, DOI 10.1128/JVI.66.11.6288-6293.1992; SLICE LW, 1992, BIOCHEMISTRY-US, V31, P1206; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STAAL FJT, 1993, AIDS RES HUM RETROV, V9, P299, DOI 10.1089/aid.1993.9.299; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; STEFFY K, 1991, MICROBIOL REV, V55, P193, DOI 10.1128/MMBR.55.2.193-205.1991; STUURMAN N, 1992, EXP CELL RES, V200, P285, DOI 10.1016/0014-4827(92)90174-7; TONGSTARKSEN SE, 1993, VIROLOGY, V195, P826, DOI 10.1006/viro.1993.1438; VERHOEF K, 1993, ANAL BIOCHEM, V210, P210, DOI 10.1006/abio.1993.1176; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; ZAPUN A, 1992, PROTEINS, V14, P10, DOI 10.1002/prot.340140104	53	54	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8366	8375						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132560				2022-12-27	WOS:A1994NB40900081
J	ALVES, PC; VIDEIRA, A				ALVES, PC; VIDEIRA, A			DISRUPTION OF THE GENE CODING FOR THE 21.3-KDA SUBUNIT OF THE PERIPHERAL ARM OF COMPLEX-I FROM NEUROSPORA-CRASSA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; BOVINE HEART-MITOCHONDRIA; ACYL-CARRIER PROTEIN; ENCODED SUBUNITS; SENSITIVE METHOD; BINDING PROTEIN; REDUCTASE; DEHYDROGENASE; SEQUENCES; INVITRO	A21.3-kDa subunit of the peripheral arm of complex I from Neurospora is encoded by a single chromosomal gene, nuo-21.3b. It is located on linkage group V of the fungal genome, linked to inl. We have isolated and characterized a genomic clone containing this nuclear gene. A DNA fragment containing a portion of the coding region of the gene and upstream flanking sequences was introduced by transformation into a wild-type strain of Neurospora crassa. A single copy transformant was selected and crossed with another strain, leading to inactivation of nuo-21.3b through repeat-induced point mutations. We have analyzed random progeny from this cross and isolated two mutant strains lacking the 21.3-kDa subunit of complex I. One of them was further characterized. Our results suggest that most, if not all, other subunits of complex I are present in the mitochondria of the mutant and assembled in a structure similar to complex I, representing Lambda 25% of the amounts of enzyme found in the wild type. Nevertheless, a major intermediate, containing proteins of the peripheral arm of complex I, accumulates in the mutant mitochondria. This indicates that the absence of the 21.3-kDa polypeptide results in a disturbed assembly of the enzyme complex, suggesting a role for this polypeptide. We observed similar rates of rotenone-sensitive NADH:ubiquinone oxide-reductase activity in mitochondrial membranes from the mutant and wild-type strains and discuss the possibility that this electron transfer is independent of the more hydrophobic part of complex I. Transformation of the mutant with the intact gene and flanking sequences restored the wild-type phenotype.	UNIV PORTO, INST CIENCIAS BIOMED ABEL SALAZAR, P-4000 OPORTO, PORTUGAL	Universidade do Porto			Videira, Arnaldo/H-8150-2013	Videira, Arnaldo/0000-0001-7267-4459				[Anonymous], [No title captured]; AZEVEDO JE, 1992, BIOCHEM J, V288, P29, DOI 10.1042/bj2880029; AZEVEDO JE, 1993, BIOCHEM J, V293, P501, DOI 10.1042/bj2930501; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Davis R.H., 1970, METHODS ENZYMOL, V17, P79, DOI [10.1016/0076-6879(71)17168-6, DOI 10.1016/0076-6879(71)17168-6]; DUARTE M, 1993, BIOCHIM BIOPHYS ACTA, V1172, P327, DOI 10.1016/0167-4781(93)90223-Z; EARLEY FGP, 1987, FEBS LETT, V219, P108, DOI 10.1016/0014-5793(87)81200-0; FILSER M, 1988, BIOCHEM PHARMACOL, V37, P2551, DOI 10.1016/0006-2952(88)90245-6; FINEL M, 1992, BIOCHEMISTRY-US, V31, P11425, DOI 10.1021/bi00161a022; FRIEDRICH T, 1989, EUR J BIOCHEM, V180, P173, DOI 10.1111/j.1432-1033.1989.tb14629.x; HALL RE, 1990, J BIOL CHEM, V265, P16484; Hatefi Y, 1978, Methods Enzymol, V53, P11; HEINRICH H, 1992, BIOCHEMISTRY-US, V31, P11420, DOI 10.1021/bi00161a021; HOFHAUS G, 1991, J MOL BIOL, V221, P1027, DOI 10.1016/0022-2836(91)80190-6; HOFHAUS G, 1993, EMBO J, V12, P3043, DOI 10.1002/j.1460-2075.1993.tb05973.x; Lee S.B., 1988, FUNGAL GENET REP, V35, P23, DOI [10.4148/1941-4765.1531, DOI 10.4148/1941-4765.1531]; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MERRIL CR, 1990, METHOD ENZYMOL, V182, P477; NEHLS U, 1992, J MOL BIOL, V227, P1032, DOI 10.1016/0022-2836(92)90519-P; Perkins DD, 1986, FUNGAL GENET NEWSL, V33, P35; PILKINGTON SJ, 1993, BIOCHEM SOC T, V21, P26, DOI 10.1042/bst0210026; PREIS D, 1991, BIOCHIM BIOPHYS ACTA, V1090, P133, DOI 10.1016/0167-4781(91)90049-R; RAGAN CI, 1987, CURR TOP BIOENERG, V15, P1; RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3; SACKMANN U, 1991, EUR J BIOCHEM, V200, P463, DOI 10.1111/j.1432-1033.1991.tb16205.x; Sambrook J, 1989, MOL CLONING LABORATO; SCHMIDT M, 1992, FEBS LETT, V313, P8, DOI 10.1016/0014-5793(92)81172-I; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; SELKER EU, 1988, P NATL ACAD SCI USA, V85, P6870, DOI 10.1073/pnas.85.18.6870; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Staben C, 1989, FUNGAL GENET NEWSL, V36, P79, DOI DOI 10.4148/1941-4765.1519; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TROPSCHUG M, 1988, J BIOL CHEM, V263, P14433; TUSCHEN G, 1990, J MOL BIOL, V213, P845, DOI 10.1016/S0022-2836(05)80268-2; VIDEIRA A, 1993, BIOCHEM J, V291, P729, DOI 10.1042/bj2910729; VIDEIRA A, 1989, EUR J BIOCHEM, V181, P493, DOI 10.1111/j.1432-1033.1989.tb14751.x; VIDEIRA A, 1990, BIOCHEM BIOPH RES CO, V171, P1168, DOI 10.1016/0006-291X(90)90807-Y; VIDEIRA A, 1990, BIOCHEM BIOPH RES CO, V166, P280, DOI 10.1016/0006-291X(90)91942-L; VIDEIRA A, 1990, J BIOL CHEM, V265; VOLLMER SJ, 1986, P NATL ACAD SCI USA, V83, P4869, DOI 10.1073/pnas.83.13.4869; WALKER JE, 1992, J MOL BIOL, V226, P1051, DOI 10.1016/0022-2836(92)91052-Q; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WALLACE DC, 1993, TRENDS GENET, V9, P128, DOI 10.1016/0168-9525(93)90207-X; WEISS H, 1991, EUR J BIOCHEM, V197, P563, DOI 10.1111/j.1432-1033.1991.tb15945.x; Werner S, 1981, Methods Biochem Anal, V27, P109, DOI 10.1002/9780470110478.ch3; WERNER S, 1977, EUR J BIOCHEM, V79, P103, DOI 10.1111/j.1432-1033.1977.tb11788.x; ZAUNER R, 1985, EUR J BIOCHEM, V150, P447, DOI 10.1111/j.1432-1033.1985.tb09042.x	48	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7777	7784						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8126004				2022-12-27	WOS:A1994NA03200114
J	KOO, JS; SPREMULLI, LL				KOO, JS; SPREMULLI, LL			EFFECT OF THE SECONDARY STRUCTURE IN THE EUGLENA-GRACILIS CHLOROPLAST RIBULOSE-BISPHOSPHATE CARBOXYLASE/OXYGENASE MESSENGER-RNA ON TRANSLATIONAL INITIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; RIBOSOMAL-PROTEIN; GENE-EXPRESSION; SEQUENCE; REGION; BINDING; RECOGNITION; MUTAGENESIS; EXTENSION; ENHANCER	The results reported in the previous paper indicate that the translational start site of the Euglena gracilis chloroplast mRNA for the large subunit of ribulose-bisphosphate carboxylase/oxygenase (rbcL) is not defined by primary sequence elements (Koo, J. S., and Spremulli, L. L. (1994) J. Biol. Chem. 269, 7494-7500). In the work presented here, the effects of secondary structure in the 5'-untranslated leader of the rbcL mRNA have been examined. Only weak secondary structure can be detected in the 5'-untranslated leader of the rbcL message by enzymatic and computer analysis. Further reduction of the weak secondary structure of this message by site-directed mutagenesis does not significantly affect the ability of this message to participate in initiation complex formation. The secondary structure near the translational start site was increased by the introduction of an inverted repeat sequence and by site-directed mutagenesis. Messages with increased secondary structure are much less active in initiation complex formation if the structural element introduced is within similar to 10 nucleotides of the start codon. These results suggest that the translational start site in this chloroplast mRNA is specified by the presence of an AUG codon in an unstructured or weakly structured region of the mRNA. No specific sequences around the start codon, either upstream or immediately downstream, were found to have important information directing the chloroplast ribosome to the start site of this mRNA.	UNIV N CAROLINA, DEPT CHEM, CHAPEL HILL, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill					NIGMS NIH HHS [GM24963] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024963] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTUVIA S, 1989, J MOL BIOL, V210, P265, DOI 10.1016/0022-2836(89)90329-X; ASANO K, 1991, J BIOL CHEM, V266, P24549; BONI IV, 1991, NUCLEIC ACIDS RES, V19, P155, DOI 10.1093/nar/19.1.155; DEBOER HA, 1990, METHOD ENZYMOL, V185, P103; DESMIT MH, 1990, PROG NUCLEIC ACID RE, V38, P1; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; FRANZETTI B, 1992, J BIOL CHEM, V267, P19075; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; GALLIE DR, 1989, P NATL ACAD SCI USA, V86, P129, DOI 10.1073/pnas.86.1.129; GOLD L, 1988, ANNU REV BIOCHEM, V57, P199, DOI 10.1146/annurev.bi.57.070188.001215; GOLD L, 1987, ESCHERICHIA COLI SAL, P1302; GREN EJ, 1984, BIOCHIMIE, V66, P1, DOI 10.1016/0300-9084(84)90188-3; GROSS G, 1990, J BIOL CHEM, V265, P17627; GUREVICH VV, 1991, ANAL BIOCHEM, V195, P207, DOI 10.1016/0003-2697(91)90318-N; HAHN V, 1988, PLANT MOL BIOL, V10, P459, DOI 10.1007/BF00014951; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; HARTZ D, 1991, J MOL BIOL, V218, P99, DOI 10.1016/0022-2836(91)90876-8; HARTZ D, 1991, J MOL BIOL, V218, P83, DOI 10.1016/0022-2836(91)90875-7; KNAPP G, 1989, METHOD ENZYMOL, V180, P192; KOO JS, 1994, J BIOL CHEM, V269, P7494; KOZAK M, 1980, CELL, V19, P79, DOI 10.1016/0092-8674(80)90390-6; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LASO MRV, 1993, J BIOL CHEM, V268, P6453; LOECHEL S, 1991, NUCLEIC ACIDS RES, V19, P6905, DOI 10.1093/nar/19.24.6905; LOWMAN HB, 1986, J BIOL CHEM, V261, P5396; MACHE R, 1990, PLANT SCI, V72, P1, DOI 10.1016/0168-9452(90)90180-V; Maniatis T., 1982, MOL CLONING; MCCARTHY JEG, 1990, TRENDS GENET, V6, P78, DOI 10.1016/0168-9525(90)90098-Q; MCCLARY JA, 1989, BIOTECHNIQUES, V7, P282; MUNSON LM, 1984, J MOL BIOL, V177, P663, DOI 10.1016/0022-2836(84)90043-3; OLINS PO, 1989, J BIOL CHEM, V264, P16973; RONEY WB, 1988, THESIS U N CAROLINA; SANTALUCIA J, 1992, SCIENCE, V256, P217, DOI 10.1126/science.1373521; SCHAUDER B, 1989, GENE, V78, P59, DOI 10.1016/0378-1119(89)90314-4; SCHULZ VP, 1990, J MOL BIOL, V211, P427, DOI 10.1016/0022-2836(90)90363-Q; SHELNESS GS, 1985, J BIOL CHEM, V260, P8637; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; SKRIPKIN EA, 1990, J MOL BIOL, V211, P447, DOI 10.1016/0022-2836(90)90364-R; SPANJAARD RA, 1989, GENE, V80, P345, DOI 10.1016/0378-1119(89)90298-9; SPRENGART ML, 1990, NUCLEIC ACIDS RES, V18, P1719, DOI 10.1093/nar/18.7.1719; SUBRAMANIAN AR, 1983, PROG NUCLEIC ACID RE, V28, P101, DOI 10.1016/S0079-6603(08)60085-9; TUERK C, 1988, P NATL ACAD SCI USA, V85, P1364, DOI 10.1073/pnas.85.5.1364; VARY CPH, 1984, NUCLEIC ACIDS RES, V12, P6763, DOI 10.1093/nar/12.17.6763; WANG CC, 1989, NUCLEIC ACIDS RES, V17, P9735, DOI 10.1093/nar/17.23.9735; WIKSTROM PM, 1992, J MOL BIOL, V224, P949, DOI 10.1016/0022-2836(92)90462-S; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; ZHANG JR, 1992, P NATL ACAD SCI USA, V89, P2605, DOI 10.1073/pnas.89.7.2605; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	48	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7501	7508						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125969				2022-12-27	WOS:A1994NA03200074
J	GERSHENGORN, MC; HEINFLINK, M; NUSSENZVEIG, DR; HINKLE, PM; FALCKPEDERSEN, E				GERSHENGORN, MC; HEINFLINK, M; NUSSENZVEIG, DR; HINKLE, PM; FALCKPEDERSEN, E			THYROTROPIN-RELEASING-HORMONE (TRH) RECEPTOR NUMBER DETERMINES THE SIZE OF THE TRH-RESPONSIVE PHOSPHOINOSITIDE POOL - DEMONSTRATION USING CONTROLLED EXPRESSION OF TRH RECEPTORS BY ADENOVIRUS-MEDIATED GENE-TRANSFER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE PHOSPHATIDYLINOSITOL POOL; PITUITARY-TUMOR CELLS; INOSITOL TRISPHOSPHATE; WRK-1 CELLS; MECHANISM; TURNOVER; RNA	We use an adenovirus vector, AdCMVmTRHR, to express thyrotropin-releasing hormone (TRH) receptors (TRH-Rs) to determine whether the size of the hormone-responsive phosphoinositide pool in mammalian cells is directly related to receptor number. Infection of HeLa cells with increasing numbers of AdCMVmTRHR caused time-dependent graded expression of TRH-Rs. Measurement of cytoplasmic free Ca2+ in individual cells permitted quantitation of the fraction of cells responsive to TRH. Infection with 100 AdCMVmTRHR particles/cell or more led to TRH responsiveness in greater than or equal to 90% of HeLa cells. Measurement of prelabeled phosphoinositides hydrolyzed during prolonged TRH stimulation assesses the size of the TRH-responsive pool. In cells infected with AdCMVmTRHR for 24 h, the size of the TRH-responsive phosphoinositide pool increased with increasing TRH-R expression. The TRH-responsive pool also increased with time after infection as the number of TRH-Rs increased, Similar observations were made in GHY and KB cells. These data confirm our previous suggestion (Cubitt, A. B., Geras-Raaka, E., and Gershengorn, M. C. (1990) Biochem. J, 271, 331-336) that there are hormone-responsive and -unresponsive pools of cellular phosphoinositides and that the maximal size of the TRH-responsive pool is directly related to the number of TRH-Rs.	CORNELL UNIV,COLL MED,DEPT MICROBIOL,NEW YORK,NY 10021; UNIV ROCHESTER,SCH MED & DENT,DEPT PHARMACOL,ROCHESTER,NY 14642; UNIV ROCHESTER,SCH MED & DENT,CTR CANC,ROCHESTER,NY 14642	Cornell University; University of Rochester; University of Rochester	GERSHENGORN, MC (corresponding author), CORNELL UNIV,COLL MED,DEPT MED,DIV MOLEC MED,BOX 44,1300 YORK AVE,NEW YORK,NY 10021, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041967] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK19974, DK43046] Funding Source: Medline; NIGMS NIH HHS [GM41967] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CUBITT AB, 1990, BIOCHEM J, V271, P331, DOI 10.1042/bj2710331; CUBITT AB, 1990, J BIOL CHEM, V265, P7907; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; FAIN JN, 1979, BIOCHEM J, V180, P655, DOI 10.1042/bj1800655; FUJIMOTO J, 1992, ENDOCRINOLOGY, V130, P1879, DOI 10.1210/en.130.4.1879; GERSHENGORN MC, 1986, ANNU REV PHYSIOL, V48, P515; GERSHENGORN MC, 1978, J CLIN INVEST, V62, P937, DOI 10.1172/JCI109222; Hokin M.R., 1964, METABOLISM PHYSL SIG, P423; HUANG MTF, 1990, NUCLEIC ACIDS RES, V18, P937, DOI 10.1093/nar/18.4.937; IMAI A, 1987, METHOD ENZYMOL, V141, P100; IMAI A, 1985, J BIOL CHEM, V260, P536; MONACO ME, 1982, J BIOL CHEM, V257, P2137; MONACO ME, 1983, J BIOL CHEM, V258, P5125; MONACO ME, 1992, ENDOCR REV, V13, P707, DOI 10.1210/er.13.4.707; NUSSENZVEIG DR, 1993, MOL ENDOCRINOL, V7, P1105, DOI 10.1210/me.7.9.1105; ORON Y, 1987, SCIENCE, V238, P1406, DOI 10.1126/science.2825350; RAMSDELL JS, 1985, MOL CELL ENDOCRINOL, V43, P173, DOI 10.1016/0303-7207(85)90081-4; RAMSDELL JS, 1986, J BIOL CHEM, V261, P5301; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; VALE W, 1971, ENDOCRINOLOGY, V89, P1485, DOI 10.1210/endo-89-6-1485; WINICOV I, 1989, J BIOL CHEM, V264, P9438	21	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6779	6783						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120038				2022-12-27	WOS:A1994MZ50300082
J	TOUHARA, K; INGLESE, J; PITCHER, JA; SHAW, G; LEFKOWITZ, RJ				TOUHARA, K; INGLESE, J; PITCHER, JA; SHAW, G; LEFKOWITZ, RJ			BINDING OF G-PROTEIN BETA-GAMMA-SUBUNITS TO PLECKSTRIN HOMOLOGY DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ADRENERGIC-RECEPTOR KINASE; SIGNAL TRANSDUCTION; MOLECULAR-CLONING; CDNA	Ligand-induced activation of many receptors leads to dissociation of the alpha- and beta gamma-subunit complexes of heterotrimeric G proteins, both of which regulate a variety of effector molecules involved in cellular signaling processes. In one case, a cytosolic enzyme, the beta-adrenergic receptor kinase (beta ARK) binds to the dissociated, prenylated, membrane-anchored beta gamma-subunits of heterotrimeric G proteins (G beta gamma) and is thereby targeted to its membrane-bound receptor substrate. Quite recently, numerous proteins involved in cellular signal transduction have been shown to contain sequences homologous with a ''domain'' originally identified in the protein ''pleckstrin'' (pleckstrin homology domain; PH domain) and subsequently found in the G beta gamma interaction region of the beta ARK sequence. Here we demonstrate that glutathione S-transferase-fusion proteins, containing sequences encompassing the PH domain of nine proteins from this group, bind G beta gamma to varying extents. Binding of G beta gamma to these fusion proteins was documented either by a direct binding assay or by ability to block G beta gamma-mediated membrane translocation of beta ARK1. G beta gamma binding to these fusion proteins was inhibited by the alpha subunit of G(o) (G(o) alpha), indicating that the binding of G beta gamma to G alpha and the PH domain-containing fusion proteins is mutually exclusive. Studies with a series of truncated PH domains derived from the Ras-guanine-nucleotide releasing factor indicate that the G beta gamma binding domain includes only the C-terminal portion of the PH domain and sequences just distal to this. Protein protein interactions between G beta gamma and PH domain-containing proteins may play a significant role in cellular signaling analogous to that previously demonstrated for Src homology 2 and 3 domains.	DUKE UNIV,MED CTR,DEPT MED,HOWARD HUGHES MED RES INST,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT BIOCHEM,HOWARD HUGHES MED RES INST,DURHAM,NC 27710; UNIV FLORIDA,J HILLIS MILLER HLTH CTR,DEPT NEUROSCI,GAINESVILLE,FL 32610	Duke University; Duke University; State University System of Florida; University of Florida			Lefkowitz, Robert/AAW-2649-2021; Pitcher, Julie/ABH-2078-2020		NHLBI NIH HHS [HL16037] Funding Source: Medline; NINDS NIH HHS [R01 NS22695] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022695] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBLAS J, 1993, J BIOL CHEM, V268, P22235; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; CASEY PJ, 1989, BIOCHEMISTRY-US, V28, P611, DOI 10.1021/bi00428a029; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; Dayhoff M.O., 1978, ATLAS PROTEIN SEQ ST; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; FRY MJ, 1993, PROTEIN SCI, V2, P1785, DOI 10.1002/pro.5560021102; HASLAM RJ, 1993, NATURE, V363, P310; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; INGLESE J, 1993, J BIOL CHEM, V268, P23735; JONES PF, 1991, CELL REGUL, V2, P1001, DOI 10.1091/mbc.2.12.1001; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LEVANON D, 1990, GENOMICS, V7, P65, DOI 10.1016/0888-7543(90)90519-Z; LUPAS AN, 1992, FEBS LETT, V314, P105, DOI 10.1016/0014-5793(92)80952-D; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; Mayer Bruce J., 1993, Trends in Cell Biology, V3, P8, DOI 10.1016/0962-8924(93)90194-6; MMUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PEITSCH MC, 1993, TRENDS BIOCHEM SCI, V18, P292, DOI 10.1016/0968-0004(93)90038-O; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; PRONIN AN, 1992, P NATL ACAD SCI USA, V89, P6220, DOI 10.1073/pnas.89.13.6220; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; SHAW G, 1993, BIOCHEM BIOPH RES CO, V195, P1145, DOI 10.1006/bbrc.1993.2164; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; SIMONDS WF, 1993, TRENDS BIOCHEM SCI, V18, P315; SUH PG, 1988, P NATL ACAD SCI USA, V85, P5419, DOI 10.1073/pnas.85.15.5419; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; VETRIS D, 1993, NATURE, V361, P236; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; WINITZ S, 1993, J BIOL CHEM, V268, P19196; WINKELMANN JC, 1990, J BIOL CHEM, V265, P20449	34	456	466	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 8	1994	269	14					10217	10220						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NF017	8144601				2022-12-27	WOS:A1994NF01700009
J	SCHUMACHER, RJ; HURST, R; SULLIVAN, WP; MCMAHON, NJ; TOFT, DO; MATTS, RL				SCHUMACHER, RJ; HURST, R; SULLIVAN, WP; MCMAHON, NJ; TOFT, DO; MATTS, RL			ATP-DEPENDENT CHAPERONING ACTIVITY OF RETICULOCYTE LYSATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN; GLUCOCORTICOID RECEPTOR-HSP90 COMPLEX; REGULATED EIF-2-ALPHA KINASE; VIRUS TRANSFORMING PROTEIN; PROGESTERONE-RECEPTOR; STEROID-RECEPTORS; UNCOATING ATPASE; BINDING-PROTEIN; HSP90; PURIFICATION	We have developed an assay for chaperone-mediated protein renaturation using thermally denatured Firefly luciferase. Dilution of denatured luciferase (>99% loss of activity) into reticulocyte lysate typically results in recovery of 5-15% activity. Addition of an ATP-regenerating system increases yields to >60%, while heat shock or the addition of denatured proteins inhibits the chaperoning activity. Reticulocyte lysate contains abundant quantities of the heat shock proteins, hsp90 and hsp70, and a 60-kDa protein homologous to the yeast stress protein, STI1. Immune isolated samples of these three proteins support recovery of up to 35% of luciferase activity in an ATP-dependent manner, suggesting that these or associated proteins are involved in the renaturation of luciferase. Furthermore, we observed a correlation between luciferase renaturation activity and the levels of hsp70 and hsp90 in reticulocyte lysate preparations. Purified hsp90 and hsp70, along with an ATP-regenerating system, are able to renature luciferase to greater than 20% of its original activity. This renaturation is most efficient when hsp90 and hsp70 are at about a 2:1 ratio and at concentrations similar to those found in reticulocyte lysate. This study provides evidence for an ATP-dependent chaperoning activity in reticulocyte lysate that involves a cooperative action of hsp70 and hsp90.	OKLAHOMA STATE UNIV,DEPT BIOCHEM & MOLEC BIOL,STILLWATER,OK 74078	Oklahoma State University System; Oklahoma State University - Stillwater	SCHUMACHER, RJ (corresponding author), MAYO GRAD SCH,DEPT BIOCHEM & MOLEC BIOL,ROCHESTER,MN 55905, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD009140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES004299, R01ES004299] Funding Source: NIH RePORTER; NCRR NIH HHS [RR07077] Funding Source: Medline; NICHD NIH HHS [HD09140] Funding Source: Medline; NIEHS NIH HHS [ES04299] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALNEMRI ES, 1993, P NATL ACAD SCI USA, V90, P6839, DOI 10.1073/pnas.90.14.6839; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BENSAUDE O, 1990, P89; BRUGGE J, 1983, MOL CELL BIOL, V3, P9, DOI 10.1128/MCB.3.1.9; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; CATELLI MG, 1985, EMBO J, V4, P3131, DOI 10.1002/j.1460-2075.1985.tb04055.x; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; CRAIG EA, 1991, TRENDS BIOCHEM SCI, V16, P135, DOI 10.1016/0968-0004(91)90055-Z; CSERMELY P, 1991, J BIOL CHEM, V266, P4943; CSERMELY P, 1993, J BIOL CHEM, V268, P1901; DALMAN FC, 1989, J BIOL CHEM, V264, P19815; DENIS M, 1987, J BIOL CHEM, V262, P11803; DUBOIS MF, 1991, J BIOL CHEM, V266, P9707; ECHOLS H, 1990, J BIOL CHEM, V265, P14697; ERNST V, 1978, J BIOL CHEM, V253, P7163; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; GAITANARIS GA, 1990, CELL, V61, P1013, DOI 10.1016/0092-8674(90)90066-N; GAO YI, 1993, MOL CELL BIOL, V13, P2478, DOI 10.1128/MCB.13.4.2478; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; GEORGOPOULOS C, 1992, TRENDS BIOCHEM SCI, V17, P295, DOI 10.1016/0968-0004(92)90439-G; GEORGOPOULOS C, 1990, STRESS PROTEINS BIOL, P191; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GREENE LE, 1990, J BIOL CHEM, V265, P6682; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HENDRIX RW, 1979, J MOL BIOL, V129, P375, DOI 10.1016/0022-2836(79)90502-3; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; HOHN T, 1979, J MOL BIOL, V129, P359, DOI 10.1016/0022-2836(79)90501-1; HONORE B, 1992, J BIOL CHEM, V267, P8485; HUNT T, 1972, J MOL BIOL, V66, P471, DOI 10.1016/0022-2836(72)90427-5; IANNOTTI AM, 1988, ARCH BIOCHEM BIOPHYS, V264, P54, DOI 10.1016/0003-9861(88)90569-3; KOST SL, 1989, MOL CELL BIOL, V9, P3829, DOI 10.1128/MCB.9.9.3829; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LANKS KW, 1992, BIOCHEM BIOPH RES CO, V184, P394, DOI 10.1016/0006-291X(92)91206-6; LEBEAU MC, 1992, J BIOL CHEM, V267, P4281; LEWIS VA, 1992, NATURE, V358, P249, DOI 10.1038/358249a0; MANNINGKRIEG UC, 1991, EMBO J, V10, P3273, DOI 10.1002/j.1460-2075.1991.tb04891.x; MATTINGLY JR, 1993, J BIOL CHEM, V268, P3925; MATTS RL, 1992, J BIOL CHEM, V267, P18160; MATTS RL, 1993, BIOCHEMISTRY-US, V32, P7323, DOI 10.1021/bi00080a001; MATTS RL, 1992, J BIOL CHEM, V267, P18168; MATTS RL, 1991, J BIOL CHEM, V266, P12695; MIYATA Y, 1991, J BIOL CHEM, V266, P8779; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; NADEAU K, 1992, PROTEIN SCI, V1, P970, DOI 10.1002/pro.5560010802; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; NGUYEN VT, 1989, J BIOL CHEM, V264, P10487; NICOLET CM, 1989, MOL CELL BIOL, V9, P3638, DOI 10.1128/MCB.9.9.3638; NIMMESGERN E, 1993, FEBS LETT, V331, P25, DOI 10.1016/0014-5793(93)80290-B; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; PEATTIE DA, 1992, BIOCHEMISTRY-US, V89, P10974; PELHAM H, 1988, NATURE, V332, P776, DOI 10.1038/332776a0; PERDEW GH, 1991, J BIOL CHEM, V266, P6708; PINTO M, 1991, J BIOL CHEM, V266, P13941; PUSKIN AV, 1982, BIOCHIM BIOPHYS ACTA, V704, P379; RAABE T, 1991, NUCLEIC ACIDS RES, V19, P6645, DOI 10.1093/nar/19.23.6645; RENOIR JM, 1984, BIOCHEMISTRY-US, V23, P6016, DOI 10.1021/bi00320a018; ROSE DW, 1987, BIOCHEMISTRY-US, V26, P6583, DOI 10.1021/bi00395a003; RYAN C, 1992, PROTEIN SCI, V1, P980, DOI 10.1002/pro.5560010803; SANCHEZ ER, 1988, MOL ENDOCRINOL, V2, P756, DOI 10.1210/mend-2-8-756; SANCHEZ ER, 1985, J BIOL CHEM, V260, P2398; SCHERRER LC, 1992, BIOCHEMISTRY-US, V31, P7325, DOI 10.1021/bi00147a017; SCHERRER LC, 1990, J BIOL CHEM, V265, P21397; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SCHMID SL, 1985, J BIOL CHEM, V260, P57; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; SCHUH S, 1985, J BIOL CHEM, V260, P4292; SHAKNOVICH R, 1992, MOL CELL BIOL, V12, P5059, DOI 10.1128/MCB.12.11.5059; SHEFFIELD WP, 1990, J BIOL CHEM, V265, P11069; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; SMITH DF, 1992, J BIOL CHEM, V267, P1350; SMITH DF, 1990, MOL ENDOCRINOL, V4, P1704, DOI 10.1210/mend-4-11-1704; SMITH DF, 1990, J BIOL CHEM, V265, P3996; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; TAI PKK, 1992, SCIENCE, V256, P1315, DOI 10.1126/science.1376003; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; YEM AW, 1992, J BIOL CHEM, V267, P2868	83	124	124	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9493	9499						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144534				2022-12-27	WOS:A1994NE05300018
J	SMITH, L; GREENFIELD, NJ; HITCHCOCKDEGREGORI, SE				SMITH, L; GREENFIELD, NJ; HITCHCOCKDEGREGORI, SE			THE EFFECTS OF DELETION OF THE AMINO-TERMINAL HELIX ON TROPONIN-C FUNCTION AND STABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE STOPPED-FLOW; RABBIT SKELETAL-MUSCLE; CA2+ BINDING-SITES; LIGHT-CHAIN KINASE; CALCIUM-BINDING; CONFORMATIONAL-CHANGES; PROTEOLYTIC FRAGMENTS; LYSINE REACTIVITIES; BIOLOGICAL-ACTIVITY; CIRCULAR-DICHROISM	Troponin C has a 14-residue a-helix at the extreme amino terminus (the N-helix) which is absent in calmodulin. To learn the significance of this region in troponin C, residues 1-14 were deleted using site-directed mutagenesis. Analysis of the mutant troponin C (DELTA14-TnC) showed that deletion of the N-helix did not alter the secondary structure of troponin C. Like wild type troponin C, it exhibited Ca2+-dependent conformational changes based on electrophoretic mobility and increases in alpha-helix content. The thermal stability of DELTA14-TnC, however, was 20-degrees-C lower than wild type troponin C in the presence or absence of divalent cations because of destabilization of the amino-terminal domain. To determine the functional consequences of the deletion, its ability to relieve troponin I and IT inhibition of the actomyosin ATPase was assayed. The results show that the mutant could relieve troponin I inhibition in the presence and absence of Ca2+ but could relieve troponin IT inhibition only to 45-50% of the wild type level, even at high concentrations. Also, the calcium affinity of the low affinity sites is reduced as evidenced by the 2.4-2.8-fold increase in Ca2+ concentration required to achieve half-maximal activation of the MgATPase and calcium titration of the metal-induced conformation monitored by far UV circular dichroism measurements. In addition, the N-helix is required for the full conformational change to take place upon the binding of Ca2+, but not Mg2+, to the high affinity sites. The results indicate that the N-helix of troponin C is important for the stability of troponin C and may play a vital role in the Ca2+-switching mechanism.	RUTGERS STATE UNIV,UNIV MED & DENT NEW JERSEY,JOINT GRAD PROGRAM MICROBIOL & MOLEC BIOL,PISCATAWAY,NJ 08854	Rutgers State University New Brunswick; Rutgers State University Medical Center	SMITH, L (corresponding author), ROBERT WOOD JOHNSON MED SCH,DEPT NEUROSCI & CELL BIOL,675 HOES LANE,PISCATAWAY,NJ 08854, USA.				NHLBI NIH HHS [HL35726-S1] Funding Source: Medline; NIGMS NIH HHS [GM36326] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036326] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMPHLETT GW, 1976, FEBS LETT, V72, P163, DOI 10.1016/0014-5793(76)80836-8; BABU A, 1988, J BIOL CHEM, V263, P15485; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BRZESKA H, 1983, FEBS LETT, V153, P169, DOI 10.1016/0014-5793(83)80141-0; CASTELLANI L, 1980, BIOCHEM BIOPH RES CO, V96, P558, DOI 10.1016/0006-291X(80)91392-3; CHEUNG HC, 1982, BIOCHEMISTRY-US, V21, P5135, DOI 10.1021/bi00264a005; COLLINS JH, 1991, J MUSCLE RES CELL M, V12, P3, DOI 10.1007/BF01781170; DASILVA ACR, 1993, EUR J BIOCHEM, V213, P599; DEDMAN JR, 1977, J BIOL CHEM, V252, P2437; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; DOBROWOLSKI Z, 1991, J BIOL CHEM, V266, P5703; DOBROWOLSKI Z, 1991, BIOCHEMISTRY-US, V30, P7089, DOI 10.1021/bi00243a008; DOBROWOLSKI Z, 1988, BIOPHYS J, V53, P587; GAULATI J, 1993, J BIOL CHEM, V268, P11685; GEORGE SE, 1990, J BIOL CHEM, V265, P9228; GOA J, 1953, SCAND J CLIN LAB INV, V5, P218, DOI 10.3109/00365515309094189; GOLOSINSKA K, 1991, J BIOL CHEM, V266, P15797; GRABAREK Z, 1981, J BIOL CHEM, V256, P3121; GRABAREK Z, 1992, J MUSCLE RES CELL M, V13, P383, DOI 10.1007/BF01738034; GRABAREK Z, 1986, J BIOL CHEM, V261, P608; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GRUDA J, 1973, BIOCHEM BIOPH RES CO, V52, P1307, DOI 10.1016/0006-291X(73)90643-8; GULATI J, 1992, J BIOL CHEM, V267, P25073; GUSEV NB, 1991, J BIOL CHEM, V266, P16622; HEAD JF, 1974, BIOCHEM J, V137, P145, DOI 10.1042/bj1370145; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; HERZBERG O, 1986, J BIOL CHEM, V261, P2638; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; HINCKE MT, 1978, CAN J BIOCHEM CELL B, V56, P384, DOI 10.1139/o78-061; HITCHCOCK SE, 1981, J MOL BIOL, V147, P153, DOI 10.1016/0022-2836(81)90083-8; HITCHCOCKDEGREGORI SE, 1982, J BIOL CHEM, V257, P2573; HITCHCOCKDEGREGORI SE, 1985, BIOCHEMISTRY-US, V24, P3305, DOI 10.1021/bi00334a035; IIO T, 1981, J BIOCHEM-TOKYO, V90, P163, DOI 10.1093/oxfordjournals.jbchem.a133446; JOHNSON JD, 1979, J BIOL CHEM, V254, P3497; JOHNSON JD, 1978, J BIOL CHEM, V253, P3775; KAREVA VV, 1986, BIOCHIM BIOPHYS ACTA, V869, P322, DOI 10.1016/0167-4838(86)90072-5; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; KAWASAKI Y, 1972, BIOCHEM BIOPH RES CO, V49, P898, DOI 10.1016/0006-291X(72)90297-5; KRETSINGER RH, 1980, CRC CR REV BIOCH MOL, V8, P119, DOI 10.3109/10409238009105467; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEAVIS PC, 1978, J BIOL CHEM, V253, P5452; LEAVIS PC, 1984, CRC CR REV BIOCH MOL, V16, P235, DOI 10.3109/10409238409108717; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MONERA OD, 1992, PROTEIN SCI, V1, P945, DOI 10.1002/pro.5560010713; MURRAY AC, 1972, BIOCHEMISTRY-US, V11, P2622, DOI 10.1021/bi00764a012; NAGY B, 1979, J BIOL CHEM, V254, P2732; NAIRN AC, 1979, BIOCHEM J, V179, P89, DOI 10.1042/bj1790089; PEARLSTONE JR, 1992, BIOCHEMISTRY-US, V31, P6545, DOI 10.1021/bi00143a026; PERRIN DD, 1967, TALANTA, V14, P833, DOI 10.1016/0039-9140(67)80105-X; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; POTTER JD, 1976, J BIOL CHEM, V251, P7551; POTTER JD, 1982, CALCIUM CELL FUNCTIO, V2, P145; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; REID RE, 1981, J BIOL CHEM, V256, P2742; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATYSHUR KA, 1988, J BIOL CHEM, V263, P1628; SHENG Z, 1991, J BIOL CHEM, V266, P5711; SILLEN LG, 1964, SPECIAL PUBLICATION, V17; SMITH L, 1993, BIOPHYS J, V64, P134; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUNDARALINGAM M, 1985, P NATL ACAD SCI USA, V82, P7944, DOI 10.1073/pnas.82.23.7944; SWENSON CA, 1992, BIOCHEMISTRY-US, V31, P3420, DOI 10.1021/bi00128a017; TEMPST P, 1989, ANAL BIOCHEM, V183, P290, DOI 10.1016/0003-2697(89)90482-X; TSALKOVA TN, 1985, J MOL BIOL, V181, P533, DOI 10.1016/0022-2836(85)90425-5; VANBERKUM MFA, 1991, J BIOL CHEM, V266, P21488; WANG CLA, 1986, EUR J BIOCHEM, V154, P225, DOI 10.1111/j.1432-1033.1986.tb09383.x; WANG CLA, 1983, J BIOL CHEM, V258, P9175; WHITE HD, 1982, METHOD ENZYMOL, V85, P698; XU GQ, 1988, J BIOL CHEM, V263, P13962; YAMAMOTO K, 1983, J BIOCHEM, V93, P1061, DOI 10.1093/oxfordjournals.jbchem.a134230; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	75	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9857	9863						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144578				2022-12-27	WOS:A1994NE05300072
J	ZAHEDI, K; PRADA, AE; DAVIS, AE				ZAHEDI, K; PRADA, AE; DAVIS, AE			TRANSCRIPTIONAL REGULATION OF THE C1-INHIBITOR GENE BY GAMMA-INTERFERON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATE VIRUS INDUCIBILITY; INDUCED NUCLEAR FACTORS; BINDING PROTEIN GENE; MAJOR LATE PROMOTER; HUMAN C1 INHIBITOR; RNA POLYMERASE-II; CELL-LINE; STIMULATED GENES; HUMAN MONOCYTES; CDNA CLONING	Treatment of the hepatoma cell line, Hep3B, with gamma-interferon (IFN) enhanced expression of C1 inhibitor (C1INH) mRNA, primarily due to an enhanced transcription rate. Hep3B cells transfected with reporter constructs containing various regions of the C1INH gene between positions -1182 and +587, and stimulated with gamma-IFN, expressed increased levels of chloramphenicol acetyltransferase in the presence of the first intron and as few as 12 bases of the 5'-flanking region. However, a 66% reduction in the inducibility of the constructs was observed when the upstream region between -582 and -252 was eliminated. Successive deletions mapped the first intron IFN-responsive elements to a region between +368 and +410. The data indicate that both the upstream and the first intron sequences can independently enhance induction of C1INH gene expression. Examination of the immediate upstream sequence of the C1INH gene reveals the absence of a TATA box. The promoter of the C1INH gene was mapped to a region within 81 bases of the upstream sequence and the first exon. Further examination indicated two regions that were potentially important for promoter activity as follows: 1) a G-C-rich region from -81 to -49, and 2) an initiator element at -3 to +5. The results indicate that the upstream sequences including -81 to -49 and the H-DNA region between -48 and -17 are not necessary for promoter activity. The initiator element from -3 to +5 is sufficient and necessary for promoter function.	UNIV CINCINNATI,COLL MED,DEPT PEDIAT,CINCINNATI,OH 45229	University System of Ohio; University of Cincinnati	ZAHEDI, K (corresponding author), CHILDRENS HOSP RES FDN,DIV NEPHROL,3333 BURNET AVE,CINCINNATI,OH 45229, USA.		Zahedi, Kamyar/AAQ-3428-2021		NICHD NIH HHS [HD22082] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022082, R37HD022082] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; CARTER PE, 1988, EUR J BIOCHEM, V173, P163, DOI 10.1111/j.1432-1033.1988.tb13980.x; CARTER PE, 1991, EUR J BIOCHEM, V197, P301, DOI 10.1111/j.1432-1033.1991.tb15911.x; DALE TC, 1989, EMBO J, V8, P831, DOI 10.1002/j.1460-2075.1989.tb03444.x; DAVIS AE, 1988, ANNU REV IMMUNOL, V6, P595, DOI 10.1146/annurev.iy.06.040188.003115; DAVIS AE, 1986, P NATL ACAD SCI USA, V83, P3161, DOI 10.1073/pnas.83.10.3161; DECKER T, 1991, MOL CELL BIOL, V11, P5147, DOI 10.1128/MCB.11.10.5147; DECKER T, 1991, EMBO J, V10, P927, DOI 10.1002/j.1460-2075.1991.tb08026.x; DONALDSON VH, 1963, AM J MED, V35, P37, DOI 10.1016/0002-9343(63)90162-1; FABER PW, 1993, J BIOL CHEM, V268, P9296; FUJITA T, 1987, CELL, V49, P357, DOI 10.1016/0092-8674(87)90288-1; GARFINKEL S, 1990, J BIOL CHEM, V265, P10309; HAMILTON AO, 1987, BIOCHEM J, V242, P809, DOI 10.1042/bj2420809; HAUPT H, 1970, EUR J BIOCHEM, V17, P254, DOI 10.1111/j.1432-1033.1970.tb01161.x; HEDA GD, 1990, BLOOD, V75, P2401; KATZ Y, 1989, J IMMUNOL, V142, P2041; KOHWI Y, 1991, GENE DEV, V5, P2547, DOI 10.1101/gad.5.12b.2547; LAPIN DF, 1992, BIOCHEM J, V281, P437; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; LEW DJ, 1991, MOL CELL BIOL, V11, P182, DOI 10.1128/MCB.11.1.182; LOTZ M, 1987, J IMMUNOL, V139, P3382; MACDONALD NJ, 1990, CELL, V60, P767, DOI 10.1016/0092-8674(90)90091-R; MIRKOVITCH J, 1992, MOL CELL BIOL, V12, P1; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MORRIS KM, 1982, J CLIN INVEST, V70, P906, DOI 10.1172/JCI110687; NAF D, 1991, P NATL ACAD SCI USA, V88, P1369, DOI 10.1073/pnas.88.4.1369; OSHEAGREENFIELD A, 1992, J BIOL CHEM, V267, P1391; PEARSE RN, 1991, P NATL ACAD SCI USA, V88, P11305, DOI 10.1073/pnas.88.24.11305; PEARSE RN, 1993, P NATL ACAD SCI USA, V90, P4314, DOI 10.1073/pnas.90.9.4314; PINE R, 1990, MOL CELL BIOL, V10, P2448, DOI 10.1128/MCB.10.6.2448; RANDAZZO BP, 1985, J IMMUNOL, V135, P1313; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; SAFER B, 1991, J BIOL CHEM, V266, P10989; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMIDT B, 1991, IMMUNOLOGY, V74, P677; SIMS SH, 1993, MOL CELL BIOL, V13, P690, DOI 10.1128/MCB.13.1.690; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; STEEL DM, 1991, BIOCHEM J, V277, P477, DOI 10.1042/bj2770477; WANG IM, 1993, J IMMUNOL, V151, P2646; WEIS L, 1992, FASEB J, V6, P3300, DOI 10.1096/fasebj.6.14.1426767; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; WILSON KC, 1992, P NATL ACAD SCI USA, V89, P11964, DOI 10.1073/pnas.89.24.11964; WRIGHT TM, 1991, J EXP MED, V173, P417, DOI 10.1084/jem.173.2.417; YAN C, 1992, P NATL ACAD SCI USA, V89, P8859, DOI 10.1073/pnas.89.19.8859; ZURAW BL, 1990, J BIOL CHEM, V265, P12664	48	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9669	9674						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144555				2022-12-27	WOS:A1994NE05300044
J	KOMALAVILAS, P; LINCOLN, TM				KOMALAVILAS, P; LINCOLN, TM			PHOSPHORYLATION OF THE INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR BY CYCLIC GMP-DEPENDENT PROTEIN-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; RECONSTITUTED LIPID VESICLES; TRISPHOSPHATE RECEPTOR; RAT AORTA; RELAXING FACTOR; NITRIC-OXIDE; CALCIUM FLUX; CA-2+ LEVELS; PURIFICATION; CGMP	Cyclic GMP (cGMP) inhibits intracellular calcium ([Ca2+](i)) mobilization in vascular smooth muscle cells by a mechanism that is not well understood. Because several studies suggest that cGMP inhibits inositol 1,4,5-trisphosphate (IP3) action, we examined the effects of cGMP-dependent protein kinase on IP3 receptor phosphorylation. The purified IP3 receptor was phosphorylated using either the cGMP- or cAMP-dependent protein kinase in vitro. Phosphorylation was time-dependent and stoichiometric using both kinases. Two-dimensional phosphopeptide mapping high performance liquid chromatography analysis, and amino acid analysis showed that identical sites were phosphorylated using either kinase, and identified serine 1755 as the site of phosphorylation. The synthetic peptide corresponding to serine 1755 (GRRESLTSFG) was phosphorylated with a K-m in the range of 30-40 mu m by both kinases. The kinetic analysis revealed that this peptide substrate is the best substrate described for cGMP kinase to date. Vascular smooth muscle cells prelabeled with [P-32]orthophosphate and treated with atrial natriuretic peptide or sodium nitroprusside to elevate cGMP also resulted in increased labeling of the IP3 receptor. Phosphorylation of IP3 receptor by cGMP kinase may regulate the function of IP3 receptor in vascular smooth muscle cells and contribute to the effect of cGMP to regulate intracellular calcium levels.	UNIV ALABAMA, DEPT PATHOL, DIV MOLEC & CELLULAR PATHOL, BIRMINGHAM, AL 35294 USA	University of Alabama System; University of Alabama Birmingham					NHLBI NIH HHS [HL 34646] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034646] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; BIRD GS, 1993, J BIOL CHEM, V268, P17917; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHADWICK CC, 1990, P NATL ACAD SCI USA, V87, P2132, DOI 10.1073/pnas.87.6.2132; CHEN XL, 1992, AM J PHYSIOL, V263, pC468, DOI 10.1152/ajpcell.1992.263.2.C468; COLBRAN JL, 1992, J BIOL CHEM, V267, P9589; COLLINS P, 1986, J PHYSIOL-LONDON, V381, P427, DOI 10.1113/jphysiol.1986.sp016336; Corbin J D, 1974, Methods Enzymol, V38, P287; CORNWELL TL, 1988, J PHARMACOL EXP THER, V247, P524; CORNWELL TL, 1989, J BIOL CHEM, V264, P1146; CORNWELL TL, 1991, MOL PHARMACOL, V40, P923; FERRIS CD, 1991, BIOCHEM BIOPH RES CO, V175, P192, DOI 10.1016/S0006-291X(05)81219-7; FERRIS CD, 1990, P NATL ACAD SCI USA, V87, P2147, DOI 10.1073/pnas.87.6.2147; FERRIS CD, 1992, ANNU REV PHYSIOL, V54, P469, DOI 10.1146/annurev.physiol.54.1.469; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FERRIS CD, 1991, P NATL ACAD SCI USA, V88, P2232, DOI 10.1073/pnas.88.6.2232; GRUETTER CA, 1979, J CYCLIC NUCL PROT, V5, P211; HAJNOCZKY G, 1993, BIOCHEM J, V293, P413, DOI 10.1042/bj2930413; HIRATA M, 1990, J BIOL CHEM, V265, P1268; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; JIN JG, 1993, AM J PHYSIOL, V264, pG470, DOI 10.1152/ajpgi.1993.264.3.G470; JOHNSON RM, 1985, MOL PHARMACOL, V27, P333; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINCOLN TM, 1983, ADV CYCL NUCL RES<D>, V15, P139; LINCOLN TM, 1989, PHARMACOL THERAPEUT, V41, P479, DOI 10.1016/0163-7258(89)90127-7; LINCOLN TM, 1977, J BIOL CHEM, V252, P4269; LINCOLN TM, 1993, FASEB J, V7, P328, DOI 10.1096/fasebj.7.2.7680013; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; MARKS AR, 1990, J BIOL CHEM, V265, P20719; MAYRLEITNER M, 1991, CELL CALCIUM, V12, P505, DOI 10.1016/0143-4160(91)90032-A; MEISHERI KD, 1986, AM J PHYSIOL, V250, pC171, DOI 10.1152/ajpcell.1986.250.1.C171; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; RAPOPORT RM, 1986, CIRC RES, V58, P407, DOI 10.1161/01.RES.58.3.407; RASHATWAR SS, 1987, P NATL ACAD SCI USA, V84, P5685, DOI 10.1073/pnas.84.16.5685; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; RUTH P, 1993, P NATL ACAD SCI USA, V90, P2623, DOI 10.1073/pnas.90.7.2623; SMITH JB, 1983, J CELL PHYSIOL, V114, P284, DOI 10.1002/jcp.1041140306; SUGDEN PH, 1976, BIOCHEM J, V159, P409, DOI 10.1042/bj1590409; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; THOMAS MK, 1990, J BIOL CHEM, V265, P14971; VROLIX M, 1988, BIOCHEM J, V255, P855, DOI 10.1042/bj2550855; WALAAS SI, 1986, J NEUROSCI, V6, P954; Walter U, 1989, REV PHYSL BIOCH PHAR, V113, P41; WHITE RE, 1993, NATURE, V361, P263, DOI 10.1038/361263a0	46	197	200	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8701	8707						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132598				2022-12-27	WOS:A1994NB41100015
J	WIPPLER, J; KOUNS, WC; SCHLAEGER, EJ; KUHN, H; HADVARY, P; STEINER, B				WIPPLER, J; KOUNS, WC; SCHLAEGER, EJ; KUHN, H; HADVARY, P; STEINER, B			THE INTEGRIN ALPHA(IIB)-BETA(3), PLATELET GLYCOPROTEIN IIB-IIIA, CAN FORM A FUNCTIONALLY ACTIVE HETERODIMER COMPLEX WITHOUT THE CYSTEINE-RICH REPEATS OF THE BETA(3) SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED HUMAN-PLATELETS; AMINO-ACID POLYMORPHISM; LIGAND-BINDING SITE; GPIIB-IIIA; GLANZMANN THROMBASTHENIA; FIBRINOGEN RECEPTOR; CELL-ADHESION; GAMMA-CHAIN; ELECTRON-MICROSCOPY; CYTOPLASMIC DOMAIN	Integrin alpha(IIb)-beta(3) binds fibrinogen via the recognition sequence Arg-Gly-Asp-Ser (RGDS). We have used the baculovirus/insect cell expression system to study the structural requirements for the formation of a functionally active fragment of alpha(IIb)-beta(3). A tandem baculovirus transfer vector was constructed containing the cDNA coding for the heavy chain of human alpha(IIb) (alpha(IIbH), amino acids 1-874) and the cDNA coding for a truncated form of human beta(3) (t beta(3); amino acids 1-469). Sf9 insect cells were infected with the corresponding baculovirus, and the produced soluble recombinant proteins were purified using an RGD-like affinity column. The bound receptor fragments were specifically eluted with RGDS and existed as a heterodimeric complex (rec alpha(IIbH)-t beta(3)) with an apparent M(r) of 160,000, In an immunocapture assay, the monoclonal antibody pl-55, which only recognizes the functionally active form of alpha(IIb)-beta(3), bound to the purified complex. Rec alpha(IIbH)-t beta(3) specifically bound I-125-fibrinogen with an affinity comparable with that of purified platelet alpha(IIb)-beta(3). Electron micrographs of rotary-shadowed rec alpha(IIb)-B-3 showed that the complex had the characteristic globular head, but the two rodlike tails were 4-6 nm shorter than those found in intact alpha(IIb)-beta(3). Thus, the cysteine-rich repeats of beta(3) are not required for assembly, stability, and functional activity of this integrin.			WIPPLER, J (corresponding author), F HOFFMANN LA ROCHE LTD, PRECLIN RES, DIV PHARMA, PRPV BAU 69-330, GRENZACHERSTSR 124, CH-4002 BASEL, SWITZERLAND.							ALIG L, 1992, J MED CHEM, V35, P4393, DOI 10.1021/jm00101a017; BAJT ML, 1992, J BIOL CHEM, V267, P22211; BAJT ML, 1992, J BIOL CHEM, V267, P3789; BEER J, 1989, J BIOL CHEM, V264, P17564; BENNETT JS, 1993, J BIOL CHEM, V268, P3580; BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; BODARY SC, 1989, J BIOL CHEM, V264, P18859; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALVETE JJ, 1991, BIOCHEM J, V274, P63, DOI 10.1042/bj2740063; CARRELL NA, 1985, J BIOL CHEM, V260, P1743; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10169, DOI 10.1073/pnas.89.21.10169; COOK JJ, 1992, BIOCHIM BIOPHYS ACTA, V1119, P312, DOI 10.1016/0167-4838(92)90219-4; DSOUZA SE, 1988, J BIOL CHEM, V263, P3943; DSOUZA SE, 1991, NATURE, V350, P66, DOI 10.1038/350066a0; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; DSOUZA SE, 1988, SCIENCE, V242, P91, DOI 10.1126/science.3262922; DSOUZA SE, 1990, J BIOL CHEM, V265, P3440; FITZGERALD LA, 1987, J BIOL CHEM, V262, P3936; FRACHET P, 1992, BIOCHEMISTRY-US, V31, P2408, DOI 10.1021/bi00123a028; FRELINGER AL, 1988, J BIOL CHEM, V263, P12397; GARTNER TK, 1985, J BIOL CHEM, V260, P1891; GINSBERG M, 1985, J BIOL CHEM, V260, P3931; GULINO D, 1992, J BIOL CHEM, V267, P1001; GULINO D, 1990, J BIOL CHEM, V265, P9575; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Inlow D., 1989, J TISSUE CULTURE MET, V12, P13; KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028; KOUNS WC, 1990, J BIOL CHEM, V265, P20594; KOUNS WC, 1991, BLOOD, V78, P3215; KOUNS WC, 1992, J BIOL CHEM, V267, P18844; KOUNS WC, 1991, THROMB RES, V63, P343, DOI 10.1016/0049-3848(91)90137-L; KOUNS WC, 1992, BLOOD, V80, P2529; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM SCT, 1989, BLOOD, V73, P1513; LAM SCT, 1987, J BIOL CHEM, V262, P947; LAM SCT, 1992, J BIOL CHEM, V267, P5649; LANZA F, 1992, J CLIN INVEST, V89, P1995, DOI 10.1172/JCI115808; LOFTUS JC, 1990, SCIENCE, V249, P915, DOI 10.1126/science.2392682; Luckow V. A, 1991, Recombinant DNA technology and applications., P97; LUCKOW VA, 1989, VIROLOGY, V170, P31, DOI 10.1016/0042-6822(89)90348-6; LYMAN S, 1990, BLOOD, V75, P2343; MCEVER RP, 1982, BLOOD, V59, P80; MUNSON PJ, 1980, ANAL BIOCHEM, V102, P318; NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x; NEWMAN PJ, 1991, P NATL ACAD SCI USA, V88, P3160, DOI 10.1073/pnas.88.8.3160; NEWMAN PJ, 1993, THROMB HAEMOSTASIS, V69, P1017; NEWMAN PJ, 1989, J CLIN INVEST, V83, P1778, DOI 10.1172/JCI114082; OTOOLE TE, 1990, CELL REGUL, V1, P883, DOI 10.1091/mbc.1.12.883; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; PARISE LV, 1985, J BIOL CHEM, V260, P698; PLOW EF, 1985, BLOOD, V66, P724; PLOW EF, 1981, J BIOL CHEM, V256, P9477; PONCZ M, 1987, J BIOL CHEM, V262, P8476; Possee RD., 1992, BACULOVIRUS EXPRESSI; ROSA JP, 1989, J BIOL CHEM, V264, P12596; Sambrook J, 1989, MOL CLONING LABORATO; SANTORO SA, 1987, CELL, V48, P867, DOI 10.1016/0092-8674(87)90083-3; SAVAGE B, 1990, J BIOL CHEM, V265, P11766; Schlaeger E.-J., 1993, Biotechnology Techniques, V7, P183; SIMS PJ, 1991, J BIOL CHEM, V266, P7345; STANSSENS P, 1989, NUCLEIC ACIDS RES, V17, P4441, DOI 10.1093/nar/17.12.4441; STEINER B, 1991, J BIOL CHEM, V266, P14986; STEINER B, 1993, J BIOL CHEM, V268, P6870; STEINER B, 1989, J BIOL CHEM, V264, P13102; SUMMERS MD, 1987, MANUAL METHODS BACIL; TAYLOR DB, 1992, J BIOL CHEM, V267, P11729; TYLER JM, 1980, J ULTRA MOL STRUCT R, V71, P95, DOI 10.1016/S0022-5320(80)90098-2; WANG RG, 1992, J CLIN INVEST, V90, P2038, DOI 10.1172/JCI116084	69	67	72	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8754	8761						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132607				2022-12-27	WOS:A1994NB41100024
J	CHEN, DG; STALLCUP, MR				CHEN, DG; STALLCUP, MR			THE HORMONE-BINDING ROLE OF 2 CYSTEINES NEAR THE C-TERMINUS OF THE MOUSE GLUCOCORTICOID RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN; DEPENDENT TRANSCRIPTIONAL ACTIVATION; HUMAN ESTROGEN-RECEPTOR; STEROID-BINDING; DEXAMETHASONE 21-MESYLATE; FUNCTIONAL DOMAINS; POINT MUTATIONS; MAMMALIAN-CELLS; AMINO-ACID; WILD-TYPE	Previous biochemical analyses with covalent affinity labels and thiol-blocking reagents suggested possible roles for one methionine residue and multiple cysteine residues in binding of steroid to the 250-amino acid hormone-binding domain at the C-terminal end of mammalian glucocorticoid receptors. To test the functional roles of these residues in the receptor's ability to bind hormone and activate transcription of target genes, the mouse glucocorticoid receptor cDNA was specifically mutated to cause single amino acid substitutions for methionine 610 and for each of the 5 cysteines (at positions 628, 644, 649, 671, and 742) in the hormone-binding domain. Among these 6 residues, only mutations in cysteine 671 and cysteine 742 caused substantial reductions in function. In transient transfection assays, the concentration of dexamethasone required for half maximal activation of a glucocorticoid-responsive reporter gene was increased by 10-40-fold by changing cysteine 742 to serine or cysteine 671 to serine or alanine. At saturating concentrations of dexamethasone, the mutant receptors activated the reporter gene to the same extent as the wild type receptor, indicating that the mutations affected only the hormone-binding function of the receptor and not its ability to bind DNA or activate transcription once the hormone was bound.	UNIV SO CALIF,DEPT PATHOL,LOS ANGELES,CA 90033; UNIV SO CALIF,DEPT BIOCHEM & MOLEC BIOL,LOS ANGELES,CA 90033	University of Southern California; University of Southern California					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK43093] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; BYRAVAN S, 1991, MOL ENDOCRINOL, V5, P752, DOI 10.1210/mend-5-6-752; CADEPOND F, 1991, J BIOL CHEM, V266, P5834; CARLSTEDTDUKE J, 1988, J BIOL CHEM, V263, P6842; CHAKRABORTI PK, 1991, J BIOL CHEM, V266, P22075; CHAKRABORTI PK, 1992, J BIOL CHEM, V267, P11366; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DALMAN FC, 1991, J BIOL CHEM, V266, P3482; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x; DANIELSEN M, 1989, CANCER RES, V49, pS2286; DANIELSEN M, 1984, MOL CELL BIOL, V4, P449, DOI 10.1128/MCB.4.3.449; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Ham J, 1989, CURR OPIN CELL BIOL, V1, P503, DOI 10.1016/0955-0674(89)90012-4; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; LIU ES, 1991, NUCLEIC ACIDS RES, V19, P5425, DOI 10.1093/nar/19.19.5425; MA WJ, 1992, J BIOL CHEM, V267, P22728; OMALLEY BW, 1992, MOL ENDOCRINOL, V6, P1359, DOI 10.1210/me.6.9.1359; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; REESE JC, 1992, J BIOL CHEM, V267, P9868; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLATTER LK, 1992, MOL ENDOCRINOL, V6, P132, DOI 10.1210/me.6.1.132; SIMONS SS, 1987, J BIOL CHEM, V262, P9676; SIMONS SS, 1989, J BIOL CHEM, V264, P14493; SMITH DF, 1990, J BIOL CHEM, V265, P3996; SMITH LI, 1988, BIOCHEMISTRY-US, V27, P3747, DOI 10.1021/bi00410a034; WAHLI W, 1991, FASEB J, V5, P2243, DOI 10.1096/fasebj.5.9.1860615; WESTPHAL HM, 1984, EMBO J, V3, P1493, DOI 10.1002/j.1460-2075.1984.tb02001.x	38	21	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7914	7918						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132510				2022-12-27	WOS:A1994NB40900016
J	LEE, MGS; RUSSELL, DG; DALESANDRO, PA; VANDERPLOEG, LHT				LEE, MGS; RUSSELL, DG; DALESANDRO, PA; VANDERPLOEG, LHT			IDENTIFICATION OF MEMBRANE-ASSOCIATED PROTEINS IN TRYPANOSOMA-BRUCEI ENCODING AN INTERNAL, EARLRAEE AMINO-ACID REPEAT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM FORM; ANTIGENIC VARIATION; AFRICAN TRYPANOSOMES; GEL-ELECTROPHORESIS; REPETITIVE PROTEINS; CULTURE FORMS; SURFACE-COAT; DNA; PURIFICATION; PARASITE	Differential screening of expression libraries with nonimmune and day 4-6 immune serum from naive rats infected with the protozoan Trypanosoma lewisi was used to identify potential cell surface protein coding genes. Several T. lewisi cDNAs that resulted were partially characterized and used to clone the homologues from Trypanosoma brucei. The nucleotide sequence of the cDNAs encoding the Tb-29 genes of the parasitic protozoan T. brucei obtained by this method (3557 nucleotides for Tb-291 and 8729 nucleotides for Tb-292) encoded predicted open reading frames of 1070 and 2550 amino acids, respectively. The Tb-29 proteins encoded a large domain with an octapeptide (EARLRAEE) repeat (79 repeats in Tb-291 and 60 in Tb-292), which shared significant similarity with the octapeptide repeat of the S-antigen of isolate NF7 of Plasmodium falciparum. The predicted amino acid sequence of the Tb-292 protein encoded potential transmembrane domains (eight in total). Indirect immunofluorescence using confocal image analysis and immunoelectron microscopy located the EARLRAEE proteins to a membranous network. The Tb-29 proteins were most abundantly distributed to the area surrounding the nucleus, the region between the nucleus and the flagellar pocket, and the region immediately underneath the flagellar pocket membrane. The subcellular distribution of Tb-29 proteins suggests that these proteins may provide a constituent associated with the cell's vesicular transport system.	WASHINGTON UNIV, SCH MED, DEPT MOLEC MICROBIOL, ST LOUIS, MO 63110 USA	Washington University (WUSTL)	LEE, MGS (corresponding author), COLUMBIA UNIV, DIV TROP MED, NEW YORK, NY 10032 USA.		Russell, David G/N-5280-2019; Russell, David G/D-4533-2009	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X	NIAID NIH HHS [AI21784, AI26889, AI34207] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026889, R01AI021784, R01AI034207] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BLACK S, 1989, MOL BIOCHEM PARASIT, V37, P65, DOI 10.1016/0166-6851(89)90103-5; BOEDTKER H, 1971, BIOCHIM BIOPHYS ACTA, V240, P448, DOI 10.1016/0005-2787(71)90539-9; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; BORST P, 1987, SCIENCE, V235, P658, DOI 10.1126/science.3544215; BORST P, 1986, ANNU REV BIOCHEM, V55, P701, DOI 10.1146/annurev.bi.55.070186.003413; BORST P, 1991, TRENDS GENET, V7, P307, DOI 10.1016/0168-9525(91)90406-G; BRUN R, 1979, ACTA TROP, V36, P289; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Clayton C.E., 1988, Genetic Engineering, V7, P1; CLAYTON CE, 1989, J BIOL CHEM, V264, P15088; COPPENS I, 1988, P NATL ACAD SCI USA, V85, P6753, DOI 10.1073/pnas.85.18.6753; COPPENS I, 1987, J PROTOZOOL, V34, P465, DOI 10.1111/j.1550-7408.1987.tb03216.x; COWMAN AF, 1985, CELL, V40, P775, DOI 10.1016/0092-8674(85)90337-X; CROSS GAM, 1990, ANNU REV IMMUNOL, V8, P83, DOI 10.1146/annurev.iy.08.040190.000503; DALESANDRO PA, 1980, EXP PARASITOL, V50, P384, DOI 10.1016/0014-4894(80)90041-7; ENGLUND PT, 1982, ANNU REV BIOCHEM, V51, P695, DOI 10.1146/annurev.bi.51.070182.003403; FAIRLAMB AH, 1978, J CELL BIOL, V76, P293, DOI 10.1083/jcb.76.2.293; GIANNINI MSH, 1987, J PARASITOL, V73, P144, DOI 10.2307/3282358; GIANNINI SH, 1979, EXP PARASITOL, V47, P342, DOI 10.1016/0014-4894(79)90087-0; GIANNINI SH, 1984, INFECT IMMUN, V43, P617, DOI 10.1128/IAI.43.2.617-621.1984; GOTTESDIENER K, 1990, MOL CELL BIOL, V10, P6079, DOI 10.1128/MCB.10.11.6079; HAJDUK SL, 1989, J BIOL CHEM, V264, P5210; KEMP DJ, 1987, ANNU REV MICROBIOL, V41, P181, DOI 10.1146/annurev.mi.41.100187.001145; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGRETH SG, 1975, J PROTOZOOL, V22, P40, DOI 10.1111/j.1550-7408.1975.tb00943.x; LEE MG, 1987, MOL CELL BIOL, V7, P357, DOI 10.1128/MCB.7.1.357; LEE MG, 1990, NUCLEIC ACIDS RES, V18, P4252, DOI 10.1093/nar/18.14.4252; LEE MGS, 1990, MOL CELL BIOL, V10, P4506, DOI 10.1128/MCB.10.9.4506; LETRANT N, 1983, J BIOL CHEM, V258, P125; LONGACRE S, 1983, MOL CELL BIOL, V3, P399, DOI 10.1128/MCB.3.3.399; MANDLIN I, 1988, TROPENMED PARASITOL, V39, P56; MELLORS A, 1989, PARASITOL TODAY, V5, P239, DOI 10.1016/0169-4758(89)90255-X; MOWATT MR, 1987, MOL CELL BIOL, V7, P2838, DOI 10.1128/MCB.7.8.2838; PETERSON DS, 1986, NATURE, V322, P566, DOI 10.1038/322566a0; RUSSELL DG, 1992, J CELL SCI, V103, P1193; SAMAD A, 1988, MOL BIOCHEM PARASIT, V29, P159, DOI 10.1016/0166-6851(88)90071-0; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SCHNEIDER A, 1988, SCIENCE, V241, P459, DOI 10.1126/science.3393912; SHAPIRO SZ, 1989, J PROTOZOOL, V36, P344, DOI 10.1111/j.1550-7408.1989.tb05524.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPINDLER KR, 1984, J VIROL, V49, P132, DOI 10.1128/JVI.49.1.132-141.1984; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDERPLOEG LHT, 1982, NUCLEIC ACIDS RES, V10, P593, DOI 10.1093/nar/10.2.593; VANDERPLOEG LHT, 1990, FRONTIERS MOL BIOL G, P51; VICKERMAN K, 1969, J PROTOZOOL, V16, P54, DOI 10.1111/j.1550-7408.1969.tb02233.x; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; VICKERMAN K, 1969, J CELL SCI, V5, P163; WEBSTER P, 1989, EUR J CELL BIOL, V49, P295; WEBSTER P, 1988, J CELL BIOL, V106, P279, DOI 10.1083/jcb.106.2.279; WEBSTER P, 1993, PARASITOL TODAY, V9, P201, DOI 10.1016/0169-4758(93)90008-4; WEBSTER P, 1989, EUR J CELL BIOL, V49, P303; YOUNG RA, 1983, SCIENCE, V222, P778, DOI 10.1126/science.6356359	52	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8408	8415						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132566				2022-12-27	WOS:A1994NB40900087
J	VOLLMER, SH; WALNER, MB; TARBELL, KV; COLMAN, RF				VOLLMER, SH; WALNER, MB; TARBELL, KV; COLMAN, RF			GUANOSINE 5'-O-[S-(4-BROMO-2,3-DIOXOBUTYL)]THIOPHOSPHATE AND ADENOSINE 5'-O-[S-(4-BROMO-2,3-DIOXOBUTYL)]THIOPHOSPHATE - NEW NUCLEOTIDE AFFINITY LABELS WHICH REACT WITH RABBIT MUSCLE PYRUVATE-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOCITRATE DEHYDROGENASE; ACTIVE-SITE; GLUTAMATE-DEHYDROGENASE; THERMODYNAMIC LINKAGES; BINDING-SITES; ANALOG; CAT; 2',5'-BISPHOSPHATE; 5'-MONOPHOSPHATE; IDENTIFICATION	Three new reactive nucleotide analogues with bromoketo substituents adjacent to a thiophosphate have been synthesized. Guanosine 5'-O-[S-(4-bromo-2,3-dioxobutyl)]thiophosphate (GMPS-BDB), reacts covalently with rabbit muscle pyruvate kinase with complete inactivation and incorporation of 1.8 mol of reagent/mol of enzyme subunit. By contrast, the mono-keto compound, guanosine 5'-O-[S-(3-bromo-2-oxopropyl)]thiophosphate (GMPS-BOP), causes no loss of pyruvate kinase activity. When the analogous adenosyl nucleotide derivatives are incubated with pyruvate kinase, the di-keto compound, adenosine 5'-O-[S-(4-bromo-2,3-dioxobutyl)]thiophosphate (AMPS-BDB), rapidly effects inactivation, whereas the mono-keto compound, adenosine 5'-O-[S-(3-bromo-2-oxopropyl)]thiophosphate (AMPS-BOP), causes no loss of activity. Complete protection against inactivation by GMPS-BDB is provided by phosphoenolpyruvate in the presence of K+ and Mn2+ and the amount of reagent incorporated (0.9 mol/reagent/mol subunit) is reduced to half that observed in the absence of protectants. Gas-phase sequencing of the tryptic peptides purified from inactive GMPS-BDB or AMPS-BDB-modified enzyme gave the cysteine-labeled peptides: C(151)DENILWLDYK(161), and (NICK165)-I-162-K-164 as the two major peptide products, with a smaller amount of N(43)TGIIC(48)TIGPASR(55). Reaction in the presence of the protectants PEP, K+, and Mn2+ yielded Cys(164) as the only labeled residue, indicating that inactivation is primarily due to modification of Cys(151). We propose that GMPS-BDB (or AMPS-BDB), which may exist in enolized form in aqueous solution, functions as a reactive analogue of phosphoenolpyruvate and GDP (ADP) to target Cys(151) in the active site of pyruvate kinase.	UNIV DELAWARE, DEPT CHEM & BIOCHEM, NEWARK, DE 19716 USA	University of Delaware			Tarbell, Kristin/E-6458-2016	Tarbell, Kristin/0000-0003-3738-379X				ANNAMALAI AE, 1981, J BIOL CHEM, V256, P276; BAILEY JM, 1987, BIOCHEMISTRY-US, V26, P6858, DOI 10.1021/bi00395a041; BAILEY JM, 1987, J BIOL CHEM, V262, P12620; BATRA SP, 1989, ARCH BIOCHEM BIOPHYS, V270, P277, DOI 10.1016/0003-9861(89)90029-5; BEDNAR RA, 1982, J PROTEIN CHEM, V1, P203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCHER T, 1955, METHOD ENZYMOL, V1, P435, DOI 10.1016/0076-6879(55)01071-9; COLE DG, 1992, BIOCHEMISTRY-US, V31, P6186, DOI 10.1021/bi00142a003; COLMAN RF, 1983, ANNU REV BIOCHEM, V52, P67, DOI 10.1146/annurev.bi.52.070183.000435; COLMAN RF, 1984, BIOCHEMISTRY-US, V23, P3281, DOI 10.1021/bi00309a025; COLMAN RF, 1990, ENZYMES, V19, P283; CONNOLLY BA, 1982, BIOCHEMISTRY-US, V21, P1983, DOI 10.1021/bi00538a002; CONNOLLY BA, 1982, BIOCHEMISTRY-US, V21, P6158, DOI 10.1021/bi00267a021; CONSLER TG, 1988, J BIOL CHEM, V263, P2794; CONSLER TG, 1992, BIOCHEMISTRY-US, V31, P7870, DOI 10.1021/bi00149a018; COTTAM GL, 1969, J BIOL CHEM, V244, P1481; DECAMP DL, 1986, J BIOL CHEM, V261, P4449; DECAMP DL, 1989, J BIOL CHEM, V264, P8430; ECKSTEIN F, 1976, BIOCHEMISTRY-US, V15, P1685, DOI 10.1021/bi00653a015; HARKINS RN, 1983, EUR J BIOCHEM, V136, P341, DOI 10.1111/j.1432-1033.1983.tb07747.x; HEYDUK E, 1992, J BIOL CHEM, V267, P3200; HUANG YC, 1984, J BIOL CHEM, V259, P2481; HUANG YC, 1989, J BIOL CHEM, V264, P12208; JAFFE EK, 1978, BIOCHEMISTRY-US, V17, P652, DOI 10.1021/bi00597a014; KAPETANOVIC E, 1985, BIOCHEMISTRY-US, V24, P7586, DOI 10.1021/bi00347a013; LIU J, 1990, ARCH BIOCHEM BIOPHYS, V277, P143, DOI 10.1016/0003-9861(90)90562-D; LONBERG N, 1983, P NATL ACAD SCI-BIOL, V80, P3661, DOI 10.1073/pnas.80.12.3661; MUIRHEAD H, 1987, BIOL MACROMOL, V3, P143; MURRAY AW, 1968, BIOCHEMISTRY-US, V7, P4023, DOI 10.1021/bi00851a032; OBERFELDER RW, 1984, BIOCHEMISTRY-US, V23, P3813, DOI 10.1021/bi00312a004; OBERFELDER RW, 1984, BIOCHEMISTRY-US, V23, P3822, DOI 10.1021/bi00312a005; OZTURK DH, 1992, BIOCHEMISTRY-US, V31, P10544, DOI 10.1021/bi00158a018; PLOWMAN KM, 1965, BIOCHEMISTRY-US, V4, P2809, DOI 10.1021/bi00888a035; POTTER RL, 1983, METHOD ENZYMOL, V91, P613; SCHMIDTBASE K, 1991, PROTEINS, V11, P153, DOI 10.1002/prot.340110208; SLOAN DL, 1976, J BIOL CHEM, V251, P2412; STAMMERS DK, 1975, J MOL BIOL, V95, P213, DOI 10.1016/0022-2836(75)90391-5; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; TOMICH JM, 1981, BIOCHEMISTRY-US, V20, P6711, DOI 10.1021/bi00526a029; VOLLMER SH, 1990, BIOCHEMISTRY-US, V29, P2495, DOI 10.1021/bi00462a009; ZALL DM, 1956, ANAL CHEM, V28, P1665, DOI 10.1021/ac60119a009	41	39	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8082	8090						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132533				2022-12-27	WOS:A1994NB40900041
J	DUNN, T; GABLE, K; BEELER, T				DUNN, T; GABLE, K; BEELER, T			REGULATION OF CELLULAR CA2+ BY YEAST VACUOLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING ADENOSINE-TRIPHOSPHATASE; NUCLEAR MAGNETIC-RESONANCE; PROTON MOTIVE FORCE; SACCHAROMYCES-CEREVISIAE; MEMBRANE-VESICLES; TRANSPORT; CALCIUM; MUTANTS; GENE; POLYPHOSPHATE	The role of vacuolar Ca2+ transport systems in regulating cellular Ca2+ was investigated by measuring the vacuolar Ca2+ transport rate, the free energy available to drive vacuolar Ca2+ transport, the ability of the vacuole to buffer lumenal Ca2+, and the vacuolar Ca2+ efflux rate. The magnitude of the Ca2+ gradient generated by the vacuolar H+ gradient best supports a 1 Ca2+:2 H+ coupling ratio for the vacuolar Ca2+/H+ exchanger. This coupling ratio along with a cytosolic Ca2+ concentration of 125 nM would give a vacuolar free Ca2+ concentration of similar to 30 mu M. The total vacuolar Ca2+ concentration is similar to 2 mM due to Ca2+ binding to vacuolar polyphosphate. The Ca2+ efflux rate from the vacuole is less than the growth rate indicating that the steady-state Ca2+ loading level of the vacuole is dependent mainly on the Ca2+ transport rate and the rate that vacuolar Ca2+ is diluted by growth. Based on the kinetic parameters of vacuolar Ca2+ accumulation in vitro, the maximum rate of Ca2+ accumulation in vivo is expected to be similar to 0.2 nmol of Ca2+ min(-1) mg protein(-1), a rate that is similar to the cellular Ca2+ accumulation rate. The cytosolic Ca2+ concentration increases from 0.1 mu M to 1-2 mu M as the extracellular Ca2+ concentration is raised from 0.3 mM to 50 mM. The rise in cytosolic Ca2+ concentration increases cellular Ca2+ from 10 to 300 nmol Ca2+/mg by increasing the rate of vacuolar Ca2+ accumulation but does not significantly alter the cellular growth rate.			DUNN, T (corresponding author), UNIFORMED SERV UNIV HLTH SCI, DEPT BIOCHEM, 4301 JONES BRIDGE RD, BETHESDA, MD 20814 USA.				NIGMS NIH HHS [GM 46495] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046495] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; CARAFOLI E, 1970, BIOCHIM BIOPHYS ACTA, V205, P18, DOI 10.1016/0005-2728(70)90057-5; CLARK JE, 1986, J BACTERIOL, V168, P1212, DOI 10.1128/jb.168.3.1212-1219.1986; DAVIS TN, 1986, CELL, V47, P423, DOI 10.1016/0092-8674(86)90599-4; DAVIS TN, 1986, YEAST CELL BIOL, P477; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; HALACHMI D, 1993, FEBS LETT, V316, P73, DOI 10.1016/0014-5793(93)81739-M; HIRATA R, 1990, J BIOL CHEM, V265, P6726; IIDA H, 1990, J BIOL CHEM, V265, P13391; KAKINUMA Y, 1981, J BIOL CHEM, V256, P859; KITAMOTO K, 1988, J BACTERIOL, V170, P2687, DOI 10.1128/jb.170.6.2687-2691.1988; LOMANDER L, 1965, PHYSIOL PLANTARUM, V18, P968, DOI 10.1111/j.1399-3054.1965.tb06993.x; LOMANDER L, 1965, PHYSIOL PLANTARUM, V18, P153, DOI 10.1111/j.1399-3054.1965.tb06878.x; Morris EO, 1958, CHEM BIOL YEASTS, P251; NAVON G, 1979, BIOCHEMISTRY-US, V18, P4487, DOI 10.1021/bi00588a006; NICOLAY K, 1982, ARCH MICROBIOL, V133, P83, DOI 10.1007/BF00413516; NOVICK P, 1989, GENETICS, V121, P659; OHSUMI Y, 1981, J BIOL CHEM, V256, P2079; OHSUMI Y, 1983, J BIOL CHEM, V258, P5614; OHYA Y, 1986, J GEN MICROBIOL, V132, P979; OHYA Y, 1991, J BIOL CHEM, V266, P13971; OKOROKOV LA, 1985, FEBS LETT, V192, P303, DOI 10.1016/0014-5793(85)80130-7; OLSON BH, 1949, J BACTERIOL, V57, P235, DOI 10.1128/JB.57.2.235-246.1949; RUBIN GM, 1973, J BIOL CHEM, V248, P3860; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SHIH CK, 1988, MOL CELL BIOL, V8, P3094, DOI 10.1128/MCB.8.8.3094; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; URECH K, 1978, ARCH MICROBIOL, V116, P275, DOI 10.1007/BF00417851	28	160	165	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7273	7278						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125940				2022-12-27	WOS:A1994NA03200039
J	GLOVER, JR; ANDREWS, DW; SUBRAMANI, S; RACHUBINSKI, RA				GLOVER, JR; ANDREWS, DW; SUBRAMANI, S; RACHUBINSKI, RA			MUTAGENESIS OF THE AMINO TARGETING SIGNAL OF SACCHAROMYCES-CEREVISIAE 3-KETOACYL-COA THIOLASE REVEALS CONSERVED AMINO-ACIDS REQUIRED FOR IMPORT INTO PEROXISOMES IN-VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL PRESEQUENCE; PROTEINS; YEAST; PEPTIDE; ENZYME; GENE	Saccharomyces cerevisiae peroxisomal 3-ketoacyl-CoA thiolase is a soluble matrix protein that does not end in a consensus peroxisomal targeting signal-1. The amino terminus of S. cerevisiae peroxisomal thiolase is conserved in 6 of 11 residues with the amino terminus of rat thiolase B, shown to act as a peroxisomal targeting signal 2 (Swinkels, B. W., Gould, S. J., Bodnar, A, G., Rachu- binski, R. A., and Subramani, S. (1991) EMBO J. 10, 3255-3262). Unlike mammalian peroxisomal thiolases, there is no extensive cleavage of S. cerevisiae thiolase upon import into peroxisomes. We demonstrate by in vivo expression that the amino terminal 16 amino acids of S. cerevisiae thiolase are necessary and sufficient for targeting to peroxisomes. This result implies that yeast, like mammalian cells, can target proteins to the peroxi- somal matrix by at least two different routes. We also demonstrate by targeted mutagenesis and in vivo expression of mutated thiolase genes that three amino acids conserved in the amino termini of all known thio- lases are critical for efficient targeting of S. cerevisiae thiolase to peroxisomes.	UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093	University of California System; University of California San Diego	GLOVER, JR (corresponding author), MCMASTER UNIV,DEPT BIOCHEM,HAMILTON L8N 3Z5,ON,CANADA.			Andrews, David/0000-0002-9266-7157	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041737, R37DK041737] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK41737] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AITCHISON JD, 1992, YEAST, V8, P721, DOI 10.1002/yea.320080905; AITCHISON JD, 1991, J BIOL CHEM, V266, P23197; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; HIJIKATA M, 1987, J BIOL CHEM, V262, P8151; JANIAK F, 1994, IN PRESS BIOCH J; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIN AS, 1990, MOL CELL BIOL, V10, P1399, DOI 10.1128/MCB.10.4.1399; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; NEEDLEMAN RB, 1975, ANAL BIOCHEM, V64, P545, DOI 10.1016/0003-2697(75)90466-2; NUTTLEY WM, 1994, J BIOL CHEM, V269, P556; NUTTLEY WM, 1993, YEAST, V9, P507, DOI 10.1002/yea.320090506; OSUMI T, 1992, BIOCHEM BIOPH RES CO, V186, P811, DOI 10.1016/0006-291X(92)90818-6; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; SEUBERT W, 1968, BIOCHIM BIOPHYS ACTA, V164, P498, DOI 10.1016/0005-2760(68)90180-X; SIKORSKI RS, 1989, GENETICS, V122, P19; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; TAGER JM, 1985, BIOCHEM BIOPH RES CO, V126, P1269, DOI 10.1016/0006-291X(85)90322-5; WANG TW, 1992, NUCLEIC ACIDS RES, V20, P3495, DOI 10.1093/nar/20.13.3495	22	127	129	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7558	7563						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125978				2022-12-27	WOS:A1994NA03200083
J	SPIVACK, J; LEIB, TK; LOBOS, JH				SPIVACK, J; LEIB, TK; LOBOS, JH			NOVEL PATHWAY FOR BACTERIAL METABOLISM OF BISPHENOL-A - REARRANGEMENTS AND STILBENE CLEAVAGE IN BISPHENOL-A METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN-ROT FUNGUS; HYDROXYLATION; LIGNIN	Bisphenol A (BPA) is metabolized by a Gram-negative aerobic bacterium via a novel pathway involving oxidative skeletal rearrangement of the BPA. Oxidation of the aliphatic methyl group of BPA leads to coproduction of the methyl-hydroxylated 2,2-bis(4-hydroxyphenyl)-1-propanol and a skeletally rearranged triol 1,2-bis(4-hydroxyphenyl)-2-propanol. The major route of metabolism (>80%) is through the rearrangement. The 1,2-bis(4-hydroxyphenyl)-2-propanol is dehydrated to 4,4'-dihydroxy-alpha-methylstilbene, which is rapidly cleaved by oxidation to 4-hydroxybenzaldehyde and 4-hydroxyacetophenone. 4-Hydroxybenzaldehyde is oxidized to 4-hydroxybenzoic acid. Both 4-hydroxybenzoic acid and 4-hydroxyacetophenone are mineralized. The minor product of BPA hydroxylation, 2,2-bis(4-hydroxyphenyl)-1-propanol, is further oxidized to form both 2,2-bis(4-hydroxyphenyl)propanoic acid and a skeletally rearranged tetraol, 2,3-bis(4-hydroxyphenyl)-1,2-propanediol. As is the case in the hydroxylation of BPA, the major product is skeletally rearranged. 2,3-Bis(4-hydroxyphenyl)-1,2-propanediol is slowly transformed to 4-hydroxyphenacyl alcohol.			SPIVACK, J (corresponding author), GE CO, CORP RES & DEV, SCHENECTADY, NY 12301 USA.							ALEXANDER HC, 1988, ENVIRON TOXICOL CHEM, V7, P19, DOI 10.1002/etc.5620070104; Barbour, 1984, MICROBIAL DEGRADATIO, P253; BAYLY RC, 1966, BIOCHEM J, V101, P293, DOI 10.1042/bj1010293; DAGLEY S, 1957, BIOCHEM J, V66, P227, DOI 10.1042/bj0660227; Dodds EC, 1944, PROC R SOC SER B-BIO, V132, P83, DOI 10.1098/rspb.1944.0005; DORN PB, 1987, CHEMOSPHERE, V16, P1501, DOI 10.1016/0045-6535(87)90090-7; GIBSON DT, 1984, MICROBIAL DEGRADATIO, P193; HOPPER DJ, 1976, BIOCHEM BIOPH RES CO, V69, P462, DOI 10.1016/0006-291X(76)90544-1; KIRK TK, 1970, ACTA CHEM SCAND, V24, P1470, DOI 10.3891/acta.chem.scand.24-1470; KIRK TK, 1975, HOLZFORSCHUNG, V29, P99, DOI 10.1515/hfsg.1975.29.3.99; KIRK TK, 1970, ACTA CHEM SCAND, V24, P3379, DOI 10.3891/acta.chem.scand.24-3379; LOBOS JH, 1992, APPL ENVIRON MICROB, V58, P1823, DOI 10.1128/AEM.58.6.1823-1831.1992; MIAO VPW, 1991, MOL GEN GENET, V226, P214, DOI 10.1007/BF00273606; MUNJKO I, 1980, VODOPRIVREDA, V12, P167; PASCZYNSKI A, 1977, MICROBIOS, V18, P111; SANDELL J, 1988, BISPHENOL A CEH PROD; SMITH RV, 1974, ARCH BIOCHEM BIOPHYS, V161, P551, DOI 10.1016/0003-9861(74)90338-5; ZAHEER SH, 1954, J CHEM SOC, P3360, DOI 10.1039/jr9540003360	18	170	186	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7323	7329						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125948				2022-12-27	WOS:A1994NA03200047
J	ARLT, G; BROOKS, DA; ISBRANDT, D; HOPWOOD, JJ; BIELICKI, J; BRADFORD, TM; BINDLOSSPETHERBRIDGE, CA; VONFIGURA, K; PETERS, C				ARLT, G; BROOKS, DA; ISBRANDT, D; HOPWOOD, JJ; BIELICKI, J; BRADFORD, TM; BINDLOSSPETHERBRIDGE, CA; VONFIGURA, K; PETERS, C			JUVENILE FORM OF MUCOPOLYSACCHARIDOSIS-VI (MAROTEAUX-LAMY SYNDROME) - A C-TERMINAL EXTENSION CAUSES INSTABILITY BUT INCREASES CATALYTIC EFFICIENCY OF ARYLSULFATASE-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL ACID-PHOSPHATASE; CULTURED HUMAN-FIBROBLASTS; ALPHA-L-IDURONIDASE; N-ACETYLGALACTOSAMINE-4-SULFATASE; PROTEIN; MATURATION; SULFATASE; GENE; PURIFICATION; BIOSYNTHESIS	A deficiency of the enzyme arylsulfatase B results in the lysosomal storage disorder Maroteaux-Lamy syndrome or mucopolysaccharidosis type VI. Severe, intermediate and mild forms of this autosomal recessively inherited disease can be clinically differentiated. To determine the molecular defect in a patient with the intermediate form of the disorder, DNA fragments generated from the patient's mRNA by reverse transcription and subsequent amplification by the polymerase chain reaction were subcloned and sequenced. The mRNA transcribed from one allele contains a 244-base pair deletion causing a frameshift and a truncation of the open reading frame. The C-terminal third of the encoded mutant polypeptide has a nonsense sequence. This mutation is due to a deletion of exon 5 in this allele. A silent A to G transition at nucleotide 1191 was present in the same allele, and the second allele was characterized by a T to C transition at nucleotide 1600 causing a mutation of the translational stop codon to a glutamine codon (*534Q) and extending the encoded polypeptide by 50 amino acids. Stable expression of the *534Q allele in LTK- cells resulted in a mutant precursor 4 kDa larger than the wild-type precursor. The majority of the mutant precursor appears to be degraded before reaching the trans Golgi. This is consistent with an altered polypeptide structure, where a number of missing or masked epitopes were observed in an enzyme immunobinding assay using a panel of monoclonal antibodies. Immunoquantification analysis showed that epitopes were most likely masked, as missing epitopes could be reformed by binding the mutant protein to a polyclonal antibody of arylsulfatase B. It is suggested that the additional amino acids at the C terminus of the arylsulfatase B polypeptide induce a protein conformational change. *534Q mutant polypeptide escaping degradation is sorted to dense lysosomes. The mutant polypeptide has an approximately 9-fold higher catalytic efficiency than wild-type arylsulfatase B.	UNIV GOTTINGEN,GOSSLERSTR 12D,W-3400 GOTTINGEN,GERMANY; ADELAIDE MED CTR WOMEN & CHILDREN,DEPT CHEM PATHOL,LYSOSOMAL DIS RES UNIT,ADELAIDE,SA 5006,AUSTRALIA	University of Gottingen; Womens & Childrens Hospital Australia			Bradford, Tessa/G-8387-2011; Brooks, Doug A/K-6714-2012	Bradford, Tessa/0000-0003-0607-1398; , Tessa/0000-0003-1442-8449; Brooks, Doug/0000-0001-9098-3626; Isbrandt, Dirk/0000-0002-4720-1016				BROOKS DA, 1991, J INHERIT METAB DIS, V14, P5, DOI 10.1007/BF01804381; BROOKS DA, 1991, AM J HUM GENET, V48, P710; BROOKS DA, 1992, BIOCHEM MED METAB B, V47, P211, DOI 10.1016/0885-4505(92)90028-W; CHELLY J, 1990, CELL, V63, P1239, DOI 10.1016/0092-8674(90)90419-F; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1625; GIBSON GJ, 1987, BIOCHEM J, V248, P755, DOI 10.1042/bj2480755; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HOPWOOD JJ, 1986, BIOCHEM J, V234, P507, DOI 10.1042/bj2340507; JIN WD, 1992, AM J HUM GENET, V50, P795; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; LEMANSKY P, 1985, J BIOL CHEM, V260, P9023; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; LITJENS T, 1991, BIOCHEM INT, V24, P209; Litjens Tom, 1992, Human Mutation, V1, P397, DOI 10.1002/humu.1380010509; MATALON R, 1974, BIOCHEM BIOPH RES CO, V61, P1450, DOI 10.1016/S0006-291X(74)80446-8; MODARESSI S, 1993, BIOL CHEM H-S, V374, P327, DOI 10.1515/bchm3.1993.374.1-6.327; MYEROWITZ R, 1981, J BIOL CHEM, V256, P3044; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; OBRIEN JF, 1974, BIOCHEM BIOPH RES CO, V60, P1170, DOI 10.1016/0006-291X(74)90435-5; PETERS C, 1990, J BIOL CHEM, V265, P3374; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUCHMAN EH, 1990, GENOMICS, V6, P149, DOI 10.1016/0888-7543(90)90460-C; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STECKEL F, 1983, J BIOL CHEM, V258, P4322; Strauss W. M., 1990, CURRENT PROTOCOLS MO; VONFIGURA K, 1977, EUR J BIOCHEM, V80, P525; VONFIGURA K, 1983, P NATL ACAD SCI-BIOL, V80, P6066; WAHEED A, 1988, EMBO J, V7, P2351, DOI 10.1002/j.1460-2075.1988.tb03079.x; WICKER G, 1991, J BIOL CHEM, V266, P21386; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6	31	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9638	9643						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144552				2022-12-27	WOS:A1994NE05300039
J	HOUGH, RF; BASS, BL				HOUGH, RF; BASS, BL			PURIFICATION OF THE XENOPUS-LAEVIS DOUBLE-STRANDED-RNA ADENOSINE-DEAMINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNWINDING MODIFYING ACTIVITY; MAMMALIAN-CELLS; PROTEIN-KINASE; MESSENGER-RNA; BINDING; CHROMATOGRAPHY; SUBSTRATE; MECHANISM; EGGS; GELS	A double-stranded RNA adenosine deaminase that catalyzes the conversion of adenosines to inosines in duplex RNA substrates was purified to near homogeneity from Xenopus laevis eggs. The final specific activity was approximately 2.0 nmol of inosine min-1 mg-1 at 25-degrees-C and pH 7.9 with a 794-base pair RNA substrate. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed a single major approximately 120-kDa protein band by silver staining. The purified enzyme migrated with an apparent molecular mass of 90 +/- 10 kDa during high performance liquid chromatography. Gel filtration of the partially purified enzyme gave an apparent molecular mass of 210 +/- 20 kDa, suggesting that the enzyme may dimerize or associate with other cellular components. Substrate modification was inhibited by excess substrate, thiol reagents, heparin, and moderate concentrations of monovalent cations.	UNIV UTAH, DEPT BIOCHEM, 50 N MED DR, SALT LAKE CITY, UT 84132 USA	Utah System of Higher Education; University of Utah					NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NCI NIH HHS [5 P30CA42014] Funding Source: Medline; NIGMS NIH HHS [GM 44073] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X; BASS BL, 1993, RNA WORLD, P383; Bass Brenda L., 1992, Seminars in Developmental Biology, V3, P425; BELHUMEUR P, 1993, MOL CELL BIOL, V13, P2846, DOI 10.1128/MCB.13.5.2846; BISCHOFF JR, 1989, VIROLOGY, V172, P106, DOI 10.1016/0042-6822(89)90112-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAN L, 1993, BIOESSAYS, V15, P33, DOI 10.1002/bies.950150106; Cleland W W, 1979, Methods Enzymol, V63, P500; FUKUDA K, 1993, INT J BIOCHEM, V25, P183, DOI 10.1016/0020-711X(93)90005-Y; GALABRU J, 1989, EUR J BIOCHEM, V178, P581, DOI 10.1111/j.1432-1033.1989.tb14485.x; GARFIN DE, 1990, METHOD ENZYMOL, V182, P425; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; HAINES DS, 1991, J CELL BIOCHEM, V46, P9, DOI 10.1002/jcb.240460104; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; HOUGH R, 1987, J BIOL CHEM, V262, P8303; HUNTER T, 1975, J BIOL CHEM, V250, P409; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; MORRISSEY LM, 1991, MOL CELL BIOL, V11, P3719, DOI 10.1128/MCB.11.7.3719; NAVARATNAM N, 1993, P NATL ACAD SCI USA, V90, P222, DOI 10.1073/pnas.90.1.222; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NISHIKURA K, 1991, EMBO J, V10, P3523, DOI 10.1002/j.1460-2075.1991.tb04916.x; OCHS D, 1983, ANAL BIOCHEM, V135, P470, DOI 10.1016/0003-2697(83)90714-5; OSTROVE S, 1990, METHOD ENZYMOL, V182, P357; POLSON AG, 1991, BIOCHEMISTRY-US, V30, P11507, DOI 10.1021/bi00113a004; REBAGLIATI MR, 1987, CELL, V48, P599, DOI 10.1016/0092-8674(87)90238-8; SHARMEEN L, 1991, P NATL ACAD SCI USA, V88, P8096, DOI 10.1073/pnas.88.18.8096; SKEIKY YAW, 1991, J MOL BIOL, V218, P517, DOI 10.1016/0022-2836(91)90698-6; SMITH HC, 1991, P NATL ACAD SCI USA, V88, P1489, DOI 10.1073/pnas.88.4.1489; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; WAGNER RW, 1990, MOL CELL BIOL, V10, P5586, DOI 10.1128/MCB.10.10.5586; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; WAGNER RW, 1988, MOL CELL BIOL, V8, P770, DOI 10.1128/MCB.8.2.770	38	98	102	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9933	9939						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144588				2022-12-27	WOS:A1994NE05300082
J	TANIGUCHI, T; CHEN, J; COOPER, AD				TANIGUCHI, T; CHEN, J; COOPER, AD			REGULATION OF CHOLESTEROL-7 ALPHA-HYDROXYLASE GENE-EXPRESSION IN HEP-G2 CELLS - EFFECT OF SERUM, BILE-SALTS, AND COORDINATE AND NONCOORDINATE REGULATION WITH OTHER STEROL-RESPONSIVE GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; 7-ALPHA-HYDROXYLASE MESSENGER-RNA; NEGATIVE FEEDBACK-CONTROL; CULTURED RAT HEPATOCYTES; A REDUCTASE-ACTIVITY; ACID SYNTHESIS; URSODEOXYCHOLIC ACID; CIRCADIAN-RHYTHM; HEPG2 CELLS; SECRETION	Regulation of cholesterol 7 alpha-hydroxylase mRNA level in Hep-G2 cells was studied and compared with that of two other sterol-responsive genes, those for the low density lipoprotein (LDL) receptor and 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. In culture medium containing 10% fetal bovine serum (complete medium) for up to 24 h, the mRNA for cholesterol 7 alpha-hydroxylase gradually increased to 2-fold of the time 0 control. Culture of Hep-G2 cells in serum-free medium for 24 h resulted in stimulation of mRNA levels for LDL receptor (5-fold) and HMG-CoA reductase (6-fold). Surprisingly, the mRNA level for cholesterol 7 alpha-hydroxylase also increased 5-fold at 8 h and 4-fold at 24 h compared with the time 0 control. The addition of beta-migrating very low density lipoprotein (beta-VLDL) (40 mug/ml) and 25-hydroxycholesterol (5 mug/ml) prevented the increase in mRNA level for the LDL receptor, and HMG-CoA reductase and the levels were 10-26% of the control at 8 h. The effect with beta-VLDL was sustained for 24 h. With 25-hydroxycholesterol, both LDL receptor and HMG-CoA reductase mRNA returned to base line by 24 h. In contrast, beta-VLDL increased cholesterol 7 alpha-hydroxylase mRNA level above the serum-free control within 8 h (+32%), and this was sustained for 24 h (+47%). There was a slight induction of cholesterol 7 alpha-hydroxylase mRNA levels by 25-hydroxycholesterol at 8 h (+18%); but by 24 h, its level was below that of the control (-47%). There was no induction of cholesterol 7 alpha-hydroxylase mRNA levels by beta-VLDL or 25-hydroxycholesterol when the cells were grown in complete medium. As determined by nuclear run-on assay, the increase in the transcriptional rate of the cholesterol 7 alpha-hydroxylase gene in cells grown in serum-free medium (3.9-fold of the rate in complete medium) and incubated with beta-VLDL (+68% above serum-free control) at 8 h, was comparable with the increase in mRNA levels (3.5-fold and +32%, respectively). When bile salts were added to serum-free medium and cells cultured for up to 24 h, chenodeoxycholate and glycochenodeoxycholate caused a marked suppression of the level of cholesterol 7 alpha-hydroxylase mRNA, while cholate and its conjugates did not. The chenodeoxycholate effect was dose-dependent and was apparent within 2 h. It occurred at the level of transcription, as judged by decreased nuclear run-on. These bile salts did not appear to effect cholesterol efflux from the cells, their viability, the rate of transcription of several housekeeping genes or albumin secretion. These results demonstrate that Hep-G2 cells will be useful for elucidating the molecular events in the regulation of the cholesterol 7 alpha-hydroxylase gene in a human liver system. In Hep-G2 cells grown in the absence of serum, the cholesterol 7 alpha-hydroxylase gene responds to sterols, hormones, and bile salts.	PALO ALTO MED RES FDN,RES INST,860 BRYANT ST,PALO ALTO,CA 94301; STANFORD UNIV,MED CTR,SCH MED,DEPT MED,STANFORD,CA 94305	Palo Alto Medical Foundation Research Institute; Stanford University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038318, P30DK038707] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 38318, P30 DK38707] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AXELSON M, 1991, J BIOL CHEM, V266, P17770; BOUSCAREL B, 1991, BIOCHEM J, V280, P589, DOI 10.1042/bj2800589; BROWN MS, 1974, J BIOL CHEM, V249, P7306; CHIANG JYL, 1990, J BIOL CHEM, V265, P3889; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOPER AD, 1976, J CLIN INVEST, V57, P1461, DOI 10.1172/JCI108416; CRAIG WC, 1985, CLIN RES, V33, P96; CRAIG WY, 1988, J BIOL CHEM, V263, P13880; CRAIG WY, 1988, J LIPID RES, V29, P299; DASHTI N, 1987, J LIPID RES, V28, P423; DAVIS RA, 1983, J BIOL CHEM, V258, P4079; EINARSSON K, 1973, METABOLISM, V22, P1477, DOI 10.1016/0026-0495(73)90015-2; ELLSWORTH JL, 1988, J CELL PHYSIOL, V135, P213, DOI 10.1002/jcp.1041350208; ELLSWORTH JL, 1991, BIOCHEM J, V279, P175, DOI 10.1042/bj2790175; ELLSWORTH JL, 1986, J LIPID RES, V27, P858; ELLSWORTH JL, 1994, IN PRESS BIOCH BIOPH; ERICKSON SK, 1986, J LIPID RES, V27, P875; EVERSON GT, 1986, J BIOL CHEM, V261, P2197; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOLCH J, 1957, J BIOL CHEM, V226, P497; HEUMAN DM, 1989, J LIPID RES, V30, P1161; HUSSAIN MM, 1992, CURR OPIN LIPIDOL, V3, P173; ISHIKAWA TT, 1974, J LIPID RES, V15, P286; JAVITT NB, 1990, FASEB J, V4, P161, DOI 10.1096/fasebj.4.2.2153592; JAVITT NB, 1989, BIOCHEM J, V262, P989, DOI 10.1042/bj2620989; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; KERN F, 1991, NEW ENGL J MED, V324, P896, DOI 10.1056/NEJM199103283241306; KUBASKA WM, 1985, J BIOL CHEM, V260, P3459; KUBASKA WM, 1987, BIOCHIM BIOPHYS ACTA, V920, P195, DOI 10.1016/0005-2760(87)90095-6; KWEKKEBOOM J, 1990, HEPATOLOGY, V12, P1209, DOI 10.1002/hep.1840120522; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; LI YC, 1990, J BIOL CHEM, V265, P12012; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALAVOLTI M, 1987, J LIPID RES, V28, P1281; MARCHEGIANO P, 1992, BIOCHEM BIOPH RES CO, V183, P1203, DOI 10.1016/S0006-291X(05)80318-3; MOLOWA DT, 1992, BIOCHEMISTRY-US, V31, P2539, DOI 10.1021/bi00124a014; NESS GC, 1990, BIOCHEM BIOPH RES CO, V172, P1150, DOI 10.1016/0006-291X(90)91568-D; NOSHIRO M, 1990, J BIOL CHEM, V265, P10036; PANDAK WM, 1991, J BIOL CHEM, V266, P3416; RUDEL LL, 1992, CIRCULATION, V86, P746; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; SHEFER S, 1990, J CLIN INVEST, V85, P1191, DOI 10.1172/JCI114552; SHEFER S, 1975, J STEROID BIOCHEM, V6, P1563, DOI 10.1016/0022-4731(75)90215-0; SPADY DK, 1992, J BIOL CHEM, V267, P5584; STANGE EF, 1989, J CLIN INVEST, V84, P173, DOI 10.1172/JCI114137; STANGE EF, 1988, HEPATOLOGY, V8, P879, DOI 10.1002/hep.1840080429; STONE BG, 1985, J CLIN INVEST, V76, P1773, DOI 10.1172/JCI112168; SUNDSETH SS, 1990, J BIOL CHEM, V265, P15090; TANIGUCHI T, 1992, CIRCULATION, V86, P75; TWISK J, 1993, BIOCHEM J, V290, P685, DOI 10.1042/bj2900685; VANZUIDEN PEA, 1983, J LIPID RES, V24, P418; VLAHCEVIC ZR, 1991, HEPATOLOGY, V13, P590, DOI 10.1002/hep.1840130331	52	61	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10071	10078						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144506				2022-12-27	WOS:A1994NE05300101
J	WOLCOTT, RG; FRANKS, BS; HANNUM, DM; HURST, JK				WOLCOTT, RG; FRANKS, BS; HANNUM, DM; HURST, JK			BACTERICIDAL POTENCY OF HYDROXYL RADICAL IN PHYSIOLOGICAL ENVIRONMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADIATION-INDUCED DAMAGE; ESCHERICHIA-COLI; AMINO-ACIDS; HYDROGEN-PEROXIDE; AQUEOUS-SOLUTION; RATE CONSTANTS; OXYGEN; SUPEROXIDE; OXIDATION; NEUTROPHILS	Rates of radiolytic inactivation of bacteria suspended in N2O-saturated solutions were dramatically increased over normal background levels when the media contained chloride or bicarbonate ions. The bacteria could be protected from this enhanced toxicity by the addition of free radical scavengers (ethanol, ascorbate, hydrogen peroxide, mannitol, glucose, EDTA, picolinic acid), indicating that the lethal reactions were extracellular in origin. Prior irradiation of chloride-containing solutions led to formation of hypochlorous acid, which was identified by detection of ring-chlorinated products when reacted with fluorescein. Prolonged irradiation of other solutions did not lead to accumulation of bactericidal agents; however, irradiation of bicarbonate-containing solutions in the presence of the spin trap 5,5-dimethyl-1-pyrroline N-oxide (DMPO) led to formation of the EPR-detectable DMPO.CO3- adduct. The results are interpreted in terms of formation of secondary radicals, among which the carbonate and chlorine radicals are uniquely toxic to bacteria. From rate comparisons of the solution components, it was concluded that the reactions involving chloride ion are unlikely to be expressed in biological environments, but that the CO3- radical could be an important intermediary oxidant in peroxide-inflicted cellular damage, particularly in spatially confined environments such as the leukocyte phagosome.	WASHINGTON STATE UNIV,DEPT CHEM,PULLMAN,WA 99164; OREGON GRAD INST SCI & TECHNOL,DEPT CHEM BIOCHEM & MOLEC BIOL,PORTLAND,OR 97291	Washington State University					NIAID NIH HHS [AI 15834] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015834] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS GE, 1972, RADIAT RES, V49, P278, DOI 10.2307/3573266; ADAMS GE, RADIAT RES, V49, P290; ALBRICH JM, 1982, FEBS LETT, V144, P157, DOI 10.1016/0014-5793(82)80591-7; ALTMAN PL, 1971, BLOOD OTHER BODY BOD; [Anonymous], 1989, STANDARD METHODS EXA, V17th; BARRETTE WC, 1988, J BACTERIOL, V170, P3655, DOI 10.1128/jb.170.8.3655-3659.1988; BARTON DHR, 1991, TETRAHEDRON LETT, V32, P311, DOI 10.1016/S0040-4039(00)92615-7; BERLETT BS, 1990, P NATL ACAD SCI USA, V87, P389, DOI 10.1073/pnas.87.1.389; BOIVIN J, 1990, TETRAHEDRON LETT, V31, P6869, DOI 10.1016/S0040-4039(00)97193-4; BRITIGAN BE, 1986, J BIOL CHEM, V261, P4429; BRUSTAD T, 1976, RADIAT RES, V66, P215, DOI 10.2307/3574392; BUETTNER GR, 1978, BIOCHEM BIOPH RES CO, V83, P69, DOI 10.1016/0006-291X(78)90398-4; BUXTON GV, 1986, RADIAT PHYS CHEM, V27, P241; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; CHEN SN, 1973, RADIAT RES, V56, P40, DOI 10.2307/3573789; CHEVION M, 1988, FREE RADICAL BIO MED, V5, P27, DOI 10.1016/0891-5849(88)90059-7; COPE VW, 1972, J CHEM SOC CHEM COMM, P227, DOI 10.1039/c39720000227; DAVIES KJA, 1987, J BIOL CHEM, V262, P9902; GABIG TG, 1984, J BIOL CHEM, V259, P3166; GRABNER G, 1973, INT J RADIAT PHYS CH, V5, P393, DOI 10.1016/0020-7055(73)90002-8; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P61; HARBOUR JR, 1978, PHOTOCHEM PHOTOBIOL, V28, P231, DOI 10.1111/j.1751-1097.1978.tb07700.x; HECKEL E, 1966, BERICH BUNSEN GESELL, V70, P149; HURST JK, 1989, CRIT REV BIOCHEM MOL, V24, P271, DOI 10.3109/10409238909082555; HURST JK, 1984, J BIOL CHEM, V259, P4812; JACOBS GP, 1985, INT J RADIAT BIOL, V47, P621, DOI 10.1080/09553008514550861; JAYSON GG, 1973, J CHEM SOC FARAD T 1, V69, P1597, DOI DOI 10.1039/F19736901597; JOHNS HE, 1988, PHYSICS RADIOLOGY, P217; Klebanoff SJ., 1988, INFLAMMATION BASIC P, P391; Koppenol W. H., 1985, ADV FREE RADICALS BI, V1, P91, DOI DOI 10.1016/8755-9668(85)90005-5; Latimer W.M., 1952, OXIDATION POTENTIALS; LILIE J, 1978, RADIAT PHYS CHEM, V11, P225, DOI 10.1016/0146-5724(78)90101-2; MATSUYAMA A, 1967, RADIAT RES, V30, P687, DOI 10.2307/3572136; MICHELSON AM, 1977, PHOTOCHEM PHOTOBIOL, V25, P55, DOI 10.1111/j.1751-1097.1977.tb07424.x; MICHELSON AM, 1984, OXYGEN RADICALS CHEM, P831; NETA P, 1988, J PHYS CHEM REF DATA, V17, P1027, DOI 10.1063/1.555808; SAMUNI A, 1978, RADIAT RES, V76, P624, DOI 10.2307/3574810; SARGENT FP, 1976, CAN J CHEM, V54, P275, DOI 10.1139/v76-041; Simic MG, 1988, OXYGEN RADICALS BIOL; SUTTON HC, 1989, FREE RADICAL BIO MED, V6, P53, DOI 10.1016/0891-5849(89)90160-3; THOMAS JK, 1965, T FARADAY SOC, V61, P702, DOI 10.1039/tf9656100702; WALLING C, 1975, ACCOUNTS CHEM RES, V8, P125, DOI 10.1021/ar50088a003; WARD JF, 1970, INT J RADIAT BIOL RE, V18, P381, DOI 10.1080/09553007014551221; WEEKS JL, 1966, J PHYS CHEM-US, V70, P2100, DOI 10.1021/j100879a005; WINTERBOURN CC, 1985, BIOCHEM J, V228, P583, DOI 10.1042/bj2280583	45	59	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9721	9728						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144563				2022-12-27	WOS:A1994NE05300052
J	ACKERMANN, EJ; KEMPNER, ES; DENNIS, EA				ACKERMANN, EJ; KEMPNER, ES; DENNIS, EA			CA2+-INDEPENDENT CYTOSOLIC PHOSPHOLIPASE A(2) FROM MACROPHAGE-LIKE P388D(1) CELLS - ISOLATION AND CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-INDEPENDENT PHOSPHOLIPASE-A2; RADIATION INACTIVATION; PURIFICATION; LINE; PHOSPHOFRUCTOKINASE; MEMBRANE; LYSOPHOSPHOLIPASE; RAT; PROTEINS; BRAIN	A novel form of an ATP-regulated, oligomeric, Ca2(+-) independent phospholipase A(2)(iPLA(2)) has been purified from the cytosol of the murine macrophage-like cell line P388D(1). The purification procedure included ammonium sulfate precipitation and sequential column chromatography on octyl-Sepharose, ATP-agarose, Mono Q fast protein liquid chromatography (FPLC), and hydroxyapatite FPLC. The resulting enzyme preparation was purified over 400,000-fold with a final specific activity of approximately 5 mu mol/min/mg using a mixed micelle assay system of Triton X-100 and dipalmitoyl phosphatidylcholine (PC). The purified enzyme was Ca2+-independent and did not show a preference for either sn-2 arachidonic acid or sn-1 alkyl-ether containing phospholipids when utilizing mixed micelles as substrate. It was found to hydrolyze dipalmitoyl-PC similar to 4-fold faster than 1-palmitoyl-2-arachidonyl-PC and similar to 15-fold faster than 1-O-hexadecyl-2-arachidonyl-PC. Triton X-100 increased the P388D(1) iPLA(2) activity with optimal activity found at a Triton/phospholipid molar ratio of 4:1. The purified enzyme was activated 2-6-fold by ATP as well as other di- and triphosphate nucleosides. This activation was sensitive to the concentration of Triton X-100 present in the assay. SDS-polyacrylamide gel electrophoresis carried out on the purified enzyme yielded a single major band at a molecular weight of about 80,000. However, radiation inactivation experiments, carried out on the cell homogenate, demonstrated a target size of 337 +/- 25 kDa, indicating that the catalytically active iPLA(2) exists as a large oligomeric complex, either through self-aggregation or association of the enzyme with other proteins.	UNIV CALIF SAN DIEGO, DEPT CHEM, LA JOLLA, CA 92093 USA; NIH, BETHESDA, MD 20892 USA	University of California System; University of California San Diego; National Institutes of Health (NIH) - USA			Dennis, Edward A./M-5554-2019	Dennis, Edward A./0000-0003-3738-3140	NICHD NIH HHS [HD 26171] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026171] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ACKERMANN L, 1993, FASEB J, V7, pA1265; CAO YZ, 1987, J BIOL CHEM, V262, P16927; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; FOE LG, 1985, J BIOL CHEM, V260, P726; FORD DA, 1991, J CLIN INVEST, V88, P331, DOI 10.1172/JCI115296; GASSAMADIAGNE A, 1989, J BIOL CHEM, V264, P9470; HARMON JT, 1985, METHOD ENZYMOL, V117, P65; HAZEN SL, 1990, J BIOL CHEM, V265, P10622; HAZEN SL, 1991, J BIOL CHEM, V266, P14526; HAZEN SL, 1993, J BIOL CHEM, V268, P9892; HIRASHIMA Y, 1992, J NEUROCHEM, V59, P708, DOI 10.1111/j.1471-4159.1992.tb09426.x; IBRAHIM SA, 1967, BIOCHIM BIOPHYS ACTA, V137, P413, DOI 10.1016/0005-2760(67)90122-1; KEMPNER ES, 1991, METHOD ENZYMOL, V197, P280; KRAMER RM, 1991, J BIOL CHEM, V266, P5268; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LISTER MD, 1988, J BIOL CHEM, V263, P7506; LISTER MD, 1989, J BIOL CHEM, V264, P8520; MIZUNO M, 1991, BIOCHIM BIOPHYS ACTA, V1084, P21, DOI 10.1016/0005-2760(91)90050-R; PIERIK AJ, 1988, BIOCHIM BIOPHYS ACTA, V962, P345, DOI 10.1016/0005-2760(88)90264-0; PIND S, 1991, BIOCHEM CELL BIOL, V69, P346, DOI 10.1139/o91-054; RAMADOSS CS, 1976, ARCH BIOCHEM BIOPHYS, V175, P487, DOI 10.1016/0003-9861(76)90536-1; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P337, DOI 10.1021/bi00052a042; ROSS MI, 1985, ARCH BIOCHEM BIOPHYS, V238, P247, DOI 10.1016/0003-9861(85)90162-6; SIMPSON CJ, 1991, BIOCHEM BIOPH RES CO, V180, P197, DOI 10.1016/S0006-291X(05)81276-8; STAFFORD RE, 1993, BIOCHIM BIOPHYS ACTA, V1167, P43, DOI 10.1016/0005-2760(93)90215-U; TANAKA Y, 1989, ARCH BIOCHEM BIOPHYS, V272, P210, DOI 10.1016/0003-9861(89)90212-9; ULEVITCH RJ, 1988, J BIOL CHEM, V263, P3079; VORA S, 1985, BIOCHEM J, V229, P333, DOI 10.1042/bj2290333; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; ZHANG Y, 1988, J BIOL CHEM, V263, P9965; ZHANG YY, 1991, METHOD ENZYMOL, V197, P456	32	231	238	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9227	9233						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132660				2022-12-27	WOS:A1994NB41100089
J	BLOCKI, FA; LOGAN, MSP; BAOLI, C; WACKETT, LP				BLOCKI, FA; LOGAN, MSP; BAOLI, C; WACKETT, LP			REACTION OF RAT-LIVER GLUTATHIONE S-TRANSFERASES AND BACTERIAL DICHLOROMETHANE DEHALOGENASE WITH DIHALOMETHANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY-CHROMATOGRAPHY; SEQUENCE-ANALYSIS; INORGANIC HALIDE; CDNA CLONE; DETOXIFICATION; PROTEINS; FORMALDEHYDE; SUBSTITUTION; METABOLISM; EXPRESSION	Dichloromethane dehalogenase from Methylophilus sp. DM11 is a glutathione S-transferase homolog that is specifically active with dihalomethane substrates. This bacterial enzyme and rat liver glutathione S transferases were purified to investigate their relative reactivity with CH2Cl2 and related substrates. Rat liver alpha class glutathione transferases were inactive and mu class enzymes showed low activity (7-23 nmol/min/mg of protein) with CH2Cl2. theta class glutathione transferase 5-5 from rat liver and Methylophilus sp. dichloromethane dehalogenase showed specific activities of greater than or equal to 1 mu mol/ min/mg of protein. Apparent K-cat/K-m were determined to be 3.3 x 10(4) and 6.0 x 10(4) L M(-1) s(-1) for the two enzymes, respectively. Dideutereo-dichloromethane was processed to dideutereo-formaldehyde, consistent with a nucleophilic halide displacement mechanism, The possibility of a GSCH(2)X reaction intermediate (GS, glutathione; X, halide) was probed using CH2ClF to generate a more stable halomethylglutathione species (GSCH(2)F). The reaction of CH2ClF with dichloromethane dehalogenase produced a kinetically identifiable intermediate that decomposed to formaldehyde at a similar rate to synthetic HOCH2CH2SCH2F. F-19-NMR revealed the transient formation of an intermediate identified as GSCH(2)F by its chemical shift, its triplet resonance, and H-F coupling constant consistent with a fluoromethylthioether. Its decomposition was matched by a stoichiometric formation of fluoride. These studies indicated that the bacterial dichloromethane dehalogenase directs a nucleophilic attack of glutathione on CH2Cl2 to produce a halomethylthioether intermediate. This focuses attention on the mechanism used by theta class glutathione transferases to generate a halomethylthioether from relatively unreactive dihalomethanes.	UNIV MINNESOTA, DEPT BIOCHEM, ST PAUL, MN 55108 USA; UNIV MINNESOTA, INST ADV STUDIES BIOL PROC TECHNOL, ST PAUL, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM041235] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41235] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMED AE, 1978, BIOCHEM PHARMACOL, V27, P2021, DOI 10.1016/0006-2952(78)90061-8; AHMED AE, 1976, DRUG METAB DISPOS, V4, P357; ANDERS MW, 1985, BIOACTIVATION FOREIG, P253; ARMSTRONG RN, 1991, CHEM RES TOXICOL, V4, P131, DOI 10.1021/tx00020a001; BLOCKI FA, 1993, PROTEIN SCI, V2, P2095, DOI 10.1002/pro.5560021210; BLOCKI FA, 1992, NATURE, V360, P269, DOI 10.1038/360269a0; BLOCKI FA, 1993, THESIS U MINNESOTA; BOGGS JE, 1960, J AM CHEM SOC, V82, P3517, DOI 10.1021/ja01499a010; BOHME H, 1949, LIEBIGS ANN CHEM, V563, P54; BOYER TD, 1983, BIOCHEM PHARMACOL, V32, P1843, DOI 10.1016/0006-2952(83)90048-5; BOYER TD, 1985, BIOCH PHARM TOXICOLO, V1, P297; DIKS RMM, 1991, BIOPROCESS ENG, V6, P93, DOI 10.1007/BF00369061; DING GJF, 1986, J BIOL CHEM, V261, P7952; DING GJF, 1985, J BIOL CHEM, V260, P3268; Gunsalus I C, 1978, Methods Enzymol, V52, P166; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HINE J, 1958, J AM CHEM SOC, V80, P824, DOI 10.1021/ja01537a018; HINE J, 1956, J AM CHEM SOC, V78, P2282, DOI 10.1021/ja01591a069; HOUSTON ME, 1989, J CHEM SOC CHEM COMM, P761, DOI 10.1039/c39890000761; INOUE M, 1981, BIOCHIM BIOPHYS ACTA, V659, P362, DOI 10.1016/0005-2744(81)90062-0; Jakoby W B, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P383; JAKOBY WB, 1977, TRENDS BIOCHEM SCI, V2, P229, DOI 10.1016/0968-0004(77)90116-5; JI X, 1992, BIOCHEMISTRY-US, V31, P1019; JOHNSON WW, 1993, J BIOL CHEM, V268, P11508; KOHLERSTAUB D, 1985, J BACTERIOL, V162, P676, DOI 10.1128/JB.162.2.676-681.1985; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAROCHE SD, 1990, J BACTERIOL, V172, P164, DOI 10.1128/JB.172.1.164-171.1990; LIU SX, 1992, J BIOL CHEM, V267, P4296; LOGAN MSP, 1993, BIOCHEM BIOPH RES CO, V197, P853, DOI 10.1006/bbrc.1993.2557; MANNERVIK B, 1982, J BIOL CHEM, V257, P9909; MANOHARAN TH, 1992, J MOL BIOL, V226, P319, DOI 10.1016/0022-2836(92)90949-K; MARUYAMA H, 1984, J BIOL CHEM, V259, P2449; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; PATTINSON N, 1980, J CHROMATOGR, V187, P409, DOI 10.1016/S0021-9673(00)80473-2; PATTINSON N, 1981, ANAL BIOCHEM, V115, P424, DOI 10.1016/0003-2697(81)90028-2; PATTINSON NR, 1981, BIOCHIM BIOPHYS ACTA, V667, P70, DOI 10.1016/0005-2795(81)90067-2; PEMBLE SE, 1992, BIOCHEM J, V287, P957, DOI 10.1042/bj2870957; REINEMER P, 1991, EMBO J, V10, P1997, DOI 10.1002/j.1460-2075.1991.tb07729.x; ROBERTS AL, 1992, ENVIRON SCI TECHNOL, V26, P2263, DOI 10.1021/es00035a027; ROGIERS V, 1991, BIOCHEM PHARMACOL, V42, P491, DOI 10.1016/0006-2952(91)90310-2; SCHOLTZ R, 1988, J BACTERIOL, V170, P5698, DOI 10.1128/jb.170.12.5698-5704.1988; SIMONS PC, 1977, ANAL BIOCHEM, V82, P334, DOI 10.1016/0003-2697(77)90169-5; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; STUCKI G, 1981, ARCH MICROBIOL, V130, P366, DOI 10.1007/BF00414602; STUCKI G, 1981, MICROBIAL DEGRADATIO, P131; Wackett Lawrence P., 1992, Biodegradation, V3, P19, DOI 10.1007/BF00189633; WIDERSTEIN M, 1992, BIOCHEM J, V285, P377, DOI 10.1042/bj2850377; ZHANG PH, 1992, BIOCHEMISTRY-US, V31, P10185, DOI 10.1021/bi00157a005	49	46	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8826	8830						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132617				2022-12-27	WOS:A1994NB41100034
J	MICANOVIC, R; PROCYK, R; LIN, WH; MATSUEDA, GR				MICANOVIC, R; PROCYK, R; LIN, WH; MATSUEDA, GR			ROLE OF HISTIDINE-373 IN THE CATALYTIC ACTIVITY OF COAGULATION-FACTOR-XIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; FIBRIN; ACTIVATION; TRANSGLUTAMINASE; EXPRESSION; MECHANISM; SEQUENCE; CLEAVAGE; PROTEINS; ENZYMES	Factor XIII catalysis proceeds via formation of thioester acyl enzyme intermediate involving an active site cysteine residue at position 314. The contribution of other residues to catalysis has not been established. Earlier studies of the pH dependence of factor XIII activity suggested the existence of a putative active site histidine. We used chemical modification and oligonucle otide directed site-specific mutagenesis to investigate the role of histidines. Photo-oxidation with methylene blue resulted in a complete loss of catalytic activity under conditions that oxidized histidine but did not affect the essential cysteine. Single substitution of each of the 14 histidine residues in the a subunit of factor XIII by asparagine or alanine led to mutants with catalytic activities generally not significantly different from the wild-type recombinant enzyme. The only exceptions were the H373N and H373A mutants that were poorly expressed, had no detectable rate of [C-14]putrescine in corporation into dimethylcasein, and failed to cross-link fibrin gamma-chains. Thus, the a subunit His-373 may function in the active site of factor XIII, by analogy with papain's mechanism, as a histidinium cation that increases the nucleophilicity of the essential Cys-314. Decreased expression levels of His-373 mutants also indicate that this residue may be critical for enzyme stability.			MICANOVIC, R (corresponding author), BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,H3124,POB 4000,PRINCETON,NJ 08543, USA.							BISHOP P, 1993, THROMB HAEMOSTASIS, V69, P1235; BISHOP PD, 1990, J BIOL CHEM, V265, P13888; BISHOP PD, 1990, BIOCHEMISTRY-US, V29, P1861, DOI 10.1021/bi00459a028; BLOMBACK B, 1985, THROMB RES, V37, P613, DOI 10.1016/0049-3848(85)90094-5; BOARD PG, 1990, THROMB HAEMOSTASIS, V63, P235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CULLEN BR, 1986, CELL, V46, P973, DOI 10.1016/0092-8674(86)90696-3; CULLEN BR, 1984, NATURE, V307, P241, DOI 10.1038/307241a0; CURTIS CG, 1974, BIOCHEMISTRY-US, V13, P3774, DOI 10.1021/bi00715a024; FOLK JE, 1983, ADV ENZYMOL RAMB, V54, P1; GOLDENBERG DP, 1988, ANNU REV BIOPHYS BIO, V17, P481; GREENBERG CS, 1988, BIOCHEM J, V256, P1013, DOI 10.1042/bj2561013; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; GRUNDMANN U, 1986, P NATL ACAD SCI USA, V83, P8024, DOI 10.1073/pnas.83.21.8024; HOLBROOK JJ, 1973, BIOCHEM J, V135, P901, DOI 10.1042/bj1350901; HORNYAK TJ, 1989, BIOCHEMISTRY-US, V28, P7326, DOI 10.1021/bi00444a027; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P6900, DOI 10.1021/bi00370a025; JAGADEESWARAN P, 1990, GENE, V86, P279, DOI 10.1016/0378-1119(90)90291-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS SD, 1976, BIOCHEMISTRY-US, V15, P5009, DOI 10.1021/bi00668a010; LORAND L, 1972, ANAL BIOCHEM, V50, P623, DOI 10.1016/0003-2697(72)90074-7; MCDONAGH J, 1972, BIOCHIM BIOPHYS ACTA, V257, P135, DOI 10.1016/0005-2795(72)90262-0; McDonagh J, 1987, HEMOSTASIS THROMBOSI, P289; MICANOVIC R, 1990, P NATL ACAD SCI USA, V87, P157, DOI 10.1073/pnas.87.1.157; MUSZBEK L, 1993, THROMB HAEMOSTASIS, V69, P282; PARAMESWARAN KN, 1981, BIOCHEMISTRY-US, V20, P3703, DOI 10.1021/bi00516a006; POLGAR L, 1974, FEBS LETT, V47, P15, DOI 10.1016/0014-5793(74)80415-1; PROCYK R, 1992, BIOCHEMISTRY-US, V31, P2273, DOI 10.1021/bi00123a009; PROCYK R, 1993, THROMB RES, V71, P127, DOI 10.1016/0049-3848(93)90179-R; Sambrook J, 1989, MOL CLONING LABORATO; SCHWARTZ ML, 1973, J BIOL CHEM, V248, P1395; SWIGERT S, 1963, NATURE, V198, P797, DOI 10.1038/198797a0; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TAKAHASHI N, 1986, P NATL ACAD SCI USA, V83, P8019, DOI 10.1073/pnas.83.21.8019; TOKUNAGA F, 1993, J BIOL CHEM, V268, P262; Westhead E W, 1972, Methods Enzymol, V25, P401, DOI 10.1016/S0076-6879(72)25035-2	36	35	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9190	9194						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132656				2022-12-27	WOS:A1994NB41100084
J	REID, RJD; BODLEY, JW; ANDERSON, D				REID, RJD; BODLEY, JW; ANDERSON, D			IDENTIFICATION OF BACTERIOPHAGE-PHI-29 PROHEAD RNA DOMAINS NECESSARY FOR IN-VITRO DNA-GP3 PACKAGING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC MUTAGENESIS; RESTRICTION FRAGMENTS; PHENOTYPIC SELECTION; DNA; SIZE	Functional domains of the bacteriophage phi 29 prohead RNA (pRNA) that are essential for in vitro packaging of DNA-gp3 into the prohead were mapped using pRNA mutants. Oligonucleotide-directed mutant pRNAs were produced that contained deletions and sequence alterations but were predicted to retain the overall secondary structure of wild type pRNA. Mutant pRNAs were compared to wild-type pRNA for prohead binding in a competition assay and for DNA packaging in the defined in vitro system. The prohead binding site was previously localized to residues 22-84 on the 120-residue domain I of pRNA by ribonuclease footprinting (Reid, R. J. D., Bodley, J. W., and Anderson, D. (1994) J. Biol. Chem. 269, 5157-5162). Mutations of pRNA within the prohead bind ing site resulted in substantial loss of prohead binding capacity, while mutations outside of the footprint had moderate effects on prohead binding. DNA gp3 packaging activity was correlated with pRNA binding activity for mutations within the footprint. This mutational analysis showed that both sequence and secondary structure of residues 40-91 of pRNA were crucial for prohead binding and that elements of the A helix formed from residues 1-28 and 117-92 were needed for DNA packaging functions other than prohead binding.	UNIV MINNESOTA,DEPT MICROBIOL & ORAL SCI,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT GENET & CELL BIOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT BIOCHEM,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities			Reid, Robert/AAR-1560-2020	Reid, Robert/0000-0002-7424-3537				BAILEY S, 1990, J BIOL CHEM, V265, P22365; CHURCHER MJ, 1993, J MOL BIOL, V230, P90, DOI 10.1006/jmbi.1993.1128; GRIMES S, 1990, J MOL BIOL, V215, P559, DOI 10.1016/S0022-2836(05)80168-8; GRIMES S, 1989, J MOL BIOL, V209, P101, DOI 10.1016/0022-2836(89)90173-3; GRIMES S, 1989, J MOL BIOL, V209, P91, DOI 10.1016/0022-2836(89)90172-1; GUO PX, 1987, NUCLEIC ACIDS RES, V15, P7081, DOI 10.1093/nar/15.17.7081; GUO PX, 1987, SCIENCE, V236, P690, DOI 10.1126/science.3107124; GUO PX, 1991, VIROLOGY, V183, P366, DOI 10.1016/0042-6822(91)90149-6; GUO PX, 1986, P NATL ACAD SCI USA, V83, P3505, DOI 10.1073/pnas.83.10.3505; HALL KB, 1992, NUCLEIC ACIDS RES, V20, P4283, DOI 10.1093/nar/20.16.4283; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; REID RJD, 1994, J BIOL CHEM, V269, P5157; WICHITWECHKARN J, 1989, NUCLEIC ACIDS RES, V17, P3459, DOI 10.1093/nar/17.9.3459; WICHITWECHKARN J, 1992, J MOL BIOL, V223, P991, DOI 10.1016/0022-2836(92)90257-K; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	16	45	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9084	9089						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132646				2022-12-27	WOS:A1994NB41100071
J	SAAVEDRAALANIS, VM; RYSAVY, P; ROSENBERG, LE; KALOUSEK, F				SAAVEDRAALANIS, VM; RYSAVY, P; ROSENBERG, LE; KALOUSEK, F			RAT-LIVER MITOCHONDRIAL PROCESSING PEPTIDASE - BOTH ALPHA-SUBUNIT AND BETA-SUBUNIT ARE REQUIRED FOR ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C REDUCTASE; YEAST MITOCHONDRIA; TARGETING PEPTIDES; PROTEASE; PROTEINS; MATRIX; CLEAVAGE; FAMILY; IMPORT; METALLOENDOPEPTIDASES	Most nuclearly encoded mitochondrial proteins are synthesized with an amino-terminal leader peptide that is cleaved by the mitochondrial processing peptidase (MPP). Purified rat liver MPP, like the Neurospora and yeast enzymes, consists of two nonidentical subunits, alpha (55 kDa) and beta (50 kDa). To confirm the functional authenticity of the recently cloned and sequenced cDNAs for the alpha and beta-MPP subunits from rat liver and to study each subunit's participation in MPP activity, we have subcloned and expressed separately in Escherichia coli the mature sequence of each subunit as a fusion protein with the maltose binding protein. After induction, about 80% of each expressed fusion protein was insoluble in aggregates or inclusion bodies, and 20% remained soluble in the supernatant. The fusion proteins in the soluble fraction were purified by affinity chromatography and treated with factor Xa, and the MPP subunits were purified to homogeneity. When mixed together, these subunits showed no activity, suggesting that they might be misfolded. Therefore, a reconstitution protocol was developed which consisted of denaturation in urea, dithiothreitol, and 2-mercaptoethanol, followed by renaturation by dilution and dialysis under reducing conditions. With this procedure, active MPP was recovered from the mixed subunits, and it could be demonstrated that both alpha- and beta-MPP subunits were necessary for activity. Reconstituted recombinant MPP resembled the native rat liver enzyme as judged by its molecular weight, its inhibition by EDTA, and its ability to process a variety of mitochondrial precursor proteins appropriately to either an intermediate or a mature form.	YALE UNIV, SCH MED, DEPT GENET, NEW HAVEN, CT 06510 USA	Yale University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK009527] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK09527] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BECKER AB, 1992, P NATL ACAD SCI USA, V89, P3835, DOI 10.1073/pnas.89.9.3835; BEHRENS M, 1991, MOL GEN GENET, V228, P167, DOI 10.1007/BF00282462; BRAUN HP, 1992, EMBO J, V11, P3219, DOI 10.1002/j.1460-2075.1992.tb05399.x; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; GELI V, 1990, J BIOL CHEM, V265, P19216; GENCIC S, 1991, EUR J BIOCHEM, V199, P123, DOI 10.1111/j.1432-1033.1991.tb16099.x; GLICK B, 1991, ANNU REV GENET, V25, P21; HARTL FU, 1986, CELL, V47, P939, DOI 10.1016/0092-8674(86)90809-3; HAWLITSCHEK G, 1988, CELL, V53, P795, DOI 10.1016/0092-8674(88)90096-7; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; ISAYA G, 1991, J CELL BIOL, V113, P65, DOI 10.1083/jcb.113.1.65; JANSEN R, 1989, GENOMICS, V4, P198, DOI 10.1016/0888-7543(89)90300-5; JENSEN RE, 1988, EMBO J, V7, P3863, DOI 10.1002/j.1460-2075.1988.tb03272.x; KALOUSEK F, 1993, TRENDS BIOCHEM SCI, V18, P249, DOI 10.1016/0968-0004(93)90174-L; KALOUSEK F, 1988, P NATL ACAD SCI USA, V85, P7536, DOI 10.1073/pnas.85.20.7536; KALOUSEK F, 1992, EMBO J, V11, P2803, DOI 10.1002/j.1460-2075.1992.tb05347.x; KITADA S, 1993, BIOCHEM BIOPH RES CO, V190, P289, DOI 10.1006/bbrc.1993.1044; KLEIBER J, 1990, P NATL ACAD SCI USA, V87, P7978, DOI 10.1073/pnas.87.20.7978; LEMIRE BD, 1989, J BIOL CHEM, V264, P20206; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; OU WJ, 1989, EMBO J, V8, P2605, DOI 10.1002/j.1460-2075.1989.tb08400.x; PACES V, 1993, P NATL ACAD SCI USA, V90, P5355, DOI 10.1073/pnas.90.11.5355; PFANNER N, 1990, ANNU REV BIOCHEM, V59, P331, DOI 10.1146/annurev.bi.59.070190.001555; POLLOCK RA, 1988, EMBO J, V7, P3493, DOI 10.1002/j.1460-2075.1988.tb03225.x; RAWLINGS ND, 1991, BIOCHEM J, V275, P389, DOI 10.1042/bj2750389; ROSENBERG LE, 1986, ANN NY ACAD SCI, V488, P99; Sambrook J, 1989, MOL CLONING LABORATO; SCHNEIDER A, 1991, EMBO J, V10, P247, DOI 10.1002/j.1460-2075.1991.tb07944.x; SCHNEIDER H, 1990, J BIOL CHEM, V265, P9881; SCHULTE U, 1989, NATURE, V339, P147, DOI 10.1038/339147a0; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WEISS H, 1990, TRENDS BIOCHEM SCI, V15, P178, DOI 10.1016/0968-0004(90)90155-5; WITTE C, 1988, EMBO J, V7, P1439, DOI 10.1002/j.1460-2075.1988.tb02961.x; YANG M, 1988, EMBO J, V7, P3857, DOI 10.1002/j.1460-2075.1988.tb03271.x; YANG M, 1991, J BIOL CHEM, V266, P6416	37	57	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9284	9288						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132665				2022-12-27	WOS:A1994NB41100096
J	SETTE, C; IONA, S; CONTI, M				SETTE, C; IONA, S; CONTI, M			THE SHORT-TERM ACTIVATION OF A ROLIPRAM-SENSITIVE, CAMP-SPECIFIC PHOSPHODIESTERASE BY THYROID-STIMULATING HORMONE IN THYROID FRTL-5 CELLS IS MEDIATED BY A CAMP-DEPENDENT PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; PROTEIN-KINASE; HUMAN-PLATELETS; OKADAIC ACID; RAT ADIPOCYTES; SERTOLI-CELL; INSULIN; AMP; DESENSITIZATION	To elucidate the mechanism causing the transient accumulation of intracellular cAMP in the FRTL-5 thyroid cell line, the short-term effect of thyroid-stimulating hormone (TSH) on phosphodiesterase (PDE) activity was studied. Together with an increase in cAMP levels, TSH produced a significant increase in total PDE activity as early as 3 min, with a maximal stimulation reached after 15 min. This short-term increase in PDE activity was dependent on the TSH concentration (ED(50) = 4 x 10(-11) M TSH). Forskolin and dibutyryl cAMP produced an even larger stimulation than that produced by TSH, suggesting that the effect of TSH is mediated by cAMP. To determine the properties of the PDE forms activated by TSR, antibodies specific for the cAMP-PDEs were used to immunoprecipitate the PDEs present in control cells, and cells incubated for 15 min in the presence of 10 nw TSH. Comparison of the activity recovered in the immunoprecipitation pellets demonstrated that TSH produced more than a 2.5-fold increase in the cAMP-PDE form(s) recognized by this antibody. Conversely, the activity remaining in the supernatants was not affected by the TSH treatment. Most of the activity recovered in the immunoprecipitation pellets (90%) was inhibited by 10 mu M Rolipram, an inhibitor specific for the high affinity cAMP-PDEs. No TSH stimulation of the Rolipram-insensitive PDE activity could be observed under these conditions. Western blot analyses with two different cAMP-PDE specific antibodies showed that a 15-min stimulation with TSH induced the appearance of a new band with electrophoretic mobility slower than the polypeptide present in unstimulated cells. The appearance of this band did not require ongoing protein synthesis because it occurred in the presence of cycloheximide. Metabolic [P-32]orthophosphate labeling of intact FRTL-5 cells indicated that the TSH treatment caused an increased P-32 incorporation into a polypeptide that co-purified with the stimulated PDE activity and had an electrophoretic mobility identical to that of the cAMP-PDE. Okadaic acid, a potent inhibitor of protein phosphatase 1 and protein phosphatase 2A, elicited a potentiation of the TSH-stimulated PDE activity. The stimulation of a PDE with the same immunological properties and Rolipram sensitivity as the cAMP-PDE stimulated by TSH in the intact cells was reproduced, in a cell-free system, by incubating soluble extracts from FRTL-5 cells with the catalytic subunit of cAMP-dependent protein kinase. These data provide evidence that TSH produces a rapid activation of a cAMP-PDE in the FRTL-5 cells through a cAMP-dependent phosphorylation.			SETTE, C (corresponding author), STANFORD MED CTR, DEPT GYNECOL & OBSTET, DIV REPROD BIOL, STANFORD, CA 94305 USA.		Sette, Claudio/S-4307-2019	Sette, Claudio/0000-0003-2864-8266	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020788] Funding Source: NIH RePORTER; NICHD NIH HHS [HD20788] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; BALL EH, 1980, J BIOL CHEM, V255, P2962; BEAVO JA, 1988, ADV SEC MESS PHOSPH, V22, P1; BENOVIC JL, 1985, J BIOL CHEM, V260, P7094; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHENG HC, 1986, J BIOL CHEM, V261, P989; CLARK RB, 1989, MOL PHARMACOL, V36, P343; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COLLINS S, 1992, TRENDS BIOCHEM SCI, V17, P37, DOI 10.1016/0968-0004(92)90425-9; CONTI M, 1982, ENDOCRINOLOGY, V110, P1189, DOI 10.1210/endo-110-4-1189; CONTI M, 1981, BIOCHEM BIOPH RES CO, V98, P1044, DOI 10.1016/0006-291X(81)91216-X; CORBIN JD, 1985, J BIOL CHEM, V260, P8731; DAVIS CW, 1984, BIOCHIM BIOPHYS ACTA, V797, P354, DOI 10.1016/0304-4165(84)90257-5; DEGERMAN E, 1990, P NATL ACAD SCI USA, V87, P533, DOI 10.1073/pnas.87.2.533; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; GETTYS TW, 1987, J BIOL CHEM, V262, P333; GETTYS TW, 1988, J BIOL CHEM, V263, P10359; GRANT PG, 1988, P NATL ACAD SCI USA, V85, P9071, DOI 10.1073/pnas.85.23.9071; HARDIE DG, 1991, METHOD ENZYMOL, V201, P469; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; LAPETINA EG, 1989, P NATL ACAD SCI USA, V86, P3131, DOI 10.1073/pnas.86.9.3131; LAZAROWSKI ER, 1990, J BIOL CHEM, V265, P13118; LOPEZAPARICIO P, 1992, BIOCHEM BIOPH RES CO, V186, P517, DOI 10.1016/S0006-291X(05)80838-1; MACPHEE CH, 1988, J BIOL CHEM, V263, P10353; MADELIAN V, 1991, AM SOC NEUROCHEM, V22; MOLLOY CJ, 1993, J BIOL CHEM, V268, P7338; NARINDRASORASAK S, 1982, J BIOL CHEM, V257, P4618; NEMOZ G, 1985, BIOCHEM PHARMACOL, V34, P2997, DOI 10.1016/0006-2952(85)90029-2; ROBERTSON DW, 1986, J MED CHEM, V29, P635, DOI 10.1021/jm00155a009; SHIBATA H, 1991, J BIOL CHEM, V266, P17948; SMITH CJ, 1991, J BIOL CHEM, V266, P13385; SWINNEN JV, 1989, P NATL ACAD SCI USA, V86, P8197, DOI 10.1073/pnas.86.21.8197; SWINNEN JV, 1989, P NATL ACAD SCI USA, V86, P5325, DOI 10.1073/pnas.86.14.5325; SWINNENJV, 1991, J BIOL CHEM, V266, P18370; TAKAHASHI S, 1990, ENDOCRINOLOGY, V126, P736, DOI 10.1210/endo-126-2-736; TAKAHASHI S, 1991, END SOC ABSTR, P1045; TAKAHASHI SI, 1991, J BIOL CHEM, V266, P7834; THOMPSON WJ, 1971, BIOCHEMISTRY-US, V10, P311; VALETTE L, 1990, BIOCHEM BIOPH RES CO, V169, P864, DOI 10.1016/0006-291X(90)91973-V	43	175	175	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9245	9252						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132662				2022-12-27	WOS:A1994NB41100091
J	SHIN, JM; SACHS, G				SHIN, JM; SACHS, G			IDENTIFICATION OF A REGION OF THE H,K-ATPASE ALPHA-SUBUNIT ASSOCIATED WITH THE BETA-SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; INTRACELLULAR-TRANSPORT; H+/K+-ATPASE; NA,K-ATPASE	The gastric H,K-ATPase consists of an alpha, beta heterodimer. To determine which part of the alpha subunit is associated with the beta subunit, hog gastric vesicles were trypsinized, which left most of the beta subunit undigested. The vesicles were solubilized with either C(12)E(8) (polyoxyethylene 8 lauryl ester) or Nonidet P-40 and then passed over a wheat germ agglutinin column, which retained the beta subunit. Among the fragments of membrane spanning segments obtained by digestion in the absence of K+, only one peptide fragment of the alpha subunit coeluted with the beta subunit, representing only the M7 and M8 membrane spanning segments of the alpha subunit along with their extracytoplasmic connecting loop. With K+ present during digestion, the fragments at 19-21 kDa and at 9.4 kDa were retained on the column, representing the M7 to C-terminal end and the M5/loop/M6 sector of the enzyme. These results provide biochemical evidence that a region of the alpha subunit containing the M7/ loop/M8 sector is bound to the beta subunit under both digestion conditions; but when the C-terminal 180-amino acid sector of the alpha subunit remains intact, as found in the presence of K+, there is an additional retention of the M5/loop/M6 sector of the alpha subunit.	WADSWORTH VET ADM MED CTR, LOS ANGELES, CA 90073 USA; UNIV CALIF LOS ANGELES, DEPT MED & PHYSIOL, LOS ANGELES, CA 90073 USA	University of California System; University of California Los Angeles					NCRR NIH HHS [1S10RR0554-01] Funding Source: Medline; NIDDK NIH HHS [R01 DK 40165] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; BESANCON M, 1993, BIOCHEMISTRY-US, V32, P2345, DOI 10.1021/bi00060a028; CHOW DC, 1992, AM J PHYSIOL, V263, pC39, DOI 10.1152/ajpcell.1992.263.1.C39; GEERING K, 1991, FEBS LETT, V285, P189, DOI 10.1016/0014-5793(91)80801-9; GREEN NM, 1989, BIOCHEM SOC T, V17, P970; HALL K, 1990, BIOCHEMISTRY-US, V29, P701, DOI 10.1021/bi00455a016; HORISBERGER JD, 1991, ANNU REV PHYSIOL, V53, P565, DOI 10.1146/annurev.physiol.53.1.565; HORISBERGER JD, 1991, J BIOL CHEM, V266, P19131; JAUNIN P, 1992, J BIOL CHEM, V267, P577; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; KARLISH SJD, 1993, J BIOL CHEM, V268, P3471; LANE LK, 1986, BIOCHEM BIOPH RES CO, V138, P185, DOI 10.1016/0006-291X(86)90264-0; LEMAS MV, 1992, J BIOL CHEM, V267, P20987; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MERCIER F, 1993, BIOCHIM BIOPHYS ACTA, V1149, P151, DOI 10.1016/0005-2736(93)90036-Y; MILLER RP, 1990, BIOCHEMISTRY-US, V29, P1524, DOI 10.1021/bi00458a025; OKAMOTO CT, 1990, BIOCHIM BIOPHYS ACTA, V1037, P360, DOI 10.1016/0167-4838(90)90038-H; RABON EC, 1990, ANNU REV PHYSIOL, V52, P321; RABON EC, 1990, BIOCHIM BIOPHYS ACTA, V1039, P277, DOI 10.1016/0167-4838(90)90260-M; RENAUD KJ, 1991, J BIOL CHEM, V266, P20491; REUBEN MA, 1990, P NATL ACAD SCI USA, V87, P6767, DOI 10.1073/pnas.87.17.6767; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHIN JM, 1993, BIOCHIM BIOPHYS ACTA, V1148, P223, DOI 10.1016/0005-2736(93)90133-K; SHULL GE, 1986, NATURE, V321, P429, DOI 10.1038/321429a0; TEUBEIT MJ, 1993, J BIOL CHEM, V268, P13914; TOH BH, 1990, P NATL ACAD SCI USA, V87, P6418, DOI 10.1073/pnas.87.16.6418; YODA A, 1970, BIOCHEM BIOPH RES CO, V40, P880, DOI 10.1016/0006-291X(70)90985-X	27	52	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8642	8646						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132592				2022-12-27	WOS:A1994NB41100006
J	HILL, DR; HLADUN, SL; SCHERER, S; POTTS, M				HILL, DR; HLADUN, SL; SCHERER, S; POTTS, M			WATER-STRESS PROTEINS OF NOSTOC COMMUNE (CYANOBACTERIA) ARE SECRETED WITH UV-A/B-ABSORBING PIGMENTS AND ASSOCIATE WITH 1,4-BETA-D-XYLANXYLANOHYDROLASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GEL-ELECTROPHORESIS; GLYCOPROTEINS; UTEX-584; PROTEOLYSIS; CULTURES; SEQUENCE; CELLS; ASSAY	Acidic water stress polypeptides (Wsp) with molecular masses of 33, 37 and 39 kDa are the most abundant soluble proteins in the cyanobacterium Nostoc commune. Wsp polypeptides and UV-A/B-absorbing pigments are secreted by cells, accumulate in the extracellular glycan sheath, and are released from desiccated colonies upon rehydration. No evidence was obtained for either glycosylation, phosphorylation, or acylation of Wsp polypeptides. NH2-terminal amino acid sequences of the 33, 37-, and 39-kDa polypeptides were identical: Ala-Leu-Tyr-Gly-Tyr-Thr-Ile-Gly-Glu-Gln-X-Ile-Gln-Asn-Pro-Ser-Asn-Pro-Ser-Asn-Gly-Lys-Gln. This consensus NH2-terminal sequence and an internal sequence (Glu-Ala-Arg-Val-Thr-Gly-Pro-Thr-Thr-Pro-Ile-Asp) showed homologies with the sequences of carbohydrate-modifying enzymes. Purified Wsp polypeptides associate with a 1,4-beta-D-xylanxylanohydrolase activity that was inhibited specifically by Wsp antiserum. In the absence of salt, Wsp polypeptides, and the water-soluble UV-A/B-absorbing pigments, form multimeric complexes through strong ionic interactions. A possible role is suggested for Wsp polypeptides in the synthesis and/or modification of a xylose-containing UV-A/B-absorbing pigment.	VIRGINIA POLYTECH INST & STATE UNIV, DEPT BIOCHEM & ANAEROB MICROBIOL, BLACKSBURG, VA 24061 USA; TECH UNIV MUNICH, INST MIKROBIOL, D-85350 FREISING, GERMANY	Virginia Polytechnic Institute & State University; Technical University of Munich			Scherer, Siegfried/I-1320-2013	Scherer, Siegfried/0000-0002-0394-9890				BIELY P, 1985, ANAL BIOCHEM, V144, P142, DOI 10.1016/0003-2697(85)90095-8; CARDEMIL L, 1979, J BIOL CHEM, V254, P736; Chaplin M.F., 1986, MASS SPECTROM, P1; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; CROWE JH, 1987, BIOCHEM J, V242, P1, DOI 10.1042/bj2420001; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; FAIRCHILD CD, 1991, J BACTERIOL, V173, P2985, DOI 10.1128/JB.173.9.2985-2992.1991; GARCIAPICHEL F, 1991, J PHYCOL, V27, P395, DOI 10.1111/j.0022-3646.1991.00395.x; Gros E., 1967, METHOD ENZYMOL, V11, P238; HASELBECK A, 1988, TOP BIOCH, V8, P1; LECHNER J, 1989, ANNU REV BIOCHEM, V58, P173, DOI 10.1146/annurev.bi.58.070189.001133; LUTHI E, 1990, APPL ENVIRON MICROB, V56, P1017; Maniatis T, 1989, MOL CLONING; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; OSHANNESSY DJ, 1987, ANAL BIOCHEM, V163, P204, DOI 10.1016/0003-2697(87)90114-X; PEAT A, 1988, PROTOPLASMA, V146, P72, DOI 10.1007/BF01405915; PEAT A, 1987, FEMS MICROBIOL LETT, V43, P223, DOI 10.1111/j.1574-6968.1987.tb02127.x; PERINI F, 1982, ANAL BIOCHEM, V123, P357, DOI 10.1016/0003-2697(82)90458-4; POTTS M, 1993, J BIOL CHEM, V268, P7632; POTTS M, 1985, ARCH MICROBIOL, V141, P51, DOI 10.1007/BF00446739; POTTS M, 1985, J BACTERIOL, V164, P1025, DOI 10.1128/JB.164.3.1025-1031.1985; POTTS M, 1984, FEMS MICROBIOL LETT, V24, P193, DOI 10.1111/j.1574-6968.1984.tb01303.x; RIETHMAN HC, 1988, J BACTERIOL, V170, P2433, DOI 10.1128/jb.170.6.2433-2440.1988; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SCANLAN DJ, 1988, METHOD ENZYMOL, V167, P599; SCHERER S, 1991, MICROBIAL ECOL, V22, P271, DOI 10.1007/BF02540229; SCHERER S, 1986, OECOLOGIA, V68, P585, DOI 10.1007/BF00378775; SCHERER S, 1988, PLANT PHYSIOL, V88, P1055, DOI 10.1104/pp.88.4.1055; SCHERER S, 1989, J BIOL CHEM, V264, P12546; STULP BK, 1987, FEMS MICROBIOL LETT, V41, P241; TARANTO PA, 1993, BIOCHIM BIOPHYS ACTA, V1168, P228, DOI 10.1016/0005-2760(93)90129-W; TERADA I, 1990, J BIOL CHEM, V265, P6576; WHITTON BA, 1979, PHYCOLOGIA, V18, P278, DOI 10.2216/i0031-8884-18-3-278.1; WIRTH SJ, 1990, J MICROBIOL METH, V12, P197, DOI 10.1016/0167-7012(90)90031-Z; WONG KKY, 1988, MICROBIOL REV, V52, P305, DOI 10.1128/MMBR.52.3.305-317.1988; ZLOTNICK GW, 1986, ANAL BIOCHEM, V153, P121, DOI 10.1016/0003-2697(86)90069-2	36	68	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7726	7734						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125999				2022-12-27	WOS:A1994NA03200107
J	QIU, XQ; JAKES, KS; FINKELSTEIN, A; SLATIN, SL				QIU, XQ; JAKES, KS; FINKELSTEIN, A; SLATIN, SL			SITE-SPECIFIC BIOTINYLATION OF COLICIN IA - A PROBE FOR PROTEIN CONFORMATION IN THE MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR LIPID BILAYERS; VOLTAGE-DEPENDENT CHANNEL; ION CHANNEL; FRAGMENT; IDENTIFICATION; TRANSLOCATION; SEQUENCE; DOMAIN; DNA	Channel-forming colicins are Escherichia coli proteins that form voltage-dependent channels in lipid bilayer membranes and are lethal to sensitive strains of E. coli. Experiments with colicin E1 have led to a model of voltage dependence based on the insertion of alpha-helical segments of the protein into the membrane in response to cis-positive voltages. This model was tested on the partly homologous colicin Ia protein, which offers certain advantages over colicin E1 as a model channel, it is active at neutral pH and exhibits comparatively well-defined single channel conductance. We describe here the creation of a specific probe for locating a particular amino acid residue on one side or the other of a planar lipid bilayer membrane, by using the biotin-streptavidin system. Site-directed mutagenesis was used to change lysine 544 of colicin Ia to cysteine. This placed a unique cysteine at a site expected, by homology to colicin E1, to cross the membrane from the cis to the trans side in association with the opening of the channel. This unique cysteine was biotinylated chemically, so that it could serve as a target for streptavidin. Incubation of the biotinylated mutant colicin with streptavidin blocked its killing activity, in vivo; incubation of wild-type colicin, which lacks cysteine, with streptavidin, did not affect its activity. Channels formed by the biotinylated mutant protein in planar lipid bilayers were abolished by streptavidin added to the cis side of the membrane, if the channels were closed, but not if they were open. Trans streptavidin had no effect on either open or closed channels. Thus, when the channel is closed, residue 544 of colicin Ia is accessible to cis streptavidin in the closed state, but the opening of the channel eliminates this accessibility.	ALBERT EINSTEIN COLL MED,DEPT PHYSIOL & BIOPHYS,BRONX,NY 10461	Yeshiva University; Albert Einstein College of Medicine					NIGMS NIH HHS [GM 29210-16] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029210, R37GM029210] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMS CK, 1991, J GEN PHYSIOL, V98, P77, DOI 10.1085/jgp.98.1.77; BAYER EA, 1989, BIOCHEM J, V259, P369, DOI 10.1042/bj2590369; COLLARINI M, 1987, EUR BIOPHYS J BIOPHY, V14, P147, DOI 10.1007/BF00253839; CRAMER WA, 1990, MOL MICROBIOL, V4, P519, DOI 10.1111/j.1365-2958.1990.tb00619.x; DANKERT JR, 1982, J BIOL CHEM, V257, P3857; ENEA V, 1982, VIROLOGY, V122, P222, DOI 10.1016/0042-6822(82)90395-6; GREEN NM, 1971, BIOCHEM J, V125, P781, DOI 10.1042/bj1250781; JAKES K, 1974, J BIOL CHEM, V249, P438; JAKES KS, 1990, J BIOL CHEM, V265, P6984; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKEY JH, 1992, FEBS LETT, V307, P26, DOI 10.1016/0014-5793(92)80895-N; LAZDUNSKI CJ, 1988, BIOCHIM BIOPHYS ACTA, V947, P445, DOI 10.1016/0304-4157(88)90003-2; LIU Q R, 1986, Proteins Structure Function and Genetics, V1, P218, DOI 10.1002/prot.340010304; MANKOVICH JA, 1986, J BACTERIOL, V168, P228, DOI 10.1128/jb.168.1.228-236.1986; MERRILL AR, 1990, BIOCHEMISTRY-US, V29, P8529, DOI 10.1021/bi00489a004; Montal M, 1974, Methods Enzymol, V32, P545; NOGUEIRA RA, 1988, J MEMBRANE BIOL, V105, P143, DOI 10.1007/BF02009167; PARKER MW, 1989, NATURE, V337, P93, DOI 10.1038/337093a0; RAYMOND L, 1986, J MEMBRANE BIOL, V92, P255, DOI 10.1007/BF01869394; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Savage D, 1992, AVIDIN BIOTIN CHEM H; SCHEIN SJ, 1978, NATURE, V276, P159, DOI 10.1038/276159a0; SLATIN S, 1986, BIOPHYS J, V49, pA412; SLATIN SL, 1986, J MEMBRANE BIOL, V92, P247, DOI 10.1007/BF01869393; SLATIN SL, 1988, INT J BIOCHEM, V20, P737, DOI 10.1016/0020-711X(88)90058-4; YAMADA M, 1982, P NATL ACAD SCI-BIOL, V79, P2827, DOI 10.1073/pnas.79.9.2827; ZHANG YL, 1992, PROTEIN SCI, V1, P1666, DOI 10.1002/pro.5560011215	28	43	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7483	7488						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125966				2022-12-27	WOS:A1994NA03200071
J	DONG, ZG; THOMA, RS; CRIMMINS, DL; MCCOURT, DW; TULEY, EA; SADLER, JE				DONG, ZG; THOMA, RS; CRIMMINS, DL; MCCOURT, DW; TULEY, EA; SADLER, JE			DISULFIDE BONDS REQUIRED TO ASSEMBLE FUNCTIONAL VON-WILLEBRAND-FACTOR MULTIMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN VONWILLEBRAND-FACTOR; PLATELET GLYCOPROTEIN-IB; AMINO-ACID RESIDUES; FACTOR-VIII BINDING; FIBRILLAR COLLAGEN; FACTOR VWF; DOMAIN; HEPARIN; IDENTIFICATION; CHROMATOGRAPHY	The hemostatic functions of human von Willebrand Factor (VWF) depend on the normal assembly of disulfide-linked multimers from similar to 250-kDa subunits. Subunits initially form dimers through disulfide bonds near the COOH terminus. Dimers then form multimers through disulfide bonds near the NH2 terminus of each subunit. Previous studies of plasma vWF and recombinant vWF fragments indicate that 1 or more of the Cys residues at position 459, 462, and 464 form intersubunit disulfide bonds. No evidence has been reported that vWF multimer formation involves additional intersubunit bonds. To probe the disulfide bond requirements for multimer formation, mutant vWF proteins were expressed in which all 3 Cys residues at positions 459, 462, and 464 were changed to either Gly or Ala. Surprisingly, none of these cysteines appears to be necessary for efficient multimer assembly. Furthermore, recombinant vWF with Gly or Ala at all three positions induces platelet aggregation in the presence of ristocetin and binds to platelet glycoprotein Ib, factor VIII, and collagen in a manner similar to wild-type recombinant vWF. These results suggest that other intersubunit disulfide bonds must exist. Direct evidence for such a bond was obtained by characterization of tryptic fragments of vWF. By Edman degradation, amino acid composition, and mass spectrometry, a disulfide bond was demonstrated between Cys(379) residues of adjacent vWF subunits, Thus, intersubunit disulfide bonds involving Cys(379) and 1 or more of the Cys residues at positions 459, 462, and 464 connect the NH2-terminal ends of the vWF subunits in a parallel orientation.	WASHINGTON UNIV,JEWISH HOSP ST LOUIS,SCH MED,HOWARD HUGHES MED INST,DEPT MED,ST LOUIS,MO 63110; WASHINGTON UNIV,JEWISH HOSP ST LOUIS,SCH MED,DEPT BIOCHEM & MOLEC BIOPHYS,ST LOUIS,MO 63110	Barnes-Jewish Hospital; Howard Hughes Medical Institute; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)			Sadler, Evan/D-8556-2011	Sadler, J. Evan/0000-0001-5705-469X				ADAMS GA, 1985, MOL CELL BIOL, V5, P1442, DOI 10.1128/MCB.5.6.1442; ANDREWS RK, 1989, BIOCHEMISTRY-US, V28, P8326, DOI 10.1021/bi00447a010; AZUMA H, 1993, J BIOL CHEM, V268, P2821; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; BURKE RL, 1986, J BIOL CHEM, V261, P2574; CRIMMINS DL, 1989, ANAL BIOCHEM, V176, P255, DOI 10.1016/0003-2697(89)90305-9; DOUCETDEBRUINE MHM, 1978, J LAB CLIN MED, V92, P96; FEDERICI AB, 1989, BRIT J HAEMATOL, V73, P93, DOI 10.1111/j.1365-2141.1989.tb00226.x; FOSTER PA, 1987, J BIOL CHEM, V262, P8443; FUJIMURA Y, 1986, J BIOL CHEM, V261, P381; FUJIMURA Y, 1987, BLOOD, V70, P985; GIRMA JP, 1986, BIOCHEMISTRY-US, V25, P3156, DOI 10.1021/bi00359a013; GRALNICK HR, 1981, BLOOD, V58, P387; HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; HUBERT AJ, 1963, HELV CHIM ACTA, V46, P1429, DOI 10.1002/hlca.19630460439; KALAFATIS M, 1987, BLOOD, V70, P1577; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; LEGAZ ME, 1973, J BIOL CHEM, V248, P3946; LYONS SE, 1992, J BIOL CHEM, V267, P4424; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; MAZURIER C, 1991, VOX SANG, V61, P61; MOHRI H, 1989, J BIOL CHEM, V264, P17361; PARETI FI, 1987, J BIOL CHEM, V262, P13835; RAINES G, 1990, THROMB RES, V60, P201, DOI 10.1016/0049-3848(90)90181-B; RANDI AM, 1992, J BIOL CHEM, V267, P21187; ROTH GJ, 1986, BIOCHEMISTRY-US, V25, P8357, DOI 10.1021/bi00374a004; SADLER JE, 1991, J BIOL CHEM, V266, P22777; SANTORO SA, 1983, BIOCHIM BIOPHYS ACTA, V756, P123, DOI 10.1016/0304-4165(83)90032-6; SIXMA JJ, 1991, EUR J BIOCHEM, V196, P369, DOI 10.1111/j.1432-1033.1991.tb15826.x; SUGIMOTO M, 1991, J BIOL CHEM, V266, P18172; TULEY EA, 1991, P NATL ACAD SCI USA, V88, P6377, DOI 10.1073/pnas.88.14.6377; VERWEIJ CL, 1987, EMBO J, V6, P2885, DOI 10.1002/j.1460-2075.1987.tb02591.x; VOORBERG J, 1990, EMBO J, V9, P797, DOI 10.1002/j.1460-2075.1990.tb08176.x; VOORBERG J, 1991, J CELL BIOL, V113, P195, DOI 10.1083/jcb.113.1.195; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; WAGNER DD, 1991, CELL, V64, P403, DOI 10.1016/0092-8674(91)90648-I; WISE RJ, 1988, CELL, V52, P229, DOI 10.1016/0092-8674(88)90511-9	39	59	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6753	6758						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120035				2022-12-27	WOS:A1994MZ50300078
J	MAGHAZACHI, AA; ALAOUKATY, A				MAGHAZACHI, AA; ALAOUKATY, A			G(S) IS THE MAJOR G-PROTEIN INVOLVED IN INTERLEUKIN-2-ACTIVATED NATURAL-KILLER (IANK) CELL-MEDIATED CYTOTOXICITY - SUCCESSFUL INTRODUCTION OF ANTI-G PROTEIN ANTIBODIES INSIDE STREPTOLYSIN O-PERMEABILIZED IANK CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; GTP-BINDING PROTEINS; ALPHA-SUBUNITS; PHOSPHOLIPASE-C; SIGNAL TRANSDUCTION; CHOLERA-TOXIN; ADENYLYL CYCLASE; ACTIVATION; RECEPTOR; PURIFICATION	In the present work, anti-G protein antibodies were introduced inside streptolysin permeabilized 0 interleukin-2-activated natural killer (IANK) cells. Successful entry of the antibodies was determined by flow cytometry and fluorescence microscopy. Permeabilized cells showed typical large granular lymphocyte morphology and remained functional, significantly lysing both NK-sensitive K562 cells and NK-resistant/IANK-sensitive RAJI target cells. This method was utilized to study the effect of anti-G protein antibodies on the functional ac tivities of IANK cells. Anti-G, antibody inhibited IANK cell killing of RAJI but not of K562 target cells. Further analysis showed that K562 and RAJI cells enhance the binding of guanosine 5'-O-(thiotriphosphate) to IANK cell membranes, and increase the hydrolysis of [P-32]GTP in these membranes. Immunoblot analysis showed that K562 and RAJI cells induce the release of cu,, but not cui, alpha(s), or alpha(q)11 from IANK cell membranes. Cumulatively, these data indicate that putative receptors recognizing H562 or RAJI target cells are coupled to G(o) in IANK cells, however, only G, seems to be coupled to receptors recognizing RAJI target cells. Our results point out the importance of G, protein as a mediator of cellular cytotoxicity of the anti-tumor effector cells.	LAURENTIAN UNIV, DEPT CHEM BIOCHEM, SUDBURY P3E 5J1, ON, CANADA; UNIV OTTAWA, FAC MED, DEPT MED, OTTAWA K1N 6N5, ON, CANADA; UNIV OTTAWA, FAC MED, DEPT MICROBIOL & IMMUNOL, OTTAWA K1N 6N5, ON, CANADA	Laurentian University; University of Ottawa; University of Ottawa	MAGHAZACHI, AA (corresponding author), NE ONTARIO REG CANC CTR, SUDBURY, ON, CANADA.			Maghazachi, Azzam/0000-0002-3310-678X				ABOOD ME, 1982, J BIOL CHEM, V257, P540; AHNERTHILGER G, 1989, METHOD CELL BIOL, V31, P63; BADER MF, 1986, J BIOL CHEM, V261, P5777; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; BLITZER RD, 1993, J BIOL CHEM, V268, P7532; BOYER JL, 1992, J BIOL CHEM, V267, P25451; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CARTER BD, 1993, P NATL ACAD SCI USA, V90, P4062, DOI 10.1073/pnas.90.9.4062; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOLDFARB RH, 1981, J IMMUNOL, V126, P2129; GOLDSMITH P, 1988, BIOCHEMISTRY-US, V27, P7085, DOI 10.1021/bi00418a062; GOLDSMITH P, 1987, J BIOL CHEM, V262, P14683; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KLEUSS C, 1992, NATURE, V358, P424, DOI 10.1038/358424a0; LOTZOVA E, 1989, CURR OPIN IMMUNOL, V1, P904, DOI 10.1016/0952-7915(89)90069-1; MAGHAZACHI A A, 1988, Journal of Immunology, V140, P2846; MAGHAZACHI AA, 1988, J IMMUNOL, V141, P4039; MAGHAZACHI AA, 1993, INT IMMUNOL, V5, P825, DOI 10.1093/intimm/5.8.825; MCFADZEAN I, 1989, NEURON, V3, P177, DOI 10.1016/0896-6273(89)90030-5; MILLIGAN G, 1992, NEUROMETHODS, P1; MORIARTY TM, 1990, NATURE, V343, P79, DOI 10.1038/343079a0; NAGLER A, 1990, J EXP MED, V171, P1527, DOI 10.1084/jem.171.5.1527; ORTALDO JR, 1988, J NATL CANCER I, V80, P999, DOI 10.1093/jnci/80.13.999; PANG IH, 1990, J BIOL CHEM, V265, P18707; PROSS HF, 1981, J CLIN IMMUNOL, V1, P51, DOI 10.1007/BF00915477; RABINOWICH H, 1992, J IMMUNOL, V149, P340; SCHWARZ RE, 1989, CANCER RES, V49, P1441; SEBOK K, 1993, J IMMUNOL, V150, P1524; SHENKER A, 1991, J BIOL CHEM, V266, P9309; SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SPIEGEL AM, 1987, MOL CELL ENDOCRINOL, V49, P1, DOI 10.1016/0303-7207(87)90058-X; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TAYLOR CW, 1990, BIOCHEM J, V272, P1; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; TING AT, 1992, J BIOL CHEM, V267, P23957; WHALEN MM, 1990, BIOCHEM J, V272, P327, DOI 10.1042/bj2720327; WINDEBANK KP, 1988, J IMMUNOL, V141, P3951; WU DQ, 1992, J BIOL CHEM, V267, P25798; WU DQ, 1992, J BIOL CHEM, V267, P1811	45	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6796	6802						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120041				2022-12-27	WOS:A1994MZ50300085
J	ARPAGAUS, M; FEDON, Y; COUSIN, X; CHATONNET, A; BERGE, JB; FOURNIER, D; TOUTANT, JP				ARPAGAUS, M; FEDON, Y; COUSIN, X; CHATONNET, A; BERGE, JB; FOURNIER, D; TOUTANT, JP			CDNA SEQUENCE, GENE STRUCTURE, AND IN-VITRO EXPRESSION OF ACE-1, THE GENE ENCODING ACETYLCHOLINESTERASE OF CLASS-A IN THE NEMATODE CAENORHABDITIS-ELEGANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-SERUM CHOLINESTERASE; DROSOPHILA-MELANOGASTER; MOLECULAR-FORMS; MESSENGER-RNA; C-ELEGANS; CATALYTIC PROPERTIES; TORPEDO-CALIFORNICA; TISSUE DISTRIBUTION; ANIONIC SUBSITES; XENOPUS OOCYTES	Three genes, ace-1, ace-2, and ace-3, encode three acetylcholinesterase classes (A, B, and C) in the nematode Caenorhabditis elegans. A fragment of genomic DNA was amplified by a polymerase chain reaction (PCR) using degenerate oligonucleotides based on sequences conserved in the cholinesterase family. This fragment mapped to chromosome X at a position that perfectly matched the location of ace-1 previously determined by genetic methods. Comparison of genomic and cDNA sequences showed that the open reading frame was interrupted by eight introns. The product of ace-1 (ACE-1, 620 amino acids) presented 42% identity with Torpedo and human acetylcholinesterases, 41% with human butyrylcholinesterase, and 35% with Drosophila acetylcholinesterase. The overall structure of cholinesterases was conserved in ACE-1 as indicated by the conserved sequence positions of Ser-216, His-468, and Glu-346 (S200, H440, E327 in Torpedo AChE) as components of the catalytic triad, of the six cysteines which form three intrachain disulfide bonds, and of Trp-99(84), a critical side chain in the choline binding site. Spodoptera Sf9 cells were infected by a recombinant baculovirus containing ace-1 cDNA. The secreted enzyme was active and existed as hydrophilic 5 and 11.5 S molecular forms. It hydrolyzed both acetylthiocholine and butyrylthiocholine and was inhibited by acetylthiocholine above 10 mM.	INRA, CTR DIFFERENCIAT CELLULAIRE & CROISSANCE, 2 PL VIALA, F-34060 MONTPELLIER, FRANCE; INRA, F-06606 ANTIBES, FRANCE	INRAE; INRAE			Chatonnet, Arnaud/AAM-5569-2021; Chatonnet, Arnaud/E-2190-2017; Cousin, Xavier/E-2542-2013	Chatonnet, Arnaud/0000-0002-4057-3896; Cousin, Xavier/0000-0002-8520-3610				Amitai G, 1991, CHOLINESTERASES STRU, V285; ARPAGAUS M, 1991, J BIOL CHEM, V266, P6966; ARPAGAUS M, 1985, NEUROCHEM INT, V7, P793, DOI 10.1016/0197-0186(85)90034-8; ARPAGAUS M, 1993, J NEUROCHEM, V61, pS146; ARPAGAUS M, 1992, EUR J BIOCHEM, V207, P1101, DOI 10.1111/j.1432-1033.1992.tb17147.x; BON S, 1986, FEBS LETT, V209, P206, DOI 10.1016/0014-5793(86)81112-7; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; BRENNER S, 1974, GENETICS, V77, P71; Chalfie M., 1988, NEMATODE CAENORHABDI, P337; CHANGEUX JP, 1966, MOL PHARMACOL, V2, P369; CHATONNET A, 1989, BIOCHEM J, V260, P625, DOI 10.1042/bj2600625; COULSON A, 1988, NATURE, V335, P184, DOI 10.1038/335184a0; COULSON A, 1991, BIOESSAYS, V13, P413, DOI 10.1002/bies.950130809; CULOTTI JG, 1981, GENETICS, V97, P281; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; EMMONS SW, 1988, NEMATODE CAENORHABDI, P47; Fedon Yann, 1993, DNA Sequence, V3, P347, DOI 10.3109/10425179309020836; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FOURNIER D, 1992, EUR J BIOCHEM, V203, P513, DOI 10.1111/j.1432-1033.1992.tb16577.x; FOURNIER D, 1989, J MOL BIOL, V210, P15, DOI 10.1016/0022-2836(89)90287-8; GIBNEY G, 1990, P NATL ACAD SCI USA, V87, P7546, DOI 10.1073/pnas.87.19.7546; GNAGEY AL, 1987, J BIOL CHEM, V262, P13290; HAAS R, 1992, MULTIDISCIPLINARY APPROACHES TO CHOLINESTERASE FUNCTIONS, P131; HALL LMC, 1986, EMBO J, V5, P2949, DOI 10.1002/j.1460-2075.1986.tb04591.x; HAREL M, 1992, P NATL ACAD SCI USA, V89, P10827, DOI 10.1073/pnas.89.22.10827; HUANG XY, 1989, P NATL ACAD SCI USA, V86, P8640, DOI 10.1073/pnas.86.22.8640; INESTROSA NC, 1987, J BIOL CHEM, V262, P4441; JOHNSON CD, 1981, GENETICS, V97, P261; JOHNSON CD, 1988, NEURON, V1, P165, DOI 10.1016/0896-6273(88)90201-2; JOHNSON CD, 1983, J NEUROCHEM, V41, P30, DOI 10.1111/j.1471-4159.1983.tb11811.x; KAMIYA Y, 1993, ZOOL SCI, V10, P43; KENNEDY BP, 1993, J MOL BIOL, V229, P890, DOI 10.1006/jmbi.1993.1094; KITTS PA, 1990, NUCLEIC ACIDS RES, V18, P5667, DOI 10.1093/nar/18.19.5667; KOLSON DL, 1985, J NEUROGENET, V2, P93, DOI 10.3109/01677068509100145; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; KREIENKAMP HJ, 1991, P NATL ACAD SCI USA, V88, P6117, DOI 10.1073/pnas.88.14.6117; KREJCI E, 1991, P NATL ACAD SCI USA, V88, P6647, DOI 10.1073/pnas.88.15.6647; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LI Y, 1993, J BIOL CHEM, V268, P5790; LOCKRIDGE O, 1979, J BIOL CHEM, V254, P8324; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P549; LOCKRIDGE O, 1978, J BIOL CHEM, V253, P361; MACPHEEQUIGLEY K, 1986, J BIOL CHEM, V261, P3565; MASSOULIE J, 1992, MULTIDISCIPLINARY APPROACHES TO CHOLINESTERASE FUNCTIONS, P285; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MAULET Y, 1990, NEURON, V4, P289, DOI 10.1016/0896-6273(90)90103-M; MEYER BJ, 1986, CELL, V47, P871, DOI 10.1016/0092-8674(86)90802-0; MUTERO A, 1992, NEUROREPORT, V3, P39, DOI 10.1097/00001756-199201000-00010; MUTERO A, 1992, J BIOL CHEM, V267, P1695; ORDENTLICH A, 1993, J BIOL CHEM, V268, P17083; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; RADIC Z, 1992, BIOCHEMISTRY-US, V31, P9760, DOI 10.1021/bi00155a032; ROSENBERRY TL, 1989, METHOD CELL BIOL, V32, P231; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAFFERMAN A, 1992, EMBO J, V11, P3561, DOI 10.1002/j.1460-2075.1992.tb05439.x; SHAFFERMAN A, 1992, J BIOL CHEM, V267, P17640; SIKORAV JL, 1988, EMBO J, V7, P2983, DOI 10.1002/j.1460-2075.1988.tb03161.x; SIKORAV JL, 1987, EMBO J, V6, P1865, DOI 10.1002/j.1460-2075.1987.tb02445.x; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TAYLOR P, 1991, J BIOL CHEM, V266, P4025; TAYLOR P, 1975, BIOCHEMISTRY-US, V14, P1989, DOI 10.1021/bi00680a029; TOUTANT JP, 1989, PROG NEUROBIOL, V32, P423, DOI 10.1016/0301-0082(89)90031-2; TOUTANT JP, 1988, J NEUROCHEM, V50, P209, DOI 10.1111/j.1471-4159.1988.tb13251.x; VELLOM DC, 1993, BIOCHEMISTRY-US, V32, P12, DOI 10.1021/bi00052a003; Wachtler K., 1988, CHOLINERGIC SYNAPSE, P57; WEISE C, 1990, EMBO J, V9, P3885, DOI 10.1002/j.1460-2075.1990.tb07607.x; Wood WB, 1988, NEMATODE CAENORHABDI	71	79	84	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9957	9965						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144590				2022-12-27	WOS:A1994NE05300086
J	YAN, W; FRANCKLYN, C				YAN, W; FRANCKLYN, C			CYTOSINE-73 IS A DISCRIMINATOR NUCLEOTIDE IN-VIVO FOR HISTIDYL-TRANSFER RNA IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCEPTOR STEM; TRIOSEPHOSPHATE ISOMERASE; MAJOR DETERMINANT; IDENTITY INVIVO; AMINOACYLATION; SYNTHETASE; RECOGNITION; SPECIFICITY; ANTICODON; CLEAVAGE	The acceptor helix of histidine tRNAs in Escherichia coli is capped by a unique base pair in which the cytosine at the discriminator position is paired with an extra guanosine at -1. In previous in vitro studies, the presence of the G-1:C73 base pair was found to be required to obtain both optimal histidylation by histidyl-tRNA synthetase and accurate 5' processing by RNase P. We investigated the role of G-1:C 73 in histidine tRNA identity and found that nucleotide substitutions conferred mischarging by other amino acids in a pattern that correlated with the discriminator base and not with the extra nucleotide at -1. As shown by primer extension experiments, the relatively minor role of the -1 nucleotide in vivo could be attributed to altered RNase P processing. These studies show that interactions of tRNAs in vivo both with RNase P during tRNA biosynthesis and with the pool of aminoacyl-tRNA synthetases can modulate the effects of substitutions at recognition nucleotides, eliciting changes in transfer RNA identity.	UNIV VERMONT, COLL MED, DEPT BIOCHEM, HLTH SCI COMPLEX B409, BURLINGTON, VT 05405 USA	University of Vermont					NIGMS NIH HHS [GM 48146] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM048146] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBER T, 1982, Journal of Molecular and Applied Genetics, V1, P419; ASAHARA H, 1993, J MOL BIOL, V231, P219, DOI 10.1006/jmbi.1993.1277; BURKARD U, 1988, J BIOL CHEM, V263, P9578; BURKARD U, 1988, J BIOL CHEM, V263, P2447; CAVARELLI J, 1993, NATURE, V362, P181, DOI 10.1038/362181a0; CHATTAPADHYAY R, 1990, BIOCHEMISTRY-US, V29, P4263, DOI 10.1021/bi00470a001; CROTHERS D, 1972, P NATL ACAD SCI USA, V69, P63; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; FRANCKLYN C, 1992, SCIENCE, V255, P1121, DOI 10.1126/science.1546312; FRANCKLYN C, 1990, P NATL ACAD SCI USA, V87, P8655, DOI 10.1073/pnas.87.21.8655; GIEGE R, 1993, PROG NUCLEIC ACID RE, V45, P129, DOI 10.1016/S0079-6603(08)60869-7; GREEN CJ, 1988, J BIOL CHEM, V263, P652; HARADA F, 1972, FEBS LETT, V19, P352, DOI 10.1016/0014-5793(72)80078-4; HASEGAWA T, 1989, BIOCHEM BIOPH RES CO, V163, P1534, DOI 10.1016/0006-291X(89)91154-6; HIMENO H, 1989, NUCLEIC ACIDS RES, V17, P7855, DOI 10.1093/nar/17.19.7855; HIMENO H, 1990, NUCLEIC ACIDS RES, V18, P6815, DOI 10.1093/nar/18.23.6815; HOLM PS, 1992, NUCLEIC ACIDS RES, V20, P421, DOI 10.1093/nar/20.3.421; HOOPER ML, 1972, FEBS LETT, V22, P149, DOI 10.1016/0014-5793(72)80241-2; HOU YM, 1989, BIOCHEMISTRY-US, V28, P4942, DOI 10.1021/bi00438a005; HOU YM, 1989, BIOCHEMISTRY-US, V28, P6800, DOI 10.1021/bi00443a003; HOU YM, 1993, P NATL ACAD SCI USA, V90, P6776, DOI 10.1073/pnas.90.14.6776; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; JAHN M, 1991, NATURE, V352, P258, DOI 10.1038/352258a0; KIRSEBOM LA, 1992, NUCLEIC ACIDS RES, V20, P425, DOI 10.1093/nar/20.3.425; KLEINA LG, 1990, J MOL BIOL, V213, P705, DOI 10.1016/S0022-2836(05)80257-8; KOMATSOULIS GA, 1993, BIOCHEMISTRY-US, V32, P7435, DOI 10.1021/bi00080a014; KOMIVES EA, 1991, BIOCHEMISTRY-US, V30, P3011, DOI 10.1021/bi00226a005; MCCLAIN WH, 1990, P NATL ACAD SCI USA, V87, P9260, DOI 10.1073/pnas.87.23.9260; MCCLAIN WH, 1991, P NATL ACAD SCI USA, V88, P6147, DOI 10.1073/pnas.88.14.6147; MCCLAIN WH, 1988, J MOL BIOL, V202, P697, DOI 10.1016/0022-2836(88)90551-7; MCLAIN WH, 1993, J MOL BIOL, V234, P257; MILELR JH, 1972, EXPT MOL GENETICS; MURGOLA EJ, 1983, MOL GEN GENET, V191, P132, DOI 10.1007/BF00330900; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; NORMANLY J, 1986, NATURE, V321, P213, DOI 10.1038/321213a0; NORMANLY J, 1986, P NATL ACAD SCI USA, V83, P6548, DOI 10.1073/pnas.83.17.6548; NORMANLY J, 1989, ANNU REV BIOCHEM, V58, P1029, DOI 10.1146/annurev.bi.58.070189.005121; ORELLANA O, 1986, MOL CELL BIOL, V6, P525, DOI 10.1128/MCB.6.2.525; PALLANCK L, 1992, J BIOL CHEM, V267, P7221; PUTZ J, 1991, SCIENCE, V252, P1696, DOI 10.1126/science.2047878; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; ROULD MA, 1991, NATURE, V352, P213, DOI 10.1038/352213a0; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIMMEL P, 1989, BIOCHEMISTRY-US, V28, P2747, DOI 10.1021/bi00433a001; SCHULMAN LH, 1991, PROG NUCLEIC ACID RE, V41, P23; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; SHERMAN JM, 1992, NUCLEIC ACIDS RES, V20, P1547, DOI 10.1093/nar/20.7.1547; SHERMAN JM, 1992, J MOL BIOL, V228, P1055, DOI 10.1016/0022-2836(92)90314-A; SHI JP, 1991, J BIOL CHEM, V266, P2705; SHIMURA Y, 1972, FEBS LETT, V22, P144, DOI 10.1016/0014-5793(72)80240-0; SPRINZL M, 1989, NUCLEIC ACIDS RES, V17, pR1, DOI 10.1093/nar/17.1.1; STIRLING DA, 1989, MOL MICROBIOL, V3, P1025, DOI 10.1111/j.1365-2958.1989.tb00253.x; STRAUS D, 1985, P NATL ACAD SCI USA, V82, P2014, DOI 10.1073/pnas.82.7.2014; YARUS M, 1972, NATURE-NEW BIOL, V239, P106, DOI 10.1038/newbio239106a0	56	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10022	10027						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144499				2022-12-27	WOS:A1994NE05300094
J	ZHENG, YW; YEN, TSB				ZHENG, YW; YEN, TSB			NEGATIVE REGULATION OF HEPATITIS-B VIRUS GENE-EXPRESSION AND REPLICATION BY OXIDATIVE STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; KAPPA-B; ACTIVATION; PROTEIN; TRANSCRIPTION; RESPONSES; RECOGNIZE; ANTIGEN; CELLS	We present data demonstrating that hydrogen peroxide markedly decreases release of progeny hepatitis B virus particles in cultured cells. The presence of reduced glutathione prevents this effect. Hydrogen peroxide also decreases secretion of the hepatitis B virus surface and e antigens, with a concomitant decrease in the steady-state levels of the corresponding viral transcripts. This effect is specific to viral gene expression, since hydrogen peroxide at the concentration used does not have any significant effect on the overall pattern of host cell protein synthesis nor on the secretion of growth hormone from a co-transfected plasmid. Since hepatitis E virus can cause acute and chronic hepatitis and since inflammatory cells release significant amounts of reactive oxygen species, including hydrogen peroxide, this phenomenon may be of pathophysiological importance in the viral life cycle.	UNIV CALIF SAN FRANCISCO,VET ADM MED CTR,DEPT PATHOL 113B,SAN FRANCISCO,CA 94121	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)								AHERN H, 1991, ASM NEWS, V57, P627; BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403; BRUSS V, 1991, P NATL ACAD SCI USA, V88, P1059, DOI 10.1073/pnas.88.3.1059; CERUTTI PA, 1991, CANCER CELL-MON REV, V3, P1; DEMPLE B, 1991, CELL, V67, P837, DOI 10.1016/0092-8674(91)90355-3; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; GANEM D, 1987, ANNU REV BIOCHEM, V56, P651, DOI 10.1146/annurev.biochem.56.1.651; GILLES PN, 1992, J VIROL, V66, P3955, DOI 10.1128/JVI.66.6.3955-3960.1992; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; HOLLINGER FB, 1990, VIROLOGY, P2171; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; MONDELLI M, 1982, J IMMUNOL, V129, P2773; NOSE K, 1991, EUR J BIOCHEM, V201, P99, DOI 10.1111/j.1432-1033.1991.tb16261.x; OU JH, 1990, J VIROL, V64, P4578, DOI 10.1128/JVI.64.9.4578-4581.1990; PENNA A, 1991, J EXP MED, V174, P1565, DOI 10.1084/jem.174.6.1565; PENNA A, 1992, J VIROL, V66, P1193, DOI 10.1128/JVI.66.2.1193-1198.1992; Sambrook J, 1989, MOL CLONING LABORATO; SCHNEIDERSCHAULIES S, 1992, J VIROL, V66, P5534, DOI 10.1128/JVI.66.9.5534-5541.1992; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SHIBANUMA M, 1991, CELL GROWTH DIFFER, V2, P583; SIFLINGERBIRNBOIM A, 1992, LAB INVEST, V67, P24; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; VALENZUELA P, 1980, ANIMAL VIRUS GENETIC, P57; YAGINUMA K, 1989, J VIROL, V63, P2914, DOI 10.1128/JVI.63.7.2914-2920.1989; YEN TSB, 1993, SEMIN VIROL, V4, P33; ZHOU DX, 1990, J BIOL CHEM, V265, P20731	27	26	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8857	8862						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132621				2022-12-27	WOS:A1994NB41100038
J	APARICIO, JF; CAFFREY, P; MARSDEN, AFA; STAUNTON, J; LEADLAY, PF				APARICIO, JF; CAFFREY, P; MARSDEN, AFA; STAUNTON, J; LEADLAY, PF			LIMITED PROTEOLYSIS AND ACTIVE-SITE STUDIES OF THE FIRST MULTIENZYME COMPONENT OF THE ERYTHROMYCIN-PRODUCING POLYKETIDE SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; FATTY-ACID SYNTHASE; SACCHAROPOLYSPORA-ERYTHRAEA; MULTIFUNCTIONAL ENZYME; DOMAIN-STRUCTURE; ORGANIZATION; SEQUENCE; PROTEINS; BIOSYNTHESIS; QUANTITIES	The domain structure of the 6-deoxyerythronolide B synthase 1 component of the erythromycin-producing polyketide synthase from Saccharopolyspora erythraea has been investigated using limited proteolysis and active-site labeling. Trypsin, elastase, endoproteinase Glu-C, and endoproteinase Arg-C were used to cleave the multienzyme, and the sizes of the resulting fragments were assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The location of fragments within the primary structure was established by N-terminal sequence analysis. The cleavage pattern followed domain boundaries previously predicted on the basis of sequence alignments, but many predicted interdomain regions were not cleaved, even under the harshest conditions used. Initial proteolysis generated three large fragments: an N-terminal fragment (about 60 kDa) housing an acyltransferase-acyl carrier protein di-domain; a central fragment (about 90 kDa) containing a ketosynthase-acyltransferase di-domain; and a C-terminal fragment (about 220 kDa) containing the remaining six domains of the multienzyme, including the third acyltransferase. The intact multienzyme behaves as a dimer of molecular mass 660 kDa on gel filtration; and the C-terminal fragment remains dimeric. However, the N-terminal and central fragments appear to be monomeric species. After proteolysis of the multienzyme, the N-terminal di-domain was found to be specifically labeled after incubation with [C-14]propionyl-CoA, providing the first evidence for its proposed role as a ''loading domain'' for the propionate starter unit. In contrast, the other two fragments were specifically acylated by [C-14]methylmalonyl-CoA, indicating that both the other two acyltransferases remain enzymatically active after proteolysis.	UNIV CAMBRIDGE,DEPT BIOCHEM,CAMBRIDGE CB2 1QW,CAMBS,ENGLAND; UNIV CAMBRIDGE,DEPT ORGAN CHEM,CAMBRIDGE CB2 1QW,CAMBS,ENGLAND; UNIV CAMBRIDGE,CAMBRIDGE CTR MOLEC RECOGNIT,CAMBRIDGE CB2 1QW,CAMBS,ENGLAND	University of Cambridge; University of Cambridge; University of Cambridge			Caffrey, Patrick/B-1409-2008; Aparicio, Jesús F./K-8686-2014	Aparicio, Jesús F./0000-0003-4242-4701; Leadlay, Peter/0000-0002-3247-509X				BEVITT DJ, 1992, EUR J BIOCHEM, V204, P39, DOI 10.1111/j.1432-1033.1992.tb16603.x; BLEILE DM, 1979, P NATL ACAD SCI USA, V76, P4385, DOI 10.1073/pnas.76.9.4385; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAFFREY P, 1992, FEBS LETT, V304, P225, DOI 10.1016/0014-5793(92)80624-P; COGGINS JR, 1986, MULTIDOMAIN PROTEINS, P1; Corcoran JW, 1981, ANTIBIOTICS, P132; CORTES J, 1990, NATURE, V348, P176, DOI 10.1038/348176a0; DONADIO S, 1992, GENE, V111, P51, DOI 10.1016/0378-1119(92)90602-L; DONADIO S, 1991, SCIENCE, V252, P675, DOI 10.1126/science.2024119; EDELMAN GM, 1973, SCIENCE, V180, P830, DOI 10.1126/science.180.4088.830; FONTANA A, 1986, BIOCHEMISTRY-US, V25, P1847, DOI 10.1021/bi00356a001; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARSDEN AFA, 1994, IN PRESS SCIENCE; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; ROBERTS GA, 1993, EUR J BIOCHEM, V214, P305, DOI 10.1111/j.1432-1033.1993.tb17925.x; ROSSMANN MG, 1981, ANNU REV BIOCHEM, V50, P497, DOI 10.1146/annurev.bi.50.070181.002433; RUBENSTEIN DS, 1991, J BIOL CHEM, V266, P11252; SENO ET, 1986, BACTERIA, V9, P231; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P481, DOI 10.1111/j.1432-1033.1983.tb07490.x; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; WITKOWSKI A, 1991, EUR J BIOCHEM, V198, P571, DOI 10.1111/j.1432-1033.1991.tb16052.x	26	88	94	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8524	8528						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132579				2022-12-27	WOS:A1994NB40900104
J	HORI, H; FENNA, RE; KIMURA, S; IKEDASAITO, M				HORI, H; FENNA, RE; KIMURA, S; IKEDASAITO, M			AROMATIC SUBSTRATE MOLECULES BIND AT THE DISTAL HEME POCKET OF MYELOPEROXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLEEN GREEN HEMEPROTEIN; HORSERADISH-PEROXIDASE; LIGAND-BINDING; CHLORINATING ACTIVITY; SPECTRAL PROPERTIES; PROSTHETIC GROUP; LACTOPEROXIDASE; COMPLEXES; RESONANCE; CHLORIDE	Binding of aromatic substrate molecules to myeloperoxidase has been investigated by EPR spectroscopy and model building. Binding of aromatic substrate molecules, such as phenol, p-cresol, resorcinol, and 4-amino salicylate, replaces the original rhombic high spin EPR spectrum of the ferric enzyme (g = 6.74, 5.18, and 1.97) by another high spin signal (g = 7.04, 4.87, and 1.93) indicating that these substrate molecules bind near the heme center of the enzyme. Salicylhydroxamic acid and benzohydroxamic acid complexes of myeloperoxidase showed EPR spectra composed of high spin (g = 6.99, 4.93, and 1.95) and low spin (2.66, 2.22, and 1.81) signals. The hydroxamic side chains of these two substrates seem to interact with the heme iron. Model building based on the three-dimensional structure of the enzyme (Zeng, J., and Fenna, R. E. (1992) J. Mel. Biol. 226, 185-207) revealed the presence of a hydrophobic pocket at the entrance of the distal heme cavity where the aromatic ring of these substrates can bind. Moreover, the six-membered ring portion of salicylhydroxamic acid and benzohydroxamic acid could bind to this hydrophobic pocket with the hydroxamic side chain placed between the imidazole of the distal His and the heme iron. The EPR results on lactoperoxidase and intestinal peroxidase also suggest the presence of an aromatic substrate binding site similar to that of myeloperoxidase.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT PHYSIOL & BIOPHYS,CLEVELAND,OH 44106; OSAKA UNIV,FAC ENGN SCI,DEPT BIOPHYS ENGN,TOYONAKA,OSAKA 560,JAPAN; UNIV MIAMI,SCH MED,DEPT BIOCHEM & MOLEC BIOL,MIAMI,FL 33101; NCI,MOLEC CARCINOGENESIS LAB,BETHESDA,MD 20892	Case Western Reserve University; Osaka University; University of Miami; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Ikeda-Saito, Masao/K-2703-2015; Ikeda-Saito, Masao/A-5992-2008		NCRR NIH HHS [RR05695] Funding Source: Medline; NIGMS NIH HHS [GM49149, GM39492] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR005695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049149, R01GM039492] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BABCOCK GT, 1985, BIOCHIM BIOPHYS ACTA, V828, P58, DOI 10.1016/0167-4838(85)90009-3; BAKKENIST ARJ, 1978, BIOCHIM BIOPHYS ACTA, V524, P45, DOI 10.1016/0005-2744(78)90101-8; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V784, P177, DOI 10.1016/0167-4838(84)90125-0; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V791, P75, DOI 10.1016/0167-4838(84)90283-8; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V788, P1, DOI 10.1016/0167-4838(84)90290-5; BRACETE AM, 1991, BIOCHIM BIOPHYS ACTA, V1080, P264, DOI 10.1016/0167-4838(91)90012-O; CALS MM, 1991, EUR J BIOCHEM, V198, P733, DOI 10.1111/j.1432-1033.1991.tb16073.x; DUGAD LB, 1990, J BIOL CHEM, V265, P7173; ERMAN JE, 1992, J AM CHEM SOC, V114, P6592, DOI 10.1021/ja00042a068; GUPTA RK, 1979, BIOCHEM BIOPH RES CO, V89, P1334, DOI 10.1016/0006-291X(79)92155-7; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; HORI H, 1990, BIOCHEMISTRY-US, V29, P7106, DOI 10.1021/bi00482a023; IKEDASAITO M, 1985, J BIOL CHEM, V260, P1688; IKEDASAITO M, 1989, J BIOL CHEM, V264, P4559; IKEDASAITO M, 1985, FEBS LETT, V184, P52, DOI 10.1016/0014-5793(85)80651-7; IKEDASAITO M, 1985, J BIOL CHEM, V260, P8301; IKEDASAITO M, 1990, ARCH BIOCHEM BIOPHYS, V283, P351, DOI 10.1016/0003-9861(90)90653-G; IKEDASAITO M, 1991, J BIOL CHEM, V266, P3611; KETTLE AJ, 1992, J BIOL CHEM, V267, P8319; KIMURA S, 1988, PROTEINS, V3, P113, DOI 10.1002/prot.340030206; KIMURA S, 1978, ARCH BIOCHEM BIOPHYS, V189, P14, DOI 10.1016/0003-9861(78)90108-X; LAMAR GN, 1992, BIOCHEMISTRY-US, V31, P9158, DOI 10.1021/bi00153a007; MAGUIRE RJ, 1971, CAN J BIOCHEM CELL B, V49, P1165, DOI 10.1139/o71-167; MODI S, 1989, BIOCHIM BIOPHYS ACTA, V996, P214, DOI 10.1016/0167-4838(89)90250-1; MORRISON M, 1976, ANNU REV BIOCHEM, V45, P861, DOI 10.1146/annurev.bi.45.070176.004241; SCHONBAUM GR, 1973, J BIOL CHEM, V248, P502; SMULEVICH G, 1991, BIOCHEMISTRY-US, V30, P772, DOI 10.1021/bi00217a029; TAMURA M, 1971, BIOCHIM BIOPHYS ACTA, V243, P239, DOI 10.1016/0005-2795(71)90081-X; THANABAL V, 1989, BIOCHEMISTRY-US, V28, P7038, DOI 10.1021/bi00443a039; THANABAL V, 1987, J AM CHEM SOC, V109, P7516, DOI 10.1021/ja00258a043; WEVER R, 1981, BIOCHIM BIOPHYS ACTA, V661, P235, DOI 10.1016/0005-2744(81)90009-7; WEVER R, 1991, J BIOL CHEM, V266, P24308; YOSHIMURA T, 1984, ARCH BIOCHEM BIOPHYS, V230, P466, DOI 10.1016/0003-9861(84)90427-2; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5; ZUURBIER KWM, 1990, BIOCHIM BIOPHYS ACTA, V1037, P140, DOI 10.1016/0167-4838(90)90159-D	35	56	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8388	8392						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132563				2022-12-27	WOS:A1994NB40900084
J	ISLAM, TA; MILLERMARTINI, DM; HOROWITZ, PM				ISLAM, TA; MILLERMARTINI, DM; HOROWITZ, PM			MUTATION OF CYSTEINE-254 FACILITATES THE CONFORMATIONAL-CHANGES ACCOMPANYING THE INTERCONVERSION OF PERSULFIDE-SUBSTITUTED AND PERSULFIDE-FREE RHODANESE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE LIVER RHODANESE; CATALYSIS; SEQUENCE; PROTEINS; ENZYME; FLUORESCENCE; MECHANISM; COVALENT; RESIDUES; BINDING	Mutants of rhodanese (EC 2.8.1.1) that substitute Ser for Cys-254 and/or Cys-263, i.e. C254S, C263S, and the double mutant C254/263S, were compared with the wild-type enzyme to test the hypothesis that the persulfide formation to give sulfur-substituted rhodanese (ES) during catalysis can exert a stabilizing influence on the global structure of the protein. Ah the ES forms were quite refractory toward limited tryptic digestion. Extensive digestion was observed only in the persulfide-free forms (E) of mutants having substitutions of Ser for Cys-254 (C254/263S and C254S). Limited proteolysis of C254/263S produced a species on SDS gels at approximately 21 kDA that was proteolyzed further to give a slightly smaller product. Amino acid sequencing, together with mass spectrometry, indicated that these two components had the same N-terminal sequence as wild-type rhodanese and that they resulted from cleavage in the C-terminal domain, first at residues Arg-186 or Arg-182 and subsequently at Arg-175 or Lys-174. In addition to increased proteolytic susceptibility, the conversion from ES to E of C254/263S was accompanied by increased hydrophobic exposure and increased quenching of the intrinsic protein fluorescence by acrylamide. The substitution of Ser for Cys-254, within the helix suggested to be involved in stabilizing the persulfide bond in ES, seems to promote the formation of flexible conformations of sulfur-free rhodanese. In keeping with this model, C254/263S shows a marked increase in the hysteresis that is observed in rhodanese catalysis at pH 7 and high ionic strength. These results can be understood in terms of a model, suggesting that there is mutual stabilization of the protein structure and the persulfide bond in the ES form of rhodanese.	UNIV TEXAS,HLTH SCI CTR,DEPT BIOCHEM,SAN ANTONIO,TX 78284	University of Texas System; University of Texas Health San Antonio					NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025177] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES05729] Funding Source: Medline; NIGMS NIH HHS [GM25177] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGRO A F, 1972, European Journal of Biochemistry, V28, P89; BLUMENTHAL KM, 1972, BIOCHIM BIOPHYS ACTA, V278, P530, DOI 10.1016/0005-2795(72)90013-X; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CHOW SF, 1985, J BIOL CHEM, V260, P9593; CHOW SF, 1985, J BIOL CHEM, V260, P2763; DAVIDSON B, 1965, J BIOL CHEM, V241, P5168; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; GUIDO K, 1976, BIOCHIM BIOPHYS ACTA, V427, P600, DOI 10.1016/0005-2795(76)90203-8; HOROWITZ P, 1983, J BIOL CHEM, V258, P7894; HOROWITZ P, 1983, BIOCHIM BIOPHYS ACTA, V747, P37, DOI 10.1016/0167-4838(83)90118-8; HOROWITZ PM, 1985, BIOCHEMISTRY-US, V24, P2587, DOI 10.1021/bi00332a001; HOROWITZ PM, 1990, J BIOL CHEM, V265, P2576; KURZBAN GP, 1989, BIOCHEMISTRY-US, V28, P8537, DOI 10.1021/bi00447a040; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MASSEY V, 1970, J BIOL CHEM, V245, P6595; MCCLURE WO, 1967, BIOCHEMISTRY-US, V6, P559, DOI 10.1021/bi00854a025; MERRILL GA, 1993, J BIOL CHEM, V268, P15611; MILLER DM, 1992, BIOCHIM BIOPHYS ACTA, V1121, P286, DOI 10.1016/0167-4838(92)90158-A; MILLER DM, 1991, J BIOL CHEM, V266, P4686; PLOEGMAN JH, 1978, J MOL BIOL, V123, P557, DOI 10.1016/0022-2836(78)90207-3; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; PLOEGMAN JH, 1973, THESIS U GRONINGEN G; RUSSELL J, 1978, J BIOL CHEM, V253, P8102; SCHLESINGER P, 1974, J BIOL CHEM, V249, P780; SORBO B, 1973, ACTA CHEM SCAND, V7, P1123; WANG SF, 1973, J BIOL CHEM, V248, P7376; WANG SF, 1968, J BIOL CHEM, V243, P5465; WENG L, 1978, J BIOL CHEM, V253, P8109; WENG L, 1978, J BIOL CHEM, V253, P8093; WESTLEY J, 1973, ADV ENZYMOL RAMB, V39, P327; Westley J., 1977, BIOORG CHEM, V1, P371	31	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7908	7913						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132509				2022-12-27	WOS:A1994NB40900015
J	MARQUEZ, LA; DUNFORD, HB				MARQUEZ, LA; DUNFORD, HB			CHLORINATION OF TAURINE BY MYELOPEROXIDASE - KINETIC EVIDENCE FOR AN ENZYME-BOUND INTERMEDIATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; HALOGENATION REACTIONS; ISOLATED NEUTROPHILS; HYPOCHLOROUS ACID; CHLORIDE; CHLOROPEROXIDASE; MECHANISM; OXIDANT; SPLEEN; CHLORAMINES	The chlorination of taurine by the myeloperoxidase-H2O2-Cl- system was investigated under steady state conditions. By systematically varying the pH and the concentrations of H2O2, Cl-, and taurine such that chloride inhibition and the unwanted formation of inactive compound II intermediate are minimized, rate data were found to fit a mechanism involving an enzyme-bound chlorinating intermediate. The mechanism we propose is as follows. [GRAPHICS] The kinetic parameters determined at pH 4.7 are: k(1) = (3.3 +/- 0.2) x 10(7) M(-1) S-1, k(2) = (2.8 +/- 1.2) x 10(6) M(-1) S-1, and k(3) = (4.4 +/- 0.2) x 10(5) M(-1) S-1. The rate constant for compound I formation (k(1)) is of the same order of magnitude as the value (1.8 x 10(7) M(-1) S-1) obtained using transient state techniques in a previous study by our group. The value of k(3) is 2 orders of magnitude greater than the nonenzymatic reaction between HOCl and taurine at the same pH. The results of this study indicate that the chlorination reaction mediated by the myeloperoxidase system in vivo may involve an enzyme intermediate species rather than free HOCl. Not only does this mechanism offer the advantage of substrate specificity but also of speed compared to the non-enzymatic reaction. This mechanism can also explain how the indiscriminate oxidation reactions by HOCl are prevented in the leukocyte. The fast formation of taurine monochloramine, a relatively nontoxic and stable compound compared to HOCl, is consistent with the proposed role of taurine in the neutrophil, that of protecting certain targets including myeloperoxidase from the attack by potent chlorinated oxidants.	UNIV ALBERTA,DEPT CHEM,EDMONTON T6G 2G2,AB,CANADA	University of Alberta			Marquez-Curtis, Leah A/M-7152-2015	Marquez-Curtis, Leah A/0000-0002-4047-2227				AGNER K, 1958, ACTA CHEM SCAND, V12, P89, DOI 10.3891/acta.chem.scand.12-0089; Agner K., 1972, STRUCTURE FUNCTION O, P329; ALBRICH JM, 1981, P NATL ACAD SCI-BIOL, V78, P210, DOI 10.1073/pnas.78.1.210; ANDREWS PC, 1982, J BIOL CHEM, V257, P13240; BAKKENIST ARJ, 1980, BIOCHIM BIOPHYS ACTA, V613, P337, DOI 10.1016/0005-2744(80)90088-1; BARBEAU A, 1978, TAURINE NEUROLOGICAL; BARON DN, 1969, CLIN SCI, V37, P205; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V788, P1, DOI 10.1016/0167-4838(84)90290-5; BRAUER G, 1960, HDB PREPARATIVE INOR, V1, P272; COCHRANE CG, 1983, J CLIN INVEST, V71, P754, DOI 10.1172/JCI110823; COTTON ML, 1973, CAN J CHEM, V51, P582, DOI 10.1139/v73-088; DAVIS JC, 1981, J BIOL CHEM, V256, P5992; DAVIS JC, 1984, INORG CHIM A-BIOINOR, V93, pL49, DOI 10.1016/S0020-1693(00)88148-7; DUNFORD HB, 1987, ARCH BIOCHEM BIOPHYS, V252, P292, DOI 10.1016/0003-9861(87)90034-8; FUKADA K, 1982, CLIN CHEM, V28, P1758; GRISHAM MB, 1984, J BIOL CHEM, V259, P404; HAGER LP, 1970, BIOCH PHAGOCYTIC PRO, P67; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; HARRISON JE, 1976, CANCER ENZYMOLOGY, P305; HAYES KC, 1981, ANNU REV NUTR, V1, P401, DOI 10.1146/annurev.nu.01.070181.002153; HELD AM, 1978, BIOCHEM BIOPH RES CO, V81, P878, DOI 10.1016/0006-291X(78)91433-X; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; IKEDASAITO M, 1985, J BIOL CHEM, V260, P1688; JENSEN MS, 1973, J CELL BIOL, V56, P379, DOI 10.1083/jcb.56.2.379; KETTLE AJ, 1988, BIOCHIM BIOPHYS ACTA, V957, P185, DOI 10.1016/0167-4838(88)90271-3; KLEBANOFF SJ, 1978, NEUTROPHIL FUNCTION, P409; Klebanoff SJ., 1988, INFLAMMATION BASIC P, P391; KURIYAMA K, 1985, SULFUR AMINO ACIDS B, P449; LAMBEIR AM, 1983, J BIOL CHEM, V258, P3558; LEARN DB, 1990, J LEUKOCYTE BIOL, V48, P174, DOI 10.1002/jlb.48.2.174; LEWIS CPL, 1990, BIOCHEM PHARMACOL, V39, P431, DOI 10.1016/0006-2952(90)90047-O; LIBBY RD, 1982, J BIOL CHEM, V257, P5030; LOMBARDINI JB, 1992, ADV EXP MED BIOL, V315; MARQUEZ LA, 1990, THESIS U ALBERTA; MCLOUGHLIN DM, 1991, BIOCHEM SOC T, V19, P73, DOI 10.1042/bst0190073; MORRISON M, 1976, ANNU REV BIOCHEM, V45, P861, DOI 10.1146/annurev.bi.45.070176.004241; NAKAMORI K, 1990, CHEM PHARM BULL, V38, P3116, DOI 10.1248/cpb.38.3116; NASKALSKI JW, 1977, BIOCHIM BIOPHYS ACTA, V485, P291, DOI 10.1016/0005-2744(77)90165-6; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Oja SS, 1985, TAURINE BIOL ACTIONS; SCHRAUFSTATTER IU, 1990, J CLIN INVEST, V85, P554, DOI 10.1172/JCI114472; SCHRAUFSTATTER IU, 1984, J CLIN INVEST, V73, P1175, DOI 10.1172/JCI111303; SCHULTZ J, 1962, ARCH BIOCHEM BIOPHYS, V96, P465, DOI 10.1016/0003-9861(62)90321-1; Soupart P., 1962, AMINO ACID POOLS, P220; STELMASZYNSKA T, 1974, EUR J BIOCHEM, V45, P305, DOI 10.1111/j.1432-1033.1974.tb03555.x; STELMASZYNSKA T, 1992, INT J BIOCHEM, V24, P121, DOI 10.1016/0020-711X(92)90237-U; SVENSSON BE, 1987, BIOCHEM J, V242, P673, DOI 10.1042/bj2420673; Thomas E L, 1986, Methods Enzymol, V132, P569; Thomas E L, 1986, Methods Enzymol, V132, P585; THOMAS EL, 1983, J CLIN INVEST, V72, P441, DOI 10.1172/JCI110992; TRACHTMAN H, 1993, BIOCHEM BIOPH RES CO, V191, P759, DOI 10.1006/bbrc.1993.1282; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; WINTERBOURN CC, 1985, BIOCHIM BIOPHYS ACTA, V840, P204, DOI 10.1016/0304-4165(85)90120-5; WRIGHT CE, 1986, ANNU REV BIOCHEM, V55, P427, DOI 10.1146/annurev.bi.55.070186.002235; Zgliczynski J. M., 1980, RETICULOENDOTHELIAL, V2, P255; ZGLICZYNSKI JM, 1971, BIOCHIM BIOPHYS ACTA, V235, P419, DOI 10.1016/0005-2744(71)90281-6; ZGLICZYNSKI JM, 1977, P SOC EXP BIOL MED, V154, P418	57	125	125	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7950	7956						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132515				2022-12-27	WOS:A1994NB40900021
J	BOCK, K; SCHUSTERKOLBE, J; ALTMAN, E; ALLMAIER, G; STAHL, B; CHRISTIAN, R; SLEYTR, UB; MESSNER, P				BOCK, K; SCHUSTERKOLBE, J; ALTMAN, E; ALLMAIER, G; STAHL, B; CHRISTIAN, R; SLEYTR, UB; MESSNER, P			PRIMARY STRUCTURE OF THE O-GLYCOSIDICALLY LINKED GLYCAN CHAIN OF THE CRYSTALLINE SURFACE-LAYER GLYCOPROTEIN OF THERMOANAEROBACTER-THERMOHYDROSULFURICUS L111-69 - GALACTOSYL TYROSINE AS A NOVEL LINKAGE UNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZATION MASS-SPECTROMETRY; ASSISTED LASER DESORPTION; CARBOHYDRATE CHAINS; CLOSTRIDIUM-THERMOCELLUM; REGULAR ARRAYS; CELL-WALLS; OLIGOSACCHARIDES; ACID; MATRIX; GLYCOSYLATION	The products of Pronase digestion of the crystalline surface layer (S-layer) glycoproteins of Thermoanaerobacter thermohydrosulfuricus strains L111-69 and L110-69 were isolated by gel permeation chromatography, cation exchange chromatography, chromatofocusing, and reversed phase high performance liquid chromatography. Four compounds were obtained which were analyzed by monosaccharide analysis, one- and two-dimensional 500 and 600 MHz H-1 and C-13 NMR spectroscopy, methylation analysis, gas-liquid chromatography/mass spectrometry, and matrix-assisted laser desorption ionization mass spectrometry. For all glycopeptides we propose the following glycan structure with galactose as the linkage sugar. 3-OMeLRhap alpha 1-[4DManp alpha 1-3LRhap alpha 1](n similar to 27) -4DManp alpha 1- 3LRhap alpha 1-3LRhap alpha 1-3LRhap alpha 1-3DGalp beta 1-OTyr STRUCTURE 1 The isolated glycopeptides resulted from Pronase cleavage at the glycosylated tyrosine residues. Tyrosine was found as the linkage amino acid in all fractions but the remaining amino acid sequences varied, indicating the presence of different glycosylation sites in the intact S-layer glycoprotein.	UNIV WIEN, ZENTRUM ULTRASTRUKTURFORSCH, A-1180 VIENNA, AUSTRIA; UNIV WIEN, LUDWIG BOLTZMANN INST MOLEK NANOTECHNOL, A-1180 VIENNA, AUSTRIA; CARLSBERG LAB, DEPT CHEM, DK-2500 VALBY, DENMARK; NATL RES COUNCIL CANADA, INST BIOL SCI, OTTAWA K1A 0R6, ON, CANADA; UNIV MUNSTER, INST MED PHYS & BIOPHYS, D-48149 MUNSTER, GERMANY; SCI SOFTWARE CO, A-1140 VIENNA, AUSTRIA	University of Vienna; Ludwig Boltzmann Institute; University of Vienna; National Research Council Canada; University of Munster			Allmaier, Guenter/F-2604-2012; Messner, Paul/Q-5345-2017	Messner, Paul/0000-0002-3246-5801; Schuster, Judith/0000-0002-5637-3688				ALTMAN E, 1988, CARBOHYD RES, V179, P245, DOI 10.1016/0008-6215(88)84122-3; ALTMAN E, 1992, BIOCHIM BIOPHYS ACTA, V1117, P71, DOI 10.1016/0304-4165(92)90164-P; AON MA, 1985, BIOCHEM J, V299, P269; BOCK K, 1990, CARBOHYD RES, V200, P33, DOI 10.1016/0008-6215(90)84180-3; BOCK K, 1991, CARBOHYD RES, V211, P219, DOI 10.1016/0008-6215(91)80093-3; CHRISTIAN R, 1988, CARBOHYD RES, V176, P160, DOI 10.1016/0008-6215(88)84069-2; CHRISTIAN R, 1993, J BACTERIOL, V175, P1250, DOI 10.1128/JB.175.5.1250-1256.1993; CUMMINGS RD, 1992, GLYCOCONJUGATES COMP, P333; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; FEIGL P, 1983, INT J MASS SPECTROM, V47, P15, DOI 10.1016/0020-7381(83)87125-3; GERWIG GJ, 1989, J BIOL CHEM, V264, P1027; GERWIG GJ, 1991, EUR J BIOCHEM, V196, P115, DOI 10.1111/j.1432-1033.1991.tb15793.x; GORIN PAJ, 1965, CAN J CHEMISTRY, V43, P2978, DOI 10.1139/v65-412; GUNNER SW, 1961, CAN J CHEM, V39, P1892, DOI 10.1139/v61-254; HAKOMORI SI, 1964, J BIOCHEM-TOKYO, V55, P205; HARTMANN E, 1989, ARCH MICROBIOL, V151, P274, DOI 10.1007/BF00413142; HARTMANN E, 1993, J BACTERIOL, V175, P4515, DOI 10.1128/JB.175.14.4515-4519.1993; HASELBECK A, 1990, GLYCOCONJUGATE J, V7, P63, DOI 10.1007/BF01050403; ISOBE M, 1981, AGR BIOL CHEM TOKYO, V45, P687, DOI 10.1080/00021369.1981.10864566; KARCHER U, 1993, J BIOL CHEM, V268, P26821; Kochetkov N K, 1966, Adv Carbohydr Chem Biochem, V21, P39; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KUPCU Z, 1984, FEBS LETT, V173, P185, DOI 10.1016/0014-5793(84)81043-1; LECHNER J, 1989, ANNU REV BIOCHEM, V58, P173, DOI 10.1146/annurev.bi.58.070189.001133; LEE YE, 1993, INT J SYST BACTERIOL, V43, P41, DOI 10.1099/00207713-43-1-41; LU PW, 1982, INSECT BIOCHEM, V12, P377, DOI 10.1016/0020-1790(82)90034-8; MATTEUZZI D, 1978, INT J SYST BACTERIOL, V28, P528, DOI 10.1099/00207713-28-4-528; MESSNER P, 1984, INT J SYST BACTERIOL, V34, P202, DOI 10.1099/00207713-34-2-202; MESSNER P, 1992, J BACTERIOL, V174, P2236, DOI 10.1128/JB.174.7.2236-2240.1992; MESSNER P, 1992, ADV MICROB PHYSIOL, V33, P213, DOI 10.1016/S0065-2911(08)60218-0; MESSNER P, 1993, NATO ADV SCI INST SE, V252, P95; MESSNER P, 1988, BACTERIAL CELL SURFA, P97; MICHON F, 1989, CARBOHYD RES, V194, P321, DOI 10.1016/0008-6215(89)85033-5; MOCK KK, 1991, BIOCHEM BIOPH RES CO, V177, P644, DOI 10.1016/0006-291X(91)91837-3; Montreuil J, 1986, CARBOHYDRATE ANAL PR, P143; MORT AJ, 1977, ANAL BIOCHEM, V82, P289, DOI 10.1016/0003-2697(77)90165-8; OCONNELL B, 1991, BIOCHEM BIOPH RES CO, V180, P1024, DOI 10.1016/S0006-291X(05)81168-4; OGATA S, 1982, ANAL BIOCHEM, V119, P351, DOI 10.1016/0003-2697(82)90597-8; RODRIGUEZ IR, 1985, BIOCHEM BIOPH RES CO, V132, P829, DOI 10.1016/0006-291X(85)91206-9; SARA M, 1989, ARCH MICROBIOL, V151, P416, DOI 10.1007/BF00416600; SCHOMBURG D, 1991, ENZYME HDB CLASS 3 H, V4; Sleytr U B, 1978, Int Rev Cytol, V53, P1, DOI 10.1016/S0074-7696(08)62240-8; SLEYTR UB, 1976, J BACTERIOL, V126, P377, DOI 10.1128/JB.126.1.377-383.1976; SLEYTR UB, 1976, J BACTERIOL, V126, P869, DOI 10.1128/JB.126.2.869-882.1976; SLEYTR UB, 1983, ANNU REV MICROBIOL, V37, P311, DOI 10.1146/annurev.mi.37.100183.001523; STAHL B, 1991, ANAL CHEM, V63, P1463, DOI 10.1021/ac00014a022; STRUCK DK, 1980, BIOCH GLYCOPROTEINS, P35; STRUPAT K, 1991, INT J MASS SPECTROM, V111, P89, DOI 10.1016/0168-1176(91)85050-V; SVENSON SB, 1979, J VIROL, V32, P583, DOI 10.1128/JVI.32.2.583-592.1979; TEESCH LM, 1992, ORG MASS SPECTROM, V27, P931, DOI 10.1002/oms.1210270902; WILSON IBH, 1991, BIOCHEM J, V275, P529, DOI 10.1042/bj2750529; 1988, CHROMATOFOCUSING POL	52	81	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7137	7144						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125923				2022-12-27	WOS:A1994NA03200018
J	DEVERAUX, Q; USTRELL, V; PICKART, C; RECHSTEINER, M				DEVERAUX, Q; USTRELL, V; PICKART, C; RECHSTEINER, M			A 26-S PROTEASE SUBUNIT THAT BINDS UBIQUITIN CONJUGATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RABBIT RETICULOCYTE LYSATE; ATP-DEPENDENT PROTEASES; IDENTIFICATION; PURIFICATION; DEGRADATION; CYCLIN; ENZYME; CELLS	Ubiquitin-mediated proteolysis provides an important mechanism for regulating a variety of cellular processes. Ubiquitin-conjugated proteins are degraded by a 26 S protease that contains more than 30 different subunits. Of these, a single 50-kDa polypeptide, subunit 5, specifically binds ubiquitin-lysozyme conjugates. Binding is inhibited by short polymeric chains of ubiquitin but not by ubiquitin monomers or by lysozyme. In addition, subunit 5 binds free ubiquitin chains with efficient association requiring at least four ubiquitins. Thus, proteins conjugated to polymers of ubiquitin may be selected for degradation by a single subunit of the 26 S protease complex.	SUNY BUFFALO,DEPT BIOCHEM,BUFFALO,NY 14214	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	DEVERAUX, Q (corresponding author), UNIV UTAH,SCH MED,DEPT BIOCHEM,SALT LAKE CITY,UT 84132, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037009] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 37009] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; COOK WJ, 1992, J BIOL CHEM, V267, P16467; COOK WJ, 1994, IN PRESS J MOL BIOL; DEVERAUX Q, 1990, J BIOL CHEM, V265, P6323; DUBIEL W, 1993, FEBS LETT, V323, P276, DOI 10.1016/0014-5793(93)81356-5; DUBIEL W, 1992, J BIOL CHEM, V267, P22699; EYTAN E, 1993, J BIOL CHEM, V268, P4668; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; HOUGH R, 1986, J BIOL CHEM, V261, P2400; HOUGH R, 1987, J BIOL CHEM, V262, P8303; HOUGH R, 1986, J BIOL CHEM, V261, P2391; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; PICKART CM, 1992, J BIOL CHEM, V267, P14418; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; RIVETT AJ, 1993, BIOCHEM J, V291, P1; SHANKLIN J, 1987, P NATL ACAD SCI USA, V84, P359, DOI 10.1073/pnas.84.2.359	24	596	605	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7059	7061						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125911				2022-12-27	WOS:A1994NA03200004
J	JORDAN, ET; GOLDSTEIN, IJ				JORDAN, ET; GOLDSTEIN, IJ			THE SEQUENCE OF A 2ND MEMBER OF THE LIMA-BEAN LECTIN GENE FAMILY AND THE EXPRESSION AND CHARACTERIZATION OF RECOMBINANT LECTIN IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASEOLUS-LUNATUS; ADENINE BINDING; CONCANAVALIN-A; SEED LECTIN; PEA LECTIN; PROTEINS; PHYTOHEMAGGLUTININ; ELECTROPHORESIS; CARBOHYDRATE; RESOLUTION	The lima bean lectin recognizes terminal alpha-D GalNAc groups and agglutinates human type A erythrocytes. We have cloned a portion of the gene encoding the (alpha subunit of the lima bean lectin. The clone was obtained using the polymerase chain reaction and verified from a genomic clone encoding the mature protein of 253 amino acids. The deduced amino acid sequence has significant overall homology with other leguminous plant lectins and contains all of the known peptide sequences isolated from lima bean lectin (LBL). Southern blot analysis reveals the presence of several genes which hybridize to the cloned gene and which we propose are genes included in the lima bean lectin gene family. We report here the sequence, expression, and characterization of LBL 2, the second member of this gene family. Milligram quantities of soluble active recombinant lima bean lectin (LBL) were obtained from Escherichia coli, using the T7 RNA polymerase expression system. SDS polyacrylamide gel electrophoresis and Western blot analysis indicate expression of one protein band of about 27 kDa in induced E. coli cells. This protein crossreacts with polyclonal antibodies raised against seed lectin (sLBL) and gave a reaction of identity with seed lectin by Ouchterlony double diffusion, specifically agglutinates type A blood cells, and is specifically inhibited by D-GalNAc. The isoelectric point of rLBL is 5.86, whereas those of the seed lectin subunits were determined to be 5.86, 5.58, and 5.20 (previously designated alpha, beta, alpha(r), respectively). rLBL binds to hydrophobic ligands independent of sugar binding, an observation similar to results obtained with sLBL. However, despite the similar activities described, several significant differences between recombinant and native lima bean lectin were found, including mobility on gel filtration, aggregation in solution, and its CD spectrum. These differences may be due to a number of factors, which will be discussed.	UNIV MICHIGAN,DEPT BIOL CHEM,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan					NIGMS NIH HHS [GM 29470] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029470] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARANGO R, 1992, EUR J BIOCHEM, V205, P575, DOI 10.1111/j.1432-1033.1992.tb16815.x; ARANGO R, 1990, FEBS LETT, V264, P104; BOYD WC, 1949, J IMMUNOL, V62, P333; CARRINGTON DM, 1985, NATURE, V313, P64, DOI 10.1038/313064a0; CLAUSEN J, 1969, IMMUNOCHEMICAL TEC 3, V1; DELBAERE LTJ, 1993, J MOL BIOL, V230, P950, DOI 10.1006/jmbi.1993.1212; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; DEWENDA Z, 1989, EMBO J, V8, P2189; DOBRES MS, 1989, PLANT PHYSIOL, V89, P833, DOI 10.1104/pp.89.3.833; EINSPAHR H, 1986, J BIOL CHEM, V261, P6518; ELLISTON K, 1988, ARCHITECTURE EUKARYO, P21; GALBRAIT.W, 1972, BIOCHEMISTRY-US, V11, P3976, DOI 10.1021/bi00771a022; GOLDBERG RB, 1983, CELL, V33, P465, DOI 10.1016/0092-8674(83)90428-2; HARADA JJ, 1990, J BIOL CHEM, V265, P4997; HOFFMAN LM, 1985, EMBO J, V4, P883, DOI 10.1002/j.1460-2075.1985.tb03714.x; Hurn B A, 1980, Methods Enzymol, V70, P104; IMBRIEMILLIGAN C, 1989, J BIOL CHEM, V264, P16793; JOSIC D, 1984, ANAL BIOCHEM, V142, P473, DOI 10.1016/0003-2697(84)90492-5; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LORIS R, 1993, BIOCHEMISTRY-US, V32, P8772, DOI 10.1021/bi00085a007; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; MALIARIK MJ, 1988, J BIOL CHEM, V263, P11274; Maniatis T., 1982, MOL CLONING; MATSUDA H, 1990, MOL IMMUNOL, V27, P571, DOI 10.1016/0161-5890(90)90076-C; MISAKI A, 1977, J BIOL CHEM, V252, P6995; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; ROBERTS DD, 1986, PHYTOCHEMISTRY, V25, P589, DOI 10.1016/0031-9422(86)88004-9; ROBERTS DD, 1982, J BIOL CHEM, V257, P1274; ROBERTS DD, 1983, ARCH BIOCHEM BIOPHYS, V224, P479, DOI 10.1016/0003-9861(83)90235-7; ROBERTS DD, 1984, J BIOL CHEM, V259, P903; ROBERTS DD, 1982, J BIOL CHEM, V257, P9198; RUDDON RW, 1974, P NATL ACAD SCI USA, V71, P1848, DOI 10.1073/pnas.71.5.1848; SCHNELL DJ, 1987, EUR J BIOCHEM, V167, P227, DOI 10.1111/j.1432-1033.1987.tb13327.x; SHAANAN B, 1991, SCIENCE, V254, P862, DOI 10.1126/science.1948067; SHARON N, 1990, FASEB J, V4, P3198, DOI 10.1096/fasebj.4.14.2227211; SHERMAN F, 1982, MOL BIOL YEAST SACCH, P301; Steczko J, 1991, Protein Expr Purif, V2, P221, DOI 10.1016/1046-5928(91)90075-T; STUBBS ME, 1986, J BIOL CHEM, V261, P6141; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; VANBOGELEN RA, 1990, ELECTROPHORESIS, V11, P1131, DOI 10.1002/elps.1150111205; VODKIN LO, 1981, PLANT PHYSIOL, V68, P766, DOI 10.1104/pp.68.3.766; YAMAUCHI D, 1990, FEBS LETT, V260, P127, DOI 10.1016/0014-5793(90)80083-U; YARWOOD A, 1985, FEBS LETT, V184, P104, DOI 10.1016/0014-5793(85)80663-3; YOUNG NM, 1992, J MOL BIOL, V228, P924, DOI 10.1016/0022-2836(92)90875-K	45	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7674	7681						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125994				2022-12-27	WOS:A1994NA03200100
J	KOO, JS; SPREMULLI, LL				KOO, JS; SPREMULLI, LL			ANALYSIS OF THE TRANSLATIONAL INITIATION REGION ON THE EUGLENA-GRACILIS CHLOROPLAST RIBULOSE-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RBCL) MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC MUTAGENESIS; ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCES; PHENOTYPIC SELECTION; EUKARYOTIC RIBOSOMES; SECONDARY STRUCTURE; COMPLEX FORMS; BINDING-SITE; FACTOR-III; GENE	The chloroplast mRNAs from Euglena gracilis fall into two classes. One group of mRNAs from this organelle contains a Shine-Dalgarno sequence 5' to the start codon, while the other group of mRNAs does not have a conserved sequence signal in the 5'-untranslated region. To investigate the start signals for E. gracilis chloroplast mRNAs that do not carry a Shine-Dalgarno sequence, 30 S initiation complex formation has been studied using a series of transcripts carrying the wild-type translational start site of ribulose-bisphosphate carboxylase/oxygenase (rbcL) or mutated derivatives of this site. Mutation of the start codon of the rbcL gene indicates that the chloroplast 30 S subunit is recognizing only the correct AUG codon. The analysis of the messages from a series of deletion mutants shows that a minimum of Lambda 20 residues 5' to the AUG codon is required for activity. Maximal activity requires the full 55-base leader sequence. Surprisingly, a transcript carrying the inverse complement of 48 bases in the leader is Lambda 60% as active as the wild-type message in promoting initiation complex formation. Introduction of a Shine-Dalgarno sequence in the 5'-leader increases the activity of the mRNA only Lambda 1.4-2-fold. The presence of an oligodeoxynucleotide containing a strong Shine-Dalgarno sequence does not significantly inhibit the formation of initiation complexes at the rbcL start site. Similar results are obtained when initiation complexes are formed with initiation factors from either E. gracilis chloroplasts or Escherichia coli.	UNIV N CAROLINA, DEPT CHEM, CHAPEL HILL, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill			Koo, J Peter/AAE-6700-2019		NIGMS NIH HHS [GM24963] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024963] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BHANGU R, 1992, BIOCHEMISTRY-US, V31, P5937, DOI 10.1021/bi00140a033; BONHAMSMITH PC, 1989, NUCLEIC ACIDS RES, V17, P2057, DOI 10.1093/nar/17.5.2057; BORISOVA GP, 1979, NUCLEIC ACIDS RES, V6, P1761, DOI 10.1093/nar/6.5.1761; CANONACO MA, 1989, EUR J BIOCHEM, V182, P501, DOI 10.1111/j.1432-1033.1989.tb14856.x; CHRISTOPHER DA, 1989, NUCLEIC ACIDS RES, V17, P7591, DOI 10.1093/nar/17.19.7591; COPERTINO DW, 1991, NUCLEIC ACIDS RES, V19, P6491, DOI 10.1093/nar/19.23.6491; DESMIT MH, 1990, PROG NUCLEIC ACID RE, V38, P1; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; DRETZEN G, 1981, ANAL BIOCHEM, V112, P295, DOI 10.1016/0003-2697(81)90296-7; ECKHARDT H, 1981, BIOCHEMISTRY-US, V20, P2075, DOI 10.1021/bi00511a002; EVSTAFIEVA AG, 1983, EMBO J, V2, P799, DOI 10.1002/j.1460-2075.1983.tb01503.x; GINGRICH JC, 1985, J BIOL CHEM, V260, P6162; GOLD JC, 1985, J BIOL CHEM, V260, P4897; GOLD L, 1988, ANNU REV BIOCHEM, V57, P199, DOI 10.1146/annurev.bi.57.070188.001215; GRAVES MC, 1983, ARCH BIOCHEM BIOPHYS, V222, P192, DOI 10.1016/0003-9861(83)90516-7; GRAVES MC, 1980, ARCH BIOCHEM BIOPHYS, V204, P444, DOI 10.1016/0003-9861(80)90055-7; GREN EJ, 1984, BIOCHIMIE, V66, P1, DOI 10.1016/0300-9084(84)90188-3; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; GUALERZI CO, 1990, RIBOSOME, P281; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HUI A, 1987, P NATL ACAD SCI USA, V84, P4762, DOI 10.1073/pnas.84.14.4762; JACOB WF, 1987, P NATL ACAD SCI USA, V84, P4757, DOI 10.1073/pnas.84.14.4757; KOO JS, 1994, J BIOL CHEM, V269, P7501; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KRAUS BL, 1986, J BIOL CHEM, V261, P4781; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MA L, 1992, J BIOL CHEM, V267, P18356; MA L, 1990, J BIOL CHEM, V265, P13560; Maniatis T., 1982, MOL CLONING; MCCARTHY JEG, 1990, TRENDS GENET, V6, P78, DOI 10.1016/0168-9525(90)90098-Q; MCCLARY JA, 1989, BIOTECHNIQUES, V7, P282; Roney W.B., 1991, NATO ASI Series Series H Cell Biology, V55, P197; SCHMITT M, 1982, EUR J BIOCHEM, V125, P389, DOI 10.1111/j.1432-1033.1982.tb06695.x; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; STEEGE DA, 1982, J BIOL CHEM, V257, P430; STEITZ JA, 1969, NATURE, V224, P957, DOI 10.1038/224957a0; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2971, DOI 10.1093/nar/10.9.2971; SUTTLE DP, 1973, BIOCHEM BIOPH RES CO, V51, P376, DOI 10.1016/0006-291X(73)91268-0; WANG CC, 1989, NUCLEIC ACIDS RES, V17, P9735, DOI 10.1093/nar/17.23.9735; WANG CC, 1991, J BIOL CHEM, V266, P17079; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	44	17	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7494	7500						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125968				2022-12-27	WOS:A1994NA03200073
J	LAEGREID, A; MEDVEDEV, A; NONSTAD, U; BOMBARA, MP; RANGES, G; SUNDAN, A; ESPEVIK, T				LAEGREID, A; MEDVEDEV, A; NONSTAD, U; BOMBARA, MP; RANGES, G; SUNDAN, A; ESPEVIK, T			TUMOR-NECROSIS-FACTOR RECEPTOR P75 MEDIATES CELL-SPECIFIC ACTIVATION OF NUCLEAR FACTOR KAPPA-B AND INDUCTION OF HUMAN CYTOMEGALOVIRUS ENHANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; MOLECULAR-CLONING; VIRUS ENHANCER; PROTEIN-KINASE; TNF RECEPTORS; EXPRESSION; BINDING; 55-KDA; ALPHA; STIMULATION	The functional role of human tumor necrosis factor receptor (TNFR) p75 was studied by the use of TNFR p75-specific agonistic antibodies. Human SW480T adenocarcinoma cells, stably transfected with a reporter construct containing beta-galactosidase under the control of human cytomegalovirus immediate early enhancer, were stimulated with anti-TNFR p75 polyclonal antiserum or monoclonal antibodies followed by measurement of beta-galactosidase activity and analysis by electrophoretic mobility shift assays. It was found that cross-linking of TNFR p75 led to strong induction of the human cytomegalovirus enhancer as well as activation of nuclear factor-kappa B (NF-kappa B). Stimulation of TNFR p75 also mediated activation of NF-kappa B in human KYM-1 rhabdomyosarcoma cells but not in other cell types such as U937 and HL-60 monocytic cells or in Eahy 926 endothelial cells. NF-kappa B activation induced by TNFR p75 was delayed approximately 15 min compared with NF-kappa B activation induced by TNFR p55, indicating that the two TNFRs activate NF-kappa B through different signaling pathways. The data presented in this study identify intracellular responses mediated by TNFR p75 which have not been reported previously and suggest that TNFR p75-induced activation of NF-kappa B is strictly cell type-specific.	UNIV TRONDHEIM,INST CANC RES,N-7005 TRONDHEIM,NORWAY; UNIV TRONDHEIM,CTR MOLEC BIOL,UNIGEN,N-7005 TRONDHEIM,NORWAY; MILES INC,INST INFLAMMAT & EXPTL MED,W HAVEN,CT 06516									ABE Y, 1993, J IMMUNOL, V150, P5070; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127; CAMERINI D, 1991, J IMMUNOL, V147, P3165; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Edgell CJ, 1983, P NATL ACAD SCI USA, V80, P734; EMEIS JJ, 1988, BLOOD, V71, P1669; ENGELMANN H, 1990, J BIOL CHEM, V265, P14497; ERIKSTEIN BK, 1991, EUR J IMMUNOL, V21, P1033, DOI 10.1002/eji.1830210426; ESPEVIK T, 1990, J EXP MED, V171, P415, DOI 10.1084/jem.171.2.415; ESPEVIK T, 1994, IN PRESS ORGAN METAB; GALLOWAY CJ, 1992, EUR J IMMUNOL, V22, P3045, DOI 10.1002/eji.1830221143; GHAZAL P, 1992, P NATL ACAD SCI USA, V89, P7630, DOI 10.1073/pnas.89.16.7630; GHAZAL P, 1987, P NATL ACAD SCI USA, V84, P3658, DOI 10.1073/pnas.84.11.3658; GRELL M, 1993, LYMPHOKINE CYTOK RES, V12, P143; GRILLI M, 1993, INT REV CYTOL, V143, P1; HOHMANN HP, 1990, J BIOL CHEM, V265, P22409; HOHMANN HP, 1989, J BIOL CHEM, V264, P14927; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Kronke M, 1992, Immunol Ser, V56, P189; KRUPPA G, 1992, J IMMUNOL, V148, P3152; LIABAKKNB, 1993, J IMMUNOL METHODS, V163, P145; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; MACKAY F, 1993, J EXP MED, V177, P1277, DOI 10.1084/jem.177.5.1277; MATHIAS S, 1991, P NATL ACAD SCI USA, V88, P10009, DOI 10.1073/pnas.88.22.10009; MEAGER A, 1991, J IMMUNOL METHODS, V144, P141, DOI 10.1016/0022-1759(91)90239-C; MEICHLE A, 1990, J BIOL CHEM, V265, P8339; NAUME B, 1991, J IMMUNOL, V146, P3045; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; SAMBUCETTI LC, 1989, EMBO J, V8, P4251, DOI 10.1002/j.1460-2075.1989.tb08610.x; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; STAMMINGER T, 1990, J GEN VIROL, V71, P105, DOI 10.1099/0022-1317-71-1-105; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; VANDENABEELE P, 1992, J EXP MED, V176, P1015, DOI 10.1084/jem.176.4.1015; VANLINT J, 1992, J BIOL CHEM, V267, P25916; VANVOORHIS WC, 1983, J EXP MED, V158, P126, DOI 10.1084/jem.158.1.126	39	79	83	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7785	7791						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8126005				2022-12-27	WOS:A1994NA03200115
J	NATHAN, B; HSU, CC; BAO, J; WU, R; WU, JY				NATHAN, B; HSU, CC; BAO, J; WU, R; WU, JY			PURIFICATION AND CHARACTERIZATION OF A NOVEL FORM OF BRAIN L-GLUTAMATE DECARBOXYLASE A CA2+-DEPENDENT PERIPHERAL MEMBRANE-PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; ACID DECARBOXYLASE	L-Glutamic acid decarboxylase (GAD) catalyzes the one-step biosynthesis of gamma-aminobutyric acid (GABA), which is widely accepted as the major inhibitory neurotransmitter in the mammalian brain. In this paper, we report the identification and purification of a new and novel form of peripheral membrane GAD (MGAD) referred to as MGADIII, using a combination of chromatography on DE52, AcA 34, hydroxylapatite and Sephadex G-200, and native gel electrophoresis. The purified MGADIII migrated as a single protein band on a native 5-25% gradient polyacrylamide gel electrophoresis and sodium dodecyl sulfate-polyacrylamide gel electrophoresis with an apparent molecular mass of 118 +/- 6 and 60 +/- 4 kDa, respectively, suggesting that it is a homodimer of 60 kDa. MGADIII was established as a Ca2+-dependent peripheral membrane protein based on Triton X-114 phase partitioning assay, liposome binding experiment, and membrane extraction studies. Several lines of evidence are presented to show that the association of MGADIII with membranes occurs during depolarization of nerve terminal and that this is a reversible process. Based on these results and previous findings that GAD associates with synaptic vesicles and is regulated by phosphorylation, a model for regulation of GAD in the nerve terminal is proposed.	UNIV KANSAS,DEPT PHYSIOL & CELL BIOL,LAWRENCE,KS 66045	University of Kansas			WU, JANG-YEN/I-6424-2013					ANGEL I, 1983, NEUROCHEM INT, V5, P697, DOI 10.1016/0197-0186(83)90095-5; Bao J., 1992, Society for Neuroscience Abstracts, V18, P1384; Bao Jun, 1993, Society for Neuroscience Abstracts, V19, P1385; BORDIER C, 1981, J BIOL CHEM, V256, P1604; CHANG YC, 1988, J NEUROSCI, V8, P2123; CHRISTGAU S, 1992, J CELL BIOL, V118, P309, DOI 10.1083/jcb.118.2.309; COVARRUBIAS M, 1980, J NEUROCHEM, V34, P1682, DOI 10.1111/j.1471-4159.1980.tb11261.x; DENNER LA, 1987, P NATL ACAD SCI USA, V84, P668, DOI 10.1073/pnas.84.3.668; ERLANDER MG, 1991, NEUROCHEM RES, V16, P215, DOI 10.1007/BF00966084; FINDLAY JBC, 1990, MOL CELL BIOL MEMBRA, P21; GOHEEN SC, 1984, J CHROMATOGR, V317, P55, DOI 10.1016/S0021-9673(01)91647-4; KANDEL ER, 1991, PRINCIPLES NEURAL SC, P206; MARTIN DL, 1982, J NEUROCHEM, V39, P1001, DOI 10.1111/j.1471-4159.1982.tb11489.x; MCLAUGHLIN BJ, 1975, BRAIN RES, V85, P355, DOI 10.1016/0006-8993(75)90813-6; Nathan B., 1992, Society for Neuroscience Abstracts, V18, P1384; NATHAN B, 1994, IN PRESS P NATL ACAD; NATHAN B, IN PRESS BRAIN RES; Roberts E, 1975, NERVOUS SYSTEM, V1, P541; WU JY, 1973, J BIOL CHEM, V248, P3029; WU JY, 1986, BRAIN RES, V373, P1, DOI 10.1016/0006-8993(86)90309-4; WU JY, 1991, NEUROCHEM RES, V16, P227, DOI 10.1007/BF00966085	21	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7249	7254						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125937				2022-12-27	WOS:A1994NA03200035
J	TSYGANKOV, AY; SPANA, C; ROWLEY, RB; PENHALLOW, RC; BURKHARDT, AL; BOLEN, JB				TSYGANKOV, AY; SPANA, C; ROWLEY, RB; PENHALLOW, RC; BURKHARDT, AL; BOLEN, JB			ACTIVATION-DEPENDENT TYROSINE PHOSPHORYLATION OF FYN-ASSOCIATED PROTEINS IN T-LYMPHOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; AMINO-TERMINAL DOMAIN; SIGNAL TRANSDUCTION; CROSS-LINKING; KINASE P56LCK; SH3 DOMAINS; ZETA-CHAIN; STIMULATION; CD4; INHIBITION	While previous studies have implicated the tyrosine protein kinase p60(fyn) in antigenic activation of T lymphocytes, it is clear that signal transduction initiated through the antigen receptor requires the concerted actions of several proteins. Here, we report our finding that the activation of p60(fyn) following TcR cross-linking results in the tyrosine phosphorylation of two Fyn-associated proteins of 82 and 116 kDa. In the cells analyzed, p116 appears to represent one of the major substrates of T-cell antigen receptor mediated tyrosine phosphorylation In activated T-cells, the interaction of these proteins is specific for p60(fyn) since neither p56(lck) nor p62(c-yes) were found to detectably associate with p82 or p116. Furthermore, the p60(fyn)-p82/p116 complex could be dissociated and then reconstituted in vitro using purified recombinant Fyn. Using this technique we demonstrated that both p82 and p116 were capable of binding to the Fyn SH2 domain while p82 was to some extent capable of independent binding to the Fyn SH3 domain. An association between p60(fyn) and phosphoproteins possibly related to the T-cell p82 and p116 was also observed in other hematopoietic cells. Thus, the activation-induced phosphorylation of the p60(fyn)-associated proteins p116 and p82 and the wide distribution of potentially similar p60(fyn)-associated proteins in hematopoietic cells suggest that p116 and p82 may play a role as physiological substrates and/or regulators of p60(fyn).			TSYGANKOV, AY (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT RES INST, DEPT MOLEC BIOL, SIGNAL TRANSDUCT LAB, H4112, PRINCETON, NJ 08543 USA.		Tsygankov, Alexander Y/K-6205-2017					APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; ARNI S, 1993, ONCOGENE, V8, P2485; BELL GM, 1992, MOL CELL BIOL, V12, P5548, DOI 10.1128/MCB.12.12.5548; BEYERS AD, 1992, P NATL ACAD SCI USA, V89, P2945, DOI 10.1073/pnas.89.7.2945; BOLEN JB, 1992, FASEB J, V6, P3403, DOI 10.1096/fasebj.6.15.1281458; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; CARMO AM, 1993, EUR J IMMUNOL, V23, P2196, DOI 10.1002/eji.1830230922; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CICHOWSKI K, 1992, J BIOL CHEM, V267, P5025; DASILVA AJ, 1992, MOL IMMUNOL, V29, P1417, DOI 10.1016/0161-5890(92)90215-J; DESEAU V, 1987, J CELL BIOCHEM, V35, P113, DOI 10.1002/jcb.240350205; FEIG LA, 1993, SCIENCE, V260, P767, DOI 10.1126/science.8484117; GAUEN LKT, 1992, MOL CELL BIOL, V12, P5438, DOI 10.1128/MCB.12.12.5438; JUNE CH, 1990, J IMMUNOL, V144, P1591; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KAMPS MP, 1991, METHOD ENZYMOL, V201, P21; KANNER SB, 1991, EMBO J, V10, P1689, DOI 10.1002/j.1460-2075.1991.tb07693.x; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; KAWAKAMI T, 1988, P NATL ACAD SCI USA, V85, P3870, DOI 10.1073/pnas.85.11.3870; KOYASU S, 1992, J BIOL CHEM, V267, P3375; LIU XQ, 1993, MOL CELL BIOL, V13, P5225, DOI 10.1128/MCB.13.9.5225; LUO KX, 1991, METHOD ENZYMOL, V201, P149; Mayer Bruce J., 1993, Trends in Cell Biology, V3, P8, DOI 10.1016/0962-8924(93)90194-6; MCCORMICK F, 1993, NATURE, V363, P15, DOI 10.1038/363015a0; MUSTELIN T, 1990, SCIENCE, V247, P1584, DOI 10.1126/science.2138816; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PLUZNIK DH, 1982, EXP HEMATOL, V10, P211; PRASAD KVS, 1993, P NATL ACAD SCI USA, V90, P7366, DOI 10.1073/pnas.90.15.7366; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SHAW AS, 1990, MOL CELL BIOL, V10, P1853, DOI 10.1128/MCB.10.5.1853; SPANA C, 1993, PROTEIN EXPRES PURIF, V4, P390, DOI 10.1006/prep.1993.1051; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; TSYGANKOV AY, 1994, J LEUKOCYTE BIOL, V55, P289, DOI 10.1002/jlb.55.3.289; TSYGANKOV AY, 1992, J BIOL CHEM, V267, P18259; TSYGANKOV AY, 1992, CELL IMMUNOL, V140, P97, DOI 10.1016/0008-8749(92)90179-S; VEILLETTE A, 1988, MOL CELL BIOL, V8, P4353, DOI 10.1128/MCB.8.10.4353; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; WAGES DS, 1992, J VIROL, V66, P1866, DOI 10.1128/JVI.66.4.1866-1874.1992; WENG ZG, 1993, J BIOL CHEM, V268, P14956	42	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7792	7800						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8126006				2022-12-27	WOS:A1994NA03200116
J	WATANABE, D; YAMADA, K; NISHINA, Y; TAJIMA, Y; KOSHIMIZU, U; NAGATA, A; NISHIMUNE, Y				WATANABE, D; YAMADA, K; NISHINA, Y; TAJIMA, Y; KOSHIMIZU, U; NAGATA, A; NISHIMUNE, Y			MOLECULAR-CLONING OF A NOVEL CA2+-BINDING PROTEIN (CALMEGIN) SPECIFICALLY EXPRESSED DURING MALE MEIOTIC GERM-CELL DEVELOPMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; MUSCLE SARCOPLASMIC-RETICULUM; RO/SS-A AUTOANTIGEN; MOUSE SPERMATOGENESIS; ENDOPLASMIC-RETICULUM; TRANSLATIONAL CONTROL; GENE-EXPRESSION; SERTOLI CELLS; MESSENGER-RNA; CPG ISLANDS	During mammalian spermatogenesis, many specific molecules are expressed. We have recently identified a 93-kDa male meiotic germ cell-specific antigen (Meg 1) exclusively expressed in germ cells from the pachytene spermatocyte to the spermatid stage using the monoclonal antibody TRA 369 (Watanabe, D., Sawada, K., Koshimizu, U., Kagawa, T., and Nishimune, Y. (1992) Mol. Reprod. Dev. 33, 307-312). In this study, we cloned a cDNA representing this antigen from a mouse testis cDNA expression library, using the monoclonal antibody TRA 369. Northern blotting showed that this transcript was 2.3 kilobases in length and was expressed only in the testis and not in other somatic tissues or in the ovary. The expression of the mRNA was first detected at the pachytene spermatocyte stage of male germ cell development, and this expression was correlated with the expression of the protein. Sequence analysis of the cDNA revealed that the predicted protein consists of 611 amino acids, including a hydrophobic NH2 terminus characteristic of a signal peptide, two sets of internal repetitive sequences (four repeats of IPDPSAVKPEDWDD and GEWXPPMIPNPXYQ), and a hydrophilic COOH terminus. The deduced amino acid sequence has 58% homology with dog calnexin (the ER membrane phosphoprotein of pancreatic cells) and significant partial homology with calreticulin (high affinity Ca2+-binding protein of the ER membrane) at the repetitive sequence. Furthermore, we demonstrated the Ca-45(2+) binding ability of this antigen by a Ca-45(2+) overlay assay, and the name calmegin is proposed for this antigen. Calmegin is a novel Ca2+-binding protein that is specifically expressed in spermatogenesis. The highly regulated, specific, and abundant expression of calmegin suggests that it has important roles in spermatogenesis.	OSAKA UNIV,MICROBIAL DIS RES INST,SUITA,OSAKA 565,JAPAN; OSAKA UNIV,SCH MED,DEPT NUTR & PHYSIOL CHEM,SUITA,OSAKA 565,JAPAN	Osaka University; Osaka University								ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; ARIEL M, 1991, P NATL ACAD SCI USA, V88, P2317, DOI 10.1073/pnas.88.6.2317; BAKSH S, 1991, J BIOL CHEM, V266; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1267; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAGOSTINO A, 1987, MOL CELL BIOL, V7, P1250, DOI 10.1128/MCB.7.3.1250; ERICKSON RP, 1990, TRENDS GENET, V6, P264, DOI 10.1016/0168-9525(90)90209-O; FENDERSON BA, 1984, DEV BIOL, V103, P117, DOI 10.1016/0012-1606(84)90013-7; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GAUNT SJ, 1982, DEV BIOL, V89, P92, DOI 10.1016/0012-1606(82)90297-4; GOLD B, 1983, DEV BIOL, V98, P392, DOI 10.1016/0012-1606(83)90368-8; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T., 1982, MOL CLONING; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; MCCAULIFFE DP, 1990, J CLIN INVEST, V86, P332, DOI 10.1172/JCI114704; MCCAULIFFE DP, 1990, J CLIN INVEST, V85, P1379, DOI 10.1172/JCI114582; MILLETTE CF, 1981, J CELL SCI, V48, P367; MILNER RE, 1991, J BIOL CHEM, V266, P7155; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; MUKAI H, 1991, BIOCHEM BIOPH RES CO, V179, P1325, DOI 10.1016/0006-291X(91)91718-R; NAKAMURA M, 1991, BIOCHEM BIOPH RES CO, V176, P1358, DOI 10.1016/0006-291X(91)90436-B; OBRIEN DA, 1984, DEV BIOL, V101, P307, DOI 10.1016/0012-1606(84)90144-1; OBRIEN DA, 1987, BIOL REPROD, V37, P147, DOI 10.1095/biolreprod37.1.147; OPAS M, 1991, J CELL PHYSIOL, V149, P160, DOI 10.1002/jcp.1041490120; RAPPOLD GA, 1987, EMBO J, V6, P1975, DOI 10.1002/j.1460-2075.1987.tb02460.x; SAMBROOK JF, 1990, CELL, V61, P197, DOI 10.1016/0092-8674(90)90798-J; SMITH MJ, 1989, EMBO J, V8, P3581, DOI 10.1002/j.1460-2075.1989.tb08530.x; TREVES S, 1990, BIOCHEM J, V271, P473, DOI 10.1042/bj2710473; VERNON RB, 1989, BIOL REPROD, V40, P1329, DOI 10.1095/biolreprod40.6.1329; WADA I, 1991, J BIOL CHEM, V266; WATANABE D, 1992, MOL REPROD DEV, V33, P307, DOI 10.1002/mrd.1080330312; WILLISON K, 1987, TRENDS GENET, V3, P351, DOI 10.1016/0168-9525(87)90296-4	37	104	110	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7744	7749						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8126001				2022-12-27	WOS:A1994NA03200109
J	KARCZEWSKI, J; ENDRIS, R; CONNOLLY, TM				KARCZEWSKI, J; ENDRIS, R; CONNOLLY, TM			DISAGREGIN IS A FIBRINOGEN RECEPTOR ANTAGONIST LACKING THE ARG-GLY-ASP SEQUENCE FROM THE TICK, ORNITHODOROS-MOUBATA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-AGGREGATION INHIBITOR; GLYCOPROTEIN-IIB/IIIA COMPLEX; IIB-IIIA; VONWILLEBRAND-FACTOR; ACTIVATED PLATELETS; POTENT INHIBITOR; ECHIS-CARINATUS; FACTOR BINDING; CELL-ADHESION; PEPTIDES	A platelet aggregation inhibitor was identified in the salivary gland of the tick Ornithodoros moubata and isolated by gel filtration and reverse phase high pressure liquid chromatography. The purified inhibitor is a similar to 6-kDa protein, which we have named disagregin. It inhibits ADP-stimulated platelet aggregation in plasma with an IC50 = 104 +/- 17 nM. Disagregin also inhibits platelet aggregation induced by other agonists, including collagen, epinephrine, platelet-activating factor, thrombin, and the thrombin receptor peptide SFLLRNPNDKYEPF. It does not, however, affect platelet shape change induced by these agonists or thrombin-induced dense granule release. Disagregin inhibits platelet aggregation by binding to the platelet fibrinogen receptor. I-125-Disagregin forms a specific complex with both subunits of the fibrinogen receptor, glycoproteins IIb and IIIa, in the presence of a chemical cross-linker. It binds to unstimulated platelets with a K-d = 42.5 +/- 7.5 nM (23,800 +/- 1600 sites/platelet) and to ADP-stimulated platelets with K-d = 39.4 +/- 6.6 nM (24,050 +/- 1500 sites/platelet). Unlabeled disagregin and the snake venom disintegrin echistatin both compete for this binding. Disagregin also completely blocks platelet adhesion to fibrinogen white partially inhibiting platelet adhesion to fibronectin and having little effect on platelet adhesion to collagen. Disagregin had no effect on the adhesion of human umbilical cord vein endothelial cells to fibrinogen or vitronectin. These cells lack the glycoprotein IIb-IIIa complex; therefore, this result is consistent with the ability of disagregin to bind selectively to platelet glycoproteins IIb and IIIa. Sequence analysis of disagregin revealed 60 residues composing a unique protein. Unlike other fibrinogen antagonists it does not contain the Arg-Gly-Asp cell recognition sequence or a conservative substitution, and it has no structural homology with the Arg-Gly-Asp-containing snake venom disintegrins. Thus, disagregin is unique both in structure and function and may serve as a useful tool for the design of therapeutically useful antithrombotic agents.	MERCK SHARP & DOHME LTD,DEPT ANIM DRUG DISCOVERY,W POINT,PA 19486	Merck & Company	KARCZEWSKI, J (corresponding author), MERCK SHARP & DOHME LTD,DEPT BIOL,W POINT,PA 19486, USA.							ALIG L, 1992, J MED CHEM, V35, P4393, DOI 10.1021/jm00101a017; CHAO BH, 1989, P NATL ACAD SCI USA, V86, P8050, DOI 10.1073/pnas.86.20.8050; CHARO IF, 1991, J BIOL CHEM, V266, P1415; CHEN CS, 1991, BIOCHIM BIOPHYS ACTA, V1075, P237, DOI 10.1016/0304-4165(91)90272-I; CINES DB, 1982, J CLIN INVEST, V69, P123, DOI 10.1172/JCI110422; Colman R., 1987, HEMOSTASIS THROMBOSI, P594; CONNOLLY TM, 1992, J BIOL CHEM, V267, P6883; COOK JJ, 1992, BIOCHIM BIOPHYS ACTA, V1119, P312, DOI 10.1016/0167-4838(92)90219-4; DENNIS MS, 1989, P NATL ACAD SCI USA, V87, P2471; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; GAN ZR, 1988, J BIOL CHEM, V263, P19827; GARSKY VM, 1989, P NATL ACAD SCI USA, V86, P4022, DOI 10.1073/pnas.86.11.4022; GARTNER TK, 1985, J BIOL CHEM, V260, P1891; HARTMAN GD, 1992, J MED CHEM, V35, P4640, DOI 10.1021/jm00102a020; HUANG TF, 1989, BIOCHEMISTRY-US, V28, P661, DOI 10.1021/bi00428a037; HUANG TF, 1987, BIOCHIM BIOPHYS ACTA, V925, P248, DOI 10.1016/0304-4165(87)90189-9; KELLER PM, 1992, J BIOL CHEM, V267, P6899; KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028; LAW JH, 1992, ANNU REV BIOCHEM, V61, P87, DOI 10.1146/annurev.bi.61.070192.000511; MAZUR P, 1991, EUR J BIOCHEM, V202, P1073, DOI 10.1111/j.1432-1033.1991.tb16472.x; PHILLIPS DR, 1988, BLOOD, V71, P831; PLOW EF, 1985, P NATL ACAD SCI USA, V82, P8057, DOI 10.1073/pnas.82.23.8057; PLOW EF, 1987, BLOOD, V70, P110; RIBEIRO JMC, 1991, COMP BIOCHEM PHYS A, V100, P109, DOI 10.1016/0300-9629(91)90190-N; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P7369, DOI 10.1021/bi00244a003; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1066; SCARBOROUGH RM, 1991, J BIOL CHEM, V266, P9359; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P1314; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1065; SEYMOUR JL, 1990, J BIOL CHEM, V265, P10143; TAUB R, 1989, J BIOL CHEM, V264, P259; TENG CM, 1991, THROMB HAEMOSTASIS, V65, P624; WAXMAN L, 1993, J BIOL CHEM, V268, P5445; WAXMAN L, 1990, SCIENCE, V248, P593, DOI 10.1126/science.2333510; WILLIAMS J, 1990, BIOCHIM BIOPHYS ACTA, V1039, P81, DOI 10.1016/0167-4838(90)90229-9	36	96	101	4	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6702	6708						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120028				2022-12-27	WOS:A1994MZ50300071
J	SUZUKI, M; IZUTA, S; YOSHIDA, S				SUZUKI, M; IZUTA, S; YOSHIDA, S			DNA-POLYMERASE-ALPHA OVERCOMES AN ERROR-PRONE PAUSE SITE IN THE PRESENCE OF REPLICATION PROTEIN-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SINGLE-STRANDED-DNA; DROSOPHILA-MELANOGASTER; BINDING-PROTEIN; INVITRO; FIDELITY; PRIMASE; INITIATION; IDENTIFICATION; MUTAGENESIS; SPECIFICITY	Eukaryotic DNA polymerase alpha pauses at some sites on the natural DNA template of M13mp2. Terminal misincorporations of dA or dG, in place of dT, by DNA polymerase alpha have been reported to be within one of the pause sites, pause site II (positions 6269 and 6270 (Fry, M., and Loeb, L.A. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 763-767)). The DNA products arrested within pause site II (position 6270) were separated, annealed with synthetic templates, and further elongated by DNA polymerase alpha. It was confirmed that a considerable amount of terminal misincorporation of dG in place of dT occurred at this position. When M13mp2 DNA was coated with various amounts of replication protein-A (RP-A), however, DNA polymerase alpha was able to overcome the pause site II, whereas pause bands at other sites barely decreased. In contrast, Escherichia coli single-stranded DNA-binding protein did not specifically abolish the arrested band at pause site II, though it generally suppressed the reaction. Since RP-A hardly increased the elongation frequency from the primer carrying a 3'-mismatched terminal deoxynucleotide, the reduction of arrested products by RP-A may be attributed to the change in the incorporation mode from noncomplementary to complementary deoxynucleotides within pause site II and may not be due to the reinitiation from the mismatched 3'-terminal deoxynucleotide. To confirm this, we amplified the reaction products at pause site III by means of a polymerase chain reaction method and showed that the complementary strand to pause site II, which was elongated in the presence of RP-A, did not carry any detectable misinsertion. Therefore, the error-prone step of the DNA synthesis catalyzed by DNA polymerase a may be readily avoided by RP-A.	NAGOYA UNIV,SCH MED,DIS MECHANISM & CONTROL RES INST,CANC CELL BIOL LAB,SHOWA KU,NAGOYA 466,JAPAN	Nagoya University			Suzuki, Motoshi/I-7246-2014	Suzuki, Motoshi/0000-0003-0682-5006				ABBOTTS J, 1988, J BIOL CHEM, V263, P15094; BEBENEK K, 1989, J BIOL CHEM, V264, P16948; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; BRILL SJ, 1991, GENE DEV, V5, P1589, DOI 10.1101/gad.5.9.1589; CARTY MP, 1992, MUTAT RES, V274, P29, DOI 10.1016/0921-8777(92)90041-Z; COTTERILL SM, 1987, P NATL ACAD SCI USA, V84, P5635, DOI 10.1073/pnas.84.16.5635; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; FAIRMAN M, 1988, BIOCHIM BIOPHYS ACTA, V951, P382, DOI 10.1016/0167-4781(88)90110-8; FAY PJ, 1982, J BIOL CHEM, V257, P5692; FRY M, 1992, P NATL ACAD SCI USA, V89, P763, DOI 10.1073/pnas.89.2.763; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HILLEBRAND GG, 1985, J BIOL CHEM, V260, P3116; HOFFMANN JS, 1993, CANCER RES, V53, P2895; HOPFIELD JJ, 1980, P NATL ACAD SCI-BIOL, V77, P5248, DOI 10.1073/pnas.77.9.5248; KAGUNI LS, 1982, P NATL ACAD SCI-BIOL, V79, P983, DOI 10.1073/pnas.79.4.983; KENNY M K, 1990, Journal of Biological Chemistry, V265, P7693; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; LOEB LA, 1986, PROG NUCLEIC ACID RE, V33, P57, DOI 10.1016/S0079-6603(08)60020-3; LOEB LA, 1982, ANNU REV BIOCHEM, V52, P429; MATSUMOTO T, 1990, P NATL ACAD SCI USA, V87, P9712, DOI 10.1073/pnas.87.24.9712; MORRISON A, 1993, EMBO J, V12, P1467, DOI 10.1002/j.1460-2075.1993.tb05790.x; MURAKAMI Y, 1992, P NATL ACAD SCI USA, V89, P952, DOI 10.1073/pnas.89.3.952; PODUST VN, 1993, NUCLEIC ACIDS RES, V21, P841, DOI 10.1093/nar/21.4.841; REYLAND ME, 1987, J BIOL CHEM, V262, P10824; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAAPER RM, 1988, P NATL ACAD SCI USA, V85, P8126, DOI 10.1073/pnas.85.21.8126; SUZUKI M, 1993, BIOCHEM MOL BIOL INT, V29, P645; TAMAI K, 1988, BIOCHIM BIOPHYS ACTA, V950, P263, DOI 10.1016/0167-4781(88)90122-4; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; WATSON JD, 1987, MOL BIOL GENE, pCH12; WEAVER DT, 1982, J BIOL CHEM, V257, P2075; WEISMANSHOMER P, 1989, BIOCHEM BIOPH RES CO, V164, P1149, DOI 10.1016/0006-291X(89)91789-0; WOLD MS, 1989, J BIOL CHEM, V264, P2801	33	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 8	1994	269	14					10225	10228						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NF017	8144602				2022-12-27	WOS:A1994NF01700011
J	BEELMAN, CA; PARKER, R				BEELMAN, CA; PARKER, R			DIFFERENTIAL-EFFECTS OF TRANSLATIONAL INHIBITION IN CIS AND IN TRANS ON THE DECAY OF THE UNSTABLE YEAST MFA2 MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS INHIBITORS; SACCHAROMYCES-CEREVISIAE; POLY(A) TAIL; INITIATION; ACID; DEGRADATION; INSTABILITY; STABILITY; REGION; GROWTH	Several observations in eukaryotic cells suggest that the processes of translation and mRNA turnover are interrelated. To understand this relationship, we examined the effects of translational inhibition on the decay of the unstable yeast MFA2 mRNA, which is degraded in a 5' to 3' direction following deadenylation (1). Although inhibition of translation in cis stabilizes several unstable mammalian transcripts, inhibiting translation of the MFA2 mRNA in cis, by the insertion of a large stem-loop structure in the 5'-untranslated region (UTR), did not affect the half-life, deadenylation rate, or appearance of specific decay intermediates. Therefore, efficient translational elongation on the MFA2 mRNA is not a requirement for the normal rate, or mechanism, of degradation of this transcript. In contrast, inhibition of translation in trans, by the addition of cycloheximide, stabilized the deadenylated form of MFA2 mRNA. Furthermore, the MFA2 transcripts that were not translated due to a stem-loop in the 5'-UTR were also stabilized in the presence of cycloheximide, suggesting that cycloheximide is likely to affect mRNA stability indirectly. These results suggest possible relationships between the mechanisms of mRNA decay and the translational process.	UNIV ARIZONA,DEPT MOLEC & CELLULAR BIOL,TUCSON,AZ 85721	University of Arizona					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045443, R37GM045443] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45443] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABASTADO JP, 1991, MOL CELL BIOL, V11, P486, DOI 10.1128/MCB.11.1.486; AHARON T, 1993, MOL CELL BIOL, V13, P1971, DOI 10.1128/MCB.13.3.1971; BAIM SB, 1988, MOL CELL BIOL, V8, P1591, DOI 10.1128/MCB.8.4.1591; BREWER G, 1989, MOL CELL BIOL, V9, P1996, DOI 10.1128/MCB.9.5.1996; CAPONIGRO G, 1993, MOL CELL BIOL, V13, P5141, DOI 10.1128/MCB.13.9.5141; CHEONG CJ, 1990, NATURE, V346, P680, DOI 10.1038/346680a0; CIGAN AM, 1988, MOL CELL BIOL, V8, P2964, DOI 10.1128/MCB.8.7.2964; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; FELICI F, 1989, MOL CELL BIOL, V9, P3260, DOI 10.1128/MCB.9.8.3260; GALLIE DR, 1990, GENE DEV, V4, P1149, DOI 10.1101/gad.4.7.1149; GRAFI G, 1993, MOL CELL BIOL, V13, P3487, DOI 10.1128/MCB.13.6.3487; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; KOELLER DM, 1991, P NATL ACAD SCI USA, V88, P7778, DOI 10.1073/pnas.88.17.7778; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; KRUYS V, 1987, P NATL ACAD SCI USA, V84, P6030, DOI 10.1073/pnas.84.17.6030; KRUYS V, 1989, SCIENCE, V245, P852, DOI 10.1126/science.2672333; LAIRDOFFRINGA IA, 1990, MOL CELL BIOL, V10, P6132, DOI 10.1128/MCB.10.12.6132; LASO MRV, 1993, J BIOL CHEM, V268, P6453; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; MICHAELIS S, 1988, MOL CELL BIOL, V8, P1309, DOI 10.1128/MCB.8.3.1309; MUNROE D, 1990, MOL CELL BIOL, V10, P3441, DOI 10.1128/MCB.10.7.3441; PARKER R, 1993, NATURE, V361, P660, DOI 10.1038/361660a0; PELTZ SW, 1992, MOL CELL BIOL, V12, P5778, DOI 10.1128/MCB.12.12.5778; PELTZ SW, 1993, CONTROL MESSENGER RN, P318; PLATT T, 1972, EXPT MOL GENETICS, P352; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; SACHS AB, 1989, CELL, V58, P857, DOI 10.1016/0092-8674(89)90938-0; SAPPRSTEIN S, 1994, MOL CELL BIOL, V2, P1438; SAVANTBHONSALE S, 1992, GENE DEV, V6, P1927, DOI 10.1101/gad.6.10.1927; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; WELLINGTON CL, 1993, MOL CELL BIOL, V13, P5034, DOI 10.1128/MCB.13.8.5034; WISDOM R, 1990, J BIOL CHEM, V265, P19015; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; YEN TJ, 1988, NATURE, V334, P580, DOI 10.1038/334580a0; ZUCKER M, 1981, NUCLEIC ACIDS RES, V9, P133	37	141	145	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9687	9692						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144558				2022-12-27	WOS:A1994NE05300047
J	CIECHANOVER, A; SHKEDY, D; OREN, M; BERCOVICH, B				CIECHANOVER, A; SHKEDY, D; OREN, M; BERCOVICH, B			DEGRADATION OF THE TUMOR-SUPPRESSOR PROTEIN-P53 BY THE UBIQUITIN-MEDIATED PROTEOLYTIC SYSTEM REQUIRES A NOVEL SPECIES OF UBIQUITIN-CARRIER PROTEIN, E2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PAPILLOMAVIRUS TYPE-16; N-END RULE; CONJUGATING ENZYME; E6 ONCOPROTEIN; P53; MUTANT; LIGASE; TRANSFORMATION; PURIFICATION; ASSOCIATION	The tumor suppressor protein p53 is extremely unstable in most cell lines. In contrast, many mutant and oncogenic species of the protein are stable. The degradation of p53 in vivo requires metabolic energy; however, the proteolytic system(s) involved have not been identified. The ubiquitin system has been implicated in the degradation of p53 in vitro. The degradation is stimulated significantly by the human papillomavirus (HPV) oncoprotein E6 that associates with p53 and facilitates conjugate formation and subsequent degradation. Complex formation between E6 and p53 is promoted by a cellular protein designated E6-associated protein (E6-AP). Initial dissection of the conjugation process have demonstrated a role for the ubiquitin-activating enzyme, E1, but the ubiquitin-carrier protein (E2, UBC) and the ubiquitin protein ligase, E3, have not been identified. In this study, we report that a novel species of ubiquitin-carrier protein designated E2-F1 (Blumenfeld, N., Gonen, H., Mayer, A., Smith, C., Siegel, N. R., Schwartz, A. L., and Ciechanover, A. (1994) J. Biol. Chem. 269,9574-9581) is involved in the conjugation and degradation of p53. This E2 enzyme recognizes non-''N-end rule'' protein substrates and appears to mediate their conjugation via a novel species of E3. The process of recognition appears to be selective; E2-F1 is not required for the conjugation and degradation of human N-myc. The involvement of E2-F1 in the in vitro process appears to be physiologically meaningful and to reproduce the in vivo process; mutant species of p53 that do not interact with E6 and are stable in vivo are not recognized by the cell free system.	TECHNION ISRAEL INST TECHNOL,FAC MED,RAPPAPORT INST RES MED SCI,IL-31096 HAIFA,ISRAEL; WEIZMANN INST SCI,DEPT IMMUNOL CHEM,IL-76100 REHOVOT,ISRAEL	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Weizmann Institute of Science	CIECHANOVER, A (corresponding author), TECHNION ISRAEL INST TECHNOL,FAC MED,DEPT BIOCHEM,POB 9649,IL-31096 HAIFA,ISRAEL.		Ciechanover, Aaron J/C-9166-2017					BLUMENFELD N, 1994, J BIOL CHEM, V269, P9574; BOISSEL JP, 1988, J BIOL CHEM, V263, P8443; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; CROOK T, 1992, EMBO J, V11, P3935, DOI 10.1002/j.1460-2075.1992.tb05487.x; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; ELIYAHU D, 1988, ONCOGENE, V3, P313; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GONEN H, 1991, J BIOL CHEM, V266, P19221; GRONOSTAJSKI RM, 1984, MOL CELL BIOL, V4, P442, DOI 10.1128/MCB.4.3.442; HAAS AL, 1985, J BIOL CHEM, V260, P2464; HALEVY O, 1990, SCIENCE, V250, P113, DOI 10.1126/science.2218501; HELLER H, 1990, J BIOL CHEM, V265, P6532; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; HUANG S, 1987, BIOCHEMISTRY-US, V26, P8242, DOI 10.1021/bi00399a033; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; JENKINS JR, 1984, NUCLEIC ACIDS RES, V12, P5609, DOI 10.1093/nar/12.14.5609; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; JOHNSTON NL, 1991, BIOCHEMISTRY-US, V30, P7514, DOI 10.1021/bi00244a021; KULKA RG, 1988, J BIOL CHEM, V263, P15726; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; RAMSAY G, 1986, MOL CELL BIOL, V6, P4450, DOI 10.1128/MCB.6.12.4450; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; REISS Y, 1988, J BIOL CHEM, V263, P2693; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Sambrook J, 1989, MOL CLONING LABORATO; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1992, EMBO J, V11, P2425, DOI 10.1002/j.1460-2075.1992.tb05307.x; SHANKLIN J, 1987, P NATL ACAD SCI USA, V84, P359, DOI 10.1073/pnas.84.2.359; STANTON LW, 1986, P NATL ACAD SCI USA, V83, P1772, DOI 10.1073/pnas.83.6.1772; SUNG P, 1991, EMBO J, V10, P2187, DOI 10.1002/j.1460-2075.1991.tb07754.x; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286	38	96	98	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9582	9589						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144545				2022-12-27	WOS:A1994NE05300031
J	FINGAR, DC; BIRNBAUM, MJ				FINGAR, DC; BIRNBAUM, MJ			A ROLE FOR RAF-1 IN THE DIVERGENT SIGNALING PATHWAYS MEDIATING INSULIN-STIMULATED GLUCOSE-TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; 3T3-L1 ADIPOCYTES; MAP KINASE; C-FOS; DIFFERENTIAL REGULATION; MOLECULAR MECHANISM; GENE-EXPRESSION; SKELETAL-MUSCLE; ADIPOSE-CELLS; PHORBOL ESTER	Downstream mediators of insulin signaling are thought to include multiple cytoplasmic serine/threonine kinases such as the product of the cellular proto-oncogene c-raf-1. To investigate a role for the Raf-1 protein kinase in insulin-stimulated glucose transport, a gene encoding an oncogenically activated Raf-1 mutant was introduced into 3T3-L1 fibroblasts by retroviral gene transfer. Expression of activated Raf-1 in differentiated 3T3-L1 adipocytes markedly increases hexose uptake compared to control adipocytes or those infected with the retroviral vector. Basal 2-deoxyglucose uptake in adipocytes expressing activated Raf-1 is approximately 40-fold higher than in parental adipocytes, and insulin further increases uptake about 1.2-fold. As determined by the plasma membrane ''sheet'' assay, Raf-1-expressing adipocytes contain greatly elevated levels of the ubiquitous glucose transporter (GLUT1) on the cell surface in the absence or presence of insulin. Total cellular GLUT1 protein is increased about 5-fold. In contrast, activated Raf-1 affects neither the expression of the ''insulin-responsive'' glucose transporter (GLUT4) nor its cellular distribution; GLUT4 is virtually undetectable on the plasma membrane in the absence of insulin and translocates normally following the addition of hormone. These data suggest that activation of Raf-1 mediates the chronic effect of insulin on hexose uptake but is not sufficient for the rapid translocation of GLUT4. Moreover, the differential effects of activated Raf-1 expression on the two transporter isoforms define divergent signaling pathways by which insulin regulates glucose transport in cultured adipocytes.	HARVARD UNIV,SCH MED,DEPT CELL BIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,PROGRAM CELL & DEV BIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School				Birnbaum, Morris/0000-0001-9972-8680	NIDDK NIH HHS [DK39519] Funding Source: Medline; NIGMS NIH HHS [GM07226] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007226] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALLOU LM, 1991, NATURE, V349, P348, DOI 10.1038/349348a0; BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; BIRNBAUM MJ, 1992, INT REV CYTOL, V137A, P239; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; BLACKSHEAR PJ, 1990, J BIOL CHEM, V265, P12131; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; CALDERHEAD DM, 1990, J BIOL CHEM, V265, P13800; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; CZECH MP, 1992, TRENDS BIOCHEM SCI, V17, P197, DOI 10.1016/0968-0004(92)90266-C; DEHERREROS AG, 1989, J BIOL CHEM, V264, P19994; DEHERREROS AG, 1989, J BIOL CHEM, V264, P9885; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; DICKENS M, 1992, BIOCHEM J, V287, P201, DOI 10.1042/bj2870201; FINGAR DC, 1993, J BIOL CHEM, V268, P3005; FINGAR DC, 1994, IN PRESS ENDOCRINOLO; GALLEGO C, 1992, P NATL ACAD SCI USA, V89, P7355, DOI 10.1073/pnas.89.16.7355; GARDNER AM, 1993, J BIOL CHEM, V268, P17896; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; HAINQUE B, 1990, J BIOL CHEM, V265, P7982; HASPEL HC, 1985, J BIOL CHEM, V260, P7219; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; HIRAKI Y, 1988, J BIOL CHEM, V263, P13655; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; HUDSON AW, 1992, J CELL BIOL, V116, P785, DOI 10.1083/jcb.116.3.785; JAMAL S, 1990, NATURE, V344, P463, DOI 10.1038/344463a0; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; KAHN CR, 1988, J CLIN INVEST, V82, P1151, DOI 10.1172/JCI113711; KOVACINA KS, 1990, J BIOL CHEM, V265, P12115; KOZKA IJ, 1991, J BIOL CHEM, V266, P11726; KOZMA L, 1993, P NATL ACAD SCI USA, V90, P4460, DOI 10.1073/pnas.90.10.4460; KYRIAKIS JM, 1993, J BIOL CHEM, V268, P16009; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LAVOINNE A, 1991, EUR J BIOCHEM, V199, P723, DOI 10.1111/j.1432-1033.1991.tb16176.x; LENORMAND P, 1993, J CELL BIOL, V122, P107; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MYERS MG, 1993, DIABETES, V42, P643, DOI 10.2337/diabetes.42.5.643; NISHIMURA H, 1993, J BIOL CHEM, V268, P8514; OSTEROP APR, 1992, J BIOL CHEM, V267, P1464; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; SCHLESSINGER J, 1993, TRENDS BIOCHEM SCI, V18, P273, DOI 10.1016/0968-0004(93)90031-H; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; STUMPO DJ, 1988, J BIOL CHEM, V263, P1611; STUMPO DJ, 1986, P NATL ACAD SCI USA, V83, P9453, DOI 10.1073/pnas.83.24.9453; SUTHERLAND C, 1993, EUR J BIOCHEM, V212, P581, DOI 10.1111/j.1432-1033.1993.tb17696.x; TABARINI D, 1985, P NATL ACAD SCI USA, V82, P4369, DOI 10.1073/pnas.82.13.4369; TOBE K, 1992, J BIOL CHEM, V267, P21089; TORDJMAN KM, 1990, BIOCHEM J, V271, P201, DOI 10.1042/bj2710201; TORDJMAN KM, 1989, P NATL ACAD SCI USA, V86, P7761, DOI 10.1073/pnas.86.20.7761; WOOD KW, 1993, P NATL ACAD SCI USA, V90, P5016, DOI 10.1073/pnas.90.11.5016; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O	58	50	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10127	10132						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144513				2022-12-27	WOS:A1994NE05300109
J	SANZ, L; BERRA, E; MUNICIO, MM; DOMINGUEZ, I; LOZANO, J; JOHANSEN, T; MOSCAT, J; DIAZMECO, MT				SANZ, L; BERRA, E; MUNICIO, MM; DOMINGUEZ, I; LOZANO, J; JOHANSEN, T; MOSCAT, J; DIAZMECO, MT			ZETA-PKC PLAYS A CRITICAL ROLE DURING STROMELYSIN PROMOTER ACTIVATION BY PLATELET-DERIVED GROWTH-FACTOR THROUGH A NOVEL PALINDROMIC ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; HYDROLYZING PHOSPHOLIPASE-C; XENOPUS-LAEVIS OOCYTES; GENE-EXPRESSION; MESSENGER-RNA; PHOSPHATIDYLCHOLINE HYDROLYSIS; TRANSCRIPTIONAL ACTIVATION; MEDIATED HYDROLYSIS; RAT FIBROBLASTS; FOS	Stromelysin is a metalloproteinase with the widest substrate specificity that plays a critical role in the induction of the metastatic phenotype in cancer cells. The mechanisms whereby growth factors and oncogenes control stromelysin expression are beginning to be characterized. We have recently demonstrated that protein kinase C isotypes down-regulatable by chronic exposure to phorbol esters are not involved in stromelysin gene expression in response to platelet-derived growth factor, ras oncogene, and phosphatidylcholine-hydrolyzing phospholipase C. We also identified a region in the stromelysin promoter, distinct from the 12-O-tetradecanoylphorbol-13-acetate-responsive element, responsible for the promoter activity in response to these stimulants. In this paper, we further characterize that promoter fragment and demonstrate that the region encompassing nucleotides -1218 to -1202, including the palindromic sequence ACTAGT, is necessary and sufficient for the control of stromelysin gene expression. The involvement of zeta-protein kinase C but not of c-raf in the stimulation of stromelysin promoter activity in response to platelet-derived growth factor is also demonstrated here. All these data suggest the existence of a bifurcation downstream of ras in the signaling mechanisms leading to stromelysin expression and DNA synthesis.	UNIV AUTONOMA MADRID,CSIC,CTR BIOL MOLEC SEVERO OCHOA,CANTO BLANCO,E-28049 MADRID,SPAIN; UNIV TROMSO,INST MED BIOL,DEPT BIOCHEM,N-9037 TROMSO,NORWAY	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); UiT The Arctic University of Tromso			Moscat, Jorge/A-7011-2009; Berra, Edurne/F-9692-2011; Lozano, José/C-2760-2014; Johansen, Terje/N-2971-2015	Berra, Edurne/0000-0002-3820-5744; Lozano, José/0000-0002-8187-2833; Johansen, Terje/0000-0003-1451-9578; Diaz-Meco, Maria/0000-0003-0147-0998; /0000-0001-9617-4141				ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; BERRA E, 1993, CELL, V74, P555, DOI 10.1016/0092-8674(93)80056-K; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; CAI H, 1992, MOL CELL BIOL, V12, P5329, DOI 10.1128/MCB.12.12.5329; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; DEHERREROS AG, 1991, J BIOL CHEM, V266, P6825; DIAZLAVIADA I, 1990, EMBO J, V9, P3907, DOI 10.1002/j.1460-2075.1990.tb07611.x; DIAZMECO MT, 1991, J BIOL CHEM, V266, P22597; DIAZMECO MT, 1993, MOL CELL BIOL, V13, P4770, DOI 10.1128/MCB.13.8.4770; DIAZMECO MT, 1992, MOL CELL BIOL, V12, P302, DOI 10.1128/MCB.12.1.302; DOMINGUEZ I, 1993, MOL CELL BIOL, V13, P1290, DOI 10.1128/MCB.13.2.1290; DOMINGUEZ I, 1991, EMBO J, V10, P3215, DOI 10.1002/j.1460-2075.1991.tb04884.x; DOMINGUEZ I, 1992, MOL CELL BIOL, V12, P3776, DOI 10.1128/MCB.12.9.3776; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; EXTON JH, 1990, J BIOL CHEM, V265, P1; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; KERR LD, 1988, SCIENCE, V242, P1424, DOI 10.1126/science.2462278; KERR LD, 1990, CELL, V61, P267, DOI 10.1016/0092-8674(90)90807-Q; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; LARRODERA P, 1990, CELL, V61, P1113, DOI 10.1016/0092-8674(90)90074-O; LOPEZBARAHONA M, 1990, J BIOL CHEM, V265, P9022; MATRISIAN LM, 1986, P NATL ACAD SCI USA, V83, P9413, DOI 10.1073/pnas.83.24.9413; MATRISIAN LM, 1985, EMBO J, V4, P1435, DOI 10.1002/j.1460-2075.1985.tb03799.x; MCDONNELL SE, 1990, MOL CELL BIOL, V10, P4284, DOI 10.1128/MCB.10.8.4284; MURPHY G, 1985, BIOCHIM BIOPHYS ACTA, V831, P49, DOI 10.1016/0167-4838(85)90148-7; OKADA Y, 1986, J BIOL CEHM, V261, P1425; OSTROWSKI LE, 1988, MOL CARCINOGEN, V1, P13, DOI 10.1002/mc.2940010106; OWEN RD, 1990, P NATL ACAD SCI USA, V87, P3866, DOI 10.1073/pnas.87.10.3866; PRICE BD, 1989, J BIOL CHEM, V264, P16638; QUINONES S, 1989, J BIOL CHEM, V264, P8339; SAUS J, 1988, J BIOL CHEM, V263, P6742; SCHMID TM, 1986, J BIOL CHEM, V261, P4184; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; VERMA IM, 1987, CELL, V51, P513, DOI 10.1016/0092-8674(87)90115-2; WOLF C, 1993, P NATL ACAD SCI USA, V90, P1843, DOI 10.1073/pnas.90.5.1843	38	42	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10044	10049						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144503				2022-12-27	WOS:A1994NE05300098
J	DAY, JR; ALBERS, JJ; LOFTONDAY, CE; GILBERT, TL; CHING, AFT; GRANT, FJ; OHARA, PJ; MARCOVINA, SM; ADOLPHSON, JL				DAY, JR; ALBERS, JJ; LOFTONDAY, CE; GILBERT, TL; CHING, AFT; GRANT, FJ; OHARA, PJ; MARCOVINA, SM; ADOLPHSON, JL			COMPLETE CDNA-ENCODING HUMAN PHOSPHOLIPID TRANSFER PROTEIN FROM HUMAN ENDOTHELIAL COILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTER TRANSFER PROTEIN; HIGH-DENSITY-LIPOPROTEIN; LIPID TRANSFER PROTEINS; HUMAN-PLASMA; SEQUENCE; CLONING; PURIFICATION; SITE	Phospholipid transfer protein, with an apparent molecular mass of 81 kDa, was purified from human plasma. The NH2-terminal amino acid sequence of a 51 kDa proteolytic fragment obtained from phospholipid transfer protein allowed degenerate primers to be designed for polymerase chain reaction and the eventual isolation of a full-length cDNA from a human endothelial cDNA-library. The cDNA is 1,750 base pairs in length and contains an open reading frame of 1,518 nucleotides encoding a leader of 17 amino acids and a mature protein of 476 residues. Northern blot analysis shows a single mRNA transcript of approximately 1.8 kilobases with a wide tissue distribution. The gene was mapped to chromosome 20 using a human/rodent somatic cell hybrid mapping panel. Phospholipid transfer protein was found to be homologous to human cholesteryl ester transfer protein, human lipopolysaccharide-binding protein, and human neutrophil bactericidal permeability increasing protein (20, 24, and 26% identity, respectively).	UNIV WASHINGTON,NW LIPID RES LABS,DEPT MED,SEATTLE,WA 98103; ZYMOGENET CORP,SEATTLE,WA 98105	University of Washington; University of Washington Seattle; Zymogenet Inc.					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 30086] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGELLON LB, 1990, BIOCHEMISTRY-US, V29, P1372, DOI 10.1021/bi00458a004; ALBERS JJ, 1984, ARTERIOSCLEROSIS, V4, P49, DOI 10.1161/01.ATV.4.1.49; BAIROCH A, 1993, NUCLEIC ACIDS RES, V21, P3097, DOI 10.1093/nar/21.13.3097; BAIROCH A, 1993, NUCLEIC ACIDS RES, V21, P3093, DOI 10.1093/nar/21.13.3093; BARKER W, 1993, NUCLEIC ACIDS RES, V21, P3089, DOI 10.1093/nar/21.13.3089; BENSON D, 1993, NUCLEIC ACIDS RES, V21, P2963, DOI 10.1093/nar/21.13.2963; CHEUNG MC, 1991, J LIPID RES, V32, P383; DAMEN J, 1982, BIOCHIM BIOPHYS ACTA, V712, P444, DOI 10.1016/0005-2760(82)90271-5; DRAYNA D, 1987, NATURE, V327, P632, DOI 10.1038/327632a0; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; GRAY PW, 1993, GENOMICS, V15, P188, DOI 10.1006/geno.1993.1030; GRAY PW, 1989, J BIOL CHEM, V264, P9505; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; JAUHIAINEN M, 1993, J BIOL CHEM, V268, P4032; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LAGROST L, 1990, J LIPID RES, V31, P1569; LEONG SR, 1990, NUCLEIC ACIDS RES, V18, P3052, DOI 10.1093/nar/18.10.3052; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; LUSIS A J, 1987, Genomics, V1, P232, DOI 10.1016/0888-7543(87)90049-8; MAROTTI KR, 1993, NATURE, V364, P73, DOI 10.1038/364073a0; NAGASHIMA M, 1988, J LIPID RES, V29, P1643; NISHIDE T, 1989, J LIPID RES, V30, P149; OHARA PJ, 1991, COMPUT APPL BIOSCI, V7, P533; OHNISHI T, 1990, J LIPID RES, V31, P397; OHTA S, 1988, FEBS LETT, V242, P31, DOI 10.1016/0014-5793(88)80979-7; PAPE ME, 1991, ARTERIOSCLER THROMB, V11, P1759, DOI 10.1161/01.ATV.11.6.1759; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; QUINET E, 1991, J CLIN INVEST, V87, P1559, DOI 10.1172/JCI115169; RICE CM, 1993, NUCLEIC ACIDS RES, V21, P2967, DOI 10.1093/nar/21.13.2967; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; TALL AR, 1983, J BIOL CHEM, V258, P2174; TALL AR, 1986, J LIPID RES, V27, P361; TALL AR, 1993, J LIPID RES, V34, P1255; TOLLEFSON JH, 1988, J LIPID RES, V29, P1593; VANDERBLIEK AM, 1988, GENE, V71, P401, DOI 10.1016/0378-1119(88)90057-1; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73	38	174	185	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9388	9391						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132678				2022-12-27	WOS:A1994NB41100111
J	KONRAD, M; MERZ, WE				KONRAD, M; MERZ, WE			REGULATION OF N-GLYCOSYLATION - LONG-TERM EFFECT OF CYCLIC-AMP MEDIATES ENHANCED SYNTHESIS OF THE DOLICHOL PYROPHOSPHATE CORE OLIGOSACCHARIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CHORIONIC-GONADOTROPIN; ASPARAGINE-LINKED OLIGOSACCHARIDES; ALPHA-SUBUNIT GENE; ENDOPLASMIC-RETICULUM; BETA-SUBUNIT; RAT-LIVER; PROTEIN GLYCOSYLATION; PHOSPHATE-MANNOSE; DEVELOPMENTAL-CHANGE; SYNTHASE ACTIVITY	The influence of 8-bromo-cAMP on N-glycosylation in JEG-3 choriocarcinoma cells was investigated using the octanoyl-tripeptide (OTP; N-octanoyl-asparagyl-I-125- tyrosyl-threonine amide) as glycosyl acceptor. In cells pretreated with 8-bromo-cAMP (2.5 nM to 1 mM), the amount of glycosylated OTP released into the culture medium was increased up to 35-foId. Under the same conditions, a 23-fold higher quantity of the glycoprotein hormone human chorionic gonadotropin was secreted. Preincubation of 10-90 min with 250 mu M 8-bromo-cAMP caused only a 2-fold increase of the total amount of glycosylated OTP, whereas it was approximately 20-fold higher when the pretreatment was extended to 40 h. This strongly suggests involvement of gene activation rather than cAMP-mediated phosphorylation. The specific activity of the oligosaccharyltransferase, as well as the mRNA levels of ribophorin I and II (presumptive subunits of the enzyme), remained unchanged. In pulse-chase experiments, [H-3]mannose incorporation into dolichol-linked Glc(3)Man(9)(GlcNAc)(2) was up to 20-fold higher in cells pretreated with 8-bromo-cAMP (250 mu M, 40 h). The radioactivity was chased from the lipid-linked oligosaccharide pool and shifted to the glycoprotein fraction 10 times more rapidly in the pretreated cells. The flux of [H-3]mannose through the dolichol phosphate mannose pool was only slightly affected by the 8-bromo-cAMP pretreatment. Our investigations show that the oligosaccharyltransferase activity in JEG-3 cells is not rate-limiting. N-Glycosylation seems to be controlled by the amount of lipid-linked core oligosaccharide. The size of the lipid-linked core oligosaccharide pool, as well as the flux through, is markedly increased by pretreat ment with 8-bromo cAMP.	UNIV HEIDELBERG,DEPT BIOCHEM 2,D-69120 HEIDELBERG,GERMANY	Ruprecht Karls University Heidelberg								ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; ALBANESE C, 1991, MOL ENDOCRINOL, V5, P693, DOI 10.1210/mend-5-5-693; BANERJEE DK, 1985, BIOCHEM BIOPH RES CO, V126, P123, DOI 10.1016/0006-291X(85)90580-7; BANERJEE DK, 1987, P NATL ACAD SCI USA, V84, P6389, DOI 10.1073/pnas.84.18.6389; BARINAGA M, 1985, NATURE, V314, P279, DOI 10.1038/314279a0; BEEBE JS, 1989, ENDOCRINOLOGY, V124, P1613, DOI 10.1210/endo-124-4-1613; BERGER P, 1990, J ENDOCRINOL, V125, P301, DOI 10.1677/joe.0.1250301; BLITHE DL, 1990, J BIOL CHEM, V265, P21951; CARSON DD, 1987, BIOCHEMISTRY-US, V26, P1598, DOI 10.1021/bi00380a017; CARSON DD, 1981, J BIOL CHEM, V256, P1552; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DSOUZA C, 1992, ANAL BIOCHEM, V203, P211, DOI 10.1016/0003-2697(92)90305-Q; DUTT A, 1986, ENDOCRINOLOGY, V118, P661, DOI 10.1210/endo-118-2-661; FENSTERMAKER RA, 1989, MOL ENDOCRINOL, V3, P1070, DOI 10.1210/mend-3-7-1070; FENSTERMAKER RA, 1990, MOL ENDOCRINOL, V4, P1480, DOI 10.1210/mend-4-10-1480; FRANC JL, 1984, BIOCHEM BIOPH RES CO, V118, P910, DOI 10.1016/0006-291X(84)91481-5; FREEZE HH, 1990, J CELL BIOCHEM, V43, P27, DOI 10.1002/jcb.240430104; FRIEDMAN G, 1986, BIOCHIM BIOPHYS ACTA, V877, P112, DOI 10.1016/0005-2760(86)90125-6; FUH VL, 1989, MOL ENDOCRINOL, V3, P1148, DOI 10.1210/mend-3-7-1148; HARFORD JB, 1980, BIOCHEM J, V188, P481, DOI 10.1042/bj1880481; HARFORD JB, 1977, BIOCHEM BIOPH RES CO, V76, P1036, DOI 10.1016/0006-291X(77)90960-3; HASHIMOTO S, 1984, P NATL ACAD SCI-BIOL, V81, P6637, DOI 10.1073/pnas.81.21.6637; HILF G, 1989, BIOCHEM BIOPH RES CO, V159, P26, DOI 10.1016/0006-291X(89)92399-1; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; HUBBARD SC, 1980, J BIOL CHEM, V255, P1782; IUSEM ND, 1984, ENDOCRINOLOGY, V114, P1448, DOI 10.1210/endo-114-4-1448; KEAN EL, 1985, J BIOL CHEM, V260, P2561; KEAN EL, 1982, J BIOL CHEM, V257, P7952; KEAN EL, 1992, BIOCHEM CELL BIOL, V70, P413, DOI 10.1139/o92-064; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOUSVELARI EE, 1983, P NATL ACAD SCI-BIOL, V80, P7146, DOI 10.1073/pnas.80.23.7146; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRMAN M A, 1991, Glycobiology, V1, P553, DOI 10.1093/glycob/1.6.553; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUCAS JJ, 1978, BIOCHIM BIOPHYS ACTA, V528, P475, DOI 10.1016/0005-2760(78)90037-1; LUCAS JJ, 1977, J BIOL CHEM, V252, P4330; MARCANTONIO EE, 1984, J CELL BIOL, V99, P2254, DOI 10.1083/jcb.99.6.2254; MARTELL RE, 1990, ENDOCRINOLOGY, V126, P2757, DOI 10.1210/endo-126-5-2757; MATZUK MM, 1989, J BIOL CHEM, V264, P2409; MATZUK MM, 1988, J BIOL CHEM, V263, P17106; MERZ WE, 1988, BIOCHEM BIOPH RES CO, V156, P1271, DOI 10.1016/S0006-291X(88)80770-8; MERZ WE, 1991, GBF MONOG SERIES, V15, P57; MILSTED A, 1987, DNA-J MOLEC CELL BIO, V6, P213, DOI 10.1089/dna.1987.6.213; NIELSEN DA, 1985, J BIOL CHEM, V260, P3585; ODATAMAI S, 1985, J BIOL CHEM, V260, P57; PAN YT, 1990, BIOCHEMISTRY-US, V29, P8077, DOI 10.1021/bi00487a013; Patterson M K Jr, 1979, Methods Enzymol, V58, P141; ROSENWALD AG, 1990, J BIOL CHEM, V265, P14544; SARKAR M, 1984, BIOCHEM J, V219, P429, DOI 10.1042/bj2190429; SCHACHTER H, 1991, Glycobiology, V1, P453, DOI 10.1093/glycob/1.5.453; SCHMITT JW, 1979, J BIOL CHEM, V254, P2291; SHARMA C, 1988, BIOCHEM BIOPH RES CO, V155, P615, DOI 10.1016/S0006-291X(88)80539-4; SIBLEY CP, 1991, MOL ENDOCRINOL, V5, P582, DOI 10.1210/mend-5-4-582; STORRING PL, 1980, J ENDOCRINOL, V84, P295, DOI 10.1677/joe.0.0840295; TONG PSL, 1983, EXP CELL RES, V149, P215, DOI 10.1016/0014-4827(83)90393-2; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; YAMASHITA K, 1982, METHOD ENZYMOL, V83, P105	59	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8659	8666						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132594				2022-12-27	WOS:A1994NB41100009
J	SHIH, HM; TOWLE, HC				SHIH, HM; TOWLE, HC			DEFINITION OF THE CARBOHYDRATE RESPONSE ELEMENT OF THE RAT S-14 GENE - CONTEXT OF THE CACGTG MOTIF DETERMINES THE SPECIFICITY OF CARBOHYDRATE REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEIN; TRANSCRIPTION FACTOR BINDS; MAJOR LATE PROMOTER; DNA-BINDING; THYROID-HORMONE; C-FOS; S14 GENE; SACCHAROMYCES-CEREVISIAE; MESSENGER RNAS14; TERNARY COMPLEX	Transcription of the S-14 gene in primary hepatocytes is stimulated in response to increased carbohydrate metabolism. We have demonstrated previously that a 30-base pair (bp) segment of the S-14 gene from -1457 to -1428 is a carbohydrate response element (ChoRE). This element contains a (5')CACGTG motif that is essential for control. DNase I footprinting experiments with liver nuclear extract revealed two factors binding within the S-14 ChoRE. In transient transfection experiments, mutation of the upstream site between -1457 and -1450 did not affect the response to elevated glucose, whereas the downstream 21-bp site between -1448 and -1428 was sufficient to mediate the glucose induction. Electrophoretic mobility shift assays indicated that the hepatic factor binding to this site in vitro is closely related or identical to the major late transcription factor (MLTF). However, replacement of the 21-bp S-14 ChoRE with the authentic MLTF binding site from the adenovirus major late promoter failed to elicit the glucose response. By systematically exchanging bases between the functional S-14 and nonresponsive adenovirus sites, the sequence (5')CACGTGNNNGCC was found to be essential for carbohydrate regulation. A segment containing this specific motif from the rat fatty acid synthase gene, another carbohydrate-responsive gene in hepatocytes, conferred a carbohydrate response when linked to the S-14 promoter. Thus, the context of the CACGTG motif provides the specificity for regulation by carbohydrate metabolism.	UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities			Shih, Hsiu-Ming/S-7023-2018		NIDDK NIH HHS [DK 26919] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026919] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BAKER RE, 1990, MOL CELL BIOL, V10, P2458, DOI 10.1128/MCB.10.6.2458; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BERGOT MO, 1992, NUCLEIC ACIDS RES, V20, P1871, DOI 10.1093/nar/20.8.1871; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BLANAR MA, 1992, SCIENCE, V256, P1014, DOI 10.1126/science.1589769; BRADSHAW MS, 1988, MOL ENDOCRINOL, V2, P1286, DOI 10.1210/mend-2-12-1286; CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; CARR CS, 1990, MOL CELL BIOL, V10, P4384, DOI 10.1128/MCB.10.8.4384; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; CARTHEW RW, 1987, GENE DEV, V1, P973, DOI 10.1101/gad.1.9.973; CHODOSH LA, 1987, SCIENCE, V238, P684, DOI 10.1126/science.3672119; FISHER F, 1993, EMBO J, V12, P5075, DOI 10.1002/j.1460-2075.1993.tb06201.x; FISHER F, 1992, EMBO J, V11, P4103, DOI 10.1002/j.1460-2075.1992.tb05503.x; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; HALAZONETIS TD, 1991, P NATL ACAD SCI USA, V88, P6162, DOI 10.1073/pnas.88.14.6162; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; JACOBY DB, 1989, J BIOL CHEM, V264, P17623; JUMP DB, 1990, J BIOL CHEM, V265, P3474; JUMP DB, 1985, ENDOCRINOLOGY, V117, P2259, DOI 10.1210/endo-117-6-2259; JUMP DB, 1984, J BIOL CHEM, V259, P2789; LEGRAVEREND C, 1993, NUCLEIC ACIDS RES, V21, P1735, DOI 10.1093/nar/21.8.1735; LIAW C, 1983, BIOCHEMISTRY-US, V22, P213, DOI 10.1021/bi00270a031; LIU ZR, 1993, J BIOL CHEM, V268, P12787; MARIASH CN, 1981, J CLIN INVEST, V68, P1485, DOI 10.1172/JCI110401; MARIASH CN, 1986, J BIOL CHEM, V261, P9583; OGAWA N, 1990, MOL CELL BIOL, V10, P2224, DOI 10.1128/MCB.10.5.2224; OPPENHEIMER JH, 1987, ENDOCR REV, V8, P288, DOI 10.1210/edrv-8-3-288; POTTER JJ, 1991, J BIOL CHEM, V266, P15457; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SHAW PE, 1992, EMBO J, V11, P3011, DOI 10.1002/j.1460-2075.1992.tb05371.x; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SHIH HM, 1992, J BIOL CHEM, V267, P13222; Sirito Mario, 1992, Gene Expression, V2, P231; SOLOMON DLC, 1993, NUCLEIC ACIDS RES, V21, P5372, DOI 10.1093/nar/21.23.5372; TREISMAN R, 1992, EMBO J, V11, P4631, DOI 10.1002/j.1460-2075.1992.tb05565.x; VAULONT S, 1989, J MOL BIOL, V209, P205, DOI 10.1016/0022-2836(89)90273-8; VAULONT S, 1986, J BIOL CHEM, V261, P7621; VAULONT S, 1989, MOL CELL BIOL, V9, P4409, DOI 10.1128/MCB.9.10.4409; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A; ZHAO GQ, 1993, MOL CELL BIOL, V13, P4505, DOI 10.1128/MCB.13.8.4505	45	110	118	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9380	9387						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132677				2022-12-27	WOS:A1994NB41100110
J	MUH, U; WILLIAMS, CH; MASSEY, V				MUH, U; WILLIAMS, CH; MASSEY, V			LACTATE MONOOXYGENASE .3. ADDITIVE CONTRIBUTIONS OF ACTIVE-SITE RESIDUES TO CATALYTIC EFFICIENCY AND STABILIZATION OF AN ANIONIC TRANSITION-STATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BAKERS-YEAST; OXIDASE; MECHANISM; FLAVOCYTOCHROME-B2; PROTEINS; INACTIVATION; RESOLUTION; OXIDATION; BINDING	Lactate monooxygenase catalyzes the conversion of L-lactate to acetate, CO2, and water with incorporation of molecular oxygen. Several amino acid residues of lac tate monooxygenase had been postulated to interact in specific ways with the bound substrate (Giegel, D. A., Williams, C. H., Jr., and Massey, V. (1990) J. Biol. Chem. 265, 6626-6632). Tyrosine 44 and arginine 293 were proposed to form a hydrogen bond and a salt bridge to the carboxyl-moiety of lactate. Tyrosine 152 was suggested to form a hydrogen bond to the alpha-hydroxyl group and could be involved in stabilizing a transient carbanionic intermediate of the substrate. The tyrosine residues were replaced with phenylalanines (Y44F, Y152F), and arginine 293 was mutated to a lysine (R293K). In all cases catalysis was significantly decreased; however, the binding affinity for L-lactate did not decrease. Instead, the K-d measured for Y152F was 10-fold lower than that for the wild type enzyme. The products of turnover with Y152F were similar to those with wild type enzyme, with 70-80% of the reaction proceeding to form acetate, CO2, and H2O. The catalytic reactions with both Y44F and R293K were substantially uncoupled, with between 60 and 80% of the catalytic turnover forming pyruvate and H2O2. For all mutant forms the reoxidation of enzyme with oxygen in the absence of pyruvate occurred at a rate similar to that measured for the wild type enzyme. The most important effect of the mutations was in the ability to stabilize the transition state analog oxalate. A linear relationship was found between the rate of reduction of the enzyme flavin and the dissociation constant for the binding of oxalate, demonstrating that many individual residues contribute to the lowering of the energy of the transition state, in addition to specific functions being assignable to some specific residues.	UNIV MICHIGAN,SCH MED,DEPT BIOL CHEM,ANN ARBOR,MI 48109; DEPT VET AFFAIRS MED CTR,ANN ARBOR,MI 48105	University of Michigan System; University of Michigan					NIGMS NIH HHS [GM 21444, GM 11106] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM011106, R01GM011106] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHOONG YS, 1981, J BIOL CHEM, V256, P8671; DUBOIS J, 1990, BIOCHEMISTRY-US, V29, P6393, DOI 10.1021/bi00479a008; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P6030, DOI 10.1021/bi00393a013; GHISLA S, 1975, J BIOL CHEM, V250, P577; GHISLA S, 1977, J BIOL CHEM, V252, P6729; Ghisla S., 1991, CHEM BIOCH FLAVOENZY, P243; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; GIEGEL DA, 1990, J BIOL CHEM, V265, P6626; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDERER F, 1991, CHEM BIOCH FLAVOENZY, V2, P153; LINDQVIST Y, 1989, J BIOL CHEM, V264, P3624; LOCKRIDGE O, 1972, J BIOL CHEM, V247, P8097; MACHEROUX P, 1993, EUR J BIOCHEM, V213, P1047, DOI 10.1111/j.1432-1033.1993.tb17852.x; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; MASSEY V, 1977, J BIOL CHEM, V252, P5612; MASSEY V, 1969, J BIOL CHEM, V244, P3999; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; MUH U, 1994, J BIOL CHEM, V269, P7982; MUH U, 1994, J BIOL CHEM, V269, P7989; MUH U, 1994, FLAVINS FLAVOPROTEIN; MULLER F, 1969, J BIOL CHEM, V244, P4007; PETERS RG, 1981, BIOCHEMISTRY-US, V20, P2564, DOI 10.1021/bi00512a031; TEGONI M, 1988, J BIOL CHEM, V263, P19278; WALSH C, 1973, J BIOL CHEM, V248, P7049; XIA ZX, 1990, J MOL BIOL, V212, P837, DOI 10.1016/0022-2836(90)90240-M; XIA ZX, 1987, P NATL ACAD SCI USA, V84, P2629, DOI 10.1073/pnas.84.9.2629	26	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7994	8000						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132520				2022-12-27	WOS:A1994NB40900028
J	PRITCHARD, KA; OBANION, MK; MIANO, JM; VLASIC, N; BHATIA, UG; YOUNG, DA; STEMERMAN, MB				PRITCHARD, KA; OBANION, MK; MIANO, JM; VLASIC, N; BHATIA, UG; YOUNG, DA; STEMERMAN, MB			INDUCTION OF CYCLOOXYGENASE-2 IN RAT VASCULAR SMOOTH-MUSCLE CELLS IN-VITRO AND IN-VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN-H SYNTHASE; HUMAN-ENDOTHELIAL-CELLS; ANGIOTENSINOGEN MESSENGER-RNA; LOW-DENSITY LIPOPROTEIN; IMMEDIATE-EARLY GENE; GROWTH-FACTOR; HUMAN-FIBROBLASTS; ARACHIDONIC-ACID; ARTERIAL INJURY; 3T3 CELLS	Prostaglandins are synthesized from arachidonic acid by the rate limiting enzyme cyclooxygenase (prostaglandin G/H synthase). Active cyclooxygenase is encoded by two distinct and independently regulated genes, termed cyclooxygenase-1 (cox1) and cyclooxygenase-2 (cox2). In this investigation, we examined the expression of cox1 and coxa mRNA in rat aorta following balloon deendothelialization (BDE) in vivo and in rat aortic smooth muscle cells (SMC) after serum stimulation in vitro. Two h after BDE, rat aortic cox2 mRNA levels increased greater than 50-fold relative to the lowest detectable levels on days 2 and 14. No message was detectable in non-BDE control rat aortas. Similar to the results found in vivo, cultured SMC exhibited a greater than 45-fold increase in cox2 mRNA levels after a 2-h exposure to serum. This increase was transient because cox2 levels declined at 4 and 8 h. In contrast, minimal changes in cox1 mRNA levels were observed after BDE or serum treatments. Increased levels of cox2 mRNA and corresponding protein synthesis led to an accumulation of total cyclooxygenase protein, which remained elevated 24 h after serum stimulation. Serum-treated SMC also generated greater amounts of cyclooxygenase-dependent metabolites than quiescent SMC as evidenced by marked increases in prostaglandin E(2) content in conditioned media, This increase is associated with a 2.5-3.0-fold increased rate of arachidonic acid conversion to prostaglandin E(2). Our data indicate that injury and serum stimulation differentially regulate mRNA and protein expression of two distinct cox genes in vascular SMC in vivo and in vitro. The findings suggest that the prostanoid responses after vascular injury are, in part, mediated by acute increases in cox2 mRNA and cyclooxygenase-2 protein.	UNIV ROCHESTER,SCH MED,DEPT MED,ROCHESTER,NY 14642; UNIV ROCHESTER,SCH MED,DEPT BIOCHEM,ROCHESTER,NY 14642	University of Rochester; University of Rochester	PRITCHARD, KA (corresponding author), NEW YORK MED COLL,DEPT EXPTL PATHOL,VALHALLA,NY 10595, USA.		; Miano, Joseph/L-5634-2018	O'Banion, M. Kerry/0000-0003-1246-3363; Miano, Joseph/0000-0001-7522-3207	NHLBI NIH HHS [1-PO HL43023R1, HL25316] Funding Source: Medline; NIDDK NIH HHS [DK1677] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL043023, R01HL025316] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKAHOSHI T, 1988, J CLIN INVEST, V82, P1219, DOI 10.1172/JCI113719; ALBRIGHTSON CR, 1985, J IMMUNOL, V135, P1872; BRINKMAN HJM, 1990, THROMB HAEMOSTASIS, V63, P291; CASSIS LA, 1988, HYPERTENSION, V11, P591, DOI 10.1161/01.HYP.11.6.591; CASSIS LA, 1988, CIRC RES, V62, P1259, DOI 10.1161/01.RES.62.6.1259; CHERVU A, 1989, J VASC SURG, V10, P129, DOI 10.1067/mva.1989.0100129; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FLETCHER BS, 1992, J BIOL CHEM, V267, P4338; GOLDBERG ID, 1979, SCIENCE, V205, P920, DOI 10.1126/science.472713; GUTSTEIN WH, 1991, MECH AGEING DEV, V57, P205, DOI 10.1016/0047-6374(91)90047-4; HABENICHT AJR, 1985, J CLIN INVEST, V75, P1381, DOI 10.1172/JCI111839; HABENICHT AJR, 1986, P NATL ACAD SCI USA, V83, P1344, DOI 10.1073/pnas.83.5.1344; HAN JW, 1990, P NATL ACAD SCI USA, V87, P3373, DOI 10.1073/pnas.87.9.3373; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; HOLLAND JA, 1988, AM J PATHOL, V132, P474; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KENT RS, 1983, J CLIN INVEST, V72, P455, DOI 10.1172/JCI110993; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; KUJUBU DA, 1993, J BIOL CHEM, V268, P5425; KUJUBU DA, 1992, J BIOL CHEM, V267, P7991; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; LEROY EC, 1984, J CLIN INVEST, V74, P1003, DOI 10.1172/JCI111467; LIBBY P, 1989, AM REV RESPIR DIS, V140, P1114, DOI 10.1164/ajrccm/140.4.1114; LIBBY P, 1988, J CLIN INVEST, V81, P487, DOI 10.1172/JCI113346; LIN LL, 1992, J BIOL CHEM, V267, P23451; LOESBERG C, 1985, EXP CELL RES, V160, P117, DOI 10.1016/0014-4827(85)90241-1; MAIER JAM, 1990, J BIOL CHEM, V265, P10805; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; MAJESKY MW, 1990, J CELL BIOL, V111, P2149, DOI 10.1083/jcb.111.5.2149; MIANO JM, 1993, AM J PATHOL, V142, P715; MIANO JM, 1990, AM J PATHOL, V137, P761; MIANO JM, 1993, ARTERIOSCLER THROMB, V13, P211, DOI 10.1161/01.ATV.13.2.211; MIANO JM, 1991, CIRCULATION, V84, P342; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981; NILSSON J, 1984, ATHEROSCLEROSIS, V53, P77, DOI 10.1016/0021-9150(84)90107-2; OBANION MK, 1992, P NATL ACAD SCI USA, V89, P4888, DOI 10.1073/pnas.89.11.4888; OBANION MK, 1991, J BIOL CHEM, V266, P23261; PASH JM, 1988, FASEB J, V2, P2613, DOI 10.1096/fasebj.2.10.2968288; PASRICHA PJ, 1992, PROSTAGLANDINS, V43, P5, DOI 10.1016/0090-6980(92)90060-7; RAZ A, 1989, ADV EXP MED BIOL, V259, P1; RAZ A, 1988, J BIOL CHEM, V263, P3022; RYSECK RP, 1992, CELL GROWTH DIFFER, V3, P443; STEMERMAN MB, 1973, AM J PATHOL, V73, P7; TAHARA K, 1991, J BIOL CHEM, V266, P440; TANNENBAUM CS, 1990, J CELL PHYSIOL, V144, P77, DOI 10.1002/jcp.1041440111; TAUBMAN MB, 1992, CIRC RES, V70, P314, DOI 10.1161/01.RES.70.2.314; TSAI AL, 1991, ADV PROSTAG THROMB L, V21, P141; VERRIER B, 1986, EMBO J, V5, P913, DOI 10.1002/j.1460-2075.1986.tb04303.x; WINN VD, 1993, J LIPID MEDIATOR, V6, P101; WU KK, 1991, P NATL ACAD SCI USA, V88, P2384, DOI 10.1073/pnas.88.6.2384; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; ZYGLEWSKA T, 1992, BIOCHIM BIOPHYS ACTA, V1131, P78, DOI 10.1016/0167-4781(92)90101-5	52	141	143	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8504	8509						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132578				2022-12-27	WOS:A1994NB40900101
J	SCHENKMAN, S; CHAVES, LB; DECARVALHO, LCP; EICHINGER, D				SCHENKMAN, S; CHAVES, LB; DECARVALHO, LCP; EICHINGER, D			A PROTEOLYTIC FRAGMENT OF TRYPANOSOMA-CRUZI TRANS-SIALIDASE LACKING THE CARBOXYL-TERMINAL DOMAIN IS ACTIVE, MONOMERIC, AND GENERATES ANTIBODIES THAT INHIBIT ENZYMATIC-ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAMINIDASE ACTIVITIES; MAMMALIAN-CELLS; ACID; PROTEINS; TRYPOMASTIGOTES; SEQUENCES; BACTERIAL; INVASION; ANTIGENS; INVITRO	trans-Sialidase isolated from trypomastigote forms of Trypanosoma cruzi, the protozoan parasite that causes Chagas' disease, is multimeric and heterogeneous in size. We show here that limited proteolysis of trans-sialidase with papain yields a single monomeric polypeptide chain of 70 kDa that conserves full enzymatic activity on soluble and membrane-bound substrates. The papain fragment lacks most of the 12-amino acid repeats of the carboxyl-terminal domain that comprises about 50% of the native trans-sialidase. When injected into rabbits, the papain-generated fragment induces antibodies that inhibit trans-sialidase activity and trypomastigote sialylation. The repeats are also not required for the stability of the enzyme or for the correct folding during the biosynthesis in Escherichia coli, but seem essential for trans-sialidase oligomerization. We conclude that trans-sialidase is composed of two structurally and functionally independent domains.	NYU MED CTR,MICHAEL HEIDELBERGER DIV IMMUNOL,NEW YORK,NY 10016; ESCOLA PAULISTA MED,DEPT MICROBIOL IMMUNOL & PARASITOL,SAO PAULO,SP,BRAZIL	New York University; Universidade Federal de Sao Paulo (UNIFESP)			Schenkman, Sergio/A-9227-2013; Chaves, Luciana Botelho/N-7925-2019; Chaves, Luciana/D-6689-2012	Schenkman, Sergio/0000-0001-9353-8480; Chaves, Luciana Botelho/0000-0002-5137-610X; Chaves, Luciana/0000-0002-5137-610X	FOGARTY INTERNATIONAL CENTER [R03TW000227] Funding Source: NIH RePORTER; FIC NIH HHS [R03 TW00227-01] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		BUSCHIAZZO A, 1992, MOL BIOCHEM PARASIT, V54, P125, DOI 10.1016/0166-6851(92)90105-S; CAMPETELLA O, 1992, PARASITOL TODAY, V8, P378, DOI 10.1016/0169-4758(92)90175-2; CAZZULO JJ, 1992, FASEB J, V6, P3259, DOI 10.1096/fasebj.6.14.1426764; CHAVES LB, 1993, MOL BIOCHEM PARASIT, V61, P97, DOI 10.1016/0166-6851(93)90162-Q; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; COTE GL, 1990, GLYCOCONJUGATE J, V7, P145, DOI 10.1007/BF01050377; CROSS GAM, 1993, ANNU REV MICROBIOL, V47, P384; DECARVALHO LCP, 1993, J EXP MED, V177, P465, DOI 10.1084/jem.177.2.465; ENGSTLER M, 1992, MOL BIOCHEM PARASIT, V54, P21, DOI 10.1016/0166-6851(92)90091-W; ENGSTLER M, 1993, PARASITOL TODAY, V9, P222, DOI 10.1016/0169-4758(93)90018-B; ENGSTLER M, 1992, HOPPESEYLERS Z PHYSL, V373, P843; HALL BF, 1993, J EUKARYOT MICROBIOL, V40, P207, DOI 10.1111/j.1550-7408.1993.tb04905.x; MACINA RA, 1989, FEBS LETT, V2, P365; PARODI AJ, 1992, EMBO J, V11, P1705, DOI 10.1002/j.1460-2075.1992.tb05221.x; PASSANITI A, 1988, J BIOL CHEM, V263, P7591; PAULSON JC, 1987, METHOD ENZYMOL, V138, P162; PEREIRA MEA, 1991, J EXP MED, V174, P179, DOI 10.1084/jem.174.1.179; PIRAS MM, 1987, MOL BIOCHEM PARASIT, V22, P135, DOI 10.1016/0166-6851(87)90043-0; POLLEVICK GD, 1993, MOL BIOCHEM PARASIT, V59, P171, DOI 10.1016/0166-6851(93)90018-S; POLLOCK JJ, 1970, BIOCHEMISTRY-US, V9, P3913, DOI 10.1021/bi00822a009; PREVIATO JO, 1985, MOL BIOCHEM PARASIT, V16, P85, DOI 10.1016/0166-6851(85)90051-9; PRIOLI RP, 1990, J IMMUNOL, V144, P4384; PRIOLI RP, 1992, MOL BIOCHEM PARASIT, V52, P85, DOI 10.1016/0166-6851(92)90038-L; ROGGENTIN P, 1989, GLYCOCONJUGATE J, V6, P349, DOI 10.1007/BF01047853; ROSENBERG I, 1991, MOL BIOCHEM PARASIT, V46, P303, DOI 10.1016/0166-6851(91)90054-A; SCHAUER R, 1983, H-S Z PHYSIOL CHEM, V364, P1053, DOI 10.1515/bchm2.1983.364.2.1053; SCHENKMAN S, 1991, CELL, V65, P1117, DOI 10.1016/0092-8674(91)90008-M; SCHENKMAN S, 1992, J EXP MED, V175, P1635, DOI 10.1084/jem.175.6.1635; SCHENKMAN S, 1993, MOL BIOCHEM PARASIT, V59, P293, DOI 10.1016/0166-6851(93)90227-O; SCHENKMAN S, 1992, J EXP MED, V175, P567, DOI 10.1084/jem.175.2.567; SCHENKMAN S, 1993, PARASITOL TODAY, V9, P218, DOI 10.1016/0169-4758(93)90017-A; UEMURA H, 1992, EMBO J, V11, P3837, DOI 10.1002/j.1460-2075.1992.tb05476.x; ZINGALES B, 1987, MOL BIOCHEM PARASIT, V26, P135, DOI 10.1016/0166-6851(87)90137-X	33	63	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7970	7975						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132517				2022-12-27	WOS:A1994NB40900024
J	SEEGERT, D; STREHLOW, I; KLOSE, B; LEVY, DE; SCHINDLER, C; DECKER, T				SEEGERT, D; STREHLOW, I; KLOSE, B; LEVY, DE; SCHINDLER, C; DECKER, T			A NOVEL INTERFERON ALPHA-REGULATED, DNA-BINDING PROTEIN PARTICIPATES IN THE REGULATION OF THE IFP53/TRYPTOPHANYL-TRANSFER-RNA SYNTHETASE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; IFN-GAMMA; INDOLEAMINE 2,3-DIOXYGENASE; TYROSINE PHOSPHORYLATION; CYTOPLASMIC ACTIVATION; MOLECULAR-CLONING; HUMAN FIBROBLASTS; RESPONSE ELEMENT; EXPRESSION; INDUCTION	We have investigated the transcriptional response of the IFP53/tryptophanyl-tRNA synthetase gene to interferon-alpha (IFN-alpha). A single gamma-interferon activation site (GAS) in proximity to the transcription start sites was found to mediate the response of the IFP53 gene to IFN-alpha. This DNA element bound two distinct protein factors, alpha-interferon activation factor 1 (AAF1) and AAF2, which were rapidly activated in the cytoplasm of IFN-alpha-treated HeLa cells. AAF1, like the gamma-interferon activation factor, bound to the GAS from different IFN-responsive promoters and contained the 91-kDa ISGF3 protein (p91). However, in complexes with the IFP53 or Ly6A/E GAS, p91 was the only ISGF3 protein, whereas in the case of the GBP GAS, the 48-kDa protein (p48) was also present. AAF2 was found to preferentially bind to the IFP53 GAS, but not at all to the GBP GAS, and contained no ISGF3 protein. Therefore, GAS-binding regulatory factors in the IFN-alpha response can either consist of proteins found in ISGF3 or be formed by distinct proteins that are similarly linked to IFN-alpha-induced signal transduction.	VIENNA BIOCTR,INST MICROBIOL & GENET,DEPT CELL BIOL & MICROBIOL,A-1030 VIENNA,AUSTRIA; FRAUNHOFER INST TOXICOL & MOLEC BIOL,D-30625 HANNOVER,GERMANY; NYU,SCH MED,DEPT PATHOL,NEW YORK,NY 10016; COLUMBIA UNIV COLL PHYS & SURG,DEPT MED,DIV MOLEC MED,NEW YORK,NY 10032	Vienna Biocenter (VBC); Fraunhofer Gesellschaft; New York University; Columbia University			Levy, David/AAG-6202-2019; Levy, David/GPS-4945-2022	Levy, David/0000-0002-7320-7788; 				AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; BUWITT U, 1992, EMBO J, V11, P489, DOI 10.1002/j.1460-2075.1992.tb05079.x; DAI W, 1990, J BIOL CHEM, V265, P19871; DALE TC, 1989, P NATL ACAD SCI USA, V86, P1203, DOI 10.1073/pnas.86.4.1203; DAVID M, 1993, J BIOL CHEM, V268, P6593; DECKER T, 1991, MOL CELL BIOL, V11, P5147, DOI 10.1128/MCB.11.10.5147; DECKER T, 1989, EMBO J, V8, P2009, DOI 10.1002/j.1460-2075.1989.tb03608.x; DECKER T, 1991, EMBO J, V10, P927, DOI 10.1002/j.1460-2075.1991.tb08026.x; Demaeyer E., 1988, INTERFERONS OTHER RE; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EILERS A, 1993, MOL CELL BIOL, V13, P3245, DOI 10.1128/MCB.13.6.3245; EILERS A, 1994, IN PRESS MOL CELL BI; FROLOVA LY, 1993, GENE, V128, P237, DOI 10.1016/0378-1119(93)90568-N; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; FU XY, 1992, CELL, V70, P323, DOI 10.1016/0092-8674(92)90106-M; GOLUB EI, 1989, NUCLEIC ACIDS RES, V9, P3047; HASSANAIN HH, 1993, J BIOL CHEM, V268, P5077; IGARASHI K, 1993, MOL CELL BIOL, V13, P1634, DOI 10.1128/MCB.13.3.1634; JOHN J, 1991, MOL CELL BIOL, V11, P4189, DOI 10.1128/MCB.11.8.4189; KANNO Y, 1993, MOL CELL BIOL, V13, P3951, DOI 10.1128/MCB.13.7.3951; KHAN KD, 1993, P NATL ACAD SCI USA, V90, P6806, DOI 10.1073/pnas.90.14.6806; KISSELEV L, 1993, TRENDS BIOCHEM SCI, V18, P263, DOI 10.1016/0968-0004(93)90178-P; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; LEVY DE, 1990, EMBO J, V9, P1105, DOI 10.1002/j.1460-2075.1990.tb08216.x; LEVY DE, 1989, GENE DEV, V3, P1362, DOI 10.1101/gad.3.9.1362; LEW DJ, 1991, MOL CELL BIOL, V11, P182, DOI 10.1128/MCB.11.1.182; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; PARRINGTON J, 1993, EUR J BIOCHEM, V214, P617, DOI 10.1111/j.1432-1033.1993.tb17961.x; PEARSE RN, 1993, P NATL ACAD SCI USA, V90, P4314, DOI 10.1073/pnas.90.9.4314; PEREZ C, 1993, MOL CELL BIOL, V13, P2182, DOI 10.1128/MCB.13.4.2182; PINE R, 1990, MOL CELL BIOL, V10, P2448, DOI 10.1128/MCB.10.6.2448; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; PORTER ACG, 1988, EMBO J, V7, P85, DOI 10.1002/j.1460-2075.1988.tb02786.x; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; RUBIN BY, 1991, J BIOL CHEM, V266, P24245; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; Sambrook J, 1989, MOL CLONING LABORATO; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; SIMS SH, 1993, MOL CELL BIOL, V13, P690, DOI 10.1128/MCB.13.1.690; STREHLOW I, 1993, J BIOL CHEM, V268, P16590; STREHLOW I, 1992, NUCLEIC ACIDS RES, V20, P3865, DOI 10.1093/nar/20.15.3865; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; VEALS SA, 1993, MOL CELL BIOL, V13, P196, DOI 10.1128/MCB.13.1.196; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; YUAN J, 1994, IN PRESS MOL CELL BI	50	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8590	8595						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132584				2022-12-27	WOS:A1994NB40900113
J	ALBERTS, AS; ARIAS, J; HAGIWARA, M; MONTMINY, MR; FERAMISCO, JR				ALBERTS, AS; ARIAS, J; HAGIWARA, M; MONTMINY, MR; FERAMISCO, JR			RECOMBINANT CYCLIC-AMP RESPONSE ELEMENT-BINDING PROTEIN (CREB) PHOSPHORYLATED ON SER-133 IS TRANSCRIPTIONALLY ACTIVE UPON ITS INTRODUCTION INTO FIBROBLAST NUCLEI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE INDUCES EXPRESSION; CATALYTIC SUBUNIT; C-FOS; SOMATOSTATIN GENE; AP-1 ACTIVITY; LIVING CELLS; INDUCTION; DEPHOSPHORYLATION; PHOSPHATASES; ISOFORMS	To date, it has not been possible to determine whether the single phosphorylation of the cyclic AMP response element binding factor (CREB) at Ser-133 is sufficient for the transcriptional activation by cAMP-mediated pathways. Previous in vivo studies investigating this point have relied upon transfection of cyclic AMP-dependent kinase (cAPK) or its activation by treatment of cells with cell-permeable cAMP analogs. However, as numerous cellular proteins, including CREB, are substrates for activated cAPK, the possibility remains that cAPK substrates other than CREB are required for the transcriptional activity of CRE-containing promoters. To further address this, we compared the activity of recombinant CREB phosphorylated on Ser-133 in both cell-free transcription assays and in vivo after introduction of the same preparations into fibroblasts by microinjection. The activity of phosphorylated CREB, non-phosphorylated CREB, and a mutant form of CREB, containing Ala substituted for Ser at position 133, was found to be nearly identical in cell-free in vitro transcription assays. In contrast, we found that only the phosphorylated CREB microinjected into fibroblasts resulted in the stimulation of expression of CRE regulated genes. These results suggest that phosphorylation of CREB on Ser-133 directly stimulates its ability to transactivate gene expression in intact cells.	UNIV CALIF SAN DIEGO, CTR CANC, DEPT MED, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, CTR CANC, DEPT PHARMACOL, LA JOLLA, CA 92093 USA; SALK INST BIOL STUDIES, CLAYTON FDN LABS PEPTIDE BIOL, LA JOLLA, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute					NIGMS NIH HHS [R01 GM 37828] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037828] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; ALBERTS AS, 1993, DNA CELL BIOL, V12, P935, DOI 10.1089/dna.1993.12.935; ALBERTS AS, 1993, MOL CELL BIOL, V13, P2104, DOI 10.1128/MCB.13.4.2104; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BERKOWITZ LA, 1989, MOL CELL BIOL, V9, P4272, DOI 10.1128/MCB.9.10.4272; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; FANTOZZI DA, 1992, J BIOL CHEM, V267, P16824; GONZALEZ GA, 1991, MOL CELL BIOL, V11, P1306, DOI 10.1128/MCB.11.3.1306; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; LAMPH WW, 1990, P NATL ACAD SCI USA, V87, P4320, DOI 10.1073/pnas.87.11.4320; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LECOCQ R, 1990, ELECTROPHORESIS, V11, P200, DOI 10.1002/elps.1150110303; LEE CQ, 1990, EMBO J, V9, P4455, DOI 10.1002/j.1460-2075.1990.tb07896.x; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; MANDELL RB, 1992, EXP CELL RES, V198, P164, DOI 10.1016/0014-4827(92)90163-3; MAURER RA, 1989, J BIOL CHEM, V264, P6870; MEINKOTH JL, 1990, P NATL ACAD SCI USA, V87, P9595, DOI 10.1073/pnas.87.24.9595; MEINKOTH JL, 1991, MOL CELL BIOL, V11, P1759, DOI 10.1128/MCB.11.3.1759; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; NIGG EA, 1985, EMBO J, V4, P2801, DOI 10.1002/j.1460-2075.1985.tb04006.x; RIABOWOL KT, 1988, COLD SPRING HARB SYM, V53, P85, DOI 10.1101/SQB.1988.053.01.013; RIABOWOL KT, 1988, NATURE, V336, P83, DOI 10.1038/336083a0; ROSE DW, 1992, J CELL BIOL, V119, P1405, DOI 10.1083/jcb.119.6.1405; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; STRUHL K, 1993, CURR BIOL, V3, P220, DOI 10.1016/0960-9822(93)90338-O; STRUTHERS RS, 1991, NATURE, V350, P622, DOI 10.1038/350622a0; SUN PQ, 1992, MOL ENDOCRINOL, V6, P1858, DOI 10.1210/me.6.11.1858; THORBURN AM, 1993, BIOTECHNIQUES, V14, P356; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	39	65	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7623	7630						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125987				2022-12-27	WOS:A1994NA03200093
J	FERREIRA, GC; FRANCO, R; LLOYD, SG; PEREIRA, AS; MOURA, I; MOURA, JJG; HUYNH, BH				FERREIRA, GC; FRANCO, R; LLOYD, SG; PEREIRA, AS; MOURA, I; MOURA, JJG; HUYNH, BH			MAMMALIAN FERROCHELATASE, A NEW ADDITION TO THE METALLOENZYME FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ELEMENT BINDING-PROTEIN; DESULFOVIBRIO-GIGAS; MOLECULAR-CLONING; MOSSBAUER-SPECTRA; PURIFICATION; PROTOPORPHYRIA; MITOCHONDRIA; FERREDOXIN; LIVER; ACID	A [2Fe-2S] cluster has been detected in mammalian ferrochelatase, the terminal enzyme of the heme biosynthetic pathway. Natural ferrochelatase, purified from mouse livers, and recombinant ferrochelatase, purified from an overproducing strain of Escherichia coli, were investigated by electron paramagnetic resonance (EPR) and Mossbauer spectroscopy. In their reduced forms, both the natural and recombinant ferrochelatases exhibited an identical EPR signal with g values (g = 2.00, 1.93, and 1.90) and relaxation properties typical of [2Fe-2S](+) cluster. Mossbauer spectra of the recombinant ferrochelatase, purified from a strain of E. coli cells transformed with a plasmid encoding murine liver ferrochelatase and grown in Fe-57-enriched medium, demonstrated unambiguously that the cluster is a [2Fe-2S] cluster. No change in the cluster oxidation state was observed during catalysis, The putative protein binding site for the Fe-S cluster in mammalian ferrochelatases is absent from the sequences of the bacterial and yeast enzymes, suggesting a possible role of the [2Fe-2S] center in regulation of mammalian ferrochelatases.	UNIV S FLORIDA, H LEE MOFFITT CANC CTR & RES INST, TAMPA, FL 33612 USA; UNIV NOVA LISBOA, FAC CIENCIAS & TECNOL, DEPT QUIM, P-2825 MONTE DE CAPARICA, PORTUGAL; EMORY UNIV, DEPT PHYS, ATLANTA, GA 30322 USA; UNIV NOVA LISBOA, INST TECNOL QUIM & BIOL, P-2780 OEIRAS, PORTUGAL	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Universidade Nova de Lisboa; Emory University; Universidade Nova de Lisboa	FERREIRA, GC (corresponding author), UNIV S FLORIDA, COLL MED, INST BIOMOLEC SCI, DEPT BIOCHEM & MOLEC BIOL, TAMPA, FL 33612 USA.		Moura, Isabel/D-6339-2013; Moura, José J G/D-6426-2013; Ferreira, Gloria C/A-4709-2012; Franco, Ricardo/C-5247-2008; Pereira, Alice S/D-7779-2013	Moura, Isabel/0000-0003-0971-4977; Moura, José J G/0000-0002-4726-2388; Ferreira, Gloria C/0000-0001-9279-2217; Franco, Ricardo/0000-0002-5139-2871; Pereira, Alice S/0000-0001-5567-6073	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047295] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 47295] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARATA BAS, 1992, EUR J BIOCHEM, V204, P773, DOI 10.1111/j.1432-1033.1992.tb16693.x; BRENNER DA, 1992, AM J HUM GENET, V50, P1203; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; Dailey H. A., 1990, BIOSYNTHESIS HEME CH, P123; DAILEY HA, 1986, METHOD ENZYMOL, V123, P401; FERREIRA GC, 1994, J BIOL CHEM, V269, P4396; FISCHER DS, 1964, CLIN CHEM, V10, P21, DOI 10.1016/0009-8981(64)90210-4; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; GRABOWSKI R, 1991, EUR J BIOCHEM, V199, P89, DOI 10.1111/j.1432-1033.1991.tb16095.x; GRABOWSKI R, 1993, TRENDS BIOCHEM SCI, V18, P297, DOI 10.1016/0968-0004(93)90040-T; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; HAMPSEY DM, 1986, J BIOL CHEM, V261, P3259; HARBIN BM, 1985, BIOCHEMISTRY-US, V24, P366, DOI 10.1021/bi00323a019; Huynh B H, 1984, Adv Inorg Biochem, V6, P163; HUYNH BH, 1980, J BIOL CHEM, V255, P3242; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; Labbe-Bois Rosine, 1994, V11, P413; LONDON IM, 1987, ENZYMES, V18, P359; MIDDLETON P, 1980, EUR J BIOCHEM, V104, P289, DOI 10.1111/j.1432-1033.1980.tb04427.x; MIDDLETON P, 1978, EUR J BIOCHEM, V88, P135, DOI 10.1111/j.1432-1033.1978.tb12430.x; MUNCK E, 1972, BIOCHEMISTRY-US, V11, P855; NAKAHASHI Y, 1990, BIOCHIM BIOPHYS ACTA, V1037, P321, DOI 10.1016/0167-4838(90)90032-B; NAKAHASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P748, DOI 10.1016/S0006-291X(05)80099-3; OHALLORAN TV, 1993, SCIENCE, V261, P715, DOI 10.1126/science.8342038; ORMEJOHNSON WH, 1982, IRON SULFUR PROTEINS, V4, P67; PHILPOTT CC, 1993, J BIOL CHEM, V268, P17655; SAMBROOK J, 1989, MOL CLONING LAB MANU, pA1; SANDS RH, 1974, Q REV BIOPHYS, V7, P443, DOI 10.1017/S0033583500001517; Schulz C., 1976, J PHYS C SOLID STATE, V37, DOI DOI 10.1051/JPHYSCOL:1976633; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TAKETANI S, 1990, J BIOL CHEM, V265, P19377; THORSON JS, 1993, J AM CHEM SOC, V115, P7539, DOI 10.1021/ja00069a078; WHITCOMBE DM, 1991, GENOMICS, V11, P1152, DOI 10.1016/0888-7543(91)90044-F; ZHANG L, 1993, P NATL ACAD SCI USA, V90, P2851, DOI 10.1073/pnas.90.7.2851	34	76	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7062	7065						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125912				2022-12-27	WOS:A1994NA03200005
J	MOON, KY; SHIN, KS; SONG, WK; CHUNG, CH; HA, DB; KANG, MS				MOON, KY; SHIN, KS; SONG, WK; CHUNG, CH; HA, DB; KANG, MS			A CANDIDATE MOLECULE FOR THE MATRIX ASSEMBLY RECEPTOR TO THE N-TERMINAL 29-KDA FRAGMENT OF FIBRONECTIN IN CHICK MYOBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; CELL-ADHESION; MONOCLONAL-ANTIBODIES; PLASMA FIBRONECTIN; SURFACE-PROTEINS; BINDING PROTEIN; DIFFERENTIATION; MUSCLE; DOMAIN; MYOGENESIS	Myoblast surface proteins with binding activity toward the N-terminal 29-kDa fragment of fibronectin were identified by two different experimental techniques: one involves radioiodination of the cell surface proteins, followed by solubilization with Triton X-100 and affinity purification on a Sepharose column conjugated with the 29-kDa fragment, and the other involves cross-linking of the 29-kDa fragment to the cells metabolically labeled with [S-35]methionine, followed by immunoprecipitation with anti-29-kDa IgG. Both approaches revealed that primary cultures of chick myoblasts contain the 66- and 48-kDa proteins that bind to the 29-kDa fragment. These binding proteins were then purified to apparent homogeneity by two successive chromatographies of the solubilized extracts of 12-day-old embryonic muscle on wheat germ agglutinin-agarose and 29-kDa fragment-Sepharose columns. However, the 48-kDa protein was found to be derived from contaminating fibroblasts upon immunoblot analysis of the myogenic cell lines, rat L8E63 and mouse C2A3, and cultured fibroblasts using the antibody raised against the 66-kDa protein. Anti-66-kDa IgG inhibited the binding of the I-125-29. kDa protein to the primary culture of myoblasts in a dose-dependent manner. On the other hand, the same antibody showed little or no effect on the initial binding of I-125-fibronectin to the cell surface, but dramatically inhibited its incorporation into deoxycholate-insoluble matrices. Furthermore, Fab fragments of anti-66-kDa IgG completely blocked the incorporation of fluoresceinated fibronectin into matrices but not its binding to the cell surface. These results suggest that fibronectin matrix assembly is mediated at least in part by the interaction of the 66-kDa protein with the N-terminal type I domain of fibronectin.	SEOUL NATL UNIV, COLL NAT SCI, DEPT MOLEC BIOL, SEOUL 151742, SOUTH KOREA	Seoul National University (SNU)			Shin, Ki Soon/AAK-1939-2020	Shin, Ki Soon/0000-0002-5701-3596				AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; BLYSTONE SD, 1992, J BIOL CHEM, V267, P3968; CHEN LB, 1978, CELL, V14, P377, DOI 10.1016/0092-8674(78)90123-X; CHIQUET M, 1979, J BIOL CHEM, V254, P5475; CHIQUET M, 1981, DEV BIOL, V88, P220, DOI 10.1016/0012-1606(81)90166-4; CHUNG CY, 1990, J CELL PHYSIOL, V142, P392, DOI 10.1002/jcp.1041420224; ENGEL L, 1990, DEV BIOL, V140, P196, DOI 10.1016/0012-1606(90)90067-S; FOGERTY FJ, 1990, J CELL BIOL, V111, P699, DOI 10.1083/jcb.111.2.699; HAUSMAN RE, 1986, DEV BIOL, V113, P40, DOI 10.1016/0012-1606(86)90106-5; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; HYNES RO, 1909, FIBRONECTIN, P546; KAUFMAN SJ, 1977, P NATL ACAD SCI USA, V74, P3888, DOI 10.1073/pnas.74.9.3888; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIMPER AH, 1991, J BIOL CHEM, V266, P9697; LOWREY AA, 1989, EXP CELL RES, V183, P1, DOI 10.1016/0014-4827(89)90414-X; MCDONALD JA, 1987, J BIOL CHEM, V262, P2957; MCDONALD JA, 1988, ANNU REV CELL BIOL, V4, P183, DOI 10.1146/annurev.cb.04.110188.001151; MCKEOWNLONGO PJ, 1983, J CELL BIOL, V97, P466, DOI 10.1083/jcb.97.2.466; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MCKEOWNLONGO PJ, 1987, J CELL BIOL, V105, P44; MCKEOWNLONGO PJ, 1988, FIBRONECTIN, P163; MENKO AS, 1987, CELL, V51, P51, DOI 10.1016/0092-8674(87)90009-2; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; MOSHER DF, 1991, ANN NY ACAD SCI, V614, P167, DOI 10.1111/j.1749-6632.1991.tb43701.x; NEFF NT, 1982, J CELL BIOL, V95, P654, DOI 10.1083/jcb.95.2.654; PIERSCHBACHER MD, 1981, CELL, V26, P259, DOI 10.1016/0092-8674(81)90308-1; PODLESKI TR, 1979, EXP CELL RES, V122, P317, DOI 10.1016/0014-4827(79)90308-2; PONTREMOLI S, 1987, P NATL ACAD SCI USA, V84, P398, DOI 10.1073/pnas.84.2.398; QUADE BJ, 1988, J BIOL CHEM, V263, P19602; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; RUOSLAHTI E, 1989, CANCER CELL-MON REV, V1, P119; SCHWARZBAUER JE, 1987, P NATL ACAD SCI USA, V84, P754, DOI 10.1073/pnas.84.3.754; SEKIGUCHI K, 1983, J BIOL CHEM, V258, P3967; SMALHEISER NR, 1987, P NATL ACAD SCI USA, V84, P6457, DOI 10.1073/pnas.84.18.6457; SOLURSH M, 1988, DEVELOPMENT, V104, P41; THIERY JP, 1989, FIBRONECTIN, P181; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURNER DC, 1974, DEV BIOL, V37, P63, DOI 10.1016/0012-1606(74)90170-5; WALSH FS, 1981, DEV BIOL, V81, P229, DOI 10.1016/0012-1606(81)90286-4; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	43	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7651	7657						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125991				2022-12-27	WOS:A1994NA03200097
J	SCHUBERT, H; KROON, BMA; MATTHIJS, HCP				SCHUBERT, H; KROON, BMA; MATTHIJS, HCP			IN-VIVO MANIPULATION OF THE XANTHOPHYLL CYCLE AND THE ROLE OF ZEAXANTHIN IN THE PROTECTION AGAINST PHOTODAMAGE IN THE GREEN-ALGA CHLORELLA-PYRENOIDOSA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II; CHLOROPHYLL; PHYTOPLANKTON; VIOLAXANTHIN; PLANTS; ENERGY	Chlorella pyrenoidosa was grown in steady state continuous cultures in either high or low light. Samples of these cultures were incubated in darkness (violaxanthin state) or in saturating light (zeaxanthin state). These samples were kept in the respective preadapted states throughout the entire photodamage treatment. Photodamage involved exposure to single-turnover flashes fired at a low (non-actinic) frequency. The damage caused by the light stress thus applied was monitored by changes in photosynthetic properties and pigment composition. Cells preadapted in the light resisted photodamage better than those kept in darkness. The low light grown cells were more vulnerable to photodamage than the high light grown cells. Our experimental approach permitted the equilibria between the components that participate in the xanthophyll cycle to be set without addition of inhibitors. Regardless of the total amount of violaxanthin being present, its conversion to anthera- and zeaxanthin is a prerequisite for protection. The protection is most effective for photosystem II. It appeared that antheraxanthin accumulates as a result of photodamaging flashes provided that these are fired in the presence of background light, i.e. with zeaxanthin present. From this, it is newly derived that the xanthophyll cycle operates in full in the light, including epoxidation of zeaxanthin. The latter conversion was also demonstrated in vitro, via nonenzymatic oxygen-dependent turnover of zeaxanthin into violaxanthin.	UNIV AMSTERDAM,AMSTERDAM RES INST SUBSTANCES ECOSYST,MICROBIOL LAB,1018 WS AMSTERDAM,NETHERLANDS; UNIV ROSTOCK,FACHBEREICH BIOL,D-18051 ROSTOCK,GERMANY	University of Amsterdam; University of Rostock	SCHUBERT, H (corresponding author), UNIV AMSTERDAM,EC SLATER INST,NIEWE ACHTERGRACHI 127,1018 WS AMSTERDAM,NETHERLANDS.		Matthijs, Hans/B-4503-2009					Allen J. F., 1986, Photosynthesis: energy transduction: a practical approach, P103; ALLEN JF, 1986, FEBS LETT, V202, P175, DOI 10.1016/0014-5793(86)80682-2; BLASS U, 1959, PLANT PHYSIOL, V34, P329, DOI 10.1104/pp.34.3.329; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DUBINSKY Z, 1987, J PLANKTON RES, V9, P607, DOI 10.1093/plankt/9.4.607; GILMORE AM, 1993, PHOTOSYNTH RES, V35, P67, DOI 10.1007/BF02185412; HAGER A, 1981, ARCH MIKROBIOL, P57; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Krinsky N. I., 1971, CAROTENOIDS, P669; LIEBLER DC, 1992, METHOD ENZYMOL, V213, P472; MANTOURA RFC, 1983, ANAL CHIM ACTA, V151, P297, DOI 10.1016/S0003-2670(00)80092-6; Mills J. D., 1986, Photosynthesis: energy transduction: a practical approach, P143; MULLINEAUX CW, 1990, BIOCHIM BIOPHYS ACTA, V1015, P231, DOI 10.1016/0005-2728(90)90025-Y; OWENS TG, 1987, J PHYCOL, V23, P79; Owens TG, 1992, RES PHOTOSYNTHESIS, VI, P179; PFUNDEL EE, 1993, PLANT PHYSIOL, V101, P65, DOI 10.1104/pp.101.1.65; REES D, 1989, FEBS LETT, V256, P85, DOI 10.1016/0014-5793(89)81723-5; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; ROWELL P, 1986, BIOCH ALGAE CYANOBAC, P201; SAPOZHNIKOV DI, 1957, DOKL AKAD NAUK SSSR+, V113, P465; SAPOZHNIKOV DJ, 1972, CAROTENOIDS OTHER VI; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; THAYER SS, 1990, PHOTOSYNTH RES, V23, P331, DOI 10.1007/BF00034864; THOMAS DM, 1965, J PHYCOL, V1, P118, DOI 10.1111/j.1529-8817.1965.tb04568.x; van Liere L, 1978, MITT INT VER LIMNOL, V21, P158; VANDERSTAAY GWM, 1992, BIOCHIM BIOPHYS ACTA, V1102, P220, DOI 10.1016/0167-4838(92)90513-D; YAMAMOTO HY, 1962, ARCH BIOCHEM BIOPHYS, V97, P168, DOI 10.1016/0003-9861(62)90060-7; YAMAMOTO HY, 1972, BIOCHIM BIOPHYS ACTA, V267, P538, DOI 10.1016/0005-2728(72)90182-X	28	46	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7267	7272						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125939				2022-12-27	WOS:A1994NA03200038
J	ALTSCHULER, Y; GALILI, G				ALTSCHULER, Y; GALILI, G			ROLE OF CONSERVED CYSTEINES OF A WHEAT GLIADIN IN ITS TRANSPORT AND ASSEMBLY INTO PROTEIN BODIES IN XENOPUS-OOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STORAGE PROTEINS; ENDOPLASMIC-RETICULUM; DEVELOPING ENDOSPERM; GOLGI-APPARATUS; MESSENGER-RNAS; ACCUMULATION; EVOLUTION; ROUTE	Following sequestration into the endoplasmic reticulum, wheat gliadin storage proteins may either be retained and packaged into protein bodies inside the or ganelle or be transported via the Golgi apparatus to vacuoles and condense into protein bodies at a post-endoplasmic reticulum location. To unravel the mechanism of this complex process of deposition, we expressed wild-type and mutant forms of two closely related gamma and aggregated gliadins in Xenopus oocytes. Although a considerable amount of the gamma-gliadin was secreted to the medium, its closely related aggregated gliadin was entirely retained within the oocytes. This differential secretion was largely due to structural variations in the C-terminal regions of the proteins. Retention of the wild-type aggregated and gamma-gliadins within the endo plasmic reticulum could not be explained by rapid assembly into insoluble deposits inasmuch as both proteins could diffuse rather efficiently within the organelle for several hours. To address more closely the role of the C-terminal region in the transport and assembly of the gamma-gliadin within the endoplasmic reticulum, 3 cysteine codons in this region were mutated, one at a time, to serine codons. The cysteine-replacement mutants improperly aggregated within the endoplasmic reticulum forming denser deposits compared with the wild-type protein.	WEIZMANN INST SCI, DEPT PLANT GENET, IL-76100 REHOVOT, ISRAEL	Weizmann Institute of Science								ALTSCHULER Y, 1993, PLANT CELL, V5, P443; BECHTEL DB, 1986, CEREAL CHEM, V63, P232; CAMPBELL WP, 1981, AUST J PLANT PHYSIOL, V8, P5, DOI 10.1071/PP9810005; CERIOTTI A, 1988, EMBO J, V7, P633, DOI 10.1002/j.1460-2075.1988.tb02857.x; DRUMMOND DR, 1985, J CELL BIOL, V100, P1148, DOI 10.1083/jcb.100.4.1148; KIM WT, 1988, PLANTA, V176, P173, DOI 10.1007/BF00392442; Kreis M., 1985, Oxford Surveys of Plant Molecular and Cell Biology, V2, P253; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LEVANONY H, 1992, J CELL BIOL, V119, P1117, DOI 10.1083/jcb.119.5.1117; OKITA TW, 1985, J BIOL CHEM, V260, P8203; PARKER ML, 1982, PLANT CELL ENVIRON, V5, P37; PARKER ML, 1982, PLANTA, V154, P277, DOI 10.1007/BF00387875; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; RUBIN R, 1992, PLANT PHYSIOL, V99, P718, DOI 10.1104/pp.99.2.718; SHEWRY PR, 1990, BIOCHEM J, V267, P1; SHOTWELL MA, 1989, BIOCH PLANTS COMPREH, V15, P297; SIMON R, 1990, PLANT CELL, V2, P941, DOI 10.1105/tpc.2.9.941; SUGIYAMA T, 1986, PLANT SCI, V44, P205, DOI 10.1016/0168-9452(86)90092-0; TATHAM AS, 1985, J CEREAL SCI, V3, P103, DOI 10.1016/S0733-5210(85)80021-7; WALLACE JC, 1988, SCIENCE, V240, P662, DOI 10.1126/science.2834822	21	27	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6677	6682						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120024				2022-12-27	WOS:A1994MZ50300067
J	AMARA, FM; CHEN, FY; WRIGHT, JA				AMARA, FM; CHEN, FY; WRIGHT, JA			PHORBOL ESTER MODULATION OF A NOVEL CYTOPLASMIC PROTEIN-BINDING ACTIVITY AT THE 3'-UNTRANSLATED REGION OF MAMMALIAN RIBONUCLEOTIDE REDUCTASE R2 MESSENGER-RNA AND ROLE IN MESSAGE STABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; BALB/C 3T3 FIBROBLASTS; UNTRANSLATED REGION; DNA-SYNTHESIS; CELLS; 12-O-TETRADECANOYLPHORBOL-13-ACETATE; EXPRESSION; MECHANISMS; SEQUENCE; SUBUNIT	The R2 gene of ribonucleotide reductase is elevated in BALB/c 3T3 fibroblasts treated with the tumor prometer, 12-O-tetradecanoylphorbol-13-acetate (TPA). TPA treatment increased the half-life of the R2 message by 3-fold, showing that TPA regulates R2 gene expression by a post-transcriptional mechanism(s). A 20-nucleotide (nt) TPA-responsive region was found within the R2 mRNA 3'-untranslated region (3'UTR), Ultraviolet crosslinking detected a novel 45-kDa protein-R2 mRNA complex migration band that bound selectively to the 20-nt fragment and did not bind to the 5'UTR or the coding region of the R2 message, or to the 3'UTRs of mRNAfrom several other genes, or to the homopolymer poly(A) se quence. The-45 KDa protein-R2 mRNA binding activity observed in unstimulated cells was markedly down regulated after TPA treatment. Deletion of a 20-nt region, containing the 20-nt sequence, from the 3'UTR caused stabilization of hybrid chloramphenicol acetyltransferase mRNA in the absence of TPA treatment. Furthermore, in vitro decay reaction mixtures supplemented with the 20-nt sense RNA transcript resulted in stabilization of R2 message. A model is presented of R2 message regulation in which a vis-element within the 20-nt sequence of the 3'UTR interacts with a cytosolic protein to form a 45-kDa protein mRNA binding complex. The TPA-induced alteration of R2 message stability is at least in part due to the down regulation of the 45-kDa protein-mRNA binding activity which is linked to a reduction in the rate of R2 mRNA degradation.	UNIV MANITOBA,MANITOBA INST CELL BIOL,WINNIPEG R3E 0V9,MB,CANADA; UNIV MANITOBA,DEPT BIOCHEM & MOLEC BIOL,WINNIPEG R3E 0V9,MB,CANADA	University of Manitoba; University of Manitoba								AMARA FM, 1993, NUCLEIC ACIDS RES, V21, P4803, DOI 10.1093/nar/21.20.4803; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; BLOSMANIS R, 1987, CANCER RES, V47, P1273; BOHJANEN PR, 1991, MOL CELL BIOL, V11, P3288, DOI 10.1128/MCB.11.6.3288; BREWER G, 1991, MOL CELL BIOL, V11, P2460, DOI 10.1128/MCB.11.5.2460; BREWER G, 1989, MOL CELL BIOL, V9, P1996, DOI 10.1128/MCB.9.5.1996; CARTER BZ, 1991, LAB INVEST, V65, P610; CHEN FY, 1993, EMBO J, V12, P3977, DOI 10.1002/j.1460-2075.1993.tb06075.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOY BK, 1989, BIOCHEM BIOPH RES CO, V162, P1417, DOI 10.1016/0006-291X(89)90832-2; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FIGGE J, 1988, CELL, V52, P713, DOI 10.1016/0092-8674(88)90409-6; HURTA RAR, 1992, J BIOL CHEM, V267, P7066; HURTA RAR, 1992, BIOCHEM CELL BIOL, V70, P1081, DOI 10.1139/o92-153; HURTA RAR, 1991, J BIOL CHEM, V266, P24097; IWAI Y, 1991, J BIOL CHEM, V266, P17959; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; LEWIS WH, 1978, J CELL PHYSIOL, V94, P287, DOI 10.1002/jcp.1040940306; LIANG HM, 1991, NUCLEIC ACIDS RES, V19, P2289, DOI 10.1093/nar/19.9.2289; MANZELLA JM, 1992, J BIOL CHEM, V267, P7077; MCCLARTY GA, 1988, BIOCHEMISTRY-US, V27, P7524, DOI 10.1021/bi00419a052; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; RONDON IJ, 1991, J BIOL CHEM, V266, P16594; SACEDA M, 1991, J BIOL CHEM, V266, P17809; SLAGA TJ, 1983, ENVIRON HEALTH PERSP, V50, P3, DOI 10.2307/3429529; SMITH KB, 1983, J CELL PHYSIOL, V117, P91, DOI 10.1002/jcp.1041170113; WEBER G, 1983, CANCER RES, V43, P3466; WHITHAM SE, 1986, BIOCHEM J, V240, P913, DOI 10.1042/bj2400913; WRIGHT JA, 1990, BIOCHEM CELL BIOL, V68, P1364, DOI 10.1139/o90-199; WRIGHT JA, 1989, INT ENCY PHARM THERA, V128, P89; YUSPA SH, 1976, CANCER RES, V36, P4062	33	46	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6709	6715						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120029				2022-12-27	WOS:A1994MZ50300072
J	LELONG, C; SETIF, P; LAGOUTTE, B; BOTTIN, H				LELONG, C; SETIF, P; LAGOUTTE, B; BOTTIN, H			IDENTIFICATION OF THE AMINO-ACIDS INVOLVED IN THE FUNCTIONAL INTERACTION BETWEEN PHOTOSYSTEM-I AND FERREDOXIN FROM SYNECHOCYSTIS SP-PCC-6803 BY CHEMICAL CROSS-LINKING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEINS; NADP+ REDUCTASE; ANABAENA PCC-7119; LINKED COMPLEX; 2FE-2S FERREDOXIN; ELECTRON-TRANSFER; BINDS FERREDOXIN; 2.5-A RESOLUTION; SP PCC-6803; PSI-E	Ferredoxin isolated from the cyanobacterium Synechocystis sp. PCC 6803 has been chemically cross-linked to purified photosystem I from the same organism. The reaction was catalyzed by N-ethyl-3-(3-dimethylaminopropyl) carbodiimide in the presence of N-hydroxysulfosuccinimide. A short reaction time and neutral pH values can be used in the presence of the two reagents, ensuring the integrity of both of the proteins and the iron-sulfur cluster of the ferredoxin. The only covalent complex detected comprised ferredoxin and the photosystem I (PSI)-D subunit, as identified by antibodies probing after electrophoresis. Electron paramagnetic resonance measurements of this covalent complex have shown that the cross-linked ferredoxin was entirely photoreducible by photosystem I and that the molar ratio of ferredoxin to PSI was close to 1. Extensive sequencing of the peptides obtained after proteolysis of the purified cross-linked product led to the identification of a covalent bond between glutamic acid 93 of ferredoxin and lysine 106 of the PSI-D subunit.	CEA SACLAY, DEPT BIOL CELLULAIRE & MOLEC,CNRS,URA 1290, SERV BIOENERGET, F-91191 GIF SUR YVETTE, FRANCE	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay								ANDERSEN B, 1992, PHYSIOL PLANTARUM, V84, P154, DOI 10.1111/j.1399-3054.1992.tb08778.x; ANDERSEN B, 1992, FEBS LETT, V311, P169, DOI 10.1016/0014-5793(92)81391-X; BOTTIN H, 1992, BIOCHIM BIOPHYS ACTA, V1101, P48, DOI 10.1016/0167-4838(92)90465-P; CARRAWAY KL, 1970, BIOCHIM BIOPHYS ACTA, V200, P564, DOI 10.1016/0005-2795(70)90112-1; CARRAWAY KL, 1968, BIOCHIM BIOPHYS ACTA, V160, P272, DOI 10.1016/0005-2795(68)90102-5; CHITNIS PR, 1989, J BIOL CHEM, V264, P18381; COLVERT KK, 1988, PHOTOSYNTH RES, V17, P231, DOI 10.1007/BF00035450; DEPASCALIS AR, 1993, PROTEIN SCI, V2, P1126, DOI 10.1002/pro.5560020707; DOLLA A, 1989, BIOCHIM BIOPHYS ACTA, V975, P395, DOI 10.1016/S0005-2728(89)80348-2; FRIEDMAN M, 1970, J BIOL CHEM, V245, P3868; GOLBECK JH, 1991, CURR TOP BIOENERG, V16, P83; GUIGLIARELLI B, 1989, J BIOL CHEM, V264, P6025; HERVAS M, 1992, PHOTOCHEM PHOTOBIOL, V56, P319, DOI 10.1111/j.1751-1097.1992.tb02166.x; HIRASAWA M, 1991, ARCH BIOCHEM BIOPHYS, V286, P171, DOI 10.1016/0003-9861(91)90024-D; HOUMARD J, 1972, P NATL ACAD SCI USA, V69, P3506, DOI 10.1073/pnas.69.12.3506; HURLEY JK, 1993, BIOCHEMISTRY-US, V32, P9346, DOI 10.1021/bi00087a013; JACOBSON BL, 1993, BIOCHEMISTRY-US, V32, P6788, DOI 10.1021/bi00077a033; KE B, 1973, P NATL ACAD SCI USA, V70, P2941, DOI 10.1073/pnas.70.10.2941; KNAFF DB, 1991, BIOCHIM BIOPHYS ACTA, V1056, P93, DOI 10.1016/S0005-2728(05)80277-4; KRAUSS N, 1993, NATURE, V361, P326, DOI 10.1038/361326a0; LAGOUTTE B, 1992, EUR J BIOCHEM, V205, P1175, DOI 10.1111/j.1432-1033.1992.tb16888.x; MATSUBARA H, 1988, METHOD ENZYMOL, V167, P387; MERATI G, 1987, FEBS LETT, V215, P37, DOI 10.1016/0014-5793(87)80109-6; ORTEGA JM, 1993, BIOCHEMISTRY-US, V32, P1141, DOI 10.1021/bi00055a020; PUEYO JJ, 1991, BIOCHIM BIOPHYS ACTA, V1059, P149, DOI 10.1016/S0005-2728(05)80199-9; PUEYO JJ, 1992, ARCH BIOCHEM BIOPHYS, V294, P367, DOI 10.1016/0003-9861(92)90697-U; REILLY P, 1988, J BIOL CHEM, V263, P17658; Rogers L.J, 1987, CYANOBACTERIA, P35; ROGNER M, 1990, J BIOL CHEM, V265, P6189; ROSEN D, 1983, BIOCHEMISTRY-US, V22, P335, DOI 10.1021/bi00271a016; ROUSSEAU F, 1993, EMBO J, V12, P1755, DOI 10.1002/j.1460-2075.1993.tb05823.x; RUPP H, 1978, BIOCHIM BIOPHYS ACTA, V537, P255, DOI 10.1016/0005-2795(78)90509-3; RYPNIEWSKI WR, 1991, BIOCHEMISTRY-US, V30, P4126, DOI 10.1021/bi00231a003; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SONOIKE K, 1993, BIOCHIM BIOPHYS ACTA, V1141, P52, DOI 10.1016/0005-2728(93)90188-L; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; TSUKIHARA T, 1990, J MOL BIOL, V216, P399, DOI 10.1016/S0022-2836(05)80330-4; TSUKIHARA T, 1981, J BIOCHEM-TOKYO, V90, P1763, DOI 10.1093/oxfordjournals.jbchem.a133654; WAGNER R, 1982, BIOCHIM BIOPHYS ACTA, V680, P317, DOI 10.1016/0005-2728(82)90145-1; WALKER MC, 1990, ARCH BIOCHEM BIOPHYS, V281, P76, DOI 10.1016/0003-9861(90)90415-U; ZANETTI G, 1988, BIOCHEMISTRY-US, V27, P3753, DOI 10.1021/bi00410a035; ZANETTI G, 1987, EUR J BIOCHEM, V169, P143, DOI 10.1111/j.1432-1033.1987.tb13591.x; ZANETTI G, 1984, J BIOL CHEM, V259, P6153; ZILBER AL, 1988, PLANT PHYSIOL, V88, P810, DOI 10.1104/pp.88.3.810	44	83	87	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10034	10039						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144501				2022-12-27	WOS:A1994NE05300096
J	THOMPSON, HL; MARSHALL, CJ; SAKLATVALA, J				THOMPSON, HL; MARSHALL, CJ; SAKLATVALA, J			CHARACTERIZATION OF 2 DIFFERENT FORMS OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE INDUCED IN POLYMORPHONUCLEAR LEUKOCYTES FOLLOWING STIMULATION BY N-FORMYLMETHIONYL-LEUCYL-PHENYLALANINE OR GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE THREONINE KINASE; RABBIT SKELETAL-MUSCLE; TUMOR-NECROSIS-FACTOR; ERK-1 GENE-PRODUCT; MAP KINASE; RESPIRATORY BURST; HUMAN-NEUTROPHILS; SIGNAL TRANSDUCTION; PHOSPHORYLATION; RECEPTOR	Incubation of polymorphonuclear leukocytes with chemoattractants, granulocyte-macrophage colony-stimulating factor (GM-CSF), or phorbol 12-myristate 13-acetate (PMA) activated both mitogen-activated protein kinase kinase (MAPKK) and mitogen-activated protein kinase (MAPK). Activation by chemoattractants was rapid and transient, being maximal by 1 min and decreasing by 10 min. The order of efficacy was formyl-met-leu-phe > C5a > > LTB4 > interleukin 8 > platelet-activating factor. In contrast, activation by GM-CSF or PMA was slow and sustained being maximal at 5 min and with little decrease by 30 min. Sustained MAPK activation required continuous activation of the MAPKK. The MAPKK induced by N-formylmethionyl-leucyl-phenylalanine, GM-CSF, or PMA was resolved into two forms by anion exchange chromatography (Mono Q). Both corresponded to a 45-kDa MAPKK antigen by Western blotting and were inactivated by serine/threonine protein phosphatase 2A. Rechromatography of both forms after dephosphorylation resulted in the antigen's eluting slightly earlier on the Mono Q gradient than when in the active state. However, the two peaks remained separate, suggesting that they are not merely different phosphoforms of the same enzyme. The MAPK cascade is a signaling pathway common to many polymorphonuclear leukocyte stimulants, which may be activated transiently or in a sustained manner.	INST CANC RES, CHESTER BEATTY LABS, LONDON SW3 6JB, ENGLAND	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	THOMPSON, HL (corresponding author), BABRAHAM INST, DEPT DEV & SIGNALLING, CYTOKINE LAB, BABRAHAM CB2 4AT, CAMBS, ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALESSANDRINI A, 1992, P NATL ACAD SCI USA, V89, P8200, DOI 10.1073/pnas.89.17.8200; ASHWORTH A, 1992, ONCOGENE, V7, P2555; BAGGIOLINI M, 1990, TRENDS BIOCHEM SCI, V15, P69, DOI 10.1016/0968-0004(90)90179-F; BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; COHEN P, 1988, METHOD ENZYMOL, V159, P390; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; CREWS CM, 1992, P NATL ACAD SCI USA, V89, P8205, DOI 10.1073/pnas.89.17.8205; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; DEVRIESSMITS AMM, 1993, SCIENCE, V357, P602; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; GOMEZCAMBRONERO J, 1992, P NATL ACAD SCI USA, V89, P7551, DOI 10.1073/pnas.89.16.7551; GOMEZCAMBRONERO J, 1990, ADV EXP MED BIOL, V314, P35; HATTORI S, 1992, J BIOL CHEM, V267, P20346; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; HSUAN JJ, 1989, BIOCHEM J, V259, P519, DOI 10.1042/bj2590519; HUGHES DA, 1993, NATURE, V364, P349, DOI 10.1038/364349a0; ITOH T, 1993, P NATL ACAD SCI USA, V90, P975, DOI 10.1073/pnas.90.3.975; JAISWAL RK, 1993, J BIOL CHEM, V268, P7055; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; MAJUMDAR S, 1991, J BIOL CHEM, V266, P9285; MATSUDA S, 1993, J BIOL CHEM, V268, P3277; MCCOLL SR, 1990, J IMMUNOL, V145, P3047; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; NAKIELNY S, 1992, EMBO J, V11, P2123, DOI 10.1002/j.1460-2075.1992.tb05271.x; OHTA S, 1992, EUR J BIOCHEM, V206, P895, DOI 10.1111/j.1432-1033.1992.tb16998.x; OKUDA K, 1992, BLOOD, V79, P2880; OMANN GM, 1987, PHYSIOL REV, V67, P285, DOI 10.1152/physrev.1987.67.1.285; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; PEVERI P, 1988, J EXP MED, V167, P1547, DOI 10.1084/jem.167.5.1547; RAINES MA, 1992, BLOOD, V79, P3350; RICHTER J, 1989, J IMMUNOL, V142, P3199; ROSSOMANDO A, 1992, P NATL ACAD SCI USA, V89, P5221, DOI 10.1073/pnas.89.12.5221; SATO N, 1993, EMBO J, V12, P4181, DOI 10.1002/j.1460-2075.1993.tb06102.x; SATOH T, 1992, J BIOL CHEM, V267, P2537; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; SEGER R, 1992, J BIOL CHEM, V267, P14373; SKLAR LA, 1986, ADV IMMUNOL, V39, P95; SOZERI O, 1992, ONCOGENE, V7, P2259; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; THOMPSON HL, 1993, BIOCHEM J, V290, P483, DOI 10.1042/bj2900483; TORRES M, 1993, J IMMUNOL, V150, P1563; WEINGARTEN R, 1990, IMMUNOL LETT, V26, P1, DOI 10.1016/0165-2478(90)90167-O; WU J, 1992, BIOCHEM J, V285, P701, DOI 10.1042/bj2850701; WU J, 1993, MOL CELL BIOL, V13, P4539, DOI 10.1128/MCB.13.8.4539; WYMANN MP, 1987, J BIOL CHEM, V262, P12048; XING MZ, 1992, J BIOL CHEM, V267, P25966	50	51	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9486	9492						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144533				2022-12-27	WOS:A1994NE05300017
J	LOH, C; ROMEO, C; SEED, B; BRUDER, JT; RAPP, U; RAO, A				LOH, C; ROMEO, C; SEED, B; BRUDER, JT; RAPP, U; RAO, A			ASSOCIATION OF RAF WITH THE CD3 DELTA-CHAIN AND GAMMA-CHAIN OF THE T-CELL RECEPTOR-CD3 COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; SERINE-THREONINE KINASE; PDGF BETA-RECEPTOR; ANTIGEN RECEPTOR; GROWTH-FACTOR; SIGNAL TRANSDUCTION; ZETA-CHAIN; PHOSPHOLIPASE-C; MONOCLONAL-ANTIBODY; BINDING-SITE	Protein kinases and phosphatases play an important role in signal transduction. In the T cell, activation via the T cell receptor-CD3 complex results in rapid tyrosine phosphorylation of proteins, as well as subsequent increases in serine/threonine phosphorylation. The Raf serine/threonine kinase has been implicated in many receptor signaling pathways, including those of platelet-derived growth factor, epidermal growth factor, insulin, and interleukin-2 receptors. We show here that Raf is associated with the T cell receptor-CD3 complex in unstimulated murine T cells. Using a COS cell expression system, we show that a hypophosphorylated form of Raf specifically associates with the CD3 gamma and delta chains but not with the CD3 epsilon or zeta chains. These results suggest that Raf mediates signal transduction from the gamma and delta chains of the T cell receptor-CD3 complex, analogous to the role played by ZAP-70 in signal transduction mediated by the zeta chain.	DIV TUMOR VIROL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02114 USA; MASSACHUSETTS GEN HOSP, DEPT MOLEC BIOL, BOSTON, MA 02114 USA; NCI, FREDERICK CANC RES & DEV CTR, VIRAL CARCINOGENESIS LAB, FREDERICK, MD 21702 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027849, R37AI027849] Funding Source: NIH RePORTER; NIAID NIH HHS [AI27849] Funding Source: Medline; NIGMS NIH HHS [GM46227] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANIYASH M, 1988, J BIOL CHEM, V263; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CANTRELL D, 1987, NATURE, V325, P540, DOI 10.1038/325540a0; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHENG SH, 1988, EMBO J, V7, P3845, DOI 10.1002/j.1460-2075.1988.tb03270.x; DASGUPTA JD, 1992, J EXP MED, V175, P285, DOI 10.1084/jem.175.1.285; DAVIES AA, 1987, J BIOL CHEM, V262, P10918; DYEMECKI SM, 1990, SCIENCE, V247, P332; GAUEN LKT, 1992, MOL CELL BIOL, V12, P5438, DOI 10.1128/MCB.12.12.5438; GLAICHENHAUS N, 1991, CELL, V64, P511, DOI 10.1016/0092-8674(91)90235-Q; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAZLAUSKAS A, 1990, EMBO J, V9, P3279, DOI 10.1002/j.1460-2075.1990.tb07527.x; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; KUBO RT, 1989, J IMMUNOL, V142, P2736; KUMJIAN DA, 1989, P NATL ACAD SCI USA, V86, P8232, DOI 10.1073/pnas.86.21.8232; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAYET C, 1991, P NATL ACAD SCI USA, V88, P2346, DOI 10.1073/pnas.88.6.2346; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARGOLIS B, 1990, EMBO J, V9, P4375, DOI 10.1002/j.1460-2075.1990.tb07887.x; MASLINSKI W, 1992, J BIOL CHEM, V267, P15281; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MORRISON DK, 1990, MOL CELL BIOL, V10, P2359, DOI 10.1128/MCB.10.5.2359; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; NARDONE J, 1993, IN PRESS P NATL ACAD; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; PARK DJ, 1991, P NATL ACAD SCI USA, V88, P5453, DOI 10.1073/pnas.88.12.5453; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; QIAN DP, 1993, J BIOL CHEM, V268, P4488; RAO A, 1984, J EXP MED, V159, P479, DOI 10.1084/jem.159.2.479; RAPP UR, 1991, ONCOGENE, V6, P495; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; ROMEO C, 1992, CELL, V68, P889, DOI 10.1016/0092-8674(92)90032-8; ROMEO C, 1991, CELL, V64, P1037, DOI 10.1016/0092-8674(91)90327-U; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SAMELSON LE, 1986, CELL, V46, P1083, DOI 10.1016/0092-8674(86)90708-7; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SCHULTZ AM, 1985, VIROLOGY, V146, P78, DOI 10.1016/0042-6822(85)90054-6; SIEGEL JN, 1990, J BIOL CHEM, V265, P18472; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; THOMPSON PA, 1991, CELL GROWTH DIFFER, V2, P609; TODDERUD G, 1990, SCIENCE, V249, P296, DOI 10.1126/science.2374928; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; WILLIAMS NG, 1992, P NATL ACAD SCI USA, V89, P2922, DOI 10.1073/pnas.89.7.2922; WONG JGP, 1990, J BIOL CHEM, V265, P4685; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	62	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8817	8825						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132616				2022-12-27	WOS:A1994NB41100033
J	UCHIDA, C; FUNAI, T; ODA, T; OHBAYASHI, K; ICHIYAMA, A				UCHIDA, C; FUNAI, T; ODA, T; OHBAYASHI, K; ICHIYAMA, A			REGULATION BY GLUCAGON OF SERINE-PYRUVATE/ALANINE-GLYOXYLATE AMINOTRANSFERASE GENE-EXPRESSION IN CULTURED RAT HEPATOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; NUCLEAR FACTOR CREB; PROTEIN-KINASE-C; CYCLIC-AMP; GLUCOCORTICOID RECEPTOR; SOMATOSTATIN GENE; MULTIHORMONAL REGULATION; MITOCHONDRIAL SERINE; DEPENDENT ACTIVATION; LIVER MITOCHONDRIA	The effects of glucagon on serine:pyruvate/alanine: glyoxylate aminotransferase (SPT/AGT) gene expression were studied in primary cultured rat hepatocytes. When hepatocytes had been precultured for 16-18 h under serum- and hormone-free conditions, the addition of glucagon caused (after a lag period of about 2 h) a remarkable increase in the cellular level of SPT/AGT mRNA by 4 h in a time- and dose-dependent manner. The induced mRNA was that far mitochondrial SPT/AGT, as judged by ribonuclease protection analysis. A nuclear run-on assay revealed that activation of transcription is responsible for the increase in mitochondrial SPT/AGT mRNA and that the maximal rate of transcription occurs 1.5 h after glucagon addition, The effect of glucagon was mimicked by 8-bromo-cAMP and suppressed by N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide, an inhibitor of cAMP-dependent protein kinase (protein kinase A), while both 12-O-tetradecanoylphorbol-13-acetate and A23187 were without effect in elevating the SPT/AGT mRNA level, suggesting that the cAMP/protein kinase A system is involved in the regulation of SPT/AGT gene expression. In hepatocytes precultured for 16-18 h under serum- and hormone-free conditions, the glucagon-induced transcription was severely inhibited by cycloheximide. When the preculture was for 2 h, on the other hand, the activation of transcription by glucagon was more rapid, and the inhibition by cycloheximide was less than that observed with cells precultured for 16-18 h, suggesting that a short-lived protein factor is involved in the hormonal regulation. The glucagon-induced expression of the SPT/AGT gene was also turned off by dexamethasone.			UCHIDA, C (corresponding author), HAMAMATSU UNIV SCH MED, DEPT BIOCHEM, 3600 HANDA CHO, HAMAMATSU, SHIZUOKA 43131, JAPAN.							BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; CHANDLER VL, 1983, CELL, V33, P489, DOI 10.1016/0092-8674(83)90430-0; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CHRIST B, 1990, BIOL CHEM H-S, V371, P395, DOI 10.1515/bchm3.1990.371.1.395; CORVERA S, 1984, BIOCHIM BIOPHYS ACTA, V804, P434, DOI 10.1016/0167-4889(84)90071-5; DEAN DC, 1989, MOL CELL BIOL, V9, P1498, DOI 10.1128/MCB.9.4.1498; EXTON JH, 1985, AM J PHYSIOL, V248, pE633, DOI 10.1152/ajpendo.1985.248.6.E633; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HOUSLAY MD, 1991, EUR J BIOCHEM, V195, P9, DOI 10.1111/j.1432-1033.1991.tb15671.x; IHRA H, 1990, J BIOL CHEM, V265, P22441; MARZLUFF WF, 1973, BIOCHEMISTRY-US, V12, P3440, DOI 10.1021/bi00742a013; MATSUDA T, 1990, J BIOCHEM-TOKYO, V108, P778, DOI 10.1093/oxfordjournals.jbchem.a123280; MESSINA JL, 1990, J BIOL CHEM, V265, P11700; MIYAJIMA H, 1989, J BIOCHEM-TOKYO, V105, P500, DOI 10.1093/oxfordjournals.jbchem.a122695; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MORI M, 1992, GENOMICS, V13, P686, DOI 10.1016/0888-7543(92)90142-F; NAKAMURA T, 1987, J BIOL CHEM, V262, P727; NODA C, 1988, J BIOL CHEM, V263, P14764; NOGUCHI T, 1978, BIOCHEM J, V170, P173, DOI 10.1042/bj1700173; NORTHROP JP, 1992, J EXP MED, V175, P1235, DOI 10.1084/jem.175.5.1235; ODA T, 1981, BIOCHEM BIOPH RES CO, V102, P568, DOI 10.1016/0006-291X(81)91557-6; ODA T, 1993, GENOMICS, V17, P59, DOI 10.1006/geno.1993.1283; ODA T, 1984, J BIOCHEM, V95, P815, DOI 10.1093/oxfordjournals.jbchem.a134673; ODA T, 1982, J BIOCHEM, V91, P219, DOI 10.1093/oxfordjournals.jbchem.a133679; ODA T, 1987, EUR J BIOCHEM, V168, P537, DOI 10.1111/j.1432-1033.1987.tb13451.x; ODA T, 1990, J BIOL CHEM, V265, P7513; PETERSEN OH, 1986, NATURE, V323, P18, DOI 10.1038/323018a0; REIK A, 1991, EMBO J, V10, P2569, DOI 10.1002/j.1460-2075.1991.tb07797.x; RUNGE D, 1991, EUR J BIOCHEM, V198, P641, DOI 10.1111/j.1432-1033.1991.tb16062.x; SASAKI K, 1984, J BIOL CHEM, V259, P5242; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SHORT JM, 1986, J BIOL CHEM, V261, P9721; SILVER G, 1990, J BIOL CHEM, V265, P3134; STALLCUP MR, 1983, J BIOL CHEM, V258, P2802; TANAKA K, 1978, J BIOCHEM-TOKYO, V84, P937, DOI 10.1093/oxfordjournals.jbchem.a132207; TANG EKY, 1992, BIOCHEM J, V283, P341, DOI 10.1042/bj2830341; TSUKADA T, 1987, J BIOL CHEM, V262, P8743; WAKELAM MJO, 1986, NATURE, V323, P68, DOI 10.1038/323068a0; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YOKOTA S, 1984, HISTOCHEMISTRY, V80, P591, DOI 10.1007/BF02400977; YOKOTA S, 1991, BIOMED RES-TOKYO, V12, P53, DOI 10.2220/biomedres.12.53	44	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8849	8856						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132620				2022-12-27	WOS:A1994NB41100037
J	PERIN, MS				PERIN, MS			THE COOH TERMINUS OF SYNAPTOTAGMIN MEDIATES INTERACTION WITH THE NEUREXINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-LATROTOXIN RECEPTOR; PROTEIN KINASE-C; SYNAPTIC VESICLES; P65; BINDING; EXOCYTOSIS; SURFACE; PEPTIDE; ANTIGEN; FAMILY	The interaction of the synaptic vesicle protein, synaptotagmin, and the presynaptic alpha-latrotoxin receptor, a neurexin, has been proposed to be involved in docking of synaptic vesicles at active sites or modulation of neurotransmitter release. Here I report the investigation of the domain of synaptotagmin responsible for this interaction. Pieces of synaptotagmin containing the carboxyl terminus are capable of purifying neurexins from solubilized brain homogenates. Pieces as small as a synthesized peptide corresponding to the COOH-terminal 34 amino acids are capable of enriching neurexins 100-fold. The binding of neurexins to synaptotagmin is calcium-independent and of moderate affinity. This COOH-terminal segment of synaptotagmin is conserved in all species characterized to date. Reflective of this, a synthetic peptide corresponding to the carboxyl terminus of Drosophila synaptotagmin is capable of purification of rat neurexins, suggesting the possibility that this interaction may also exist in Drosophila. I propose that the carboxyl terminus of synaptotagmin binds to the carboxyl terminus of the neurexins and that this interaction may mediate docking of synaptic vesicles or modulation of neurotransmitter release.			PERIN, MS (corresponding author), BAYLOR COLL MED,DIV NEUROSCI,HOUSTON,TX 77030, USA.				NINDS NIH HHS [R01 NS30541] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030541] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; INOUE A, 1992, J BIOL CHEM, V267, P10613; LEVEQUE C, 1992, P NATL ACAD SCI USA, V89, P3625, DOI 10.1073/pnas.89.8.3625; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366, DOI 10.1073/pnas.85.19.7366; NISHIZUKA Y, 1989, JAMA-J AM MED ASSOC, V262, P1826, DOI 10.1001/jama.262.13.1826; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; PERIN MS, 1988, EMBO J, V7, P2697, DOI 10.1002/j.1460-2075.1988.tb03123.x; PERIN MS, 1991, J BIOL CHEM, V266, P615; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PETRENKO AG, 1990, EMBO J, V9, P2023, DOI 10.1002/j.1460-2075.1990.tb08331.x; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; SAKI RK, 1988, SCIENCE, V245, P1474; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUDHOF TC, 1993, CELL, V75, P1; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; TUGAL HB, 1991, BIOCHEM J, V279, P699, DOI 10.1042/bj2790699; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; WENDLAND B, 1991, NEURON, V6, P993, DOI 10.1016/0896-6273(91)90239-V; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925	33	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8576	8581						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132583				2022-12-27	WOS:A1994NB40900111
J	WOJCIKIEWICZ, RJH; FURUICHI, T; NAKADE, S; MIKOSHIBA, K; NAHORSKI, SR				WOJCIKIEWICZ, RJH; FURUICHI, T; NAKADE, S; MIKOSHIBA, K; NAHORSKI, SR			MUSCARINIC RECEPTOR ACTIVATION DOWN-REGULATES THE TYPE-I INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR BY ACCELERATING ITS DEGRADATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEUROBLASTOMA-CELLS; CEREBELLAR GRANULE CELLS; TRISPHOSPHATE RECEPTOR; FUNCTIONAL EXPRESSION; ENDOPLASMIC-RETICULUM; INTRACELLULAR CA-2+; INHIBITION; SH-SY5Y; BINDING; STIMULATION	Stimulation of SH-SY5Y human neuroblastoma cells with carbachol, a muscarinic agonist, down-regulates the type I inositol 1,4,5 trisphosphate (InsP(3)) receptor by > 90% with maximal and half-maximal effects after similar to 6 h and similar to 1 h, respectively. Examination of the mechanistic basis of this down-regulation revealed that carbachol increased the rate of type I InsP(3) receptor degradation (radiolabeled immunoprecipitable receptor was lost from cells with half-times of > 8 h and similar to 1 h in the absence and presence of carbachol, respectively) and that the concentration of type I InsP(3) receptor mRNA, despite a transient decrease after 3 h, did not correlate with levels of the receptor. Only those muscarinic receptor subtypes coupled to stimulation of phosphoinositide hydrolysis were capable of causing type I InsP(3) receptor down-regulation. Ca2+ mobilization was pivotal to the mechanism of receptor down-regulation, since perturbation of Ca2+ homeostasis with either EGTA or thapsigargin blocked the ability of carbachol to accelerate receptor degradation. Studies with thapsigargin also revealed that both functional InsP(3)-sensitive Ca2+ stores and persistent elevation of InsP(3) concentration were required for down-regulation to occur. In conclusion, phosphoinositidase C-linked muscarinic receptors down-regulate the type I InsP(3) receptor by accelerating its degradation. It appears that this process is initiated by persistent discharge of intracellular Ca2+ stores via the channels formed by tetramerically complexed type I InsP(3) receptors.	UNIV LEICESTER,DEPT CELL PHYSIOL & PHARMACOL,LEICESTER LE1 9HN,ENGLAND; UNIV TOKYO,INST MED SCI,DEPT MOLEC NEUROBIOL,MINATO KU,TOKYO 108,JAPAN	University of Leicester; University of Tokyo			Mikoshiba, Katsuhiko/N-7943-2015	Furuichi, Teiichi/0000-0002-9676-1888	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADFORD PG, 1992, J BIOL CHEM, V267, P20959; CHADWICK CC, 1990, P NATL ACAD SCI USA, V87, P2132, DOI 10.1073/pnas.87.6.2132; CHALLISS RAJ, 1993, METH NEUROSCI, V18, P224; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FERRIS CD, 1992, J NEUROSCI, V12, P1567; FUKAMAUCHI F, 1991, J NEUROCHEM, V56, P716, DOI 10.1111/j.1471-4159.1991.tb08210.x; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; FURUICHI T, 1993, RECEPTOR CHANNEL, V1, P11; GERSHENGORN MC, 1986, ANNU REV PHYSIOL, V48, P515; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; LAMBERT DG, 1990, BIOCHEM J, V265, P555, DOI 10.1042/bj2650555; LAMBERT DG, 1990, BIOCHEM PHARMACOL, V40, P2291, DOI 10.1016/0006-2952(90)90725-Z; MAGNUSSON A, 1993, FEBS LETT, V323, P229, DOI 10.1016/0014-5793(93)81345-Z; MCGOWAN EB, 1989, BIOCHEM BIOPH RES CO, V158, P432, DOI 10.1016/S0006-291X(89)80065-8; MENNITI FS, 1991, MOL PHARMACOL, V40, P727; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MISSIAEN L, 1992, NATURE, V357, P599, DOI 10.1038/357599a0; MITCHELL FM, 1993, BIOCHEM J, V293, P495, DOI 10.1042/bj2930495; MIYAWAKI A, 1991, P NATL ACAD SCI USA, V88, P4911, DOI 10.1073/pnas.88.11.4911; NAKADE S, 1991, BIOCHEM J, V277, P125, DOI 10.1042/bj2770125; NAKAGAWA T, 1991, P NATL ACAD SCI USA, V88, P6244, DOI 10.1073/pnas.88.14.6244; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Sambrook J, 1989, MOL CLONING LABORATO; STEEL MC, 1993, MOL PHARMACOL, V43, P694; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TOBIN AB, 1992, MOL PHARMACOL, V42, P1042; WALL SJ, 1991, MOL PHARMACOL, V40, P783; WATRAS J, 1991, J NEUROSCI, V11, P3239; WHITHAM EM, 1991, EUR J PHARM-MOLEC PH, V206, P181, DOI 10.1016/S0922-4106(05)80017-3; WOJCIKIEWICZ RJH, 1992, J NEUROCHEM, V59, P383, DOI 10.1111/j.1471-4159.1992.tb08916.x; WOJCIKIEWICZ RJH, 1991, J BIOL CHEM, V266, P22234; WOJCIKIEWICZ RJH, 1993, TRENDS PHARMACOL SCI, V14, P279, DOI 10.1016/0165-6147(93)90131-3; WOJCIKIEWICZ RJH, 1994, IN PRESS J NEUROCHEM	40	127	128	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7963	7969						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132516				2022-12-27	WOS:A1994NB40900023
J	GOMEZPUERTAS, P; SATRUSTEGUI, J; BOGONEZ, E				GOMEZPUERTAS, P; SATRUSTEGUI, J; BOGONEZ, E			SYNAPTIC VESICLES ISOLATED FROM P-32 PRELABELED SYNAPTOSOMES CONTAIN A PHOSPHOPROTEIN OF APPARENT M(R) 65,000 (PP65), A POSSIBLE SUBSTRATE FOR PKC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RAT CORTICAL SYNAPTOSOMES; NEUROTRANSMITTER RELEASE; PHORBOL ESTER; BRAIN SYNAPTOSOMES; NORADRENALINE RELEASE; INTACT SYNAPTOSOMES; MEMBRANE-PROTEINS; GLUTAMATE RELEASE; PHASE-SEPARATION	the present study, we have investigated the subcellular localization of pp65, a synaptosomal phosphoprotein of apparent M(r)65,000. The results obtained strongly support that pp65 is localized to synaptic vesicles. The solubility properties of pp65, especially its partitioning into the detergent phase of Triton X-114, indicated that it is tightly associated with the membrane of synaptic vesicles. pp65 is multiply phosphorylated exclusively on serine. By studying the decay of labeled phosphate following incubation of P-32-prelabeled synaptosomes in the presence of cold inorganic phosphate, we have found that pp65 shows an unusually high turnover of phosphate. Exposure of synaptosomes to 1 mu m phorbol 12-myristate 13-acetate prior to prelabeling with P-32(i) led to a reduction in the steady state phosphorylation of pp65, and tryptic/chymotryptic mapping was shown to selectively affect phosphopeptide 4. Identical results were obtained following incubation of synaptosomes with the protein kinase C (PKC) inhibitor, GF109203 X. These results indicated that one of the protein kinases involved in steady state phosphorylation of pp65 is PKC dependent or is PKC itself. Several characteristics of pp65 reported in the present study suggest a regulatory role in nerve terminal function.	UNIV AUTONOMA MADRID, CONSEJO SUPER INVEST CIENT, CTR BIOL MOLEC SEVERO OCHOA, DEPT BIOL MOLEC, E-28049 MADRID, SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)			Satrustegui, Jorgina/R-6732-2019; Gomez-Puertas, Paulino/G-8821-2014	Gomez-Puertas, Paulino/0000-0003-3131-729X; Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667				ABDULGHANI M, 1991, P NATL ACAD SCI USA, V88, P1803, DOI 10.1073/pnas.88.5.1803; ADAMVIZI V, 1983, J NEUROCHEM, V41, P780, DOI 10.1111/j.1471-4159.1983.tb04808.x; AGUILERA J, 1993, J NEUROCHEM, V60, P709, DOI 10.1111/j.1471-4159.1993.tb03205.x; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BOGONEZ E, 1992, NEUROSCI LETT, V142, P123, DOI 10.1016/0304-3940(92)90354-A; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BUXBAUM JD, 1987, J NEUROCHEM, V49, P1161, DOI 10.1111/j.1471-4159.1987.tb10007.x; DEKKER LV, 1989, J NEUROCHEM, V52, P24, DOI 10.1111/j.1471-4159.1989.tb10893.x; DEKKER LV, 1989, NATURE, V342, P74, DOI 10.1038/342074a0; DELORENZO RJ, 1979, P NATL ACAD SCI USA, V76, P1838, DOI 10.1073/pnas.76.4.1838; DIAZGUERRA MJM, 1988, BIOCHIM BIOPHYS ACTA, V970, P157, DOI 10.1016/0167-4889(88)90174-7; DUNKLEY PR, 1986, J NEUROCHEM, V46, P1692; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; GOMEZPUERTAS P, 1991, J NEUROCHEM, V56, P2039, DOI 10.1111/j.1471-4159.1991.tb03464.x; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Harlow E, 1988, ANTIBODIES LABORATOR, P471; HELL JW, 1988, EMBO J, V7, P3023, DOI 10.1002/j.1460-2075.1988.tb03166.x; HOOPER NM, 1991, BIOCHEM J, V280, P745, DOI 10.1042/bj2800745; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; IPATA PL, 1968, BIOCHEMISTRY-US, V7, P507, DOI 10.1021/bi00842a004; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JOHNSTON PA, 1991, NEURON, V7, P101, DOI 10.1016/0896-6273(91)90078-E; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; KOSHLAND DE, 1987, TRENDS BIOCHEM SCI, V12, P225, DOI 10.1016/0968-0004(87)90114-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCMAHON HT, 1991, BIOCHIM BIOPHYS ACTA, V1059, P243, DOI 10.1016/S0005-2728(05)80210-5; NICHOLS RA, 1987, J NEUROCHEM, V48, P615, DOI 10.1111/j.1471-4159.1987.tb04137.x; NICHOLS RA, 1990, NATURE, V343, P647, DOI 10.1038/343647a0; ODA T, 1991, J NEUROCHEM, V56, P1263, DOI 10.1111/j.1471-4159.1991.tb11420.x; ROBINSON PJ, 1991, FEBS LETT, V282, P388, DOI 10.1016/0014-5793(91)80520-D; ROBINSON PJ, 1992, J BIOL CHEM, V267, P21637; ROBINSON PJ, 1983, J NEUROCHEM, V41, P909, DOI 10.1111/j.1471-4159.1983.tb09034.x; ROBINSON PJ, 1991, MOL NEUROBIOL, V5, P87, DOI 10.1007/BF02935541; ROBINSON PJ, 1991, NEUROSCI RES COMMUN, V9, P167; RODNIGHT R, 1986, J PHYSIOLOGY PARIS, V81, P340; SIHRA TS, 1992, J BIOL CHEM, V267, P1983; Thomas P, 1992, Curr Opin Neurobiol, V2, P308, DOI 10.1016/0959-4388(92)90120-A; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; VERMILION JL, 1978, J BIOL CHEM, V253, P2694; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; WANG JKT, 1989, P NATL ACAD SCI USA, V86, P2253, DOI 10.1073/pnas.86.7.2253; Wharton DC., 1967, METHOD ENZYMOL, P245; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; WILKINSON RJ, 1989, NEUROCHEM INT, V15, P191, DOI 10.1016/0197-0186(89)90100-9; WU WCS, 1982, P NATL ACAD SCI-BIOL, V79, P5249, DOI 10.1073/pnas.79.17.5249	46	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7564	7570						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125979				2022-12-27	WOS:A1994NA03200084
J	HOUWELING, M; JAMIL, H; HATCH, GM; VANCE, DE				HOUWELING, M; JAMIL, H; HATCH, GM; VANCE, DE			DEPHOSPHORYLATION OF CTP PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE IS NOT REQUIRED FOR BINDING TO MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED RAT HEPATOCYTES; CHOLINE-PHOSPHATE CYTIDYLTRANSFERASE; CHINESE-HAMSTER OVARY; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; FATTY-ACIDS; HELA-CELLS; ENDOPLASMIC-RETICULUM; OKADAIC ACID; PHOSPHORYLCHOLINE CYTIDYLYLTRANSFERASE; INDUCED INHIBITION	The sequence of the reversible phosphorylation and activation of CTP:phosphocholine cytidylyltransferase was investigated. Treatment of primary rat hepatocytes with oleic acid or phospholipase C caused a significant increase in the activity and amount of particulate cytidylyltransferase which correlated with decreased cytidylyltransferase activity and protein in the cytosol. The increase in membrane associated cytidylyltransferase is accompanied by a decrease in the phosphorylation of the enzyme. Reversal of membrane association resulted in an increased amount of phosphorylated cytidylyltransferase in the cytosol. We wished to determine if dephosphorylation of the enzyme were a prerequisite for its translocation from the cytosol to the membranes. In vitro studies with membranes from oleic acid- or phospholipase C-treated cells showed that phosphorylated cytosolic cytidylyltransferase associated with these membranes with negligible dephosphorylation. Incubation of hepatocytes with oleic acid for different periods of time demonstrated that cytidylyltransferase associated with membranes in an active, phosphorylated form and was subsequently dephosphorylated. This result was supported by comparison of phosphopeptide maps of P-32-labeled cytidylyltransferase obtained from cytosolic, as well as membrane fractions of control, oleic acid-treated, or phospholipase C-treated cells. These studies revealed dephosphorylation on some sites and phosphorylation on other sites. Our data strengthen the hypothesis that a change in the lipid composition of membranes can mediate the initial binding of cytidylyltransferase to the membrane and that subsequently the enzyme becomes dephosphorylated.	UNIV ALBERTA,DEPT BIOCHEM,EDMONTON T6G 2S2,AB,CANADA	University of Alberta	HOUWELING, M (corresponding author), UNIV ALBERTA,LIPID & LIPOPROT RES GRP,EDMONTON T6G 2S2,AB,CANADA.							AEBERHARD EE, 1986, BIOCHIM BIOPHYS ACTA, V875, P6, DOI 10.1016/0005-2760(86)90004-4; ANDERSON KE, 1985, BIOCHIM BIOPHYS ACTA, V835, P360, DOI 10.1016/0005-2760(85)90292-9; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; CHANDER A, 1988, BIOCHIM BIOPHYS ACTA, V958, P343, DOI 10.1016/0005-2760(88)90219-6; COOK HW, 1985, CAN J BIOCHEM CELL B, V63, P145, DOI 10.1139/o85-021; CORNELL R, 1987, BIOCHIM BIOPHYS ACTA, V919, P26, DOI 10.1016/0005-2760(87)90214-1; DAVIS RA, 1979, J BIOL CHEM, V254, P2010; HATCH GM, 1992, J BIOL CHEM, V267, P15751; HATCH GM, 1990, BIOCHIM BIOPHYS ACTA, V1042, P374, DOI 10.1016/0005-2760(90)90167-V; HATCH GM, 1991, BIOCHIM BIOPHYS ACTA, V1081, P25, DOI 10.1016/0005-2760(91)90245-D; HOUWELING M, 1991, BIOCHEM J, V278, P347, DOI 10.1042/bj2780347; HOUWELING M, 1993, EUR J BIOCHEM, V214, P927, DOI 10.1111/j.1432-1033.1993.tb17996.x; JAMIL H, 1993, BIOCHEM J, V291, P419, DOI 10.1042/bj2910419; JAMIL H, 1990, J BIOL CHEM, V265, P4332; JAMIL H, 1992, J BIOL CHEM, V267, P1752; KENNEDY EP, 1988, LIPIDS MEMBRANES PAS, P171; KENT C, 1990, PROG LIPID RES, V29, P87, DOI 10.1016/0163-7827(90)90010-I; KISS Z, 1992, ARCH BIOCHEM BIOPHYS, V296, P457, DOI 10.1016/0003-9861(92)90597-P; MOCK T, 1986, BIOCHEM CELL BIOL, V64, P413, DOI 10.1139/o86-058; PADDON HB, 1980, BIOCHIM BIOPHYS ACTA, V620, P636, DOI 10.1016/0005-2760(80)90156-3; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V795, P433, DOI 10.1016/0005-2760(84)90169-3; PELECH SL, 1983, J BIOL CHEM, V258, P6782; PELECH SL, 1981, J BIOL CHEM, V256, P8283; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V779, P217, DOI 10.1016/0304-4157(84)90010-8; SANGHERA JS, 1989, J BIOL CHEM, V264, P1215; SLACK BE, 1991, J BIOL CHEM, V266, P24503; SLEIGHT R, 1983, J BIOL CHEM, V258, P836; TESSNER TG, 1991, J BIOL CHEM, V266, P16261; TIJBURG LBM, 1990, BIOCHIM BIOPHYS ACTA, V1004, P1; UTAL AK, 1991, J BIOL CHEM, V266, P24084; Vance D E, 1981, Methods Enzymol, V71 Pt C, P576; VANCE DE, 1990, BIOCHEM CELL BIOL, V68, P1151, DOI 10.1139/o90-172; WATKINS JD, 1992, ARCH BIOCHEM BIOPHYS, V292, P360, DOI 10.1016/0003-9861(92)90003-F; WATKINS JD, 1991, J BIOL CHEM, V266, P21113; WATKINS JD, 1990, J BIOL CHEM, V265, P2190; WEINHOLD PA, 1984, J BIOL CHEM, V259, P315; WEINHOLD PA, 1986, J BIOL CHEM, V261, P5104; YAO ZM, 1990, J BIOL CHEM, V265, P4326	38	69	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7544	7551						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125976				2022-12-27	WOS:A1994NA03200081
J	WEGLOHNER, W; SUBRAMANIAN, AR				WEGLOHNER, W; SUBRAMANIAN, AR			MULTICOPY GTPASE CENTER PROTEIN L12 OF ARABIDOPSIS CHLOROPLAST RIBOSOME IS ENCODED BY A CLUSTERED NUCLEAR GENE FAMILY WITH THE EXPRESSED MEMBERS CLOSELY LINKED TO TRNA(PRO) GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; CDNA CLONES; SEQUENCE; SPINACH; HOMOLOGY; TRANSIT; CLONING; PLANT; RNA	A conserved architectural feature of ribosomes is a protuberance (the stalk) in the large subunit, essential for ribosomal interactions with translational factors and GTP hydrolysis and generated by two dimers of L12, the only multicopy protein in ribosomes. In higher plants, the rpl12 gene for chloroplast L12 is located in the nucleus. We report here the cloning and sequencing of this nuclear gene from Arabidopsis thaliana, revealing the first gene family for a chloroplast ribosomal protein (RP). A single cluster/haploid genome of three rpl12 genes is located in the sequenced 9.1-kilobase region of the Arabidopsis genome. Two of the rpl12 genes encode identical mature proteins, and the third encodes a 25% divergent RP, although the chloroplast-targeting transit peptide in each is distinct. The rpl12 genes encoding identical RPs are closely linked at their 5' ends to identical cytosolic tRNA(Pro) genes with a <250-base pair spacer. Reverse transcriptase polymerase chain reaction experiments with total RNA isolated from Arabidopsis (and characterization of several L12 cDNA clones) show that only the tRNA-linked rpl12 genes are expressed. We also show (by polymerase chain reaction experiments with isolated total DNA) that this tRNA(Pro) rpl12 gene linkage is conserved in spinach (inferred to contain a single gene copy) indicating its importance. The previously described enhanced translation of spinach L12 mRNA from its two tandem AUG codons and the two functional rpl12 genes in Arabidopsis probably provide two mechanisms for generating the four copies of L12/chloroplast ribosome, qualitatively different from those attempted in eubacteria.	MAX PLANCK INST MOLEC GENET,D-14195 BERLIN,GERMANY	Max Planck Society								Ausubel FM., 2006, ENZYMATIC MANIPULATI; AXELOS M, 1989, MOL GEN GENET, V219, P106, DOI 10.1007/BF00261164; BACHMANN BJ, 1990, MICROBIOL REV, V54, P130, DOI 10.1128/MMBR.54.2.130-197.1990; BARTSCH M, 1982, P NATL ACAD SCI-BIOL, V79, P6871, DOI 10.1073/pnas.79.22.6871; BISANZSEYER C, 1992, PLANT MOL BIOL, V18, P337, DOI 10.1007/BF00034960; BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; DOWNING WL, 1987, J MOL BIOL, V194, P609, DOI 10.1016/0022-2836(87)90238-5; EGEBJERG J, 1990, J MOL BIOL, V213, P275, DOI 10.1016/S0022-2836(05)80190-1; ELHAG GA, 1992, NUCLEIC ACIDS RES, V20, P689, DOI 10.1093/nar/20.4.689; FRANZETTI B, 1992, NUCLEIC ACIDS RES, V20, P4153, DOI 10.1093/nar/20.16.4153; GANTT JS, 1991, EMBO J, V10, P3073, DOI 10.1002/j.1460-2075.1991.tb07859.x; GAVEL Y, 1990, FEBS LETT, V261, P455, DOI 10.1016/0014-5793(90)80614-O; GIESE K, 1990, BIOCHEMISTRY-US, V29, P10562, DOI 10.1021/bi00498a020; GIESE K, 1989, BIOCHEMISTRY-US, V28, P3525, DOI 10.1021/bi00434a056; GIESE K, 1990, THESIS FREE U BERLIN; GREEN GA, 1989, PLANT MOL BIOL, V13, P727, DOI 10.1007/BF00016029; Hallick RB, 1983, PLANT MOL BIOL REPOR, V1, P38, DOI [10.1007/BF02712675, DOI 10.1007/BF02712675]; HEIN J, 1989, MOL BIOL EVOL, V6, P649; HEIN J, 1989, MOL BIOL EVOL, V6, P669; ITOH T, 1978, FEBS LETT, V96, P392, DOI 10.1016/0014-5793(78)80445-1; KANG HA, 1992, MOL GEN GENET, V233, P487, DOI 10.1007/BF00265449; KEEGSTRA K, 1988, BIOESSAYS, V9, P15, DOI 10.1002/bies.950090105; LAGRANGE T, 1993, MOL CELL BIOL, V13, P2614, DOI 10.1128/MCB.13.4.2614; LARKIN JC, 1989, GENE DEV, V3, P500, DOI 10.1101/gad.3.4.500; LEIJONMARCK M, 1984, BIOCHEM INT, V8, P69; LI YQ, 1992, FEBS LETT, V300, P199, DOI 10.1016/0014-5793(92)80845-8; Liljas A, 1986, STRUCTURE FUNCTION G, P379; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; MACHE R, 1991, TRANSLATIONAL APPARA; MAGER WH, 1988, BIOCHIM BIOPHYS ACTA, V949, P1, DOI 10.1016/0167-4781(88)90048-6; MARQUIS D, 1978, J MOL BIOL, V119, P557, DOI 10.1016/0022-2836(78)90202-4; MARTINGALLARDO A, 1992, NAT GENET, V1, P34, DOI 10.1038/ng0492-34; Meyerowitz E. M., 1992, Methods in Arabidopsis research., P100; Moller W., 1986, STRUCTURE FUNCTION G, P309; MONK RJ, 1981, CELL, V24, P301, DOI 10.1016/0092-8674(81)90319-6; REMACHA M, 1990, CURR GENET, V17, P535, DOI 10.1007/BF00313084; Sambrook J, 1989, MOL CLONING LABORATO; SCHMIDT J, 1993, J BIOL CHEM, V268, P27447; SCHMIDT J, 1993, NUCLEIC ACIDS RES, V21, P2519, DOI 10.1093/nar/21.10.2519; SCHMIDT J, 1993, TRANSLATIONAL APPARATUS, P555; SCHMIDT M, 1993, BIOCHIM BIOPHYS ACTA, V1172, P349, DOI 10.1016/0167-4781(93)90230-B; SIBOLD C, 1990, BIOCHIM BIOPHYS ACTA, V1050, P61, DOI 10.1016/0167-4781(90)90142-O; SMEEKENS S, 1990, TRENDS BIOCHEM SCI, V15, P73, DOI 10.1016/0968-0004(90)90180-J; SMOOKER PM, 1990, J BIOL CHEM, V265, P16699; STEWARD KL, 1991, J MOL BIOL, V218, P23, DOI 10.1016/0022-2836(91)90870-C; Stewart WN., 1983, PALEOBOTANY EVOLUTIO; SUBRAMANIAN AR, 1975, J MOL BIOL, V95, P1, DOI 10.1016/0022-2836(75)90330-7; SUBRAMANIAN AR, 1993, TRENDS BIOCHEM SCI, V18, P177, DOI 10.1016/0968-0004(93)90110-9; SUBRAMANIAN AR, 1991, TRANSLATIONAL APPARA, P95; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; TERHORST C, 1973, EUR J BIOCHEM, V34, P138, DOI 10.1111/j.1432-1033.1973.tb02740.x; THOMPSON MD, 1992, PLANT MOL BIOL, V18, P931, DOI 10.1007/BF00019207; WITTMANN HG, 1983, ANNU REV BIOCHEM, V52, P35, DOI 10.1146/annurev.bi.52.070183.000343; WOOL IG, 1990, RIBOSOME, P203; ZHOU DX, 1992, J BIOL CHEM, V267, P23515	55	16	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7330	7336						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125949				2022-12-27	WOS:A1994NA03200048
J	ZAK, O; TRINDER, D; AISEN, P				ZAK, O; TRINDER, D; AISEN, P			PRIMARY RECEPTOR-RECOGNITION SITE OF HUMAN TRANSFERRIN IS IN THE C-TERMINAL LOBE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-SERUM TRANSFERRIN; EMBRYO RED-CELLS; IRON RELEASE; CHICK RETICULOCYTES; HUMAN LACTOFERRIN; RAT TRANSFERRIN; HALF-MOLECULES; BINDING SITES; OVOTRANSFERRIN; FRAGMENTS	The role of the transferrin receptor in capturing and conveying transferrin through the cell during the iron-donating cycle of receptor-mediated endocytosis has been studied extensively. Nevertheless, almost nothing is known of how human transferrin binds to its receptor. In an initial approach toward delineating the receptor-recognition site(s) of human transferrin, we have studied the interactions of proteolytically-cleaved, single-sited fragments of transferrin, representing the N- and C-lobes of the molecule respectively, with cells expressing the transferrin receptor on their plasma membranes. Only the C-fragment was found capable of donating iron to hepatoma-derived HuH-7 cells or of binding to surface receptors of HuH-7 and leukemic K562 cells. Although no association of N- and C-fragments could be demonstrated by gel chromatography, the presence of excess N-fragment strengthened the binding of C-fragment by an order of magnitude. An explanation of these observations is that the primary receptor recognition site of human transferrin is on the C-lobe of the protein, but that prior binding of this lobe to receptor enables the N-lobe to respond to receptor as well, either directly or by interaction with the bound C-lobe.	ALBERT EINSTEIN COLL MED,DEPT PHYSIOL & BIOPHYS,BRONX,NY 10461; ALBERT EINSTEIN COLL MED,DEPT MED,BRONX,NY 10461	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine					NIDDK NIH HHS [DK15056, DK37927] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015056, R01DK037927] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AISEN P, 1968, BIOCHEM BIOPH RES CO, V32, P220, DOI 10.1016/0006-291X(68)90372-0; AISEN P, 1989, IRON CARRIERS IRON P, P353; ALCANTARA J, 1993, MOL MICROBIOL, V8, P1135, DOI 10.1111/j.1365-2958.1993.tb01658.x; ANDERSON BF, 1987, P NATL ACAD SCI USA, V84, P1769, DOI 10.1073/pnas.84.7.1769; BAILEY S, 1988, BIOCHEMISTRY-US, V27, P5804, DOI 10.1021/bi00415a061; BAKER EN, 1992, J INORG BIOCHEM, V47, P147, DOI 10.1016/0162-0134(92)84061-Q; BALI PK, 1991, BIOCHEMISTRY-US, V30, P9947, DOI 10.1021/bi00105a019; BALI PK, 1991, BIOCHEMISTRY-US, V30, P324, DOI 10.1021/bi00216a003; BALI PK, 1992, BIOCHEMISTRY-US, V31, P3963, DOI 10.1021/bi00131a011; BROWNMASON A, 1987, BIOCHEM J, V245, P103, DOI 10.1042/bj2450103; BROWNMASON A, 1984, J BIOL CHEM, V259, P1866; DAY CL, 1992, J BIOL CHEM, V267, P13857; EGAN TJ, 1993, BIOCHEMISTRY-US, V32, P8162, DOI 10.1021/bi00083a016; ESPARZA I, 1980, BIOCHIM BIOPHYS ACTA, V624, P479, DOI 10.1016/0005-2795(80)90089-6; FEENEY RE, 1966, STRUCT BOND, V1, P149; GARRICK MD, 1993, J BIOL CHEM, V268, P14867; Harris D., 1989, IRON CARRIERS IRON P, P239; HEMMAPLARDH D, 1976, INT J APPL RADIAT IS, V27, P89, DOI 10.1016/0020-708X(76)90182-4; JAMROZ RC, 1993, P NATL ACAD SCI USA, V90, P1320, DOI 10.1073/pnas.90.4.1320; KEUNG WM, 1982, J BIOL CHEM, V257, P1184; KLAUSNER RD, 1983, P NATL ACAD SCI-BIOL, V80, P2263, DOI 10.1073/pnas.80.8.2263; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; KLOTZ IM, 1971, BIOCHEMISTRY-US, V10, P3065, DOI 10.1021/bi00792a013; KUHN LC, 1989, SCHWEIZ MED WSCHR, V119, P1319; LINEBACKZINS J, 1980, J BIOL CHEM, V255, P708; MACGILLIVRAY RTA, 1983, J BIOL CHEM, V258, P3543; MASON AB, 1993, BIOCHEMISTRY-US, V32, P5472, DOI 10.1021/bi00071a025; MASON AB, 1987, J BIOL CHEM, V262, P9011; MASON AB, 1987, BIOCHEM J, V247, P417, DOI 10.1042/bj2470417; OE H, 1988, J BIOCHEM-TOKYO, V103, P1066, DOI 10.1093/oxfordjournals.jbchem.a122381; ORATORE A, 1989, BIOCHEM J, V257, P301, DOI 10.1042/bj2570301; PARK I, 1985, P NATL ACAD SCI USA, V82, P3149, DOI 10.1073/pnas.82.10.3149; SASAKI K, 1993, AM J HEMATOL, V42, P74, DOI 10.1002/ajh.2830420115; SIPE DM, 1991, J BIOL CHEM, V266, P8002; TRINDER D, 1988, BIOCHIM BIOPHYS ACTA, V943, P440, DOI 10.1016/0005-2736(88)90375-6; YOUNG SP, 1982, BIOCHIM BIOPHYS ACTA, V718, P35, DOI 10.1016/0304-4165(82)90006-X; ZAK O, 1990, BIOCHIM BIOPHYS ACTA, V1052, P24, DOI 10.1016/0167-4889(90)90052-F; ZAK O, 1983, BIOCHIM BIOPHYS ACTA, V742, P490, DOI 10.1016/0167-4838(83)90266-2; ZAK O, 1985, BIOCHIM BIOPHYS ACTA, V829, P348, DOI 10.1016/0167-4838(85)90243-2; ZAPOLSKI EJ, 1976, BIOCHIM BIOPHYS ACTA, V421, P80, DOI 10.1016/0304-4165(76)90171-9	40	67	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7110	7114						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125919				2022-12-27	WOS:A1994NA03200014
J	QUATTROCHI, LC; VU, T; TUKEY, RH				QUATTROCHI, LC; VU, T; TUKEY, RH			THE HUMAN CYP1A2 GENE AND INDUCTION BY 3-METHYLCHOLANTHRENE - A REGION OF DNA THAT SUPPORTS AH-RECEPTOR BINDING AND PROMOTER-SPECIFIC INDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YA SUBUNIT GENE; XENOBIOTIC RESPONSIVE ELEMENTS; TRANSCRIPTION FACTOR AP-1; PLANAR AROMATIC-COMPOUNDS; REGULATORY ELEMENTS; INDUCIBLE EXPRESSION; DIOXIN RECEPTOR; MAMMALIAN-CELLS; MESSENGER-RNAS; P-450C GENE	The gene for cytochrome P4501A2 is constitutively expressed in the liver of vertebrates and shows induced expression when an organism is exposed to polycyclic aromatic hydrocarbons and halogenated hydrocarbons. To identify DNA elements regulating transcription of the human CYP1A2 gene, transient transfection experiments were conducted in the human hepatoma cell line HepG2. Dissection of the 5'-flanking portion of the CYP1A2 gene identified two regions that contributed to the overall induction by 3-methylcholanthrene. One region located at -2532/-2423 contains an xenobiotic-responsive element-like sequence, termed X1, that binds a nuclear 2,3,7,8-tetrachlorodibenzo-p-dioxin inducible protein in HepG2 and wild type mouse Hepa-1 cells, but not in the Ah receptor nuclear translocation defective mouse C- mutant c4 cells. In addition, deletion of this region of the CYP1A2 gene reduces the 3-methylcholanthrene (3-MC)-initiated induction of chloramphenicol acetyltransferase activity in both promoter- and enhancer-specific constructs. The second responsive region is located at -2259/-1987. This region of the gene contains a second xenobiotic responsive element-like element, but this element does not associate with the nuclear Ah receptor. However, there does exist several potential AP1 binding sites and a conserved TATA box. A DNA fragment from -2259/-1970 that contains these elements was shown to function as an efficient eukaryotic promoter, in addition to supporting 3-MC-induced promoter activity These results suggest that Ah receptor-specific and promoter-specific elements regulate the expression of the human CYP1A2 gene.	UNIV CALIF SAN DIEGO,CTR CANC 0812,DEPT PHARMACOL,LA JOLLA,CA 92093	University of California System; University of California San Diego					NIGMS NIH HHS [GM36590] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARKER CW, 1992, J BIOL CHEM, V267, P8050; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCHER P, 1986, NUCLEIC ACIDS RES, V14, P10009, DOI 10.1093/nar/14.24.10009; CONNEY AH, 1982, CANCER RES, V42, P4875; CORSARO CM, 1981, SOMAT CELL GENET, V7, P603, DOI 10.1007/BF01549662; DENISON MS, 1989, J BIOL CHEM, V264, P16478; DENISON MS, 1988, P NATL ACAD SCI USA, V85, P2528, DOI 10.1073/pnas.85.8.2528; DENISON MS, 1988, J BIOL CHEM, V263, P17221; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; FRAIN M, 1989, CELL, V59, P145, DOI 10.1016/0092-8674(89)90877-5; FUJISAWASEHARA A, 1988, P NATL ACAD SCI USA, V85, P5859, DOI 10.1073/pnas.85.16.5859; FUJISAWASEHARA A, 1987, NUCLEIC ACIDS RES, V15, P4179, DOI 10.1093/nar/15.10.4179; GONZALEZ FJ, 1984, MOL PHARMACOL, V26, P117; GONZALEZ FJ, 1990, PHARMACOL THERAPEUT, V45, P1, DOI 10.1016/0163-7258(90)90006-N; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREENLEE WF, 1979, J BIOL CHEM, V254, P9814; HINES RN, 1988, CARCINOGENESIS, V9, P1599, DOI 10.1093/carcin/9.9.1599; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; JONES PBC, 1985, SCIENCE, V227, P1499, DOI 10.1126/science.3856321; KARIN M, 1990, New Biologist, V2, P126; KAWAJIRI K, 1984, J BIOL CHEM, V259, P145; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LI Y, 1992, J BIOL CHEM, V267, P15097; NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1; NEUHOLD LA, 1989, MOL CELL BIOL, V9, P2378, DOI 10.1128/MCB.9.6.2378; NGUYEN T, 1992, J BIOL CHEM, V267, P13535; NORMAN RL, 1978, J BIOL CHEM, V253, P8640; OKEY AB, 1979, J BIOL CHEM, V254, P1636; OKINO ST, 1992, J BIOL CHEM, V267, P6991; OKINO ST, 1993, PHARMACOGENETICS, V3, P101, DOI 10.1097/00008571-199304000-00006; PUGA A, 1992, DNA CELL BIOL, V11, P269, DOI 10.1089/dna.1992.11.269; QUATTROCHI LC, 1989, MOL PHARMACOL, V36, P66; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; RUSHMORE TH, 1990, P NATL ACAD SCI USA, V87, P3826, DOI 10.1073/pnas.87.10.3826; SAATCIOGLU F, 1990, MOL CELL BIOL, V10, P6408, DOI 10.1128/MCB.10.12.6408; SCHOLER H, 1986, SCIENCE, V232, P76, DOI 10.1126/science.3006253; SHEN ES, 1989, J BIOL CHEM, V264, P17754; TELAKOWSKIHOPKINS CA, 1988, P NATL ACAD SCI USA, V85, P1000, DOI 10.1073/pnas.85.4.1000; TUKEY RH, 1984, BIOCHEMISTRY-US, V23, P6003, DOI 10.1021/bi00320a016; TUKEY RH, 1982, CELL, V31, P275, DOI 10.1016/0092-8674(82)90427-5; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WILHELMSSON A, 1990, EMBO J, V9, P69, DOI 10.1002/j.1460-2075.1990.tb08081.x; YAO EF, 1992, BIOCHEMISTRY-US, V31, P5060, DOI 10.1021/bi00136a019	44	168	172	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6949	6954						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120057				2022-12-27	WOS:A1994MZ50300105
J	ELKHOURY, J; THOMAS, CA; LOIKE, JD; HICKMAN, SE; CAO, L; SILVERSTEIN, SC				ELKHOURY, J; THOMAS, CA; LOIKE, JD; HICKMAN, SE; CAO, L; SILVERSTEIN, SC			MACROPHAGES ADHERE TO GLUCOSE-MODIFIED BASEMENT-MEMBRANE COLLAGEN-IV VIA THEIR SCAVENGER RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							NON-ENZYMATIC GLUCOSYLATION; GLYCOSYLATION END-PRODUCTS; HUMAN-MONOCYTES; CELL-LINE; BINDING; IDENTIFICATION; COMPLICATIONS; DEGRADATION; ADHESION; PROTEINS	Scavenger receptors have been reported to mediate macrophage adhesion to serum coated plastic surfaces. We report here that scavenger receptors promote the divalent cation independent adhesion of human monocytes and macrophages to surfaces coated with non-enzymatically glycated collagen IV but not to surfaces coated with native collagen IV. Ligands for scavenger receptor types I and II blocked adhesion of monocytes and macrophages to non-enzymatically glycated collagen IV but had no effect on adhesion of these cells to albumin-coated surfaces. U937 human promonocyte-like cells transfected with cDNA encoding bovine scavenger receptor I or II adhered to surfaces coated with glycated-collagen IV but not to surfaces coated with native collagen IV. A synthetic peptide homologous to the domain of bovine scavenger receptor that binds modified low density lipoproteins (residues 327-343) inhibited the adhesion of U937 cells transfected with cDNA encoding bovine scavenger receptor II to glycated collagen IV, whereas a control peptide from the alpha helical domain of scavenger receptor II (residues 121-137) had no effect on adhesion of these cells. Macrophages plated on surfaces coated with glycated collagen IV were unable to endocytose acetylated low density lipoproteins from the medium, suggesting that their scavenger receptors were occupied in binding these cells to the substrate. These findings suggest new roles for scavenger receptors in the accelerated development of vascular lesions observed in diabetics.	COLUMBIA UNIV,COLL PHYS & SURG,DEPT PHYSIOL & CELLULAR BIOPHYS,NEW YORK,NY 10032	Columbia University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032210, P50HL021006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020516, R01AI020516] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-21006, HL-32210] Funding Source: Medline; NIAID NIH HHS [AI-20516] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACTON S, 1993, J BIOL CHEM, V268, P3530; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; COHEN MP, 1981, BIOCHEM BIOPH RES CO, V100, P1549, DOI 10.1016/0006-291X(81)90695-1; DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D; EBLE AS, 1983, J BIOL CHEM, V258, P9406; FRAZER I, 1993, NATURE, V364, P343; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GREENBERG S, 1991, J IMMUNOL METHODS, V139, P115, DOI 10.1016/0022-1759(91)90358-M; HAYASHI K, 1991, BIOCHIM BIOPHYS ACTA, V1082, P152; JONES BM, 1989, J IMMUNOL METHODS, V125, P41, DOI 10.1016/0022-1759(89)90076-8; KIRSTEIN M, 1990, P NATL ACAD SCI USA, V87, P9010, DOI 10.1073/pnas.87.22.9010; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; KRIEGER M, 1993, J BIOL CHEM, V268, P4569; KULL FC, 1983, APPL BIOCHEM BIOTECH, V8, P97, DOI 10.1007/BF02778090; LOIKE JD, 1991, P NATL ACAD SCI USA, V88, P1044, DOI 10.1073/pnas.88.3.1044; LOIKE JD, 1986, AM J PHYSIOL, V251, pC128, DOI 10.1152/ajpcell.1986.251.1.C128; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; MICHL J, 1983, J EXP MED, V157, P1746, DOI 10.1084/jem.157.6.1746; PALKAMA T, 1991, IMMUNOLOGY, V74, P432; ROHRER L, 1990, NATURE, V343, P570, DOI 10.1038/343570a0; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; TARSIO JF, 1988, DIABETES, V37, P532, DOI 10.2337/diabetes.37.5.532; TOBIAS JW, 1987, BLOOD, V69, P1265; VLASSARA H, 1985, P NATL ACAD SCI USA, V82, P5588, DOI 10.1073/pnas.82.17.5588; WRIGHT SD, 1983, P NATL ACAD SCI-BIOL, V80, P5699, DOI 10.1073/pnas.80.18.5699; ZHANG HF, 1993, J BIOL CHEM, V268, P5535	26	151	156	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 8	1994	269	14					10197	10200						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NF017	8144597				2022-12-27	WOS:A1994NF01700004
J	LAINE, RO; SHAY, NF; KILBERG, MS				LAINE, RO; SHAY, NF; KILBERG, MS			NUCLEAR RETENTION OF THE INDUCED MESSENGER-RNA FOLLOWING AMINO ACID-DEPENDENT TRANSCRIPTIONAL REGULATION OF MAMMALIAN RIBOSOMAL-PROTEINS L17 AND S25	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATIONAL CONTROL; RAT-LIVER; CELLS; EXPRESSION; IDENTIFICATION; GENES; TRANSPORT; YEAST	An amino acid starvation-induced mRNA, increased up to 4-fold in the absence of amino acids, was identified previously as rat 60 S subunit ribosomal protein L17. The data presented here demonstrate that among ribosomal proteins, L17, as well as the smaller subunit ribosomal protein S25, are uniquely regulated by amino acid deprivation of cells; the increase in L17 and S25 mRNA content in response to substrate starvation is not shared by the 11 other ribosomal proteins tested. When rat Fao hepatoma cells were incubated in the presence of actinomycin D, the L17 mRNA level decayed below the basal level, regardless of medium amino acid content, and nuclear run-off assays confirmed that nutrient starvation leads to enhanced transcription of the L17 ribosomal protein gene. Likewise, the induction of S25 mRNA also was prevented in the presence of actinomycin D. Furthermore, the induction of L17 and S25 mRNA content was blocked by cycloheximide, demonstrating the requirement for a newly synthesized protein in the signaling pathway. Northern analysis with RNA isolated from cytoplasmic, polysomal, and nuclear enriched fractions indicated that the starvation-dependent increase in the S25 and L17 mRNAs is retained within the nucleus and not is available for translation. Amino acid refeeding of the cells caused the translocation of the stored nuclear mRNAs to the polysomal fraction.	UNIV FLORIDA,J HILLIS MILLER HLTH CTR,DEPT BIOCHEM & MOLEC BIOL,BOX 100245,GAINESVILLE,FL 32610	State University System of Florida; University of Florida					NIDDK NIH HHS [DK-31580] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031580] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABASTADO JP, 1991, MOL CELL BIOL, V11, P486, DOI 10.1128/MCB.11.1.486; ADELMAN RR, 1974, METHOD ENZYMOL, V31, P201; AMALDI F, 1989, TRENDS BIOCHEM SCI, V14, P175, DOI 10.1016/0968-0004(89)90269-7; ANGERER LM, 1992, DEV BIOL, V149, P27, DOI 10.1016/0012-1606(92)90261-E; BURMEISTER LA, 1991, J BIOL CHEM, V266, P22905; CARDINALI B, 1993, NUCLEIC ACIDS RES, V21, P2301, DOI 10.1093/nar/21.10.2301; CHAN SO, 1992, MOL CELL BIOCHEM, V117, P71; CHESTER KA, 1989, BIOCHIM BIOPHYS ACTA, V1009, P297, DOI 10.1016/0167-4781(89)90119-X; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARKE SD, 1992, FASEB J, V6, P3146, DOI 10.1096/fasebj.6.13.1397836; DAVIS LG, 1986, BASIC METHODS MOL BI, P143; DESJARDIN LE, 1993, J BIOL CHEM, V268, P6953; ENGLESBERG E, 1986, J MEMBRANE BIOL, V91, P199, DOI 10.1007/BF01868814; FALIKS D, 1982, NUCLEIC ACIDS RES, V10, P789, DOI 10.1093/nar/10.3.789; GUERRINI L, 1993, MOL CELL BIOL, V13, P3202, DOI 10.1128/MCB.13.6.3202; GUIDOTTI GG, 1978, BIOCHIM BIOPHYS ACTA, V515, P239; HARALSON MA, 1975, J BIOL CHEM, V250, P8618; HENRY JL, 1993, CANCER RES, V53, P1403; HINNEBUSCH AG, 1990, TRENDS BIOCHEM SCI, V15, P148, DOI 10.1016/0968-0004(90)90215-W; HOPE IA, 1985, CELL, V43, P177, DOI 10.1016/0092-8674(85)90022-4; KILBERG MS, 1986, TRENDS BIOCHEM SCI, V11, P183, DOI 10.1016/0968-0004(86)90138-6; KILBERG MS, 1994, FASEB J, V8, P13, DOI 10.1096/fasebj.8.1.8299885; KITAGAWA M, 1991, FEBS LETT, V283, P210, DOI 10.1016/0014-5793(91)80590-Y; KONDOH N, 1992, CANCER RES, V52, P791; LAINE RO, 1991, J BIOL CHEM, V266, P16969; LI ML, 1992, FEBS LETT, V298, P142, DOI 10.1016/0014-5793(92)80041-E; LI ML, 1991, GENE, V107, P329, DOI 10.1016/0378-1119(91)90335-9; MEYUHAS O, 1987, MOL CELL BIOL, V7, P2691, DOI 10.1128/MCB.7.8.2691; Meyuhas O., 1984, RECOMBINANT DNA CELL, P243; NIEUWINT RTM, 1985, CURR GENET, V10, P1, DOI 10.1007/BF00418486; POGUEGEILE K, 1991, MOL CELL BIOL, V11, P3842, DOI 10.1128/MCB.11.8.3842; SHAY NF, 1991, J BIOL CHEM, V265, P17844; SMITH JR, 1990, J BIOL CHEM, V265, P2306; SUZUKI K, 1991, BIOCHEM BIOPH RES CO, V178, P322, DOI 10.1016/0006-291X(91)91817-V	34	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9693	9697						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144559				2022-12-27	WOS:A1994NE05300048
J	SANGADALA, S; WALTERS, FS; ENGLISH, LH; ADANG, MJ				SANGADALA, S; WALTERS, FS; ENGLISH, LH; ADANG, MJ			A MIXTURE OF MANDUCA-SEXTA AMINOPEPTIDASE AND PHOSPHATASE ENHANCES BACILLUS-THURINGIENSIS INSECTICIDAL CRYIA(C) TOXIN BINDING AND (RB+-K+)-RB-86 EFFLUX IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANE; DELTA-ENDOTOXINS; HELIOTHIS-VIRESCENS; MIDGUT; SPECIFICITY; RESISTANCE; RECEPTOR; IDENTIFICATION; QUANTITIES; MECHANISM	CryIA(c) delta-endotoxin, a member of the CryI family of Bacillus thuringiensis insecticidal proteins, specifically recognizes and binds with high affinity to target proteins in the midgut of susceptible insects. Protein blots of Manduca sexta brush-border membranes probed with I-125-CryIA(c) identify a major binding protein of 120 kDa and a minor binding protein of 65 kDa. Monoclonal antibodies were raised against the 120-kDa toxin binding protein. Using isoelectric focusing and monoclonal antibodies (2B3, 8G1, and 12B8) 120- and 65-kDa brush-border proteins were isolated. Labeled CryIA(c) and monoclonal antibodies probed to blots of the affinity-selected proteins recognized the 120- and 65-kDa proteins. When reconstituted into phospholipid vesicles, antibody-selected proteins increased toxin binding (35%) and enhanced toxin-induced Rb-86+ release up to 1000-fold. The 120-kDa protein was identified as aminopeptidase N (EC 3.4.11.2). A CryIA(c)-sensitive phosphatase was also present in the 120/65-kDa protein mixture. These findings provide the first identification of B. thuringiensis toxin binding proteins, although confirmation is needed in vivo.	UNIV GEORGIA, DEPT ENTOMOL, ATHENS, GA 30602 USA; ECOGEN INC, LANGHORNE, PA 19047 USA	University System of Georgia; University of Georgia								Adang M. J., 1991, Biotechnology for biological control of pests and vectors., P3; BARBARAT B, 1986, J BIOL CHEM, V261, P4455; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; ENGLISH L, 1992, INSECT BIOCHEM MOLEC, V22, P1, DOI 10.1016/0965-1748(92)90093-T; ENGLISH LH, 1989, INSECT BIOCHEM, V19, P145, DOI 10.1016/0020-1790(89)90085-1; ENGLISH LH, 1991, INSECT BIOCHEM, V21, P177, DOI 10.1016/0020-1790(91)90048-J; FERRE J, 1991, P NATL ACAD SCI USA, V88, P5119, DOI 10.1073/pnas.88.12.5119; GARCZYNSKI SF, 1991, APPL ENVIRON MICROB, V57, P2816, DOI 10.1128/AEM.57.10.2816-2820.1991; GOULD F, 1992, P NATL ACAD SCI USA, V89, P7986, DOI 10.1073/pnas.89.17.7986; Harlow E., 1988, ANTIBODIES LABORATOR, P1; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; KNOWLES BH, 1991, P ROY SOC B-BIOL SCI, V245, P31, DOI 10.1098/rspb.1991.0084; KNOWLES BH, 1987, BIOCHIM BIOPHYS ACTA, V924, P509, DOI 10.1016/0304-4165(87)90167-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MERRIL CR, 1980, ANAL BIOCHEM, V105, P361; NILSSON BO, 1987, J IMMUNOL METHODS, V99, P67; ODDOU P, 1991, EUR J BIOCHEM, V188, P209; OLSEN J, 1989, FEBS LETT, V251, P275, DOI 10.1016/0014-5793(89)81470-X; PLAKIDOUDYMOCK S, 1993, BIOCHEM J, V290, P59, DOI 10.1042/bj2900059; PLAKIDOUDYMOCK S, 1993, BIOCHIM BIOPHYS ACTA, V1145, P105, DOI 10.1016/0005-2736(93)90386-E; SACCHI VF, 1986, FEBS LETT, V204, P213, DOI 10.1016/0014-5793(86)80814-6; TAKEDA S, 1993, COMP BIOCHEM PHYS B, V104, P81, DOI 10.1016/0305-0491(93)90341-2; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VADLAMUDI RK, 1993, J BIOL CHEM, V268, P12334; VANRIE J, 1990, SCIENCE, V247, P72, DOI 10.1126/science.2294593; VANRIE J, 1989, EUR J BIOCHEM, V186, P239, DOI 10.1111/j.1432-1033.1989.tb15201.x; VANRIE J, 1990, APPL ENVIRON MICROB, V56, P1378, DOI 10.1128/AEM.56.5.1378-1385.1990; WATT VM, 1989, J BIOL CHEM, V264, P5480; WOLFERSBERGER MG, 1990, EXPERIENTIA, V46, P475, DOI 10.1007/BF01954236; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0	31	254	276	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10088	10092						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144508				2022-12-27	WOS:A1994NE05300103
J	ADELI, K				ADELI, K			REGULATED INTRACELLULAR DEGRADATION OF APOLIPOPROTEIN-B IN SEMIPERMEABLE HEPG2 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; TREATED RAT HEPATOCYTES; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; G2 CELLS; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE; PROTEIN-DEGRADATION; CYSTEINE PROTEASE; HEPATOMA-CELLS; SECRETION	A digitonin-permeabilized HepG2 cell system has been developed and used to characterize the pathway responsible for apolipoprotein B-100 (apoB) degradation. Degradation of S-35-labeled apoB occurred after an initial lag period and resulted in the loss of approximately 75.8% of apoB after 2 h of chase. The degradation rate in permeabilized cells was slower than that in intact cells, but approximately the same percentage of apoB was lost over 2 h of chase. The loss of intact apoB in permeabilized cells coincided with the appearance of a number of degradation fragments, including 335- and 70-kDa fragments. The detection of a 70-kDa fragment was a sensitive indicator of degradation. ApoB degradation was inhibited at temperatures below 37 degrees C and maximally activated at 42 degrees C. Degradation was also pH dependent, with inhibition at pH greater than or equal to 7.5. ApoB decay was stimulated by ATP supplementation but not GTP and was inhibited in the presence of energy inhibitors. Degradation was not significantly affected by cycloheximide. However, the stability of the 70-kDa fragment was prolonged with cycloheximide. Preincubation of cells with brefeldin A and nocodazole, as well as monensin, did not diminish the degradation of intact apoB or the appearance of the 70-kDa fragment, suggesting a lack of requirement for intracellular transport from the endoplasmic reticulum. Among the various protease inhibitors tested, degradation was most sensitive to N-acetylleucylleucylnorleucinal (ALLN), which abolished the generation of the 70-kDa fragment in a dose-dependent manner. ALLN-sensitive degradation of apoB was unaffected by the calcium ionophore, A23187. Interestingly, degradation of unglycosylated apoB, detected in tunicamycin-pretreated cells, occurred earlier, resulted in generation of additional fragments, and was largely uninhibited by ALLN. In summary, apoB degradation occurs in permeabilized HepG2 cells by a temperature- and pH-sensitive, pre-Golgi degradation system and is catalyzed by a calcium-independent, ALLN sensitive protease. Specificity of the initial apoB cleavage may require the proper N-linked glycosylation of the protein in the endoplasmic reticulum.			ADELI, K (corresponding author), UNIV WINDSOR,DEPT CHEM & BIOCHEM,400 SUNSET ST,WINDSOR N9B 3P4,ON,CANADA.			Adeli, Khosrow/0000-0002-5839-5709				ADELI K, 1990, FEBS LETT, V263, P345, DOI 10.1016/0014-5793(90)81410-P; ADELI K, 1992, BIOCHEM CELL BIOL, V70, P1301, DOI 10.1139/o92-177; AMITAY R, 1992, J BIOL CHEM, V267, P20694; BAUER HC, 1985, BIOCHEM BIOPH RES CO, V128, P368, DOI 10.1016/0006-291X(85)91688-2; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; BOREN J, 1990, J BIOL CHEM, V265, P10556; BOREN J, 1992, J BIOL CHEM, V267, P9858; CARTWRIGHT IJ, 1993, J BIOL CHEM, V268, P20937; DASHTI N, 1989, J LIPID RES, V30, P1365; DAVIS RA, 1989, J LIPID RES, V30, P1185; DAVIS RA, 1990, J BIOL CHEM, V265, P10005; DIXON JL, 1991, J BIOL CHEM, V266, P5080; FISKUM G, 1980, P NATL ACAD SCI-BIOL, V77, P3430, DOI 10.1073/pnas.77.6.3430; FURUKAWA S, 1992, J BIOL CHEM, V267, P22630; GAY RJ, 1968, CLIN CHEM, V14, P740; GODA Y, 1989, FASEB J, V3, P2488, DOI 10.1096/fasebj.3.13.2680705; INOUE S, 1992, J BIOL CHEM, V267, P9080; INOUE S, 1991, J BIOL CHEM, V266, P13311; KAPTEIN A, 1991, BIOCHEM J, V278, P557, DOI 10.1042/bj2780557; KATZ J, 1985, J CELL BIOCHEM, V28, P207, DOI 10.1002/jcb.240280304; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LE A, 1990, J BIOL CHEM, V265, P14001; LEONARD DA, 1987, J BIOL CHEM, V262, P7914; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; LUSIS AJ, 1987, J BIOL CHEM, V262, P7594; MEIGS TE, 1992, J BIOL CHEM, V267; Murachi T. M., 1983, CALCIUM CELL FUNCTIO, V4, P377; OLDEN K, 1978, CELL, V13, P461, DOI 10.1016/0092-8674(78)90320-3; OMURA T, 1970, J BIOCHEM-TOKYO, V67, P249, DOI 10.1093/oxfordjournals.jbchem.a129248; PULLINGER CR, 1989, J LIPID RES, V30, P1065; SASKI T, 1990, J ENZYM INHIB, V3, P195; SATO R, 1990, J BIOL CHEM, V265, P11880; SPARKS JD, 1992, J CLIN INVEST, V89, P1418, DOI 10.1172/JCI115731; SPARKS JD, 1990, J BIOL CHEM, V265, P8854; STRUCK DK, 1978, J BIOL CHEM, V255, P5332; SUITAMANGANO P, 1982, J BIOL CHEM, V257, P11463; THERIAULT A, 1992, BIOCHEM BIOPH RES CO, V186, P617, DOI 10.1016/0006-291X(92)90791-I; THRIFT RN, 1992, P NATL ACAD SCI USA, V89, P9161, DOI 10.1073/pnas.89.19.9161; URADE R, 1992, J BIOL CHEM, V267, P15152; WHITE AL, 1992, J BIOL CHEM, V267, P15657; WILKSTROM L, 1992, J BIOL CHEM, V267, P5; YE SQ, 1993, J BIOL CHEM, V268, P8497	44	110	110	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9166	9175						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132654				2022-12-27	WOS:A1994NB41100081
J	FORCE, WR; TILLMAN, JB; SPRUNG, CN; SPINDLER, SR				FORCE, WR; TILLMAN, JB; SPRUNG, CN; SPINDLER, SR			HOMODIMER AND HETERODIMER DNA-BINDING AND TRANSCRIPTIONAL RESPONSIVENESS TO TRIIODOTHYRONINE (T-3) AND 9-CIS-RETINOIC ACID ARE DETERMINED BY THE NUMBER AND ORDER OF HIGH-AFFINITY HALF-SITES IN A T-3 RESPONSE ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; RAT GROWTH-HORMONE; RETINOID-X-RECEPTOR; NUCLEAR RECEPTORS; GENE; PROTEIN; BETA; RXR; 3,5,3'-TRIIODOTHYRONINE; PROMOTER	T-3 (triiodothyronine) response elements (TREs) consist of pairs of strong and weak (S and W), 10-nucleotide Ts receptor (TR) monomer binding sites (half-sites). We report that the number and order of S and W half-sites in a direct repeat TRE determines whether it mediates ligand-dependent or independent transcriptional activation or inhibition in the presence of TR or TR and 9-cis-retinoic acid receptor (RXR); and whether a TRE is preferentially bound by TR homodimers, TR-RXR heterodimers, or CV1 cell TR accessory protein (TRAP)-TR heterodimers. TR homodimers bound equally to TREs composed of the 5'-S and 3'-W (SW) and the opposite (WS) arrangement of half-sites. TR-RXR gamma heterodimers bound SW better than WS. TR-TRAP heterodimers bound WS better than SW. Transcription of a reporter gene cis-linked to WS responded to unliganded TR and RXR, and either ligand stimulated expression 2-fold more. Reporter expression cis-linked to SW was not altered by unliganded receptors, and Ts stimulated transcription only in the presence of both TR and RXR. SS was strongly activated by liganded, but not by unliganded TR. SS was activated by unliganded TR and RXR gamma together, and Ts further stimulated transcription a-fold. Under these conditions, transcription was inhibited 60% by 9-cis-retinoic acid.	UNIV CALIF RIVERSIDE,DEPT BIOCHEM,RIVERSIDE,CA 92521	University of California System; University of California Riverside				Tillman, John/0000-0003-2912-2370	NIDDK NIH HHS [DK40164] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040164] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSSON ML, 1992, NUCLEIC ACIDS RES, V20, P4803, DOI 10.1093/nar/20.18.4803; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BEEBE JS, 1991, MOL ENDOCRINOL, V5, P85, DOI 10.1210/mend-5-1-85; BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116; BRENT GA, 1989, J BIOL CHEM, V264, P178; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; CRONE DE, 1990, J BIOL CHEM, V265, P10851; DARLING DS, 1991, MOL ENDOCRINOL, V5, P73, DOI 10.1210/mend-5-1-73; DARLING DS, 1993, J BIOL CHEM, V268, P10221; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FONDELL JD, 1993, GENE DEV, V7, P1400, DOI 10.1101/gad.7.7b.1400; FORMAN BM, 1990, MOL ENDOCRINOL, V4, P1293, DOI 10.1210/mend-4-9-1293; FORMAN BM, 1992, MOL ENDOCRINOL, V6, P429, DOI 10.1210/me.6.3.429; FORMAN BM, 1988, MOL ENDOCRINOL, V2, P902, DOI 10.1210/mend-2-10-902; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; HERMANN T, 1992, MOL ENDOCRINOL, V6, P1153, DOI 10.1210/me.6.7.1153; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; ING NH, 1992, J BIOL CHEM, V267, P17617; KIM HS, 1992, MOL ENDOCRINOL, V6, P1489, DOI 10.1210/me.6.9.1489; KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KOST TA, 1983, NUCLEIC ACIDS RES, V11, P8287, DOI 10.1093/nar/11.23.8287; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; MADER S, 1993, J BIOL CHEM, V268, P591; MANGELSDORF DJ, 1991, CELL, V66, P555, DOI 10.1016/0092-8674(81)90018-0; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MIYAMOTO T, 1993, MOL ENDOCRINOL, V7, P224, DOI 10.1210/me.7.2.224; MURRAY MB, 1988, J BIOL CHEM, V263, P12770; MURRAY MB, 1989, MOL ENDOCRINOL, V3, P1434, DOI 10.1210/mend-3-9-1434; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; ODONNELL AL, 1991, MOL ENDOCRINOL, V5, P94, DOI 10.1210/mend-5-1-94; PARKER BA, 1979, J VIROL, V31, P360, DOI 10.1128/JVI.31.2.360-369.1979; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; RIBEIRO RC, 1992, MOL ENDOCRINOL, V6, P1142, DOI 10.1210/me.6.7.1142; Sambrook J, 1989, MOL CLONING LABORATO; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; SAP J, 1990, EMBO J, V9, P887, DOI 10.1002/j.1460-2075.1990.tb08186.x; STRAIT KA, 1992, MOL ENDOCRINOL, V6, P1874, DOI 10.1210/me.6.11.1874; TILLMAN JB, 1993, MOL CELL ENDOCRINOL, V95, P101, DOI 10.1016/0303-7207(93)90034-H; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; YEN PM, 1992, J BIOL CHEM, V267, P3565; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	51	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8863	8871						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132622				2022-12-27	WOS:A1994NB41100039
J	GHAZIZADEH, S; BOLEN, JB; FLEIT, HB				GHAZIZADEH, S; BOLEN, JB; FLEIT, HB			PHYSICAL AND FUNCTIONAL ASSOCIATION OF SRC-RELATED PROTEIN-TYROSINE KINASES WITH FC-GAMMA-RII IN MONOCYTIC THP-1 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN RECEPTOR; LYMPHOCYTES-B; CROSS-LINKING; HIGH-AFFINITY; U937 CELLS; IGG FC; ACTIVATION; PHOSPHORYLATION; CD4; HETEROGENEITY	Aggregation of Fc gamma RII (CD 32), a low affinity receptor for immunoglobulin G (IgG), on the monocytic cell line THP-1 induces protein tyrosine kinase (PTK) activity. Several distinct cellular proteins, including Fc gamma RII itself, are phosphorylated on tyrosine following crosslinking of the receptor. Fc gamma RII lacks intrinsic PTK activity. In this report we demonstrate that a kinase activity was coprecipitated with Fc gamma RII in THP-1 cells. The kinetics of the receptor associated kinase activity paralleled the appearance of tyrosine phosphorylation events observed following Fc gamma RII activation of THP-1 cells. Several proteins were associated with the receptor. Reimmunoprecipitation analysis demonstrated that lyn gene products were among the proteins coprecipitated with Fc gamma RII. p59(hck) (Hck) and p56(lyn) (Lyn) were the most abundant Src-related PTKs (Src-PTKs) in THP-1 cells. Enzymatic activity of both kinases, as measured by an in vitro ki nase assay, was increased following specific cross-linking of Fc gamma RII. Furthermore, Fc gamma RII was specifically associated with both enzymes following its engagement and served as a substrate for both of these kinases. The association of Fc gamma RII with Src-PTK was specific for Fc gamma RII activation of THP-1 cells, since activation of cells via the high affinity Fc gamma receptor, Fc gamma RI (CD 64), did not result in association of Fc gamma RII with Hck or Lyn. Our data demonstrate a functional and physical association of Fc gamma RII with lick and Lyn consistent with the involvement of Src-PTK in Fc gamma RII-mediated signal transduction.	SUNY STONY BROOK, DEPT PATHOL, STONY BROOK, NY 11794 USA; BRISTOL MYERS SQUIBB PHARMACEUT RES INST, DEPT MOLEC BIOL, PRINCETON, NJ 08543 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Bristol-Myers Squibb					NCI NIH HHS [CA38055] Funding Source: Medline; NCRR NIH HHS [RR05736] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R23CA038055, R01CA038055] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMIGORENA S, 1992, SCIENCE, V256, P1808, DOI 10.1126/science.1535455; ANDERSON CL, 1990, J EXP MED, V171, P1333, DOI 10.1084/jem.171.4.1333; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; BOLEN JB, 1991, ADV CANCER RES, V57, P103; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BROOKS DG, 1989, J EXP MED, V170, P1369, DOI 10.1084/jem.170.4.1369; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; EISEMAN E, 1990, CANCER CELL-MON REV, V2, P303; EISEMAN E, 1992, NATURE, V355, P78; ERNST LK, 1993, P NATL ACAD SCI USA, V90, P6023, DOI 10.1073/pnas.90.13.6023; GHAZIZADEH S, 1994, J IMMUNOL, V152, P30; HAMADA F, 1993, P NATL ACAD SCI USA, V90, P6305, DOI 10.1073/pnas.90.13.6305; HUANG MM, 1992, J BIOL CHEM, V267, P5467; HUNZIKER W, 1990, NATURE, V345, P628, DOI 10.1038/345628a0; HUTCHCROFT JE, 1992, P NATL ACAD SCI USA, V89, P9107, DOI 10.1073/pnas.89.19.9107; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; INDIK Z, 1991, J CLIN INVEST, V88, P1766, DOI 10.1172/JCI115496; KEEGAN AD, 1992, IMMUNOL TODAY, V13, P63, DOI 10.1016/0167-5699(92)90136-U; KOLANUS W, 1992, EMBO J, V11, P4861, DOI 10.1002/j.1460-2075.1992.tb05592.x; LANIER LL, 1989, NATURE, V342, P803, DOI 10.1038/342803a0; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; LIAO F, 1992, P NATL ACAD SCI USA, V89, P3659, DOI 10.1073/pnas.89.8.3659; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; LOONEY RJ, 1986, J IMMUNOL, V136, P1641; MUSTELIN T, 1990, ONCOGENE, V5, P809; ODIN JA, 1991, SCIENCE, V254, P1785, DOI 10.1126/science.1837175; RANKIN BM, 1993, J IMMUNOL, V150, P605; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RIGLEY KP, 1989, EUR J IMMUNOL, V19, P481, DOI 10.1002/eji.1830190311; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SALCEDO TW, 1993, J EXP MED, V177, P1475, DOI 10.1084/jem.177.5.1475; SAMELSON LE, 1992, J BIOL CHEM, V267, P24913; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SCHOLL PR, 1992, J IMMUNOL, V149, P1751; UNKELESS JC, 1988, ANNU REV IMMUNOL, V6, P251, DOI 10.1146/annurev.iy.06.040188.001343; VANDEWINKEL JGJ, 1993, IMMUNOL TODAY, V14, P215, DOI 10.1016/0167-5699(93)90166-I; VANDEWINKEL JGJ, 1991, J LEUKOCYTE BIOL, V49, P511, DOI 10.1002/jlb.49.5.511; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; YAMANASHI Y, 1991, CELL REGUL, V2, P979, DOI 10.1091/mbc.2.12.979; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	43	162	204	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8878	8884						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132624				2022-12-27	WOS:A1994NB41100041
J	JOHNSON, JD; NAKKULA, RJ; VASULKA, C; SMILLIE, LB				JOHNSON, JD; NAKKULA, RJ; VASULKA, C; SMILLIE, LB			MODULATION OF CA2+ EXCHANGE WITH THE CA2+-SPECIFIC REGULATORY SITES OF TROPONIN-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE STOPPED-FLOW; MAGNESIUM BINDING; CALCIUM; PROBE; DANSYLAZIRIDINE; CALMODULIN; RESOLUTION; AFFINITY	Calcium (Ca2+) binding to the N-terminal Ca2+-specific sites on troponin C (TnC) regulate the contraction-relaxation cycle of skeletal muscle. A mutant TnC (F29W) and dansylaziridine-labeled TnC undergo large fluorescence increases when Ca2+ binds to their Ca2+-specific sites (half-maximal at pCa 5.8). calmidazolium and the additional mutation of Met-82 to Gln (F29W,M82Q) increased Ca2+ affinity at these Ca2+ sites by similar to 4-fold (half-maximal at pCa similar to 6.4). Calmidazolium and the M82Q mutation decreased the rate of Ca2+ dissociation from the Ca2+-specific sites similar to 3.4-fold (from similar to 462 +/- 84/s to similar to 138 +/- 30/s) at 22 degrees C. Ca2+ associated with the Ca2+-specific sites of these proteins at 1-2 x 10(8) M(-1) s(-1) at 4 degrees C. These drug- and mutation-induced increases in Ca2+ affinity occur solely from large decreases in the Ca2+ off-rate without an effect on the Ca2+ on rate. Thus, Ca2+ can bind to the Ca2+-specific sites of TnC as rapidly as it can diffuse to the protein, consistent with the extreme speed of skeletal muscle contraction. Drugs and/or site-directed mutagenesis can modify the Ca2+ sensitivity and the rate of Ca2+ exchange with TnC's Ca2+-specific sites to perhaps alter the rate of relaxation and/or the rate of rise of tension.	UNIV ALBERTA,DEPT BIOCHEM,MED RES COUNCIL,PROT STRUCT & FUNCT GRP,EDMONTON T6G 2H7,AB,CANADA	University of Alberta	JOHNSON, JD (corresponding author), OHIO STATE UNIV,MED CTR,DEPT MED BIOCHEM,333 HAMILTON HALL,1645 NEIL AVE,COLUMBUS,OH 43210, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033727] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK33727] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAYLEY P, 1984, BIOCHEM BIOPH RES CO, V120, P185, DOI 10.1016/0006-291X(84)91431-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLOSE R, 1965, J PHYSIOL-LONDON, V180, P542, DOI 10.1113/jphysiol.1965.sp007716; ELSALEH SC, 1987, J BIOL CHEM, V262, P17240; GRABAREK Z, 1992, J MUSCLE RES CELL M, V13, P383, DOI 10.1007/BF01738034; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; IIO T, 1981, J BIOCHEM-TOKYO, V90, P163, DOI 10.1093/oxfordjournals.jbchem.a133446; IIO T, 1980, J BIOCHEM-TOKYO, V88, P547, DOI 10.1093/oxfordjournals.jbchem.a133002; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; JOHNSON JD, 1979, J BIOL CHEM, V254, P3497; JOHNSON JD, 1978, J BIOL CHEM, V253, P6451; JOHNSON JD, 1978, J BIOL CHEM, V253, P3775; KASTURI R, 1993, J BIOL CHEM, V268, P7958; LEAVIS PC, 1984, CRC CR REV BIOCH MOL, V16, P235, DOI 10.3109/10409238409108717; PEARLSTONE JR, 1992, BIOCHEMISTRY-US, V31, P6545, DOI 10.1021/bi00143a026; Potter J. D., 1981, REGULATION MUSCLE CO, P241; POTTER JD, 1975, J BIOL CHEM, V250, P4628; ROSENFELD SS, 1985, J BIOL CHEM, V260, P242; SATYSHUR KA, 1988, J BIOL CHEM, V263, P1628; SOLARO RJ, 1986, J PHARMACOL EXP THER, V238, P502; TRIGOGONZALEZ G, 1992, BIOCHEMISTRY-US, V31, P7009, DOI 10.1021/bi00146a001; WAHR PA, 1993, BIOPHYS J, V64, pA24	23	55	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8919	8923						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132628				2022-12-27	WOS:A1994NB41100046
J	KAISER, P; SEUFERT, W; HOFFERER, L; KOFLER, B; SACHSENMAIER, C; HERZOG, H; JENTSCH, S; SCHWEIGER, M; SCHNEIDER, R				KAISER, P; SEUFERT, W; HOFFERER, L; KOFLER, B; SACHSENMAIER, C; HERZOG, H; JENTSCH, S; SCHWEIGER, M; SCHNEIDER, R			A HUMAN UBIQUITIN-CONJUGATING ENZYME HOMOLOGOUS TO YEAST UBC8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPAIR GENE RAD6; SACCHAROMYCES-CEREVISIAE; CARRIER PROTEIN; CELL-CYCLE; DNA; EXPRESSION; RECEPTOR; CLONING; DEGRADATION; HISTONES	Ubiquitin-conjugating enzymes catalyze the covalent attachment of ubiquitin to cellular substrates. Here we describe the isolation of a novel ubiquitin-conjugating enzyme from human placenta and the cloning of the corresponding cDNA. DNA sequencing revealed that this gene, UbcH2, encodes a protein with significant sequence similarity to yeast UBC8. In contrast to a previous report (Qin, S., Nakajima, B., Nomura, M., and Arfin, S.M. (1991) J. Biol. Chem. 266, 15549-15554), we discovered that UBC8 is interrupted by a single intron bearing an unusual branch point sequence. The revised amino acid sequence of yeast UBC8 exhibits 54% amino acid sequence identity to human UbcH2. Moreover, full-length UbcH2 and UBC8 enzymes expressed from their cDNAs show similar enzymatic activities in vitro by catalyzing the ubiquitination of histones, suggesting that the two enzymes may fulfill similar functions in vivo. Interestingly, comparison of the enzymatic activities of a truncated UBC8 (Qin, S., Nakajima, B., Nomura, M. and Arfin, S.M. (1991) J. Biol. Chem. 266, 15549-15554) and of the full-length enzyme (this report) suggests, that the first 12 amino-terminal residues of UBC8 are required for ubiquitination of histones in vitro but not for thiolester formation with ubiquitin. This suggests that the NH, terminus of UBC8 may be necessary either for substrate recognition or for the transfer of ubiquitin onto substrates. The UbcH2 gene is located on chromosome 7 and shows a complex expression pattern with at least five different mRNAs.	UNIV INNSBRUCK, INST BIOCHEM, A-6020 INNSBRUCK, AUSTRIA; MAX PLANCK GESELL, FRIEDRICH MIESCHER LAB, D-72076 TUBINGEN, GERMANY	University of Innsbruck; Eberhard Karls University of Tubingen; Max Planck Society			Herzog, Herbert/B-8294-2008; Seufert, Wolfgang/F-7136-2019	Seufert, Wolfgang/0000-0001-8938-9064; Kofler, Barbara/0000-0002-1198-4776				BALL E, 1987, CELL, V51, P221, DOI 10.1016/0092-8674(87)90149-8; BERGHAMMER H, 1993, BIOTECHNIQUES, V14, P522; DABEVA MD, 1986, P NATL ACAD SCI USA, V83, P5854, DOI 10.1073/pnas.83.16.5854; ENGEBRECHT J, 1991, CELL, V66, P1257, DOI 10.1016/0092-8674(91)90047-3; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; GOLDKNOPF IL, 1975, BIOCHEM BIOPH RES CO, V65, P951, DOI 10.1016/S0006-291X(75)80478-5; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; Harris E.L.-V., 1990, PROTEIN PURIFICATION; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; HOLTKE HJ, 1992, BIOTECHNIQUES, V12, P104; HOLTKE HJ, 1990, NUCLEIC ACIDS RES, V18, P5843, DOI 10.1093/nar/18.19.5843; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; KAISER P, 1992, MOL GEN GENET, V232, P231, DOI 10.1007/BF00280001; KOKEN MHM, 1991, P NATL ACAD SCI USA, V88, P8865, DOI 10.1073/pnas.88.20.8865; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; MUELLER RD, 1985, J BIOL CHEM, V260, P5147; NISHIZAWA M, 1992, EMBO J, V11, P2433, DOI 10.1002/j.1460-2075.1992.tb05308.x; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; QIN S, 1991, J BIOL CHEM, V266, P15549; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHNEIDER R, 1990, EMBO J, V9, P1431, DOI 10.1002/j.1460-2075.1990.tb08259.x; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SIEGELMAN M, 1986, SCIENCE, V231, P823, DOI 10.1126/science.3003913; STJOHN T, 1986, SCIENCE, V231, P845, DOI 10.1126/science.3003914; SULLIVAN ML, 1989, P NATL ACAD SCI USA, V86, P9861, DOI 10.1073/pnas.86.24.9861; SUNG P, 1988, GENE DEV, V2, P1476, DOI 10.1101/gad.2.11.1476; WATKINS JF, 1993, GENE DEV, V7, P250, DOI 10.1101/gad.7.2.250; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	35	58	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8797	8802						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132613				2022-12-27	WOS:A1994NB41100030
J	LIU, QJ; HUANG, SS; HUANG, JS				LIU, QJ; HUANG, SS; HUANG, JS			KINASE-ACTIVITY OF THE TYPE-V TRANSFORMING GROWTH-FACTOR-BETA RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT RECEPTOR; TGF-BETA; PROTEIN-KINASES; COMPLETE SEQUENCE; BOVINE LIVER; CELLS; CASEIN; PHOSPHORYLATION; IDENTIFICATION; INHIBITORS	The type V TGF-beta receptor purified from bovine liver plasma membranes catalyzed the phosphorylation of casein using [gamma-P-32]ATP as co-substrate (K-m,K-app similar to 10 mu M). TGF-beta stimulated the casein phosphorylation by the type V receptor with a half-optimal concentration of similar to 0.3 NM. Both TGF-beta-stimulated and -unstimulated phosphorylations occurred at serine residues. Amino acid sequences of P-32-labeled peptides from reverse phase HPLC of the tryptic digests of casein P-32-phosphorylated by the type V receptor were analyzed by automated Edman degradation. Alignment of phosphorylation site amino acid sequences of the P-32-labeled peptides revealed a recognition motif (S-X-E/S(P)) for the kinase activity of the type V receptor. The type V receptor catalyzed the phosphorylation of an octadecapeptide designated peptide SESTE (SKDIGS*ES*TEDQAMEDKK)) (the asterisk indicates the phosphorylated residue) containing the major phosphorylation site sequence of casein. The K-m,K-app and V-max for peptide SESTE were determined to be 0.3 mu M and 2.2 nmol of P-32 incorporation/min/mg of enzyme, respectively. The phosphorylation of peptide SESTE by the type V receptor was stimulated by TGF-beta or polylysine but inhibited by heparin. Like intact casein, peptide SESTE was phosphorylated at 2 close serine residues (-S*-E-S*-T-E-) by the type V receptor. The type V receptor also phosphorylated a variant of peptide SESTE, peptide AESTE (SKDIGAES*TEDQAMEDKK). However, the type V receptor appeared not to phosphorylate peptide SEATE (SKDIGSEATEDQAMEDKK) in which an alanine residue replaced 1 of the 2 close serine residues (at the C-terminal side) of peptide SESTE. These results suggest that the type V receptor is capable of exerting interdependent phosphorylation.	ST LOUIS UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOL, ST LOUIS, MO 63104 USA	Saint Louis University					NCI NIH HHS [CA 38808] Funding Source: Medline; NHLBI NIH HHS [HL 41782] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA038808] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041782] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRIGNON G, 1977, FEBS LETT, V76, P274, DOI 10.1016/0014-5793(77)80167-1; CHEIFETZ S, 1988, J BIOL CHEM, V263, P16984; CHEIFETZ S, 1988, J BIOL CHEM, V263, P17225; CHEIFETZ S, 1986, J BIOL CHEM, V261, P9972; CHEN RH, 1993, SCIENCE, V260, P1335, DOI 10.1126/science.8388126; FROLIK CA, 1984, J BIOL CHEM, V259, P995; FUJITAYAMAGUCHI Y, 1988, BIOCHEM BIOPH RES CO, V157, P955, DOI 10.1016/S0006-291X(88)80967-7; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HATHAWAY GM, 1982, CURR TOP CELL REGUL, V21, P101; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KIMCHI A, 1988, SCIENCE, V240, P196, DOI 10.1126/science.2895499; KUO MD, 1990, J BIOL CHEM, V265, P16455; LAIHO M, 1991, J BIOL CHEM, V266, P9108; MARSHAK DR, 1991, METHOD ENZYMOL, V200, P134; MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MERCIER JC, 1971, EUR J BIOCHEM, V23, P41, DOI 10.1111/j.1432-1033.1971.tb01590.x; MERCIER JC, 1973, EUR J BIOCHEM, V35, P222, DOI 10.1111/j.1432-1033.1973.tb02829.x; MITCHELL EJ, 1992, MOL BIOL CELL, V3, P1295, DOI 10.1091/mbc.3.11.1295; ODA Y, 1993, J BIOL CHEM, V268, P27318; OGRADY P, 1992, J BIOL CHEM, V267, P21033; OGRADY P, 1991, J BIOL CHEM, V266, P8583; OGRADY P, 1991, BIOCHEM BIOPH RES CO, V179, P378, DOI 10.1016/0006-291X(91)91381-L; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Ribadeau Dumas B., 1972, European Journal of Biochemistry, V25, P505, DOI 10.1111/j.1432-1033.1972.tb01722.x; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Roberts AB, 1990, PEPTIDE GROWTH FACTO, P419; SEGARINI PR, 1988, J BIOL CHEM, V263, P8366; SEGARINI PR, 1992, J BIOL CHEM, V267, P1048; STONE KL, 1988, TECHNIQUES PROTEIN C, P377; WANG YH, 1988, ANAL BIOCHEM, V174, P537, DOI 10.1016/0003-2697(88)90053-X	32	15	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9221	9226						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132659				2022-12-27	WOS:A1994NB41100088
J	NORRIS, FA; MAJERUS, PW				NORRIS, FA; MAJERUS, PW			HYDROLYSIS OF PHOSPHATIDYLINOSITOL 3,4-BISPHOSPHATE BY INOSITOL POLYPHOSPHATE 4-PHOSPHATASE ISOLATED BY AFFINITY ELUTION CHROMATOGRAPHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL TRANSDUCTION; HUMAN PLATELETS; PHOSPHOINOSITIDE 3-KINASE; ACTIVATED NEUTROPHILS; BOVINE BRAIN; RAT-LIVER; PATHWAY; 3-PHOSPHATE; THROMBIN; PDGF	Inositol polyphosphate 4-phosphatase is a monomeric 110-kDa protein that hydrolyzes two substrates in the inositol phosphate pathway. Inositol 3,4-bisphosphate is converted to inositol 3-phosphate, and inositol 1,3,4-trisphosphate is converted to inositol 1,3-bisphosphate. We have exploited the fact that inositol hexasulfate inhibits the enzyme to devise an affinity elution scheme from a Mono S cation exchange column that resulted in an 11,300-fold purified preparation of rat brain 4-phosphatase, The resulting 4-phosphatase hydrolyzed phosphatidylinositol 3,4-bisphosphate to phosphatidylinositol 3-phosphate with a first order rate constant 120-fold greater than that for inositol 3,4 bisphosphate and 900-fold greater than that for inositol 1,3,4-trisphosphate. This is now the third example wherein the same enzyme hyrolyzes both an inositol lipid and its analogous inositol phosphate.	WASHINGTON UNIV,SCH MED,DEPT BIOL CHEM,DIV HEMATOL ONCOL,ST LOUIS,MO 63110	Washington University (WUSTL)	NORRIS, FA (corresponding author), WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,DIV HEMATOL ONCOL,ST LOUIS,MO 63110, USA.				NHGRI NIH HHS [HG 00304] Funding Source: Medline; NHLBI NIH HHS [HL 14147, HL 16634] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016634, P50HL014147, R01HL016634] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000304] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AMES BN, 1960, J BIOL CHEM, V235, P769; BANSAL VS, 1990, J BIOL CHEM, V265, P1806; BANSAL VS, 1987, J BIOL CHEM, V262, P9444; BREARLEY CA, 1993, BIOCHEM J, V290, P145, DOI 10.1042/bj2900145; CALDWELL KK, 1991, J BIOL CHEM, V266, P18378; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; COUGHLIN SR, 1989, SCIENCE, V243, P1191; CUNNINGHAM TW, 1990, J BIOL CHEM, V265, P21676; CUNNINGHAM TW, 1991, BIOCHEM BIOPH RES CO, V175, P568, DOI 10.1016/0006-291X(91)91603-A; DOWNES CP, 1991, CELL SIGNAL, V3, P501, DOI 10.1016/0898-6568(91)90027-R; ESCOBEDO JA, 1988, NATURE, V335, P85, DOI 10.1038/335085a0; GAUDETTE DC, 1993, J BIOL CHEM, V268, P13773; KUCERA GL, 1990, J BIOL CHEM, V265, P5345; LIPS DL, 1989, J BIOL CHEM, V264, P19911; LIPS DL, 1989, J BIOL CHEM, V264, P8759; MARECEK JF, 1991, TETRAHEDRON LETT, V32, P1863, DOI 10.1016/S0040-4039(00)85982-1; MATZARIS M, 1994, J BIOL CHEM, V269, P3397; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NOLAN RD, 1990, J BIOL CHEM, V265, P2441; PITTET D, 1989, J BIOL CHEM, V264, P18489; SCOPES RK, 1977, BIOCHEM J, V161, P253, DOI 10.1042/bj1610253; SERUNIAN LA, 1989, J BIOL CHEM, V264, P17809; SERUNIAN LA, 1990, J VIROL, V64, P4718, DOI 10.1128/JVI.64.10.4718-4725.1990; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; SULTAN C, 1991, J BIOL CHEM, V266, P23554; TRAYNORKAPLAN AE, 1988, NATURE, V334, P353, DOI 10.1038/334353a0; von der Haar F, 1974, Methods Enzymol, V34, P163; YAMAMOTO K, 1990, J BIOL CHEM, V265, P22086; YORK JD, 1990, P NATL ACAD SCI USA, V87, P9548, DOI 10.1073/pnas.87.24.9548	30	70	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8716	8720						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132601				2022-12-27	WOS:A1994NB41100018
J	SCHNEIDER, A; OPPLIGER, W; JENO, P				SCHNEIDER, A; OPPLIGER, W; JENO, P			PURIFIED INNER MEMBRANE PROTEASE-I OF YEAST MITOCHONDRIA IS A HETERODIMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MICROSOMAL SIGNAL PEPTIDASE; COLI LEADER PEPTIDASE; ESCHERICHIA-COLI; PURIFICATION	Inner membrane protease I is bound to the outer face of the yeast mitochondrial inner membrane and mediates the proteolytic maturation of cytochrome b(2) and cytochrome oxidase subunit II. We have previously shown that one of its subunits is a 21.4-kDa integral membrane protein encoded by the nuclear IMP1 gene. We have now purified the active protease approximately 300-fold from yeast mitochondria. It has an apparent molecular weight of 35,000 and contains not only Imp1p but also a previously unrecognized 19-kDa subunit. Partial amino acid sequencing identifies this subunit as the product of the recently described IMP2 gene (Nunnari, J., Fox, T., and Walter, P. (1993) Science 262, 1997-2004).			SCHNEIDER, A (corresponding author), UNIV BASEL,BIOZENTRUM,CH-4056 BASEL,SWITZERLAND.							BAKER RK, 1987, BIOCHEMISTRY-US, V26, P8561, DOI 10.1021/bi00400a010; BEHRENS M, 1991, MOL GEN GENET, V228, P167, DOI 10.1007/BF00282462; DETERS D, 1976, ANAL BIOCHEM, V70, P263, DOI 10.1016/S0003-2697(76)80067-X; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; GREENBURG G, 1989, J BIOL CHEM, V264, P15762; HALPIN C, 1989, EMBO J, V8, P3917, DOI 10.1002/j.1460-2075.1989.tb08572.x; HARLOW E, 1988, ANTIBODIES LABORATOR; HORST M, 1993, EMBO J, V12, P3035, DOI 10.1002/j.1460-2075.1993.tb05972.x; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; SCHNEIDER A, 1991, EMBO J, V10, P247, DOI 10.1002/j.1460-2075.1991.tb07944.x; VANDIJL JM, 1992, EMBO J, V11, P2819, DOI 10.1002/j.1460-2075.1992.tb05349.x; VANDIJL JM, 1990, MOL GEN GENET, V223, P233, DOI 10.1007/BF00265059; VERNER K, 1988, SCIENCE, V241, P1307, DOI 10.1126/science.2842866; ZWIZINSKI C, 1980, J BIOL CHEM, V255, P7973	14	29	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8635	8638						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132591				2022-12-27	WOS:A1994NB41100004
J	SINE, SM; QUIRAM, P; PAPANIKOLAOU, F; KREIENKAMP, HJ; TAYLOR, P				SINE, SM; QUIRAM, P; PAPANIKOLAOU, F; KREIENKAMP, HJ; TAYLOR, P			CONSERVED TYROSINES IN THE ALPHA-SUBUNIT OF THE NICOTINIC ACETYLCHOLINE-RECEPTOR STABILIZE QUATERNARY AMMONIUM GROUPS OF AGONISTS AND CURARIFORM ANTAGONISTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN BC3H-1 CELLS; BINDING-SITE; DELTA-SUBUNIT; CHOLINERGIC RECEPTOR; MOUSE FIBROBLASTS; MUSCLE-CELLS; AMINO-ACIDS; ACTIVATION; LIGAND; MUTAGENESIS	Studies with site directed labeling reagents have identified residues near the ligand binding pocket of the nicotinic acetylcholine receptor. Among these residues are three conserved tyrosines, Tyr-93, Tyr-190, and Tyr-198 of the alpha subunit. Previous studies combined mutagenesis, expression in Xenopus oocytes, and dose-response analysis to examine contributions of these tyrosines to agonist affinity. In this study, we prepared a series of mutants at each position, expressed them in 293 HEK cells, and studied binding of agonists and antagonists to mutant receptors on intact cells. We show that all three tyrosines contribute to binding of agonists, and that each tyrosine contributes roughly equally to the binding energy. Although the contributions are roughly equivalent, the nature of the contribution is not equivalent at each position. For Tyr-93 and Tyr-190 the aromatic hydroxyl is essential, whereas for Tyr-198 aromaticity of the side chain is essential. Nearly identical results were obtained for the elementary quaternary ligand tetramethylammonium, indicating that these tyrosines contribute to stabilization of the quaternary ammonium portion of agonist. Tyr-190 and Tyr-198 also contribute to binding of the competitive antagonist dimethyl-d-tubocurarine; the side chain specificity for binding supports tyrosine interactions with one of two quaternary ammonium groups in dimethyl-d-tubocurarine. Y190F, in addition to altering binding affinity, also affects the equilibrium between activatable and desensitized receptor states.	UNIV CALIF SAN DIEGO, DEPT PHARMACOL, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego	SINE, SM (corresponding author), MAYO CLIN & MAYO FDN, DEPT PHYSIOL, RECEPTOR BIOL LAB, ROCHESTER, MN 55905 USA.			Kreienkamp, Hans-Jurgen/0000-0002-8871-9970	NIGMS NIH HHS [GM 24437] Funding Source: Medline; NINDS NIH HHS [NS 31744] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031744, R01NS031744] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMSON SN, 1989, J BIOL CHEM, V264, P12666; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; COHEN JB, 1991, J BIOL CHEM, V266, P23354; CZAJKOWSKI C, 1991, J BIOL CHEM, V266, P22603; CZAJKOWSKI C, 1993, P NATL ACAD SCI USA, V90, P6285, DOI 10.1073/pnas.90.13.6285; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; DILGER J, 1992, BIOPHYS J, V57, P723; DILGER JP, 1992, PFLUG ARCH EUR J PHY, V420, P479, DOI 10.1007/BF00374622; FRANKE C, 1993, BIOPHYS J, V64, P339, DOI 10.1016/S0006-3495(93)81374-2; GALZI JL, 1991, FEBS LETT, V294, P198, DOI 10.1016/0014-5793(91)80668-S; GALZI JL, 1990, J BIOL CHEM, V265, P10430; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; PAULING P, 1973, CHEM-BIOL INTERACT, V6, P351, DOI 10.1016/0009-2797(73)90056-2; PEDERSEN SE, 1990, P NATL ACAD SCI USA, V87, P2785, DOI 10.1073/pnas.87.7.2785; SINE S, 1979, J BIOL CHEM, V254, P3315; SINE SM, 1987, J PHYSIOL-LONDON, V385, P325, DOI 10.1113/jphysiol.1987.sp016496; SINE SM, 1982, J BIOL CHEM, V257, P8106; SINE SM, 1991, J BIOL CHEM, V266, P19369; SINE SM, 1986, J PHYSIOL-LONDON, V373, P129, DOI 10.1113/jphysiol.1986.sp016039; SINE SM, 1984, BIOPHYS J, V46, P277, DOI 10.1016/S0006-3495(84)84022-9; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; SINE SM, 1990, J GEN PHYSIOL, V96, P395, DOI 10.1085/jgp.96.2.395; SINE SM, 1991, J BIOL CHEM, V266, P13679; SINE SM, 1988, J BIOL CHEM, V263, P18052; SINE SM, 1981, J BIOL CHEM, V256, P6692; SUSSMAN JL, 1992, MULTIDISCIPLINARY APPROACHES TO CHOLINESTERASE FUNCTIONS, P95; TOMASELLI GF, 1991, BIOPHYS J, V60, P721, DOI 10.1016/S0006-3495(91)82102-6; WEILAND G, 1977, J BIOL CHEM, V252, P7648	30	128	128	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8808	8816						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132615				2022-12-27	WOS:A1994NB41100032
J	WAGNER, ACC; WISHART, MJ; MULDERS, SM; BLEVINS, PM; ANDREWS, PC; LOWE, AW; WILLIAMS, JA				WAGNER, ACC; WISHART, MJ; MULDERS, SM; BLEVINS, PM; ANDREWS, PC; LOWE, AW; WILLIAMS, JA			GP-3, A NEWLY CHARACTERIZED GLYCOPROTEIN ON THE INNER SURFACE OF THE ZYMOGEN GRANULE MEMBRANE, UNDERGOES REGULATED SECRETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PANCREATIC LIPASE; ELECTROPHORETIC TRANSFER; TRITON X-114; ATP-DIPHOSPHOHYDROLASE; NITROCELLULOSE SHEETS; POLYACRYLAMIDE GELS; MAJOR GLYCOPROTEIN; PHASE-SEPARATION; PHOSPHOLIPASE-C; RAT PANCREAS	We have recently reported the cloning of the rat zymogen granule membrane glycoprotein GP-3 and the related pancreatic secretory lipase (Wishart, M. J., Andrews, P. C., Nichols, R., Blevins, G. T., Logsdon, C. D., and Williams, J. A (1993) J. Biol. Chem. 268, 10303-10311). Specific antipeptide antibodies were generated against both GP-3 and secretory lipase and used for the biochemical and physiological characterization of GP-3. Western blotting confirmed that GP-3 was found exclusively in zymogen granule membranes and was absent from zymogen granule content which contains the majority of secretory lipase. Extraction of zymogen granule membranes with Triton X-114 showed GP-3 to be significantly more hydrophobic than lipase. The GP-3 amino acid sequence contains one potential N-linked glycosylation site at Asn-336. The loss of concanavalin A labeling after both chemical deglycosylation with trifluoromethanesulfonic acid and enzymatic deglycosylation with N-glycanase showed GP-3 to possess a small N-linked oligosaccharide side chain. Digestion of intact and permeabilized zymogen granules with the nonspecific protease Pronase localized GP-3 to the inner surface of zymogen granule membranes. Since GP-3 is resident on the inner surface of the zymogen granule membrane, it should appear on the outer cellular surface after exocytosis. Although membrane attachment of GP-3 was resistant to treatment with phosphatidylinositol-specific phospholipase C, we observed that GP-3 is released into the pancreatic juice and that secretion of GP-3 was greatly enhanced by cholecystokinin.	UNIV MICHIGAN, DEPT PHYSIOL, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT INTERNAL MED, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT BIOCHEM, ANN ARBOR, MI 48109 USA; STANFORD UNIV, DEPT MED, STANFORD, CA 94305 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University				Andrews, Philip/0000-0001-6843-5420; Williams, John/0000-0002-6063-7615	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R01DK043294, R01DK045722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER; NIDDK NIH HHS [P-30-DK-34933, DK 45722] Funding Source: Medline; NIGMS NIH HHS [5T32-GM08322] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEAUDOIN AR, 1983, EUR J CELL BIOL, V29, P218; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BURNHAM DB, 1985, BIOCHEM J, V227, P743, DOI 10.1042/bj2270743; CHOW M, 1992, Current Opinion in Cell Biology, V4, P629, DOI 10.1016/0955-0674(92)90082-N; COYNE KE, 1993, J BIOL CHEM, V268, P6689; DELISLE RC, 1984, AM J PHYSIOL, V246, pG411, DOI 10.1152/ajpgi.1984.246.4.G411; ERICKSON PF, 1982, J IMMUNOL METHODS, V51, P241, DOI 10.1016/0022-1759(82)90263-0; FERGUSON MAJ, 1992, BIOCHEM J, V284, P297, DOI 10.1042/bj2840297; FUKUOKA SI, 1992, P NATL ACAD SCI USA, V89, P1189, DOI 10.1073/pnas.89.4.1189; FUKUOKA SI, 1991, P NATL ACAD SCI USA, V88, P2898, DOI 10.1073/pnas.88.7.2898; FUKUOKA SI, 1990, NUCLEIC ACIDS RES, V18, P5900, DOI 10.1093/nar/18.19.5900; GILLER T, 1992, J BIOL CHEM, V267, P16509; GORDON JI, 1991, J BIOL CHEM, V266, P8647; GRUSBY MJ, 1990, CELL, V60, P451, DOI 10.1016/0092-8674(90)90596-7; HAVINGA JR, 1985, EUR J CELL BIOL, V39, P70; HOOPS TC, 1991, J BIOL CHEM, V266, P4257; HORVATH E, 1989, J NEUROSCI RES, V24, P398, DOI 10.1002/jnr.490240309; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBEL D, 1984, BIOCHIM BIOPHYS ACTA, V769, P611, DOI 10.1016/0005-2736(84)90060-9; LEBEL D, 1988, BIOCHEM BIOPH RES CO, V154, P818, DOI 10.1016/0006-291X(88)90213-6; LEBEL D, 1980, J BIOL CHEM, V255, P1227; MALTESE WA, 1990, FASEB J, V4, P3319, DOI 10.1096/fasebj.4.15.2123808; MARIDONNEAUPARINI I, 1992, J BIOL CHEM, V267, P6396; PAQUET MR, 1982, EUR J CELL BIOL, V28, P20; POSNETT DN, 1989, METHOD ENZYMOL, V178, P739; PRYDE JG, 1986, BIOCHEM J, V233, P525, DOI 10.1042/bj2330525; PRYDE JG, 1986, TRENDS BIOCHEM SCI, V11, P160, DOI 10.1016/0968-0004(86)90132-5; PUTNAM WS, 1989, AM J PHYSIOL, V256, pG698, DOI 10.1152/ajpgi.1989.256.4.G698; RINDLER MJ, 1990, EUR J CELL BIOL, V53, P154; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; RONZIO RA, 1978, BIOCHIM BIOPHYS ACTA, V508, P65, DOI 10.1016/0005-2736(78)90189-X; RUCKER RB, 1993, J NUTR, V123, P977; SCHAFER WR, 1992, ANNU REV GENET, V26, P209, DOI 10.1146/annurev.ge.26.120192.001233; Scheele George A., 1993, P121; SPICER SS, 1992, J HISTOCHEM CYTOCHEM, V40, P1, DOI 10.1177/40.1.1370305; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAGNER ACC, 1992, AM J PHYSIOL, V263, pC1172, DOI 10.1152/ajpcell.1992.263.6.C1172; WANG K, 1989, METHOD ENZYMOL, V172, P687, DOI 10.1016/S0076-6879(89)72038-3; Williams John A., 1993, P167; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; WISHART MJ, 1993, J BIOL CHEM, V268, P10303	42	46	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9099	9104						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132647				2022-12-27	WOS:A1994NB41100073
J	WANG, YB; HAHN, TM; TSAI, SY; WOO, SLC				WANG, YB; HAHN, TM; TSAI, SY; WOO, SLC			FUNCTIONAL-CHARACTERIZATION OF A UNIQUE LIVER GENE PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PHENYLALANINE-HYDROXYLASE; TISSUE-SPECIFIC EXPRESSION; SERINE DEHYDRATASE GENE; NUCLEAR FACTOR-IV; HUMAN ALPHA-1-ANTITRYPSIN GENE; DNA-BINDING PROTEINS; NUCLEOTIDE-SEQUENCE; MESSENGER-RNA; RAT-LIVER; CHLORAMPHENICOL ACETYLTRANSFERASE	Human phenylalanine hydroxylase (PAH) is specifically expressed in the liver to convert L phenylalanine to L-tyrosine. Deficiency of the PAH enzyme causes classic phenylketonuria, a common genetic disorder. The human PAH gene has a TATA-less promoter with multiple transcriptional initiation sites. A 9-kilobase DNA fragment 5'-flanking to the human BAH gene is sufficient to confer tissue- and developmental stage-specific expression of a reporter gene in transgenic mice. Deletion studies showed that the -121-base pair proximal promoter still retained a significant level of activity in hepatic cells. At least two protein binding sites, PAH-A and PAH-B, were identified in the proximal region of the human PAH promoter using rat liver nuclear extract. The PAH-A site covers a unique palindromic sequence, and the PAH-B site contains CCCTCCC repeats. Both elements are ubiquitous and essential regulatory elements for transcriptional activity. Nuclear protein factors that bind to the PAH-A and -B sites are detected in different cell types and are distinct from previously characterized transcription factors. No tissue-specific transcription factor binding sites have been detected within the proximal promoter region of the human PAH gene. These results suggest that the BAH gene promoter has a unique organization of regulatory elements for its tissue-specific expression in comparison with other liver gene promoters.	BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine				Wang, Yibin/0000-0003-0852-0767	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD017711, R01HD017711] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-17711] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; AZIZKHAN JC, 1986, BIOCHEMISTRY-US, V25, P6228, DOI 10.1021/bi00368a059; BALKE MC, 1990, MOL CELL BIOL, V10, P6632; BLASBAND AJ, 1990, MOL CELL BIOL, V10, P2111, DOI 10.1128/MCB.10.5.2111; BOAM DSW, 1989, BIOCHEM J, V264, P233, DOI 10.1042/bj2640233; BROOKS AR, 1991, J BIOL CHEM, V266, P7848; CHOW BKC, 1991, J BIOL CHEM, V266, P18927; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; CITRON BA, 1992, P NATL ACAD SCI USA, V89, P1181; CLEVIDENCE DE, 1993, P NATL ACAD SCI USA, V90, P3948, DOI 10.1073/pnas.90.9.3948; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; COSTA RH, 1991, NUCLEIC ACIDS RES, V19, P4139, DOI 10.1093/nar/19.15.4139; COSTA RH, 1988, MOL CELL BIOL, V8, P81, DOI 10.1128/MCB.8.1.81; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; DESIMONE V, 1992, BIOCHIM BIOPHYS ACTA, V1132, P119, DOI 10.1016/0167-4781(92)90001-G; DESIMONE V, 1987, EMBO J, V6, P2759, DOI 10.1002/j.1460-2075.1987.tb02570.x; DESIMONE V, 1991, EMBO J, V10, P1435, DOI 10.1002/j.1460-2075.1991.tb07664.x; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; Eisensmith Randy C., 1992, Human Mutation, V1, P13, DOI 10.1002/humu.1380010104; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; FRAIN M, 1989, CELL, V59, P145, DOI 10.1016/0092-8674(89)90877-5; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAYSON DR, 1988, SCIENCE, V239, P786, DOI 10.1126/science.3257586; GREENGARD O, 1977, PEDIATR RES, V11, P669, DOI 10.1203/00006450-197705000-00009; HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777; HSIEH MC, 1979, J EXP ZOOL, V208, P161, DOI 10.1002/jez.1402080204; Kaufman S., 1976, ADV NEUROCHEM, P1; KILEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448; KONECKI DS, 1992, BIOCHEMISTRY-US, V31, P8363, DOI 10.1021/bi00150a033; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; LAI E, 1992, SEMIN LIVER DIS, V12, P246, DOI 10.1055/s-2007-1007396; LAIMINS L, 1982, P NATL ACAD SCI USA, V79, P6563; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LI Y, 1987, MOL CELL BIOL, V8, P4362; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; LOU R, 1992, CELL, V71, P231; LUCERO MA, 1989, NUCLEIC ACIDS RES, P2281; MARIE P, 1989, SCIENCE, V244, P343; Maxam A M, 1980, Methods Enzymol, V65, P499; MCGEE MM, 1972, BIOCHEM J, V127, P669, DOI 10.1042/bj1270669; MELTON DW, 1984, P NATL ACAD SCI-BIOL, V81, P2147, DOI 10.1073/pnas.81.7.2147; MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; NODA C, 1990, BIOCHEM BIOPH RES CO, V168, P335, DOI 10.1016/0006-291X(90)91713-3; NODA C, 1990, J BIOCHEM-TOKYO, V108, P622, DOI 10.1093/oxfordjournals.jbchem.a123253; OGAWA H, 1988, P NATL ACAD SCI USA, V85, P5809, DOI 10.1073/pnas.85.16.5809; PUGE BF, 1991, GENE DEV, V5, P1935; RAIHA NCR, 1973, PEDIATR RES, V7, P1; RAYMONDJEAN M, 1988, P NATL ACAD SCI USA, V85, P757, DOI 10.1073/pnas.85.3.757; REIJNEN MJ, 1992, P NATL ACAD SCI USA, V89, P6300, DOI 10.1073/pnas.89.14.6300; ROBSON KJH, 1982, P NATL ACAD SCI-BIOL, V79, P4701, DOI 10.1073/pnas.79.15.4701; Scriver Charles R., 1993, Developmental Brain Dysfunction, V6, P11; SCRIVER CR, 1980, ANNU REV GENET, V14, P179, DOI 10.1146/annurev.ge.14.120180.001143; SCRIVER CR, 1989, METABOLIC BASIS INHE, V2, P495; SEHGAL A, 1988, MOL CELL BIOL, V8, P3160, DOI 10.1128/MCB.8.8.3160; SHEN RF, 1987, NUCLEIC ACIDS RES, V15, P8399, DOI 10.1093/nar/15.20.8399; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; SMALE S, 1991, GENE DEV, V5, P1935; SU Y, 1990, BIOCHEM BIOPH RES CO, V170, P892, DOI 10.1016/0006-291X(90)92175-Y; SU Y, 1992, GENE, V120, P301, DOI 10.1016/0378-1119(92)90110-B; SVENSSON E, 1994, IN PRESS EUR J HUM G; TIAN JM, 1991, GENE DEV, V5, P2225, DOI 10.1101/gad.5.12a.2225; TRAVIS A, 1991, MOL CELL BIOL, V11, P5756, DOI 10.1128/MCB.11.11.5756; TRONCHE F, 1990, MOL BIOL MED, V7, P173; VACHER J, 1990, SCIENCE, V250, P1732, DOI 10.1126/science.1702902; VALERIO D, 1985, EMBO J, V4, P437, DOI 10.1002/j.1460-2075.1985.tb03648.x; WANG YB, 1992, J BIOL CHEM, V267, P15105; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; XANTHOPOULOS KG, 1991, P NATL ACAD SCI USA, V88, P3807, DOI 10.1073/pnas.88.9.3807; YEOH GCT, 1988, DIFFERENTIATION, V38, P42, DOI 10.1111/j.1432-0436.1988.tb00590.x	73	21	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9137	9146						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132651				2022-12-27	WOS:A1994NB41100078
J	ZHAO, ZZ; LAROCQUE, R; HO, WT; FISCHER, EH; SHEN, SH				ZHAO, ZZ; LAROCQUE, R; HO, WT; FISCHER, EH; SHEN, SH			PURIFICATION AND CHARACTERIZATION OF PTP2C, A WIDELY DISTRIBUTED PROTEIN-TYROSINE-PHOSPHATASE CONTAINING 2 SH2 DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE SIMILARITY; HUMAN-PLACENTA; RECEPTOR; KINASE; IDENTIFICATION; EXPRESSION; CORKSCREW; ENCODES; BINDING; TORSO	PTP2C, a widely distributed protein tyrosine phosphatase (PTP) containing two SH2 domains, was expressed as a recombinant enzyme in Escherichia coli and purified to near homogeneity. The purified enzyme and a truncated form lacking the SH2 domains (Delta SH2-PTP2C) have been characterized with four commonly used substrates. Both forms showed pH optima of around neutrality for protein substrates but below 5.5 for a peptide substrate and para-nitrophenylphosphate. The dependence of the enzymes on ionic strength varied with the nature of the substrates involved. Like its analog PTP1C, PTP2C displayed a specific activity of less than 0.1% of that observed with other known PTPs toward protein substrates. Deletion of the SH2 domains increased its activity by 12-45-fold, depending on the substrates used. Limited trypsinolysis which cleaved about 4 kDa from the carboxyl terminus resulted in a 2-5-fold activation of the full-length enzyme but was es sentially without effect on the truncated enzyme. Both forms showed similar responses to effecters including activators (e.g. anionic phospholipids) or inhibitors (e.g. vanadate, molybdate, or Zn2+). PTP2C and Delta SH2-PTP2C were phosphorylated in vitro by mitogen-activated protein kinase, protein kinase C, and various protein tyrosine kinases; in the latter case, they underwent au todephosphorylation. No significant effect of the phosphorylation reactions on enzyme activity could be ob served in vitro.	NATL RES COUNCIL CANADA, BIOTECHNOL RES INST, MOLEC BIOL SECT, MONTREAL H4P 2R2, PQ, CANADA	National Research Council Canada	ZHAO, ZZ (corresponding author), UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM042508] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK07902] Funding Source: Medline; NIGMS NIH HHS [GM42508] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI M, 1992, FEBS LETT, V314, P335, DOI 10.1016/0014-5793(92)81500-L; AHMAD S, 1993, P NATL ACAD SCI USA, V90, P2197, DOI 10.1073/pnas.90.6.2197; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; DAUM G, 1993, ANAL BIOCHEM, V211, P50, DOI 10.1006/abio.1993.1231; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; FREEMAN RM, 1992, P NATL ACAD SCI USA, V89, P11239, DOI 10.1073/pnas.89.23.11239; HIRAGA A, 1992, EUR J BIOCHEM, V209, P195, DOI 10.1111/j.1432-1033.1992.tb17277.x; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KUHNE MR, 1993, J BIOL CHEM, V268, P11479; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P13434; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; PEI DH, 1993, P NATL ACAD SCI USA, V90, P1092, DOI 10.1073/pnas.90.3.1092; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1123, DOI 10.1073/pnas.89.3.1123; POT DA, 1991, J BIOL CHEM, V266, P19688; ROBETS DV, 1977, ENZYME KINETICS, P109; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; SPRENGER F, 1989, NATURE, V338, P478, DOI 10.1038/338478a0; STIDIES FW, 1990, METHOD ENZYMOL, V185, P60; SUGIMOTO S, 1993, J BIOL CHEM, V268, P11221; TONKS NK, 1991, METHOD ENZYMOL, V201, P427; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TSUDA L, 1993, CELL, V72, P407, DOI 10.1016/0092-8674(93)90117-9; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; WALTON KM, 1993, ANNU REV BIOCHEM, V62, P101; YEUNG YG, 1992, J BIOL CHEM, V267, P23447; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836; YI TL, 1993, MOL CELL BIOL, V13, P3350, DOI 10.1128/MCB.13.6.3350; ZHAO ZH, 1993, P NATL ACAD SCI USA, V90, P4251, DOI 10.1073/pnas.90.9.4251; ZHAO ZZ, 1991, BIOCHEM BIOPH RES CO, V176, P1454, DOI 10.1016/0006-291X(91)90450-L; ZHAO ZZ, 1993, J BIOL CHEM, V268, P2816	35	79	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8780	8785						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132610				2022-12-27	WOS:A1994NB41100027
J	NEUENSCHWANDER, PF; MORRISSEY, JH				NEUENSCHWANDER, PF; MORRISSEY, JH			ROLES OF THE MEMBRANE-INTERACTIVE REGIONS OF FACTOR VIIA AND TISSUE FACTOR - THE FACTOR VIIA GLA DOMAIN IS DISPENSABLE FOR BINDING TO TISSUE FACTOR BUT IMPORTANT FOR ACTIVATION OF FACTOR-X	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; COAGULATION FACTOR-XA; BOVINE FACTOR-X; BLOOD-COAGULATION; COFACTOR FUNCTION; CELLULAR RECEPTOR; PROTEIN; CALCIUM; COMPLEX; PHOSPHOLIPIDS	The roles of the putative membrane-interactive regions of factor VIIa (fVIIa) and tissue factor (TF) have been examined. Enzymatic removal of the 4-carboxyglutamic acid (Gla) domain of fVIIa had no effect on hydrolysis of a tripeptidyl chromogenic substrate in the absence or presence of TF. Additionally, Gla-domainless fVIIa (GdVIIa) was similar to native fVIIa in activating factor X in the absence of TF and phospholipid. However, GdVIIa in complex with recombinant soluble TF (sTF) was 76-fold less efficient in factor X activation than was fVIIa.sTF. The difference increased to 740-fold using TF relipidated in vesicles composed of 80% phosphatidylcholine and 20% phosphatidylserine (TF/PCPS). While Gla domain deletion produced a 10(3)-fold increase in the K-d for binding to TF/PCPS, the K-d for binding to TF/PC increased only 20-fold, and that for sTF in the absence of phospholipid increased 10-fold. K-d values for GdVIIa binding to TF/PCPS, TF/PC, or sTF were nearly identical. Thus, most of the binding energy required for formation of the fVIIa.TF complex was present even after Gla domain deletion. Both fVIIa and GdVIIa were capable of binding sTF in the presence of excess divalent metal-ion chelator, suggesting Ca2+-independent binding or the presence of a novel very high affinity Ca2+ binding site in fVIIa. The results demonstrate that the effect of the Gla domain on the K-d is apparent only in the presence of PS, and that interactions involving the fVIIa Gla domain and phospholipid are critical for efficient proteolysis of factor X on a membrane surface.	OKLAHOMA MED RES FDN, CARDIOVASC BIOL RES PROGRAM, OKLAHOMA CITY, OK 73104 USA	Oklahoma Medical Research Foundation			Morrissey, James H/H-4933-2011; Morrissey, James H./GLR-5645-2022	Morrissey, James H/0000-0002-1570-1569; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008710, R01HL047014] Funding Source: NIH RePORTER; NHLBI NIH HHS [F32 HL08710, R01 HL47014] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BACH R, 1986, BIOCHEMISTRY-US, V25, P4007, DOI 10.1021/bi00362a005; BACH R, 1988, BIOCHEMISTRY-US, V27, P4227, DOI 10.1021/bi00412a004; Bevington P.R., 1969, DATA REDUCTION ERROR; BOM VJJ, 1990, BIOCHEM J, V265, P327, DOI 10.1042/bj2650327; BROZE GJ, 1985, J BIOL CHEM, V260, P917; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; CROMPTON IE, 1986, BIOCHEM J, V239, P221, DOI 10.1042/bj2390221; CUTSFORTH GA, 1989, BIOCHEMISTRY-US, V28, P7453, DOI 10.1021/bi00444a045; DAHLBACK B, 1990, J BIOL CHEM, V265; ESMON NL, 1983, J BIOL CHEM, V258, P5548; FIORE MM, 1994, J BIOL CHEM, V269, P143; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; HAGEN FS, 1986, P NATL ACAD SCI USA, V83, P2412, DOI 10.1073/pnas.83.8.2412; HIGASHI S, 1992, J BIOL CHEM, V267, P17990; HUSTEN EJ, 1987, J BIOL CHEM, V262, P12953; Jesty J, 1988, Thromb Res, V50, P745, DOI 10.1016/0049-3848(88)90333-7; Jesty J, 1976, Methods Enzymol, V45, P95; KOMIYAMA Y, 1990, BIOCHEMISTRY-US, V29, P9418, DOI 10.1021/bi00492a016; KRISHNASWAMY S, 1992, J BIOL CHEM, V267, P23696; LAWSON JH, 1992, J BIOL CHEM, V267, P4834; LEBONNIEC BF, 1992, J BIOL CHEM, V267, P6970; MANN KG, 1984, PROG HEMOST THROMB, V7, P1; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; MORITA T, 1986, J BIOL CHEM, V261, P4015; MORRISON SA, 1983, BIOCHEMISTRY-US, V22, P4053, DOI 10.1021/bi00286a010; MORRISSEY JH, 1987, CELL, V50, P129, DOI 10.1016/0092-8674(87)90669-6; MORRISSEY JH, 1988, THROMB RES, V50, P481, DOI 10.1016/0049-3848(88)90197-1; MUTUCUMARANA VP, 1992, J BIOL CHEM, V267; NELSESTUEN GL, 1978, BIOCHEMISTRY-US, V17, P2134, DOI 10.1021/bi00604a017; NEMERSON Y, 1988, BLOOD, V71, P1; NEUENSCHWANDER P, 1988, BLOOD, V72, P1761; NEUENSCHWANDER PF, 1992, J BIOL CHEM, V267, P14477; NEUENSCHWANDER PF, 1993, THROMB HAEMOSTASIS, V70, P970; RAPAPORT SI, 1991, ANN NY ACAD SCI, V614, P51, DOI 10.1111/j.1749-6632.1991.tb43691.x; RAWALASHEIKH R, 1992, BLOOD, V79, P398; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; ROY S, 1991, J BIOL CHEM, V266, P4665; ROY S, 1991, J BIOL CHEM, V266, P22063; RUF W, 1992, J BIOL CHEM, V267, P6375; RUF W, 1991, J BIOL CHEM, V266, P2158; RUF W, 1991, J BIOL CHEM, V266, P15719; RUF W, 1991, J BIOL CHEM, V266, P16256; SAKAI T, 1990, J BIOL CHEM, V265, P1890; SCHIODT J, 1992, FEBS LETT, V306, P265, DOI 10.1016/0014-5793(92)81014-D; SKOGEN WF, 1984, J BIOL CHEM, V259, P2306; SMITH RL, 1973, J BIOL CHEM, V248, P2418; TOOMEY JR, 1991, J BIOL CHEM, V266, P19198; WAXMAN E, 1992, BIOCHEMISTRY-US, V31, P3998, DOI 10.1021/bi00131a015; WILDGOOSE P, 1993, BIOCHEMISTRY-US, V32, P114, DOI 10.1021/bi00052a016; WILDGOOSE P, 1990, P NATL ACAD SCI USA, V87, P7290, DOI 10.1073/pnas.87.18.7290; WILDGOOSE P, 1992, THROMB HAEMOSTASIS, V67, P679; ZUR M, 1978, J BIOL CHEM, V253, P2203	53	106	116	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8007	8013						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132522				2022-12-27	WOS:A1994NB40900030
J	CHAO, TSO; FOSTER, DA; RAPP, UR; ROSNER, MR				CHAO, TSO; FOSTER, DA; RAPP, UR; ROSNER, MR			DIFFERENTIAL RAF REQUIREMENT FOR ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE BY GROWTH-FACTORS, PHORBOL ESTERS, AND CALCIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; SIGNALING PATHWAYS; MURINE FIBROBLASTS; CELLS; MEMBRANE; PHOSPHORYLATION; THAPSIGARGIN; STIMULATION; 3T3-CELLS; BINDING	Although a pathway that requires sequential activation of Ras, Raf, and MAP kinase kinase has been proposed as the major mechanism for stimulation of mitogen-activated protein kinase (MAP kinase), alternative pathways also exist. A wide variety of extracellular stimuli have been shown to activate MAP kinase; however, the precise mechanisms by which these stimuli mediate the signaling events have not been elucidated. Using a Balb/c-derived cell line expressing a dominant-negative mutant of Raf, we determined whether Raf is required for the activation of MAP kinase by growth factors, phorbol esters, and calcium. Insulin-like growth factor I (IGF-I), epidermal growth factor (EGF), and phorbol 12,13-dibutyrate activated Ras in both mutant and control cells. However, stimulation of MAP kinase by IGF-I was nearly abolished in the dominant-negative Raf mutant. Stimulation of MAP kinase by the Ca2+ mobilizer thapsigargin was also inhibited in the presence of the Raf mutant. In contrast, EGF and phorbol 12,13-dibutyrate remained potent stimulators of MAP kinase in the dominant-negative Raf cells. The activation of MAP kinase by these stimuli can be further distinguished by differential requirements for Ca2+ and protein kinase C. These results suggest that Raf is required for the activation of MAP kinase by IGF-I and calcium, whereas EGF and possibly phorbol eaters may employ alternative Raf-independent pathways for MAP kinase activation.	UNIV CHICAGO,BEN MAY INST,CHICAGO,IL 60637; UNIV CHICAGO,DEPT PHARMACOL & PHYSIOL,CHICAGO,IL 60637; CUNY HUNTER COLL,DEPT BIOL SCI,NEW YORK,NY 10021; NCI,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21702	University of Chicago; University of Chicago; City University of New York (CUNY) System; Hunter College (CUNY); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)					NCI NIH HHS [CA35541, CA46677] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA035541, R29CA046677, R01CA046677] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHN NG, 1990, J BIOL CHEM, V265, P11487; ANDERSON NG, 1991, J BIOL CHEM, V266, P10131; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAO TSO, 1992, J BIOL CHEM, V267, P19876; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; GALLEGO C, 1992, P NATL ACAD SCI USA, V89, P7355, DOI 10.1073/pnas.89.16.7355; GEAHLEN RL, 1986, ANAL BIOCHEM, V153, P151, DOI 10.1016/0003-2697(86)90074-6; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; GRAY GM, 1988, J BIOL CHEM, V263, P10714; GRISWOLDPRENNER I, 1993, J BIOL CHEM, V268, P13050; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LALLEMAIN G, 1991, CELL REGUL, V2, P675, DOI 10.1091/mbc.2.8.675; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LU KH, 1992, P NATL ACAD SCI USA, V89, P3889, DOI 10.1073/pnas.89.9.3889; MACNICOL AM, 1993, CELL, V73, P571, DOI 10.1016/0092-8674(93)90143-E; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; PELECH SL, 1992, SCIENCE, V257, P1355, DOI 10.1126/science.1382311; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; QURESHI SA, 1991, ONCOGENE, V6, P995; QURESHI SA, 1993, BIOCHEM BIOPH RES CO, V192, P969, DOI 10.1006/bbrc.1993.1510; SATOH T, 1990, P NATL ACAD SCI USA, V87, P5993, DOI 10.1073/pnas.87.15.5993; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; TAKISHIMA K, 1991, P NATL ACAD SCI USA, V88, P2520, DOI 10.1073/pnas.88.6.2520; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TROPPMAIR J, 1992, ONCOGENE, V7, P1867; TUCKER MS, 1993, J NEUROCHEM, V61, P1376, DOI 10.1111/j.1471-4159.1993.tb13631.x; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WILLIAMS NG, 1993, P NATL ACAD SCI USA, V90, P5772, DOI 10.1073/pnas.90.12.5772; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O	39	134	135	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7337	7341						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125950				2022-12-27	WOS:A1994NA03200049
J	HELL, JW; APPLEYARD, SM; YOKOYAMA, CT; WARNER, C; CATTERALL, WA				HELL, JW; APPLEYARD, SM; YOKOYAMA, CT; WARNER, C; CATTERALL, WA			DIFFERENTIAL PHOSPHORYLATION OF 2 SIZE FORMS OF THE N-TYPE CALCIUM-CHANNEL ALPHA-L SUBUNIT WHICH HAVE DIFFERENT COOH TERMINI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; OMEGA-CONOTOXIN GVIA; SKELETAL-MUSCLE; BETA-SUBUNIT; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; CA2+ CHANNELS; DIHYDROPYRIDINE RECEPTOR; PERIPHERAL NEURONS; CATALYTIC SUBUNIT	Two size forms of the class B N-type calcium channel alpha 1 subunit were recently identified with CNB1, an anti-peptide antibody directed against an intracellular loop of this channel (Westenbroek, R. E., Hell, J. W., Warner, C., Dubel, S. J., Snutch, T. P., and Catterall, W.A, (1992) Neuron 9, 1099-1115). To investigate the biochemical differences between these two size forms, the antibodies CNB3 and CNB4 were raised against peptides with sequences corresponding to the COOH-terminal end of the full-length form. Immunoblot experiments demonstrated that both antibodies specifically recognize the longer form of 250 kDa, indicating that the COOH-terminal regions of the two size forms of the class B N-type channel alpha 1 subunit are different. Phosphorylation experiments with immunopurified calcium channels and different second messenger activated protein kinases revealed that both the 220- and 250-kDa forms of the class B N-type calcium channel alpha 1 subunit are substrates for cAMP-dependent protein kinase, cGMP-dependent protein kinase, and protein kinase C. These three kinases incorporated approximately 1 mol of phosphate/mol of binding sites for omega-conotoxin (omega-CgTx) GVIA, a ligand specific for the N-type calcium channel, and may regulate the activity of both forms in vivo. In contrast, calcium- and calmodulin dependent protein kinase II (CaM kinase II) phosphorylated only the long form of the class B N-type calcium channel alpha 1 subunit, with a stoichiometry of 0.5 mol of phosphate/mol of total omega-CgTx GVIA binding sites. Specific phosphorylation of the long form of the class B alpha 1 subunit by CaM kinase II may differentially regulate the function of N-type calcium channels containing different size forms of their alpha 1 subunits in vivo.	UNIV WASHINGTON, GRAD PROGRAM NEUROBIOL, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle	HELL, JW (corresponding author), UNIV WASHINGTON, DEPT PHARMACOL, SEATTLE, WA 98195 USA.		Hell, Johannes W./P-5085-2019		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS22625] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLIJANIAN MK, 1991, J BIOL CHEM, V266, P20192; AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; CHIN H, 1991, GENOMICS, V11, P914, DOI 10.1016/0888-7543(91)90014-6; CURTIS BM, 1985, P NATL ACAD SCI USA, V82, P2528, DOI 10.1073/pnas.82.8.2528; Dado R., 1993, Society for Neuroscience Abstracts, V19, P1330; DEJONGH KS, 1989, P NATL ACAD SCI USA, V86, P8585; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; DIVERSEPIERLUISSI M, 1993, NEURON, V10, P753, DOI 10.1016/0896-6273(93)90175-Q; DOERNER D, 1990, J NEUROSCI, V10, P1699; DOLPHIN AC, 1990, ANNU REV PHYSIOL, V52, P243; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; FLOCKERZI V, 1986, EUR J BIOCHEM, V161, P217, DOI 10.1111/j.1432-1033.1986.tb10145.x; FUJITA Y, 1993, NEURON, V10, P585, DOI 10.1016/0896-6273(93)90162-K; GLOSSMANN H, 1990, REV PHYSIOL BIOCH P, V114, P1; GROSS RA, 1988, NEUROSCI LETT, V88, P50, DOI 10.1016/0304-3940(88)90314-X; GROSS RA, 1989, J NEUROPHYSIOL, V61, P97, DOI 10.1152/jn.1989.61.1.97; GROSS RA, 1990, J PHYSIOL-LONDON, V429, P483, DOI 10.1113/jphysiol.1990.sp018268; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; HELL JW, 1993, J BIOL CHEM, V268, P19451; HELL JW, 1994, IN PRESS ANN NY ACAD; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; HYMEL L, 1988, P NATL ACAD SCI USA, V85, P4290, DOI 10.1073/pnas.85.12.4290; JAHN H, 1988, EUR J BIOCHEM, V178, P535, DOI 10.1111/j.1432-1033.1988.tb14480.x; JAY SD, 1991, J BIOL CHEM, V266, P3287; JAY SD, 1990, SCIENCE, V248, P490, DOI 10.1126/science.2158672; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; LAI Y, 1990, J BIOL CHEM, V265, P20839; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MCENERY MW, 1991, P NATL ACAD SCI USA, V88, P11095, DOI 10.1073/pnas.88.24.11095; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MILLER RJ, 1990, FASEB J, V4, P3291, DOI 10.1096/fasebj.4.15.1979294; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; MUNDINAWEILENMANN C, 1991, J BIOL CHEM, V266, P4067; NASTAINCZYK W, 1987, EUR J BIOCHEM, V169, P137, DOI 10.1111/j.1432-1033.1987.tb13590.x; NIIDOME T, 1992, FEBS LETT, V308, P7, DOI 10.1016/0014-5793(92)81038-N; NUNOKI K, 1989, P NATL ACAD SCI USA, V86, P6816, DOI 10.1073/pnas.86.17.6816; OCALLAHAN CM, 1988, BIOCHEMISTRY-US, V27, P6071, DOI 10.1021/bi00416a036; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; ROTMAN EI, 1992, J BIOL CHEM, V267, P16100; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SAKAMOTO J, 1991, J BIOL CHEM, V266, P18914; SEINO S, 1992, P NATL ACAD SCI USA, V89, P584, DOI 10.1073/pnas.89.2.584; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; STRIESSNIG J, 1990, P NATL ACAD SCI USA, V87, P9108, DOI 10.1073/pnas.87.23.9108; SWARTZ KJ, 1993, NATURE, V361, P165, DOI 10.1038/361165a0; SWARTZ KJ, 1993, NEURON, V11, P305, DOI 10.1016/0896-6273(93)90186-U; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TAKAHASHI M, 1987, SCIENCE, V236, P88, DOI 10.1126/science.2436296; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WEI XY, 1991, J BIOL CHEM, V266, P21943; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754; WOODGETT JR, 1987, J BIOL CHEM, V262, P4836; YANG J, 1993, NEURON, V10, P127, DOI 10.1016/0896-6273(93)90305-B; YOSHIDA A, 1992, FEBS LETT, V309, P343, DOI 10.1016/0014-5793(92)80804-P	78	79	81	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7390	7396						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125957				2022-12-27	WOS:A1994NA03200057
J	TRIEBER, CA; ROTHERY, RA; WEINER, JH				TRIEBER, CA; ROTHERY, RA; WEINER, JH			MULTIPLE PATHWAYS OF ELECTRON-TRANSFER IN DIMETHYL-SULFOXIDE REDUCTASE OF ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; IRON-SULFUR MOLYBDOENZYME; NUCLEOTIDE-SEQUENCE; FORMATE DEHYDROGENASE; FUMARATE REDUCTASE; DIMETHYLSULFOXIDE REDUCTASE; METHANOBACTERIUM-FORMICICUM; WOLINELLA-SUCCINOGENES; NITRATE REDUCTASE; CLONING	The catalytic subunit of dimethyl sulfoxide (Me(2)SO) reductase, DmsA, contains six blocks of sequence that are homologous to other members of the superfamily of prokaryotic molybdoenzymes. The amino-terminal block contains 5 conserved residues (Cys(38), Cys(42), Cys(75) Lys(28), and Arg(77)). Site-directed mutagenesis of these residues did not alter membrane localization but in some cases less enzyme accumulated. The activity of Me(2)SO reductase was monitored by measuring Me(2)SO-dependent anaerobic growth, benzyl viologen, or dimethylnaphthoquinol oxidase activity, and using a quinol pool-coupling assay. Only Cys(75) and Lys(28) mutant enzymes were able to support anaerobic growth with Me(2)SO suggesting a critical role for Cys(38), Cys(42), and Arg(77). Benzyl viologen oxidase activity was retained in the mutants although with reduced efficiency in Cys(42)-Ser. Electron transport with dimethylnaphthoquinol was reduced in Cys(38)-Ser, Cys(42)-Ser, and Cys(75)-Ser and almost totally eliminated in the Arg(77)-Ser mutant. Cys(38)-Ser, Cys(42)-Ser, and Arg(77)-Ser were unable to support quinol oxidation although electron transfer from the quinol pool to the [Fe-S] centers in DmsB was normal. These results indicate that the amino-terminal region is involved in functional electron transfer from the quinol pool to Me(2)SO and that electrons from benzyl viologen, dimethylnaphthoquinol, and menaquinol may follow different paths within the catalytic subunit.	UNIV ALBERTA,DEPT BIOCHEM,EDMONTON T6G 2H7,AB,CANADA; UNIV ALBERTA,MED RES COUNCIL PROGRAM MOLEC BIOL MEMBRANES,EDMONTON T6G 2H7,AB,CANADA	University of Alberta; University of Alberta				Trieber, Catharine/0000-0002-1336-1126; Rothery, Richard/0000-0003-3265-1783				BERG BL, 1991, J BIOL CHEM, V266, P22380; BILOUS PT, 1988, J BACTERIOL, V170, P1511, DOI 10.1128/jb.170.4.1511-1518.1988; BILOUS PT, 1988, MOL MICROBIOL, V2, P785, DOI 10.1111/j.1365-2958.1988.tb00090.x; BILOUS PT, 1985, J BACTERIOL, V162, P1151, DOI 10.1128/JB.162.3.1151-1155.1985; BLASCO F, 1989, MOL GEN GENET, V218, P249, DOI 10.1007/BF00331275; BLASCO F, 1990, MOL GEN GENET, V222, P104, DOI 10.1007/BF00283030; BOKRANZ M, 1991, ARCH MICROBIOL, V156, P119, DOI 10.1007/BF00290984; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; CAMMACK R, 1990, BIOCHEMISTRY-US, V29, P8410, DOI 10.1021/bi00488a030; Gibson T.J., 1984, THESIS CAMBRIDGE U U; JOHNSON MK, 1988, J BIOL CHEM, V263, P14732; KRAFFT T, 1992, EUR J BIOCHEM, V206, P503, DOI 10.1111/j.1432-1033.1992.tb16953.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; PIERSON DE, 1990, J BACTERIOL, V172, P2194, DOI 10.1128/jb.172.4.2194-2198.1990; ROTHERY RA, 1991, BIOCHEMISTRY-US, V30, P8296, DOI 10.1021/bi00098a003; SAMBASIVARAO D, 1991, CURR MICROBIOL, V23, P105, DOI 10.1007/BF02092258; SAMBASIVARAO D, 1991, J BACTERIOL, V173, P5935, DOI 10.1128/jb.173.19.5935-5943.1991; SAMBASIVARAO D, 1990, J BACTERIOL, V172, P5938, DOI 10.1128/jb.172.10.5938-5948.1990; Sambrook J, 1989, MOL CLONING LABORATO; SAUTER M, 1992, MOL MICROBIOL, V6, P1523, DOI 10.1111/j.1365-2958.1992.tb00873.x; SHUBER AP, 1986, J BIOL CHEM, V261, P2942; TARTOF KD, 1987, FOCUS, V9, P12; WEINER JH, 1992, BIOCHIM BIOPHYS ACTA, V1102, P1, DOI 10.1016/0167-4838(92)90493-W; WEINER JH, 1986, P NATL ACAD SCI USA, V83, P2056, DOI 10.1073/pnas.83.7.2056; WEINER JH, 1988, J BACTERIOL, V170, P1505, DOI 10.1128/jb.170.4.1505-1510.1988; WESTENBERG DJ, 1990, J BIOL CHEM, V265, P19560; WHITE WB, 1992, J BACTERIOL, V174, P4997, DOI 10.1128/JB.174.15.4997-5004.1992; WOOTTON JC, 1991, BIOCHIM BIOPHYS ACTA, V1057, P157, DOI 10.1016/S0005-2728(05)80100-8; YAMATO I, 1975, J BIOCHEM, V77, P705, DOI 10.1093/oxfordjournals.jbchem.a130774; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZINONI F, 1986, P NATL ACAD SCI USA, V83, P4650, DOI 10.1073/pnas.83.13.4650	33	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7103	7109						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125918				2022-12-27	WOS:A1994NA03200013
J	CASELLA, JF; TORRES, MA				CASELLA, JF; TORRES, MA			INTERACTION OF CAP-Z WITH ACTIN - THE NH2-TERMINAL DOMAINS OF THE ALPHA-1 AND BETA-SUBUNITS ARE NOT REQUIRED FOR ACTIN CAPPING, AND ALPHA-1-BETA AND ALPHA-2-BETA HETERODIMERS BIND DIFFERENTIALLY TO ACTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; Z-LINE; PROTEIN; PURIFICATION; IMMUNOFLUORESCENCE; IDENTIFICATION; LOCALIZATION	Cap Z is a widely distributed, highly conserved, heterodimeric protein that binds to the barbed ends of actin filaments, but does not sever filaments. In chicken, two variant cDNAs (alpha 1 and alpha 2) encoding proteins homologous to the alpha subunit of Cap Z have been described versus one for the beta subunit. To establish the effect of each subunit and of the two potential heterodimers (alpha 1 beta and alpha 2 beta) on actin and to explore the functional domains of the proteins, RNA transcripts derived from these cDNAs were studied using in vitro translation Sequential deletion mutants at the carboxyl and amino termini of the alpha subunit and at the amino terminus of the beta subunit were constructed, and the ability of each mutant to recombine with its heterologous subunit was assessed by gel filtration. The interaction of the individual subunits, heterodimers, and mutants with actin was studied using cosedimentation and quantitative binding assays. This study demonstrates that 1) both alpha 1 beta and alpha 2 beta heterodimers assemble in vitro after translation and bind selectively to the barbed ends of actin filaments; 2) the affinity of alpha 1 beta heterodimers for actin (K-D = 1.6 x 10(-10) M) is similar to 4-fold higher than that of alpha 2 beta heterodimers (K-D = 6.3 x 10(-10) M); 3) the amino-terminal 40% of the alpha 1 subunit (amino acids 1-115) and the amino-terminal 31% of the beta subunit (amino acids 1-86) are not required for high affinity binding of Cap Z to the barbed ends of actin filaments; and 4) the carboxyl-terminal 55 amino acids of the alpha subunit appear to be required for binding to actin, as are the carboxyl-terminal 15 amino acids of the beta subunit.			CASELLA, JF (corresponding author), JOHNS HOPKINS UNIV, SCH MED,DEPT PEDIAT,DIV PEDIAT HEMATOL, ROSS RES BLDG,RM 1125, 720 RUTLAND AVE, BALTIMORE, MD 21205 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040697] Funding Source: NIH RePORTER; NHLBI NIH HHS [R29 HL38855] Funding Source: Medline; NIAMS NIH HHS [R01 AR40697] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AMATRUDA JF, 1992, J CELL BIOL, V117, P1067, DOI 10.1083/jcb.117.5.1067; ANKENBAUER T, 1989, NATURE, V342, P822, DOI 10.1038/342822a0; CALDWELL JE, 1989, J BIOL CHEM, V264, P12648; CALDWELL JE, 1989, BIOCHEMISTRY-US, V28, P8506, DOI 10.1021/bi00447a036; CASELLA JF, 1987, J CELL BIOL, V105, P371, DOI 10.1083/jcb.105.1.371; CASELLA JF, 1989, P NATL ACAD SCI USA, V86, P5800, DOI 10.1073/pnas.86.15.5800; CASELLA JF, 1986, J BIOL CHEM, V261, P915; CASELLA JF, 1991, METHOD ENZYMOL, V196, P140; COOPER JA, 1991, CELL MOTIL CYTOSKEL, V18, P204, DOI 10.1002/cm.970180306; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; HARTMANN H, 1989, J BIOL CHEM, V264, P12639; HAUS U, 1991, BIOCHEM BIOPH RES CO, V181, P833, DOI 10.1016/0006-291X(91)91265-E; HUG C, 1992, J CELL BIOL, V116, P923, DOI 10.1083/jcb.116.4.923; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; MCPHERSON GA, 1983, COMPUT PROG BIOMED, V17, P107, DOI 10.1016/0010-468X(83)90031-4; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; POLLARD TD, 1983, ANAL BIOCHEM, V134, P406, DOI 10.1016/0003-2697(83)90316-0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAFER DA, 1992, J CELL BIOL, V118, P335, DOI 10.1083/jcb.118.2.335	20	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6992	6998						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120062				2022-12-27	WOS:A1994MZ50300111
J	PATRICK, DR; OLIFF, A; HEIMBROOK, DC				PATRICK, DR; OLIFF, A; HEIMBROOK, DC			IDENTIFICATION OF A NOVEL RETINOBLASTOMA GENE-PRODUCT BINDING-SITE ON HUMAN PAPILLOMAVIRUS TYPE-16 E7 PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E2F TRANSCRIPTION FACTOR; LARGE T-ANTIGEN; CARCINOMA CELL-LINES; DNA-BINDING; SUPPRESSOR PROTEIN; MUTATIONAL ANALYSIS; ESCHERICHIA-COLI; 2 DISTINCT; HIGH-RISK; CYCLIN-A	Transformation of mammalian cells by human papil lomavirus type 16 appears to require binding of the viral E7 protein to the cellular retinoblastoma growth suppresser gene product (pRB). Binding of E7 protein to pRB inhibits several of pRB's biochemical properties, including association with the transcription factor E2F. Fragments of E7 protein derived from its conserved region 2 (CR2) domain bind to pRB and are sufficient to inhibit binding of full-length E7 protein to pRB. However, these CR2 fragments exhibit reduced affinity for pRB compared to the full-length protein and do not inhibit formation of the pRB E2F complex. These observations suggest the existence of additional contact sites between the E7 protein and pRB. In the current study we have identified a region of E7, distinct from the CR2 domain, which is sufficient to bind pRB. This new pRB binding motif encompasses the zinc-binding conserved region 3 (CR3) domain of E7. Studies with a series of pRB deletion mutants suggest that pRB residues between amino acids 803 and 841 are necessary for binding to the E7 CR3 domain. An E7 CR3 peptide inhibits binding of E2F to pRB, indicating that E2F and E7(31-98) bind to pRB at the same or overlapping sites. These results are consistent with a model in which optimal binding of E7 to pRB requires at least two distinct contact sites: the previously identified high affinity interaction between the E7 CR2 domain and the pRB ''pocket'' region, and a second interaction between the E7 CR3 domain and the COOH-terminal region of pRB. The latter interaction is sufficient for E7's inhibition of E2F binding to pRB.	MERCK SHARP & DOHME LTD,RES LABS,DEPT CANC RES,W POINT,PA 19486	Merck & Company								BAGCHI S, 1991, CELL, V65, P1063, DOI 10.1016/0092-8674(91)90558-G; BAKER CC, 1987, J VIROL, V61, P962, DOI 10.1128/JVI.61.4.962-971.1987; BANDARA LR, 1991, NATURE, V352, P249, DOI 10.1038/352249a0; BANDARA LR, 1991, NATURE, V351, P494, DOI 10.1038/351494a0; BARBOSA MS, 1989, J VIROL, V63, P1404, DOI 10.1128/JVI.63.3.1404-1407.1989; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHESTERS PM, 1990, J GEN VIROL, V71, P449, DOI 10.1099/0022-1317-71-2-449; CHITTENDEN T, 1991, CELL, V65, P1073, DOI 10.1016/0092-8674(91)90559-H; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; DEVILLIERS EM, 1989, J VIROL, V63, P4898, DOI 10.1128/JVI.63.11.4898-4903.1989; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; DYSON N, 1992, J VIROL, V66, P4606, DOI 10.1128/JVI.66.7.4606-4611.1992; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; EDMONDS C, 1989, J VIROL, V63, P2650, DOI 10.1128/JVI.63.6.2650-2656.1989; EDWARDS GM, 1992, J BIOL CHEM, V267, P7971; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; HECK DV, 1992, P NATL ACAD SCI USA, V89, P4442, DOI 10.1073/pnas.89.10.4442; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; HIEBERT SW, 1991, J VIROL, V65, P3547, DOI 10.1128/JVI.65.7.3547-3552.1991; HU QJ, 1990, EMBO J, V9, P1147, DOI 10.1002/j.1460-2075.1990.tb08221.x; HUANG PS, 1993, MOL CELL BIOL, V13, P953, DOI 10.1128/MCB.13.2.953; HUANG S, 1991, NATURE, V350, P160, DOI 10.1038/350160a0; HUANG S, 1990, EMBO J, V9, P1815, DOI 10.1002/j.1460-2075.1990.tb08306.x; HUBER HE, 1993, P NATL ACAD SCI USA, V90, P3325; JEFFERSON JR, 1990, BIOCHEMISTRY-US, V29, P6687, DOI 10.1021/bi00480a019; JONES RE, 1992, J BIOL CHEM, V267, P908; JONES RE, 1990, J BIOL CHEM, V265, P12782; KAELIN WG, 1990, MOL CELL BIOL, V10, P3761, DOI 10.1128/MCB.10.7.3761; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; KAELIN WG, 1992, CELL, V70, P853; KANDA T, 1988, J VIROL, V62, P610, DOI 10.1128/JVI.62.2.610-613.1988; LEE WH, 1987, NATURE, V329, P642, DOI 10.1038/329642a0; MCINTYRE MC, 1993, J VIROL, V67, P3142, DOI 10.1128/JVI.67.6.3142-3150.1993; MUDRYJ M, 1991, CELL, V65, P1243, DOI 10.1016/0092-8674(91)90019-U; MUNGER K, 1991, J VIROL, V65, P3943; MUNGER K, 1992, CANCER SURV, V12, P197; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; MUNGER K, 1989, J VIROL, V63, P4417; NEVINS JR, 1992, SCIENCE, V258, P424; PATRICK DR, 1992, J BIOL CHEM, V267, P6910; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; PHELPS WC, 1992, J VIROL, V66, P2418, DOI 10.1128/JVI.66.4.2418-2427.1992; RAWLS JA, 1990, J VIROL, V64, P6121, DOI 10.1128/JVI.64.12.6121-6129.1990; RAYCHAUDHURI P, 1991, GENE DEV, V5, P1200, DOI 10.1101/gad.5.7.1200; RILEY TEW, 1990, MOL CELL BIOL, V10, P6664, DOI 10.1128/MCB.10.12.6664; RUSTGI AK, 1991, NATURE, V352, P541, DOI 10.1038/352541a0; SANG BC, 1992, P NATL ACAD SCI USA, V89, P8063, DOI 10.1073/pnas.89.17.8063; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; SEEDORF K, 1985, VIROLOGY, V145, P181, DOI 10.1016/0042-6822(85)90214-4; SHIRODKAR S, 1992, CELL, V68, P157, DOI 10.1016/0092-8674(92)90214-W; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; STAMMERS DK, 1991, FEBS LETT, V283, P298, DOI 10.1016/0014-5793(91)80613-8; STIRDIVANT SM, 1992, MOL CELL BIOL, V12, P1905, DOI 10.1128/MCB.12.5.1905; STOREY A, 1990, J GEN VIROL, V71, P965, DOI 10.1099/0022-1317-71-4-965; STOREY A, 1988, EMBO J, V7, P1815, DOI 10.1002/j.1460-2075.1988.tb03013.x; WANG NP, 1990, CELL GROWTH DIFFER, V1, P233; WATANABE S, 1990, J VIROL, V64, P207, DOI 10.1128/JVI.64.1.207-214.1990; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; YEE C, 1985, AM J PATHOL, V119, P363; zur Hausen H, 1987, PAPILLOMAVIRUSES, P245	63	80	82	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6842	6850						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120046				2022-12-27	WOS:A1994MZ50300091
J	HOLZ, RW; BRONDYK, WH; SENTER, RA; KUIZON, L; MACARA, IG				HOLZ, RW; BRONDYK, WH; SENTER, RA; KUIZON, L; MACARA, IG			EVIDENCE FOR THE INVOLVEMENT OF RAB3A IN CA2+-DEPENDENT EXOCYTOSIS FROM ADRENAL CHROMAFFIN CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; CATECHOLAMINE SECRETION; ENDOPLASMIC-RETICULUM; GOLGI-COMPLEX; RAS; EXPRESSION; VESICLES; PATHWAY; INVITRO; YEAST	Bovine chromaffin cells are nondividing primary secretory cells that store and secrete catecholamine and a variety of proteins including chromogranins, opiate peptides, and opiate precursors. A transient transfection technique based upon the expression of human growth hormone as a reporter for the regulated secretory pathway was used to study the role of a Ras-like, GTP-binding protein, Rab3a, in Ca2+-dependent exocytosis. Immunocytochemistry and flow cytometry revealed that growth hormone and Rab proteins were coexpressed in the same cells. Overexpression of the wild type protein and expression of a mutant protein Rab3aQ81L both inhibited nicotinic agonist-stimulated exocytosis in intact cells. Expression of Rab3aQ81L also inhibited Ca2+-dependent secretion from permeabilized cells. Two other mutants, Rab3aN135I and Rab3aT36N, which correspond to dominant acting mutants of Ras, caused limited and no inhibition, respectively, of agonist-stimulated exocytosis. These data provide direct evidence that Rab3a plays an important role in Ca(2+-)triggered exocytosis. We suggest that Rab3a is an inhibitor of secretion, perhaps as part of a pre-fusion complex with secretory vesicles. Elevated Ca2+ may trigger exocytosis by overcoming the inhibition by Rab3a.	UNIV VERMONT,DEPT PATHOL,BURLINGTON,VT 05405	University of Vermont	HOLZ, RW (corresponding author), UNIV MICHIGAN,SCH MED,DEPT PHARMACOL,ANN ARBOR,MI 48109, USA.				NCI NIH HHS [R01 CA56300] Funding Source: Medline; NEI NIH HHS [F32EY06411] Funding Source: Medline; NIDDK NIH HHS [R01-DK 27959] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA056300] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY006411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027959] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BADER MF, 1989, J BIOL CHEM, V264, P16426; BALCH WE, 1989, J BIOL CHEM, V264, P16965; BITTNER MA, 1992, J BIOL CHEM, V267, P16226; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BITTNER MA, 1986, J BIOL CHEM, V261, P182; BRONDYK WH, 1993, J BIOL CHEM, V268, P9410; BURSTEIN E, 1989, MOL CELL BIOL, V9, P4807, DOI 10.1128/MCB.9.11.4807; BURSTEIN ES, 1992, J BIOL CHEM, V267, P22715; CORCORAN JJ, 1990, AM J PHYSIOL, V259, pC161, DOI 10.1152/ajpcell.1990.259.1.C161; DARCHEN F, 1990, P NATL ACAD SCI USA, V87, P5692, DOI 10.1073/pnas.87.15.5692; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; HOLZ RW, 1982, J NEUROCHEM, V39, P635, DOI 10.1111/j.1471-4159.1982.tb07940.x; LLEDO PM, 1993, NATURE, V364, P540, DOI 10.1038/364540a0; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; MA WJ, 1992, J BIOL CHEM, V267, P22728; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; MIZOGUCHI A, 1990, J BIOL CHEM, V265, P11872; NGSEE JK, 1993, MOL BIOL CELL, V4, P747, DOI 10.1091/mbc.4.7.747; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OBERHAUSER AF, 1992, NATURE, V360, P270, DOI 10.1038/360270a0; OHARAIMAIZUMI M, 1992, J NEUROCHEM, V58, P2275, DOI 10.1111/j.1471-4159.1992.tb10974.x; OLOFSSON B, 1988, ONCOGENE, V3, P231; PADFIELD PJ, 1992, P NATL ACAD SCI USA, V89, P1656, DOI 10.1073/pnas.89.5.1656; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; SANO K, 1989, BIOCHEM BIOPH RES CO, V158, P377, DOI 10.1016/S0006-291X(89)80058-0; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SENYSHYN J, 1992, FEBS LETT, V309, P41, DOI 10.1016/0014-5793(92)80735-Y; STACEY DW, 1991, MOL CELL BIOL, V11, P4053, DOI 10.1128/MCB.11.8.4053; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; VITALE N, 1993, J BIOL CHEM, V268, P14175; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; WICKPW, 1993, J BIOL CHEM, V268, P10983; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8	38	206	208	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 8	1994	269	14					10229	10234						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NF017	8144603				2022-12-27	WOS:A1994NF01700012
J	OMOTE, H; PARK, MY; MAEDA, M; FUTAI, M				OMOTE, H; PARK, MY; MAEDA, M; FUTAI, M			THE ALPHA/BETA SUBUNIT INTERACTION IN H+-ATPASE (ATP SYNTHASE) - AN ESCHERICHIA-COLI ALPHA-SUBUNIT MUTATION (ARG-ALPHA-296 -] CYS) RESTORES COUPLING EFFICIENCY TO THE DELETERIOUS BETA-SUBUNIT MUTANT (SER-BETA-174 -] PHE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING ATPASE; GLYCINE-RICH SEQUENCE; UNCD MUTANTS; B-SUBUNIT; F1-ATPASE; RESIDUES; BINDING; DNA; SITE; IDENTIFICATION	The Ser-beta 174 residue of the Escherichia coli H+-ATPase beta subunit has been shown to be near the catalytic site together with Gly-beta 149, Gly-beta 172, Glu-beta 192, and Val-beta 198 (Iwamoto, A., Park, M.-Y., Maeda, M., and Futai, M. (1993) J. Biol. Chem. 268, 3156-3160). In this study, we introduced various residues at position 174 and found that the larger the side chain volume of the residue introduced, the lower the enzyme activity became. The Phe-beta 174 mutant was defective in energy coupling between catalysis and transport, whereas the Leu-beta 174 mutant could couple efficiently, although both mutants had essentially the same ATPase activities (similar to 10% of the wild type). The defective energy coupling of the Phe-beta 174 mutant was suppressed by the second mutation (Arg-alpha 296 --> Cys) in the alpha subunit. The Cys-alpha 296/Phe-beta 174 mutant had essentially the same membrane ATPase activity as the Phe-beta 174 single mutant when assayed under the conditions that stabilize the double mutant enzyme. These results indicate the importance of the alpha/beta interaction, especially that between the regions near Arg-alpha 296 and Ser-beta 174, for energy coupling in the H+-ATPase. The 2 residues (Ser-beta 174 and Arg-alpha 296) may be located nearby at the interface of the two subunits. About 1 mol of N-[C-14]ethylmaleimide could bind to 1 mol of the alpha subunit of Cys-alpha 296/Phe-beta 174 or Cys-alpha 296 mutant ATPase, but could not inhibit the enzyme activity. This is the first intersubunit mutation/suppression approach to ATPase catalysis and its energy coupling.			OMOTE, H (corresponding author), OSAKA UNIV,INST SCI & IND RES,DEPT ORGAN CHEM & BIOCHEM,IBARAKI,OSAKA 567,JAPAN.		OMOTE, Hiroshi/B-1635-2011					CHOTHIA C, 1975, NATURE, V254, P304, DOI 10.1038/254304a0; CROSS RL, 1982, J BIOL CHEM, V257, P2101; DUNCAN TM, 1985, J BIOL CHEM, V260, P4901; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; FUTAI M, 1974, P NATL ACAD SCI USA, V71, P2725, DOI 10.1073/pnas.71.7.2725; FUTAI M, 1992, J EXP BIOL, V172, P443; HATEFI Y, 1982, P NATL ACAD SCI-BIOL, V79, P1756, DOI 10.1073/pnas.79.6.1756; HSU SY, 1987, FEBS LETT, V218, P222, DOI 10.1016/0014-5793(87)81050-5; IDA K, 1991, J BIOL CHEM, V266, P5424; IWAMOTO A, 1993, J BIOL CHEM, V268, P3156; IWAMOTO A, 1991, J BIOL CHEM, V266, P16350; KANAZAWA H, 1980, J BIOCHEM-TOKYO, V88, P695, DOI 10.1093/oxfordjournals.jbchem.a133022; KANAZAWA H, 1980, P NATL ACAD SCI-BIOL, V77, P7005, DOI 10.1073/pnas.77.12.7005; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; KUMAMOTO CA, 1987, J BIOL CHEM, V262, P3060; KUMAMOTO CA, 1986, J BIOL CHEM, V261, P37; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAGGIO MB, 1987, J BIOL CHEM, V262, P8981; MAGGIO MB, 1988, J BIOL CHEM, V263, P4619; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; NAKAJIMA H, 1979, J BIOCHEM-TOKYO, V85, P303, DOI 10.1093/oxfordjournals.jbchem.a132325; NAKAMOTO RK, 1993, J BIOL CHEM, V268, P867; NOUMI T, 1986, J BIOL CHEM, V261, P9196; NOUMI T, 1984, J BIOL CHEM, V259, P71; NOUUMI T, 1984, J BIOL CHEM, V259, P10076; OMOTE H, 1992, J BIOL CHEM, V267, P20571; PAGAN J, 1990, ARCH BIOCHEM BIOPHYS, V277, P283, DOI 10.1016/0003-9861(90)90580-R; PARSONAGE D, 1988, FEBS LETT, V232, P111, DOI 10.1016/0014-5793(88)80397-1; PARSONAGE D, 1987, J BIOL CHEM, V262, P6301; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SENIOR AE, 1993, J BIOL CHEM, V268, P6989; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; SENIOR AE, 1992, J BIOL CHEM, V267, P21471; SOGA S, 1989, ARCH BIOCHEM BIOPHYS, V268, P643, DOI 10.1016/0003-9861(89)90332-9; TAKEYAMA M, 1990, J BIOL CHEM, V265, P21279; TURINA P, 1993, J BIOL CHEM, V268, P6978; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x	41	28	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 8	1994	269	14					10265	10269						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NF017	8144607				2022-12-27	WOS:A1994NF01700017
J	KATZ, ML; CHRISTIANSON, JS; NORBURY, NE; GAO, CL; SIAKOTOS, AN; KOPPANG, N				KATZ, ML; CHRISTIANSON, JS; NORBURY, NE; GAO, CL; SIAKOTOS, AN; KOPPANG, N			LYSINE METHYLATION OF MITOCHONDRIAL ATP SYNTHASE SUBUNIT-C STORED IN TISSUES OF DOGS WITH HEREDITARY CEROID-LIPOFUSCINOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STORAGE BODY PROTEIN; BATTENS DISEASE; CARNITINE	Certain forms of ceroid lipofuscinosis, a hereditary degenerative disease, are characterized by accumulation of large amounts of subunit c of mitochondrial ATP synthase in lysosomal storage bodies of numerous tissues. The subunit c protein appears to constitute a major fraction of the total storage body protein. In previous studies it was demonstrated that hydrolysates of total storage body protein from affected humans and sheep contain significant amounts of epsilon-N-trimethyllysine (TML). This finding suggested that one or both of the two lysine residues of subunit c might be methylated in the stored form of the protein. The normal subunit c protein from mitochondria does not appear to be methylated. Using a putative canine model for the juvenile form of ceroid lipofuscinosis, analyses were conducted to determine whether lysosomal storage of subunit c was accompanied by lysine methylation of this protein. In affected dogs, as in humans and sheep with hereditary ceroid lipofuscinosis, the storage bodies were found to contain large amounts of subunit c protein, as indicated by polyacrylamide gel electrophoresis and partial amino acid sequence analysis. The subunit c protein partially purified from isolated storage bodies was found to contain lysine and TML in an almost equimolar ratio. Normal subunit c contains 2 lysine residues, one at position 7 and the other at position 43. Removal of the first 7 residues of the partially purifIed protein through sequential Edman degradation resulted in a dramatic increase in the TML to Lysine ratio in the residual protein. This suggests that lysine residue 43 is methylated. Confirmation that residue 43 of the stored protein is TML was obtained by amino acid sequence analysis after cleavage of the protein with trypsin. This finding strongly suggests that specific methylation of lysine residue 43 of mitochondrial ATP synthase plays a central role in the lysosomal storage of this protein.	INDIANA UNIV,SCH MED,DEPT PATHOL,INDIANAPOLIS,IN 46223; NATL VET INST,N-0033 OSLO,NORWAY	Indiana University System; Indiana University-Purdue University Indianapolis; Norwegian Veterinary Institute	KATZ, ML (corresponding author), UNIV MISSOURI,MASON INST OPHTHALMOL,COLUMBIA,MO 65212, USA.		Christianson, J Scott/E-7349-2018	Christianson, J Scott/0000-0002-7937-208X	NEI NIH HHS [EY08813] Funding Source: Medline; NINDS NIH HHS [NS30171, NS30155] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030155, R01NS030171] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; Boustany R M, 1988, Am J Med Genet Suppl, V5, P47; BRONSON RT, 1993, ANN NEUROL, V33, P381, DOI 10.1002/ana.410330408; Dyken P R, 1988, Am J Med Genet Suppl, V5, P69; FEARNLEY IM, 1990, BIOCHEM J, V268, P751, DOI 10.1042/bj2680751; Goebel H H, 1988, Am J Med Genet Suppl, V5, P127, DOI 10.1002/ajmg.1320310617; HALL NA, 1991, BIOCHEM J, V275, P269, DOI 10.1042/bj2750269; Jolly R D, 1988, Am J Med Genet Suppl, V5, P159, DOI 10.1002/ajmg.1320310619; JOLLY RD, 1980, NEUROPATH APPL NEURO, V6, P195, DOI 10.1111/j.1365-2990.1980.tb00290.x; KATZ ML, 1992, BIOCHIM BIOPHYS ACTA, V1138, P97, DOI 10.1016/0925-4439(92)90048-R; KATZ ML, 1984, EXP EYE RES, V38, P137, DOI 10.1016/0014-4835(84)90098-8; KATZ ML, 1991, AM J PATHOL, V138, P323; KOMINAMI E, 1992, J BIOCHEM, V111, P278, DOI 10.1093/oxfordjournals.jbchem.a123749; Koppang N, 1988, Am J Med Genet Suppl, V5, P117, DOI 10.1002/ajmg.1320310616; LABADIE J, 1976, BIOCHEM J, V160, P85, DOI 10.1042/bj1600085; Paik W. K., 1980, PROTEIN METHYLATION; Palmer D N, 1988, Am J Med Genet Suppl, V5, P141, DOI 10.1002/ajmg.1320310618; PALMER DN, 1993, J INHERIT METAB DIS, V16, P292, DOI 10.1007/BF00710268; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; PALMER DN, 1990, LIPOFUSCIN CEROID PI, P211; Park I. K., 1990, PROTEIN METHYLATION, P1; REBOUCHE CJ, 1991, AM J CLIN NUTR, V54, pS1147, DOI 10.1093/ajcn/54.6.1147s; SEBALD W, 1981, CURR TOP BIOENERG, V12, P1; SEBALD W, 1979, FUNCTION MOL ASPECTS, P63; Zimmerman HM, 1976, PROGR NEUROPATHOLOGY, V3, P203	25	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9906	9911						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144584				2022-12-27	WOS:A1994NE05300078
J	KIM, JS; SHANE, B				KIM, JS; SHANE, B			ROLE OF FOLYLPOLYGLUTAMATE SYNTHETASE IN THE METABOLISM AND CYTOTOXICITY OF 5-DEAZAACYCLOTETRAHYDROFOLATE, AN ANTI-PURINE DRUG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-LINES; RAT-LIVER; METHOTREXATE; RESISTANCE; ACID; POLYGLUTAMYLATION; ANALOG	Chinese hamster ovary (CHO) cells expressing human and Escherichia coli folylpolyglutamate synthetase (FPGS) activities were used as models to study factors regulating the cytotoxicity and metabolism of 5-deazaacyclotetrahydrofolate (DATHF), an anti-purine agent that requires conversion to polyglutamate forms to be a potent inhibitor of its target enzymes. The sensitivity of cells continuously exposed to DATHF was not influenced by FPGS activity. After short term exposure to DATHF, cells expressing higher levels of human FPGS were more sensitive to the drug while cells expressing low levels were resistant. Cells expressing E. coli FPGS solely in the cytosol were resistant to DATHF and accumulated only low levels of the drug. Expression of E. coli FPGS in the mitochondria of these cells restored drug sensitivity and cytosolic drug accumulation. DATHF is extensively metabolized in the mitochondria of mammalian cells and, despite an inability to enter the mitochondria, folylpolyglutamates and DATHF polyglutamates formed in the mitochondria are released into the cytosol without prior hydrolysis. DATHF was not solely an inhibitor of de novo purine biosynthesis but also inhibited glycine synthesis in the cell.	UNIV CALIF BERKELEY,DEPT NUTR SCI,BERKELEY,CA 94720	University of California System; University of California Berkeley					NCI NIH HHS [CA-41991] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041991] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARREDO J, 1992, MOL PHARMACOL, V42, P687; BEARDSLEY GP, 1989, J BIOL CHEM, V264, P328; BEARDSLEY GP, 1990, CHEMISTRY AND BIOLOGY OF PTERIDINES 1989, P1001; CHABNER BA, 1985, J CLIN INVEST, V76, P907, DOI 10.1172/JCI112088; CICHOWICZ DJ, 1987, BIOCHEMISTRY-US, V26, P504, DOI 10.1021/bi00376a024; HANLON MH, 1990, CANCER RES, V50, P3207; HORNE DW, 1992, J NUTR, V122, P2204, DOI 10.1093/jn/122.11.2204; KELLEY JL, 1990, J MED CHEM, V33, P561, DOI 10.1021/jm00164a014; KIM JS, 1993, J BIOL CHEM, V268, P21680; Lenz H.-J., 1993, Proceedings of the American Association for Cancer Research Annual Meeting, V34, P504; LI WW, 1992, CANCER RES, V52, P1434; LI WW, 1992, CANCER RES, V52, P3908; LIN BF, 1993, J BIOL CHEM, V268, P21674; LIN BF, 1994, J BIOL CHEM, V269, P9705; LOWE KE, 1993, J BIOL CHEM, V268, P21665; MCCLOSKEY DE, 1991, J BIOL CHEM, V266, P6181; MORAN RG, 1985, MOL PHARMACOL, V27, P156; OSBORNE CB, 1993, J BIOL CHEM, V268, P21657; PIZZORNO G, 1988, CANCER RES, V48, P2149; PIZZORNO G, 1989, CANCER RES, V49, P5275; SOKOLOSKI JA, 1989, CANCER RES, V49, P4824; TAYLOR RT, 1982, ARCH BIOCHEM BIOPHYS, V217, P609, DOI 10.1016/0003-9861(82)90543-4; WILSON SD, 1984, ANAL BIOCHEM, V142, P529, DOI 10.1016/0003-2697(84)90502-5	23	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9714	9720						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144562				2022-12-27	WOS:A1994NE05300051
J	MAEDA, T; WATANABE, Y; KUNITOMO, H; YAMAMOTO, M				MAEDA, T; WATANABE, Y; KUNITOMO, H; YAMAMOTO, M			CLONING OF THE PKA1 GENE ENCODING THE CATALYTIC SUBUNIT OF THE CAMP-DEPENDENT PROTEIN-KINASE IN SCHIZOSACCHAROMYCES-POMBE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; SACCHAROMYCES-CEREVISIAE; SEXUAL DEVELOPMENT; ADENYLYL CYCLASE; CDC25 GENE; FBP1 GENE; MEIOSIS; SEQUENCE; MUTANTS; PATHWAY	We have isolated Schizosaccharomyces pombe genes that confer sterility to the fission yeast cell when expressed from a multicopy plasmid. One of these genes strongly hybridized to a probe carrying the open reading frame of Saccharomyces cerevisiae TPK1, which encodes a catalytic subunit of the cAMP-dependent protein kinase (protein kinase A). This S. pombe gene, named pka1, has a coding potential of 512 amino acids, and the deduced gene product is 60% identical with the S. cerevisiae Tpk1 protein in the C-terminal 320 amino acids. Disruption of pka1 slows cell growth but is not lethal. The resultant cells, however, are highly derepressed for sexual development, readily undergoing conjugation and sporulation in the absence of nitrogen starvation. They are, thus, phenotypically indistinguishable from the adenylyl cyclase-defective (cyr1-) cells previously characterized, except that the pka1- spores are retarded in germination, whereas the cyr1- spores are not. Disruption of pka1 is epistatic to a defect in cgs1, which encodes the regulatory subunit of protein kinase A. These results strongly suggest that the product of pka1 is a catalytic subunit of protein kinase A and, furthermore, that S. pombe has only one gene encoding it. This situation contrasts with the case of S. cerevisiae, in which three genes encode the catalytic subunits.	UNIV TOKYO,SCH SCI,DEPT BIOPHYS & BIOCHEM,TOKYO 113,JAPAN	University of Tokyo			KUNITOMO, HIROFUMI/G-4963-2014	KUNITOMO, HIROFUMI/0000-0001-7312-7051; Watanabe, Yoshinori/0000-0002-5488-4812				BEACH D, 1982, MOL GEN GENET, V187, P326, DOI 10.1007/BF00331138; BEACH D, 1985, CURR GENET, V10, P297, DOI 10.1007/BF00365626; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; CALLEJA GB, 1980, PLANT CELL PHYSIOL, V21, P613, DOI 10.1093/oxfordjournals.pcp.a076036; CAMONIS JH, 1986, EMBO J, V5, P375, DOI 10.1002/j.1460-2075.1986.tb04222.x; DEVOTI J, 1991, EMBO J, V10, P3759, DOI 10.1002/j.1460-2075.1991.tb04945.x; EGEL R, 1974, EXP CELL RES, V88, P127, DOI 10.1016/0014-4827(74)90626-0; FOSTER JL, 1988, J BIOL CHEM, V263, P1676; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; Gutz H., 1974, HDB GENETICS, V1, P395; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HOFFMAN CS, 1990, GENETICS, V124, P807; HOFFMAN CS, 1991, GENE DEV, V5, P561, DOI 10.1101/gad.5.4.561; IINO Y, 1985, P NATL ACAD SCI USA, V82, P2447, DOI 10.1073/pnas.82.8.2447; IINO Y, 1985, MOL GEN GENET, V198, P416, DOI 10.1007/BF00332932; IINO Y, 1991, EMBO J, V10, P221, DOI 10.1002/j.1460-2075.1991.tb07939.x; ISSHIKI T, 1992, GENE DEV, V6, P2455, DOI 10.1101/gad.6.12b.2455; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KALDERON D, 1988, GENE DEV, V2, P1539, DOI 10.1101/gad.2.12a.1539; KAWAMUKAI M, 1991, CELL REGUL, V2, P155, DOI 10.1091/mbc.2.2.155; MAEDA T, 1990, P NATL ACAD SCI USA, V87, P7814, DOI 10.1073/pnas.87.20.7814; Matsumoto K, 1985, Yeast, V1, P15, DOI 10.1002/yea.320010103; MOCHIZUKI N, 1992, MOL GEN GENET, V233, P17, DOI 10.1007/BF00587556; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NURSE P, 1985, MOL GEN GENET, V198, P497, DOI 10.1007/BF00332946; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Robinson GA, 1971, CYCLIC AMP; ROBINSON LC, 1987, SCIENCE, V235, P1218, DOI 10.1126/science.3547648; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sherman F., 1986, METHODS YEAST GENETI; SHOJI S, 1983, BIOCHEMISTRY-US, V22, P3702, DOI 10.1021/bi00284a025; Southern E, 1979, Methods Enzymol, V68, P152; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; THOMAS PS, 1980, P NATL ACAD SCI USA, V77, P520; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; WATANABE Y, 1988, EMBO J, V7, P761, DOI 10.1002/j.1460-2075.1988.tb02873.x; YAMAWAKIKATAOKA Y, 1989, P NATL ACAD SCI USA, V86, P5693, DOI 10.1073/pnas.86.15.5693; YOUNG D, 1989, P NATL ACAD SCI USA, V86, P7989, DOI 10.1073/pnas.86.20.7989	42	130	132	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9632	9637						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144551				2022-12-27	WOS:A1994NE05300038
J	SIVARAM, P; CHOI, SY; CURTISS, LK; GOLDBERG, IJ				SIVARAM, P; CHOI, SY; CURTISS, LK; GOLDBERG, IJ			AN AMINO-TERMINAL FRAGMENT OF APOLIPOPROTEIN-B BINDS TO LIPOPROTEIN-LIPASE AND MAY FACILITATE ITS BINDING TO ENDOTHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							FIBROBLAST GROWTH-FACTOR; LOW-DENSITY LIPOPROTEINS; RECEPTOR-RELATED PROTEIN; HEPARAN-SULFATE; PLASMA-LIPOPROTEINS; SURFACE; IDENTIFICATION; EMULSION; B-100	Lipoprotein lipase (LPL), the principal enzyme which hydrolyzes triglycerides in circulating plasma lipoproteins, functions while bound to the luminal surface of endothelial cells. LPL is a heparin-binding protein and has been assumed to associate with endothelial cell heparan sulfate proteoglycans (HSPG). Recently, using ligand blotting and affinity chromatography we identified a 116-kDa heparin-releasable LPL-binding protein (hrp-116) from endothelial cells which was not a HSPG (Sivaram, P., Klein, M. G., and Goldberg, I. J. (1992) J. Biol. Chem. 267,16517-16522). This suggested that, like a number of other heparin-binding proteins, LPL binding to cells also involves non-HSPG proteins. Using heparin-agarose affinity chromatography, a 116-kDa LPL-binding protein was purified from endothelial cell extracts. Microsequencing of peptides generated by Lys-C protease digestion revealed complete homology with four different regions in the NH2-terminal part of human apolipoprotein B (apoB). Western blots using anti-apoB monoclonal antibodies (mAb) that recognize the NH2-terminal region of apoB confirmed that a 116-kDa fragment of apoB was present on endothelial cell membranes. Further evidence that LPL associates with the NH2-terminal region of apoB was obtained by showing 1) that an NH2-terminal fragment of apoB obtained from apoB-transfected CHO cells bound LPL on ligand blots and 2) that NH 2-terminal fragments of apoB generated by thrombin digestion of low density lipoprotein bind LPL. Evidence that the NH2-terminal region of apoB mediates LPL interaction with endothelial cells was obtained using monoclonal antibodies. mAb3 and mAb19, which recognize epitopes near the NH2 terminus of apoB, inhibited I-125-LPL binding to cells by 60-65%. In contrast, mAb47, which has determinants at the COOH-terminal end of apoB, inhibited LPL binding by only about 10%. The inhibitory effects of mAb3 and mAb19 were abolished following treatment of cells with heparin, which removes the 116-kDa LPL-binding protein. Furthermore, incubation of I-125-LPL in medium containing an NH2-terminal apoB fragment reduced LPL binding to cells. These data suggest that an NH2-terminal fragment of apoB that binds to endothelial surfaces facilitates LPL binding to cells.	COLUMBIA UNIV COLL PHYS & SURG, DEPT MED, 630 W 168TH ST, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, SPECIALIZED CTR RES ARTERIOSCLEROSIS, NEW YORK, NY 10032 USA; SCRIPPS RES INST, LA JOLLA, CA 92037 USA	Columbia University; Columbia University; Scripps Research Institute					NHLBI NIH HHS [HL 21006, HL 45095] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045095, R37HL045095, P50HL021006] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATHA DH, 1984, P NATL ACAD SCI-BIOL, V81, P1030, DOI 10.1073/pnas.81.4.1030; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CHAN L, 1992, J BIOL CHEM, V267, P25621; CHAPPELL DA, 1992, J BIOL CHEM, V267, P25764; CURTISS LK, 1982, J BIOL CHEM, V257, P5213; DECKELBAUM RJ, 1990, BIOCHEMISTRY-US, V29, P1136, DOI 10.1021/bi00457a006; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; FORGEZ P, 1986, BIOCHEM BIOPH RES CO, V140, P250, DOI 10.1016/0006-291X(86)91083-1; GOLDBERG IJ, 1986, J CLIN INVEST, V78, P1523, DOI 10.1172/JCI112744; JACKSON RL, 1985, FEBS LETT, V190, P297, DOI 10.1016/0014-5793(85)81304-1; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; KOUNNAS MZ, 1993, J BIOL CHEM, V268, P14176; LOETSCHER H, 1990, CELL, V61, P352; MAHLEY RW, 1979, BIOCHIM BIOPHYS ACTA, V575, P81, DOI 10.1016/0005-2760(79)90133-4; MCKEONE BJ, 1993, J CLIN INVEST, V91, P1926, DOI 10.1172/JCI116411; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P3; NILSSONEHLE P, 1976, J LIPID RES, V17, P536; Olivecrona Thomas, 1993, Current Opinion in Lipidology, V4, P187, DOI 10.1097/00041433-199306000-00003; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; SAXENA U, 1991, J BIOL CHEM, V266, P17516; SAXENA U, 1992, J CLIN INVEST, V89, P373, DOI 10.1172/JCI115595; SAXENA U, 1990, J BIOL CHEM, V265, P12880; SHIMADA K, 1985, J CLIN INVEST, V75, P1308, DOI 10.1172/JCI111831; SHIMADA K, 1981, BIOCHIM BIOPHYS ACTA, V710, P117; SIVARAM P, 1992, J BIOL CHEM, V267, P16517; SIVARAM P, 1993, ANAL BIOCHEM, V214, P511, DOI 10.1006/abio.1993.1531; SOCORRO L, 1985, PREP BIOCHEM, V15, P133, DOI 10.1080/10826068508062267; STINS MF, 1993, J LIPID RES, V34, P1853; TENG BB, 1990, J BIOL CHEM, V265, P20616; THRIFT RN, 1992, P NATL ACAD SCI USA, V89, P9161, DOI 10.1073/pnas.89.19.9161; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; WEISGRABER KH, 1987, J BIOL CHEM, V262; YANG CY, 1989, ARTERIOSCLEROSIS, V9, P96, DOI 10.1161/01.ATV.9.1.96; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; YOUNG SG, 1987, J BIOL CHEM, V262, P16604	37	55	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9409	9412						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144523				2022-12-27	WOS:A1994NE05300004
J	TANSEY, MG; LUBYPHELPS, K; KAMM, KE; STULL, JT				TANSEY, MG; LUBYPHELPS, K; KAMM, KE; STULL, JT			CA2+-DEPENDENT PHOSPHORYLATION OF MYOSIN LIGHT-CHAIN KINASE DECREASES THE CA2+ SENSITIVITY OF LIGHT-CHAIN PHOSPHORYLATION WITHIN SMOOTH-MUSCLE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; RABBIT MESENTERIC-ARTERY; PHOTOBLEACHING RECOVERY; F-ACTIN; CALMODULIN; CONTRACTION; RELAXATION; DIFFUSION; SKELETAL; BINDING	Myosin light chain kinase (MLCK) is phosphorylated in contracting smooth muscle. The rate of phosphorylation of MLCK is slower than the rates of increase in cytosolic Ca2+ concentrations and phosphorylation of the regulatory light chain of myosin in intact tracheal smooth muscle cells in culture. In permeable cells, increasing the Ca2+ concentration increased the extent of myosin light chain and MLCK phosphorylation. The Ca2+ concentration required for half-maximal phosphorylation was 500 nM for MLCK and 250 nM for myosin light chain. Addition of KN-62 or a synthetic peptide CK II, inhibitors of multifunctional Ca2+/calmodulin-dependent protein kinase II activity, abolished MLCK phosphorylation. Under these conditions, the Ca2+ concentration required for half-maximal light chain phosphorylation decreased to 170 nM. Thus, the Ca2+ concentrations required for MLCK phosphorylation are greater than those required for light chain phosphorylation in smooth muscle cells. Furthermore, phosphorylation of MLCK decreases the Ca2+ sensitivity of light chain phosphorylation. These results can be explained by a regulatory scheme in which calmodulin available for myosin light chain kinase activation is limiting. This is supported by the retention of calmodulin when tracheal smooth muscle cells and tissues are permeabilized in relaxing solution and by the low mobility of rhodamine-calmodulin in intact tracheal smooth muscle cells.	UNIV TEXAS, SW MED CTR, DEPT PHYSIOL, 5323 HARRY HINES BLVD, DALLAS, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas				Luby-Phelps, Katherine/0000-0002-8378-1409	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR007354] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032607, R37HL026043, R23HL032607, R01HL026043] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR07354] Funding Source: Medline; NHLBI NIH HHS [HL 32607, HL 26043] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOWMAN BF, 1992, J BIOL CHEM, V267, P5346; COHEN DM, 1978, J GEN PHYSIOL, V72, P369, DOI 10.1085/jgp.72.3.369; COLBRAN RJ, 1989, BIOCHEM J, V258, P313, DOI 10.1042/bj2580313; ELSON EL, 1989, METHOD CELL BIOL, V30, P307; FUJIWARA T, 1989, J PHYSIOL-LONDON, V408, P535, DOI 10.1113/jphysiol.1989.sp017474; GARDNER JP, 1989, PFLUG ARCH EUR J PHY, V414, P484, DOI 10.1007/BF00585061; GOUGH AH, 1993, J CELL BIOL, V121, P1095, DOI 10.1083/jcb.121.5.1095; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAI CM, 1989, ANNU REV PHYSIOL, V51, P285, DOI 10.1146/annurev.physiol.51.1.285; HARTSHORNE DJ, 1987, PHYSL GASTROINTESTIN, P423; HASHIMOTO Y, 1990, ARCH BIOCHEM BIOPHYS, V278, P41, DOI 10.1016/0003-9861(90)90228-Q; HINRICHSEN RD, 1993, P NATL ACAD SCI USA, V90, P1585, DOI 10.1073/pnas.90.4.1585; HOU L, 1990, BIOPHYS J, V58, P31, DOI 10.1016/S0006-3495(90)82351-1; IKEBE M, 1990, J BIOL CHEM, V265, P8975; ITOH T, 1986, J PHYSIOL-LONDON, V376, P231, DOI 10.1113/jphysiol.1986.sp016151; KAMM KE, 1989, J BIOL CHEM, V264, P21223; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; KITAZAWA T, 1991, J BIOL CHEM, V266, P1708; KLEE CB, 1991, NEUROCHEM RES, V16, P1059, DOI 10.1007/BF00965851; KUBOTA Y, 1992, AM J PHYSIOL, V262, pC405, DOI 10.1152/ajpcell.1992.262.2.C405; LUBYPHELPS K, 1985, J CELL BIOL, V101, P1245, DOI 10.1083/jcb.101.4.1245; MEISHERI KD, 1985, CALCIUM CONTRACTILIT, P191; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER JR, 1983, MOL PHARMACOL, V24, P235; MOCHIZUKI H, 1993, J BIOL CHEM, V268, P9143; MORELAND RS, 1986, AM J PHYSIOL, V251, pC892, DOI 10.1152/ajpcell.1986.251.6.C892; OWENS GK, 1986, J CELL BIOL, V102, P343, DOI 10.1083/jcb.102.2.343; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; PROVANCE DW, 1993, J CELL SCI, V106, P565; REMBOLD CM, 1988, CIRC RES, V63, P593, DOI 10.1161/01.RES.63.3.593; RUEGG JC, 1984, FEBS LETT, V170, P383, DOI 10.1016/0014-5793(84)81349-6; SIMON JR, 1988, BIOPHYS J, V54, P801, DOI 10.1016/S0006-3495(88)83018-2; STULL JT, 1978, J BIOL CHEM, V253, P5932; STULL JT, 1983, FED PROC, V42, P21; STULL JT, 1990, J BIOL CHEM, V265, P16683; STULL JT, 1986, ENZYMES, V17, P113; TANG DC, 1992, J BIOL CHEM, V267, P11839; TANG DC, 1993, FEBS LETT, V331, P272, DOI 10.1016/0014-5793(93)80351-T; TANSEY MG, 1992, J BIOL CHEM, V267, P12511; TAYLOR DA, 1988, J BIOL CHEM, V263, P14456; TAYLOR DA, 1989, J BIOL CHEM, V264, P6207; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; TSIEN RY, 1982, J CELL BIOL, V94, P325, DOI 10.1083/jcb.94.2.325	43	146	149	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9912	9920						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144585				2022-12-27	WOS:A1994NE05300079
J	DEBOLAND, AR; MORELLI, S; BOLAND, R				DEBOLAND, AR; MORELLI, S; BOLAND, R			1,25(OH)(2)-VITAMIN D-3 SIGNAL-TRANSDUCTION IN CHICK MYOBLASTS INVOLVES PHOSPHATIDYLCHOLINE HYDROLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PHOSPHOLIPASE-D ACTIVATION; MUSCLE CALCIUM-UPTAKE; SKELETAL-MUSCLE; HL-60 GRANULOCYTES; PHOSPHATIDIC-ACID; 12-O-TETRADECANOYLPHORBOL 13-ACETATE; PHOSPHOINOSITIDE HYDROLYSIS; DIACYLGLYCEROL FORMATION; ENDOTHELIAL-CELLS	1,25-Dihydroxyvitamin D-3 (1,25(OH)(2)D-3) rapidly stimulates the biphasic formation of diacylglycerol (DAG) in chick myoblasts. Neomycin (0.5 mM), an inhibitor of phosphoinositide hydrolysis, abolished the first phase (1 min) but had no effect on the second 1,25(OH)(2)D-3-induced DAG peak (5 min). In myoblasts prelabeled with [H-3]choline, 1,25(OH)(2)D-3 increased the release of [H-3]choline (maximally at 5 min), with a concomitant decrease in phosphatidylcholine and the absence of significant changes in phosphocholine. 1,25(OH)(2)D-3 caused a significant increase in phosphatidylethanol (PEt) formation in myoblasts in the presence of 1.5% ethanol. The effects of 1,25(OH)(2)D-3 were time- and dose-dependent (10(-11) to 10(-8) M) and specific as 25OHD(3) and 24,25(OH)(2)D-3 failed to accumulate PEt. 12-O-Tetradecanoylphorbol-13-acetate also stimulated PEt formation. The combination of 1,25(OH)(2)D-3 and 12-O-tetradecanoylphorbol-13-acetate was more effective than either compound alone. Neither the PKC inhibitor H-7 nor PKC down-regulation blocked the hormone-induced increase in PEt. The effects of 1,25(OH)(2)D-3 were, however, inhibited in the absence of extracellular Ca2+ (+EGTA) and by nifedipine and verapamil, whereas the Ca2+ ionophore A23181 also increased PEt generation. The data support the notion that 1,25(OH)(2)D-3 triggers the hydrolysis of phosphatidylcholine in myoblasts through a Ca2+-dependent, PKC-independent, phospholipase D-catalyzed mechanism.	UNIV NACL SUR,DEPT BIOL,RA-8000 BAHIA BLANCA,ARGENTINA	National University of the South								ANTHES JC, 1989, BIOCHEM BIOPH RES CO, V163, P657, DOI 10.1016/0006-291X(89)92187-6; BELLIDO T, 1993, MOL CELL ENDOCRINOL, V90, P231, DOI 10.1016/0303-7207(93)90156-E; BESTERMAN JM, 1986, P NATL ACAD SCI USA, V83, P6785, DOI 10.1073/pnas.83.18.6785; BILLAH MM, 1989, J BIOL CHEM, V264, P9069; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; BOCCKINO SB, 1987, J BIOL CHEM, V262, P15309; BOLAND R, 1986, ENDOCR REV, V7, P434, DOI 10.1210/edrv-7-4-434; CABOT MC, 1988, BIOCHIM BIOPHYS ACTA, V959, P46, DOI 10.1016/0005-2760(88)90148-8; CABOT MC, 1988, FEBS LETT, V233, P153, DOI 10.1016/0014-5793(88)81374-7; DEBOLAND AR, 1987, ENDOCRINOLOGY, V120, P1858, DOI 10.1210/endo-120-5-1858; EXTON JH, 1990, J BIOL CHEM, V265, P1; FERNANDEZ LM, 1990, CALCIFIED TISSUE INT, V47, P314, DOI 10.1007/BF02555915; FOLCH J, 1957, J BIOL CHEM, V226, P497; GIULIANI DL, 1984, CALCIFIED TISSUE INT, V36, P200, DOI 10.1007/BF02405318; GRILLONE LR, 1988, J BIOL CHEM, V263, P2658; GUY GR, 1982, CANCER RES, V42, P1980; IRVING HR, 1987, J BIOL CHEM, V262, P3440; JALINK K, 1990, J BIOL CHEM, V265, P12232; KESTER M, 1992, J CELL PHYSIOL, V150, P578, DOI 10.1002/jcp.1041500319; LISCOVITCH M, 1989, J BIOL CHEM, V264, P11762; LISCOVITCH M, 1989, J BIOL CHEM, V264, P1450; LISCOVITCH M, 1987, BIOCHEM J, V241, P81, DOI 10.1042/bj2410081; MARTIN TW, 1989, BIOCHEM BIOPH RES CO, V165, P319, DOI 10.1016/0006-291X(89)91072-3; MARTIN TW, 1988, BIOCHIM BIOPHYS ACTA, V962, P282, DOI 10.1016/0005-2760(88)90258-5; MASSHEIMER V, 1992, BIOCHEM J, V281, P349, DOI 10.1042/bj2810349; MORELLI S, 1993, BIOCHEM J, V289, P675, DOI 10.1042/bj2890675; MUIR JG, 1987, J CELL PHYSIOL, V130, P382, DOI 10.1002/jcp.1041300311; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OLSON SC, 1991, J BIOL CHEM, V266, P17236; ONEILL MC, 1972, J CELL BIOL, V52, P52, DOI 10.1083/jcb.52.1.52; PAI JK, 1988, J BIOL CHEM, V263, P12472; PELECH SL, 1989, TRENDS BIOCHEM SCI, V14, P28, DOI 10.1016/0968-0004(89)90086-8; POLVERINO AJ, 1988, BIOCHIM BIOPHYS ACTA, V970, P75, DOI 10.1016/0167-4889(88)90224-8; PUTNEY JW, 1980, NATURE, V284, P345, DOI 10.1038/284345a0; QIAN Z, 1990, J BIOL CHEM, V265, P3607; REINHOLD SL, 1990, FASEB J, V4, P208, DOI 10.1096/fasebj.4.2.2105252; TAKAI T, 1979, J BIOL CHEM, V254, P9761; TAKUWA N, 1987, BIOCHEM J, V243, P647, DOI 10.1042/bj2430647	38	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8675	8679						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132595				2022-12-27	WOS:A1994NB41100011
J	HARAGUCHI, Y; CHUNG, AB; NEILL, S; WALLACE, DC				HARAGUCHI, Y; CHUNG, AB; NEILL, S; WALLACE, DC			OXBOX AND REBOX, OVERLAPPING PROMOTER ELEMENTS OF THE MITOCHONDRIAL F0F1-ATP SYNTHASE BETA-SUBUNIT GENE - OXBOX/REBOX IN THE ATPSYN-BETA PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE ADP/ATP TRANSLOCATOR; OXIDATIVE-PHOSPHORYLATION; DIFFERENTIAL EXPRESSION; TRANSCRIPTIONAL CONTROL; NUCLEAR GENES; SEQUENCE; DNA; GENOME; CELLS	Three positive (PR1-3) and one negative (NR1) transcriptional control domain have been tentatively mapped in the promoter of the human F0F1-ATP synthase beta subunit gene (ATPsyn beta) in the context of expression in myogenic cells. Lipofection of promoter-chloramphenicol acetyltransferase fusion constructs into C2C12 myogenic cells revealed that two of the three positive domains (PR1 and PR2) function in both myoblasts and myotubes, whereas the third positive domain (PR3) and the sole negative domain (NR1) seem to function only in myotubes. PR1 contains a cluster of four CCAAT cis-elements, PR2 is a small 44-base pair region containing an SP1-like motif, and PR3 is a region previously shown to be recognized by both OXBOX- and REBOX-binding factors. By site-directed polymerase chain reaction linker mutations, the activity of the OXBOX/REBOX cis-element in myoblasts is shown to be masked by flanking sequences in PR3. The negative domain, NR1, is located between 300 and 1,000 base pairs upstream from the OXBOX/REBOX elements in a region containing multiple ALu repeats. Mobility gel shift analysis of DNA-protein complexes using competitor DNAs verified the involvement of both OXBOX- and REBOX-binding factors in PR3. Similar experiments show SP1-specific binding at PR2. These data with observations of OXBOX and REBOX-specific binding of an OXBOX/REBOX-like region within the conserved sequence block C of the human mitochondrial DNA D-loop sequence are consistent with the idea that OXBOX and REBOX DNA-binding factors coordinate the expression of mitochondrial energy genes in highly oxidative tissues by working with well characterized general transcription factors such as SP1 and CCAAT DNA-binding proteins, which exist in the nucleus, and MTF, which exists in the mitochondrion.	EMORY UNIV,SCH MED,DEPT GENET & MOLEC MED,ATLANTA,GA 30322	Emory University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045572] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45572] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; CHODOSH LA, 1988, CURRENT PROTOCOLS MO; CHUNG AB, 1992, J BIOL CHEM, V267, P21154; CHUNG AB, 1993, THESIS EMORY U GRADU; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; HEDDI A, 1993, J BIOL CHEM, V268, P12156; IZQUIERDO JM, 1990, J BIOL CHEM, V265, P9090; KAGAWA Y, 1990, INT J BIOCHEM, V22, P219; KINGSTON RE, 1988, CURRENT PROTOCOLS MO; LI K, 1989, J BIOL CHEM, V264, P13998; LI K, 1990, J BIOL CHEM, V265, P20585; LUCIAKOVA K, 1992, EUR J BIOCHEM, V207, P252; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MIGNOTTE F, 1991, BIOL CELL, V71, P67, DOI 10.1016/0248-4900(91)90052-O; NECKELMANN N, 1989, GENOMICS, V5, P829, DOI 10.1016/0888-7543(89)90125-0; OHTA S, 1988, J BIOL CHEM, V263, P11257; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; SUZUKI H, 1991, J BIOL CHEM, V266, P2333; TOMURA H, 1990, J BIOL CHEM, V265, P6525; TORRONI A, 1990, J BIOL CHEM, V265, P20589; WEBSTER KA, 1990, J CELL PHYSIOL, V142, P566, DOI 10.1002/jcp.1041420316; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	27	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9330	9334						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132672				2022-12-27	WOS:A1994NB41100103
J	FONTES, EPB; EAGLE, PA; SIPE, PS; LUCKOW, VA; HANLEYBOWDOIN, L				FONTES, EPB; EAGLE, PA; SIPE, PS; LUCKOW, VA; HANLEYBOWDOIN, L			INTERACTION BETWEEN A GEMINIVIRUS REPLICATION PROTEIN AND ORIGIN DNA IS ESSENTIAL FOR VIRAL REPLICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLDEN MOSAIC-VIRUS; CASSAVA LATENT VIRUS; B-GENOME COMPONENT; MAIZE STREAK VIRUS; WHEAT DWARF VIRUS; COAT PROTEIN; NUCLEOTIDE-SEQUENCE; SYMPTOM DEVELOPMENT; INITIATOR PROTEINS; TRANSGENIC PLANTS	The geminivirus, tomato golden mosaic virus (TGMV), encodes one protein, AL1, that is absolutely required for viral DNA replication. AL1 interacts with the TGMV DNA genome by binding specifically to the viral origin of replication. We have investigated the nature and significance of AL1/origin interactions in vitro and in vivo by using competitive DNA binding and transient replication assays. Competition assays established that a 13-base pair (bp) element (5'-GGTAGTAAGGTAG) containing two 5-bp direct repeat motifs separated by a 3-bp central core constitutes a high affinity AL1 binding site. DNAs containing intact 3' repeat sequences plus core (TAAGGTAG and ccTAGTAAGGTAG) were stronger competitors for AL1 binding than DNAs containing intact 5' repeat sequences plus core (GGTAGTAA and GGTAGTA-AccTAG), thereby demonstrating that AL1 interacts differently with the repeat motifs. Replication in tobacco protoplasts established that the AL1 binding site is an essential cis-acting element for viral replication. No replication was detected for DNAs containing mutations in either of the repeat motifs of the AL1 recognition sequence when AL1 was provided in trans from a plant gene expression vector. In contrast, a DNA with a mutation in the 5' repeat motif (ccTAGTAAGGTAG) replicated when both AL1 and AL3, a TGMV protein involved in viral DNA accumulation, were provided in trans. No replication was detected for a DNA containing a mutation in the 3' repeat motif (GGTAGTAAccTAG) in the presence of AL1 and AL3. The in vitro and in vivo results suggest that binding of AL1 to the 3' repeat element is an essential step in DNA replication, while binding to the 5' repeat element may serve to enhance viral replication.	N CAROLINA STATE UNIV,DEPT BIOCHEM,RALEIGH,NC 27695; MONSANTO CO,CORP RES,ST LOUIS,MO 63198	University of North Carolina; North Carolina State University; Monsanto			Fontes, Elizabeth/K-3159-2012	Fontes, Elizabeth/0000-0002-7986-1369				ACCOTTO GP, 1989, EMBO J, V8, P1033, DOI 10.1002/j.1460-2075.1989.tb03470.x; AN GH, 1985, PLANT PHYSIOL, V79, P568, DOI 10.1104/pp.79.2.568; BISARO DM, 1982, NUCLEIC ACIDS RES, V10, P4913, DOI 10.1093/nar/10.16.4913; BOULTON MI, 1993, VIROLOGY, V192, P85, DOI 10.1006/viro.1993.1010; BRIDDON RW, 1989, VIROLOGY, V172, P628, DOI 10.1016/0042-6822(89)90205-5; BROUGH CL, 1988, J GEN VIROL, V69, P503, DOI 10.1099/0022-1317-69-3-503; CORUZZI G, 1984, EMBO J, V3, P1671, DOI 10.1002/j.1460-2075.1984.tb02031.x; DAVIES JW, 1989, TRENDS GENET, V5, P77, DOI 10.1016/0168-9525(89)90030-9; ELMER JS, 1988, PLANT MOL BIOL, V10, P225, DOI 10.1007/BF00027399; ELMER JS, 1988, NUCLEIC ACIDS RES, V16, P7043, DOI 10.1093/nar/16.14.7043; ETESSAMI P, 1991, J GEN VIROL, V72, P1005, DOI 10.1099/0022-1317-72-5-1005; FARIA J C, 1990, Phytopathology, V80, P983; FONTES EPB, 1992, PLANT CELL, V4, P597, DOI 10.1105/tpc.4.5.597; FRISCHMUTH S, 1991, VIROLOGY, V185, P596, DOI 10.1016/0042-6822(91)90530-O; FRISCHMUTH T, 1993, VIROLOGY, V196, P666, DOI 10.1006/viro.1993.1523; GILBERTSON RL, 1993, J GEN VIROL, V74, P23, DOI 10.1099/0022-1317-74-1-23; HALEY A, 1992, VIROLOGY, V188, P905, DOI 10.1016/0042-6822(92)90551-Y; HAMILTON WDO, 1984, EMBO J, V3, P2197, DOI 10.1002/j.1460-2075.1984.tb02114.x; HANLEYBOWDOIN L, 1990, P NATL ACAD SCI USA, V87, P1446, DOI 10.1073/pnas.87.4.1446; HANLEYBOWDOIN L, 1988, NUCLEIC ACIDS RES, V16, P10511, DOI 10.1093/nar/16.22.10511; HARRISON BD, 1985, ANNU REV PHYTOPATHOL, V23, P55, DOI 10.1146/annurev.py.23.090185.000415; HEYRAUD F, 1993, EMBO J, V12, P4445, DOI 10.1002/j.1460-2075.1993.tb06130.x; HOWARTH AJ, 1989, J GEN VIROL, V70, P2717, DOI 10.1099/0022-1317-70-10-2717; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; JUNGHANS H, 1990, BIOTECHNIQUES, V8, P176; KAY R, 1987, SCIENCE, V236, P1299, DOI 10.1126/science.236.4806.1299; KELLY TJ, 1988, J BIOL CHEM, V263, P17889; KOONIN EV, 1992, J GEN VIROL, V73, P2763, DOI 10.1099/0022-1317-73-10-2763; Kornberg A., 1992, DNA REPLICATION; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P482; LAZAROWITZ SG, 1989, EMBO J, V8, P1023, DOI 10.1002/j.1460-2075.1989.tb03469.x; LAZAROWITZ SG, 1991, VIROLOGY, V180, P70, DOI 10.1016/0042-6822(91)90010-9; LAZAROWITZ SG, 1992, PLANT CELL, V4, P799, DOI 10.1105/tpc.4.7.799; LAZAROWITZ SG, 1992, CRIT REV PLANT SCI, V11, P327, DOI [10.1080/07352689209382350, 10.1080/713608038]; LIN HJL, 1992, J VIROL, V66, P5443, DOI 10.1128/JVI.66.9.5443-5452.1992; MORRIS B, 1990, NUCLEIC ACIDS RES, V18, P197, DOI 10.1093/nar/18.1.197; MULLINEAUX PM, 1985, PLANT MOL BIOL, V5, P125, DOI 10.1007/BF00020095; MYERS RM, 1981, CELL, V25, P373, DOI 10.1016/0092-8674(81)90056-8; PARSONS R, 1992, J VIROL, V66, P1933, DOI 10.1128/JVI.66.4.1933-1942.1992; PILARTZ M, 1992, VIROLOGY, V189, P800, DOI 10.1016/0042-6822(92)90610-2; REVINGTON GN, 1989, PLANT CELL, V1, P985, DOI 10.1105/tpc.1.10.985; ROGERS SG, 1986, CELL, V45, P593, DOI 10.1016/0092-8674(86)90291-6; RUSHING AE, 1987, PHYTOPATHOLOGY, V77, P1231, DOI 10.1094/Phyto-77-1231; Sambrook J, 1989, MOL CLONING LABORATO; SAUNDERS K, 1991, NUCLEIC ACIDS RES, V19, P2325, DOI 10.1093/nar/19.9.2325; SCHALK HJ, 1989, EMBO J, V8, P359, DOI 10.1002/j.1460-2075.1989.tb03385.x; STANLEY J, 1985, J GEN VIROL, V66, P1055, DOI 10.1099/0022-1317-66-5-1055; STANLEY J, 1990, P NATL ACAD SCI USA, V87, P6291, DOI 10.1073/pnas.87.16.6291; STENGER DC, 1991, P NATL ACAD SCI USA, V88, P8029, DOI 10.1073/pnas.88.18.8029; SUNTER G, 1990, VIROLOGY, V179, P69, DOI 10.1016/0042-6822(90)90275-V; SUNTER G, 1993, VIROLOGY, V195, P275, DOI 10.1006/viro.1993.1374; SUNTER G, 1989, VIROLOGY, V173, P647, DOI 10.1016/0042-6822(89)90577-1; THOMASHOW MF, 1980, CELL, V19, P729, DOI 10.1016/S0092-8674(80)80049-3; THOMMES P, 1993, FEBS LETT, V319, P95, DOI 10.1016/0014-5793(93)80044-U; TIMMERMANS MCP, 1992, NUCLEIC ACIDS RES, V20, P4047, DOI 10.1093/nar/20.15.4047; TOWNSEND R, 1985, EMBO J, V4, P33, DOI 10.1002/j.1460-2075.1985.tb02313.x; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; VONARNIM A, 1992, VIROLOGY, V186, P286, DOI 10.1016/0042-6822(92)90083-2; WANG PZ, 1993, EMBO J, V12, P45, DOI 10.1002/j.1460-2075.1993.tb05630.x; YANG L, 1993, P NATL ACAD SCI USA, V90, P5086, DOI 10.1073/pnas.90.11.5086	60	205	215	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8459	8465						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132573				2022-12-27	WOS:A1994NB40900094
J	MELCHIOR, GW; CASTLE, CK; MURRAY, RW; BLAKE, WL; DINH, DM; MAROTTI, KR				MELCHIOR, GW; CASTLE, CK; MURRAY, RW; BLAKE, WL; DINH, DM; MAROTTI, KR			APOLIPOPROTEIN-A-I METABOLISM IN CHOLESTERYL ESTER TRANSFER PROTEIN TRANSGENIC MICE - INSIGHTS INTO THE MECHANISMS RESPONSIBLE FOR LOW PLASMA HIGH-DENSITY-LIPOPROTEIN LEVELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID TRANSFER PROTEIN; MESSENGER-RNA LEVELS; HEPATIC LIPASE; CYNOMOLGUS MONKEY; RAT-LIVER; HUMAN-SERUM; PRE-BETA; INTERCONVERSION; DEFICIENCY; HDL	Expression of simian cholesteryl ester transfer protein (CETP) in C57BL/6 mice causes the animals' high density lipoprotein (HDL) levels to decrease. The purpose of these studies was to determine how CETP expression caused that reduction. Chemical analysis showed that the HDL of the CETP transgenic mice had about twice as much triglyceride and only about 60% as much cholesteryl ester as the HDL from the C57BL/6 mice. Both strains of mouse had high levels of a circulating lipase. When plasma from the mice was incubated at 37 degrees C for 5 h, the triglycerides in the HDL were hydrolyzed, and apoA-I was shed from the particle. However, apoA-I was shed from the CETP HDL more rapidly than it was shed from the C57BL/6 HDL. Because ''free'' apoA-I is rapidly cleared by the kidney, increased production of free apoA-I would be expected to shorten the average life span of apoA-I in the mouse. Kinetic analyses indicated that the life span of apoA-I was significantly reduced in the CETP transgenic mice. It was concluded that CETP expression enriched the core of the HDL with triglyceride, which rendered it vulnerable to lipolysis, causing apoA-I to be shed from the particle. That-shortened the life span of apoA-I in the CETP mice, which led to lower plasma levels of the protein.	UPJOHN LABS,DEPT MOLEC BIOL RES,KALAMAZOO,MI 49001		MELCHIOR, GW (corresponding author), UPJOHN LABS,DEPT METAB DIS RES,7250-209-4,KALAMAZOO,MI 49001, USA.							AGELLON LB, 1991, J BIOL CHEM, V266, P10796; ALLAIN CC, 1974, CLIN CHEM, V20, P470; BARTER PJ, 1987, AM HEART J, V113, P538, DOI 10.1016/0002-8703(87)90628-4; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BELFRAGE P, 1969, J LIPID RES, V10, P341; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; CASTLE CK, 1991, J LIPID RES, V32, P439; CHESEBRO B, 1968, CLIN CHIM ACTA, V20, P527, DOI 10.1016/0009-8981(68)90313-6; CLAY MA, 1992, BIOCHIM BIOPHYS ACTA, V1124, P52, DOI 10.1016/0005-2760(92)90125-F; EISENBERG S, 1984, J LIPID RES, V25, P1017; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRANCESCHINI G, 1989, ARTERIOSCLEROSIS, V9, P462, DOI 10.1161/01.ATV.9.4.462; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; GLASS C, 1985, J BIOL CHEM, V260, P744; GLASS CK, 1983, J BIOL CHEM, V258, P7161; Glomset J A, 1973, Adv Lipid Res, V11, P1; GROOT PHE, 1983, BIOCHIM BIOPHYS ACTA, V751, P393, DOI 10.1016/0005-2760(83)90298-9; HAYEK T, 1992, J CLIN INVEST, V90, P505, DOI 10.1172/JCI115887; HENNESSY LK, 1993, BIOCHEMISTRY-US, V32, P5759, DOI 10.1021/bi00073a006; HOPKINS GJ, 1986, J LIPID RES, V27, P1265; HOROWITZ BS, 1993, J CLIN INVEST, V91, P1743, DOI 10.1172/JCI116384; ISHIDA BY, 1990, J LIPID RES, V31, P227; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; KUNITAKE ST, 1992, J LIPID RES, V33, P1807; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAROTTI KR, 1992, ARTERIOSCLER THROMB, V12, P736, DOI 10.1161/01.ATV.12.6.736; MARSH JB, 1991, METABOLISM, V40, P26, DOI 10.1016/0026-0495(91)90187-2; MCGOWAN MW, 1983, CLIN CHEM, V29, P538; MCPHERSON R, 1991, ARTERIOSCLER THROMB, V11, P476, DOI 10.1161/01.ATV.11.3.476; MELCHIOR GW, 1984, J LIPID RES, V25, P979; MELCHIOR GW, 1990, BIOCHIM BIOPHYS ACTA, V1043, P97, DOI 10.1016/0005-2760(90)90115-E; MELCHIOR GW, 1989, ARTERIOSCLEROSIS, V9, P470, DOI 10.1161/01.ATV.9.4.470; NEARY RH, 1988, CLIN CHIM ACTA, V171, P239, DOI 10.1016/0009-8981(88)90149-0; NEWNHAM HH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P57, DOI 10.1016/0005-2760(90)90218-M; PAPE ME, 1991, ARTERIOSCLER THROMB, V11, P1759, DOI 10.1161/01.ATV.11.6.1759; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; QUIG DW, 1990, ANNU REV NUTR, V10, P169, DOI 10.1146/annurev.nu.10.070190.001125; QUINET E, 1991, J CLIN INVEST, V87, P1559, DOI 10.1172/JCI115169; QUINET EM, 1990, J CLIN INVEST, V85, P357, DOI 10.1172/JCI114446; RESCIGNO A, 1973, J CLIN ENDOCR METAB, V36, P263, DOI 10.1210/jcem-36-2-263; SCHUMAKER VN, 1973, ACCOUNTS CHEM RES, V6, P398, DOI 10.1021/ar50072a002; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SHEN BW, 1977, P NATL ACAD SCI USA, V74, P837, DOI 10.1073/pnas.74.3.837; SHIPLEY RA, 1972, TRACER METHODS IN VI, P77; SHIRAI K, 1981, BIOCHEM BIOPH RES CO, V100, P591, DOI 10.1016/S0006-291X(81)80217-3; SLOOP CH, 1987, J LIPID RES, V28, P225; Snedecor G.W., 1967, STAT METHODS; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; TAKEGOSHI T, 1988, JPN J MED, V27, P295, DOI 10.2169/internalmedicine1962.27.295; WINKLER KE, 1989, J LIPID RES, V30, P989; WINKLER KE, 1989, J LIPID RES, V30, P979; YAMASHITA S, 1990, J CLIN INVEST, V86, P688, DOI 10.1172/JCI114764; YAMASHITA S, 1991, METABOLISM, V40, P756, DOI 10.1016/0026-0495(91)90097-G	54	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8044	8051						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132527				2022-12-27	WOS:A1994NB40900035
J	DEVITRY, C				DEVITRY, C			CHARACTERIZATION OF THE GENE OF THE CHLOROPLAST RIESKE IRON-SULFUR PROTEIN IN CHLAMYDOMONAS-REINHARDTII - INDICATIONS FOR AN UNCLEAVED LUMEN TARGETING SEQUENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C REDUCTASE; AMINO-ACID-SEQUENCE; MEMBRANE-PROTEINS; COMPLEMENTARY-DNA; TRANSIT PEPTIDES; COMPLEX; CLONING; ORGANIZATION; IMPORT; CDNA	The sequence of the nuclear gene encoding the Rieske iron-sulfur protein of the cytochrome b(6) f complex of Chlamydomonas reinhardtii has been established. Comparison of genomic clones and amplified cDNA indicates that the petC gene is interrupted by four introns within the coding sequence of the mature protein. The nucleotide sequence predicts a precursor protein of 206 amino acid residues with a transit peptide of 29 amino acids. The transit peptide is shorter than that of higher plants and has a basic region typical for the transfer through the chloroplast envelope, but no hydrophobic segment at the C-terminal end as is found in proteins transferred through the thylakoid membrane. The mature protein shows a high degree of homology with that of higher plants and has an N-terminal hydrophobic segment as in other Rieske proteins. Biochemical data (Breyton, C., de Vitry, C., and Popot, J.-L. (1994) J. Biol. Chem. 269, 7597-7602) indicate that the chloroplast Rieske protein of C. reinhardtii is an extrinsic membrane protein. Therefore, this N-terminal hydrophobic segment is not a transmembrane segment but may act as an uncleaved N-terminal thylakoid membrane transfer signal sequence. There are other examples of uncleaved hydrophobic membrane transfer signal in secreted proteins, although these are rare.			DEVITRY, C (corresponding author), INST BIOL PHYSICOCHIM,CTR NATL RECH SCI,URA 1187,13 RUE PIERRE & MARIE CURIE,F-75005 PARIS,FRANCE.							BARTLING D, 1990, BOT MAG TOKYO, V2, P119; BECKMANN JD, 1987, J BIOL CHEM, V262, P8901; BRANDT U, 1993, J BIOL CHEM, V268, P8387; BREYTON C, 1994, J BIOL CHEM, V269, P7597; BUSCHLEN S, 1991, FEBS LETT, V284, P257, DOI 10.1016/0014-5793(91)80698-3; DAVIDSON E, 1992, BIOCHEMISTRY-US, V31, P3342, DOI 10.1021/bi00128a006; DEBOER AD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P221, DOI 10.1016/0304-4157(91)90015-O; DRAPIER D, 1992, PLANT CELL, V4, P283, DOI 10.2307/3869540; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FONG SE, 1992, CURR GENET, V21, P527, DOI 10.1007/BF00351664; FRANZEN LG, 1990, FEBS LETT, V260, P165, DOI 10.1016/0014-5793(90)80094-Y; FRANZEN LG, 1989, PLANT MOL BIOL, V12, P463, DOI 10.1007/BF00017585; GAVEL Y, 1990, FEBS LETT, V261, P455, DOI 10.1016/0014-5793(90)80614-O; GLICK BS, 1992, TRENDS BIOCHEM SCI, V17, P453, DOI 10.1016/0968-0004(92)90487-T; GOLDSCHMIDTCLERMONT M, 1986, PLANT MOL BIOL, V6, P13, DOI 10.1007/BF00021302; HAGEMAN J, 1990, PLANT CELL, V2, P479, DOI 10.1105/tpc.2.5.479; Hallick RB, 1989, PLANT MOL BIOL REP, V7, P266, DOI [10.1007/BF02668635, DOI 10.1007/BF02668635]; HARNISCH U, 1985, EUR J BIOCHEM, V149, P95, DOI 10.1111/j.1432-1033.1985.tb08898.x; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HAUSKA G, 1988, J BIOENERG BIOMEMBR, V20, P211, DOI 10.1007/BF00768395; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; KALLAS T, 1988, P NATL ACAD SCI USA, V85, P5794, DOI 10.1073/pnas.85.16.5794; KIRWIN PM, 1988, J BIOL CHEM, V263, P18128; KNAFF DB, 1993, PHOTOSYNTH RES, V35, P117, DOI 10.1007/BF00014743; KO K, 1989, EMBO J, V8, P3187, DOI 10.1002/j.1460-2075.1989.tb08477.x; LEMAIRE C, 1986, BIOCHIM BIOPHYS ACTA, V851, P229, DOI 10.1016/0005-2728(86)90130-1; LUTCKE HA, 1987, EMBO J, V6, P43, DOI 10.1002/j.1460-2075.1987.tb04716.x; MADUENO F, 1992, PLANT MOL BIOL, V20, P289, DOI 10.1007/BF00014496; MALKIN R, 1992, PHOTOSYNTH RES, V33, P121, DOI 10.1007/BF00039175; MAYES SR, 1991, PLANT MOL BIOL, V17, P287; MAYFIELD SP, 1989, PLANT MOL BIOL, V12, P683, DOI 10.1007/BF00044159; MCREYNOLDS L, 1978, NATURE, V273, P723, DOI 10.1038/273723a0; MERCHANT S, 1990, J BIOL CHEM, V265, P12372; MERCHANT S, 1987, J BIOL CHEM, V262, P9062; MEYER TF, 1984, P NATL ACAD SCI-BIOL, V81, P6110, DOI 10.1073/pnas.81.19.6110; PALMITER RD, 1978, P NATL ACAD SCI USA, V75, P94, DOI 10.1073/pnas.75.1.94; PFEFFERKORN B, 1986, FEBS LETT, V206, P233, DOI 10.1016/0014-5793(86)80987-5; POPOT JL, 1990, ANNU REV BIOPHYS BIO, V19, P369; Poyton Robert O., 1992, Trends in Cell Biology, V2, P369, DOI 10.1016/0962-8924(92)90049-S; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rochaix J. D., 1988, PLANT MOL BIOL PRACT, P253; SALTER AH, 1992, PLANT MOL BIOL, V20, P569, DOI 10.1007/BF00040617; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1987, FEBS LETT, V219, P161, DOI 10.1016/0014-5793(87)81210-3; SEGUIREAL B, 1992, FEBS LETT, V313, P2, DOI 10.1016/0014-5793(92)81171-H; SILFLOW CD, 1985, MOL CELL BIOL, V5, P2389, DOI 10.1128/MCB.5.9.2389; STEPPUHN J, 1987, MOL GEN GENET, V210, P171, DOI 10.1007/BF00337775; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; USUI S, 1990, BIOCHEM BIOPH RES CO, V167, P575, DOI 10.1016/0006-291X(90)92063-6; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; WIDGER WR, 1991, PHOTOSYNTH RES, V30, P71, DOI 10.1007/BF00042005; WIDGER WR, 1991, CELL CULTURE SOMATIC, V7, P149; WRIGHT HT, 1990, J MOL BIOL, V213, P513; YE RD, 1988, J BIOL CHEM, V263, P4869; YE RD, 1987, J BIOL CHEM, V262, P3718; YUN CH, 1990, EUR J BIOCHEM, V194, P399, DOI 10.1111/j.1432-1033.1990.tb15633.x; ZIMMER WE, 1988, J BIOL CHEM, V263, P19370	59	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7603	7609						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125984				2022-12-27	WOS:A1994NA03200090
J	ZHANG, XL; MATHEWS, CK				ZHANG, XL; MATHEWS, CK			EFFECT OF DNA CYTOSINE METHYLATION UPON DEAMINATION-INDUCED MUTAGENESIS IN A NATURAL TARGET SEQUENCE IN DUPLEX DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HEAT-INDUCED DEAMINATION; VERTEBRATE GENOMES; CPG DINUCLEOTIDE; METHYLTRANSFERASE; RESIDUES; 5-METHYLCYTOSINE; MUTATION; REPAIR; CELLS; REPLICATION	Are 5-methylcytosine residues in DNA hot spots for transition mutagenesis? Numerous studies identify 1) structural changes induced by DNA methylation, 2) high percentages of human mutations that result from GC to AT transition pathways, and 3) differences between G.C and G.mC base pairs in susceptibility to nonenzymatic deamination. However, investigations of chemical stability necessarily involve non-physiological conditions for chemical analysis of deamination. Here we describe an experiment that compares rates of deamination-induced mutagenesis between a G.C and G.mC base pair, when both are present in duplex DNA, incubated at 37 degrees C and pH 7.4, within identical sequence contexts, in a natural mutational target (the Escherichia coli lacZ alpha gene) that selects for mutagenesis at the specific site under investigation. Under these conditions the rate of spontaneous deamination at G.mC exceeds that at G.C by more than 21-fold. Our data implicate differences in chemical stability toward deamination as a major causal factor relating DNA cytosine methylation to spontaneous mutagenesis.	OREGON STATE UNIV,DEPT BIOCHEM & BIOPHYS,CORVALLIS,OR 97331	Oregon State University								BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BROWN TC, 1987, CELL, V50, P945, DOI 10.1016/0092-8674(87)90521-6; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; EHRLICH M, 1986, BIOSCIENCE REP, V6, P387, DOI 10.1007/BF01116426; EVANS BE, 1975, BIOCHEMISTRY-US, V14, P621, DOI 10.1021/bi00674a024; FREDERICO LA, 1993, BIOCHEMISTRY-US, V32, P6523, DOI 10.1021/bi00077a005; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; HODGESGARCIA Y, 1992, BIOCHEMISTRY-US, V31, P7595, DOI 10.1021/bi00148a022; JONES PA, 1992, BIOESSAYS, V14, P33, DOI 10.1002/bies.950140107; KRICKER MC, 1992, P NATL ACAD SCI USA, V89, P1075, DOI 10.1073/pnas.89.3.1075; KUNKEL TA, 1984, P NATL ACAD SCI-BIOL, V81, P1494, DOI 10.1073/pnas.81.5.1494; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P362; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; NEDDERMANN P, 1993, J BIOL CHEM, V268, P21218; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; ROBERTS JD, 1988, P NATL ACAD SCI USA, V85, P7064, DOI 10.1073/pnas.85.19.7064; Sambrook J, 1989, MOL CLONING LABORATO; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Shapiro R, 1981, CHROMOSOME DAMAGE RE, P3; SHEN JC, 1992, CELL, V71, P1073, DOI 10.1016/S0092-8674(05)80057-1; SHENOY S, 1987, J MOL BIOL, V197, P617, DOI 10.1016/0022-2836(87)90468-2; SMITH SS, 1992, P NATL ACAD SCI USA, V89, P4744, DOI 10.1073/pnas.89.10.4744; SOBER HA, 1968, HDB BIOCH SELECTED D, pG12; SOWERS LC, 1989, MUTAT RES, V215, P131, DOI 10.1016/0027-5107(89)90225-X; SOWERS LC, 1987, MUTAT RES, V177, P201, DOI 10.1016/0027-5107(87)90003-0; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; WANG RYH, 1982, BIOCHIM BIOPHYS ACTA, V697, P371, DOI 10.1016/0167-4781(82)90101-4; WIEBAUER K, 1989, NATURE, V339, P234, DOI 10.1038/339234a0; WU JC, 1987, J BIOL CHEM, V262, P4778	41	45	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7066	7069						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125913				2022-12-27	WOS:A1994NA03200006
J	MURPHY, G; NGUYEN, Q; COCKETT, MI; ATKINSON, SJ; ALLAN, JA; KNIGHT, CG; WILLENBROCK, F; DOCHERTY, AJP				MURPHY, G; NGUYEN, Q; COCKETT, MI; ATKINSON, SJ; ALLAN, JA; KNIGHT, CG; WILLENBROCK, F; DOCHERTY, AJP			ASSESSMENT OF THE ROLE OF THE FIBRONECTIN-LIKE DOMAIN OF GELATINASE-A BY ANALYSIS OF A DELETION MUTANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN 72-KDA GELATINASE; C-TERMINAL DOMAIN; TISSUE INHIBITOR; IV COLLAGENASE; MATRIX METALLOPROTEINASES; ACTIVATION; BINDING; PURIFICATION; STROMELYSIN; IDENTIFICATION	The properties of a deletion mutant Delta(V191-Q364) of gelatinase A, which represents the removal of the fibronectin like type II repeats defined by exons 5-7, were compared with those of full length gelatinase A. Both enzymes underwent self-activation over a similar time course in the presence of 4-aminophenylmercuric acetate. The fully active enzymes had similar k(cat)/K-m values for the cleavage of an octapeptide substrate, but the deletion mutant had 50% of the activity of wild type gelatinase A against beta-casein and 10% of the activity against gelatin. The cleavage pattern for gelatin was similar for both enzymes but differed for type IV collagen. Comparison of the rates of association of the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 and their N-terminal domains to both forms of gelatinase indicated that the fibronectin-like domain plays little role in TIMP binding. The deletion mutant failed to bind to collagen, while the wild type gelatinase bound tightly, indicating that the fibronectin-like domain is the sole site of collagen binding. Both gelatinases could be activated by concanavalin A-activated fibroblasts, suggesting that the fibronectin-like domain is not required for the membrane-mediated activation process.	UNIV LONDON,QUEEN MARY & WESTFIELD COLL,DEPT BIOCHEM,LONDON E1 4NS,ENGLAND	University of London; Queen Mary University London	MURPHY, G (corresponding author), STRANGEWAYS RES LAB,WORTS CAUSEWAY,CAMBRIDGE CB1 4RN,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BANYAI L, 1991, FEBS LETT, V282, P23, DOI 10.1016/0014-5793(91)80436-7; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; Bos E S, 1981, J Immunoassay, V2, P187, DOI 10.1080/15321818108056977; CAWSTON TE, 1981, BIOCHIM BIOPHYS ACTA, V657, P73, DOI 10.1016/0005-2744(81)90131-5; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; COLLIER IE, 1991, GENOMICS, V9, P429, DOI 10.1016/0888-7543(91)90408-7; DOCHERTY AJP, 1992, TRENDS BIOTECHNOL, V10, P200, DOI 10.1016/0167-7799(92)90214-G; FESSLER LI, 1984, J BIOL CHEM, V259, P9783; FRIDMAN R, 1992, J BIOL CHEM, V267, P15398; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; GOLDBERG GI, 1989, P NATL ACAD SCI USA, V86, P8207, DOI 10.1073/pnas.86.21.8207; HIPPS DS, 1991, BIOL CHEM H-S, V372, P287, DOI 10.1515/bchm3.1991.372.1.287; HOWARD EW, 1991, J BIOL CHEM, V266, P13070; HOWARD EW, 1991, J BIOL CHEM, V266, P17972; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; KOKLITIS PA, 1991, BIOCHEM J, V276, P217, DOI 10.1042/bj2760217; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; MURPHY G, 1992, BIOCHEM J, V283, P637, DOI 10.1042/bj2830637; MURPHY G, 1992, J BIOL CHEM, V267, P9612; MURPHY G, 1981, BIOCHEM J, V199, P807, DOI 10.1042/bj1990807; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; MURPHY G, 1992, AM J RESP CELL MOL, V7, P120, DOI 10.1165/ajrcmb/7.2.120; NIEDZWIECKI L, 1992, BIOCHEMISTRY-US, V31, P12618, DOI 10.1021/bi00165a011; OKADA Y, 1986, J BIOL CHEM, V261, P14245; OSHEA M, 1992, BIOCHEMISTRY-US, V31, P10146, DOI 10.1021/bi00157a002; WILLENBROCK F, 1993, BIOCHEMISTRY-US, V32, P4330, DOI 10.1021/bi00067a023	29	176	180	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6632	6636						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120015				2022-12-27	WOS:A1994MZ50300058
J	DUTCZAK, WJ; BALLATORI, N				DUTCZAK, WJ; BALLATORI, N			TRANSPORT OF THE GLUTATHIONE-METHYLMERCURY COMPLEX ACROSS LIVER CANALICULAR MEMBRANES ON REDUCED GLUTATHIONE CARRIERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT TRANSPORT; RAT-LIVER; BILIARY TRANSPORT; PLASMA-MEMBRANES; S-CONJUGATE; VESICLES; BILE; MECHANISMS; SECRETION; TAUROCHOLATE	Methylmercury transport across liver canalicular membranes into bile, a major route of excretion of this toxic compound, is dependent upon intracellular GSH, and a glutathione-methylmercury complex (CH3Hg.SG) has been detected in liver tissue and bile. To examine whether the CH3Hg.SG complex is itself transported across the canalicular membrane and to identify the transport system involved, studies were performed in isolated rat liver canalicular plasma membrane vesicles. Uptake of (CH3Hg.SG)-Hg-203 (10 muM) into an osmotically active space was temperature-sensitive and unaffected by either ATP (5 mM) or an inwardly directed Na+ gradient (100 mM); however, CH3Hg.SG uptake was enhanced by a valinomycin-induced K+ diffusion potential (inside-positive) indicating that its transport was electrogenic. Transport of CH3Hg.SG exhibited saturation kinetics with both high affinity (K(m) = 12 +/- 2 muM, V(max) = 0.23 +/- 0.02 nmol.mg-1.20 s-1) and low affinity (K(m) = 1.47 +/- 0.22 mM, V(max) = 1.23 +/- 0.14 nmol.mg-1.20 s-1) components. Uptake of this complex was inhibited by GSH, the GSH analog ophthalmic acid, S-methyl, S-ethyl, S-butyl, S-hexyl, S-octyl, and S-dinitrophenyl glutathione, but not by GSSG, bile acids, amino acids, and P-glycoprotein inhibitors. Furthermore, GSH competitively inhibited (K(i) = 83 muM) and trans-stimulated CH3Hg-SG uptake into the canalicular vesicles. These studies provide the first kinetic characterization of a transport system for glutathione-mercaptides and indicate that CH3Hg.SG is not a substrate for the ATP-dependent, canalicular GSSG or glutathione S-conjugate carriers, but appears to be a substrate for canalicular carriers that also transport GSH. Because efflux systems for GSH are found in all mammalian cells, transport of glutathione-metal complexes by such carriers may be a common mechanism for the removal of methylmercury and possibly other metals from cells.	UNIV ROCHESTER,SCH MED,DEPT ENVIRONM MED,ROCHESTER,NY 14642	University of Rochester					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK039165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006484, P30ES001247] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-39165] Funding Source: Medline; NIEHS NIH HHS [ES-01247, ES-06484] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABERG B, 1969, ARCH ENVIRON HEALTH, V19, P478, DOI 10.1080/00039896.1969.10666872; AKERBOOM T, 1984, EUR J BIOCHEM, V141, P211, DOI 10.1111/j.1432-1033.1984.tb08177.x; AKERBOOM TPM, 1991, J BIOL CHEM, V266, P13147; BALLATORI N, 1985, AM J PHYSIOL, V248, pG238, DOI 10.1152/ajpgi.1985.248.2.G238; BALLATORI N, 1991, DRUG METAB REV, V23, P83, DOI 10.3109/03602539109029757; BALLATORI N, 1986, J BIOL CHEM, V261, P6216; BALLATORI N, 1983, AM J PHYSIOL, V244, pG435, DOI 10.1152/ajpgi.1983.244.4.G435; BALLATORI N, 1982, SCIENCE, V216, P61, DOI 10.1126/science.7063871; BALLATORI N, 1985, FUND APPL TOXICOL, V5, P816, DOI 10.1016/0272-0590(85)90165-4; FERNANDEZCHECA JC, 1993, J BIOL CHEM, V268, P10836; FERNANDEZCHECA JC, 1992, J BIOL CHEM, V267, P1667; GARCIARUIZ C, 1992, J BIOL CHEM, V267, P22256; HINCHMAN CA, 1991, J BIOL CHEM, V266, P22179; INOUE M, 1984, J BIOL CHEM, V259, P4998; INOUE M, 1983, EUR J BIOCHEM, V134, P467, DOI 10.1111/j.1432-1033.1983.tb07590.x; INSKIP MJ, 1985, J APPL TOXICOL, V5, P113, DOI 10.1002/jat.2550050302; ISHIKAWA T, 1990, J BIOL CHEM, V265, P19279; KOBAYASHI K, 1990, J BIOL CHEM, V265, P7737; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAGOS L, 1978, BIOCHEM PHARMACOL, V27, P2203, DOI 10.1016/0006-2952(78)90078-3; MEIER PJ, 1984, J BIOL CHEM, V259, P614; MEIER PJ, 1984, J CELL BIOL, V98, P991, DOI 10.1083/jcb.98.3.991; MULLER M, 1991, J BIOL CHEM, V266, P18920; NISHIDA T, 1991, P NATL ACAD SCI USA, V88, P6590, DOI 10.1073/pnas.88.15.6590; NORSETH T, 1971, ARCH ENVIRON HEALTH, V22, P568, DOI 10.1080/00039896.1971.10665903; OMATA S, 1978, BIOCHEM PHARMACOL, V27, P1700; ORLOWSKI M, 1963, BIOCHIM BIOPHYS ACTA, V73, P676; REFSVIK T, 1978, ACTA PHARMACOL TOX, V42, P135; REFSVIK T, 1975, ACTA PHARMACOL TOX, V36, P67; SCHARSCHMIDT BF, 1979, J LAB CLIN MED, V93, P790; SIMMONS TW, 1992, J PHARMACOL EXP THER, V262, P1182; SIMPSON RB, 1961, J AM CHEM SOC, V83, P4711, DOI 10.1021/ja01484a005; TORIBARA TY, 1985, INT J APPL RADIAT IS, V36, P903, DOI 10.1016/0020-708X(85)90025-0	33	86	87	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9746	9751						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144567				2022-12-27	WOS:A1994NE05300056
J	MU, D; MEDZIHRADSZKY, KF; ADAMS, GW; MAYER, P; HINES, WM; BURLINGAME, AL; SMITH, AJ; CAI, DY; KLINMAN, JP				MU, D; MEDZIHRADSZKY, KF; ADAMS, GW; MAYER, P; HINES, WM; BURLINGAME, AL; SMITH, AJ; CAI, DY; KLINMAN, JP			PRIMARY STRUCTURES FOR A MAMMALIAN CELLULAR AND SERUM COPPER AMINE OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMILORIDE-BINDING-PROTEIN; ACTIVE-SITE; ACID-SEQUENCE; MOLECULAR-CLONING; DIAMINE OXIDASE; LYSYL OXIDASE; CDNA; PLASMA; GENE; IDENTIFICATION	The 6-hydroxydopa quinone-containing active sit peptide from bovine serum amine oxidase has been found to be highly homologous to a segment of a cloned human kidney amiloride-binding protein (Barbry, P., Champe, M., Chassande, O., Munemitsu, S., Champigny, G., Lingueglia, E., Maes, P., Frelin, C., Tartar, A., Ullrich, A., and Lazdunski, M. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 7347-7351). Additionally, a second 38-residue tryptic peptide (peptide XI) isolated from bovine serum amine oxidase shows 82% identity with a portion near the carboxyl terminus of the human kidney amiloride-binding protein. When an extended active site peptide was isolated from porcine kidney diamine oxidase (Janes, S. M., Palcic, M. M., Scaman, C. H., Smith, A. J., Brown, D. E., Dooley, D. M., Mure, M., and Klinman, J. P. (1992) Biochemistry 31, 12147-12154), it was found to be fully contained in the human kidney amiloride-binding protein. Examination of amiloride binding to bovine serum amine oxidase and porcine kidney diamine oxidase reveals dissociation constants of 196 and 9.1 muM, respectively. Taken together, these findings indicate that the cDNA isolated for human kidney amiloride-binding protein encodes a human kidney diamine oxidase. Two oligonucleotides, based on the tryptic peptide XI and active-site peptide of bovine serum amine oxidase, were used to amplify a portion of cDNA from a commercial bovine liver cDNA library through the use of the polymerase chain reaction. A full-length clone (2.7 kilobase pairs) for bovine serum amine oxidase was subsequently obtained through screening of the same cDNA library with the amplified 0.7-kilobase pair cDNA. These studies provide the first primary sequences for a mammalian cellular and serum copper amine oxidase. Computer alignment of amine oxidase cDNA-derived protein sequences reveals three conserved histidine residues, which are likely to be ligands to copper.	UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720; UNIV CALIF SAN FRANCISCO,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94143; STANFORD UNIV,MED CTR,BECKMAN CTR,STANFORD,CA 94305	University of California System; University of California Berkeley; University of California System; University of California San Francisco; Stanford University			Mu, David/E-8933-2011	Mu, David/0000-0002-7762-0182	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039296] Funding Source: NIH RePORTER; NCRR NIH HHS [RR 01614] Funding Source: Medline; NIGMS NIH HHS [GM39296] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARBRY P, 1989, BIOCHEMISTRY-US, V28, P3744, DOI 10.1021/bi00435a018; BARBRY P, 1990, HUM GENET, V85, P587, DOI 10.1007/BF00193579; BARBRY P, 1990, P NATL ACAD SCI USA, V87, P7347, DOI 10.1073/pnas.87.19.7347; BARKER GJ, 1986, BIOCHEM J, V237, P609; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN T, 1987, NUCLEIC ACIDS RES, V15, P3179, DOI 10.1093/nar/15.7.3179; BRUINENBERG PG, 1989, BIOCHIM BIOPHYS ACTA, V1008, P157, DOI 10.1016/0167-4781(80)90003-2; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CHAPLIN DD, 1990, CURRENT PROTOCOLS MO, V1; DAGOSTINO L, 1989, BIOCHIM BIOPHYS ACTA, V993, P228, DOI 10.1016/0304-4165(89)90169-4; Dooley D. M., 1993, BIOINORGANIC CHEM CO, P459; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GEORGE DG, 1986, NUCLEIC ACIDS RES, V14, P11, DOI 10.1093/nar/14.1.11; GIARTOSIO A, 1988, BIOCHEM BIOPH RES CO, V154, P66, DOI 10.1016/0006-291X(88)90650-X; HAMALAINEN ER, 1991, GENOMICS, V11, P508, DOI 10.1016/0888-7543(91)90057-L; HARTMANN C, 1993, BIOCHEMISTRY-US, V32, P2234, DOI 10.1021/bi00060a015; HYSMITH RM, 1987, BIOCH CELL BIOL, V66, P821; JANES SM, 1991, BIOCHEMISTRY-US, V30, P4599, DOI 10.1021/bi00232a034; JANES SM, 1990, SCIENCE, V248, P981, DOI 10.1126/science.2111581; JANES SM, 1992, BIOCHEMISTRY-US, V31, P12147, DOI 10.1021/bi00163a025; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE CC, 1988, SCIENCE, V239, P1288, DOI 10.1126/science.3344434; LEE CC, 1990, PCR PROTOCOLS GUIDE, P46; LEICHT M, 1982, NATURE, V297, P655, DOI 10.1038/297655a0; LEWINSOHN R, 1981, J PHARM PHARMACOL, V33, P569, DOI 10.1111/j.2042-7158.1981.tb13868.x; LINGUEGLIA E, 1993, FEBS LETT, V318, P95, DOI 10.1016/0014-5793(93)81336-X; MCCRACKEN J, 1987, J AM CHEM SOC, V109, P4064, DOI 10.1021/ja00247a037; McIntire W. S., 1993, COPPER CONTAINING AM, P97; MU D, 1992, J BIOL CHEM, V267, P7979; MU D, 1993, THESIS U CALIFORNIA; MURE M, 1993, J AM CHEM SOC, V115, P7117, DOI 10.1021/ja00069a008; NEUMANN R, 1975, J BIOL CHEM, V250, P6362; ROSSI A, 1992, FEBS LETT, V301, P253, DOI 10.1016/0014-5793(92)80251-B; SAMBROOK J, 1988, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT RA, 1985, J AM CHEM SOC, V107, P4348, DOI 10.1021/ja00300a055; TAMURA H, 1989, J BIOCHEM-TOKYO, V105, P299, DOI 10.1093/oxfordjournals.jbchem.a122657; TRACKMAN PC, 1991, BIOCHEMISTRY-US, V30, P8282, DOI 10.1021/bi00247a025; TRACKMAN PC, 1990, BIOCHEMISTRY-US, V29, P4863, DOI 10.1021/bi00472a016; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WEN DX, 1992, J BIOL CHEM, V267, P21011; YAMADA H, 1964, BIOCHIM BIOPHYS ACTA, V81, P165, DOI 10.1016/0926-6569(64)90347-5; YAMASHITA MM, 1990, P NATL ACAD SCI USA, V87, P5648, DOI 10.1073/pnas.87.15.5648; YASUNOBU KT, 1976, MOL CELL BIOCHEM, V13, P3, DOI 10.1007/BF01732392; ZEIDAN H, 1980, J BIOL CHEM, V255, P7621; ZHANG XP, 1993, J BACTERIOL, V175, P5617, DOI 10.1128/JB.175.17.5617-5627.1993; [No title captured]	48	104	106	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9926	9932						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144587				2022-12-27	WOS:A1994NE05300081
J	YAN, SD; SCHMIDT, AM; ANDERSON, GM; ZHANG, JH; BRETT, J; ZOU, YS; PINSKY, D; STERN, D				YAN, SD; SCHMIDT, AM; ANDERSON, GM; ZHANG, JH; BRETT, J; ZOU, YS; PINSKY, D; STERN, D			ENHANCED CELLULAR OXIDANT STRESS BY THE INTERACTION OF ADVANCED GLYCATION END-PRODUCTS WITH THEIR RECEPTORS BINDING-PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LIPID-PEROXIDATION; TRANSCRIPTION FACTOR; GLYCOSYLATION; ACTIVATION; GLUCOSE; SURFACE; COMPLICATIONS; GENERATION; ANTIBODIES	Attack by reactive oxygen intermediates, common to many kinds of cell/tissue injury, has been implicated in the development of diabetic and other vascular diseases. Such oxygen-free radicals can be generated by advanced glycation end products (AGEs), which are nonenzymatically glycated and oxidized proteins. Since cellular interactions of AGEs are mediated by specific cellular binding proteins, receptor for AGE (RAGE) and the lactoferrin-like polypeptide (LF-L), we tested the hypothesis that AGE ligands tethered to the complex of RAGE and LF-L could induce oxidant stress. AGE albumin or AGEs immunoisolated from diabetic plasma resulted in induction of endothelial cell (EC) oxidant stress, including the generation of thiobarbituric acid reactive substances (TBARS) and resulted in the activation of NF-kappaB, each of which was blocked by antibodies to AGE receptor polypeptides and by antioxidants. Infusion of AGE albumin into normal animals led to the appearance of malondialdehyde determinants in the vessel wall and increased TBARS in the tissues, activation of NF-kappaB, and induction of heme oxygenase mRNA. AGE-induced oxidant stress was inhibited by pretreatment of animals with either antibodies to the AGE receptor/binding proteins or antioxidants. These data indicate that interaction of AGEs with cellular targets, such as ECs, leads to oxidant stress resulting in changes in gene expression and other cellular properties, potentially contributing to the development of vascular lesions. Further studies will be required to dissect whether oxidant stress occurs on the cell surface or at an intracellular locus.	COLUMBIA UNIV COLL PHYS & SURG, DEPT MED, NEW YORK, NY 10032 USA; MERCK SHARP & DOHME LTD, W POINT, PA 19486 USA	Columbia University; Merck & Company	YAN, SD (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT PHYSIOL & CELLULAR BIOPHYS, 630 W 168 ST, NEW YORK, NY 10032 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042507, R01HL042833] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL42833, HL42507] Funding Source: Medline; NIA NIH HHS [AG00602] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON GM, 1991, MOL CELL BIOL, V11, P1935, DOI 10.1128/MCB.11.4.1935; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; BALLA G, 1992, J BIOL CHEM, V267, P18148; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; BORCH RF, 1971, J AM CHEM SOC, V93, P2897, DOI 10.1021/ja00741a013; BRETT J, 1993, AM J PATHOL, V143, P1699; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; DAVID GS, 1974, BIOCHEMISTRY-US, V13, P1014, DOI 10.1021/bi00702a028; DENEKE SM, 1985, J APPL PHYSIOL, V58, P571, DOI 10.1152/jappl.1985.58.2.571; DENNERY PA, 1990, AM J RESP CELL MOL, V3, P137, DOI 10.1165/ajrcmb/3.2.137; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ESMON NL, 1982, J BIOL CHEM, V257, P859; ESPOSITO C, 1989, J EXP MED, V170, P1387, DOI 10.1084/jem.170.4.1387; GODIN DV, 1988, MOL CELL BIOCHEM, V84, P223, DOI 10.1007/BF00421057; GODING JW, 1976, J IMMUNOL METHODS, V13, P215, DOI 10.1016/0022-1759(76)90068-5; GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P259, DOI 10.1042/bj1990259; HABERLAND ME, 1985, P NATL ACAD SCI USA, V82, P2693, DOI 10.1073/pnas.82.9.2693; HICKS M, 1989, ARCH BIOCHEM BIOPHYS, V268, P249, DOI 10.1016/0003-9861(89)90586-9; HORIUCHI S, 1986, J BIOL CHEM, V261, P4962; HUNT JV, 1990, DIABETES, V39, P1420, DOI 10.2337/diabetes.39.11.1420; JAIN SK, 1991, DIABETES, V40, P1241, DOI 10.2337/diabetes.40.10.1241; KAGEYAMA H, 1988, CANCER RES, V48, P4795; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; MONTGOMERY KF, 1991, P NATL ACAD SCI USA, V88, P6523, DOI 10.1073/pnas.88.15.6523; MULLARKEY CJ, 1990, BIOCHEM BIOPH RES CO, V173, P932, DOI 10.1016/S0006-291X(05)80875-7; NAKAYAMA H, 1991, J IMMUNOL METHODS, V140, P119; NEEPER M, 1992, J BIOL CHEM, V267, P14998; OBERLEY LW, 1988, FREE RADICAL BIO MED, V5, P113, DOI 10.1016/0891-5849(88)90036-6; REHMAN J, 1989, COMP BIOCH PHYSL B, V93, P929; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P336, DOI 10.1161/01.ATV.10.3.336; RUDERMAN NB, 1992, FASEB J, V6, P2905, DOI 10.1096/fasebj.6.11.1644256; SAKURAI T, 1990, BIOCHIM BIOPHYS ACTA, V1043, P27, DOI 10.1016/0005-2760(90)90106-8; SATO Y, 1979, BIOCHEM MED METAB B, V21, P104, DOI 10.1016/0006-2944(79)90061-9; SCHMIDT AM, 1994, J BIOL CHEM, V269, P9882; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; SCHMIDT AM, 1993, J CLIN INVEST, V91, P2155, DOI 10.1172/JCI116442; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SELL DR, 1989, J BIOL CHEM, V264, P21597; STITES D, 1982, BASIC CLIN IMMUNOL, P34; TESFAMARIAM B, 1992, AM J PHYSIOL, V263, pH321, DOI 10.1152/ajpheart.1992.263.2.H321; Vaitukaitis J L, 1981, Methods Enzymol, V73, P46; WAUTIER JL, 1992, 7TH INT S BIOL VASC, P45; YANG Z, 1991, J EXP MED, V174, P515, DOI 10.1084/jem.174.3.515	44	1076	1125	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9889	9897						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144582				2022-12-27	WOS:A1994NE05300076
J	GHIGO, JM; WANDERSMAN, C				GHIGO, JM; WANDERSMAN, C			A CARBOXYL-TERMINAL 4-AMINO ACID MOTIF IS REQUIRED FOR SECRETION OF THE METALLOPROTEASE PRTG THROUGH THE ERWINIA-CHRYSANTHEMI PROTEASE SECRETION PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; EXTRACELLULAR PROTEASES; ALPHA-HEMOLYSIN; PROTEINS; CLONING; SIGNAL; EXPRESSION; SEQUENCE; SYSTEMS; GENE	PrtG is an extracellular metalloprotease secreted by the Gram-negative bacterium Erwinia chrysanthemi through a signal peptide-independent secretion pathway. Previous studies showed that the PrtG secretion signal is COOH-terminal and located in the last 56 residues of PrtG. We have now performed a deletion and elongation mapping of a short secretion competent COOH-terminal peptide CterG. This approach allowed us to show that: (i) the smaller COOH-terminal sequence containing the information necessary to promote the secretion of a small polypeptide is contained in the last 29 residues of PrtG; (ii) a low but significant level of secretion can be promoted by the last 15 residues of PrtG when fused to the COOH terminus of a non-secreted PrtG derivative; (iii) the extreme COOH-terminal sequence Dxxx, where xs are hydrophobic residues, is a conserved motif in all constructs that are secreted through the E. chrysanthemi transporter. (vi) This motif has to be COOH terminally exposed since addition of even one amino acid impairs the secretion of CterG. The extent of the secretion defect observed with the COOH terminally extended variants correlates with the length of the extension. These results indicate a key role for the COOH-terminal exposition of the last four amino acids in the secretion of PrtG.	INST PASTEUR, UNITE GENET MOLEC, CNRS, URA 1149, F-75724 PARIS 15, FRANCE	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris			GHIGO, Jean-Marc/AAP-4011-2021	GHIGO, Jean-Marc/0000-0001-6528-118X				AITCHISON JD, 1992, MOL MICROBIOL, V6, P3455, DOI 10.1111/j.1365-2958.1992.tb01780.x; DELEPELAIRE P, 1989, J BIOL CHEM, V264, P9083; DELEPELAIRE P, 1990, J BIOL CHEM, V265, P17118; FATH MJ, 1991, J BACTERIOL, V173, P7549, DOI 10.1128/jb.173.23.7549-7556.1991; GHIGO JM, 1992, MOL GEN GENET, V236, P135, DOI 10.1007/BF00279652; GHIGO JM, 1992, RES MICROBIOL, V143, P857, DOI 10.1016/0923-2508(92)90073-W; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GRAY L, 1989, J CELL SCI, P45; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; KENNY B, 1992, MOL MICROBIOL, V6, P1477, DOI 10.1111/j.1365-2958.1992.tb00868.x; LETOFFE S, 1989, MOL MICROBIOL, V3, P79, DOI 10.1111/j.1365-2958.1989.tb00106.x; LETOFFE S, 1992, J BACTERIOL, V174, P4920; LETOFFE S, 1990, EMBO J, V9, P1375, DOI 10.1002/j.1460-2075.1990.tb08252.x; LETOFFE S, 1991, J BACTERIOL, V173, P2160; MACKMAN N, 1986, CURR TOP MICROBIOL, V125, P159; MIERENDORF RC, 1987, METHOD ENZYMOL, V152, P556; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Sambrook J, 1989, MOL CLONING LABORATO; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHEU AK, 1992, MOL MICROBIOL, V6, P231, DOI 10.1111/j.1365-2958.1992.tb02004.x; SEBO P, 1993, MOL MICROBIOL, V9, P999, DOI 10.1111/j.1365-2958.1993.tb01229.x; STANLEY P, 1991, MOL MICROBIOL, V5, P2391, DOI 10.1111/j.1365-2958.1991.tb02085.x; WANDERSMAN C, 1992, TRENDS GENET, V8, P317, DOI 10.1016/0168-9525(92)90264-5; WANDERSMAN C, 1987, J BACTERIOL, V169, P5046, DOI 10.1128/jb.169.11.5046-5053.1987; WELCH RA, 1991, MOL MICROBIOL, V60, P101; ZHANG F, 1993, P NATL ACAD SCI USA, V90, P4211, DOI 10.1073/pnas.90.9.4211	28	80	83	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8979	8985						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132636				2022-12-27	WOS:A1994NB41100055
J	KIM, ML; VOSS, EW				KIM, ML; VOSS, EW			QUANTITATION OF INTERACTION ANTI-METATYPE MONOCLONAL-ANTIBODIES SPECIFIC FOR THE VARIABLE REGIONS OF A HIGH-AFFINITY LIGANDED MONOCLONAL-ANTIBODY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCYL ANTIBODIES; IDIOTYPE FAMILY; BINDING	Four hamster monoclonal anti-metatype antibodies were characterized in terms of their binding properties with liganded murine monoclonal single-chain anti-fluorescein antibody 4-4-20. Based on induced delays in the rate of ligand (fluorescein) dissociation upon the binding of each monoclonal anti-Met antibody, apparent K-d values were determined for monoclonal antibodies 3A5-1, P1E11, 4A6, and 2C3 (3.6 x 10(-8), 3.6 x 10(-8), 5.0 x 10(-8), and 2.6 x 10(-7) M, respectively). The interaction of hamster monoclonal antibody 3A5-1 with liganded SCA 4-4-20 and IgG 4-4-20 was also evaluated on the basis of deuterium oxide exchange to assess the relative ability of each antibody to stabilize the intrinsic dynamics of the variable domains of the single-chain molecule. The results indicated a correlation between the apparent K-d of the monoclonal anti-Met antibody and the degree of delay in the rate of ligand dissociation from the primary antibody.	UNIV ILLINOIS,DEPT MICROBIOL,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign								BATES RM, 1985, MOL IMMUNOL, V22, P871, DOI 10.1016/0161-5890(85)90072-0; BEDZYK WD, 1990, J BIOL CHEM, V265, P133; BEDZYK WD, 1990, J BIOL CHEM, V265, P18615; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; COELHOSAMPAIO T, 1993, BIOCHEMISTRY-US, V32, P10929, DOI 10.1021/bi00092a001; DENZIN LK, 1992, J BIOL CHEM, V267, P8925; DENZIN LK, 1991, J BIOL CHEM, V266, P14095; ENGLANDER SW, 1992, ANNU REV BIOPH BIOM, V21, P243, DOI 10.1146/annurev.biophys.21.1.243; HERRON JN, 1986, BIOCHEMISTRY-US, V25, P4602, DOI 10.1021/bi00364a022; HERRON JN, 1989, PROTEINS, V5, P271, DOI 10.1002/prot.340050404; KRANZ DM, 1982, J BIOL CHEM, V257, P6987; KRANZ DM, 1981, J BIOL CHEM, V256, P4433; KRANZ DM, 1981, MOL IMMUNOL, V18, P889, DOI 10.1016/0161-5890(81)90012-2; PANTOLIANO MW, 1991, BIOCHEMISTRY-US, V30, P10117, DOI 10.1021/bi00106a007; SWINDLEHURST CA, 1991, BIOPHYS J, V59, P619, DOI 10.1016/S0006-3495(91)82277-9; TETIN SY, 1992, BIOCHEMISTRY-US, V48, P12029; VOSS EW, 1988, MOL IMMUNOL, V25, P751, DOI 10.1016/0161-5890(88)90111-3; VOSS EW, 1980, MOL IMMUNOL, V17, P505, DOI 10.1016/0161-5890(80)90090-5; WATT RM, 1977, IMMUNOCHEMISTRY, V14, P533, DOI 10.1016/0019-2791(77)90308-1; Weber G, 1975, Adv Protein Chem, V29, P1, DOI 10.1016/S0065-3233(08)60410-6; WEIDNER KM, 1992, J BIOL CHEM, V267, P10281; WEIDNER KM, 1993, MOL IMMUNOL, V30, P1003, DOI 10.1016/0161-5890(93)90125-U; WEIDNER KM, 1991, J BIOL CHEM, V266, P2513; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4	24	7	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8695	8700						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132597				2022-12-27	WOS:A1994NB41100014
J	MARFATIA, SM; LUE, RA; BRANTON, D; CHISHTI, AH				MARFATIA, SM; LUE, RA; BRANTON, D; CHISHTI, AH			IN-VITRO BINDING-STUDIES SUGGEST A MEMBRANE-ASSOCIATED COMPLEX BETWEEN ERYTHROID P55, PROTEIN-4.1, AND GLYCOPHORIN-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TYROSINE-PHOSPHATASE; EZRIN; IDENTIFICATION; BAND-4.1; HOMOLOGY; DOMAIN; KINASE; TALIN; LOCALIZATION; CALMODULIN	p55 is a palmitoylated peripheral membrane phosphoprotein of human erythrocytes. Primary structure of p55 includes a single copy of the SH3 motif, a COOH-terminal guanylate kinase domain, and an NH2-terminal domain of unknown function. Although the function of p55 is not known, interest in this component has been heightened by its similarity to the Drosophila tumor suppressor discs-large (dlg). In this report we provide evidence for the direct association of p55 with the NH2-terminal 30-kDa domain of protein 4.1, a key component of the erythroid membrane skeleton. In addition, p55 also binds to the cytoplasmic domain of glycophorin C, a transmembrane protein of red blood cells. We also provide evidence demonstrating the direct association of the 30-kDa domain of protein 4.1 with the cytoplasmic domain of glycophorin C. Taken together, these results suggest the existence of a novel ternary complex at the erythroid plasma membrane involving protein 4.1, p55, and glycophorin C. Since isoforms of protein 4.1, p55, and glycophorin C are present in many non erythroid cells, the binding interactions may be prototypical of similar associations that modulate cytoskeletal-membrane linkage of broad significance.	TUFTS UNIV,ST ELIZABETHS MED CTR,SCH MED,DEPT BIOMED RES,BOSTON,MA 02135; HARVARD UNIV,BIOL LABS,DEPT CELLULAR & DEV BIOL,CAMBRIDGE,MA 02138	St. Elizabeth's Medical Center; Tufts University; Harvard University					NHLBI NIH HHS [HL17411, HL37462, HL51445] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL017411, R01HL051445, R56HL051445, P01HL037462] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLOISIO N, 1993, BLOOD, V82, P1323, DOI 10.1182/blood.V82.4.1323.bloodjournal8241323; BENNETT V, 1989, BIOCHIM BIOPHYS ACTA, V988, P107, DOI 10.1016/0304-4157(89)90006-3; BRYANT PJ, 1991, CELL, V66, P451; BRYANTPJ, 1992, CELL, V68, P621; DAS AK, 1992, BIOCHIM BIOPHYS ACTA, V1108, P128, DOI 10.1016/0005-2736(92)90016-F; DISCHER D, 1993, J BIOL CHEM, V268, P7186; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GOEBL MG, 1992, TRENDS BIOCHEM SCI, V17, P99, DOI 10.1016/0968-0004(92)90244-4; GOULD KL, 1989, EMBO J, V8, P4133, DOI 10.1002/j.1460-2075.1989.tb08598.x; GU MX, 1991, P NATL ACAD SCI USA, V88, P5867, DOI 10.1073/pnas.88.13.5867; KELLY GM, 1991, J BIOL CHEM, V266, P12469; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; LETO TL, 1984, J BIOL CHEM, V259, P4603; LETO TL, 1986, MEMBRANE SKELETONS C, P201; LING E, 1988, J BIOL CHEM, V263, P2209; LOMBARDO CR, 1992, J BIOL CHEM, V267, P9540; OHANIAN V, 1984, EUR J BIOCHEM, V144, P375, DOI 10.1111/j.1432-1033.1984.tb08474.x; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; REID ME, 1989, RED CELL, P553; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; RUFF P, 1991, P NATL ACAD SCI USA, V88, P6595, DOI 10.1073/pnas.88.15.6595; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SATO N, 1992, J CELL SCI, V103, P131; SHAHROKH Z, 1991, J BIOL CHEM, V266, P12082; TANAKA T, 1991, J BIOL CHEM, V266, P1134; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949	27	154	154	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8631	8634						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132590				2022-12-27	WOS:A1994NB41100003
J	LEE, PY; HRUBY, DE				LEE, PY; HRUBY, DE			PROTEOLYTIC CLEAVAGE OF VACCINIA VIRUS VIRION PROTEINS - MUTATIONAL ANALYSIS OF THE SPECIFICITY DETERMINANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; CORE PROTEINS; POLYPEPTIDE; MATURATION; POLIOVIRUS; POLYPROTEIN; SITE; MUTAGENESIS; BIOGENESIS; PRECURSOR	Previous studies have suggested that cleavage of vaccinia virus core protein precursors occurs within the consensus tripeptide motif -A-G down arrow X-. As an approach to delineate the sequence and structural features of the precursor polypeptides that are responsible for directing site-specific scission within this element, site-directed mutagenesis procedures were employed in concert with an in vivo trans-processing assay of the P25K: FLAG reporter plasmid. The results obtained suggest that residue occupancy at the P1' site (following the nomenclature of Schechter and Berger (Schechter, I., and Berger, A. (1976) Biochem. Biophys. Res. Commun. 27, 157-162), the positions at the amino and carboxyl-proximal residues are indicated as P1, P2, etc., and P1', P2', etc., respectively) was extremely permissive, with only a proline substitution blocking cleavage. In contrast, the permissible occupancy of the P1 (serine or alanine) and P2 (cysteine, serine, or asparagine) sites was extremely restricted. Analysis of P1/P2 double mutants supported this conclusion and suggested additional levels of combinatorial stringency. Insertion or deletion of sequences immediately adjacent (amino or carboxyl-terminal) to the -A-G-X- motif completely abrogated cleavage, suggesting the presence of additional important structural determinants. Mutation of the conserved proline or basic amino acid residues in these regions had no effect on cleavage, whereas it appeared that the presence of a hydrophobic residue in the P4 site was required.	OREGON STATE UNIV, CTR GENE RES & BIOTECHNOL, DEPT MICROBIOL, CORVALLIS, OR 97331 USA	Oregon State University					NIAID NIH HHS [AI-29367] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029367] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON CW, 1990, VIROLOGY, V177, P259, DOI 10.1016/0042-6822(90)90479-B; BINNS MM, 1989, VIROLOGY, V170, P288, DOI 10.1016/0042-6822(89)90380-2; BINNS MM, 1988, J GEN VIROL, V69, P1275, DOI 10.1099/0022-1317-69-6-1275; BLAIR WS, 1990, J VIROL, V64, P1784, DOI 10.1128/JVI.64.4.1784-1793.1990; BLAIR WS, 1991, J VIROL, V65, P6111, DOI 10.1128/JVI.65.11.6111-6123.1991; DEGROOT RJ, 1990, EMBO J, V9, P2631, DOI 10.1002/j.1460-2075.1990.tb07445.x; DEWALT PG, 1989, J VIROL, V63, P3444, DOI 10.1128/JVI.63.8.3444-3452.1989; DOUGHERTY WG, 1989, VIROLOGY, V182, P17; GORDON J, 1991, VIROLOGY, V181, P671, DOI 10.1016/0042-6822(91)90901-M; HRUBY DE, 1979, J VIROL, V29, P705, DOI 10.1128/JVI.29.2.705-715.1979; KATZ E, 1970, P NATL ACAD SCI USA, V66, P677, DOI 10.1073/pnas.66.3.677; KAY J, 1990, BIOCHIM BIOPHYS ACTA, V1048, P1, DOI 10.1016/0167-4781(90)90015-T; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEE PY, 1993, J VIROL, V67, P4252, DOI 10.1128/JVI.67.7.4252-4263.1993; LOPEZOTIN C, 1989, J BIOL CHEM, V264, P9107; PALLAI PV, 1989, J BIOL CHEM, V264, P9738; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SILVER M, 1982, VIROLOGY, V117, P341, DOI 10.1016/0042-6822(82)90474-3; TRITCH RJ, 1991, J VIROL, V65, P922, DOI 10.1128/JVI.65.2.922-930.1991; VANSLYKE JK, 1991, J GEN VIROL, V72, P411, DOI 10.1099/0022-1317-72-2-411; VANSLYKE JK, 1993, VIRUS GENES, V7, P311, DOI 10.1007/BF01703388; VANSLYKE JK, 1991, VIROLOGY, V183, P467, DOI 10.1016/0042-6822(91)90976-I; WEBSTER A, 1989, J GEN VIROL, V70, P3225, DOI 10.1099/0022-1317-70-12-3225; WHITEHEAD SS, 1994, IN PRESS VIROLOGY; YANG WP, 1988, VIROLOGY, V167, P578, DOI 10.1016/0042-6822(88)90120-1; YPMAWONG MF, 1987, J VIROL, V61, P3181, DOI 10.1128/JVI.61.10.3181-3189.1987; YPMAWONG MF, 1988, J BIOL CHEM, V263, P17846; ZHANG L, 1993, GENE, V129, P197, DOI 10.1016/0378-1119(93)90269-9	29	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8616	8622						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132587				2022-12-27	WOS:A1994NB40900117
J	MACEDO, AL; MOURA, I; SURERUS, KK; PAPAEFTHYMIOU, V; LIU, MY; LEGALL, J; MUNCK, E; MOURA, JJG				MACEDO, AL; MOURA, I; SURERUS, KK; PAPAEFTHYMIOU, V; LIU, MY; LEGALL, J; MUNCK, E; MOURA, JJG			THIOL/DISULFIDE FORMATION ASSOCIATED WITH THE REDOX ACTIVITY OF THE [FE3S4] CLUSTER OF DESULFOVIBRIO-GIGAS FERREDOXIN-II - H-1-NMR AND MOSSBAUER SPECTROSCOPIC STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEINS; ELECTRON-PARAMAGNETIC-RES; SPIN-COUPLING MODEL; 3 FORMS; 3-IRON CLUSTERS; 3FE CLUSTERS; PURIFICATION	Desulfovibrio gigas ferredoxin II (FdII) is a small protein (alpha(4) subunit structure as isolated; M(r) approximate to 6400 per subunit; 6 cysteine residues) containing one Fe3S4 cluster per alpha-subunit. The x-ray structure of FdII has revealed a disulfide bridge formed by Cys-18 and Cys-42 approximately 13 Angstrom away from the center of the cluster; moreover, the x-ray structure indicates that Cys-11 forms a disulfide bridge with a methanethiol. In the oxidized state, FdII(ox), the H-1 NMR spectra, exhibit four low-field contact-shifted resonances at 29, 24, 18, and 15.5 ppm whereas the reduced state, FdII(R) (S = 2), yields two features at +18.5 and -11 ppm. In the course of studying the redox behavior of FdII, we have discovered a stable intermediate, FdII(int), that yields H-1 resonances at 24, 21.5, 21, and 14 ppm. This intermediate appears in the potential range where the cluster (E'o approximate to -130 mV) is reduced from the [Fe3S4](1+) to the [Fe3S4](o) state. FdII(int) is observed during reductive titrations with dithionite or hydrogen/hydrogenase or after partial oxidation of FdII(R) by 2,6 dichlorophenolindophenol or air. Our studies show that a total of three electrons per alpha-subunit are transferred to FdII. Our experiments demonstrate the absence of a methanethiol-Cys-11 linkage in our preparations, and we propose that two of the three electrons are used for the reduction of the disulfide bridge. Mossbauer (and EPR) studies show that the Fe3S4 cluster of FdIl(int) is at the same oxidation level as FdII(ox), but indicate some changes in the exchange couplings among the three ferric sites. Our data suggest that the differences in the NMR and Mossbauer spectra of FdII(ox) and FdII(int) result from conformational changes attending the breaking or formation of the disulfide bridge. The present study suggests that experiments be undertaken to explore an in vivo redox function for the disulfide bridge.	UNL,INST TECNOL QUIM & BIOL,P-2780 OEIRAS,PORTUGAL; CARNEGIE MELLON UNIV,DEPT CHEM,PITTSBURGH,PA 15213; UNIV IOANNINA,DEPT PHYS,IOANNINA,GREECE; UNIV GEORGIA,DEPT BIOCHEM,ATHENS,GA 30602	Universidade Nova de Lisboa; Carnegie Mellon University; University of Ioannina; University System of Georgia; University of Georgia	MACEDO, AL (corresponding author), UNIV NOVA LISBOA,FAC CIENCIAS & TECNOL,QUINTA DA TORRE,P-2825 MONTE DE CAPARICA,PORTUGAL.		Moura, Isabel/D-6339-2013; Moura, José J G/D-6426-2013; Macedo, Anjos L/D-7216-2013	Moura, Isabel/0000-0003-0971-4977; Moura, José J G/0000-0002-4726-2388; Macedo, Anjos L/0000-0002-2613-4838	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041482] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-41482] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTONIO MR, 1982, J BIOL CHEM, V257, P6646; BARTON LL, 1970, BACTERIOL P, V134; BERTRAND P, 1984, BIOCHIMIE, V66, P77, DOI 10.1016/0300-9084(84)90182-2; BRUSCHI M, 1976, BIOCHIM BIOPHYS ACTA, V449, P275, DOI 10.1016/0005-2728(76)90139-0; CAMMACK R, 1977, BIOCHIM BIOPHYS ACTA, V490, P311, DOI 10.1016/0005-2795(77)90006-X; CHEN L, 1993, ARCH BIOCHEM BIOPHYS, V303, P44, DOI 10.1006/abbi.1993.1253; CLARK WM, 1972, OXIDATION REDUCTION, P364; DAY EP, 1988, J BIOL CHEM, V263, P3684; FAUQUE G, 1991, VARIATIONS AUTOTROPH, P271; GAYDA JP, 1982, J CHEM PHYS, V77, P3387, DOI 10.1063/1.444281; GAYDA JP, 1983, J CHEM PHYS, V79, P5732, DOI 10.1063/1.445661; GRASSETTI DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; GUIGLIARELLI B, 1986, J CHEM PHYS, V85, P2774, DOI 10.1063/1.451033; GUIGLIARELLI B, 1986, BIOCHIM BIOPHYS ACTA, V871, P149, DOI 10.1016/0167-4838(86)90168-8; HUNT J, 1992, J BIOL CHEM, V267, P21479; HUYNH BH, 1980, J BIOL CHEM, V255, P3242; IISMAA SE, 1991, J BIOL CHEM, V266, P2153; KENT TA, 1980, P NATL ACAD SCI-BIOL, V77, P6574, DOI 10.1073/pnas.77.11.6574; KISSINGER CR, 1991, J MOL BIOL, V219, P693, DOI 10.1016/0022-2836(91)90665-S; KNIGHT E, 1966, J BIOL CHEM, V241, P2752; LEGALL J, 1967, CR ACAD SCI D NAT, V264, P2580; LEGALL J, 1979, CURR TOP BIOENERG, V9, P237; MACEDO AL, 1993, INORG CHEM, V32, P1101, DOI 10.1021/ic00059a013; MACEDO AL, 1993, IN PRESS MAGNETIC RE; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; MORENO C, 1991, 3RD P INT C MOL BIOL; MORENO C, 1993, IN PRESS J INORG BIO; MOURA I, 1986, J AM CHEM SOC, V108, P349, DOI 10.1021/ja00262a057; MOURA JJG, 1977, BIOCHIM BIOPHYS ACTA, V459, P278, DOI 10.1016/0005-2728(77)90028-7; MOURA JJG, 1982, J BIOL CHEM, V257, P6259; MUNCK E, 1988, METAL CLUSTERS PROTE, P302; PAPAEFTHYMIOU V, 1987, J AM CHEM SOC, V109, P4703, DOI 10.1021/ja00249a037; SURERUS KK, 1987, J AM CHEM SOC, V109, P3805, DOI 10.1021/ja00246a062; SURERUS KK, 1989, THESIS U MINNESOTA; THOMSON AJ, 1981, BIOCHIM BIOPHYS ACTA, V670, P93, DOI 10.1016/0005-2795(81)90053-2	35	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8052	8058						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132528				2022-12-27	WOS:A1994NB40900036
J	IZUMI, M; MIYAZAWA, H; HARAKAWA, S; YATAGAI, F; HANAOKA, F				IZUMI, M; MIYAZAWA, H; HARAKAWA, S; YATAGAI, F; HANAOKA, F			IDENTIFICATION OF A POINT MUTATION IN THE CDNA OF THE CATALYTIC SUBUNIT OF DNA-POLYMERASE-ALPHA FROM A TEMPERATURE-SENSITIVE MOUSE FM3A CELL-LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE ESSENTIAL GENE; PRIMASE P49 SUBUNIT; SACCHAROMYCES-CEREVISIAE; HEAT-LABILE; I GENE; DROSOPHILA-MELANOGASTER; NUCLEOTIDE-SEQUENCE; TSFT20 STRAIN; MUTANT; REPLICATION	DNA polymerase at is a key enzyme in eukaryotic chromosomal DNA replication. tsFT20 is a temperature-sensitive mutant cell line derived from mouse mammary carcinoma FM3A cells, and the cells contain heat-labile DNA polymerase alpha and are arrested at the S phase at the nonpermissive temperature. We isolated cDNA of the catalytic subunit of DNA polymerase alpha from tsFT20 cells. DNA sequence analysis revealed that the cDNA from tsFT20 has a single mutation, a cytosine to thymine substitution that changes amino acid 1180 from serine to phenylalanine. We have also shown that tsFT20 cells could be rescued by transfection with the wild-type cDNA. These results demonstrate that the point mutation in the gene of DNA polymerase cu causes the temperatue-sensitive phenotype of tsFT20 cells and provide additional evidence that DNA polymerase cu is essential for chromosomal replication in mamma lian cells. We also detected mutation sites in one spontaneous and six N-methyl-N'-nitro-N-nitrosoguanidine-induced growth revertants of tsFT20 cells by single strand conformation polymorphism analyses and direct sequencing. All revertant cell lines had a second point mutation adjacent to the first mutation site in tsFT20 cells.	INST PHYS & CHEM RES,CELLULAR PHYSIOL LAB,WAKO,SAITAMA 35101,JAPAN; INST PHYS & CHEM RES,BIODESIGN RES GRP,WAKO,SAITAMA 35101,JAPAN; INST PHYS & CHEM RES,DIV RADIOISOTOPE TECHNOL,WAKO,SAITAMA 35101,JAPAN	RIKEN; RIKEN; RIKEN								ADLER DA, 1991, GENOMICS, V9, P642, DOI 10.1016/0888-7543(91)90357-K; AGUILERA A, 1988, GENETICS, V119, P779; BAMBARA RA, 1991, BIOCHIM BIOPHYS ACTA, V1088, P11, DOI 10.1016/0167-4781(91)90147-E; BUDD M, 1987, P NATL ACAD SCI USA, V84, P2838, DOI 10.1073/pnas.84.9.2838; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; COTTERILL S, 1992, NUCLEIC ACIDS RES, V20, P4325, DOI 10.1093/nar/20.16.4325; COULONDRE C, 1977, J MOL BIOL, V117, P577, DOI 10.1016/0022-2836(77)90059-6; DAMAGNEZ V, 1991, MOL GEN GENET, V226, P182, DOI 10.1007/BF00273602; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; EKI T, 1987, EXP CELL RES, V171, P24, DOI 10.1016/0014-4827(87)90248-5; EKI T, 1990, J BIOL CHEM, V265, P26; FOIANI M, 1989, MOL CELL BIOL, V9, P3081, DOI 10.1128/MCB.9.7.3081; GONG SS, 1990, NUCLEIC ACIDS RES, V18, P3509, DOI 10.1093/nar/18.12.3509; HIROSE F, 1991, NUCLEIC ACIDS RES, V19, P4991, DOI 10.1093/nar/19.18.4991; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; IZUMI M, 1991, EXP CELL RES, V197, P229, DOI 10.1016/0014-4827(91)90427-V; LINN S, 1991, CELL, V66, P185, DOI 10.1016/0092-8674(91)90608-2; LUCCHINI G, 1988, MOL GEN GENET, V212, P459, DOI 10.1007/BF00330850; LUCCHINI G, 1990, GENE, V90, P99, DOI 10.1016/0378-1119(90)90444-V; LUCCHINI G, 1987, EMBO J, V6, P737, DOI 10.1002/j.1460-2075.1987.tb04815.x; MIYAZAWA H, 1993, J BIOL CHEM, V268, P8111; MURAKAMI Y, 1986, EXP CELL RES, V163, P135, DOI 10.1016/0014-4827(86)90565-3; MURAKAMI Y, 1985, P NATL ACAD SCI USA, V82, P1761, DOI 10.1073/pnas.82.6.1761; NAKABEPPU Y, 1993, MOL CELL BIOL, V13, P4157, DOI 10.1128/MCB.13.7.4157; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PIZZAGALLI A, 1988, P NATL ACAD SCI USA, V85, P3772, DOI 10.1073/pnas.85.11.3772; PRUSSAK CE, 1989, J BIOL CHEM, V264, P4957; Sambrook J, 1989, MOL CLONING LABORATO; SPICER EK, 1988, J BIOL CHEM, V263, P7478; SPINARDI L, 1991, NUCLEIC ACIDS RES, V19, P4009, DOI 10.1093/nar/19.14.4009; TAKADATAKAYAMA R, 1991, J BIOL CHEM, V266, P15716; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TSAI YJ, 1979, BIOCHEM BIOPH RES CO, V91, P1190, DOI 10.1016/0006-291X(79)92005-9; UCHIDA S, 1990, MOL CELL BIOL, V10, P577, DOI 10.1128/MCB.10.2.577; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; WONG SW, 1986, J BIOL CHEM, V261, P7958; WONG SW, 1988, EMBO J, V7, P37, DOI 10.1002/j.1460-2075.1988.tb02781.x	40	14	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7639	7644						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125989				2022-12-27	WOS:A1994NA03200095
J	LENTING, PJ; DONATH, MJSH; VANMOURIK, JA; MERTENS, K				LENTING, PJ; DONATH, MJSH; VANMOURIK, JA; MERTENS, K			IDENTIFICATION OF A BINDING-SITE FOR BLOOD-COAGULATION FACTOR IXA ON THE LIGHT-CHAIN OF HUMAN FACTOR-VIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-C; PORCINE FACTOR-VIII; VON-WILLEBRAND FACTOR; VONWILLEBRAND-FACTOR; FACTOR-XA; MONOCLONAL-ANTIBODIES; FACTOR-VA; CATALYZED INACTIVATION; PHOSPHOLIPID-VESICLES; A1/A3-C1-C2 DIMER	The interaction between human factor IXa and factor VIII or its constituent units was investigated. Equilibrium binding studies were performed employing factor VIII light chain that was immobilized on a monoclonal antibody. Factor VIII light chain was observed to bind factor IXa with high affinity (K-d = 14.8 +/- 3.2 nM) and approximately 1:1 stoichiometry. Optimal interaction required NaCl concentrations below 0.2 M and the presence of Ca2+ ions. Factor VIII light chain in solution effectively inhibited binding of factor IXa to the immobilized light chain (K-i = 10.9 +/- 1.9 nM). The isolated factor VIII light chain and the factor VIII heterodimer were equally effective in factor IXa binding, demonstrating that this interaction did not require the factor VIII heavy chain. Factor Xa and activated Protein C were found to be inefficient (K-i greater than or equal to 1.2 mu M) in competing with factor IXa, indicating that the high affinity for factor VII light chain was unique for factor IXa. The factor IXa-factor VIII light chain interaction was inhibited by von Willebrand factor, but this effect was abolished by cleavage of the factor VIII light chain by thrombin. An antibody that inhibits von Willebrand factor-factor VIII complex formation did not compete for factor IXa binding. In contrast, association of factor IXa with the factor VIII light chain was inhibited by an antibody directed against the factor VIII region Gln(1778)-Asp(1840). We propose that this sequence provides a factor IXa binding site and that its exposure requires dissociation of the factor VIII-von Willebrand factor complex.	NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,DEPT BLOOD COAGULAT,1066 CX AMSTERDAM,NETHERLANDS				Lenting, Peter/AAH-5663-2019; Lenting, Peter/F-8269-2013	Lenting, Peter/0000-0002-7937-3429; Lenting, Peter/0000-0002-7937-3429				ANDERSSON LO, 1981, BIOCHEM J, V200, P161, DOI 10.1042/bj2000161; ANDERSSON LO, 1986, P NATL ACAD SCI USA, V83, P2979, DOI 10.1073/pnas.83.9.2979; ANNAMALAI AE, 1987, BLOOD, V70, P139; ARAI M, 1989, J CLIN INVEST, V83, P1978, DOI 10.1172/JCI114107; BERTINA RM, 1984, BIOCHEM BIOPH RES CO, V125, P177, DOI 10.1016/S0006-291X(84)80351-4; BIETH JG, 1984, BIOCHEM MED METAB B, V32, P387, DOI 10.1016/0006-2944(84)90046-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DUFFY EJ, 1992, J BIOL CHEM, V267, P17006; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1991, J BIOL CHEM, V266, P8957; FAY PJ, 1989, BIOCHIM BIOPHYS ACTA, V994, P142, DOI 10.1016/0167-4838(89)90153-2; FAY PJ, 1991, J BIOL CHEM, V266, P2172; FOSTER PA, 1990, BLOOD, V75, P1999; GUINTO ER, 1984, J BIOL CHEM, V259, P3986; KANE WH, 1988, BLOOD, V71, P539; KAUFMAN RJ, 1988, J BIOL CHEM, V263, P6352; KISIEL W, 1979, J CLIN INVEST, V64, P761, DOI 10.1172/JCI109521; LAMPHEAR BJ, 1992, BLOOD, V80, P3120; LAMPHEAR BJ, 1992, J BIOL CHEM, V267, P3725; LEYTE A, 1989, BIOCHEM J, V257, P679, DOI 10.1042/bj2570679; LEYTE A, 1991, J BIOL CHEM, V266, P740; LEYTE A, 1991, BIOCHEM J, V274, P257, DOI 10.1042/bj2740257; LEYTE A, 1989, BIOCHEM J, V263, P187, DOI 10.1042/bj2630187; LOLLAR P, 1985, BIOCHEMISTRY-US, V24, P8056, DOI 10.1021/bi00348a033; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; LOLLAR P, 1984, BLOOD, V63, P1303; LOLLAR P, 1989, BIOCHEMISTRY-US, V28, P666, DOI 10.1021/bi00428a038; MANN KG, 1990, BLOOD, V76, P1; MERTENS K, 1982, THROMB HAEMOSTASIS, V47, P96; MERTENS K, 1984, BIOCHEM J, V223, P599, DOI 10.1042/bj2230599; MERTENS K, 1985, THROMB HAEMOSTASIS, V54, P654; NAKANE PK, 1974, J HISTOCHEM CYTOCHEM, V22, P1084, DOI 10.1177/22.12.1084; OBRIEN DP, 1992, BIOCHEMISTRY-US, V31, P2805, DOI 10.1021/bi00125a022; PRECUP JW, 1991, BLOOD, V77, P1929; PRYZDIAL ELG, 1991, J BIOL CHEM, V266, P8969; ROTBLAT F, 1985, BIOCHEMISTRY-US, V24, P4294, DOI 10.1021/bi00337a007; SADLER JE, 1987, MOL BASIS BLOOD DISE, P575; STEL HV, 1983, THROMB HAEMOSTASIS, V50, P860; STEL HV, 1984, THESIS U AMSTERDAM, P51; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; TRACY PB, 1983, P NATL ACAD SCI-BIOL, V80, P2380, DOI 10.1073/pnas.80.8.2380; VEERMAN ECI, 1983, THROMB RES, V33, P89; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; WALKER FJ, 1987, ARCH BIOCHEM BIOPHYS, V252, P322, DOI 10.1016/0003-9861(87)90037-3; WALKER FJ, 1990, J BIOL CHEM, V265, P1484	46	148	159	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7150	7155						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125924				2022-12-27	WOS:A1994NA03200020
J	VYAS, TB; MOOERS, SU; NARAYAN, SR; SIEGMAN, MJ; BUTLER, TM				VYAS, TB; MOOERS, SU; NARAYAN, SR; SIEGMAN, MJ; BUTLER, TM			CROSS-BRIDGE CYCLING AT REST AND DURING ACTIVATION - TURNOVER OF MYOSIN-BOUND ADP IN PERMEABILIZED SMOOTH-MUSCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT CHAIN PHOSPHORYLATION; HEAVY-MEROMYOSIN; TENSION; MECHANISM; BINDING; CALCIUM; STRESS; ACTIN; CA-2+	Single turnover experiments were performed on myosin-bound ADP by measuring the time course of incorporation of [H-3]ADP following rapid formation of [H-3]ATP by photolysis of caged [H-3]ATP. Permeabilized rabbit portal veins were incubated in a solution at 20 degrees C with 1 mM MgATP, 20 mM phosphocreatine, 1 mg/ml creatine phosphokinase, and containing [C-14]ATP and high specific activity caged [H-3]ATP. At variable times following a UV flash, the muscle was frozen, nucleotides were extracted, and the ratio H-3:C-14 in ADP was compared to that in ATP. At rest, the exchange of bound ADP occurred with a rate constant of 0.004 s(-1). When the myosin light chain was about 80% thiophosphorylated, and the muscle was generating maximum isometric force, there appeared a fast phase of ADP exchange (44% of the total) which had a rate constant of 0.2 s(-1). The change in rate of ADP exchange on myosin is sufficient to explain the measured increase in ATPase activity upon thiophosphorylation of the myosin light chain. A simple analysis of the data suggests that there is a 50-fold increase in the cycling rate of cross-bridges in the muscle upon phosphorylation under isometric conditions. The fraction of ADP exchanged at 10 s following photolytic release of [H-3]ATP was found to be approximately linearly related to the degree of thiophosphorylation of the myosin light chain. This supports the idea that phosphorylation of the light chain causes the transition of myosin from the resting (slow ATPase) cycle into the activated (fast ATPase) cycle, and that the fraction of myosin in the fast cycle is directly determined by the degree of light chain phosphorylation. The data are also consistent with the cooperativity model described previously by Vyas ct al. (Vyas, T. B., Mooers, S. U., Narayan, S. R., Witherell, J. C., Siegman, M. J., and Butler, T. M. (1992) Am. J. Physiol. 263, C210-C219).			VYAS, TB (corresponding author), THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT PHYSIOL,PHILADELPHIA,PA 19107, USA.				NHLBI NIH HHS [T35 HL07599, HL15835] Funding Source: Medline; NIDDK NIH HHS [DK37598] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL015835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037598] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BUTLER TM, 1983, AM J PHYSIOL, V244, pC234, DOI 10.1152/ajpcell.1983.244.3.C234; BUTLER TM, 1989, AM J PHYSIOL, V256, pC59, DOI 10.1152/ajpcell.1989.256.1.C59; BUTLER TM, 1990, AM J PHYSIOL, V258, pC1092, DOI 10.1152/ajpcell.1990.258.6.C1092; BUTLER TM, 1986, AM J PHYSIOL, V251, pC945, DOI 10.1152/ajpcell.1986.251.6.C945; CASSIDY P, 1979, J BIOL CHEM, V254, P1148; GERTHOFFER WT, 1987, J PHARMACOL EXP THER, V240, P8; GREENE LE, 1987, J BIOL CHEM, V262, P4177; HAEBERLE JR, 1985, J MUSCLE RES CELL M, V6, P347, DOI 10.1007/BF00713174; HAEBERLE JR, 1985, PFLUG ARCH EUR J PHY, V403, P215, DOI 10.1007/BF00584103; HAI CM, 1989, ANNU REV PHYSIOL, V51, P285, DOI 10.1146/annurev.physiol.51.1.285; HARTSHORNE DJ, 1987, PHYSL GASTROINTESTIN, P423; JIANG MJ, 1989, PFLUG ARCH EUR J PHY, V413, P637, DOI 10.1007/BF00581814; KUSHMERICK MJ, 1987, CARDIAC ENERGETICS, P17; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; MORELAND S, 1987, AM J PHYSIOL, V252, pH1049, DOI 10.1152/ajpheart.1987.252.6.H1049; NISHIYE E, 1993, J PHYSIOL-LONDON, V460, P247, DOI 10.1113/jphysiol.1993.sp019470; RATZ PH, 1987, CIRC RES, V60, P410, DOI 10.1161/01.RES.60.3.410; ROSENFELD SS, 1984, J BIOL CHEM, V259, P1908; SELLERS JR, 1982, J BIOL CHEM, V257, P3880; SELLERS JR, 1985, J BIOL CHEM, V260, P5815; SIEGMAN MJ, 1984, PFLUG ARCH EUR J PHY, V401, P385, DOI 10.1007/BF00584340; TANSEY MG, 1990, FEBS LETT, V270, P219, DOI 10.1016/0014-5793(90)81272-P; TAYLOR EW, 1992, HEART CARDIOVASCULAR, P1281; TRYBUS KM, 1989, J CELL BIOL, V109, P2887, DOI 10.1083/jcb.109.6.2887; VYAS TB, 1992, AM J PHYSIOL, V263, pC210, DOI 10.1152/ajpcell.1992.263.1.C210; WALKER JW, 1988, J AM CHEM SOC, V110, P7170, DOI 10.1021/ja00229a036	26	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7316	7322						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125947				2022-12-27	WOS:A1994NA03200046
J	SATOH, H; NAGAE, Y; IMMENSCHUH, S; SATOH, T; MULLEREBERHARD, U				SATOH, H; NAGAE, Y; IMMENSCHUH, S; SATOH, T; MULLEREBERHARD, U			IDENTIFICATION OF A LIVER PREFERENCE ENHANCER ELEMENT OF THE RAT HEMOPEXIN GENE AND ITS INTERACTION WITH NUCLEAR FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE RECEPTOR SUPERFAMILY; APOLIPOPROTEIN-A-I; TRANSCRIPTION FACTOR BINDS; ACID RESPONSE PATHWAYS; 9-CIS RETINOIC ACID; THYROID-HORMONE; OVALBUMIN GENE; ORPHAN RECEPTORS; DNA-BINDING; COUP-TF	Transcription of hemopexin (Hx) occurs predominantly in the liver. To investigate the contribution of the cis-acting enhancer element to the hepatocyte preferential expression, we performed chloramphenicol acetyltransferase (CAT) assays in HepG2 cells. A strong enhancer element was identified by successive truncation to reside in the region -157/-104 from the cap site. The Hx region -145/-125 interacts with rat liver nuclear pro teins, as shown by standard DNA-protein binding assays. The nucleotide sequence -(141)AGACTTTGACCT-(130) includes, in reverse orientation, a direct repeat of the imperfect AGGTCA sequence, one of the recognition motifs of the steroid-thyroid hormone receptor superfamily. That this AGGTCA repeat is an enhancer core of the Hx element was affirmed by mutational analyses, In electrophoretic mobility shift assays, oligonucleotides, corresponding to binding regions of chicken ovalbumin upstream promoter transcription factor (COUP-TF) and apolipoprotein AI regulatory protein 1 (ARP 1) but not of hepatocyte nuclear factor-4 (HNF-4), competed with the Hx element for binding sites. Co-transfection analyses indicated that HNF-4 does not affect CAT expression whereas ARP-I and COUP-TF repress it. Antibody supershift analyses suggested that HNF-4 and COUP-TF may not be major factors binding to the Hx element.	CORNELL UNIV, COLL MED, DEPT PEDIAT, NEW YORK, NY 10021 USA; CORNELL UNIV, COLL MED, DEPT BIOCHEM, NEW YORK, NY 10021 USA; CORNELL UNIV, COLL MED, DEPT PHARMACOL, NEW YORK, NY 10021 USA	Cornell University; Cornell University; Cornell University			Immenschuh, Stephan/AAM-9181-2020	Immenschuh, Stephan/0000-0003-3722-5791	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030203] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-30203] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTRUDA F, 1988, J MOL EVOL, V27, P102, DOI 10.1007/BF02138368; BAGCHI MK, 1992, ENDOCR REV, V13, P525, DOI 10.1210/er.13.3.525; BARNARD ML, 1993, BIOCHEM BIOPH RES CO, V192, P82, DOI 10.1006/bbrc.1993.1384; BAUMANN H, 1987, BIOCHEM BIOPH RES CO, V146, P1218, DOI 10.1016/0006-291X(87)90778-9; BRUNEL F, 1988, J BIOL CHEM, V263, P10180; COONEY AJ, 1991, J VIROL, V65, P2853, DOI 10.1128/JVI.65.6.2853-2860.1991; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; COONEY AJ, 1993, J BIOL CHEM, V268, P4152; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; COUREY AJ, 1992, TRANSCRIPTIONAL REGU, V2, P743; CRABTREE GR, 1992, TRANSCRIPTIONAL REGU, V2, P1063; DAVIES DM, 1979, BIOCHEM BIOPH RES CO, V91, P1504, DOI 10.1016/0006-291X(79)91235-X; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; DESIMONE V, 1992, BIOCHIM BIOPHYS ACTA, V1132, P119, DOI 10.1016/0167-4781(92)90001-G; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DURAND B, 1992, CELL, V71, P73, DOI 10.1016/0092-8674(92)90267-G; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GARCIA AD, 1993, J VIROL, V67, P3940, DOI 10.1128/JVI.67.7.3940-3950.1993; GIRALT M, 1991, J BIOL CHEM, V266, P21991; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; HADDAD IA, 1986, J BIOL CHEM, V261, P3268; HALLENBECK PL, 1992, P NATL ACAD SCI USA, V89, P5572, DOI 10.1073/pnas.89.12.5572; HATA S, 1992, BIOCHIM BIOPHYS ACTA, V1131, P211, DOI 10.1016/0167-4781(92)90080-J; HWUNG YP, 1988, MOL CELL BIOL, V8, P2070, DOI 10.1128/MCB.8.5.2070; ING NH, 1992, J BIOL CHEM, V267, P17617; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; JOHNSON PF, 1990, CELL GROWTH DIFFER, V1, P47; KARATHANASIS SK, 1992, HIGH DENSITY LIPOPRO, V3, P21; KIMURA A, 1993, J BIOL CHEM, V268, P11125; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; KNOLL BJ, 1983, NUCLEIC ACIDS RES, V11, P6733, DOI 10.1093/nar/11.19.6733; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; LAI E, 1991, TRENDS BIOCHEM SCI, V16, P427, DOI 10.1016/0968-0004(91)90169-V; LIU YH, 1991, J BIOL CHEM, V266, P21880; MANGELSDORF DJ, 1992, TRANSCRIPTIONAL REGU, V2, P1137; METZGER S, 1993, J BIOL CHEM, V268, P16831; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; MIYATA KS, 1993, J BIOL CHEM, V268, P19169; MLODZIK M, 1990, CELL, V60, P211, DOI 10.1016/0092-8674(90)90737-Y; Muller- Eberhard U, 1974, STRUCTURE FUNCTION P, V1, ppp; MULLEREBERHARD U, 1988, METHOD ENZYMOL, V163, P536; MULLEREBERHARD U, 1993, AM J HEMATOL, V42, P59, DOI 10.1002/ajh.2830420112; NAGAE Y, 1992, BIOCHEM BIOPH RES CO, V185, P420, DOI 10.1016/S0006-291X(05)81002-2; NIELSEN DA, 1983, P NATL ACAD SCI-BIOL, V80, P5198, DOI 10.1073/pnas.80.17.5198; NIKKILA H, 1991, BIOCHEMISTRY-US, V30, P823, DOI 10.1021/bi00217a036; NITSCH D, 1993, P NATL ACAD SCI USA, V90, P5479, DOI 10.1073/pnas.90.12.5479; OMALLEY BW, 1992, MOL ENDOCRINOL, V6, P1359, DOI 10.1210/me.6.9.1359; PASTORCIC M, 1986, MOL CELL BIOL, V6, P2784, DOI 10.1128/MCB.6.8.2784; POLI V, 1989, NUCLEIC ACIDS RES, V17, P9351; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; POLI V, 1989, P NATL ACAD SCI USA, V86, P8202, DOI 10.1073/pnas.86.21.8202; POWER RF, 1991, SCIENCE, V252, P1546, DOI 10.1126/science.2047861; POWER RF, 1992, TRENDS PHARMACOL SCI, V13, P318, DOI 10.1016/0165-6147(92)90099-R; RITCHIE HH, 1990, NUCLEIC ACIDS RES, V18, P6857, DOI 10.1093/nar/18.23.6857; ROSEN ED, 1993, J BIOL CHEM, V268, P11534; ROTTMAN JN, 1991, MOL CELL BIOL, V11, P3814, DOI 10.1128/MCB.11.7.3814; SAGAMI I, 1986, MOL CELL BIOL, V6, P4259, DOI 10.1128/MCB.6.12.4259; Sambrook J, 1989, MOL CLONING LABORATO; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; SMITH A, 1981, J BIOL CHEM, V256, P902; SWERTS JP, 1992, J BIOL CHEM, V267, P10596; TIAN JM, 1991, GENE DEV, V5, P2225, DOI 10.1101/gad.5.12a.2225; TRAN P, 1992, MOL CELL BIOL, V12, P4666, DOI 10.1128/MCB.12.10.4666; VINCENT SH, 1988, ARCH BIOCHEM BIOPHYS, V265, P539, DOI 10.1016/0003-9861(88)90159-2; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; WIDOM RL, 1992, MOL CELL BIOL, V12, P3380, DOI 10.1128/MCB.12.8.3380; WIJNHOLDS J, 1988, EMBO J, V7, P2757, DOI 10.1002/j.1460-2075.1988.tb03130.x; XANTHOPOULOS KG, 1991, P NATL ACAD SCI USA, V88, P3807, DOI 10.1073/pnas.88.9.3807; ZHONG WM, 1993, EMBO J, V12, P537, DOI 10.1002/j.1460-2075.1993.tb05685.x	72	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6851	6858						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120047				2022-12-27	WOS:A1994MZ50300092
J	DOIRON, B; CUIF, MH; KAHN, A; DIAZGUERRA, MJM				DOIRON, B; CUIF, MH; KAHN, A; DIAZGUERRA, MJM			RESPECTIVE ROLES OF GLUCOSE, FRUCTOSE, AND INSULIN IN THE REGULATION OF THE LIVER-SPECIFIC PYRUVATE-KINASE GENE PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							POST-TRANSCRIPTIONAL REGULATION; RAT HEPATOCYTES; GLUCOKINASE GENE; PRIMARY CULTURES; EXPRESSION; STIMULATION; PHOSPHORYLATION; INDUCTION; PROTEIN; CELLS	The L-type pyruvate kinase (L-PK) is a key enzyme of the glycolytic pathway mainly expressed in the liver. Rat liver contains a regulatory protein that inhibits glucokinase (GK) activity. The effect of this protein is greatly reinforced by the fructose 6-phosphate and antagonized by the fructose 1-phosphate (Van Schaftingen, E. (1989) fur. J. Biochem. 179, 179-184). In hepatocytes, fructose in low concentrations is phosphorylated into fructose 1-phosphate, and therefore is able to activate GK in the absence of insulin via the regulatory protein in the liver. In primary culture of rat hepatocytes, 0.2 mM fructose in the presence of 20 or 40 mM glucose stimulated the activity of the L-PK gene promoter fused with the chloramphenicol acetyltransferase reporter gene, regardless of the addition of insulin, through the glucose/insulin response element. A constitutive GK expression vector co-transfected with the L-PK/ chloramphenicol acetyltransferase construct is also able to confer an insulin-independent glucose responsiveness in hepatocytes. Thus, the insulin effect on glucose-dependent activation of the L-PK promoter is, under these experimental conditions, to permit glucose phosphorylation through the stimulation of the GK synthesis. In the presence of glucose, the L-PK promoter can also be activated by a post-translational GK activation, mediated by a low concentration of fructose acting via the regulatory protein of glucokinase.	INST COCHIN GENET MOLEC, INSERM, U129, F-75014 PARIS, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)			Díaz-Guerra, María José M/M-2855-2014	Díaz-Guerra, María José M/0000-0003-3843-3912				BERGOT MO, 1992, NUCLEIC ACIDS RES, V20, P1871, DOI 10.1093/nar/20.8.1871; DAVIES DR, 1990, EUR J BIOCHEM, V192, P283, DOI 10.1111/j.1432-1033.1990.tb19225.x; DECAUX JF, 1989, J BIOL CHEM, V264, P11584; DECAUX JF, 1991, J BIOL CHEM, V266, P3432; DETHEUX M, 1993, FEBS LETT, V321, P111, DOI 10.1016/0014-5793(93)80089-D; FOUFELLE F, 1992, J BIOL CHEM, V267, P20543; GIFFHORNKATZ S, 1986, EUR J BIOCHEM, V159, P513, DOI 10.1111/j.1432-1033.1986.tb09916.x; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRANNER D, 1990, J BIOL CHEM, V265, P10173; HAYZER DJ, 1990, BIOCHEM J, V270, P261, DOI 10.1042/bj2700261; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; KOGAWA M, 1983, ACTA ENDOCRINOL-COP, V103, P385, DOI 10.1530/acta.0.1030385; LEFRANCOISMARTINEZ AM, 1994, FASEB J, V8, P89, DOI 10.1096/fasebj.8.1.8299894; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; MARIE S, 1993, J BIOL CHEM, V268, P23881; MATSUDA T, 1990, J BIOCHEM-TOKYO, V108, P778, DOI 10.1093/oxfordjournals.jbchem.a123280; MUNNICH A, 1987, J BIOL CHEM, V262, P17065; NOGUCHI T, 1985, J BIOL CHEM, V260, P4393; NOUSPIKEL T, 1992, EUR J BIOCHEM, V210, P365, DOI 10.1111/j.1432-1033.1992.tb17430.x; Sambrook J, 1989, MOL CLONING LABORATO; SLEIN MW, 1963, METHOD ENZYMAT AN, P1238; Van den Berghe G, 1986, Prog Biochem Pharmacol, V21, P1; VANDERCAMMEN A, 1990, EUR J BIOCHEM, V191, P483, DOI 10.1111/j.1432-1033.1990.tb19147.x; VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P173; VANSCHAFTINGEN E, 1991, FASEB J, V5, P326, DOI 10.1096/fasebj.5.3.2001793; VANSCHAFTINGEN E, 1992, ADV ENZYME REGUL, V32, P133; VAULONT S, 1986, J BIOL CHEM, V261, P7621	27	82	84	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	1994	269	14					10213	10216						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NF017	8144600				2022-12-27	WOS:A1994NF01700008
J	HONG, JX; HAUN, RS; TSAI, SC; MOSS, J; VAUGHAN, M				HONG, JX; HAUN, RS; TSAI, SC; MOSS, J; VAUGHAN, M			EFFECT OF ADP-RIBOSYLATION FACTOR AMINO-TERMINAL DELETIONS ON ITS GTP-DEPENDENT STIMULATION OF CHOLERA-TOXIN ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING; PROTEIN ACTIVATORS; ADENYLATE-CYCLASE; BOVINE BRAIN; EXPRESSION; MEMBRANES	It has been proposed that the amino-terminal domain of ADP-ribosylation factor (ARF) is critical for its stimulation of cholera toxin ADP-ribosyltransferase activity. In this study, recombinant ARF1 (rARF1), rDELTA13ARF1 (recombinant ARF1 lacking the first 13 amino acids) and rPKA14ARF1 (recombinant ARF1 in which the first 14 amino acids were replaced by the first 7 amino acids of the cAMP-dependent protein kinase catalytic subunit) were used to assess the effect of the amino terminus on the ability of ARF to enhance ADP-ribosylation of agmatine by the cholera toxin A subunit. The GTP-dependent ARF activities of rDELTA13ARF1 and rPKA14ARF1 were similar to that of rARF1, whereas the GTP requirement for half-maximal activation of cholera toxin A, was somewhat higher for rARF1 than it was for rDELTA13ARF1 and rPKA14ARF1. These results are consistent with the view that the amino terminus of ARF1 is not critical for its action as a GTP-dependent activator of cholera toxin.			HONG, JX (corresponding author), NHLBI,CELLULAR METAB LAB,ROOM 5N-307,BLDG 10,BETHESDA,MD 20892, USA.							BALCH WE, 1992, J BIOL CHEM, V267, P13053; BOMAN AL, 1992, NATURE, V358, P512, DOI 10.1038/358512a0; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; HAUN RS, 1992, BIOTECHNIQUES, V13, P515; HAUN RS, 1993, J BIOL CHEM, V268, P7064; KAHN RA, 1984, J BIOL CHEM, V259, P6228; KAHN RA, 1988, J BIOL CHEM, V263, P8282; KAHN RA, 1991, J BIOL CHEM, V266, P15595; KHAN R, 1992, J BIOL CHEM, V267, P13039; KUNZ BC, 1993, BIOCHEMISTRY-US, V32, P6643, DOI 10.1021/bi00077a017; LEE CM, 1992, J BIOL CHEM, V267, P9028; LENHARD JM, 1992, J BIOL CHEM, V267, P13047; MONACO L, 1990, P NATL ACAD SCI USA, V87, P2206, DOI 10.1073/pnas.87.6.2206; MOSS J, 1981, P NATL ACAD SCI USA, V78, P4806; MURTAGH JJ, 1992, J BIOL CHEM, V267, P9654; PRICE SR, 1988, P NATL ACAD SCI USA, V85, P5488, DOI 10.1073/pnas.85.15.5488; PRICE SR, 1992, J BIOL CHEM, V267, P17766; SERVENTI IM, 1993, J BIOL CHEM, V268, P4863; SERVENTI IM, 1991, J BIOL CHEM, V268, P23053; SEWELL JL, 1988, P NATL ACAD SCI USA, V85, P4620, DOI 10.1073/pnas.85.13.4620; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TSAI SC, 1987, P NATL ACAD SCI USA, V84, P5139, DOI 10.1073/pnas.84.15.5139; TSAI SC, 1988, J BIOL CHEM, V263, P1768; TSAI SC, 1991, J BIOL CHEM, V266, P8213; TSAI SC, 1993, J BIOL CHEM, V268, P10820; TSAI SC, 1992, P NATL ACAD SCI USA, V89, P6272; TSUCHIYA M, 1991, J BIOL CHEM, V266, P2772; WALKER MW, 1992, J BIOL CHEM, V267, P3230; WEISS O, 1989, J BIOL CHEM, V264, P21066	29	49	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9743	9745						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144566				2022-12-27	WOS:A1994NE05300055
J	DASSO, LLT; TAYLOR, CW				DASSO, LLT; TAYLOR, CW			INTERACTIONS BETWEEN CA2+-MOBILIZING RECEPTORS AND THEIR G-PROTEINS IN HEPATOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; CYTOPLASMIC FREE CALCIUM; HUMAN-PLATELETS; FURA-2-LOADED HEPATOCYTES; GUANINE-NUCLEOTIDES; ADENYLATE-CYCLASE; RAT HEPATOCYTES; PHOSPHOLIPASE-C; BINDING; AGONIST	In hepatocytes, different receptors that share an ability to stimulate inositol 1,4,5-trisphosphate formation by activating guanine nucleotide-binding proteins (G proteins) evoke Ca2+ signals that are characteristic of the receptor that evoked them. High affinity, guanine nucleotide-sensitive binding of agonists to their receptors provides a convenient means of assessing receptor-G protein interactions. We used these methods to examine the extent to which different Ca2+-mobilizing receptors share G protein pools. Although our earlier results (Dasso, L. L. T., and Taylor, C. W. (1992) Mol. Pharmacol. 42, 453-457) showed that activated V-1-vasopressin receptors prevented alpha(1)-adrenoreceptors from associating with G proteins, our present results show that neither alpha(1)-adrenergic agonists nor angiotensin II influences the interaction between V-1 receptors and their G proteins, This asymmetric scavenging of G proteins by alpha(1)-adrenoreceptors and V-1 receptors is not a consequence of there being more of the latter and may result either from V-1 receptors binding more tightly to G proteins or from their ability to interact with a second G protein pool. We speculate that the different interactions among V-1 receptors, alpha(1)-adrenoreceptors, and their G proteins contribute to the differently shaped Ca2+ spikes evoked by these receptors.	DEPT PHARMACOL,CAMBRIDGE CB2 1QJ,CAMBS,ENGLAND				Taylor, Colin/G-2447-2010	Taylor, Colin/0000-0001-7771-1044	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABRAMSON SN, 1987, MOL PHARMACOL, V31, P103; Bockaert J, 1991, Curr Opin Neurobiol, V1, P32, DOI 10.1016/0959-4388(91)90008-U; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGESS G M, 1986, P311; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; DASSO LLT, 1992, MOL PHARMACOL, V42, P453; DASSO LLT, 1991, BIOCHEM J, V280, P791, DOI 10.1042/bj2800791; DELEAN A, 1980, J BIOL CHEM, V255, P7108; DUDLEY DT, 1990, MOL PHARMACOL, V38, P370; FAIN JN, 1985, FEBS LETT, V192, P251, DOI 10.1016/0014-5793(85)80118-6; FLORIO VA, 1989, J BIOL CHEM, V264, P3909; FUXE K, 1988, ACTA PHYSIOL SCAND, V134, P317, DOI 10.1111/j.1748-1716.1988.tb08497.x; GOODHARDT M, 1982, J BIOL CHEM, V257, P1577; GOPALAKRISHNAN V, 1988, ENDOCRINOLOGY, V123, P922, DOI 10.1210/endo-123-2-922; GRAESER D, 1993, MOL PHARMACOL, V43, P434; GRANDT R, 1986, BIOCHEM J, V237, P669, DOI 10.1042/bj2370669; HAN C, 1987, MOL PHARMACOL, V32, P505; HOUSLAY MD, 1986, BIOCHEM J, V238, P109, DOI 10.1042/bj2380109; KAWANISHI T, 1989, J BIOL CHEM, V264, P12859; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KLEUSS C, 1992, SCIENCE, V358, P424; LEE TWT, 1986, BIOCHEMISTRY-US, V25, P7009, DOI 10.1021/bi00370a038; MAY DC, 1988, BIOCHEMISTRY-US, V27, P4888, DOI 10.1021/bi00413a045; MOHELL N, 1985, EUR J PHARMACOL, V115, P231, DOI 10.1016/0014-2999(85)90695-8; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NEUBIG RR, 1985, MOL PHARMACOL, V28, P475; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; SANCHEZBUENO A, 1993, BIOCHEM J, V291, P163, DOI 10.1042/bj2910163; SANCHEZBUENO A, 1993, BIOCHEM J, V291, P169, DOI 10.1042/bj2910169; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; TAYLOR CW, 1990, BIOCHEM J, V272, P1; TAYLOR SJ, 1990, J BIOL CHEM, V265, P17150; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3811, DOI 10.1021/bi00611a021; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; WOODS NM, 1987, CELL CALCIUM, V8, P79, DOI 10.1016/0143-4160(87)90038-8	37	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8647	8652						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132593				2022-12-27	WOS:A1994NB41100007
J	MILLER, MW; HANOVER, JA				MILLER, MW; HANOVER, JA			FUNCTIONAL NUCLEAR-PORES RECONSTITUTED WITH BETA-1-4 GALACTOSE-MODIFIED O-LINKED N-ACETYLGLUCOSAMINE GLYCOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE-EXTRACTS; XENOPUS EGGS; PROTEIN IMPORT; DNA-REPLICATION; COMPLEX GLYCOPROTEINS; ASSEMBLY INVITRO; TRANSPORT; IDENTIFICATION; GLYCOSYLATION; ENVELOPE	Nuclear pore proteins bearing O-linked N-acetylglucosamine (GlcNAc) are involved in nuclear transport, although a role for their glycosylation is not established. Xenopus egg extracts capable of reforming functional nuclei in vitro yielded nuclei with impaired transport and reduced nuclear pore density when depleted of wheat germ agglutinin-binding proteins. Many of the nuclear pores remaining in wheat germ agglutinin-depleted nuclei showed a striking loss of internal structure. Nuclear transport and normal nuclear pore structure were restored by the addition of nuclear pore glycoproteins from rat liver or Xenopus eggs. Glycoproteins modified by the addition of galactose to O-linked GlcNAc were also competent for assembling normal nuclear pores and restoring nuclear transport. Aphidicolin-sensitive DNA synthesis was unaffected by the removal or modification of O-linked GlcNAc glycoproteins. These data argue against a requirement for a lectin-like recognition of O-linked GlcNAc glycoproteins in nuclear pore assembly, nuclear transport, or DNA synthesis.	NIDDKD,BIOCHEM & METAB LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)								AKEY CW, 1989, J CELL BIOL, V109, P971, DOI 10.1083/jcb.109.3.971; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; CARMOFONSECA M, 1991, EUR J CELL BIOL, V55, P17; CARROLL SM, 1981, J BIOL CHEM, V256, P8357; CHOU CF, 1992, J BIOL CHEM, V267, P3901; CORDES V, 1991, EUR J CELL BIOL, V55, P31; COX LS, 1992, J CELL SCI, V101, P43; DABAUVALLE MC, 1990, CHROMOSOMA, V100, P56, DOI 10.1007/BF00337603; DABAUVALLE MC, 1991, BIOL CELL, V72, P25, DOI 10.1016/0248-4900(91)90074-W; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; DINGWALL C, 1992, SCIENCE, V258, P942, DOI 10.1126/science.1439805; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; FINLAY DR, 1990, CELL, V60, P17, DOI 10.1016/0092-8674(90)90712-N; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; FORBES DJ, 1983, CELL, V34, P13, DOI 10.1016/0092-8674(83)90132-0; FORBES DJ, 1992, ANNU REV CELL BIOL, V8, P495, DOI 10.1146/annurev.cb.08.110192.002431; GARCIABUSTOS J, 1991, BIOCHIM BIOPHYS ACTA, V1071, P83, DOI 10.1016/0304-4157(91)90013-M; GOLDFARB DS, 1986, NATURE, V322, P641, DOI 10.1038/322641a0; HALTIWANGER RS, 1992, BIOCHEM SOC T, V20, P264, DOI 10.1042/bst0200264; HANOVER JA, 1987, J BIOL CHEM, V262, P9887; HART GW, 1989, ANNU REV BIOCHEM, V58, P841; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; KEARSE KP, 1991, P NATL ACAD SCI USA, V88, P1701, DOI 10.1073/pnas.88.5.1701; KELLY WG, 1993, J BIOL CHEM, V268, P10416; LENO GH, 1991, METHOD CELL BIOL, V36, P561; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; LOHKA MJ, 1988, CELL BIOL INT REP, V12, P833, DOI 10.1016/0309-1651(88)90091-4; MILLER M, 1991, PHYSIOL REV, V71, P909, DOI 10.1152/physrev.1991.71.3.909; NEWMEYER DD, 1986, J CELL BIOL, V103, P2091, DOI 10.1083/jcb.103.6.2091; NEWMEYER DD, 1986, EMBO J, V5, P501, DOI 10.1002/j.1460-2075.1986.tb04239.x; NEWMEYER DD, 1988, CELL, V52, P641, DOI 10.1016/0092-8674(88)90402-3; NEWPORT J, 1987, CELL, V48, P219, DOI 10.1016/0092-8674(87)90425-9; PARK MK, 1987, P NATL ACAD SCI USA, V84, P6462, DOI 10.1073/pnas.84.18.6462; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; RICHARDSON WD, 1988, CELL, V52, P655, DOI 10.1016/0092-8674(88)90403-5; ROGERS GN, 1986, J BIOL CHEM, V261, P5947; SADLER JE, 1979, J BIOL CHEM, V254, P2112; SHEEHAN MA, 1988, J CELL BIOL, V106, P1, DOI 10.1083/jcb.106.1.1; SILVER PA, 1991, CELL, V64, P489, DOI 10.1016/0092-8674(91)90233-O; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; STARR CM, 1990, J CELL BIOL, V110, P1861, DOI 10.1083/jcb.110.6.1861; STERNEMARR R, 1992, J CELL BIOL, V116, P271, DOI 10.1083/jcb.116.2.271; SUKEGAWA J, 1993, CELL, V72, P29, DOI 10.1016/0092-8674(93)90047-T; TRAYER IP, 1971, J BIOL CHEM, V246, P6666; VIGERS GPA, 1991, J CELL BIOL, V112, P545, DOI 10.1083/jcb.112.4.545; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; WHYTOCK S, 1988, J MICROSC-OXFORD, V151, P115, DOI 10.1111/j.1365-2818.1988.tb04618.x; WOLFF B, 1988, EXP CELL RES, V178, P318, DOI 10.1016/0014-4827(88)90402-8; YONEDA Y, 1987, EXP CELL RES, V173, P586, DOI 10.1016/0014-4827(87)90297-7	54	56	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9289	9297						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132666				2022-12-27	WOS:A1994NB41100097
J	MIYAZAWA, K; SHIMOMURA, T; NAKA, D; KITAMURA, N				MIYAZAWA, K; SHIMOMURA, T; NAKA, D; KITAMURA, N			PROTEOLYTIC ACTIVATION OF HEPATOCYTE GROWTH-FACTOR IN RESPONSE TO TISSUE-INJURY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE CHAIN FORM; SCATTER FACTOR; MESSENGER-RNA; MOLECULAR-CLONING; EPITHELIAL-CELLS; HEPATOPOIETIN-A; RAT HEPATOCYTES; PURIFICATION; RECEPTOR; LIVER	Hepatocyte growth factor (HGF) is a potent mitogen for hepatocytes and renal tubular epithelial cells and may play an important role in regeneration following hepatic and renal injury. HGF is first synthesized as a single chain precursor which is then converted to a heterodimeric form by proteolytic processing. This proteolytic conversion is required for HGF to function as a mitogen. In this study, we examined whether the proteolytic activation of HGF occurred in response to hepatic and renal injury. HGF remained as an inactive single chain form in the liver, kidney, lung, and spleen of normal rats. The production of HGF markedly increased in the liver after hepatotoxin treatment and in the kidney after nephrotoxin treatment. A significant portion of the increased HGF was converted to the active heterodimeric form, whereas in other tissues, conversion did not occur although the production of HGF increased in some of them. Furthermore, an enzymatic activity that converts the single chain form of HGF to the active heterodimeric form was detected in the injured liver but not in the normal liver. These results indicate that HGF is proteolytically activated in response to tissue injury, and this activation is mediated by an enzymatic activity which is induced exclusively in the injured tissues. Thus, the proteolytic activation system functions in vivo as a mechanism for localizing HGF activities to injured tissues.	KANSAI MED UNIV, INST LIVER RES, MORIGUCHI, OSAKA 570, JAPAN; MITSUBISHI KASEI CORP, RES CTR, MIDORI KU, YOKOHAMA 227, JAPAN	Kansai Medical University			MIYAZAWA, KEIJI/I-9713-2014					ASAMI O, 1991, J BIOCHEM-TOKYO, V109, P8; BIRCH HE, 1986, J BIOL CHEM, V261, P8077; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; COULOMBE JJ, 1963, CLIN CHEM, V9, P102; DIRENZO MF, 1991, ONCOGENE, V6, P1997; GAK E, 1992, FEBS LETT, V311, P17, DOI 10.1016/0014-5793(92)81356-Q; GOHDA E, 1988, J CLIN INVEST, V81, P414, DOI 10.1172/JCI113334; GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937; HARTMANN G, 1992, P NATL ACAD SCI USA, V89, P11574, DOI 10.1073/pnas.89.23.11574; HERNANDEZ J, 1992, J CELL PHYSIOL, V150, P116, DOI 10.1002/jcp.1041500116; IGAWA T, 1991, BIOCHEM BIOPH RES CO, V174, P831, DOI 10.1016/0006-291X(91)91493-V; IGAWA T, 1993, AM J PHYSIOL, V265, pF63; KAN M, 1991, BIOCHEM BIOPH RES CO, V174, P331, DOI 10.1016/0006-291X(91)90524-B; KAPLAN AP, 1988, METHOD ENZYMOL, V163, P3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOKKER NA, 1992, EMBO J, V11, P2503, DOI 10.1002/j.1460-2075.1992.tb05315.x; MIYAZAWA K, 1993, J BIOL CHEM, V268, P10024; MIYAZAWA K, 1989, BIOCHEM BIOPH RES CO, V163, P967, DOI 10.1016/0006-291X(89)92316-4; MIYAZAWA K, 1991, EUR J BIOCHEM, V197, P15, DOI 10.1111/j.1432-1033.1991.tb15876.x; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; NAKA D, 1992, J BIOL CHEM, V267, P20114; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1987, FEBS LETT, V224, P311, DOI 10.1016/0014-5793(87)80475-1; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; OKAJIMA A, 1990, EUR J BIOCHEM, V193, P375, DOI 10.1111/j.1432-1033.1990.tb19349.x; OKAJIMA A, 1993, EUR J BIOCHEM, V213, P113, DOI 10.1111/j.1432-1033.1993.tb17740.x; RUBIN JS, 1991, P NATL ACAD SCI USA, V88, P415, DOI 10.1073/pnas.88.2.415; SHIMA N, 1991, BIOCHEM BIOPH RES CO, V180, P1151, DOI 10.1016/S0006-291X(05)81187-8; SHIMOMURA T, 1992, CYTOTECHNOLOGY, V8, P219, DOI 10.1007/BF02522039; SHIMOMURA T, 1993, J BIOL CHEM, V268, P22927; STRAIN AJ, 1991, J CLIN INVEST, V87, P1853, DOI 10.1172/JCI115207; TAJIMA H, 1992, J BIOCHEM-TOKYO, V111, P401, DOI 10.1093/oxfordjournals.jbchem.a123769; TAMURA M, 1993, J BIOL CHEM, V268, P8140; TASHIRO K, 1990, P NATL ACAD SCI USA, V87, P3200, DOI 10.1073/pnas.87.8.3200; TSUBOUCHI H, 1991, HEPATOLOGY, V13, P1; WEIDNER KM, 1991, P NATL ACAD SCI USA, V88, P7001, DOI 10.1073/pnas.88.16.7001; WROBLEWSKI F, 1956, P SOC EXP BIOL MED, V91, P569; ZARNEGAR R, 1989, CANCER RES, V49, P3314	38	216	222	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8966	8970						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132634				2022-12-27	WOS:A1994NB41100053
J	LETEURTRE, F; KOHLHAGEN, G; FESEN, MR; TANIZAWA, A; KOHN, KW; POMMIER, Y				LETEURTRE, F; KOHLHAGEN, G; FESEN, MR; TANIZAWA, A; KOHN, KW; POMMIER, Y			EFFECTS OF DNA METHYLATION ON TOPOISOMERASE-I AND TOPOISOMERASE-II CLEAVAGE ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC PROTOONCOGENE; CPG BINDING-PROTEIN; HEAT-SHOCK GENES; ANTITUMOR DRUGS; CYTOSINE METHYLATION; SV40 DNA; SITES; SEQUENCE; CAMPTOTHECIN; CHROMATIN	DNA methylation is deregulated during oncogenesis. Since several major anti-cancer drugs act on topoisomerases, we investigated the effects of cytosine methylation on topoisomerase cleavage activities. Both topoisomerase I and II cleavage patterns were modified by CpG methylation in c-myc gene DNA fragments. Topoisomerase II changes, mainly cleavage reduction, occurred for methylation sites within 7 base pairs from the topoisomerase II breaks and were different for VM-26 and azatoxin. For topoisomerase I, cleavage enhancement as well as suppression were observed. Using synthetic methylated oligonucleotides, we show that hemimethylation is sufficient to alter topoisomerase I activity. Cytosine methylation on the scissile strand within the topoisomerase I consensus sequence had strong effects. Cleavage was stimulated by methylation at position -4 and was strongly inhibited by methylation at position -3 (with position -1 being the enzyme linked nucleotide). This inhibitory effect was attributed to the presence of a methyl group in the major groove, since the transition uracil to thymine also inhibited cleavage. Altogether these results suggest an interaction of topoisomerase I with the DNA major grove at positions -3 and -4. In addition, DNA methylation may have profound effects on the activity of topoisomerases and may alter the distribution of cleavage sites produced by anticancer drugs in chromatin.	NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,MOLEC PHARMACOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)				Francois, Leteurtre/0000-0001-7373-6180				[Anonymous], DEV CANC CHEMOTHERAP; BEDNARIK DP, 1991, NEW BIOL, V3, P969; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; BOYES J, 1992, EMBO J, V11, P327, DOI 10.1002/j.1460-2075.1992.tb05055.x; CAPRANICO G, 1990, NUCLEIC ACIDS RES, V18, P4553, DOI 10.1093/nar/18.15.4553; Champoux JJ, 1990, DNA TOPOLOGY ITS BIO, P217; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; CULOTTA V, 1988, CELL, V52, P585, DOI 10.1016/0092-8674(88)90471-0; DARBY MK, 1986, EMBO J, V5, P2257, DOI 10.1002/j.1460-2075.1986.tb04493.x; EDWARDS KA, 1982, NUCLEIC ACIDS RES, V10, P2565, DOI 10.1093/nar/10.8.2565; FLEISCHMANN G, 1984, P NATL ACAD SCI-BIOL, V81, P6958, DOI 10.1073/pnas.81.22.6958; GILMOUR DS, 1987, MOL CELL BIOL, V7, P141, DOI 10.1128/MCB.7.1.141; HAUSHEER FH, 1989, CARCINOGENESIS, V10, P1131, DOI 10.1093/carcin/10.6.1131; HODGESGARCIA Y, 1992, BIOCHEMISTRY-US, V31, P7595, DOI 10.1021/bi00148a022; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIEH T-S, 1992, Current Opinion in Cell Biology, V4, P396, DOI 10.1016/0955-0674(92)90004-V; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; JAXEL C, 1991, J BIOL CHEM, V266, P20418; JAXEL C, 1988, NUCLEIC ACIDS RES, V16, P11157, DOI 10.1093/nar/16.23.11157; KAS E, 1992, EMBO J, V11, P705, DOI 10.1002/j.1460-2075.1992.tb05103.x; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; KITAMURA Y, 1992, P NATL ACAD SCI USA, V89, P5532, DOI 10.1073/pnas.89.12.5532; KOVESDI I, 1987, P NATL ACAD SCI USA, V84, P2180, DOI 10.1073/pnas.84.8.2180; KREUZER KN, 1984, J BIOL CHEM, V259, P5339; KROEGER PE, 1992, BIOCHEMISTRY-US, V31, P2492, DOI 10.1021/bi00124a008; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LETEURTRE F, 1993, BIOCHEMISTRY-US, V32, P8955, DOI 10.1021/bi00085a029; LETEURTRE F, 1992, CANCER RES, V52, P4478; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; LUND K, 1990, J BIOL CHEM, V265, P13856; MAKOS M, 1993, CANCER RES, V53, P2719; MALINEN T, 1991, BLOOD, V77, P2435; MINFORD J, 1986, BIOCHEMISTRY-US, V25, P9, DOI 10.1021/bi00349a002; NELKIN BD, 1991, BLOOD, V77, P2431; NYCE J, 1989, CANCER RES, V49, P5829; NYCE J, 1993, P NATL ACAD SCI USA, V90, P2960, DOI 10.1073/pnas.90.7.2960; OHTANIFUJITA N, 1993, ONCOGENE, V8, P1063; ONO T, 1989, MUTAT RES, V219, P39, DOI 10.1016/0921-8734(89)90039-8; OSHEROFF N, 1991, BIOESSAYS, V13, P269, DOI 10.1002/bies.950130603; PARKER LH, 1993, J MOL BIOL, V231, P6, DOI 10.1006/jmbi.1993.1252; POMMIER Y, 1992, CANCER RES, V52, P3125; POMMIER Y, 1993, MOLECULAR BIOLOGY OF DNA TOPOISOMERASES AND ITS APPLICATION CHEMOTHERAPY, P215; POMMIER Y, 1991, J MOL BIOL, V222, P909, DOI 10.1016/0022-2836(91)90585-T; POMMIER Y, 1993, CAUSES CONSEQUENCES, P277; Pommier Y, 1993, CANCER CHEMOTHERAPY, P214; PORTER SE, 1989, NUCLEIC ACIDS RES, V17, P8521, DOI 10.1093/nar/17.21.8521; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; RIGGS AD, 1992, TRENDS GENET, V8, P169, DOI 10.1016/0168-9525(92)90219-T; RIOU JF, 1989, BIOCHEMISTRY-US, V28, P9104, DOI 10.1021/bi00449a022; RIOU JF, 1986, BIOCHEM BIOPH RES CO, V137, P154, DOI 10.1016/0006-291X(86)91189-7; RIOU JF, 1986, BIOCHEM PHARMACOL, V35, P4409, DOI 10.1016/0006-2952(86)90756-2; ROWE TC, 1986, MOL CELL BIOL, V6, P985, DOI 10.1128/MCB.6.4.985; SASAKI T, 1992, MOL CELL BIOL, V12, P3819, DOI 10.1128/MCB.12.9.3819; SHUMAN S, 1993, J BIOL CHEM, V268, P18943; STEVNSNER T, 1989, J BIOL CHEM, V264, P10110; STEWART AF, 1990, CELL, V60, P141; SUETAKE I, 1993, NUCLEIC ACIDS RES, V21, P2125, DOI 10.1093/nar/21.9.2125; TAN KB, 1989, J NATL CANCER I, V81, P1732, DOI 10.1093/jnci/81.22.1732; UDVARDY A, 1986, J MOL BIOL, V191, P231, DOI 10.1016/0022-2836(86)90260-3; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; YU BW, 1993, J BIOL CHEM, V268, P19586; ZWELLING LA, 1985, CANCER METAST REV, V4, P263, DOI 10.1007/BF00048092	66	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7893	7900						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132507				2022-12-27	WOS:A1994NB40900013
J	MIYAGOE, Y; GALIBERT, MD; GEORGATSOU, E; FOUREL, G; MEO, T				MIYAGOE, Y; GALIBERT, MD; GEORGATSOU, E; FOUREL, G; MEO, T			PROMOTER ELEMENTS OF THE MOUSE COMPLEMENT C4 GENE CRITICAL FOR TRANSCRIPTION ACTIVATION AND START SITE LOCATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; SEX-LIMITED PROTEIN; SLP-GENES; INVITRO TRANSCRIPTION; ALBUMIN PROMOTER; BINDING PROTEIN; BOX-BINDING; DNA-BINDING; INITIATION; C-4	We have explored the template and factor requirements for transcription of the gene encoding the murine complement component C4, expressed predominantly but not exclusively in liver and mononuclear phagocytes. Competition experiments in transcription assays with liver nuclear extracts show that the regions upstream of the transcription initiation site are largely dispensable for obtaining basal levels of accurately initiated transcription. Activated transcription, however, depends on three upstream regulatory factors, two of which interact with target sites seemingly related to NF-1 (region -112/-87) and USF (region -85/-64), respectively. A third upstream regulatory factor has been detected by the surprising finding that double-stranded oligomers covering sequences proximal to the cap site (position -48 to -7) stimulate transcription from the C4 promoter specifically. Results of nucleotide deletions and site-directed mutations argue that the C4 initiator, that is, the most critical element for basal and accurate transcription of the gene, overlaps the cap site and extends into the transcribed sequences (-1 to +12). Immediately downstream of this region lies a last regulatory element (within the +5 to +43 boundaries) indispensable for high levels of transcription. These data assume wider interest because the C4 promoter does not contain TATA or CAAT boxes and does not feature any of the elements characteristic of the TATA less genes so far reported.	INST PASTEUR,UNITE IMMUNOL,F-75724 PARIS 15,FRANCE; INST PASTEUR,INST NATL SANTE RECH MED,F-75724 PARIS 15,FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris								ARKHIPOVA IR, 1991, EMBO J, V10, P1169, DOI 10.1002/j.1460-2075.1991.tb08057.x; AYER DE, 1988, MOL CELL BIOL, V8, P2021, DOI 10.1128/MCB.8.5.2021; BEAUPAIN D, 1990, NUCLEIC ACIDS RES, V18, P6509, DOI 10.1093/nar/18.22.6509; BOHMANN D, 1987, NATURE, V325, P268, DOI 10.1038/325268a0; BRUNEL F, 1991, NUCLEIC ACIDS RES, V19, P5237, DOI 10.1093/nar/19.19.5237; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; CARCAMO J, 1991, P NATL ACAD SCI USA, V88, P8052, DOI 10.1073/pnas.88.18.8052; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; CEREGHINI S, 1988, GENE DEV, V2, P957, DOI 10.1101/gad.2.8.957; CHAPLIN DD, 1983, P NATL ACAD SCI-BIOL, V80, P6947, DOI 10.1073/pnas.80.22.6947; CHODOSH LA, 1987, SCIENCE, V238, P684, DOI 10.1126/science.3672119; COLTEN HR, 1992, J APPL PHYSIOL, V72, P1; COURTOIS G, 1988, P NATL ACAD SCI USA, V85, P7937, DOI 10.1073/pnas.85.21.7937; COX BJ, 1988, NUCLEIC ACIDS RES, V16, P6857, DOI 10.1093/nar/16.14.6857; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUVALVALENTIN G, 1992, P NATL ACAD SCI USA, V89, P504, DOI 10.1073/pnas.89.2.504; EPHRUSSI A, 1986, NATURE, V313, P798; GALIBERT MD, 1993, J IMMUNOL, V151, P6099; GEORGATSOU E, 1993, P NATL ACAD SCI USA, V90, P3626, DOI 10.1073/pnas.90.8.3626; GITELMAN SE, 1992, MOL CELL BIOL, V12, P2124, DOI 10.1128/MCB.12.5.2124; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; HARIHARAN N, 1990, P NATL ACAD SCI USA, V87, P1526, DOI 10.1073/pnas.87.4.1526; HEARD JM, 1987, MOL CELL BIOL, V7, P2425, DOI 10.1128/MCB.7.7.2425; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JOHANSSON BG, 1972, SCAND J CLIN LAB INV, V29, P117, DOI 10.3109/00365517209102759; LORENI F, 1988, MOL CELL BIOL, V8, P2350, DOI 10.1128/MCB.8.6.2350; Maniatis T, 1989, DECONTAMINATION DILU; MEANS AL, 1990, MOL CELL BIOL, V10, P653, DOI 10.1128/MCB.10.2.653; MIYAGOE Y, 1993, P NATL ACAD SCI USA, V90, P5786, DOI 10.1073/pnas.90.12.5786; MONACI P, 1988, EMBO J, V7, P2075, DOI 10.1002/j.1460-2075.1988.tb03047.x; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NAKATANI Y, 1990, P NATL ACAD SCI USA, V87, P4289, DOI 10.1073/pnas.87.11.4289; NAKATANI Y, 1990, NATURE, V348, P86, DOI 10.1038/348086a0; NAKAYAMA K, 1987, J IMMUNOL, V138, P620; NAKAYAMA K, 1990, IMMUNOGENETICS, V31, P361, DOI 10.1007/BF02115011; NONAKA M, 1986, P NATL ACAD SCI USA, V83, P7883, DOI 10.1073/pnas.83.20.7883; OGATA RT, 1991, J IMMUNOL, V147, P2756; OGATA RT, 1989, J BIOL CHEM, V264, P16565; OSHEAGREENFIELD A, 1992, J BIOL CHEM, V267, P1391; PASWELL J, 1988, J CLIN INVEST, V82, P1676; PERLMUTTER DH, 1986, ANNU REV IMMUNOL, V4, P231, DOI 10.1146/annurev.iy.04.040186.001311; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; ROSA PA, 1987, J IMMUNOL, V139, P1568; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; SHREFFLER DC, 1984, PHILOS T ROY SOC B, V306, P395, DOI 10.1098/rstb.1984.0100; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; STAVENHAGEN JB, 1988, CELL, V55, P247, DOI 10.1016/0092-8674(88)90047-5; TOSI M, 1985, IMMUNOL REV, V87, P151, DOI 10.1111/j.1600-065X.1985.tb01149.x; VAULONT S, 1989, MOL CELL BIOL, V9, P4409, DOI 10.1128/MCB.9.10.4409; WEIS L, 1992, FASEB J, V6, P3300, DOI 10.1096/fasebj.6.14.1426767; YU CY, 1991, J IMMUNOL, V146, P1057; YU DY, 1988, J IMMUNOL, V141, P4381; ZAWEL L, 1992, Current Opinion in Cell Biology, V4, P488, DOI 10.1016/0955-0674(92)90016-6; ZAWEL L, 1992, PROG NUCLEIC ACIDS R, V45, P67	59	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8268	8279						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132550				2022-12-27	WOS:A1994NB40900067
J	RANCANO, C; RUBIO, T; CORREAS, I; ALONSO, MA				RANCANO, C; RUBIO, T; CORREAS, I; ALONSO, MA			GENOMIC STRUCTURE AND SUBCELLULAR-LOCALIZATION OF MAL, A HUMAN T-CELL-SPECIFIC PROTEOLIPID PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; NERVOUS-SYSTEM MYELIN; TRANSMEMBRANE PROTEINS; ENDOPLASMIC-RETICULUM; CHROMAFFIN GRANULES; MEMBRANE-PROTEIN; PROLINE RESIDUES; PROTON CHANNEL; GENE; SEQUENCE	Genomic DNA clones containing the T-cell-specific human MAL gene were isolated. Restriction and sequence analysis revealed four exons and three introns. Each hydrophobic segment of MAL together with its adjacent hydrophilic sequence correlates closely with one exon of the gene. RNase protection analysis revealed that the previously described MAL mRNA, which contains the sequences present in the four exons, is the mRNA species predominant in T-cells. A remarkable similarity was found between the hydrophobicity pattern of MAL and those of the peripheral membrane protein 22 (PMP-22) and the 16-kDa proteolipid of vacuolar H+-ATPases. Direct evidence supporting that MAL is a proteolipid was obtained by extracting bacterial lysates expressing recombinant MAL protein with lipophilic solvents used to extract lipids. The use of two different antibodies raised against distinct peptides from the MAL molecule has allowed the localization of MAL in the endoplasmic reticulum of T-cells. This subcellular localization is in agreement with the presence of a RWKSS motif in the COOH-terminal tail of MAL, next to its last putative transmembrane domain, that fits with one of the consensus sequences (RXKXX) for residency in the endoplasmic reticulum for transmembrane proteins. A possible function for MAL protein in T-cells is discussed based on its subcellular localization and the unique lipid-like properties of the proteolipid proteins.	UNIV AUTONOMA MADRID,CONSEJO SUPER INVEST CIENT,CTR BIOL MOLEC SEVERO OCHOA,E-28049 MADRID,SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)			Correas, Isabel/O-4061-2018; Alonso, Miguel A/J-3945-2016	Correas, Isabel/0000-0002-2286-186X; Alonso, Miguel A/0000-0002-7001-8826				ALONSO MA, 1987, P NATL ACAD SCI USA, V84, P1997, DOI 10.1073/pnas.84.7.1997; ALONSO MA, 1988, IMMUNOGENETICS, V27, P91, DOI 10.1007/BF00351081; BIRMAN S, 1990, FEBS LETT, V261, P303, DOI 10.1016/0014-5793(90)80577-6; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; BULINSKI JC, 1986, METHOD ENZYMOL, V184, P453; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DERMIETZEL R, 1989, FEBS LETT, V253, P1, DOI 10.1016/0014-5793(89)80917-2; DIEHL HJ, 1986, P NATL ACAD SCI USA, V83, P9807, DOI 10.1073/pnas.83.24.9807; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FILLINGAME RH, 1991, J BACTEIROL, V173, P2639; FINBOW ME, 1992, PROTEIN ENG, V5, P7, DOI 10.1093/protein/5.1.7; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; HARLOW E, 1988, ANTIBODIES LABORATOR; HASEBE M, 1992, BIOCHEM BIOPH RES CO, V183, P856, DOI 10.1016/0006-291X(92)90562-Y; INGRAHAM HA, 1986, MOL CELL BIOL, V6, P2923, DOI 10.1128/MCB.6.8.2923; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; JONGSTRA J, 1987, J EXP MED, V165, P601, DOI 10.1084/jem.165.3.601; KANAZAWA H, 1983, MICROBIOL REV, V47, P285; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; KWON BS, 1989, P NATL ACAD SCI USA, V86, P1963, DOI 10.1073/pnas.86.6.1963; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURSEN RA, 1984, P NATL ACAD SCI-BIOL, V81, P2912, DOI 10.1073/pnas.81.9.2912; LEITCH B, 1990, EXP CELL RES, V190, P218, DOI 10.1016/0014-4827(90)90189-H; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; MAELICKE A, 1988, TRENDS BIOCHEM SCI, V13, P199, DOI 10.1016/0968-0004(88)90081-3; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; MEAGHER L, 1990, NUCLEIC ACIDS RES, V18, P6712, DOI 10.1093/nar/18.22.6712; MILLER MD, 1989, J IMMUNOL, V143, P2907; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NELSON H, 1989, FEBS LETT, V247, P147, DOI 10.1016/0014-5793(89)81259-1; NELSON H, 1990, J BIOL CHEM, V265, P20390; NELSON N, 1992, Current Opinion in Cell Biology, V4, P654, DOI 10.1016/0955-0674(92)90086-R; NODA M, 1983, NATURE, V305, P818, DOI 10.1038/305818a0; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PATARCA R, 1988, P NATL ACAD SCI USA, V85, P2733, DOI 10.1073/pnas.85.8.2733; POPOT JL, 1991, J MEMBRANE BIOL, V120, P233, DOI 10.1007/BF01868534; ROSENBERG AH, 1987, GENE AMST, V56, P215; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANSOM MSP, 1992, PROTEIN ENG, V5, P53, DOI 10.1093/protein/5.1.53; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; SCHANBERG LE, 1991, P NATL ACAD SCI USA, V88, P603, DOI 10.1073/pnas.88.2.603; SCHLESINGER MJ, 1981, ANNU REV BIOCHEM, V50, P193, DOI 10.1146/annurev.bi.50.070181.001205; SCHNEIDER A, 1992, NATURE, V358, P758, DOI 10.1038/358758a0; SHIN J, 1991, P NATL ACAD SCI USA, V88, P1918, DOI 10.1073/pnas.88.5.1918; SLAVUTSKY I, 1986, CANCER GENET CYTOGEN, V21, P335, DOI 10.1016/0165-4608(86)90214-1; SMADJA N, 1983, CANCER GENET CYTOGEN, V8, P1, DOI 10.1016/0165-4608(83)90060-2; SMITH MW, 1988, J MOL EVOL, V27, P45, DOI 10.1007/BF02099729; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; SPURR NK, 1991, CYTOGENET CELL GENET, V58, P142, DOI 10.1159/000133162; STOFFEL W, 1984, P NATL ACAD SCI-BIOL, V81, P5012, DOI 10.1073/pnas.81.16.5012; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; WHITE JM, 1992, SCIENCE, V258, P917, DOI 10.1126/science.1439803; WILLIAMS KA, 1991, BIOCHEMISTRY-US, V30, P8919, DOI 10.1021/bi00101a001; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	63	43	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8159	8164						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132541				2022-12-27	WOS:A1994NB40900052
J	MISSIAEN, L; DESMEDT, H; PARYS, JB; CASTEELS, R				MISSIAEN, L; DESMEDT, H; PARYS, JB; CASTEELS, R			COACTIVATION OF INOSITOL TRISPHOSPHATE-INDUCED CA2+ RELEASE BY CYTOSOLIC CA2+ IS LOADING-DEPENDENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; 1,4,5-TRISPHOSPHATE RECEPTOR; CALCIUM OSCILLATIONS; LUMINAL CA2+; SYMPATHETIC NEURONS; ACINAR-CELLS; STORES; CHANNELS; MODEL; ENTRY	Luminal and cytosolic Ca2+ control the sensitivity of the intracellular Ca2+ stores to inositol 1,4,5-trisphosphate (InsP(3)). In this work, we have characterized how luminal Ca2+ interfered with the stimulation of the InsP(3) receptor by cytosolic Ca2+ in permeabilized A7r5 smooth muscle cells. InsP(3)-induced Ca2+ release from stores containing 34 pmol of Ca2+/10(6) cells absolutely depended on a simultaneous rise in cytosolic Ca2+ concentration in the submicromolar range. This stimulation by cytosolic Ca2+ was more pronounced when the stores were preincubated with Ca2+. In contrast, fully loaded stores containing 3400 pmol of Ca2+/10(6) cells already responded to InsP(3) in the absence of cytosolic Ca2+ and the release from these stores was much less stimulated by increasing the cytosolic Ca2+ concentration. The loading dependence of the release was not due to a higher cytosolic Ca2+ concentration around more loaded stores sensitizing the InsP(3) receptor by binding at a cytoplasmic site. Luminal Ca2+ was therefore found to functionally substitute for cytosolic Ca2+ in triggering Ca2+ release in the presence of a constant InsP(3) concentration. These findings are relevant for explaining base line Ca2+ spiking in non-excitable cells.			MISSIAEN, L (corresponding author), KATHOLIEKE UNIV LEUVEN, FYSIOL LAB, CAMPUS GASTHUISBERG, HERESTR 49, B-3000 LOUVAIN, BELGIUM.			Parys, Jan/0000-0002-3591-4967				BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BIRD GSJ, 1993, J BIOL CHEM, V268, P8425; BOOTMAN MD, 1992, J BIOL CHEM, V267, P25113; DELISLE S, 1992, J BIOL CHEM, V267, P7963; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; FERRIS CD, 1992, ANNU REV PHYSIOL, V54, P469, DOI 10.1146/annurev.physiol.54.1.469; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.physiol.55.1.427; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FOSKETT JK, 1991, J BIOL CHEM, V266, P14535; FRIEL DD, 1992, NEURON, V8, P1109, DOI 10.1016/0896-6273(92)90132-W; GALIONE A, 1993, SCIENCE, V261, P348, DOI 10.1126/science.8392748; GILL DL, 1989, NATURE, V342, P16, DOI 10.1038/342016a0; GIRARD S, 1993, SCIENCE, V260, P229, DOI 10.1126/science.8385801; GOLDBETER A, 1990, P NATL ACAD SCI USA, V87, P1461, DOI 10.1073/pnas.87.4.1461; HAROOTUNIAN AT, 1991, SCIENCE, V251, P75, DOI 10.1126/science.1986413; IINO M, 1992, NATURE, V360, P76, DOI 10.1038/360076a0; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; JACOB R, 1990, BIOCHIM BIOPHYS ACTA, V1052, P427, DOI 10.1016/0167-4889(90)90152-4; JACOB R, 1988, NATURE, V335, P40, DOI 10.1038/335040a0; JAFFE LF, 1991, P NATL ACAD SCI USA, V88, P9883, DOI 10.1073/pnas.88.21.9883; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; LECHLEITER JD, 1992, CELL, V69, P283, DOI 10.1016/0092-8674(92)90409-6; LEE HC, 1993, SCIENCE, V261, P352, DOI 10.1126/science.8392749; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; LOOMISHUSSELBEE JW, 1993, BIOCHEM J, V289, P861, DOI 10.1042/bj2890861; MALGAROLI A, 1990, J BIOL CHEM, V265, P3005; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; MISSIAEN L, 1992, J BIOL CHEM, V267, P22961; MISSIAEN L, 1991, NATURE, V352, P241, DOI 10.1038/352241a0; MISSIAEN L, 1992, NATURE, V357, P599, DOI 10.1038/357599a0; MIYAZAKI S, 1992, SCIENCE, V257, P251, DOI 10.1126/science.1321497; NUNN DL, 1992, MOL PHARMACOL, V41, P115; OLDERSHAW KA, 1993, BIOCHEM J, V292, P631, DOI 10.1042/bj2920631; PARKER I, 1991, P ROY SOC B-BIOL SCI, V246, P269, DOI 10.1098/rspb.1991.0154; PARYS JB, 1992, J BIOL CHEM, V267, P18776; PARYS JB, 1993, J BIOL CHEM, V268, P25206; PETERSEN OH, 1992, J PHYSIOL-LONDON, V448, P1; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; ROONEY TA, 1991, J BIOL CHEM, V266, P12272; TAYLOR CW, 1991, PHARMACOL THERAPEUT, V51, P97, DOI 10.1016/0163-7258(91)90043-L; TREGEAR RT, 1991, P ROY SOC B-BIOL SCI, V243, P263, DOI 10.1098/rspb.1991.0040; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; WAKUI M, 1989, NATURE, V339, P317, DOI 10.1038/339317a0; WAKUI M, 1990, CELL, V63, P1025, DOI 10.1016/0092-8674(90)90505-9; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; ZHANG BX, 1993, J BIOL CHEM, V268, P10997; ZHAO H, 1990, J BIOL CHEM, V265, P20856	50	84	84	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7238	7242						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125936				2022-12-27	WOS:A1994NA03200033
J	OOHASHI, T; SUGIMOTO, M; MATTEI, MG; NINOMIYA, Y				OOHASHI, T; SUGIMOTO, M; MATTEI, MG; NINOMIYA, Y			IDENTIFICATION OF A NEW COLLAGEN-IV CHAIN, ALPHA-6(IV), BY CDNA ISOLATION AND ASSIGNMENT OF THE GENE TO CHROMOSOME XQ22, WHICH IS THE SAME LOCUS FOR COL4A5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE COLLAGEN; ALPORT SYNDROME; GOODPASTURE ANTIGEN; GLOBULAR DOMAIN; X-CHROMOSOME; LOCALIZATION; REGION; ALPHA-1(IV); MUTATIONS; PROMOTER	To date, five distinct alpha chains have been identified in basement membrane collagen IV. We have cloned a gene encoding a new a chain belonging to basement membrane collagen IV by cDNA isolation under low stringency conditions. Isolation of overlapping clones and the technique of 5' rapid amplification of cDNA ends enabled us to derive the primary structure of the entire polypeptide. The deduced collagen polypeptide contained 1678 amino acid residues, including a 21-residue signal peptide, a 24-residue amino-terminal NC domain, a central 1405-residue collagenous (COL1) domain, and a 228-residue carboxyl-terminal NC1 domain. We have designated this newly found alpha chain as the alpha 6(IV) chain. The gene was mapped to chromosome Xq22 by in situ hybridization of metaphase lymphocytes. This is the same region of chromosome X where the gene coding for the alpha 5(IV) collagen chain (COL4A5) resides. Mutations in COL4A5 have been characterized in more than 50 patients with Alport syndrome. However, some of the X-linked cases of Alport syndrome are not apparently caused by COL4A5 mutations. The gene we describe in this paper therefore seems to be a candidate for mutations in this group of Alport syndrome patients.	OKAYAMA UNIV,SCH MED,DEPT MOLEC BIOL & BIOCHEM,OKAYAMA 700,JAPAN; OKAYAMA UNIV,SCH MED,DEPT OPHTHALMOL,OKAYAMA 700,JAPAN; HOP ENFANTS LA TIMONE,GRP HOSP TIMONE,INST SANTE & RECH MED,UNITE 242,MARSEILLE 13385,FRANCE	Okayama University; Okayama University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille			Oohashi, Toshitaka/B-1599-2011	Oohashi, Toshitaka/0000-0002-9302-1913	NATIONAL EYE INSTITUTE [R01EY007334] Funding Source: NIH RePORTER; NEI NIH HHS [EY07334] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BUTKOWSKI RJ, 1989, KIDNEY INT, V35, P1195, DOI 10.1038/ki.1989.110; BUTKOWSKI RJ, 1990, J LAB CLIN MED, V115, P365; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GUNWAR S, 1991, J BIOL CHEM, V266, P14088; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HOSTIKKA SL, 1988, J BIOL CHEM, V263, P19488; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; JOHANSSON C, 1991, CONNECT TISSUE RES, V25, P229, DOI 10.3109/03008209109029159; JUNQUIERA LC, 1986, BASIC HISTOLOGY; KAMAGATA Y, 1992, J BIOL CHEM, V267, P23753; LANGEVELD JPM, 1991, J BIOL CHEM, V266, P2622; Maniatis T., 1982, MOL CLONING; MARIYAMA M, 1992, J BIOL CHEM, V267, P1253; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; MORRISON KE, 1991, AM J HUM GENET, V49, P545; MYERS JC, 1990, AM J HUM GENET, V46, P1024; OVERBEEK PA, 1981, BIOCHIM BIOPHYS ACTA, V656, P195, DOI 10.1016/0005-2787(81)90087-3; POSCHL E, 1988, EMBO J, V7, P2687, DOI 10.1002/j.1460-2075.1988.tb03122.x; Rohrbach DH, 1993, MOL CELLULAR ASPECTS; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIEBOLD B, 1987, EUR J BIOCHEM, V168, P569, DOI 10.1111/j.1432-1033.1987.tb13455.x; SMEETS HJM, 1992, KIDNEY INT, V42, P83, DOI 10.1038/ki.1992.264; SOININEN R, 1988, J BIOL CHEM, V263, P17217; SOININEN R, 1987, FEBS LETT, V225, P188; SUGIMOTO M, 1993, FEBS LETT, V330, P122, DOI 10.1016/0014-5793(93)80256-T; TIMPL R, 1986, INT REV EXP PATHOL, V29, P1; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; TRYGGVASON K, 1993, KIDNEY INT, V43, P38, DOI 10.1038/ki.1993.8; WIESLANDER J, 1985, J BIOL CHEM, V260, P8564; YAMAGUCHI N, 1991, INVEST OPHTH VIS SCI, V32, P2924; ZHOU J, 1991, GENOMICS, V9, P1, DOI 10.1016/0888-7543(91)90214-Y	32	87	88	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7520	7526						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125972				2022-12-27	WOS:A1994NA03200077
J	ELBENNA, J; RUEDI, JM; BABIOR, BM				ELBENNA, J; RUEDI, JM; BABIOR, BM			CYTOSOLIC GUANINE-NUCLEOTIDE-BINDING PROTEIN RAC2 OPERATES IN-VIVO AS A COMPONENT OF THE NEUTROPHIL RESPIRATORY BURST OXIDASE - TRANSFER OF RAC2 AND THE CYTOSOLIC OXIDASE COMPONENTS P47(PHOX) AND P67(PHOX) TO THE SUBMEMBRANOUS ACTIN CYTOSKELETON DURING OXIDASE ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; CELL-FREE SYSTEM; NADPH OXIDASE; PLASMA-MEMBRANE; CYTOCHROME-B; PHOSPHORYLATION; GTP; ASSOCIATION; ELECTROPHORESIS; IDENTIFICATION	The respiratory burst oxidase is responsible for O-2(-) production in stimulated neutrophils and B lymphocytes. Components of this oxidase include cytochrome b(558), a membrane-bound flavohemoprotein; the cytosolic polypeptides p47(phox) and p67(phox); and one or more small G proteins including Rad1 Rac2, and/or Rap1A. We found that when normal neutrophils were activated, small percentages of each of the cytosolic proteins p47(phox) p67(phox), and Rac2 were transferred to the membrane cytoskeleton. However, Rac2 was not transferred to the membrane during activation of p47(phox)-deficient neutrophils. In normal cells, some p47(phox) also became associated with the non-cytoskeletal portion of the plasma membrane, but p67(Phox), Rac2, and O-2(-)-forming activity were restricted to the cytoskeleton. Neutrophil activation also causes the phosphorylation of multiple serines in p47(phox), The most heavily phosphorylated forms of p47(phox) were found solely in the membrane cytoskeleton. These results suggest that 1) the membrane cytoskeleton participates in respiratory burst oxidase activation, 2) the fully phosphorylated p47(phox) is located in the active oxidase, which resides in the membrane cytoskeleton, and 3) Rac2 acts like a dedicated component of the respiratory burst oxidase.			ELBENNA, J (corresponding author), SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA.				NIAID NIH HHS [AI-24227, AI-28479, AI-30742] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI130742, R01AI028479, R01AI030742, R37AI024227, R01AI024227] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; AHARONI I, 1990, J LEUKOCYTE BIOL, V48, P107, DOI 10.1002/jlb.48.2.107; BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205; BABIOR BM, 1992, ADV ENZYMOL RAMB, V65, P49; CARLIER MF, 1991, J BIOL CHEM, V266, P1; CASSIMERIS L, 1990, J CELL BIOL, V110, P1067, DOI 10.1083/jcb.110.4.1067; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; CROWLEY CA, 1980, NEW ENGL J MED, V302, P1163, DOI 10.1056/NEJM198005223022102; DINAUER MC, 1987, NATURE, V327, P717, DOI 10.1038/327717a0; DORSEUIL O, 1992, J BIOL CHEM, V267, P20540; FOX JEB, 1985, J BIOL CHEM, V260, P1970; HARPER AM, 1984, BIOCHEM J, V219, P519, DOI 10.1042/bj2190519; HAYAKAWA T, 1986, J BIOL CHEM, V261, P9109; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LETO TL, 1990, SCIENCE, V248, P727, DOI 10.1126/science.1692159; LETO TL, 1991, J BIOL CHEM, V266, P19812; LIGETI E, 1988, BIOCHEMISTRY-US, V27, P193, DOI 10.1021/bi00401a029; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; MARKERT M, 1984, METHOD ENZYMOL, V105, P358; NAKANISHI A, 1992, J BIOL CHEM, V267, P19072; NAUSEEF WM, 1991, J BIOL CHEM, V266, P5911; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; OKAMURA N, 1988, BLOOD, V72, P811; OKAMURA N, 1988, J BIOL CHEM, V263, P6777; PARK JW, 1992, J BIOL CHEM, V267, P17327; PARKOS CA, 1985, J BIOL CHEM, V260, P6541; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PICK E, 1993, EUR J BIOCHEM, V217, P441, DOI 10.1111/j.1432-1033.1993.tb18264.x; QUINN MT, 1989, NATURE, V342, P198, DOI 10.1038/342198a0; QUINN MT, 1989, BIOCHIM BIOPHYS ACTA, V987, P83, DOI 10.1016/0005-2736(89)90458-6; ROTROSEN D, 1990, J BIOL CHEM, V265, P19910; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; SCHWARZ HP, 1985, BLOOD, V66, P1452; SENGELOV H, 1992, J BIOL CHEM, V267, P14912; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UHLINGER DJ, 1993, J BIOL CHEM, V268, P8624; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P7195, DOI 10.1073/pnas.86.18.7195; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WOODMAN RC, 1991, J CLIN INVEST, V87, P1345, DOI 10.1172/JCI115138	44	166	167	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6729	6734						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120032				2022-12-27	WOS:A1994MZ50300075
J	NODA, K; SAAD, Y; GRAHAM, RM; KARNIK, SS				NODA, K; SAAD, Y; GRAHAM, RM; KARNIK, SS			THE HIGH-AFFINITY STATE OF THE BETA-2-ADRENERGIC RECEPTOR REQUIRES UNIQUE INTERACTION BETWEEN CONSERVED AND NONCONSERVED EXTRACELLULAR LOOP CYSTEINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC RECEPTORS; SITE-DIRECTED MUTAGENESIS; INTRAMOLECULAR DISULFIDE BRIDGES; LIGAND-BINDING; ADENYLATE-CYCLASE; RHODOPSIN; ACTIVATION; MEMBRANE; CELL; IDENTIFICATION	A disulfide bond between two extracellular cysteines, conserved in all G protein-coupled receptors, is believed to be critical for stabilization of the ligand-binding pocket. The beta(2)-adrenergic receptor (beta(2)-AR) contains two conserved cysteines (Cys(l06) and Cys(184)) as well as two other extracellular cysteines (Cys(190) and Cys(191)). The specificity of the interactions between these four cysteines has not yet been clearly established. Mutants encoding alanines for specific extracellular cysteines in the beta(2)-AR gene were constructed and expressed in COS-l and Chinese hamster ovary cells. Ala(106) Ala(184,180,191), and Ala(l06,184,190,191) mutants displayed low affinity for the beta-antagonist, I-125-cyanopindolol and insensitivity to dithiothreitol (DTT). The Ala(106,191) mutant displayed an intermediate affinity and DTT sensitivity. Mutants Ala(184) Ala(184,190), and Ala(184,191) displayed high affinity and DTT sensitivity, indicating that a solvent-accessible disulfide bond(s) is present in these mutant receptors as in the wild-type beta(2)-AR. Additionally, thermal stability studies provided evidence that the extracellular disulfide bonds are essential for stabilization of the high affinity state of the receptor. These studies indicate that the covalent linkage between loops 1 and 2 of the beta(2)-AR extracellular domains involves the formation of disulfide bonds, uniquely between Cys(106) and Cys(191), and Cys(184) and Cys(190), and is, thus, distinct from that of other G-protein-coupled receptors.	CLEVELAND CLIN FDN, RES INST, DEPT CARDIOVASC BIOL, CLEVELAND, OH 44195 USA	Cleveland Clinic Foundation			Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753	NATIONAL EYE INSTITUTE [R01EY009704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL033713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019583] Funding Source: NIH RePORTER; NEI NIH HHS [EYO9704] Funding Source: Medline; NHLBI NIH HHS [R01 HL057470, HL33713] Funding Source: Medline; NINDS NIH HHS [NS19583] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGERMEISTER W, 1983, BIOCHIM BIOPHYS ACTA, V729, P219, DOI 10.1016/0005-2736(83)90488-1; CHANEY WG, 1986, SOMAT CELL MOLEC GEN, V12, P237, DOI 10.1007/BF01570782; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; DIXON RAF, 1987, EMBO J, V6, P3269, DOI 10.1002/j.1460-2075.1987.tb02645.x; DOHLMAN HG, 1990, BIOCHEMISTRY-US, V29, P2335, DOI 10.1021/bi00461a018; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; FRASER CM, 1989, J BIOL CHEM, V264, P9266; GOLDENBERG DP, 1992, TRENDS BIOCHEM SCI, V17, P257, DOI 10.1016/0968-0004(92)90405-X; HARTMAN SC, 1988, P NATL ACAD SCI USA, V85, P8047, DOI 10.1073/pnas.85.21.8047; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; KHORANA HG, 1992, J BIOL CHEM, V267, P1; KOBILKA BK, 1990, J BIOL CHEM, V265, P7610; KURTENBACH E, 1990, J BIOL CHEM, V265; LIGGETT SB, 1989, BIOCHEM BIOPH RES CO, V165, P257, DOI 10.1016/0006-291X(89)91063-2; LO KM, 1984, P NATL ACAD SCI-BIOL, V81, P2285, DOI 10.1073/pnas.81.8.2285; MALBON CC, 1987, TRENDS BIOCHEM SCI, V12, P172, DOI 10.1016/0968-0004(87)90081-8; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; MOXHAM CP, 1985, BIOCHEMISTRY-US, V24, P6072, DOI 10.1021/bi00343a007; MOXHAM CP, 1988, MOL PHARMACOL, V33, P486; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; PARINI A, 1987, CIRC RES, V61, P100; PEDERSEN SE, 1985, J BIOL CHEM, V260, P4150; Richardson J. S., 1989, PREDICTION PROTEIN S, P1; SALMAN KN, 1976, EUR J PHARMACOL, V36, P41, DOI 10.1016/0014-2999(76)90254-5; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAVARESE TM, 1992, J BIOL CHEM, V267, P11439; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Stamnes MA, 1990, CURR OPIN CELL BIOL, V2, P1104, DOI 10.1016/0955-0674(90)90163-9; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; VAUQUELIN G, 1979, J BIOL CHEM, V254, P4462; WEISSMAN JS, 1992, P NATL ACAD SCI USA, V89, P9900, DOI 10.1073/pnas.89.20.9900; WONG A, 1987, MOL PHARMACOL, V31, P368; WONG SKF, 1988, J BIOL CHEM, V263, P7925; YAMANO Y, 1992, BIOCHEM BIOPH RES CO, V187, P1426, DOI 10.1016/0006-291X(92)90461-S	43	121	122	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6743	6752						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120034				2022-12-27	WOS:A1994MZ50300077
J	ISMAILOV, II; MCDUFFIE, JH; BENOS, DJ				ISMAILOV, II; MCDUFFIE, JH; BENOS, DJ			PROTEIN-KINASE A PHOSPHORYLATION AND G-PROTEIN REGULATION OF PURIFIED RENAL NA+ CHANNELS IN PLANAR BILAYER-MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE SODIUM-CHANNEL; SUBUNIT; A6; VASOPRESSIN	Purified bovine renal epithelial Na+ channels incorporated into planar lipid bilayer membranes were used to evaluate the biophysical consequences of its phosphorylation by protein kinase A (PKA). We also studied the effects of pertussis toxin-induced ADP-ribosylation on single channel activity of nonphosphorylated and PKA phosphorylated channels. PKA-induced phosphorylation resulted in a significant increase in single channel open probability (P-o) with no change in single channel conductance, as well as increased the probability of multiple channel openings in the bilayer. Further, PKA conferred a voltage sensitivity to channel gating without affecting open channel conduction properties. PKA-phosphorylated Na+ channels were inhibited by subsequent ADP-ribosylation with pertussis toxin (PTX). Addition of guanosine 5'-3-O-(thio)triphosphate reversed this inhibition. However, exposure of nonphosphorylated Na+ channels to PTX increased channel open probability by a factor of 3-5. These results demonstrate that a cAMP-dependent pathway is an important regulatory element for amiloride-sensitive Na+ channels and that the effects of PTX-induced ADP-ribosylation of the channel-associated Gi protein on function depend upon the previous phosphorylation state of the protein.	UNIV ALABAMA,DEPT PHYSIOL & BIOPHYS,BIRMINGHAM,AL 35294	University of Alabama System; University of Alabama Birmingham					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037206] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 37206] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALVAREZ O, 1985, J ELECTROPHYSIOL TEC, V12, P159; AUSIELLO DA, 1992, J BIOL CHEM, V267, P4759; BARBRY P, 1990, BIOCHEMISTRY-US, V29, P1039, DOI 10.1021/bi00456a028; BARBRY P, 1990, P NATL ACAD SCI USA, V87, P7347, DOI 10.1073/pnas.87.19.7347; BENOS DJ, 1987, J BIOL CHEM, V262, P10613; BENOS DJ, 1992, REV PHYSIOL BIOCH P, V120, P31, DOI 10.1007/BFb0036122; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CANTIELLO HF, 1990, J BIOL CHEM, V265, P21624; CANTIELLO HF, 1989, J BIOL CHEM, V264, P20867; CANTIELLO HF, 1991, AM J PHYSIOL, V261, pC882, DOI 10.1152/ajpcell.1991.261.5.C882; GARTY H, 1988, PHYSIOL REV, V68, P309, DOI 10.1152/physrev.1988.68.2.309; KEMENDY AE, 1992, AM J PHYSIOL, V263, pC825, DOI 10.1152/ajpcell.1992.263.4.C825; LINGUEGLIA E, 1993, EUR J BIOCHEM, V216, P679, DOI 10.1111/j.1432-1033.1993.tb18188.x; LINGUEGLIA E, 1993, FEBS LETT, V318, P95, DOI 10.1016/0014-5793(93)81336-X; MARUNAKA Y, 1991, AM J PHYSIOL, V260, pC1071, DOI 10.1152/ajpcell.1991.260.5.C1071; OH Y, 1993, AM J PHYSIOL, V264, pC1489, DOI 10.1152/ajpcell.1993.264.6.C1489; OH YS, 1993, AM J PHYSIOL, V265, pC85, DOI 10.1152/ajpcell.1993.265.1.C85; OH YS, 1993, PROTEIN EXPRES PURIF, V4, P312, DOI 10.1006/prep.1993.1040; OHARA A, 1993, AM J PHYSIOL, V264, pC352, DOI 10.1152/ajpcell.1993.264.2.C352; PRAT AG, 1993, AM J PHYSIOL, V265, pC224, DOI 10.1152/ajpcell.1993.265.1.C224; PRAT AG, 1993, AM J PHYSIOL, V265, pC218, DOI 10.1152/ajpcell.1993.265.1.C218; SARIBANSOHRABY S, 1984, SCIENCE, V225, P745, DOI 10.1126/science.6463652; SARIBANSOHRABY S, 1988, J BIOL CHEM, V263, P13875; SMITH PR, 1991, P NATL ACAD SCI USA, V88, P6971, DOI 10.1073/pnas.88.16.6971; STAUB O, 1992, J CELL BIOL, V119, P1497, DOI 10.1083/jcb.119.6.1497	25	58	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 8	1994	269	14					10235	10241						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NF017	8144604				2022-12-27	WOS:A1994NF01700013
J	NOTHWEHR, SF; STEVENS, TH				NOTHWEHR, SF; STEVENS, TH			SORTING OF MEMBRANE-PROTEINS IN THE YEAST SECRETORY PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FACTOR-II RECEPTOR; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; GOLGI RETENTION; CYTOPLASMIC TAIL; KEX2 PROTEASE; ALPHA-FACTOR; VACUOLE; LOCALIZATION		UNIV OREGON, INST MOLEC BIOL, EUGENE, OR 97403 USA	University of Oregon				Stevens, Tom/0000-0001-6427-6848	NIGMS NIH HHS [GM 38006, GM 32448] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038006, R37GM032448, R01GM032448] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEIJON C, 1993, J CELL BIOL, V122, P307, DOI 10.1083/jcb.122.2.307; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; AOKI D, 1992, P NATL ACAD SCI USA, V89, P4319, DOI 10.1073/pnas.89.10.4319; BELTZER JP, 1991, EMBO J, V10, P3735, DOI 10.1002/j.1460-2075.1991.tb04942.x; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; CONRADT B, 1992, J CELL BIOL, V119, P1469, DOI 10.1083/jcb.119.6.1469; COOPER A, 1992, J CELL BIOL, V119, P1459, DOI 10.1083/jcb.119.6.1459; CUNNINGHAM KW, 1989, YEAST, V5, P25, DOI 10.1002/yea.320050105; DAVIS NG, 1993, J CELL BIOL, V122, P53, DOI 10.1083/jcb.122.1.53; DENFERT C, 1991, MOL CELL BIOL, V11, P5727, DOI 10.1128/MCB.11.11.5727; FRANZUSOFF A, 1989, EMBO J, V8, P2695, DOI 10.1002/j.1460-2075.1989.tb08410.x; GRAHAM TR, 1991, J CELL BIOL, V114, P207, DOI 10.1083/jcb.114.2.207; HARDWICK KG, 1992, EMBO J, V11, P4187, DOI 10.1002/j.1460-2075.1992.tb05512.x; HAUSLER A, 1992, GLYCOBIOLOGY, V2, P77, DOI 10.1093/glycob/2.1.77; HILL K, 1992, GENETICS, V130, P273; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; JENNESS DD, 1986, CELL, V46, P345, DOI 10.1016/0092-8674(86)90655-0; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; KLIONSKY DJ, 1990, J BIOL CHEM, V265, P5349; KUCHLER K, 1993, J CELL BIOL, V120, P1203, DOI 10.1083/jcb.120.5.1203; LJUNGDAHL PO, 1992, CELL, V71, P463, DOI 10.1016/0092-8674(92)90515-E; Machamer C E, 1991, Trends Cell Biol, V1, P141, DOI 10.1016/0962-8924(91)90001-P; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; NISHIKAWA S, 1993, P NATL ACAD SCI USA, V90, P8179, DOI 10.1073/pnas.90.17.8179; NOTHWEHR SF, 1993, J CELL BIOL, V121, P1197, DOI 10.1083/jcb.121.6.1197; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; PELHAM HRB, 1993, CELL, V75, P603, DOI 10.1016/0092-8674(93)90479-A; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; RAYMOND CK, 1992, INT REV CYTOL, V139, P59, DOI 10.1016/S0074-7696(08)61410-2; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Riezman Howard, 1993, Trends in Cell Biology, V3, P273, DOI 10.1016/0962-8924(93)90056-7; ROBERTS CJ, 1989, J CELL BIOL, V108, P1363, DOI 10.1083/jcb.108.4.1363; ROBERTS CJ, 1992, J CELL BIOL, V119, P69, DOI 10.1083/jcb.119.1.69; ROHRER J, 1993, MOL BIOL CELL, V4, P511, DOI 10.1091/mbc.4.5.511; ROTHMAN JH, 1990, CELL, V61, P1063, DOI 10.1016/0092-8674(90)90070-U; SANDERS SL, 1992, J BIOL CHEM, V267, P13791; SCHIMMOLLER F, 1993, J CELL SCI, V106, P823; SCHULZEGARG C, 1993, J CELL BIOL, V122, P541, DOI 10.1083/jcb.122.3.541; SEEGER M, 1992, J CELL BIOL, V118, P531, DOI 10.1083/jcb.118.3.531; SINGER B, 1990, J CELL BIOL, V110, P1911, DOI 10.1083/jcb.110.6.1911; SINGERKRUGER B, 1993, J BIOL CHEM, V268, P14376; SWEET DJ, 1992, EMBO J, V11, P423, DOI 10.1002/j.1460-2075.1992.tb05071.x; TAN PK, 1993, J CELL BIOL, V123, P1707, DOI 10.1083/jcb.123.6.1707; TEASDALE RD, 1992, J BIOL CHEM, V267, P4084; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q; VATER CA, 1992, J CELL BIOL, V119, P773, DOI 10.1083/jcb.119.4.773; VIDA TA, 1990, J CELL BIOL, V111, P2871, DOI 10.1083/jcb.111.6.2871; WEISZ OA, 1993, J CELL BIOL, V122, P1185, DOI 10.1083/jcb.122.6.1185; WICHMANN H, 1992, CELL, V71, P1131, DOI 10.1016/S0092-8674(05)80062-5; WILCOX CA, 1991, J CELL BIOL, V115, P297, DOI 10.1083/jcb.115.2.297; WILCOX CA, 1992, MOL BIOL CELL, V3, P1353, DOI 10.1091/mbc.3.12.1353; WILSBACH K, 1993, EMBO J, V12, P3049, DOI 10.1002/j.1460-2075.1993.tb05974.x; Wilsbach Kathleen, 1993, Trends in Cell Biology, V3, P426, DOI 10.1016/0962-8924(93)90031-U	56	83	83	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	1994	269	14					10185	10188						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NF017	8144594				2022-12-27	WOS:A1994NF01700001
J	KHAN, WA; BLOBE, GC; RICHARDS, AL; HANNUN, YA				KHAN, WA; BLOBE, GC; RICHARDS, AL; HANNUN, YA			IDENTIFICATION, PARTIAL-PURIFICATION, AND CHARACTERIZATION OF A NOVEL PHOSPHOLIPID-DEPENDENT AND FATTY ACID-ACTIVATED PROTEIN-KINASE FROM HUMAN PLATELETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED HUMAN-PLATELETS; RAT-BRAIN; SPHINGOSINE INHIBITION; ALLOSTERIC REGULATION; PHOSPHATIDIC-ACID; KINETIC-ANALYSIS; LEUKEMIC-CELLS; OLEIC-ACID; C-EPSILON; DIACYLGLYCEROL	A novel lipid-dependent protein kinase in human platelets was partially purified and characterized. This enzyme was calcium-independent and was selective for phosphatidic acid as a cofactor/activator with initial activation observed at approximately 2 mol % and peak activity achieved at 4 mol % phosphatidic acid. In the presence of phosphatidylserine, enzyme activation was observed with concentrations of phosphatidic acid as low as 0.5 mol % with peak activity at 2 mol %. Other anionic phospholipids also activated the enzyme but to a lesser extent and with less potency. Enzyme activity was independent of diacylglycerol or phorbol esters and the enzyme did not bind [H-3]phorbol dibutyrate. In a soluble protein kinase assay, the enzyme was activated by cis-unsaturated fatty acids with maximum activation occurring at 5-10 muM sodium oleate. Western blot analysis showed that this enzyme did not cross-react immunologically with antibodies raised against the currently identified isoenzymes of protein kinase C. A number of additional biochemical criteria distinguished this enzyme from known isoenzymes of protein kinase C. These biochemical and immunologic data define a novel lipid-dependent protein kinase in human platelets. The role of this enzyme in signal transduction as a phosphatidic acid-activated enzyme and as a possible target for cis-unsaturated fatty acids is discussed.	DUKE UNIV,MED CTR,DEPT MED,BOX 3355,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT CELL BIOL,DURHAM,NC 27710	Duke University; Duke University			Blobe, Gerard/AAJ-5945-2020	Blobe, Gerard/0000-0002-4274-8901	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043707] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL43707] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALDASSARE JJ, 1992, J BIOL CHEM, V267, P15585; BOCCKINO SB, 1991, P NATL ACAD SCI USA, V88, P6210, DOI 10.1073/pnas.88.14.6210; CRABOS M, 1992, BIOCHEM J, V288, P891, DOI 10.1042/bj2880891; ELIAS L, 1985, J BIOL CHEM, V260, P7023; ELTOUNY S, 1990, J BIOL CHEM, V265, P16437; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HANNUN YA, 1987, J BIOL CHEM, V262, P13620; HANNUN YA, 1985, J BIOL CHEM, V260, P39; HANNUN YA, 1990, J BIOL CHEM, V265, P2962; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; KARNIGUIAN A, 1990, BIOCHEM J, V268, P325, DOI 10.1042/bj2680325; KHAN WA, 1993, J BIOL CHEM, V268, P5063; KHAN WA, 1992, J BIOL CHEM, V267, P3605; Kitano T, 1986, Methods Enzymol, V124, P349; KLEMM DJ, 1988, EXP HEMATOL, V16, P855; KLEMM DJ, 1988, ARCH BIOCHEM BIOPHYS, V265, P496, DOI 10.1016/0003-9861(88)90154-3; KOIDE H, 1992, P NATL ACAD SCI USA, V89, P1149, DOI 10.1073/pnas.89.4.1149; KROLL MH, 1989, J CELL PHYSIOL, V139, P558, DOI 10.1002/jcp.1041390315; MIZUNO K, 1991, EUR J BIOCHEM, V202, P931, DOI 10.1111/j.1432-1033.1991.tb16453.x; MURPHY CT, 1991, BIOCHIM BIOPHYS ACTA, V1133, P46, DOI 10.1016/0167-4889(91)90240-X; NAKANISHI H, 1992, J BIOL CHEM, V267, P16347; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OGITA K, 1992, P NATL ACAD SCI USA, V89, P1592, DOI 10.1073/pnas.89.5.1592; SAIDO TC, 1992, BIOCHEMISTRY-US, V31, P482, DOI 10.1021/bi00117a026; SANO K, 1983, J BIOL CHEM, V262, P13620; SCHAAP D, 1990, J BIOL CHEM, V265, P7301; SEIFERT R, 1987, BIOCHEM BIOPH RES CO, V149, P762, DOI 10.1016/0006-291X(87)90433-5; SIESS W, 1983, J BIOL CHEM, V258, P4683; TSUKUDA M, 1988, BIOCHEM BIOPH RES CO, V155, P1387, DOI 10.1016/S0006-291X(88)81295-6; WERNER MH, 1991, MOL PHARMACOL, V39, P547; WETSEL WC, 1992, J CELL BIOL, V117, P121, DOI 10.1083/jcb.117.1.121; YOSHIDA K, 1992, P NATL ACAD SCI USA, V89, P6443, DOI 10.1073/pnas.89.14.6443	32	62	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9729	9735						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144564				2022-12-27	WOS:A1994NE05300053
J	MATSUKA, YV; MEDVED, LV; BREW, SA; INGHAM, KC				MATSUKA, YV; MEDVED, LV; BREW, SA; INGHAM, KC			THE NH2-TERMINAL FIBRIN-BINDING SITE OF FIBRONECTIN IS FORMED BY INTERACTING 4TH AND 5TH FINGER DOMAINS - STUDIES WITH RECOMBINANT FINGER FRAGMENTS EXPRESSED IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLASMA FIBRONECTIN; INSOLUBLE GLOBULIN; CROSS-LINKING; FACTOR-XIIIA; MODULES; SEQUENCE; PROTEINS; GELS; ACID	The NH2-terminal 29-kDa Fib-1 fragment consisting of the first five finger modules of fibronectin (F1-5) binds reversibly to fibrin and facilitates cross-linking by Factor XIII. To narrow down the fibrin-binding site within this region, we have used recombinant technology to express a number of individual fingers, rF1, rF2, rF3, rF4, and rF5, and their pairs, rF1-2 rF2-3, and rF4-5, as fusion proteins in Escherichia coli. These recombinant fragments were separated from the carrier maltose-binding protein by digestion with human factor Xa or other proteases, and their structural integrity was confirmed by spectroscopic and calorimetric methods. The recombinant F1 and F4-5 exhibited fluorescence-detected melting transitions of the same magnitude and with the same midpoint (T(m)) as their natural analogues prepared from Fib-1 by proteolysis. Differential scanning calorimetry experiments further demonstrated that these fragments are properly folded and have compact structures identical to the natural ones. Isolated rF4 melts at a much lower temperature than rF5 or the bimodular fragment rF4-5, indicating the loss of a stabilizing interaction between fingers 4 and 5. Comparison of fluorescence spectra of individual rF4 and rF5 with that of rF4-5 was also consistent with an interaction that affects the environment of Trp residue(s). rF2 also melts at a lower temperature than rF3 or rF2-3, suggesting a stabilizing interaction between the second and third fingers as well. When tested on fibrin-Sepharose, only the bimodular fragment rF4-5 was able to bind. All other fragments, including individual fingers 4 and 5, failed to bind. Thus, fibrin binding is not a common property of all fingers. The results indicate that a recognition site for fibrin is located within fingers 4 and 5. The interaction between these neighboring domains may play an important role in proper orientation of the residues forming this site.	AMER RED CROSS,J HOLLAND LAB,15601 CRABBS BRANCH WAY,ROCKVILLE,MD 20855	American Red Cross				Medved, Leonid/0000-0002-3665-9849	NHLBI NIH HHS [HL21791, HL44336] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021791, P50HL044336] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BORSI L, 1986, ANAL BIOCHEM, V155, P335, DOI 10.1016/0003-2697(86)90443-4; CARR ME, 1987, J LAB CLIN MED, V110, P747; CHOW TW, 1983, THROMB RES, V29, P243, DOI 10.1016/0049-3848(83)90146-9; DUFOUR S, 1991, EXP CELL RES, V193, P331, DOI 10.1016/0014-4827(91)90104-3; GRINNELL F, 1980, CELL, V19, P517, DOI 10.1016/0092-8674(80)90526-7; HE MG, 1993, J PROTEIN CHEM, V12, P1, DOI 10.1007/BF01024906; HEENE D L, 1973, Thrombosis Research, V2, P137, DOI 10.1016/0049-3848(73)90025-X; Henschen A., 1986, BLOOD COAGULATION, V171, P241; HORMANN H, 1985, PLASMA FIBRONECTIN S, P99; INGHAM KC, 1989, J BIOL CHEM, V264, P16977; KIM JS, 1993, PROTEIN SCI, V2, P348; KIRSCHBAUM NE, 1990, J BIOL CHEM, V265, P13669; LITVINOVICH SV, 1991, J MOL BIOL, V217, P563, DOI 10.1016/0022-2836(91)90758-X; MCCLARIN JA, 1986, SCIENCE, V234, P1526, DOI 10.1126/science.3024321; MCDONAGH RP, 1981, FEBS LETT, V127, P174, DOI 10.1016/0014-5793(81)80198-6; MOSHER DF, 1976, J BIOL CHEM, V251, P1639; MOSHER DF, 1983, ANN NY ACAD SCI, V408, P583, DOI 10.1111/j.1749-6632.1983.tb23275.x; NAGAI K, 1987, METHOD ENZYMOL, V153, P461; ODERMATT E, 1982, J MOL BIOL, V159, P109, DOI 10.1016/0022-2836(82)90034-1; OKADA M, 1985, J BIOL CHEM, V260, P1811; PARAMESWARAN KN, 1990, P NATL ACAD SCI USA, V87, P8472, DOI 10.1073/pnas.87.21.8472; Privalov P L, 1986, Methods Enzymol, V131, P4; PROCYK R, 1990, BIOPOLYMERS, V29, P559, DOI 10.1002/bip.360290311; RUOSLAHTI E, 1975, J EXP MED, V141, P497, DOI 10.1084/jem.141.2.497; SEIDL M, 1983, H-S Z PHYSIOL CHEM, V364, P83, DOI 10.1515/bchm2.1983.364.1.83; SEKIGUCHI K, 1983, J BIOL CHEM, V258, P3967; SOTTILE J, 1991, J BIOL CHEM, V266, P12840; STATHAKIS NE, 1978, BLOOD, V51, P1211; VANZONNEVELD AJ, 1986, J BIOL CHEM, V261, P14214; VARETSKAYA TV, 1961, UKR BIOKHIM ZH, V32, P13; WILLIAMS MJ, 1993, BIOCHEMISTRY-US, V32, P7388, DOI 10.1021/bi00080a008	31	42	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9539	9546						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144540				2022-12-27	WOS:A1994NE05300025
J	RHIE, G; BEALE, SI				RHIE, G; BEALE, SI			REGULATION OF HEME OXYGENASE ACTIVITY IN CYANIDIUM-CALDARIUM BY LIGHT, GLUCOSE, AND PHYCOBILIN PRECURSORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIVERDIN-IX-ALPHA; CHLOROPHYLL SYNTHESIS; ARABIDOPSIS-THALIANA; PARTIAL-PURIFICATION; EUGLENA-GRACILIS; BIOSYNTHESIS; PHYCOCYANIN; PROTEIN; ALGA; APOPROTEIN	Cyanobacteria, red algae, and cryptophytes contain Phycobiliproteins which function as photosynthetic light-harvesting pigments. The chromophores of phycobiliproteins are phycobilins, open-chain tetrapyrroles that are synthesized from protoheme. The first step of phycobilin formation is the conversion of protoheme to biliverdin IXalpha in a reaction that is catalyzed by heme oxygenase. In the unicellular red alga, Cyanidium caldarium, light is required for the accumulation of phycobiliproteins. It has been reported previously that the synthesis of the apoprotein components of allophycocyanin and phycocyanin is induced by light in C. caldarium, that the phycobilin precursors, delta-aminolevulinic acid (ALA), protoporphyrin IX, and protoheme can substitute for light, and that the regulation is exerted at the level of mRNA synthesis. We have determined that a key enzyme of phycobilin formation is induced by light in C. caldarium. Extractable heme oxygenase activity is low in dark-grown cells, and it increases approximately 6-fold during the first 24 h after the cells are illuminated. After 24 h, the activity decreases to a level approximately equal to the initial activity. Heme oxygenase is induced in unilluminated cells by administration of ALA. D-Glucose, which is known to inhibit phycocyanin accumulation in C. caldarium, inhibits the induction of heme oxygenase by light or ALA. Induction of heme oxygenase by light or ALA is blocked by cycloheximide, an inhibitor of cytoplasmic protein synthesis, but not by chloramphenicol, an inhibitor of chloroplast protein synthesis. Rifampicin, an inhibitor of algal chloroplast RNA synthesis, and gabaculine, a competitive inhibitor of ALA biosynthesis, block the induction of heme oxygenase by light but not by ALA. These results indicate that heme oxygenase in C. caldarium is induced by phycobilin precursors. The induction by light and the repression of the induction by D-glucose are probably indirect effects mediated by the effects of light and D-glucose on phycobilin precursor formation. The results also indicate that heme oxygenase is encoded by a nuclear gene and is synthesized on cytoplasmic ribosomes.	BROWN UNIV, DIV BIOL & MED, PROVIDENCE, RI 02912 USA	Brown University								ALLEN MB, 1959, ARCH MIKROBIOL, V32, P270, DOI 10.1007/BF00409348; BEALE SI, 1984, ARCH BIOCHEM BIOPHYS, V235, P371, DOI 10.1016/0003-9861(84)90210-8; BEALE SI, 1983, PLANT PHYSIOL, V71, P263, DOI 10.1104/pp.71.2.263; BEALE SI, 1971, PLANT PHYSIOL, V47, P230, DOI 10.1104/pp.47.2.230; BEALE SI, 1993, CHEM REV, V93, P785, DOI 10.1021/cr00018a008; BEALE SI, 1990, PLANT PHYSIOL, V93, P1273, DOI 10.1104/pp.93.4.1273; BEALE SI, 1991, J BIOL CHEM, V266, P22328; BEALE SI, 1991, J BIOL CHEM, V266, P22333; BEALE SI, 1991, J BIOL CHEM, V266, P22341; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN SB, 1984, BIOCHEM J, V217, P265, DOI 10.1042/bj2170265; BROWN SB, 1984, BIOCHEM J, V220, P861, DOI 10.1042/bj2200861; COLE WJ, 1967, J AM CHEM SOC, V89, P3643, DOI 10.1021/ja00990a055; CORNEJO J, 1988, J BIOL CHEM, V263, P11915; DOEMEL WN, 1971, J GEN MICROBIOL, V67, P17, DOI 10.1099/00221287-67-1-17; DOUGLAS SE, 1993, IN PRESS J MAR BIOTE; DWARKI VJ, 1987, J BIOL CHEM, V262, P16958; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; HORTNER H, 1982, EUR J BIOCHEM, V128, P179; HOUGHTON JD, 1989, CARLSBERG RES COMMUN, V54, P131, DOI 10.1007/BF02907183; HOUGHTON JD, 1988, BIOCHEM J, V254, P907, DOI 10.1042/bj2540907; KONCZ C, 1992, PLANT MOL BIOL, V20, P963, DOI 10.1007/BF00027166; KONCZ C, 1990, EMBO J, V9, P1337, DOI 10.1002/j.1460-2075.1990.tb08248.x; LIN S, 1990, PLANT PHYSIOL, V93, P772, DOI 10.1104/pp.93.2.772; MCDONAGH AF, 1980, BIOCHEM J, V189, P193, DOI 10.1042/bj1890193; NICHOLS KE, 1960, NATURE, V188, P870, DOI 10.1038/188870b0; ORSAT B, 1992, FEBS LETT, V303, P181, DOI 10.1016/0014-5793(92)80514-H; REINBOTHE S, 1991, PLANT PHYSIOL BIOCH, V29, P297; REINBOTHE S, 1992, NATO ADV SCI I A-LIF, V226, P43; REITH M, 1993, PLANT CELL, V5, P645; RHIE GE, 1992, J BIOL CHEM, V267, P16088; SECKBACH J, 1991, J PHYCOL, V27, P794, DOI 10.1111/j.0022-3646.1991.00794.x; STEINMULLER K, 1984, PLANT PHYSIOL, V76, P935, DOI 10.1104/pp.76.4.935; TROXLER RF, 1978, BIOCHEM J, V172, P569, DOI 10.1042/bj1720569; TROXLER RF, 1979, ARCH BIOCHEM BIOPHYS, V195, P53, DOI 10.1016/0003-9861(79)90326-6; TROXLER RF, 1972, BIOCHEMISTRY-US, V11, P4235, DOI 10.1021/bi00773a007; TROXLER RF, 1966, PLANT PHYSIOL, V41, P491, DOI 10.1104/pp.41.3.491; TROXLER RF, 1989, J BIOL CHEM, V264, P20596; TURNER L, 1992, PLANT PHYSIOL BIOCH, V30, P309	39	20	23	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9620	9626						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144549				2022-12-27	WOS:A1994NE05300036
J	SHEN, HG; YAO, BY; MUELLER, DM				SHEN, HG; YAO, BY; MUELLER, DM			PRIMARY STRUCTURAL CONSTRAINTS OF P-LOOP OF MITOCHONDRIAL F1-ATPASE FROM YEAST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-RAS P21; GLYCINE-RICH SEQUENCE; ESCHERICHIA-COLI; ATP-SYNTHASE; BETA-SUBUNIT; 3-DIMENSIONAL STRUCTURES; FUNCTIONAL SITES; ADENYLATE KINASE; CATALYTIC SITE; GTP HYDROLYSIS	Nucleotide binding proteins, including ras, elongation factor Tu, adenylate kinase, and the mitochondrial F1-ATPase have a glycine-rich motif known as the P-loop or the Walker A sequence (Walker, J. E., Saraste, M., Runswick, M. J., and Gay, N. J. (1982) EMBO J. 1, 945-951). The primary structural constraints have been determined in the P-loop located in the beta-subunit of the mitochondrial ATPase from yeast. The primary structural constraints were determined for 9 residues that form the P-loop, 190Gly-Gly-Ala-Gly-Val-Gly-Lys-Thr-Val198. Each residue was tested individually for possible functional replacements while keeping the primary structure of the remainder of the molecule constant. This analysis indicates with greater than 95% confidence that Gly190, Gly195, and Lys196 are invariant and Thr197 can only be replaced with Ser. The most alterable residue is Gly191, where 10 replacements, even Phe, form a functional enzyme. The remaining positions allow some amino acid replacements while restricting others. The primary structural constraints of the P-loop of the mitochondrial F1 suggests that the three-dimensional structure of the P-loop is similar to that of ras.	UNIV HLTH SCI CHICAGO MED SCH, DEPT BIOL CHEM, N CHICAGO, IL 60064 USA	Chicago Medical School					NIGMS NIH HHS [1R01GM44412] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044412] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON WS, 1992, J BIOENERG BIOMEMBR, V24, P469, DOI 10.1007/BF00762364; BECKER DM, 1991, METHOD ENZYMOL, V194, P182; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; DERBYSHIRE KM, 1986, GENE, V46, P145, DOI 10.1016/0378-1119(86)90398-7; DREUSICKE D, 1988, J MOL BIOL, V203, P1021, DOI 10.1016/0022-2836(88)90126-X; DUNCAN TM, 1992, J BIOENERG BIOMEMBR, V24, P453, DOI 10.1007/BF00762362; FRANKEN SM, 1993, BIOCHEMISTRY-US, V32, P8411, DOI 10.1021/bi00084a005; FUTAI M, 1992, J BIOENERG BIOMEMBR, V24, P463, DOI 10.1007/BF00762363; GOODY RS, 1992, PHILOS T ROY SOC B, V336, P3, DOI 10.1098/rstb.1992.0037; GRUBMEYER C, 1982, J BIOL CHEM, V257, P2092; ISSARTEL JP, 1992, EXPERIENTIA, V48, P351, DOI 10.1007/BF01923429; JOHN J, 1993, J BIOL CHEM, V268, P923; JURNAK F, 1985, SCIENCE, V230, P32, DOI 10.1126/science.3898365; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MUELLER DM, 1989, BIOCHEM BIOPH RES CO, V164, P381, DOI 10.1016/0006-291X(89)91730-0; MUELLER DM, 1988, J BIOL CHEM, V263, P5634; MUELLER DM, 1989, J BIOL CHEM, V264, P16552; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; OLIPHANT AR, 1986, GENE, V44, P177, DOI 10.1016/0378-1119(86)90180-0; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; PENEFSKY HS, 1991, ADV ENZYMOL RELAT AR, V64, P173; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; REIDHAAROLSON JF, 1988, SCIENCE, V241, P53, DOI 10.1126/science.3388019; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SCHLICHTING I, 1990, NATURE, V345, P309, DOI 10.1038/345309a0; SENIOR AE, 1993, J BIOL CHEM, V268, P6989; SENIOR AE, 1992, J BIOENERG BIOMEMBR, V24, P479, DOI 10.1007/BF00762365; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; TAKEYAMA M, 1990, J BIOL CHEM, V265, P21279; TODD RD, 1980, J BIOL CHEM, V255, P5461; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; VALENCIA A, 1991, P NATL ACAD SCI USA, V88, P5443, DOI 10.1073/pnas.88.12.5443; WALKER JE, 1984, BIOCHIM BIOPHYS ACTA, V768, P164, DOI 10.1016/0304-4173(84)90003-X; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4; WILKENS S, 1992, ARCH BIOCHEM BIOPHYS, V299, P105, DOI 10.1016/0003-9861(92)90250-Z	40	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9424	9428						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144526				2022-12-27	WOS:A1994NE05300008
J	DAVIS, JP; ZHOU, MM; VANETTEN, RL				DAVIS, JP; ZHOU, MM; VANETTEN, RL			KINETIC AND SITE-DIRECTED MUTAGENESIS STUDIES OF THE CYSTEINE RESIDUES OF BOVINE LOW-MOLECULAR-WEIGHT PHOSPHOTYROSYL PROTEIN PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC ACID-PHOSPHATASE; TYROSINE PHOSPHATASES; PURIFICATION; LIVER; HEART; EXPRESSION; RECEPTOR; CLONING; LAR; INTERMEDIATE	The roles of the 8 conserved cysteines and 1 arginine in the low molecular weight phosphotyrosyl protein phosphatases were investigated using site-directed mutagenesis of the recombinant bovine heart enzyme. Single mutants of cysteine to serine were studied for each cysteine; alanine replacements were also made for Cys-12, Cys-17, and Arg-18. The CD spectra of the purified proteins were effectively superimposable, consistent with the conclusion that no major structural alterations had occurred, but H-1 NMR spectroscopy did reveal some spectral shifts in the aromatic region. Kinetic analysis of the mutant proteins demonstrated that only Cys-12, Cys-17, and Arg-18 had significantly altered catalytic activity toward the substrate p-nitrophenyl phosphate at pH 5. The Cys-12 and Arg-18 mutants were effectively inactive. Thus, it is concluded that Cys-12 is the catalytic nucleophile, and Arg-18 presumably serves an essential function in substrate binding. The C17S mutant had 6% residual activity compared with wild type protein, whereas the C17A mutant had 37% activity. Consistent with the observed activity of the Cys-17 mutant, a covalent phosphocysteine intermediate was trapped and identified by P-31 NMR, Further kinetic analysis of C17A using several aryl phosphate monoester substrates with different leaving group pK(alpha), values indicated that no change in the rate-determining step of the catalytic mechanism had occurred, that is, dephosphorylation of the covalent phosphoenzyme intermediate remains rate-limiting. The C17A mutant had a 4-fold higher phosphate K-i and slightly higher K-m values for p-nitrophenyl phosphate suggesting that Cys-17 may be important for optimal positioning of the substrate phosphate moiety.	PURDUE UNIV, DEPT CHEM, W LAFAYETTE, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus					NIAID NIH HHS [AI 27713] Funding Source: Medline; NIGMS NIH HHS [GM 27003] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027003] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BITTENCOURT HMS, 1976, BIOCHIM BIOPHYS ACTA, V438, P153, DOI 10.1016/0005-2744(76)90231-X; BOIVIN P, 1987, INT J BIOCHEM, V19, P613, DOI 10.1016/0020-711X(87)90227-8; BOIVIN P, 1986, BIOCHEM BIOPH RES CO, V134, P557, DOI 10.1016/S0006-291X(86)80456-9; BUNTON CA, 1967, J ORG CHEM, V32, P2806, DOI 10.1021/jo01284a037; CAMICI G, 1989, J BIOL CHEM, V264, P2560; CHARBONNEAU H, 1992, ANNU REV CELL BIOL, V8, P463, DOI 10.1146/annurev.cellbio.8.1.463; CHERNOFF J, 1985, ARCH BIOCHEM BIOPHYS, V240, P135, DOI 10.1016/0003-9861(85)90016-5; CHIARUGI P, 1992, FEBS LETT, V310, P9, DOI 10.1016/0014-5793(92)81134-8; CHO HJ, 1992, J AM CHEM SOC, V114, P7296, DOI 10.1021/ja00044a052; CIRRI P, 1993, FEBS LETT, V214, P647; DAVIS JP, 1992, OCT ASBMB FALL S STR, P99; DISSING J, 1991, J BIOL CHEM, V266, P20619; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; GUAN KL, 1991, J BIOL CHEM, V266, P17026; HEINRIKSON RL, 1969, J BIOL CHEM, V244, P299; KIRBY AJ, 1967, J AM CHEM SOC, V89, P415, DOI 10.1021/ja00978a044; KLEPPE K, 1971, J MOL BIOL, V56, P341, DOI 10.1016/0022-2836(71)90469-4; KNACK I, 1981, H-S Z PHYSIOL CHEM, V362, P1119, DOI 10.1515/bchm2.1981.362.2.1119; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAIDLER PM, 1982, ARCH BIOCHEM BIOPHYS, V216, P512, DOI 10.1016/0003-9861(82)90240-5; LAU KHW, 1989, BIOCHEM J, V257, P23, DOI 10.1042/bj2570023; LAWRENCE GL, 1981, ARCH BIOCHEM BIOPHYS, V206, P122, DOI 10.1016/0003-9861(81)90073-4; Leatherbarrow R.J, 1987, ENZFITTER NONLINEAR; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUNDBLAD RL, 1991, CHEM REAGENTS PROTEI, P8; LUTZ RA, 1985, CLIN CHEM, V31, P656; MANAO G, 1992, J PROTEIN CHEM, V11, P333, DOI 10.1007/BF01024871; OKADA M, 1986, BIOCHEM J, V239, P155, DOI 10.1042/bj2390155; POT DA, 1992, BIOCHIM BIOPHYS ACTA, V1136, P35, DOI 10.1016/0167-4889(92)90082-M; POT DA, 1991, J BIOL CHEM, V266, P19688; RAMPONI G, 1989, FEBS LETT, V250, P469, DOI 10.1016/0014-5793(89)80778-1; SAINI MS, 1981, J BIOL CHEM, V256, P453; SALL DJ, 1993, J MED CHEM, V36, P2350, DOI 10.1021/jm00068a012; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; TAGA EM, 1982, ARCH BIOCHEM BIOPHYS, V214, P505, DOI 10.1016/0003-9861(82)90054-6; TONKS NK, 1988, J BIOL CHEM, V263, P6731; WAHEED A, 1988, BIOCHEMISTRY-US, V27, P4265, DOI 10.1021/bi00412a010; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315; WO YYP, 1992, BIOCHEMISTRY-US, V31, P1712, DOI 10.1021/bi00121a019; WO YYP, 1992, J BIOL CHEM, V267, P10856; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012; ZHANG ZY, 1990, ARCH BIOCHEM BIOPHYS, V282, P39, DOI 10.1016/0003-9861(90)90084-C; ZHANG ZY, 1991, BIOCHEMISTRY-US, V30, P8954, DOI 10.1021/bi00101a006; ZHANG ZY, 1991, J BIOL CHEM, V266, P1516; ZHANG ZY, 1992, BIOCHEMISTRY-US, V31, P1701, DOI 10.1021/bi00121a018; ZHOU MM, 1993, BIOCHEMISTRY-US, V32, P8479, DOI 10.1021/bi00084a012	47	62	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8734	8740						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132604				2022-12-27	WOS:A1994NB41100021
J	HODEL, A; SCHAFER, T; GEROSA, D; BURGER, MM				HODEL, A; SCHAFER, T; GEROSA, D; BURGER, MM			IN CHROMAFFIN CELLS, THE MAMMALIAN SEC1P HOMOLOG IS A SYNTAXIN 1A-BINDING PROTEIN ASSOCIATED WITH CHROMAFFIN GRANULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							INTEGRAL MEMBRANE-PROTEIN; SYNAPTIC VESICLES; BINDING; HPC-1; BRAIN; IDENTIFICATION; SYNAPTOBREVIN; CLEAVAGE; CLONING; ANTIGEN	Membrane proteins of the synaptic vesicle and the presynaptic plasma membrane together with soluble proteins form a secretory fusion complex conserved from yeast to neurons (Sollner, T., Whiteheart, S. W., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P., and Rothman, J. E. (1993) Nature 362, 318- 324). Two of the membrane proteins have been localized in chromaffin cells, which secrete catecholamines stored in chromaffin granules. Syntaxin 1A and 1B are found in a plasma membrane-enriched fraction, whereas synaptobrevin is concentrated on the granules. Recombinant syntaxin 1A has been used in an affinity chromatography assay to isolate syntaxin receptor proteins of the chromaffin granules. Solubilized granule membranes contain a single protein with high affinity for syntaxin 1A. Sequencing revealed partial homology with Sec1p, a hydrophilic yeast protein acting late in the secretory process. Genetic suppressor analyses predicted the interaction of Sec1p with Sso1p, a yeast homologue of syntaxin 1A, and with Sec4p, a homologue of rab3A (Aalto, M., Ronne, H., and Keranen, S. (1993) EMBO J. 12, 4095-4104). Although rab3A is present on chromaffin granules, we did not detect it bound to syntaxin 1A together with the mammalian Sec1p homologue (mSec1). The mSec1 peptide sequences are almost identical with respective sequences of a soluble protein, termed Munc-18, reported to be the only brain protein with affinity for recombinant syntaxin 1A (Hata, Y., Slaughter, C. A, and Sudhof, T C. (1993) Nature 366, 347-351). The mSec1/Munc-18 may be a receptor protein for syntaxin 1A on the transmitter vesicles mediating their interaction with the plasma membrane in docking and fusion.	FRIEDRICH MIESCHER INST,CH-4002 BASEL,SWITZERLAND	Friedrich Miescher Institute for Biomedical Research								AALTO MK, 1991, YEAST, V7, P643, DOI 10.1002/yea.320070613; AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; AHNERTHILGER G, 1993, NEUROSCIENCE, V53, P547, DOI 10.1016/0306-4522(93)90219-6; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BITTNER MA, 1988, J NEUROCHEM, V51, P451, DOI 10.1111/j.1471-4159.1988.tb01059.x; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; DARCHEN F, 1990, P NATL ACAD SCI USA, V87, P5692, DOI 10.1073/pnas.87.15.5692; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HORIKAWA HPM, 1993, FEBS LETT, V330, P236, DOI 10.1016/0014-5793(93)80281-X; HOSONO R, 1992, J NEUROCHEM, V58, P1517, DOI 10.1111/j.1471-4159.1992.tb11373.x; INOUE A, 1992, BIOCHEM BIOPH RES CO, V187, P1144, DOI 10.1016/0006-291X(92)91316-I; INOUE A, 1992, J BIOL CHEM, V267, P10613; JONES DH, 1974, BIOCHIM BIOPHYS ACTA, V356, P276, DOI 10.1016/0005-2736(74)90268-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; OCONNOR VM, 1993, FEBS LETT, V326, P255, DOI 10.1016/0014-5793(93)81802-7; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; POLSON A, 1980, IMMUNOL COMMUN, V9, P475, DOI 10.3109/08820138009066010; SALZBERG A, 1993, DEVELOPMENT, V117, P1309; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SMIRNOVA T, 1993, SCIENCE, V262, P430, DOI 10.1126/science.8105537; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1993, CELL, V75, P1; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; TRIFARO JM, 1989, NEUROSCIENCE, V29, P1, DOI 10.1016/0306-4522(89)90327-8; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925	31	93	94	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8623	8626						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132588				2022-12-27	WOS:A1994NB41100001
J	BETTS, JC; AGRANOFF, AB; NABEL, GJ; SHAYMAN, JA				BETTS, JC; AGRANOFF, AB; NABEL, GJ; SHAYMAN, JA			DISSOCIATION OF ENDOGENOUS CELLULAR CERAMIDE FROM NF-KAPPA-B ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; SPHINGOMYELIN TURNOVER; PHOSPHOLIPASE-C; PROTEIN-KINASE; HL-60 CELLS; SPHINGOSINE; DIFFERENTIATION; DIACYLGLYCEROL; GROWTH	The participation of cell ceramide in tumor necrosis factor (TNF)-alpha-stimulated NF-kappa B activation in Jurkat T cells and HL-60 cells was studied. TNF-alpha readily stimulated NF-kappa B activity in both cell lines as assayed by electrophoretic mobility shift assay and the use of a human immunodeficiency virus-chloramphenicol acetyltransferase reporter construct. However, TNF-alpha stimulation did not increase cell ceramide levels in either cell line. The exogenous addition of a short chain ceramide, N-acetylsphingosine, to Jurkat cells had no effect on NF-kappa B activity. When Jurkat T cells were exposed to the glucosylceramide synthase inhibitor, 1-phenyl-2-decanoylamino-3-morpholino-1-propanol, endogenous ceramide levels increased 4-fold. The increase in ceramide, however, did not result in NF-kappa B activation nor did it potentiate TNF-alpha or phorbol ester-stimulated activity. We conclude that TNF-alpha-induced NF-kappa B activation occurs in Jurkat and HL-60 cell lines that do not demonstrate an increase in TNF-alpha-induced ceramide. Increasing ceramide levels by the addition of short chain ceramides or the use of a glucosylceramide synthase inhibitor can be dissociated from activation of NF-kappa B by TNF-alpha.	UNIV MICHIGAN, MED CTR, DEPT INTERNAL MED, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT BIOL CHEM, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, HOWARD HUGHES MED INST, ANN ARBOR, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan					NIAID NIH HHS [AI 29179] Funding Source: Medline; NIDDK NIH HHS [DK41487] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041487] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABE A, 1992, EUR J BIOCHEM, V210, P765, DOI 10.1111/j.1432-1033.1992.tb17479.x; BALLOU LR, 1992, J BIOL CHEM, V267, P20044; CLARK MA, 1988, BIOCHEM J, V250, P125, DOI 10.1042/bj2500125; DBAIBO GS, 1993, J BIOL CHEM, V268, P17762; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; FAUCHER M, 1988, J BIOL CHEM, V263, P5319; KIM MY, 1991, J BIOL CHEM, V266, P484; LADENSON RC, 1993, J BIOL CHEM, V268, P7650; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; MATHIAS S, 1991, P NATL ACAD SCI USA, V88, P10009, DOI 10.1073/pnas.88.22.10009; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; PAUL P, 1992, ANAL BIOCHEM, V204, P265, DOI 10.1016/0003-2697(92)90237-2; PREISS J, 1986, J BIOL CHEM, V261, P8597; RADIN NS, 1993, ADV LIPID RES, V26, P183; RADIN NS, 1993, NEUROPROTOCOLS, V3, P145; RAINES MA, 1993, J BIOL CHEM, V268, P14572; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SCHUTZE S, 1991, J EXP MED, V174, P975, DOI 10.1084/jem.174.5.975; SHAYMAN JA, 1991, J BIOL CHEM, V266, P22968; SHAYMAN JA, 1990, J BIOL CHEM, V265, P12135; YOUNES A, 1992, J BIOL CHEM, V267, P842	24	79	79	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8455	8458						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132572				2022-12-27	WOS:A1994NB40900093
J	CASTELLS, MC; WU, XY; ARM, JP; AUSTEN, KF; KATZ, HR				CASTELLS, MC; WU, XY; ARM, JP; AUSTEN, KF; KATZ, HR			CLONING OF THE GP49B GENE OF THE IMMUNOGLOBULIN SUPERFAMILY AND DEMONSTRATION THAT ONE OF ITS 2 PRODUCTS IS AN EARLY-EXPRESSED MAST-CELL SURFACE PROTEIN ORIGINALLY DESCRIBED AS GP49	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING TRANSCRIPTION FACTORS; CONNECTIVE-TISSUE-TYPE; SULFATE-E-PROTEOGLYCAN; ADHESION MOLECULE; MESSENGER-RNA; ALPHA-CHAIN; W/WV MICE; RECEPTOR; FIBROBLASTS; ANTIGEN	gp49 was originally defined as a 49-kDa surface glycoprotein preferentially expressed on mouse interleukin-3-dependent, bone marrow-derived mast cells, which are immature progenitor cells. A previously cloned cDNA (gp49A) indicated that gp49 was a member of the immunoglobulin (Ig) superfamily, and genomic DNA analysis indicated that two genes might encode a gp49 family. We have now characterized a 5.6 kilobase pair gene, gp49B, that encodes two novel gp49 cDNAs, gp49B1 and gp49B2. The two cDNAs are identical except that gp49B2 is missing exon 6, which encodes a predicted transmembrane domain. In contrast to gp49A, gp49B1 and gp49B2 have 32 additional amino acids at their C termini containing 4 of the 6 consensus amino acids of the antigen receptor homology 1 motif found on several signal transducing members of the Ig superfamily. When COS-7 cells were transfected with either the gp49B1 or gp49B2 cDNA, only the gp49B1 transfectants bound the B23.1 monoclonal antibody that originally defined gp49. Reverse transcriptase-polymerase chain reaction analysis of the transfectants established that both transcripts were expressed, suggesting that the product of the gp49B2 transcript was not inserted in the plasma membrane, Thus, cloning of the gp49B gene has established the organization of one of the gp49 genes and provided evidence of alternate splicing of transcripts from that gene.	BRIGHAM & WOMENS HOSP, DEPT RHEUMATOL IMMUNOL, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital	CASTELLS, MC (corresponding author), HARVARD UNIV, SCH MED,DEPT MED,SEELEY G MUDD BLDG,RM 607, 250 LONGWOOD AVE, BOSTON, MA 02115 USA.				NIAID NIH HHS [AI-22531, AI-07306, AI-32101] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI022531, R01AI022531, T32AI007306, R01AI032101] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTSCHUL SF, 1986, B MATH BIOL, V48, P603, DOI 10.1016/S0092-8240(86)90010-8; AMIGORENA S, 1992, NATURE, V358, P337, DOI 10.1038/358337a0; ARM JP, 1991, J BIOL CHEM, V266, P15966; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BROOKS DG, 1989, J EXP MED, V170, P1369, DOI 10.1084/jem.170.4.1369; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; DAYTON ET, 1988, P NATL ACAD SCI USA, V85, P569, DOI 10.1073/pnas.85.2.569; GALLI SJ, 1982, J CELL BIOL, V95, P435, DOI 10.1083/jcb.95.2.435; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; HOGARTH PM, 1991, J IMMUNOL, V146, P369; KATZ HR, 1989, J IMMUNOL, V142, P919; KATZ HR, 1990, J IMMUNOL, V145, P3412; KATZ HR, 1992, J IMMUNOL, V148, P868; KATZ HR, 1983, P NATL ACAD SCI-BIOL, V80, P5916, DOI 10.1073/pnas.80.19.5916; KEEGAN AD, 1992, IMMUNOL TODAY, V13, P63, DOI 10.1016/0167-5699(92)90136-U; KENNELLY PJ, 1991, J BIOL CHEM, V266, P1555; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; ODIN JA, 1991, SCIENCE, V254, P1785, DOI 10.1126/science.1837175; ORKIN SH, 1992, BLOOD, V80, P575; OTSU K, 1987, J EXP MED, V165, P615, DOI 10.1084/jem.165.3.615; RAPPAPORT EF, 1993, EXP HEMATOL, V21, P689; RAZIN E, 1983, J EXP MED, V157, P189, DOI 10.1084/jem.157.1.189; RAZIN E, 1984, J IMMUNOL, V132, P1479; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; REYES AA, 1991, MOL CELL BIOL, V11, P1654, DOI 10.1128/MCB.11.3.1654; REYNOLDS DS, 1988, J BIOL CHEM, V263, P12783; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; TEPLER I, 1989, J BIOL CHEM, V264, P5912; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WILLIAMS AF, 1987, IMMUNOL TODAY, V8, P298, DOI 10.1016/0167-5699(87)90016-8; YE ZS, 1992, J IMMUNOL, V149, P897; ZON LI, 1991, J BIOL CHEM, V266, P22948	35	96	100	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8393	8401						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132564				2022-12-27	WOS:A1994NB40900085
J	POON, PP; STORMS, RK				POON, PP; STORMS, RK			THYMIDYLATE SYNTHASE IS LOCALIZED TO THE NUCLEAR PERIPHERY IN THE YEAST SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN RIBONUCLEOTIDE REDUCTASE; TRANSFER-RNA; CELL-CYCLE; BIOSYNTHETIC-ENZYMES; BETA-GALACTOSIDASE; ESCHERICHIA-COLI; GENE-EXPRESSION; MITOCHONDRIAL; DEOXYRIBONUCLEOTIDE; PROTEIN	To date, the organization of DNA precursor synthesis within eukaryotic cells remains unresolved. Previous studies have suggested the existence of a multienzyme complex that is responsible for DNA precursor synthesis and is associated with sites of replication within the nucleus. Contrasting this, other studies have proposed that DNA precursor synthesis occurs outside the nucleus. To further these studies, we have addressed the location where thymidylate synthase resides in yeast. Subcellular fractionation experiments indicate thymidylate synthase is associated with purified nuclei. Consistent with this, immunofluorescence analysis suggests that thymidylate synthase is situated at the nuclear periphery.	CONCORDIA UNIV, DEPT BIOL, MONTREAL H3G 1M8, PQ, CANADA	Concordia University - Canada			Storms, Reginald/B-2405-2013					AMMERER G, 1983, METHOD ENZYMOL, V101, P192; ANDREWS BJ, 1992, NATURE, V355, P393, DOI 10.1038/355393a0; AYUSAWA D, 1983, J BIOL CHEM, V258, P48; BABA M, 1987, J ELECTRON MICR TECH, V5, P249, DOI 10.1002/jemt.1060050305; BISSON LF, 1981, J BIOL CHEM, V256, P2456; CAPLAN AJ, 1991, J CELL BIOL, V114, P609, DOI 10.1083/jcb.114.4.609; CASADABAN MJ, 1983, METHOD ENZYMOL, V100, P293; CELLA R, 1991, EUR J BASIC APPL HIS, V35, P61; CHATTON B, 1988, J BIOL CHEM, V263, P52; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; DESHAIES RJ, 1990, MOL CELL BIOL, V10, P6024, DOI 10.1128/MCB.10.11.6024; ENGSTROM Y, 1988, EMBO J, V7, P1615, DOI 10.1002/j.1460-2075.1988.tb02987.x; FRANKE WW, 1974, INT REV CYTOL, P71; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; GILLMAN EC, 1991, MOL CELL BIOL, V11, P2382, DOI 10.1128/MCB.11.5.2382; GREENWOOD MT, 1986, J BACTERIOL, V168, P1336, DOI 10.1128/jb.168.3.1336-1342.1986; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P7410, DOI 10.1073/pnas.79.23.7410; HALL MN, 1984, CELL, V36, P1057, DOI 10.1016/0092-8674(84)90055-2; HALL MN, 1990, P NATL ACAD SCI USA, V87, P6954, DOI 10.1073/pnas.87.18.6954; HARDWICK KG, 1990, EMBO J, V9, P623, DOI 10.1002/j.1460-2075.1990.tb08154.x; HARVEY G, 1988, J CELL PHYSIOL, V134, P25, DOI 10.1002/jcp.1041340104; IDE GJ, 1981, CURR GENET, V4, P85, DOI 10.1007/BF00365686; JOHNSON L F, 1992, Current Opinion in Cell Biology, V4, P149, DOI 10.1016/0955-0674(92)90025-8; KOERNER TJ, 1991, METHOD ENZYMOL, V194, P477; Kornberg A, 1992, DNA REPLICATION, P53; KUCERA R, 1986, EXP CELL RES, V167, P417, DOI 10.1016/0014-4827(86)90182-5; KUNZ BA, 1991, ANNU REV GENET, V25, P339, DOI 10.1146/annurev.ge.25.120191.002011; LEEDS JM, 1985, MOL CELL BIOL, V5, P3443, DOI 10.1128/MCB.5.12.3443; LI JM, 1989, J CELL BIOL, V109, P1411, DOI 10.1083/jcb.109.4.1411; LOHR D, 1988, YEAST PRACTICAL APPR, P125; MATHEWS CK, 1991, J THEOR BIOL, V152, P25, DOI 10.1016/S0022-5193(05)80502-8; MATHEWS CK, 1988, TRENDS BIOCHEM SCI, V13, P394, DOI 10.1016/0968-0004(88)90182-X; MCINTOSH EM, 1988, MOL CELL BIOL, V8, P4616, DOI 10.1128/MCB.8.11.4616; MCNEIL JB, 1980, CURR GENET, V2, P17, DOI 10.1007/BF00445690; NIGG EA, 1991, CELL, V66, P15, DOI 10.1016/0092-8674(91)90135-L; OVADI J, 1991, J THEOR BIOL, V152, P1, DOI 10.1016/S0022-5193(05)80500-4; PERLMAN D, 1981, CELL, V25, P525, DOI 10.1016/0092-8674(81)90071-4; POON PP, 1993, THESIS CONCORDIA U M; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; REDDY GPV, 1980, P NATL ACAD SCI-BIOL, V77, P3312; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; ROSE AM, 1992, MOL CELL BIOL, V12, P5652, DOI 10.1128/MCB.12.12.5652; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; ROTHBLATT J, 1989, METHOD CELL BIOL, V32, P1; SHERMAN F, 1991, METHODS BIOL, V196, P1; SIKORSKA M, 1990, BIOCHEM CELL BIOL, V68, P880, DOI 10.1139/o90-130; STORMS RK, 1979, J BACTERIOL, V4, P73; TAYLOR GR, 1987, J BIOL CHEM, V262, P5298; WICKREMASINGHE RG, 1983, BIOCHIM BIOPHYS ACTA, V740, P243, DOI 10.1016/0167-4781(83)90132-X; WU M, 1987, J BIOL CHEM, V262, P12275	51	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8341	8347						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132557				2022-12-27	WOS:A1994NB40900077
J	SANTOSO, S; KALB, R; KROLL, H; WALKA, M; KIEFEL, V; MUELLERECKHARDT, C; NEWMAN, PJ				SANTOSO, S; KALB, R; KROLL, H; WALKA, M; KIEFEL, V; MUELLERECKHARDT, C; NEWMAN, PJ			A POINT MUTATION LEADS TO AN UNPAIRED CYSTEINE RESIDUE AND A MOLECULAR-WEIGHT POLYMORPHISM OF A FUNCTIONAL PLATELET BETA(3) INTEGRIN SUBUNIT - THE SR-A ALLOANTIGEN SYSTEM OF GPIIIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE GLYCOPROTEIN-IIIA; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; AMINO-ACID POLYMORPHISM; GLANZMANN THROMBASTHENIA; MONOCLONAL-ANTIBODY; IIB; POLYPEPTIDE; SEQUENCE; EPITOPES; PROTEIN	Recently, we described a low frequency platelet alloantigen on human platelet membrane glycoprotein (GP) IIIa, termed Sr-a, that was involved in neonatal alloimmune thrombocytopenia. To identify the molecular nature of the Sr-a alloantigen, we analyzed the nucleotide sequence of polymerase chain reaction-amplified GPIIIa mRNA, and found a C-2004-->T substitution in seven Sr-a positive individuals which results in an Arg(636) --> Cys polymorphism within the cysteine-rich region of GPIIIa. Analysis of allele-specific recombinant forms of GPIIIa that differed only at amino acid residue 636 showed that anti Sr-a alloantibodies reacted with the Cys(636), but not the Arg(636), recombinant form of GPIIIa. Interestingly, under reducing conditions, the Cys(636) form of GPIIIa migrated with a slightly increased apparent molecular weight compared with the Arg(636) form. Following treatment with Endoglycosidase H, both allelic forms of GPIIIa exhibited the same mobility, however the Sr-a epitope was lost. Sr-a positive platelets express the same number of GPIIb-IIIa complexes on their surface as wild-type Sr-a negative platelets, and also aggregate normally in response to a variety of platelet agonists. Based upon these results, we conclude that 1) GPIIIa residue 636 specifically controls the formation and expression of the Sr-a alloantigenic determinant, and 2) an unpaired cysteine residue alters the N-linked glycosylation pattern of the extracellular domain of GPIIIa, but affects neither the degree of surface expression nor the adhesive function of the GPIIb-IIIa complex.	BLOOD CTR SE WISCONSIN INC,BLOOD RES INST,MILWAUKEE,WI 53233; MED COLL WISCONSIN,DEPT CELLULAR BIOL,MILWAUKEE,WI 53233; MED COLL WISCONSIN,DEPT PHARMACOL,MILWAUKEE,WI 53233	Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	SANTOSO, S (corresponding author), JUSTUS LIEBIG UNIV,INST CLIN IMMUNOL & TRANSFUS MED,LANGHANSSTR 7,D-35392 GIESSEN,GERMANY.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-44612] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASTER RH, 1989, PLATELET IMMUNOBIOLO, P387; BEER J, 1989, J BIOL CHEM, V264, P17564; BOGAERT T, 1987, CELL, V51, P929, DOI 10.1016/0092-8674(87)90580-0; BURK CD, 1991, J CLIN INVEST, V87, P270, DOI 10.1172/JCI114982; CALVETE JJ, 1991, BIOCHEM J, V274, P63, DOI 10.1042/bj2740063; DESIMONE DW, 1988, J BIOL CHEM, V263, P5333; FITZGERALD LA, 1987, J BIOL CHEM, V262, P3936; GOLDBERGER A, 1991, BLOOD, V78, P681; KALOMIRIS EL, 1985, BIOCHEMISTRY-US, V24, P5430, DOI 10.1021/bi00341a022; KEKOMAKI R, 1992, TRANSFUSION MED, V2, P27, DOI 10.1111/j.1365-3148.1992.tb00131.x; KEKOMAKI R, 1993, BRIT J HAEMATOL, V83, P306, DOI 10.1111/j.1365-2141.1993.tb08286.x; KIEFEL V, 1987, BLOOD, V70, P1722; KIEFEL V, 1991, BRIT J HAEMATOL, V79, P256, DOI 10.1111/j.1365-2141.1991.tb04530.x; KIEFEL V, 1990, LABORATORY METHODS I, P241; KIEFFER N, 1990, ANNU REV CELL BIOL, V6, P329; KOUNS WC, 1991, BLOOD, V78, P3215; KROLL H, 1990, BLOOD, V76, P2296; KUIJPERS RWAM, 1993, BLOOD, V81, P70; KUIJPERS RWAM, 1992, J CLIN INVEST, V89, P381, DOI 10.1172/JCI115596; LYMAN S, 1990, BLOOD, V75, P2343; MCEVER RP, 1982, BLOOD, V59, P80; MCFARLAND JG, 1991, BLOOD, V78, P2276; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mueller-Eckhardt C, 1990, Transfus Med Rev, V4, P98, DOI 10.1016/S0887-7963(90)70254-4; NEWMAN PJ, 1991, THROMB HAEMOSTASIS, V66, P111; NEWMAN PJ, 1991, P NATL ACAD SCI USA, V88, P3160, DOI 10.1073/pnas.88.8.3160; NEWMAN PJ, 1985, MOL IMMUNOL, V22, P719, DOI 10.1016/0161-5890(85)90103-8; NEWMAN PJ, 1989, J CLIN INVEST, V83, P1778, DOI 10.1172/JCI114082; NEWMAN PJ, 1985, BLOOD, V65, P227; NEWMAN PJ, 1988, J CLIN INVEST, V82, P739, DOI 10.1172/JCI113656; NIEWIAROWSKI S, 1989, BIOCHIM BIOPHYS ACTA, V983, P91, DOI 10.1016/0005-2736(89)90384-2; SANTOSO S, 1989, BRIT J HAEMATOL, V72, P191, DOI 10.1111/j.1365-2141.1989.tb07682.x; SANTOSO S, 1993, J CLIN INVEST, V92, P2427, DOI 10.1172/JCI116849; SMITH JW, 1993, J IMMUNOL METHODS, V158, P77, DOI 10.1016/0022-1759(93)90260-E; TSUJI T, 1986, J BIOCHEM-TOKYO, V100, P1387, DOI 10.1093/oxfordjournals.jbchem.a121845; WANG L, 1991, P JPN ACAD B-PHYS, V67, P102, DOI 10.2183/pjab.67.102; WANG RG, 1992, J CLIN INVEST, V90, P2038, DOI 10.1172/JCI116084; WANG RG, 1993, BLOOD, V82, P3386; ZIMRIN AB, 1990, J BIOL CHEM, V265, P8590	39	57	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8439	8444						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132570				2022-12-27	WOS:A1994NB40900091
J	TORRI, AF; KUNKEL, TA; ENGLUND, PT				TORRI, AF; KUNKEL, TA; ENGLUND, PT			A BETA-LIKE DNA-POLYMERASE FROM THE MITOCHONDRION OF THE TRYPANOSOMATID CRITHIDIA-FASCICULATA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETOPLAST DNA; DEOXYRIBONUCLEIC-ACID; CATALYTIC SUBUNIT; XENOPUS-LAEVIS; REPLICATION; GAMMA; PURIFICATION; MINICIRCLES; FIDELITY; SITES	The mitochondrial DNA in Crithidia fasciculata, a trypanosomatid parasite, is known as kinetoplast DNA. Kinetoplast DNA has a very unusual structure, consisting of several thousand minicircles and a few dozen maxicircles, all topologically interlocked into a giant network. There is one network within each cell's single mitochondrion. We previously purified a 43-kDa DNA polymerase from C. fasciculata mitochondria (Torri, A. F., and Englund, P. T. (1992) J. Biol. Chem. 267, 4786-4792). This enzyme has properties very different from those of a DNA polymerase gamma, the conventional mitochondrial polymerase. In addition to its small size, it is nonprocessive, has no detectable exonuclease activity, and has very low fidelity. In all of these respects, the polymerase resembles a DNA polymerase beta, a gap-filling enzyme thought to function in DNA repair in the nucleus of other eukaryotes. We speculate that this enzyme may have been specially imported into the C. fasciculata mitochondrion to repair the many gaps found in minicircles following their replication. This is the first example of a beta-like polymerase from the mitochondrion of any eukaryote.	NIEHS,MOLEC GENET LAB,RES TRIANGLE PK,NC 27709	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	TORRI, AF (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205, USA.		Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788	NIGMS NIH HHS [GM 13604, GM 27608] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027608, R01GM027608, F32GM013604] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNE R, 1990, TRENDS GENET, V6, P177, DOI 10.1016/0168-9525(90)90173-4; COSGROVE WB, 1970, J PROTOZOOL, V17, P172, DOI 10.1111/j.1550-7408.1970.tb02350.x; FERGUSON M, 1992, CELL, V70, P621, DOI 10.1016/0092-8674(92)90431-B; FOURY F, 1989, J BIOL CHEM, V264, P20552; INSDORF NF, 1989, J BIOL CHEM, V264, P21498; INSDORF NF, 1989, J BIOL CHEM, V264, P21491; KITCHIN PA, 1984, J BIOL CHEM, V259, P5532; Kornberg A., 1992, DNA REPLICATION; KUNKEL TA, 1985, J BIOL CHEM, V260, P5787; KUNKEL TA, 1988, J BIOL CHEM, V263, P4450; KUNKEL TA, 1992, J BIOL CHEM, V267, P18251; KUNKEL TA, 1989, BIOCHEMISTRY-US, V28, P988, DOI 10.1021/bi00429a011; MELENDY T, 1988, CELL, V55, P1083, DOI 10.1016/0092-8674(88)90252-8; PAPANICOLAOU C, 1986, J MOL BIOL, V189, P435, DOI 10.1016/0022-2836(86)90315-3; RAY DS, 1987, PLASMID, V17, P177, DOI 10.1016/0147-619X(87)90026-6; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; RYAN KA, 1988, ANNU REV MICROBIOL, V42, P339, DOI 10.1146/annurev.mi.42.100188.002011; Sambrook J, 1989, MOL CLONING LABORATO; SIMPSON L, 1990, SCIENCE, V250, P512, DOI 10.1126/science.1700474; SIMPSON L, 1987, ANNU REV MICROBIOL, V41, P363, DOI 10.1146/annurev.mi.41.100187.002051; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; STALKER DM, 1976, BIOCHEMISTRY-US, V15, P3114, DOI 10.1021/bi00659a027; STRAUSS P, 1993, FASEB J, V7, P1394; STUART K, 1992, INT REV CYTOL, V141, P65, DOI 10.1016/S0074-7696(08)62063-X; TORRI AF, 1992, J BIOL CHEM, V267, P4786; WERNETTE CM, 1986, J BIOL CHEM, V261, P4764; YAMAGUCHI M, 1980, NATURE, V285, P45, DOI 10.1038/285045a0; YAMAGUCHI M, 1980, J BIOL CHEM, V255, P7002	28	35	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8165	8171						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132542				2022-12-27	WOS:A1994NB40900053
J	LI, CY; WATKINS, JA; GLASS, J				LI, CY; WATKINS, JA; GLASS, J			THE H+-ATPASE FROM RETICULOCYTE ENDOSOMES RECONSTITUTED INTO LIPOSOMES ACTS AS AN IRON TRANSPORTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTIC VESICLES; ADENOSINE-TRIPHOSPHATASE; TRANSFERRIN; MEMBRANE; SUBUNIT; MOBILIZATION; BINDING; F1	The H+-ATPase from reticulocyte endosomes was purified and reconstituted into liposomes, and protein-dependent iron transport was observed. Reconstitution of the H+-ATPase into liposomes was performed by sonicating a lipid mixture, with a composition similar to the reticulocyte plasma membrane, in a buffer containing ferric citrate. The nonencapsulated iron:citrate was removed by gel filtration and the proteoliposomes diluted into 1 mM FerroZine. Upon addition of ascorbate, an initial efflux of 2.9 +/- 0.3 x 10(-2) mu mol of iron/mg of ATPase/min and 56 +/- 7% of total internal Fe(II) was detected by formation of the Fe(II)-FerroZine complex with an absorbance at 562 nm or radioactivity of Fe-59(II)-FerroZine following separation using gel filtration. Both thiosulfate and ferrocyanide could substitute for ascorbate. Citrate or EGTA could substitute for FerroZine. The initial rate of Fe(II) efflux was decreased by 41 or 17% using 100 mu M of the cation channel inhibitor N,N'-dicyclohexylcarbodiimide or 70 mu M of the ATP hydrolysis inhibitor N-ethylmaleimide, respectively, but was unaffected by the presence of ATP. The amount of iron transported was decreased 51 or 39% by 100 mu M N,N'-dicyclohexylcarbodiimide or 70 mu M of the ATPase inhibitor 7-chloro-4-nitrobenz-2-oxa-1,3-dazole. The amount of Fe(III) transport was 80% lower than Fe(II) when reductants were not present internally or externally although the apparent rate constants were identical when ascorbate was externally present. These results suggest that this vacuolar H+-ATPase may transport iron.	LOUISIANA STATE UNIV,CTR MED,CTR EXCELLENCE CANC RES TREATMENT & EDUC,DEPT MED,DIV HEMATOL ONCOL,SHREVEPORT,LA 71130	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK037866, R01DK037866] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-37866] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARAI H, 1987, BIOCHEMISTRY-US, V26, P6632, DOI 10.1021/bi00395a011; CHEN JW, 1984, BIOCHIM BIOPHYS ACTA, V777, P151, DOI 10.1016/0005-2736(84)90508-X; CHOE HR, 1987, BLOOD, V70, P1035; COWART RE, 1993, ANAL BIOCHEM, V211, P151, DOI 10.1006/abio.1993.1246; EGYED A, 1988, BRIT J HAEMATOL, V68, P483, DOI 10.1111/j.1365-2141.1988.tb04241.x; FENG Y, 1992, J BIOL CHEM, V267, P5817; HAMAZAKI S, 1992, EXP HEMATOL, V20, P436; HANADA H, 1991, BIOCHEM BIOPH RES CO, V176, P1062, DOI 10.1016/0006-291X(91)90391-J; INMAN RS, 1993, J BIOL CHEM, V268, P8521; KOHLBRENNER WE, 1982, J BIOL CHEM, V257, P3441; LI CY, 1993, FASEB J, V7, pA817; LI CY, 1993, BIOPHYS J, V64, pA335; LI CY, 1991, FASEB J, V5, pA749; LI CY, 1991, BLOOD, V78, pA87; LIPPE G, 1991, BIOCHEM BIOPH RES CO, V181, P764, DOI 10.1016/0006-291X(91)91256-C; MORGAN EH, 1988, BIOCHIM BIOPHYS ACTA, V943, P428, DOI 10.1016/0005-2736(88)90374-4; NUMA MS, 1991, EUR J CELL BIOL, V56, P19; NUNEZ MT, 1990, J BIOL CHEM, V265, P6688; SENIOR AE, 1980, J BIOL CHEM, V255, P7211; SIMPSON RJ, 1987, BIOCHIM BIOPHYS ACTA, V898, P187, DOI 10.1016/0005-2736(87)90037-X; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; SUUN SZ, 1987, J BIOL CHEM, V262, P14790; THORSTENSEN K, 1988, J BIOL CHEM, V263, P16837; WATKINS JA, 1992, BIOCHEMISTRY-US, V31, P5820, DOI 10.1021/bi00140a018; WHITE MD, 1976, BIOCHIM BIOPHYS ACTA, V436, P567, DOI 10.1016/0005-2736(76)90441-7	25	38	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 8	1994	269	14					10242	10246						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NF017	8144605				2022-12-27	WOS:A1994NF01700014
J	FORCE, WR; SPINDLER, SR				FORCE, WR; SPINDLER, SR			3,5,3'-L-TRIIODOTHYRONINE (THYROID HORMONE)-INDUCED PROTEIN-DNA INTERACTIONS IN THE THYROID-HORMONE RESPONSE ELEMENTS AND CELL-TYPE-SPECIFIC ELEMENTS OF THE RAT GROWTH-HORMONE GENE REVEALED BY IN-VIVO DIMETHYL SULFATE FOOTPRINTING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; LIGATION MEDIATED PCR; AUXILIARY PROTEIN; NUCLEAR PROTEINS; BINDING-SITES; T3 RECEPTOR; POU-DOMAIN; PROMOTER; PITUITARY; EXPRESSION	The cell type-specific element and 3,5,3'-L-triiodothyronine (thyroid hormone) (T3) response element of the rat growth hormone gene act synergistically to produce cell type-specific, T3-regulated expression. Pit-1 is a pituitary cell type-specific transcription factor that binds the cell type-specific element and is essential to its activity. T3 receptors bind as homodimers and heterodimers to the T3 response element and are essential for its activity. Here, we report the use of ligation-mediated polymerase chain reaction in vivo dimethyl sulfate footprinting to study the effects of T3 on protein-DNA interactions in the rat growth hormone gene promoter in vivo. T3-responsive guanine methylation was detected only in and near the T3 response element and the Pit-1 binding sites. The results indicate that within 2 h, T3 induces occupancy of the T3 response element and Pit-1 sites by their respective trans-acting factors in vivo.	UNIV CALIF RIVERSIDE,DEPT BIOCHEM,RIVERSIDE,CA 92521	University of California System; University of California Riverside					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040164] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK40164] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSSON ML, 1992, NUCLEIC ACIDS RES, V20, P4803, DOI 10.1093/nar/20.18.4803; BANCROFT FC, 1969, J CELL BIOL, V43, P432, DOI 10.1083/jcb.43.3.432; BANCROFT FC, 1970, IN VITRO CELL DEV B, V6, P180; BRENT GA, 1989, J BIOL CHEM, V264, P178; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; BRENT GA, 1988, MOL ENDOCRINOL, V2, P792, DOI 10.1210/mend-2-9-792; CASANOVA JN, 1985, J BIOL CHEM, V60, P11744; CATANZARO DF, 1987, MOL ENDOCRINOL, V1, P90, DOI 10.1210/mend-1-1-90; COPP RP, 1989, MOL ENDOCRINOL, V3, P790, DOI 10.1210/mend-3-5-790; CRENSHAW EB, 1989, GENE DEV, V3, P959, DOI 10.1101/gad.3.7.959; CREW MD, 1986, J BIOL CHEM, V261, P5018; DALMAN FC, 1990, J BIOL CHEM, V265, P3615; DARLING DS, 1991, MOL ENDOCRINOL, V5, P73, DOI 10.1210/mend-5-1-73; DAVIS KD, 1992, J BIOL CHEM, V267, P3185; EVANS RM, 1982, P NATL ACAD SCI-BIOL, V79, P7659, DOI 10.1073/pnas.79.24.7659; FERL RJ, 1987, J BIOL CHEM, V262, P7947; FORCE WR, 1994, J BIOL CHEM, V269, P8863; FORMAN BM, 1990, MOL ENDOCRINOL, V4, P1293, DOI 10.1210/mend-4-9-1293; GARCIAVILLALBA P, 1993, BIOCHEM BIOPH RES CO, V191, P580, DOI 10.1006/bbrc.1993.1257; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GUERIN SL, 1988, MOL ENDOCRINOL, V2, P1101, DOI 10.1210/mend-2-11-1101; HERMANN T, 1992, MOL ENDOCRINOL, V6, P1153, DOI 10.1210/me.6.7.1153; HROMAS R, 1988, NUCLEIC ACIDS RES, V19, P953; INGRAHAM HA, 1990, ANNU REV PHYSIOL, V52, P773; KAPILOFF MS, 1991, SCIENCE, V253, P786, DOI 10.1126/science.1652153; KIM HS, 1992, MOL ENDOCRINOL, V6, P1489, DOI 10.1210/me.6.9.1489; KING IN, 1993, J BIOL CHEM, V268, P495; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KOENIG RJ, 1987, P NATL ACAD SCI USA, V84, P5670, DOI 10.1073/pnas.84.16.5670; KOLCHINSKY AM, 1976, NUCLEIC ACIDS RES, V3, P11, DOI 10.1093/nar/3.1.11; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LIRA SA, 1993, MOL ENDOCRINOL, V7, P694, DOI 10.1210/me.7.5.694; MANGALAM HJ, 1989, GENE DEV, V3, P946, DOI 10.1101/gad.3.7.946; Maxam A M, 1980, Methods Enzymol, V65, P499; MCCORMICK A, 1990, NATURE, V345, P829, DOI 10.1038/345829a0; MIYAMOTO T, 1993, MOL ENDOCRINOL, V7, P224, DOI 10.1210/me.7.2.224; MUELLER PR, 1988, GENE DEV, V2, P412, DOI 10.1101/gad.2.4.412; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; MURRAY MB, 1989, MOL ENDOCRINOL, V3, P1434, DOI 10.1210/mend-3-9-1434; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; NELSON C, 1986, NATURE, V322, P557, DOI 10.1038/322557a0; NYBORG JK, 1986, J BIOL CHEM, V261, P5685; NYBORG JK, 1985, ENDOCRINOLOGY, V116, P2361, DOI 10.1210/endo-116-6-2361; PAN WT, 1990, J BIOL CHEM, V265, P7022; PFEIFER GP, 1989, SCIENCE, V246, P810, DOI 10.1126/science.2814502; RIBEIRO RC, 1992, MOL ENDOCRINOL, V6, P1142, DOI 10.1210/me.6.7.1142; SALUZ H, 1989, P NATL ACAD SCI USA, V86, P2602, DOI 10.1073/pnas.86.8.2602; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; SCHAUFELE F, 1990, J BIOL CHEM, V265, P17189; SCHAUFELE F, 1992, MOL ENDOCRINOL, V6, P656, DOI 10.1210/me.6.4.656; SCHAUFELE F, 1990, J BIOL CHEM, V265, P14592; SPINDLER SR, 1982, J BIOL CHEM, V257, P1627; STRAIT KA, 1992, MOL ENDOCRINOL, V6, P1874, DOI 10.1210/me.6.11.1874; TANSEY WP, 1993, J BIOL CHEM, V268, P14906; TASHJIAN AH, 1968, ENDOCRINOLOGY, V82, P342, DOI 10.1210/endo-82-2-342; TASHJIAN AH, 1972, 4TH P INT C END, P648; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; VOZ ML, 1992, MOL CELL BIOL, V12, P3991, DOI 10.1128/MCB.12.9.3991; WEST BL, 1987, MOL CELL BIOL, V7, P1193, DOI 10.1128/MCB.7.3.1193; WIGHT PA, 1988, MOL ENDOCRINOL, V2, P536, DOI 10.1210/mend-2-6-536; WILLIAMS GR, 1991, J BIOL CHEM, V266, P19636; YE ZS, 1988, J BIOL CHEM, V263, P7821; YE ZS, 1987, J BIOL CHEM, V262, P6313; YEN PM, 1992, J BIOL CHEM, V267, P23248; YEN PM, 1992, J BIOL CHEM, V267, P3656; YU LY, 1977, J BIOL CHEM, V252, P3870; ZHANG X, 1992, NATURE, V358, P581; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	69	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9682	9686						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144557				2022-12-27	WOS:A1994NE05300046
J	YANG, ZY; ENGEL, JD				YANG, ZY; ENGEL, JD			BIOCHEMICAL-CHARACTERIZATION OF THE DEVELOPMENTAL STAGE-SPECIFIC AND TISSUE-SPECIFIC ERYTHROID TRANSCRIPTION FACTOR, NF-E4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLOBIN GENE; NUCLEAR-PROTEIN FACTORS; DOMINANT CONTROL REGION; BINDING-PROTEIN; GEL-ELECTROPHORESIS; CELL LINES; PROMOTER; ENHANCER; EXPRESSION; ELEMENT	Analysis of the nuclear factors responsible for erythroid gene regulation has led to the cloning of several transcriptional regulatory proteins with clear lines of evidence suggesting or demonstrating their roles in tissue-specific gene expression. However, the erythroid cell lineage-restricted proteins that have been characterized to date do not differ significantly in activity during the distinct developmental stages of erythropoiesis, a characteristic that might be expected for a nuclear factor that actively participates in the differential regulation of various alpha- or beta-type globin genes (called globin gene switching) at distinct stages of embryonic development. We reported previously the identification of such a differentially expressed DNA binding activity, which appeared to be present in mature definitive (adult) erythroid cells but absent in immature definitive or primitive (embryonic) erythroid cells. Here we detail the biochemical properties of this erythroid tissue- and developmental stage-specific DNA binding activity (called nuclear factor-erythroid 4; NF-E4), which contains characteristics of a molecule that may be intimately involved in globin gene switching.	NORTHWESTERN UNIV, DEPT BIOCHEM MOLEC BIOL & CELL BIOL, EVANSTON, IL 60208 USA	Northwestern University					NHLBI NIH HHS [HL 24415] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024415] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKIYAMA Y, 1974, BIKEN J, V17, P105; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; ANTONIOU M, 1988, EMBO J, V7, P377, DOI 10.1002/j.1460-2075.1988.tb02824.x; BARTON MC, 1993, GENE DEV, V7, P1796, DOI 10.1101/gad.7.9.1796; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; BRIEGEL K, 1993, GENE DEV, V7, P1097, DOI 10.1101/gad.7.6.1097; BROWN JL, 1974, J BIOL CHEM, V249, P3960; BRUNS GAP, 1973, PHILOS T ROY SOC B, V266, P225, DOI 10.1098/rstb.1973.0050; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CATALA F, 1989, NUCLEIC ACIDS RES, V17, P3811, DOI 10.1093/nar/17.10.3811; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CHAVRIER P, 1990, EMBO J, V9, P1209, DOI 10.1002/j.1460-2075.1990.tb08228.x; CHOI OR, 1986, NATURE, V323, P731, DOI 10.1038/323731a0; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; CROSBY SD, 1991, MOL CELL BIOL, V11, P3835, DOI 10.1128/MCB.11.8.3835; DEBOER E, 1988, EMBO J, V7, P4203, DOI 10.1002/j.1460-2075.1988.tb03317.x; DOLAN M, 1981, CELL, V24, P669, DOI 10.1016/0092-8674(81)90093-3; DOLAN M, 1983, J BIOL CHEM, V258, P3983; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; EMERSON BM, 1989, CELL, V57, P1189, DOI 10.1016/0092-8674(89)90056-1; EMERSON BM, 1987, P NATL ACAD SCI USA, V84, P4786, DOI 10.1073/pnas.84.14.4786; EMERSON BM, 1985, CELL, V41, P21, DOI 10.1016/0092-8674(85)90057-1; EMERSON BM, 1984, P NATL ACAD SCI-BIOL, V81, P95, DOI 10.1073/pnas.81.1.95; ENGEL JD, 1991, SEMIN HEMATOL, V28, P158; FOLEY KP, 1992, GENE DEV, V6, P730, DOI 10.1101/gad.6.5.730; FORRESTER WC, 1987, NUCLEIC ACIDS RES, V15, P10159, DOI 10.1093/nar/15.24.10159; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GALLARDA JL, 1989, GENE DEV, V3, P1845, DOI 10.1101/gad.3.12a.1845; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; HARTZOG GA, 1993, MOL CELL BIOL, V13, P44, DOI 10.1128/MCB.13.1.44; HESSE JE, 1986, P NATL ACAD SCI USA, V83, P4312, DOI 10.1073/pnas.83.12.4312; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1989, P NATL ACAD SCI USA, V86, P1781, DOI 10.1073/pnas.86.6.1781; JENDRISAK J, 1987, METHOD ENZYMOL, V152, P359; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; LEONARD MW, 1993, DEVELOPMENT, V119, P519; LEWIS CD, 1988, GENE DEV, V2, P863, DOI 10.1101/gad.2.7.863; LICHTSTEINER S, 1989, CELL, V57, P1179, DOI 10.1016/0092-8674(89)90055-X; MANTOVANI R, 1988, NUCLEIC ACIDS RES, V16, P4299, DOI 10.1093/nar/16.10.4299; MILLER LJ, 1993, MOL CELL BIOL, V13, P2776; MOSCOVICI C, 1977, CELL, V11, P95, DOI 10.1016/0092-8674(77)90320-8; NEY PA, 1993, MOL CELL BIOL, V13, P5604, DOI 10.1128/MCB.13.9.5604; NICKOL JM, 1988, P NATL ACAD SCI USA, V85, P2548, DOI 10.1073/pnas.85.8.2548; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; PHILIPSEN S, 1990, EMBO J, V9, P2159, DOI 10.1002/j.1460-2075.1990.tb07385.x; PRUZINA S, 1991, NUCLEIC ACIDS RES, V19, P1413, DOI 10.1093/nar/19.7.1413; ROSENBERG UB, 1986, NATURE, V319, P336, DOI 10.1038/319336a0; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SIMON MC, 1992, NAT GENET, V1, P92, DOI 10.1038/ng0592-92; TALBOT D, 1990, EMBO J, V9, P2169, DOI 10.1002/j.1460-2075.1990.tb07386.x; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; XIAO JH, 1987, GENE DEV, V1, P794, DOI 10.1101/gad.1.8.794; YAMAMOTO M, 1985, P NATL ACAD SCI USA, V82, P3702, DOI 10.1073/pnas.82.11.3702; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; YANG ZY, 1991, JH S CONT M, P249	60	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10079	10087						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144507				2022-12-27	WOS:A1994NE05300102
J	FUJIMURA, K; TANAKA, K; NAKANO, A; TOHE, A				FUJIMURA, K; TANAKA, K; NAKANO, A; TOHE, A			THE SACCHAROMYCES-CEREVISIAE MSI4 GENE ENCODES THE YEAST COUNTERPART OF COMPONENT-A OF RAB GERANYLGERANYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; ACTIVATING PROTEIN; SMG P25A; ENDOPLASMIC-RETICULUM; MUTATIONAL ANALYSIS; NEGATIVE REGULATOR; ADENYLATE-CYCLASE; GOLGI-APPARATUS; YPT1 PROTEIN; CHOROIDEREMIA	We describe the isolation of MSI4 as a multicopy Suppressor of ira1 (inhibitory regulator of Ras). We find it encodes a 66-kDa protein with three regions similar to component A of Rab geranylgeranyltransferase and Rab guanine nucleotide dissociation inhibitor. A gene disruption experiment showed that MSI4 is essential for cell growth. To investigate its functions further, we constructed a strain whose MSI4 is driven by the GAL1 promoter. This strain accumulated the endoplasmic reticulum precursor form of a vacuolar enzyme, carboxypeptidase Y, under the restrictive conditions. Moreover, we showed that the activity of geranylgeranyl-transferase for Ypt1p was very low in the mutant shifted to glucose medium. We propose that the MSI4 gene product is a yeast counterpart of component A of Rab geranylgeranyltransferase that is essential for Ypt1p to localize on membranes.	UNIV TOKYO, FAC SCI, DEPT BIOL, BUNKYO KU, TOKYO 113, JAPAN	University of Tokyo			Nakano, Akihiko/A-6420-2016; Nakano, Akihiko/G-4942-2014; Nakano, Akihiko/C-6185-2009	Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X; Kamada, Konomi/0000-0002-2186-8728				ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; ARAKI S, 1990, J BIOL CHEM, V265, P13007; ARMSTRONG SA, 1993, J BIOL CHEM, V268, P12221; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BECKER J, 1991, EMBO J, V10, P785, DOI 10.1002/j.1460-2075.1991.tb08010.x; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; Cremers Frans P. M., 1992, Human Molecular Genetics, V1, P71, DOI 10.1093/hmg/1.2.71; FARNSWORTH CC, 1991, P NATL ACAD SCI USA, V88, P6196, DOI 10.1073/pnas.88.14.6196; FINEGOLD AA, 1991, P NATL ACAD SCI USA, V88, P4448, DOI 10.1073/pnas.88.10.4448; GALLWITZ D, 1983, NATURE, V306, P704, DOI 10.1038/306704a0; GIBBS JB, 1989, MICROBIOL REV, V53, P171, DOI 10.1128/MMBR.53.2.171-185.1989; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; JONES S, 1991, MOL CELL BIOL, V11, P2641, DOI 10.1128/MCB.11.5.2641; KOHL NE, 1991, J BIOL CHEM, V266, P18884; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; MARSHALL MS, 1989, EMBO J, V8, P1105, DOI 10.1002/j.1460-2075.1989.tb03480.x; MATSUI Y, 1990, MOL CELL BIOL, V10, P4116, DOI 10.1128/MCB.10.8.4116; MERRY DE, 1992, P NATL ACAD SCI USA, V89, P2135, DOI 10.1073/pnas.89.6.2135; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; NEWMAN AP, 1987, J CELL BIOL, V105, P1587, DOI 10.1083/jcb.105.4.1587; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; ROBINSON LC, 1987, SCIENCE, V235, P1218, DOI 10.1126/science.3547648; ROSSI G, 1991, NATURE, V351, P158, DOI 10.1038/351158a0; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; RUGGIERI R, 1989, P NATL ACAD SCI USA, V86, P8778, DOI 10.1073/pnas.86.22.8778; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; Sambrook J, 1989, MOL CLONING LABORATO; SASAKI T, 1990, J BIOL CHEM, V265, P2333; SCHMITT HD, 1988, CELL, V53, P635, DOI 10.1016/0092-8674(88)90579-X; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SHERMAN F, 1986, LABORATORY COURSE MA; SHIRAYAMA M, 1993, MOL GEN GENET, V240, P323, DOI 10.1007/BF00280382; SHIRAYAMA M, 1994, IN PRESS YEAST, V10; SIKORSKI RS, 1989, GENETICS, V122, P19; TANAKA K, 1991, P NATL ACAD SCI USA, V88, P468, DOI 10.1073/pnas.88.2.468; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; TANAKA K, 1989, MOL CELL BIOL, V9, P757, DOI 10.1128/MCB.9.2.757; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALDHERR M, 1993, NAT GENET, V3, P193, DOI 10.1038/ng0393-193; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; WICKERHAM LJ, 1946, J BACTERIOL, V52, P293, DOI 10.1128/JB.52.3.293-301.1946; WIESENBERGER G, 1992, J BIOL CHEM, V267, P6963	53	41	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9205	9212						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132658				2022-12-27	WOS:A1994NB41100086
J	HURLEY, MM; ABREU, C; GRONOWICZ, G; KAWAGUCHI, H; LORENZO, J				HURLEY, MM; ABREU, C; GRONOWICZ, G; KAWAGUCHI, H; LORENZO, J			EXPRESSION AND REGULATION OF BASIC FIBROBLAST GROWTH-FACTOR MESSENGER-RNA LEVELS IN MOUSE OSTEOBLASTIC MC3T3-E1 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPILLARY ENDOTHELIAL-CELLS; FACTOR GENE-EXPRESSION; MESSENGER-RNA; FACTOR-BETA; EXTRACELLULAR-MATRIX; ALKALINE-PHOSPHATASE; NUCLEOTIDE-SEQUENCE; COLLAGEN-SYNTHESIS; DNA-SYNTHESIS; BONE-CELLS	Basic fibroblast growth factor (bFGF) is a potent mitogen for bone cells and is a constituent of the bone matrix. We have found that osteoblastic MC3T3-E1 cells expressed bFGF mRNA transcript of 4.5 kilobases (kb). We examined factors that regulate the expression of bFGF mRNA and protein in MC3T3-E1 cells. Treatment of MC3T3-E1 cells with bFGF (10 nM) for 4-48 h induced another 7-kb bFGF transcript at 4 h. Treatment of MC3T3-E1 cells with TGF beta (10 ng/ml) also induced the 7-kb transcript of bFGF mRNA. In contrast, heparin, parathyroid hormone, and interleukin-1 had no effect on bFGF mRNA. Western blot analyses revealed that MC3T3-E1 cells produced a 24-kDa bFGF protein, which was increased by TGF beta. Immunofluorescence showed that bFGF protein was localized to the cytoplasm in serum deprived MC3T3-E1 cells. Treatment of these cultures with medium containing fetal calf serum or TGF beta caused increased cytoplasmic staining for bFGF and marked shape change. Furthermore, in the cells treated with TGF beta there was both nuclear and cytoplasmic staining for the protein. These data demonstrate that bFGF mRNA and protein are expressed in osteoblastic cells and are regulated by treatment with TGF beta and bFGF. Production of bFGF may be important as an autocrine and paracrine mediator of bone cell replication, differentiation, and function.	UNIV CONNECTICUT,CTR HLTH,DEPT ORTHOPED,FARMINGTON,CT 06030; NEWINGTON VET HOSP,DEPT MED,NEWINGTON,CT 06470	University of Connecticut	HURLEY, MM (corresponding author), UNIV CONNECTICUT,CTR HLTH,DEPT MED,DIV ENDOCRINOL & METAB,FARMINGTON,CT 06030, USA.			Gronowicz, Gloria/0000-0001-7158-3598	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042362, P01AR038933, R01AR042368] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-42362, AR-38933, AR-42368] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; ABRAHAM JA, 1986, EMBO J, V5, P2523, DOI 10.1002/j.1460-2075.1986.tb04530.x; AZIZKHAN JC, 1980, P NATL ACAD SCI-BIOL, V77, P2762, DOI 10.1073/pnas.77.5.2762; BALDIN V, 1990, EMBO J, V9, P1511, DOI 10.1002/j.1460-2075.1990.tb08269.x; BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047; BOUCHE G, 1987, P NATL ACAD SCI USA, V84, P6770, DOI 10.1073/pnas.84.19.6770; BUGLER B, 1991, MOL CELL BIOL, V11, P573, DOI 10.1128/MCB.11.1.573; CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3987; GLOBUS RK, 1989, ENDOCRINOLOGY, V124, P1539, DOI 10.1210/endo-124-3-1539; GLOBUS RK, 1988, ENDOCRINOLOGY, V123, P98, DOI 10.1210/endo-123-1-98; GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95, DOI 10.1210/edrv-8-2-95; Gospodarowicz D, 1990, CLIN ORTHOP RELAT R, V257, P231; HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665; Hill DJ, 1992, GROWTH FACTORS, V6, P277, DOI 10.3109/08977199209021540; HIRAKI Y, 1988, AIOCH BIOPHYS AC, V966, P91; HORTON WE, 1989, J CELL PHYSIOL, V141, P8, DOI 10.1002/jcp.1041410103; HURLEY MM, 1993, J BIOL CHEM, V268, P5588; HURLEY MM, 1992, ENDOCRINOLOGY, V130, P2675, DOI 10.1210/en.130.5.2675; IBBOTSON KJ, 1989, J BONE MINER RES, V4, P37; INOUE H, 1989, J CELL PHYSIOL, V138, P329, DOI 10.1002/jcp.1041380216; KANDEL J, 1991, CELL, V66, P1095, DOI 10.1016/0092-8674(91)90033-U; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; KUROKAWA T, 1987, FEBS LETT, V213, P189, DOI 10.1016/0014-5793(87)81489-8; LOGAN A, 1990, J ENDOCRINOL, V125, P339, DOI 10.1677/joe.0.1250339; MCCARTHY TL, 1989, ENDOCRINOLOGY, V125, P2118, DOI 10.1210/endo-125-4-2118; MIGNATTI P, 1991, J CELL BIOCHEM, V47, P201, DOI 10.1002/jcb.240470303; MOENNER M, 1986, P NATL ACAD SCI USA, V83, P5024, DOI 10.1073/pnas.83.14.5024; MORRISON R, 1981, J BIOL CHEM, V266, P728; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; MURPHY PR, 1988, MOL ENDOCRINOL, V2, P591, DOI 10.1210/mend-2-7-591; NODA M, 1989, J CELL BIOL, V109, P2529, DOI 10.1083/jcb.109.5.2529; NUGENT MA, 1992, J BIOL CHEM, V267, P21256; PLOUET J, 1989, J CELL PHYSIOL, V141, P392, DOI 10.1002/jcp.1041410221; QUARTO N, 1991, J CELL PHYSIOL, V147, P311, DOI 10.1002/jcp.1041470217; RENKO M, 1990, J CELL PHYSIOL, V144, P108, DOI 10.1002/jcp.1041440114; RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1; RODAN SB, 1989, J BIOL CHEM, V264, P19934; SAKSELA O, 1990, J CELL BIOL, V110, P767, DOI 10.1083/jcb.110.3.767; SANDBERG M, 1988, DEV BIOL, V130, P324, DOI 10.1016/0012-1606(88)90438-1; SASADA R, 1988, MOL CELL BIOL, V8, P588, DOI 10.1128/MCB.8.2.588; SATO Y, 1988, J CELL BIOL, V107, P1199, DOI 10.1083/jcb.107.3.1199; SEYEDIN SM, 1985, P NATL ACAD SCI USA, V82, P2267, DOI 10.1073/pnas.82.8.2267; SHEN V, 1989, BONE MINER, V7, P205, DOI 10.1016/0169-6009(89)90078-0; SHIMASAKI S, 1988, BIOCHEM BIOPH RES CO, V157, P256, DOI 10.1016/S0006-291X(88)80041-X; SHING Y, 1984, SCIENCE, V223, P1926; STERNFELD MD, 1988, J CELL PHYSIOL, V136, P297, DOI 10.1002/jcp.1041360212; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; WEEKS DL, 1989, CELL, V1, P861; WEICH HA, 1991, J CELL BIOCHEM, V47, P158, DOI 10.1002/jcb.240470209	51	104	105	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9392	9396						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132679				2022-12-27	WOS:A1994NB41100112
J	BARTELS, F; BERGEL, H; BIGALKE, H; FREVERT, J; HALPERN, J; MIDDLEBROOK, J				BARTELS, F; BERGEL, H; BIGALKE, H; FREVERT, J; HALPERN, J; MIDDLEBROOK, J			SPECIFIC ANTIBODIES AGAINST THE ZN2+-BINDING DOMAIN OF CLOSTRIDIAL NEUROTOXINS RESTORE EXOCYTOSIS IN CHROMAFFIN CELLS TREATED WITH TETANUS OR BOTULINUM A NEUROTOXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIC-STRENGTH SOLUTION; LIGHT CHAIN; NEUROTRANSMITTER RELEASE; INHIBITS EXOCYTOSIS; TOXIN; PROTEINS; GANGLIOSIDES; ZINC	Although tetanus and botulinum A neurotoxins are ineffective in cultured chromaffin cells, they will inhibit carbachol-induced release of noradrenaline provided they gain access to the cytosol either through artificial pores generated in the plasma membrane or by binding to incorporated exogenous gangliosides. The block of exocytosis persists for weeks followed by a slow recovery of cell function. When specific anti-botulinum A toxin antibodies are introduced into cells through pores after manifestation of the block by botulinum A neurotoxin, restoration of exocytotic function is accelerated and fully reestablished within 4 days. The same time course of restoration is seen with anti-tetanus toxin antibodies in cells poisoned by tetanus toxin. Since the light chains of the toxins are enzymatically active, we have introduced polyclonal and monoclonal anti-light chain antibodies into the cytosol. Of all light chain antibodies tested, only those directed against the peptide homologous to the zinc-binding sequence, which is present in both neurotoxins, restored exocytosis regardless of which toxin caused the block. These results indicate that the zinc-binding domain is directly involved in the interaction of the light chains with their substrates and that the toxins have to be present continuously to maintain the block.	MED SCH HANNOVER,INST TOXICOL,D-30625 HANNOVER,GERMANY; PHARMATEC,D-60486 FRANKFURT,GERMANY; US FDA,PUBL HLTH SERV,BETHESDA,MD 20892; USA,MED RES INST INFECT DIS,DIV TOXICOL,FREDERICK,MD 21701	Hannover Medical School; United States Public Health Service; US Food & Drug Administration (FDA)								AHNERTHILGER G, 1989, FEBS LETT, V242, P245, DOI 10.1016/0014-5793(89)80478-8; AHNERTHILGER G, 1989, J NEUROCHEM, V52, P1751, DOI 10.1111/j.1471-4159.1989.tb07253.x; ALDERSON K, 1991, NEUROLOGY, V41, P1800, DOI 10.1212/WNL.41.11.1800; AMBACHE N, 1948, NATURE, V161, P482, DOI 10.1038/161482b0; BARTELS F, 1992, INFECT IMMUN, V60, P302, DOI 10.1128/IAI.60.1.302-307.1992; BERGEY GK, 1987, J NEUROPHYSIOL, V57, P121, DOI 10.1152/jn.1987.57.1.121; BITTNER MA, 1989, J BIOL CHEM, V264, P10354; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; CURTIS D R, 1968, Brain Research, V10, P208, DOI 10.1016/0006-8993(68)90123-6; DASGUPTA BR, 1984, TOXICON, V22, P415, DOI 10.1016/0041-0101(84)90085-0; DUCHEN LW, 1968, Q J EXP PHYSIOL CMS, V53, P84, DOI 10.1113/expphysiol.1968.sp001948; HABERMANN E, 1988, J NEUROCHEM, V51, P522, DOI 10.1111/j.1471-4159.1988.tb01069.x; HABIG WH, 1986, J NEUROCHEM, V47, P930; JAHN R, 1993, J NEUROCHEM, V61, P12, DOI 10.1111/j.1471-4159.1993.tb03533.x; KENIMER JG, 1983, INFECT IMMUN, V42, P942, DOI 10.1128/IAI.42.3.942-948.1983; KOSAKI S, 1981, JPN J MED SCI BIOL, V34, P61; LAMBERT H, 1990, BIOCHEM CELL BIOL, V68, P729, DOI 10.1139/o90-105; LINK E, 1992, BIOCHEM BIOPH RES CO, V189, P1017, DOI 10.1016/0006-291X(92)92305-H; LIVETT BG, 1984, PHYSIOL REV, V64, P1103, DOI 10.1152/physrev.1984.64.4.1103; MARXEN P, 1990, TOXICON, V28, P1077, DOI 10.1016/0041-0101(90)90146-X; MARXEN P, 1989, TOXICON, V27, P849, DOI 10.1016/0041-0101(89)90097-4; MARXEN P, 1991, TOXICON, V29, P181, DOI 10.1016/0041-0101(91)90102-W; MARXEN P, 1989, NEUROSCI LETT, V107, P261, DOI 10.1016/0304-3940(89)90828-8; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; OLSEN KM, 1987, CLIN PHARMACY, V6, P570; PENNER R, 1986, NATURE, V324, P76, DOI 10.1038/324076a0; PESTRONK A, 1978, SCIENCE, V199, P1223, DOI 10.1126/science.204007; SANDERS D, 1992, N-S ARCH PHARMACOL, V346, P358; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1992, EMBO J, V11, P3577, DOI 10.1002/j.1460-2075.1992.tb05441.x; SCHIAVO G, 1992, J BIOL CHEM, V267, P23479; SPAUN J, 1970, B WORLD HEALTH ORGAN, V42, P523; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; WRIGHT JF, 1992, J BIOL CHEM, V267, P9053	34	42	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8122	8127						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132537				2022-12-27	WOS:A1994NB40900046
J	DAHNKE, T; TSAI, MD				DAHNKE, T; TSAI, MD			MECHANISM OF ADENYLATE KINASE - THE CONSERVED ASPARTATE-140 AND ASPARTATE-141 ARE IMPORTANT FOR TRANSITION-STATE STABILIZATION INSTEAD OF SUBSTRATE-INDUCED CONFORMATIONAL-CHANGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; X-RAY; SITE; PHOSPHOLIPASE-A2; CATALYSIS; PROTEINS; NMR	The goal of this work is to evaluate the quantitative contribution of Asp-140 and Asp-141 to conformational (changes and/or substrate stabilization in the catalysis by chicken muscle adenylate kinase (AK), by use of kinetic and structural analysis of the single alanine mutants D140A and D141A as well as the salt bridge double mutants R138M,D140A and R132M,D14A. The single mutants D140A and D141A displayed small increases in K-m (6-12-fold) and moderate decreases in k(cat) (17-78-fold). Kinetic analysis with the slowly reacting substrate system MgATP and dAMP suggested that the decrease in k(cat) is not caused by a decrease in the conformational step(s) relative to the chemical step. Most of the kinetic constants of the double mutants R138M,D140A and R132M,D141A are similar to those of the single mutants R138M and R132M, respectively. Detailed analysis by two-dimensional NMR indicated no appreciable changes in the conformations of the free enzyme or the complex with MgAP(5)A (where AP(5)A is P-1,P-5-bis(5'-adenosyl)pentaphosphate), for both single and double mutants. These results taken together suggest that Asp-140 and Asp-141 are unimportant for substrate-induced conformational changes in AK; their roles are mainly to assist Arg-138 and Arg-132 in stabilizing the transition state. The structural results also suggest that AK is a flexible enzyme.	OHIO STATE UNIV,DEPT CHEM,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT BIOCHEM,COLUMBUS,OH 43210	Ohio State University; Ohio State University			Tsai, Ming-Daw/G-4689-2019	Tsai, Ming-Daw/0000-0003-1374-0414	NCRR NIH HHS [RR01458] Funding Source: Medline; NIGMS NIH HHS [GM43268] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043268] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BODENHAUSEN G, 1984, J MAGN RESON, V58, P370, DOI 10.1016/0022-2364(84)90142-2; BYEON IJL, 1993, BIOCHEMISTRY-US, V32, P12508, DOI 10.1021/bi00097a031; CLELAND WW, 1986, INVESTIGATION RATE 1, V1, P791; DAHNKE T, 1992, BIOCHEMISTRY-US, V31, P3818; DREUSICKE D, 1988, J MOL BIOL, V199, P359, DOI 10.1016/0022-2836(88)90319-1; DUPUREUR CM, 1992, BIOCHEMISTRY-US, V31, P6402, DOI 10.1021/bi00143a007; DUPUREUR CM, 1992, J AM CHEM SOC, V114, P2748, DOI 10.1021/ja00033a076; DUTILH CE, 1975, EUR J BIOCHEM, V53, P91, DOI 10.1111/j.1432-1033.1975.tb04045.x; HAASE GHW, 1989, J MOL BIOL, V207, P151, DOI 10.1016/0022-2836(89)90446-4; KISHI F, 1986, J BIOL CHEM, V261, P2942; LI YS, 1993, J AM CHEM SOC, V115, P8523, DOI 10.1021/ja00072a001; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; Pace C N, 1986, Methods Enzymol, V131, P266; PACE CN, 1990, TRENDS BIOCHEM SCI, V15, P14, DOI 10.1016/0968-0004(90)90124-T; RHOADS DG, 1968, J BIOL CHEM, V243, P3963; SANDERS CR, 1989, BIOCHEMISTRY-US, V28, P9028, DOI 10.1021/bi00449a011; SCHULZ GE, 1987, COLD SPRING HARB SYM, V52, P429, DOI 10.1101/SQB.1987.052.01.050; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; SHI ZT, 1993, BIOCHEMISTRY-US, V32, P6450, DOI 10.1021/bi00076a019; TANIZAWA Y, 1987, J BIOCHEM-TOKYO, V101, P1289, DOI 10.1093/oxfordjournals.jbchem.a121993; TIAN G, 1990, BIOCHEMISTRY-US, V29, P4296, DOI 10.1021/bi00470a006; TIAN G, 1988, BIOCHEMISTRY-US, V27, P5544, DOI 10.1021/bi00415a024; TSAI MD, 1991, BIOCHEMISTRY-US, V30, P6806, DOI 10.1021/bi00242a002; YAN HG, 1990, BIOCHEMISTRY-US, V29, P6385, DOI 10.1021/bi00479a007; YAN HG, 1990, BIOCHEMISTRY-US, V29, P10956, DOI 10.1021/bi00501a013	26	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8075	8081						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132532				2022-12-27	WOS:A1994NB40900040
J	MORELL, MK; PAUL, K; OSHEA, NJ; KANE, HJ; ANDREWS, TJ				MORELL, MK; PAUL, K; OSHEA, NJ; KANE, HJ; ANDREWS, TJ			MUTATIONS OF AN ACTIVE-SITE THREONYL RESIDUE PROMOTE BETA-ELIMINATION AND OTHER SIDE REACTIONS OF THE ENEDIOL INTERMEDIATE OF THE RIBULOSEBISPHOSPHATE CARBOXYLASE REACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; BISPHOSPHATE CARBOXYLASE; TRIOSEPHOSPHATE ISOMERASE; SLOW INACTIVATION; ESCHERICHIA-COLI; XYLULOSE 1,5-BISPHOSPHATE; FUNCTIONAL-ROLE; CATALYTIC SITE; LARGE SUBUNIT	The side chain of residue threonine 65 within the active site of ribulosebisphosphate carboxylase participates in a network of hydrogen bonds and ionic interactions involving the phosphate moiety attached to C-1 of the substrate. This residue was replaced with serine, alanine, and valine in the enzyme from Synechococcus PCC 6301. The mutant enzymes were stable, expressed abundantly by Escherichia coli, and retained the ability to form gel-filterable complexes with the reaction-intermediate analog, 2'-carboxyarabinitol-1,5-bisphosphate. The substitutions reduced the K-cat/K-m(CO2) (where K-cat is the substrate-saturated turnover rate) of the enzyme from 17- to 340-fold with the more radical substitutions causing more severe reductions. The CO2/O-2 specificity also deteriorated progressively, the valine replacement causing a 2.3 fold reduction. In concert with these changes, a compound tentatively identified as 1-deoxy-D-glycero-2,3-pentodiulose-5-phosphate, the product of beta elimination of the 2,3-enediol(ate) intermediate of the catalytic reaction, appeared among the reaction products in progressively increasing amounts. In the case of the valine substitution, it comprised 13% of the ribulose bisphosphate consumed. The mutant enzymes also partitioned more of their reaction flux to pentulose bisphosphate isomers of ribulose bisphosphate. By contrast, the diversion of carboxylated product to pyruvate, as a result of beta elimination of the three-carbon aci-carbanion intermediate of the carboxylation reaction, was ameliorated by the replacements, the valine mutant showing a 5-fold improvement in this parameter. These observations focus attention on a geometric conflict which exists between the requirements for stabilization of the 5-carbon enediol(ate) and 3-carbon aci-carbanion intermediates. This conflict must be resolved by a change in the angle of the C-1/bridge oxygen bond during each catalytic cycle. The network of hydrogen bonds involving the side chain of threonine 65 must play a crucial role in facilitating reaction of the enediol(ate) with the gaseous substrate and in shepherding this subsequent movement.	AUSTRALIAN NATL UNIV,SCH BIOL SCI,PLANT ENVIRONM BIOL GRP,CANBERRA,ACT 2601,AUSTRALIA	Australian National University			Morell, Matthew/AAQ-5368-2021	Morell, Matthew/0000-0003-4467-1626				ANDRES J, 1992, CHEM PHYS LETT, V198, P515, DOI 10.1016/0009-2614(92)80037-C; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; ANDREWS TJ, 1991, J BIOL CHEM, V266, P9447; ANDREWS TJ, 1973, BIOCHEMISTRY-US, V12, P11, DOI 10.1021/bi00725a003; ANDREWS TJ, 1988, J BIOL CHEM, V263, P12213; BOWES G, 1971, BIOCHEM BIOPH RES CO, V45, P716, DOI 10.1016/0006-291X(71)90475-X; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CLELAND WW, 1990, BIOCHEMISTRY-US, V29, P3194, DOI 10.1021/bi00465a006; Collatz GJ, 1979, CARNEGIE I WASH YR B, V78, P171; EDMONDSON DL, 1990, PLANT PHYSIOL, V93, P1383, DOI 10.1104/pp.93.4.1383; EDMONDSON DL, 1990, FEBS LETT, V260, P62, DOI 10.1016/0014-5793(90)80066-R; EDMONDSON DL, 1990, PLANT PHYSIOL, V93, P1376, DOI 10.1104/pp.93.4.1376; EDMONDSON DL, 1990, PLANT PHYSIOL, V93, P1390, DOI 10.1104/pp.93.4.1390; GATENBY AA, 1985, NATURE, V314, P617, DOI 10.1038/314617a0; GIERSCH C, 1980, ARCH BIOCHEM BIOPHYS, V205, P246, DOI 10.1016/0003-9861(80)90105-8; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GUTTERIDGE S, 1990, BIOCHIM BIOPHYS ACTA, V1015, P1, DOI 10.1016/0005-2728(90)90210-U; GUTTERIDGE S, 1993, J BIOL CHEM, V268, P7818; GUTTERIDGE S, 1991, J BIOL CHEM, V266, P7359; HARPEL MR, 1993, ANAL BIOCHEM, V209, P367, DOI 10.1006/abio.1993.1136; HARTMAN FC, 1993, ADV ENZYMOL RAMB, V67, P1; Horecker B. L., 1958, BIOCHEM PREP, V6, P83; Isbell H. S., 1973, ADV CHEM SER, V117, P70; IYENGAR R, 1981, BIOCHEMISTRY-US, V20, P1229, DOI 10.1021/bi00508a027; JAWOROWSKI A, 1984, J BIOL CHEM, V259, P6783; JORDAN DB, 1984, PLANTA, V161, P308, DOI 10.1007/BF00398720; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; LEE BG, 1991, ARCH BIOCHEM BIOPHYS, V291, P263, DOI 10.1016/0003-9861(91)90133-4; LORIMER GH, 1973, NATURE, V243, P359, DOI 10.1038/243359a0; LORIMER GH, 1989, J BIOL CHEM, V264, P9873; LORIMER GH, 1993, BIOCHEMISTRY-US, V32, P9018, DOI 10.1021/bi00086a006; MCCURRY SD, 1977, J BIOL CHEM, V252, P8344; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; MIZIORKO HM, 1979, J BIOL CHEM, V254, P270; MIZIORKO HM, 1987, PROGR PHOTOSYNTHESIS, V3, P403; MORELL MK, 1992, ARCH BIOCHEM BIOPHYS, V299, P295, DOI 10.1016/0003-9861(92)90278-5; NEWMAN J, 1990, J BIOL CHEM, V265, P15154; PAECH C, 1978, BIOCHEM BIOPH RES CO, V83, P1084, DOI 10.1016/0006-291X(78)91506-1; PAUL K, 1991, BIOCHEMISTRY-US, V30, P10019, DOI 10.1021/bi00105a029; PIERCE J, 1986, J BIOL CHEM, V261, P248; POMPLIANO DL, 1990, BIOCHEMISTRY-US, V29, P3186, DOI 10.1021/bi00465a005; RICHARD JP, 1985, BIOCHEMISTRY-US, V24, P949, DOI 10.1021/bi00325a021; ROBINSON SP, 1989, PLANT PHYSIOL, V90, P968, DOI 10.1104/pp.90.3.968; ROSE IA, 1981, PHILOS T ROY SOC B, V293, P131, DOI 10.1098/rstb.1981.0067; Sambrook J, 1989, MOL CLONING LABORATO; SCHLOSS JV, 1990, P NATO ASI ENZYMATIC, P321; SCHNEIDER G, 1990, EMBO J, V9, P2045, DOI 10.1002/j.1460-2075.1990.tb07371.x; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8764; ZHU GH, 1991, PLANT PHYSIOL, V97, P1354, DOI 10.1104/pp.97.4.1354; ZHU GH, 1991, PLANT PHYSIOL, V97, P1348, DOI 10.1104/pp.97.4.1348	50	39	39	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					8091	8098						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132534				2022-12-27	WOS:A1994NB40900042
J	STOLE, E; BRYANT, FR				STOLE, E; BRYANT, FR			INTRODUCTION OF A TRYPTOPHAN REPORTER GROUP INTO LOOP-1 OF THE RECA PROTEIN - EXAMINATION OF THE CONFORMATIONAL STATES OF THE RECA-SSDNA COMPLEX BY FLUORESCENCE SPECTROSCOPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; PROMOTED ATP HYDROLYSIS; ESCHERICHIA-COLI; ADP; ISOMERIZATION; INHIBITION	Site-directed mutagenesis was used to replace His-163 in the Loop 1 region of the recA protein with a tryptophan residue. The [H163W]recA protein binds single-stranded DNA (ssDNA), catalyzes ssDNA-dependent ATP hydrolysis, and is fully active in the three-strand exchange reaction. In addition, the fluorescence properties of the Trp-163 reporter group are very sensitive to the binding of nucleotide cofactors to the [H163W]recA-ssDNA complex. The fluorescence of Trp-163 is modestly quenched by the binding of ADP (21%) and strongly quenched by the nonhydrolyzable ATP analog, ATP gamma S (70%); since ADP and ATP gamma S stabilize the closed and open conformations of the recA-ssDNA complex, respectively, the quenched states observed with these nucleotides likely reflect differences in the fluorescence properties of tryptophan 163 in these two states. ATP has a more complex time dependent effect on Trp-163 fluorescence. When ATP is added to [H163W]recA-ssDNA complexes, there is an immediate quenching of Trp-163 fluorescence (44%) which is intermediate in intensity between that observed with ADP and ATP gamma S. The ATP-induced quenching gradually decreases with time as the pool of ATP is converted to ADP by the ATP hydrolysis activity of the [H163W]recA protein. These results are discussed with regard to the nucleotide cofactor-dependent conformational transitions of the recA-ssDNA complex.	JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT BIOCHEM,BALTIMORE,MD 21205	Johns Hopkins University					NCI NIH HHS [CA 09110] Funding Source: Medline; NIGMS NIH HHS [GM 36516] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036516] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; BRENNER SL, 1988, J MOL BIOL, V204, P959, DOI 10.1016/0022-2836(88)90055-1; BRYANT FR, 1988, J BIOL CHEM, V263, P8716; BRYANT FR, 1986, J BIOL CHEM, V261, P2988; COTTERILL SM, 1982, BIOCHEMISTRY-US, V21, P4332, DOI 10.1021/bi00261a023; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; COX MM, 1983, J BIOL CHEM, V258, P2586; EGELMAN EH, 1993, CURR OPIN STRUC BIOL, V3, P189, DOI 10.1016/S0959-440X(05)80151-4; ELLEDGE SJ, 1987, MOL CELL BIOL, V7, P2783, DOI 10.1128/MCB.7.8.2783; GRIFFITH JD, 1988, CRC CRIT REV BIOC S1, V23, P43; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LEE JW, 1990, BIOCHEMISTRY-US, V29, P7677, DOI 10.1021/bi00485a017; LEE JW, 1990, BIOCHEMISTRY-US, V29, P7666, DOI 10.1021/bi00485a016; MEAH YS, 1993, J BIOL CHEM, V268, P23991; MENGE KL, 1988, BIOCHEMISTRY-US, V27, P2635, DOI 10.1021/bi00407a055; MENGE KL, 1992, BIOCHEMISTRY-US, V31, P5151, DOI 10.1021/bi00137a009; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MUENCH KA, 1991, J BIOL CHEM, V266, P844; MUENCH KA, 1990, J BIOL CHEM, V265, P11560; PINSINCE JM, 1993, J MOL BIOL, V233, P59, DOI 10.1006/jmbi.1993.1484; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; WEINSTOCK GM, 1979, P NATL ACAD SCI USA, V76, P126, DOI 10.1073/pnas.76.1.126	26	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	1994	269	11					7919	7925						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB409	8132511				2022-12-27	WOS:A1994NB40900017
J	HEI, YJ; PELECH, SL; CHEN, XS; DIAMOND, J; MCNEILL, JH				HEI, YJ; PELECH, SL; CHEN, XS; DIAMOND, J; MCNEILL, JH			PURIFICATION AND CHARACTERIZATION OF A NOVEL RIBOSOMAL S6 KINASE FROM SKELETAL-MUSCLE OF INSULIN-TREATED RATS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; NERVE GROWTH-FACTOR; SEA STAR OOCYTES; 3T3 CELLS; PHOSPHORYLATION SITES; XENOPUS OOCYTES; MAP KINASES; MITOGEN; IDENTIFICATION; RAPAMYCIN	The predominant 40 S ribosomal protein S6 kinase in skeletal muscle extracts from insulin-treated rats was purified over 10,000-fold to near homogeneity with similar to 4.5% recovery of starting activity. This S6 kinase was resolved from the catalytic subunit of cAMP-dependent protein kinase only by the seventh and final column chromatography step. The purified S6 kinase migrated as a tight doublet of similar to 31 kDa on an SDS-polyacrylamide gel, and it was eluted from gel filtration columns with a similar apparent M(r), which indicated that the enzyme exists as a monomer. This S6 kinase was immunologically distinct from the other known insulin-activated S6 kinases, i.e. p70(S6K) and p90(rsk). It was inhibited by [ethylenebis(oxyethylenenitrilo)]tetraacetic acid and beta-glycerophosphate at concentrations routinely used to stabilize p70(S6K) and p90(rsk). In addition to S6, phosvitin was also a substrate, whereas myelin basic protein, casein, protamine, and histones were poorly phosphorylated if at all by the purified S6 kinase. The purified enzyme was inactivated upon incubation with serine/threonine-specific protein phosphatase 2A, which indicated that it may be an intermediary component in a cascade of insulin-activated protein kinases.	UNIV BRITISH COLUMBIA,FAC PHARMACEUT SCI,DIV PHARMACOL & TOXICOL,VANCOUVER V6T 1Z3,BC,CANADA; UNIV BRITISH COLUMBIA,FAC MED,DEPT MED,BIOMED RES CTR,VANCOUVER V6T 1Z3,BC,CANADA; KINETEK BIOTECHNOL CORP,VANCOUVER V5Z 1A1,BC,CANADA	University of British Columbia; University of British Columbia								ALCORTA DA, 1989, MOL CELL BIOL, V9, P3850, DOI 10.1128/MCB.9.9.3850; BALLOU LM, 1988, J BIOL CHEM, V263, P1188; BALLOU LM, 1988, P NATL ACAD SCI USA, V85, P7154, DOI 10.1073/pnas.85.19.7154; BANERJEE P, 1990, P NATL ACAD SCI USA, V87, P8550, DOI 10.1073/pnas.87.21.8550; BLENIS J, 1991, CANCER CELL-MON REV, V3, P445; BRANDON SD, 1991, J BIOL CHEM, V266, P380; CALVO V, 1992, P NATL ACAD SCI USA, V89, P7571, DOI 10.1073/pnas.89.16.7571; CHEN RH, 1991, MOL CELL BIOL, V11, P1861, DOI 10.1128/MCB.11.4.1861; CHUNG J, 1991, P NATL ACAD SCI USA, V88, P4981, DOI 10.1073/pnas.88.11.4981; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; CICIRELLI MF, 1988, FEBS LETT, V241, P195, DOI 10.1016/0014-5793(88)81060-3; CICIRELLI MF, 1988, J BIOL CHEM, V263, P2009; COBB MH, 1986, J BIOL CHEM, V261, P2994; DAHMUS ME, 1981, J BIOL CHEM, V256, P3319; DELGRANDE RW, 1982, EUR J BIOCHEM, V123, P421; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DUVERNAY VH, 1978, BIOCHEMISTRY-US, V17, P2045, DOI 10.1021/bi00604a003; ERIKSON E, 1986, J BIOL CHEM, V261, P350; ERIKSON E, 1991, J BIOL CHEM, V266, P5249; ERIKSON RL, 1991, J BIOL CHEM, V266, P6007; FERRARI S, 1992, P NATL ACAD SCI USA, V89, P7282, DOI 10.1073/pnas.89.15.7282; FLOTOW H, 1991, J BIOL CHEM, V266, P3724; GREGORY JS, 1989, J BIOL CHEM, V264, P18397; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; HANSSON A, 1985, EUR J BIOCHEM, V151, P97, DOI 10.1111/j.1432-1033.1985.tb09073.x; HECHT LB, 1988, BIOCHEM BIOPH RES CO, V152, P1200, DOI 10.1016/S0006-291X(88)80412-1; HEI YJ, 1993, J BIOL CHEM, V268, P13203; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; JENO P, 1989, J BIOL CHEM, V264, P1293; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; KOZMA SC, 1989, EMBO J, V8, P4125, DOI 10.1002/j.1460-2075.1989.tb08597.x; KOZMA SC, 1990, P NATL ACAD SCI USA, V87, P7365, DOI 10.1073/pnas.87.19.7365; KOZMA SC, 1992, REV PHYSIOL BIOCH P, V119, P123; KRIEG J, 1988, J BIOL CHEM, V263, P11473; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE HA, 1992, EMBO J, V11, P1743, DOI 10.1002/j.1460-2075.1992.tb05226.x; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LAVOINNE A, 1991, EUR J BIOCHEM, V199, P723, DOI 10.1111/j.1432-1033.1991.tb16176.x; LEPEUCH CJ, 1983, P NATL ACAD SCI-BIOL, V80, P6858; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSUDA Y, 1987, J BIOL CHEM, V262, P2832; MERRIL CR, 1979, P NATL ACAD SCI USA, V76, P4335, DOI 10.1073/pnas.76.9.4335; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; MUTOH T, 1988, J BIOL CHEM, V263, P15853; NAKAJO S, 1983, BIOCHEM BIOPH RES CO, V113, P1010, DOI 10.1016/0006-291X(83)91099-9; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; PELECH SL, 1990, BIOCHEM CELL BIOL, V68, P1297, DOI 10.1139/o90-194; PELECH SL, 1993, CURR BIOL, V3, P513, DOI 10.1016/0960-9822(93)90043-N; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; PELECH SL, 1992, SCIENCE, V257, P1355, DOI 10.1126/science.1382311; PELECH SL, 1991, J BIOL CHEM, V266, P8696; PERISIC O, 1983, J BIOL CHEM, V258, P3998; POSADA J, 1993, MOL CELL BIOL, V13, P2546, DOI 10.1128/MCB.13.4.2546; PRICE DJ, 1989, J BIOL CHEM, V264, P13825; PRICE DJ, 1991, J BIOL CHEM, V266, P16281; PRICE DJ, 1990, P NATL ACAD SCI USA, V87, P7944, DOI 10.1073/pnas.87.20.7944; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; REINHARD C, 1992, P NATL ACAD SCI USA, V89, P4052, DOI 10.1073/pnas.89.9.4052; Rhoads RE, 1991, CURR OPIN CELL BIOL, V3, P1019, DOI 10.1016/0955-0674(91)90123-G; SANGHERA JS, 1992, BIOCHEM J, V283, P829, DOI 10.1042/bj2830829; SANGHERA JS, 1990, J BIOL CHEM, V265, P52; SOMMERCORN J, 1993, J CLIN INVEST, V91, P509, DOI 10.1172/JCI116229; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; SUTHERLAND C, 1993, EUR J BIOCHEM, V212, P581, DOI 10.1111/j.1432-1033.1993.tb17696.x; SWEET LJ, 1990, MOL CELL BIOL, V10, P2413, DOI 10.1128/MCB.10.5.2413; TABARINI D, 1987, BIOCHEM BIOPH RES CO, V144, P891, DOI 10.1016/S0006-291X(87)80048-7; TAO M, 1980, J BIOL CHEM, V255, P2563; TERADA N, 1992, BIOCHEM BIOPH RES CO, V186, P1315, DOI 10.1016/S0006-291X(05)81549-9; TRAUGH JA, 1986, PROG NUCLEIC ACID RE, V33, P195; WETTENHALL REH, 1984, J BIOL CHEM, V259, P2084	74	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7816	7823						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8126008				2022-12-27	WOS:A1994NA03200119
J	ISHIBASHI, T; NAKABEPPU, Y; SEKIGUCHI, M				ISHIBASHI, T; NAKABEPPU, Y; SEKIGUCHI, M			ARTIFICIAL CONTROL OF NUCLEAR TRANSLOCATION OF DNA-REPAIR METHYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE ACTIVITY; DEFICIENT HUMAN-CELLS; ESCHERICHIA-COLI; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; ALKYLATING-AGENTS; ESTROGEN-RECEPTOR; GLUCOCORTICOID RECEPTOR; CELLULAR-RESISTANCE; PROTEIN; EXPRESSION	We constructed a recombinant plasmid carrying a chimeric cDNA that encodes a fusion protein, ER:MGMT, composed of the ligand-binding domain of the human estrogen receptor and the human O-6-methylguanine-DNA methyltransferase. By introducing this plasmid into the methyltransferase-deficient human cell line HeLa MR, a system was established in which nuclear translocation of the ER:MGMT fusion protein can be controlled by estrogen. On in situ immunostaining using anti-MGMT, the cytoplasm of ER:MGMT-carrying cells was preferentially stained and nuclear staining occurred only when the cells were exposed to estrogen. The estrogen-dependent nuclear translocation of ER: MGMT was confirmed by Western blotting analysis of fractionated cell extracts. The fusion protein was translocated into the nucleus within 1 h after estrogen treatment and remained there unless estrogen was removed. The methyltransferase activity of the fusion protein was as active as the authentic methyltransferase enzyme, regardless of the presence or absence of estrogen. The ER:MGMT-producing cells were sensitive to (1-(4-amino-2-methyl-5-pyrimi- dinyl)methyl-3-(2- chloroethyl)-3-nitrosourea (ACNU) in the absence of estrogen, and estrogen treatment rendered the cells as resistant to ACNU as the ordinary Mer(+) cell line, HeLa S3, thereby indicating that translocation of the methyltransferase into the nucleus is a prerequisite for repair of the chromosomal DNA damaged by alkylating agents. Taking advantage of the artificial control of cellular localization of the fusion protein, we examined the timing of the nuclear translocation required to execute efficient DNA repair. We obtained evidence that the methyltransferase must repair the DNA damage as soon as the DNA is exposed to ACNU, in order to avoid cell cycle arrest at the G(2) phase.	KYUSHU UNIV, MED INST BIOREGULAT, DEPT BIOCHEM, FUKUOKA 812, JAPAN	Kyushu University			Nakabeppu, Yusaku/A-8902-2011	Nakabeppu, Yusaku/0000-0002-6739-242X				BOEHMELT G, 1992, EMBO J, V11, P4641, DOI 10.1002/j.1460-2075.1992.tb05566.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; BRENT TP, 1987, CANCER RES, V47, P3384; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DAY RS, 1980, NATURE, V288, P724, DOI 10.1038/288724a0; DOLAN ME, 1985, CANCER RES, V45, P6413; DOLAN ME, 1990, P NATL ACAD SCI USA, V87, P5368, DOI 10.1073/pnas.87.14.5368; DUMENCO LL, 1993, SCIENCE, V259, P219, DOI 10.1126/science.8421782; ECKERT RL, 1982, CANCER RES, V42, P139; FUKUHARA M, 1992, JPN J CANCER RES, V83, P72, DOI 10.1111/j.1349-7006.1992.tb02354.x; GERSON SL, 1986, CARCINOGENESIS, V7, P745, DOI 10.1093/carcin/7.5.745; GOTH R, 1974, P NATL ACAD SCI USA, V71, P639, DOI 10.1073/pnas.71.3.639; HAYAKAWA H, 1990, J MOL BIOL, V213, P739, DOI 10.1016/S0022-2836(05)80260-8; ISHIZAKI K, 1986, MUTAT RES, V166, P135, DOI 10.1016/0167-8817(86)90011-8; ISHIZAKI K, 1987, MUTAT RES, V184, P121, DOI 10.1016/0167-8817(87)90068-X; KARRAN P, 1985, P NATL ACAD SCI USA, V82, P5285, DOI 10.1073/pnas.82.16.5285; KOIKE G, 1990, J BIOL CHEM, V265, P14754; KUMAR V, 1986, EMBO J, V5, P2231, DOI 10.1002/j.1460-2075.1986.tb04489.x; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; LOVELESS A, 1969, NATURE, V223, P206, DOI 10.1038/223206a0; LUDLUM DB, 1990, MUTAT RES, V233, P117, DOI 10.1016/0027-5107(90)90156-X; NAKABEPPU Y, 1993, MOL CELL BIOL, V13, P4157, DOI 10.1128/MCB.13.7.4157; NAKATSURU Y, 1993, P NATL ACAD SCI USA, V90, P6468, DOI 10.1073/pnas.90.14.6468; OLSSON M, 1980, J BIOL CHEM, V255, P569; PEGG AE, 1990, CANCER RES, V50, P6119; PEGG AE, 1983, J BIOL CHEM, V258, P2327; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; RENOIR JM, 1990, J BIOL CHEM, V265, P10740; ROBINS P, 1983, NUCLEIC ACIDS RES, V11, P7743, DOI 10.1093/nar/11.22.7743; SAIJO N, 1980, CANCER CHEMOTH PHARM, V4, P165; SAMSON L, 1986, P NATL ACAD SCI USA, V83, P5607, DOI 10.1073/pnas.83.15.5607; SASSANFAR M, 1991, J BIOL CHEM, V266, P2767; SIBGHATULLAH, 1992, BIOCHEMISTRY-US, V31, P7998, DOI 10.1021/bi00149a034; SINGER B, 1982, ANNU REV BIOCHEM, V51, P655, DOI 10.1146/annurev.bi.51.070182.003255; SUKUMAR S, 1991, ORIGINS OF HUMAN CANCER, P153; SWANN PF, 1990, MUTAT RES, V233, P81, DOI 10.1016/0027-5107(90)90153-U; TAKAHASHI K, 1988, J BIOL CHEM, V263, P13490; TOBEY RA, 1975, NATURE, V254, P245, DOI 10.1038/254245a0; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WOOD ML, 1991, ORIGINS OF HUMAN CANCER, P137; YAGI T, 1984, CARCINOGENESIS, V5, P593, DOI 10.1093/carcin/5.5.593	43	28	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7645	7650						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125990				2022-12-27	WOS:A1994NA03200096
J	MAENAKA, K; KAWAI, G; WATANABE, K; SUNADA, F; KUMAGAI, I				MAENAKA, K; KAWAI, G; WATANABE, K; SUNADA, F; KUMAGAI, I			FUNCTIONAL AND STRUCTURAL ROLE OF A TRYPTOPHAN GENERALLY OBSERVED IN PROTEIN-CARBOHYDRATE INTERACTION - TRP-62 OF HEN EGG-WHITE LYSOZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-1-NMR SPECTRA; BINDING; RESOLUTION; SPECTROSCOPY; SUBSTRATE; RESIDUES; COMPLEX; SITE	In order to elucidate the role of the aromatic ring in recognition of the sugar ring, Trp-62 of hen egg white lysozyme, which is proposed on the basis of x-ray crystallography data to make contact with a sugar ring through van der Waals interaction, was replaced with aliphatic amino acids (Leu, Ile, Val, and Ala) and Gly by site-directed mutagenesis. In spite of the loss of the aromatic effect, these mutant lysozymes, except for the Trp-62 --> Gly mutant, showed higher bacteriolytic activity than the wild-type lysozyme. Furthermore, the Trp-62 --> Gly mutant still retained appreciable bacteriolytic activity. On the other hand, by these replacements, the enzymatic activities toward non-charged substrates were markedly reduced. Additionally, the side-chain structure of position 62 was found to be largely responsible for recognition of a saccharide ring in its active site cleft. NMR analysis of the Trp-62 --> Leu and Trp-62 -->, Gly mutants indicated that the structural effects of Trp-62 replacements were localized in the loop region around position 62 and the part of the beta-sheet containing the hydrogen bonding network important for enzymatic activity. Thus, we conclude that Trp-62 not only interacts with oligosaccharide through van der Waals contact, but also maintains the local structural conformation to produce the lysozyme-oligosaccharide interaction.	UNIV TOKYO, FAC ENGN, DEPT IND CHEM, BUNKYO KU, TOKYO 113, JAPAN	University of Tokyo								ARCHER DB, 1990, BIO-TECHNOL, V8, P741, DOI 10.1038/nbt0890-741; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BLAKE CCF, 1981, J MOL BIOL, V147, P73, DOI 10.1016/0022-2836(81)90080-2; BLAKE CCF, 1967, PROC R SOC SER B-BIO, V167, P378, DOI 10.1098/rspb.1967.0035; CHEETHAM JC, 1992, J MOL BIOL, V224, P613, DOI 10.1016/0022-2836(92)90548-X; DAVIS DG, 1985, J AM CHEM SOC, V107, P2820, DOI 10.1021/ja00295a052; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; FUKAMIZO T, 1992, EUR J BIOCHEM, V210, P351, DOI 10.1111/j.1432-1033.1992.tb17428.x; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; HAYASHI K, 1965, J BIOCHEM-TOKYO, V58, P227, DOI 10.1093/oxfordjournals.jbchem.a128190; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050; Imoto T., 1972, ENZYMES, V7, P665; JOHNSON LN, 1988, CURR TOP MICROBIOL, V139, P81; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUMAGAI I, 1989, J BIOCHEM-TOKYO, V105, P946, DOI 10.1093/oxfordjournals.jbchem.a122784; KUMAGAI I, 1992, J BIOL CHEM, V267, P4608; KUMAGAI I, 1993, EUR J BIOCHEM, V212, P151, DOI 10.1111/j.1432-1033.1993.tb17645.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MILLER GL, 1950, ARCH BIOCHEM, V29, P420; MIRANKER A, 1991, NATURE, V349, P633, DOI 10.1038/349633a0; NANJO F, 1988, J BIOCHEM-TOKYO, V104, P255, DOI 10.1093/oxfordjournals.jbchem.a122453; PARRY RM, 1965, P SOC EXP BIOL MED, V119, P384; QUIOCHO FA, 1988, CURR TOP MICROBIOL, V139, P135; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; REDFIELD C, 1988, BIOCHEMISTRY-US, V27, P122, DOI 10.1021/bi00401a020; SMITH LJ, 1993, J MOL BIOL, V229, P930, DOI 10.1006/jmbi.1993.1097; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; STRYNADKA NCJ, 1991, J MOL BIOL, V220, P401, DOI 10.1016/0022-2836(91)90021-W; UEDA T, 1990, J BIOCHEM-TOKYO, V108, P886, DOI 10.1093/oxfordjournals.jbchem.a123297; Vyas NK, 1991, CURR OPIN STRUC BIOL, V1, P732, DOI 10.1016/0959-440X(91)90172-P; Wuthrich K., 1986, NMR PROTEINS NUCL AC; YAMADA H, 1985, ANAL BIOCHEM, V146, P71, DOI 10.1016/0003-2697(85)90397-5; YAMASAKI N, 1976, J BIOCHEM-TOKYO, V80, P409, DOI 10.1093/oxfordjournals.jbchem.a131292	35	55	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7070	7075						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125914				2022-12-27	WOS:A1994NA03200007
J	SCHWABE, M; ZHAO, J; KUNG, HF				SCHWABE, M; ZHAO, J; KUNG, HF			DIFFERENTIAL EXPRESSION AND LIGAND-INDUCED MODULATION OF THE HUMAN INTERLEUKIN-6 RECEPTOR ON INTERLEUKIN-6-RESPONSIVE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-6 SIGNAL TRANSDUCER; TUMOR-NECROSIS-FACTOR; GROWTH-FACTOR; INTERFERON RECEPTOR; BREAST-CARCINOMA; MULTIPLE-MYELOMA; RAT HEPATOCYTES; DOWN-REGULATION; GAMMA-RECEPTOR; IFN-GAMMA	The human interleukin-6 receptor (IL-6) was differentially expressed on IL-6-dependent (U266 and SKO-007) and -independent (RPMI8226) myeloma cells as well as melanoma cells (A375-C6) that are growth-inhibited by IL-6. U266 and SKO-007 cells expressed four distinct IL-6R complexes (molecular masses of 100, 120, 145, and 165 kDa) as revealed by affinity cross-linking of iodinated IL-6. RPMI8226 and A375-C6 cells primarily expressed the 165-kDa complex relative to the others. Immunoprecipitation and antibody competition studies showed that the 100- and 120-kDa complexes contained the gp80 subunit, whereas the 145- and 165-kDa complexes contained the gp130 subunit of the IL-6R. Assay solubilized U266 plasma membrane proteins by affinity cross-linking or ligand blotting revealed that only gp80 bound IL-6 specifically. Induction of an IL-6 response was associated with ligand-induced down-regulation of gp130 and was inhibited by neutralizing antin-IL-6 antibodies. Furthermore, the relative ratios of gp80 to gp130 determined the binding kinetics of the IL-6R, yielding high- and low affinity binding sites by Scatchard plots. Our data imply that distinct IL-6 bioactivities are based upon the differential expression and regulation by IL-6 of its ligand binding (gp80) and signal-transducing (gp130) receptor subunits.			SCHWABE, M (corresponding author), NCI,FREDERICK CANC RES & DEV CTR,BIOCHEM PHYSIOL LAB,BIOL RESPONSE MODIFIERS PROGRAM,BLDG 560,FREDERICK,MD 21701, USA.							Aarden L, 1985, LYMPHOKINES, V10, P175; BAUER J, 1989, J EXP MED, V170, P1537, DOI 10.1084/jem.170.5.1537; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRAKENHOFF JPJ, 1990, J IMMUNOL, V145, P561; BRANCA AA, 1986, J INTERFERON RES, V6, P305, DOI 10.1089/jir.1986.6.305; BRANCA AA, 1982, J BIOL CHEM, V257, P13197; CHEN L, 1988, P NATL ACAD SCI USA, V85, P8037, DOI 10.1073/pnas.85.21.8037; COULIE PG, 1987, EUR J IMMUNOL, V17, P1435, DOI 10.1002/eji.1830171008; DALESSANDRO F, 1993, J BIOL CHEM, V268, P2149; FALTYNEK CR, 1990, J INTERFERON RES, V10, P55, DOI 10.1089/jir.1990.10.55; FALTYNEK CR, 1986, J IMMUNOL, V136, P4134; FALTYNEK CR, 1986, J INTERFERON RES, V6, P639, DOI 10.1089/jir.1986.6.639; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HIRANO T, 1990, IMMUNOL TODAY, V11, P443, DOI 10.1016/0167-5699(90)90173-7; HIRATA Y, 1989, J IMMUNOL, V143, P2900; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; LEEBEEK FWG, 1992, J BIOL CHEM, V267, P14832; LEVY Y, 1991, J CLIN INVEST, V88, P696, DOI 10.1172/JCI115355; LIU JW, 1992, J BIOL CHEM, V267, P16763; LOKESHWAR VB, 1989, J BIOL CHEM, V264, P19318; LU C, 1992, P NATL ACAD SCI USA, V89, P9215, DOI 10.1073/pnas.89.19.9215; MAY LT, 1991, J BIOL CHEM, V266, P9950; MORINAGA Y, 1989, J IMMUNOL, V143, P3538; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; NESBITT JE, 1992, MOL BIOL CELL, V3, P103, DOI 10.1091/mbc.3.1.103; NESBITT JE, 1992, J BIOL CHEM, V267, P5739; NORDAN RP, 1986, SCIENCE, V233, P566, DOI 10.1126/science.3726549; PIETZKO D, 1993, J BIOL CHEM, V268, P4250; ROSEJOHN S, 1990, EUR J BIOCHEM, V190, P79, DOI 10.1111/j.1432-1033.1990.tb15548.x; ROSEJOHN S, 1991, J BIOL CHEM, V266, P3841; SANCEAU J, 1991, J IMMUNOL, V147, P2630; SCHWAB G, 1991, BLOOD, V77, P587; SCHWABE M, 1988, EUR J IMMUNOL, V18, P2009, DOI 10.1002/eji.1830181221; SEHGAL PB, 1990, J INVEST DERMATOL, V94, pS2, DOI 10.1111/1523-1747.ep12874963; SHALABY MR, 1989, CELL IMMUNOL, V121, P372, DOI 10.1016/0008-8749(89)90036-1; SIDELL N, 1991, J IMMUNOL, V146, P3809; SNYERS L, 1990, P NATL ACAD SCI USA, V87, P2838, DOI 10.1073/pnas.87.7.2838; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; TAGA T, 1992, P NATL ACAD SCI USA, V89, P10998, DOI 10.1073/pnas.89.22.10998; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TAMM I, 1991, P NATL ACAD SCI USA, V88, P4414, DOI 10.1073/pnas.88.10.4414; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; WONG GG, 1988, IMMUNOL TODAY, V9, P137, DOI 10.1016/0167-5699(88)91200-5; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; ZHANG XG, 1989, BLOOD, V74, P11	54	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7201	7209						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125932				2022-12-27	WOS:A1994NA03200028
J	COOK, JR; EMANUEL, SL; DONNELLY, RJ; SOH, JM; MARIANO, TM; SCHWARTZ, B; RHEE, SJ; PESTKA, S				COOK, JR; EMANUEL, SL; DONNELLY, RJ; SOH, JM; MARIANO, TM; SCHWARTZ, B; RHEE, SJ; PESTKA, S			SUBLOCALIZATION OF THE HUMAN INTERFERON-GAMMA RECEPTOR ACCESSORY FACTOR GENE AND CHARACTERIZATION OF ACCESSORY FACTOR ACTIVITY BY YEAST ARTIFICIAL CHROMOSOMAL FRAGMENTATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISMS; HUMAN FIBROBLAST INTERFERON; HUMAN IMMUNE INTERFERON; MOLECULAR CHARACTERIZATION; TYROSINE PHOSPHORYLATION; HAMSTER-CELLS; EXPRESSION; ALPHA; TRANSCRIPTION; PURIFICATION	A chromosomal fragmentation procedure was employed to produce a deletion set of yeast artificial chromosomes (YACs) from a parental YAC, CART D142H8, known to map to human chromosome 21q and to encode the human interferon-gamma receptor (Hu-IFN-gamma R) accessory factor gene as well as the phosphoribosylglycinamide formyltransferase (CART) gene. When expressed in Chinese hamster ovary cells, these deleted YACs retain accessory factor activity, as judged by major histocompatibility complex class I antigen inducibility, until the deletions from the acentric end exceed 390 kilobases (kb). Therefore, the accessory factor (AF-1) gene can be localized to a 150-kb region at the left (centric) end of the parental 540-kb GART YAC. Cells containing functional YACs are also able to induce the ISGF3 gamma and gamma-activated factor (GAF) transcription factors, but were not protected against encephalomyocarditis virus (EMCV) upon treatment with Hu-IFN-gamma. Therefore, the Hu-IFN-gamma R and the AF-1 are sufficient for some, but not all, of the actions of Hu-IFN-gamma. We postulate that an additional accessory factor (AF-2) required for antiviral activity against EMCV is encoded on chromosome 21q.			COOK, JR (corresponding author), UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT MOLEC GENET & MICROBIOL,PISCATAWAY,NJ 08854, USA.				NATIONAL CANCER INSTITUTE [R01CA046465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007403] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA46465] Funding Source: Medline; NIAID NIH HHS [T32 AI07403] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; CHENG S, 1993, MAMM GENOME, V4, P338, DOI 10.1007/BF00357094; COOK JR, 1992, P NATL ACAD SCI USA, V89, P11317, DOI 10.1073/pnas.89.23.11317; COOK JR, 1994, IN PRESS GENET ANAL; DONALDSON DH, 1992, HUM MOL GENET, V1, P651, DOI 10.1093/hmg/1.8.651; Donnelly Robert J., 1992, Journal of Interferon Research, V12, pS216; Familletti P C, 1981, Methods Enzymol, V78, P387; FRIESEN HJ, 1981, ARCH BIOCHEM BIOPHYS, V206, P432, DOI 10.1016/0003-9861(81)90111-9; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; GIBBS VC, 1991, MOL CELL BIOL, V11, P5860, DOI 10.1128/MCB.11.12.5860; GUTCH MJ, 1992, P NATL ACAD SCI USA, V89, P11141; HEMMI S, 1992, P NATL ACAD SCI USA, V89, P2737, DOI 10.1073/pnas.89.7.2737; HIBINO Y, 1992, J BIOL CHEM, V267, P3741; HIBINO Y, 1991, J BIOL CHEM, V266, P6948; JUNG V, 1988, SOMAT CELL MOLEC GEN, V14, P583, DOI 10.1007/BF01535312; JUNG V, 1990, J BIOL CHEM, V265, P1827; JUNG V, 1987, P NATL ACAD SCI USA, V84, P4151, DOI 10.1073/pnas.84.12.4151; JUNG V, 1991, THESIS RUTGERS U PIS; KALINA U, 1993, J VIROL, V67, P1702, DOI 10.1128/JVI.67.3.1702-1706.1993; KUMAR CS, 1989, J BIOL CHEM, V264, P17939; KUNG HF, 1986, METHOD ENZYMOL, V119, P204; LANGER JA, 1988, IMMUNOL TODAY, V9, P393, DOI 10.1016/0167-5699(88)91241-8; LANGER JA, 1990, SOMAT CELL MOLEC GEN, V16, P321; LEVY DE, 1989, GENE DEV, V3, P1362, DOI 10.1101/gad.3.9.1362; LEWIS BC, 1992, GENET ANAL-BIOMOL E, V9, P86, DOI 10.1016/1050-3862(92)90003-N; LUTFALLA G, 1993, GENOMICS, V16, P366, DOI 10.1006/geno.1993.1199; MARIANO TM, 1987, J BIOL CHEM, V262, P5812; MOSCHERA JA, 1986, METHOD ENZYMOL, V119, P177; PAVAN WJ, 1990, P NATL ACAD SCI USA, V87, P1300, DOI 10.1073/pnas.87.4.1300; PAVAN WJ, 1991, GENE, V106, P125, DOI 10.1016/0378-1119(91)90576-W; PAVAN WJ, 1990, MOL CELL BIOL, V10, P4163, DOI 10.1128/MCB.10.8.4163; RASHIDBAIGI A, 1986, P NATL ACAD SCI USA, V83, P384, DOI 10.1073/pnas.83.2.384; RAZIUDDIN A, 1984, P NATL ACAD SCI-BIOL, V81, P5504, DOI 10.1073/pnas.81.17.5504; REHBERG E, 1982, J BIOL CHEM, V257, P1497; ROSEN DR, 1992, HUM MOL GENET, V1, P547, DOI 10.1093/hmg/1.7.547; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; SOH J, 1993, P NATL ACAD SCI USA, V90, P8737, DOI 10.1073/pnas.90.18.8737; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; VANCAMP G, 1990, SOMAT CELL MOLEC GEN, V16, P241	40	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					7013	7018						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120065				2022-12-27	WOS:A1994MZ50300114
J	DE, SK; MARSH, JW				DE, SK; MARSH, JW			HIV-1 NEF INHIBITS A COMMON ACTIVATION PATHWAY IN NIH-3T3 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; PHOSPHOLIPASE-C; MESSENGER-RNA; CALCIUM POOLS; T-CELLS; TYPE-1; EXPRESSION; GENE; INDUCTION	The human immunodeficiency virus type 1 (HlV-1) Nef is a myristylated 27-kDa, cytoplasmic protein. It is attributed to have suppressive effects on LTR-based expression and T cell activation. Additionally, SIV nef has been shown to possess an essential in vivo function in the development of immunodeficiency. To define the bio chemical activity of HIV-1 Nef in a signal transduction pathway, we have transduced murine NIH-3T3 cells with a retroviral nef expression system, In nef-expressing cells, but not in controls, the proliferative response to bombesin and platelet-derived growth factor (PDGF) was eliminated. Analysis of an early signal pathway metabolite, inositol l,4,5-trisphosphate following bombesin and PDGF treatment to quiscent cells, revealed that both control and nef-transformed cells displayed similar kinetics of signal formation. Normally, inositol 1,4,5-trisphosphate mediates increase in the cytosolic free Ca2+ ([Ca2+](i)). Upon stimulation with bombesin or PDGF, control cells displayed a 2-4-fold increase of [Ca2+](i) over the basal level, while the [Ca2+](i) response in nef-expressing NIH-3T3 cells was lacking or highly diminished. However, the release of [Ca2+](i) from the intracellular store of the nef-expressing cells by an endomembrane Ca2+ ATPase inhibitor, thapsigargin, revealed that these cells contained normal Ca2+ stores. These results suggest a specific, definable biochemical activity for the HIV-1 Nef protein in the context of a well characterized cellular activation pathway. Our results thus define, for the first time, a unique function of Nef that is not limited to an alteration of T cell function or of expression of a T cell surface antigen.			DE, SK (corresponding author), NIMH,MOLEC BIOL LAB,BLDG 36,RM 1B08,BETHESDA,MD 20892, USA.							AHMED N, 1988, SCIENCE, V241, P1481; AKESON M, 1992, J MEMBRANE BIOL, V125, P81; ARYA SK, 1985, SCIENCE, V229, P69, DOI 10.1126/science.2990040; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BIAN JH, 1991, J BIOL CHEM, V266, P8801; BIDEN TJ, 1986, J BIOL CHEM, V261, P7223; BLUMBERG BM, 1992, J VIROL, V66, P5256, DOI 10.1128/JVI.66.9.5256-5264.1992; CHENGMAYER C, 1989, SCIENCE, V246, P1629, DOI 10.1126/science.2531920; CHUEH SH, 1987, J BIOL CHEM, V262, P13857; DANOFF SK, 1988, BIOCHEM J, V254, P701, DOI 10.1042/bj2540701; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; DE SK, 1990, J BIOL CHEM, V265, P15267; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; GARCIA JV, 1993, J VIROL, V67, P1511, DOI 10.1128/JVI.67.3.1511-1516.1993; GHOSH TK, 1989, NATURE, V340, P236, DOI 10.1038/340236a0; GHOSH TK, 1990, SCIENCE, V248, P1653, DOI 10.1126/science.2163543; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUY B, 1987, NATURE, V330, P266, DOI 10.1038/330266a0; HILL TD, 1990, SCIENCE, V248, P1660, DOI 10.1126/science.2163545; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; KHAN AA, 1992, P NATL ACAD SCI USA, V89, P2849, DOI 10.1073/pnas.89.7.2849; KIM SY, 1989, P NATL ACAD SCI USA, V86, P9544, DOI 10.1073/pnas.86.23.9544; KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011; LUCIW PA, 1987, P NATL ACAD SCI USA, V84, P1434, DOI 10.1073/pnas.84.5.1434; LURIA S, 1991, P NATL ACAD SCI USA, V88, P5326, DOI 10.1073/pnas.88.12.5326; MAITRA RK, 1991, VIROLOGY, V182, P522, DOI 10.1016/0042-6822(91)90593-Z; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; MULLANEY JM, 1988, P NATL ACAD SCI USA, V85, P2499, DOI 10.1073/pnas.85.8.2499; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NIEDERMAN TMJ, 1989, P NATL ACAD SCI USA, V86, P1128, DOI 10.1073/pnas.86.4.1128; NIEDERMAN TMJ, 1992, J VIROL, V66, P6213, DOI 10.1128/JVI.66.10.6213-6219.1992; RENARD DC, 1992, BIOCHEM J, V281, P775, DOI 10.1042/bj2810775; ROBERTGUROFF M, 1990, J VIROL, V64, P3391, DOI 10.1128/JVI.64.7.3391-3398.1990; RONNSTRAND L, 1992, EMBO J, V11, P3911, DOI 10.1002/j.1460-2075.1992.tb05484.x; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; SKOWRONSKI J, 1993, EMBO J, V12, P703, DOI 10.1002/j.1460-2075.1993.tb05704.x; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F	38	58	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6656	6660						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120020				2022-12-27	WOS:A1994MZ50300063
J	OTSU, M; OMURA, F; YOSHIMORI, T; KIKUCHI, M				OTSU, M; OMURA, F; YOSHIMORI, T; KIKUCHI, M			PROTEIN DISULFIDE-ISOMERASE ASSOCIATES WITH MISFOLDED HUMAN LYSOZYME IN-VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; BINDING-PROTEIN; PRE-GOLGI; DEGRADATION; SECRETION; COMPONENT; CLEAVAGE; COMPLEX; FAMILY; BONDS	Wild-type human lysozyme (hLZM) is quantitatively secreted into the media when expressed in mouse fibroblast cells, but some misfolded hLZMs are retained and rapidly degraded in a pre-Golgi compartment (Omura, F., Otsu, M., Yoshimori, T., Tashiro, Y., and Kikuchi, M. (1992) Eur. J. Biochem. 210, 591-599). To detect the association with misfolded hLZMs of cellular proteins involved in their folding, retention, and pre-Golgi degradation, a co-precipitation experiment was carried out using anti-hLZM antibody and metabolically labeled cell lysates, which were treated with a membrane-permeable cross-linking reagent. Here we report that protein disulfide isomerase associated in vivo with misfolded hLZMs, but not with the wild-type protein, and discuss the possible role of protein disulfide isomerase in the quality control of newly synthesized proteins in the endoplasmic reticulum.	PROT ENGN RES INST,SUITA,OSAKA 565,JAPAN; KANSAI MED UNIV,DEPT PHYSIOL,MORIGUCHI,OSAKA 570,JAPAN	Kansai Medical University								AMARA JF, 1989, J CELL BIOL, V109, P3315, DOI 10.1083/jcb.109.6.3315; BULLEID NJ, 1988, NATURE, V335, P649, DOI 10.1038/335649a0; CHAUDHURI MM, 1992, BIOCHEM J, V281, P645, DOI 10.1042/bj2810645; CHENG SY, 1987, J BIOL CHEM, V262, P11221; CHESSLER SD, 1992, J BIOL CHEM, V267, P7751; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; GEETHAHABIB M, 1988, CELL, V54, P1053, DOI 10.1016/0092-8674(88)90120-1; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HAYANO T, 1993, FEBS LETT, V328, P203, DOI 10.1016/0014-5793(93)80993-5; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; INAKA K, 1991, J BIOL CHEM, V266, P12599; JOHN DCA, 1993, EMBO J, V12, P1587, DOI 10.1002/j.1460-2075.1993.tb05803.x; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KOIVU J, 1987, J BIOL CHEM, V262, P6447; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMANTIA ML, 1993, CELL, V74, P899, DOI 10.1016/0092-8674(93)90469-7; LE AQ, 1992, J BIOL CHEM, V267, P1072; NOIVA R, 1993, J BIOL CHEM, V268, P19210; NOIVA R, 1992, J BIOL CHEM, V267, P3553; OMURA F, 1991, EUR J BIOCHEM, V198, P477, DOI 10.1111/j.1432-1033.1991.tb16038.x; OMURA F, 1992, EUR J BIOCHEM, V205, P551, DOI 10.1111/j.1432-1033.1992.tb16812.x; OMURA F, 1992, EUR J BIOCHEM, V210, P591, DOI 10.1111/j.1432-1033.1992.tb17459.x; PERSSON R, 1991, J CELL BIOL, V112, P257, DOI 10.1083/jcb.112.2.257; ROTH RA, 1987, BIOCHEMISTRY-US, V26, P4179, DOI 10.1021/bi00388a001; SCHAIFF WT, 1992, J EXP MED, V176, P657, DOI 10.1084/jem.176.3.657; TANIYAMA Y, 1988, BIOCHEM BIOPH RES CO, V152, P962, DOI 10.1016/S0006-291X(88)80377-2; TSAO YS, 1992, J CELL BIOL, V116, P57, DOI 10.1083/jcb.116.1.57; URADE R, 1992, J BIOL CHEM, V267, P15152; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800	31	57	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6874	6877						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120049				2022-12-27	WOS:A1994MZ50300095
J	WEINACKER, A; CHEN, A; AGREZ, M; CONE, RI; NISHIMURA, S; WAYNER, E; PYTELA, R; SHEPPARD, D				WEINACKER, A; CHEN, A; AGREZ, M; CONE, RI; NISHIMURA, S; WAYNER, E; PYTELA, R; SHEPPARD, D			ROLE OF THE INTEGRIN ALPHA-V-BETA-6 IN CELL ATTACHMENT TO FIBRONECTIN - HETEROLOGOUS EXPRESSION OF INTACT AND SECRETED FORMS OF THE RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-V SUBUNIT; BETA-1 SUBUNIT; MONOCLONAL-ANTIBODIES; VITRONECTIN RECEPTOR; EPITHELIAL-CELLS; SURFACE-ANTIGENS; ADHESION; BINDING; DOMAINS; INTEGRIN-ALPHA-V-BETA-5	The integrin alpha v beta 6 has been shown to be a fibronectin binding protein. To determine whether the cytoplasmic and transmembrane domains of alpha v beta 6 are necessary for binding to fibronectin, a truncated, secreted form of the integrin lacking these domains was engineered and expressed in Chinese hamster ovary cells. Fibronectin affinity chromatography demonstrated that the secreted integrin, like its full-length counterpart, was capable of binding fibronectin. Monoclonal antibodies were made to secreted alpha v beta 6 and to beta 6-transfected NIH 3T3 cells. In experiments designed to determine whether alpha v beta 6 can mediate cell attachment to fibronectin, full-length human beta 6 was expressed in Chinese hamster ovary cells and in the human colon carcinoma cell line SW480. beta 6-expressing cells were identified by alpha v beta 6-specific antibodies, and the beta 6-transfectants were used in cell-adhesion assays, In Chinese hamster ovary cells, human beta 6 associated with hamster alpha v but was incapable of mediating cell attachment to fibronectin. However, expression of beta 6 in these cells had the dominant negative effect of decreasing alpha v beta 5-dependent adhesion to vitronectin. In SW480 cells, beta 6 expression conferred the ability to bind to fibronectin even in the presence of inhibitory antibodies against beta 1 integrins. In such cells, fibronectin binding ability could be blocked by an antibody to alpha v integrins. These results constitute the first direct evidence that alpha v beta 6 mediates cell attachment to fibronectin.	UNIV CALIF SAN FRANCISCO,CTR OCCUPAT & ENVIRONM HLTH,CTR LUNG BIOL,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHARMACOL,SAN FRANCISCO,CA 94143; UNIV NEWCASTLE,CANC RES UNIT,NEWCASTLE,NSW 2300,AUSTRALIA; UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Newcastle; University of Minnesota System; University of Minnesota Twin Cities					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047412, P01HL025816] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL47412, HL25816, HL/A133259] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BODARY SC, 1990, J BIOL CHEM, V265, P5938; BOSSY B, 1990, BIOCHEMISTRY-US, V29, P10191, DOI 10.1021/bi00496a006; BREUSS JM, 1993, J HISTOCHEM CYTOCHEM, V41, P1521, DOI 10.1177/41.10.8245410; BRIESEWITZ R, 1993, J BIOL CHEM, V268, P2989; BROWN PJ, 1988, EXP CELL RES, V177, P303, DOI 10.1016/0014-4827(88)90464-8; BROWN PJ, 1985, SCIENCE, V228, P1448, DOI 10.1126/science.4012302; BUSK M, 1992, J BIOL CHEM, V267, P5790; CHERESH DA, 1989, CELL, V57, P59, DOI 10.1016/0092-8674(89)90172-4; CHUNTHARAPAI A, 1993, EXP CELL RES, V205, P345, DOI 10.1006/excr.1993.1096; DANA N, 1991, P NATL ACAD SCI USA, V88, P3106, DOI 10.1073/pnas.88.8.3106; DITTEL BN, 1993, BLOOD, V81, P2272; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; FRACHET P, 1992, BIOCHEMISTRY-US, V31, P2408, DOI 10.1021/bi00123a028; HAYASHI Y, 1990, J CELL BIOL, V110, P175, DOI 10.1083/jcb.110.1.175; HOUGHTON AN, 1982, J EXP MED, V156, P1755, DOI 10.1084/jem.156.6.1755; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; MCDONALD JA, 1989, AM J PHYSIOL, V257, pL331, DOI 10.1152/ajplung.1989.257.6.L331; REAL FX, 1985, CANCER RES, V45, P4401; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; Sambrook J, 1989, MOL CLONING LABORATO; SHEPPARD D, 1990, J BIOL CHEM, V265, P11502; SHEPPARD D, 1992, J BIOL CHEM, V267, P17409; SMITH JW, 1990, J BIOL CHEM, V265, P11008; SOLOWSKA J, 1991, J CELL BIOL, V114, P1079, DOI 10.1083/jcb.114.5.1079; SOLOWSKA J, 1989, J CELL BIOL, V109, P853, DOI 10.1083/jcb.109.2.853; TAKADA Y, 1992, J CELL BIOL, V119, P913, DOI 10.1083/jcb.119.4.913; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; ZHANG ZH, 1993, J CELL BIOL, V122, P235, DOI 10.1083/jcb.122.1.235	30	230	241	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6940	6948						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120056				2022-12-27	WOS:A1994MZ50300104
J	CHUNDURU, SK; CODY, V; LUFT, JR; PANGBORN, W; APPLEMAN, JR; BLAKLEY, RL				CHUNDURU, SK; CODY, V; LUFT, JR; PANGBORN, W; APPLEMAN, JR; BLAKLEY, RL			METHOTREXATE-RESISTANT VARIANTS OF HUMAN DIHYDROFOLATE-REDUCTASE - EFFECTS OF PHE31 SUBSTITUTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; HYDROPHOBIC INTERACTIONS; VERTEBRATE SOURCES; CRYSTAL-STRUCTURE; HYDRIDE TRANSFER; TRANSIENT-STATE; FUNCTIONAL-ROLE; BONE-MARROW; BINDING	Substitution of glycine or alanine for phenylalanine 31 in human dihydrofolate reductase produces variants that are inhibited less by methotrexate (MTX) than the previously reported serine variant. The 100 times decrease in MTX affinity for the glycine variant is due to slower binding, and to inability of the initial complex to isomerize to a nondissociating conformer. A polar group at position 31 is unnecessary for resistance, but residues larger than serine confer no resistance. The glycine variant best fulfills criteria for gene therapy: low K(m) for H-2folate, high k(cat), and good stability. Although k(cat) is unaltered by these mutations, the rate of hydride transfer is greatly decreased. Presteady-state measurements have enabled a complete catalytic scheme to be constructed for the glycine variant that predicts observed steady-state behavior. The crystal structures of inhibitor complexes of the serine, alanine, and glycine mutants and of the wild-type enzyme show that the mutations cause little perturbation of the protein backbone, of side chains of residues at the active site, or of the bound inhibitor. A molecule of bound water occupies the space vacated by the phenyl group.	ST JUDE CHILDRENS RES HOSP, DEPT MOLEC PHARMACOL, 332 N LAUDERDALE, POB 318, MEMPHIS, TN 38101 USA; MED FDN BUFFALO INC, BUFFALO, NY 14203 USA	St Jude Children's Research Hospital					NCI NIH HHS [P30 CA 21765, R01 CA 31922] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA031922, P30CA021765] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHRWEILER PM, 1991, BIOCHEMISTRY-US, V30, P7801, DOI 10.1021/bi00245a020; APPLEMAN JR, 1988, J BIOL CHEM, V263, P10304; APPLEMAN JR, 1990, J BIOL CHEM, V265, P2740; APPLEMAN JR, 1988, J BIOL CHEM, V263, P9187; APPLEMAN JR, 1989, J BIOL CHEM, V264, P2625; BEARD WA, 1989, J BIOL CHEM, V264, P9391; BENKOVIC SJ, 1988, SCIENCE, V239, P1105, DOI 10.1126/science.3125607; BLAKLEY RL, 1985, BIOCHEMISTRY-US, V24, P4772, DOI 10.1021/bi00339a010; CODY V, 1992, ANTI-CANCER DRUG DES, V7, P483; COREY CA, 1990, BLOOD, V75, P337; DAVIES JF, 1990, BIOCHEMISTRY-US, V29, P9467, DOI 10.1021/bi00492a021; DELCAMP TJ, 1983, BIOCHEMISTRY-US, V22, P633, DOI 10.1021/bi00272a017; FINZEL BC, 1987, J APPL CRYSTALLOGR, V20, P53, DOI 10.1107/S0021889887087144; FREI B, 1991, BIOTECHNIQUES, V19, P420; HENDRICKSON WA, 1980, COMPUTING CRYSTALLOG; KELLIS JT, 1988, NATURE, V333, P784, DOI 10.1038/333784a0; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LI LY, 1992, BIOCHEMISTRY-US, V31, P7826, DOI 10.1021/bi00149a012; LI M, 1992, HUM GENE THER, V3, P381, DOI 10.1089/hum.1992.3.4-381; MARGOSIAK SA, 1993, ARCH BIOCHEM BIOPHYS, V305, P499, DOI 10.1006/abbi.1993.1453; MCTIGUE MA, 1992, BIOCHEMISTRY-US, V31, P7264, DOI 10.1021/bi00147a009; NOZAKI Y, 1971, J BIOL CHEM, V246, P2211; OEFNER C, 1988, EUR J BIOCHEM, V174, P377, DOI 10.1111/j.1432-1033.1988.tb14108.x; PRENDERGAST NJ, 1988, BIOCHEMISTRY-US, V27, P3664, DOI 10.1021/bi00410a022; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWEITZER BI, 1989, J BIOL CHEM, V264, P20786; SRIMATKANDADA S, 1989, J BIOL CHEM, V264, P3524; STONE SR, 1984, BIOCHEM PHARMACOL, V33, P175, DOI 10.1016/0006-2952(84)90472-6; STONE SR, 1986, BIOCHIM BIOPHYS ACTA, V869, P275, DOI 10.1016/0167-4838(86)90067-1; STUBER D, 1986, P839; STUBER D, 1990, IMMUNOLOGICAL METHOD, V4, P121; TAIRA K, 1988, J MED CHEM, V31, P129, DOI 10.1021/jm00396a019; THILLET J, 1988, J BIOL CHEM, V263, P12500; TSAY JT, 1990, BIOCHEMISTRY-US, V29, P6428, DOI 10.1021/bi00479a014; WILLIAMS DA, 1987, J EXP MED, V166, P210, DOI 10.1084/jem.166.1.210; WILLIAMS JW, 1979, BIOCHEMISTRY-US, V18, P2567, DOI 10.1021/bi00579a021; WILLIAMS JW, 1980, BIOCHEM PHARMACOL, V29, P589, DOI 10.1016/0006-2952(80)90381-0; WU YD, 1987, J AM CHEM SOC, V109, P2226, DOI 10.1021/ja00241a074	39	63	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9547	9555						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144541				2022-12-27	WOS:A1994NE05300026
J	HAGLER, J; LUO, Y; SHUMAN, S				HAGLER, J; LUO, Y; SHUMAN, S			FACTOR-DEPENDENT TRANSCRIPTION TERMINATION BY VACCINIA RNA-POLYMERASE - KINETIC COUPLING AND REQUIREMENT FOR ATP HYDROLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS EARLY TRANSCRIPTION; MESSENGER-RNA; ESCHERICHIA-COLI; (GUANINE-7-)METHYLTRANSFERASE COMPLEX; CAPPING ENZYME; ELONGATION; VIRIONS; INVITRO; PURIFICATION; PROMOTER	Transcription termination during synthesis of vaccinia early mRNAs occurs downstream of a UUUUUNU signal in the nascent transcript and requires a virus-encoded termination factor (VTF), which is identical with the vaccinia mRNA capping enzyme. Using purified transcription complexes halted at defined sites on linear DNA templates, we have examined the order and timing of events during a single round of elongation and termination. We find that although cap synthesis occurs by the time the nascent RNA is 31 nucleotides long, capping enzyme is not stably associated with the elongation complex at this stage. Stable interaction, defined by the formation of a termination-competent complex, requires a longer nascent RNA, eg. 51 nucleotides, but does not depend on prior transcription of the termination signal. The acquisition of termination competence correlates temporally with the physical association of capping enzyme/VTF with the elongation complex, as revealed by UV cross-linking of the capping enzyme large subunit to the nascent RNA chain. Subsequent induction of termination and transcript release by capping enzyme requires energy, specifically the hydrolysis of ATP. The choice of termination site is flexible and is determined by a kinetic balance between the rate of polymerase elongation and the rate of signaling. Signaling rate is related directly to the concentration of hydrolyzable ATP. An apparent lower limit of 33 nucleotides between the 5' boundary of the termination signal and the most proximal termination site implies that the UUUUUNU signal must be extruded from the RNA polymerase before it can be acted upon by VTF. Similarities between VTF-dependent termination and rho-dependent termination underscore an evolutionarily conserved mechanism for RNA signal transduction to the elongating RNA polymerase.			HAGLER, J (corresponding author), MEM SLOAN KETTERING CANC CTR,MOLEC BIOL PROGRAM,NEW YORK,NY 10021, USA.				NIGMS NIH HHS [GM 42498] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042498] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARIAS JA, 1989, J BIOL CHEM, V264, P3223; ARNDT KM, 1990, J MOL BIOL, V213, P79, DOI 10.1016/S0022-2836(05)80123-8; BAJSZAR G, 1983, J VIROL, V45, P62; BAROUDY BM, 1980, J BIOL CHEM, V255, P4372; BARTHOLOMEW B, 1986, J BIOL CHEM, V261, P14266; BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; DISSINGER S, 1992, J MOL BIOL, V219, P11; EARL PL, 1990, J VIROL, V64, P2448, DOI 10.1128/JVI.64.5.2448-2451.1990; GEISELMANN J, 1992, BIOCHEMISTRY-US, V31, P121, DOI 10.1021/bi00116a018; GERSHON PD, 1990, P NATL ACAD SCI USA, V87, P4401, DOI 10.1073/pnas.87.11.4401; GERSHOWITZ A, 1978, J VIROL, V27, P399, DOI 10.1128/JVI.27.2.399-408.1978; HAGLER J, 1992, SCIENCE, V255, P983, DOI 10.1126/science.1546295; HAGLER J, 1993, J BIOL CHEM, V268, P2166; HAGLER J, 1992, J VIROL, V66, P2982, DOI 10.1128/JVI.66.5.2982-2989.1992; HAGLER J, 1992, J BIOL CHEM, V267, P7644; HAGLER J, 1992, P NATL ACAD SCI USA, V89, P10009; INK BS, 1989, J VIROL, V63, P4632, DOI 10.1128/JVI.63.11.4632-4644.1989; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; KATES J, 1970, J MOL BIOL, V50, P1, DOI 10.1016/0022-2836(70)90100-2; KERPPOLA TK, 1991, FASEB J, V5, P2833, DOI 10.1096/fasebj.5.13.1916107; LEVIN JR, 1987, J MOL BIOL, V196, P61, DOI 10.1016/0022-2836(87)90511-0; LI J, 1993, J BIOL CHEM, V268, P20016; LI J, 1993, J BIOL CHEM, V268, P2773; LIBBY RT, 1989, EMBO J, V8, P3153, DOI 10.1002/j.1460-2075.1989.tb08469.x; LUO Y, 1991, J BIOL CHEM, V266, P13303; LUO Y, 1993, J BIOL CHEM, V268, P21253; LUO Y, 1991, VIROLOGY, V185, P432, DOI 10.1016/0042-6822(91)90793-B; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; MOSS B, 1991, J BIOL CHEM, V266, P1355; PAOLETTI E, 1978, VIROLOGY, V87, P317, DOI 10.1016/0042-6822(78)90137-X; REINES D, 1989, J BIOL CHEM, V264, P10799; RICHARDSON JP, 1990, BIOCHIM BIOPHYS ACTA, V1048, P127, DOI 10.1016/0167-4781(90)90048-7; ROHRMANN G, 1986, CELL, V46, P1029, DOI 10.1016/0092-8674(86)90702-6; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; SHUMAN S, 1980, J BIOL CHEM, V255, P5396; SHUMAN S, 1990, J BIOL CHEM, V265, P11960; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1980, J BIOL CHEM, V255, P1588; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; SPENCER E, 1980, J BIOL CHEM, V255, P5388; STEINMETZ EJ, 1990, J BIOL CHEM, V265, P18408; VENKATESAN S, 1980, J BIOL CHEM, V255, P903; VEOMETT GE, 1973, ICN UCL S MOL BIOL, P127; WATANABE Y, 1974, FEBS LETT, V41, P331, DOI 10.1016/0014-5793(74)81241-X; WU SY, 1993, P NATL ACAD SCI USA, V90, P6606, DOI 10.1073/pnas.90.14.6606	45	45	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10050	10060						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144504				2022-12-27	WOS:A1994NE05300099
J	HERSCOVICS, A; SCHNEIKERT, J; ATHANASSIADIS, A; MOREMEN, KW				HERSCOVICS, A; SCHNEIKERT, J; ATHANASSIADIS, A; MOREMEN, KW			ISOLATION OF A MOUSE GOLGI MANNOSIDASE CDNA, A MEMBER OF A GENE FAMILY CONSERVED FROM YEAST TO MAMMALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; PROCESSING ALPHA-MANNOSIDASE; RAT-LIVER; GLYCOPROTEIN-BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; TRIMMING MAN9-MANNOSIDASE; EXPRESSION CLONING; PIG-LIVER; PURIFICATION	The amino acid sequence of the specific alpha-mannosidase involved in N-oligosaccharide processing in Saccharomyces cerevisiae was found to have a high degree of similarity to the deduced amino acid sequence of rabbit liver alpha-mannosidase partial cDNA, demonstrating that processing mannosidases have been conserved through eukaryotic evolution. Regions of sequence identity were chosen to design degenerate oligonucleotide primers that can be used to prepare probes using the polymerase chain reaction (PCR) for cloning processing mannosidases from other eukaryotes. Using these primers for PCR with mouse liver cDNA as template, two related but distinct PCR products were obtained. The amino acid sequences of PCR1 and PCR2 were 88 and 65% identical with the corresponding sequence of the rabbit enzyme, respectively. Southern blot analysis of mouse genomic DNA using PCR1 and PCR2 as probes revealed that they are derived from two different genes, indicating the existence of a mammalian mannosidase gene family with at least two members. Using PCR2 as a probe, a novel mouse cDNA was isolated from a 3T3 cDNA library. It contains an open reading frame which encodes a type II membrane protein of 73 kDa with a cytoplasmic region of about 35 amino acids, a Ca2+ binding consensus sequence, and a single N-glycosylation site. Northern blot analysis of mouse tissues and L cells revealed tissue-specific expression of multiple transcripts, ranging in size from 4.2 to 8.5 kilobases, that suggests a complex pattern of gene regulation. Transient expression of the influenza hemagglutinin epitope-tagged cDNA in COS cells followed by indirect immunofluorescence with monoclonal antibody 12CA5 showed that the cloned mannosidase is primarily localized in a juxtanuclear position corresponding to the Golgi. The C-terminal domain lacking the putative transmembrane region was shown to have alpha-mannosidase activity when expressed in COS cells as a secreted Protein A fusion product.	MIT,CTR CANC RES,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)	HERSCOVICS, A (corresponding author), MCGILL UNIV,MCGILL CANC CTR,3655 DRUMMOND ST,MONTREAL H3G 1Y6,QUEBEC,CANADA.		Moremen, Kelley/AAD-4661-2019		NIGMS NIH HHS [GM47533, GM31318, GM31265] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031318, R01GM047533, R01GM031318] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM, 1988, MOL REPROD DEV; BAUSE E, 1992, EUR J BIOCHEM, V208, P451, DOI 10.1111/j.1432-1033.1992.tb17207.x; BISCHOFF J, 1990, J BIOL CHEM, V265, P17110; BISCHOFF J, 1983, J BIOL CHEM, V258, P7907; BISCHOFF J, 1986, J BIOL CHEM, V261, P4758; BONAY P, 1991, EUR J BIOCHEM, V197, P229, DOI 10.1111/j.1432-1033.1991.tb15903.x; CAMIRAND A, 1991, J BIOL CHEM, V266, P15120; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DENNIS JW, 1986, CANCER RES, V46, P5131; DESANTIS R, 1987, BIOCHEM BIOPH RES CO, V142, P348, DOI 10.1016/0006-291X(87)90280-4; ELBEIN AD, 1991, FASEB J, V5, P3055, DOI 10.1096/fasebj.5.15.1743438; ESMON B, 1984, J BIOL CHEM, V259, P322; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; FORSEE WT, 1981, J BIOL CHEM, V256, P6577; FORSEE WT, 1989, J BIOL CHEM, V264, P3869; FUKUDA M N, 1990, Glycobiology, V1, P9, DOI 10.1093/glycob/1.1.9; GRONDIN B, 1992, GLYCOBIOLOGY, V2, P369, DOI 10.1093/glycob/2.4.369; HARDUINLEPERS A, 1993, J BIOL CHEM, V268, P14348; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HERSCOVICS A, 1987, ANAL BIOCHEM, V166, P85, DOI 10.1016/0003-2697(87)90550-1; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; JELINEKKELLY S, 1988, J BIOL CHEM, V263, P14757; JELINEKKELLY S, 1985, J BIOL CHEM, V260, P2253; JOZIASSE DH, 1992, GLYCOBIOLOGY, V2, P271, DOI 10.1093/glycob/2.4.271; KOLODZIEJ P, 1989, MOL CELL BIOL, V9, P5387, DOI 10.1128/MCB.9.12.5387; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KUKOWSKALATALLO JF, 1990, GENE DEV, V4, P1288, DOI 10.1101/gad.4.8.1288; LARSEN RD, 1989, P NATL ACAD SCI USA, V86, P8227, DOI 10.1073/pnas.86.21.8227; LEJBKOWICZ F, 1992, P NATL ACAD SCI USA, V89, P9612, DOI 10.1073/pnas.89.20.9612; LUBAS WA, 1988, J BIOL CHEM, V263, P3990; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; MOREMEN KW, 1991, J CELL BIOL, V115, P1521, DOI 10.1083/jcb.115.6.1521; MOREMEN KW, 1989, P NATL ACAD SCI USA, V86, P5276, DOI 10.1073/pnas.86.14.5276; MOREMEN KW, 1994, IN PRESS GLYCOBIOLOG; MOREMEN KW, 1990, GLYCOCONJUGATE J, V7, P401; NEWTON SA, 1989, JNCI-J NATL CANCER I, V81, P1024, DOI 10.1093/jnci/81.13.1024; NGUYEN M, 1992, J BIOL CHEM, V267, P26157; PUCCIA R, 1993, BIOCHEM J, V290, P21, DOI 10.1042/bj2900021; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; ROTH J, 1990, EUR J CELL BIOL, V53, P131; Sambrook J, 1989, MOL CLONING LABORATO; SANCHEZLOPEZ R, 1988, J BIOL CHEM, V263, P11892; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schachter H, 1991, CURR OPIN STRUC BIOL, V1, P755, DOI 10.1016/0959-440X(91)90175-S; SCHWEDEN J, 1989, BIOCHEM J, V264, P347, DOI 10.1042/bj2640347; SCHWEDEN J, 1986, EUR J BIOCHEM, V157, P563, DOI 10.1111/j.1432-1033.1986.tb09703.x; SHAPER JH, 1992, CURR OPIN STRUC BIOL, V2, P701; SHOUP VA, 1976, J BIOL CHEM, V251, P3845; TABAS I, 1979, J BIOL CHEM, V254, P1655; TULSIANI DRP, 1988, J BIOL CHEM, V263, P5408; TULSIANI DRP, 1982, J BIOL CHEM, V257, P3660; TULSIANI DRP, 1985, J BIOL CHEM, V260, P3081; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0; YOSHIHISA T, 1990, J BIOL CHEM, V265, P22418; ZIEGLER F D, 1991, Glycobiology, V1, P605, DOI 10.1093/glycob/1.6.605	58	83	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9864	9871						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144579				2022-12-27	WOS:A1994NE05300073
J	KAWASAKI, K; PHILPOTT, A; AVILION, AA; BERRIOS, M; FISHER, PA				KAWASAKI, K; PHILPOTT, A; AVILION, AA; BERRIOS, M; FISHER, PA			CHROMATIN DECONDENSATION IN DROSOPHILA EMBRYO EXTRACTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEXES; CHAIN-LIKE POLYPEPTIDE; XENOPUS-LAEVIS; DEVELOPMENTAL REGULATION; AFFINITY PURIFICATION; ALKALINE-PHOSPHATASE; NUCLEOLAR PROTEIN; EUKARYOTIC CELLS; DNA-REPLICATION; SPERM CHROMATIN	Decondensation of sperm chromatin in cell-free Drosophila embryo extracts was efficient, rapid, and synchronous. The decondensation activity was N-ethylmaleimide-resistant, soluble, and heat-stable. Two specific proteins, X and Y, were removed selectively from Xenopus sperm coincident with morphological decondensation. A heat-stable protein, p22, was purified to apparent homogeneity from Drosophila melanogaster embryos by a procedure optimized for the purification of Xenopus laevis nucleoplasmin. Although itself capable of catalyzing decondensation of Xenopus sperm, the precise relationship of Drosophila p22 to Xenopus nucleoplasmin is unclear. Drosophila p22 and Xenopus nucleoplasmin were immunologically distinct. Moreover, p22 was present as a nuclear protein throughout Drosophila development as determined both by immunoblot and by indirect immunofluorescence analyses. Drosophila embryo extracts largely or completely immunodepleted of p22 lost some but not all heat-stable decondensation activity. These observations lead to the conclusion that Drosophila embryo extracts contain at least two heat-stable sperm decondensation factors.	SUNY STONY BROOK,HLTH SCI CTR,DEPT PHARMACOL SCI,STONY BROOK,NY 11794; WELLCOME CRC INST,CAMBRIDGE CB2 1QR,ENGLAND; SUNY STONY BROOK,HLTH SCI CTR,DEPT PHARMACOL SCI,STONY BROOK,NY 11794; INST PHYS & CHEM RES,CELLULAR & MOLEC BIOL LAB,HIROSAWA,SAITAMA 35101,JAPAN	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; RIKEN				Philpott, Anna/0000-0003-3789-2463	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLIS CD, 1977, DEV BIOL, V56, P372, DOI 10.1016/0012-1606(77)90277-9; BEDFORD JM, 1972, AM J ANAT, V133, P213, DOI 10.1002/aja.1001330206; BERRIOS M, 1989, MED LAB SCI, V46, P276; BERRIOS M, 1986, J CELL BIOL, V103, P711, DOI 10.1083/jcb.103.3.711; BERRIOS M, 1979, J CELL SCI, V39, P1; BERRIOS M, 1991, P NATL ACAD SCI USA, V88, P219, DOI 10.1073/pnas.88.1.219; BERRIOS M, 1990, EXP CELL RES, V191, P64, DOI 10.1016/0014-4827(90)90036-A; BERRIOS M, 1994, IN PRESS BIOTECH HIS; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BONNEANDREA C, 1984, EMBO J, V3, P1193, DOI 10.1002/j.1460-2075.1984.tb01950.x; BURGLIN TR, 1987, GENE DEV, V1, P97, DOI 10.1101/gad.1.1.97; CREVEL G, 1991, EMBO J, V10, P4361, DOI 10.1002/j.1460-2075.1991.tb05014.x; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; DINGWALL C, 1987, EMBO J, V6, P69, DOI 10.1002/j.1460-2075.1987.tb04720.x; FISHER PA, 1982, J CELL BIOL, V92, P674, DOI 10.1083/jcb.92.3.674; FISHER PA, 1988, BIOCHEM SOC T, V16, P134, DOI 10.1042/bst0160134; HARLOW E, 1988, ANTIBODIES LABORATOR; ISHIMI Y, 1991, J BIOL CHEM, V266, P7025; JACOBSLORENA M, 1977, DEV BIOL, V57, P385, DOI 10.1016/0012-1606(77)90223-8; KLEINSCHMIDT J, 1986, EMBO J, V5, P3547, DOI 10.1002/j.1460-2075.1986.tb04681.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPEYRE B, 1987, P NATL ACAD SCI USA, V84, P1472, DOI 10.1073/pnas.84.6.1472; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; MCCONNELL M, 1987, J CELL BIOL, V105, P1087, DOI 10.1083/jcb.105.3.1087; MCGADEY J, 1970, HISTOCHEMISTRY, V23, P180, DOI 10.1007/BF00305851; OHSUMI K, 1991, DEV BIOL, V148, P295, DOI 10.1016/0012-1606(91)90338-4; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; SCHMIDTZACHMANN MS, 1987, EMBO J, V6, P1881, DOI 10.1002/j.1460-2075.1987.tb02447.x; SMITH DE, 1984, J CELL BIOL, V99, P20, DOI 10.1083/jcb.99.1.20; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; ULITZUR N, 1992, J CELL BIOL, V119, P17, DOI 10.1083/jcb.119.1.17; ULITZUR N, 1989, FEBS LETT, V259, P113, DOI 10.1016/0014-5793(89)81507-8; WEDLICH D, 1988, CELL TISSUE RES, V254, P295; WHALEN AM, 1991, J CELL BIOL, V112, P203, DOI 10.1083/jcb.112.2.203; Zweidler A, 1978, Methods Cell Biol, V17, P223, DOI 10.1016/S0091-679X(08)61145-0	36	55	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					10169	10176						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144519				2022-12-27	WOS:A1994NE05300115
J	SMITH, DM; TRAN, HM; SOO, VW; MCQUISTON, SA; TARTAGLIA, LA; GOEDDEL, DV; EPSTEIN, LB				SMITH, DM; TRAN, HM; SOO, VW; MCQUISTON, SA; TARTAGLIA, LA; GOEDDEL, DV; EPSTEIN, LB			ENHANCED SYNTHESIS OF TUMOR NECROSIS FACTOR-INDUCIBLE PROTEINS, PLASMINOGEN-ACTIVATOR INHIBITOR-2, MANGANESE SUPEROXIDE-DISMUTASE, AND PROTEIN 28/5.6, IS SELECTIVELY TRIGGERED BY THE 55-KDA TUMOR-NECROSIS-FACTOR RECEPTOR IN HUMAN-MELANOMA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; FACTOR TNF RECEPTOR; FACTOR-ALPHA; MONOCLONAL-ANTIBODIES; SYNERGISTIC INDUCTION; HUMAN-FIBROBLASTS; INTERFERON-GAMMA; EXPRESSION; CLONING; BINDING	We have demonstrated that A375 melanoma cells express mRNA for both types of tumor necrosis factor (TNF) receptors and receptor proteins on their plasma membranes. Specific agonist and blocking antibodies to either 55-kDa (TNF-R1) or 75-kDa (TNF-R2) TNF receptors combined with two-dimensional gel analysis were employed to determine which receptor type is responsible for mediating the induction of individual melanoma proteins. Our results indicate that the enhanced synthesis of proteins 21/>7 (M(r)/pI), 28/5.6, and 41/5.7 is selectively induced through TNF-R1. TNF induces these proteins; antagonist antibody to TNF-R1 prevents their induction by TNF, and TNF-R1 agonist induces them in the absence of TNF. Identification of these proteins by immunoblot analysis proved that 21/>7 is manganese superoxide dismutase, protein 28/5.6 is unrelated to 27/28-kDa heat shock protein, and protein 41/5.7 is plasminogen activator inhibitor-2. Furthermore, TNF cytotoxicity for A375 cells is also mediated by TNF-R1. These studies indicate that TNF-R1 is a critical signaling receptor for TNF action on A375 cells and demonstrate the potential use of TNF-R1 antibodies to selectively block or enhance specific effects of TNF on melanoma cells.	UNIV CALIF SAN FRANCISCO,CANC RES INST,SAN FRANCISCO,CA 94143; GENENTECH INC,DEPT MOLEC BIOL,S SAN FRANCISCO,CA 94080; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; Roche Holding; Genentech; University of California System; University of California San Francisco					NCI NIH HHS [CA 4446, CA 27903] Funding Source: Medline; NIA NIH HHS [AG08938] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA027903, R01CA027903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG008938] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARRIGO AP, 1990, MOL CELL BIOL, V10, P3857; ARRIGO AP, 1990, MOL CELL BIOL, V10, P1276, DOI 10.1128/MCB.10.3.1276; BERESINI MH, 1990, ELECTROPHORESIS, V11, P232, DOI 10.1002/elps.1150110307; BERESINI MH, 1988, J IMMUNOL, V140, P485; BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127; BROUCKAERT P, 1992, LYMPHOKINE CYTOK RES, V11, P193; CAMUSSI G, 1991, EUR J BIOCHEM, V202, P3, DOI 10.1111/j.1432-1033.1991.tb16337.x; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; CHURCH SL, 1993, P NATL ACAD SCI USA, V90, P3113, DOI 10.1073/pnas.90.7.3113; CHURCH SL, 1992, DEV BIOL, V149, P177, DOI 10.1016/0012-1606(92)90274-K; DEMBIC Z, 1990, Cytokine, V2, P231, DOI 10.1016/1043-4666(90)90022-L; DUFFY MJ, 1992, CLIN EXP METASTAS, V10, P145, DOI 10.1007/BF00132746; ENGELMANN H, 1990, J BIOL CHEM, V265, P14497; EPSTEIN LB, 1991, CYTOKINES PRACTICAL; ESPEVIK T, 1990, J EXP MED, V171, P415, DOI 10.1084/jem.171.2.415; GARRELS JI, 1979, J BIOL CHEM, V254, P7961; GHER G, 1992, J IMMUNOL, V149, P911; GRAY PW, 1990, P NATL ACAD SCI USA, V87, P7380, DOI 10.1073/pnas.87.19.7380; GREENBLATT MS, 1992, BLOOD, V80, P1339; GRELL M, 1993, LYMPHOKINE CYTOK RES, V12, P143; HALL SC, 1993, P NATL ACAD SCI USA, V90, P1927, DOI 10.1073/pnas.90.5.1927; HARRIS CA, 1991, J IMMUNOL, V147, P149; HIGUCHI M, 1992, BIOCHEM BIOPH RES CO, V182, P638, DOI 10.1016/0006-291X(92)91780-T; HO YS, 1988, FEBS LETT, V229, P256, DOI 10.1016/0014-5793(88)81136-0; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JAATTELA M, 1991, LAB INVEST, V64, P724; JOHNSON SE, 1990, J BIOL CHEM, V265, P6642; KRONKE M, 1991, TUMOR NECROSIS FACTO, P189; KRUPPA G, 1992, J IMMUNOL, V148, P3152; KWEE JK, 1991, CANCER LETT, V57, P199, DOI 10.1016/0304-3835(91)90157-D; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; LOETSCHER A, 1992, 8TH P INT C IMM BUD, P236; LOPEZ MF, 1991, 2D PAGE 91, P313; MALLETT S, 1991, IMMUNOL TODAY, V12, P220, DOI 10.1016/0167-5699(91)90033-P; MONTGOMERY AMP, 1993, CANCER RES, V53, P693; NAKAMURA M, 1992, THROMB RES, V65, P709, DOI 10.1016/0049-3848(92)90110-V; OBERLEY LW, 1983, SUPEROXIDE DISMUTASE, V2, P127; OSTADE XV, 1993, NATURE, V361, P266; OTTER T, 1987, ANAL BIOCHEM, V162, P370, DOI 10.1016/0003-2697(87)90406-4; PATTON WF, 1990, BIOTECHNIQUES, V8, P518; PENNICA D, 1992, BIOCHEMISTRY-US, V31, P1134, DOI 10.1021/bi00119a023; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; PYTEL BA, 1990, J CELL PHYSIOL, V144, P416, DOI 10.1002/jcp.1041440308; QUAX PHA, 1991, J CELL BIOL, V115, P191, DOI 10.1083/jcb.115.1.191; SAKLATVALA J, 1991, BIOCHEM J, V277, P635, DOI 10.1042/bj2770635; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SMITH DM, 1992, TUMOR NECROSIS FACTOR : STRUCTURE-FUNCTION RELATIONSHIP AND CLINICAL APPLICATION, P173; SMITH DM, 1991, 2D PAGE 91, P145; SUMIYOSHI K, 1992, INT J CANCER, V50, P345, DOI 10.1002/ijc.2910500303; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; TARTAGLIA LA, 1992, J BIOL CHEM, V267, P4304; TARTAGLIA LA, 1993, J IMMUNOL, V151, P4637; VANDENABEELE P, 1992, J EXP MED, V176, P1015, DOI 10.1084/jem.176.4.1015; VILCEK J, 1991, J BIOL CHEM, V266, P7313; WISPE JR, 1989, BIOCHIM BIOPHYS ACTA, V994, P30, DOI 10.1016/0167-4838(89)90058-7; WONG GHW, 1992, J IMMUNOL, V149, P3350; YANAGA F, 1992, FEBS LETT, V314, P297, DOI 10.1016/0014-5793(92)81493-6	59	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9898	9905						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144583				2022-12-27	WOS:A1994NE05300077
J	VOLLAND, C; URBANGRIMAL, D; GERAUD, G; HAGUENAUERTSAPIS, R				VOLLAND, C; URBANGRIMAL, D; GERAUD, G; HAGUENAUERTSAPIS, R			ENDOCYTOSIS AND DEGRADATION OF THE YEAST URACIL PERMEASE UNDER ADVERSE CONDITIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE ATPASE; COLI SHUTTLE VECTORS; SACCHAROMYCES-CEREVISIAE; ALPHA-FACTOR; CATABOLITE INACTIVATION; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; RESTRICTION SITES; UBIQUITIN PATHWAY; TRANSPORT-SYSTEM	Yeast uracil permease follows the secretory pathway to the plasma membrane and is phosphorylated on serine residues in a post-Golgi compartment. The protein was found to be rather stable in growing cells, but its turnover rate (half-life of about 7 h) was much faster than that of most yeast proteins. Several adverse conditions triggered the rapid degradation of uracil permease, and so a loss of uracil uptake. Turnover was rapid when yeast cells were starved of either nitrogen, phosphate, or carbon, and as they approached the stationary growth phase. Rapid permease degradation was also promoted by the inhibition of protein synthesis. The degradation of uracil permease in response to several stresses was strikingly slower in the two mutants, end3 and end4, that are deficient in the internalization step of receptor-mediated endocytosis. Thus, internalization is the first step in the permease degradative pathway. Uracil permease is degraded in the vacuole, since pep4 mutant cells lacking vacuolar protease activities accumulated large amounts of uracil permease, which was located within the vacuole by immunofluorescence. We have yet to determine whether adverse conditions enhance permease endocytosis and subsequent degradation or divert internalized uracil permease from a recycling to a degradative pathway.	UNIV PARIS 07, INST JACQUES MONOD, 2 PL JUSSIEU, F-75251 PARIS 05, FRANCE	UDICE-French Research Universities; Universite Paris Cite			Haguenauer-Tsapis, Rosine/C-5446-2012					AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; BENITO B, 1991, BIOCHIM BIOPHYS ACTA, V1063, P265, DOI 10.1016/0005-2736(91)90381-H; BUSTURIA A, 1986, J GEN MICROBIOL, V132, P379; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; CHEVALLIER MR, 1982, MOL CELL BIOL, V2, P977, DOI 10.1128/MCB.2.8.977; CHIRIO MC, 1990, EUR J BIOCHEM, V194, P293, DOI 10.1111/j.1432-1033.1990.tb19456.x; DAVIS NG, 1993, J CELL BIOL, V122, P53, DOI 10.1083/jcb.122.1.53; DEJUAN C, 1986, FEBS LETT, V207, P258, DOI 10.1016/0014-5793(86)81500-9; DULIC V, 1991, METHOD ENZYMOL, V194, P697; ERASO P, 1987, FEBS LETT, V224, P193, DOI 10.1016/0014-5793(87)80446-5; FINLEY D, 1992, MOL CELLULAR BIOL YE, V2, P539; GANCEDO JM, 1982, MOL CELL BIOCHEM, V43, P89, DOI 10.1007/BF00423096; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GRENSON M, 1969, EUR J BIOCHEM, V11, P249, DOI 10.1111/j.1432-1033.1969.tb00767.x; HARE JF, 1990, BIOCHIM BIOPHYS ACTA, V1031, P71, DOI 10.1016/0304-4157(90)90003-U; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HUNT T, 1991, NATURE, V349, P100, DOI 10.1038/349100a0; JENNESS DD, 1986, CELL, V46, P345, DOI 10.1016/0092-8674(86)90655-0; JUND R, 1977, J MEMBRANE BIOL, V36, P233, DOI 10.1007/BF01868153; JUND R, 1988, EUR J BIOCHEM, V171, P417, DOI 10.1111/j.1432-1033.1988.tb13806.x; KUCHLER K, 1993, J CELL BIOL, V120, P1203, DOI 10.1083/jcb.120.5.1203; LACROUTE F, 1968, J BACTERIOL, V95, P824, DOI 10.1128/JB.95.3.824-832.1968; LAGUNAS R, 1982, J BACTERIOL, V152, P19; LASZLO L, 1990, FEBS LETT, V261, P365, DOI 10.1016/0014-5793(90)80593-8; LJUNGDAHL PO, 1992, CELL, V71, P463, DOI 10.1016/0092-8674(92)90515-E; MARSH M, 1993, CURR BIOL, V3, P30, DOI 10.1016/0960-9822(93)90142-B; MECHLER B, 1982, BIOCHEM BIOPH RES CO, V107, P770, DOI 10.1016/0006-291X(82)90590-3; MORI S, 1992, J BIOL CHEM, V267, P6429; PANARETOU B, 1992, EUR J BIOCHEM, V206, P635, DOI 10.1111/j.1432-1033.1992.tb16968.x; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; PIPER RC, 1992, J CELL BIOL, V117, P729, DOI 10.1083/jcb.117.4.729; RAMOS J, 1989, J BACTERIOL, V171, P3545, DOI 10.1128/jb.171.6.3545-3548.1989; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; RIEZMAN H, 1986, TRENDS BIOCHEM SCI, V11, P325, DOI 10.1016/0968-0004(86)90290-2; Riezman Howard, 1993, Trends in Cell Biology, V3, P273, DOI 10.1016/0962-8924(93)90056-7; ROBERTS CJ, 1992, J CELL BIOL, V119, P69, DOI 10.1083/jcb.119.1.69; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SEUFERT W, 1992, EMBO J, V11, P3077, DOI 10.1002/j.1460-2075.1992.tb05379.x; SHULMAN RW, 1977, J BIOL CHEM, V252, P1344; SILVE S, 1991, MOL CELL BIOL, V11, P1114, DOI 10.1128/MCB.11.2.1114; SIMEON A, 1992, FEBS LETT, V301, P231, DOI 10.1016/0014-5793(92)81254-J; SINGER B, 1990, J CELL BIOL, V110, P1911, DOI 10.1083/jcb.110.6.1911; SMYTHE E, 1991, EUR J BIOCHEM, V202, P689, DOI 10.1111/j.1432-1033.1991.tb16424.x; TACHIBANA C, 1992, MOL CELL BIOL, V12, P4601, DOI 10.1128/MCB.12.10.4601; THEVELEIN JM, 1991, MOL MICROBIOL, V5, P1301, DOI 10.1111/j.1365-2958.1991.tb00776.x; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q; VEINOTDREBOT LM, 1989, J BIOL CHEM, V264, P19473; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; VOLLAND C, 1992, J BIOL CHEM, V267, P23767; WICHMANN H, 1992, CELL, V71, P1131, DOI 10.1016/S0092-8674(05)80062-5; WILSON DW, 1989, NATURE, V339, P355, DOI 10.1038/339355a0; WOOLFORD CA, 1986, MOL CELL BIOL, V6, P2500, DOI 10.1128/MCB.6.7.2500; WOOLFORD JL, 1991, MOL CELLULAR BIOL YE, V1, P587; ZANOLARI B, 1991, MOL CELL BIOL, V11, P5251, DOI 10.1128/MCB.11.10.5251; [No title captured]	58	232	234	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	1994	269	13					9833	9841						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE053	8144575				2022-12-27	WOS:A1994NE05300069
J	COOK, GA; MYNATT, RL; KASHFI, K				COOK, GA; MYNATT, RL; KASHFI, K			YONETANI-THEORELL ANALYSIS OF HEPATIC CARNITINE PALMITOYLTRANSFERASE-I INHIBITION INDICATES 2 DISTINCT INHIBITORY BINDING-SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; MALONYL-COA; APPARENT-KI; ACTIVE-SITE; SENSITIVITY; ACYLTRANSFERASE; AFFINITY; INSULIN; VALUES	Analysis of inhibitor studies indicates that carnitine palmitoyltransferase-I has two separate sites for inhibitor binding. One site is located on the cytoplasmic side of the mitochondrial outer membrane. Malonyl-CoA, the most important physiological inhibitor of carnitine palmitoyltransferase-I, binds primarily to this site, but it can also bind to another site. A second inhibitory site is located at the active site of carnitine palmitoyltransferase-I. Coenzyme A, a product/inhibitor of carnitine palmitoyltransferase-I binds primarily at this site and can inhibit carnitine palmitoyltransferase-I at physiological concentrations, but can also attenuate malonyl-CoA inhibition. Analogs of malonyl-CoA and other simpler compounds containing two carbonyl groups but no coenzyme A moiety inhibit only at the cytoplasmic she, indicating that this site has an absolute requirement for two carbonyl groups but has no absolute requirement for a coenzyme A moiety. Inhibitors acting through the active site included the active-site-directed inhibitor (+)-hemipalmitoylcarpitinium. These studies support the existence of two regulatory binding sites for the control of hepatic fatty acid oxidation: (a) the active site, for regulation by the inhibitory binding of coenzyme A and acetyl-CoA, and (b) a separate regulatory malonyl-CoA-binding site that is physically separated from the active site.			COOK, GA (corresponding author), UNIV TENNESSEE,CTR HLTH SCI,COLL MED,DEPT PHARMACOL,874 UNION AVE,MEMPHIS,TN 38163, USA.		Mynatt, Randall L/N-1980-2017	Mynatt, Randall L/0000-0003-4399-0019	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007641, R01HL040929] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32-HL07641, HL-40929] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; BIRD MI, 1984, BIOCHEM J, V222, P639, DOI 10.1042/bj2220639; BREMER J, 1981, BIOCHIM BIOPHYS ACTA, V665, P628, DOI 10.1016/0005-2760(81)90282-4; BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420; COOK GA, 1980, BIOCHEM J, V192, P955, DOI 10.1042/bj1920955; COOK GA, 1984, J BIOL CHEM, V259, P2030; COOK GA, 1987, J BIOL CHEM, V262, P2050; DECLERCQ PE, 1985, J BIOL CHEM, V260, P2516; ESSER V, 1993, J BIOL CHEM, V268, P5817; FRITZ IB, 1963, J LIPID RES, V4, P279; GAMBLE MS, 1985, J BIOL CHEM, V260, P9516; GANDOUR RD, 1992, J ORG CHEM, V57, P3426, DOI 10.1021/jo00038a035; GANDOUR RD, 1993, J MED CHEM, V36, P237, DOI 10.1021/jm00054a007; GHADIMINEJAD I, 1991, BIOCHIM BIOPHYS ACTA, V1083, P166, DOI 10.1016/0005-2760(91)90038-J; GRANTHAM BD, 1986, BIOCHEM J, V233, P589, DOI 10.1042/bj2330589; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; KASHFI K, 1992, BIOCHEM J, V282, P909, DOI 10.1042/bj2820909; KASHFI K, 1988, BIOCHEM SOC T, V16, P1010, DOI 10.1042/bst0161010; KASHFI K, 1991, BIOCHEM BIOPH RES CO, V176, P600; KIORPES TC, 1984, J BIOL CHEM, V259, P9750; KOLODZIEJ MP, 1993, FEBS LETT, V327, P294, DOI 10.1016/0014-5793(93)81007-M; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; MILLS SE, 1983, BIOCHEM J, V214, P83, DOI 10.1042/bj2140083; MURTHY MSR, 1987, P NATL ACAD SCI USA, V84, P378, DOI 10.1073/pnas.84.2.378; PARSONS DF, 1966, ANN NY ACAD SCI, V137, P643, DOI 10.1111/j.1749-6632.1966.tb50188.x; SAGGERSON ED, 1981, FEBS LETT, V129, P225, DOI 10.1016/0014-5793(81)80170-6; STEPHENS TW, 1987, BIOCHEM J, V243, P405, DOI 10.1042/bj2430405; WOELTJE KF, 1990, J BIOL CHEM, V265, P10720; WOLDEGIORGIS G, 1992, ARCH BIOCHEM BIOPHYS, V295, P348, DOI 10.1016/0003-9861(92)90527-4; YONETANI T, 1982, METHOD ENZYMOL, V87, P500	30	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8803	8807						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132614				2022-12-27	WOS:A1994NB41100031
J	NAKANISHI, M; KAGAWA, Y; NARITA, Y; HIRATA, H				NAKANISHI, M; KAGAWA, Y; NARITA, Y; HIRATA, H			PURIFICATION AND RECONSTITUTION OF AN INTESTINAL NA+-DEPENDENT NEUTRAL L-ALPHA-AMINO ACID TRANSPORTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORDER MEMBRANE-VESICLES; RAT-BRAIN; EXPRESSION CLONING; FUNCTIONAL-CHARACTERIZATION; GLUTAMATE TRANSPORTER; SYSTEM; PROTEIN; SOLUBILIZATION; IDENTIFICATION; GLYCOPROTEIN	Using an improved reconstitution method, we have purified an Na+-dependent neutral L-alpha-amino acid transporter from rabbit small intestine to apparent homogeneity. The preparation solubilized with octaethylene glycol dodecyl ether (C(12)E(8)) was purified by successive chromatographies on DEAE-Toyopearl and lentil lectin-Sepharose 4B columns. The transport activity was assayed by reconstitution of the protein into liposomes. The specific activity of the final preparation was 1364-fold that of brush border membrane vesicles. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis, the active fractions gave one band of 90 kDa. Kinetic analysis using proteoliposomes reconstituted with the purified fraction showed that alanine transport was mediated by high affinity system with K-t value of 0.19 mM and J(max) value of 2.8 nmol/mg protein/s. Analysis of the amino acid composition of the purified transporter revealed that the transporter is very hydrophobic protein. From its specific activities for transport of individual amino acids this transporter was concluded to possess broad specificity for neutral L-alpha-amino acids. Furthermore, inhibition study of other amino acids allowed us to identify this transport pathway as the intestinal system B.	JICHI MED SCH,DEPT BIOCHEM,MINAMIKWACHI,TOCHIGI 32904,JAPAN; NAGOYA CITY UNIV,SCH MED,DEPT BIOCHEM,MIZUHO KU,NAGOYA,AICHI 467,JAPAN; HIMEJI INST TECHNOL,FAC SCI,DEPT LIFE SCI,HIMEJI,HYOGO 67812,JAPAN	Jichi Medical University; Nagoya City University; University of Hyogo								BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BOYD CAR, 1987, AMINO ACID TRANSPORT, P123; DANBOLT NC, 1990, BIOCHEMISTRY-US, V29, P6734, DOI 10.1021/bi00480a025; DANIEL H, 1991, J BIOL CHEM, V266, P19917; DUDECK KL, 1987, J BIOL CHEM, V262, P12565; FAFOURNOUX P, 1989, J BIOL CHEM, V264, P4805; FASS SJ, 1977, J BIOL CHEM, V252, P583; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; HAMMERMAN MR, 1977, J BIOL CHEM, V252, P591; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; IM WB, 1980, J BIOL CHEM, V255, P764; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, FEBS LETT, V89, P47, DOI 10.1016/0014-5793(78)80519-5; KIM JW, 1991, NATURE, V352, P725, DOI 10.1038/352725a0; KOEPSELL H, 1986, REV PHYSIOL BIOCH P, V104, P65, DOI 10.1007/BFb0031013; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOPEZCORCUERA B, 1991, J BIOL CHEM, V266, P24809; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAENZ DD, 1992, J BIOL CHEM, V267, P1510; MAENZ DD, 1992, J BIOL CHEM, V267, P22079; MCCORMICK JI, 1988, P NATL ACAD SCI USA, V85, P7877, DOI 10.1073/pnas.85.21.7877; MERRIL CR, 1984, METHOD ENZYMOL, V104, P441; NAKANISHI M, 1993, BIOCHIM BIOPHYS ACTA, V1151, P193, DOI 10.1016/0005-2736(93)90104-8; NISHINO H, 1978, P NATL ACAD SCI USA, V75, P3856, DOI 10.1073/pnas.75.8.3856; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; PAJOR AM, 1992, J BIOL CHEM, V267, P3557; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; RADIAN R, 1986, J BIOL CHEM, V261, P5437; RADIAN R, 1985, J BIOL CHEM, V260, P1859; RAJENDRAN VM, 1987, J BIOL CHEM, V262, P14974; SCHALI C, 1986, BIOCHEM J, V235, P189, DOI 10.1042/bj2350189; SIGRISTNELSON K, 1975, J BIOL CHEM, V250, P5674; STEVENS BR, 1987, J BIOL CHEM, V262, P6546; STEVENS BR, 1982, J MEMBRANE BIOL, V66, P213, DOI 10.1007/BF01868496; STEVENS BR, 1984, ANNU REV PHYSIOL, V46, P417; STEVENS BR, 1992, AM J PHYSIOL, V263, pR458, DOI 10.1152/ajpregu.1992.263.3.R458; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TAMARAPPOO BK, 1992, J BIOL CHEM, V267, P2370; TATE SS, 1992, P NATL ACAD SCI USA, V89, P1, DOI 10.1073/pnas.89.1.1; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	41	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					9325	9329						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132671				2022-12-27	WOS:A1994NB41100102
J	ROBERTS, DL; BENNETT, DW; FORST, SA				ROBERTS, DL; BENNETT, DW; FORST, SA			IDENTIFICATION OF THE SITE OF PHOSPHORYLATION ON THE OSMOSENSOR, ENVZ OF ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 REGULATORY COMPONENTS; PORIN GENE-EXPRESSION; OMPC GENES; TRANSCRIPTIONAL ACTIVATOR; PROTEIN-KINASE; OSMOREGULATORY EXPRESSION; ENVIRONMENTAL SENSOR; SIGNAL TRANSDUCTION; DNA-BINDING; K-12	EnvZ is a membrane-bound histidine kinase that functions as an osmotic sensor capable of phosphorylating the regulator protein OmpR in Escherichia coli. To characterize the site of phosphorylation biochemically, we overexpressed a 36-kDa truncated EnvZ protein (Glu-106 to Gly-450) that formed inclusion bodies in the cell. After solubilization, the inclusion body form of EnvZ was cleaved into two major fragments with molecular weights of 25,000 and 10,000. The 25-kDa fragment, EnvZ(c), was purified and found to exist as a dimer. N-terminal sequence analysis established that cleavage had occurred at Arg-214, indicating that EnvZ(c) contained most of the cytoplasmic domain of EnvZ. After labeling EnvZ(c) with [gamma-P-32]ATP, the protein was proteo proteolytically digested, and the resulting peptides were separated by reverse phase chromatography using high performance liquid chromatography. One major radioactive peptide containing greater than 90% of the recovered peptide-associated radioactivity was isolated. Amino acid analysis of this purified peptide indicated that the composition was consistent with a peptide that contained His-243. The amino acid sequence of this peptide was determined to be MAGVSHDLRTP (residues 238-248). These results indicate that His-243 is the major site of phosphorylation on EnvZ and represents the first biochemical characterization of the site of phosphorylation of a membrane histidine kinase of the two-component regulatory family of molecules in bacteria.	UNIV WISCONSIN,DEPT BIOL SCI,MILWAUKEE,WI 53201; UNIV WISCONSIN,DEPT CHEM,MILWAUKEE,WI 53201	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM044671] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM44671] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIBA H, 1989, J BIOL CHEM, V264, P14090; AIBA H, 1989, J BIOL CHEM, V264, P8563; AIBA H, 1990, FEBS LETT, V261, P19, DOI 10.1016/0014-5793(90)80626-T; Alphen W V, 1977, J Bacteriol, V131, P623; BRISSETTE RE, 1991, J BACTERIOL, V173, P601, DOI 10.1128/jb.173.2.601-608.1991; CUI JS, 1993, J BIOL CHEM, V268, P5040; ELLIOTT JI, 1978, ARCH BIOCHEM BIOPHYS, V190, P351, DOI 10.1016/0003-9861(78)90285-0; FORST S, 1990, J BACTERIOL, V172, P3473, DOI 10.1128/jb.172.6.3473-3477.1990; FORST S, 1987, J BIOL CHEM, V262, P16433; FORST S, 1989, P NATL ACAD SCI USA, V86, P6052, DOI 10.1073/pnas.86.16.6052; FORST S, 1988, ANNU REV CELL BIOL, V4, P21, DOI 10.1146/annurev.cb.04.110188.000321; HALL MN, 1981, J MOL BIOL, V151, P1, DOI 10.1016/0022-2836(81)90218-7; HARLOCKER SL, 1993, J BACTERIOL, V175, P1956, DOI 10.1128/JB.175.7.1956-1960.1993; HESS JF, 1988, NATURE, V336, P139, DOI 10.1038/336139a0; IGO M M, 1990, New Biologist, V2, P5; IGO MM, 1989, GENE DEV, V3, P598, DOI 10.1101/gad.3.5.598; IGO MM, 1988, J BACTERIOL, V170, P5971, DOI 10.1128/jb.170.12.5971-5973.1988; IGO MM, 1989, GENE DEV, V3, P1725, DOI 10.1101/gad.3.11.1725; JO YL, 1986, J BIOL CHEM, V261, P15253; MATSUYAMA SI, 1986, J BACTERIOL, V168, P1309, DOI 10.1128/jb.168.3.1309-1314.1986; MIZUNO T, 1982, J BIOL CHEM, V257, P13692; MIZUNO T, 1990, MOL MICROBIOL, V4, P1077, DOI 10.1111/j.1365-2958.1990.tb00681.x; NAKASHIMA K, 1991, J BIOL CHEM, V266, P10775; NINFA AJ, 1991, J BIOL CHEM, V266, P6888; NORIOKA S, 1986, J BIOL CHEM, V261, P7113; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; RAMPERSAUD A, 1989, J BIOL CHEM, V264, P18693; RAMPERSAUD A, 1991, J BACTERIOL, V173, P6882, DOI 10.1128/jb.173.21.6882-6888.1991; RUSSO FD, 1991, J MOL BIOL, V222, P567, DOI 10.1016/0022-2836(91)90497-T; SLAUCH JM, 1988, J BACTERIOL, V170, P439, DOI 10.1128/jb.170.1.439-441.1988; SLAUCH JM, 1989, J MOL BIOL, V210, P281, DOI 10.1016/0022-2836(89)90330-6; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; SWANSON RV, 1993, MOL MICROBIOL, V8, P435, DOI 10.1111/j.1365-2958.1993.tb01588.x; TAYLOR RK, 1983, J MOL BIOL, V166, P273, DOI 10.1016/S0022-2836(83)80085-0; WAUKAU J, 1992, J BACTERIOL, V174, P1522, DOI 10.1128/jb.174.5.1522-1527.1992; YANG Y, 1993, J MOL BIOL, V231, P335, DOI 10.1006/jmbi.1993.1286; YANG Y, 1991, P NATL ACAD SCI USA, V88, P11057, DOI 10.1073/pnas.88.24.11057	37	45	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1994	269	12					8728	8733						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB411	8132603				2022-12-27	WOS:A1994NB41100020
J	BRUSILOW, WSA; MONTICELLO, RA				BRUSILOW, WSA; MONTICELLO, RA			SYNTHESIS AND ASSEMBLY OF THE F-0 PROTON CHANNEL FROM F-0 GENES CLONED INTO BACTERIOPHAGE-LAMBDA AND INTEGRATED INTO THE ESCHERICHIA-COLI CHROMOSOME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING ATPASE; F1F0 ATPASE; H+-ATPASE; EXPRESSION; SUBUNITS; OPERON; UNC; DNA; F1F0-ATPASE; SYNTHASE	The promoter region and the first four genes of the Escherichia coli proton-translocating ATPase (unc) operon, uncIBEF, were cloned into bacteriophage lambda, enabling this region to be recombined into an unc-deleted E. coli chromosome at the lambda att site. The resultant E. coli strain, carrying single-copy F-0 genes, was tested for synthesis and assembly of functional F-0 proton channels. Membranes isolated from this strain contained all three F-0 subunits and were capable of binding purified F-1 and reconstituting F1F0-dependent energy coupling activities. The presence of these F-0 sectors did not affect cell growth or membrane proton permeability assayed by fluorescence quenching. When compared with wild type membranes, membranes from the single-copy F-0 strain contained less a and b subunits. When the single-copy lambda F-0 strain was transformed with an F-1 plasmid, the cells became phenotypically and biochemically Unc(+) with membrane-bound ATPase and ATP synthase activities that were 50-60% of wild type. The results demonstrate that F-0 produced from single-copy genes in the absence of F-1 is membrane-bound and functional (i.e. reconstitutable) but not freely permeable to protons. The presence of F-1 genes and/or subunits during F-0 synthesis and assembly both increases the relative amounts of membrane-bound a and b subunits and produces an F-0 sector more like that found in wild type cells than is produced from the single-copy F-0 genes alone.			BRUSILOW, WSA (corresponding author), WAYNE STATE UNIV,SCH MED,DEPT BIOCHEM,SCOTT HALL,540 E CANFIELD AVE,DETROIT,MI 48201, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K04AI000882] Funding Source: NIH RePORTER; NIAID NIH HHS [KO4-AI00882] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANGOV E, 1991, J BACTERIOL, V173, P407, DOI 10.1128/jb.173.1.407-411.1991; ANGOV E, 1988, J BACTERIOL, V170, P459, DOI 10.1128/jb.170.1.459-462.1988; ARIS JP, 1985, J BIOL CHEM, V260, P1207; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BRUSILOW WSA, 1993, MOL MICROBIOL, V9, P419, DOI 10.1111/j.1365-2958.1993.tb01703.x; BRUSILOW WSA, 1987, J BACTERIOL, V169, P4984, DOI 10.1128/jb.169.11.4984-4990.1987; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; COX GB, 1987, CURR TOP BIOENERG, V15, P163; COX GB, 1981, J BACTERIOL, V148, P30, DOI 10.1128/JB.148.1.30-42.1981; FILLINGAME RH, 1986, J BACTERIOL, V165, P244, DOI 10.1128/jb.165.1.244-251.1986; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; GROVE CL, 1987, J BACTERIOL, V169, P2158, DOI 10.1128/jb.169.5.2158-2164.1987; GUNSALUS RP, 1982, P NATL ACAD SCI-BIOL, V79, P320, DOI 10.1073/pnas.79.2.320; MONTICELLO RA, 1992, J BACTERIOL, V174, P3370, DOI 10.1128/jb.174.10.3370-3376.1992; NIEUWENHUIS FJR, BIOCHIM BIOPHYS ACTA, V325, P62; OSTROW KS, 1986, J BACTERIOL, V168, P1165, DOI 10.1128/jb.168.3.1165-1171.1986; PATI S, 1989, J BIOL CHEM, V264, P2640; PATI S, 1991, BIOCHEMISTRY-US, V30, P4710, DOI 10.1021/bi00233a011; SCARPETTA MA, 1991, J BIOL CHEM, V266; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; SOLOMON KA, 1988, J BACTERIOL, V171, P3039; WALKER JE, 1984, BIOCHEM J, V224, P799, DOI 10.1042/bj2240799	22	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7285	7289						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125942				2022-12-27	WOS:A1994NA03200041
J	HAWEL, L; TJANDRAWINATA, RR; FUKUMOTO, GH; BYUS, CV				HAWEL, L; TJANDRAWINATA, RR; FUKUMOTO, GH; BYUS, CV			BIOSYNTHESIS AND SELECTIVE EXPORT OF 1,5-DIAMINOPENTANE (CADAVERINE) IN MYCOPLASMA-FREE CULTURED-MAMMALIAN-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; SPERMINE N1-ACETYLTRANSFERASE ACTIVITY; ORNITHINE DECARBOXYLASE; ALPHA-DIFLUOROMETHYLORNITHINE; LIQUID-CHROMATOGRAPHY; POLYAMINE METABOLISM; HEPATOMA-CELLS; EXCRETION; GROWTH; ACCUMULATION	Macrophage-like RAW 264 and H35 hepatoma cells grown under serum-free conditions exported putrescine and an unidentified diamine into the culture medium. Unlike putrescine, the unknown compound could be detected only extracellularly. Analyses of dansylated polyamine standards and mass spectroscopy confirmed that the unknown compound was cadaverine (1,5-diaminopentane). The cells were free of mycoplasma as evidenced by a negative result using a probe specific for prokaryotic rRNA. After prophylactic treatments with two different mycoplasmacidal agents, the cells continued to export cadaverine. Attempts to ''infect'' a noncadaverine-exporting cell line with culture medium and cell-free lysates proved unsuccessful, establishing that cadaverine was in fact a bona fide product of these mammalian cells. Cadaverine export by RAW 264 and H35 cells was stimulated by lipopolysaccharide and insulin, respectively. However, administration of exogenous ornithine caused cadaverine export to decrease significantly with concomitant increases in putrescine export. alpha-Difluoromethylornithine, a selective inhibitor of ornithine decarboxylase, inhibited both cadaverine and putrescine export. When cells were labeled with [H-3]lysine, the great majority of the radioactivity recovered in exported polyamines was found in cadaverine. The cumulative data suggested that cadaverine formation may be caused by the action of intracellular ornithine decarboxylase upon lysine to produce cadaverine, which is then effluxed from the cell with a high degree of efficiency.	UNIV CALIF RIVERSIDE,DIV BIOMED SCI,RIVERSIDE,CA 92521; UNIV CALIF RIVERSIDE,DEPT BIOCHEM,RIVERSIDE,CA 92521	University of California System; University of California Riverside; University of California System; University of California Riverside			Tjandrawinata, Raymond R/F-1889-2013	Tjandrawinata, Raymond R/0000-0003-0461-9874	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006128] Funding Source: NIH RePORTER; NIEHS NIH HHS [ESO6128] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALHONENHONGISTO L, 1982, BIOCHEM J, V202, P267, DOI 10.1042/bj2020267; ALHONENHONGISTO L, 1982, BIOCHEM BIOPH RES CO, V106, P291, DOI 10.1016/0006-291X(82)91108-1; ALHONENHONGISTO L, 1987, BIOCHEM J, V247, P651, DOI 10.1042/bj2470651; BACHRACH U, 1985, CANCER RES, V45, P2159; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BYUS CV, 1991, J CELL PHYSIOL, V149, P9, DOI 10.1002/jcp.1041490103; DAVIS RH, 1989, ARCH BIOCHEM BIOPHYS, V271, P315, DOI 10.1016/0003-9861(89)90281-6; DAVIS RH, 1992, MICROBIOL REV, V56, P280, DOI 10.1128/MMBR.56.2.280-290.1992; FOTHERGILL JC, 1977, J GEN MICROBIOL, V99, P139, DOI 10.1099/00221287-99-1-139; GILBERT RS, 1991, ANAL BIOCHEM, V199, P86, DOI 10.1016/0003-2697(91)90273-V; GONZALEZ GG, 1991, CANCER RES, V51, P2932; HOLTTA E, 1983, BIOCHEM J, V210, P945; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; PEGG AE, 1988, CANCER RES, V48, P759; PEGG AE, 1979, BIOCHIM BIOPHYS ACTA, V568, P416, DOI 10.1016/0005-2744(79)90310-3; PEGG AE, 1990, BIOCHEM J, V267, P331, DOI 10.1042/bj2670331; PEGG AE, 1989, J BIOL CHEM, V264, P11744; PEGG AE, 1988, CANCER RES, V48, P2678; PEGG AE, 1988, ISI ATLAS-BIOCHEM, P11; PERSSON L, 1977, ACTA PHYSIOL SCAND, V100, P424, DOI 10.1111/j.1748-1716.1977.tb05966.x; POHJANPELTO P, 1985, J BIOL CHEM, V260, P8532; PORTER CW, 1991, CANCER RES, V51, P3715; Segel I.H., 1975, ENZYME KINETICS; TABOR CW, 1976, ANNU REV BIOCHEM, V45, P285, DOI 10.1146/annurev.bi.45.070176.001441; TAFFET SM, 1985, J CELL PHYSIOL, V122, P215, DOI 10.1002/jcp.1041220209; TAKIGAWA M, 1983, CANCER RES, V43, P3723; WALLACE HM, 1986, FEBS LETT, V194, P60, DOI 10.1016/0014-5793(86)80051-5; WEEKS CE, 1982, P NATL ACAD SCI-BIOL, V79, P6028, DOI 10.1073/pnas.79.19.6028; WU VS, 1984, BIOCHIM BIOPHYS ACTA, V804, P89, DOI 10.1016/0167-4889(84)90102-2	30	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7412	7418						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125959				2022-12-27	WOS:A1994NA03200060
J	MO, HQ; VANDAMME, EJM; PEUMANS, WJ; GOLDSTEIN, IJ				MO, HQ; VANDAMME, EJM; PEUMANS, WJ; GOLDSTEIN, IJ			ISOLATION AND CHARACTERIZATION OF AN N-ACETYL-D-GALACTOSAMINE-BINDING LECTIN FROM DUTCH IRIS BULBS WHICH RECOGNIZES THE BLOOD-GROUP-A DISACCHARIDE (GALNAC-ALPHA-1-3GAL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BANDEIRAEA-SIMPLICIFOLIA SEEDS; NIGRA L BARK; AFFINITY-CHROMATOGRAPHY; CARBOHYDRATE; PROTEINS; OLIGOSACCHARIDES; PURIFICATION	A blood group type A disaccharide (GalNAc alpha 1-3Gal)binding lectin has been purified from Dutch Iris (Iris x hollandica) bulbs to electrophoretic homogeneity by consecutive affinity chromatography on columns of immobilized asialofetuin-Sepharose 4B and Synsorb A disaccharide (GalNAc alpha 1-3Gal beta-O-(CH2)(8)CONH-Synsorb). This lectin agglutinates both native and trypsin-treated rabbit erythrocytes, but not human erythrocytes, irrespective of blood group type.	UNIV MICHIGAN, DEPT BIOL CHEM, ANN ARBOR, MI 48109 USA; KATHOLIEKE UNIV LEUVEN, FYTOPATHOL & PLANTENBESCHERMING LAB, B-3001 LOUVAIN, BELGIUM	University of Michigan System; University of Michigan; KU Leuven			Van Damme, Els/U-3904-2019; Van Damme, Els J/B-4410-2015	Van Damme, Els/0000-0001-9848-766X; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029470] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 29470] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN MH, 1992, J AM SOC MASS SPECTR, V3, P18, DOI 10.1016/1044-0305(92)85014-B; Andrews PC, 1992, TECHNIQUES PROTEIN C, VIII, P515; AXELSSON K, 1969, ACTA CHEM SCAND, V23, P1815, DOI 10.3891/acta.chem.scand.23-1815; BAKER DA, 1983, BIOCHEMISTRY-US, V22, P2741, DOI 10.1021/bi00280a023; CROWLEY JF, 1982, METHOD ENZYMOL, V83, P368; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; EDGE ASB, 1987, J BIOL CHEM, V262, P16135; FRIEDMAN M, 1970, J BIOL CHEM, V245, P3868; GOLDSTEIN IJ, 1980, NATURE, V285, P66, DOI 10.1038/285066b0; HAMMOND KS, 1976, ANAL BIOCHEM, V74, P292, DOI 10.1016/0003-2697(76)90210-4; HAYES CE, 1974, J BIOL CHEM, V249, P1904; IYER PNS, 1976, ARCH BIOCHEM BIOPHYS, V177, P330, DOI 10.1016/0003-9861(76)90444-6; KAKU H, 1990, ARCH BIOCHEM BIOPHYS, V277, P255, DOI 10.1016/0003-9861(90)90576-K; KOBATA A, 1992, J CHROMATOGR, V597, P111, DOI 10.1016/0021-9673(92)80101-Y; KONAMI Y, 1983, H-S Z PHYSIOL CHEM, V364, P397, DOI 10.1515/bchm2.1983.364.1.397; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIENER IE, 1986, LECTINS PROPERTRIES; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARCH SC, 1974, ANAL BIOCHEM, V60, P149, DOI 10.1016/0003-2697(74)90139-0; RINDERLE SJ, 1989, J BIOL CHEM, V264, P16123; ROBERTS DD, 1984, J BIOL CHEM, V259, P903; SHARON N, 1990, FASEB J, V4, P3198, DOI 10.1096/fasebj.4.14.2227211; SHIBATA S, 1982, J BIOL CHEM, V257, P9324; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; SO LL, 1967, J BIOL CHEM, V242, P1917; SUNDARI CS, 1991, BIOCHIM BIOPHYS ACTA, V1065, P35; TOLLEFSEN SE, 1983, J BIOL CHEM, V258, P5165; TOWNSEND RR, 1986, BIOCHEMISTRY-US, V25, P5716, DOI 10.1021/bi00367a055; WARREN L, 1959, J BIOL CHEM, V234, P1971; WU AM, 1992, J BIOL CHEM, V267, P19130; WU JH, 1993, MOL IMMUNOL, V30, P333, DOI 10.1016/0161-5890(93)90062-G; YAMASHITA K, 1992, BIOCHEMISTRY-US, V31, P11647, DOI 10.1021/bi00161a052; YAMASHITA K, 1992, J BIOL CHEM, V267, P25414	33	20	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7666	7673						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125993				2022-12-27	WOS:A1994NA03200099
J	MURDZAINGLIS, DL; MODRIANSKY, M; PATEL, HV; WOLDEGIORGIS, G; FREEMAN, KB; GARLID, KD				MURDZAINGLIS, DL; MODRIANSKY, M; PATEL, HV; WOLDEGIORGIS, G; FREEMAN, KB; GARLID, KD			SINGLE MUTATION IN UNCOUPLING PROTEIN OF RAT BROWN ADIPOSE-TISSUE MITOCHONDRIA ABOLISHES GDP SENSITIVITY OF H+ TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING-SITE; FATTY-ACID ACTIVATION; RECONSTITUTION; TRANSLOCATION; MECHANISM; SEQUENCE; CARRIER	The uncoupling protein is one of a family of mitochondrial transport proteins involved in energy metabolism. It dissipates oxidative energy to generate heat, either by catalyzing proton transport directly or by catalyzing fatty acid anion transport, thus enabling fatty acids to act as cycling protonophores. This transport process is tightly regulated by purine nucleotides. We have expressed uncoupling protein in yeast and examined its proton transport activity after its reconstitution into proteoliposomes. A directed change of Arg(276) to Leu or Gln completely abolished nucleotide inhibition of protonophoretic action of the reconstituted mutant uncoupling proteins without affecting the transport process. Arg(276) is the first residue of functional importance to be identified in uncoupling protein. Mutation of the homologous residue in the yeast ADP/ATP translocator prevented the growth of yeast on a nonfermentable carbon source, presumably by interfering with nucleotide exchange (Nelson, D. R., Lawson, J. E., Klingenberg, M., and Douglas, M. G. (1993) J. Mol. Biol. 230, 1159-1170). Demonstration of the essential role of a single homologous residue in protein-nucleotide interaction within these two transporters is the first direct evidence that uncoupling protein and the ADP/ATP translocator belong to the same gene family.	OREGON GRAD INST SCI & TECHNOL,DEPT CHEM BIOCHEM & MOLEC BIOL,PORTLAND,OR 97291; MCMASTER UNIV,DEPT BIOCHEM,HAMILTON L8N 3Z5,ON,CANADA	McMaster University			Modriansky, Martin/A-6338-2008	Modriansky, Martin/0000-0001-7692-0338; Garlid, Keith/0000-0002-6777-1235	NHLBI NIH HHS [HL 43814] Funding Source: Medline; NIGMS NIH HHS [GM 31086] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031086] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AQUILA H, 1987, FEBS LETT, V212, P1, DOI 10.1016/0014-5793(87)81546-6; CASTEILLA L, 1989, NUCLEIC ACIDS RES, V17, P2131, DOI 10.1093/nar/17.5.2131; CUNNINGHAM SA, 1986, EUR J BIOCHEM, V157, P415, DOI 10.1111/j.1432-1033.1986.tb09683.x; HIMMSHAGEN J, 1990, FASEB J, V4, P2890, DOI 10.1096/fasebj.4.11.2199286; JEZEK P, 1987, FEBS LETT, V211, P89, DOI 10.1016/0014-5793(87)81280-2; JEZEK P, 1990, J BIOL CHEM, V265, P19303; JEZEK P, 1990, J BIOL CHEM, V265, P19296; KAMP F, 1992, P NATL ACAD SCI USA, V89, P11367, DOI 10.1073/pnas.89.23.11367; KATIYAR SS, 1989, P NATL ACAD SCI USA, V86, P2559, DOI 10.1073/pnas.86.8.2559; KLINGENBERG M, 1985, EMBO J, V4, P3087, DOI 10.1002/j.1460-2075.1985.tb04049.x; KLINGENBERG M, 1990, TRENDS BIOCHEM SCI, V15, P108, DOI 10.1016/0968-0004(90)90194-G; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MAYINGER P, 1992, BIOCHEMISTRY-US, V31, P10536, DOI 10.1021/bi00158a017; MURDZAINGLIS DL, 1991, J BIOL CHEM, V266, P11871; MURDZAINGLIS DL, 1993, FASEB J, V7, pA1108; NEDERGAARD J, 1992, NEW COMPREHENSIVE BI, V23, P385; NELSON DR, 1993, J MOL BIOL, V230, P1159, DOI 10.1006/jmbi.1993.1233; OROSZ DE, 1993, ANAL BIOCHEM, V210, P7, DOI 10.1006/abio.1993.1143; RUNSWICK MJ, 1990, BIOCHEMISTRY-US, V29, P11033, DOI 10.1021/bi00502a004; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; STRIELEMAN PJ, 1985, J BIOL CHEM, V260, P3402; WINKLER E, 1992, EUR J BIOCHEM, V203, P295, DOI 10.1111/j.1432-1033.1992.tb19859.x	22	33	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7435	7438						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125963				2022-12-27	WOS:A1994NA03200064
J	TORDAI, A; FRANKLIN, RA; PATEL, H; GARDNER, AM; JOHNSON, GL; GELFAND, EW				TORDAI, A; FRANKLIN, RA; PATEL, H; GARDNER, AM; JOHNSON, GL; GELFAND, EW			CROSS-LINKING OF SURFACE IGM STIMULATES THE RAS/RAF-1/MEK/MAPK CASCADE IN HUMAN B-LYMPHOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; MAP KINASE; TYROSINE PHOSPHORYLATION; MEMBRANE IMMUNOGLOBULIN; ANTIGEN RECEPTOR; CELL ACTIVATION; EXPRESSION; S6; IDENTIFICATION; PROLIFERATION	The mechanism by which mitogen-activated protein kinase (MAPK) is activated in human B cells following cross-linking of the antigen receptor was investigated. Following anti-IgM antibody and phorbol 12-myristate 13-acetate (PMA) stimulation, we demonstrate the activation of Res, Raf-1, and MAPK/ERK kinase (MEK), all of which are thought to participate in an important signaling cascade that leads to MAPK activation. We detected the kinase activities of Raf-1 and MEK toward purified recombinant substrates for each in this pathway (MEK for Raf-1 and MAPK for MEK). Following stimulation with either anti-IgM or PMA, Ras activation was observed, and the ability of Raf-1 to phosphorylate recombinant kinase-inactive MEK was increased by approximately 10-fold. Similarly, MEK activity toward kinase-active or -inactive recombinant MAPK also increased upon anti-IgM or PMA treatment. Furthermore, the activation of both MAPK and p(90rsk) was demonstrated under identical conditions in the B cells. We conclude that activation of B lymphocytes through the antigen receptor stimulates distinct members of the Ras/Raf-1/MEK cascade and this mechanism is likely to be responsible for MAPK and p(90rsk) activation in these cells.	NATL JEWISH CTR IMMUNOL & RESP MED,DEPT PEDIAT,DIV BASIC SCI,DENVER,CO 80206	National Jewish Health				Franklin, Richard A./0000-0003-0299-9578; Gardner, Anne/0000-0001-7095-772X	NIAID NIH HHS [R01-AI29704, P01-AI29903] Funding Source: Medline; NIDDK NIH HHS [DK37871] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI029903, R01AI029704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037871] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; ALCORTA DA, 1989, MOL CELL BIOL, V9, P3850, DOI 10.1128/MCB.9.9.3850; ALVEREZ E, 1991, J BIOL CHEM, V266, P15277; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BIJSTERBOSCH MK, 1985, CELL, V41, P999, DOI 10.1016/S0092-8674(85)80080-5; BRUNSWICK M, 1991, P NATL ACAD SCI USA, V88, P1311, DOI 10.1073/pnas.88.4.1311; CAMBIER JC, 1992, FASEB J, V6, P3207, DOI 10.1096/fasebj.6.13.1397843; CASILLAS A, 1991, J BIOL CHEM, V266, P19088; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; CHEN RH, 1990, MOL CELL BIOL, V10, P3204, DOI 10.1128/MCB.10.6.3204; CHEUNG RK, 1991, J BIOL CHEM, V266, P8667; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DEVRIESSMITS AMM, 1992, NATURE, V357, P602, DOI 10.1038/357602a0; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; FRANKLIN RA, 1993, J IMMUNOL, V151, P1802; GARDNER AM, 1993, J BIOL CHEM, V268, P17896; GARDNER AM, 1994, IN PRESS METHODS ENZ; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GLENNEY JR, 1992, BIOCHIM BIOPHYS ACTA, V1134, P113, DOI 10.1016/0167-4889(92)90034-9; GOLD MR, 1991, P NATL ACAD SCI USA, V88, P3436, DOI 10.1073/pnas.88.8.3436; GOLD MR, 1990, NATURE, V345, P810, DOI 10.1038/345810a0; GOLD MR, 1992, BIOCHEM J, V287, P269, DOI 10.1042/bj2870269; HAYCOCK JW, 1992, P NATL ACAD SCI USA, V89, P2365, DOI 10.1073/pnas.89.6.2365; JELINEK DF, 1987, ADV IMMUNOL, V40, P1, DOI 10.1016/S0065-2776(08)60237-0; KLEMSZ MJ, 1989, J IMMUNOL, V143, P1032; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; MARX J, 1993, SCIENCE, V260, P1588, DOI 10.1126/science.8503004; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PELECH SL, 1992, SCIENCE, V257, P1355, DOI 10.1126/science.1382311; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; RETH M, 1991, IMMUNOL TODAY, V12, P196, DOI 10.1016/0167-5699(91)90053-V; ROIFMAN CM, 1992, BIOCHEM BIOPH RES CO, V183, P411, DOI 10.1016/0006-291X(92)90496-8; ROIFMAN CM, 1991, J IMMUNOL, V146, P2965; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; SEGER R, 1992, J BIOL CHEM, V267, P14373; SEYFERT VL, 1989, MOL CELL BIOL, V9, P2083, DOI 10.1128/MCB.9.5.2083; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; TERADA N, 1993, J BIOL CHEM, V268, P12062; THOMAS G, 1992, CELL, V68, P3, DOI 10.1016/0092-8674(92)90199-M; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C	46	80	80	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 11	1994	269	10					7538	7543						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NA032	8125975				2022-12-27	WOS:A1994NA03200080
J	BRADFUTE, DL; SIMONI, RD				BRADFUTE, DL; SIMONI, RD			NONSTEROL COMPOUNDS THAT REGULATE CHOLESTEROGENESIS - ANALOGS OF FARNESYL PYROPHOSPHATE REDUCE 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE LEVELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A REDUCTASE; MEVALONATE-DERIVED PRODUCT; HAMSTER OVARY CELLS; HMG COA REDUCTASE; ENDOPLASMIC-RETICULUM; MEMBRANE DOMAIN; MESSENGER-RNA; DEGRADATION; SQUALENE; ENZYME	Farnesyl acetate and ethyl farnesyl ether, two analogues of farnesyl pyrophosphate, stimulate post-transcriptional down-regulation of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme in the biosynthesis of cholesterol and isoprenoids. Farnesyl acetate and ethyl farnesyl ether reduce translation of HMG-CoA reductase mRNA and enhance degradation of the enzyme, the same regulatory effects attributed to the putative non-sterol regulatory metabolite (Goldstein, J. L., and frown, M. S. (1990) Nature 343, 425-430). HMGal, a fusion protein consisting of the membrane domain of HMG-CoA reductase linked to Escherichia coli beta-galactosidase, is subject to the same regulated degradation as HMG-CoA reductase (Skalnik, D. G., Narita, H., Kent, C,, and Simoni, R. D. (1988) J. Biol. Chem. 263, 6836-6841). At 10 mu g/ml (37.8 mu M), farnesyl acetate and ethyl farnesyl ether trigger a 50-80% reduction in HMGal activity. Farnesyl acetate reduces the synthesis of HMG-CoA reductase and HMGal by 60-80%, but neither farnesyl compound affects HMG-CoA reductase mRNA levels. Farnesyl acetate and ethyl farnesyl ether stimulated the degradation of HMG-CoA reductase and HMGal, reducing the half-lives of the enzymes by 40-70%. In addition to their regulatory ef fects on HMG-CoA reductase, these farnesyl compounds also directly disrupt sterol synthesis.	STANFORD UNIV,DEPT BIOL SCI,STANFORD,CA 94305	Stanford University					NHLBI NIH HHS [HL26502] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026502] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERTOLINO A, 1978, BIOCHIM BIOPHYS ACTA, V530, P17, DOI 10.1016/0005-2760(78)90122-4; BILLER SA, 1988, J MED CHEM, V31, P1869, DOI 10.1021/jm00118a001; BRADFUTE DL, 1992, J BIOL CHEM, V267, P18308; BROWN MS, 1980, J LIPID RES, V21, P505; BROWN PC, 1983, MOL CELL BIOL, V3, P1097, DOI 10.1128/MCB.3.6.1097; CHIN DJ, 1985, MOL CELL BIOL, V5, P634, DOI 10.1128/MCB.5.4.634; CHUN KT, 1990, J BIOL CHEM, V265, P22004; CHUN KT, 1992, J BIOL CHEM, V267, P4236; COREY EJ, 1976, J AM CHEM SOC, V98, P1291, DOI 10.1021/ja00421a056; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DEMONTELLANO PRO, 1977, BIOCHEMISTRY-US, V16, P2680; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; HARDEMAN EC, 1983, P NATL ACAD SCI-BIOL, V80, P1516, DOI 10.1073/pnas.80.6.1516; INOUE S, 1991, J BIOL CHEM, V266, P13311; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NAKANISHI M, 1988, J BIOL CHEM, V263, P8929; OLENDER EH, 1992, J BIOL CHEM, V267, P4223; PANINI SR, 1989, J BIOL CHEM, V264, P11044; PARKER RA, 1993, J BIOL CHEM, V268, P11230; PEARCE BC, 1992, J MED CHEM, V35, P3595, DOI 10.1021/jm00098a002; PEFFLEY D, 1985, J BIOL CHEM, V260, P9949; ROITELMAN J, 1992, J BIOL CHEM, V267, P25264; ROITELMAN J, 1991, J BIOL CHEM, V266, P16085; ROTHBLAT GH, 1976, IN VITRO CELL DEV B, V12, P554; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; SHARMA RC, 1993, BIOTECHNIQUES, V14, P176; SIMENSKY M, 1982, J BIOL CHEM, V257, P7284; SKALNIK DG, 1988, J BIOL CHEM, V263, P6836	29	96	97	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6645	6650						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120018				2022-12-27	WOS:A1994MZ50300061
J	HAYASHI, JI; OHTA, S; KAGAWA, Y; KONDO, H; KANEDA, H; YONEKAWA, H; TAKAI, D; MIYABAYASHI, S				HAYASHI, JI; OHTA, S; KAGAWA, Y; KONDO, H; KANEDA, H; YONEKAWA, H; TAKAI, D; MIYABAYASHI, S			NUCLEAR BUT NOT MITOCHONDRIAL GENOME INVOLVEMENT IN HUMAN AGE-RELATED MITOCHONDRIAL DYSFUNCTION - FUNCTIONAL INTEGRITY OF MITOCHONDRIAL-DNA FROM AGED SUBJECTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STROKE-LIKE EPISODES; NORMAL HUMAN-CELLS; PROTEIN-SYNTHESIS; HUMAN FIBROBLAST; LACTIC-ACIDOSIS; HUMAN-TISSUES; HUMAN BRAIN; HELA-CELLS; MUTATION; DELETION	The role of mtDNA and nuclear genome in human aging was examined by their intercellular transfer using skin fibroblasts and mtDNA-less HeLa cells (rho(0)-HeLa cells). We found in vivo age-related reductions in the activity of cytochrome c oxidase in human skin fibroblasts obtained from 16 donors of various ages (0-97 years). The abnormality in mitochondria of the aged donors was not attributable to either decrease in the copy number of mtDNA molecules or increase in the copy number of deletion mutant mtDNA molecules, but to significant decrease in overall polypeptide synthesis in the mitochondria. However, intercellular mtDNA transfer experiments showed that fibroblast mtDNA from elderly donors is functionally intact. By contrast, intercellular transfer of HeLa nuclei to fibroblasts from aged donors restored cytochrome c oxidase activity, suggesting that the age related phenotype was nuclear recessive. However, during subsequent cultivation of these hybrids, the activity gradually reduced again, associated with gradual chromosome loss. These observations support the idea that accumulation of nuclear recessive somatic mutations, but not mtDNA mutations, is responsible for the in vivo age-related mitochondrial dysfunction observed in human skin fibroblasts.	SAITAMA CANC CTR,RES INST,DEPT BIOCHEM,INA,SAITAMA 362,JAPAN; JICHI MED SCH,DEPT BIOCHEM,MINAMI KAWACHI,TOCHIGI 32904,JAPAN; TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT BIOL,TOKYO,TOKYO 103,JAPAN; TOKYO METROPOLITAN INST MED SCI,DEPT LAB ANIM SCI,TOKYO,TOKYO 113,JAPAN; TOHOKU UNIV,SCH MED,DEPT PEDIAT,SENDAI,MIYAGI 980,JAPAN	Jichi Medical University; Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Medical Science; Tohoku University	HAYASHI, JI (corresponding author), UNIV TSUKUBA,INST BIOL SCI,TSUKUBA,IBARAKI 305,JAPAN.							ALLEN JA, 1980, NATURE, V287, P244, DOI 10.1038/287244a0; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; ATTARDI G, 1991, PROG NEUROPATH, V7, P75; BACKER JM, 1980, SCIENCE, V209, P297, DOI 10.1126/science.6770466; BODENTEICH A, 1991, GENE, V108, P305, DOI 10.1016/0378-1119(91)90451-G; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x; GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H; GOLDSTEIN S, 1982, J CELL PHYSIOL, V112, P419, DOI 10.1002/jcp.1041120316; GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114; HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V179, P1023, DOI 10.1016/0006-291X(91)91921-X; HAYASHI JI, 1986, CANCER RES, V46, P4001; HAYASHI JI, 1989, CANCER RES, V49, P4715; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; HAYASHI JI, 1991, PROG NEUROPATH, V7, P93; HAYASHI JI, 1992, SOMAT CELL MOLEC GEN, V18, P123, DOI 10.1007/BF01233159; HAYASHI JI, 1987, EXP CELL RES, V172, P218, DOI 10.1016/0014-4827(87)90108-X; HAYASHI JI, 1984, CANCER RES, V44, P3957; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590; LINNANE AW, 1992, MUTAT RES, V275, P195, DOI 10.1016/0921-8734(92)90023-I; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; MARIOTTINI P, 1986, P NATL ACAD SCI USA, V83, P1563, DOI 10.1073/pnas.83.6.1563; MIQUEL J, 1991, ARCH GERONTOL GERIAT, V12, P99, DOI 10.1016/0167-4943(91)90022-I; MITA S, 1988, CANCER RES, V48, P4578; MIYABAYASHI S, 1984, BRAIN DEV-JPN, V6, P362, DOI 10.1016/S0387-7604(84)80112-6; MONNAT RJ, 1986, GENE, V43, P205, DOI 10.1016/0378-1119(86)90208-8; MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895; MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9; MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167; MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H; NIRANJAN BG, 1982, SCIENCE, V215, P73, DOI 10.1126/science.6797067; PEREIRASMITH OM, 1988, P NATL ACAD SCI USA, V85, P6042, DOI 10.1073/pnas.85.16.6042; REIS RJS, 1983, J BIOL CHEM, V258, P9078; ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; SHAY JW, 1987, MUTAT RES, V186, P149, DOI 10.1016/0165-1110(87)90028-5; SOONG NW, 1992, NAT GENET, V2, P318; SUGIYAMA S, 1991, BIOCHEM BIOPH RES CO, V180, P894, DOI 10.1016/S0006-291X(05)81149-0; SUN AS, 1975, ARCH BIOCHEM BIOPHYS, V170, P1, DOI 10.1016/0003-9861(75)90092-2; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E; YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0; ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7	58	111	115	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6878	6883						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120050				2022-12-27	WOS:A1994MZ50300096
J	KRIEF, S; FEVE, B; BAUDE, B; ZILBERFARB, V; STROSBERG, AD; PAIRAULT, J; EMORINE, LJ				KRIEF, S; FEVE, B; BAUDE, B; ZILBERFARB, V; STROSBERG, AD; PAIRAULT, J; EMORINE, LJ			TRANSCRIPTIONAL MODULATION BY N-BUTYRIC ACID OF BETA-1-ADRENERGIC, BETA-2-ADRENERGIC, AND BETA-3-ADRENERGIC RECEPTOR BALANCE IN 3T3-P442A ADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOLATILE FATTY-ACIDS; CANCER CELL-LINES; SODIUM-BUTYRATE; 3T3-F442A ADIPOCYTES; HELA-CELLS; ADRENERGIC RECEPTORS; MOLECULAR-CLONING; GENE-EXPRESSION; MESSENGER-RNA; 3T3-L1 PREADIPOCYTES	3T3-F442A adipocytes, which express major beta 3-adrenergic receptors (beta 3-AR) (90%) and minor beta 1-AR (<10%) and beta 2-AR (<1%) populations, were used to investigate regulation by n-butyric acid of beta-AR subtype expression. Following butyrate treatment, EC(50), values of beta 1- and beta 2-selective agonists, dobutamine and fenoterol, were decreased, whereas that of the beta 3-selective agonist BRL37344 was increased. Direct binding and competition of (-)-[I-125]iodocyanopindolol binding by selective beta 1- and beta 2-AR antagonists, CGP20712A and ICI118551, and by the beta 3-AR agonist, BRL37344, revealed that both beta 1- and beta 2-AR were increased in butyrate-treated adipocytes, whereas beta 3-AR almost totally disappeared. In control adipocytes, beta 1-, beta 2-, and beta 3-AR transcripts (quantitated by a polymerase chain reaction assay) represented 6.5, 0.5, and 93% of total beta-AR mRNA, respectively. In butyrate exposed cells, proportions of beta-AR proteins and mRNAs were, respectively, 87 and 94% for beta 1 and 9 and 1% for beta 2-AR. beta 3-ARs were barely detectable in binding assays and accounted for 4.5% of beta-AR transcripts. Variations of beta-AR protein and mRNA levels were accompanied by parallel changes in the transcription rates of the corresponding genes. The differential regulation of the three beta-ARs by n-butyric acid, a dietary factor produced from colonic fermentation, may have significant nutritional and energetic consequences.	CNRS,UNITE PROPRE RECH 0415,F-75014 PARIS,FRANCE; UNIV PARIS 07,INST COCHIN GENET MOLEC,F-75014 PARIS,FRANCE; HOP HENRI MONDOR,INSERM,U282,F-94010 CRETEIL,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)				Feve, Bruno/0000-0001-6577-9009; Krief, Stephane/0000-0002-5543-731X				ANDREWS GK, 1987, NUCLEIC ACIDS RES, V15, P5461, DOI 10.1093/nar/15.13.5461; ANTRAS J, 1991, J BIOL CHEM, V266, P1157; ANTRAS J, 1991, MOL CELL ENDOCRINOL, V82, P183, DOI 10.1016/0303-7207(91)90030-V; BECKERANDRE M, 1989, NUCLEIC ACIDS RES, V17, P9437, DOI 10.1093/nar/17.22.9437; BOFFA LC, 1981, J BIOL CHEM, V256, P9612; BOHAN CA, 1989, VIROLOGY, V172, P573, DOI 10.1016/0042-6822(89)90200-6; BRESNICK EH, 1990, P NATL ACAD SCI USA, V87, P3977, DOI 10.1073/pnas.87.10.3977; BRONNIKOV G, 1992, J BIOL CHEM, V267, P2006; CHAMPIGNY O, 1991, P NATL ACAD SCI USA, V88, P10774, DOI 10.1073/pnas.88.23.10774; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; DANKERT J, 1981, CLIN CHIM ACTA, V110, P301, DOI 10.1016/0009-8981(81)90359-4; DEFAZIO A, 1992, J BIOL CHEM, V267, P18008; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; EMORINE LJ, 1991, BIOCHEM PHARMACOL, V41, P853, DOI 10.1016/0006-2952(91)90188-B; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; FEVE B, 1991, J BIOL CHEM, V266, P20329; FEVE B, 1990, J BIOL CHEM, V265, P16343; FEVE B, 1992, J BIOL CHEM, V267, P15909; GILL RK, 1993, P NATL ACAD SCI USA, V90, P2984, DOI 10.1073/pnas.90.7.2984; GRAHAM KA, 1988, J CELL PHYSIOL, V136, P63, DOI 10.1002/jcp.1041360108; GRANNEMAN JG, 1991, MOL PHARMACOL, V40, P895; HENNEBERRY RC, 1977, NATURE, V268, P252, DOI 10.1038/268252a0; HOFSTEE BHJ, 1952, SCIENCE, V116, P329, DOI 10.1126/science.116.3013.329; KASSIS S, 1984, J BIOL CHEM, V259, P4910; KRIEF S, 1993, J CLIN INVEST, V91, P344, DOI 10.1172/JCI116191; LAI E, 1982, J BIOL CHEM, V257, P6691; LEVITT MD, 1968, ANN NY ACAD SCI, V150, P75, DOI 10.1111/j.1749-6632.1968.tb19033.x; LEVYWILSON B, 1981, P NATL ACAD SCI-BIOL, V78, P2189, DOI 10.1073/pnas.78.4.2189; LIN MC, 1979, J BIOL CHEM, V254, P4684; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MUZZIN P, 1991, J BIOL CHEM, V266, P24053; NAHMIAS C, 1991, EMBO J, V10, P3721, DOI 10.1002/j.1460-2075.1991.tb04940.x; NAMBI P, 1986, BIOCHEM PHARMACOL, V35, P3813, DOI 10.1016/0006-2952(86)90669-6; ORMANDY CJ, 1992, ENDOCRINOLOGY, V131, P982, DOI 10.1210/en.131.2.982; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; REHNMARK S, 1990, J BIOL CHEM, V265, P16464; REMESY C, 1976, Annales de Recherches Veterinaires, V7, P39; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; SAMUELS HH, 1980, J BIOL CHEM, V255, P2499; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P650; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; STADEL JM, 1987, EUR J PHARMACOL, V143, P35, DOI 10.1016/0014-2999(87)90732-1; STORER GB, 1983, NUTR RES, V3, P519, DOI 10.1016/S0271-5317(83)80013-X; TALLMAN JF, 1977, P NATL ACAD SCI USA, V74, P873, DOI 10.1073/pnas.74.3.873; THOMAS RF, 1992, P NATL ACAD SCI USA, V89, P4490, DOI 10.1073/pnas.89.10.4490; TOSCANI A, 1990, J BIOL CHEM, V265, P5722; TOSCANI A, 1988, ONCOGENE RES, V3, P233; VANSPRONSEN A, 1993, EUR J BIOCHEM, V213, P1117, DOI 10.1111/j.1432-1033.1993.tb17861.x; VIDALI G, 1978, P NATL ACAD SCI USA, V75, P2239, DOI 10.1073/pnas.75.5.2239	52	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 4	1994	269	9					6664	6670						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MZ503	8120022				2022-12-27	WOS:A1994MZ50300065
